<SEC-DOCUMENT>0001585364-20-000096.txt : 20201105
<SEC-HEADER>0001585364-20-000096.hdr.sgml : 20201105
<ACCEPTANCE-DATETIME>20201105081705
ACCESSION NUMBER:		0001585364-20-000096
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		104
CONFORMED PERIOD OF REPORT:	20200926
FILED AS OF DATE:		20201105
DATE AS OF CHANGE:		20201105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PERRIGO Co plc
		CENTRAL INDEX KEY:			0001585364
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36353
		FILM NUMBER:		201288815

	BUSINESS ADDRESS:	
		STREET 1:		THE SHARP BUILDING
		STREET 2:		HOGAN PLACE
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 TY74
		BUSINESS PHONE:		269-673-8451

	MAIL ADDRESS:	
		STREET 1:		515 EASTERN AVENUE
		CITY:			ALLEGAN
		STATE:			MI
		ZIP:			49010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PERRIGO Co Ltd
		DATE OF NAME CHANGE:	20130828
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cy20q310q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:c1fb51d2cb29412789db05a37ed924ac,x:242fc186a05243ca9351838aca19185f-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:sheci="http://fasb.org/stm/sheci/2020-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2020-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2020-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2020-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2020-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2020-01-31" xmlns:equity="http://fasb.org/dis/equity/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:ides="http://fasb.org/dis/ides/2020-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2020-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2020-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2020-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2020-01-31" xmlns:ei="http://fasb.org/dis/ei/2020-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2020-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2020-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2020-01-31" xmlns:srt-all="http://fasb.org/srt-all/2020-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2020-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2020-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2020-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2020-01-31" xmlns:se="http://fasb.org/dis/se/2020-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2020-01-31" xmlns:hco="http://fasb.org/dis/hco/2020-01-31" xmlns:soi="http://fasb.org/stm/soi/2020-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2020-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:debt="http://fasb.org/dis/debt/2020-01-31" xmlns:spc="http://fasb.org/stm/spc/2020-01-31" xmlns:ts="http://fasb.org/dis/ts/2020-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:rd="http://fasb.org/dis/rd/2020-01-31" xmlns:sr="http://fasb.org/dis/sr/2020-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2020-01-31" xmlns:guar="http://fasb.org/dis/guar/2020-01-31" xmlns:te="http://fasb.org/dis/te/2020-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:ni="http://fasb.org/dis/ni/2020-01-31" xmlns:dr="http://fasb.org/dis/dr/2020-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2020-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2020-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2020-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2020-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2020-01-31" xmlns:iago="http://fasb.org/dis/iago/2020-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2020-01-31" xmlns:con="http://fasb.org/dis/con/2020-01-31" xmlns:leas="http://fasb.org/dis/leas/2020-01-31" xmlns:com="http://fasb.org/stm/com/2020-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2020-01-31" xmlns:inv="http://fasb.org/dis/inv/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2020-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2020-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2020-01-31" xmlns:oi="http://fasb.org/dis/oi/2020-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2020-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2020-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:cn-part="http://fasb.org/cn-part/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2020-01-31" xmlns:srt-std="http://fasb.org/srt-std/2020-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2020-01-31" xmlns:re="http://fasb.org/dis/re/2020-01-31" xmlns:ir="http://fasb.org/dis/ir/2020-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2020-01-31" xmlns:soc="http://fasb.org/stm/soc/2020-01-31" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2020-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2020-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2020-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2020-01-31" xmlns:regop="http://fasb.org/dis/regop/2020-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2020-01-31" xmlns:ero="http://fasb.org/dis/ero/2020-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2020-01-31" xmlns:prgo="http://www.perrigo.com/20200926" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2020-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:invco="http://fasb.org/dis/invco/2020-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2020-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2020-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2020-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2020-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2020-01-31" xmlns:aro="http://fasb.org/dis/aro/2020-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2020-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2020-01-31" xmlns:pay="http://fasb.org/dis/pay/2020-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2020-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2020-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2020-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2020-01-31" xmlns:eps="http://fasb.org/dis/eps/2020-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2020-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2020-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:crcrb="http://fasb.org/dis/crcrb/2020-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2020-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2020-01-31" xmlns:lea="http://fasb.org/dis/lea/2020-01-31" xmlns:disops="http://fasb.org/dis/disops/2020-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2020-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2020-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2020-01-31" xmlns:nt="http://fasb.org/dis/nt/2020-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2020-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2020-01-31" xmlns:cce="http://fasb.org/dis/cce/2020-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2020-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2020-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2020-01-31" xmlns:acec="http://fasb.org/dis/acec/2020-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2020-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2020-01-31" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2020-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2020-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2020-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2020-01-31" xmlns:ru="http://fasb.org/dis/ru/2020-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2020-01-31" xmlns:foct="http://fasb.org/dis/foct/2020-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2020-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2020-01-31" xmlns:diha="http://fasb.org/dis/diha/2020-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ap="http://fasb.org/dis/ap/2020-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:eui="http://fasb.org/dis/eui/2020-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:AmendmentFlag" id="Fact-080589869AA4523694C24D6A1EB18D76-wk-Fact-080589869AA4523694C24D6A1EB18D76" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:CurrentFiscalYearEndDate" id="Fact-F52CC22CAFC6541AA5C1BC499C360BE5-wk-Fact-F52CC22CAFC6541AA5C1BC499C360BE5">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:DocumentFiscalPeriodFocus" id="Fact-B7C367A42A2A5681BDE85D8E403B1477-wk-Fact-B7C367A42A2A5681BDE85D8E403B1477">Q3</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:DocumentFiscalYearFocus" id="Fact-00A6A27193FD569BBECC43F49FA92970-wk-Fact-00A6A27193FD569BBECC43F49FA92970">2020</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:EntityCentralIndexKey" id="Fact-3A8649AF84BD555DBCD52F9D8D4B0802-wk-Fact-3A8649AF84BD555DBCD52F9D8D4B0802">0001585364</ix:nonNumeric><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2019Q4YTD" name="prgo:FairValueAssetsLevel1Level2Level3TransfersAmount" id="Fact-69F1A902B6EB506097CEC8105F4743DF-wk-Fact-69F1A902B6EB506097CEC8105F4743DF">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2020Q3QTD" name="prgo:FairValueAssetsLevel1Level2Level3TransfersAmount" id="Fact-70398BB5BF9D54E1B51D7CE2C36D44B5-wk-Fact-70398BB5BF9D54E1B51D7CE2C36D44B5">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FD2019Q1QTD" name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact-1BC5D98B000A53BAB30A669FF3779455-wk-Fact-1BC5D98B000A53BAB30A669FF3779455">0.19</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FD2019Q2QTD" name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact-AE29932A8FD55F6F97EC72EBA6B87E67-wk-Fact-AE29932A8FD55F6F97EC72EBA6B87E67">0.21</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FD2019Q3QTD" name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact-BB7BFAC6451229877EBEC23AD3C4292A-wk-Fact-BB7BFAC6451229877EBEC23AD3C4292A">0.21</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FD2020Q1QTD" name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact-BEFBB065E2235886BF32D3FC32A6D007-wk-Fact-BEFBB065E2235886BF32D3FC32A6D007">0.23</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FD2020Q2QTD" name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact-87AB193135CC5AA8BF7E1F46FB5F2D6F-wk-Fact-87AB193135CC5AA8BF7E1F46FB5F2D6F">0.23</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FD2020Q3QTD" name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact-4AD8C02FC9D31266C63CC23AD304215A-wk-Fact-4AD8C02FC9D31266C63CC23AD304215A">0.23</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="EUR_PER_shares" contextRef="FI2019Q4" name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact-36FF158B285751FDBBA35BFED8EDF509-wk-Fact-36FF158B285751FDBBA35BFED8EDF509">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="EUR_PER_shares" contextRef="FI2020Q3" name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact-5561F050463B50EB8963E7AC68F57744-wk-Fact-5561F050463B50EB8963E7AC68F57744">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-C5D6331F141C590C9481D4188B0F3AF8-wk-Fact-C5D6331F141C590C9481D4188B0F3AF8">10000000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2020Q3" name="us-gaap:CommonStockSharesAuthorized" id="Fact-41C5F3DB27985BB09E029C7C7D98D774-wk-Fact-41C5F3DB27985BB09E029C7C7D98D774">10000000000</ix:nonFraction><ix:nonNumeric contextRef="FI2020Q3" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Fact-7F6ACDB680D5575C828B63660769F7D4-wk-Fact-7F6ACDB680D5575C828B63660769F7D4">us-gaap:DebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="FI2020Q3" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="Fact-D12C984E2926521EB58CC5F84FF5302F-wk-Fact-D12C984E2926521EB58CC5F84FF5302F">us-gaap:LongtermDebtNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="FI2020Q3" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Fact-E85449064D685A11A629FCBF8473E3CA-wk-Fact-E85449064D685A11A629FCBF8473E3CA">us-gaap:OtherNoncurrentAssets</ix:nonNumeric><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" id="Fact-C38866AB76F55F639DB0CB5920AA88AA-wk-Fact-C38866AB76F55F639DB0CB5920AA88AA">868400000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usd" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember" name="us-gaap:LineOfCredit" id="Fact-95BE3103A6095233A6D5CFB41CD8AF32-wk-Fact-95BE3103A6095233A6D5CFB41CD8AF32">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="case" contextRef="FD2018Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember" name="us-gaap:LossContingencyClaimsDismissedNumber" id="Fact-10A4623254485662BBCF1F72D511E284-wk-Fact-10A4623254485662BBCF1F72D511E284">1</ix:nonFraction><ix:nonNumeric contextRef="FI2020Q3" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Fact-E21D998F4F345CA1B04090D1D5405947-wk-Fact-E21D998F4F345CA1B04090D1D5405947">us-gaap:OtherCurrentLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="FI2020Q3" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="Fact-EF1A4F985B4355C8ADD8D2BE74CA2789-wk-Fact-EF1A4F985B4355C8ADD8D2BE74CA2789">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2019Q4" name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact-E50ED4A92D1C518FBC448851806CD181-wk-Fact-E50ED4A92D1C518FBC448851806CD181">0.0001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2020Q3" name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact-E5E7F435D0A6551A8D86B8D48872B0BE-wk-Fact-E5E7F435D0A6551A8D86B8D48872B0BE">0.0001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-D3818411758F5BF7B0B7403E2ED87EDF-wk-Fact-D3818411758F5BF7B0B7403E2ED87EDF">10000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2020Q3" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-7183F9DE039652CF96B33D3EC27D6A04-wk-Fact-7183F9DE039652CF96B33D3EC27D6A04">10000000</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FD2019Q3QTD" name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact-297D872A7AF7549EBE87C23B32F1EE6F-wk-Fact-297D872A7AF7549EBE87C23B32F1EE6F">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FD2019Q3YTD" name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact-180A933B76D3555598DC0D1DC25BBFF1-wk-Fact-180A933B76D3555598DC0D1DC25BBFF1">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FD2020Q3QTD" name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact-50CD09433BF05683836AC666AA95ED8B-wk-Fact-50CD09433BF05683836AC666AA95ED8B">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FD2020Q3YTD" name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact-75EB8D316FF858B7A25C9B228BAEB451-wk-Fact-75EB8D316FF858B7A25C9B228BAEB451">0</ix:nonFraction><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="Fact-7D52EBE017A655778785E719D7A559F4-wk-Fact-7D52EBE017A655778785E719D7A559F4">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:TypeOfRevenueExtensibleList" id="Fact-B86F185E22895AFA8B10AD27E84E64D5-wk-Fact-B86F185E22895AFA8B10AD27E84E64D5">us-gaap:ProductMember</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="prgo-20200926.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="FD2020Q3YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q4Oct30">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-03-29</xbrli:startDate>
			<xbrli:endDate>2020-06-27</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-03-29</xbrli:startDate>
			<xbrli:endDate>2020-06-27</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-03-29</xbrli:startDate>
			<xbrli:endDate>2020-06-27</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-03-29</xbrli:startDate>
			<xbrli:endDate>2020-06-27</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-03-31</xbrli:startDate>
			<xbrli:endDate>2019-06-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-03-31</xbrli:startDate>
			<xbrli:endDate>2019-06-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-03-31</xbrli:startDate>
			<xbrli:endDate>2019-06-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-03-31</xbrli:startDate>
			<xbrli:endDate>2019-06-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_StatementGeographicalAxis_country_IE">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_StatementGeographicalAxis_country_IE">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_StatementGeographicalAxis_country_IE">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_StatementGeographicalAxis_country_IE">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionandLicenseAgreementsandSupplyAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-08-07</xbrli:startDate>
			<xbrli:endDate>2020-08-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Jul2_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:GenericProductAcquisitionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-02</xbrli:startDate>
			<xbrli:endDate>2019-07-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4Oct30_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-10-30</xbrli:startDate>
			<xbrli:endDate>2020-10-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-03</xbrli:startDate>
			<xbrli:endDate>2020-01-03</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Jul1_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q2May17_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:GenericProductAcquisitionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-05-17</xbrli:startDate>
			<xbrli:endDate>2019-05-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Jul1_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RosemontPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:CSCIMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-19</xbrli:startDate>
			<xbrli:endDate>2020-06-19</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Jul8_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-08</xbrli:startDate>
			<xbrli:endDate>2019-07-08</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4April1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-01</xbrli:startDate>
			<xbrli:endDate>2020-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:BudesonideNasalSprayandTriamcinoloneNasalSprayMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1Feb13_us-gaap_BusinessAcquisitionAxis_prgo_DexsilMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:DexsilMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-02-13</xbrli:startDate>
			<xbrli:endDate>2020-02-13</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-03</xbrli:startDate>
			<xbrli:endDate>2020-01-03</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_ReportingUnitAxis_prgo_BCSMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">prgo:BCSMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_EvamistBrandedProductMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:EvamistBrandedProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:GenericProductAcquisitionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_ReportingUnitAxis_prgo_BCSMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">prgo:BCSMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_prgo_MeasurementInputProjectedRoyaltiesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prgo:ContingentConsiderationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">prgo:MeasurementInputProjectedRoyaltiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prgo:ContingentConsiderationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharma2020ContingentMilestonePaymentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RoyaltyPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RoyaltyPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-17</xbrli:startDate>
			<xbrli:endDate>2020-06-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:RON</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:RON</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun19_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_DebtInstrumentAxis_prgo_SeniorNotesdue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:SeniorNotesdue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-07-06</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-08-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2014EuroDenominatedTermLoandueDecember52019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2014EuroDenominatedTermLoandueDecember52019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-08</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-08</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueMay2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NotedueMay2021Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2020Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NotedueNovember2020Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-19</xbrli:startDate>
			<xbrli:endDate>2020-06-19</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-07-06</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-08-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NotedueNovember2021Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-08</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct31">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2May">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-05-01</xbrli:startDate>
			<xbrli:endDate>2020-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Nov29_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-11-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Aug22">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-08-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2011Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2011-01-01</xbrli:startDate>
			<xbrli:endDate>2011-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2010Q1SD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2009-01-01</xbrli:startDate>
			<xbrli:endDate>2009-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q1Aug15">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-08-15</xbrli:startDate>
			<xbrli:endDate>2017-08-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2010Q4CollaborationPayment">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2010-01-01</xbrli:startDate>
			<xbrli:endDate>2010-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2014Q4CalendarYear">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2012-01-01</xbrli:startDate>
			<xbrli:endDate>2012-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-11-04</xbrli:startDate>
			<xbrli:endDate>2020-11-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q2Apr26">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-04-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitSupermarketChainsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:MasonCapitalPentwaterandSimilarCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q4Dec23_srt_LitigationCaseAxis_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitSeveralCountiesinNewYorkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-23</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_LitigationCaseAxis_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q4Dec27_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthcareManagementOrganizationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2012Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2011-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3Aug27_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitSuffolkCountyofNewYorkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-08-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q4Nov14">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-11-14</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-28</xbrli:startDate>
			<xbrli:endDate>2017-06-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_srt_LitigationCaseAxis_prgo_CanadianClassActionComplaintMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CanadianClassActionComplaintMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q3Jul27">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-07-27</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OverarchingConspiracyClassActionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-04-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CasesFiledinIsraelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q2Jun21">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-21</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CasesFiledinIsraelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StateAttorneyGeneralComplaintMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-10</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_LitigationCaseAxis_prgo_OtherCasesRelatedtoEventsin20152017Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OtherCasesRelatedtoEventsin20152017Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Dec21_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitSupermarketChainsAmendedComplaintMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-21</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q3Aug03_srt_LitigationCaseAxis_prgo_PricefixingLawsuitManagedCareOrganizationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitManagedCareOrganizationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-03</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1Feb_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-02-01</xbrli:startDate>
			<xbrli:endDate>2020-02-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:AcetaminophenLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-09-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_TalcumPowderLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q4Dec11_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareServiceCompanyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthcareServiceCompanyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OverarchingConspiracyClassActionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-07-14</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthInsuranceCarrierMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-16</xbrli:startDate>
			<xbrli:endDate>2019-01-16</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:InrePerrigoCompanyplcSec.Litig.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q4Dec16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q2Jun9_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OverarchingConspiracyClassActionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-09</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-07-14</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_LitigationCaseAxis_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:InIsraelCasesRelatedtoIrishTaxEventsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthPlansMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-18</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthInsuranceCarrierMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-01-16</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q2May31_srt_LitigationCaseAxis_prgo_FirstManhattanandSimilarCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:FirstManhattanandSimilarCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3Sep4_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitDrugWholesalerandDistributorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3Jul9_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugstoreChainMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitDrugstoreChainMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-07-09</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:InrePerrigoCompanyplcSec.Litig.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-05-31</xbrli:startDate>
			<xbrli:endDate>2019-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q2May31_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:MasonCapitalPentwaterandSimilarCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q2May31_srt_LitigationCaseAxis_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CasesFiledinIsraelMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4Oct6_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-10-06</xbrli:startDate>
			<xbrli:endDate>2020-10-06</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-07-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_RoofersPensionFundMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RoofersPensionFundMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-07-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q2Apr30_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-04-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1Mar1_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHarrisCountyofTexasMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHarrisCountyofTexasMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_LitigationCaseAxis_prgo_CarmignacFirstManhattanandSimilarCasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CarmignacFirstManhattanandSimilarCasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-09-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:CSCIMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-06-28</xbrli:startDate>
			<xbrli:endDate>2020-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-30</xbrli:startDate>
			<xbrli:endDate>2019-09-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit><xbrli:unit id="brand">
		<xbrli:measure>prgo:brand</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="ratio">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit><xbrli:unit id="EUR_PER_shares">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:EUR</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="gbp">
		<xbrli:measure>iso4217:GBP</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit><xbrli:unit id="eur">
		<xbrli:measure>iso4217:EUR</xbrli:measure>
	</xbrli:unit><xbrli:unit id="lawsuit">
		<xbrli:measure>prgo:lawsuit</xbrli:measure>
	</xbrli:unit><xbrli:unit id="product">
		<xbrli:measure>prgo:product</xbrli:measure>
	</xbrli:unit><xbrli:unit id="pharmaceutical_company">
		<xbrli:measure>prgo:pharmaceutical_company</xbrli:measure>
	</xbrli:unit><xbrli:unit id="ils">
		<xbrli:measure>iso4217:ILS</xbrli:measure>
	</xbrli:unit><xbrli:unit id="promissory_note">
		<xbrli:measure>prgo:promissory_note</xbrli:measure>
	</xbrli:unit><xbrli:unit id="manufacturer">
		<xbrli:measure>prgo:manufacturer</xbrli:measure>
	</xbrli:unit><xbrli:unit id="case">
		<xbrli:measure>prgo:case</xbrli:measure>
	</xbrli:unit><xbrli:unit id="retailer">
		<xbrli:measure>prgo:retailer</xbrli:measure>
	</xbrli:unit><xbrli:unit id="supermarket">
		<xbrli:measure>prgo:supermarket</xbrli:measure>
	</xbrli:unit><xbrli:unit id="tender">
		<xbrli:measure>prgo:tender</xbrli:measure>
	</xbrli:unit><xbrli:unit id="claim">
		<xbrli:measure>prgo:claim</xbrli:measure>
	</xbrli:unit><xbrli:unit id="complaint">
		<xbrli:measure>prgo:complaint</xbrli:measure>
	</xbrli:unit><xbrli:unit id="plaintiff">
		<xbrli:measure>prgo:plaintiff</xbrli:measure>
	</xbrli:unit><xbrli:unit id="individual">
		<xbrli:measure>prgo:individual</xbrli:measure>
	</xbrli:unit><xbrli:unit id="USD_PER_ILS">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>iso4217:ILS</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="health_plan">
		<xbrli:measure>prgo:health_plan</xbrli:measure>
	</xbrli:unit><xbrli:unit id="class">
		<xbrli:measure>prgo:class</xbrli:measure>
	</xbrli:unit><xbrli:unit id="defendant">
		<xbrli:measure>prgo:defendant</xbrli:measure>
	</xbrli:unit><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2253-wk-Fact-02352B46854A58049795BE464FC233D9" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1946-wk-Fact-058668D8C7005426B4C3D67A9EF7BA2C" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560" toRefs="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1411-wk-Fact-06EE885C336D559890E9C0003A71C4FD" toRefs="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d27108e1552-wk-Fact-08EF9BC9348C54B681F5C4E593B63CBA" toRefs="TextSelection-7A8EDA421AAF55FDAD0D4EAB26DA18BC-0-wk-Footnote-7A8EDA421AAF55FDAD0D4EAB26DA18BC_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d46894e4331-wk-Fact-0D4BBC7E5651503EA28DC2F31CF06DD6" toRefs="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d46894e4852-wk-Fact-1304196B6B745288B99541373B5E5AF1" toRefs="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681" toRefs="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2566-wk-Fact-152380BDE3875A368ADC1645FA22C174" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1536-wk-Fact-15F3950C89195B8AB60F572451958777" toRefs="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d24840e3276-wk-Fact-17F7D38C41C65D89B57E9524630DF06F" toRefs="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1264-wk-Fact-18CC7AAB145A5D47B3481557211BBDCA" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2507-wk-Fact-1C660C6F8C885777917A013B8B8DFE59" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d24840e3296-wk-Fact-1D68F3544CDE5E28B26B49940823EEB2" toRefs="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2331-wk-Fact-1EDEA42D38F954E886C6569B8C981F6C" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d46894e4246-wk-Fact-21E5ECF72BF157788F6A7ECF9B4C5A3A" toRefs="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d46894e4678-wk-Fact-29E7FACF98905FD6A4F2915EDDDBFD85" toRefs="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1" toRefs="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2039-wk-Fact-2D3B683CCB6757D19D2C95D94D3569F4" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3442-wk-Fact-36210C25EE665D12BAF6DC136D86364C" toRefs="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1225-wk-Fact-392CC0D02686521681FB64A94FFD57EC" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1517-wk-Fact-397C83A0249153ACAFF833332FBC93C2" toRefs="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA" toRefs="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1861-wk-Fact-42B3AB8BE2AD78DD55A147301E355CC4" toRefs="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2195-wk-Fact-43B0F047528459B790AAD8A9134D6AA2" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3539-wk-Fact-4834881B4668519E87F6E7AF053C9407 d57757e3758-wk-Fact-4834881B4668519E87F6E7AF053C9407" toRefs="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3461-wk-Fact-4B312B45A7B45F5AA356D35F99AED5E3" toRefs="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2273-wk-Fact-4D78AA98677C5D8A90ACFBB38F4EAF9B" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d13015e1215-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC d78798e1482-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC d78798e3672-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC d46894e8692-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC d50250e3185-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1431-wk-Fact-529F834E8BC45200AAA6A530453B7278" toRefs="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1615-wk-Fact-52DE8508E9D450FE88B0F7906CEBEA51" toRefs="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3323-wk-Fact-54659D50AABB58A8AD490252A3CAEC7D" toRefs="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d46894e4166-wk-Fact-599FFCCBEE295646BFAB4B90802D2614" toRefs="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d19403e1144-wk-Fact-5B9A12A4436158F6ACA797BEE8428DE3" toRefs="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-0-wk-Footnote-2A32F48D88195E6AAF1DE8E30AB8BCED_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d24840e3315-wk-Fact-5BE07753BFF65ECD8A5D8EE3A14DA068" toRefs="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e3433-wk-Fact-5D0DBD67D2B657C3B59581DD44F1C634" toRefs="TextSelection-5B20844D52F450CDAEB6F6645EF39AB1-0-wk-Footnote-5B20844D52F450CDAEB6F6645EF39AB1_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d19403e1163-wk-Fact-657D3A9C033253C599DE3B568A3ADD2A" toRefs="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-0-wk-Footnote-2A32F48D88195E6AAF1DE8E30AB8BCED_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4" toRefs="TextSelection-0688D3D2ED7051959163C0B2BE4AA6D3-0-wk-Footnote-0688D3D2ED7051959163C0B2BE4AA6D3_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1813-wk-Fact-6B00D7D90C21501FB740932FEEDF4550" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3480-wk-Fact-6BF6FF194208528A9F268E547BB40BDD" toRefs="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2175-wk-Fact-6C2AFC76F3FB504D9DEA13D586331121" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1799-wk-Fact-6DF28A47AB0B5975A658DB56F5C2CA31" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1780-wk-Fact-6EEFC2D6DBC153698EBF0227D6A28251" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1490-wk-Fact-71631B201A095930921056960D3E9895" toRefs="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599" toRefs="TextSelection-0688D3D2ED7051959163C0B2BE4AA6D3-0-wk-Footnote-0688D3D2ED7051959163C0B2BE4AA6D3_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3400-wk-Fact-7C700D4A75525FDDAC3C3171E75DFFE5" toRefs="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2409-wk-Fact-8433D7C2B404533EAFB42C71B825CE9F" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3420-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE d57757e3739-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE" toRefs="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3342-wk-Fact-8A111B173C555B0CB5779ABD1C5D2650" toRefs="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1833-wk-Fact-8A4E1F61401D575EBEACA2D6DA95348C" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2724-wk-Fact-8A512266646C595482EF17DA8AAAAA8E d50250e2714-wk-Fact-8A512266646C595482EF17DA8AAAAA8E" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1471-wk-Fact-8AFFEC2E9E6C53B4A4EBDD28B0FBE7F5" toRefs="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2351-wk-Fact-8BD2C497D6995B9FBEC20505802E4864" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2117-wk-Fact-8DA178F61A0B599B8927F372D1AD84EA" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1557-wk-Fact-8E7B51E0001651F59334F63E30A68520" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d13015e1177-wk-Fact-91F79D5851FA52E297E9A21CD478C108 d78798e1444-wk-Fact-91F79D5851FA52E297E9A21CD478C108 d78798e3634-wk-Fact-91F79D5851FA52E297E9A21CD478C108 d46894e7597-wk-Fact-91F79D5851FA52E297E9A21CD478C108 d50250e2181-wk-Fact-91F79D5851FA52E297E9A21CD478C108" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2097-wk-Fact-9563BEF0C0E95D478DFD17FFD936C48D" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2487-wk-Fact-98DD498FAEFC5940AEE42CD74D33C288" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3500-wk-Fact-98E41D9BAFA85AA09C857F17FB3EF40F" toRefs="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1635-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8 d18029e1865-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8" toRefs="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1576-wk-Fact-A829969C34F8533CBEBD61A503F3030A" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d46894e4506-wk-Fact-AB00C328FFCF5CB3851B97436FC40313" toRefs="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E" toRefs="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3362-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C d57757e3728-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C" toRefs="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1590-wk-Fact-AD7CC1BE401157C8B74B161CB4B58DB3" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d13015e1196-wk-Fact-AD8DF8663E025098BD5438A9C8F58044 d78798e1463-wk-Fact-AD8DF8663E025098BD5438A9C8F58044 d78798e3653-wk-Fact-AD8DF8663E025098BD5438A9C8F58044 d46894e9921-wk-Fact-AD8DF8663E025098BD5438A9C8F58044 d50250e2240-wk-Fact-AD8DF8663E025098BD5438A9C8F58044" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2744-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050 d50250e2772-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d46894e4760-wk-Fact-B13EFE4368D2570FA220BB1C13CE1E61" toRefs="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e3453-wk-Fact-B9EA1E3D2DD758478C3781F4783BED45" toRefs="TextSelection-5B20844D52F450CDAEB6F6645EF39AB1-0-wk-Footnote-5B20844D52F450CDAEB6F6645EF39AB1_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E" toRefs="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d24840e3257-wk-Fact-C9C00F121CB951659C3760707A8C41F4" toRefs="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1555-wk-Fact-D48BD2E94F145A76A5EF2CAD1ECCB884" toRefs="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d29539e1610-wk-Fact-D577BC6DA12759CFAC580716E5395C92" toRefs="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0" toRefs="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2019-wk-Fact-D8FA5406EF085766869DD5593BBE73C1" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1373-wk-Fact-D9AC2B84885C5079A384B35225979290" toRefs="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="2" fromRefs="d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152" toRefs="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1244-wk-Fact-DD3F6F8837535D62BCEAA41CB8BB7E87" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1206-wk-Fact-DE9A4C836BA8550DB1E1A87EB6EAE22E" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d13015e1235-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60 d78798e1502-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60 d78798e3692-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60 d46894e10978-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60 d50250e3243-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60" toRefs="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3381-wk-Fact-E1A5E9B08C5A58CBB315756126068B88" toRefs="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2429-wk-Fact-E1FC9D6A150754FCB60DFBF799663B3D" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1575-wk-Fact-E2A067A72A7050A1B47B74D981EB006A" toRefs="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d57757e3519-wk-Fact-E609865B9D3A57D7B8FF4D93924A4F7E" toRefs="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e2586-wk-Fact-E721BAA9C2B050908B37049D4B6BBD68" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d78798e1966-wk-Fact-EEDAC2A820335BAE87547B31EBD9B783" toRefs="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" linkRole="http://www.xbrl.org/2003/role/link" order="1" fromRefs="d18029e1392-wk-Fact-F517600BDA77548BB75F8EDE3B58EAEA" toRefs="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"></ix:relationship></ix:resources></ix:header></div><div><a id="s2913FF906978558AAE0553ED36B745B3"></a></div><div style="line-height:120%;text-align:center;"><hr></hr></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:14pt;"><span style="font-family:Arial;font-size:14pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;font-size:14pt;"><span style="font-family:Arial;font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;font-size:11pt;"><span style="font-family:Arial;font-size:11pt;font-weight:bold;">WASHINGTON, D.C. 20549</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">_______________________________________________</span></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:14pt;"><span style="font-family:Arial;font-size:14pt;">&#160;</span><span style="font-family:Arial;font-size:14pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d6876e980-wk-Fact-5AA0D2C5246452E6B4E3246A0F193E25" name="dei:DocumentType" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:14pt;font-weight:bold;">10-Q</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:14pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">_______________________________________________</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:center;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;"><span><ix:nonNumeric id="d6876e1001-wk-Fact-2CE5869673FC52E1A46A97E59314C942" name="dei:DocumentQuarterlyReport" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><span style="font-family:Arial;font-size:11pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;font-weight:bold;">For the quarterly period ended: </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d6876e1010-wk-Fact-A56602DC41B21DAEB4A4C22C80CF8576" name="dei:DocumentPeriodEndDate" contextRef="FD2020Q3YTD" format="ixt:datemonthdayyearen">September 26, 2020</ix:nonNumeric></span></span></span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">OR</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;"><span><ix:nonNumeric id="d6876e1032-wk-Fact-FC5BBF704F78587682A4D6E1C8F65F58" name="dei:DocumentTransitionReport" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:11pt;"><span style="font-family:Arial;font-size:11pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;font-weight:bold;">For the transition period from </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> to </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Commission file number </span><span><ix:nonNumeric id="d6876e1051-wk-Fact-C3D891927A6957EF9EA75A7BF637FA86" name="dei:EntityFileNumber" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-weight:bold;">001-36353</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">_______________________________________________</span></div><div style="line-height:120%;text-align:center;font-size:16pt;"><span><ix:nonNumeric id="d6876e1060-wk-Fact-88AB4A4410E45D49B0E3B61BDF7CB822" name="dei:EntityRegistrantName" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:16pt;font-weight:bold;">Perrigo Company plc</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:16pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">(Exact name of registrant as specified in its charter)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">_______________________________________________</span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:48%;"></td><td style="width:5%;"></td><td style="width:47%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d6876e1085-wk-Fact-8A6233AF77755D239FEF5A89D89A6B11" name="dei:EntityIncorporationStateCountryCode" contextRef="FD2020Q3YTD" format="ixt-sec:edgarprovcountryen">Ireland</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Not Applicable</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">(State or other jurisdiction of</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">incorporation or organization)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">(I.R.S. Employer</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span><ix:nonNumeric id="d6876e1122-wk-Fact-FD52F00C12A05676993C23782D4DF9E1" name="dei:EntityAddressAddressLine1" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">The Sharp Building,</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d6876e1127-wk-Fact-784E7DD5B57856BD8CC1A42A3E8B2C3F" name="dei:EntityAddressAddressLine2" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Hogan Place,</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d6876e1132-wk-Fact-E22E7A90AFD85501BC5673EEEF93529B" name="dei:EntityAddressCityOrTown" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Dublin 2,</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d6876e1137-wk-Fact-574E860FE4A852C8A38DD8C574F4199E" name="dei:EntityAddressCountry" contextRef="FD2020Q3YTD" format="ixt-sec:countrynameen"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Ireland</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d6876e1142-wk-Fact-819B865E1A475DE08F2BA8029FEFA056" name="dei:EntityAddressPostalZipCode" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">D02 TY74</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">+</span><span><ix:nonNumeric id="d6876e1150-wk-Fact-A6A7A79C690358E9B108907CBC18D822" name="dei:CountryRegion" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">353</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d6876e1155-wk-Fact-674BEE2162B659E487821874B4C2FFA1" name="dei:CityAreaCode" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">1</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d6876e1160-wk-Fact-6E85550F271D54DD93C4DD4822C7AAC6" name="dei:LocalPhoneNumber" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">7094000</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">(Address, including zip code, and telephone number, including </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">area code, of registrant&#8217;s principal executive offices)</span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Not Applicable</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:37%;"></td><td style="width:25%;"></td><td style="width:38%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d6876e1213-wk-Fact-E5C535CF577E58DEA93DD22375D80DAC" name="dei:Security12bTitle" contextRef="FD2020Q3YTD">Ordinary shares</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d6876e1218-wk-Fact-9FBF779EDB3A54799BB56AF0B74CF091" name="dei:TradingSymbol" contextRef="FD2020Q3YTD">PRGO</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d6876e1223-wk-Fact-91E382F457A2593DAE24BCC89F5D2CFA" name="dei:SecurityExchangeName" contextRef="FD2020Q3YTD" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:12pt;"><span style="font-family:Arial;font-size:9pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d6876e1228-wk-Fact-91C82F7BF2B25BB49BD7816604829AE5" name="dei:EntityCurrentReportingStatus" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;">&#160; </span><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9746;</span><span style="font-family:Arial;font-size:9pt;">&#160;&#160;&#160;&#160;No&#160;</span><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9744;</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:12pt;"><span style="font-family:Arial;font-size:9pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d6876e1242-wk-Fact-B48E57BAD9215D47983A81D5FA4DB713" name="dei:EntityInteractiveDataCurrent" contextRef="FD2020Q3YTD"><span style="font-family:Arial;font-size:9pt;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;">&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9746;</span><span style="font-family:Arial;font-size:9pt;">&#160;&#160;&#160;No&#160;</span><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9744;</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;,  &#8220;smaller reporting company&#8221;, and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:22%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:3%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d6876e1278-wk-Fact-8309E7D80AF25FB28A79D4ED68A75663" name="dei:EntityFilerCategory" contextRef="FD2020Q3YTD" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9746;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accelerated filer </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-accelerated filer </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Smaller reporting company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;"><span><ix:nonNumeric id="d6876e1328-wk-Fact-11A1699E695D5D72A13FC1619EDDD4FD" name="dei:EntitySmallBusiness" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Emerging growth company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;"><span><ix:nonNumeric id="d6876e1339-wk-Fact-564C3A8DE0AA500D93E04F56C83CC4C5" name="dei:EntityEmergingGrowthCompany" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="10" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9744;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). </span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:12pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span><span><ix:nonNumeric id="d6876e1504-wk-Fact-28C7C6ADE97E59D9A0B44DF8F9765673" name="dei:EntityShellCompany" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Arial;font-size:9pt;">&#160;&#160;</span><span style="font-family:Arial;font-size:9pt;">Yes</span><span style="font-family:Arial;font-size:9pt;">&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:12pt;">&#9746;</span><span style="font-family:Arial;font-size:9pt;">&#160;No</span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">As of </span><span style="font-family:Arial;font-size:9pt;">October&#160;30, 2020</span><span style="font-family:Arial;font-size:9pt;">, there were </span><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6876e1526-wk-Fact-46487EDAD3B558C686FE3C82EBA771C2" name="dei:EntityCommonStockSharesOutstanding" contextRef="I2020Q4Oct30" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">136,491,307</ix:nonFraction></span></span><span style="font-family:Arial;font-size:9pt;"> ordinary shares outstanding.</span></div><div style="line-height:120%;text-align:center;"><hr></hr></div><div><br/></div><hr style="page-break-after:always"></hr><div><a id="s5217640F3BCE53D9A01464EF4D5B95E1"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PERRIGO COMPANY PLC</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">FORM 10-Q</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">INDEX</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:81%;"></td><td style="width:11%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">PAGE</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">NUMBER</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s4BFD2C841C3C50B1923A3521F21F91D5"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Cautionary Note Regarding Forward-Looking Statements</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s4BFD2C841C3C50B1923A3521F21F91D5"> 1</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PART I. FINANCIAL INFORMATION</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s4F9AE643024253C38F7979C8686F8618"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Item&#160;1. Financial Statements (Unaudited)</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sB5F15E06943454BBB562C3913A1C5A0E"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Condensed Consolidated Statements of Operations </span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sB5F15E06943454BBB562C3913A1C5A0E"> 2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s00B6570316C8555C9BDFE9F1F6579F14"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Condensed Consolidated Statements of Comprehensive Income</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s00B6570316C8555C9BDFE9F1F6579F14"> 3</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s433A3606320A5C9CA3C2A76B22BDD0D0"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Condensed Consolidated Balance Sheets </span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s433A3606320A5C9CA3C2A76B22BDD0D0"> 4</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s695F6E7B1D2E53CA82420272439A3FDB"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Condensed Consolidated Statements of Shareholders' Equity</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s695F6E7B1D2E53CA82420272439A3FDB"> 5</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s28673D083583539C88DAE7DD33C531F5"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Condensed Consolidated Statements of Cash Flows</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s28673D083583539C88DAE7DD33C531F5"> 7</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s11FF556E31155CDD962D128C0F82C466"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Notes to the Condensed Consolidated Financial Statements</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s54388EBEFB445B11AB98129252518AD4"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Summary of Significant Accounting Policies</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s54388EBEFB445B11AB98129252518AD4"> 8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s612D07A762DA56AB961D86277A297B7E"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Revenue Recognition</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s612D07A762DA56AB961D86277A297B7E"> 10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Acquisitions and Divestitures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"> 12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sA22C0BF6568353F7A17EED302ECA8493"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Goodwill and Intangible Assets</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sA22C0BF6568353F7A17EED302ECA8493"> 17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s0A29042737555056BB23C3E8EAA3D7A5"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Inventories</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s0A29042737555056BB23C3E8EAA3D7A5"> 19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">6</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sBFE17B0A00B45FB196C8960332ACE955"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Fair Value Measurements</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sBFE17B0A00B45FB196C8960332ACE955"> 19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">7</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sF4B58DD1964A5338A17E7D9B8F660A6D"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Investments</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sF4B58DD1964A5338A17E7D9B8F660A6D"> 23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">8</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sA96858DADB665A6D80635E985E64DDB1"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Derivative Instruments and Hedging Activities</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sA96858DADB665A6D80635E985E64DDB1"> 23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">9</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s5C415D6F8F16571ABE301BD0CB1A1A36"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Leases</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s5C415D6F8F16571ABE301BD0CB1A1A36"> 29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">10</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Indebtedness</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"> 31</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">11</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sFB7F09E97D4D50879B04022FA3F53DDF"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Earnings per Share and Shareholders' Equity</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sFB7F09E97D4D50879B04022FA3F53DDF"> 32</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">12</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s834B42D5C6E05A798C3BA3951A46C56D"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Accumulated Other Comprehensive Income (Loss)</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s834B42D5C6E05A798C3BA3951A46C56D"> 33</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">13</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Income Taxes</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sAF954DA7DF52564E89822E8DA956F14A"> 33</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">14</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s5958A14DA1AE536285E42C2A91B4FD9C"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Contingencies</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s5958A14DA1AE536285E42C2A91B4FD9C"> 36</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">15</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sFCF65F79C6DC5F8B95292CBCBA6EED54"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Restructuring Charges</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sFCF65F79C6DC5F8B95292CBCBA6EED54"> 47</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:normal;">16</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sBBE7203EDB115E499A5C44697C1474D8"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Segment Information</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sBBE7203EDB115E499A5C44697C1474D8"> 48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s3991A6CB0C0F51368CE62BF88A9B8F72"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s3991A6CB0C0F51368CE62BF88A9B8F72"> 48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s87EB8ED01EC950CBA8AE029B499C58F9"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s87EB8ED01EC950CBA8AE029B499C58F9"> 71</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s70C5210E4B2955B482777298109E5AC9"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Item&#160;4. Controls and Procedures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s70C5210E4B2955B482777298109E5AC9"> 71</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PART II. OTHER INFORMATION</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s455A8BFA4D2B5F6EB3B61AA2D02EC9E8"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Item&#160;1. Legal Proceedings</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s455A8BFA4D2B5F6EB3B61AA2D02EC9E8"> 72</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s57F4E14597D15F9B98722F296A7178DD"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Item&#160;1A. Risk Factors</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s57F4E14597D15F9B98722F296A7178DD"> 72</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sAA3A9D93003A53E680166666816EF3A4"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Item&#160;6. Exhibits</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#sAA3A9D93003A53E680166666816EF3A4"> 73</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s14ADC13C18425A0AB0E7AACFA15229F0"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Signatures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;text-decoration:none;" href="#s14ADC13C18425A0AB0E7AACFA15229F0"> 74</a></div></td></tr></table></div></div><div><br/></div><hr style="page-break-after:always"></hr><div><a id="s4BFD2C841C3C50B1923A3521F21F91D5"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certain statements in this report are &#8220;forward-looking statements&#8221; within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our, or our industry&#8217;s actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives, assumptions, future events or future performance contained in this report, including certain statements contained in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; "forecast," &#8220;predict,&#8221; &#8220;potential&#8221; or the negative of those terms or other comparable terminology.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control, including: the effect of the novel coronavirus (COVID-19) pandemic and the associated economic downturn and supply chain impacts on the Company's business, the timing, amount and cost of any share repurchases; future impairment charges; customer acceptance of new products; competition from other industry participants, some of whom have greater marketing resources or larger market shares in certain product categories than we do; pricing pressures from customers and consumers; resolution of uncertain tax positions, including the Company's appeal of the Notice of Assessment ("NoA") issued by the Irish Office of the Revenue Commissioners (&#8220;Irish Revenue&#8221;) and the Notices of Proposed Adjustment ("NOPAs") issued by the U.S. Internal Revenue Service and the impact that an adverse result in any such proceeding could have on operating results, cash flows and liquidity; potential third-party claims and litigation, including litigation relating to alleged price-fixing in the generic pharmaceutical industry, alleged class action and individual securities law claims, and alleged product liability claims and litigation relating to uncertain tax positions, including the NoA and NOPAs; potential impacts of ongoing or future government investigations and regulatory initiatives; potential costs and reputational impact of product recalls and sales halts; the impact of tax reform legislation and healthcare policy; general economic conditions; fluctuations in currency exchange rates and interest rates; the consummation of announced acquisitions or dispositions and the success of such transactions, and our ability to realize the desired benefits thereof; and our ability to execute and achieve the desired benefits of announced cost-reduction efforts, and strategic and other initiatives. An adverse result with respect to our appeal of any material outstanding tax assessments or litigation, could ultimately require the use of corporate assets to pay such assessments, damages from third-party claims, and related interest and/or penalties, and any such use of corporate assets would limit the assets available for other corporate purposes. Statements regarding the separation of the RX business, including the expected benefits, anticipated timing, form of any such separation and whether the separation ultimately occurs, are all subject to various risks and uncertainties, including future financial and operating results, our ability to separate the business, the effect of existing interdependencies with our manufacturing and shared service operations, and the tax consequences of the planned separation to us or our shareholders. These and other important factors, including those discussed in our form 10-K for the year-ended December 31, 2019, this report under &#8220;Risk Factors&#8221; and in any subsequent filings with the United States Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this report are made only as of the date hereof, and unless otherwise required by applicable securities laws, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">TRADEMARKS, TRADE NAMES AND SERVICE MARKS</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">This report contains trademarks, trade names and service marks that are the property of Perrigo Company plc, as well as, for informational purposes, trademarks, trade names, and service marks that are the property of other organizations.&#160;Solely for convenience,&#160;certain trademarks, trade names, and service marks referred to in this report appear without the </span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">,</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:Arial;font-size:10pt;">&#8482; and </span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">SM </sup></span><span style="font-family:Arial;font-size:10pt;">symbols, but those references are not intended to indicate that we or the applicable owner, as the case may be, will not assert, to the fullest extent under applicable law, our or their rights to such trademarks, trade names, and service marks.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 1</span></div></div><hr style="page-break-after:always"></hr><div><a id="s4F9AE643024253C38F7979C8686F8618"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PART I. &#160;&#160;&#160;&#160;FINANCIAL INFORMATION</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ITEM 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS (UNAUDITED)</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sB5F15E06943454BBB562C3913A1C5A0E"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PERRIGO COMPANY PLC</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(in millions, except per share amounts)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(unaudited)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1177-wk-Fact-91F79D5851FA52E297E9A21CD478C108" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,213.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1196-wk-Fact-AD8DF8663E025098BD5438A9C8F58044" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,191.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1215-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,773.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1235-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,514.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1250-wk-Fact-D6166CD88DD15F24801DF34453CB9491" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">785.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1269-wk-Fact-F244B3D2D80955E6B5620B5DF32AB4DB" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">778.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1288-wk-Fact-F6825A5E3B995584B76CA6D36B71F7AE" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,427.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1308-wk-Fact-2C56732F6E4250198917B3F0D82295C2" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,222.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1328-wk-Fact-81F2C0765D1F55CEBAE0B0B84CC8BAD1" name="us-gaap:GrossProfit" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">428.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1347-wk-Fact-AD2ACF45FA9A594896046BDA40B217E8" name="us-gaap:GrossProfit" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">412.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1366-wk-Fact-94F8C04EAA7A5E6A8ED126684364C4A7" name="us-gaap:GrossProfit" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,346.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1386-wk-Fact-E0BE943D0E5D5FFDB6C129BEC94092EC" name="us-gaap:GrossProfit" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,292.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating expenses</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Distribution</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1570-wk-Fact-99C564A157E95227BA2A1C248D3BAFD6" name="us-gaap:ProductionAndDistributionCosts" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1589-wk-Fact-07BF4A38132353559A3A90D57ED725BF" name="us-gaap:ProductionAndDistributionCosts" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1608-wk-Fact-CF83589A6DBE5EBD875948E1289631EF" name="us-gaap:ProductionAndDistributionCosts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">73.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1628-wk-Fact-2B5974317800565A819F347B006A1CC9" name="us-gaap:ProductionAndDistributionCosts" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1648-wk-Fact-B76A2215A9FB5E669F6857D6D232EC96" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1667-wk-Fact-C96559780CA455C395496D78394DADC6" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1686-wk-Fact-A101BE0CE48450198FF03B004B337CF5" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">131.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1706-wk-Fact-6995F2F37A915DC7B3451C0F78757BC3" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">128.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Selling</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1726-wk-Fact-8E1297B39280587C887EC2AEE44BDA00" name="us-gaap:SellingAndMarketingExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">138.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1745-wk-Fact-FE9E6D0CB4915980B3F8753DAEB332A2" name="us-gaap:SellingAndMarketingExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">134.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1764-wk-Fact-475D33601BDA5AA2B28FFC511898AB75" name="us-gaap:SellingAndMarketingExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">413.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1784-wk-Fact-5CC9BFA62E165CB280B1F6231EDB396B" name="us-gaap:SellingAndMarketingExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">422.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Administration</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1804-wk-Fact-F213C6019F6758539A9F782BC2DE32E9" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">116.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1823-wk-Fact-FB3A32D0E72C5E61B89842E6BC8586D0" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">131.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1842-wk-Fact-0D17087452555E1E91EE906BFD05727E" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">357.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1862-wk-Fact-D5DFC8CE8BDE5D7588DDE4046D7C0722" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">384.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Impairment charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1883-wk-Fact-4D169481AB5B5439BA8EBDCF9C20A388" name="us-gaap:AssetImpairmentCharges" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">202.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1902-wk-Fact-C0F88143E9155820ABA93477D1402976" name="us-gaap:AssetImpairmentCharges" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1921-wk-Fact-0066578628895F70805AFE67D1011EBB" name="us-gaap:AssetImpairmentCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">202.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1941-wk-Fact-940FE1DE4ED55FADA37E655425AB20A1" name="us-gaap:AssetImpairmentCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Restructuring</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1961-wk-Fact-5BF31FADFAC15078AB8889D459B13191" name="us-gaap:RestructuringCharges" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1980-wk-Fact-75C4561F82FE56D48E65977895A9597F" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e1999-wk-Fact-18F9BED0F94059D18D6FF41F640DA407" name="us-gaap:RestructuringCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2019-wk-Fact-CA124A1C3230592D914E7CD3C91A98A9" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other operating expense (income)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2039-wk-Fact-67B631F017F15D3290CE486121FD8F8A" name="prgo:OtherOperatingIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2059-wk-Fact-67ACD959FE545FF6A7CC8890AB397236" name="prgo:OtherOperatingIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">8.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2078-wk-Fact-65887CFEF969526A82AD691B482EBB58" name="prgo:OtherOperatingIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2099-wk-Fact-D2E3C15D6299558FAD65B4212506C6E5" name="prgo:OtherOperatingIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total operating expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2119-wk-Fact-C8BC34D36EF350019379EC378D12FFF4" name="us-gaap:OperatingExpenses" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">523.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2138-wk-Fact-E2E4D47006425A84B21A8A4FECE43DBF" name="us-gaap:OperatingExpenses" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">358.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2157-wk-Fact-1CEDAF324F975565ADA1730C3B8A6584" name="us-gaap:OperatingExpenses" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,178.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2177-wk-Fact-8FFB3A412D4D5CE6853853A2555A9148" name="us-gaap:OperatingExpenses" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,080.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2279-wk-Fact-13D0525FEB2D521BAD5C1613BADE0743" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">95.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2299-wk-Fact-6BF69FF58FFC512D8BE1DC951310FDC7" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2318-wk-Fact-CB2087D04AEC530794406BF111E1F908" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">167.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2338-wk-Fact-55D56F3E881C56179BCAACFE76CCD34E" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">211.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in financial assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2440-wk-Fact-9A435B691FD4522F831473B58764B232" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2460-wk-Fact-F1A3342D60F05ED0A88E726F9A316B8B" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2480-wk-Fact-AA69DA9C163E5A8AB11F17B108E0C11E" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2501-wk-Fact-8FC648BE938852AEAA299EA381B9DB24" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2522-wk-Fact-5563699BAF3D5510876A69B2F5003B29" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">34.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2541-wk-Fact-39CFAD777BBD500CA31E9B3E378D9D52" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">30.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2560-wk-Fact-2003F8F9485B5D92A9E51B11C3D690BB" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">97.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2580-wk-Fact-3BAD30E281D250B1806640BA4ED547C2" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">90.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2600-wk-Fact-7B895DB86A395FD8B2B3DCF0CCA06EA8" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2619-wk-Fact-D7BE36645A5C5C96AF8894AA8DB436F6" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">71.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2639-wk-Fact-097957692A2D57108C52A7A00CE0061D" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">17.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2659-wk-Fact-A9690FAD7D5A5627A4159FEEA0CFF4AA" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">65.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2680-wk-Fact-2DE3346961E05C41A57A9022876AB1F7" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2699-wk-Fact-936FEA0BC82A50A380BF335F54EC8FCF" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2718-wk-Fact-58778DCFB5C15CE5933FBA3C0454796C" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2738-wk-Fact-43E7CF76DF365C59AED53F502E3D6F2B" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Income (loss) before income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2759-wk-Fact-974556F193AF51178BEB5B79F11339B6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">127.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2779-wk-Fact-E7E85D617DAD56499190A63949698B6F" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">97.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2798-wk-Fact-7B964245CECA5999862A7250839E5546" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">58.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2818-wk-Fact-397684C7C0AF531288C3A768F51B87D8" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">205.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Income tax expense </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2838-wk-Fact-13F42C9E0AB7572EA0D58C2C70CC35B7" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2857-wk-Fact-A0900931255F52D09A510DBECD67D1F5" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2876-wk-Fact-963850785D655FAFBD85C4312DBB4FA5" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2896-wk-Fact-7B53CCA407665087A69A9D1AAB70AB08" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e2921-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">154.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2941-wk-Fact-E71A91499A5557858B57177F0D58A3CB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2960-wk-Fact-08FB4EC393345107970F7A706AE01243" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e2980-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">165.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Earnings (loss) per share</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e3164-wk-Fact-3F016BC883125AE787BA41DAE927C058" name="us-gaap:EarningsPerShareBasic" contextRef="FD2020Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">1.13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3184-wk-Fact-B5FD5441F8D65F1BA1BFC4EFBF4713AA" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3203-wk-Fact-20DF8348799F54F08B2599045EB5C45B" name="us-gaap:EarningsPerShareBasic" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.09</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3223-wk-Fact-B992C4FB57B45FA58F50C2B3E56A779C" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13015e3243-wk-Fact-CA3135BEE17C548A8E59897B4A85B089" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2020Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">1.13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3263-wk-Fact-6FC11F00A888585293AF5C83EC8D3BD6" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.67</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3282-wk-Fact-7C4675C037705523A6385C1DB288F8AC" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.09</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3302-wk-Fact-B7A62C2E6A605695B4A26C863DA81F10" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted-average shares outstanding</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3481-wk-Fact-78E62AC728A75531BF9A6E884F5303D3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3500-wk-Fact-1C2EF28688725C7D80F2C8088A76769A" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3519-wk-Fact-C1E53D38F6B7552B9D0690947347E060" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3539-wk-Fact-53FE4EB273C15CA4BE767C70DBCA9CA1" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3559-wk-Fact-5C5C30AFBA8C5A51A10D8E788B640859" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3578-wk-Fact-C8E3779330DE5F4FA67C150EA14283BA" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3597-wk-Fact-F22C375A219F547E8118FB44221651D2" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">137.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13015e3617-wk-Fact-3543D9576257501785C04A94408B4FD0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 2</span></div></div><hr style="page-break-after:always"></hr><div><a id="s00B6570316C8555C9BDFE9F1F6579F14"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PERRIGO COMPANY PLC</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(in millions)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(unaudited)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1175-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">154.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1195-wk-Fact-E71A91499A5557858B57177F0D58A3CB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1214-wk-Fact-08FB4EC393345107970F7A706AE01243" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1234-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">165.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income (loss):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency translation adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1331-wk-Fact-F683094658AD5E2C8D1FA45A6A9969B9" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">86.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1350-wk-Fact-EA8AB16F21255C328B59141405DC4BC1" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">74.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1370-wk-Fact-3B1B0553C98D57C89A2F4700B0C70E88" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1390-wk-Fact-BBA0FC2AB8B1531E945F753A3A024235" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">63.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in fair value of derivative financial instruments, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1411-wk-Fact-DAF7525265345F5793CB7943623F36F0" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1431-wk-Fact-617AD2395C3A5D5E9FE7767F467FCCEE" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1450-wk-Fact-76F71DADF2EE503D85301BFEE96C5E4E" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1471-wk-Fact-90F8C475DAB852CBA16B7D81E7545222" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in post-retirement and pension liability, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1491-wk-Fact-478BFF7CCE4353E685E6A39DAD607B5B" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1511-wk-Fact-8EB003F7711459F8AD7E555A65114AD1" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1531-wk-Fact-A0331B96494C550E8A4CE6FDC2C0F84B" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1552-wk-Fact-FEA0B95E0F8551AA86210C3D0DF73E57" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income (loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1573-wk-Fact-41F0EC93E96E566ABA687EEFF4EA8600" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1592-wk-Fact-B55D38643BC659D6BE67B97A4EF336FC" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">42.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1612-wk-Fact-90E2EFBA909E53649BADCFE90EC3C82B" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">64.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1632-wk-Fact-C6BCC5C7D3735A9D9F2D6F32C48BA865" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">28.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6879e1658-wk-Fact-A786637DA62856288BFEE40B02A94C11" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">71.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1678-wk-Fact-7E2EFE2849E456AF96AFD44F2086A5F8" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1697-wk-Fact-5FA57E2320045FDB95D3C798F257D892" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">76.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6879e1717-wk-Fact-D21BD5A85B1359B1B6B160B843A21FA7" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">137.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 3</span></div></div><hr style="page-break-after:always"></hr><div><a id="s433A3606320A5C9CA3C2A76B22BDD0D0"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PERRIGO COMPANY PLC</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(in millions, except per share amounts)</span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(unaudited)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Assets</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1084-wk-Fact-B08D4E5650455C41A96B10AB95755662" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">849.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1103-wk-Fact-D151DAE0165F515AA946E2641B39957C" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">354.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable, net of allowance for credit losses of $6.3 and $6.7, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1118-wk-Fact-5F34D6CB74115D559052A99CE98C66D1" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,097.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1137-wk-Fact-7CAB09AD34E952A4BA0FD3BEB0AA603A" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,243.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1157-wk-Fact-D5426A6C267D5922AD6216A00522426B" name="us-gaap:InventoryNet" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,100.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1176-wk-Fact-CE06DA9DF0A8583C86A12692EB25FCB9" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">967.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1196-wk-Fact-A98CA9491C4A5F689031A6A85DBD7BEC" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">350.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1215-wk-Fact-C861EFF2BF4D503BB9201F2A42EDF17A" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">165.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1235-wk-Fact-E5ADCC0F3F7C50DF8823F83A70ECD24E" name="us-gaap:AssetsCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,398.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1254-wk-Fact-0C578EAB1BCA54999E98700EA58D4303" name="us-gaap:AssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,730.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1274-wk-Fact-A552481193E8551794060A0CDD695D03" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">918.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1293-wk-Fact-6B8804A158695C78AC4BEE502F7DA950" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">902.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1313-wk-Fact-E6F78C2EB5D957A0995950F29DB10E47" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">132.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1332-wk-Fact-E70D989FFA1C5AD380968DF9112E78C9" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">129.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill and indefinite-lived intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1352-wk-Fact-E3EFA56D1F5259CFB31AF29E652531BE" name="prgo:GoodwillAndIndefiniteLivedIntangibles" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,854.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1371-wk-Fact-B98CD79C84835C2BBD3BB25BFCDF8122" name="prgo:GoodwillAndIndefiniteLivedIntangibles" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,185.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1391-wk-Fact-9536CD6C7F7D5A3596D2A15D17CC7DA8" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,895.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1410-wk-Fact-655BE46BAB8E5BD6AE9CAEEFADCBC8E4" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,921.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1431-wk-Fact-95AB029F4A5054C3909C27A0726478BF" name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1450-wk-Fact-61902C9BDAB85E76811AD77E8ED57BBD" name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1470-wk-Fact-DC2E5588F3A55F56AFFD7D98D434D642" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">369.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1489-wk-Fact-AE36FC0EAA59592C9DF2A437B6CF2354" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">426.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total non-current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1509-wk-Fact-7AFADFFB51955286BD8FE26FA0BD2172" name="us-gaap:AssetsNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8,177.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1528-wk-Fact-408650279E7E53A691D470FAC94022ED" name="us-gaap:AssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8,570.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1553-wk-Fact-787E99A35A81503989617F4B938A50C2" name="us-gaap:Assets" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11,576.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1572-wk-Fact-BCC4DA49384256F793F37AC4E26ADB03" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11,301.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Liabilities and Shareholders&#8217; Equity</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1633-wk-Fact-2908C1A7F7435910B7170DD41A359689" name="us-gaap:AccountsPayableCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">536.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1652-wk-Fact-E1731DCD99FF5085B1CCB55F93CFE478" name="us-gaap:AccountsPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">520.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1667-wk-Fact-EE9066D6FF6056D89507FB7A496DA3E6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">155.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1686-wk-Fact-CB2A4B5BBA9753F6A6F3B1573368E59E" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">156.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1706-wk-Fact-6C7D58AD71E45961A0FF7EC194B665F0" name="prgo:AccruedCustomerPrograms" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">370.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1725-wk-Fact-35AB05C2FEA1576C846CD69E954EFDC8" name="prgo:AccruedCustomerPrograms" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">394.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1745-wk-Fact-B133E738D00D55D7B2BA8209126EC1DD" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">237.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1764-wk-Fact-3B702F5058385EA3B90581548AE01221" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">229.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1784-wk-Fact-B085B78B882E5546B9BAF6F628653544" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1803-wk-Fact-633E87256F8E5CA0B7A80FD1F0A965A0" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1823-wk-Fact-1A290D85FA3C5B7F9821989DFADE8849" name="us-gaap:LongTermDebtCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1842-wk-Fact-D36C8F9CB1795F2FAD96068388C7EC47" name="us-gaap:LongTermDebtCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1863-wk-Fact-BCA652715A7E57A6A707EDBB4CB8E558" name="us-gaap:LiabilitiesCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,336.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1882-wk-Fact-68E4E10650DF5668B209C32F53CDF363" name="us-gaap:LiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,335.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Long-term debt, less current portion</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1902-wk-Fact-F430BF656C9D59D4B7C0DED9C182B3BC" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,543.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1921-wk-Fact-3D3715BC11DE5A3DB437F324C420D917" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,365.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1941-wk-Fact-DBD85E21F36550558404550CDA6EF93A" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">313.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1960-wk-Fact-95FD16A6604453A7855CCF5E8C283EB8" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">280.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1980-wk-Fact-614067DF65F95D03B7E0545F687953F2" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">562.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e1999-wk-Fact-2961551383765F2683446732EB57DBAB" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">515.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2019-wk-Fact-BEF425A55D6E53768D309EFA034ADBA4" name="us-gaap:LiabilitiesNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,419.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2038-wk-Fact-07F72667C83F5EFFB564C38668FE0048" name="us-gaap:LiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,161.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2058-wk-Fact-BA6429A7F5A758F79B984087488DD3AC" name="us-gaap:Liabilities" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,755.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2077-wk-Fact-5F645EABEEF95366842A4F98F3610E1C" name="us-gaap:Liabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,497.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">Commitments and contingencies - Refer to Note 14</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2097-wk-Fact-B0AE97948A365647988ED3C298466661" name="us-gaap:CommitmentsAndContingencies" contextRef="FI2020Q3" unitRef="usd" xsi:nil="true" scale="6" format="ixt:nocontent"></ix:nonFraction></span><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2116-wk-Fact-1548CD04FAF95D2FB8E3F13DCA074CFD" name="us-gaap:CommitmentsAndContingencies" contextRef="FI2019Q4" unitRef="usd" xsi:nil="true" scale="6" format="ixt:nocontent"></ix:nonFraction></span><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Shareholders&#8217; equity</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Controlling interests:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Preferred shares, $0.0001 par value per share, 10 shares authorized</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2218-wk-Fact-E7C3674617595562A2DFD9FD40037E93" name="us-gaap:PreferredStockValue" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2237-wk-Fact-9E7543ED2E6C5455890A0CB6AB55FD87" name="us-gaap:PreferredStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ordinary shares, &#8364;0.001 par value per share, 10,000 shares authorized</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2257-wk-Fact-0C98A059094859BC971510ADB80FFE29" name="us-gaap:CommonStockValue" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,299.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2276-wk-Fact-24AE47D344FA51D9AD3EBD89682ECE3D" name="us-gaap:CommonStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,359.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accumulated other comprehensive income</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2297-wk-Fact-34131CDA17AB5B55929586B106286EBA" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">203.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2316-wk-Fact-8D77E76C12D35A9AB036A03D933E13B4" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">139.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Retained earnings (accumulated deficit)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d73195e2336-wk-Fact-B1484A6A38415FB2B217BC927C6E1DD4" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,683.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d73195e2356-wk-Fact-0AC7FAF7146E559CB0A056BE9793B4A6" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,695.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total controlling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2377-wk-Fact-846869810E8450D8BE8B8396EBFB23D6" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,820.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2396-wk-Fact-D06E57F29B8B5F4A8D9A0640CB3E74C9" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,803.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Noncontrolling interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2416-wk-Fact-DD18E88E31485C509A2C16EA786ED3EA" name="us-gaap:MinorityInterest" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2435-wk-Fact-813D32CDFA31544C97125290B6DAA56E" name="us-gaap:MinorityInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total shareholders&#8217; equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2455-wk-Fact-31AC25C6418C5EF1B128E90C0ACF41AC" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,820.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2474-wk-Fact-0B2C8A56E41B50B9A53F5BC365D5ADBB" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,804.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities and shareholders' equity</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2499-wk-Fact-55A9CC725DB7548C9E80765FF1C65801" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11,576.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2518-wk-Fact-5FF813B284E15ACC80A4BDE2078F8B0E" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11,301.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Supplemental Disclosures of Balance Sheet Information</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Preferred shares, issued and outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2615-wk-Fact-ED5C6E2B36D85F3C9F06E7627B85CF44" name="us-gaap:PreferredStockSharesIssued" contextRef="FI2020Q3" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2634-wk-Fact-D5715894AA7C55F88D22CB7CAD4F6EBC" name="us-gaap:PreferredStockSharesIssued" contextRef="FI2019Q4" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ordinary shares, issued and outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2654-wk-Fact-32F98CB82DCA5BDBA176F6B7D87B3808" name="us-gaap:CommonStockSharesIssued" contextRef="FI2020Q3" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d73195e2673-wk-Fact-979A52AFE87552A3A6D7CBF8E3134BF4" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q4" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 4</span></div></div><hr style="page-break-after:always"></hr><div><a id="s695F6E7B1D2E53CA82420272439A3FDB"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">PERRIGO COMPANY PLC</span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(in millions, except per share amounts)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(unaudited)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"></td></tr><tr><td style="width:46%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Ordinary Shares<br/>Issued</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Retained<br/>Earnings<br/>(Accumulated Deficit)</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1202-wk-Fact-919029BBB7BC51A196399921CAC3EAEC" name="us-gaap:SharesOutstanding" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">135.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1221-wk-Fact-0BAAA231E16652EBA4BFF1D7844F22AC" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,421.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1240-wk-Fact-09E288712835517CB242674E00D62E5C" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">84.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1260-wk-Fact-CA8D6337EF8858208913920FF026E877" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,838.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1280-wk-Fact-8262C131AC5C5959962BF53EEBB9FE9F" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,668.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Adoption of new accounting standards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1348-wk-Fact-81A2E9EA594256FBB47E3FCF64A4F37B" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1368-wk-Fact-1916987E127D505D80728AEB4FEB23E9" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1442-wk-Fact-E931C1D49E64575797D12B51F38AAA47" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">63.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1461-wk-Fact-C476197AFBDE55889E03CB06AAAB118C" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">63.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1514-wk-Fact-9468C459B1BA520CBE9637AA7408EDE6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">15.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1554-wk-Fact-2915EEE6E8A55E56843B94167DBC5386" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">15.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Restricted stock plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1575-wk-Fact-C1CF07C10DBB519A860643D50EAD94C2" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for stock options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1681-wk-Fact-78FCFDFD363D536FA4AC69AAB161847A" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1739-wk-Fact-4709BDF0324D533FB868AFD4060A1809" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for restricted stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1773-wk-Fact-8CE442FD5C4B52E08AEF09D4E0309258" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e1831-wk-Fact-A0A801FFCBBC527EBCB7936D312685BA" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash dividends, $0.19 per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1865-wk-Fact-63F757725D865244862C205B2724E4A3" name="us-gaap:DividendsCommonStockCash" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1924-wk-Fact-DC7BC9C15E75541AB6F89BB02D0A492E" name="us-gaap:DividendsCommonStockCash" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Shares withheld for payment of employees' withholding tax liability</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1945-wk-Fact-46F5B40FE3CC5D5EB5F3AA087845D7D1" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e1960-wk-Fact-A6736529B9D45F30A047D8EBAB8CCEA8" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e2019-wk-Fact-29FEE159C13F5C00B36031ADE13E6DC2" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at March 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2041-wk-Fact-7D477C283C865F91BB95AEF78771A9AD" name="us-gaap:SharesOutstanding" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2060-wk-Fact-64A78F5CB7F5520C9EF7B387AF62FFE8" name="us-gaap:StockholdersEquity" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,409.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2079-wk-Fact-52D65AD178C557D68921EEE5F222793A" name="us-gaap:StockholdersEquity" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">69.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e2099-wk-Fact-9ECCECE03CF45DEE8E5C9C4CA8650AA8" name="us-gaap:StockholdersEquity" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,777.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2119-wk-Fact-BA5CF86B4B9F517A8135A942E8597EA7" name="us-gaap:StockholdersEquity" contextRef="FI2019Q1" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,700.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2284-wk-Fact-950C2E193B105B5D85BCE025A13695DB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2303-wk-Fact-2994FB3EB9F45485AC6AEDF70085CEA7" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2356-wk-Fact-C5F74F6188435CB6ACD0EE8DCC48E439" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2395-wk-Fact-187DE2A4F2D4504584C31118D13F2F19" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Stock options exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2429-wk-Fact-E89CD54CBCEF530285FE3FC0F227D59C" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2487-wk-Fact-863DB1D0B01C5F4DA73891FCCA7A691B" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for stock options</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2521-wk-Fact-F54F4DA3EBEF5ACABB306DC3B6AE465F" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2579-wk-Fact-11B6540D668255FF93E21E31A81E266D" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for restricted stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2613-wk-Fact-B8DCA67146195B438047C6521C7D3134" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2671-wk-Fact-F5113C2D5FCD5B8B905B16CB02F54686" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash dividends, $0.21 per share</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e2705-wk-Fact-199818663C165C72B2F24C78ECF2A7E9" name="us-gaap:DividendsCommonStockCash" contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e2764-wk-Fact-3198362BEE0C56B28FF310B6BDE087D7" name="us-gaap:DividendsCommonStockCash" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Shares withheld for payment of employees' withholding tax liability</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e2799-wk-Fact-BC7902EAE1DE5045B00816F79AAE5FE5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e2858-wk-Fact-51E0329C3BD957B692D203F9262DB8CB" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at June 29, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2879-wk-Fact-212CB96294545CEFB7D6F90C45CEA9CB" name="us-gaap:SharesOutstanding" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2898-wk-Fact-74C0A61F98BD52B4872C21399AE42374" name="us-gaap:StockholdersEquity" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,395.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2917-wk-Fact-F562D6631F205CA9A74148758FAC34C5" name="us-gaap:StockholdersEquity" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">99.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e2937-wk-Fact-86B334C9E383555D9177B5E4A091E01D" name="us-gaap:StockholdersEquity" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,768.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e2957-wk-Fact-3DA0E683129350C8AC6C516CF184A954" name="us-gaap:StockholdersEquity" contextRef="FI2019Q2" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,726.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3123-wk-Fact-7E08041E3BC754679799E159D406B21F" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3142-wk-Fact-E71A91499A5557858B57177F0D58A3CB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e3195-wk-Fact-09B0D8908379593DBB84F98C4B6C3A8E" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">42.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e3235-wk-Fact-B55D38643BC659D6BE67B97A4EF336FC" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">42.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Stock options exercised</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3270-wk-Fact-6A3FE5A4172B59959D7BA97CCE085663" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3328-wk-Fact-D0E931DBF4D85009B6E0F1DA0C090D72" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Restricted stock plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3348-wk-Fact-6A1FF210695B54B586FFAC8F0310C07E" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for stock options</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3454-wk-Fact-AC8479F1C2E855078A4981F6928A9366" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3512-wk-Fact-2A61D90847D35003A818AB8CA94E127C" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for restricted stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3546-wk-Fact-0D4FE56646D857FCACA46C9381BC4BC2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3604-wk-Fact-679443BC21EE52F29E088721D5B21E0C" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash dividends, $0.21 per share</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e3638-wk-Fact-919AB70CC29A5D69BB0BA9583432B19F" name="us-gaap:DividendsCommonStockCash" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e3697-wk-Fact-C80667C4A6E951D498F67285A77E8519" name="us-gaap:DividendsCommonStockCash" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Shares withheld for payment of employees' withholding tax liability</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e3732-wk-Fact-23275A4D5EF055188874C49208903E47" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e3791-wk-Fact-F451111BD0BE5E61AE4492DE6EEB71D0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at September 28, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3812-wk-Fact-BBCA5923A5225459864D35C83E57C2CC" name="us-gaap:SharesOutstanding" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3831-wk-Fact-CA15807E74495141930F07036BE6E096" name="us-gaap:StockholdersEquity" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,378.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3850-wk-Fact-151FD4BBAE745621AA3C874C258B59D2" name="us-gaap:StockholdersEquity" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">56.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e3870-wk-Fact-C02B77CBCFBF54C9B36214973056E96D" name="us-gaap:StockholdersEquity" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,676.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e3890-wk-Fact-F9026000C3035C2593B1B2196B1BD8C3" name="us-gaap:StockholdersEquity" contextRef="FI2019Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,758.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 5</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">PERRIGO COMPANY PLC</span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY (CONTINUED)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(in millions, except per share amounts)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(unaudited)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"></td></tr><tr><td style="width:46%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Ordinary Shares<br/>Issued</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Retained<br/>Earnings<br/>(Accumulated Deficit)</span></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4138-wk-Fact-D507145B780057A29523743891388CF7" name="us-gaap:SharesOutstanding" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4157-wk-Fact-6A2E12D2A4705F1CAD4BAC51C4819680" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,359.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4176-wk-Fact-E2902A17BE1D5AB38330DA9EA8BD38AA" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">139.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4196-wk-Fact-68733B1EC6A65C808BC698C3ABFA4E24" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,695.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4216-wk-Fact-D06E57F29B8B5F4A8D9A0640CB3E74C9" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,803.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4284-wk-Fact-FAC3B202B6F15C9DB25C0420E219D498" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4303-wk-Fact-59B9364B2F12503686C5D2B3F09AED37" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4356-wk-Fact-0B0976D9C4A452B5ACE288E099408AF6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">103.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4396-wk-Fact-DDFBA54E478D59FEAD34600C8AB93A0C" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">103.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Restricted stock plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4417-wk-Fact-9CDE1314AEC8580F892FE575452FA159" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for stock options</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4523-wk-Fact-B9255D57CBA55D2BA391BBF9660CFEF0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4581-wk-Fact-1F2B4A113C5C51F1863B4D4164625BC8" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for restricted stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4615-wk-Fact-D79753EAC3E0596CBC5580855C00D6F6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4673-wk-Fact-45FB7436848957F6AA51106CB5136FDB" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash dividends, $0.23 per share</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4707-wk-Fact-9A4BDDC843C35403BCDD46FC8407EA6F" name="us-gaap:DividendsCommonStockCash" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4766-wk-Fact-0FB2A9B13E9E5FE1B6F1AE2DCBDE4081" name="us-gaap:DividendsCommonStockCash" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Shares withheld for payment of employees' withholding tax liability</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4787-wk-Fact-B25C967A781A593CB63EC7D41362EC4F" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4802-wk-Fact-ED0C78F363DB5EA288AA79233B1CCFDF" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4861-wk-Fact-F9A13477EEB557648843EA554A9116CF" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at March 28, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4882-wk-Fact-731519E00E455588B3275DFC59D2DE04" name="us-gaap:SharesOutstanding" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4901-wk-Fact-CE44ED2C63595C62AA2D71901D5B2C46" name="us-gaap:StockholdersEquity" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,339.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4920-wk-Fact-07256A7AABE353CDA4D1DD1D92C4318E" name="us-gaap:StockholdersEquity" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">35.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e4940-wk-Fact-5E34A4DFEAEF52D4AA6309DE69485E9D" name="us-gaap:StockholdersEquity" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,589.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e4960-wk-Fact-1A401CE6D02753EA973F1C551DDF1395" name="us-gaap:StockholdersEquity" contextRef="FI2020Q1" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,786.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5126-wk-Fact-92343C9C02BA581DA615F53B62104870" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5145-wk-Fact-C341ED6A2E5D5867B1F7740A9C5E8CC3" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5198-wk-Fact-F1BA7E81821D57B3B04D569C482F4A7F" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">84.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5237-wk-Fact-31E8408E11B75A818843134129F7922B" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">84.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Restricted stock plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5257-wk-Fact-2B3CC67BA6B0541BAEDF2E147317A08C" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for stock options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5363-wk-Fact-E6AF07E6FE1C5952B2C2E0649C2452A6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5421-wk-Fact-9BF7C70A25CC589DA6A3753F395CAD15" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for restricted stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5455-wk-Fact-1CD85BB0CFB752B49E220A96E6DD12BB" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5513-wk-Fact-F2F736B69A11553ABEBDB5C34420BF84" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash dividends, $0.23 per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5547-wk-Fact-07C5B950E1C9530D9448C25CD4696F56" name="us-gaap:DividendsCommonStockCash" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5606-wk-Fact-5C8E69A5B1EB53A1B2A599061F208A5C" name="us-gaap:DividendsCommonStockCash" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Shares withheld for payment of employees' withholding tax liability</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5627-wk-Fact-78AED5C819F356F0AF7FBD747BFE13E7" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5642-wk-Fact-5F82F53D4C335F219799BD41E88240E2" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5701-wk-Fact-D7ED7939C5B050E092F5DC926D15E0C8" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at June 27, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5722-wk-Fact-93E6F763AC765C9EA1458E9B38DE81EF" name="us-gaap:SharesOutstanding" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5741-wk-Fact-60D762E5825150829B8F9EFB583EA4D1" name="us-gaap:StockholdersEquity" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,318.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5760-wk-Fact-2A1C5E6A5B2B54FEAD2EEBBCC4261619" name="us-gaap:StockholdersEquity" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">120.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5780-wk-Fact-810ED380803957DE8D023266A73C47FF" name="us-gaap:StockholdersEquity" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,528.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e5800-wk-Fact-1318198479BF57A8810BAB00AE766131" name="us-gaap:StockholdersEquity" contextRef="FI2020Q2" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,910.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5965-wk-Fact-D5AF79DF33E0553DBCAD8C47E5EEE4D4" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">154.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e5985-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">154.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6040-wk-Fact-927703C172E25D7797B907787A799936" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6079-wk-Fact-41F0EC93E96E566ABA687EEFF4EA8600" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for stock options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6113-wk-Fact-01067141B0285BA19EA9A1F4ADA3DDA2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6171-wk-Fact-8B6AC875DAE95993971D7D216F015CAE" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Compensation for restricted stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6205-wk-Fact-742D581D96CB56708D21103AA94EF9CF" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6263-wk-Fact-58F8626D7E215405B2FA2ED5071439C9" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash dividends, $0.23 per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e6297-wk-Fact-74F8F9D79B465408AB6520B3B66178C7" name="us-gaap:DividendsCommonStockCash" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e6356-wk-Fact-7F1E77FC635752808333DA75D33A2D1B" name="us-gaap:DividendsCommonStockCash" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Shares withheld for payment of employees' withholding tax liability</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e6391-wk-Fact-2F4C180A219E5A06A9E41EC1B7582A35" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e6450-wk-Fact-1301F3D90EBC5E2FAFD78799033B7D01" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Minority share purchase</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6471-wk-Fact-043EECBD788D53ACB754B78C197305D3" name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e6485-wk-Fact-3D1620220EE451F4A9502D188524CEEF" name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e6544-wk-Fact-8F4FBF61050458B4B3C358388326F8BB" name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at September 26, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6565-wk-Fact-89FC093427065AB395F88B7182D71D4E" name="us-gaap:SharesOutstanding" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6584-wk-Fact-F99B7AF9F64E581687294D6B33C2AA46" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7,299.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6603-wk-Fact-6E44D95C44115A8395CECBD5423A2DA3" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">203.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d93954e6623-wk-Fact-C269320FF2955943AB7A441DCB0952BC" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1,683.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d93954e6643-wk-Fact-846869810E8450D8BE8B8396EBFB23D6" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5,820.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 6</span></div></div><hr style="page-break-after:always"></hr><div><a id="s28673D083583539C88DAE7DD33C531F5"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PERRIGO COMPANY PLC</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(in millions)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(unaudited)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Cash Flows From (For) Operating Activities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1125-wk-Fact-08FB4EC393345107970F7A706AE01243" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1144-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">165.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Adjustments to derive cash flows:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1200-wk-Fact-F53C91BDE1545CB7A7B87535C8EBE85F" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">284.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1219-wk-Fact-1EBD0EE6FC245540AA0CF754F341EF39" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">293.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Loss (Gain) on sale of business</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1239-wk-Fact-45394A79770C5D8897868EE5B0D2D8AE" name="us-gaap:GainLossOnSaleOfBusiness" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">18.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1258-wk-Fact-F7C32398D30C5C45996AAF182AE08A6B" name="us-gaap:GainLossOnSaleOfBusiness" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1279-wk-Fact-B8F7E44E3117500FBA940FB5C245BDC5" name="us-gaap:ShareBasedCompensation" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">43.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1298-wk-Fact-37BB27C8399B52AA8DFF412DCB67A4F2" name="us-gaap:ShareBasedCompensation" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Impairment charges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1318-wk-Fact-0066578628895F70805AFE67D1011EBB" name="us-gaap:AssetImpairmentCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">202.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1337-wk-Fact-940FE1DE4ED55FADA37E655425AB20A1" name="us-gaap:AssetImpairmentCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in financial assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1357-wk-Fact-AA69DA9C163E5A8AB11F17B108E0C11E" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1377-wk-Fact-8FC648BE938852AEAA299EA381B9DB24" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1398-wk-Fact-58778DCFB5C15CE5933FBA3C0454796C" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1417-wk-Fact-43E7CF76DF365C59AED53F502E3D6F2B" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Restructuring charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1438-wk-Fact-18F9BED0F94059D18D6FF41F640DA407" name="us-gaap:RestructuringCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1457-wk-Fact-CA124A1C3230592D914E7CD3C91A98A9" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1477-wk-Fact-132A8191D6E85839813F643013F48C0D" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1496-wk-Fact-EFE1E702640F52489DE1AD255309E893" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amortization of debt premium</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1516-wk-Fact-8F5740CE831C55538D0276ED799D083A" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1536-wk-Fact-647FA7FC6EB756D6988A8A56EA3642A1" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-cash adjustments, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1557-wk-Fact-8358E596BDA4557C80C64844E121E06C" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1577-wk-Fact-18C532D0EF8653F6B10BD42099A23BC3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">38.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Subtotal</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1597-wk-Fact-43F19EFD8A4451D2A9C05CEC800A6E8E" name="us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">570.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1616-wk-Fact-929B96EEC4605CF3A757CFAC8F9F0884" name="us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">523.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Increase (decrease) in cash due to:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1677-wk-Fact-3A0C045B101459BAB6A01306BC42DC0E" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">106.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1696-wk-Fact-EADE9CA2BDF45BA4AA255B64651FF2A0" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1717-wk-Fact-19A041549D865206A6A65FCB9DACF76A" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">93.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1737-wk-Fact-2B666BA3C8B45F30B768C2F5C262ECB0" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">78.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1758-wk-Fact-80BEE97128A95061AA020B03F5829560" name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1778-wk-Fact-55AFE617029E577AAD3C4F3196E05370" name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1799-wk-Fact-910D30438BAF5942BBFADD9D77411048" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e1818-wk-Fact-C0F826805E3C5DCE8399761ED23C3643" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1838-wk-Fact-2819F56CAA1E53CD9CBE2563895954F6" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1858-wk-Fact-2488C50035825EB498108DA401C8C955" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">10.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1880-wk-Fact-E4C7C8A67C675697B868D6E5C68CE4C1" name="prgo:IncreaseDecreaseInAccruedCustomerPrograms" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">35.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1900-wk-Fact-D2ED3C5A50D05C95A50087BF1C07F11D" name="prgo:IncreaseDecreaseInAccruedCustomerPrograms" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">82.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1921-wk-Fact-E85C4D94547D5939B4AD7BFF10A5B87D" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">16.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1941-wk-Fact-8DF369619E0C5AE09B1E3C235A2D10C6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">24.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1962-wk-Fact-2371B8F5DC7350299C865823EFC2BAC9" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e1982-wk-Fact-44AB84F02F5E5D6599F952BC72D1C231" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">65.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other, net </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2003-wk-Fact-B8C39DC0731157B0A7722241EDBB1564" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">13.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2022-wk-Fact-57BDBD2CBB0A5565B2D2BF7DFE00AE48" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">20.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Subtotal</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2042-wk-Fact-376C912B89FA53BF8E41C9C039ED7B1C" name="us-gaap:IncreaseDecreaseInOperatingCapital" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2062-wk-Fact-B40D5D89C92E59639D35D6BCA6F0691A" name="us-gaap:IncreaseDecreaseInOperatingCapital" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">224.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net cash from (for) operating activities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2083-wk-Fact-16B85FB1A4205BC692DC5BDC4776C7C7" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">525.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2102-wk-Fact-8C65F63B772054D5B7DB1F1EC2D3736D" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">298.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Cash Flows From (For) Investing Activities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Proceeds from royalty rights</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2163-wk-Fact-2DCA5A977293548E9EC79C42BB5B6DAD" name="prgo:ProceedsfromRoyaltiesReceivedInvestingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2182-wk-Fact-BE307687BEB85E06A2190299CB8EB98A" name="prgo:ProceedsfromRoyaltiesReceivedInvestingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase of equity method investment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2202-wk-Fact-A89EB36389905E01820EF04565506A05" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2222-wk-Fact-7D53F4105D1C50678CD0FE00D6A49171" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Acquisitions of businesses, net of cash acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2242-wk-Fact-F81A03979969542981CFF0C72F1196B8" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2262-wk-Fact-C27C12EF117E53F79E869FB509FCEC04" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">749.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Proceeds from the Royalty Pharma contingent milestone</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2283-wk-Fact-55C585F130B55907A21C9C23C7959A13" name="prgo:ProceedsfromContingentMilestonePayment" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2302-wk-Fact-BE4A49FC30CC5C3DB0C3C38249A5BBA4" name="prgo:ProceedsfromContingentMilestonePayment" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">250.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Asset acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2323-wk-Fact-5E98CE8BB7C151FC9DDA0203929EA2ED" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2343-wk-Fact-9C1C73F90D9A5E029A02B3E03D7EC3AF" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">86.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Additions to property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2364-wk-Fact-9CBE35742ADE5F3D8B7DC5292EB868EE" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">104.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2384-wk-Fact-40AF8462E0565D2E811A7D28A11C4AB8" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">90.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net proceeds from sale of business</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2405-wk-Fact-99738CEFD3EF5DA7BEBC2F1C2337F115" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">187.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2424-wk-Fact-AEC794A4388A59A1845E8B33133F255D" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">183.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other investing, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2444-wk-Fact-B3B45CCE25F25E849F40975DC17F4EBE" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">8.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2463-wk-Fact-EA34EC96385A5F7E85E536825C79DD8D" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net cash from (for) investing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2483-wk-Fact-698B15B623535C10B4AFA068387EE671" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">60.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2503-wk-Fact-BB5D52B604C351C494BF3728A6C8B8D2" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">489.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Cash Flows From (For) Financing Activities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Issuances of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2565-wk-Fact-95D980E8E959500BA87B9D5D432E67EE" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">743.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2584-wk-Fact-87E245D04E6052CA95AC6AC8C5E355EA" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">600.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payments on long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2604-wk-Fact-8C2368EE2DD25DA4B4AD71A1BC305312" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">590.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2624-wk-Fact-AEF78218F56852A3A5FB72FE99D34E74" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">476.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Borrowings (repayments) of revolving credit agreements and other financing, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2645-wk-Fact-520CBCA2C1F35128B48E2567D697E8F2" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2664-wk-Fact-600104C4EB20567BA2D4E58A58EA6D72" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred financing fees </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2684-wk-Fact-D66E88AEF5A05C7D868CBD0E52EA4BC1" name="us-gaap:PaymentsOfFinancingCosts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2704-wk-Fact-6A7EFC278FED58C992AF0D8182EAC639" name="us-gaap:PaymentsOfFinancingCosts" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Premiums on early debt retirement</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2725-wk-Fact-B26EA1203062EFF0263846F00FA1FCF4" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2745-wk-Fact-9491F5349BBB5E6CA1256218AAB22856" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Issuance of ordinary shares</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2766-wk-Fact-A52BF06CDC225A11B05172EAFCB1CB86" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2785-wk-Fact-EC7630C811305379897F7C0D1DDBF35F" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash dividends</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2805-wk-Fact-AE637BF800EA5FE08A302FD57CA35A6C" name="us-gaap:PaymentsOfDividends" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">93.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2825-wk-Fact-7A3348648872590EA2F12582E3F33F04" name="us-gaap:PaymentsOfDividends" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other financing, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2846-wk-Fact-2D9421D511BD594785D2B54303FD3F11" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">14.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2866-wk-Fact-54E055EDB9EF515CA1E074D94C1D1AF2" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">7.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net cash from (for) financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2887-wk-Fact-184AAD8157AF534AB79D013A2D18FE83" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2906-wk-Fact-5213AD317A695D40B3E721D484F38FE1" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Effect of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2926-wk-Fact-163AEE4D2536556C8791E7B5C6C841A9" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2945-wk-Fact-340BC6158CF958A6ACBC36025665A1E2" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net increase (decrease) in cash and cash equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e2965-wk-Fact-03BD4D7D560B5195A48D8ECC6EB9D90A" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">495.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d13017e2984-wk-Fact-6CCF08BBE7E25A19B1ACF22FFFF9B5AC" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">152.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash and cash equivalents, beginning of period</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e3005-wk-Fact-ACD4FA4832435311AF626F2A11B39C26" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">354.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e3024-wk-Fact-46F1A11719E3509D8B11D5949905AEB3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">551.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash and cash equivalents, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e3049-wk-Fact-58BB8483DAC05DE7AAF556A0DEE62432" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">849.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d13017e3068-wk-Fact-FDB9871650AB5338976C30B8DEE11436" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2019Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">398.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 7</span></div></div><hr style="page-break-after:always"></hr><div><a id="s11FF556E31155CDD962D128C0F82C466"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 1</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s54388EBEFB445B11AB98129252518AD4"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">NOTE 1 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="TextSelection-936C8E4E15C95481820A20F081C56695-0-wk-Fact-FCB7FFD329EF5B09B4409EDD660DE356" continuedAt="TextSelection-936C8E4E15C95481820A20F081C56695-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </span></ix:nonNumeric></div><ix:continuation id="TextSelection-936C8E4E15C95481820A20F081C56695-1" continuedAt="TextSelection-936C8E4E15C95481820A20F081C56695-2"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">General Information</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">The Company</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are dedicated to making lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold.&#160;We are a leading provider of over-the-counter ("OTC") health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. We are also a leading producer of generic prescription pharmaceutical topical products such as creams, lotions, and gels as well as nasal sprays and inhalers. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="TextSelection-DA42D19738E857629AFFB22794863D30-0-wk-Fact-5A518B35AE3F59DB898F38A665F26F20" continuedAt="TextSelection-DA42D19738E857629AFFB22794863D30-1" escape="true"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><ix:continuation id="TextSelection-DA42D19738E857629AFFB22794863D30-1" continuedAt="TextSelection-DA42D19738E857629AFFB22794863D30-2"><span style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span></ix:continuation><span style="font-family:Arial;font-size:10pt;"><ix:continuation id="TextSelection-DA42D19738E857629AFFB22794863D30-2">.</ix:continuation> <ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ConsolidationPolicyTextBlock" id="TextSelection-E5A54F1B17BE587F967FBD58E1FE1E73-0-wk-Fact-3EA6AE7C84AF547284EA4F35297682C4" escape="true">In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</ix:nonNumeric></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Segment Reporting </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our reporting and operating segments are as follows: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Consumer Self-Care Americas</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">CSCA</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our consumer self-care business (OTC, contract manufacturing, infant formula, and oral self-care categories and our divested animal health category) in the U.S., Mexico and Canada. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Consumer Self-Care International</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">CSCI</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our branded consumer self-care business primarily in Europe, our consumer self-care businesses in the United Kingdom and Australia, and our divested liquid licensed products business in the United Kingdom.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Prescription Pharmaceuticals</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">RX</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our prescription pharmaceuticals business in the U.S., predominantly generics, and our pharmaceuticals and diagnostic businesses in Israel.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Reclassifications</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certain prior period amounts have been reclassified from other current assets to other non-current assets on our balance sheet to conform to the current period presentation. Such reclassification had no impact on net income or earnings per share.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 8</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 1</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="TextSelection-378B663A7FE55BED9FF5137D0F6159DD-0-wk-Fact-DC3A7A24EEF85A66A0D9657553463030" escape="true"><ix:continuation id="TextSelection-936C8E4E15C95481820A20F081C56695-2" continuedAt="TextSelection-936C8E4E15C95481820A20F081C56695-3"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standard Pronouncements</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. <ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="TextSelection-DAD6D04F9120500CB67116019A77492C-0-wk-Fact-4FA43792D28258389AAB9F24102E520C" continuedAt="TextSelection-DAD6D04F9120500CB67116019A77492C-1" escape="true">As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</ix:nonNumeric></span></div><ix:continuation id="TextSelection-DAD6D04F9120500CB67116019A77492C-1"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:26%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:41%;"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted </span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Standard</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Description</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2018-14: Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans  </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other post-retirement plans. </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">December 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we will no longer be required to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. We will be required to disclose an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, if applicable. </span></div><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance enhances and simplifies various aspects of the income tax accounting guidance in ASC 740.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">January 1, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we do not expect a material impact on the Consolidated Financial Statements.</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Standard Update</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 1, 2020, we adopted ASU 2016-13 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASC 326")</span><span style="font-family:Arial;font-size:10pt;">, which replaces the incurred loss methodology with an expected loss methodology that is referred to as the Current Expected Credit Loss ("CECL") methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We adopted ASC 326 using the modified retrospective method for all financial assets measured at amortized cost, which includes trade receivables and contract assets. The cumulative effect of adopting ASC 326 was not material. </span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Allowance for Credit Losses</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and for reasonable and supportable forecasts. Historical credit loss experience provides the primary basis for estimation of expected credit losses. Adjustments to historical loss information may be made for significant changes in a geographic location&#8217;s economic conditions. Receivables that do not share risk characteristics are evaluated on an individual basis. These receivables are not included in the collective evaluation.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The allowance for credit losses is a valuation account that is deducted from the instruments&#8217; cost basis to present the net amount expected to be collected. Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible. </span></div></ix:continuation></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 9</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 1</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="TextSelection-C9AD8225A0DC550694B80F95BDFBB8CB-0-wk-Fact-E4DC6DFEC5555D89A910B803CC08DF90" escape="true"><ix:continuation id="TextSelection-936C8E4E15C95481820A20F081C56695-3"><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table presents the allowance for credit losses activity (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:76.31027253668763%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:57%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1525-wk-Fact-735196DD20B957B2B4120AF2E1F8FCC4" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="FI2020Q2" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1544-wk-Fact-D8CCAD9B9909561382639359A4072805" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Provision for credit losses, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1559-wk-Fact-2D3950B91EEE50C5B016195A43D7013C" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1578-wk-Fact-8DA8E7845E455D179A16B9DABBD41403" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Receivables written-off</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6883e1598-wk-Fact-30F36CAE4BFF566AB85A0A2B722C9823" name="us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6883e1618-wk-Fact-DC57F56A5B995A5D88CE6C68A5BE63A4" name="us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Recoveries collected</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1639-wk-Fact-46E908BBFEFA5A05B302AEB1AB1A2DA5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1658-wk-Fact-46D3EAF1F94352FB93E5F5837EF471E9" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Currency translation adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1678-wk-Fact-4631D656036557AA89B5DC95B7760EBE" name="prgo:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d6883e1697-wk-Fact-A58FD694406551FFBD1A08A9D2DD954D" name="prgo:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1723-wk-Fact-5A1CD941C7525446B4A569E7E33C711B" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d6883e1742-wk-Fact-5A1CD941C7525446B4A569E7E33C711B" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation></ix:nonNumeric><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s612D07A762DA56AB961D86277A297B7E"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 2 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="TextSelection-B4B3C4CF674951868DB5B341E0157BC4-0-wk-Fact-8B06042F419950608C3ABA2436E54B80" continuedAt="TextSelection-B4B3C4CF674951868DB5B341E0157BC4-1" escape="true"><span style="font-family:Arial;font-weight:bold;">REVENUE RECOGNITION</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-B4B3C4CF674951868DB5B341E0157BC4-1" continuedAt="TextSelection-B4B3C4CF674951868DB5B341E0157BC4-2"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Disaggregation of Revenue</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-0-wk-Fact-61AD78FA54AD553FA6F12F1D2C9F9FA9" continuedAt="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-1" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We generated net sales in the following geographic locations</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></span><span style="font-family:Arial;font-size:10pt;">(in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:526px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:134px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">U.S.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1206-wk-Fact-DE9A4C836BA8550DB1E1A87EB6EAE22E" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">820.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1225-wk-Fact-392CC0D02686521681FB64A94FFD57EC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">785.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1244-wk-Fact-DD3F6F8837535D62BCEAA41CB8BB7E87" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,571.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1264-wk-Fact-18CC7AAB145A5D47B3481557211BBDCA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,323.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Europe</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">326.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">334.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,011.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">991.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">All other countries</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">66.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">191.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">200.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1444-wk-Fact-91F79D5851FA52E297E9A21CD478C108" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,213.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1463-wk-Fact-AD8DF8663E025098BD5438A9C8F58044" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,191.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1482-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,773.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1502-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,514.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"></sup></span><span style="font-family:Arial;font-size:8pt;">(1)  <ix:footnote id="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Derived from the location of the entity that sells to a third party.</ix:footnote></span></div><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:72px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(2)  <ix:footnote id="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="TextSelection-4217738E32425A0CA150B80B85D9D810-1">Includes Ireland net sales of </ix:footnote></span><ix:continuation id="TextSelection-4217738E32425A0CA150B80B85D9D810-1"><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d78798e1535-wk-Fact-777739C88F5458FD97072B94A884ACB5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_country_IE" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d78798e1539-wk-Fact-D490B719F9405AAEA6CD9E886BC21C81" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_country_IE" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, respectively, and </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d78798e1551-wk-Fact-785C42BE34D450829F0F567A78E16CBC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_country_IE" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d78798e1556-wk-Fact-09CB522366FF5AE2A4653792E4240826" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_country_IE" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:8pt;">, respectively.</span></ix:continuation></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(3)  <ix:footnote id="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Includes net sales generated primarily in Israel, Mexico, Australia and Canada.</ix:footnote></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"></span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Product Category</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We re-aligned our product categories in our </span><span style="font-family:Arial;">CSCA</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;">CSCI</span><span style="font-family:Arial;font-size:10pt;"> segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 10</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 2</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-B4B3C4CF674951868DB5B341E0157BC4-2"><ix:continuation id="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-1" continuedAt="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-2"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following is a summary of our net sales by category (in millions); the comparative periods reflect the product category re-alignment: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:304px;"></td><td style="width:6px;"></td><td style="width:79px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:79px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:79px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:79px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Upper respiratory</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1908-wk-Fact-0BA2FB3E6CEFDE829E52C23D08C7F02A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">114.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1927-wk-Fact-07165EDB3C0005A6D9D2C23D4017AF82" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">123.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1946-wk-Fact-058668D8C7005426B4C3D67A9EF7BA2C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">385.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1966-wk-Fact-EEDAC2A820335BAE87547B31EBD9B783" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">377.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Digestive health</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e1981-wk-Fact-98212D0D96F6C3C466A6C23D091CC246" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">107.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2000-wk-Fact-C74F19076DA00A5A112EC23D401D8661" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">85.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2019-wk-Fact-D8FA5406EF085766869DD5593BBE73C1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">326.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2039-wk-Fact-2D3B683CCB6757D19D2C95D94D3569F4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">293.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Pain and sleep-aids</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2059-wk-Fact-034B81C2CBF9BD393C6BC23D090C4C72" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2078-wk-Fact-A071C9820456842D5C8DC23D400BDA15" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">89.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2097-wk-Fact-9563BEF0C0E95D478DFD17FFD936C48D" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">318.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2117-wk-Fact-8DA178F61A0B599B8927F372D1AD84EA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">272.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Nutrition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2137-wk-Fact-284B913344E890E80267C23D08DE1D31" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2156-wk-Fact-62E52EE1F31D31AECA10C23D4005FDC0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">97.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2175-wk-Fact-6C2AFC76F3FB504D9DEA13D586331121" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">290.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2195-wk-Fact-43B0F047528459B790AAD8A9134D6AA2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">282.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Healthy lifestyle</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2215-wk-Fact-B655005C6314FA6A5234C23D08EAFD02" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">86.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2234-wk-Fact-5B5B45D14A2090C385D7C23D40001AF2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">87.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2253-wk-Fact-02352B46854A58049795BE464FC233D9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">253.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2273-wk-Fact-4D78AA98677C5D8A90ACFBB38F4EAF9B" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">250.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Oral self-care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2293-wk-Fact-B8F573B70839E2A8BBFFC23D091C44CD" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2312-wk-Fact-AF98BE21034CD26C4FE6C23D3FBF0A4B" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2331-wk-Fact-1EDEA42D38F954E886C6569B8C981F6C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">199.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2351-wk-Fact-8BD2C497D6995B9FBEC20505802E4864" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Skincare and personal hygiene</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2371-wk-Fact-C9CD9CB7062A2550FB5AC23D08E347EF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2390-wk-Fact-56C2DDD0574A5F4F2A28C23D3FE2DE4F" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2409-wk-Fact-8433D7C2B404533EAFB42C71B825CE9F" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">138.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2429-wk-Fact-E1FC9D6A150754FCB60DFBF799663B3D" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">136.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Vitamins, minerals, and supplements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2449-wk-Fact-560EE9F6818EE9154A68C23D08C74EBA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2468-wk-Fact-B0487950B5F34DB9F3D2C23D3FF990C4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2487-wk-Fact-98DD498FAEFC5940AEE42CD74D33C288" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2507-wk-Fact-1C660C6F8C885777917A013B8B8DFE59" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Animal health</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2528-wk-Fact-29AAAE7CC23E70F54FDDC23D08B8004C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2547-wk-Fact-6E4DC9AC015A4D32CCEDC23D3FDC3B64" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2566-wk-Fact-152380BDE3875A368ADC1645FA22C174" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2586-wk-Fact-E721BAA9C2B050908B37049D4B6BBD68" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">43.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other CSCA</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2608-wk-Fact-2B31A4553CCB3532E5BFC23D08D85530" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2627-wk-Fact-FC07D92174658F508F43C23D40114902" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">48.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total CSCA</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2686-wk-Fact-C31A12065CA4018CCDDCC23D08FB9B33" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">664.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2705-wk-Fact-6F06EEC2D6D104D37336C23D40236485" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">613.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2724-wk-Fact-8A512266646C595482EF17DA8AAAAA8E" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,992.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2744-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,777.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Skincare and personal hygiene</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2846-wk-Fact-1CEE4F89C13D0FD65017C23D090738E5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2865-wk-Fact-49F7A7C0DF94949D258AC23D3FEE6494" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">88.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2884-wk-Fact-96A1FE303DEB527D9AE1AA9ABB759C95" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">275.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2904-wk-Fact-A43072A5AB705B8C9F96F1F79BA64C42" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">296.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Upper respiratory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2924-wk-Fact-511A300C66A83A6A98A6C23D08C7DB95" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2943-wk-Fact-CD334F190A4079CC036CC23D4030E2C7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2962-wk-Fact-51F74971F2425151B7F21CDE4D75CA25" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">191.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e2982-wk-Fact-203E920C49D0599D8A5AEB6E8CADC555" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">193.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Vitamins, minerals, and supplements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3002-wk-Fact-EABE5FE0AFF8E6951059C23D08F21821" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">52.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3021-wk-Fact-5209399D4C0D67ADF0D7C23D3FCB5161" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3040-wk-Fact-1BC7BA0E70C2579693D29CA3419C0AD3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">139.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3060-wk-Fact-1B3ED369658C5A089B57614E70D0B4C2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">133.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Pain and sleep-aids</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3080-wk-Fact-6585952DEDEDBD690281C23D091CD8F4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3099-wk-Fact-0D30585BDB8F6CB1E0DCC23D402A8636" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3118-wk-Fact-92B66DC3F3165509AACC0627F70E5ED9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">136.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3138-wk-Fact-7549CA5CE3735D7A960AB846BCAAD4B2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">120.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Healthy lifestyle</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3158-wk-Fact-367FB9D370F1C284D64CC23D09017471" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3177-wk-Fact-4C7D6B25F1C676F25CDBC23D3FC53AEB" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">38.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3196-wk-Fact-EDC8D1B7C46D575D9E0373FAA1D31DE6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">124.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3216-wk-Fact-83D0FE368A125A93BD1316D73741EF9D" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">134.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Oral self-care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3236-wk-Fact-8B51BAB28B593BE0AFB0C23D092CA27D" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3255-wk-Fact-2BDA96D43C5AFB711DA8C23D4036B5FD" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3274-wk-Fact-4A580B34A6A65C3582B04D244E112F75" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">68.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3294-wk-Fact-E4219D2880045D41BD97B0E73287F360" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Digestive health</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3314-wk-Fact-D44FDABBBFA4C08856D2C23D090CEE66" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3333-wk-Fact-589D1B628216950C54C2C23D3FD69344" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3352-wk-Fact-2120E84AB0985415B71B435911C6E4F9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3372-wk-Fact-DC1E744471D659E3998040BADDACF6CF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other CSCI</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3395-wk-Fact-AC489B599FC5ECFC2807C23D08B8F63A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3414-wk-Fact-AF406491037E2EFA5369C23D3FE7F0FE" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3433-wk-Fact-5D0DBD67D2B657C3B59581DD44F1C634" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">88.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3453-wk-Fact-B9EA1E3D2DD758478C3781F4783BED45" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">100.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3473-wk-Fact-F13FA3A1ED61A1698A2CC23D090CBAD3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">339.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3492-wk-Fact-83F126B674510C0DDA76C23D403C42D9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">347.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3511-wk-Fact-A8E55B983BFE55EAA0C2CD7EB512EAAB" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,042.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3531-wk-Fact-6A9C3E189E13591A95A5A88A23378280" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,025.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3551-wk-Fact-9FCC6F1E4EF2B5BD9BB0C23D092C86FD" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3570-wk-Fact-447E72E2DB5FAC45B5C1C23D3FF3CCC7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">230.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3589-wk-Fact-F4F655B41C045B60A17D25F0408DC766" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">738.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3609-wk-Fact-F09B459D0AD95E23A8B13DB22EF55A16" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">711.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3634-wk-Fact-91F79D5851FA52E297E9A21CD478C108" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,213.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3653-wk-Fact-AD8DF8663E025098BD5438A9C8F58044" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,191.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3672-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,773.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3692-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,514.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)&#160;&#160;&#160;&#160;<ix:footnote id="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Includes net sales from our OTC contract manufacturing business.</ix:footnote></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><ix:footnote id="TextSelection-0688D3D2ED7051959163C0B2BE4AA6D3-0-wk-Footnote-0688D3D2ED7051959163C0B2BE4AA6D3_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</ix:footnote>&#160;&#160;&#160;&#160;</span></div></td></tr></table></ix:continuation><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-2" continuedAt="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-3"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(3)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:footnote id="TextSelection-5B20844D52F450CDAEB6F6645EF39AB1-0-wk-Footnote-5B20844D52F450CDAEB6F6645EF39AB1_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US"><ix:continuation id="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-3"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div></ix:continuation></ix:footnote></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d78798e3755-wk-Fact-E70B3C3C55A9528BA86FD04C9A959E2B" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">76.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d78798e3759-wk-Fact-6B512596A05852E7BEF8BA3349BB7D7B" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">190.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, respectively, and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d78798e3771-wk-Fact-36F823D4B9555AFC812CCA6BB27FD04F" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">73.9</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d78798e3776-wk-Fact-DF965D55DD065D4BAC8E430BCBB4F56F" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">207.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Contract Balances</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="TextSelection-2330D0F775F8505E9693D047096B3182-0-wk-Fact-F626EE55B6FD5AC9B03F2FD841D58078" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table provides information about contract assets from contracts with customers (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:26%;"></td><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Short-term contract assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3909-wk-Fact-520F91612E125B18A6A44E728BB41C70" name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d78798e3928-wk-Fact-F8E15D2E4CBE528F8016731B697B7111" name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 11</span></div></div><hr style="page-break-after:always"></hr><div><a id="sA0BB308013C05849BCFF1B0C8BBA3C08"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 3</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 3 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="TextSelection-61E0E639A20E565B805CB864BF579610-0-wk-Fact-640E7239819158E69F0618C9014DA863" continuedAt="TextSelection-61E0E639A20E565B805CB864BF579610-1" escape="true"><span style="font-family:Arial;font-weight:bold;">ACQUISITIONS AND DIVESTITURES</span><span style="font-family:Arial;font-size:10pt;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-61E0E639A20E565B805CB864BF579610-1" continuedAt="TextSelection-61E0E639A20E565B805CB864BF579610-2"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 26, 2020</span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Sanofi Brands</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">August&#160;7, 2020</span><span style="font-family:Arial;font-size:10pt;">, we entered into a definitive agreement to acquire </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d14264e999-wk-Fact-88E00E5FB0987BE3D98D470D0E1EC6BC" name="prgo:NumberofBrandsAcquired" contextRef="D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember" unitRef="brand" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> Eastern European OTC dermatological skincare and hair loss treatment brands, Emolium</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, Iwostin</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, and Loxon</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> from Sanofi for </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;<ix:nonFraction id="d14264e1016-wk-Fact-57A1CF50FE8AE51523574710A9CBF2D9" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember" unitRef="eur" decimals="-5" scale="6" format="ixt:numdotdecimal">52.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and additional consideration for the transfer of related inventory on hand. On </span><span style="font-family:Arial;font-size:10pt;">October&#160;30, 2020</span><span style="font-family:Arial;font-size:10pt;">, the transaction closed for </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;<ix:nonFraction id="d14264e1024-wk-Fact-6556DD63010CA8B0D6D28A6513B98ECB" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2020Q4Oct30_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="eur" decimals="-5" scale="6" format="ixt:numdotdecimal">53.3</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> (approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1028-wk-Fact-31EC76D625B41FDDDF548A674B8AF80C" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2020Q4Oct30_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">), subject to post-closing conditions. The acquisition will be accounted for as a business combination and operating results attributable to the products will be included in our CSCI segment. This transaction builds on our self-care transformation and strengthens our skincare and personal hygiene portfolio.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Oral Care Assets of High Ridge Brands</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">April&#160;1, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired the oral care assets of High Ridge Brands ("Dr. Fresh") for total purchase consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1047-wk-Fact-B1C83BFC9C705FFB9C714F470F8EA4AC" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2020Q4April1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">113.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, subject to customary post-closing adjustments, including a working capital settlement. After post-closing adjustments as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, total cash consideration paid was </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1055-wk-Fact-189E5FFA2E49A18CEC9F471B70881D8E" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, net of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1059-wk-Fact-F7F0231568F056F48812D7D1F043E4C8" name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> that we allocated as prepayment of contract consideration for transitional services to be received related to the transaction. </span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"> This acquisition includes the children&#8217;s oral care value brand, Firefly</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, in addition to the REACH</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and Dr. Fresh</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> brands, and a licensing portfolio. The U.S. operations, which represent a significant portion of the business, will be reported in our CSCA segment and the remaining non-U.S. operations will be reported in our CSCI segment.</span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we incurred </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1095-wk-Fact-90FFF9958A33B9E3F475C69EC83EE486" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1099-wk-Fact-8911545EDCDA51C4B2A17FA09743936E" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> of general transaction costs (legal, banking and other professional fees), respectively. The amounts were recorded in </span><span style="font-family:Arial;font-size:10pt;">Administration</span><span style="font-family:Arial;font-size:10pt;"> expenses within the CSCA segment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The acquisition of Dr. Fresh was accounted for as a business combination and has been reported in our Condensed Consolidated Statements of Operations as of the acquisition date. From </span><span style="font-family:Arial;font-size:10pt;">April&#160;1, 2020</span><span style="font-family:Arial;font-size:10pt;"> through </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, the acquisition generated </span><span style="font-family:Arial;font-size:10pt;">Net sales</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1127-wk-Fact-E86C012F30D953D2A53D8257C5719FAC" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.4</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and Net income of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1131-wk-Fact-85085DACB2ED5C61987781647D7CEEF9" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which included </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1136-wk-Fact-DC8166D791FB54C8A568343A1524DE3C" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> related to inventory costs stepped up to acquisition date fair value.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are in the process of gathering significant relevant information needed to complete the valuation for the assets acquired and liabilities assumed. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired and liabilities assumed will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset and liability fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we recorded measurement period adjustments relating to valuation updates that reduced the acquisition basis of definite lived intangibles by </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1160-wk-Fact-6E1090EA1E0370D5572647177AB5DEA8" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" contextRef="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and reduced goodwill by </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1164-wk-Fact-B956351F13673B8D6F41471973E724F4" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> with an offsetting increase to working capital. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="TextSelection-BA2240AF43B555D795BE5241A92AD87D-0-wk-Fact-5C0D743C8DE35C6C9216214BF8513718" continuedAt="TextSelection-BA2240AF43B555D795BE5241A92AD87D-1" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the consideration paid for Dr. Fresh and the provisional amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 12</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 3</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-61E0E639A20E565B805CB864BF579610-2" continuedAt="TextSelection-61E0E639A20E565B805CB864BF579610-3"><ix:continuation id="TextSelection-BA2240AF43B555D795BE5241A92AD87D-1" continuedAt="TextSelection-BA2240AF43B555D795BE5241A92AD87D-2"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:534px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:368px;"></td><td style="width:6px;"></td><td style="width:154px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Oral Care Assets of High Ridge Brands (Dr. Fresh)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase price paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1224-wk-Fact-189E5FFA2E49A18CEC9F471B70881D8E" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1281-wk-Fact-5690939657A9719E3271471E030F2DE4" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1301-wk-Fact-0D5FCEF0F1C36847F6E4471E943CB563" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1321-wk-Fact-B4A42733994A1300BC90471EA37A5A37" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1341-wk-Fact-E98E23146FF1AFE038F6471EB2D887B0" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1361-wk-Fact-BBF67EF052E1B7E76561471EC391AC16" name="prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1381-wk-Fact-C592AD988D1C2800517B471ED1C35BA1" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1406-wk-Fact-DB2BF6E09265BE1D8F25471F873EB184" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1422-wk-Fact-46275AF75AB88C3247A8471F85AE58F3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1442-wk-Fact-974AADFFF5FD7B70B1AE471F84D57B52" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1462-wk-Fact-5D4C83F5D4AA15AFD453471F84D5AAC9" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">43.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1487-wk-Fact-A8B1D2B58E1913411949471F84E5C5EC" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">66.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1507-wk-Fact-4EE19551C6ACF42D3086471F9B412D93" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">122.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1548-wk-Fact-1150F92DC389CF482F44471FAFEADFE4" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1563-wk-Fact-F88E05DD92862DEC47AB471FC0492408" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1583-wk-Fact-71401E0EE68240DC89D6471FCC25168D" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1603-wk-Fact-6AE3565AE9918860569D471FDCB0195B" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1623-wk-Fact-75BD4D5EAAA0D3553C6A471FE9D753A4" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1649-wk-Fact-1D129D9A23EC8686C1C2471FFC335D35" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1669-wk-Fact-526C4CFA59CCF72913514720118C7B66" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><ix:continuation id="TextSelection-BA2240AF43B555D795BE5241A92AD87D-2"></ix:continuation>The goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1682-wk-Fact-C592AD988D1C2800517B471ED1C35BA1" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.9</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Dr. Fresh into Perrigo. Preliminarily, goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1686-wk-Fact-15CFF4B2B7A056828D55E0301E503B37" name="us-gaap:Goodwill" contextRef="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1690-wk-Fact-1E0DA6DDB3E85F6B81CB860709185940" name="us-gaap:Goodwill" contextRef="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> was allocated to our CSCA and CSCI segments, respectively. We are currently evaluating the tax deductibility of the provisional goodwill. We expect some portion to be deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, license agreements, and customer relationships which are being amortized over a weighted average useful life of approximately </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e1694-wk-Fact-DD0EB3D65ECE54929B61CC02525CD6AF" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="D2020Q4April1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember" format="ixt-sec:duryear">17.8</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;"> years</span><span style="font-family:Times New Roman;font-size:10pt;">.</span><span style="font-family:Arial;font-size:10pt;"> Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names and developed technology were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Dexsil</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup>&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">February&#160;13, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired Dexsil</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">,</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:Arial;font-size:10pt;">a silicon supplement brand, from RXW Group Nv, for total cash consideration paid of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1729-wk-Fact-84AAF4D957035954A7128FC2B3DFA6E5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="D2020Q1Feb13_us-gaap_BusinessAcquisitionAxis_prgo_DexsilMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">. The transaction was accounted for as an asset acquisition, in which we capitalized the consideration paid as a brand-named intangible asset. We began amortizing the brand intangible over a </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e1733-wk-Fact-2AFA8AD6FC355DE3A9E457D3A30F49B8" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="D2020Q1Feb13_us-gaap_BusinessAcquisitionAxis_prgo_DexsilMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember" format="ixt-sec:duryear">25</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our CSCI segment. </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 13</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 3</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-61E0E639A20E565B805CB864BF579610-3" continuedAt="TextSelection-61E0E639A20E565B805CB864BF579610-4"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Steripod</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup>&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">January&#160;3, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired Steripod</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. Total consideration paid was </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1760-wk-Fact-9BC8C203D2065486A33C4759043579FE" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">. The transaction was accounted for as an asset acquisition, in which we capitalized </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1764-wk-Fact-5FB95FEBAF7350E68D86F36A4F52CCA3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.1</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> as a brand-named intangible asset. The remainder of the purchase price was allocated to working capital. We began amortizing the brand intangible over a </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e1768-wk-Fact-F4004F05AFF55CB28796ABF8C389D466" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember" format="ixt-sec:duryear">25</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our CSCA segment. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition Accounted for as a Business Combination During the Year Ended December 31, 2019</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Ranir Global Holdings, LLC </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">July&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;">, we acquired </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d14264e1793-wk-Fact-E68D84BCEFB65C30BB2D613E7DAB11EF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="ratio" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> of the outstanding equity interest in Ranir Global Holdings, LLC ("Ranir"), a privately-held company, for total base consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1797-wk-Fact-825F9EA7AC1350F3902F571540C382D5" name="prgo:BusinessCombinationBaseConsiderationTransferred" contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">750.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> in a debt-free, cash-free transaction. After post-closing adjustments, total cash consideration paid was </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1801-wk-Fact-381CF6D750525AF0AD36B58DD6AB8C81" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">747.7</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, net of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1805-wk-Fact-1F1547DE73B95D6197B769223F2019E0" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.5</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> cash acquired. We funded the transaction with cash on hand and borrowings under the 2018 Revolver (as defined in </span><a style="font-family:Arial;font-size:10pt;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"><span style="font-family:Arial;font-size:10pt;">Note 10</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Ranir is headquartered in Grand Rapids, Michigan and is a leading global supplier of private label and branded oral self-care products. Ranir's U.S. operations are reported in our CSCA segment and its non-U.S. operations are reported in our CSCI segment. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The acquisition of Ranir was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From July&#160;1, 2019 through December 31, 2019, Ranir generated </span><span style="font-family:Arial;font-size:10pt;">Net sales</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1831-wk-Fact-DE340A29F8BF5367A492D669179CE54C" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" contextRef="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">151.4</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and had </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1835-wk-Fact-B074B1B8132153629E56DF133670C7AA" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" contextRef="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.6</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> of Net income, which is inclusive of a non-recurring charge of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e1839-wk-Fact-40F89CE067E651F1B0CA7B0EFA90545F" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" contextRef="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> related to inventory costs stepped up to acquisition date fair value. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 14</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 3</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-61E0E639A20E565B805CB864BF579610-4" continuedAt="TextSelection-61E0E639A20E565B805CB864BF579610-5"><ix:nonNumeric contextRef="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="TextSelection-C0159BCD3983554D8214468EA7C30D6C-0-wk-Fact-BE345AA164585017ABE0DBD97586C462" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the consideration paid for Ranir and the amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:522px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:378px;"></td><td style="width:6px;"></td><td style="width:131px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Ranir</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase price paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1897-wk-Fact-48661FFB66ED5B178383C29BB4E5CBC9" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">759.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1959-wk-Fact-1F1547DE73B95D6197B769223F2019E0" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1974-wk-Fact-64CCF72213A8517197D7445508C913D4" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e1994-wk-Fact-31B1D8817D645459BA2518228D3210DF" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">59.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2014-wk-Fact-D091DE1A78B250F3858D490EBF1BA49E" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2034-wk-Fact-89A8BEA6111E5B4D933C6340D623D3AB" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2054-wk-Fact-34716EC0D4C25AE78A3354D660F6BC10" name="prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2074-wk-Fact-8AFACF6C6A325041A51767010F4B962F" name="us-gaap:Goodwill" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">292.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Definite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2123-wk-Fact-6B19ED27C7CB58AD81286AFAE04C29C3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">48.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2138-wk-Fact-AD66AE8E6C6B5760BC03C880B7D98347" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">260.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2158-wk-Fact-B6764A8130455276A774262FB5B9FE4D" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Indefinite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2201-wk-Fact-8703B1F68EAC55D5B7BBDC310F798CC2" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">39.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2226-wk-Fact-31CA45B41D885D20B0C668FD85D1BDD4" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">389.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2241-wk-Fact-D8D39702D8875A81B30E367B7EE73DF9" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2266-wk-Fact-3A0015BA90C75E07903497AD9A58CE23" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">844.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2307-wk-Fact-E7080E51F0B65C31BFC11E17F51679C1" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2323-wk-Fact-8401C278D603555BB86FCC38CEA99B3E" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2343-wk-Fact-4A95F4FBE39E5656998B5528FB72F9DE" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2363-wk-Fact-631E20BF90A8556593C1B1EDBAD2DFFB" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2383-wk-Fact-6A9E945C3FE25C53B2BD955A0D840F75" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2403-wk-Fact-054D4139F8BA5794A735378DD4D4AF58" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2428-wk-Fact-6B8DA38F28EF5FC483927801660F6DFF" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">85.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2448-wk-Fact-3622042B715455BC913D4DFF07B32FEB" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">759.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e2463-wk-Fact-8AFACF6C6A325041A51767010F4B962F" name="us-gaap:Goodwill" contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">292.7</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Perrigo and Ranir. Goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e2467-wk-Fact-2814265B3CC650459363EC8B07055D30" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">212.6</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e2471-wk-Fact-FFE7310EBCCB579B8E1CBAA92D2C16EF" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.1</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> was </span><span style="font-family:Arial;font-size:10pt;background-color:#ffffff;">allocated to our CSCA and CSCI segments, respectively.</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">We expect </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d14264e2481-wk-Fact-1F54E8462E435591AA143EFDE818C729" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">252.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> to be deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, developed product technologies, and customer relationships. Trademarks and trade names were assigned useful lives that ranged from </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e2486-wk-Fact-0C3E19BFD1675C5389DFA086833E3D29" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="D2019Q3Jul1_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember" format="ixt-sec:duryear">20</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e2490-wk-Fact-B704A82C0510542081E738310F645C99" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="D2019Q3Jul1_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember" format="ixt-sec:duryear">25</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;"> years. Developed product technologies were assigned </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e2494-wk-Fact-B155DC6F44625522AFA33E8D86EA6621" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" format="ixt-sec:duryear">10</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;">-year useful lives and customer relationships were assigned </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e2498-wk-Fact-C3A89F6EF2DF5D7D91364A5803DDC8F8" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">24</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;">-year useful lives. Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names, developed technology, and in-process research and development ("IPR&amp;D") were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates. The opening balance sheet is final. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 15</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 3</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-61E0E639A20E565B805CB864BF579610-5" continuedAt="TextSelection-61E0E639A20E565B805CB864BF579610-6"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 28, 2019</span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Generic Product Acquisitions</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">July&#160;2, 2019</span><span style="font-family:Arial;font-size:10pt;">, we purchased the Abbreviated New Drug Application ("ANDA") for a generic gel product for </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e2535-wk-Fact-D8FCFC11917FC440B41FC6A60DE5B094" name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="D2019Q3Jul2_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in cash, which we capitalized as a developed product technology intangible asset. We launched the product during the third quarter of 2019 and began amortizing it over a </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e2539-wk-Fact-D1365010AB336CC361A2C6A817B7F95D" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="D2019Q3Jul2_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" format="ixt-sec:duryear">20</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our RX segment.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">May&#160;17, 2019</span><span style="font-family:Arial;font-size:10pt;">, we purchased the ANDA for a generic product used to relieve pain, for </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e2553-wk-Fact-2DBE4FBAD0945E85927CF318157E75C8" name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="D2019Q2May17_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in cash, which we capitalized as a developed product technology intangible asset. We launched the product during the third quarter of 2019 and began amortizing it over a </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e2557-wk-Fact-02EB613E4FCE5344BB36055DD1237828" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="D2019Q2May17_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" format="ixt-sec:duryear">20</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our RX segment.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Budesonide Nasal Spray and Triamcinolone Nasal Spray</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">April&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;">, we purchased product ANDAs and other records and registrations of Budesonide Nasal Spray, a generic equivalent of Rhinocort Allergy</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, and Triamcinolone Nasal Spray, a generic equivalent of Nasacort Allergy</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, from Barr Laboratories, Inc. ("Barr"), a subsidiary of Teva Pharmaceuticals, for </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e2584-wk-Fact-1A2A2FFC6D305A39B25C771D682AB622" name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in cash. We previously developed and marketed the products in collaboration with Barr under a development, marketing and commercialization agreement that originated in August 2003. Under this prior agreement, we paid Barr a percentage of net income from products sold by Perrigo in the U.S. By purchasing the assets from Barr and terminating the original development, marketing and commercialization agreement, we are now entitled to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d14264e2588-wk-Fact-35D40805E8515210A1BC3234B4B176F8" name="prgo:IncomefromSalesOwnedbytheCompanyPercent" contextRef="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> of the income from sales of the product. Operating results attributable to these products are included within our </span><span style="font-family:Arial;">CSCA</span><span style="font-family:Arial;font-size:10pt;"> segment. The intangible assets acquired are classified as developed product technology with a </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d14264e2598-wk-Fact-12759B5D447F5797B8DC1F1D2AA41F6C" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember" format="ixt-sec:duryear">10</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;">-year useful life.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Pro Forma Impact of Business Combinations</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="TextSelection-8847CFA703D9597AAC7FBEA5428C41FE-0-wk-Fact-E5D1DB4D66A958758D180634260EF358" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table presents unaudited pro forma information as if the Ranir acquisition had occurred on </span><span style="font-family:Arial;font-size:10pt;">January&#160;1, 2018</span><span style="font-family:Arial;font-size:10pt;"> and as if the acquisition of Dr. Fresh had occurred on </span><span style="font-family:Arial;font-size:10pt;">January&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;"> and had been combined with the results reported in our Condensed Consolidated Statements of Operations for all periods presented (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:539px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:134px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:95px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(Unaudited)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2823-wk-Fact-527738FC112B5E34BD355D924001142C" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,213.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2842-wk-Fact-D1823D5D276057EC84978C0DB57FA482" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,217.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2861-wk-Fact-07ABD67D641E5564A5FEB4FEFB8E3DC4" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,803.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2881-wk-Fact-CFA4DE3A158A5736AECB749DF70B37BE" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,732.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d14264e2901-wk-Fact-591A3699447351B68A12FDB49D29146A" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">154.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2921-wk-Fact-C112C408D34357708ABBD23EB379C334" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">108.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2940-wk-Fact-E826BD760242599EBA36E14F60473A3E" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d14264e2960-wk-Fact-D6009E6C4B4A58B49A39FFEC40A19629" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">180.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><span style="font-family:Arial;font-size:11pt;"></span><span style="font-family:Arial;font-size:10pt;">The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, depreciation of property, plant and equipment that have been revalued, certain acquisition-related charges, and related tax effects.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Divestitures During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 26, 2020</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Rosemont Pharmaceuticals Business </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">June&#160;19, 2020</span><span style="font-family:Arial;font-size:10pt;">, we completed the sale of our U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for cash consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>&#163;<ix:nonFraction id="d14264e2998-wk-Fact-17E3945D01A95182A37455FF51C8BC5D" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember" unitRef="gbp" decimals="-5" scale="6" format="ixt:numdotdecimal">155.6</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> (approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e3002-wk-Fact-937B0E65A0715D3DA1F9C3896396656F" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">195.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">). The sale resulted in a pre-tax loss of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e3006-wk-Fact-D8966BB1B0B953A6B7B824D44C6A0CB6" name="us-gaap:GainLossOnSaleOfBusiness" contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">18.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> recorded in our CSCI segment in </span><span style="font-family:Arial;font-size:10pt;">Other (income) expense, net</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations. The charge included professional fees and a </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e3016-wk-Fact-D2D8D330B26653D5AABD633FEA959B44" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">46.4</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> write-off of foreign currency translation adjustment from Accumulated other comprehensive income.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 16</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 3</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-61E0E639A20E565B805CB864BF579610-6"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Divestitures During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 28, 2019</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Animal Health Business</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">July&#160;8, 2019</span><span style="font-family:Arial;font-size:10pt;">, we completed the sale of our animal health business to PetIQ for cash consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e3043-wk-Fact-66AE698EC7B024AF9068C6AE7E526651" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="D2019Q3Jul8_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">182.5</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which resulted in a pre-tax gain of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d14264e3047-wk-Fact-79DC13E7F160F4F0C7EAC6AFD865C86D" name="us-gaap:GainLossOnSaleOfBusiness" contextRef="D2019Q3Jul8_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">71.7</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> recorded in our CSCA segment in </span><span style="font-family:Arial;font-size:10pt;">Other (income) expense, net</span><span style="font-family:Arial;font-size:10pt;"> on the Consolidated Statements of Operations.</span></div></ix:continuation><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sA22C0BF6568353F7A17EED302ECA8493"></a></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-weight:bold;">NOTE 4 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="TextSelection-8AC01F771CBF52CDB532DEDBEE3296FB-0-wk-Fact-05D99BF4C8D45E7380A01E2678CAF2AF" continuedAt="TextSelection-8AC01F771CBF52CDB532DEDBEE3296FB-1" escape="true"><span style="font-family:Arial;font-weight:bold;">GOODWILL AND INTANGIBLE ASSETS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-8AC01F771CBF52CDB532DEDBEE3296FB-1" continuedAt="TextSelection-8AC01F771CBF52CDB532DEDBEE3296FB-2"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfGoodwillTextBlock" id="TextSelection-AB2FC31CEBB55474BAB527118C4880B9-0-wk-Fact-38E0C72831E55AADBDD0D47C276284EC" continuedAt="TextSelection-AB2FC31CEBB55474BAB527118C4880B9-1" escape="true"><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="29"></td></tr><tr><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Purchase accounting adjustments </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Business acquisitions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Business divestitures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Impairments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency translation adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1233-wk-Fact-9B07A567BB515B1B9308B55A729EDEFD" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,899.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d18029e1252-wk-Fact-2CDC47E3D27A5213B5F0A8BD5A2B51F2" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">10.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1273-wk-Fact-EFB27D1937B65FFFB14197E2FC548E1E" name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1292-wk-Fact-6342767680C65B9DA0F853DF56342238" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1311-wk-Fact-E19F2A17F6CA5120A1D828C9C16DFF64" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d18029e1331-wk-Fact-10F7FBF60F1E503CAE7C2C1FC971C6AC" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1351-wk-Fact-51C26CB2A9D9598AA3710CF35F1E5D05" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,898.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1373-wk-Fact-D9AC2B84885C5079A384B35225979290" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,203.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1392-wk-Fact-F517600BDA77548BB75F8EDE3B58EAEA" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1411-wk-Fact-06EE885C336D559890E9C0003A71C4FD" name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d18029e1431-wk-Fact-529F834E8BC45200AAA6A530453B7278" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">115.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1451-wk-Fact-DEC07CC035AE59A39FBD6E863364E0AF" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1471-wk-Fact-8AFFEC2E9E6C53B4A4EBDD28B0FBE7F5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1490-wk-Fact-71631B201A095930921056960D3E9895" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,129.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1517-wk-Fact-397C83A0249153ACAFF833332FBC93C2" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,013.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1536-wk-Fact-15F3950C89195B8AB60F572451958777" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1555-wk-Fact-D48BD2E94F145A76A5EF2CAD1ECCB884" name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1575-wk-Fact-E2A067A72A7050A1B47B74D981EB006A" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d18029e1594-wk-Fact-212539EC2EE557549BA0175770657AA3" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">202.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d18029e1615-wk-Fact-52DE8508E9D450FE88B0F7906CEBEA51" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1635-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">811.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total goodwill</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1665-wk-Fact-F640560DE1B05837A43A92F60C44E0D3" name="us-gaap:Goodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,116.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1684-wk-Fact-C42E97F8297F5D7399C86906FA63F086" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1704-wk-Fact-69716D2F92625A6EB0094BC31E92AA92" name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d18029e1723-wk-Fact-2E8E9C6404FF5CCD81C2600939B468D8" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">115.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d18029e1743-wk-Fact-62B61D2745B25324A56137F4EF2474EF" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">202.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1764-wk-Fact-BE3763BEE40E5AF8B25DF881E89468FA" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e1783-wk-Fact-248FCA9AED205126B0C1390A37E150E0" name="us-gaap:Goodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,839.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)  <ix:footnote id="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="TextSelection-AAF2B058377252C08C16DBD93163BDBC-1">We had accumulated goodwill impairments of </ix:footnote></span><ix:continuation id="TextSelection-AAF2B058377252C08C16DBD93163BDBC-1"><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d18029e1804-wk-Fact-7BD3F3E2CE5356958C1964237A2D2E54" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">868.4</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> as of each of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">.</span></ix:continuation></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:8pt;"><ix:continuation id="TextSelection-AB2FC31CEBB55474BAB527118C4880B9-1"><span style="font-family:Arial;font-size:8pt;">(2)  <ix:footnote id="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-1">We had accumulated goodwill impairments of </ix:footnote></span><ix:continuation id="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-1"><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d18029e1821-wk-Fact-43F6794FAEAA222D6AB1472E08CE955C" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">109.2</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d18029e1825-wk-Fact-2DFC56C3FB0C5FEBB7C8E043421D92BD" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">311.6</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> as of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span></ix:continuation></ix:continuation><span style="font-family:Arial;font-size:8pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">RX U.S. Reporting Unit Goodwill </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, our RX U.S. reporting unit had an indication of potential impairment driven primarily by the stoppage of production and distribution of albuterol sulfate inhalation aerosol and voluntary U.S. nationwide recall to the retail level, after we learned that some units may not dispense due to clogging, combined with a decline in market multiples. We prepared an impairment test as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and determined the carrying value of the RX U.S. reporting unit exceeded its estimated fair value. We recognized a goodwill impairment of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e1861-wk-Fact-42B3AB8BE2AD78DD55A147301E355CC4" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">202.4</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, leaving </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e1865-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">811.1</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> of goodwill in this reporting unit after the impairment. The change in fair value from previous estimates was driven by the financial impact of the recall in the current period and related changes in estimates of future cash flows (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sBFE17B0A00B45FB196C8960332ACE955"><span style="font-family:Arial;font-size:10pt;">Note 6</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Other Reporting Unit Goodwill</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;">, our Branded Consumer Self-care ("BCS") reporting unit included in the CSCI segment had an indication of potential impairment which was driven by a decrease in forecasted cash flows in the second half of </span><span style="font-family:Arial;font-size:10pt;">2020</span><span style="font-family:Arial;font-size:10pt;"> related to impacts from the COVID-19 pandemic. We prepared an impairment test as of </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;"> and determined that the fair value of the BCS reporting unit exceeded net book value by less than </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d18029e1903-wk-Fact-012EE67D328A5813992D524B716A1A8C" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" contextRef="FI2020Q3_us-gaap_ReportingUnitAxis_prgo_BCSMember" unitRef="ratio" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;">, consistent with our last annual impairment test as of </span><span style="font-family:Arial;font-size:10pt;">October&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;">.&#160;While </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d18029e1912-wk-Fact-7FA33B6745775C0DA5352400119FD02C" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2020Q3QTD_us-gaap_ReportingUnitAxis_prgo_BCSMember" unitRef="usd" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> impairment was recorded as of </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;">, future developments such as deterioration in business performance or market multiples could reduce the fair value of this reporting unit and lead to impairment in a future period. There was no indication of impairment during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. Goodwill remaining in this reporting unit was </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e1928-wk-Fact-D16310DA500C51AE9ACCD4FC2AC47C6E" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_ReportingUnitAxis_prgo_BCSMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">995.5</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 17</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 4</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-8AC01F771CBF52CDB532DEDBEE3296FB-2"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Intangible Assets</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" id="TextSelection-731C8A51282257ACB45EC0E3FEBB6C69-0-wk-Fact-EF9946F0D4E55BD587C698574C7D72FA" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Intangible assets and related accumulated amortization consisted of the following (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.85534591194968%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Indefinite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2249-wk-Fact-641550394E9C5ED9B4FCFADBF9F0D276" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2287-wk-Fact-CFB8EDD39F095A069429BD2B3EC48DF3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2322-wk-Fact-B2F668A867AA51058C70C5FD6EA5DACB" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2360-wk-Fact-791C8B2140625B8B8BDE770C5DD5497E" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2405-wk-Fact-239B4AB169425F7FB769C5BEDA6E4225" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2443-wk-Fact-2C94F03BB2B25D0D941702094D8F714C" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">68.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Definite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2567-wk-Fact-1ED514F49402506C9F309505D7886B06" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">134.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2586-wk-Fact-635D5EF1B774576D83297C516BF68B10" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2605-wk-Fact-0D4CD2B9E854570F912C2135307398C9" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">126.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2625-wk-Fact-A40A6B4881B75393AB27E019457D9F7F" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2640-wk-Fact-4C8BA4B2E34D577FA2DB8D918D8BE1D6" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,335.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2659-wk-Fact-7309965C33235FDBB63E1FF8918DA9AB" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">731.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2678-wk-Fact-02EC7B5AC11B57039D2F8EF4DE83E3B9" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,392.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2698-wk-Fact-5A52889D13565796A0301B30F0A9A03E" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">755.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2718-wk-Fact-08E39CD9514A574291B708DC32FCE638" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,866.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2737-wk-Fact-5F16BAD18A105384A880265F27B86CC8" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">776.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2756-wk-Fact-A9F9B16E7F6753F0B2F01BA3A2C8DFDF" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,805.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2776-wk-Fact-8A65BEF6A27452938D033F848754DC4C" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">671.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2796-wk-Fact-5F30AF751D5F51759248271A457DAEE6" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,462.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2815-wk-Fact-FEA1E5117F9F5A2CB637700CBD1E1701" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">313.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2834-wk-Fact-926D689A0ED9524D87FC899D5B20AB2E" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,353.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2854-wk-Fact-97054A07F55E5D3685F4AD63DB035807" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">250.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-compete agreements</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2875-wk-Fact-C2C1AED96AC65E47BBA64156190D4774" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2894-wk-Fact-57FC564B12205054B169D8792642146E" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2913-wk-Fact-93E5BC89A31E5A0C8354D2F278F1B06B" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2933-wk-Fact-76DEFA84BF5B53A9B14575366C3209E0" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2958-wk-Fact-A5DDBE2F5BC85D0C8B48C23D4ECF658F" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,805.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2977-wk-Fact-F7E49D4866FB55C1951A664B4985F6A3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,909.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e2996-wk-Fact-8517B956B5E7519BA5BE7A95D0A82F83" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,685.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e3016-wk-Fact-B96B9E5C830450C7BBB4FD9C10389FEF" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,763.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e3036-wk-Fact-02B117AEA9925D1CB807B640458CA089" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,819.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e3055-wk-Fact-F7E49D4866FB55C1951A664B4985F6A3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,909.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e3074-wk-Fact-65E09C1B01BB547ABFD482910050B042" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,753.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d18029e3094-wk-Fact-B96B9E5C830450C7BBB4FD9C10389FEF" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,763.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We recorded amortization expense of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e3117-wk-Fact-9EC6EFD4DD3D5D5AB75DE9600F9BE5CD" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">73.9</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e3121-wk-Fact-B5DA864A4FA15076A7E87E8E669E0A74" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">219.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, respectively, and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e3133-wk-Fact-C505C4899C9C5A9293E87934EEE6ED3E" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">78.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e3138-wk-Fact-66166F7248AF5BEDB989DACED3CFEE17" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">227.7</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Evamist Branded Product</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the three months ended September 28, 2019, we identified impairment indicators related to our Evamist branded product, which is a definite-lived intangible asset in our </span><span style="font-family:Arial;">RX</span><span style="font-family:Arial;font-size:10pt;"> segment. The indicators related to a decline in sales volume and a corresponding reduction in our long-range revenue forecast. We recorded an asset impairment of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e3166-wk-Fact-00CA28DDDFE0EAE3C85FC67F7C3F6E8D" name="us-gaap:AssetImpairmentCharges" contextRef="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_EvamistBrandedProductMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Generic Product</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the three months ended June 29, 2019, we identified impairment indicators for a certain definite-lived intangible asset related to changes in pricing and competition in the market, which lowered the projected cash flows we expect to generate from the asset. We recorded an asset impairment of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e3181-wk-Fact-DD63AB03777E5F359E6EEA8EF7EDAC20" name="us-gaap:AssetImpairmentCharges" contextRef="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.8</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> in our RX segment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In-process R&amp;D </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"> </span><span style="font-family:Arial;font-size:10pt;">We recorded impairment charges of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d18029e3198-wk-Fact-2C11426402B0567B9D1302BC48D83069" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" contextRef="FD2019Q3YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> on certain IPR&amp;D assets in the CSCA and RX segments during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, due to changes in projected development and regulatory timelines.</span></div></ix:continuation><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 18</span></div></div><hr style="page-break-after:always"></hr><div><a id="s0A29042737555056BB23C3E8EAA3D7A5"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 5</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 5 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:InventoryDisclosureTextBlock" id="TextSelection-6D2CD836F40B54D9A5626724D7C2C5C0-0-wk-Fact-C52B8ADCA548578E9A542C854737DA46" continuedAt="TextSelection-6D2CD836F40B54D9A5626724D7C2C5C0-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">INVENTORIES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="TextSelection-A0E361EBEE395B398B287272648AE6BB-0-wk-Fact-218EADB08F0D5097A46E15D5669F3805" escape="true"><ix:continuation id="TextSelection-6D2CD836F40B54D9A5626724D7C2C5C0-1"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Major components of inventory were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finished goods</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1062-wk-Fact-8B19980750E35AC98CB21D832B04F623" name="us-gaap:InventoryFinishedGoods" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">618.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1081-wk-Fact-DE7C2F955B7454D2B4D68A47BADF8E28" name="us-gaap:InventoryFinishedGoods" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">530.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1096-wk-Fact-8191C19286A4508A862070650CC9EA04" name="us-gaap:InventoryWorkInProcess" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">201.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1115-wk-Fact-3DEDF1ADA57053B9B54C97105981E7D8" name="us-gaap:InventoryWorkInProcess" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">186.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Raw materials</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1135-wk-Fact-4484925822985B248571616685E1B0E8" name="us-gaap:InventoryRawMaterials" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">280.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1154-wk-Fact-7535C309593C5FADBC2F891060401DBF" name="us-gaap:InventoryRawMaterials" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">250.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1179-wk-Fact-D5426A6C267D5922AD6216A00522426B" name="us-gaap:InventoryNet" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,100.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d15087e1198-wk-Fact-CE06DA9DF0A8583C86A12692EB25FCB9" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">967.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation></ix:nonNumeric><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sBFE17B0A00B45FB196C8960332ACE955"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 6 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FairValueDisclosuresTextBlock" id="TextSelection-B819797A9B905466AA0C3E79EF3354D3-0-wk-Fact-C4BB90B5A48956B397DC72E7AEAAD2D8" continuedAt="TextSelection-B819797A9B905466AA0C3E79EF3354D3-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-B819797A9B905466AA0C3E79EF3354D3-1" continuedAt="TextSelection-B819797A9B905466AA0C3E79EF3354D3-2"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 1, 2020, we adopted ASU 2018-13: Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement ("Topic 820"). The amendments in this ASU remove disclosure requirements in Topic 820 related to the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. Additionally, Topic 820 adds disclosure requirements for the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. We have amended certain of our quantitative Level 3 fair value measurement disclosures to add the range and weighted average of significant unobservable inputs used.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="TextSelection-8B64CE1B91EE5DE39C592F6D321B5C39-0-wk-Fact-E2A3B1D2ECBF5A87BF8C1A37C312ED46" continuedAt="TextSelection-8B64CE1B91EE5DE39C592F6D321B5C39-1" escape="true"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Measured at fair value on a recurring basis:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Investment securities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1582-wk-Fact-36CC7507C53E5EFBBE8E4413DD4BEEFC" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1601-wk-Fact-1838DBF169C1538B88EB59775EC327BA" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1621-wk-Fact-F22ECE751D645C979608C36AF04C07B4" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1640-wk-Fact-178AA8E8AB9C5C7889057FBD7D15AC3A" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1659-wk-Fact-FA31AD55D51B5459A8752EB80F3033DD" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1679-wk-Fact-385A898358845DBFA1EA5AB5DED0153B" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1699-wk-Fact-1DB59FBBCAA35893A9BEEEDAC114B0E5" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1718-wk-Fact-DB0A2D589FBF52669F9F5F11CC7C520F" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1737-wk-Fact-AE99261ED3A85F759090F061621842DB" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1757-wk-Fact-63EFA36EDCDF5EB19BBB6AFCA5199774" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1776-wk-Fact-99A47401F6015E34803D431E962E6D94" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1796-wk-Fact-0AEC62F90D695732B894CA5FBF811A06" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1821-wk-Fact-833BDAB7B08056F8B1C0DE558D3EE7AA" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1840-wk-Fact-93347F2201625BECBA2B1760F3A4B483" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1859-wk-Fact-F54310EB528E54C28FEBF15CD78D5FD9" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1879-wk-Fact-DBF399AA6756580D998F9FC7976D4155" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1898-wk-Fact-E5EC0E8325835F2EAE4B892431038874" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1918-wk-Fact-EF47A67E240755CBA16B112A0898053A" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Funds associated with Israeli severance liability</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1943-wk-Fact-B53E4E09B3715F4FB2D150FE92BBBB83" name="prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1962-wk-Fact-CFD1B6B384FA5765BD6D28A4E54C3179" name="prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e1981-wk-Fact-677519CF07355F7082AECC553D252A8E" name="prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2001-wk-Fact-CB9D298C57E1535695A0DC77F11D55BE" name="prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2020-wk-Fact-412BD16712405A6A93E52C5E8C0997D8" name="prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2040-wk-Fact-9DA31FF39F755DB688F7BE630441060C" name="prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Royalty Pharma contingent milestone</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2065-wk-Fact-FA343B8446865774B105DBF6BCF394A1" name="prgo:PotentialContingentMilestonePayments" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2084-wk-Fact-9984B460F91B5157B54F137E02ED3154" name="prgo:PotentialContingentMilestonePayments" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2103-wk-Fact-26102473A78C561EB83D3D9ADFE3AA6B" name="prgo:PotentialContingentMilestonePayments" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">121.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2123-wk-Fact-9E7CFD90316A5CA88125B27AD8DD245C" name="prgo:PotentialContingentMilestonePayments" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2142-wk-Fact-7405618011BE525CAB5898AB369E4CB9" name="prgo:PotentialContingentMilestonePayments" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2162-wk-Fact-765023F3B9C05E499162491E34C54261" name="prgo:PotentialContingentMilestonePayments" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">95.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2192-wk-Fact-37FD76B65D8B5C0F9A6E97BD4F5F93FE" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2211-wk-Fact-EBBF8FFF73FC5F539410DBAFBE7948EC" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2231-wk-Fact-83D9E0FCB9F256A09F7143A6F73C7325" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">121.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2250-wk-Fact-5D83EE77A4AA58CCA6C9EDB160DE0933" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2269-wk-Fact-03A818074D5659FF8749F34A29041FD4" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2289-wk-Fact-63D6BFA7FA3F54F99CD9564A2CD89CCC" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">95.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2571-wk-Fact-332609C5F06C5B1C835BD9FD52E5C751" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2590-wk-Fact-AA255E2C13CC5C07B17E50FECE1AEC2C" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2610-wk-Fact-3CF3C04A179B5BC0AFB81A99FB32E49B" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2629-wk-Fact-92F3E12F01035F4785325F22869DDADA" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2648-wk-Fact-B8C82417C95352FA81BA7C209D2E870D" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2668-wk-Fact-5299C0D20DE553C89AF99FE594FB2B34" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Contingent consideration payments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2688-wk-Fact-73C3064026B6533C9707501785AF3D2F" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2707-wk-Fact-D9BA1E889AA35B048737D21CE7D53415" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2726-wk-Fact-9EA999B5AD8F51B09514EDABAE08D19E" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2746-wk-Fact-4706F93EA3C15D8FA3DE760F24C0AAFF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2765-wk-Fact-ED05330B56BB501F82053A5033746A97" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2785-wk-Fact-D842AED3E5685AF8A8F7278C7199717C" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2815-wk-Fact-265FE7951A835E5EB4F33EAC739F7456" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2834-wk-Fact-8048B5BB99615B858B6AFD0515E8DB15" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2854-wk-Fact-061CE9757D7253D9B3BA3AA25857FEF8" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2873-wk-Fact-B25B1FB54F0D5C04AC307C9B20345D75" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2892-wk-Fact-E6A743672E5D548B9A4DD6D82D8C5788" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e2912-wk-Fact-64459C5EFEB05D16A2627BFD5D2087AF" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Measured at fair value on a non-recurring basis:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3323-wk-Fact-54659D50AABB58A8AD490252A3CAEC7D" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3342-wk-Fact-8A111B173C555B0CB5779ABD1C5D2650" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3362-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">811.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3381-wk-Fact-E1A5E9B08C5A58CBB315756126068B88" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3400-wk-Fact-7C700D4A75525FDDAC3C3171E75DFFE5" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3420-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,013.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3442-wk-Fact-36210C25EE665D12BAF6DC136D86364C" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3461-wk-Fact-4B312B45A7B45F5AA356D35F99AED5E3" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3480-wk-Fact-6BF6FF194208528A9F268E547BB40BDD" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3500-wk-Fact-98E41D9BAFA85AA09C857F17FB3EF40F" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3519-wk-Fact-E609865B9D3A57D7B8FF4D93924A4F7E" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3539-wk-Fact-4834881B4668519E87F6E7AF053C9407" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3569-wk-Fact-8B6B4BFA0AE15F5BB80F5E9237EA3770" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3588-wk-Fact-6A742F0FC83A56B48D66F8A555F1015D" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3608-wk-Fact-E9470754EDD750E69E007E10862FCA31" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">811.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3627-wk-Fact-F7CF883001755C41B7EE516136604022" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3646-wk-Fact-3E93E11C81BC59A39D05BE5C9126C275" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e3666-wk-Fact-24BE0F9CCA515A0CB0B233F26F70F768" name="us-gaap:AssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,036.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><ix:footnote id="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">During the </span><span style="font-family:Arial;font-size:8pt;">three months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d57757e3724-wk-Fact-1DBACFC7E2FAD86095884735D7A95AFC" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,013.5</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d57757e3728-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">811.1</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;">. During the year ended December 31, 2019, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d57757e3734-wk-Fact-FB61E320C0B958E7A1A8AF9CC4D9A307" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,122.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d57757e3739-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE" name="us-gaap:GoodwillFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,013.1</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:8pt;">. </span></div></ix:footnote></td></tr></table></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-8B64CE1B91EE5DE39C592F6D321B5C39-1" continuedAt="TextSelection-8B64CE1B91EE5DE39C592F6D321B5C39-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(2)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-8B64CE1B91EE5DE39C592F6D321B5C39-2"><div style="line-height:120%;text-align:left;font-size:8pt;"><ix:footnote id="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-1"><span style="font-family:Arial;font-size:8pt;">During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d57757e3754-wk-Fact-4E97D7D4712B5F31AB299EA02A429AF8" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">55.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> were written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d57757e3758-wk-Fact-4834881B4668519E87F6E7AF053C9407" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.3</ix:nonFraction> million</span></span></ix:footnote><span style="font-family:Arial;font-size:8pt;"><ix:continuation id="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-1">.</ix:continuation> </span></div></ix:continuation></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 19</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 6</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-B819797A9B905466AA0C3E79EF3354D3-2" continuedAt="TextSelection-B819797A9B905466AA0C3E79EF3354D3-3"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">There were </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d57757e3773-wk-Fact-2253F06DCC95551785B866D13CCAB527" name="prgo:FairValueAssetsLevel1Level2Level3TransfersAmount" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> transfers within Level 3 fair value measurements during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> or the year ended </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Royalty Pharma Contingent Milestone Receipts </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="TextSelection-69817A63A21653B9B54CE971E0DC09B0-0-wk-Fact-66216B36DB5D5C94ADB99832D1B392D7" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the change in fair value of the Royalty Pharma contingent milestone (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:555px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:160px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:85px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:85px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4006-wk-Fact-518FF95A1F715EA9B33D3218344051E2" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2020Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">99.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4025-wk-Fact-4B26F13DB8065CB492AE8373631552A8" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2019Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">89.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4044-wk-Fact-C664B0C12A56573C8DC0426C0ABDDCAA" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2019Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">95.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4064-wk-Fact-FB7F0371B61D5F82855EFE3FA5AC72BE" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2018Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">323.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payments received</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4079-wk-Fact-2E89A2325EF45A799E383073E7C632F0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" contextRef="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4098-wk-Fact-04E6CF7A80795345BC6E2ABC957ED8F0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" contextRef="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4117-wk-Fact-4197538218665FA8B056AA04C344B1D2" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" contextRef="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d57757e4137-wk-Fact-8D90D929A87850118518728341537D08" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" contextRef="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">250.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in fair value</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4158-wk-Fact-33D18A5B3DF6516C85BDA7251C707652" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4177-wk-Fact-65AC4873392B5E35B04618367BBBA5C8" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4196-wk-Fact-2FB983C2B2055588A90FC662E28905E5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4216-wk-Fact-147B3B0A6C3A5392B2939A5090D14FFB" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4241-wk-Fact-E2E568A1657D57B9B3C65222EE5D73C0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">121.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4260-wk-Fact-7AF8594DC19A5A1E89CAD97EF55E5829" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2019Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">91.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4279-wk-Fact-E2E568A1657D57B9B3C65222EE5D73C0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">121.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4299-wk-Fact-7AF8594DC19A5A1E89CAD97EF55E5829" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2019Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">91.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We value our contingent milestone payment from Royalty Pharma using a modified Black-Scholes Option Pricing Model ("BSOPM"). Key inputs in the BSOPM are the estimated volatility and rate of return of royalties on global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> that are received by Royalty Pharma until the contingent milestones are resolved. As of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, volatility and the estimated fair value of the milestones had a positive relationship such that higher volatility translates to a higher estimated fair value of the contingent milestone payments. Rate of return and the estimated fair value of the milestones had an inverse relationship, such that a lower rate of return correlates with a higher estimated fair value of the contingent milestone payments. We assess volatility and rate of return inputs quarterly by analyzing certain market volatility benchmarks and the risk associated with Royalty Pharma achieving the underlying projected royalties. <ix:nonNumeric contextRef="FD2020Q3YTD" name="prgo:ScheduleofFairValueAssumptionsTableTextBlock" id="TextSelection-F5F9A21F3D1E5B789C1A6A6D7B72CD37-0-wk-Fact-D8FD89044C2356179621D661B7E62A8E" continuedAt="TextSelection-F5F9A21F3D1E5B789C1A6A6D7B72CD37-1" escape="true">The table below represents the volatility and rate of return:</ix:nonNumeric></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><ix:continuation id="TextSelection-F5F9A21F3D1E5B789C1A6A6D7B72CD37-1"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:306px;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:113px;"></td><td style="width:82px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:82px;"></td><td style="width:10px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Volatility</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4411-wk-Fact-CAF9A001C1265BD9AF3AEA94735066AD" name="prgo:FairValueAssumptionVolatility" contextRef="FD2020Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">30.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4426-wk-Fact-9AE24A1D56425A24AA7367FE703A8212" name="prgo:FairValueAssumptionVolatility" contextRef="FD2019Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">30.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Rate of return</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4442-wk-Fact-5569E3B2762C5F52820711B433CCF8AF" name="prgo:FairValueAssumptionsRateofReturn" contextRef="FD2020Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember" unitRef="ratio" decimals="4" scale="-2" format="ixt:numdotdecimal">6.84</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4457-wk-Fact-A4E0EEE110B35CDFB52AF74A5F10EE3F" name="prgo:FairValueAssumptionsRateofReturn" contextRef="FD2019Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember" unitRef="ratio" decimals="4" scale="-2" format="ixt:numdotdecimal">7.99</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></ix:continuation><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, the fair value of the Royalty Pharma contingent milestone payment related to 2020 increased by </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4482-wk-Fact-33D18A5B3DF6516C85BDA7251C707652" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.2</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4486-wk-Fact-2FB983C2B2055588A90FC662E28905E5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.9</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively, to </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4490-wk-Fact-BB2F6E822DA159DC92FDFCBF0642E6AB" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">121.2</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which is recorded on the Condensed Consolidated Balance Sheets within </span><span style="font-family:Arial;font-size:10pt;">Prepaid expenses and other current assets</span><span style="font-family:Arial;font-size:10pt;">. The adjustments were driven by higher projected global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> compared to the estimates in the prior period, and the estimated probability of achieving the earn-out. During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, the fair value of the Royalty Pharma contingent milestone payments increased by </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4512-wk-Fact-65AC4873392B5E35B04618367BBBA5C8" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4516-wk-Fact-147B3B0A6C3A5392B2939A5090D14FFB" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.5</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively. These adjustments were driven by higher projected global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;  </sup></span><span style="font-family:Arial;font-size:10pt;">and the estimated probability of achieving the earn-out. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></span><span style="font-family:Arial;font-size:10pt;">were </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4536-wk-Fact-F3C0158D2E2D5F3AB41DFF5F43A0CDC1" name="prgo:NetSalesIncludedinCalculationForMilestonePayment" contextRef="FD2018Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">337.5</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> in 2018, which triggered the </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4540-wk-Fact-EA22D2657A735EC6AE55D3AF071E41C6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" contextRef="FD2019Q1QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">250.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> milestone payment received during the first quarter of 2019. There is </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d57757e4544-wk-Fact-676F99D1727459929CF44CCF5DD05A6E" name="prgo:NetSalesIncludedinCalculationForMilestonePayment" contextRef="FD2019Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember" unitRef="usd" decimals="-5" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> contingent milestone based on 2019 sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">. In order for us to receive the remaining contingent milestone payment of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4553-wk-Fact-1C55D070B86C5CD9AB56239ABF64ACB3" name="prgo:AssetAdjustedFairValueifSalesThresholdMet" contextRef="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">400.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales, as defined in the agreement, in 2020 must exceed </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4561-wk-Fact-55AE1DFB862C5D14970EB9755F7524D4" name="prgo:NetSalesThresholdForMilestonePayment" contextRef="FD2020Q4YTD_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">351.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">. If Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales do not meet the prescribed threshold in 2020, we will write off the </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4569-wk-Fact-BB2F6E822DA159DC92FDFCBF0642E6AB" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">121.2</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> asset and record a loss. If the prescribed threshold is exceeded, we will increase the asset to </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4573-wk-Fact-18C2B646E31D597EB425F17529709E77" name="prgo:AssetAdjustedFairValueifSalesThresholdMet" contextRef="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">400.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and recognize income of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d57757e4578-wk-Fact-A84D2832B76153EDBFBE9FB62084B091" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="FD2020Q4YTD_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">278.8</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Change in financial assets</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations. </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 20</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 6</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-B819797A9B905466AA0C3E79EF3354D3-3" continuedAt="TextSelection-B819797A9B905466AA0C3E79EF3354D3-4"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Contingent Consideration Payments</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="TextSelection-6F2DFA1C6D5D5CEEBDFDC0155E0E7EEE-0-wk-Fact-BB2D066CA98F51A69CC4A92819F4F859" escape="true"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the change in fair value of contingent consideration payments (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:202px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4818-wk-Fact-FDE8D81E2B8C51338CB1F673959FC1BC" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2020Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4837-wk-Fact-27065BEF097357698B574D47843D64A7" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2019Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4856-wk-Fact-30B36C59B80950ADAFB632B2929D5A2E" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4876-wk-Fact-99EB50F5421A52C2A38EBD54CC0A92E8" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Changes in value</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4891-wk-Fact-A981082373AE5731B772D5FEDB570885" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="FD2020Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4910-wk-Fact-8E0C508AFDDE549DBCCBE884C8B12D9C" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="FD2019Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4929-wk-Fact-1602300E8B42538BB234BFD06BD6A609" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="FD2020Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d57757e4949-wk-Fact-DC47CC2B317C54DAA95F6535B0A9F909" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="FD2019Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Settlements and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4970-wk-Fact-DD854960707B5D899A1586238FFF35AF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="FD2020Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e4989-wk-Fact-E1035CD67C3E5386BC3CB3D4E65AAAAF" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="FD2019Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5008-wk-Fact-93924379FB7E5F2C866FD402EB6FFDFA" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="FD2020Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d57757e5028-wk-Fact-519DEA7ABB0D5371B3A97892C0AD524B" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="FD2019Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5054-wk-Fact-DD51C41395C35D49ACE49FCED409D1EC" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5073-wk-Fact-EE5D61B7D8AA5602B14AC4C33924D237" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2019Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5092-wk-Fact-DD51C41395C35D49ACE49FCED409D1EC" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5112-wk-Fact-EE5D61B7D8AA5602B14AC4C33924D237" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2019Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product. The fair value adjustments are recorded in </span><span style="font-family:Arial;font-size:10pt;">Other operating expense (income)</span><span style="font-family:Arial;font-size:10pt;">  on the Condensed Consolidated Statements of Operations.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, the contingent consideration payments liability was primarily comprised of sales-based milestones related to an IPR&amp;D asset acquired in a prior transaction in our RX segment. The contingent consideration payments liability also included certain event-based milestones, which were immaterial. <ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="TextSelection-7A49C6773C7058F085111A186D163D1E-0-wk-Fact-416277D257565845BF8EFE33D02DC630" continuedAt="TextSelection-7A49C6773C7058F085111A186D163D1E-1" escape="true">The fair value of our contingent consideration sales-based milestones as of </ix:nonNumeric></span><ix:continuation id="TextSelection-7A49C6773C7058F085111A186D163D1E-1" continuedAt="TextSelection-7A49C6773C7058F085111A186D163D1E-2"><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, was calculated using the following significant unobservable inputs:</span></ix:continuation></div><ix:continuation id="TextSelection-7A49C6773C7058F085111A186D163D1E-2" continuedAt="TextSelection-7A49C6773C7058F085111A186D163D1E-3"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:29%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Valuation Technique</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Unobservable Input</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Range (Weighted Average)</span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Contingent consideration payments: sales-based milestones </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Discounted cash flow</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Projected royalties</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5347-wk-Fact-18CDA24ABA5350E1A3F97CD23B3121FA" name="prgo:ContingentConsiderationPaymentsSalesbasedMilestones" contextRef="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_prgo_MeasurementInputProjectedRoyaltiesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Projected year of payment of sales-based milestones</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021 - 2036 (2027)</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5422-wk-Fact-D10AEA480BAA578F9C80C861911D054B" name="prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent" contextRef="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">26.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></ix:continuation><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-7A49C6773C7058F085111A186D163D1E-3" continuedAt="TextSelection-7A49C6773C7058F085111A186D163D1E-4"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-7A49C6773C7058F085111A186D163D1E-4"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Unobservable inputs were weighted based on the relative estimated milestone payments.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The discount rate of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d57757e5451-wk-Fact-D10AEA480BAA578F9C80C861911D054B" name="prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent" contextRef="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">26.0</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> was based on our assessment of the rate of return and development and commercialization risk of the related IPR&amp;D project. We reevaluate the significant unobservable inputs of the sales-based milestones quarterly based on project developments and changes in contingent elements of the liability.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Non-recurring Fair Value Measurements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"> The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">RX U.S. Reporting Unit Goodwill </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">When determining the fair value of our RX U.S. reporting unit for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we utilized a combination of comparable company and discounted cash flow techniques. In our comparable company market approach, we considered observable market information and transactions for companies that we deemed to be of a comparable nature, scope, and size of our RX U.S. reporting unit (Level 2 inputs). Our cash flow projections included revenue assumptions related to new and existing products, plus gross margin and operating expenses based on the reporting unit&#8217;s growth plans (Level 3 inputs). In our discounted cash flow analysis, we used a long-term growth rate of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d57757e5491-wk-Fact-158429DCEC7C5AD1ED67473E4B7A4416" name="prgo:ReportingUnitFairValuePercent" contextRef="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">0.0</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;">, which assumes new product launches will, over time, offset decreases in cash </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 21</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 6</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-B819797A9B905466AA0C3E79EF3354D3-4" continuedAt="TextSelection-B819797A9B905466AA0C3E79EF3354D3-5"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">flows of existing portfolio products with definite lives. We used a discount rate of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d57757e5498-wk-Fact-6774F4B6B5662C7436854741D51BD622" name="prgo:ReportingUnitFairValuePercent" contextRef="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">10.3</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> in this analysis. The discount rate correlates with the required investment return and risk that we believe market participants would apply to the projected growth rate. In addition, we burdened projected free cash flows with the capital spending deemed necessary to support the cash flows and applied blended jurisdictional tax rates ranging from </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d57757e5502-wk-Fact-9FED2571DEF4336DFE49474BB74B8C62" name="prgo:BlendedJurisdictionalTaxRatesPercent" contextRef="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">19.1</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d57757e5506-wk-Fact-7970A23F06CAFF1E7E9A474DBB190CB9" name="prgo:BlendedJurisdictionalTaxRatesPercent" contextRef="FD2020Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">21.7</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;">. We weighted indications of fair value resulting from the market approach and present value techniques, considering the reasonableness of the range of measurements and the point within the range that we determined was most representative of fair market conditions (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#s4FA8299FAFB154038583DC7BC119296B"><span style="font-family:Arial;font-size:10pt;">Note 4</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Fixed Rate Long-term Debt</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="TextSelection-5E7CD08147D65E45A4BAF77FE52CE498-0-wk-Fact-564E65AAF4D853BF87A6096BC28029C9" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:520px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:233px;"></td><td style="width:6px;"></td><td style="width:56px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:56px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:56px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:56px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Public Bonds</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Carrying Value (excluding discount)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5815-wk-Fact-68F0395B64E15DEEAD44DC02FA262544" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,760.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5853-wk-Fact-C5FB5FCB320A58F291D514066509E654" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,600.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5893-wk-Fact-FFE5F38C1B0D5D86B230990470AAD965" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,969.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e5931-wk-Fact-1C520AC6E91D5F1FB5D03A6CB8376713" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,618.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Private placement note</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Carrying value (excluding premium)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e6154-wk-Fact-3D6A1C6BB42F57AA98740C6E6155A54E" name="us-gaap:LongTermDebt" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">157.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e6193-wk-Fact-F3B9ABAB784B5538B44753DB0BA191D1" name="us-gaap:LongTermDebt" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">151.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e6232-wk-Fact-7C44EEC5C9C45FEB9BA63B95668FD79A" name="us-gaap:LongTermDebt" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">168.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d57757e6271-wk-Fact-738D0D61D0295AD59A21FEE8582FA011" name="us-gaap:LongTermDebt" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">168.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><ix:continuation id="TextSelection-B819797A9B905466AA0C3E79EF3354D3-5">The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, promissory notes related to our equity method investment in Kazmira, and variable rate long-term debt, approximate their fair value.</ix:continuation> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 22</span></div></div><hr style="page-break-after:always"></hr><div><a id="sF4B58DD1964A5338A17E7D9B8F660A6D"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 7</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 7 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="TextSelection-493DD824957053D499BFA3CB8987FE8B-0-wk-Fact-53693C5C0A995CDB95CC12D684DACED7" continuedAt="TextSelection-493DD824957053D499BFA3CB8987FE8B-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">INVESTMENTS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-493DD824957053D499BFA3CB8987FE8B-1"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="TextSelection-DE19D03B396E55629125301FCD68052B-0-wk-Fact-853A12CEDBC45B45A17EEAA8D9292C04" escape="true"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.79643231899266%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:28%;"></td><td style="width:1%;"></td><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1088-wk-Fact-E4FF286F423256099229C90435975EBC" name="us-gaap:EquitySecuritiesFvNi" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1107-wk-Fact-1E0CDA974D835AF888E93386A1CD81AD" name="us-gaap:EquitySecuritiesFvNi" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1144-wk-Fact-5B9A12A4436158F6ACA797BEE8428DE3" name="us-gaap:EquitySecuritiesFvNi" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1163-wk-Fact-657D3A9C033253C599DE3B568A3ADD2A" name="us-gaap:EquitySecuritiesFvNi" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Equity method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1198-wk-Fact-82B53E17CE0D58D29BEE362B2AB09405" name="us-gaap:EquityMethodInvestments" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">69.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1217-wk-Fact-8EEC5AC762325F3790845453033E6004" name="us-gaap:EquityMethodInvestments" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:footnote id="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-0-wk-Footnote-2A32F48D88195E6AAF1DE8E30AB8BCED_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1) </span></div></ix:footnote></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-1"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Measured at fair value using the Net Asset Value practical expedient.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:EquityMethodInvestmentsTextBlock" id="TextSelection-9B2D8853973D55CD947A5158CFBD5526-0-wk-Fact-3A6606E6C18C517A81849A0458BE40F7" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions):</span></div><div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"></td></tr><tr><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d19403e1504-wk-Fact-9F6291E1145D52F288BD2EF9BED0B445" name="us-gaap:EquitySecuritiesFvNiGainLoss" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1524-wk-Fact-A2D180A28B035243A6FED6498DBC5CE5" name="us-gaap:EquitySecuritiesFvNiGainLoss" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1539-wk-Fact-F80D4EB782525CDD8598A7F5EEB94E48" name="us-gaap:EquitySecuritiesFvNiGainLoss" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d19403e1558-wk-Fact-1E077FA3175E531BB80A2294FE0A20D9" name="us-gaap:EquitySecuritiesFvNiGainLoss" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Equity method</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d19403e1593-wk-Fact-59D6D236DA0350A686D6463CBD543B31" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d19403e1613-wk-Fact-657351420B8C5868A1080B22600FC9B1" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d19403e1629-wk-Fact-C95FEA61C7C155DBA34E8664AE877537" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d19403e1649-wk-Fact-5C9784C2C3765D27AD658F430F0D73B6" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 17, 2020, we announced our entrance into the cannabidiol&#160;(&#8220;CBD&#8221;) market through a strategic investment in and long-term supply agreement with Kazmira LLC ("Kazmira"), a leading supplier of hemp-based CBD products free of tetrahydrocannabinol (&#8220;THC-free&#8221;) based in Watkins, Colorado. In addition to the supply agreement, we acquired an approximate </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d19403e1672-wk-Fact-0681BED7FD8054539575AD8B9DE20DE8" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="ratio" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> equity stake in Kazmira for </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d19403e1676-wk-Fact-7553203D6C915DDA8B019E969B431527" name="us-gaap:EquityMethodInvestments" contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> with </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d19403e1680-wk-Fact-81E39720DC06545EB6E8B07ABD9E53BE" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" contextRef="D2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> paid at close of the transaction and the balance due within </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d19403e1684-wk-Fact-DAA9B3FADFA3575D81B6B9539B35920B" name="prgo:EquityMethodInvestmentPeriodforPayment" contextRef="D2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" format="ixt-sec:durmonth">18</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;"> months thereafter. Our minority equity investment initiates the first phase of the partnership in which we will collaborate to scale-up Kazmira&#8217;s facilities and laboratories, in accordance with current Good Manufacturing Practices, to produce THC-free CBD from industrial hemp that meets our standards for reliability and consistency. In the second phase of the partnership, we will work to launch THC-free hemp-based CBD products in a number of global markets, while leveraging our supply agreement with Kazmira, which is exclusive for the U.S. store brand market. We will report our equity method earnings from Kazmira in our Condensed Consolidated Financial Statements on a quarterly lag.</span></div></ix:continuation><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sA96858DADB665A6D80635E985E64DDB1"></a></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 8 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="TextSelection-873C0C9658C65743A34C68B91D294820-0-wk-Fact-2AE4FE836E2452C1A3D3925E58F3A083" continuedAt="TextSelection-873C0C9658C65743A34C68B91D294820-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-873C0C9658C65743A34C68B91D294820-1" continuedAt="TextSelection-873C0C9658C65743A34C68B91D294820-2"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Cross Currency Swaps</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 15, 2019, we entered into a cross-currency swap designated as a net investment hedge to hedge the EUR currency exposure of our net investment in European operations. This agreement is a contract to exchange floating-rate Euro payments for floating-rate U.S. dollar payments. The payments are based on a notional basis of </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;<ix:nonFraction id="d46894e989-wk-Fact-6FE8FC7C70A353D09CA85E95F01DCDBC" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="eur" decimals="-5" scale="6" format="ixt:numdotdecimal">450.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d46894e993-wk-Fact-8DC8EEC9295F528F89F4CC91C97E0A14" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">498.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">) and settle quarterly. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Swaps </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">There were no active designated or non-designated interest rate swaps as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Forwards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Net Investment Hedge</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 19, 2020, we entered into a foreign currency forward contract designated as a net investment hedge of the GBP currency exposure of our net investment in certain of our U.K. operations. The hedge had a notional basis of </span><span style="font-family:Arial;font-size:10pt;"><span>&#163;<ix:nonFraction id="d46894e1033-wk-Fact-FA1A3706AA0F50A1ABB1E596DDBB9B55" name="us-gaap:DerivativeNotionalAmount" contextRef="I2020Q2Jun19_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="gbp" decimals="-5" scale="6" format="ixt:numdotdecimal">155.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d46894e1037-wk-Fact-9582C69F0CA55225A0094282A347E78B" name="us-gaap:DerivativeNotionalAmount" contextRef="I2020Q2Jun19_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">194.5</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">) and was settled during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 23</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 8</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-873C0C9658C65743A34C68B91D294820-2" continuedAt="TextSelection-873C0C9658C65743A34C68B91D294820-3"><ix:nonNumeric contextRef="FD2020Q3YTD" name="prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock" id="TextSelection-C620C3E9F6675D28A61BE45C2DC3AD54-0-wk-Fact-BB0ECD8758B75218800CF7FD6903C2E2" escape="true"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">Foreign currency forward contracts were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:55.55555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:44%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Notional Amount</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Israeli Shekel (ILS)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1185-wk-Fact-9D14F6FD826057508A770B4CB3464B22" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">398.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1204-wk-Fact-EA28353A03185E62A977737D8ECF4CF8" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">712.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">European Euro (EUR)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1224-wk-Fact-204707CB183D57488728317C1EF38913" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">193.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1243-wk-Fact-F75B0855E2B559D2B5913AFDA5F80D0D" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">157.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">United States Dollar (USD)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1268-wk-Fact-A18F2427381052658DEC467EBF33B4AC" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1287-wk-Fact-9B149008209F57DD8B5AF4785E78922F" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Danish Krone (DKK)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1312-wk-Fact-F8E2849B1D2C58298BFEFCBF2DAE3491" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">59.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1331-wk-Fact-831F6E7435725FAC882EB87FFE8B42B3" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">51.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">British Pound (GBP)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1356-wk-Fact-B43AF619DEC554D0A52A7C057A4FCD87" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">56.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1375-wk-Fact-689DC5B775995233B4C1A3609E02747D" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">86.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Swedish Krona (SEK)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1400-wk-Fact-C5E070F418D95C3CB54E05BAF8577662" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1419-wk-Fact-8D5B44DE6D7852CFAACCC2ECFED84CDA" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Chinese Yuan (CNY)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1444-wk-Fact-543061E4FBEC59EDAFF620751FA07BE5" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1463-wk-Fact-3152B595DA135DC99AF507E9694D2727" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Canadian Dollar (CAD)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1488-wk-Fact-A79A42D39AFE5B8C9807959D1ED1B7E4" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1507-wk-Fact-1A0FA050930C5CA1A18CF02A0DC3FBBA" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Polish Zloty (PLZ)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1532-wk-Fact-A0C26FE0F4E55D27BDF54A3755F2D5D5" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1551-wk-Fact-6FB1CE0CD4E9589A93C3CA42E58E6529" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Mexican Peso (MPX)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1577-wk-Fact-5DC35844A0EE5016B546B492AC7D1985" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1596-wk-Fact-79055ED6A8EC560393B422E6DBB69001" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Norwegian Krone (NOK)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1621-wk-Fact-98C2B758F4BD54DF92D001C6098B84E2" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1640-wk-Fact-C8E6AA596D1255E184BDBFC13FED68C4" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Switzerland Franc (CHF)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1665-wk-Fact-5BD8422386525FA1BDF0ED0E2F477517" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1684-wk-Fact-EA93CCE4A79E57D39EAF35C8F35F5D34" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Romanian New Leu (RON)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1709-wk-Fact-8BB0F91B222E50EAAC770276B9F46EE9" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1728-wk-Fact-72490E8C6F78568FBBEDFC736264AC5F" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1753-wk-Fact-5826FBC76E615164AF01FB71FA6EB4F2" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1772-wk-Fact-A84E1758A9DB5199AD6653536C0DEE99" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1802-wk-Fact-BFF31DA155645AC29116EE0F01BBC56E" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">961.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e1821-wk-Fact-C3D40E92DBEF5D819B4ACA8AB6616595" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,257.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The maximum term of our forward currency exchange contracts is </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d46894e1837-wk-Fact-347CF64549A85DC5814B5F47B64B30EF" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" format="ixt-sec:durmonth">18</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:10pt;"> months.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Effects of Derivatives on the Financial Statements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="TextSelection-AF4978E033FE555ABEBFABB3F4B2553F-0-wk-Fact-81652683FFE35765B3070EF2A9BB230F" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:742px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:306px;"></td><td style="width:237px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2106-wk-Fact-A8166D7055835AD28723D079531BF15A" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2125-wk-Fact-2745E9955AC45B1EB75682E036BD9C7D" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2150-wk-Fact-1EEA78ED871E5D7E89902FD8AB95D4C1" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2169-wk-Fact-52224F8FE8865E78A12CBDC265BE0FF5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total designated derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2204-wk-Fact-AF1DF41DD88953DD98D986EBD75FAB4E" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2020Q3_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2223-wk-Fact-21DB91D2B4EB5E4E95B61DCDDE62E970" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2019Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2304-wk-Fact-5D04E54EF83356778A03B3DA468CD9A4" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2323-wk-Fact-03D018CA9DC658B2BF03769317FE4992" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:654px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:218px;"></td><td style="width:237px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2572-wk-Fact-7AD6C422083F5669BCF37F131A6D7D95" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2591-wk-Fact-5B529DB2AC2D547C9FA2DF0E4781FC7D" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2672-wk-Fact-7B8336FF16A8563FA7310124425E8E2B" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e2691-wk-Fact-CFCBF37D5E5557DB92F53C6B00381D4E" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 24</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 8</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-AB4882FADC4756FDA95E26A432F836D6-0-wk-Fact-C3F2DD3E16D45904955BB85D36491B6B" continuedAt="TextSelection-AB4882FADC4756FDA95E26A432F836D6-1" escape="true"><ix:continuation id="TextSelection-873C0C9658C65743A34C68B91D294820-3" continuedAt="TextSelection-873C0C9658C65743A34C68B91D294820-4"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:743px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:206px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:58px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:95px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3102-wk-Fact-F9BB330908A958B389DE6D9A65D75614" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3131-wk-Fact-CF1F8CB77897545D89804CC70A99C8C0" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3162-wk-Fact-4FE1B746FAE85DB1B49F9CFB005E5F07" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3182-wk-Fact-0A925A88A82D5544BF55E75FFACAF962" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3212-wk-Fact-B82207B6F36A57BB8993A663C46192D2" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3243-wk-Fact-35818FEE1DD35FA2B83D7A9C065ACC80" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3298-wk-Fact-337CC590139B5BB78093EF8A0A2F45B9" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3328-wk-Fact-C741D96B2BB45DDA91D807EE06EC8EA3" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3358-wk-Fact-1747913D54B05B5BB27B3AAAE6C58495" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3388-wk-Fact-FE25B67C3DAC54E486BC0B3C3E0B22CE" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3418-wk-Fact-6681933326045EAEBA00C707B9A1085F" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3530-wk-Fact-F424503B07F4577F985CCE39F88E8ADF" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3591-wk-Fact-220D175BD38153BDBB6D82D5FB07CD45" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contract</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3611-wk-Fact-9C85F8E333ED5CC6B3213EB433D2214B" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">11.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3672-wk-Fact-62533127690553D6A9EF5B45B9E0A7AC" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e3704-wk-Fact-D052A3B050575AC195770FB75B127428" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e3765-wk-Fact-03CAD9D624F252368697F44B4CD08714" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:240px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:95px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Treasury locks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4166-wk-Fact-599FFCCBEE295646BFAB4B90802D2614" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4195-wk-Fact-4E4E6875C0055BD9A818AFF6C683AD6D" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4226-wk-Fact-13A500EE2DAF5B3BA398046A1BA652E0" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4246-wk-Fact-21E5ECF72BF157788F6A7ECF9B4C5A3A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4275-wk-Fact-D535B0A4FF2F5C598E2CAA02D4E152CC" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4306-wk-Fact-28BD628AD3725EDD9C96928BBED8C160" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4331-wk-Fact-0D4BBC7E5651503EA28DC2F31CF06DD6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4360-wk-Fact-E8B4F9BB720D52049DCE56F8C025444B" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4391-wk-Fact-91F60300B0E55D5A861F966B5614DE6D" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4446-wk-Fact-28833CA101C751CD9BD27C34A22E99C5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4476-wk-Fact-6F916AB2EF7457A097AE031F0FD942C0" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4506-wk-Fact-AB00C328FFCF5CB3851B97436FC40313" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4535-wk-Fact-B8105E0702895BF28D6B5C3F324DF880" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4566-wk-Fact-7BAF1B1517AB5DD2884CE85CD45200FE" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4678-wk-Fact-29E7FACF98905FD6A4F2915EDDDBFD85" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">18.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4739-wk-Fact-1943B7319D9750658295047FA3F01742" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contract</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4760-wk-Fact-B13EFE4368D2570FA220BB1C13CE1E61" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">11.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4821-wk-Fact-A3B4F3D7480A5B1FA65E2A47FFB4C677" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e4852-wk-Fact-1304196B6B745288B99541373B5E5AF1" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">29.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e4913-wk-Fact-888679DD295157B09E5D018A488001B2" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1) <ix:footnote id="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="TextSelection-7ACFB08571BF59F18A819B39ECF73646-1">Net </ix:footnote></span><ix:continuation id="TextSelection-7ACFB08571BF59F18A819B39ECF73646-1" continuedAt="TextSelection-7ACFB08571BF59F18A819B39ECF73646-2"><span style="font-family:Arial;font-size:8pt;">loss</span><span style="font-family:Arial;font-size:8pt;"> of </span><span style="font-family:Arial;font-size:8pt;"><span>$<ix:nonFraction id="d46894e4932-wk-Fact-F83673EC6FC750CE8C9EB4EC0077DD8B" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.4</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:8pt;"> is expected to be reclassified out of AOCI into earnings during the next 12 months.</span></ix:continuation></div><ix:continuation id="TextSelection-7ACFB08571BF59F18A819B39ECF73646-2"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation></ix:continuation></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 25</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 8</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-873C0C9658C65743A34C68B91D294820-4" continuedAt="TextSelection-873C0C9658C65743A34C68B91D294820-5"><ix:continuation id="TextSelection-AB4882FADC4756FDA95E26A432F836D6-1"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:240px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:68px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:95px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5331-wk-Fact-C4F61373C5CB589D9021A8D9C6F79A57" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e5360-wk-Fact-E7E78F71BBF1561EBF0A75498EC2113A" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5391-wk-Fact-420D7C1D01425699B540FD8CDF433697" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5411-wk-Fact-E835612657E951B2A0627D709061FB0D" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5440-wk-Fact-98D4CB4B715E5A6D9BE71C1C7D730A00" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e5470-wk-Fact-D7A7D7BFFEDF5D30B4BC5F2DCA3D10B5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5526-wk-Fact-76211C3FE6E95B39B847EFEB8BA3C189" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5556-wk-Fact-494EBF65ADEB5969825276951CD89017" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5586-wk-Fact-B2D20690AE255B47BED53F915BE05075" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5615-wk-Fact-392782BD04A85150A41A871708CE7B63" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5645-wk-Fact-379ED6809C9B5064933BE135C5BC6513" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5757-wk-Fact-DD8EB5992B68D4FBDE30C6CFB50C4534" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e5817-wk-Fact-787D02DE69487AA678E0C6CFF6C9D52D" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:240px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:68px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:126px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:95px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6217-wk-Fact-EC680F6AF58D5F639FCBAA2015365B4D" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e6246-wk-Fact-337BCF5FA9D45C6AB94351EB1FBA8B9C" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6277-wk-Fact-0FD55D6AD71B571C9F29A154B933E220" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6297-wk-Fact-A514A87AAF0E5DE7B4CC734B1F95401B" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6326-wk-Fact-8895ACBD0AA65D59B7AB31D086EF861A" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e6356-wk-Fact-5EEB269411165131849D4C5C5F76D200" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e6412-wk-Fact-7D27581043FA53499880273DBD5D000E" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e6443-wk-Fact-F50059C19B485D778BC2E64CF3F6DE19" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6474-wk-Fact-A311F3C562F75FC99BED5731D6DC6C60" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e6503-wk-Fact-DBBA0B64F13F5020B77FA09536226083" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e6534-wk-Fact-22F3646BA2A053808BAB41BF94150A9C" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6647-wk-Fact-DD8EB5992B68D4FBDE30C6CFB50C4534" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6707-wk-Fact-787D02DE69487AA678E0C6CFF6C9D52D" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="TextSelection-67ABA3FAB1965BAF8192A13BD9296519-0-wk-Fact-0AE07E05C1715C6D81FD1D1CB9F636BB" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:768px;border-collapse:collapse;text-align:left;"><tr><td colspan="19"></td></tr><tr><td style="width:200px;"></td><td style="width:5px;"></td><td style="width:166px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e6978-wk-Fact-DAAADB183FF6513C8699DBA964587595" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e6997-wk-Fact-0CABFBF24B7F530AA2D6411A0E1BAE11" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">14.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7018-wk-Fact-037C67AB1EEB5AEFBE5898B7FEBA78B4" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e7037-wk-Fact-1823CCB5C5465F5290BFE8C5330F8B26" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">27.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7068-wk-Fact-ABD9D14BC2F25529839BC3958EE8A31E" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e7087-wk-Fact-A3017ACA4EC75C46860D1D339A75D6FE" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7108-wk-Fact-7AC3A230869A51D493933B05B64AF679" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7127-wk-Fact-E8F318C9DE365593A1BA752E49BA320A" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7167-wk-Fact-F9B49A6D45F7557CB7FDD1AFB31780E1" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e7186-wk-Fact-A4BB7E752EB25B69A9021542E484675D" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">15.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7207-wk-Fact-8BCD871B33765EBF83CAA425DF318139" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e7226-wk-Fact-8B65B3D3A1695F7FA5FD2C490BF38C95" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">26.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 26</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 8</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="TextSelection-ED862E47D4FF5BFF8AA9D241CC1A8B64-0-wk-Fact-CF8BC13C43FE5BA68C06943843BB0903" continuedAt="TextSelection-ED862E47D4FF5BFF8AA9D241CC1A8B64-1" escape="true"><ix:continuation id="TextSelection-873C0C9658C65743A34C68B91D294820-5" continuedAt="TextSelection-873C0C9658C65743A34C68B91D294820-6"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:353px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7597-wk-Fact-91F79D5851FA52E297E9A21CD478C108" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,213.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7616-wk-Fact-D6166CD88DD15F24801DF34453CB9491" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">785.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7636-wk-Fact-5563699BAF3D5510876A69B2F5003B29" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">34.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e7655-wk-Fact-7B895DB86A395FD8B2B3DCF0CCA06EA8" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e8028-wk-Fact-B82207B6F36A57BB8993A663C46192D2" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8048-wk-Fact-337CC590139B5BB78093EF8A0A2F45B9" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8068-wk-Fact-239E956BB72F51A9A15E0470AD5E0832" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8087-wk-Fact-99E83F3538E0533E8BF4FDBFE4ADACB7" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8112-wk-Fact-35818FEE1DD35FA2B83D7A9C065ACC80" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8131-wk-Fact-C741D96B2BB45DDA91D807EE06EC8EA3" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8151-wk-Fact-C0074B9CCAA558B8AF98847BBBD685FF" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8170-wk-Fact-C35EA94B92E6554F8601B1E60A1F1E31" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8283-wk-Fact-FADB15BCB8655C61AD81A9CB13897F9B" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8302-wk-Fact-826A8490D3965850B01F0E35C58DBFAF" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e8322-wk-Fact-CF1F8CB77897545D89804CC70A99C8C0" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8342-wk-Fact-23280D6B0B3D57E28663DC8E0492ACE8" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:353px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8692-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,773.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8711-wk-Fact-F6825A5E3B995584B76CA6D36B71F7AE" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,427.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8731-wk-Fact-2003F8F9485B5D92A9E51B11C3D690BB" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">97.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e8750-wk-Fact-097957692A2D57108C52A7A00CE0061D" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">17.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e9123-wk-Fact-E8B4F9BB720D52049DCE56F8C025444B" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9143-wk-Fact-28833CA101C751CD9BD27C34A22E99C5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9163-wk-Fact-97D1655FB6435CA2849860725E4A5115" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9182-wk-Fact-29EFA7F241755307A488B6B6B4A79B18" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9207-wk-Fact-91F60300B0E55D5A861F966B5614DE6D" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9226-wk-Fact-6F916AB2EF7457A097AE031F0FD942C0" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9246-wk-Fact-158CF7CCA37B553583A56B9D9C0C5E9B" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9265-wk-Fact-64A883DF228957AAA143159FE21A4E8D" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Treasury locks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9378-wk-Fact-793F4C5A03705FA6B4A38A93A017CB36" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9397-wk-Fact-FEB07EA63AF0523DBBAC5CAA2CFA0B48" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e9417-wk-Fact-4E4E6875C0055BD9A818AFF6C683AD6D" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9437-wk-Fact-0BCF786186E059579ED3AAD98C522FF3" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9549-wk-Fact-66AD461E202D597A92E804CC4DC2C0A8" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9568-wk-Fact-77B7508D8DC6566C8AA433FAA4D3920D" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e9588-wk-Fact-D535B0A4FF2F5C598E2CAA02D4E152CC" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9608-wk-Fact-EA597E258A7959E49CB2B97546EBDC86" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 27</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 8</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-ED862E47D4FF5BFF8AA9D241CC1A8B64-1"><ix:continuation id="TextSelection-873C0C9658C65743A34C68B91D294820-6"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:353px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9921-wk-Fact-AD8DF8663E025098BD5438A9C8F58044" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,191.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9940-wk-Fact-F244B3D2D80955E6B5620B5DF32AB4DB" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">778.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e9960-wk-Fact-39CFAD777BBD500CA31E9B3E378D9D52" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">30.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e9979-wk-Fact-D7BE36645A5C5C96AF8894AA8DB436F6" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">71.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10353-wk-Fact-98D4CB4B715E5A6D9BE71C1C7D730A00" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10372-wk-Fact-76211C3FE6E95B39B847EFEB8BA3C189" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10392-wk-Fact-023DA22505D95809ABC7F7B518F19B7A" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10411-wk-Fact-F8D2FB23A4465F278F2CDAB4DDE422D8" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e10436-wk-Fact-D7A7D7BFFEDF5D30B4BC5F2DCA3D10B5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10456-wk-Fact-494EBF65ADEB5969825276951CD89017" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10476-wk-Fact-872395A1712D54BF9DE8E068033B2A95" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10495-wk-Fact-D466F0ED96C25004B6782E0F981F2752" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10608-wk-Fact-DA9FA53ABF68508F97D819D3DFD7A988" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10627-wk-Fact-9835F8C6807C51F7B5B2248143C949C2" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e10647-wk-Fact-E7E78F71BBF1561EBF0A75498EC2113A" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10667-wk-Fact-F4EC940011CF56539060EAB48A0FE12E" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:353px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:69px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10978-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,514.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e10997-wk-Fact-2C56732F6E4250198917B3F0D82295C2" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,222.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11017-wk-Fact-3BAD30E281D250B1806640BA4ED547C2" name="us-gaap:InterestIncomeExpenseNet" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">90.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e11036-wk-Fact-A9690FAD7D5A5627A4159FEEA0CFF4AA" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">65.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11410-wk-Fact-8895ACBD0AA65D59B7AB31D086EF861A" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e11429-wk-Fact-7D27581043FA53499880273DBD5D000E" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11450-wk-Fact-E3BD00A3BB2D531F8FBB4C2383E49A37" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11469-wk-Fact-04BB1C8DDF89528BBA6071943104D868" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e11494-wk-Fact-5EEB269411165131849D4C5C5F76D200" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e11514-wk-Fact-F50059C19B485D778BC2E64CF3F6DE19" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11535-wk-Fact-A6A3B82C499F5F44A52AAF974CEDD17E" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11554-wk-Fact-36E4891153C85874A42784B6BB1468DC" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11667-wk-Fact-7D5EAFC93BBB5A3696599DC92B7CBDC1" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11686-wk-Fact-7271AB4BD14F501F9D0020235C9C7B91" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d46894e11706-wk-Fact-337BCF5FA9D45C6AB94351EB1FBA8B9C" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d46894e11726-wk-Fact-60CBEF83BE8F5570912E79BF51E98A6E" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation></ix:continuation><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 28</span></div></div><hr style="page-break-after:always"></hr><div><a id="s5C415D6F8F16571ABE301BD0CB1A1A36"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 9</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 9 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:LesseeFinanceLeasesTextBlock" id="TextSelection-19B4F9B8492757099F9E331B541BD6C0-0-wk-Fact-9C5803FFA7295E38B5A7B9B707158A6D" continuedAt="TextSelection-19B4F9B8492757099F9E331B541BD6C0-1" escape="true"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:LesseeOperatingLeasesTextBlock" id="TextSelection-A3279B220BBB5DC489A0807C71BAD32F-0-wk-Fact-6239D2B9EA45519CB10C4B13E02823E5" continuedAt="TextSelection-A3279B220BBB5DC489A0807C71BAD32F-1" escape="true"><span style="font-family:Arial;font-weight:bold;">LEASES</span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="TextSelection-19B4F9B8492757099F9E331B541BD6C0-1" continuedAt="TextSelection-19B4F9B8492757099F9E331B541BD6C0-2"><ix:continuation id="TextSelection-A3279B220BBB5DC489A0807C71BAD32F-1" continuedAt="TextSelection-A3279B220BBB5DC489A0807C71BAD32F-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="prgo:AssetsandLiabilitiesLesseeTableTextBlock" id="TextSelection-D9F3A961531D53EDB050ACF704134DAE-0-wk-Fact-10C8A2EA4CD95EE0889E18810ED7C527" escape="true"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:160px;"></td><td style="width:5px;"></td><td style="width:306px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:89px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1090-wk-Fact-E6F78C2EB5D957A0995950F29DB10E47" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">132.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1109-wk-Fact-E70D989FFA1C5AD380968DF9112E78C9" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">129.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1139-wk-Fact-77848684BD345B8E855AE2F8637F8D71" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1158-wk-Fact-2BA975E647E95BB5B5E1DD5F9F64E60C" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1198-wk-Fact-D29717650C8151568B9C06B28A21AE73" name="prgo:RightofUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">161.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1217-wk-Fact-2551717F29E05A94903E0ED76D21A7B8" name="prgo:RightofUseAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">157.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:160px;"></td><td style="width:5px;"></td><td style="width:306px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:89px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1382-wk-Fact-2E038EB8989F507486229B44351F5D0C" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1401-wk-Fact-006E56C6678E5F358A2BD95B10942A1F" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1431-wk-Fact-6EC9622FE4F4522DA664A376025886AA" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1450-wk-Fact-347D4591F71A53FDA11AE77ACE07CF8F" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-Current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1541-wk-Fact-A42F5C49CA0C5D40AE9633D00CF40658" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">106.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1560-wk-Fact-5D9C10947FFD542BBB375BC20899A221" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Long-term debt, less current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1595-wk-Fact-7AFD9A407FB25005B06FA9AC060142CA" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1614-wk-Fact-2ED2BBE193CA5462A356F995C37140C0" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1654-wk-Fact-DA0868E164755B6AB278E653758C7BE5" name="prgo:LeaseLiabilities" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">164.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e1673-wk-Fact-1550D1905399561E8B51F131EE7C6477" name="prgo:LeaseLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">158.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The below table shows our lease assets and liabilities by reporting segment (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:796px;border-collapse:collapse;text-align:left;"><tr><td colspan="33"></td></tr><tr><td style="width:72px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:73px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:73px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:73px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:73px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2245-wk-Fact-0A24B5EDF75B5E0F8BAB8CF2F95CE38C" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2264-wk-Fact-2687F5CA861D56F0A52A216FEAE0DBA3" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2284-wk-Fact-F56524CCAA5E5D5182C8B976E0754F7F" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2303-wk-Fact-A6654748BDDC51F98CF26C21C8038F29" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2322-wk-Fact-AAE9145F96205B1BAAF972E1D55FF5D5" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2342-wk-Fact-B0F2DE8D8E2C52738C942A7418CD02CD" name="us-gaap:OperatingLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2361-wk-Fact-DAB52B839AD25E77B780B7D3AA81BA7C" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2380-wk-Fact-5E2AD08F1EC256CE9397A2E7DE10CF4A" name="us-gaap:FinanceLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2400-wk-Fact-38FD8E1AB2645639A55C4F604E5C840A" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2419-wk-Fact-130FAA6C93195E2FBBF1C38CC0CE9AF1" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2438-wk-Fact-E3B2EA48C9765C1F9A69A0AB562183D2" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2458-wk-Fact-164D93A34AB05B568CB4897E91940D2A" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2477-wk-Fact-9E9E9068F4C05A7997A12FAB6739FCB4" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2497-wk-Fact-C8ED786505CF59D4BEAB6F63BB69908D" name="us-gaap:OperatingLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2516-wk-Fact-B6E4AAA7D9AC530CB089B55430AAE567" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2535-wk-Fact-65CD5DF3004A516AB695DDEBC8269663" name="us-gaap:FinanceLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2560-wk-Fact-BC8F390BE28C56E6A18174C7B8D0FD71" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2579-wk-Fact-D8453BDC413F5317B0617E0992C3266C" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">35.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2598-wk-Fact-29873327758C5DF6891A1C0E55355218" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2618-wk-Fact-AAD391CA35DA553694DF31B4E6CF3F03" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2637-wk-Fact-8FDC609CDD615D58A04299A0DF4285EB" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2657-wk-Fact-631F80864EDA50CEA1D4A540A3DBFFB6" name="us-gaap:OperatingLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2676-wk-Fact-4E7890D862B5544BAB85CE463F2DBD59" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2695-wk-Fact-E813185A69A25BCD80F80C0A2D939B23" name="us-gaap:FinanceLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2720-wk-Fact-15FD8798A5AF511CB00B88A879FBBEDC" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2739-wk-Fact-762622E785545FC98A65EE04564F7DD0" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2758-wk-Fact-547E3AC54ED5557385F4BC36601B7FAF" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2778-wk-Fact-046BF7343B605BC4B054DC6392BAF50A" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2797-wk-Fact-AE281FE50AA557E5926C8B64A9416D7E" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2817-wk-Fact-0E33F8D09E44534DAE23F636A3B825D1" name="us-gaap:OperatingLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2836-wk-Fact-0F6908E177D65C619938711DE1F83FC2" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2855-wk-Fact-50A967927E24586881E15E0D154E70D6" name="us-gaap:FinanceLeaseLiability" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2885-wk-Fact-E6F78C2EB5D957A0995950F29DB10E47" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">132.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2904-wk-Fact-E70D989FFA1C5AD380968DF9112E78C9" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">129.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2924-wk-Fact-77848684BD345B8E855AE2F8637F8D71" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2943-wk-Fact-2BA975E647E95BB5B5E1DD5F9F64E60C" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2962-wk-Fact-C4FAB7EFBE345C5CACFA184428C74B1F" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">138.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e2982-wk-Fact-9CB668778CAC5AE6818D7220F616AFD3" name="us-gaap:OperatingLeaseLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">133.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3001-wk-Fact-808BFB1A78645289A7794C45B8425FE8" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3020-wk-Fact-BF7B87762556547281235ADA652485A8" name="us-gaap:FinanceLeaseLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:LeaseCostTableTextBlock" id="TextSelection-47F5B4075EBD5FA28A76167AFED8BEB6-0-wk-Fact-6FC033A8900651C4BFDB518AEB57944C" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Lease expense was as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:177px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:87px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:89px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:89px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3257-wk-Fact-C9C00F121CB951659C3760707A8C41F4" name="us-gaap:OperatingLeaseCost" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3276-wk-Fact-17F7D38C41C65D89B57E9524630DF06F" name="us-gaap:OperatingLeaseCost" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3296-wk-Fact-1D68F3544CDE5E28B26B49940823EEB2" name="us-gaap:OperatingLeaseCost" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3315-wk-Fact-5BE07753BFF65ECD8A5D8EE3A14DA068" name="us-gaap:OperatingLeaseCost" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3514-wk-Fact-E5DC962A24105EC8A2999E54FB498E22" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3533-wk-Fact-CEDA58BA85D65F54B9F9960A967EA702" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3553-wk-Fact-DA5DE931E7295537B63FEC05393A604C" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3572-wk-Fact-D9EEFC2D36F95D8FAB9E4A66AD4B1FE0" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3592-wk-Fact-5E6FF5C959AF5FB294F15DF423E48773" name="us-gaap:FinanceLeaseInterestExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3611-wk-Fact-A6D129F6970B59F288377CC8902A6BD1" name="us-gaap:FinanceLeaseInterestExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3630-wk-Fact-96591D55C01D52D092712DB88F177FB1" name="us-gaap:FinanceLeaseInterestExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3650-wk-Fact-DBA961647DF6553B8567A0E93F1E1CFD" name="us-gaap:FinanceLeaseInterestExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3680-wk-Fact-C8E9D2B32EDA5030A6C8F5FC64F52374" name="prgo:FinanceLeaseCost" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3699-wk-Fact-F43840A85B5256ECB9C06ABF39291DBA" name="prgo:FinanceLeaseCost" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3719-wk-Fact-C31F2682A35B5D98B5F10F1BF9D17EBC" name="prgo:FinanceLeaseCost" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3738-wk-Fact-2DFE43349F495AAE922054A93C80EED6" name="prgo:FinanceLeaseCost" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><ix:footnote id="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US"><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"></span><span style="font-family:Arial;font-size:8pt;"></span><span style="font-family:Arial;font-size:8pt;">(1)  Includes short-term leases and variable lease costs, which are immaterial</span><span style="font-family:Arial;font-size:8pt;">.</span></div></ix:footnote></ix:nonNumeric><div style="line-height:120%;padding-left:24px;text-indent:48px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">&#160;&#160;&#160;&#160;</span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 29</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 9</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-19B4F9B8492757099F9E331B541BD6C0-2"><ix:continuation id="TextSelection-A3279B220BBB5DC489A0807C71BAD32F-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="TextSelection-93C3972108115223BCABD3172586A4A3-0-wk-Fact-F93B55CEB729515EB3CA025161ED9FEC" escape="true"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="TextSelection-F3C5BF7F88545CE2B4905A9457EB3E09-0-wk-Fact-94E8D687252B5C3ABFF3B6480B36A343" escape="true"><div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The annual future maturities of our leases as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:192px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3892-wk-Fact-8DCA306B42275B0187BD985740EEF0BD" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3911-wk-Fact-74CC2A473DF1579FBFE40FF7E09E5E8F" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3931-wk-Fact-84D1E386E63A5A809037B8EAFBF1902A" name="prgo:LeaseLiabilityPaymentsRemainderofFiscalYear" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3951-wk-Fact-B1C23D85B22456C29F96BE94DD729332" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3970-wk-Fact-974AC05037785A01B295C02B01D730C1" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e3989-wk-Fact-BF7A818FE9A15245820CD546AD399D63" name="prgo:LeaseLiabilityPaymentsDueYearOne" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4015-wk-Fact-EE5E306001CC518C8C46400AE969B36A" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4034-wk-Fact-FD4CB199498D5D748E6B2DF9049C13DE" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4053-wk-Fact-58DC6C4AF59E5E72A569A3AFF802BB2C" name="prgo:LeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4079-wk-Fact-FDC61D2B4E875A1A9E5445D7DD6E7CCA" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4098-wk-Fact-F76D10AAC0555442B8A6237819A015F3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4117-wk-Fact-8E07D0D54380579CAA7A482982077FF6" name="prgo:LeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4143-wk-Fact-DDE3B1C05FCF5CC5A9B008D908C17B50" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4162-wk-Fact-92B3FC0AB6695BD184BF8894DBC880B8" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4181-wk-Fact-882824021FC4572A978695EAF643177E" name="prgo:LeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">After 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4207-wk-Fact-9850409A4AF9537F829BBFE51920B932" name="prgo:LesseeOperatingLeaseLiabilitytobePaidafterYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4226-wk-Fact-564D8D5D3F555F248C814ADA6725B0D0" name="prgo:FinanceLeaseLiabilitytobePaidafterYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4245-wk-Fact-BCDB5EBAE14B561AB52B09DA5F582229" name="prgo:LeaseLiabilityPaymentsDueafterYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">68.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Total lease payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4271-wk-Fact-620F94638DFD567F94E5EE8EABAC4637" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">157.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4290-wk-Fact-EF142D5D38BA53AA9D87277CF362E38A" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4309-wk-Fact-351C117D423C545989845F04B1DDEB71" name="prgo:LeaseLiabilityPaymentsDue" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">188.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Less: Interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4335-wk-Fact-51FBE160895D5786B57A7873F234607A" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4354-wk-Fact-BD12D618893E5E88A95DE8F29400CD03" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4373-wk-Fact-31099CD0B72D585C8C18A377CB34942D" name="prgo:LeaseLiabilityUndiscountedExcessAmount" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Present value of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4404-wk-Fact-C4FAB7EFBE345C5CACFA184428C74B1F" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">138.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4423-wk-Fact-808BFB1A78645289A7794C45B8425FE8" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4443-wk-Fact-DA0868E164755B6AB278E653758C7BE5" name="prgo:LeaseLiabilities" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">164.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" id="TextSelection-F81B8B353BFF5E258B64339A49F59119-0-wk-Fact-A53BE1B1774551DE830FA450606E8825" escape="true"><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our weighted average lease terms and discount rates are as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:473px;"></td><td style="width:5px;"></td><td style="width:89px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:89px;"></td><td style="width:10px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Weighted-average remaining lease term (in years)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d24840e4568-wk-Fact-CAA4CC9CE899590CA825DE726554F8E3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2020Q3" format="ixt-sec:duryear">6.54</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d24840e4582-wk-Fact-98DF8366DB435FBEB0B8B09C11A5E7E2" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2019Q3" format="ixt-sec:duryear">6.58</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d24840e4602-wk-Fact-416A5C049BE057CFA82402018CB3B365" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2020Q3" format="ixt-sec:duryear">9.03</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d24840e4616-wk-Fact-91FDFB7F937959E5B5B7839437DA3223" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2019Q3" format="ixt-sec:duryear">10.90</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted-average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Operating leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4672-wk-Fact-B2ABD19EF5125F4D8E3C2C758F2A7A0A" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="FI2020Q3" unitRef="ratio" decimals="4" scale="-2" format="ixt:numdotdecimal">3.80</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4687-wk-Fact-CAB38A800B635D569AAF2B2B98DEB9CF" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="FI2019Q3" unitRef="ratio" decimals="4" scale="-2" format="ixt:numdotdecimal">4.17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4708-wk-Fact-7D3E4689BCE1538E943B00D3D53983D8" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="FI2020Q3" unitRef="ratio" decimals="4" scale="-2" format="ixt:numdotdecimal">3.20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4723-wk-Fact-4A30C8E167AC5470A35502638FE5372D" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="FI2019Q3" unitRef="ratio" decimals="4" scale="-2" format="ixt:numdotdecimal">3.50</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="prgo:LesseeCashFlowClassificationsTableTextBlock" id="TextSelection-BDBA49A8318B56E68D2AE85B5E2F98BE-0-wk-Fact-54FEDE533FAB54D7A9607F7DBCBFE3E3" escape="true"><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our lease cash flow classifications are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:473px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:89px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:89px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4916-wk-Fact-DC12FD08CCC85B95A3740E6E684C52F8" name="us-gaap:OperatingLeasePayments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4935-wk-Fact-810C887854EC562DB96DB9EBB8F9E095" name="us-gaap:OperatingLeasePayments" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4960-wk-Fact-2CB2E7C861BA5F09A3C27DDBDA6DCCFA" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e4979-wk-Fact-CCF2C0E8303F53E7B14F5487866693D0" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Financing cash flows for finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e5004-wk-Fact-2CC7226A9D7754D1AB5BC505FDA47901" name="us-gaap:FinanceLeasePrincipalPayments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e5023-wk-Fact-63AA5071E5FB5668B91AB208EF68E817" name="us-gaap:FinanceLeasePrincipalPayments" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new finance lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e5094-wk-Fact-433A3E0531835095A8E27239D1D51B75" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e5113-wk-Fact-4FAABEEC8A055EF893D6F89410B2B58C" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new operating lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e5138-wk-Fact-DC40CDB996225DBA9847ACC8454BC50E" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d24840e5157-wk-Fact-9B1977136DA759E9AEA5C70CDCB9D453" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 30</span></div></div><hr style="page-break-after:always"></hr><div><a id="sF883DFF8F7F254E1ACF1AFCBB94077B2"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 10</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 10 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:DebtDisclosureTextBlock" id="TextSelection-26DCA37977AD578FB3E19C8656FC95C8-0-wk-Fact-DA110A30ADB95094950386357C70EF1B" continuedAt="TextSelection-26DCA37977AD578FB3E19C8656FC95C8-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">INDEBTEDNESS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-26DCA37977AD578FB3E19C8656FC95C8-1" continuedAt="TextSelection-26DCA37977AD578FB3E19C8656FC95C8-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfDebtTableTextBlock" id="TextSelection-3CC330EE8B6B507C91C5920EB7051A64-0-wk-Fact-F4C0E4B87BE654EAB59764BEA2BE9109" escape="true"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total borrowings outstanding are summarized as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.48427672955975%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:27%;"></td><td style="width:5%;"></td><td style="width:22%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Term loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2019 Term loan due August 15, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1206-wk-Fact-5DBD723F8CA05E91A4DE5E7408145B0B" name="us-gaap:LoansPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">600.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1225-wk-Fact-33822536587A5AEEAA3C879BE36327E1" name="us-gaap:LoansPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">600.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Notes and Bonds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:underline;">Coupon</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:underline;">Due</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1427-wk-Fact-7B8E6A30547951F8B99BE6BD717917F3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.500</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1432-wk-Fact-76C54A7D72495AD9BBE6CA09A4C949B1" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" format="ixt:datemonthdayyearen">March 15, 2021</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1447-wk-Fact-23A1CEB354B65121905F0D8A99CF3C8C" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1466-wk-Fact-0F07F502238856719195123582CEE69F" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">280.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1487-wk-Fact-8ADD1509DCF05121AD93145957B69581" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.500</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1492-wk-Fact-A6480BDBD64A53118A050C806E8E2AB1" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member" format="ixt:datemonthdayyearen">December 15, 2021</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1507-wk-Fact-B0228E40039F5C75A539BA4157FE1E40" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1526-wk-Fact-BD72C25AE70D5DC2B25EFBEB165F3E67" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">309.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1547-wk-Fact-86F912DFCED45D7FB2E1514F9EE589E4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">5.105</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonNumeric id="d27108e1552-wk-Fact-08EF9BC9348C54B681F5C4E593B63CBA" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member">July 28, 2023</ix:nonNumeric></span></span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1569-wk-Fact-6E1AF8334F855FAC88056E8F024E4292" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">157.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1588-wk-Fact-FFEF8242A15558DEA4FAC150709AF729" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">151.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1609-wk-Fact-C51A5E106AC156D2838EEB6CAB8974A8" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">4.000</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1614-wk-Fact-11CD92C9D0A95D96A8324FC5E1013A46" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" format="ixt:datemonthdayyearen">November 15, 2023</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1629-wk-Fact-8553C53280E35E32867AC83B54575328" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">215.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1648-wk-Fact-EBF37C34A9E254D384507AECD1F4B433" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">215.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1669-wk-Fact-606FE2D771E6585A9CEAD9A926CE50FF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.900</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1674-wk-Fact-E16CA418CD925843ADCB588C6B2B08D2" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member" format="ixt:datemonthdayyearen">December 15, 2024</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1689-wk-Fact-62304D75160A571993DE4E1CD5822D0B" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">700.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1708-wk-Fact-0B0780ED5E775049B542666D79B3147B" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">700.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1730-wk-Fact-50782DAE575D51EE8D6954767F9741C2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">4.375</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1735-wk-Fact-11AEDD2CEA2C5BF88FAE7C107E324367" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member" format="ixt:datemonthdayyearen">March 15, 2026</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1750-wk-Fact-1CC5F57FCADF58C684215049A0F241C7" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">700.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1769-wk-Fact-F507A4C4427755EC91163DABBCC12188" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">700.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1790-wk-Fact-A85A0640E48A5079A4BA4DB2C4B7DC6F" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.150</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1795-wk-Fact-298A6395E8FF5E54B0DDF87EEE0752ED" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member" format="ixt:datemonthdayyearen">June 15, 2030</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1810-wk-Fact-7DF57422509E585982327D708B14DEBF" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">750.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1829-wk-Fact-31A781BA333C5D9FB1AEB5B196812DBA" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1850-wk-Fact-868CAE4A932F58B497DD293686A9D859" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">5.300</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1855-wk-Fact-4C3959F7C4F650A1A46198C5B8EC0DCE" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" format="ixt:datemonthdayyearen">November 15, 2043</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1870-wk-Fact-878B6D963FB2530EA6BD743872C8973B" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">90.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1889-wk-Fact-6543969CEBB95CDBA9C4BFFB53FDA3DA" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">90.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1910-wk-Fact-7C5C00B66D1952B58EC734328114F56B" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">4.900</ix:nonFraction>%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d27108e1915-wk-Fact-DB19A32ABA4457AAAF2E8FCF16993FBE" name="us-gaap:DebtInstrumentDescription" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member" format="ixt:datemonthdayyearen">December 15, 2044</ix:nonNumeric></span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1930-wk-Fact-ED39FBFD8D9E5C91B0C41E65B649E312" name="us-gaap:SeniorNotes" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">303.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1949-wk-Fact-E3F18C7A02135CC69249D5928A0F6117" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">303.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total notes and bonds</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e1990-wk-Fact-9287490D823B54F082FA392FBF2C5CCB" name="us-gaap:SeniorNotes" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,917.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2009-wk-Fact-0E26F4BB1DB55033810AD395060886C5" name="us-gaap:SeniorNotes" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,751.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Other financing</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2050-wk-Fact-E1606F88A73B53699223D55D86E69F20" name="us-gaap:OtherLongTermDebt" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">61.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2069-wk-Fact-54C51A8585625AC9AB67CB9BC8A3374E" name="us-gaap:OtherLongTermDebt" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unamortized premium (discount), net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d27108e2110-wk-Fact-29FD9101EDBB53578915241ABA78EEC3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2130-wk-Fact-EA2CAFB37A95549DA517A71C654F0520" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">7.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred financing fees</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d27108e2171-wk-Fact-F26D5AF10B645E769088134C9E400D65" name="us-gaap:DebtInstrumentFeeAmount" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.9</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d27108e2191-wk-Fact-783A800C9508564DBBB5D1765C72E822" name="us-gaap:DebtInstrumentFeeAmount" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total borrowings outstanding</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2233-wk-Fact-F9DBBE31BCD8596CBE4EEE8DB2DD76B8" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,560.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2252-wk-Fact-351A0889B8BF598DB9BF4859F7B30948" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,369.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d27108e2293-wk-Fact-3DC6FA6B46FE5173B7B7759E90882478" name="us-gaap:DebtCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.5</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d27108e2313-wk-Fact-F97CC33280EC5755AA584B26ECDD59A0" name="us-gaap:DebtCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total long-term debt less current portion</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2360-wk-Fact-F430BF656C9D59D4B7C0DED9C182B3BC" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,543.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d27108e2379-wk-Fact-3D3715BC11DE5A3DB437F324C420D917" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,365.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:72px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)  <ix:footnote id="TextSelection-7A8EDA421AAF55FDAD0D4EAB26DA18BC-0-wk-Footnote-7A8EDA421AAF55FDAD0D4EAB26DA18BC_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</ix:footnote></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are in compliance with all covenants under our debt agreements as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Revolving Credit Agreements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 8, 2018, we entered into a </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2466-wk-Fact-6B432C6B3CF353168878C00C722488D5" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember" unitRef="usd" decimals="INF" scale="9" format="ixt:numdotdecimal">1.0</ix:nonFraction> billion</span></span><span style="font-family:Arial;font-size:10pt;"> revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2470-wk-Fact-6D997290DE2C5304B374D8345AFBB958" name="us-gaap:LineOfCredit" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember" unitRef="usd" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> borrowings outstanding under the 2018 Revolver as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> or </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Term Loans</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 8, 2018, we refinanced the </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;<ix:nonFraction id="d27108e2493-wk-Fact-88898D4DE08558EC91EF920714CF24DF" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2014EuroDenominatedTermLoandueDecember52019Member" unitRef="eur" decimals="INF" scale="6" format="ixt:numdotdecimal">350.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> outstanding under the previous term loan with the proceeds of a new </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;<ix:nonFraction id="d27108e2497-wk-Fact-422DF42600FA5C348994915785CD8DD0" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member" unitRef="eur" decimals="INF" scale="6" format="ixt:numdotdecimal">350.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2501-wk-Fact-8EADDE1CD06E58758A049F437FFE21B8" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">431.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">) term loan, maturing on March 8, 2020 (the "2018 Term Loan"). During the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, we made </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2514-wk-Fact-7A20F829733B53878A6EDFBA4EF3C35D" name="us-gaap:RepaymentsOfDebt" contextRef="FD2019Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.7</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> in scheduled principal repayments on the 2018 Term Loan. On August 15, 2019, we refinanced the </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;<ix:nonFraction id="d27108e2518-wk-Fact-659453EFD17A58A0962F503CFC8053E6" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member" unitRef="eur" decimals="INF" scale="6" format="ixt:numdotdecimal">284.4</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2522-wk-Fact-BA3EB8507FA85CBF9F1E1C418B06D5C4" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">317.1</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">) outstanding under the 2018 Term Loan with the proceeds of a new </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2526-wk-Fact-572D4C796BC95348ACEA306D3660380B" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">600.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> term loan, maturing on August 15, 2022. As a result of the refinancing, during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2539-wk-Fact-0902512623DA08C58560C6E098F62B56" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q3QTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, consisting of the write-off of deferred financing fees in </span><span style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Notes and Bonds</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">2020 Notes and 2021 Notes Redemption</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 19, 2020, Perrigo Finance Unlimited Company, a public unlimited company incorporated under the laws of Ireland ("Perrigo Finance") and an indirect wholly-owned finance subsidiary of Perrigo whose primary </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 31</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 10</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-26DCA37977AD578FB3E19C8656FC95C8-2"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">purpose is to finance the business and operations of Perrigo and its affiliates, issued $</span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2568-wk-Fact-A65552EF47D75CCDBA0598D4BFC2C274" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">750.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2572-wk-Fact-9A1B04E42A3154BCAB58972A60B885CB" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="I2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.150</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due 2030 (the &#8220;2020 Notes") and received net proceeds of $</span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2576-wk-Fact-4D074E9D378E5B92A82ECB723A48EEDC" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" contextRef="D2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">737.1</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> after fees and market discount. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2020 Notes will mature on June 15, 2030. The 2020 Notes are governed by a base indenture and a third supplemental indenture (collectively, the "2020 Indenture"). The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo and no other subsidiary of Perrigo guarantees the 2020 Notes. There are no restrictions under the 2020 Notes on Perrigo's ability to obtain funds from its subsidiaries. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. On July 6, 2020, the proceeds of the 2020 Notes were used to fund the redemption of Perrigo Finance's </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2580-wk-Fact-0F07F502238856719195123582CEE69F" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">280.4</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2584-wk-Fact-07C24C03C80158F3A2252BD158D30E76" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.500</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due March 15, 2021 and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2589-wk-Fact-BD72C25AE70D5DC2B25EFBEB165F3E67" name="us-gaap:SeniorNotes" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">309.6</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2593-wk-Fact-DB453EC39671531FA828D10925165378" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.500</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due December 15, 2021 (collectively, the "2021 Notes"). The balance will be used for general corporate purposes which may include the repayment or redemption of additional indebtedness.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As a result of the early redemption of the 2021 Notes, during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of $</span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2611-wk-Fact-6537BFE5729390A2695E4757BF3733B9" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3QTD_us-gaap_DebtInstrumentAxis_prgo_SeniorNotesdue2021Member" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">20.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations, consisting of the premium on debt repayments, the write-off of deferred financing fees, and the write-off of the remaining bond discounts.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Financing</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". The balance outstanding under the facilities was </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2632-wk-Fact-79BCEF2D5DBB5748894EEFDF225D68B7" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. There were </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2640-wk-Fact-CD24F5BAA60E5E6DAB76867F2DE185D4" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> borrowings outstanding under the facilities as of </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 17, 2020, we incurred debt of $</span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2655-wk-Fact-A60DF794312B7106AE8D475B2900A31C" name="us-gaap:NotesPayable" contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.3</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> related to our equity method investment in Kazmira pursuant to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d27108e2659-wk-Fact-5989D17103B95CF7B39A84EA8751A934" name="prgo:NumberofPromissoryNotes" contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="promissory_note" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> Promissory Notes, with </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2663-wk-Fact-4E08E8264768FF35E04E475BD2152F3B" name="us-gaap:NotesPayable" contextRef="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2020Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2667-wk-Fact-C6F80EF26B04617D9D06475C1899D4FE" name="us-gaap:NotesPayable" contextRef="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueMay2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.8</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d27108e2671-wk-Fact-66B33A4611CF13CF31A1475C54D309F1" name="us-gaap:NotesPayable" contextRef="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.8</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> to be settled in November 2020, May 2021 and November 2021, respectively (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sF4B58DD1964A5338A17E7D9B8F660A6D"><span style="font-family:Arial;font-size:10pt;">Note 7</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have financing leases that are reported in the above table under "Other financing" (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#s5C415D6F8F16571ABE301BD0CB1A1A36"><span style="font-family:Arial;font-size:10pt;">Note 9</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div></ix:continuation><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sFB7F09E97D4D50879B04022FA3F53DDF"></a></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 11 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:EarningsPerShareTextBlock" id="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-0-wk-Fact-9BBBE923DD395D55A8C0BBBDBC6F1CC7" continuedAt="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY</span></ix:nonNumeric></div><ix:continuation id="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-1" continuedAt="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-2"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Earnings per Share</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="TextSelection-B77A81E8428E5776A32397D1C9913924-0-wk-Fact-A7C3FE4B89FE589A9401DB06F36C501A" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29539e1261-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">154.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1281-wk-Fact-E71A91499A5557858B57177F0D58A3CB" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">92.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1295-wk-Fact-08FB4EC393345107970F7A706AE01243" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1315-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">165.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1484-wk-Fact-78E62AC728A75531BF9A6E884F5303D3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1503-wk-Fact-1C2EF28688725C7D80F2C8088A76769A" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1517-wk-Fact-C1E53D38F6B7552B9D0690947347E060" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1537-wk-Fact-53FE4EB273C15CA4BE767C70DBCA9CA1" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards*</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1557-wk-Fact-8E7B51E0001651F59334F63E30A68520" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1576-wk-Fact-A829969C34F8533CBEBD61A503F3030A" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1590-wk-Fact-AD7CC1BE401157C8B74B161CB4B58DB3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1610-wk-Fact-D577BC6DA12759CFAC580716E5395C92" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1630-wk-Fact-5C5C30AFBA8C5A51A10D8E788B640859" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1649-wk-Fact-C8E3779330DE5F4FA67C150EA14283BA" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1663-wk-Fact-F22C375A219F547E8118FB44221651D2" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">137.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1683-wk-Fact-3543D9576257501785C04A94408B4FD0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">136.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS*</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1780-wk-Fact-6EEFC2D6DBC153698EBF0227D6A28251" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1799-wk-Fact-6DF28A47AB0B5975A658DB56F5C2CA31" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1813-wk-Fact-6B00D7D90C21501FB740932FEEDF4550" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29539e1833-wk-Fact-8A4E1F61401D575EBEACA2D6DA95348C" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">*  <ix:footnote id="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-1">In the period of a net loss, diluted shares equal basic shares.</ix:footnote></span></div><ix:continuation id="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-1"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></ix:continuation></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 32</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 11</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-2" continuedAt="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-3"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Shareholders' Equity</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Share Repurchases</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><ix:continuation id="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-3" continuedAt="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-4"><span style="font-family:Arial;font-size:10pt;">In October 2018, our Board of Directors authorized up to </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d29539e1900-wk-Fact-C716557A9C245E7585E05BF21B218794" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="I2018Q4Oct31" unitRef="usd" decimals="INF" scale="9" format="ixt:numdotdecimal">1.0</ix:nonFraction>&#160;billion</span></span><span style="font-family:Arial;font-size:10pt;"> of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program. We did not repurchase any shares during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span></ix:continuation><span style="font-family:Arial;font-size:10pt;"><ix:continuation id="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-4">.</ix:continuation> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s834B42D5C6E05A798C3BA3951A46C56D"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 12 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="TextSelection-A3A00063D01F5E0CBBEFCD4A9131B8C0-0-wk-Fact-AAD21562617650B699130BEF0EE14C8D" continuedAt="TextSelection-A3A00063D01F5E0CBBEFCD4A9131B8C0-1" escape="true"><span style="font-family:Arial;font-weight:bold;">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></ix:nonNumeric></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-E7BDB5B72A4B593F9CB0B8EF21536F9A-0-wk-Fact-58842F08D572509B85844DB3049A3CAA" escape="true"><ix:continuation id="TextSelection-A3A00063D01F5E0CBBEFCD4A9131B8C0-1"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Changes in our AOCI balances, net of tax were as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value of Derivative Financial Instruments, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign Currency Translation Adjustments</span><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Post-Retirement and Pension Liability Adjustments, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total AOCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1117-wk-Fact-18AEB8A226835859BC4F2C9F05D03ADC" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1136-wk-Fact-20C3F5BB631951E59307A7F3386B3E62" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">132.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29815e1155-wk-Fact-CA3BF53D4128507687F2D2ACF02ECEB5" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">6.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1176-wk-Fact-E2902A17BE1D5AB38330DA9EA8BD38AA" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">139.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">OCI before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29815e1191-wk-Fact-B704476621A95EA3B6E3CF878EE12E32" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">11.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1211-wk-Fact-550DC8BC68425D2B98C7D150862FFCDB" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29815e1230-wk-Fact-2C73FE3A1E5F566287F2C0343F92DFBB" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1251-wk-Fact-DB11CD00771E584986E590D4B7BAB658" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amounts reclassified from AOCI</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29815e1271-wk-Fact-0097DAC1E6C4571C9BC996F74323E894" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1291-wk-Fact-FDEAF037013B58459AEF9E1FD7C07376" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">46.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1310-wk-Fact-20A33940652B5DCEB9B329A4C88DFB3D" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1330-wk-Fact-60A1D1F26E955A0F9D5841335FED0076" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">45.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29815e1355-wk-Fact-B20327F26C6F5C67B17997AFA514E0A0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1375-wk-Fact-3625B4BE859F52CA908CA7E007B560A4" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29815e1394-wk-Fact-50C63609DB25589EB10E3138E31074EA" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1415-wk-Fact-90E2EFBA909E53649BADCFE90EC3C82B" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">64.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at September 26, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1435-wk-Fact-5496BF5985345B02B5E84A7C61AD3683" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1454-wk-Fact-D9CA19BBFB455C538C5BA1FBD32A2C97" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">213.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d29815e1473-wk-Fact-4B48C4082C165BFB9A36FE77D43C9D8F" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">10.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d29815e1494-wk-Fact-6E44D95C44115A8395CECBD5423A2DA3" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">203.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1) Refer to </span><a style="font-family:Arial;font-size:8pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:8pt;">Note 3</span></a><span style="font-family:Arial;font-size:8pt;"> Rosemont Pharmaceuticals business divestiture for information regarding amounts reclassified from AOCI.</span></div></ix:continuation></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div><a id="sAF954DA7DF52564E89822E8DA956F14A"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 13 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:IncomeTaxDisclosureTextBlock" id="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-0-wk-Fact-D6017A71618352BD9F97F604BFBAD07D" continuedAt="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-1" escape="true"><span style="font-family:Arial;font-weight:bold;">INCOME TAXES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-1" continuedAt="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="TextSelection-9E4DEBE991DB5F069BB67BA24AF85175-0-wk-Fact-267F0B4893975E3E8A3294B1F26DAB98" escape="true"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The effective tax rates were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:391px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:78px;"></td><td style="width:14px;"></td><td style="width:5px;"></td><td style="width:82px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:82px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:82px;"></td><td style="width:10px;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d30888e1122-wk-Fact-72FF522241F751AC91A8CDC58E3C3D1A" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2020Q3QTD" unitRef="ratio" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">21.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d30888e1137-wk-Fact-FEF77BDDC2F55F999C146F29AF630924" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q3QTD" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d30888e1152-wk-Fact-D7A79F155FAB5D298669F1205CF46F8F" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2020Q3YTD" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">78.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d30888e1167-wk-Fact-27B55B8AF0085FDE8E8FEBFA8BB7C1C5" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q3YTD" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">19.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"></span><span style="font-family:Arial;font-size:10pt;">The effective tax rate for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> increased compared to the prior period primarily due to non-deductible goodwill impairments and Base Erosion and Anti-Abuse Tax ("BEAT"), offset by additional interest deductions provided for in the U.S. Coronavirus Aid, Relief, and Economic Security ("CARES") Act and the early adoption of the final and proposed business interest expense deduction limitation regulations in the current period.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Tax Cuts and Jobs Act of 2017 introduced a new tax on U.S. corporations that derive benefits from certain deductible payments to non-U.S. affiliates called the Base Erosion and Anti-Abuse Tax ("BEAT"). BEAT applies when base eroding payments exceed three percent of total deductions and where BEAT exceeds adjusted regular income tax.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We recorded a valuation allowance against all U.S. deferred tax assets as of December 31, 2016. We have continued to maintain a full valuation allowance against all U.S. deferred tax assets since and intend to continue maintaining this valuation allowance until there is sufficient evidence to support the reversal of all or some portion of these allowances. Given our current earnings and anticipated future earnings, we believe there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available that all or a portion of the valuation allowance against the U.S. deferred tax assets will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense in the period of the release. The exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we actually achieve.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 33</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 13</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-2" continuedAt="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-3"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">IRS Audit of Fiscal Years Ended June 29, 2013, June 28, 2014, and June 27, 2015</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In connection with its audits of Perrigo Company, a Michigan corporation and wholly-owned indirect subsidiary of Perrigo Company plc, for the fiscal years ended June 29, 2013, June 28, 2014, and June 27, 2015 the IRS issued a draft Notice of Proposed Adjustment ("NOPA") on August 22, 2019, reducing Perrigo Company&#8217;s deductible interest expense for fiscal tax years 2014-2015 on </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1230-wk-Fact-C15D35249C2359AD879B3DF291570412" name="prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" contextRef="I2019Q3Aug22" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">7.5</ix:nonFraction> billion</span></span><span style="font-family:Arial;font-size:10pt;"> in debts owed by it to Perrigo Company plc. A final NOPA was issued in early May 2020 without change.&#160;The debts were incurred in connection with the Elan merger transaction in 2013. The final NOPA caps the interest rate on the debts for U.S. federal tax purposes at </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d30888e1234-wk-Fact-7EA7F21841D0503E8470D5B0E669495D" name="prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" contextRef="D2020Q2May" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">130.0</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> of the Applicable Federal Rate (a blended rate reduction of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d30888e1238-wk-Fact-E48AF6F8B2175DF0A5854F427ABE0862" name="prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" contextRef="D2020Q2May" unitRef="ratio" decimals="INF" scale="-2" format="ixt:numdotdecimal">4.0</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> per annum), on the stated ground that the loans were not negotiated on an arms&#8217;-length basis. The final NOPA proposes a reduction in gross interest expense of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1242-wk-Fact-E8DE17E0AA865769A0069B8E148779A0" name="prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" contextRef="D2020Q2May" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">480.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> for fiscal years 2014 and 2015. If the IRS were to prevail in its proposed adjustment, the Company estimates an increase in tax expense of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1246-wk-Fact-931D00279F8A512682217AE2320F7867" name="prgo:IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" contextRef="D2020Q2May" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">170.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, excluding interest and penalties, for fiscal years ended June 28, 2014 through June 27, 2015. In addition, we expect the IRS to seek similar adjustments for the period from June 28, 2015 through December 31, 2018 with potential section 163(j) carryover impacts beyond December 2018. If those further adjustments were sustained, based on preliminary calculations and subject to further analysis, the Company's current best estimate is that the additional tax expense will not exceed </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1251-wk-Fact-3CEE011507385562B8B3C3B5B1ABD0B8" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" contextRef="D2020Q2May" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">200.0</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, excluding interest and penalties. No further adjustments beyond this period are expected. The Company strongly disagrees with the IRS position, as reflected in its detailed written response to the draft NOPA on September 20, 2019. At this stage, we are unable to estimate the liability, if any, associated with this matter. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">IRS Audit of Fiscal Years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1266-wk-Fact-6D6B772E0FD653CEB6994AB5DC1F0837" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="D2017Q1Aug15" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">163.6</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> of Federal income tax, penalties, and interest assessed and collected by the IRS, plus statutory interest thereon from the dates of payment, for the fiscal tax years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012 (the &#8220;2009 tax year,&#8221; &#8220;2010 tax year,&#8221; &#8220;2011 tax year,&#8221; and &#8220;2012 tax year,&#8221; respectively). In response to our complaint, the United States District Court for Western District of Michigan scheduled a new trial date for January 26, 2021. The IRS audits of those years culminated in the issuances of two statutory notices of deficiency: (1) on August 27, 2014 for the 2009 and 2010 tax years and (2) on April 20, 2017 for the 2011 and 2012 tax years. The statutory notices of deficiency both included un-agreed income adjustments related principally to transfer pricing adjustments regarding the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States. In addition, the statutory notice of deficiency for the 2011 and 2012 tax years included the capitalization of certain expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits. We fully paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and filed timely claims for refund on June 11, 2015 and June 7, 2017 for the 2009-2010 tax years and 2011-2012 tax years, respectively. Upon the disallowance of such refund claims, we timely filed the above complaint, which seeks refunds of tax, interest, and penalties of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1270-wk-Fact-254902D2F5535AE4ADAB37C1E7EB788B" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="D2010Q1SD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.2</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2009 tax year, </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1274-wk-Fact-2C066AAC4D795C57ABEF7AABA022BD3E" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="D2010Q4CollaborationPayment" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">61.5</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2010 tax year, </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1278-wk-Fact-A5B7F3DEC4E451E483E43E28533E3BE7" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="D2011Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.2</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2011 tax year, and </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1282-wk-Fact-AAFADD0718665901B1DF5E45C39B6A91" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="D2014Q4CalendarYear" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.7</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2012 tax year, for a total of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1287-wk-Fact-6D6B772E0FD653CEB6994AB5DC1F0837" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="D2017Q1Aug15" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">163.6</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in </span><span style="font-family:Arial;font-size:10pt;">Other non-current assets</span><span style="font-family:Arial;font-size:10pt;"> on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in </span><span style="font-family:Arial;font-size:10pt;">Other non-current assets</span><span style="font-family:Arial;font-size:10pt;"> on our balance sheet during the three months ended July 1, 2017. The total cumulative deferred charge that the Company is seeking to receive in this litigation is approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1299-wk-Fact-4EF4ECD3A0495D56B6B6655E957AAFA5" name="prgo:CumulativeDeferredChargeTaxLitigation" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">101.8</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;">, which reflects (i) a deduction of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1303-wk-Fact-40E91CABFC1E52A4A5DD92190DE0F574" name="prgo:IncomeTaxOverpaymentsAppliedtoSucceedingYears" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.7</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> from the total reflected above due to overpayments credited to succeeding years and (ii) the impact of a previously conceded royalty due to Perrigo U.S. on all omeprazole sales that equates to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d30888e1307-wk-Fact-CFAD64D8F16B5E57A37BD03B262F7E82" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" contextRef="FD2020Q3YTD" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">24.0</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> of the above refund claims. That </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d30888e1312-wk-Fact-CFAD64D8F16B5E57A37BD03B262F7E82" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" contextRef="FD2020Q3YTD" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">24.0</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> concession would also apply to any omeprazole adjustments that may be asserted by the IRS for future years. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">IRS Audit of Fiscal Years Ended December 31, 2011, December 31, 2012, and December 31, 2013</span><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, Inc. ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The NOPA carries forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#8217;s intellectual property, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The NOPA proposes a </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 34</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 13</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-3" continuedAt="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-4"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">payment of </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d30888e1333-wk-Fact-4E171A3FA42A559099D4E1DFF67FB6C3" name="prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" contextRef="I2019Q2Apr26" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">843.0</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which represents additional tax and a </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d30888e1337-wk-Fact-DC365657B2F75423BB6AA1203AA231F3" name="prgo:IRSNoticeofProposedAdjustmentPenaltyPercent" contextRef="I2019Q2Apr26" unitRef="ratio" decimals="3" scale="-2" format="ixt:numdotdecimal">40.0</ix:nonFraction>%</span></span><span style="font-family:Arial;font-size:10pt;"> penalty. This amount excludes consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagree with the IRS position and will pursue all available administrative and judicial remedies, including those available under the U.S. - Ireland Income Tax Treaty to alleviate double taxation. Accordingly, on April 14, 2020, we filed a request for Competent Authority Assistance with the IRS. The request was accepted and is under review. No payment of the additional amounts is required until the matter is resolved administratively, judicially, or through treaty negotiation.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 22, 2016, we received a NOPA from the IRS regarding the deductibility of litigation costs related to the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012, and December 31, 2013.&#160;We strongly disagree with the IRS&#8217;s position asserted in the NOPA and are contesting it.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Irish Revenue Audit of Fiscal Years Ended December 31, 2012 and December 31, 2013</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On October 30, 2018, we received an audit finding letter from the Irish Office of the Revenue Commissioners (&#8220;Irish Revenue&#8221;) for the years ended December 31, 2012 and December 31, 2013. The audit finding letter relates to the tax treatment of the 2013 sale of the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> intellectual property and other assets related to Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> to Biogen Idec from Elan Pharma. The consideration paid by Biogen to Elan Pharma took the form of an upfront payment and future contingent royalty payments. Irish Revenue issued a Notice of Amended Assessment (&#8220;NoA&#8221;) on November 29, 2018 which assesses an Irish corporation tax liability against Elan Pharma in the amount of </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;<ix:nonFraction id="d30888e1367-wk-Fact-AE424E11E4375AC2A4A9607697F16AC7" name="prgo:IncomeTaxExaminationUnsettledAssessedAuditLiability" contextRef="I2018Q4Nov29_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember" unitRef="eur" decimals="-6" scale="6" format="ixt:numdotdecimal">1,636</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, not including interest or any applicable penalties.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We strongly disagree with this assessment and believe that the NoA is without merit and incorrect as a matter of law. We will pursue all available administrative and judicial avenues as may be necessary or appropriate. In connection with that, we filed an appeal of the NoA on December 27, 2018 in the Tax Appeals Commission which is the statutory body charged with considering whether the NoA is properly founded as a matter of tax law. Separately, we were also granted leave by the Irish High Court on February 25, 2019 to seek judicial review of the issuance of the NoA by Irish Revenue.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The judicial review case is based on our belief that, by issuing the NoA, Irish Revenue breached Elan Pharma's rights and legitimate expectations as a taxpayer. The Irish High Court heard the judicial review case in June 2020 and, on November 4, 2020, the High Court ruled that the issuance of the NoA did not violate the Company&#8217;s rights and legitimate expectations. Because the Irish High Court did not quash the NoA, absent an appeal by Elan Pharma, the amended assessment can be examined on its merits by the Irish Tax Appeals Commission. Our case before the Irish Tax Appeals Commission has been stayed since February 2019 by Order of the Irish High Court pending determination of the judicial review case. We will now assess the Irish High Court's decision before deciding whether to pursue an appeal of the judicial review case to the Irish Court of Appeal or reactivate our appeal before the Tax Appeals Commission. Any appeal against the judgment of the High Court in the judicial review case would have to be filed within </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonNumeric id="d30888e1383-wk-Fact-B1829FAF2B517253BE6C9367F415E064" name="prgo:PeriodAvailabletoFileAppeal" contextRef="D2020Q3_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" format="ixt-sec:durday">28</ix:nonNumeric> days</span></span><span style="font-family:Arial;font-size:10pt;"> of the Order made by the High Court consequent upon the judgment delivered on November 4, 2020. That Court Order is expected to be made within a period of weeks once the question of liability for the litigation costs of the judicial review case has been decided by the High Court. </span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"></span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d30888e1394-wk-Fact-C03892B4264911A98D09936E030C3B0A" name="prgo:PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal" contextRef="D2020Q3_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="usd" decimals="0" scale="0" format="ixt-sec:numwordsen">No</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> payment will be required unless both the judicial review case and the appeal pending before the Tax Appeals Commission are finally determined against Elan Pharma.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Tax Authority Audit of Fiscal Year Ended June 27, 2015 and Calendar Years Ended December 31, 2015 through December 31, 2017</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Israel Tax Authority is auditing our fiscal year ended June 27, 2015, and calendar years ended December 31, 2015, December 31, 2016 and December 31, 2017.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Although we believe that our tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments, which could be material.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 35</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 13</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-4"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. However, we are not able to estimate a reasonably possible range of how these events may impact our unrecognized tax benefits in the next twelve months.</span></div></ix:continuation><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div><a id="s5958A14DA1AE536285E42C2A91B4FD9C"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 14 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-0-wk-Fact-4AC64A7CC87D56D5B80C846188DB4EC2" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-1" escape="true"><span style="font-family:Arial;font-weight:bold;">CONTINGENCIES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-1" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-2"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Price-Fixing Lawsuits</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Perrigo is a defendant in several cases in the generic pricing multidistrict litigation </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">MDL No. 2724 (United States District Court for Eastern District of Pennsylvania)</span><span style="font-family:Arial;font-size:10pt;">. This multidistrict litigation, which has many cases that do not include Perrigo, includes class action and opt-out cases for federal and state antitrust claims, as well as complaints filed by various of the States alleging violations of state antitrust laws.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On July 14, 2020, the court issued an order designating the following cases to proceed on a more expedited basis than the other cases in </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">MDL No. 2724:</span><span style="font-family:Arial;font-size:10pt;"> (a) the States&#8217; May 2019 case alleging an overarching conspiracy involving more than </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1017-wk-Fact-0D463B1A1EA15B7AA2AF09FB67E5B9FA" name="prgo:NumberofProductsincludedinExpeditedCases" contextRef="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember" unitRef="product" decimals="INF" scale="0" format="ixt:numdotdecimal">120</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> products (which does not name Perrigo a defendant) and (b) class actions alleging &#8220;single drug&#8221; conspiracies involving Clomipramine, Pravastatin, and Clobetasol. Perrigo is a defendant in the Clobetasol cases but not the others. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Class Action Complaints</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">(a) Single Drug Conspiracy Class Actions</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have been named as a co-defendant with certain other generic pharmaceutical manufacturers in a number of class actions alleging single-product conspiracies to fix or raise the prices of certain drugs and/or allocate customers for those products starting, in some instances, as early as June 2013. The class actions were filed on behalf of putative classes of (a) direct purchasers, (b) end payors, and (c) indirect resellers. The products in question are Clobetasol gel, Desonide, and Econazole. The court denied motions to dismiss each of the complaints alleging &#8220;single drug&#8221; conspiracies involving Perrigo, and the cases are proceeding in discovery. As noted above, the Clobetasol cases have been designated to proceed on a more expedited schedule than the other cases. That schedule has not yet been set.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">(b) &#8220;Overarching Conspiracy&#8221; Class Actions</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The same </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1050-wk-Fact-3BEA7C6212B4571684B839F34B95CDEB" name="prgo:NumberofPutativeClasses" contextRef="FI2012Q2" unitRef="class" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> putative classes, including (a) direct purchasers, (b) end payors, and (c) indirect resellers, have filed </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1054-wk-Fact-01ECC4ABB7F25EB39D63AAA1CC6A6A0B" name="prgo:NumberofSetsofClassActionComplaints" contextRef="FI2012Q2" unitRef="class" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> sets of class action complaints alleging that Perrigo and other manufacturers (and some individuals) entered into an &#8220;overarching conspiracy&#8221; that involved allocating customers, rigging bids and raising, maintaining, and fixing prices for various products. Each class brings claims for violations of Sections 1 and 3 of the Sherman Antitrust Act as well as several state antitrust and consumer protection statutes. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 36</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-2" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-3"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Filed in June 2018, and later amended in December 2018 (with respect to direct purchasers) and April 2019 (with respect to end payors and indirect resellers), the first set of &#8220;overarching conspiracy&#8221; class actions include allegations against Perrigo and approximately </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1064-wk-Fact-6BB88D42245F5F0480216FDE214C4BD2" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">27</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers involving </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1068-wk-Fact-9E5795780E385A808ECF45DFB5C66BCC" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember" unitRef="product" decimals="INF" scale="0" format="ixt:numdotdecimal">135</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> drugs with allegations dating back to March 2011. The allegations against Perrigo concern only </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1072-wk-Fact-ECCE8AEFC4635838A1BE336ADEC4533C" name="prgo:LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany" contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> formulations (cream and ointment) of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1076-wk-Fact-E22E9FD4344E59848AE450D605F42835" name="prgo:LossContingencyNumberOfPrescriptionPharmaceuticals" contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> of the products at issue, Nystatin. The court denied motions to dismiss the first set of &#8220;overarching conspiracy&#8221; class actions, and they are proceeding in discovery. </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1080-wk-Fact-6E9FD07F3911E6B5111BC621E383C7B8" name="prgo:NumberofCasesIncludedinExpeditedSchedule" contextRef="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">None</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> of these cases are included in the group of cases on a more expedited schedule pursuant to the court&#8217;s July 14, 2020 order.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In December 2019, both the end payor and indirect reseller class plaintiffs filed a second set of "overarching conspiracy&#8221; class actions against Perrigo, dozens of other manufacturers of generic prescription pharmaceuticals, and certain individuals dating back to July 2009 (end payors) or January 2010 (indirect resellers). The direct purchaser plaintiffs filed their second round overarching conspiracy complaint in February 2020 with claims dating back to July 2009. On March 11, 2020, the indirect reseller plaintiffs filed a motion to amend their second round December 2019 complaint, and that motion was granted. On September 4, 2020, the end payor plaintiffs amended their second round complaint. On October 21, 2020, the direct purchaser plaintiffs amended their second round complaint.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">This second set of overarching complaints allege conspiracies relating to the sale of various products that are not at issue in the earlier-filed overarching conspiracy class actions, the majority of which Perrigo neither makes nor sells. The amended indirect reseller complaint alleges that Perrigo conspired in connection with its sales of Betamethasone Dipropionate lotion, Imiquimod cream, Desonide cream and ointment, and Hydrocortisone Valerate cream. The amended end payor complaint alleges that Perrigo conspired in connection with its sale of the following drugs: Adapalene, Ammonium Lactate, Betamethasone Dipropionate, Bromocriptine Mesylate, Calcipotriene Betamethasone Dipropionate, Ciclopirox, Clindamycin Phosphate, Erythromycin, Fenofibrate, Fluocinonide, Fluticasone Propionate, Halobetasol Proprionate, Hydrocortisone Acetate, Hydrocortisone Valerate, Imiquimod, Methazolamide, Mometasone Furoate, Permethrin, Prochlorperazine Maleate, Pormethazine HCL, Tacrolimus, and Triamcinolone Acetonide. The amended direct purchaser complaint alleges that Perrigo conspired in connection with its sale of the following drugs: Adapalene, Ammonium Lactate, Betamethasone Dipropionate, Bromocriptine Mesylate, Ciclopirox, Clindamycin Phosphate, Fenofibrate, Fluocinonide, Halobetasol Proprionate, Hydrocortisone Valerate, Methazolamide, Permethrin, Prochlorperazine Maleate, Promethazine HCL, Tacrolimus, and Triamcinolone Acetonide.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Perrigo has not yet responded to the second set of overarching conspiracy complaints, and responses are currently or will be stayed.</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Opt-Out Complaints</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 22, 2018, Perrigo was named a co-defendant along with </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1115-wk-Fact-45BC06B0C9445817893D12373A3AA60F" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">35</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers in a complaint filed by </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1119-wk-Fact-284E3A35F648596598E751BF824C89D2" name="prgo:LossContingencyNumberOfSupermarketChains" contextRef="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember" unitRef="supermarket" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> supermarket chains alleging that defendants conspired to fix prices of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1123-wk-Fact-740A598B7E455966B78EE4423341C591" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember" unitRef="product" decimals="INF" scale="0" format="ixt:numdotdecimal">31</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceutical products starting in 2013. On December 21, 2018, an amended complaint was filed that adds additional products and allegations against a total of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1127-wk-Fact-2655EFFD47F35AE19B3094A479AEFA78" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2018Q4Dec21_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">39</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> manufacturers for </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1131-wk-Fact-B5F5BE2A1AF65BF4A29DC66B02F006DF" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2018Q4Dec21_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember" unitRef="product" decimals="INF" scale="0" format="ixt:numdotdecimal">33</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> products. The only allegations specific to Perrigo relate to Clobetasol, Desonide, Econazole, Nystatin cream, and Nystatin ointment. Perrigo moved to dismiss this complaint on February 21, 2019. The motion was denied on August 15, 2019. The case is proceeding in  discovery. On February 3, 2020, the plaintiffs requested leave to file a second amended complaint. The proposed amended complaint adds dozens of additional products and allegations to the original complaint. Perrigo is discussed in connection with allegations concerning an additional drug, Fenofibrate. Defendants opposed the motion for leave to file a second amended complaint and the court has yet to rule on the issue.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 3, 2018, a large managed care organization filed a complaint against Perrigo alleging price-fixing and customer allocation concerning </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1141-wk-Fact-6B1BBB1138C85A8FA7310F8FAF96A4E2" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2018Q3Aug03_srt_LitigationCaseAxis_prgo_PricefixingLawsuitManagedCareOrganizationMember" unitRef="product" decimals="INF" scale="0" format="ixt:numdotdecimal">17</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> different products among </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1145-wk-Fact-D7525966FB055731BF650EE61055BB2E" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2018Q3Aug03_srt_LitigationCaseAxis_prgo_PricefixingLawsuitManagedCareOrganizationMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">27</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> manufacturers including Perrigo. The only allegations specific to Perrigo concern Clobetasol. Perrigo moved to dismiss this complaint on February 21, 2019. Plaintiff filed a second amended complaint in April 2019 that adds additional products and allegations. The amended allegations that concern Perrigo include: Clobetasol, Desonide, Econazole, and Nystatin. The motion to dismiss was denied on August 15, 2019. The case is proceeding in discovery.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 16, 2019, a similar suit was brought by a health insurance carrier in the U.S. District Court for the District of Minnesota alleging a conspiracy to fix prices of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1156-wk-Fact-6EE49B86884D57DBB241764B3D7450DA" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember" unitRef="product" decimals="INF" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> products among </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1160-wk-Fact-57B342874F685EEFAD38BD486F996037" name="us-gaap:LossContingencyNumberOfDefendants" contextRef="D2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> defendants. The only </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 37</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-3" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-4"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">allegations specific to Perrigo concern Clobetasol gel, Desonide, Econazole, Nystatin cream, and Nystatin ointment. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On July 18, 2019, </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1173-wk-Fact-3E821DFA608B5CF28740BD8F76557E68" name="prgo:LossContingenciesNumberofHealthPlans" contextRef="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember" unitRef="health_plan" decimals="INF" scale="0" format="ixt:numdotdecimal">87</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> health plans filed a Praecipe to Issue Writ of Summons in Pennsylvania state court to commence an action against </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1177-wk-Fact-D4885976F1835B5BA29F5504471B14F5" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">53</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic pharmaceutical manufacturers and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1181-wk-Fact-6881A07F08C95A8CBBB33673A4C5E406" name="prgo:LossContingencyNumberOfIndividuals" contextRef="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember" unitRef="individual" decimals="INF" scale="0" format="ixt:numdotdecimal">17</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> individuals, alleging antitrust violations concerning generic pharmaceutical drugs. While Perrigo was named as a defendant, no complaint has been filed and the precise allegations and products at issue have not been identified</span><span style="font-family:Times New Roman;font-size:10pt;">. </span><span style="font-family:Arial;font-size:10pt;">Proceedings in the case, including the filing of a complaint, have been stayed at the request of the plaintiffs.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 11, 2019, a health care service company filed a complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1195-wk-Fact-DC0FEF4C1D9450FAAAC4798699FFEAB3" name="prgo:LossContingencyNumberofCodefendants" contextRef="I2019Q4Dec11_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareServiceCompanyMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">38</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other multi-district litigation ("MDL") complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin cream/ointment. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 16, 2019, a Medicare Advantage claims recovery company filed a complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1205-wk-Fact-EB57FADA75C15E2688B30E2EE3293532" name="prgo:LossContingencyNumberofCodefendants" contextRef="I2019Q4Dec16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">39</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, and Econazole. The complaint was originally filed in the District of Connecticut but will be consolidated into the MDL. Perrigo has not yet had the opportunity to respond to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 23, 2019, several counties in New York filed an amended complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1215-wk-Fact-9D3E460FA2525AEE8CDB74F27165B790" name="prgo:LossContingencyNumberofCodefendants" contextRef="I2019Q4Dec23_srt_LitigationCaseAxis_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">28</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was originally filed in New York State court but was removed to federal court and will likely be consolidated into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 27, 2019, a healthcare management organization filed a complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1226-wk-Fact-731930D2CE4D55D7A17024AAE275A311" name="prgo:LossContingencyNumberofCodefendants" contextRef="I2019Q4Dec27_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">25</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was filed originally in the Northern District of California but will be consolidated into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 1, 2020, Harris County of Texas filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1236-wk-Fact-E12016DD556D5D44B0730E7964A10226" name="prgo:LossContingencyNumberofCodefendants" contextRef="I2020Q1Mar1_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHarrisCountyofTexasMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">29</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The products at issue that plaintiffs claim Perrigo manufacturers or sells include: Adapalene, Betamethasone Dipropionate, Ciclopirox, Clindamycin, Clobetasol, Desonide, Econazole, Ethinyl Estradiol/Levonorgestrel, Fenofibrate, Fluocinolone, Fluocinonide, Gentamicin, Glimepiride, Griseofulvin, Halobetasol Propionate, Hydrocortisone Valerate, Ketoconazole, Mupirocin, Nystatin, Olopatadine, Permethrin, Prednisone, Promethazine, Scopolamine, and Triamcinolone Acetonide</span><span style="font-family:Times New Roman;font-size:10pt;">. </span><span style="font-family:Arial;font-size:10pt;">The complaint was originally filed in the Southern District of Texas but has been transferred to the MDL. Harris County amended its complaint in May 2020. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In May 2020, </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1250-wk-Fact-7C829317C0395EF4886493F6EF75F588" name="prgo:LossContingenciesNumberofHealthPlans" contextRef="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember" unitRef="health_plan" decimals="INF" scale="0" format="ixt-sec:numwordsen">seven</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> health plans filed a writ of summons in the Pennsylvania Court of Common Pleas in Philadelphia concerning an as-yet unfiled complaint against Perrigo, </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1254-wk-Fact-2484FCAD39D9554CB799612DC73CB485" name="prgo:NumberofDozensofManufacturers" contextRef="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> dozen other manufacturers, and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1258-wk-Fact-5DDC7BFDD033522BAC5CE0491D85A3D6" name="prgo:LossContingencyNumberOfIndividuals" contextRef="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember" unitRef="defendant" decimals="INF" scale="0" format="ixt-sec:numwordsen">seventeen</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> individuals, concerning alleged antitrust violations in connection with the pricing and sale of generic prescription pharmaceutical products. No complaint has yet been filed, so the precise allegations and products at issue are not yet clear. In addition, Defendants are in the process of being served, and proceedings in the case will likely be stayed.  </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 9, 2020, a health insurance carrier filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1268-wk-Fact-9A8B1A21D1F854C2AE4E44E0B9A6F03A" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2020Q2Jun9_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">25</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 38</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-4" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-5"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was filed in the Eastern District of Pennsylvania and has been transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On July 9, 2020, a drugstore chain filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d35415e1281-wk-Fact-3648945122F1ADD7D153476DA6CDF76D" name="prgo:NumberofOtherPharmaceuticalCompanies" contextRef="I2020Q3Jul9_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugstoreChainMember" unitRef="pharmaceutical_company" decimals="INF" scale="0" format="ixt:numdotdecimal">39</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. Perrigo is also listed in connection with Fenofibrate. The complaint was filed in the Eastern District of Pennsylvania and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 27, 2020, Suffolk County of New York filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1292-wk-Fact-3DC1FEE8852F165BE74647624B98BB66" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2020Q3Aug27_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">35</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin cream and ointment. The other products at issue that plaintiffs claim Perrigo manufacturers or sells include: Adapalene gel; Albuterol; Benazepril HCTZ; Clotrimazole; Diclofenac Sodium; Fenofibrate; Fluocinonide; Glimepiride; Ketoconazole; Meprobamate; Imiquimod; Triamcinolone Acetonide; Erythromycin/Ethyl Solution; Betamethasone Valerate; Ciclopirox Olamine; Terconazole; Hydrocortisone Valerate; Fluticasone Propionate; Desoximetasone; Clindamycin Phosphate; Halobetasol Propionate; Hydrocortisone Acetate; Promethazine HCL, Mometasone Furoate; and Amiloride HCTZ. The complaint was filed in the Eastern District of New York and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On September 4, 2020, a drug wholesaler and distributor filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1302-wk-Fact-89B8669C2306F4F940DC4771CF6B7F9A" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2020Q3Sep4_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">39</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on Adapalene Cream, Ammonium Lactate cream and lotion, Betamethasone Dipropionate lotion, Bromocriptine tablets, Calcipotriene Betamethasone Dipropionate (Cal Beta Dip) Ointment, Ciclopirox shampoo cream and solution, Clindamycin solution, Clobetasol, Desonide cream and ointment, Econazole cream, Erythromycin base alcohol solution, Fenofibrate, Fluticasone lotion, Halobetasol cream and ointment, Hydrocortisone Acetate suppositories, Hydrocortisone valerate cream, Imiquimod cream, Methazolamide tablets, Mometasone furoate cream, ointment and solution, Nystatin, Prochlorperazine suppositories, Promethazine HCL suppositories, Tacrolimus ointment, and Triamcinolone cream and ointment. The complaint was filed in the Eastern District of Pennsylvania and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">State Attorney General Complaint </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 10, 2020, the Connecticut Attorney General&#8217;s office filed a lawsuit on behalf of Connecticut and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1317-wk-Fact-49418E65FBC158F99500D502BB32CDC1" name="prgo:LossContingencyNumberofAdditionalStatesandTerritories" contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember" unitRef="plaintiff" decimals="INF" scale="0" format="ixt:numdotdecimal">50</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other states and territories against Perrigo, </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1321-wk-Fact-44A3DC0FE7675BC88DCD49E04B249996" name="prgo:LossContingencyNumberOfManufacturers" contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">35</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other generic pharmaceutical manufacturers, and certain individuals (including </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1325-wk-Fact-CDA5965856765588A7A7587CAA12051A" name="prgo:LossContingencyNumberofFormerEmployees" contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember" unitRef="defendant" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> former and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1329-wk-Fact-2D2399A6D92C50B59ED3EC07C786EC8C" name="dei:EntityNumberOfEmployees" contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember" unitRef="defendant" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> current Perrigo employee), alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of eighty products. The allegations against Perrigo focus on the following drugs: Adapalene Cream, Ammonium Lactate cream and lotion, Betamethasone dipropionate lotion, Bromocriptine tablets, Calcipotriene Betamethasone Dipropionate (Cal Beta Dip) Ointment, Ciclopirox cream and solution, Clindamycin solution, Desonide cream and ointment, Econazole cream, Erythromycin base alcohol solution, Fluticasone cream and lotion, Halobetasol cream and ointment, Hydrocortisone Acetate suppositories, Hydrocortisone Valerate cream, Imiquimod cream, Methazolamide tablets, Nystatin ointment, Prochlorperazine suppositories, Promethazine HCL suppositories, Tacrolimus ointment, and Triamcinolone cream and ointment. The Complaint was filed in the District of Connecticut</span><span style="font-family:Times New Roman;font-size:10pt;">,</span><span style="font-family:Arial;font-size:10pt;"> but has been transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 39</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-5" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-6"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Canadian Class Action Complaint</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1349-wk-Fact-BBE9FD49CEC35734BB5D2BAA54CDCFEA" name="prgo:LossContingencyNumberOfManufacturers" contextRef="FI2020Q2_srt_LitigationCaseAxis_prgo_CanadianClassActionComplaintMember" unitRef="manufacturer" decimals="INF" scale="0" format="ixt:numdotdecimal">29</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. Perrigo has not yet responded to the complaint.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Securities Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In the United States (cases related to events in 2015-2017)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On May 18, 2016, a shareholder filed a securities case against us and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund v. Papa, et al.</span><span style="font-family:Arial;font-size:10pt;">).&#160;The plaintiff purported to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa.&#160;In general, the allegations concerned the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015.&#160;The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016.&#160;On July 19, 2016, a different shareholder filed a securities class action against us and our former CEO, Joseph Papa, also in the District of New Jersey (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson v. Papa, et al.</span><span style="font-family:Arial;font-size:10pt;">). The plaintiff purported to represent a class of persons who sold put options on our shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims were the same as those made in the original complaint filed in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case described above. On December 8, 2016, the court consolidated the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</span><span style="font-family:Arial;font-size:10pt;"> case under the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case number. In February 2017, the court selected the lead plaintiffs for the consolidated case and the lead counsel to the putative class. In March 2017, the court entered a scheduling order.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 21, 2017, the court-appointed lead plaintiffs filed an amended complaint that superseded the original complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</span><span style="font-family:Arial;font-size:10pt;"> case. In the amended complaint, the lead plaintiffs seek to represent </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1413-wk-Fact-F5F5DA77944C54FBBBB7F3165D50EBF8" name="prgo:NumberofPutativeClasses" contextRef="I2017Q2Jun21" unitRef="class" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> classes of shareholders: (i) shareholders who purchased shares during the period from April 21, 2015 through May 3, 2017 on the U.S. exchanges; (ii) shareholders who purchased shares during the same period on the Tel Aviv exchange; and (iii) shareholders who owned shares on November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (the final day of the Mylan tender offer) regardless of whether the shareholders tendered their shares. The amended complaint names as defendants us and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1417-wk-Fact-FE8F4D05E7A05FAEA93D61528F674586" name="prgo:LossContingencyNumberOfIndividuals" contextRef="I2017Q2Jun21" unitRef="individual" decimals="INF" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The amended complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b</span><span style="font-family:Times New Roman;font-size:10pt;">&#8209;</span><span style="font-family:Arial;font-size:10pt;">5) and 14(e) against all defendants and 20(a) control person liability against the </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1426-wk-Fact-FE8F4D05E7A05FAEA93D61528F674586" name="prgo:LossContingencyNumberOfIndividuals" contextRef="I2017Q2Jun21" unitRef="individual" decimals="INF" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> individuals. In general, the allegations concern the actions taken by us and the former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1430-wk-Fact-916DF117B1B153ED948A4644D5D7E515" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2017Q2Jun21" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> royalty stream. The amended complaint does not include an estimate of damages. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#8217; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#8217;Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the Tysabri&#174; accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are Perrigo Company plc, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issues regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1438-wk-Fact-C82576AAEECE5B129A332E34086FCBC8" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2018Q3Jul27" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 40</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-6" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-7"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">generic prescription pharmaceuticals. The defendants who remain in the case (the Company, Mr. Papa, and Ms. Brown) have filed answers denying liability, and the discovery stage of litigation has begun. Discovery in the class action is currently scheduled to end in January 2021. We intend to defend the lawsuit vigorously.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On November 14, 2019, the court granted the lead plaintiffs&#8217; motion and certified </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1451-wk-Fact-2A9D9DC0BB1A5E07AE98E944CFA27FDD" name="prgo:NumberofPutativeClasses" contextRef="I2019Q4Nov14" unitRef="class" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Defendants filed a petition for leave to appeal in the Third Circuit challenging the certification of the tender offer class. On April 30, 2020, the Third Circuit denied leave to appeal. The District Court has approved the issuance of a notice of the pendency of the class action, and the notice has been sent to shareholders who are eligible to participate in the classes.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unless otherwise noted, each of the lawsuits discussed in the following sections is pending in the U.S. District Court for the District of New Jersey and has been assigned to the same judges hearing the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case. The allegations in the complaints relate to events during certain portions of the 2015 through 2017 calendar years, including the period of the Mylan tender offer. All but one of these lawsuits allege violations of federal securities laws, but none are class actions. </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1464-wk-Fact-F658D9F2940B55568BE37B0F760E24D4" name="prgo:NumberofCasesAllegingOnlyStateLawClaims" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member" unitRef="lawsuit" decimals="INF" scale="0" format="ixt-sec:numwordsen">One</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> lawsuit (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;">) alleges only state law claims. Discovery in all these cases, except </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;">, is underway and currently scheduled to end in early September 2021. We intend to defend all these lawsuits vigorously.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Carmignac, First Manhattan</span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">and Similar Cases</span><span style="font-family:Arial;font-size:10pt;">. The following </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1487-wk-Fact-194B08FCAC0758A98CBE45C16C15BAB1" name="prgo:NumberofCaseswithSimilarFactualAllegations" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_CarmignacFirstManhattanandSimilarCasesMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">seven</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed by the same law firm and generally make the same factual assertions but, at times, differ as to which securities laws violations they allege:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:76%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac Gestion, S.A. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">11/1/2017</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan Co. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/16/2018; amended 4/20/2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">10/29/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Schwab Capital Trust, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">1/31/2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/22/2019</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Principal Funds, Inc., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3/5/2020</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3/31/2020</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The original complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan</span><span style="font-family:Arial;font-size:10pt;"> case named Perrigo, Mr. Papa, Ms. Brown, and Mr. Coucke as defendants. Mr. Coucke was dismissed as a defendant after the plaintiffs agreed to apply the July 2018 ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case to these two cases. The complaints in each of the other cases name only Perrigo, Mr. Papa, and Ms. Brown as defendants. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint asserts claims under Sections 10(b) (and Rule 10b-5 thereunder) and all cases except </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Aberdeen</span><span style="font-family:Arial;font-size:10pt;"> assert claims under Section 14(e) of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The control person claims against the individual defendants are limited to the period from April 2015 through April 2016 in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> case. The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan</span><span style="font-family:Arial;font-size:10pt;"> cases also assert claims under Section 18 of the Exchange Act.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint alleges inadequate disclosures concerning the valuation and integration of Omega, the financial guidance we provided, our reporting about the generic prescription pharmaceutical business and its prospects, and the activities surrounding the efforts to defeat the Mylan tender offer during 2015, and, in each of the cases other than </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;">, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1636-wk-Fact-B6A89A8C20BE5CCB82741E268A56A9BC" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2017Q2May31_srt_LitigationCaseAxis_prgo_FirstManhattanandSimilarCasesMember" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals. The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan</span><span style="font-family:Arial;font-size:10pt;"> complaint also alleges improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> asset. With the exception of </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;">, each of these cases relates to events during the period from April 2015 through May 2017. Many of the allegations in these cases overlap with the allegations of the June 2017 amended complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, though the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Nationwide Mutual, Schwab Capital, Aberdeen, Principal Funds </span><span style="font-family:Arial;font-size:10pt;">and</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> Kuwait </span><span style="font-family:Arial;font-size:10pt;">complaints do </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 41</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-7" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-8"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">not include the factual allegations that the court dismissed in the July 2018 ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After the court issued its July 2018 opinion in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, the parties in </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan </span><span style="font-family:Arial;font-size:10pt;">conferred and agreed that the ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case would apply equally to the common allegations in their cases. The later filed cases adopted a similar posture. The defendants in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and other cases listed above filed motions to dismiss addressing the additional allegations in such cases. On July 31, 2019, the court granted such motions to dismiss in part and denied them in part. That ruling applies to each of the above cases. The defendants have filed answers in each case denying liability. Each case is currently in the discovery phase.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Mason Capital</span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">,</span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Pentwater</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">and Similar Cases</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">. </span><span style="font-family:Arial;font-size:10pt;">The following </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1716-wk-Fact-B339F893C09854C3B13291355A2B36FA" name="prgo:NumberofCaseswithSimilarFactualAllegations" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">eight</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed by the same law firm and generally make the same factual allegations:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:76%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital L.P., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">1/26/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater Equity Opportunities Master Fund Ltd., et al. &#160;v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">1/26/2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">11/15/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">11/15/2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">12/18/2019</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">12/20/2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Burlington Loan Management DAC v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/12/2020</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3/2/2020</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater </span><span style="font-family:Arial;font-size:10pt;">case originally named Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1841-wk-Fact-990BFB7E40C15139A27A0B271CA7E2A5" name="prgo:LossContingencyNumberOfIndividuals" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember" unitRef="individual" decimals="INF" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo as defendants. In the July 2018 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> ruling, the court dismissed without prejudice each of the defendants other than Perrigo, Mr. Papa and Ms.&#160;Brown from that case; these plaintiffs later agreed that this ruling would apply to their cases as well. The complaints in each of the other cases in the above table name only Perrigo, Mr. Papa, and Ms. Brown as defendants.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint asserts claims under Section 14(e) of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">WCM </span><span style="font-family:Arial;font-size:10pt;">case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Universities Superannuation Scheme </span><span style="font-family:Arial;font-size:10pt;">case also assert claims under Section 10(b) of the Exchange Act and Rule 10b-5 thereunder.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint alleges inadequate disclosure during the tender offer period in 2015 and at various times concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1868-wk-Fact-1BF3199A844E5867A0BDAF5AE90C9C0E" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2017Q2May31_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> asset. The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">WCM </span><span style="font-family:Arial;font-size:10pt;">complaint also makes these allegations for the period through May 2017 and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Universities Superannuation Scheme</span><span style="font-family:Arial;font-size:10pt;"> complaint also concerns certain times during 2016. Many of the factual allegations in these cases overlap with the allegations of the June 2017 amended complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital </span><span style="font-family:Arial;font-size:10pt;">and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater</span><span style="font-family:Arial;font-size:10pt;"> cases include factual allegations similar to those in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> case described above.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After the court issued its July 2018 opinion in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, the parties in each of the above cases</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> </span><span style="font-family:Arial;font-size:10pt;">conferred and agreed that the ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case would apply equally to the common allegations in their cases. The defendants in each of these cases have filed answers denying liability, and each of the cases is currently in the discovery phase.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Harel Insurance</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">and</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">Cases</span><span style="font-family:Arial;font-size:10pt;">. The following </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e1937-wk-Fact-881FB5461B2B5F0C8D9E31414ACD2B52" name="prgo:NumberofCaseswithSimilarFactualAllegations" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed by the same law firm and generally make the same factual allegations relating to the period from February 2014 through May 2017 (in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> case) and from August 2014 through May 2017 (in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;"> case):</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 42</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-8" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-9"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:76%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/13/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">4/20/2018</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;"> cases originally named Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2005-wk-Fact-B11025368B8958A89D3E2DBAD4C70112" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">13</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo as defendants (adding </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2009-wk-Fact-F2F3AD2578F057ED8B9A9589E20903BD" name="prgo:LossContingencyNumberofDefendantsAdded" contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember" unitRef="defendant" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> more individual defendants not sued in the other cases described in this section). In the July 2018 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> ruling, the court dismissed without prejudice </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2018-wk-Fact-AF68AE6429BF5DF78CA58757455F3333" name="prgo:LossContingencyNumberofDefendantsDismissedwithoutPrejudice" contextRef="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">8</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> of the </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2022-wk-Fact-28C0F7CD747F59E6B890E6370F3FA46D" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" contextRef="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_RoofersPensionFundMember" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> defendants other than Perrigo, Mr. Papa and Ms.&#160;Brown from that case. These plaintiffs later agreed that that ruling would apply to these cases as well and also dismissed their claims against the two additional individuals that only these plaintiffs had named as defendants.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint asserts claims under Sections 10(b) and 14(e) of the Securities Exchange Act and Rule 10b-5 thereunder against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> case also asserts claims based on Israeli securities laws.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each of the complaints alleges inadequate disclosure around the tender offer events in 2015 and at various times during the relevant periods concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2041-wk-Fact-043FCCC08E9C5C21A8B2D5C3C25042EA" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2017Q2Apr30_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> asset from February 2014 until the withdrawal of past financial statements in April 2017. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After the court issued its July 2018 opinion in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, the parties in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;"> cases conferred and agreed that such ruling would apply equally to the common allegations in their cases. The defendants in each of these cases have filed answers denying liability, and each of the cases is currently in the discovery phase.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">Other Cases Related to Events in 2015-2017</span><span style="font-family:Arial;font-size:10pt;">. Certain allegations in the following </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2073-wk-Fact-A9109D55DF955A4398375132ECC55386" name="prgo:NumberofCaseswithSimilarFactualAllegations" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_OtherCasesRelatedtoEventsin20152017Member" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> cases also overlap with the allegations of the June 2017 amended complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and with allegations in </span><span style="font-family:Arial;font-size:10pt;">one</span><span style="font-family:Arial;font-size:10pt;"> or more of the other individual cases described in the sections above:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:76%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/6/2019</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields Capital I LP, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">6/4/2020</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">4/21/2020</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each of the above complaints names Perrigo, Mr. Papa, and Ms. Brown as defendants. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Sculptor Master Fund (formerly OZ)</span><span style="font-family:Arial;font-size:10pt;"> complaint asserts claims under Sections 10(b) and 14(e) of the Securities Exchange Act and Rule 10b-5 thereunder against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The parties have agreed that the court's rulings in July 2018 in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and in July 2019 in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and related cases will apply to this case as well. The defendants have filed answers denying liability. The plaintiffs are participating in the discovery proceedings in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and the various individual cases described above.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">BlackRock Global</span><span style="font-family:Arial;font-size:10pt;"> complaint also asserts claims under Securities Exchange Act section 10(b) (and SEC Rule 10b-5) and section 14(e) against all defendants and section 20(a) control person claims against the individual defendants largely based on the same events during the period from April 2015 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer period in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2175-wk-Fact-95340D0CE81C58569777B8AF64EFB0C2" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2017Q2May31_srt_LitigationCaseAxis_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, alleged lower performance in the generic prescription drug business during 2015 and alleged improper accounting for the Tysabri&#174; asset. The parties have begun discussions about the schedule for how this case should proceed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 43</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-9" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-10"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> Highfields </span><span style="font-family:Arial;font-size:10pt;">federal case complaint asserted claims under Sections 14(e) and 18 of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. As originally filed in the U.S. District Court for the District of Massachusetts, the</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> Highfields</span><span style="font-family:Arial;font-size:10pt;"> complaint also alleged claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. The factual allegations generally were similar to the factual allegations in the Amended Complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case described above, except that the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;"> plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs. In March 2020, the District of Massachusetts court granted defendants&#8217; motion and transferred the case to the U.S. District Court for the District of New Jersey so that the activities in the case could proceed in tandem with the other cases in the District of New Jersey described above. After the transfer, in June 2020, the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;"> plaintiffs voluntarily dismissed their federal lawsuit. The same </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;"> plaintiffs the same day then filed a new lawsuit in Massachusetts State Court asserting the same factual allegations as in their federal lawsuit and alleging only Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In September 2020, the defendants submitted a motion to dismiss' plaintiffs filed an opposition in late October; defendants&#8217; reply is due in mid-November 2020.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In Israel (cases related to events in 2015-2017)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Because our shares are traded on the Tel Aviv exchange under a dual trading arrangement, we are potentially subject to securities litigation in Israel. </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2220-wk-Fact-E30E7E1C165A5AD29B9C7642DF3D9077" name="prgo:LossContingencyNumberOfCases" contextRef="FI2018Q4_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">Three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed; </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2224-wk-Fact-AD688CFD93C85FCEB214CBA0270F203E" name="us-gaap:LossContingencyClaimsDismissedNumber" contextRef="FD2017Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> was voluntarily dismissed in each of 2017 and 2018 and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2228-wk-Fact-0618BF4735DA568D88A8FBA40C2D6531" name="prgo:LossContingencyNumberOfCasesStayed" contextRef="FD2018Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> was stayed in 2018. We are consulting Israeli counsel about our response to these allegations and we intend to defend this case vigorously. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al.</span><span style="font-family:Arial;font-size:10pt;"> The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp; Young LLP (the Company&#8217;s auditor), and </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2243-wk-Fact-657E4A8A4AAD5A44B57F2E5D3096214F" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" contextRef="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The complaint alleges violations under U.S. securities laws of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2247-wk-Fact-657E4A8A4AAD5A44B57F2E5D3096214F" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" contextRef="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" unitRef="defendant" decimals="INF" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> individuals or, in the alternative, under Israeli securities laws. In general, the allegations concern the actions taken by us and our former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure concerning purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company, alleges price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2251-wk-Fact-BEBC799C111C544FAF3AAD985652E1B8" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" contextRef="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri&#174; royalty stream. The plaintiff indicates an initial, preliminary class damages estimate of </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2255-wk-Fact-EB281AA612295526872DB9259FA8EC5F" name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" unitRef="ils" decimals="-8" scale="9" format="ixt:numdotdecimal">2.7</ix:nonFraction> billion</span></span><span style="font-family:Arial;font-size:10pt;"> NIS (approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d35415e2260-wk-Fact-42DEACAC78E05FCEB855DEF06739F86C" name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">760.0</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;">&#160;million at </span><span style="font-family:Arial;font-size:10pt;">1</span><span style="font-family:Arial;font-size:10pt;"> NIS = </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2268-wk-Fact-BB1BD07F7C395E71AC610CA6797902AE" name="us-gaap:ForeignCurrencyExchangeRateRemeasurement1" contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" unitRef="USD_PER_ILS" decimals="2" scale="0" format="ixt:numdotdecimal">0.28</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> cents). After the other </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2272-wk-Fact-E1CA703305D85218AE5D01555A3260E8" name="us-gaap:LossContingencyClaimsDismissedNumber" contextRef="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In the United States (cases related to Irish Tax events)</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 3, 2019, a shareholder filed a complaint against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in the U.S. District Court for the Southern District of New York (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Masih v. Perrigo Company, et al.</span><span style="font-family:Arial;font-size:10pt;">). Plaintiff purported to represent a class of shareholders for the period November 8, 2018 through December 20, 2018, inclusive. The complaint alleged violations of Securities Exchange Act section 10(b) (and Rule 10b&#8209;5) against all defendants and section 20(a) control person liability against the individual defendants. In general the allegations contended that the Company, in its Form 10&#8209;Q filed November 8, 2018, disclosed information about an October 31, 2018 audit finding letter received from Irish tax authorities but failed to disclose enough material information about that letter until December 20, 2018, when we filed a current report on Form 8&#8209;K about Irish tax matters. The plaintiff did not provide an estimate of class damages. The court selected lead plaintiffs and changed the name of the case to In re </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Perrigo Company plc Sec. Litig</span><span style="font-family:Arial;font-size:10pt;">. The lead plaintiffs filed an amended complaint on April </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 44</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-10" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-11"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">12, 2019, which named the same defendants, asserted the same class period, and invoked the same Exchange Act sections. The amended complaint generally repeated the allegations of the original complaint with a few additional details and adds that the defendants also failed to timely disclose the Irish tax authorities&#8217; Notice of Amended Assessment received on November 29, 2018. Defendants filed a motion to dismiss on May 3, 2019. On May 31, 2019, the plaintiffs filed a second amended complaint, which asserted a longer class period (March 1, 2018 through December 20, 2018) and added </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2302-wk-Fact-C6A0CF03093254F8897150B15DAF1311" name="prgo:LossContingencyNumberofDefendantsAdded" contextRef="D2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member" unitRef="defendant" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> additional individual defendant, former CEO Uwe Roehrhoff. In general, the second amended complaint contends that Perrigo&#8217;s disclosures about the Irish tax audit were inadequate beginning with Perrigo&#8217;s 10-K filed on March 1, 2018 through December 20, 2018 and repeats many of the allegations of the April 2019 amended complaint. The </span><span style="font-family:Arial;font-size:10pt;">second</span><span style="font-family:Arial;font-size:10pt;"> amended complaint alleges violations of Securities Exchange Act section 10(b) (and SEC Rule 10b-5) against all defendants and section 20(a) control person liability against the </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2310-wk-Fact-AD276F19FECA525D969F4A65C0EAAA45" name="prgo:LossContingencyNumberOfIndividuals" contextRef="I2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member" unitRef="defendant" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> individual defendants. All defendants filed a joint motion to dismiss, and the motion was fully briefed. On January 23, 2020, the court granted the motion to dismiss in part and denied it in part, dismissing Mr. Roehrhoff as a defendant and dismissing allegations of inadequate disclosures related to the audit by Irish Revenue during the period March 2018 through October 30, 2018. The court permitted the plaintiffs to pursue their claims against us, Mr. Kessler, and Mr. Winowiecki related to disclosures after Perrigo received the October 30, 2018 audit findings letter and later events through December 20, 2018. The defendants filed answers on February 13, 2020 denying liability, and the court held a scheduling conference on February 28, 2020, and issued a scheduling order on March 3, 2020. Discovery on the remaining issues is underway. Plaintiffs filed a motion for class certification, which was granted in September 2020. We intend to defend the lawsuit vigorously.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In Israel (case related to Irish Tax events)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Baton v. Perrigo Company plc, et. al</span><span style="font-family:Arial;font-size:10pt;">.). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">In re Perrigo Company plc Sec. Litig </span><span style="font-family:Arial;font-size:10pt;">case in New York federal court. This case alleges that persons who invested through the Tel Aviv stock exchange can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. In 2019, the court granted </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2333-wk-Fact-B52D812C0C1E5D3593B9A532611FCB2E" name="prgo:LossContingencyNumberOfCasesStayed" contextRef="FD2019Q4YTD_srt_LitigationCaseAxis_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember" unitRef="case" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> requests by Perrigo to stay the proceedings pending the resolution of proceedings in the United States.&#160;Perrigo filed a further request for a stay in February 2020, and the court granted the stay indefinitely. The plaintiff has filed a motion to lift the stay; Perrigo has filed an opposition; the court has requested further briefing from the plaintiff. We intend to defend the lawsuit vigorously. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Claim Arising from the Omega Acquisition</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 16, 2016, we and Perrigo Ireland 2 brought an arbitral claim ("Claim") against Alychlo NV ("Alychlo") and Holdco I BE NV (together the "Sellers") in accordance with clause 26.2 of the Share Purchase Agreement dated November 6, 2014 ("SPA") and the rules of the Belgian Centre for Arbitration and Mediation ("CEPANI"). Our Claim relates to the accuracy and completeness of information about Omega provided by the Sellers as part of the sale process, the withholding of information by the Sellers during that process and breaches of Sellers&#8217; warranties. We are seeking monetary damages from the Sellers. The Sellers served their respective responses to the Claim on February 20, 2017. In its response, Alychlo has asserted a counterclaim for monetary damages contending that we breached a warranty in the SPA and breached the duty of good faith in performing the SPA. Alychlo subsequently filed papers seeking permission to introduce an additional counterclaim theory of recovery related to the Irish tax issues disclosed by the Company such that if the position of the Irish tax authorities prevails, Alychlo would have further basis for its counterclaim against Perrigo. In June 2019, the Tribunal denied permission for Alychlo to introduce the additional counterclaim and dismissed certain aspects of the original Alychlo counterclaim. There can be no assurance that our Claim will be successful, and the Sellers deny liability for the Claim. To the extent that aspects of Alychlo&#8217;s counterclaim survived the Tribunal&#8217;s ruling in June 2019, we deny that Alychlo is entitled to any relief (including monetary relief). The arbitration proceedings are confidential as required by the SPA and the rules of the CEPANI.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Matters </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our Board of Directors received a shareholder demand letter dated October 30, 2018 relating to the allegations in the securities cases and price fixing lawsuits described above. The letter demands that the Board of Directors initiate an action against certain current and former executives and Board members to recover damages </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 45</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-11" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-12"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">allegedly caused to the Company. In response, the Company reminded the shareholder that any derivative claim can only proceed in accordance with Irish law, the law that governs the Company&#8217;s internal affairs. The shareholder responded that he would file a lawsuit asserting derivative claims.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On October 2, 2019, the shareholder filed a derivative action in the U.S. District Court for the District of New Jersey styled </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford, et al.</span><span style="font-family:Arial;font-size:10pt;"> The case was assigned to the same judges who are handling the Roofers' Pension Fund securities class action and related opt out cases described above. In addition to the Company, the lawsuit names as defendants current Board members Alford, Classon, Karaboutis, Kindler, O&#8217;Connor, Parker, and Samuels, current CEO Kessler, former Board members Smith, Brlas, Cohen, Fouse, Hoffing, Jandernoa, Kunkle, and Morris, former CEO Hendrickson, former CEO Papa, former CFO Brown, former CFO Winowiecki, and former Executive Vice Presidents Boothe and Coucke. The lawsuit seeks to authorize the shareholder to pursue claims on behalf of the Company against all the individual defendants for breach of their fiduciary duties and for unjust enrichment, and against the current director defendants, former director Mr. Smith, and current CEO Mr. Kessler for violations of Securities Exchange Act &#167;&#167; 14(a) (proxy statement disclosures) and 29(b) (disgorgement as a result of alleged violations of &#167;&#160;14(a)). The complaint alleges that the following events indicate that the individuals in their respective capacities failed to exercise appropriate control over the management of the Company and made inadequate public disclosures concerning the integration of Omega after acquisition; the Company&#8217;s past and prospective organic growth; the defense against the Mylan 2015 tender offer; the alleged collusive pricing activities regarding generic prescription products; the accounting by the Company for the Tysabri&#174; royalty stream; the 2018 Irish tax audit including potential liabilities for Irish taxes; and the April 2019 assertion of tax liabilities by the U.S. Internal Revenue Service (many of these factual events also underlie the multiple securities cases discussed earlier in this Note 14). All defendants have filed motions to dismiss asserting various reasons to dismiss. Plaintiff filed his opposition in March 2020. Defendants&#8217; filed replies in support of dismissal in June 2020. The court granted the motion to dismiss without prejudice on August 21, 2020. No appeal or other proceedings have been filed by the plaintiff. Therefore, we consider this case to have ended. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Talcum Powder</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has been named, together with other manufacturers, in product liability lawsuits in state courts in California</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">,</span><span style="font-family:Arial;font-size:10pt;"> Florida, Missouri, New Jersey and Illinois and in the Southern District of Mississippi alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos.&#160;All but one of these cases involve a legacy talcum powder product that has not been manufactured by the Company since 1999.&#160; One of the pending actions involves a current prescription product that contains talc as an excipient. The Company has been named in </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2389-wk-Fact-E93ADE9E20235EF88E2B459017B40C27" name="prgo:LossContingencyNumberofLawsuits" contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_TalcumPowderLitigationMember" unitRef="lawsuit" decimals="INF" scale="0" format="ixt:numdotdecimal">32</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2393-wk-Fact-C3DC59D97B8755F68CD56263A697C902" name="prgo:NumberofTendersAccepted" contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_TalcumPowderLitigationMember" unitRef="tender" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> additional matter. The Company has several defenses and intends to aggressively defend these lawsuits.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Ranitidine</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In February 2020, the resulting actions involving Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. This MDL now includes </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2422-wk-Fact-C0E551755D6C54B29C3DCCF893468937" name="prgo:LossContingencyNumberofMasterComplaints" contextRef="D2020Q1Feb_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember" unitRef="complaint" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> master complaints. The Company is named in </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2426-wk-Fact-9D77F2344D54543BA5AD38E0625B3810" name="prgo:LossContingencyNumberofMasterComplaintsNamingCompany" contextRef="D2020Q1Feb_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember" unitRef="complaint" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> of those: the Master Personal Injury Complaint and the Consolidated Consumer Class Action Complaint.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 46</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 14</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-12" continuedAt="TextSelection-F39B2842DE065CA6B6970EED5C36E563-13"><div style="line-height:120%;text-indent:48px;font-size:11pt;"><span style="font-family:Arial;font-size:10pt;"> As of October 6, 2020, the Company has been named in </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2436-wk-Fact-C73D1F8C3D68D6692FF14777EDF2913E" name="prgo:LossContingencyNumberofLawsuits" contextRef="D2020Q4Oct6_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="INF" scale="0" format="ixt-sec:numwordsen">forty-two</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> of the MDL&#8217;s consolidated personal injury lawsuits in various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company is named in these lawsuits with manufacturers of the national brand Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and other manufacturers of ranitidine products distributors, repackagers,</span><span style="font-family:Arial;font-size:11pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;">and/or retailers. Plaintiffs seek compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence.&#160;The Company is named in this lawsuit with manufacturers of the national brand Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and other manufacturers of ranitidine products and/or retailers. This action has been noticed to the MDL, but the New Mexico Attorney General is opposing consolidation. Some of the Company&#8217;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these and other consolidated cases. We intend to defend all of these lawsuits vigorously.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:174%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Acetaminophen</span><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has received requests for indemnification and defense of several consumer fraud claims involving its store brand infants&#8217; and children&#8217;s acetaminophen products.&#160;In September 2020, the Company was directly named as a defendant in </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2466-wk-Fact-7A12FEFF77C64129B3719373930766AE" name="prgo:LossContingencyNumberofLawsuits" contextRef="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember" unitRef="lawsuit" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> suit filed in the Central District of California. The Company has also received </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2470-wk-Fact-0B9DAE5E3BD64AD2A2CC9377252B97D1" name="prgo:LossContingencyNumberofClaimsforIndemnificationorDefense" contextRef="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember" unitRef="claim" decimals="INF" scale="0" format="ixt:numdotdecimal">14</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> different claims for indemnification or defense from </span><span style="font-family:Arial;font-size:10pt;"><span><ix:nonFraction id="d35415e2474-wk-Fact-A15BCD5F03265EBD77FF9380DFA23265" name="prgo:LossContingencyNumberofRetailers" contextRef="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember" unitRef="retailer" decimals="INF" scale="0" format="ixt:numdotdecimal">9</ix:nonFraction></span></span><span style="font-family:Arial;font-size:10pt;"> different retailers for lawsuits filed in California, Illinois and Pennsylvania, with nationwide class action allegations.&#160; </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><ix:continuation id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-13">The Plaintiffs generally allege that the children&#8217;s and infants&#8217; acetaminophen products have identical drug concentration amounts, yet the infants&#8217; product costs more than the children&#8217;s product and consumers have been misled into purchasing the more expensive product. The Company will aggressively defend the suit in which it is named and is continuing to assess whether, or to what extent, the Company may contribute in the lawsuits filed against its retail customers.</ix:continuation>&#160; </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sFCF65F79C6DC5F8B95292CBCBA6EED54"></a></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 15 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="TextSelection-5F03528CA64658F3991231ABDF8C87E9-0-wk-Fact-09BF950CBA29536C95A0BD7658BD9CAD" continuedAt="TextSelection-5F03528CA64658F3991231ABDF8C87E9-1" escape="true"><span style="font-family:Arial;font-weight:bold;">RESTRUCTURING CHARGES</span></ix:nonNumeric></div><ix:continuation id="TextSelection-5F03528CA64658F3991231ABDF8C87E9-1"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. <ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="TextSelection-4238780E1BCB5489BEF8902BEDC89BA3-0-wk-Fact-3679E983AE585CE298C5F9FDC37CCBF2" continuedAt="TextSelection-4238780E1BCB5489BEF8902BEDC89BA3-1" escape="true">The following reflects our restructuring activity (in millions):</ix:nonNumeric></span></div><ix:continuation id="TextSelection-4238780E1BCB5489BEF8902BEDC89BA3-1"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:184px;"></td><td style="width:6px;"></td><td style="width:86px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:86px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:86px;"></td><td style="width:4px;"></td><td style="width:8px;"></td><td style="width:6px;"></td><td style="width:86px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1187-wk-Fact-4F3964B14EE95490B87E3FFFDB7DDEEA" name="us-gaap:RestructuringReserve" contextRef="FI2020Q2" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1206-wk-Fact-7CC0F84D6A345497AAF4CA4E4FFF43A1" name="us-gaap:RestructuringReserve" contextRef="FI2019Q2" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1225-wk-Fact-511D9364691053989384ED52AD2CDC34" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1245-wk-Fact-B9F4AC0D70B65EAFBE81C240B2898B3C" name="us-gaap:RestructuringReserve" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Additional charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1260-wk-Fact-5027DCF09BFB558BB07011C9C82D585B" name="prgo:RestructuringAdditionalCharges" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1279-wk-Fact-FBFF309707355AD1AB6670F1280213A5" name="prgo:RestructuringAdditionalCharges" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1298-wk-Fact-0E15AD82BEE25DC6AE3CA6734D412410" name="prgo:RestructuringAdditionalCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1318-wk-Fact-C547FD32F6535A0E974A4315579924FD" name="prgo:RestructuringAdditionalCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d40578e1338-wk-Fact-6E2355E2D0A55FCFA793110D38370D1B" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d40578e1358-wk-Fact-62D4F9D32DA956278C6358123439915C" name="us-gaap:PaymentsForRestructuring" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d40578e1378-wk-Fact-AA94A569A2CD516288E739DF6C330940" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d40578e1399-wk-Fact-5AD16F6B45895769B8BC259C08574F67" name="us-gaap:PaymentsForRestructuring" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-cash adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1420-wk-Fact-45E5EFB7B7ED5C17A0906D343F9F8B57" name="us-gaap:RestructuringReserveSettledWithoutCash2" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d40578e1439-wk-Fact-AF622381152F57DEB3FC4930905BB9F2" name="us-gaap:RestructuringReserveSettledWithoutCash2" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1459-wk-Fact-EDC3BE1E581356D29E3C32795A4E2E39" name="us-gaap:RestructuringReserveSettledWithoutCash2" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d40578e1479-wk-Fact-F52BF1BCB3E9593FB43B2E58D98B1AEA" name="us-gaap:RestructuringReserveSettledWithoutCash2" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1505-wk-Fact-16B6FB6754E958CF9DECBF310B4A9FAB" name="us-gaap:RestructuringReserve" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1524-wk-Fact-42F66091CD3254BBA7B22CFE879574EB" name="us-gaap:RestructuringReserve" contextRef="FI2019Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1543-wk-Fact-16B6FB6754E958CF9DECBF310B4A9FAB" name="us-gaap:RestructuringReserve" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d40578e1563-wk-Fact-42F66091CD3254BBA7B22CFE879574EB" name="us-gaap:RestructuringReserve" contextRef="FI2019Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The charges incurred during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> were primarily associated with actions taken to streamline the organization. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The charges incurred during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;"> were primarily associated with the reorganization of our executive management team and other actions taken to streamline the organization. Of the amount recorded during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d40578e1612-wk-Fact-6BCE28B04E8F5C28B56A631BB78D6501" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction> million</span></span><span style="font-family:Arial;font-size:10pt;"> related primarily to the sales force reorganization in France within the CSCI segment. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">There were no other material restructuring programs that significantly impacted any other reportable segments for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> or </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">.  All charges are recorded in </span><span style="font-family:Arial;font-size:10pt;">Restructuring</span><span style="font-family:Arial;font-size:10pt;"> expense on the Condensed Consolidated Statements of Operations. The remaining </span><span style="font-family:Arial;font-size:10pt;"><span>$<ix:nonFraction id="d40578e1639-wk-Fact-16B6FB6754E958CF9DECBF310B4A9FAB" name="us-gaap:RestructuringReserve" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.9</ix:nonFraction>&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> liability for employee severance benefits is expected to be paid within the next year.</span></div></ix:continuation><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 47</span></div></div><hr style="page-break-after:always"></hr><div><a id="sBBE7203EDB115E499A5C44697C1474D8"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 1</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 16</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">NOTE 16 &#8211; </span><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:SegmentReportingDisclosureTextBlock" id="TextSelection-D4615D0F0CE753FAA708F2A6819774A3-0-wk-Fact-511B45A992595EA49367552C720E8FC9" continuedAt="TextSelection-D4615D0F0CE753FAA708F2A6819774A3-1" escape="true"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-D4615D0F0CE753FAA708F2A6819774A3-1"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our segments reflect the way in which our management makes operating decisions, allocates resources, and manages the growth and profitability of the Company.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="TextSelection-5B8274CA90E157E4A5DEEC1D423311B7-0-wk-Fact-A057D712AB7B5763AF2C82E109C9D2CF" continuedAt="TextSelection-5B8274CA90E157E4A5DEEC1D423311B7-1" escape="true"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The tables below show select financial measures by reporting segment (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:38%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1128-wk-Fact-36FDF8D4279E5CAFAA12EF1BE812082A" name="us-gaap:Assets" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,747.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1147-wk-Fact-B87D7D253CD955E1BF55873356FBEC64" name="us-gaap:Assets" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,990.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1167-wk-Fact-6C070F8FE2A258BCAA04FE47D8CB343A" name="us-gaap:Assets" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,606.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1186-wk-Fact-C79FBE4AA1B557B19287603E98A44953" name="us-gaap:Assets" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4,682.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1211-wk-Fact-31E2A4C682EF5323A59FF85A4D167B53" name="us-gaap:Assets" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,221.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1230-wk-Fact-8713CFA4FB47519D85EC2F5EBED81C61" name="us-gaap:Assets" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,628.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1260-wk-Fact-787E99A35A81503989617F4B938A50C2" name="us-gaap:Assets" contextRef="FI2020Q3" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11,576.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1279-wk-Fact-BCC4DA49384256F793F37AC4E26ADB03" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11,301.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"></td></tr><tr><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1710-wk-Fact-C31A12065CA4018CCDDCC23D08FB9B33" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">664.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1729-wk-Fact-C89D22E6E9CA5E50834397537E7B2327" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">123.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1748-wk-Fact-0B33B5C5FF885D1BAE86AB582252604A" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1768-wk-Fact-6F06EEC2D6D104D37336C23D40236485" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">613.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1787-wk-Fact-239DA0A88AE75A0F9A803976AD4C7B89" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1807-wk-Fact-6A2183DDFC69564E898F481F638AC97A" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1822-wk-Fact-F13FA3A1ED61A1698A2CC23D090CBAD3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">339.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1841-wk-Fact-5260E9F4A2DF546D8CC452BDD999F598" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1860-wk-Fact-8041DE7321B053E3B385DB022D7ED73E" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1880-wk-Fact-83F126B674510C0DDA76C23D403C42D9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">347.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1899-wk-Fact-959017DBBDB65EBAACCE34DB825B3009" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1918-wk-Fact-4458EA2AE6A45785B5D0FA8119917AAE" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">43.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1939-wk-Fact-9FCC6F1E4EF2B5BD9BB0C23D092C86FD" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d50250e1958-wk-Fact-CDFB00C196EB55CEA23996FD31CFFF78" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">180.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1978-wk-Fact-D1C25D59C38D5C878C2248130458DD42" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e1998-wk-Fact-447E72E2DB5FAC45B5C1C23D3FF3CCC7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">230.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2017-wk-Fact-7FDAC38E20E559D7941F85B994D675AA" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2036-wk-Fact-28131B4CD3545A8DB2A0C9ED7C4ABCDE" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2057-wk-Fact-0886091FEEEC5A6D812E8857AB370693" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d50250e2076-wk-Fact-65FA39AC6EA756CEB014077D3B8CF8F4" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">48.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2096-wk-Fact-AE27E980A1ED57EFB7E33C6204186E68" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2116-wk-Fact-B4A94A8CD7FB565B861F00AB95595EFB" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d50250e2135-wk-Fact-6F95439F3BFD592E9D554A2540BDF831" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">59.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2155-wk-Fact-A85FA3C33F435E15A1CFCA97967A740F" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2181-wk-Fact-91F79D5851FA52E297E9A21CD478C108" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,213.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d50250e2200-wk-Fact-13D0525FEB2D521BAD5C1613BADE0743" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">95.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2220-wk-Fact-9EC6EFD4DD3D5D5AB75DE9600F9BE5CD" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">73.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2240-wk-Fact-AD8DF8663E025098BD5438A9C8F58044" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,191.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2259-wk-Fact-6BF69FF58FFC512D8BE1DC951310FDC7" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2279-wk-Fact-C505C4899C9C5A9293E87934EEE6ED3E" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">78.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"></td></tr><tr><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2714-wk-Fact-8A512266646C595482EF17DA8AAAAA8E" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,992.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2733-wk-Fact-76AFF08E4B5B50CC8C0DB1080AEB8051" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">354.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2752-wk-Fact-08726A0E89E457488B109B42527C52D8" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">38.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2772-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,777.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2791-wk-Fact-DEF0585FE46552D4874EF1ED8E36A4F6" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">283.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2811-wk-Fact-A9426829A0605D579909324D52E7C8EE" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2826-wk-Fact-A8E55B983BFE55EAA0C2CD7EB512EAAB" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,042.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2845-wk-Fact-A6D847CCF2CB5FF39546A9B99C6325E3" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2864-wk-Fact-2829346B5F8A5D11BAF5F91EFF483403" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">116.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2884-wk-Fact-6A9C3E189E13591A95A5A88A23378280" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,025.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2903-wk-Fact-3A7CE3BE43245464A74C978BFC46F418" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2922-wk-Fact-75A9D3F0A04F5C16AC0F912F2BED1050" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">130.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2943-wk-Fact-F4F655B41C045B60A17D25F0408DC766" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">738.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d50250e2962-wk-Fact-71635A61367B5E91857261EBAEAC64EA" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">81.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e2982-wk-Fact-8AB6BA57A1E75662AFCB0EC056124A9C" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">63.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3002-wk-Fact-F09B459D0AD95E23A8B13DB22EF55A16" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">711.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3021-wk-Fact-C265CE623C185F01897A6F90441C5ADD" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">95.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3040-wk-Fact-37B7C6473A2557F88A9B7147931EE2DC" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">65.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3061-wk-Fact-352F2D30828B55B28B374FEC64A21776" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d50250e3080-wk-Fact-DCD4E44E8E295C25B16C16973C41B4BE" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">151.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3100-wk-Fact-9C31299FD8415D5CB07E1CDB4E1CA8EF" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3120-wk-Fact-C09992B79A7C519A939DA4519EB61D12" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(<ix:nonFraction id="d50250e3139-wk-Fact-02FCF54DD3F95D4780FA81E532C680FC" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">185.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3159-wk-Fact-362133ADCF78592791A3004DAC2B8146" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3185-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,773.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3204-wk-Fact-CB2087D04AEC530794406BF111E1F908" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">167.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3223-wk-Fact-B5DA864A4FA15076A7E87E8E669E0A74" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">219.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3243-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3,514.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3262-wk-Fact-55D56F3E881C56179BCAACFE76CCD34E" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">211.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><ix:nonFraction id="d50250e3282-wk-Fact-66166F7248AF5BEDB989DACED3CFEE17" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">227.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><ix:continuation id="TextSelection-5B8274CA90E157E4A5DEEC1D423311B7-1"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></ix:continuation><div><a id="s3991A6CB0C0F51368CE62BF88A9B8F72"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-weight:bold;">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s90590CBB79E552418C624468BA29A551"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">EXECUTIVE OVERVIEW</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the financial statements included in this Form 10-Q and our Form 10-K for the year ended </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;"> (the &#8220;2019 Form 10-K&#8221;). These historical financial statements may not be indicative of our future performance. This discussion contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks referred to under &#8220;Risk Factors&#8221; in Item 1A of our 2019 Form 10-K and </span><a style="font-family:Arial;font-size:10pt;" href="#s57F4E14597D15F9B98722F296A7178DD"><span style="font-family:Arial;font-size:10pt;">Part II. Item 1A</span></a><span style="font-family:Arial;font-size:10pt;"> of this Form 10-Q.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 48</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Executive Overview</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are dedicated to making lives better by bringing quality, affordable self-care products that consumers trust everywhere they are sold.&#160;We are a leading provider of over-the-counter ("OTC") health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. We are also a leading producer of generic prescription pharmaceutical topical products such as creams, lotions, and gels as well as nasal sprays and inhalers.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Our Segments</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our reporting and operating segments are as follows: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Consumer Self-Care Americas</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">CSCA</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our consumer self-care business (OTC, contract manufacturing, infant formula, and oral self-care categories and our divested animal health category) in the U.S., Mexico and Canada. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Consumer Self-Care International</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">CSCI</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our branded consumer self-care business primarily in Europe, our consumer self-care businesses in the United Kingdom and Australia, and our divested liquid licensed products business in the United Kingdom.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Prescription Pharmaceuticals</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">RX</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our prescription pharmaceuticals business in the U.S., predominantly generics, and our pharmaceuticals and diagnostic businesses in Israel.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our segments reflect the way in which our management makes operating decisions, allocates resources, and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in </span><a style="font-family:Arial;font-size:10pt;" href="#s612D07A762DA56AB961D86277A297B7E"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 2</span></a><span style="font-family:Arial;font-size:10pt;"> and </span><a style="font-family:Arial;font-size:10pt;" href="#sBBE7203EDB115E499A5C44697C1474D8"><span style="font-family:Arial;font-size:10pt;">Note 16</span></a><span style="font-family:Arial;font-size:10pt;">. For results by segment, see "Segment Results" below.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Highlights</span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Effective July 29, 2020, our board of directors appointed Katherine C. Doyle to serve as a director of the Company and a member of its Audit Committee.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 19, 2020, Perrigo Finance Unlimited Company (&#8220;Perrigo Finance&#8221;) issued $</span><span style="font-family:Arial;font-size:10pt;">750.0 million</span><span style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </span><span style="font-family:Arial;font-size:10pt;">3.150%</span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due 2030 (the &#8220;2020 Notes") and received net proceeds of $</span><span style="font-family:Arial;font-size:10pt;">737.1 million</span><span style="font-family:Arial;font-size:10pt;"> after fees and market discount. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2020 Notes will mature on June 15, 2030. The 2020 Notes are governed by the 2020 Indenture. The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo and, no other subsidiary of Perrigo guarantees the 2020 Notes. There are no restrictions under the 2020 Notes on Perrigo's ability to obtain funds from its subsidiaries. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. On July 6, 2020, the net proceeds of the 2020 Notes were used to fund the redemption of Perrigo Finance's </span><span style="font-family:Arial;font-size:10pt;">$280.4 million</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;">3.500%</span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due March 15, 2021 and </span><span style="font-family:Arial;font-size:10pt;">$309.6 million</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;">3.500%</span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due December 15, 2021 (collectively, the "2021 Notes"). The balance will be used for general corporate purposes which may include the repayment or redemption of additional indebtedness. As a result of the early redemption of the 2021 Notes, during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of $</span><span style="font-family:Arial;font-size:10pt;">20.0 million</span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations, consisting of the premium on debt repayments, the write-off of deferred financing fees, and the write-off of the remaining bond discounts.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We previously announced a plan to separate our RX business, which, if completed, would enable us to focus solely on our consumer-focused businesses. A separation of the RX business could include a possible sale, spin-off, merger or other form. We have incurred significant preparation costs due to the announced plan to separate, and if completed we could incur total costs in the range of </span><span style="font-family:Arial;font-size:10pt;">$45.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;">$80.0 million</span><span style="font-family:Arial;font-size:10pt;">, excluding restructuring expenses and transaction costs, depending on timing and structure of a transaction. We have not committed to a time frame for a separation. </span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 49</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Executive Overview</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Impact of COVID-19 Pandemic</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"></span><span style="font-family:Arial;font-size:10pt;">We have been impacted by the novel coronavirus (COVID-19) global pandemic and the responses by government entities to combat the virus. We currently continue to operate in all our jurisdictions and are complying with the rules and guidelines prescribed in each jurisdiction. We are closely monitoring the impact of COVID-19 on all aspects of our business and geographies. Our first priority has been, and will continue to be, the safety of our employees who continue to come to work and are dedicated to keeping our essential products flowing into the market. We have taken extra precautions at our facilities to help ensure the health and safety of our employees that are in line with guidance from global and local health authorities. Among other precautions implemented, we have generally restricted access to our production facilities worldwide to essential employees only and permitted a limited number of nonessential employees into other facilities with a strict approval process, implemented a multi-step pre-screening access process before an employee can enter a facility, communicated regularly with employees and provided education and implemented controls related to physical distancing and hygiene measures, implemented remote work arrangements where appropriate, restricted business travel, and prioritized production of essential products for several months following the initial outbreak. To date, these arrangements have not materially affected our ability to maintain our business operations, including the operation of financial reporting systems, internal control over financial reporting, and disclosure controls and procedures.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Both the outbreak of the disease and the actions to slow its spread have had an adverse impact on our operations by, among other things, increasing absenteeism, affecting the supply of raw materials and third party supplied finished goods, and preventing many of our employees from coming to work. We have responded to such impacts by, among other things, implementing protocols to protect the health of factory workers, adjusting production schedules, and seeking alternate suppliers where available, and so far, most of our facilities have continued to produce at high levels despite these challenges. However, a number of jurisdictions that relaxed such restrictions, or have experienced limited public adherence with suggested safety measures, have experienced new surges in COVID-19 cases. Many of these jurisdictions are now contemplating or implementing new or renewed restrictions. As such, as the pandemic continues or intensifies, it is possible that these or other challenges may begin having a larger impact on our operations. Additionally, concerns over the economic impact of COVID-19 have caused extreme volatility in financial and other capital markets which has adversely impacted, and may continue to adversely impact our stock price and our ability to access capital markets. The situation surrounding COVID-19 remains fluid, and we are actively managing our response and assessing potential impacts to our financial condition, supply chains and other operations, employees, results of operations, consumer demand for our products, and our ability to access capital. The magnitude of any such adverse impact cannot currently be determined due to a number of uncertainties surrounding COVID-19 (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#s57F4E14597D15F9B98722F296A7178DD"><span style="font-family:Arial;font-size:10pt;">Item 1A. Risk Factors</span></a><span style="font-family:Arial;font-size:10pt;"> for related risks).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we have experienced a number of changes in product sales mix across all our Segments, which we attribute to consumer and customer behavior surrounding the COVID-19 pandemic. In March and April of 2020, we experienced a surge in demand for certain of our essential health-care and self-care products in both the CSCA and CSCI segments. This was followed by a slow-down in demand in May and June in both the CSCA and CSCI segments for some of the products in which we previously saw surges, which we attribute primarily to consumer pantry de-load. In the third quarter, demand in our CSCA segment normalized and was not significantly impacted by the pandemic. Our CSCI segment also experienced lower consumer demand during the second and third quarters, with some improvement in the third quarter, for certain other self-care products that were impacted by the movement and social distancing restrictions put in place to combat spreading of the virus, such as travel bans, country lock-downs and school closings. In March and April of 2020 our RX segment saw strong demand for Albuterol. In the latter half of the second quarter, our RX segment experienced a decrease in demand for base products due to lower volume of U.S. prescriptions from pandemic and lock down-related reductions in doctor visits, which partially rebounded in the third quarter. Also in the third quarter, we voluntarily recalled Albuterol and established an estimated recall reserve. Consequently, on a year-to-date basis, after accounting for both the positive and negative sales impacts related to the pandemic, excluding Albuterol, we believe COVID-19 did not significantly impact our consolidated net sales. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In the same time frame, we had incremental operating costs of approximately $11.0 million related to COVID-19 and estimate that full year incremental operating costs will be between $15.0 million to $20.0 million, primarily related to the precautions implemented to keep our employees safe and properly rewarded during the pandemic as well as increased material costs. We also experienced a decrease in our effective tax rate due to </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 50</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Executive Overview</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">additional interest and depreciation deductions provided for in the CARES Act enacted on March 27, 2020 resulting in a reduction of income tax expense by approximately </span><span style="font-family:Arial;font-size:10pt;">$30.8 million</span><span style="font-family:Arial;font-size:10pt;"> during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. Given our financial strength, we expect to continue to maintain sufficient liquidity as we manage through the current environment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Moving forward, whether the trends we've experienced in our segments will continue or change is uncertain and will likely depend on the duration and severity of the COVID-19 pandemic and the annual cold and flu season. If the pandemic intensifies or there is a second wave, it is possible that we could see another surge in demand for our essential self-care products. However, this could lead to continued lower demand for certain self-care products in our CSCI segment, as well as products in our RX segment. Additionally, we could experience continued slow-down in demand for our essential products sold in the initial sales surge if consumers continue to pantry de-load, all of which could depend on the duration and severity of the COVID-19 pandemic and related illnesses.  </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div><a id="sC9F69355A1925786BCC22B655519005E"></a></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">RESULTS OF OPERATIONS</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s7C94BC00FC59556D8FE627BFD2C84448"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONSOLIDATED</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Consolidated Financial Results</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Month Comparison</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,213.7</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,191.1</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">428.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">412.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">35.3</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">34.7</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(95.5</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">54.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income (loss) %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(7.9</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">4.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;text-align:center;"><img src="chart-a264a626c33153a5abb.jpg" alt="chart-a264a626c33153a5abb.jpg" style="height:273px;width:346px;"></img></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;text-align:center;"><img src="chart-85469c30e3cc5f78a30.jpg" alt="chart-85469c30e3cc5f78a30.jpg" style="height:273px;width:346px;"></img></div></div></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">* </span><span style="font-family:Arial;font-size:8pt;">Total net sales by geography is derived from the location of the entity that sells to a third party. </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> vs. </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales increased </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$22.6 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$19.8 million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">2%</span><span style="font-family:Arial;font-size:10pt;">, net increase due primarily to an increase in the CSCA segment of </span><span style="font-family:Arial;font-size:10pt;">$48.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">, which includes </span><span style="font-family:Arial;font-size:10pt;">$24.5 million</span><span style="font-family:Arial;font-size:10pt;"> of demand driven growth across most product categories led by continued consumer channel shifting from traditional brick and mortar outlets to e-commerce and </span><span style="font-family:Arial;font-size:10pt;">$23.5 million</span><span style="font-family:Arial;font-size:10pt;"> from the acquisition of the oral care assets of High Ridge Brands ("Dr. Fresh"). These gains were partially offset by a </span><span style="font-family:Arial;font-size:10pt;">$20.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decline in net sales in our RX segment as </span><span style="font-family:Arial;font-size:10pt;">$23.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> in pre-recall albuterol sulfate inhalation </span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 51</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Consolidated</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-left:48px;padding-bottom:8px;text-align:left;"><span style="font-family:Arial;font-size:10pt;">aerosol ("Albuterol") sales were more than offset by the establishment of the estimated Albuterol recall reserve of </span><span style="font-family:Arial;font-size:10pt;">$31.2&#160;million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$8.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> from discontinued lower margin distribution products. Due primarily to pandemic-related consumer behavior, net sales in our CSCI segment decreased </span><span style="font-family:Arial;font-size:10pt;">$7.8&#160;million</span><span style="font-family:Arial;font-size:10pt;"> as lower demand in certain product categories more than offset increased demand in other categories; and</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$2.8&#160;million</span><span style="font-family:Arial;font-size:10pt;"> increase due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$10.0 million</span><span style="font-family:Arial;font-size:10pt;"> increase primarily from favorable Euro foreign currency translation; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$9.2 million</span><span style="font-family:Arial;font-size:10pt;"> increase due to the absence of the Ranitidine retail market withdrawal included in the prior year period; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$16.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease due to our divested Rosemont pharmaceuticals business and Canoderm prescription product, both previously included in our CSCI segment, and our divested animal health business previously included in our CSCA segment. </span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">decreased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$149.9 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">276%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$15.3 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in gross profit due primarily to increased net sales as described above, which were partially offset by the net charge of </span><span style="font-family:Arial;font-size:10pt;">$22.5 million</span><span style="font-family:Arial;font-size:10pt;"> from the Albuterol recall and an increase in commodity costs for a certain OTC brand. Gross profit as a percentage of net sales increased </span><span style="font-family:Arial;font-size:10pt;">60</span><span style="font-family:Arial;font-size:10pt;"> basis points due primarily to the absence of the Ranitidine retail market withdrawal included in the prior year period, partially offset by the net charge from the Albuterol recall and unfavorable product mix; more than offset by</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$165.2 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in operating expenses due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">A </span><span style="font-family:Arial;font-size:10pt;">$202.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> goodwill impairment charge in the current year period related to RX goodwill, partially offset by the absence of a $10.8 million impairment charge related to a definite-lived intangible asset in the prior year period; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The absence of $12.5 million in acquisition and integration-related charges related to the acquisition of Ranir in the prior year period;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The absence of a $7.1 million asset abandonment charge related to our waste water treatment plant in Vermont recorded in the prior year period; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$4.4 million decrease in restructuring expenses that were related primarily to the reorganization of our executive management team; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$4.0 million insurance reimbursement received in the current year period.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> Month Comparison</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:372px;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:178px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:10px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">3,773.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">3,514.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,346.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,292.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">35.7</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">36.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">167.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">211.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">4.4</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">6.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 52</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Consolidated</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;text-align:center;"><img src="chart-714199db9f68549eabb.jpg" alt="chart-714199db9f68549eabb.jpg" style="height:273px;width:346px;"></img></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;text-align:center;"><img src="chart-9c392cf67c4954c4ab1.jpg" alt="chart-9c392cf67c4954c4ab1.jpg" style="height:273px;width:346px;"></img></div></div></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">* </span><span style="font-family:Arial;font-size:8pt;">Total net sales by geography is derived from the location of the entity that sells to a third party. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> vs. </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales increased </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$259.2&#160;million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">7%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> due to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$334.6 million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">10%</span><span style="font-family:Arial;font-size:10pt;">, net increase due primarily to an increase in the CSCA segment of </span><span style="font-family:Arial;font-size:10pt;">$259.5 million</span><span style="font-family:Arial;font-size:10pt;">, including </span><span style="font-family:Arial;font-size:10pt;">$142.0 million</span><span style="font-family:Arial;font-size:10pt;"> from our acquisitions of Ranir and Dr. Fresh and </span><span style="font-family:Arial;font-size:10pt;">$117.5 million</span><span style="font-family:Arial;font-size:10pt;"> of demand driven growth across most product categories, which was due primarily to increased consumer COVID-19 related demand and benefited from strong e-commerce performance, and the incremental impact of new product sales. In our CSCI segment, net sales increased </span><span style="font-family:Arial;font-size:10pt;">$50.4 million</span><span style="font-family:Arial;font-size:10pt;"> due primarily to Ranir and Dr. Fresh contributing </span><span style="font-family:Arial;font-size:10pt;">$40.6 million</span><span style="font-family:Arial;font-size:10pt;"> and an overall increase from the incremental impact of new product sales and increased demand in certain product categories more than offsetting the decrease in demand of other categories, both due to pandemic-related factors, and discontinued products of </span><span style="font-family:Arial;font-size:10pt;">$5.3&#160;million</span><span style="font-family:Arial;font-size:10pt;">. The </span><span style="font-family:Arial;font-size:10pt;">$24.7 million</span><span style="font-family:Arial;font-size:10pt;"> increase in the RX segment was due primarily to pre-recall Albuterol sales of </span><span style="font-family:Arial;font-size:10pt;">$142.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> and an increase of </span><span style="font-family:Arial;font-size:10pt;">$24.4 million</span><span style="font-family:Arial;font-size:10pt;"> in other new product offerings. These increases were partially offset by pricing pressure, a decline in the base business due to lower prescription volumes related to the pandemic and lock down-related reductions in doctor visits, </span><span style="font-family:Arial;font-size:10pt;">$31.2&#160;million</span><span style="font-family:Arial;font-size:10pt;"> for the establishment of the estimated Albuterol recall reserve, and </span><span style="font-family:Arial;font-size:10pt;">$24.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> of discontinued lower margin distribution products; further partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$75.4 million</span><span style="font-family:Arial;font-size:10pt;"> decrease due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$65.3 million</span><span style="font-family:Arial;font-size:10pt;"> decrease due to our divested Rosemont pharmaceuticals business and Canoderm prescription product, both previously included in our CSCI segment, and our divested animal health business previously included in our CSCA segment; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$19.3 million</span><span style="font-family:Arial;font-size:10pt;"> decrease primarily from unfavorable Euro and Peso foreign currency translation; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$9.2 million</span><span style="font-family:Arial;font-size:10pt;"> increase due to the absence of the Ranitidine retail market withdrawal included in the prior year period.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">decreased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$44.1&#160;million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">21%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$53.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in gross profit due primarily to increased net sales as described above, which were partially offset by the net charge of </span><span style="font-family:Arial;font-size:10pt;">$22.5 million</span><span style="font-family:Arial;font-size:10pt;"> from the Albuterol recall, operational inefficiencies, increased labor and overhead costs associated with the COVID-19 pandemic, and an increase in commodity costs for a certain OTC brand. Gross profit as a percentage of net sales decreased </span><span style="font-family:Arial;font-size:10pt;">110 basis point</span><span style="font-family:Arial;font-size:10pt;">s due primarily to the gross profit factors discussed above and unfavorable product mix; more than offset by</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 53</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Consolidated</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$97.6&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in operating expenses due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">A </span><span style="font-family:Arial;font-size:10pt;">$202.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> goodwill impairment charge in the current year period related to RX goodwill, partially offset by the absence of $42.9 million of impairment charges related to definite-lived intangible assets and IPR&amp;D assets in the prior year period; further offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$25.7 million decrease in restructuring expenses related primarily to the reorganization of our sales force in France and the reorganization of our executive management team in the prior year; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$26.5 million decrease in administration expenses due primarily to a reduction in legal and professional fees, the absence of acquisition and integration-related charges related to the acquisition of Ranir, the absence of expenses from the divested animal health business, and a reduction in employee related expenses, partially offset by an increase in insurance expense, the inclusion of expenses from our acquisitions of Ranir and Dr. Fresh, and incremental costs of operating in the current COVID-19 environment, including employee bonuses and costs related to measures implemented to keep employees safe;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$8.1 million decrease in selling expense due primarily to the reduction in selling, advertising, and promotion expenses in response to consumer sentiment and behavior during the COVID-19 pandemic in the CSCI segment and the absence of expenses from the divested animal health business, partially offset by the inclusion of expenses from our acquisitions of Ranir and Dr. Fresh; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The absence of a $7.1 million asset abandonment charge related to our waste water treatment plant in Vermont taken in the prior year period.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Recent Developments</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Internal Revenue Service Complaint</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As previously disclosed, on August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover </span><span style="font-family:Arial;font-size:10pt;">$163.6 million</span><span style="font-family:Arial;font-size:10pt;"> of Federal income tax, penalties, and interest assessed and collected by the IRS, plus statutory interest thereon from the dates of payment, for the fiscal tax years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012. In response to our complaint, the United States District Court for Western District of Michigan scheduled a new trial date for January 26, 2021 (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 13</span></a><span style="font-family:Arial;font-size:10pt;">).</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Internal Revenue Service Notice of Proposed Adjustment </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As previously disclosed, on April 26, 2019, we received a revised Notice of Proposed Adjustment ("NOPA") from the IRS regarding transfer pricing positions related to the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012 and December 31, 2013. We strongly disagree with the IRS position and will pursue all available administrative and judicial remedies, including those available under the U.S. - Ireland Income Tax Treaty to alleviate double taxation. Accordingly, on April 14, 2020, we filed a request for Competent Authority Assistance with the IRS (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 13</span></a><span style="font-family:Arial;font-size:10pt;">). The request was accepted and is under review.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Internal Revenue Service Notice of Proposed Adjustment</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On May 7, 2020, we received a final NOPA from the IRS, which was unchanged from the draft NOPA previously received, regarding the deductibility of interest related to the IRS audit of Perrigo Company for the years ended June 28, 2014 and June 27, 2015. We strongly disagree with the IRS position and are pursuing all available administrative and judicial remedies (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 13</span></a><span style="font-family:Arial;font-size:10pt;">). </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Irish Tax Appeals Commission Notice of Amended Assessment</span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On October 30, 2018, we received an audit finding letter from the Irish Office of the Revenue Commissioners (&#8220;Irish Revenue&#8221;) for the years ended December 31, 2012 and December 31, 2013 relating to the tax treatment of the 2013 sale of the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> intellectual property and other assets related to Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> to Biogen Idec from Elan Pharma. We strongly disagree with this assessment and believe that the Notice of Amended Assessment ("NoA") is without merit and incorrect as a matter of law and appealed the assessment to the Tax Appeals Commission. Separately, we were granted leave by the Irish High Court on February 25, 2019 to seek </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 54</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Consolidated</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">judicial review of the issuance of the NoA by Irish Revenue. The High Court held a hearing in June 2020 regarding the judicial review case and on November 4, 2020 ruled that the NoA did not violate our rights and legitimate expectations as a taxpayer. Because the Irish High Court did not quash the NoA in the judicial review case, absent an appeal by Elan Pharma in the judicial review case, the amended assessment can be examined on its merits by the Irish Tax Appeals Commission (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 13</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sF3F9CC25FFC85632BDA9B888FA1CD01C"></a></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONSUMER SELF-CARE AMERICAS</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Recent Trends and Developments </span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In March and April of 2020, we experienced a surge in demand for many of our OTC and infant nutrition products, which we attributed to consumer reaction to the outbreak of COVID-19. In May and June, the initial surge slowed, and we experienced a decrease in demand for some of these products, which we attributed primarily to consumers' de-load of pantry stocking that occurred during the initial March and April surge. During the third quarter, demand normalized and COVID-19 did not have a significant impact on our net sales. It is possible that we could still experience a lower demand for some of the products sold in the initial surge if consumers continue to pantry de-load, however, this could depend on the duration and severity of the COVID-19 pandemic and related illnesses. Alternatively, it is possible that we could experience another surge in demand if a concentrated wave of COVID-19 occurs.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 17, 2020, we announced our entrance into the CBD market through a strategic investment in and long-term supply agreement with Kazmira LLC ("Kazmira"), a leading supplier of hemp-based, THC-free CBD products. In addition to the supply agreement, we acquired an approximate </span><span style="font-family:Arial;font-size:10pt;">20%</span><span style="font-family:Arial;font-size:10pt;"> equity stake in Kazmira for </span><span style="font-family:Arial;font-size:10pt;">$50.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> with </span><span style="font-family:Arial;font-size:10pt;">$15.0 million</span><span style="font-family:Arial;font-size:10pt;"> paid at close of the transaction and the balance due within </span><span style="font-family:Arial;font-size:10pt;">18</span><span style="font-family:Arial;font-size:10pt;"> months. Our minority equity investment initiates the first phase of the partnership in which we will collaborate to scale-up Kazmira&#8217;s facilities and laboratories, in accordance with current Good Manufacturing Practices and to produce THC-free CBD from industrial hemp that meets our standards for reliability and consistency. In the second phase of the partnership, we will work to launch THC-free, hemp-based CBD products in a number of global markets, while leveraging our supply agreement with Kazmira, which is exclusive for the U.S. store brand market (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sF4B58DD1964A5338A17E7D9B8F660A6D"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 7</span></a><span style="font-family:Arial;font-size:10pt;"> and </span><a style="font-family:Arial;font-size:10pt;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"><span style="font-family:Arial;font-size:10pt;">Note 10</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><span style="font-family:Arial;font-size:11pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On April 6, 2020, we received approval from the U.S. Food and Drug Administration on our abbreviated new drug application ("ANDA") for OTC diclofenac sodium topical gel 1%, the store brand equivalent to Voltaren</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> gel. On September 8, 2020, we launched this product to our retail partners under store brand labels, which provides consumers with a high-quality, value alternative for the temporary relief of arthritis pain. </span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">April&#160;1, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired Dr. Fresh for total purchase consideration of </span><span style="font-family:Arial;font-size:10pt;">$113.0 million</span><span style="font-family:Arial;font-size:10pt;">, subject to customary post-closing adjustments, including a working capital settlement. After post-closing adjustments as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, total cash consideration paid was </span><span style="font-family:Arial;font-size:10pt;">$106.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">. This acquisition includes the children&#8217;s oral care value brand, Firefly</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, in addition to the REACH</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and Dr. Fresh</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> brands, and a licensing portfolio. The addition of these brands positions us as the number one fastest-growing value brand player in the children&#8217;s oral care category and the licensing portfolio will enable creative solutions for our customers (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">January&#160;3, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired Steripod</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. Total consideration paid was </span><span style="font-family:Arial;font-size:10pt;">$26.0 million</span><span style="font-family:Arial;font-size:10pt;">. The transaction was accounted for as an asset acquisition, in which we capitalized </span><span style="font-family:Arial;font-size:10pt;">$25.1 million</span><span style="font-family:Arial;font-size:10pt;"> as a brand-named intangible asset. The remainder of the purchase price was allocated to working capital. The acquisition, which includes a portfolio of antibacterial toothbrush protectors, kids&#8217; toothbrush protectors and tongue cleaners, complements our current portfolio of oral self-care products, and leverages our manufacturing and marketing platform (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">). </span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 55</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">CSCA</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Segment Financial Results</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Month Comparison</span></div><div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:58.280922431865825%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">664.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">613.3</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">217.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">185.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">32.7</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">30.2</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">123.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">81.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">18.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">13.3</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> vs. </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales increased </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$50.7 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">8%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$48.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">8%</span><span style="font-family:Arial;font-size:10pt;">, net increase due primarily to an increase of </span><span style="font-family:Arial;font-size:10pt;">$23.5 million</span><span style="font-family:Arial;font-size:10pt;"> from our acquisition of Dr. Fresh and demand driven growth across most product categories benefiting from e-commerce growth as consumers continued to shift purchasing towards online where we have greater market share, which more than offset lower traditional brick and mortar purchases. More specifically, OTC net sales growth of </span><span style="font-family:Arial;font-size:10pt;">$15.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> was driven by strong demand in the pain, allergy, and digestive health categories, resulting from strong e-commerce growth and incremental new product sales including Prevacid</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, Diclofenac sodium topical gel 1%, and Esomeprazole Mini. These increases were partially offset by a decrease in sales of cough and cold products included in our upper respiratory category due to a weaker start to the cough and cold season and normal pricing pressure. Nutrition net sales growth of </span><span style="font-family:Arial;font-size:10pt;">$5.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> was due primarily to new product sales from an infant formula launch at a major retailer in the prior year, greater shipments in the infant formula contract manufacturing business, and e-commerce growth, which were partially offset by multi-year pricing contracts. Growth in the oral self-care category was driven by strong e-commerce performance and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$2.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> increase due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$7.4 million</span><span style="font-family:Arial;font-size:10pt;"> increase due to the absence of the Ranitidine retail market withdrawal included in the prior year period; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$2.9&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease from unfavorable Mexican peso foreign currency translation; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$1.8 million</span><span style="font-family:Arial;font-size:10pt;"> decrease related to our divested animal health business.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">increased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$42.3 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">52%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due primarily to:</span></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$32.0 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in gross profit due primarily to increased net sales as described above. Gross profit as a percentage of net sales increased </span><span style="font-family:Arial;font-size:10pt;">250</span><span style="font-family:Arial;font-size:10pt;"> basis points due primarily to the absence of the Ranitidine retail market withdrawal included in the prior year period and higher margin new product sales, partially offset by normal pricing pressure; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$10.3&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease in operating expenses due primarily to the absence of a $7.1 million asset abandonment charge related to our waste water treatment plant in Vermont taken in the prior year period and a $4.0 million insurance reimbursement received in the current year period.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> Month Comparison</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 56</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">CSCA</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:374px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:178px;"></td><td style="width:6px;"></td><td style="width:77px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:77px;"></td><td style="width:10px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,992.2</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,777.2</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">632.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">565.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">31.7</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">31.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">354.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">283.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">17.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">15.9</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> vs. </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales increased </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$215.0 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">12%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$259.5 million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">15%</span><span style="font-family:Arial;font-size:10pt;">, net increase due primarily to an increase of </span><span style="font-family:Arial;font-size:10pt;">$142.0 million</span><span style="font-family:Arial;font-size:10pt;"> from our acquisitions of Ranir and Dr. Fresh and demand driven growth across most product categories, which was due primarily to increased consumer COVID-19 related demand and benefited from strong e-commerce performance. More specifically, OTC net sales growth of </span><span style="font-family:Arial;font-size:10pt;">$100.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> across most product categories was due primarily to the net increase of consumer COVID-19 related demand, overall market growth, favorable consumer conversion in digestive health products, and the incremental impact of new product sales led by Prevacid</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, Diclofenac sodium topical gel 1%, and Esomeprazole Mini. All of these drivers benefited from continued robust e-commerce growth. These increases were partially offset by normal pricing pressure on certain products. Nutrition net sales growth of </span><span style="font-family:Arial;font-size:10pt;">$11.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> was due primarily to new product sales from an infant formula launch at a major retailer in the prior year, partially offset by multi-year pricing contracts and a </span><span style="font-family:Arial;font-size:10pt;">$5.8&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease due to discontinued products. In the oral self-care category, growth was driven by the incremental impact of new product sales benefiting from e-commerce growth; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$44.5 million</span><span style="font-family:Arial;font-size:10pt;"> decrease due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$43.7 million</span><span style="font-family:Arial;font-size:10pt;"> decrease due to our divested animal health business; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$8.2 million</span><span style="font-family:Arial;font-size:10pt;"> decrease from unfavorable Mexican peso foreign currency translation; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$7.4 million</span><span style="font-family:Arial;font-size:10pt;"> increase due to the absence of the Ranitidine retail market withdrawal included in the prior year period.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">increased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$71.2&#160;million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">25%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$66.3 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in gross profit due primarily to increased net sales as described above, partially offset by operating inefficiencies at one of our infant nutrition facilities as well as increased labor and overhead costs associated with the COVID-19 pandemic. Gross profit as a percentage of net sales decreased </span><span style="font-family:Arial;font-size:10pt;">10 basis point</span><span style="font-family:Arial;font-size:10pt;">s due primarily to the operating inefficiencies described above, pricing pressure on certain products, and the divested animal health business, partially offset by the absence of the Ranitidine retail market withdrawal included in the prior year period, and higher margin new product sales; and</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$4.9 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in operating expenses due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The absence of a $7.1 million asset abandonment charge related to our waste water treatment plant in Vermont taken in the prior year period and a $4.0 million insurance reimbursement received in the current year period; partially offset by  </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$6.3 million increase in selling and administration expenses due primarily to the inclusion of expenses from our acquisitions of Ranir and Dr. Fresh and an increase in promotion expenses on branded products, partially offset by a reduction in employee related expenses and the absence of expenses from the divested animal health business.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sDD2EBE5AA401599EAF039BD94C29B393"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONSUMER SELF-CARE INTERNATIONAL </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Recent Trends and Developments </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 57</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">CSCI</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Throughout the year, we experienced demand shifts for certain products, which we attributed to consumer reactions related to the COVID-19 pandemic and the movement and social distancing restrictions put in place to combat spreading of the virus, such as travel bans, and country lock-downs. Certain products in our pain and sleep-aids and vitamins, minerals and supplements ("VMS") categories increased, while products in our skincare and personal hygiene, and healthy lifestyle categories decreased. It is possible that demand in our skincare and personal hygiene, and healthy lifestyle categories may continue to decrease due to continued movement and social distancing restrictions, which could depend on the duration and severity of the COVID-19 pandemic and related illnesses.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">August&#160;7, 2020</span><span style="font-family:Arial;font-size:10pt;">, we entered into a definitive agreement to acquire </span><span style="font-family:Arial;font-size:10pt;">three</span><span style="font-family:Arial;font-size:10pt;"> Eastern European OTC dermatological skincare and hair loss treatment brands, Emolium</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, Iwostin</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, and Loxon</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> from Sanofi for </span><span style="font-family:Arial;font-size:10pt;">&#8364;52.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> and additional consideration for the transfer of related inventory on hand. On </span><span style="font-family:Arial;font-size:10pt;">October&#160;30, 2020</span><span style="font-family:Arial;font-size:10pt;">, the transaction closed for </span><span style="font-family:Arial;font-size:10pt;">&#8364;53.3&#160;million</span><span style="font-family:Arial;font-size:10pt;"> (approximately </span><span style="font-family:Arial;font-size:10pt;">$62.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">), subject to post-closing conditions. The acquisition will be accounted for as a business combination. This transaction builds on our self-care transformation and strengthens our skincare and personal hygiene portfolio.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Consistent with our strategy to reconfigure our portfolio to focus on our consumer self-care businesses, on </span><span style="font-family:Arial;font-size:10pt;">June&#160;19, 2020</span><span style="font-family:Arial;font-size:10pt;">, we completed the sale of our U.K.- based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K. headquartered private equity firm for cash consideration of </span><span style="font-family:Arial;font-size:10pt;">&#163;155.6&#160;million</span><span style="font-family:Arial;font-size:10pt;"> (approximately </span><span style="font-family:Arial;font-size:10pt;">$195.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">), which resulted in a pre-tax loss of </span><span style="font-family:Arial;font-size:10pt;">$18.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">February&#160;13, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired Dexsil</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">,</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:Arial;font-size:10pt;">a silicon supplement brand, from RXW Group NV, for total cash consideration paid of approximately </span><span style="font-family:Arial;font-size:10pt;">$8.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">. The transaction was accounted for as an asset acquisition, in which we capitalized the consideration paid as a brand-named intangible asset. The acquisition provides additional opportunities for growth through new product launches and geographic expansion (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Segment Financial Results</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Month Comparison</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:58.280922431865825%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">339.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">347.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">154.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">156.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">45.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">45.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">10.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">13.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">3.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">3.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> vs. </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">decreased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$8.5 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$7.8&#160;million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">2%</span><span style="font-family:Arial;font-size:10pt;">, net decrease due primarily to lower sales of cough and cold OTC products in the upper respiratory category and lower consumer demand for anti-parasite products in the skincare and personal hygiene category due to pandemic-related consumer behavior, travel bans, social distancing measures, country lock-downs, and school closings, and a </span><span style="font-family:Arial;font-size:10pt;">$2.9&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease from discontinued products. These decreases were partially offset by incremental new product sales including line extensions in the ACO dermatology product and the XLS Forte-Five weight management brand in the skincare and personal hygiene and healthy lifestyle categories, respectively, and higher net sales in our pain and sleep-aids and VMS categories due to pandemic-related consumer behavior; and</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$14.6 million</span><span style="font-family:Arial;font-size:10pt;"> decrease due to our divested Rosemont pharmaceuticals business and Canoderm prescription product previously included in the Nordic region; partially offset by</span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 58</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">CSCI</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$12.1&#160;million</span><span style="font-family:Arial;font-size:10pt;"> increase from favorable foreign currency translation primarily related to the Euro; and</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$1.8 million</span><span style="font-family:Arial;font-size:10pt;"> increase due to the absence of the Ranitidine retail market withdrawal included in the prior year period.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income decreased </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$3.0 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">23%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to:</span></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$2.2&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in gross profit due primarily to the decrease in net sales as described above and higher commodity costs for a certain OTC brand. Gross profit as a percentage of net sales increased </span><span style="font-family:Arial;font-size:10pt;">50</span><span style="font-family:Arial;font-size:10pt;"> basis points due primarily to the absence of the Ranitidine retail market withdrawal included in the prior year period, partially offset by the divested Rosemont pharmaceuticals business, unfavorable product mix, and higher commodity costs for a certain OTC brand; and</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$0.8 million</span><span style="font-family:Arial;font-size:10pt;"> increase in operating expenses due primarily to unfavorable Euro foreign currency translation, partially offset by the absence of expenses from the divested Rosemont pharmaceuticals business and a decrease in administration and restructuring expenses.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> Month Comparison</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:372px;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:178px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:10px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,042.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,025.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">483.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">480.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">46.3</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">46.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">45.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">18.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">4.4</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">vs.</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">increased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$17.0&#160;million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">2%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$50.4 million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">5%</span><span style="font-family:Arial;font-size:10pt;">, net increase due primarily to a </span><span style="font-family:Arial;font-size:10pt;">$40.6 million</span><span style="font-family:Arial;font-size:10pt;"> increase from our acquisitions of Ranir and Dr. Fresh and an increase in demand for products in our pain and sleep-aids and VMS categories due to pandemic-related consumer behavior. The segment also benefited from the incremental impact of new product sales, including line extensions in the ACO dermatology product line and the XLS Forte-Five weight management brand in the skincare and personal hygiene and healthy lifestyle categories, respectively. These increases were partially offset by lower consumer demand of certain self-care products in the upper respiratory, skincare and personal hygiene and healthy lifestyle categories due to pandemic-related consumer behavior, travel bans, social distancing measures as well as country lock-downs and discontinued products of </span><span style="font-family:Arial;font-size:10pt;">$5.3&#160;million</span><span style="font-family:Arial;font-size:10pt;">; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$33.4 million</span><span style="font-family:Arial;font-size:10pt;"> decrease due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$21.6 million</span><span style="font-family:Arial;font-size:10pt;"> decrease due to our divested Rosemont pharmaceuticals business and Canoderm prescription product previously included in the Nordic region; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$13.6 million</span><span style="font-family:Arial;font-size:10pt;"> decrease from unfavorable foreign currency translation primarily related to the Euro; partially offset by </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$1.8 million</span><span style="font-family:Arial;font-size:10pt;"> increase due to the absence of the Ranitidine retail market withdrawal included in the prior year period.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 59</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">CSCI</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">increased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$27.3&#160;million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">148%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$3.3&#160;million</span><span style="font-family:Arial;font-size:10pt;"> increase in gross profit due primarily to increased net sales as described above, partially offset by higher commodity costs for a certain OTC brand. Gross profit as a percentage of net sales decreased </span><span style="font-family:Arial;font-size:10pt;">50 basis point</span><span style="font-family:Arial;font-size:10pt;">s due primarily to the addition of the oral self-care category, which has a relatively lower gross margin than the overall portfolio, unfavorable product mix, and an increase in commodity costs, partially offset by positive pricing trends and the absence of the Ranitidine retail market withdrawal included in the prior year period; and</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$24.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in operating expenses due primarily to:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$18.1 million decrease in selling and administration expenses due primarily to a reduction in selling, advertising, and promotion expenses in response to consumer sentiment and behavior during the COVID-19 pandemic, partially offset by the inclusion of expenses from our acquisitions of Ranir and Dr. Fresh; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$10.4 million decrease due to the absence of restructuring expenses related to the reorganization of our sales force in France; partially offset by </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><span style="font-family:Arial;font-size:10pt;">&#9702;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$4.1 million increase in R&amp;D expenses towards continued innovation efforts.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s8B9F16AD34255E1BB05B725DDD542711"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PRESCRIPTION PHARMACEUTICALS</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Recent Trends and Developments </span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We experienced more moderate pricing reductions compared to the prior year in our </span><span style="font-family:Arial;">RX</span><span style="font-family:Arial;font-size:10pt;"> segment, but pricing erosion continues due to approvals for products competing with our portfolio and overall competitive pressures. We expect some softness in pricing to continue to impact the segment for the foreseeable future.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On September 17, 2020, we initiated a voluntary nationwide recall to the retail level of Albuterol as a result of complaints from patients that some units may not dispense due to clogging. Corrective action plans are underway and a definitive time-line for product reintroduction has not been determined at this time. As a result of the recall, we recorded a net charge of </span><span style="font-family:Arial;font-size:10pt;">$22.5 million</span><span style="font-family:Arial;font-size:10pt;"> in our Condensed Consolidated Statements of Operations during the third quarter. We launched Albuterol in the first quarter of 2020 after receiving approval from the U.S. Food and Drug Administration on our abbreviated new drug application on February 24, 2020, along with our partner Catalent Pharma Solutions.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the three months ended September&#160;26, 2020, our RX U.S. reporting unit had an indication of potential impairment primarily from the stoppage of production and distribution of Albuterol and voluntary nationwide recall at the retail level, combined with a decline in market multiples. We prepared an impairment test as of September&#160;26, 2020, determined the carrying value of the RX U.S. reporting unit exceeded its estimated fair value and recorded a goodwill impairment of </span><span style="font-family:Arial;font-size:10pt;">$202.4&#160;million</span><span style="font-family:Arial;font-size:10pt;">.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Starting in the second quarter, with a partial rebound in the third quarter, we experienced a reduction in demand for certain of our existing base products due to lower prescription volumes related to pandemic and lock-down-related reductions in doctor visits. The decrease in demand of existing base products was market-wide and did not result in market share loss.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Segment Financial Results</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Three Month Comparison</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 60</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">RX</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:58.280922431865825%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">210.7</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">230.3</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">57.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">71.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">27.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">31.0</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(180.6</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">19.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income (loss) %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(85.7</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">8.5</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> vs. </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Three Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales decreased </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$19.6 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">9%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due primarily to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$20.5&#160;million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">9%</span><span style="font-family:Arial;font-size:10pt;">, net decrease due primarily to </span><span style="font-family:Arial;font-size:10pt;">$23.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> in pre-recall Albuterol sales being more than offset by the establishment of the estimated Albuterol recall reserve of </span><span style="font-family:Arial;font-size:10pt;">$31.2&#160;million</span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;">$8.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> from discontinued lower margin distribution products, and a slight decline in the base business. Net sales increased from other new products by </span><span style="font-family:Arial;font-size:10pt;">$3.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">, mainly from the Scopolamine patch relaunch. </span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">decreased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$200.3 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">1,017%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, primarily due to:</span></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$14.4 million</span><span style="font-family:Arial;font-size:10pt;"> decrease in gross profit, and a </span><span style="font-family:Arial;font-size:10pt;">400</span><span style="font-family:Arial;font-size:10pt;"> basis point decrease in gross profit as a percentage of net sales, due primarily to the net charge of </span><span style="font-family:Arial;font-size:10pt;">$22.5 million</span><span style="font-family:Arial;font-size:10pt;"> from the Albuterol recall; and</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$185.9 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in operating expenses due primarily to the </span><span style="font-family:Arial;font-size:10pt;">$202.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> goodwill impairment charge in the current year period, partially offset by the absence of a $10.8 million impairment charge related to a definite-lived intangible asset in the prior year period and a decrease in R&amp;D expenses driven by lower clinical study costs.</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Nine</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> Month Comparison</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:372px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:178px;"></td><td style="width:6px;"></td><td style="width:71px;"></td><td style="width:14px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:75px;"></td><td style="width:10px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">738.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">711.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">230.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">246.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gross profit %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">31.2</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">34.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(81.2</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">95.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating income (loss) %</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(11.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">13.4</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> vs. </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Nine Months Ended</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Net sales </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">increase</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">d </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$27.2 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">4%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due primarily to: </span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$24.7 million</span><span style="font-family:Arial;font-size:10pt;">, or </span><span style="font-family:Arial;font-size:10pt;">3%</span><span style="font-family:Arial;font-size:10pt;">, net increase due primarily to </span><span style="font-family:Arial;font-size:10pt;">$142.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> from Albuterol sales prior to the recall and an increase of </span><span style="font-family:Arial;font-size:10pt;">$24.4 million</span><span style="font-family:Arial;font-size:10pt;"> in other new product sales driven by the Scopolamine relaunch and Diclofenac sodium topical gel 1%. These increases were partially offset by pricing pressure, including for testosterone gel 1.62% (which still had 180-day market exclusivity in the prior year period), a decline in the base business, which was due to lower prescription volumes related to pandemic and lock-down-related reductions in doctor visits, </span><span style="font-family:Arial;font-size:10pt;">$31.2&#160;million</span><span style="font-family:Arial;font-size:10pt;"> for the establishment of the estimated Albuterol recall reserve, and </span><span style="font-family:Arial;font-size:10pt;">$24.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> of discontinued lower margin distribution products.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Operating income </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">decreased</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">$176.2 million</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, or </span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">185%</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">, due to: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$15.9&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in gross profit due primarily to the net charge of </span><span style="font-family:Arial;font-size:10pt;">$22.5 million</span><span style="font-family:Arial;font-size:10pt;"> from the Albuterol recall and third party operational inefficiencies on partnered products, offset by the increase in net sales as </span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 61</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">RX</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-left:48px;"><span style="font-family:Arial;font-size:10pt;">described above. Gross profit as a percentage of net sales decreased </span><span style="font-family:Arial;font-size:10pt;">340 basis point</span><span style="font-family:Arial;font-size:10pt;">s, due primarily to the gross profit factors discussed above and pricing pressure; and</span></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$160.3&#160;million</span><span style="font-family:Arial;font-size:10pt;"> increase in operating expenses due primarily to the </span><span style="font-family:Arial;font-size:10pt;">$202.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> goodwill impairment in the current year period, partially offset by the absence of $38.7 million of impairment charges related to definite-lived intangible assets in the prior year period and a decrease in selling and administration costs related primarily to a reduction in employee related expenses.</span></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s18217FDAB0FB51D98E056A3F0B4EB1EA"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Unallocated Expenses</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unallocated expenses are comprised of certain corporate services not allocated to our reporting segments and are recorded in Operating income on the Condensed Consolidated Statements of Operations. Unallocated expenses were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:391px;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">48.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">59.8</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">151.3</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">185.1</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;">$11.2&#160;million</span><span style="font-family:Arial;font-size:10pt;"> in unallocated expenses during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> compared to the prior year period was due primarily to the absence of $12.5 million in acquisition and integration-related charges related to the acquisition of Ranir and a $5.6 million decrease in legal and consulting fees, partially offset by an increase of $3.2 million in insurance related expenses.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;">$33.8&#160;million</span><span style="font-family:Arial;font-size:10pt;"> in unallocated expenses during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> compared to the prior year period was due primarily to a $27.9 million decrease in legal and consulting fees, a $13.3 million decrease in Restructuring expense related primarily to the reorganization of our executive management team, and the absence of $12.5 million in acquisition and integration-related charges related to the acquisition of Ranir, partially offset by an increase of $12.8 million in employee incentive compensation expenses, which included COVID-19 bonuses for production employees, and an increase of $11.7 million in insurance related expenses.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div><a id="s041CB446D5625F6494CAAA27B3FCD950"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Change in Financial Assets, Interest expense, net, Other (income) expense, net and Loss on extinguishment of debt (Consolidated)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:610px;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:224px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td><td style="width:5px;"></td><td style="width:6px;"></td><td style="width:82px;"></td><td style="width:4px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in financial assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(22.2</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(2.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(25.9</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(18.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">34.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">30.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">97.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">90.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">0.4</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(71.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">17.1</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(65.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Loss on extinguishment of debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">20.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">0.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">20.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">0.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Change in Financial Assets</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"></span><span style="font-family:Arial;font-size:10pt;">The proceeds from our 2017 sale of the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> financial asset consisted of $2.2 billion in upfront cash and up to $250.0 million and $400.0 million in contingent milestone payments related to 2018 and 2020, respectively. During the year ended December 31, 2019 we received the $250.0 million contingent milestone payment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, the fair value of the Royalty Pharma contingent milestone payment related to 2020 increased by </span><span style="font-family:Arial;font-size:10pt;">$22.2 million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$25.9 million</span><span style="font-family:Arial;font-size:10pt;">, respectively to </span><span style="font-family:Arial;font-size:10pt;">$121.2&#160;million</span><span style="font-family:Arial;font-size:10pt;">, which is recorded on the Condensed Consolidated Balance Sheets within </span><span style="font-family:Arial;font-size:10pt;">Prepaid expenses and other current assets</span><span style="font-family:Arial;font-size:10pt;">. The adjustments were driven by higher projected global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> compared to the estimates in the prior period, and the estimated probability of achieving the earn-out. During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, the fair value of the Royalty Pharma contingent milestone payments increased by </span><span style="font-family:Arial;font-size:10pt;">$2.6 million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$18.5 million</span><span style="font-family:Arial;font-size:10pt;">, respectively. These adjustments were driven by higher projected global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></span><span style="font-family:Arial;font-size:10pt;">and the estimated probability of achieving the earn-out. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 62</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unallocated, Interest, Other, and Taxes</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></span><span style="font-family:Arial;font-size:10pt;">were </span><span style="font-family:Arial;font-size:10pt;">$337.5 million</span><span style="font-family:Arial;font-size:10pt;"> in 2018, which triggered the </span><span style="font-family:Arial;font-size:10pt;">$250.0 million</span><span style="font-family:Arial;font-size:10pt;"> milestone payment received during the first quarter of 2019. There is no contingent milestone based on 2019 sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">. In order for us to receive the remaining contingent milestone payment of </span><span style="font-family:Arial;font-size:10pt;">$400.0 million</span><span style="font-family:Arial;font-size:10pt;">, Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales, as defined in the agreement, in 2020 must exceed </span><span style="font-family:Arial;font-size:10pt;">$351.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">. If Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales do not meet the prescribed threshold in 2020, we will write off the </span><span style="font-family:Arial;font-size:10pt;">$121.2&#160;million</span><span style="font-family:Arial;font-size:10pt;"> asset and record a loss. If the prescribed threshold is exceeded, we will increase the asset to </span><span style="font-family:Arial;font-size:10pt;">$400.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> and recognize income of </span><span style="font-family:Arial;font-size:10pt;">$278.8&#160;million</span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Change in financial assets</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sBFE17B0A00B45FB196C8960332ACE955"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 6</span></a><span style="font-family:Arial;font-size:10pt;">). </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Interest Expense, Net</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">$3.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> increase for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, compared to the prior year period was due primarily to a reduction in interest income received and changes in our underlying hedge exposure.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">$7.2 million</span><span style="font-family:Arial;font-size:10pt;"> increase for the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, compared to the prior year period was due primarily to changes in our underlying hedge exposure and the addition of interest expense on our 2020 Notes and two Promissory Notes related to our equity method investment in Kazmira.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Other (Income) Expense, Net </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">$71.4 million</span><span style="font-family:Arial;font-size:10pt;"> increase in expense during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> compared to the prior year period was due primarily to the absence of the pre-tax gain of </span><span style="font-family:Arial;font-size:10pt;">$71.7 million</span><span style="font-family:Arial;font-size:10pt;"> on the sale of our animal health business (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">). </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">$82.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> increase in expense during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> compared to the prior year period was due primarily to the absence of the pre-tax gain of </span><span style="font-family:Arial;font-size:10pt;">$71.7 million</span><span style="font-family:Arial;font-size:10pt;"> on the sale of our animal health business and the </span><span style="font-family:Arial;font-size:10pt;">$18.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> pre-tax loss on the divestiture of our Rosemont Pharmaceuticals business, partially offset by a decrease of $5.3 million in losses on investment securities (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Loss on Extinguishment of Debt</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of $</span><span style="font-family:Arial;font-size:10pt;">20.0 million</span><span style="font-family:Arial;font-size:10pt;"> as a result of the early redemption of the 2021 Notes, consisting of the premium on debt repayments, the write-off of deferred financing fees, and the write-off of the remaining bond discounts (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 10</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s5E6CDE65D006578587F8BCD60453A8C1"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Income Taxes (Consolidated)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The effective tax rates were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:387px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77px;"></td><td style="width:16px;"></td><td style="width:5px;"></td><td style="width:81px;"></td><td style="width:11px;"></td><td style="width:5px;"></td><td style="width:81px;"></td><td style="width:11px;"></td><td style="width:5px;"></td><td style="width:81px;"></td><td style="width:11px;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(21.1</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">5.2</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">78.9</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">19.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"></span><span style="font-family:Arial;font-size:10pt;">The effective tax rate for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> increased compared to the prior period primarily due to non-deductible goodwill impairments and the Base Erosion and Anti-Abuse Tax ("BEAT"), offset by additional interest deductions provided for in the CARES Act and the early adoption of the final and proposed business interest expense deduction limitation regulations in the current period. The CARES Act reduced income tax expense by approximately </span><span style="font-family:Arial;font-size:10pt;">$30.8 million</span><span style="font-family:Arial;font-size:10pt;"> in the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, of which </span><span style="font-family:Arial;font-size:10pt;">$15.9&#160;million</span><span style="font-family:Arial;font-size:10pt;"> relates to retroactive adjustments to the 2019 tax year while </span><span style="font-family:Arial;font-size:10pt;">$14.9 million</span><span style="font-family:Arial;font-size:10pt;"> relates to the first, second and third quarters of the 2020 tax year (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 13</span></a><span style="font-family:Arial;font-size:10pt;"> for more information on income taxes).</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="sD1D97D6D08045B4B8971BB225FEE0056"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We finance our operations with internally generated funds, supplemented by credit arrangements with third parties and capital market financing. We routinely monitor current and expected operational requirements and </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 63</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Financial Condition, Liquidity and Capital Resources</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">financial market conditions to evaluate other available financing sources including term and revolving bank credit and securities offerings. In determining our future capital requirements we regularly consider, among other factors, known trends and uncertainties, such as the Notice of Assessment ("NoA") and the Notices of Proposed Adjustment ("NOPAs"), the current COVID-19 pandemic, and other contingencies. We note that no payment of the additional amounts assessed by Irish Revenue pursuant to the NoA or proposed by the IRS in the NOPAs is currently required, and no such payment is expected to be required, unless and until a final determination of the matter is reached that is adverse to us (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 13</span></a><span style="font-family:Arial;font-size:10pt;"> for additional information on the NoA and NOPAs). Based on the foregoing, management believes that our operations and borrowing resources are sufficient to provide for our short-term and long-term capital requirements, as described below. However, an adverse result with respect to our appeal of any material outstanding tax assessments or litigation, including securities or drug pricing matters and product liability cases, could ultimately require the use of corporate assets to pay such assessments, damages resulting from third-party claims, and related interest and/or penalties, and any such use of corporate assets would limit the assets available for other corporate purposes. As such, we continue to evaluate the impact of the above factors on liquidity and may determine that modifications to our capital structure are appropriate if market conditions deteriorate, favorable capital market opportunities become available, or any change in conditions relating to the NoA, the NOPAs, the COVID-19 pandemic or other contingencies have a material impact on our capital requirements.</span></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div><a id="s92D36DED6C4853658EC30E3B4F456FA8"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash and Cash Equivalents</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;"><img src="chart-d9320a08f029506eb1b.jpg" alt="chart-d9320a08f029506eb1b.jpg" style="height:246px;width:402px;"></img></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">* </span><span style="font-family:Arial;font-size:8pt;">Working capital represents current assets less current liabilities, excluding cash and cash equivalents, and excluding current indebtedness. </span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cash, cash equivalents, cash flows from operations, and borrowings available under our credit facilities are expected to be sufficient to finance our liquidity and capital expenditures in both the short and long term. Although our lenders have made commitments to make funds available to us in a timely fashion under our revolving credit agreements and overdraft facilities, if economic conditions worsen, including due to the COVID-19 pandemic, or new information becomes publicly available impacting the institutions&#8217; credit rating or capital ratios, these lenders may be unable or unwilling to lend money pursuant to our existing credit facilities. Should our outlook on liquidity requirements change substantially from current projections, we may seek additional sources of liquidity in the future.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 64</span></div></div><hr style="page-break-after:always"></hr><div><a id="sC5F12B7B4DC758128F376D6D66DCFCB1"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Financial Condition, Liquidity and Capital Resources</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash Generated by (Used in) Operating Activities</span></div><div style="line-height:120%;text-align:center;"><img src="chart-b33f6037e4655baeb60.jpg" alt="chart-b33f6037e4655baeb60.jpg" style="height:244px;width:466px;"></img></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">$227.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in operating cash inflow was due primarily to:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$118.5 million</span><span style="font-family:Arial;font-size:10pt;"> increase in cash from the change in accounts receivable, due primarily to timing of sales and receipt of payments;</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$56.8 million</span><span style="font-family:Arial;font-size:10pt;"> increase in cash from the change in accrued income taxes, due primarily to the CARES Act and adoption of final and proposed 163(j) regulations, as well as the absence of tax liability on the Royalty Pharma contingent milestone payment received in the prior year;</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$47.2 million</span><span style="font-family:Arial;font-size:10pt;"> increase in cash from the change in accrued customer programs, due primarily to pricing dynamics in our RX segment, as well as timing of rebate and chargeback payments in our RX and CSCA segments; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$47.0 million</span><span style="font-family:Arial;font-size:10pt;"> increase in cash from the change in net earnings after adjustments for items including deferred income taxes, impairment charges, restructuring charges, changes in our financial assets, share-based compensation, loss on extinguishment of debt, amortization of debt premium, loss (gain) on sale of business, and depreciation and amortization; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$19.1&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease in cash from the change in prepaid expenses, due primarily to an increase in our directors and officers prepaid insurance, payments made for annual prepaid expenses, and a payment made for a transitional service agreement, partially offset by payments received related to our cross currency swap; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$18.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease in cash from the change in accounts payable, due primarily to the timing of payments and mix of payment terms.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 65</span></div></div><hr style="page-break-after:always"></hr><div><a id="sD72779C87E1250D79A417B0AFE500058"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Financial Condition, Liquidity and Capital Resources</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash Generated by (Used in) Investing Activities</span></div><div style="line-height:120%;text-align:center;"><img src="chart-a7f9749e3d245919a3a.jpg" alt="chart-a7f9749e3d245919a3a.jpg" style="height:244px;width:466px;"></img></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">$429.5&#160;million</span><span style="font-family:Arial;font-size:10pt;"> decrease in cash used in investing cash flow was due primarily to:</span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$643.5 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in cash due to the absence of the cash paid for the acquisition for Ranir, partially offset by the cash paid for the acquisition of Dr. Fresh (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">);</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$52.1 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in cash due to the decrease in spending on asset acquisitions, primarily related to the purchase of the Steripod</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></span><span style="font-family:Arial;font-size:10pt;">brand for </span><span style="font-family:Arial;font-size:10pt;">$25.1 million</span><span style="font-family:Arial;font-size:10pt;"> and the</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> </span><span style="font-family:Arial;font-size:10pt;">Dexsil</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></span><span style="font-family:Arial;font-size:10pt;">brand for approximately </span><span style="font-family:Arial;font-size:10pt;">$8.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">, offset by prior year acquisitions, including two ANDAs for generic products for </span><span style="font-family:Arial;font-size:10pt;">$15.7&#160;million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$49.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">, and Budesonide Nasal Spray and Triamcinolone Nasal Spray for </span><span style="font-family:Arial;font-size:10pt;">$14.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">); and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$4.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in cash due primarily to the net proceeds from the sale of our Rosemont Pharmaceuticals business, partially offset by the proceeds from the sale of our animal health business (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">); partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$250.0 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in cash due to the absence of the Royalty Pharma contingent milestone proceeds received in the prior year period</span><span style="font-family:Arial;font-size:9pt;"> </span><span style="font-family:Arial;font-size:10pt;">(refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sBFE17B0A00B45FB196C8960332ACE955"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 6</span></a><span style="font-family:Arial;font-size:10pt;">);</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$15.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in cash for the purchase of our equity method investment in Kazmira LLC (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sF4B58DD1964A5338A17E7D9B8F660A6D"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 7</span></a><span style="font-family:Arial;font-size:10pt;">); and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$14.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in cash due to the change in capital spending, primarily to increase tablet and infant formula capacity and for software and technology initiatives.</span></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s887BFD0B4D3057E1B0D5A9EC7801E714"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Cash Generated by (Used in) Financing Activities</span></div><div style="line-height:120%;text-align:center;"><img src="chart-808658f7fe4a50dc91f.jpg" alt="chart-808658f7fe4a50dc91f.jpg" style="height:244px;width:466px;"></img></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;">$13.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in financing cash flow was due primarily to:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$114.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in cash due to the increase in payments on long-term debt; </span></div></td></tr></table><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 66</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Financial Condition, Liquidity and Capital Resources</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$19.0 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in cash due to payment of premiums on the early redemption of the 2021 Notes;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$9.4&#160;million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in cash due to an increase in dividend payments; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$5.7 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">decrease</span><span style="font-family:Arial;font-size:10pt;"> in cash due to an increase in deferred financing fees related to the issuance of long-term debt; partially offset by</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">$143.8 million</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">increase</span><span style="font-family:Arial;font-size:10pt;"> in cash for the issuance of long-term debt (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 10</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Dividends</span><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The declaration and payment of dividends, if any, is subject to the discretion of our Board of Directors and will depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements, and other factors our Board of Directors may consider relevant. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Share Repurchases</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In October 2018, our Board of Directors authorized up to </span><span style="font-family:Arial;font-size:10pt;">$1.0&#160;billion</span><span style="font-family:Arial;font-size:10pt;"> of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program. We did not repurchase any shares during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a id="s5EA142B67E125C89B06FFDB10BC285AE"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Borrowings and Capital Resources</span></div><div style="line-height:120%;text-align:left;"><img src="chart-d5285169e2e55593a5f.jpg" alt="chart-d5285169e2e55593a5f.jpg" style="height:240px;width:318px;"></img></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;"><img src="chart-dbb01a79444f5cd1986.jpg" alt="chart-dbb01a79444f5cd1986.jpg" style="height:240px;width:360px;"></img></div></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Revolving Credit Agreements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 8, 2018, we entered into a </span><span style="font-family:Arial;font-size:10pt;">$1.0 billion</span><span style="font-family:Arial;font-size:10pt;"> revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were </span><span style="font-family:Arial;font-size:10pt;">no</span><span style="font-family:Arial;font-size:10pt;"> borrowings outstanding under the 2018 Revolver as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> or </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Term Loans and Notes</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">On June 19, 2020, Perrigo Finance issued $</span><span style="font-family:Arial;font-size:10pt;">750.0 million</span><span style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </span><span style="font-family:Arial;font-size:10pt;">3.150%</span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due 2030 and received net proceeds of $</span><span style="font-family:Arial;font-size:10pt;">737.1 million</span><span style="font-family:Arial;font-size:10pt;"> after fees and market discount. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2020 Notes will mature on June 15, 2030. The 2020 Notes are governed by the 2020 Indenture. The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo and, no other subsidiary of Perrigo guarantees the 2020 Notes. There are no restrictions under the 2020 Notes on Perrigo's ability to obtain funds from its subsidiaries. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. On July 6, 2020, the proceeds of the 2020 Notes were used to fund the redemption of the 2021 Notes. The balance will be used for general corporate purposes, which may include the repayment or redemption of additional indebtedness. As a result of the early redemption of the 2021 Notes, during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of $</span><span style="font-family:Arial;font-size:10pt;">20.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations, </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 67</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Financial Condition, Liquidity and Capital Resources</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">consisting of the premium on debt repayments, the write-off of deferred financing fees, and the write-off of the remaining bond discounts.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 8, 2018, we refinanced the </span><span style="font-family:Arial;font-size:10pt;">&#8364;350.0 million</span><span style="font-family:Arial;font-size:10pt;"> outstanding under the previous term loan with the proceeds of a new </span><span style="font-family:Arial;font-size:10pt;">&#8364;350.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;">$431.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">) term loan, maturing on March 8, 2020 (the "2018 Term Loan"). During the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, we made </span><span style="font-family:Arial;font-size:10pt;">$24.7 million</span><span style="font-family:Arial;font-size:10pt;"> in scheduled principal repayments on the 2018 Term Loan. On August 15, 2019, we refinanced the </span><span style="font-family:Arial;font-size:10pt;">&#8364;284.4 million</span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;">$317.1 million</span><span style="font-family:Arial;font-size:10pt;">) outstanding under the 2018 Term Loan with the proceeds of a new </span><span style="font-family:Arial;font-size:10pt;">$600.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> term loan, maturing on August 15, 2022 (the "2019 Term Loan"). As a result of the refinancing, during the three months ended </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of </span><span style="font-family:Arial;font-size:10pt;">$0.2 million</span><span style="font-family:Arial;font-size:10pt;">, consisting of the write-off of deferred financing fees in </span><span style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"></span><span style="font-family:Arial;font-size:10pt;">We had </span><span style="font-family:Arial;font-size:10pt;">$2.9 billion</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$2.8 billion</span><span style="font-family:Arial;font-size:10pt;"> outstanding under our notes and bonds as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively. We had </span><span style="font-family:Arial;font-size:10pt;">$600.0 million</span><span style="font-family:Arial;font-size:10pt;"> outstanding under our 2019 Term Loan as of both </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Other Financing</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June, 17 2020, we incurred debt of $</span><span style="font-family:Arial;font-size:10pt;">34.3 million</span><span style="font-family:Arial;font-size:10pt;"> related to our equity method investment in Kazmira pursuant to </span><span style="font-family:Arial;font-size:10pt;">two</span><span style="font-family:Arial;font-size:10pt;"> Promissory Notes, with </span><span style="font-family:Arial;font-size:10pt;">$3.7 million</span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;">$5.8 million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$24.8 million</span><span style="font-family:Arial;font-size:10pt;"> to be settled in November 2020, May 2021, and November 2021, respectively (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sF4B58DD1964A5338A17E7D9B8F660A6D"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 7</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Overdraft Facilities</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have overdraft facilities available that we use to support our cash management operations. The balance outstanding under the facilities was </span><span style="font-family:Arial;font-size:10pt;">$0.3 million</span><span style="font-family:Arial;font-size:10pt;"> as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. There were </span><span style="font-family:Arial;font-size:10pt;">no</span><span style="font-family:Arial;font-size:10pt;"> borrowings outstanding under the facilities as of </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Leases</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We had </span><span style="font-family:Arial;font-size:10pt;">$164.8 million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$158.2 million</span><span style="font-family:Arial;font-size:10pt;"> of lease liabilities and </span><span style="font-family:Arial;font-size:10pt;">$161.4 million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$157.5 million</span><span style="font-family:Arial;font-size:10pt;"> of lease assets as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Accounts Receivable Factoring</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The total amount factored on a non-recourse basis and excluded from accounts receivable was </span><span style="font-family:Arial;font-size:10pt;">$6.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$10.0 million</span><span style="font-family:Arial;font-size:10pt;"> at </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are in compliance with all covenants under our debt agreements as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#s5C415D6F8F16571ABE301BD0CB1A1A36"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 9</span></a><span style="font-family:Arial;font-size:10pt;"> and </span><a style="font-family:Arial;font-size:10pt;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"><span style="font-family:Arial;font-size:10pt;">Note 10</span></a><span style="font-family:Arial;font-size:10pt;"> for more information on all of the above lease activity and debt facilities, respectively).</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s5FA2DFF5AEA95B2D8A679E5EDE9E9E01"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Credit Ratings</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our credit ratings on </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> were Baa3 (stable) and BBB- (stable) by Moody's Investors Service and S&amp;P Global Ratings, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Credit rating agencies review their ratings periodically and, therefore, the credit rating assigned to us by each agency may be subject to revision at any time. Accordingly, we are not able to predict whether current credit ratings will remain as disclosed above. Factors that can affect our credit ratings include changes in operating performance, the economic environment, our financial position, and changes in business strategy. If changes in our credit ratings were to occur, they could impact, among other things, future borrowing costs, access to capital markets, and vendor financing terms.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s8D9E8972BB89554097722988CD1F53FA"></a></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Off-Balance Sheet Arrangements</span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have no off-balance sheet arrangements that have a material current effect or that are reasonably likely to have a material future effect on our financial condition, changes in financial condition, net sales or expenses, results of operations, liquidity, capital expenditures, or capital resources. We acquire and collaborate on potential </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 68</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Financial Condition, Liquidity and Capital Resources</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">products still in development and enter into R&amp;D arrangements with third parties that often require milestone payments to the third-party contingent upon the occurrence of certain future events linked to the success of the asset in development. Milestone payments may be required contingent upon the successful achievement of an important point in the development life cycle of the product. Because of the contingent nature of these payments, they are not included in our table of contractual obligations included in our 2019 Form 10-K and referred to below.</span></div><div><a id="sAE7D64142BCB50259B5522BEE23B6226"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Contractual Obligations and Commitments </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Other than the obligations related to the changes in our debt structure from the addition of the 2020 Notes and Promissory Notes related to our equity method investment in Kazmira and redemption of the 2021 Notes, as discussed in </span><a style="font-family:Arial;font-size:10pt;" href="#sF883DFF8F7F254E1ACF1AFCBB94077B2"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 10</span></a><span style="font-family:Arial;font-size:10pt;">, there were no material changes in contractual obligations as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> from those provided in our 2019 Form 10-K. Below is a revised schedule of our enforceable and legally binding obligations as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> related to our short and long-term debt arrangements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Payment Due</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">2020 </span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">2021-2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">2023-2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">After 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:10px;padding-top:10px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Short and long-term debt </span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">37.3</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">888.5</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">1,290.4</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2,399.4</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">4,615.6</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)    Short-term and long-term debt includes interest payments, which were calculated using the effective interest rate at </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(2)    Reflects remaining three months of 2020.</span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div><a id="sA949FD22D58E5EC9B811C2C7BC8C36AD"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Significant Accounting Policies</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Other than the adoption of ASU 2016-13 Financial Instruments - Credit Losses (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#s54388EBEFB445B11AB98129252518AD4"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 1</span></a><span style="font-family:Arial;font-size:10pt;">) and ASU 2018-13 Fair Value Measurement Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sBFE17B0A00B45FB196C8960332ACE955"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 6</span></a><span style="font-family:Arial;font-size:10pt;">), there have been no material changes to the accounting policies disclosed in our 2019 Form 10-K.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;">Critical Accounting Estimates</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The determination of certain amounts in our financial statements requires the use of estimates. These estimates are based upon our historical experiences combined with management&#8217;s understanding of current facts and circumstances. Although the estimates are considered reasonable based on the currently available information, actual results could differ from the estimates we have used. Below are the updates regarding critical accounting estimates which required judgment in the preparation of our financial statements during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. The below disclosures should be read in conjunction with our 2019 Form 10-K.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Change in Financial Assets</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We valued our contingent milestone payments from Royalty Pharma using a modified Black-Scholes Option Pricing Model ("BSOPM"). Key inputs in the BSOPM are the estimated volatility and rate of return of royalties on global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> that are received by Royalty Pharma until the contingent milestones are resolved. As of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, volatility and the estimated fair value of the milestones had a positive relationship such that higher volatility translates to a higher estimated fair value of the contingent milestone payments. Rate of return and the estimated fair value of the milestones had an inverse relationship, such that a lower rate of return correlates with a higher estimated fair value of the contingent milestone payments. We assess volatility and rate of return inputs quarterly by analyzing certain market volatility benchmarks and the risk associated with Royalty Pharma achieving the underlying projected royalties. The table below represents the volatility and rate of return:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:306px;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:113px;"></td><td style="width:82px;"></td><td style="width:10px;"></td><td style="width:5px;"></td><td style="width:82px;"></td><td style="width:10px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Volatility</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">30.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">30.0</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Rate of return</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">6.84</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">7.99</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We also consider Biogen&#8217;s quarterly Tysabri earnings along with forecasts from third party analysts in our royalty projections.&#160;In our estimation process as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we considered risks associated with </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 69</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unallocated, Interest, Other, and Taxes</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">COVID-19 on Tysabri sales in 2020, including but not limited to, the potential for disruptions and delays in dosing of Tysabri in physician office and hospital settings.&#160;We will continue monitoring Tysabri earnings and the development of COVID-19 impacts in our quarterly valuation assessment. In order for us to receive the remaining contingent milestone payment of </span><span style="font-family:Arial;font-size:10pt;">$400.0 million</span><span style="font-family:Arial;font-size:10pt;">, Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales, as defined in the agreement, in 2020 must exceed </span><span style="font-family:Arial;font-size:10pt;">$351.0&#160;million</span><span style="font-family:Arial;font-size:10pt;">. If Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales do not meet the prescribed threshold in 2020, we will write off the </span><span style="font-family:Arial;font-size:10pt;">$121.2&#160;million</span><span style="font-family:Arial;font-size:10pt;"> asset and record a loss. If the prescribed threshold is exceeded, we will increase the asset to </span><span style="font-family:Arial;font-size:10pt;">$400.0&#160;million</span><span style="font-family:Arial;font-size:10pt;"> and recognize income of </span><span style="font-family:Arial;font-size:10pt;">$278.8&#160;million</span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Change in financial assets</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sBFE17B0A00B45FB196C8960332ACE955"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 6</span></a><span style="font-family:Arial;font-size:10pt;">). </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Goodwill</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Goodwill represents amounts paid for an acquisition in excess of the fair value of net assets received. After completing the divestiture of our Rosemont Pharmaceuticals business, we have five reporting units subject to impairment testing annually, which we perform on the first day of the fourth quarter of the fiscal year. We perform impairment testing more frequently if events suggest an impairment may exist. The test for impairment requires us to make several estimates about fair value, most of which are based on projected future cash flows and market valuation multiples. The estimates associated with the goodwill impairment tests are considered critical due to the judgments required in determining fair value amounts, including projected future cash flows that include assumptions about future performance. The discount rates used in testing each of our reporting units&#8217; goodwill for impairment during our interim and annual testing are based on the weighted average cost of capital determined for each of our reporting units. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The discounted cash flow forecasts used for our reporting units include assumptions about future activity levels in the near term and longer-term. If growth in our reporting units is lower than expected, we may experience deterioration in our cash flow forecasts that may indicate goodwill in one or more reporting units is impaired in future impairment tests. An increase in the discount rate could negatively impact the estimated fair value of the reporting units and lead to a future impairment. Certain macroeconomic factors which are not controlled by the reporting units, such as rising inflation or interest rates, could cause an increase in the discount rate to occur. Deterioration in performance of our reporting units, such as lower than expected revenue or profitability that has a sustained impact on future periods, could also represent potential indicators of impairment requiring further impairment analysis.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We reviewed our reporting units for impairment indicators during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.&#160; We evaluated the weighted average cost of capital, market multiples, and forecasted cash flows of each reporting unit, among other factors.&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our RX U.S. reporting unit had an indication of potential impairment during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> driven primarily by the stoppage of production and distribution of albuterol sulfate inhalation aerosol and voluntary nationwide recall to the retail level, after we learned that some units may not dispense due to clogging, combined with a decline in market multiples. We prepared a quantitative analysis as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and determined the carrying value of the RX U.S. reporting unit exceeded its estimated fair value. We recognized a goodwill impairment of </span><span style="font-family:Arial;font-size:10pt;">$202.4&#160;million</span><span style="font-family:Arial;font-size:10pt;">, leaving </span><span style="font-family:Arial;font-size:10pt;">$811.1&#160;million</span><span style="font-family:Arial;font-size:10pt;"> of goodwill in this reporting unit after the impairment. The RX U.S. reporting unit is at risk for future impairments if it experiences further deterioration in business performance or market multiples or increases in discount rates.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our Branded Consumer Self-care ("BCS") reporting unit included in the CSCI segment had an indication of potential impairment during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;"> driven by a decrease in forecasted cash flows in the second half of </span><span style="font-family:Arial;font-size:10pt;">2020</span><span style="font-family:Arial;font-size:10pt;">&#160;related to impacts from the COVID-19 pandemic.&#160;We prepared a quantitative analysis as of </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;"> and determined that the fair value of the BCS reporting unit continued to exceed net book value by less than </span><span style="font-family:Arial;font-size:10pt;">10%</span><span style="font-family:Arial;font-size:10pt;">.&#160;As a result of the relatively narrow margin between fair value and net book value during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;">, this reporting unit is at risk for future impairments if it experiences deterioration in business performance or market multiples or increases in discount rates. We performed sensitivity analysis on the discounted cash flow valuation that was prepared to estimate the enterprise value of the BCS reporting unit. Discount rates and perpetual revenue growth rates were increased and decreased by increments of 25 or 50 basis points. A 75 basis point increase in the discount rate, or a 50 basis point increase in the discount rate combined with a 25 basis point decrease in the residual growth rate, would indicate potential impairment for this reporting unit. Our sensitivities for the BCS reporting unit assume a corresponding decrease in market valuation multiples. Based on the sensitivity of the discount rate assumption on this analysis, an increase in the discount rate over the next twelve </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 70</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> - Item 2</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unallocated, Interest, Other, and Taxes</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">months could negatively impact the estimated fair value of the reporting unit and lead to a future impairment. Certain macroeconomic factors which are not controlled by the BCS reporting unit, such as rising inflation or interest rates, could cause an increase in the discount rate to occur. Deterioration in performance of the BCS reporting unit over the next twelve months, such as lower than expected revenue or profitability that has a sustained impact on future periods, could also represent potential indicators of impairment requiring further impairment analysis. There was no indication of impairment during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. Goodwill remaining in this reporting unit was </span><span style="font-family:Arial;font-size:10pt;">$995.5 million</span><span style="font-family:Arial;font-size:10pt;"> as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We continue to monitor the progress of our reporting units and assess them for potential impairment should impairment indicators arise, as applicable, and at least annually during our fourth quarter impairment testing.&#160; </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s87EB8ED01EC950CBA8AE029B499C58F9"></a></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ITEM 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">There have been no material changes to our quantitative or qualitative disclosures found in Item 7A,&#160;"Quantitative and Qualitative Disclosures about Market Risk," of our 2019 Form 10-K. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s70C5210E4B2955B482777298109E5AC9"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ITEM 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">CONTROLS AND PROCEDURES</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act) as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in ensuring that all material information relating to us and our consolidated subsidiaries required to be included in our periodic SEC filings would be made known to them by others within those entities in a timely manner and that no changes are required at this time.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Evaluation of the Effectiveness of Internal Control over Financial Reporting</span></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our management assessed the effectiveness of our internal control over financial reporting as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. The framework used in carrying out our evaluation was the 2013 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Internal Control&#160;- Integrated Framework</span><span style="font-family:Arial;font-size:10pt;"> published by the Committee of Sponsoring Organizations ("COSO") of the Treadway Commission. In evaluating our information technology controls, we also used components of the framework contained in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Control Objectives for Information and related Technology</span><span style="font-family:Arial;font-size:10pt;">, which was developed by the Information Systems Audit and Control Association&#8217;s IT Governance Institute, as a complement to the COSO internal control framework. Management has concluded that our internal control over financial reporting was effective as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. The results of management&#8217;s assessment have been reviewed with our Audit Committee.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Changes in Internal Control over Financial Reporting</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We acquired Ranir during the third quarter of 2019 and the oral care assets of High Ridge Brands during the second quarter of 2020 (refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sA0BB308013C05849BCFF1B0C8BBA3C08"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 3</span></a><span style="font-family:Arial;font-size:10pt;">). As permitted by Securities and Exchange Commission Staff interpretive guidance for newly acquired businesses, management excluded Ranir and the oral care asset of High Ridge Brands from its evaluation of internal control over financial reporting as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. We are in the process of documenting and testing both Companies' internal controls over financial reporting. We will incorporate Ranir and the oral care assets of High Ridge Brands into our annual reports on internal control over financial reporting for our years ending December 31, 2020 and December 31, 2021, respectively. As of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, assets excluded from management&#8217;s assessment totaled </span><span style="font-family:Arial;font-size:10pt;">$1.0 billion</span><span style="font-family:Arial;font-size:10pt;"> and contributed </span><span style="font-family:Arial;font-size:10pt;">$261.9 million</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;">Net sales</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">$16.5 million</span><span style="font-family:Arial;font-size:10pt;"> of Operating income</span><span style="font-family:Arial;font-size:9pt;"> </span><span style="font-family:Arial;font-size:10pt;">in our Condensed Consolidated Statements of Operations for the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s9AA38238299D5B3CBC027E88B1AF4014"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">PART II. &#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">OTHER INFORMATION</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 71</span></div></div><hr style="page-break-after:always"></hr><div><a id="s455A8BFA4D2B5F6EB3B61AA2D02EC9E8"></a></div><div><div style="line-height:120%;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ITEM 1.&#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">LEGAL PROCEEDINGS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Refer to </span><a style="font-family:Arial;font-size:10pt;" href="#sAF954DA7DF52564E89822E8DA956F14A"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 13</span></a><span style="font-family:Arial;font-size:10pt;"> and </span><a style="font-family:Arial;font-size:10pt;" href="#s5958A14DA1AE536285E42C2A91B4FD9C"><span style="font-family:Arial;font-size:10pt;">Item 1. Note 14</span></a><span style="font-family:Arial;font-size:10pt;"> of the Notes to the Condensed Consolidated Financial Statements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><a id="s57F4E14597D15F9B98722F296A7178DD"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ITEM 1A.&#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">RISK FACTORS</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our Annual Report on Form 10-K for the year ended December 31, 2019 includes a detailed discussion of our risk factors. At the time of this filing, there have been no material changes to the risk factors that were included in the Form 10-K, other than as described below.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Adverse Economic Impacts of Coronavirus Pandemic</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic, as the new coronavirus, unknown to health officials just three months earlier, spread rapidly from Asia to the Middle East, Europe, and the United States.&#160;As the pandemic continues, many actions taken to reduce the spread of the coronavirus remain in effect, including quarantines, government restrictions on movement, business closures and suspensions, canceled events and activities, self-isolation, and other voluntary and/or mandated changes in behavior. Both the outbreak of the disease and the actions to slow its spread have had an adverse impact on our operations by, among other things, increasing absenteeism, affecting the supply of raw materials and third party supplied finished goods, and preventing many of our employees from coming to work.&#160;The Company has responded to such impacts by, among other things, implementing protocols to protect the health of factory workers, adjusting production schedules, and seeking alternate suppliers where available, and so far, most of our facilities have continued to produce at high levels despite these challenges. However, a number of jurisdictions that relaxed such restrictions, or have experienced limited public adherence with suggested safety measures, have experienced new surges in COVID-19 cases. Many of these jurisdictions are now contemplating or implementing new or renewed restrictions. Going forward, the continued spread of the disease and the actions to slow it could have an adverse impact on our financial condition, our supply chains and other operations, our results of our operations, consumer demand for our products and our ability to access capital. The magnitude of any such adverse impacts cannot currently be determined, but such adverse impacts could be material, depending on: the duration, intensity, and continued spread of the disease; the duration of business closure and similar government orders; the process by which government authorities permit businesses to reopen and employees to return to work and the publics willingness to adhere to suggested safety measures; the scale and timing of any additional waves of the outbreak as restrictions on community movement are relaxed; the severity of any economic downturn resulting from the pandemic; the effectiveness of the Company's efforts at mitigation; and other factors, both known and unknown, many of which are likely to be outside our control. In addition, to the extent that any increased sales of our products during the initial stages of the outbreak may reflect "pantry stocking", consumer demand for such products in future periods may be correspondingly reduced. Further, lower consumer demand for certain other self-care products in our CSCI segment may continue and volume of U.S. prescriptions could decrease in our RX segment in future periods depending on the course of the pandemic and related responses to combat the virus. It is also possible that a change in the course of the pandemic may affect consumer demand for products in future periods in ways we do not currently anticipate.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">In connection with delays in the implementation of the EU's Medical Device Regulation due to the COVID-19 pandemic, the designation of a Notified Body certifying certain of our products expired, which could adversely affect our sales of these products in the EU.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We market certain products that are subject to the EU&#8217;s Medical Device Directive (&#8220;MDD&#8221;) and will be subject to the EU&#8217;s Medical Device Regulation (&#8220;MDR&#8221;), both of which require that products be certified by designated assessment entities (&#8220;Notified Bodies&#8221;) prior to sale. The date of application of the MDR, and as a result the date of repeal of the MDD, has been deferred by 12 months to May 26, 2021 due to the pandemic. In connection with this extension, Notified Bodies designated under the prior MDD regime were allowed to continue their related governance of medical devices for one additional year, until May 25, 2021, subject to them having a designation under MDD in place throughout this time. During this time, the MDD designation of a Notified Body that certifies certain products in our portfolio has expired. The current regulations are not clear on the treatment of the existing certificates granted by such a Notified Body during this period, and we have engaged in detailed discussions with the relevant authorities to enable continuity of supply. While we do not expect a material impact on our business, there can be no assurances that our ability to sell these products in the EU will not be interrupted, slowed or otherwise adversely affected.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 72</span></div></div><hr style="page-break-after:always"></hr><div><a id="sAA3A9D93003A53E680166666816EF3A4"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;color:#006ebf;font-weight:bold;">Perrigo Company plc</span><span style="font-family:Arial;font-size:10pt;"> -  Item 6</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Exhibits</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">ITEM 6.&#160;&#160;&#160;&#160;</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">EXHIBITS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:89%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Exhibit</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513478578/d642570dex41.htm"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Certificate of Incorporation of Perrigo Company plc (formerly known as Perrigo Company Limited) (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 filed on December 19, 2013).</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3.2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536417000136/cy17q210qex32memo.htm"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Memorandum and Articles of Association of Perrigo Company plc, as amended and restated (incorporated by reference from Exhibit 3.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2017).</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">31.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="cy20q310qex311.htm"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Rule 13a-14(a) Certification by Murray S. Kessler, Chief Executive Officer (filed herewith).</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">31.2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="cy20q310qex312.htm"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Rule 13a-14(a) Certification by Raymond P. Silcock, Chief Financial Officer (filed herewith).</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">32</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:none;color:#0000FF;-sec-extract:exhibit;" href="cy20q310qex32.htm"><span style="font-family:Arial;font-size:10pt;text-decoration:none;">Certification Pursuant to 18 United States Code 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934 (furnished herewith).</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">101. INS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">101.SCH</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">XBRL Taxonomy Extension Schema Document.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">101.CAL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">101.DEF</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">101.LAB</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">XBRL Taxonomy Extension Label Linkbase Document.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">101.PRE</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Cover Page Interactive Date File, formatted in Inline XBRL (contained in Exhibit 101).</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 73</span></div></div><hr style="page-break-after:always"></hr><div><a id="s14ADC13C18425A0AB0E7AACFA15229F0"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">SIGNATURES</span><span style="font-family:Arial;font-size:12pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:6%;"></td><td style="width:25%;"></td><td style="width:4%;"></td><td style="width:65%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">PERRIGO COMPANY PLC</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(Registrant)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Date:</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">November&#160;5, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">/s/ Murray S. Kessler</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Murray S. Kessler</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Chief Executive Officer and President</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(Principal Executive Officer)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Date:</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">November&#160;5, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">/s/ Raymond P. Silcock</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Raymond P. Silcock</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Chief Financial Officer</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">(Principal Accounting and Financial Officer)</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"> 74</span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>cy20q310qex311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sD0C5C6C8B66D5A239C8B2890E3BE5FCE"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CERTIFICATION </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">I, </font><font style="font-family:Arial;font-size:10pt;">Murray S. Kessler</font><font style="font-family:Arial;font-size:10pt;">, certify that: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">I have reviewed this report on Form 10-Q of Perrigo Company plc;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Date: </font><font style="font-family:Arial;font-size:10pt;">November&#160;5, 2020</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:49.21875%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">/s/ Murray S. Kessler</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Murray S. Kessler</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>cy20q310qex312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s27AB24901DDF58DC97743A8A2C5D524D"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Exhibit 31.2 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CERTIFICATION </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">I, Raymond P. Silcock, certify that: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">I have reviewed this report on Form 10-Q of Perrigo Company plc;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Date: </font><font style="font-family:Arial;font-size:10pt;">November&#160;5, 2020</font><font style="font-family:Arial;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:63.4765625%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">/s/ Raymond P. Silcock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Raymond P. Silcock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>cy20q310qex32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sE74371B3AB8A50D9A2E101020D280FD8"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Exhibit 32 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">The following statement is being made to the Securities and Exchange Commission solely for the purposes of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), which carries with it certain criminal penalties in the event of a knowing or willful misrepresentation. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Securities and Exchange Commission </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">450 Fifth Street NW </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Washington, D.C. 20549 </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:5%;"></td><td style="width:91%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Re:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Perrigo Company plc</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Ladies and Gentlemen: </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In accordance with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), each of the undersigned hereby certifies that: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:90px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">this Quarterly Report on Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:90px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Perrigo Company plc.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;padding-left:90px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:6%;"></td><td style="width:30%;"></td><td style="width:4%;"></td><td style="width:60%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">November&#160;5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">/s/ Murray S. Kessler</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Murray S. Kessler</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Chief Executive Officer and President</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">November&#160;5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">/s/ Raymond P. Silcock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Raymond P. Silcock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>prgo-20200926.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.perrigo.com/20200926" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:prgo="http://www.perrigo.com/20200926" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20200926_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20200926_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20200926_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20200926_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>2115100 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2415402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>2315301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAndDivestitures" roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestitures">
        <link:definition>2103100 - Disclosure - Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAndDivestituresDetails" roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails">
        <link:definition>2403403 - Disclosure - Acquisitions and Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAndDivestituresDivestitureDetails" roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails">
        <link:definition>2403405 - Disclosure - Acquisitions and Divestitures - Divestiture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails">
        <link:definition>2403402 - Disclosure - Acquisitions and Divestitures - Oral Care Assets of High Ridge Brands and Ranir Global Holdings,LLC Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetailsCalc2" roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetailsCalc2">
        <link:definition>2403402 - Disclosure - Acquisitions and Divestitures - Oral Care Assets of High Ridge Brands and Ranir Global Holdings,LLC Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAndDivestituresProFormaInformationDetails" roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails">
        <link:definition>2403404 - Disclosure - Acquisitions and Divestitures - Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.perrigo.com/role/AcquisitionsTables">
        <link:definition>2303301 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1004000 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1004501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>1006000 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfOperations" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations">
        <link:definition>1001000 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfOperationsParenthetical" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical">
        <link:definition>1001001 - Statement - Condensed Consolidated Statements of Operations (parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical">
        <link:definition>1005001 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfShareholdersEquityStatement" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement">
        <link:definition>1005000 - Statement - Condensed Consolidated Statements of Shareholders' Equity Statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.perrigo.com/role/Contingencies">
        <link:definition>2118100 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesDetails" roleURI="http://www.perrigo.com/role/ContingenciesDetails">
        <link:definition>2418401 - Disclosure - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CoverPage" roleURI="http://www.perrigo.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivities" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities">
        <link:definition>2111100 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails">
        <link:definition>2411403 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails">
        <link:definition>2411406 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails">
        <link:definition>2411404 - Disclosure - Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails">
        <link:definition>2411402 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails">
        <link:definition>2411405 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesTables" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables">
        <link:definition>2311301 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquity" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity">
        <link:definition>2114100 - Disclosure - Earnings Per Share and Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquityDetails" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails">
        <link:definition>2414402 - Disclosure - Earnings Per Share and Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAndShareholdersEquityTables" roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables">
        <link:definition>2314301 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.perrigo.com/role/FairValueMeasurements">
        <link:definition>2108100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails">
        <link:definition>2408404 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueOfContingentConsiderationDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails">
        <link:definition>2408405 - Disclosure - Fair Value Measurements - Fair Value of Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails">
        <link:definition>2408402 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails">
        <link:definition>2408403 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails">
        <link:definition>2408406 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables">
        <link:definition>2308301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssets" roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssets">
        <link:definition>2105100 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails">
        <link:definition>2405403 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsGoodwillDetails" roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails">
        <link:definition>2405402 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails">
        <link:definition>2405404 - Disclosure - Goodwill and Intangible Assets - Intangible categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsTables" roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables">
        <link:definition>2305301 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.perrigo.com/role/IncomeTaxes">
        <link:definition>2117100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesDetails">
        <link:definition>2417402 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.perrigo.com/role/IncomeTaxesTables">
        <link:definition>2317301 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Indebtedness" roleURI="http://www.perrigo.com/role/Indebtedness">
        <link:definition>2113100 - Disclosure - Indebtedness</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails">
        <link:definition>2413403 - Disclosure - Indebtedness - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleOfBorrowingsOutstandingDetails" roleURI="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails">
        <link:definition>2413402 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2" roleURI="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2">
        <link:definition>2413402 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessTables" roleURI="http://www.perrigo.com/role/IndebtednessTables">
        <link:definition>2313301 - Disclosure - Indebtedness (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.perrigo.com/role/Inventories">
        <link:definition>2107100 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.perrigo.com/role/InventoriesDetails">
        <link:definition>2407402 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.perrigo.com/role/InventoriesTables">
        <link:definition>2307301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.perrigo.com/role/Investments">
        <link:definition>2109100 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDetails" roleURI="http://www.perrigo.com/role/InvestmentsDetails">
        <link:definition>2409402 - Disclosure - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.perrigo.com/role/InvestmentsTables">
        <link:definition>2309301 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.perrigo.com/role/Leases">
        <link:definition>2112100 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesOfLeasesDetails" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails">
        <link:definition>2412404 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2">
        <link:definition>2412404 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3">
        <link:definition>2412404 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails">
        <link:definition>2412402 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCashFlowClassificationsDetails" roleURI="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails">
        <link:definition>2412406 - Disclosure - Leases - Lease Cash Flow Classifications (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseExpenseDetails" roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails">
        <link:definition>2412403 - Disclosure - Leases - Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.perrigo.com/role/LeasesTables">
        <link:definition>2312301 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" roleURI="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails">
        <link:definition>2412405 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.perrigo.com/role/RestructuringCharges">
        <link:definition>2119100 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesDetails" roleURI="http://www.perrigo.com/role/RestructuringChargesDetails">
        <link:definition>2419402 - Disclosure - Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesTables" roleURI="http://www.perrigo.com/role/RestructuringChargesTables">
        <link:definition>2319301 - Disclosure - Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.perrigo.com/role/RevenueRecognition">
        <link:definition>2102100 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails">
        <link:definition>2402404 - Disclosure - Revenue Recognition - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleOfContractBalancesDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails">
        <link:definition>2402405 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails">
        <link:definition>2402402 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleOfRevenueByProductDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails">
        <link:definition>2402403 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.perrigo.com/role/RevenueRecognitionTables">
        <link:definition>2302301 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.perrigo.com/role/SegmentInformation">
        <link:definition>2120100 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.perrigo.com/role/SegmentInformationDetails">
        <link:definition>2420402 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.perrigo.com/role/SegmentInformationTables">
        <link:definition>2320301 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPolicies" roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails">
        <link:definition>2401403 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>2301302 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="prgo_A2014EuroDenominatedTermLoandueDecember52019Member" name="A2014EuroDenominatedTermLoandueDecember52019Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A2018EuroDenominatedTermLoandueMarch82020Member" name="A2018EuroDenominatedTermLoandueMarch82020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A2018RevolverMember" name="A2018RevolverMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A2019EuroDenominatedTermLoandueAugust152022Member" name="A2019EuroDenominatedTermLoandueAugust152022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A3.150SeniorNotesdueJune152030Member" name="A3.150SeniorNotesdueJune152030Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" name="A3.500UnsecuredSeniornotesdueMarch152021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A3.5SeniornotedueDecember152021Member" name="A3.5SeniornotedueDecember152021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A3.9seniornotedue2024Member" name="A3.9seniornotedue2024Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" name="A4.00UnsecuredSeniorNotesdueNovember152023Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A4.375seniornotedueMarch152026Member" name="A4.375seniornotedueMarch152026Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A4.9SeniorLoandue2044Member" name="A4.9SeniorLoandue2044Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A5.105SeniornotedueJuly282023Member" name="A5.105SeniornotedueJuly282023Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" name="A5.30UnsecuredSeniorNotesdueNovember152043Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" name="AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="prgo_AccruedCustomerPrograms" name="AccruedCustomerPrograms" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_AccumulatedOtherComprehensiveIncomeRollForward" name="AccumulatedOtherComprehensiveIncomeRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_AcetaminophenLitigationMember" name="AcetaminophenLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_AnimalHealthMember" name="AnimalHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_AssetAdjustedFairValueifSalesThresholdMet" name="AssetAdjustedFairValueifSalesThresholdMet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="prgo_AssetsandLiabilitiesLesseeTableTextBlock" name="AssetsandLiabilitiesLesseeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_BCSMember" name="BCSMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member" name="BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_BlendedJurisdictionalTaxRatesPercent" name="BlendedJurisdictionalTaxRatesPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_BrandMember" name="BrandMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember" name="BudesonideNasalSprayandTriamcinoloneNasalSprayMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_BusinessCombinationBaseConsiderationTransferred" name="BusinessCombinationBaseConsiderationTransferred" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_CSCIMember" name="CSCIMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_CanadianClassActionComplaintMember" name="CanadianClassActionComplaintMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_CarmignacFirstManhattanandSimilarCasesMember" name="CarmignacFirstManhattanandSimilarCasesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_CasesFiledinIsraelMember" name="CasesFiledinIsraelMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" name="CashFlowHedgeGainLossReclassifiedtoEarningsNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" name="ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_ConsumerSelfCareAmericasMember" name="ConsumerSelfCareAmericasMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_ConsumerSelfCareInternationalMember" name="ConsumerSelfCareInternationalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_ContingentConsiderationMember" name="ContingentConsiderationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_ContingentConsiderationPaymentsSalesbasedMilestones" name="ContingentConsiderationPaymentsSalesbasedMilestones" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent" name="ContingentConsiderationPaymentsSalesbasedMilestonesPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_ContractManufacturingMember" name="ContractManufacturingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_ControllingInterestAbstract" name="ControllingInterestAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_CumulativeDeferredChargeTaxLitigation" name="CumulativeDeferredChargeTaxLitigation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_DenominatorAbstract" name="DenominatorAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_DexsilMember" name="DexsilMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_DigestiveHealthMember" name="DigestiveHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember" name="DistributionandLicenseAgreementsandSupplyAgreementsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_EquityMethodInvestmentPeriodforPayment" name="EquityMethodInvestmentPeriodforPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_EvamistBrandedProductMember" name="EvamistBrandedProductMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_FairValueAssetsLevel1Level2Level3TransfersAmount" name="FairValueAssetsLevel1Level2Level3TransfersAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract" name="FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_FairValueAssumptionVolatility" name="FairValueAssumptionVolatility" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_FairValueAssumptionsRateofReturn" name="FairValueAssumptionsRateofReturn" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_FinanceLeaseCost" name="FinanceLeaseCost" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="prgo_FinanceLeaseLiabilitytobePaidafterYearFour" name="FinanceLeaseLiabilitytobePaidafterYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" name="FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_FirstManhattanandSimilarCasesMember" name="FirstManhattanandSimilarCasesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" name="FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" name="GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_GenericProductAcquisitionMember" name="GenericProductAcquisitionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_GoodwillAndIndefiniteLivedIntangibles" name="GoodwillAndIndefiniteLivedIntangibles" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_HarelInsuranceandTIAACREFFCasesMember" name="HarelInsuranceandTIAACREFFCasesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_HealthyLifestyleMember" name="HealthyLifestyleMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member" name="HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" name="IRSNoticeofProposedAdjustmentPenaltyPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" name="IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" name="IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_InIsraelCasesRelatedtoIrishTaxEventsMember" name="InIsraelCasesRelatedtoIrishTaxEventsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" name="IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" name="IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" name="IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability" name="IncomeTaxExaminationUnsettledAssessedAuditLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears" name="IncomeTaxOverpaymentsAppliedtoSucceedingYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="prgo_IncomefromSalesOwnedbytheCompanyPercent" name="IncomefromSalesOwnedbytheCompanyPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_IncreaseDecreaseInAccruedCustomerPrograms" name="IncreaseDecreaseInAccruedCustomerPrograms" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_InrePerrigoCompanyplcSec.Litig.Member" name="InrePerrigoCompanyplcSec.Litig.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" name="InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" name="IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_KazmiraLLCMember" name="KazmiraLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LeaseLiabilities" name="LeaseLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_LeaseLiabilitiesPaymentsDueAbstract" name="LeaseLiabilitiesPaymentsDueAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LeaseLiabilityPaymentsDue" name="LeaseLiabilityPaymentsDue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LeaseLiabilityPaymentsDueYearFour" name="LeaseLiabilityPaymentsDueYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LeaseLiabilityPaymentsDueYearOne" name="LeaseLiabilityPaymentsDueYearOne" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LeaseLiabilityPaymentsDueYearThree" name="LeaseLiabilityPaymentsDueYearThree" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LeaseLiabilityPaymentsDueYearTwo" name="LeaseLiabilityPaymentsDueYearTwo" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LeaseLiabilityPaymentsDueafterYearFour" name="LeaseLiabilityPaymentsDueafterYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" name="LeaseLiabilityPaymentsRemainderofFiscalYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LeaseLiabilityUndiscountedExcessAmount" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LesseeCashFlowClassificationsTableTextBlock" name="LesseeCashFlowClassificationsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" name="LesseeOperatingLeaseLiabilitytobePaidafterYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" name="LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LossContingenciesNumberofHealthPlans" name="LossContingenciesNumberofHealthPlans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberOfCases" name="LossContingencyNumberOfCases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberOfCasesStayed" name="LossContingencyNumberOfCasesStayed" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" name="LossContingencyNumberOfGenericPrescriptionPharmaceuticals" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberOfIndividuals" name="LossContingencyNumberOfIndividuals" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberOfManufacturers" name="LossContingencyNumberOfManufacturers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberOfPrescriptionPharmaceuticals" name="LossContingencyNumberOfPrescriptionPharmaceuticals" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberOfSupermarketChains" name="LossContingencyNumberOfSupermarketChains" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberofAdditionalStatesandTerritories" name="LossContingencyNumberofAdditionalStatesandTerritories" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberofClaimsforIndemnificationorDefense" name="LossContingencyNumberofClaimsforIndemnificationorDefense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LossContingencyNumberofCodefendants" name="LossContingencyNumberofCodefendants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" name="LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberofDefendantsAdded" name="LossContingencyNumberofDefendantsAdded" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice" name="LossContingencyNumberofDefendantsDismissedwithoutPrejudice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberofFormerEmployees" name="LossContingencyNumberofFormerEmployees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany" name="LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_LossContingencyNumberofLawsuits" name="LossContingencyNumberofLawsuits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LossContingencyNumberofMasterComplaints" name="LossContingencyNumberofMasterComplaints" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LossContingencyNumberofMasterComplaintsNamingCompany" name="LossContingencyNumberofMasterComplaintsNamingCompany" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_LossContingencyNumberofRetailers" name="LossContingencyNumberofRetailers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_MasonCapitalPentwaterandSimilarCasesMember" name="MasonCapitalPentwaterandSimilarCasesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_MeasurementInputProjectedRoyaltiesMember" name="MeasurementInputProjectedRoyaltiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_NetSalesIncludedinCalculationForMilestonePayment" name="NetSalesIncludedinCalculationForMilestonePayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="prgo_NetSalesThresholdForMilestonePayment" name="NetSalesThresholdForMilestonePayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_NotedueMay2021Member" name="NotedueMay2021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_NotedueNovember2020Member" name="NotedueNovember2020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_NotedueNovember2021Member" name="NotedueNovember2021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_NumberofBrandsAcquired" name="NumberofBrandsAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_NumberofCasesAllegingOnlyStateLawClaims" name="NumberofCasesAllegingOnlyStateLawClaims" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofCasesIncludedinExpeditedSchedule" name="NumberofCasesIncludedinExpeditedSchedule" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofCaseswithSimilarFactualAllegations" name="NumberofCaseswithSimilarFactualAllegations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofDozensofManufacturers" name="NumberofDozensofManufacturers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofOtherPharmaceuticalCompanies" name="NumberofOtherPharmaceuticalCompanies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofProductsincludedinExpeditedCases" name="NumberofProductsincludedinExpeditedCases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofPromissoryNotes" name="NumberofPromissoryNotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofPutativeClasses" name="NumberofPutativeClasses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofSetsofClassActionComplaints" name="NumberofSetsofClassActionComplaints" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="prgo_NumberofTendersAccepted" name="NumberofTendersAccepted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_NumeratorAbstract" name="NumeratorAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_NutritionMember" name="NutritionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OralCareAssetsofHighRidgeBrandsMember" name="OralCareAssetsofHighRidgeBrandsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OralSelfcareMember" name="OralSelfcareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OtherCSCAMember" name="OtherCSCAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OtherCSCIMember" name="OtherCSCIMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OtherCasesRelatedtoEventsin20152017Member" name="OtherCasesRelatedtoEventsin20152017Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OtherExpenseIncomeNetMember" name="OtherExpenseIncomeNetMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OtherGeographicalAreasMember" name="OtherGeographicalAreasMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_OtherOperatingIncomeLoss" name="OtherOperatingIncomeLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_OverarchingConspiracyClassActionsMember" name="OverarchingConspiracyClassActionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PainandSleepaidsMember" name="PainandSleepaidsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal" name="PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="prgo_PeriodAvailabletoFileAppeal" name="PeriodAvailabletoFileAppeal" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_PotentialContingentMilestonePayments" name="PotentialContingentMilestonePayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember" name="PriceFixingLawsuitDrugWholesalerandDistributorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PriceFixingLawsuitDrugstoreChainMember" name="PriceFixingLawsuitDrugstoreChainMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember" name="PriceFixingLawsuitSuffolkCountyofNewYorkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember" name="PriceFixingLawsuitSupermarketChainsAmendedComplaintMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PriceFixingLawsuitSupermarketChainsMember" name="PriceFixingLawsuitSupermarketChainsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitHarrisCountyofTexasMember" name="PricefixingLawsuitHarrisCountyofTexasMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitHealthInsuranceCarrierMember" name="PricefixingLawsuitHealthInsuranceCarrierMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitHealthPlansMember" name="PricefixingLawsuitHealthPlansMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitHealthcareManagementOrganizationMember" name="PricefixingLawsuitHealthcareManagementOrganizationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitHealthcareServiceCompanyMember" name="PricefixingLawsuitHealthcareServiceCompanyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitManagedCareOrganizationMember" name="PricefixingLawsuitManagedCareOrganizationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember" name="PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember" name="PricefixingLawsuitSeveralCountiesinNewYorkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PrivatePlacementNoteMember" name="PrivatePlacementNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_ProceedsfromContingentMilestonePayment" name="ProceedsfromContingentMilestonePayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" name="ProceedsfromRoyaltiesReceivedInvestingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_PublicBondsandPrivatePlacementMember" name="PublicBondsandPrivatePlacementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_RXPharmaceuticalsMember" name="RXPharmaceuticalsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_RanirGlobalHoldingsLLCMember" name="RanirGlobalHoldingsLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_RanitidineLitigationMember" name="RanitidineLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_ReportingUnitFairValuePercent" name="ReportingUnitFairValuePercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_RestructuringAdditionalCharges" name="RestructuringAdditionalCharges" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="prgo_RightofUseAsset" name="RightofUseAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="prgo_RoofersPensionFundMember" name="RoofersPensionFundMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_RosemontPharmaceuticalsMember" name="RosemontPharmaceuticalsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember" name="RoyaltyPharma2020ContingentMilestonePaymentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_RoyaltyPharmaContingentMilestonePaymentsMember" name="RoyaltyPharmaContingentMilestonePaymentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_RoyaltyPharmaMember" name="RoyaltyPharmaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_SanofiBrandsMember" name="SanofiBrandsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_ScheduleOfDebtInstrumentsTable" name="ScheduleOfDebtInstrumentsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" name="ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_ScheduleofFairValueAssumptionsTableTextBlock" name="ScheduleofFairValueAssumptionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" name="ScheduleofForeignCurrencyForwardContractsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_SeniorNotesdue2021Member" name="SeniorNotesdue2021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_SkincareandPersonalHygieneMember" name="SkincareandPersonalHygieneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_StateAttorneyGeneralComplaintMember" name="StateAttorneyGeneralComplaintMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember" name="StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_SteripodMember" name="SteripodMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_TalcumPowderLitigationMember" name="TalcumPowderLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_TrademarksTradeNamesandBrandsMember" name="TrademarksTradeNamesandBrandsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_UpperRespiratoryMember" name="UpperRespiratoryMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="prgo_VitaminsMineralsandSupplementsMember" name="VitaminsMineralsandSupplementsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>prgo-20200926_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestitures" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestitures" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresDivestitureDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetailsCalc2" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsTables" xlink:href="prgo-20200926.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:href="prgo-20200926.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Contingencies" xlink:href="prgo-20200926.xsd#Contingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesDetails" xlink:href="prgo-20200926.xsd#ContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CoverPage" xlink:href="prgo-20200926.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurements" xlink:href="prgo-20200926.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:href="prgo-20200926.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssets" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsGoodwillDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxes" xlink:href="prgo-20200926.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:href="prgo-20200926.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesTables" xlink:href="prgo-20200926.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Indebtedness" xlink:href="prgo-20200926.xsd#Indebtedness" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#IndebtednessAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:href="prgo-20200926.xsd#IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2" xlink:href="prgo-20200926.xsd#IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessTables" xlink:href="prgo-20200926.xsd#IndebtednessTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Inventories" xlink:href="prgo-20200926.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesDetails" xlink:href="prgo-20200926.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesTables" xlink:href="prgo-20200926.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Investments" xlink:href="prgo-20200926.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsDetails" xlink:href="prgo-20200926.xsd#InvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsTables" xlink:href="prgo-20200926.xsd#InvestmentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Leases" xlink:href="prgo-20200926.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:href="prgo-20200926.xsd#LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2" xlink:href="prgo-20200926.xsd#LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3" xlink:href="prgo-20200926.xsd#LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:href="prgo-20200926.xsd#LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:href="prgo-20200926.xsd#LeasesLeaseCashFlowClassificationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:href="prgo-20200926.xsd#LeasesLeaseExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesTables" xlink:href="prgo-20200926.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:href="prgo-20200926.xsd#LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringCharges" xlink:href="prgo-20200926.xsd#RestructuringCharges" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:href="prgo-20200926.xsd#RestructuringChargesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesTables" xlink:href="prgo-20200926.xsd#RestructuringChargesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognition" xlink:href="prgo-20200926.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfContractBalancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:href="prgo-20200926.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformation" xlink:href="prgo-20200926.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationDetails" xlink:href="prgo-20200926.xsd#SegmentInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationTables" xlink:href="prgo-20200926.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_13cb0a1c-3aa6-b33f-7de7-50a371870e4f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_13cb0a1c-3aa6-b33f-7de7-50a371870e4f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_bc48fdc5-5f6e-a6eb-f9ed-071a5504d94b" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_bc48fdc5-5f6e-a6eb-f9ed-071a5504d94b" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestitures" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_da4cf1b0-0536-62c5-a2f7-39ebee30c7c7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_da4cf1b0-0536-62c5-a2f7-39ebee30c7c7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_82f7a9c8-5cab-422f-5799-58d2c9d0eeba" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_82f7a9c8-5cab-422f-5799-58d2c9d0eeba" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a18efcf9-a8a4-d83a-d9b9-4d3e8d0824b4" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a18efcf9-a8a4-d83a-d9b9-4d3e8d0824b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_23342d82-307c-3217-191a-2bb829b5f56d" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_23342d82-307c-3217-191a-2bb829b5f56d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_64b0fcb2-d878-b7d3-3797-cd47da5ce396" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_64b0fcb2-d878-b7d3-3797-cd47da5ce396" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_3539d818-ee9d-ff95-0499-85ecc253cb57" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_3539d818-ee9d-ff95-0499-85ecc253cb57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_57088d99-3f43-6bbf-c330-0bf0e1b35b0b" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_Goodwill_57088d99-3f43-6bbf-c330-0bf0e1b35b0b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76f234a9-ce64-3a56-e04a-a2fe0dc0fc0f" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76f234a9-ce64-3a56-e04a-a2fe0dc0fc0f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_04760c71-663a-7924-77bc-f3981d83c705" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_04760c71-663a-7924-77bc-f3981d83c705" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_bbbc7f17-85c5-0186-f230-9e6b74ebcfe8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_bbbc7f17-85c5-0186-f230-9e6b74ebcfe8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_19cc30d3-10ab-48ba-1cb4-85ecc6e1e97e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_19cc30d3-10ab-48ba-1cb4-85ecc6e1e97e" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_e189c01b-ede7-f245-1506-85ecc6d5a304" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_e189c01b-ede7-f245-1506-85ecc6d5a304" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_cb50642b-319b-21c1-e013-85ecc56ef1c5" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_cb50642b-319b-21c1-e013-85ecc56ef1c5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0405878e-4386-6b05-373c-4d94ee5cff7c" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0405878e-4386-6b05-373c-4d94ee5cff7c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_760096d2-421c-8d66-252b-991238994949" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e3739ba9-6cc1-cb02-d398-684e2d8499e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_760096d2-421c-8d66-252b-991238994949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eb364910-d8a1-9e85-be8b-e974730e90fe" xlink:type="locator" />
    <link:calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c5f90ce9-465b-7893-c5ee-ccfc9cffcdd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eb364910-d8a1-9e85-be8b-e974730e90fe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_64b0fcb2-d878-b7d3-3797-cd47da5ce396" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_eb364910-d8a1-9e85-be8b-e974730e90fe" xlink:type="arc" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_Goodwill_57088d99-3f43-6bbf-c330-0bf0e1b35b0b" xlink:type="arc" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_82f7a9c8-5cab-422f-5799-58d2c9d0eeba" xlink:type="arc" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a18efcf9-a8a4-d83a-d9b9-4d3e8d0824b4" xlink:type="arc" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_23342d82-307c-3217-191a-2bb829b5f56d" xlink:type="arc" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_3539d818-ee9d-ff95-0499-85ecc253cb57" xlink:type="arc" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_da4cf1b0-0536-62c5-a2f7-39ebee30c7c7" xlink:type="arc" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76f234a9-ce64-3a56-e04a-a2fe0dc0fc0f" xlink:type="arc" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_890c1838-8769-5d6a-a8ac-69ac5a4e6125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_04760c71-663a-7924-77bc-f3981d83c705" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetailsCalc2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AcquisitionsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_747c610f-77b4-c7d9-7726-85ecc5eb2e06" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:to="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_747c610f-77b4-c7d9-7726-85ecc5eb2e06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c124af4a-c1a7-5bd7-f6b9-0a8199d145c1" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c124af4a-c1a7-5bd7-f6b9-0a8199d145c1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_657ba5b9-6efd-7796-881d-42495ee333b2" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_657ba5b9-6efd-7796-881d-42495ee333b2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_17a41c51-6fe7-c037-64c3-3ef6c9692a94" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_17a41c51-6fe7-c037-64c3-3ef6c9692a94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe7a6688-63e6-c3a8-34a9-6a59f12ca16e" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_ab484ca2-f1cb-0039-314b-234414f208fb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe7a6688-63e6-c3a8-34a9-6a59f12ca16e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26247a2d-7bac-8834-3dc5-06c993b10b2c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26247a2d-7bac-8834-3dc5-06c993b10b2c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2107189c-f25f-5667-a3b4-dbf4394a5e32" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2107189c-f25f-5667-a3b4-dbf4394a5e32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_aa7cc103-d668-cf3b-6875-81c99ffeac19" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_InventoryNet_aa7cc103-d668-cf3b-6875-81c99ffeac19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_33b4d214-779b-2177-f7ba-19f0abb03b76" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_33b4d214-779b-2177-f7ba-19f0abb03b76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_844e7c43-dfe0-790d-4f5e-8b1150390e12" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_PreferredStockValue_844e7c43-dfe0-790d-4f5e-8b1150390e12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_130b8997-2f7a-8192-a853-ff9fb4629d95" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_CommonStockValue_130b8997-2f7a-8192-a853-ff9fb4629d95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_355fc088-038d-3905-0784-91db0d020a77" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_355fc088-038d-3905-0784-91db0d020a77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18ff0284-4873-6ef0-806f-4fb76051c01f" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18ff0284-4873-6ef0-806f-4fb76051c01f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_02ec7b38-4afa-636c-3b62-de1bd1bf96c1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_MinorityInterest_02ec7b38-4afa-636c-3b62-de1bd1bf96c1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_a0e4a1b3-b018-392a-9b7d-09729b37d6a1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_Liabilities_a0e4a1b3-b018-392a-9b7d-09729b37d6a1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a0e4a1b3-b018-392a-9b7d-09729b37d6a1" xlink:to="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_95fe5c6d-e90e-6d2c-8e9a-8339666be1b8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_AccountsPayableCurrent_95fe5c6d-e90e-6d2c-8e9a-8339666be1b8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9eef8c70-87b0-cf2a-9025-8b985649a106" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9eef8c70-87b0-cf2a-9025-8b985649a106" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccruedCustomerPrograms" xlink:label="loc_prgo_AccruedCustomerPrograms_9d0c4258-6bc8-a11a-9a72-85ecc3981a8b" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_prgo_AccruedCustomerPrograms_9d0c4258-6bc8-a11a-9a72-85ecc3981a8b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4deaf78d-f730-176a-d6c6-47d6fc92ced8" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4deaf78d-f730-176a-d6c6-47d6fc92ced8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0b15a280-646f-6bd5-2e9d-a4e71ea429af" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0b15a280-646f-6bd5-2e9d-a4e71ea429af" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_7cbd6f8c-b887-d072-e261-363a7bab4365" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_LongTermDebtCurrent_7cbd6f8c-b887-d072-e261-363a7bab4365" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_5bbc57aa-3e57-6e89-45da-f54ff12ccdd7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a0e4a1b3-b018-392a-9b7d-09729b37d6a1" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_5bbc57aa-3e57-6e89-45da-f54ff12ccdd7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a1517e9b-48ef-ec4d-5351-733e917bf402" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5bbc57aa-3e57-6e89-45da-f54ff12ccdd7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a1517e9b-48ef-ec4d-5351-733e917bf402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e498812a-ea06-2933-72f6-8e959ed1c719" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5bbc57aa-3e57-6e89-45da-f54ff12ccdd7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e498812a-ea06-2933-72f6-8e959ed1c719" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_44e41183-ff71-8a5d-6bae-236dd27ab6c0" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5bbc57aa-3e57-6e89-45da-f54ff12ccdd7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_44e41183-ff71-8a5d-6bae-236dd27ab6c0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c8c1ef7d-82ef-ec40-66d0-45806fc53a6e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c8c1ef7d-82ef-ec40-66d0-45806fc53a6e" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_7a1bac67-2def-6d61-a1fa-001f549dec43" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_7a1bac67-2def-6d61-a1fa-001f549dec43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_753ca67e-e0b1-89f6-0f4c-664d01a2b0f7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_753ca67e-e0b1-89f6-0f4c-664d01a2b0f7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_660d037d-5031-2fde-c0d3-d2b6978292ac" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_660d037d-5031-2fde-c0d3-d2b6978292ac" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_57470abd-1326-d3e1-5b42-70a878766d18" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_57470abd-1326-d3e1-5b42-70a878766d18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1aefa3b7-6b7a-d481-5bdc-6b8b587c627e" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1aefa3b7-6b7a-d481-5bdc-6b8b587c627e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e8d445f0-ef04-1060-9e57-9c1edeba123f" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e8d445f0-ef04-1060-9e57-9c1edeba123f" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_797d2802-c185-28eb-bcf1-85ecc6b46d88" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_797d2802-c185-28eb-bcf1-85ecc6b46d88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4b0bcec4-8cac-770b-1104-d9ba7647c257" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4b0bcec4-8cac-770b-1104-d9ba7647c257" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_aff0d730-1c4a-bdf8-50f5-49065c1c5889" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_aff0d730-1c4a-bdf8-50f5-49065c1c5889" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4392a9aa-12d6-0a02-3bb4-a001e4753188" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_4bd6cce4-82bf-a7c4-1028-ad47e749cc21" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4392a9aa-12d6-0a02-3bb4-a001e4753188" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_7762b598-6b5d-8e72-7b31-85ecc205b81d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_7762b598-6b5d-8e72-7b31-85ecc205b81d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_0b277ed9-58e8-8212-b2b2-cd279fc6be74" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_0b277ed9-58e8-8212-b2b2-cd279fc6be74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c7e64fd7-0b56-e309-1408-1e90657554b0" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c7e64fd7-0b56-e309-1408-1e90657554b0" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ProceedsfromContingentMilestonePayment" xlink:label="loc_prgo_ProceedsfromContingentMilestonePayment_cff5fdfe-fa76-9c7a-07e4-85ecc4fcead2" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_prgo_ProceedsfromContingentMilestonePayment_cff5fdfe-fa76-9c7a-07e4-85ecc4fcead2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_264230fd-69ca-95db-ec0e-094bdb4afcad" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_264230fd-69ca-95db-ec0e-094bdb4afcad" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca48a49a-2cde-cf3d-6904-e8f08b6e1fbb" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca48a49a-2cde-cf3d-6904-e8f08b6e1fbb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_1666bbcb-08fd-7927-10f4-e387ec1a1103" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_1666bbcb-08fd-7927-10f4-e387ec1a1103" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e33e3b56-416a-9757-52a3-44ee94cae9bf" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e33e3b56-416a-9757-52a3-44ee94cae9bf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_06529ffd-62cf-ac47-b8f8-c38a666da5ee" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_06529ffd-62cf-ac47-b8f8-c38a666da5ee" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7f9580a9-3805-cc3a-42fd-74ab6d116d7a" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7f9580a9-3805-cc3a-42fd-74ab6d116d7a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_c837e12a-08a8-6d98-6718-5c7ec2ef2ab7" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_c837e12a-08a8-6d98-6718-5c7ec2ef2ab7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_256c079d-e2c7-ac5e-3c5e-07268b40f489" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_256c079d-e2c7-ac5e-3c5e-07268b40f489" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_31759b8b-3cac-45cb-bf69-90917ca27e37" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_31759b8b-3cac-45cb-bf69-90917ca27e37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a217bad1-c076-d01c-43fb-4959b256b731" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a217bad1-c076-d01c-43fb-4959b256b731" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends_17a4f643-13f7-97f5-0c15-ee712bbc980c" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsOfDividends_17a4f643-13f7-97f5-0c15-ee712bbc980c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6af9b322-bd28-b53c-6ab5-52bafd228259" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6af9b322-bd28-b53c-6ab5-52bafd228259" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3fb4920-0b72-7fd0-429d-d910e936dd99" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3fb4920-0b72-7fd0-429d-d910e936dd99" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:to="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c58d44c2-787c-c623-c1df-7c45a5b4945e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c58d44c2-787c-c623-c1df-7c45a5b4945e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_18a65075-1a13-bb2d-8065-615b21bcf681" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_18a65075-1a13-bb2d-8065-615b21bcf681" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4b5a2c0b-d445-0a7a-a932-da5d5a12d2f1" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4f9ed30-225d-b1c2-4b66-efe0757ad41c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4b5a2c0b-d445-0a7a-a932-da5d5a12d2f1" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:to="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ff0f538-863f-dffc-da3e-5378e55a2439" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ff0f538-863f-dffc-da3e-5378e55a2439" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_01f4f849-ade5-f04f-1204-64d74a0c2886" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_01f4f849-ade5-f04f-1204-64d74a0c2886" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductionAndDistributionCosts" xlink:label="loc_us-gaap_ProductionAndDistributionCosts_8b4a6f82-6941-ccf3-b4dc-ffef0c763060" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:to="loc_us-gaap_ProductionAndDistributionCosts_8b4a6f82-6941-ccf3-b4dc-ffef0c763060" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_922daf79-4589-2010-458b-2bc250462d25" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_922daf79-4589-2010-458b-2bc250462d25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_fc7b03d4-701f-ff27-f198-5ffc5f6468d8" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:to="loc_us-gaap_SellingAndMarketingExpense_fc7b03d4-701f-ff27-f198-5ffc5f6468d8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c156c847-bbc0-f5d6-c7be-d450851582a1" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c156c847-bbc0-f5d6-c7be-d450851582a1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_85606f35-512d-87bf-8e37-0924416c5c8a" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:to="loc_us-gaap_AssetImpairmentCharges_85606f35-512d-87bf-8e37-0924416c5c8a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:to="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherOperatingIncomeLoss" xlink:label="loc_prgo_OtherOperatingIncomeLoss_483214e8-6eb4-5d5a-567a-85ecc4ee6bb3" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d1241922-8a19-0b86-133e-a1933036fe7e" xlink:to="loc_prgo_OtherOperatingIncomeLoss_483214e8-6eb4-5d5a-567a-85ecc4ee6bb3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_c4625961-7415-0c04-2a77-eedae7fb48a7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_c4625961-7415-0c04-2a77-eedae7fb48a7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_e88f68c7-9329-a525-c4c6-a80142d73a88" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_e88f68c7-9329-a525-c4c6-a80142d73a88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_497f98e6-8a11-3c53-7076-ee6aaae664ce" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_497f98e6-8a11-3c53-7076-ee6aaae664ce" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6a75c878-dfaf-e368-936e-ce293fe86f6f" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6a75c878-dfaf-e368-936e-ce293fe86f6f" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/Contingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/ContingenciesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CoverPage" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:type="extended">
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_5725cc08-c2d3-e3be-c98f-85ecc6a239f7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_55e9bf16-806a-aca0-b7be-775eb64f3211" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_5725cc08-c2d3-e3be-c98f-85ecc6a239f7" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_55e9bf16-806a-aca0-b7be-775eb64f3211" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_dceb38e6-a6bb-1446-ef15-2f2590d227ee" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_5725cc08-c2d3-e3be-c98f-85ecc6a239f7" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_dceb38e6-a6bb-1446-ef15-2f2590d227ee" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_194fc9b2-c8ba-d561-3eb3-bb44e4ffe3ff" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_1004df3a-82bc-b6a6-4161-e8010d9a4c7e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_194fc9b2-c8ba-d561-3eb3-bb44e4ffe3ff" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_1004df3a-82bc-b6a6-4161-e8010d9a4c7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_d45ff758-5dbd-8825-279e-eb661b8a9470" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_194fc9b2-c8ba-d561-3eb3-bb44e4ffe3ff" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_d45ff758-5dbd-8825-279e-eb661b8a9470" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f60858b4-cb31-daa2-3699-140a0e3df912" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f60858b4-cb31-daa2-3699-140a0e3df912" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d4a7f8fa-b280-c9a4-a4d4-d0fdac5ff806" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d4a7f8fa-b280-c9a4-a4d4-d0fdac5ff806" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_00c75ee1-7e23-8bf0-c6da-d606aeaefb69" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_af215e1c-178f-4b5a-52a9-2a63249848b5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_00c75ee1-7e23-8bf0-c6da-d606aeaefb69" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_af215e1c-178f-4b5a-52a9-2a63249848b5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_8821f6d8-5bb2-66d0-8cfc-a6862008a4d4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_00c75ee1-7e23-8bf0-c6da-d606aeaefb69" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_8821f6d8-5bb2-66d0-8cfc-a6862008a4d4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_557c76cc-6367-ee82-4523-d733118a2381" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_557c76cc-6367-ee82-4523-d733118a2381" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_874eb2ee-d325-4408-e764-5934366c7052" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_874eb2ee-d325-4408-e764-5934366c7052" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e582a366-0482-1dcf-89f1-d39554844dbb" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e582a366-0482-1dcf-89f1-d39554844dbb" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" xlink:label="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_48f1fd19-eb45-7b67-4848-85ecc51aea63" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:to="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_48f1fd19-eb45-7b67-4848-85ecc51aea63" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PotentialContingentMilestonePayments" xlink:label="loc_prgo_PotentialContingentMilestonePayments_119036d2-af40-4119-109e-85ecc68f467e" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:to="loc_prgo_PotentialContingentMilestonePayments_119036d2-af40-4119-109e-85ecc68f467e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillFairValueDisclosure" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_c3e93530-87f1-34a7-32f8-d0ad1e0b311b" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_c3e93530-87f1-34a7-32f8-d0ad1e0b311b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_ec51bf37-fcea-cecb-cb8f-88dc0989d8d8" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f6e033ad-7025-b6e1-c62b-b572fe209bf1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_ec51bf37-fcea-cecb-cb8f-88dc0989d8d8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a63bfe00-8c71-75eb-c989-1230f0c1a19e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_46346561-8cfb-ab6e-79bb-c44fc2165bf6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a63bfe00-8c71-75eb-c989-1230f0c1a19e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_46346561-8cfb-ab6e-79bb-c44fc2165bf6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dbdba778-4684-25b5-9c31-40f70d32b8a5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a63bfe00-8c71-75eb-c989-1230f0c1a19e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dbdba778-4684-25b5-9c31-40f70d32b8a5" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/Indebtedness" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_535a2650-0afd-ab3b-1421-a50fb29a33a7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:to="loc_us-gaap_DebtCurrent_535a2650-0afd-ab3b-1421-a50fb29a33a7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a1517e9b-48ef-ec4d-5351-733e917bf402" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a1517e9b-48ef-ec4d-5351-733e917bf402" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_0A33DF3D7AFD94DE096147475E7FB559_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_0A33DF3D7AFD94DE096147475E7FB559_24a12e71-c608-2518-a205-fc6cd2741c32" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_0A33DF3D7AFD94DE096147475E7FB559_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:to="loc_us-gaap_SeniorNotes_0A33DF3D7AFD94DE096147475E7FB559_24a12e71-c608-2518-a205-fc6cd2741c32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_0A33DF3D7AFD94DE096147475E7FB559_c92e3ce6-308c-41b9-b422-38477ab06454" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_0A33DF3D7AFD94DE096147475E7FB559_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:to="loc_us-gaap_OtherLongTermDebt_0A33DF3D7AFD94DE096147475E7FB559_c92e3ce6-308c-41b9-b422-38477ab06454" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0A33DF3D7AFD94DE096147475E7FB559_06e25057-4745-bda3-07eb-b43c87981e73" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_0A33DF3D7AFD94DE096147475E7FB559_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0A33DF3D7AFD94DE096147475E7FB559_06e25057-4745-bda3-07eb-b43c87981e73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_0A33DF3D7AFD94DE096147475E7FB559_d5e8ea34-a09b-4d4e-3675-92e0a097eb5a" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_0A33DF3D7AFD94DE096147475E7FB559_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_0A33DF3D7AFD94DE096147475E7FB559_d5e8ea34-a09b-4d4e-3675-92e0a097eb5a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaap_LoansPayable_0A33DF3D7AFD94DE096147475E7FB559_6efbf973-b2f6-6832-cbe1-344c8be1e3ef" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_0A33DF3D7AFD94DE096147475E7FB559_953ea721-8ca2-c279-5f21-21e2baee7616" xlink:to="loc_us-gaap_LoansPayable_0A33DF3D7AFD94DE096147475E7FB559_6efbf973-b2f6-6832-cbe1-344c8be1e3ef" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IndebtednessTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/Inventories" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_16140565CD755C47A3075ECD10264E30" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_5A175EB2D4235A2D9E35028088DAEA13" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_16140565CD755C47A3075ECD10264E30" xlink:to="loc_us-gaap_InventoryFinishedGoods_5A175EB2D4235A2D9E35028088DAEA13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaap_InventoryWorkInProcess_32FA30C61AA25EEDA87B315984A5B297" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_16140565CD755C47A3075ECD10264E30" xlink:to="loc_us-gaap_InventoryWorkInProcess_32FA30C61AA25EEDA87B315984A5B297" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_3C6A5BF0B08055639092BADE1312671F" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_16140565CD755C47A3075ECD10264E30" xlink:to="loc_us-gaap_InventoryRawMaterials_3C6A5BF0B08055639092BADE1312671F" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/InventoriesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/Investments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/InvestmentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/Leases" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:type="extended">
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_B065797D58ED52929155E027241EB7A8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_FBB80FA0A155519495A850BBD5AC2F7E" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_B065797D58ED52929155E027241EB7A8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_FBB80FA0A155519495A850BBD5AC2F7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_E0833DA93151559EA4A06CCA001CCEF8" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_B065797D58ED52929155E027241EB7A8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_E0833DA93151559EA4A06CCA001CCEF8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilities" xlink:label="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_119FA3AF8225511C8D96EA874F6A477E" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:to="loc_us-gaap_OperatingLeaseLiability_119FA3AF8225511C8D96EA874F6A477E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_83409E52FFD65855A71989C271B30184" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:to="loc_us-gaap_FinanceLeaseLiability_83409E52FFD65855A71989C271B30184" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_AA8A2D3CEA535C5AAE0FF96465C28874" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_AA8A2D3CEA535C5AAE0FF96465C28874" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9BD0FE31FD6F5D55BDB7A30A712A5031" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9BD0FE31FD6F5D55BDB7A30A712A5031" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2BE574B84EFF5E90965B521E3A3E3C7F" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2BE574B84EFF5E90965B521E3A3E3C7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_833977B1B59A56F78A6BF21594CFE95E" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_833977B1B59A56F78A6BF21594CFE95E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E725B31246B657D089BC7D79B42A9AB9" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E725B31246B657D089BC7D79B42A9AB9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:label="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_39710BD631535438B0E2C44413BB646D" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_39710BD631535438B0E2C44413BB646D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B013B1DC6D845A019D1612C56BC039D9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_583C466C8EC65B3EA7F2BADE89B3BE34" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_583C466C8EC65B3EA7F2BADE89B3BE34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_C806DC7BB25A5FC7BCD279C09750B47C" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_C806DC7BB25A5FC7BCD279C09750B47C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9399F4BB2A3C55DDB089170E4DCCD38C" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9399F4BB2A3C55DDB089170E4DCCD38C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4F3E8542194D59E396CD0E9AD7006281" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4F3E8542194D59E396CD0E9AD7006281" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_BE5EC91E51075D71861ADF343132F1B1" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_BE5EC91E51075D71861ADF343132F1B1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:label="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_A8A560F1EEF35779A24E81879C4963D9" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_A8A560F1EEF35779A24E81879C4963D9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDue" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_040821AC72735C56AC33E836F8781E41" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:label="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_719FB8E9DB055D5BB0A082D95525C08E" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_719FB8E9DB055D5BB0A082D95525C08E" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_719FB8E9DB055D5BB0A082D95525C08E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_AA8A2D3CEA535C5AAE0FF96465C28874" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_719FB8E9DB055D5BB0A082D95525C08E" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_583C466C8EC65B3EA7F2BADE89B3BE34" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearOne" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearOne_C23E268CBBB258DE852C6F7379C176B7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearOne_C23E268CBBB258DE852C6F7379C176B7" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearOne_C23E268CBBB258DE852C6F7379C176B7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9BD0FE31FD6F5D55BDB7A30A712A5031" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearOne_C23E268CBBB258DE852C6F7379C176B7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_C806DC7BB25A5FC7BCD279C09750B47C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_101298920B8554CAB4470BC02C1DABFE" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_101298920B8554CAB4470BC02C1DABFE" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_101298920B8554CAB4470BC02C1DABFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2BE574B84EFF5E90965B521E3A3E3C7F" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_101298920B8554CAB4470BC02C1DABFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9399F4BB2A3C55DDB089170E4DCCD38C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearThree" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_02B9C477A7755D259F5941F0AC37C440" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearThree_02B9C477A7755D259F5941F0AC37C440" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree_02B9C477A7755D259F5941F0AC37C440" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_833977B1B59A56F78A6BF21594CFE95E" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree_02B9C477A7755D259F5941F0AC37C440" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4F3E8542194D59E396CD0E9AD7006281" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearFour" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_8A298C4CE0DD52139803B20FC279E698" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFour_8A298C4CE0DD52139803B20FC279E698" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour_8A298C4CE0DD52139803B20FC279E698" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E725B31246B657D089BC7D79B42A9AB9" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour_8A298C4CE0DD52139803B20FC279E698" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_BE5EC91E51075D71861ADF343132F1B1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_C1B0422FA66F53D6A3EBDA9C870FC4BB" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_C1B0422FA66F53D6A3EBDA9C870FC4BB" xlink:type="arc" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_C1B0422FA66F53D6A3EBDA9C870FC4BB" xlink:to="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_39710BD631535438B0E2C44413BB646D" xlink:type="arc" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_C1B0422FA66F53D6A3EBDA9C870FC4BB" xlink:to="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_A8A560F1EEF35779A24E81879C4963D9" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_B013B1DC6D845A019D1612C56BC039D9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2D405C737B228652BC0685F146B76A71_E0833DA93151559EA4A06CCA001CCEF8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2D405C737B228652BC0685F146B76A71_E0833DA93151559EA4A06CCA001CCEF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_2D405C737B228652BC0685F146B76A71_83409E52FFD65855A71989C271B30184" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_B013B1DC6D845A019D1612C56BC039D9" xlink:to="loc_us-gaap_FinanceLeaseLiability_2D405C737B228652BC0685F146B76A71_83409E52FFD65855A71989C271B30184" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2D405C737B228652BC0685F146B76A71_FBB80FA0A155519495A850BBD5AC2F7E" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2D405C737B228652BC0685F146B76A71_FBB80FA0A155519495A850BBD5AC2F7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_2D405C737B228652BC0685F146B76A71_119FA3AF8225511C8D96EA874F6A477E" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:to="loc_us-gaap_OperatingLeaseLiability_2D405C737B228652BC0685F146B76A71_119FA3AF8225511C8D96EA874F6A477E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDue" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_040821AC72735C56AC33E836F8781E41" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_2D405C737B228652BC0685F146B76A71_B065797D58ED52929155E027241EB7A8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_2D405C737B228652BC0685F146B76A71_B065797D58ED52929155E027241EB7A8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilities" xlink:label="loc_prgo_LeaseLiabilities_2D405C737B228652BC0685F146B76A71_4D66CD7CB54F59C498512976402793E5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_2D405C737B228652BC0685F146B76A71_040821AC72735C56AC33E836F8781E41" xlink:to="loc_prgo_LeaseLiabilities_2D405C737B228652BC0685F146B76A71_4D66CD7CB54F59C498512976402793E5" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3" xlink:type="extended">
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDue" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_2AF7C22A5DC19D76FD8585F146B893BC_040821AC72735C56AC33E836F8781E41" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2AF7C22A5DC19D76FD8585F146B893BC_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_2AF7C22A5DC19D76FD8585F146B893BC_040821AC72735C56AC33E836F8781E41" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2AF7C22A5DC19D76FD8585F146B893BC_BBE233AA7FB356C7A377EA53B6ACF3CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2AF7C22A5DC19D76FD8585F146B893BC_B013B1DC6D845A019D1612C56BC039D9" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_2AF7C22A5DC19D76FD8585F146B893BC_040821AC72735C56AC33E836F8781E41" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2AF7C22A5DC19D76FD8585F146B893BC_B013B1DC6D845A019D1612C56BC039D9" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilities" xlink:label="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2703367717685F958B6166137F5C82DF" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2703367717685F958B6166137F5C82DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1E17061C952F5030BF73105153D42017" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1E17061C952F5030BF73105153D42017" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_B06FEE7ABFEA5B82A7DF511F0596DEB7" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_B06FEE7ABFEA5B82A7DF511F0596DEB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_DE679AE4CF3F55B5949BB6BDA47CC4D5" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_4D66CD7CB54F59C498512976402793E5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_DE679AE4CF3F55B5949BB6BDA47CC4D5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RightofUseAsset" xlink:label="loc_prgo_RightofUseAsset_F50FE4A4BA305CBCA96538D6CB1346E5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_05EB1C8D9F8153A1AB07531B385D0BF8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_RightofUseAsset_F50FE4A4BA305CBCA96538D6CB1346E5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_05EB1C8D9F8153A1AB07531B385D0BF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_82295AF51CC5566A9FFA31EA7752335F" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_RightofUseAsset_F50FE4A4BA305CBCA96538D6CB1346E5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_82295AF51CC5566A9FFA31EA7752335F" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FinanceLeaseCost" xlink:label="loc_prgo_FinanceLeaseCost_22BAE684A00156549AD31F625332AC6A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8D7306BBFB165D1F82F1FAC2F400531B" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_FinanceLeaseCost_22BAE684A00156549AD31F625332AC6A" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8D7306BBFB165D1F82F1FAC2F400531B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3B61F66C8D5B59D4B2F323EE3EBFDCF8" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_FinanceLeaseCost_22BAE684A00156549AD31F625332AC6A" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3B61F66C8D5B59D4B2F323EE3EBFDCF8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RestructuringCharges" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RevenueRecognition" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/SegmentInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/SegmentInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>prgo-20200926_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestitures" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestitures" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresDivestitureDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsTables" xlink:href="prgo-20200926.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:href="prgo-20200926.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Contingencies" xlink:href="prgo-20200926.xsd#Contingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesDetails" xlink:href="prgo-20200926.xsd#ContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CoverPage" xlink:href="prgo-20200926.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurements" xlink:href="prgo-20200926.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:href="prgo-20200926.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssets" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsGoodwillDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxes" xlink:href="prgo-20200926.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:href="prgo-20200926.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesTables" xlink:href="prgo-20200926.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Indebtedness" xlink:href="prgo-20200926.xsd#Indebtedness" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#IndebtednessAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:href="prgo-20200926.xsd#IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessTables" xlink:href="prgo-20200926.xsd#IndebtednessTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Inventories" xlink:href="prgo-20200926.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesDetails" xlink:href="prgo-20200926.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesTables" xlink:href="prgo-20200926.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Investments" xlink:href="prgo-20200926.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsDetails" xlink:href="prgo-20200926.xsd#InvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsTables" xlink:href="prgo-20200926.xsd#InvestmentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Leases" xlink:href="prgo-20200926.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:href="prgo-20200926.xsd#LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:href="prgo-20200926.xsd#LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:href="prgo-20200926.xsd#LeasesLeaseCashFlowClassificationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:href="prgo-20200926.xsd#LeasesLeaseExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesTables" xlink:href="prgo-20200926.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:href="prgo-20200926.xsd#LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringCharges" xlink:href="prgo-20200926.xsd#RestructuringCharges" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:href="prgo-20200926.xsd#RestructuringChargesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesTables" xlink:href="prgo-20200926.xsd#RestructuringChargesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognition" xlink:href="prgo-20200926.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfContractBalancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:href="prgo-20200926.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformation" xlink:href="prgo-20200926.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationDetails" xlink:href="prgo-20200926.xsd#SegmentInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationTables" xlink:href="prgo-20200926.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_21F22B71A609213AD43246E066252370" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_21F22B71A609213AD43246E066252370" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21F22B71A609213AD43246E066252370" xlink:to="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21F22B71A609213AD43246E066252370" xlink:to="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EF9BA2F80BD1632EEA8A46E066277F42" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EF9BA2F80BD1632EEA8A46E066277F42" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:label="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:to="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_5A0BD2C08FAB926FB9CF46E06627D6DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_StockholdersEquity_5A0BD2C08FAB926FB9CF46E06627D6DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0627074126FDDD9C230846E06628302B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0627074126FDDD9C230846E06628302B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestitures" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:to="loc_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BrandMember" xlink:label="loc_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:to="loc_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SanofiBrandsMember" xlink:label="loc_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DexsilMember" xlink:label="loc_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SteripodMember" xlink:label="loc_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GenericProductAcquisitionMember" xlink:label="loc_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember" xlink:label="loc_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofBrandsAcquired" xlink:label="loc_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomefromSalesOwnedbytheCompanyPercent" xlink:label="loc_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5DD79CC03C12CD8C4503C698D21F8906" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5DD79CC03C12CD8C4503C698D21F8906" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5DD79CC03C12CD8C4503C698D21F8906" xlink:to="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5DD79CC03C12CD8C4503C698D21F8906" xlink:to="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CSCIMember" xlink:label="loc_prgo_CSCIMember_86F2AFFF4EFC99E17A78C698D21FB690" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:to="loc_prgo_CSCIMember_86F2AFFF4EFC99E17A78C698D21FB690" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_D76E04E97251A7CBE2A3C6AD14ED76EB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_D76E04E97251A7CBE2A3C6AD14ED76EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RosemontPharmaceuticalsMember" xlink:label="loc_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:to="loc_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AnimalHealthMember" xlink:label="loc_prgo_AnimalHealthMember_AFB125643F323A36501FC6ADAF666AAC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:to="loc_prgo_AnimalHealthMember_AFB125643F323A36501FC6ADAF666AAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_AC4AF8CB32F53F36BE95C698D221A120" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_AC4AF8CB32F53F36BE95C698D221A120" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:to="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:to="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:to="loc_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:to="loc_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_BF1C6DB82055014CE9C86A87FC4023B9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_BF1C6DB82055014CE9C86A87FC4023B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BF1C6DB82055014CE9C86A87FC4023B9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BF1C6DB82055014CE9C86A87FC4023B9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanirGlobalHoldingsLLCMember" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_30CAEA79423B7425FC736A87FC41F28B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_30CAEA79423B7425FC736A87FC41F28B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_30CAEA79423B7425FC736A87FC41F28B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_30CAEA79423B7425FC736A87FC41F28B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember" xlink:label="loc_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_E19A8B54F9305BE020496A87FC426BDE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_E19A8B54F9305BE020496A87FC426BDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TrademarksTradeNamesandBrandsMember" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TrademarksTradeNamesandBrandsMember" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_EFDC1A210049964398666A87FC43D842" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_EFDC1A210049964398666A87FC43D842" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_D1D745840770847AD5636A87FC435AFC" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_D1D745840770847AD5636A87FC435AFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_D1D745840770847AD5636A87FC435AFC" xlink:to="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_D1D745840770847AD5636A87FC435AFC" xlink:to="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_F05B7A43D72FFC7337526A87FC4432B1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_F05B7A43D72FFC7337526A87FC4432B1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_600E8F8D52F3323B85A26A87FC44CF6F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_600E8F8D52F3323B85A26A87FC44CF6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationBaseConsiderationTransferred" xlink:label="loc_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A22D1B3CF7224AB7F25D6A87FC5446F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A22D1B3CF7224AB7F25D6A87FC5446F2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_024BD5CF0EC7285588B56A87FC541451" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A22D1B3CF7224AB7F25D6A87FC5446F2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_024BD5CF0EC7285588B56A87FC541451" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_024BD5CF0EC7285588B56A87FC541451" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_024BD5CF0EC7285588B56A87FC541451" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_E308078DF2536CD4CAC66A87FC552F8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_E308078DF2536CD4CAC66A87FC552F8A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanirGlobalHoldingsLLCMember" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_FE57AFBC7851DCA0F89A6A87FC55E959" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_FE57AFBC7851DCA0F89A6A87FC55E959" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:to="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:to="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:to="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:to="loc_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:to="loc_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_4C02528C19E44E7CD8B66A868C23867D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_NetIncomeLoss_4C02528C19E44E7CD8B66A868C23867D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/Contingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6D571DE1B368B50920699368F9F261F5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6D571DE1B368B50920699368F9F261F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6D571DE1B368B50920699368F9F261F5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6D571DE1B368B50920699368F9F261F5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_74ED86063D30B6E4EA869368F9F38E19" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE" xlink:to="loc_us-gaap_SubsequentEventMember_74ED86063D30B6E4EA869368F9F38E19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis" xlink:label="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:to="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:to="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember" xlink:label="loc_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:to="loc_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:to="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:to="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember" xlink:label="loc_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OverarchingConspiracyClassActionsMember" xlink:label="loc_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitDrugstoreChainMember" xlink:label="loc_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember" xlink:label="loc_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember" xlink:label="loc_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_StateAttorneyGeneralComplaintMember" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CanadianClassActionComplaintMember" xlink:label="loc_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSupermarketChainsMember" xlink:label="loc_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember" xlink:label="loc_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitManagedCareOrganizationMember" xlink:label="loc_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthInsuranceCarrierMember" xlink:label="loc_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthcareServiceCompanyMember" xlink:label="loc_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember" xlink:label="loc_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember" xlink:label="loc_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthcareManagementOrganizationMember" xlink:label="loc_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHarrisCountyofTexasMember" xlink:label="loc_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member" xlink:label="loc_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthPlansMember" xlink:label="loc_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member" xlink:label="loc_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CasesFiledinIsraelMember" xlink:label="loc_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InrePerrigoCompanyplcSec.Litig.Member" xlink:label="loc_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TalcumPowderLitigationMember" xlink:label="loc_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanitidineLitigationMember" xlink:label="loc_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CarmignacFirstManhattanandSimilarCasesMember" xlink:label="loc_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FirstManhattanandSimilarCasesMember" xlink:label="loc_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_MasonCapitalPentwaterandSimilarCasesMember" xlink:label="loc_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HarelInsuranceandTIAACREFFCasesMember" xlink:label="loc_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoofersPensionFundMember" xlink:label="loc_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCasesRelatedtoEventsin20152017Member" xlink:label="loc_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InIsraelCasesRelatedtoIrishTaxEventsMember" xlink:label="loc_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:type="locator" />
    <link:definitionArc order="31" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AcetaminophenLitigationMember" xlink:label="loc_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:type="locator" />
    <link:definitionArc order="32" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofProductsincludedinExpeditedCases" xlink:label="loc_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofPutativeClasses" xlink:label="loc_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofSetsofClassActionComplaints" xlink:label="loc_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCasesAllegingOnlyStateLawClaims" xlink:label="loc_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfManufacturers" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofOtherPharmaceuticalCompanies" xlink:label="loc_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofFormerEmployees" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityNumberOfEmployees" xlink:label="loc_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofAdditionalStatesandTerritories" xlink:label="loc_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany" xlink:label="loc_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfPrescriptionPharmaceuticals" xlink:label="loc_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCasesIncludedinExpeditedSchedule" xlink:label="loc_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfSupermarketChains" xlink:label="loc_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCaseswithSimilarFactualAllegations" xlink:label="loc_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingenciesNumberofHealthPlans" xlink:label="loc_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofDozensofManufacturers" xlink:label="loc_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfIndividuals" xlink:label="loc_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofCodefendants" xlink:label="loc_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfCases" xlink:label="loc_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfCasesStayed" xlink:label="loc_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofDefendantsAdded" xlink:label="loc_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice" xlink:label="loc_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofLawsuits" xlink:label="loc_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofTendersAccepted" xlink:label="loc_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofMasterComplaints" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:type="locator" />
    <link:definitionArc order="31" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:type="locator" />
    <link:definitionArc order="32" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofClaimsforIndemnificationorDefense" xlink:label="loc_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:type="locator" />
    <link:definitionArc order="33" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofRetailers" xlink:label="loc_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:type="locator" />
    <link:definitionArc order="34" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CoverPage" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_2BA546D24F3E0B372FD646E066E7A757" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="loc_us-gaap_HedgingDesignationAxis_2BA546D24F3E0B372FD646E066E7A757" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2BA546D24F3E0B372FD646E066E7A757" xlink:to="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2BA546D24F3E0B372FD646E066E7A757" xlink:to="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_B3BC0217D039B3B3093946E066E892D1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:to="loc_us-gaap_NondesignatedMember_B3BC0217D039B3B3093946E066E892D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_31174D15E8BA1D62BE8746E066E8F6C5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_31174D15E8BA1D62BE8746E066E8F6C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_31174D15E8BA1D62BE8746E066E8F6C5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_31174D15E8BA1D62BE8746E066E8F6C5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_99AB23957103788F391446E066E976BC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_99AB23957103788F391446E066E976BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:to="loc_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_DB0A65BEED804620F3DD46E066E92DF8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_DB0A65BEED804620F3DD46E066E92DF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_DB0A65BEED804620F3DD46E066E92DF8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_DB0A65BEED804620F3DD46E066E92DF8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_5487246EEA0F6F4DD20F46E066EAC6F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_5487246EEA0F6F4DD20F46E066EAC6F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_AAC856EC9637A628922846E066EA64B5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:to="loc_us-gaap_CurrencySwapMember_AAC856EC9637A628922846E066EA64B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2D154082A38F57C592C3920D91D5197E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2D154082A38F57C592C3920D91D5197E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9BF82E9C5CFF4AC6B7CA8D1D623BE364_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2D154082A38F57C592C3920D91D5197E" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9BF82E9C5CFF4AC6B7CA8D1D623BE364_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72E03FEBF664524A8FAB5D7FDF3A1833" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2D154082A38F57C592C3920D91D5197E" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72E03FEBF664524A8FAB5D7FDF3A1833" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72E03FEBF664524A8FAB5D7FDF3A1833" xlink:to="loc_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B4BC2097C05D4F2DA7A58D13D9375A64_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_B4BC2097C05D4F2DA7A58D13D9375A64_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherExpenseIncomeNetMember" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgesAbstract" xlink:label="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:to="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_12135F3A229BEF0FFDF76A87FA5CE8AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_12135F3A229BEF0FFDF76A87FA5CE8AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_12135F3A229BEF0FFDF76A87FA5CE8AE" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_12135F3A229BEF0FFDF76A87FA5CE8AE" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember" xlink:label="loc_us-gaap_TreasuryLockMember_521E608D2911A596FD426A87FA5DD52D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_TreasuryLockMember_521E608D2911A596FD426A87FA5DD52D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_D29C7EEEB588AADD19E66A87FA5DA121" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_InterestRateSwapMember_D29C7EEEB588AADD19E66A87FA5DA121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9614C3A101C811AE06C36A87FA5D24F4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9614C3A101C811AE06C36A87FA5D24F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_1158D5D6CABFD31705986A87FA5D81FE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_CurrencySwapMember_1158D5D6CABFD31705986A87FA5D81FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8563723B1D5A0517FC6F6A87FA5E9090" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8563723B1D5A0517FC6F6A87FA5E9090" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8563723B1D5A0517FC6F6A87FA5E9090" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8563723B1D5A0517FC6F6A87FA5E9090" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_00B984A37FB28DCC0B3C6A87FA5F9338" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:to="loc_us-gaap_InterestExpenseMember_00B984A37FB28DCC0B3C6A87FA5F9338" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_BAFAEFD5360A6BF036C06A87FA5F337D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:to="loc_us-gaap_SalesRevenueNetMember_BAFAEFD5360A6BF036C06A87FA5F337D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_4A313799AECED3BA90C86A87FA5F7939" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:to="loc_us-gaap_CostOfSalesMember_4A313799AECED3BA90C86A87FA5F7939" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_0F83CAC39544B63ABE2A6A87FA6189C7" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_0F83CAC39544B63ABE2A6A87FA6189C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:to="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:to="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:to="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_ILS" xlink:label="loc_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD" xlink:label="loc_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_DKK" xlink:label="loc_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP" xlink:label="loc_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SEK" xlink:label="loc_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CNY" xlink:label="loc_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CAD" xlink:label="loc_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_PLN" xlink:label="loc_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_MXN" xlink:label="loc_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_NOK" xlink:label="loc_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CHF" xlink:label="loc_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_RON" xlink:label="loc_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_XXX" xlink:label="loc_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:to="loc_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:to="loc_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8DAF42A529A15041B8B013B87748D128" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8DAF42A529A15041B8B013B87748D128" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_78CB49E91F3426BEC08F8D13D94EBBEE_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8DAF42A529A15041B8B013B87748D128" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_78CB49E91F3426BEC08F8D13D94EBBEE_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8DAF42A529A15041B8B013B87748D128" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember" xlink:label="loc_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:to="loc_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_7CC878CD40FF5B53BECB240563D80DD1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_7CC878CD40FF5B53BECB240563D80DD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_334E67124F3B50EF8608F6F01B3593B2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:to="loc_us-gaap_InterestRateSwapMember_334E67124F3B50EF8608F6F01B3593B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_D66C760699A85B9CBD87E257B6359D50" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_D66C760699A85B9CBD87E257B6359D50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_FCEF15ACBFCF5B7992838D13D94F575D_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D66C760699A85B9CBD87E257B6359D50" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_FCEF15ACBFCF5B7992838D13D94F575D_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D66C760699A85B9CBD87E257B6359D50" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_E4383BBBC8DA5986BDE3879BF655AC03" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_SalesRevenueNetMember_E4383BBBC8DA5986BDE3879BF655AC03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_17950FFFBCCD5A9A8A32DBCAB25CBD22" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_CostOfSalesMember_17950FFFBCCD5A9A8A32DBCAB25CBD22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_2303328B8D145D88AF651D6985C2D81B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_InterestExpenseMember_2303328B8D145D88AF651D6985C2D81B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherExpenseIncomeNetMember" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_8CAAB3CE14C8564189090E48CF418A14" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_8CAAB3CE14C8564189090E48CF418A14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:to="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_3DD527E2F321DEF0ED018D13D9526154_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:to="loc_us-gaap_HedgingDesignationDomain_3DD527E2F321DEF0ED018D13D9526154_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:to="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:to="loc_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41E48D59E5505D11B4844322ED4A6C33" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41E48D59E5505D11B4844322ED4A6C33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_D6ED5B71487B5A628D1466CE7D7883B8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_D6ED5B71487B5A628D1466CE7D7883B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4255D0E60A3A5547B7D26229DB1815B8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4255D0E60A3A5547B7D26229DB1815B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3846FA7DDBA055ECAD42D9DEE004FA51" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3846FA7DDBA055ECAD42D9DEE004FA51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_A63B18840AAE5A27AABDBF4C949BE6AE" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_A63B18840AAE5A27AABDBF4C949BE6AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_D57A08146A1C5BA99D7B1A541E462695" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_D57A08146A1C5BA99D7B1A541E462695" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_189B03E17ECB5C7892217FCD60156C22" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_189B03E17ECB5C7892217FCD60156C22" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_254A3A181A7699D944C4474D6CF58ADE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_srt_RangeAxis_254A3A181A7699D944C4474D6CF58ADE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_254A3A181A7699D944C4474D6CF58ADE" xlink:to="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_254A3A181A7699D944C4474D6CF58ADE" xlink:to="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_63CB12F13E112951D556474D9EF7778A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:to="loc_srt_MinimumMember_63CB12F13E112951D556474D9EF7778A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_471DF9C1633420CC1737474E00F97843" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:to="loc_srt_MaximumMember_471DF9C1633420CC1737474E00F97843" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_BFFE1FA35823F36BD1924746EEB0CEB6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_BFFE1FA35823F36BD1924746EEB0CEB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_BFFE1FA35823F36BD1924746EEB0CEB6" xlink:to="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_BFFE1FA35823F36BD1924746EEB0CEB6" xlink:to="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_513658F22DA97C9202F44747174327A2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8" xlink:to="loc_prgo_RXPharmaceuticalsMember_513658F22DA97C9202F44747174327A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_9B9D885BE693A4D447A34746C8E0F14A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_ValuationTechniqueAxis_9B9D885BE693A4D447A34746C8E0F14A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_9B9D885BE693A4D447A34746C8E0F14A" xlink:to="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_9B9D885BE693A4D447A34746C8E0F14A" xlink:to="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1958676D0DD9623DF7E54746C8E04310" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1958676D0DD9623DF7E54746C8E04310" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6E4E7E0A8000289008BB4746C8E04D5D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6E4E7E0A8000289008BB4746C8E04D5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6E4E7E0A8000289008BB4746C8E04D5D" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6E4E7E0A8000289008BB4746C8E04D5D" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationMember" xlink:label="loc_prgo_ContingentConsiderationMember_7D9B63BE20C201CAD5904746C8F022EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA" xlink:to="loc_prgo_ContingentConsiderationMember_7D9B63BE20C201CAD5904746C8F022EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:to="loc_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7B17004100333C56F4534746C8F0BEBD" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7B17004100333C56F4534746C8F0BEBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7B17004100333C56F4534746C8F0BEBD" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7B17004100333C56F4534746C8F0BEBD" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_8E6FEE5D67D958B636E74746C8F014BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_8E6FEE5D67D958B636E74746C8F014BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaMember" xlink:label="loc_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:to="loc_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_258ECF707924E3F9620E4746C8F07908" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_258ECF707924E3F9620E4746C8F07908" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_258ECF707924E3F9620E4746C8F07908" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_258ECF707924E3F9620E4746C8F07908" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_8D043D2469EEAEC4E5DA4746C8F0A3BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:to="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_8D043D2469EEAEC4E5DA4746C8F0A3BE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:to="loc_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_E72E8839CA22762872944746C8F0A51A" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_E72E8839CA22762872944746C8F0A51A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_E72E8839CA22762872944746C8F0A51A" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_E72E8839CA22762872944746C8F0A51A" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_40C9FE06F3B19BEBB8114746C8F013DB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_40C9FE06F3B19BEBB8114746C8F013DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_64B8BC2548F47A4FF33E4746C8F0CF65" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_64B8BC2548F47A4FF33E4746C8F0CF65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_64B8BC2548F47A4FF33E4746C8F0CF65" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_64B8BC2548F47A4FF33E4746C8F0CF65" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1031CDC45FD7B60BD8A24746C8F02D8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1031CDC45FD7B60BD8A24746C8F02D8A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_46B7EDF8FB905D34D34B4746C8F0C952" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_46B7EDF8FB905D34D34B4746C8F0C952" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssetsLevel1Level2Level3TransfersAmount" xlink:label="loc_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssumptionVolatility" xlink:label="loc_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssumptionsRateofReturn" xlink:label="loc_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NetSalesIncludedinCalculationForMilestonePayment" xlink:label="loc_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AssetAdjustedFairValueifSalesThresholdMet" xlink:label="loc_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NetSalesThresholdForMilestonePayment" xlink:label="loc_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ReportingUnitFairValuePercent" xlink:label="loc_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BlendedJurisdictionalTaxRatesPercent" xlink:label="loc_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_726791F7C5DCFDFCF84985ED3D0E945F_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_726791F7C5DCFDFCF84985ED3D0E945F_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationMember" xlink:label="loc_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:to="loc_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_1561CBCFE56BD47F89F685ED3D0FB035_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:to="loc_us-gaap_ValuationTechniqueDomain_1561CBCFE56BD47F89F685ED3D0FB035_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:to="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D2448E10F7D9F015EEA985ED3D10768E_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D2448E10F7D9F015EEA985ED3D10768E_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_MeasurementInputProjectedRoyaltiesMember" xlink:label="loc_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:to="loc_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestones" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:to="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:to="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:to="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:to="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:to="loc_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B32898E077707EF7263C4732E66781F5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B32898E077707EF7263C4732E66781F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B32898E077707EF7263C4732E66781F5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B32898E077707EF7263C4732E66781F5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_CB87ED18CFAE685B80D84732E6676642" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_CB87ED18CFAE685B80D84732E6676642" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D7C2202BD76F6B28B57D4732E668ED36" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D7C2202BD76F6B28B57D4732E668ED36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" xlink:label="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PotentialContingentMilestonePayments" xlink:label="loc_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:to="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillFairValueDisclosure" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:to="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6292CB4CE50CD232193B4D57918BEC81" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6292CB4CE50CD232193B4D57918BEC81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6292CB4CE50CD232193B4D57918BEC81" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6292CB4CE50CD232193B4D57918BEC81" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11C4F73A0E59C03355C84D57918B5EEE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11C4F73A0E59C03355C84D57918B5EEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11C4F73A0E59C03355C84D57918B5EEE" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11C4F73A0E59C03355C84D57918B5EEE" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_D5EF270A68C9BC1748004D57918BED68" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_D5EF270A68C9BC1748004D57918BED68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2D83A7766FB8832A972585ED3BB68667_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_2D83A7766FB8832A972585ED3BB68667_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_8F9EF2E43EB25DB0879CED883BC5ABB4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="loc_us-gaap_DebtInstrumentAxis_8F9EF2E43EB25DB0879CED883BC5ABB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6586088F556FABE7E0B585ED3BB6211C_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8F9EF2E43EB25DB0879CED883BC5ABB4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6586088F556FABE7E0B585ED3BB6211C_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8F9EF2E43EB25DB0879CED883BC5ABB4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PublicBondsandPrivatePlacementMember" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:to="loc_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PrivatePlacementNoteMember" xlink:label="loc_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:to="loc_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2DDD445488325CF6B24685ED3BB7F162_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2DDD445488325CF6B24685ED3BB7F162_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:to="loc_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:to="loc_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9688C31E7D7DF147275547308588F54E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9688C31E7D7DF147275547308588F54E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9688C31E7D7DF147275547308588F54E" xlink:to="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9688C31E7D7DF147275547308588F54E" xlink:to="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_354EFE58E63542849328473086BE837B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E" xlink:to="loc_prgo_RXPharmaceuticalsMember_354EFE58E63542849328473086BE837B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:to="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:to="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:to="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BCSMember" xlink:label="loc_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:to="loc_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B3461CA8B90EC0EC51EE472B780A7C2B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:to="loc_us-gaap_Goodwill_B3461CA8B90EC0EC51EE472B780A7C2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8ED417BFD21CA6A33ECA472B780F82AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8ED417BFD21CA6A33ECA472B780F82AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8ED417BFD21CA6A33ECA472B780F82AA" xlink:to="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8ED417BFD21CA6A33ECA472B780F82AA" xlink:to="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_7FA663DAB2A598DF7FD4472B780F8BAA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_7FA663DAB2A598DF7FD4472B780F8BAA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_70A8EE251866DE082F6F472B780FA7D4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_70A8EE251866DE082F6F472B780FA7D4" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_F98435D4D0429BA2E9BE472B7810D56C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:to="loc_prgo_RXPharmaceuticalsMember_F98435D4D0429BA2E9BE472B7810D56C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:to="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:type="extended">
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7BF3AE04ED13399789E9C686DDF7F70C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7BF3AE04ED13399789E9C686DDF7F70C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7BF3AE04ED13399789E9C686DDF7F70C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7BF3AE04ED13399789E9C686DDF7F70C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_EvamistBrandedProductMember" xlink:label="loc_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:to="loc_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GenericProductAcquisitionMember" xlink:label="loc_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:to="loc_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_A54F85B2EAB783F7C81EC686DDF884F0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_A54F85B2EAB783F7C81EC686DDF884F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_A54F85B2EAB783F7C81EC686DDF884F0" xlink:to="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_A54F85B2EAB783F7C81EC686DDF884F0" xlink:to="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_9D046294FEB83328642AC686DDF96A29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89" xlink:to="loc_prgo_RXPharmaceuticalsMember_9D046294FEB83328642AC686DDF96A29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4895525DC7EA6C5EB53FC686DDF93CB1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4895525DC7EA6C5EB53FC686DDF93CB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4895525DC7EA6C5EB53FC686DDF93CB1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4895525DC7EA6C5EB53FC686DDF93CB1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TrademarksTradeNamesandBrandsMember" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_B292B09A1EDD588408D9C686DDFAA2B2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_B292B09A1EDD588408D9C686DDFAA2B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B8E2ACF8FB4133C368B8C686DDFC03D4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B8E2ACF8FB4133C368B8C686DDFC03D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B8E2ACF8FB4133C368B8C686DDFC03D4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B8E2ACF8FB4133C368B8C686DDFC03D4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_47FE0503C90B7495A971C686DDFF6BB1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_AssetImpairmentCharges_47FE0503C90B7495A971C686DDFF6BB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_91529276D9D1784F426B936A7519347C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_91529276D9D1784F426B936A7519347C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_91529276D9D1784F426B936A7519347C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_91529276D9D1784F426B936A7519347C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_E32B2C5940F2012D0CE1936AA1A65D3A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A" xlink:to="loc_us-gaap_SubsequentEventMember_E32B2C5940F2012D0CE1936AA1A65D3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueCommissionersIrelandMember" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:to="loc_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:label="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CumulativeDeferredChargeTaxLitigation" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears" xlink:label="loc_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability" xlink:label="loc_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PeriodAvailabletoFileAppeal" xlink:label="loc_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal" xlink:label="loc_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/Indebtedness" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_KazmiraLLCMember" xlink:label="loc_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:to="loc_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_6F52D2A7596BD4E1500B478858BB8ADD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:to="loc_us-gaap_DebtInstrumentAxis_6F52D2A7596BD4E1500B478858BB8ADD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6F52D2A7596BD4E1500B478858BB8ADD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6F52D2A7596BD4E1500B478858BB8ADD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2018RevolverMember" xlink:label="loc_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2014EuroDenominatedTermLoandueDecember52019Member" xlink:label="loc_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2018EuroDenominatedTermLoandueMarch82020Member" xlink:label="loc_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_A99476D7842BDF6B3891478858BCD6EF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_A99476D7842BDF6B3891478858BCD6EF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.150SeniorNotesdueJune152030Member" xlink:label="loc_prgo_A3.150SeniorNotesdueJune152030Member_B2A050DF4B0C5E8B5202478858BC7E3B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A3.150SeniorNotesdueJune152030Member_B2A050DF4B0C5E8B5202478858BC7E3B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_282AFDA27F5D8342C3F1478858BCC9AC" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_282AFDA27F5D8342C3F1478858BCC9AC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.5SeniornotedueDecember152021Member" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member_6BF09CF35D26CF4B41FD478858BD600B" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A3.5SeniornotedueDecember152021Member_6BF09CF35D26CF4B41FD478858BD600B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueNovember2020Member" xlink:label="loc_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueMay2021Member" xlink:label="loc_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueNovember2021Member" xlink:label="loc_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SeniorNotesdue2021Member" xlink:label="loc_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BE79696B239C3A180515478858BEADC2" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BE79696B239C3A180515478858BEADC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofPromissoryNotes" xlink:label="loc_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfDebtInstrumentsTable" xlink:label="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:to="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.5SeniornotedueDecember152021Member" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A5.105SeniornotedueJuly282023Member" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.9seniornotedue2024Member" xlink:label="loc_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.375seniornotedueMarch152026Member" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.150SeniorNotesdueJune152030Member" xlink:label="loc_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.9SeniorLoandue2044Member" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IndebtednessTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/Inventories" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/InventoriesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/InventoriesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/Investments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_F39D1771C2DB5D248402C15CC3978907" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_F39D1771C2DB5D248402C15CC3978907" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_96B86B5258C9879A795A4F80C91C7369_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_F39D1771C2DB5D248402C15CC3978907" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_96B86B5258C9879A795A4F80C91C7369_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_EFCD39B0AC4D5C0CB67EDD24A90A2060" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_F39D1771C2DB5D248402C15CC3978907" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_EFCD39B0AC4D5C0CB67EDD24A90A2060" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_KazmiraLLCMember" xlink:label="loc_prgo_KazmiraLLCMember_C28B94AEF16A5BB8B2155656ACE0DAB7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_EFCD39B0AC4D5C0CB67EDD24A90A2060" xlink:to="loc_prgo_KazmiraLLCMember_C28B94AEF16A5BB8B2155656ACE0DAB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_DB32F88D0927890A6B1E4F80C91CA113_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_DB32F88D0927890A6B1E4F80C91CA113_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_C8BF2638B3945D468963E9D957640184" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_C8BF2638B3945D468963E9D957640184" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1B2CBF4C129E66BF25504F80C91D8E52_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_C8BF2638B3945D468963E9D957640184" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1B2CBF4C129E66BF25504F80C91D8E52_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F256B4A5EAC95CFBB9B5CE3BF8C3D4BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_C8BF2638B3945D468963E9D957640184" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F256B4A5EAC95CFBB9B5CE3BF8C3D4BB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherExpenseIncomeNetMember" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_06E3AC26AFAF50B586FD7891FF4C59D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F256B4A5EAC95CFBB9B5CE3BF8C3D4BB" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_06E3AC26AFAF50B586FD7891FF4C59D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_EquityMethodInvestmentPeriodforPayment" xlink:label="loc_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/InvestmentsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/Leases" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5D6764E43B105172815B6AD908EF513D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5D6764E43B105172815B6AD908EF513D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_EC18E385E476D2BB4F2058320F394813_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5D6764E43B105172815B6AD908EF513D" xlink:to="loc_us-gaap_SegmentDomain_EC18E385E476D2BB4F2058320F394813_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5D6764E43B105172815B6AD908EF513D" xlink:to="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_DE261E4C6F015D9284D9F5721F7018F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_DE261E4C6F015D9284D9F5721F7018F9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_9501A7214B415F4CB6DE7FE378BB0418" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_9501A7214B415F4CB6DE7FE378BB0418" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_4B20AE90B47351CD9E88F6E5D883DE1F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_prgo_RXPharmaceuticalsMember_4B20AE90B47351CD9E88F6E5D883DE1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_CC7C987C7C935BE997810AEB5B770F89" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_CC7C987C7C935BE997810AEB5B770F89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7A84B25BA4CE5C289023D58D393D523A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7A84B25BA4CE5C289023D58D393D523A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RightofUseAsset" xlink:label="loc_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilities" xlink:label="loc_prgo_LeaseLiabilities_5C52231D014055C2862DE4A4A6F488B2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_prgo_LeaseLiabilities_5C52231D014055C2862DE4A4A6F488B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RestructuringCharges" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1D93448E69AD592C9ACD18CCC81BC90A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1D93448E69AD592C9ACD18CCC81BC90A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_220384FC033841809BE6AFE96D607734_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1D93448E69AD592C9ACD18CCC81BC90A" xlink:to="loc_us-gaap_SegmentDomain_220384FC033841809BE6AFE96D607734_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_DD0E2FCB79225001BF58E592BB3AB81D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1D93448E69AD592C9ACD18CCC81BC90A" xlink:to="loc_us-gaap_SegmentDomain_DD0E2FCB79225001BF58E592BB3AB81D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CSCIMember" xlink:label="loc_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_DD0E2FCB79225001BF58E592BB3AB81D" xlink:to="loc_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_A79DE6BF53385B3180B467518ED75CA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:to="loc_us-gaap_RestructuringCharges_A79DE6BF53385B3180B467518ED75CA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:to="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RestructuringAdditionalCharges" xlink:label="loc_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RestructuringChargesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognition" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:to="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_8188F7CCA6DAE70B1CB4497E488AEF4F_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:to="loc_srt_ProductsAndServicesDomain_8188F7CCA6DAE70B1CB4497E488AEF4F_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:to="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContractManufacturingMember" xlink:label="loc_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:to="loc_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D14F278EA81A56A7803D9E8BD9816374" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D14F278EA81A56A7803D9E8BD9816374" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4C3AA1AD59C357E9BA633E7B16BEA493" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6CDEAA3047BD537B9A9591EAA25A8F7A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4C3AA1AD59C357E9BA633E7B16BEA493" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6CDEAA3047BD537B9A9591EAA25A8F7A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6CDEAA3047BD537B9A9591EAA25A8F7A" xlink:to="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_30714E95422656FBCE624EBBAC2EB245_A723845F03105FE4BAED2415F819685D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:to="loc_srt_SegmentGeographicalDomain_30714E95422656FBCE624EBBAC2EB245_A723845F03105FE4BAED2415F819685D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:to="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherGeographicalAreasMember" xlink:label="loc_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE" xlink:label="loc_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62A69772209B59E694B414AB98A0A5A4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4C3AA1AD59C357E9BA633E7B16BEA493" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62A69772209B59E694B414AB98A0A5A4" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5653F419B67419F10E0F46E067BC6388" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5653F419B67419F10E0F46E067BC6388" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ED616FAFB0F580AC626D46E067B800D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ED616FAFB0F580AC626D46E067B800D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ED616FAFB0F580AC626D46E067B800D7" xlink:to="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ED616FAFB0F580AC626D46E067B800D7" xlink:to="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_7DD6A242FFFD51F5661B46E067B9AC75" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_7DD6A242FFFD51F5661B46E067B9AC75" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_EECF75F314C2922C62C846E067B9649D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_EECF75F314C2922C62C846E067B9649D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_DCBFEF4E90057240620446E067B9E935" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:to="loc_prgo_RXPharmaceuticalsMember_DCBFEF4E90057240620446E067B9E935" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_A5BCD428539613D9C2F146E067B9BC5F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:to="loc_srt_ProductOrServiceAxis_A5BCD428539613D9C2F146E067B9BC5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_A5BCD428539613D9C2F146E067B9BC5F" xlink:to="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_A5BCD428539613D9C2F146E067B9BC5F" xlink:to="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_UpperRespiratoryMember" xlink:label="loc_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DigestiveHealthMember" xlink:label="loc_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PainandSleepaidsMember" xlink:label="loc_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NutritionMember" xlink:label="loc_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HealthyLifestyleMember" xlink:label="loc_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralSelfcareMember" xlink:label="loc_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SkincareandPersonalHygieneMember" xlink:label="loc_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_VitaminsMineralsandSupplementsMember" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AnimalHealthMember" xlink:label="loc_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCSCAMember" xlink:label="loc_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCSCIMember" xlink:label="loc_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_05E64D35BFB9E9C173E746E067BC1D28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5653F419B67419F10E0F46E067BC6388" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_05E64D35BFB9E9C173E746E067BC1D28" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SegmentInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_06AC7A8B15A070E3E8A89879AA724ACE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_06AC7A8B15A070E3E8A89879AA724ACE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_06AC7A8B15A070E3E8A89879AA724ACE" xlink:to="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_06AC7A8B15A070E3E8A89879AA724ACE" xlink:to="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_8E9FF91ADCBB893243619879AA7A1BFC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_prgo_RXPharmaceuticalsMember_8E9FF91ADCBB893243619879AA7A1BFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86D7E3DB764F621DDBE49879AA7C98D1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86D7E3DB764F621DDBE49879AA7C98D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>prgo-20200926_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_23E4270B30EB87ED897285ED3CBA366A_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_51A4077F082F51A3AE59191E01A772E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_51A4077F082F51A3AE59191E01A772E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51A4077F082F51A3AE59191E01A772E4" xlink:to="lab_us-gaap_EarningsPerShareAbstract_51A4077F082F51A3AE59191E01A772E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_3108E33BE6DA09C2643B85ED3CBACBA6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_403437CE3829522F925A900130F44064" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share and Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_3108E33BE6DA09C2643B85ED3CBACBA6_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_403437CE3829522F925A900130F44064" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_403437CE3829522F925A900130F44064" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_403437CE3829522F925A900130F44064" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_403437CE3829522F925A900130F44064" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_58E64A3D60DD52BE7D7D85ED3B9E74BC_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_39B2FF85BC2F514DB2465B8D3FF88F07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_39B2FF85BC2F514DB2465B8D3FF88F07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_39B2FF85BC2F514DB2465B8D3FF88F07" xlink:to="lab_us-gaap_SegmentReportingAbstract_39B2FF85BC2F514DB2465B8D3FF88F07" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_71239A7EF1DA16B8FEEF85ED3B9E8941_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_5C0150773F045588B87E539BE41EB9F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_71239A7EF1DA16B8FEEF85ED3B9E8941_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_5C0150773F045588B87E539BE41EB9F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_5C0150773F045588B87E539BE41EB9F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_5C0150773F045588B87E539BE41EB9F8" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_5C0150773F045588B87E539BE41EB9F8" xlink:type="arc" />
    <link:label id="lab_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C_terseLabel_en-US" xlink:label="lab_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C_label_en-US" xlink:label="lab_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C_documentation_en-US" xlink:label="lab_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Numerator: [Abstract]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumeratorAbstract" xlink:label="loc_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:to="lab_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128" xlink:to="lab_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128" xlink:type="arc" />
    <link:label id="lab_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE_terseLabel_en-US" xlink:label="lab_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE_label_en-US" xlink:label="lab_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:label id="lab_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE_documentation_en-US" xlink:label="lab_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DenominatorAbstract" xlink:label="loc_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:to="lab_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding for basic EPS</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of share-based awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding for diluted EPS</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anti-dilutive share-based awards excluded from computation of diluted EPS (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Repurchases of ordinary shares (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_9238126BFB254D1756B185ED3BAF0D0B_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_E9A011041E9F5F7089B64A5DDDD2FBB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_E9A011041E9F5F7089B64A5DDDD2FBB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_E9A011041E9F5F7089B64A5DDDD2FBB8" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_E9A011041E9F5F7089B64A5DDDD2FBB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_30A3B09DE77581402E2885ED3BAF2CC9_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_47086C0D4ED7587D985EEBC1018499DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_30A3B09DE77581402E2885ED3BAF2CC9_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_47086C0D4ED7587D985EEBC1018499DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_47086C0D4ED7587D985EEBC1018499DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_47086C0D4ED7587D985EEBC1018499DC" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_47086C0D4ED7587D985EEBC1018499DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7E0E8F11C8499BA8146585ED3BAFAD69_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7E0E8F11C8499BA8146585ED3BAFAD69_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ED96194A9AA24DC0CA8085ED3BAF248C_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ABD93A3EC3A85CD69CA97EDCFE548F32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ED96194A9AA24DC0CA8085ED3BAF248C_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ABD93A3EC3A85CD69CA97EDCFE548F32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ABD93A3EC3A85CD69CA97EDCFE548F32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ABD93A3EC3A85CD69CA97EDCFE548F32" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ABD93A3EC3A85CD69CA97EDCFE548F32" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_50043383F328519E2E0185ED3BB08E77_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_C54BAEADFC995E0EA807A44A8A19CFC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_50043383F328519E2E0185ED3BB08E77_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_C54BAEADFC995E0EA807A44A8A19CFC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_C54BAEADFC995E0EA807A44A8A19CFC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_C54BAEADFC995E0EA807A44A8A19CFC0" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_C54BAEADFC995E0EA807A44A8A19CFC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_E08FC955DB7C78884A3A85ED3BB0DA8B_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_EA432CE9AFDD57C5A28B4131DC06D828" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, par value (in EUR per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_E08FC955DB7C78884A3A85ED3BB0DA8B_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_EA432CE9AFDD57C5A28B4131DC06D828" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EA432CE9AFDD57C5A28B4131DC06D828" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_EA432CE9AFDD57C5A28B4131DC06D828" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_EA432CE9AFDD57C5A28B4131DC06D828" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_BD582BDBF83147D7155085ED3BB005E9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_1323AC73D3EA5D67A37159ECB6D0A49E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_BD582BDBF83147D7155085ED3BB005E9_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_1323AC73D3EA5D67A37159ECB6D0A49E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1323AC73D3EA5D67A37159ECB6D0A49E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_1323AC73D3EA5D67A37159ECB6D0A49E" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_1323AC73D3EA5D67A37159ECB6D0A49E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_0E7E9A8AC18D4A56BC3747475E9636FB_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_0E7E9A8AC18D4A56BC3747475E9636FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0E7E9A8AC18D4A56BC3747475E9636FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0E7E9A8AC18D4A56BC3747475E9636FB" xlink:to="lab_us-gaap_DebtDisclosureAbstract_0E7E9A8AC18D4A56BC3747475E9636FB" xlink:type="arc" />
    <link:label id="lab_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9_label_en-US" xlink:label="lab_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9_documentation_en-US" xlink:label="lab_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfDebtInstrumentsTable" xlink:label="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:to="lab_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:to="lab_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:type="arc" />
    <link:label id="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A_terseLabel_en-US" xlink:label="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019 Term loan due August 15, 2022</link:label>
    <link:label id="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A_label_en-US" xlink:label="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2019 Euro-Denominated Term Loan due August 15, 2022 [Member]</link:label>
    <link:label id="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A_documentation_en-US" xlink:label="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2019 Euro-Denominated Term Loan due August 15, 2022 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:to="lab_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:type="arc" />
    <link:label id="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D_terseLabel_en-US" xlink:label="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.500% Unsecured Senior notes due March 15, 2021</link:label>
    <link:label id="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D_label_en-US" xlink:label="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.500% Unsecured Senior notes due March 15, 2021 [Member]</link:label>
    <link:label id="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D_documentation_en-US" xlink:label="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.500% Unsecured Senior notes due March 15, 2021 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:to="lab_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:type="arc" />
    <link:label id="lab_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF_terseLabel_en-US" xlink:label="lab_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.500% Senior note due December 15, 2021</link:label>
    <link:label id="lab_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF_label_en-US" xlink:label="lab_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.5% Senior note due December 15, 2021 [Member]</link:label>
    <link:label id="lab_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF_documentation_en-US" xlink:label="lab_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.5% Senior note due 2021 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.5SeniornotedueDecember152021Member" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:to="lab_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:type="arc" />
    <link:label id="lab_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C_terseLabel_en-US" xlink:label="lab_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.105% Senior note due July 28, 2023</link:label>
    <link:label id="lab_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C_label_en-US" xlink:label="lab_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.105% Senior note due July 28, 2023 [Member]</link:label>
    <link:label id="lab_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C_documentation_en-US" xlink:label="lab_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.105% Senior note due July 28, 2023 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A5.105SeniornotedueJuly282023Member" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:to="lab_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:type="arc" />
    <link:label id="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98_terseLabel_en-US" xlink:label="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.00% unsecured senior notes due November 15, 2023</link:label>
    <link:label id="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98_label_en-US" xlink:label="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.00% Unsecured Senior Notes due November 15, 2023 [Member]</link:label>
    <link:label id="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98_documentation_en-US" xlink:label="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.00% Unsecured Senior Notes due November 15, 2023 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:to="lab_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:type="arc" />
    <link:label id="lab_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196_terseLabel_en-US" xlink:label="lab_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.9% senior note due December 15, 2024</link:label>
    <link:label id="lab_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196_label_en-US" xlink:label="lab_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.9% senior note due 2024 [Member]</link:label>
    <link:label id="lab_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196_documentation_en-US" xlink:label="lab_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.9% senior note due 2024 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.9seniornotedue2024Member" xlink:label="loc_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:to="lab_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:type="arc" />
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303_terseLabel_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.375% senior note due March 15, 2026</link:label>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303_label_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.375% senior note due March 15, 2026 [Member]</link:label>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303_documentation_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.375% senior note due March 15, 2026 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.375seniornotedueMarch152026Member" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:to="lab_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:type="arc" />
    <link:label id="lab_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429_terseLabel_en-US" xlink:label="lab_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.150% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429_label_en-US" xlink:label="lab_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.150% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429_documentation_en-US" xlink:label="lab_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.150% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.150SeniorNotesdueJune152030Member" xlink:label="loc_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:to="lab_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:type="arc" />
    <link:label id="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5_terseLabel_en-US" xlink:label="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.30% unsecured senior notes due November 15, 2043</link:label>
    <link:label id="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5_label_en-US" xlink:label="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.30% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:label id="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5_documentation_en-US" xlink:label="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.30% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:to="lab_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:type="arc" />
    <link:label id="lab_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C_terseLabel_en-US" xlink:label="lab_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.9% senior notes due December 15, 2044</link:label>
    <link:label id="lab_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C_label_en-US" xlink:label="lab_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.9% Senior Loan due 2044 [Member]</link:label>
    <link:label id="lab_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C_documentation_en-US" xlink:label="lab_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.9% Senior Loan due 2044 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.9SeniorLoandue2044Member" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:to="lab_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="lab_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD_label_en-US" xlink:label="lab_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:to="lab_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Description</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:to="lab_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2_netLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Notes and Bonds</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2_label_en-US" xlink:label="lab_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:to="lab_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:to="lab_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unamortized premium (discount), net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred financing fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Current indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128_label_en-US" xlink:label="lab_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:to="lab_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_D09AB338C848BF336BE7A5F7DC616A63_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_1A117DF85D9F568780AD7B0C244EF17F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1A117DF85D9F568780AD7B0C244EF17F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1A117DF85D9F568780AD7B0C244EF17F" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_1A117DF85D9F568780AD7B0C244EF17F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_4E571DF239A0AC146DB1A5F7DC627C40_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_4E571DF239A0AC146DB1A5F7DC627C40_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_20F0D8DB51CC23549B1AA5F7DC62B608_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_422308B4BDB55C338C8A1CB03ED79D6A" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_422308B4BDB55C338C8A1CB03ED79D6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_422308B4BDB55C338C8A1CB03ED79D6A" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_422308B4BDB55C338C8A1CB03ED79D6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_7880AA8B567D492EE960A5F7DC62435C_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_D6723707C9FA5DA6AC16DF9DC27F0EAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for credit losses, net</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_7880AA8B567D492EE960A5F7DC62435C_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_D6723707C9FA5DA6AC16DF9DC27F0EAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_D6723707C9FA5DA6AC16DF9DC27F0EAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_D6723707C9FA5DA6AC16DF9DC27F0EAB" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_D6723707C9FA5DA6AC16DF9DC27F0EAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CEA904D122ACCCB02D18A5F7DC633FD8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CBC76B7780585672B29B4A805FBB68C9" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Receivables written-off</link:label>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CEA904D122ACCCB02D18A5F7DC633FD8_label_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CBC76B7780585672B29B4A805FBB68C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for Loan and Lease Losses, Write-offs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CBC76B7780585672B29B4A805FBB68C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CBC76B7780585672B29B4A805FBB68C9" xlink:to="lab_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CBC76B7780585672B29B4A805FBB68C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_3839CF4580770642C848A5F7DC63440C_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_FD5C2DA28B745442B7F8FCFCC8847830" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recoveries collected</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_3839CF4580770642C848A5F7DC63440C_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_FD5C2DA28B745442B7F8FCFCC8847830" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_FD5C2DA28B745442B7F8FCFCC8847830" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_FD5C2DA28B745442B7F8FCFCC8847830" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_FD5C2DA28B745442B7F8FCFCC8847830" xlink:type="arc" />
    <link:label id="lab_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_DB551E2A15B08F7AA6CCA5F7DC63D409_terseLabel_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_DB551E2A15B08F7AA6CCA5F7DC63D409_label_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</link:label>
    <link:label id="lab_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_DB551E2A15B08F7AA6CCA5F7DC63D409_documentation_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:label="loc_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:to="lab_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_40D35EABC766B041DC43A5F7DC63F764_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_0CEB8EB1BD54551EAEF83EF0DDAF749B" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0CEB8EB1BD54551EAEF83EF0DDAF749B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0CEB8EB1BD54551EAEF83EF0DDAF749B" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_0CEB8EB1BD54551EAEF83EF0DDAF749B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeasesAbstract_630607532CF35571B54E4F80C8C0B6F6_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract_52815F92E6DF573E8A7E1E11CD3B32F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_52815F92E6DF573E8A7E1E11CD3B32F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_52815F92E6DF573E8A7E1E11CD3B32F6" xlink:to="lab_us-gaap_LeasesAbstract_52815F92E6DF573E8A7E1E11CD3B32F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseCost_514803C1CB8876ADD6504F80C8C0ABF7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_A93853146A5D50D5BB4C4BA987BFD0D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_514803C1CB8876ADD6504F80C8C0ABF7_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_A93853146A5D50D5BB4C4BA987BFD0D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_A93853146A5D50D5BB4C4BA987BFD0D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost_A93853146A5D50D5BB4C4BA987BFD0D6" xlink:to="lab_us-gaap_OperatingLeaseCost_A93853146A5D50D5BB4C4BA987BFD0D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_607147FC03DCDC0CE8044F80C8C03AFA_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_607147FC03DCDC0CE8044F80C8C03AFA_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0FB73C158BF8D850A6514F80C8C0DD63_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_18AD06D45F7552B4B7F6F8B953FC63F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0FB73C158BF8D850A6514F80C8C0DD63_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_18AD06D45F7552B4B7F6F8B953FC63F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_18AD06D45F7552B4B7F6F8B953FC63F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_18AD06D45F7552B4B7F6F8B953FC63F4" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_18AD06D45F7552B4B7F6F8B953FC63F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_0880FCB5B6A750DA0CBD4F80C8C1E58E_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense_1B9D96F365D759BE9CA63043731521BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_0880FCB5B6A750DA0CBD4F80C8C1E58E_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense_1B9D96F365D759BE9CA63043731521BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_1B9D96F365D759BE9CA63043731521BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense_1B9D96F365D759BE9CA63043731521BD" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense_1B9D96F365D759BE9CA63043731521BD" xlink:type="arc" />
    <link:label id="lab_prgo_FinanceLeaseCost_64D2DDFC87DA8254B5044F80C8C18C14_totalLabel_en-US" xlink:label="lab_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total finance leases</link:label>
    <link:label id="lab_prgo_FinanceLeaseCost_64D2DDFC87DA8254B5044F80C8C18C14_label_en-US" xlink:label="lab_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_prgo_FinanceLeaseCost_64D2DDFC87DA8254B5044F80C8C18C14_documentation_en-US" xlink:label="lab_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FinanceLeaseCost" xlink:label="loc_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:to="lab_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_FD2DD5EAF798F5A353A585ED3D50967C_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D91E5DCAE4F75AEFABBB408773FEDCC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D91E5DCAE4F75AEFABBB408773FEDCC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D91E5DCAE4F75AEFABBB408773FEDCC8" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D91E5DCAE4F75AEFABBB408773FEDCC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_A2BA31CD170003C3911285ED3D5018B3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_B496013DE38753D9824ADB9801D3DE96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_A2BA31CD170003C3911285ED3D5018B3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_B496013DE38753D9824ADB9801D3DE96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_B496013DE38753D9824ADB9801D3DE96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_B496013DE38753D9824ADB9801D3DE96" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_B496013DE38753D9824ADB9801D3DE96" xlink:type="arc" />
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_D15B7DD31E2204D2924485ED3D5104A7_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite and Indefinite-lived Intangible Assets</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_D15B7DD31E2204D2924485ED3D5104A7_label_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_D15B7DD31E2204D2924485ED3D5104A7_documentation_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:to="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_A69A17CDCEB88B25858F85ED3C360BC3_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract_77CDD74AE5125E9DB4623A3856340056" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77CDD74AE5125E9DB4623A3856340056" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77CDD74AE5125E9DB4623A3856340056" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract_77CDD74AE5125E9DB4623A3856340056" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_A6DC5475C084478A3C3585ED3C36CD56_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_039171E9C8F65AB4B47D246F7900A019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_A6DC5475C084478A3C3585ED3C36CD56_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_039171E9C8F65AB4B47D246F7900A019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_039171E9C8F65AB4B47D246F7900A019" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_039171E9C8F65AB4B47D246F7900A019" xlink:to="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_039171E9C8F65AB4B47D246F7900A019" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_14A1172AC5B4C97F3A9F80FB451A2229_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_B730A1D72A3B5C1F999BB5B5FAAF688E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_B730A1D72A3B5C1F999BB5B5FAAF688E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_B730A1D72A3B5C1F999BB5B5FAAF688E" xlink:to="lab_us-gaap_IncomeStatementAbstract_B730A1D72A3B5C1F999BB5B5FAAF688E" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_12A0C10355840668CF6A80FB451A54B5_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList_C9AEDF69DB9F5259BEE805028000FA96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_12A0C10355840668CF6A80FB451A54B5_label_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList_C9AEDF69DB9F5259BEE805028000FA96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRevenueExtensibleList" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList_C9AEDF69DB9F5259BEE805028000FA96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRevenueExtensibleList_C9AEDF69DB9F5259BEE805028000FA96" xlink:to="lab_us-gaap_TypeOfRevenueExtensibleList_C9AEDF69DB9F5259BEE805028000FA96" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_72D9CE0AEE48C8FF6B8380FB451A140A_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_8DE17555A4505A18950FEFA9FB251BE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_72D9CE0AEE48C8FF6B8380FB451A140A_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_8DE17555A4505A18950FEFA9FB251BE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_8DE17555A4505A18950FEFA9FB251BE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_8DE17555A4505A18950FEFA9FB251BE8" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_8DE17555A4505A18950FEFA9FB251BE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_FF94A3D1B46225FB7FBC85ED3CD5D04D_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_E062A38D307D50419D94D9605055FC74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_E062A38D307D50419D94D9605055FC74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_E062A38D307D50419D94D9605055FC74" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_E062A38D307D50419D94D9605055FC74" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_73D0F72C285587BF0E6385ED3CD5C789_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_6E5D5C6D96D552048FCC86134ADEB248" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_73D0F72C285587BF0E6385ED3CD5C789_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_6E5D5C6D96D552048FCC86134ADEB248" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6E5D5C6D96D552048FCC86134ADEB248" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_6E5D5C6D96D552048FCC86134ADEB248" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_6E5D5C6D96D552048FCC86134ADEB248" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_34E1FD88B0ADBD15F29085ED3BA018F3_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:to="lab_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryFinishedGoods_B1874ECFDB43EF65DBE185ED3BA13ED2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods_0A02571BED8A5CC78F3AA10FC392F6E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_B1874ECFDB43EF65DBE185ED3BA13ED2_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods_0A02571BED8A5CC78F3AA10FC392F6E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_0A02571BED8A5CC78F3AA10FC392F6E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods_0A02571BED8A5CC78F3AA10FC392F6E4" xlink:to="lab_us-gaap_InventoryFinishedGoods_0A02571BED8A5CC78F3AA10FC392F6E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWorkInProcess_31AFE81B81B97B0DB6E685ED3BA151B4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess_3A50A946793C5CBD9C5BFA38129C1466" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_31AFE81B81B97B0DB6E685ED3BA151B4_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess_3A50A946793C5CBD9C5BFA38129C1466" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaap_InventoryWorkInProcess_3A50A946793C5CBD9C5BFA38129C1466" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess_3A50A946793C5CBD9C5BFA38129C1466" xlink:to="lab_us-gaap_InventoryWorkInProcess_3A50A946793C5CBD9C5BFA38129C1466" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRawMaterials_8052F004C59ECFA80C1785ED3BA18419_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials_4D3AE61520E85709BBD3173ABC5FC98B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_8052F004C59ECFA80C1785ED3BA18419_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials_4D3AE61520E85709BBD3173ABC5FC98B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_4D3AE61520E85709BBD3173ABC5FC98B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials_4D3AE61520E85709BBD3173ABC5FC98B" xlink:to="lab_us-gaap_InventoryRawMaterials_4D3AE61520E85709BBD3173ABC5FC98B" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_944508D6C9B11A83DC2E85ED3BA1F7FE_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_EB64BEBEDE945EBCAE1F7BAB7EA3960D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_944508D6C9B11A83DC2E85ED3BA1F7FE_label_en-US" xlink:label="lab_us-gaap_InventoryNet_EB64BEBEDE945EBCAE1F7BAB7EA3960D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_EB64BEBEDE945EBCAE1F7BAB7EA3960D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_EB64BEBEDE945EBCAE1F7BAB7EA3960D" xlink:to="lab_us-gaap_InventoryNet_EB64BEBEDE945EBCAE1F7BAB7EA3960D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_FBEF1ED022303AA0F35985ED3C2DBD28_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:type="arc" />
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_76F725CCBBC670C4847485ED3C2D62F7_terseLabel_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts</link:label>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_76F725CCBBC670C4847485ED3C2D62F7_label_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_76F725CCBBC670C4847485ED3C2D62F7_documentation_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts [Table Text Block]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:label="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:to="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_315D5C4F4942098E652E85ED3C2D3D59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2DBD69CDC7525F53B7EC3455CFE610E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_315D5C4F4942098E652E85ED3C2D3D59_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2DBD69CDC7525F53B7EC3455CFE610E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2DBD69CDC7525F53B7EC3455CFE610E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2DBD69CDC7525F53B7EC3455CFE610E4" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2DBD69CDC7525F53B7EC3455CFE610E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_98E807C0683BF414AFDA85ED3C2DAE1A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EC43E1AB15EC55EBB615710D98CFB70F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_98E807C0683BF414AFDA85ED3C2DAE1A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EC43E1AB15EC55EBB615710D98CFB70F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EC43E1AB15EC55EBB615710D98CFB70F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EC43E1AB15EC55EBB615710D98CFB70F" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EC43E1AB15EC55EBB615710D98CFB70F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_6131CBD737950C31A3D985ED3C2DF6E0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_50086BF860EB586A955A91755A718EE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain/(Loss) Recognized against Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_6131CBD737950C31A3D985ED3C2DF6E0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_50086BF860EB586A955A91755A718EE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_50086BF860EB586A955A91755A718EE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_50086BF860EB586A955A91755A718EE9" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_50086BF860EB586A955A91755A718EE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_62E87B957C759788680985ED3C2DEB77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_37B2B58FD3485FCB9FB23DDA1E659CA1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classification of Gain (Loss) Recognized in Earnings on Fair Value and Cash Flow Hedging Relationships</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_62E87B957C759788680985ED3C2DEB77_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_37B2B58FD3485FCB9FB23DDA1E659CA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_37B2B58FD3485FCB9FB23DDA1E659CA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_37B2B58FD3485FCB9FB23DDA1E659CA1" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_37B2B58FD3485FCB9FB23DDA1E659CA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of derivative financial instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in post-retirement and pension liability, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39" xlink:type="arc" />
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_34C82D837175845E377D7C8B2644D1CA_terseLabel_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location of Lease Assets and Liabilities</link:label>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_34C82D837175845E377D7C8B2644D1CA_label_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_34C82D837175845E377D7C8B2644D1CA_documentation_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:label="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:to="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_130F5473E3247BC87B0E7C8B2644BC50_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_F2328572073658EAB5D2115FBDB97753" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_130F5473E3247BC87B0E7C8B2644BC50_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_F2328572073658EAB5D2115FBDB97753" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_F2328572073658EAB5D2115FBDB97753" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_F2328572073658EAB5D2115FBDB97753" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_F2328572073658EAB5D2115FBDB97753" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_F957BE45C11439192AF67C8B2644CAF3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_B4987C4237D45CEA8C5759671F1C606D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_F957BE45C11439192AF67C8B2644CAF3_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_B4987C4237D45CEA8C5759671F1C606D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_B4987C4237D45CEA8C5759671F1C606D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_B4987C4237D45CEA8C5759671F1C606D" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_B4987C4237D45CEA8C5759671F1C606D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_972CD6A64632DFC6AA5A7C8B2645BC19_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C08EB032E9855A59B9038D36625C7D8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease Liability Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_972CD6A64632DFC6AA5A7C8B2645BC19_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C08EB032E9855A59B9038D36625C7D8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C08EB032E9855A59B9038D36625C7D8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C08EB032E9855A59B9038D36625C7D8C" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C08EB032E9855A59B9038D36625C7D8C" xlink:type="arc" />
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_E113E6902CE6ED4426A97C8B26452459_terseLabel_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Lease Terms and Discount Rates</link:label>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_E113E6902CE6ED4426A97C8B26452459_label_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_E113E6902CE6ED4426A97C8B26452459_documentation_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:label="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:to="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:type="arc" />
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_768F2B1FD898AB5684EE7C8B26451E4E_terseLabel_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Cash Flow Classifications</link:label>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_768F2B1FD898AB5684EE7C8B26451E4E_label_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Cash Flow Classifications [Table Text Block]</link:label>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_768F2B1FD898AB5684EE7C8B26451E4E_documentation_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Cash Flow Classifications [Table Text Block]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:label="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:to="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:to="lab_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:type="arc" />
    <link:label id="lab_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858_terseLabel_en-US" xlink:label="lab_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kazmira, LLC</link:label>
    <link:label id="lab_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858_label_en-US" xlink:label="lab_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kazmira, LLC [Member]</link:label>
    <link:label id="lab_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858_documentation_en-US" xlink:label="lab_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kazmira, LLC [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_KazmiraLLCMember" xlink:label="loc_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:to="lab_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:type="arc" />
    <link:label id="lab_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3_terseLabel_en-US" xlink:label="lab_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018 Revolver due March 8, 2023</link:label>
    <link:label id="lab_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3_label_en-US" xlink:label="lab_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2018 Revolver [Member]</link:label>
    <link:label id="lab_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3_documentation_en-US" xlink:label="lab_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2018 Revolver [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2018RevolverMember" xlink:label="loc_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:to="lab_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:type="arc" />
    <link:label id="lab_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211_terseLabel_en-US" xlink:label="lab_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2014 Term loan due December 5, 2019</link:label>
    <link:label id="lab_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211_label_en-US" xlink:label="lab_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2014 Euro-Denominated Term Loan due December 5, 2019 [Member]</link:label>
    <link:label id="lab_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211_documentation_en-US" xlink:label="lab_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2014 Euro-Denominated Term Loan due December 5, 2019 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2014EuroDenominatedTermLoandueDecember52019Member" xlink:label="loc_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:to="lab_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:type="arc" />
    <link:label id="lab_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E_terseLabel_en-US" xlink:label="lab_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018 Term loan due March 8, 2020</link:label>
    <link:label id="lab_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E_label_en-US" xlink:label="lab_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2018 Euro-Denominated Term Loan due March 8, 2020 [Member]</link:label>
    <link:label id="lab_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E_documentation_en-US" xlink:label="lab_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2018 Euro-Denominated Term Loan due March 8, 2020 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2018EuroDenominatedTermLoandueMarch82020Member" xlink:label="loc_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:to="lab_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:type="arc" />
    <link:label id="lab_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22_terseLabel_en-US" xlink:label="lab_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note due November 2020</link:label>
    <link:label id="lab_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22_label_en-US" xlink:label="lab_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note due November 2020 [Member]</link:label>
    <link:label id="lab_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22_documentation_en-US" xlink:label="lab_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note due November 2020 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueNovember2020Member" xlink:label="loc_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:to="lab_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:type="arc" />
    <link:label id="lab_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA_terseLabel_en-US" xlink:label="lab_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note due May 2021</link:label>
    <link:label id="lab_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA_label_en-US" xlink:label="lab_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note due May 2021 [Member]</link:label>
    <link:label id="lab_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA_documentation_en-US" xlink:label="lab_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note due May 2021 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueMay2021Member" xlink:label="loc_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:to="lab_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:type="arc" />
    <link:label id="lab_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF_terseLabel_en-US" xlink:label="lab_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note due November 2021</link:label>
    <link:label id="lab_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF_label_en-US" xlink:label="lab_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note due November 2021 [Member]</link:label>
    <link:label id="lab_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF_documentation_en-US" xlink:label="lab_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note due November 2021 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueNovember2021Member" xlink:label="loc_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:to="lab_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:type="arc" />
    <link:label id="lab_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3_terseLabel_en-US" xlink:label="lab_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes due 2021</link:label>
    <link:label id="lab_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3_label_en-US" xlink:label="lab_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3_documentation_en-US" xlink:label="lab_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes due 2021 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SeniorNotesdue2021Member" xlink:label="loc_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:to="lab_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114_label_en-US" xlink:label="lab_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:to="lab_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:to="lab_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from issuance of senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:to="lab_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Promissory notes</link:label>
    <link:label id="lab_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2_label_en-US" xlink:label="lab_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:to="lab_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE_terseLabel_en-US" xlink:label="lab_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of promissory notes</link:label>
    <link:label id="lab_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE_label_en-US" xlink:label="lab_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Promissory Notes</link:label>
    <link:label id="lab_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE_documentation_en-US" xlink:label="lab_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Promissory Notes</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofPromissoryNotes" xlink:label="loc_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:to="lab_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ADAF4407771B3182A3044F371DF203A6_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_73FB81186A78D7DE6E164F371DF2E332_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7FCFAE52EDB65E4D87E0C0236C626B91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring and Nonrecurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_73FB81186A78D7DE6E164F371DF2E332_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7FCFAE52EDB65E4D87E0C0236C626B91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7FCFAE52EDB65E4D87E0C0236C626B91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7FCFAE52EDB65E4D87E0C0236C626B91" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7FCFAE52EDB65E4D87E0C0236C626B91" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_BA03FCB550E316BE1FB24F371DF2CA35_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90303C696297512EAE0A1EA4C56B45CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_BA03FCB550E316BE1FB24F371DF2CA35_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90303C696297512EAE0A1EA4C56B45CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90303C696297512EAE0A1EA4C56B45CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90303C696297512EAE0A1EA4C56B45CD" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90303C696297512EAE0A1EA4C56B45CD" xlink:type="arc" />
    <link:label id="lab_prgo_ScheduleofFairValueAssumptionsTableTextBlock_7A91AA301F56A18DCD7A4F371DF228D1_terseLabel_en-US" xlink:label="lab_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Assumptions</link:label>
    <link:label id="lab_prgo_ScheduleofFairValueAssumptionsTableTextBlock_7A91AA301F56A18DCD7A4F371DF228D1_label_en-US" xlink:label="lab_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Assumptions [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleofFairValueAssumptionsTableTextBlock_7A91AA301F56A18DCD7A4F371DF228D1_documentation_en-US" xlink:label="lab_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Assumptions [Table Text Block]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleofFairValueAssumptionsTableTextBlock" xlink:label="loc_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:to="lab_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_637110CAE4D84AC3D8D94F371DF3B102_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1C61EC3198A755599B4BA05EE76DB166" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Level 3 Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_637110CAE4D84AC3D8D94F371DF3B102_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1C61EC3198A755599B4BA05EE76DB166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1C61EC3198A755599B4BA05EE76DB166" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1C61EC3198A755599B4BA05EE76DB166" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1C61EC3198A755599B4BA05EE76DB166" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3E8651C7D05E97E7BE2E4F371DF38774_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_594546008700513581ACE37C06E4FA72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3E8651C7D05E97E7BE2E4F371DF38774_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_594546008700513581ACE37C06E4FA72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_594546008700513581ACE37C06E4FA72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_594546008700513581ACE37C06E4FA72" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_594546008700513581ACE37C06E4FA72" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_A24DDD4AEC77D85A1D194F371DF303DF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_17731D1D36D85B949F7C5E8A0686E645" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_A24DDD4AEC77D85A1D194F371DF303DF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_17731D1D36D85B949F7C5E8A0686E645" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_17731D1D36D85B949F7C5E8A0686E645" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_17731D1D36D85B949F7C5E8A0686E645" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_17731D1D36D85B949F7C5E8A0686E645" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:type="arc" />
    <link:label id="lab_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C_label_en-US" xlink:label="lab_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:to="lab_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:type="arc" />
    <link:label id="lab_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="lab_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:type="arc" />
    <link:label id="lab_currency_ILS_363A1E416A66AE052BB546E066F2B101_terseLabel_en-US" xlink:label="lab_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Israeli Shekel (ILS)</link:label>
    <link:label id="lab_currency_ILS_363A1E416A66AE052BB546E066F2B101_label_en-US" xlink:label="lab_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Israel, New Shekels</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_ILS" xlink:label="loc_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:to="lab_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:type="arc" />
    <link:label id="lab_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7_terseLabel_en-US" xlink:label="lab_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">European Euro (EUR)</link:label>
    <link:label id="lab_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7_label_en-US" xlink:label="lab_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:to="lab_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:type="arc" />
    <link:label id="lab_currency_USD_7392EF81AC73535C020346E066F26CFC_terseLabel_en-US" xlink:label="lab_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States Dollar (USD)</link:label>
    <link:label id="lab_currency_USD_7392EF81AC73535C020346E066F26CFC_label_en-US" xlink:label="lab_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD" xlink:label="loc_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:to="lab_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:type="arc" />
    <link:label id="lab_currency_DKK_BBB6F0F950E374DD495346E066F358BC_terseLabel_en-US" xlink:label="lab_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Danish Krone (DKK)</link:label>
    <link:label id="lab_currency_DKK_BBB6F0F950E374DD495346E066F358BC_label_en-US" xlink:label="lab_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Denmark, Kroner</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_DKK" xlink:label="loc_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:to="lab_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:type="arc" />
    <link:label id="lab_currency_GBP_A49561C470BAFE114EED46E066F3F7C3_terseLabel_en-US" xlink:label="lab_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">British Pound (GBP)</link:label>
    <link:label id="lab_currency_GBP_A49561C470BAFE114EED46E066F3F7C3_label_en-US" xlink:label="lab_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP" xlink:label="loc_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:to="lab_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:type="arc" />
    <link:label id="lab_currency_SEK_830B4F1825742FF35E9C46E066F3301F_terseLabel_en-US" xlink:label="lab_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Swedish Krona (SEK)</link:label>
    <link:label id="lab_currency_SEK_830B4F1825742FF35E9C46E066F3301F_label_en-US" xlink:label="lab_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sweden, Kronor</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SEK" xlink:label="loc_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:to="lab_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:type="arc" />
    <link:label id="lab_currency_CNY_DDC43703595D0C133D3C46E066F37A18_terseLabel_en-US" xlink:label="lab_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chinese Yuan (CNY)</link:label>
    <link:label id="lab_currency_CNY_DDC43703595D0C133D3C46E066F37A18_label_en-US" xlink:label="lab_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CNY" xlink:label="loc_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:to="lab_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:type="arc" />
    <link:label id="lab_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7_terseLabel_en-US" xlink:label="lab_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canadian Dollar (CAD)</link:label>
    <link:label id="lab_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7_label_en-US" xlink:label="lab_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CAD" xlink:label="loc_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:to="lab_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:type="arc" />
    <link:label id="lab_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9_terseLabel_en-US" xlink:label="lab_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Polish Zloty (PLZ)</link:label>
    <link:label id="lab_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9_label_en-US" xlink:label="lab_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Poland, Zlotych</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_PLN" xlink:label="loc_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:to="lab_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:type="arc" />
    <link:label id="lab_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB_terseLabel_en-US" xlink:label="lab_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mexican Peso (MPX)</link:label>
    <link:label id="lab_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB_label_en-US" xlink:label="lab_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_MXN" xlink:label="loc_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:to="lab_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:type="arc" />
    <link:label id="lab_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F_terseLabel_en-US" xlink:label="lab_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Norwegian Krone (NOK)</link:label>
    <link:label id="lab_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F_label_en-US" xlink:label="lab_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Norway, Krone</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_NOK" xlink:label="loc_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:to="lab_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:type="arc" />
    <link:label id="lab_currency_CHF_8D8F68A692A0262F66F646E066F497FA_terseLabel_en-US" xlink:label="lab_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Switzerland Franc (CHF)</link:label>
    <link:label id="lab_currency_CHF_8D8F68A692A0262F66F646E066F497FA_label_en-US" xlink:label="lab_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Switzerland, Francs</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CHF" xlink:label="loc_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:to="lab_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:type="arc" />
    <link:label id="lab_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149_terseLabel_en-US" xlink:label="lab_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Romanian New Leu (RON)</link:label>
    <link:label id="lab_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149_label_en-US" xlink:label="lab_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Romania, New Lei</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_RON" xlink:label="loc_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:to="lab_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:type="arc" />
    <link:label id="lab_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F_terseLabel_en-US" xlink:label="lab_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F_label_en-US" xlink:label="lab_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">No currency</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_XXX" xlink:label="loc_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:to="lab_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:to="lab_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:to="lab_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:to="lab_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:type="arc" />
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum remaining maturity of foreign currency derivatives</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2E69621D79C882E2255FC23AD87105AD_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_2E69621D79C882E2255FC23AD87105AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2E69621D79C882E2255FC23AD87105AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2E69621D79C882E2255FC23AD87105AD" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_2E69621D79C882E2255FC23AD87105AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C96AE40E4685194A6D0985ED3BB42D01_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C96AE40E4685194A6D0985ED3BB42D01_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_1F80448F962DA2D0602585ED3BB59B0B_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_1F80448F962DA2D0602585ED3BB59B0B_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_F119D272D0E65BA9F99E85ED3BB5A7FF_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_F119D272D0E65BA9F99E85ED3BB5A7FF_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_2D83A7766FB8832A972585ED3BB68667_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_2D83A7766FB8832A972585ED3BB68667_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:type="arc" />
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_17F20EDD54ADC007F4F585ED3BB6FEC9_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_17F20EDD54ADC007F4F585ED3BB6FEC9_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:type="arc" />
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_1AEE48BBBD7516988A2685ED3BB60BD6_verboseLabel_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Public Bonds</link:label>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_1AEE48BBBD7516988A2685ED3BB60BD6_label_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Public Bonds and Private Placement [Member]</link:label>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_1AEE48BBBD7516988A2685ED3BB60BD6_documentation_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Bonds and Private Placement</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PublicBondsandPrivatePlacementMember" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:to="lab_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:type="arc" />
    <link:label id="lab_prgo_PrivatePlacementNoteMember_8341D536068FB9A0A59885ED3BB79DA4_terseLabel_en-US" xlink:label="lab_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private placement note</link:label>
    <link:label id="lab_prgo_PrivatePlacementNoteMember_8341D536068FB9A0A59885ED3BB79DA4_label_en-US" xlink:label="lab_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement Note [Member]</link:label>
    <link:label id="lab_prgo_PrivatePlacementNoteMember_8341D536068FB9A0A59885ED3BB79DA4_documentation_en-US" xlink:label="lab_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Private Placement Note [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PrivatePlacementNoteMember" xlink:label="loc_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:to="lab_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_7168BC9E092FCA2D8B1185ED3BB7C620_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_7168BC9E092FCA2D8B1185ED3BB7C620_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2DDD445488325CF6B24685ED3BB7F162_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2DDD445488325CF6B24685ED3BB7F162_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0A19DD8E68FC563CDF8A85ED3BB8FAE7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0A19DD8E68FC563CDF8A85ED3BB8FAE7_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_79B5A26A18121834231985ED3BB8FE76_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_79B5A26A18121834231985ED3BB8FE76_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5B7B8E08BF7808BB142C85ED3BB82EE8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5B7B8E08BF7808BB142C85ED3BB82EE8_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorNotes_DB5078E6C15A7852171F85ED3BB8B5E2_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Public bonds</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:to="lab_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_6D5EEA4709D6826E7AB885ED3BB9B4AA_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Private placement note</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_6D5EEA4709D6826E7AB885ED3BB9B4AA_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:to="lab_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6955941FD307030FD3F985ED3DBA5CC1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_BF12312B702658F1AE5CADA7BAC5DCCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Components of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6955941FD307030FD3F985ED3DBA5CC1_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_BF12312B702658F1AE5CADA7BAC5DCCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_BF12312B702658F1AE5CADA7BAC5DCCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_BF12312B702658F1AE5CADA7BAC5DCCE" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_BF12312B702658F1AE5CADA7BAC5DCCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_6F984441C6E0B38AB1A38A65D7A6254B_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_6F984441C6E0B38AB1A38A65D7A6254B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6F984441C6E0B38AB1A38A65D7A6254B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6F984441C6E0B38AB1A38A65D7A6254B" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_6F984441C6E0B38AB1A38A65D7A6254B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:to="lab_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed product technology, formulations, and product rights</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:type="arc" />
    <link:label id="lab_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9_terseLabel_en-US" xlink:label="lab_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Brand</link:label>
    <link:label id="lab_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9_label_en-US" xlink:label="lab_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Brand [Member]</link:label>
    <link:label id="lab_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9_documentation_en-US" xlink:label="lab_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Brand [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BrandMember" xlink:label="loc_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:to="lab_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:type="arc" />
    <link:label id="lab_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB_terseLabel_en-US" xlink:label="lab_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sanofi Brands</link:label>
    <link:label id="lab_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB_label_en-US" xlink:label="lab_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sanofi Brands [Member]</link:label>
    <link:label id="lab_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB_documentation_en-US" xlink:label="lab_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sanofi Brands [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SanofiBrandsMember" xlink:label="loc_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:to="lab_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:type="arc" />
    <link:label id="lab_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1_terseLabel_en-US" xlink:label="lab_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dexsil</link:label>
    <link:label id="lab_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1_label_en-US" xlink:label="lab_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dexsil [Member]</link:label>
    <link:label id="lab_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1_documentation_en-US" xlink:label="lab_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dexsil [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DexsilMember" xlink:label="loc_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:to="lab_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:type="arc" />
    <link:label id="lab_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99_terseLabel_en-US" xlink:label="lab_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Steripod</link:label>
    <link:label id="lab_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99_label_en-US" xlink:label="lab_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Steripod [Member]</link:label>
    <link:label id="lab_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99_documentation_en-US" xlink:label="lab_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Steripod [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SteripodMember" xlink:label="loc_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:to="lab_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:type="arc" />
    <link:label id="lab_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7_terseLabel_en-US" xlink:label="lab_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Generic Product Acquisition</link:label>
    <link:label id="lab_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7_label_en-US" xlink:label="lab_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Generic Product Acquisition [Member]</link:label>
    <link:label id="lab_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7_documentation_en-US" xlink:label="lab_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Generic Product Acquisition [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GenericProductAcquisitionMember" xlink:label="loc_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:to="lab_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:type="arc" />
    <link:label id="lab_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D_terseLabel_en-US" xlink:label="lab_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Budesonide Nasal Spray and Triamcinolone Nasal Spray</link:label>
    <link:label id="lab_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D_label_en-US" xlink:label="lab_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Budesonide Nasal Spray and Triamcinolone Nasal Spray [Member]</link:label>
    <link:label id="lab_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D_documentation_en-US" xlink:label="lab_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Budesonide Nasal Spray and Triamcinolone Nasal Spray [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember" xlink:label="loc_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:to="lab_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB_terseLabel_en-US" xlink:label="lab_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of brands acquired</link:label>
    <link:label id="lab_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB_label_en-US" xlink:label="lab_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Brands Acquired</link:label>
    <link:label id="lab_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB_documentation_en-US" xlink:label="lab_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Brands Acquired</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofBrandsAcquired" xlink:label="loc_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:to="lab_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life of intangible assets</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to acquire the ANDA</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:type="arc" />
    <link:label id="lab_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09_terseLabel_en-US" xlink:label="lab_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income from sales owned by the company (percent)</link:label>
    <link:label id="lab_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09_label_en-US" xlink:label="lab_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income from Sales Owned by the Company, Percent</link:label>
    <link:label id="lab_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09_documentation_en-US" xlink:label="lab_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income from Sales Owned by the Company, Percent</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomefromSalesOwnedbytheCompanyPercent" xlink:label="loc_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:to="lab_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_F200977B41B0A29FE6D18D13D93649FD_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_F200977B41B0A29FE6D18D13D93649FD_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateSwapMember_C6B37318D0B878D3C1478D1D631A9295_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_C6B37318D0B878D3C1478D1D631A9295_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:to="lab_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_19DA1EF7A4033A9A13CB8D13D93643CC_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_19DA1EF7A4033A9A13CB8D13D93643CC_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_B4BC2097C05D4F2DA7A58D13D9375A64_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_B4BC2097C05D4F2DA7A58D13D9375A64_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueNetMember_254F804D991B6D56EEFB8D13D9374B4D_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Sales</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_254F804D991B6D56EEFB8D13D9374B4D_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:to="lab_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfSalesMember_82682ABE39E43C4203CA8D13D938070A_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_82682ABE39E43C4203CA8D13D938070A_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:to="lab_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseMember_92C080513623A31FF5D28D13D9384CB4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_92C080513623A31FF5D28D13D9384CB4_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:to="lab_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:type="arc" />
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_CE5E9A604D6A74334C018D13D9380C4C_terseLabel_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_CE5E9A604D6A74334C018D13D9380C4C_label_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Expense (Income), Net [Member]</link:label>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_CE5E9A604D6A74334C018D13D9380C4C_documentation_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Expense (Income), Net [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherExpenseIncomeNetMember" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:to="lab_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_F96C00BE05A4DD621B4C8D13D939A50F_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_F96C00BE05A4DD621B4C8D13D939A50F_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_FB1E1A5FAF7FBB19CA388D13D939E2A3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_FB1E1A5FAF7FBB19CA388D13D939E2A3_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_FD0E588CA556812FED838D13D93AEAC5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_FD0E588CA556812FED838D13D93AEAC5_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_88F4D44C5A8288DA104B8D13D93AEB48_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_88F4D44C5A8288DA104B8D13D93AEB48_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:to="lab_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2058A2A34C41892B929B8D13D93ACD49_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2058A2A34C41892B929B8D13D93ACD49_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_978A0B4F45FDCBA3ADCF8D13D93BEFA2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The effects of cash flow hedging:</link:label>
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_978A0B4F45FDCBA3ADCF8D13D93BEFA2_label_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Cash Flow Hedges on Results of Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:to="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9E4923DB738F92540A458D13D93B5AAD_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9E4923DB738F92540A458D13D93B5AAD_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Cash Flow Hedges [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_E8B2935719D96964CE668D13D93B4B1B_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_E8B2935719D96964CE668D13D93B4B1B_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_21DAA072C3FCDB3261728D13D93CD738_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_21DAA072C3FCDB3261728D13D93CD738_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgesAbstract_EA97C00A6000CEBD45AF8D13D93D929D_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgesAbstract_EA97C00A6000CEBD45AF8D13D93D929D_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cash Flow Hedges [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgesAbstract" xlink:label="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:to="lab_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_2AA55E1682ABF131037C8D13D93DB037_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_2AA55E1682ABF131037C8D13D93DB037_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsAbstract_252361EA22231D6ED97B4F80C91BF117_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract_61383A9D4B7C5DBD9A785C36EDA97493" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_61383A9D4B7C5DBD9A785C36EDA97493" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract_61383A9D4B7C5DBD9A785C36EDA97493" xlink:to="lab_us-gaap_InvestmentsAbstract_61383A9D4B7C5DBD9A785C36EDA97493" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_48FAAD11799E8DF165DF4F80C91BF9DB_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_48FAAD11799E8DF165DF4F80C91BF9DB_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_C167F2DA91F3B80CF13B4F80C91C5D51_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_C167F2DA91F3B80CF13B4F80C91C5D51_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_DB32F88D0927890A6B1E4F80C91CA113_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_DB32F88D0927890A6B1E4F80C91CA113_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_57842863987447C695074F80C91DE977_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_57842863987447C695074F80C91DE977_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_2CAD22F3F7345212D0164F80C91DECE0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_2CAD22F3F7345212D0164F80C91DECE0_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9F853BD8543F603E475F4F80C91EEC9D_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9F853BD8543F603E475F4F80C91EEC9D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_7AD5BF446ADCF1881D8A4F80C91EC7D3_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities, fair value method</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_7AD5BF446ADCF1881D8A4F80C91EC7D3_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:to="lab_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestments_1A1DE231DE9E0701D65B4F80C91E3CB7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities, equity method, other non-current assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_1A1DE231DE9E0701D65B4F80C91E3CB7_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:to="lab_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_99B72E897D8C5DE7733D4F80C91FEDD3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Equity securities, fair value method, other expense (income)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_99B72E897D8C5DE7733D4F80C91FEDD3_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_05B60430DB2A64E8D0AC4F80C91FA12F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Equity securities, equity method, other expense (income)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_05B60430DB2A64E8D0AC4F80C91FA12F_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_D0D028CE328F025E60CB4F80C91F528D_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership Interest (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_D0D028CE328F025E60CB4F80C91F528D_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_41551E33ADBB5FBB2BA84F80C91F3C77_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount paid for investment upon close of the transaction</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_41551E33ADBB5FBB2BA84F80C91F3C77_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:type="arc" />
    <link:label id="lab_prgo_EquityMethodInvestmentPeriodforPayment_FD9EB68758C392D0FBEA4F80C91F43D8_terseLabel_en-US" xlink:label="lab_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period for payment of balance of equity method investment</link:label>
    <link:label id="lab_prgo_EquityMethodInvestmentPeriodforPayment_FD9EB68758C392D0FBEA4F80C91F43D8_label_en-US" xlink:label="lab_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Period for Payment</link:label>
    <link:label id="lab_prgo_EquityMethodInvestmentPeriodforPayment_FD9EB68758C392D0FBEA4F80C91F43D8_documentation_en-US" xlink:label="lab_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Period for Payment</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_EquityMethodInvestmentPeriodforPayment" xlink:label="loc_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:to="lab_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:to="lab_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:type="arc" />
    <link:label id="lab_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974_terseLabel_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RX</link:label>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974_label_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RX Pharmaceuticals [Member]</link:label>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974_documentation_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RX Pharmaceuticals [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:to="lab_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measured at fair value on a non-recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Measured at fair value on a recurring basis:</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:type="arc" />
    <link:label id="lab_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87_terseLabel_en-US" xlink:label="lab_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funds associated with Israeli severance liability</link:label>
    <link:label id="lab_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87_label_en-US" xlink:label="lab_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure</link:label>
    <link:label id="lab_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87_documentation_en-US" xlink:label="lab_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" xlink:label="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:to="lab_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:type="arc" />
    <link:label id="lab_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699_terseLabel_en-US" xlink:label="lab_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Pharma contingent milestone</link:label>
    <link:label id="lab_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699_label_en-US" xlink:label="lab_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Contingent Milestone Payments</link:label>
    <link:label id="lab_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699_documentation_en-US" xlink:label="lab_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Contingent Milestone Payments</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PotentialContingentMilestonePayments" xlink:label="loc_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:to="lab_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Cash Flow Hedge Liability at Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:type="arc" />
    <link:label id="lab_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC_terseLabel_en-US" xlink:label="lab_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measured at fair value on a non-recurring basis:</link:label>
    <link:label id="lab_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC_label_en-US" xlink:label="lab_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC_documentation_en-US" xlink:label="lab_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="lab_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC_label_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillFairValueDisclosure" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:to="lab_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-lived Intangible Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill carrying amount</link:label>
    <link:label id="lab_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F_label_en-US" xlink:label="lab_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:to="lab_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible assets carrying value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_CAD6A08B02D968088B1685ED3D8898E2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_9521E3D9A1D657BCB6D4408BB9708143" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_CAD6A08B02D968088B1685ED3D8898E2_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_9521E3D9A1D657BCB6D4408BB9708143" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9521E3D9A1D657BCB6D4408BB9708143" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_9521E3D9A1D657BCB6D4408BB9708143" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_9521E3D9A1D657BCB6D4408BB9708143" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryLockMember_0C69FF8E41024099C09F8D1C7A2645E5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Lock</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_0C69FF8E41024099C09F8D1C7A2645E5_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember" xlink:label="loc_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:to="lab_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_C2FCD21791BB29EF22648D13D9515A71_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_C2FCD21791BB29EF22648D13D9515A71_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_4E6D6F3D7C348BDF334B8D13D9529C20_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_4E6D6F3D7C348BDF334B8D13D9529C20_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:to="lab_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_3DD527E2F321DEF0ED018D13D9526154_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_3DD527E2F321DEF0ED018D13D9526154_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:to="lab_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_NondesignatedMember_E7B53984F36D21FD6C548D13D9531386_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-designated derivatives:</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_E7B53984F36D21FD6C548D13D9531386_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:to="lab_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_689205FF6DF94C0D186F8D13D953E0BC_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain/(Loss) Recognized against Earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_689205FF6DF94C0D186F8D13D953E0BC_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:to="lab_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Commissioners, Ireland</link:label>
    <link:label id="lab_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6_label_en-US" xlink:label="lab_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Commissioners, Ireland [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueCommissionersIrelandMember" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:to="lab_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:type="arc" />
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax examination, debts subject to limit of deductibility of interest expense</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:to="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:type="arc" />
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32_terseLabel_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate cap on debts for U.S. Federal tax purposes, as percent of Applicable Federal Rate</link:label>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32_label_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</link:label>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32_documentation_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:to="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:type="arc" />
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:to="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:type="arc" />
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:to="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:type="arc" />
    <link:label id="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax examination, estimated increase to tax expense from audit adjustment to fiscal years 2014 and 2015, excluding interest and penalties</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:label="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:to="lab_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax examination, estimate of additional tax expense for the period from June 28, 2015 through December 31, 2019, excluding interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Estimate of Possible Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:to="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax examination, penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:type="arc" />
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8_terseLabel_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative deferred charge related to tax litigation</link:label>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8_label_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Deferred Charge, Tax Litigation</link:label>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8_documentation_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative Deferred Charge, Tax Litigation</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CumulativeDeferredChargeTaxLitigation" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:to="lab_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:type="arc" />
    <link:label id="lab_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax overpayments applied to succeeding years</link:label>
    <link:label id="lab_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A_label_en-US" xlink:label="lab_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Overpayments Applied to Succeeding Years</link:label>
    <link:label id="lab_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A_documentation_en-US" xlink:label="lab_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Overpayments Applied to Succeeding Years</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears" xlink:label="loc_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:to="lab_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:type="arc" />
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432_terseLabel_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty conceded on all omeprazole sales as a percent of refund claims (percent)</link:label>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432_label_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</link:label>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432_documentation_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:to="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:type="arc" />
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IRS notice of proposed adjustment amount from 2011,2012 and 2013 audit of Athena, including penalty</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:to="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:type="arc" />
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IRS notice of proposed adjustment, penalty (percent)</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IRS Notice of Proposed Adjustment, Penalty, Percent</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">IRS Notice of Proposed Adjustment, Penalty, Percent</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:to="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:type="arc" />
    <link:label id="lab_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsettled audit assessment from income tax examination</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Unsettled Assessed Audit Liability</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Unsettled Assessed Audit Liability</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability" xlink:label="loc_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:to="lab_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:type="arc" />
    <link:label id="lab_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF_terseLabel_en-US" xlink:label="lab_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period available to file appeal against the judgment of the High Court</link:label>
    <link:label id="lab_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF_label_en-US" xlink:label="lab_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Period Available to File Appeal</link:label>
    <link:label id="lab_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF_documentation_en-US" xlink:label="lab_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Period Available to File Appeal</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PeriodAvailabletoFileAppeal" xlink:label="loc_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:to="lab_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:type="arc" />
    <link:label id="lab_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48_terseLabel_en-US" xlink:label="lab_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment required before final determination of the judicial review case and appeal pending before the Tax Appeals Commission</link:label>
    <link:label id="lab_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48_label_en-US" xlink:label="lab_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment of Assessment due before Final Determination of Tax Case and Appeal</link:label>
    <link:label id="lab_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48_documentation_en-US" xlink:label="lab_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment of Assessment due before Final Determination of Tax Case and Appeal</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal" xlink:label="loc_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:to="lab_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5D925CB0198266A4762B85ED3CF720D4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7C861CE8B3CE55A1B7F294482EC8C0CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5D925CB0198266A4762B85ED3CF720D4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7C861CE8B3CE55A1B7F294482EC8C0CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7C861CE8B3CE55A1B7F294482EC8C0CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7C861CE8B3CE55A1B7F294482EC8C0CD" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7C861CE8B3CE55A1B7F294482EC8C0CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_68CF7A806A778B970DE7497E488A9F23_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_68CF7A806A778B970DE7497E488A9F23_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_8C1E538826C165946EF4497E488A899B_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_8C1E538826C165946EF4497E488A899B_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:to="lab_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:type="arc" />
    <link:label id="lab_srt_ProductsAndServicesDomain_8188F7CCA6DAE70B1CB4497E488AEF4F_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_8188F7CCA6DAE70B1CB4497E488AEF4F_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:to="lab_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:type="arc" />
    <link:label id="lab_prgo_ContractManufacturingMember_AE9883703B432565BA5B497E488A03F3_terseLabel_en-US" xlink:label="lab_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract manufacturing</link:label>
    <link:label id="lab_prgo_ContractManufacturingMember_AE9883703B432565BA5B497E488A03F3_label_en-US" xlink:label="lab_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:label id="lab_prgo_ContractManufacturingMember_AE9883703B432565BA5B497E488A03F3_documentation_en-US" xlink:label="lab_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContractManufacturingMember" xlink:label="loc_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:to="lab_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_B1C7EE34B5A171B6EE51497E488A8F29_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_B1C7EE34B5A171B6EE51497E488A8F29_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:type="arc" />
    <link:label id="lab_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703_label_en-US" xlink:label="lab_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="lab_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F_terseLabel_en-US" xlink:label="lab_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document type</link:label>
    <link:label id="lab_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F_label_en-US" xlink:label="lab_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F" xlink:to="lab_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F" xlink:type="arc" />
    <link:label id="lab_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D" xlink:to="lab_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document period end date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E" xlink:to="lab_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E" xlink:type="arc" />
    <link:label id="lab_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E_label_en-US" xlink:label="lab_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E" xlink:to="lab_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3_label_en-US" xlink:label="lab_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3" xlink:to="lab_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity registrant name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12_label_en-US" xlink:label="lab_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12" xlink:to="lab_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB" xlink:to="lab_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7" xlink:to="lab_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A" xlink:to="lab_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B" xlink:to="lab_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049_label_en-US" xlink:label="lab_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049" xlink:to="lab_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA" xlink:to="lab_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA" xlink:type="arc" />
    <link:label id="lab_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C_terseLabel_en-US" xlink:label="lab_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C_label_en-US" xlink:label="lab_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C" xlink:to="lab_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F_label_en-US" xlink:label="lab_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F" xlink:to="lab_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F" xlink:to="lab_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637_label_en-US" xlink:label="lab_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637" xlink:to="lab_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F_label_en-US" xlink:label="lab_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F" xlink:to="lab_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66_label_en-US" xlink:label="lab_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66" xlink:to="lab_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7" xlink:to="lab_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity central index key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B" xlink:to="lab_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B" xlink:type="arc" />
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5" xlink:to="lab_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current calendar year end date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264" xlink:to="lab_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity filer category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6_label_en-US" xlink:label="lab_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6" xlink:to="lab_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity small business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C" xlink:to="lab_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity emerging growth company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB" xlink:to="lab_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB" xlink:type="arc" />
    <link:label id="lab_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882_label_en-US" xlink:label="lab_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882" xlink:to="lab_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity common stock, shares outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document calendar year focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63" xlink:to="lab_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document calendar period focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030" xlink:to="lab_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B_label_en-US" xlink:label="lab_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B" xlink:to="lab_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B" xlink:type="arc" />
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_418BC67A104D951359D049580914A3F0_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1ECBB623BAFD5F1FA05BC04E39831030" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_418BC67A104D951359D049580914A3F0_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1ECBB623BAFD5F1FA05BC04E39831030" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1ECBB623BAFD5F1FA05BC04E39831030" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1ECBB623BAFD5F1FA05BC04E39831030" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1ECBB623BAFD5F1FA05BC04E39831030" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_520C99D9344CD321249685ED3B92F100_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97F0D4319B8A5606A89510AA8655EB2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_520C99D9344CD321249685ED3B92F100_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97F0D4319B8A5606A89510AA8655EB2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97F0D4319B8A5606A89510AA8655EB2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97F0D4319B8A5606A89510AA8655EB2C" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97F0D4319B8A5606A89510AA8655EB2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_BB446D4B08AAC7DEDC7585ED3B924BDE_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_2CE2487C52AF5A259CEDD954E5FE686E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_BB446D4B08AAC7DEDC7585ED3B924BDE_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_2CE2487C52AF5A259CEDD954E5FE686E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2CE2487C52AF5A259CEDD954E5FE686E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_2CE2487C52AF5A259CEDD954E5FE686E" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_2CE2487C52AF5A259CEDD954E5FE686E" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_410B90CC54255B0487DB85ED3B92FAA6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9FA20E1615FE58B5A4CC62C1DB4E8B49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_410B90CC54255B0487DB85ED3B92FAA6_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9FA20E1615FE58B5A4CC62C1DB4E8B49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9FA20E1615FE58B5A4CC62C1DB4E8B49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9FA20E1615FE58B5A4CC62C1DB4E8B49" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9FA20E1615FE58B5A4CC62C1DB4E8B49" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:type="arc" />
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE_terseLabel_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CSCA</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE_label_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumer Self-Care Americas [Member]</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE_documentation_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumer Self-Care Americas [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:to="lab_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:type="arc" />
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4_terseLabel_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CSCI</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4_label_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumer Self-Care International [Member]</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4_documentation_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumer Self-Care International [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:to="lab_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unallocated</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44_label_en-US" xlink:label="lab_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:to="lab_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:to="lab_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible Asset Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468_label_en-US" xlink:label="lab_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:to="lab_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509_terseLabel_en-US" xlink:label="lab_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509_label_en-US" xlink:label="lab_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:to="lab_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224_label_en-US" xlink:label="lab_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:to="lab_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A_label_en-US" xlink:label="lab_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:to="lab_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:type="arc" />
    <link:label id="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69_terseLabel_en-US" xlink:label="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Oral Care Assets of High Ridge Brands (Dr. Fresh)</link:label>
    <link:label id="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69_label_en-US" xlink:label="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oral Care Assets of High Ridge Brands [Member]</link:label>
    <link:label id="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69_documentation_en-US" xlink:label="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Oral Care Assets of High Ridge Brands [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:to="lab_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:type="arc" />
    <link:label id="lab_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004_terseLabel_en-US" xlink:label="lab_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ranir Global Holdings, LLC</link:label>
    <link:label id="lab_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004_label_en-US" xlink:label="lab_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ranir Global Holdings, LLC [Member]</link:label>
    <link:label id="lab_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004_documentation_en-US" xlink:label="lab_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ranir Global Holdings, LLC [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanirGlobalHoldingsLLCMember" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:to="lab_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:type="arc" />
    <link:label id="lab_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A_terseLabel_en-US" xlink:label="lab_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution and License Agreements and Supply Agreements</link:label>
    <link:label id="lab_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A_label_en-US" xlink:label="lab_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution and License Agreements and Supply Agreements [Member]</link:label>
    <link:label id="lab_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A_documentation_en-US" xlink:label="lab_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distribution and License Agreements and Supply Agreements [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember" xlink:label="loc_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:to="lab_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships and distribution networks</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:type="arc" />
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3_terseLabel_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks, trade names, and brands</link:label>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3_label_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks, Trade Names, and Brands [Member]</link:label>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3_documentation_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trademarks, Trade Names, and Brands [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TrademarksTradeNamesandBrandsMember" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:to="lab_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment of contract consideration for transitional services</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding equity interest acquired (percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:type="arc" />
    <link:label id="lab_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C_verboseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total base consideration</link:label>
    <link:label id="lab_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C_label_en-US" xlink:label="lab_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Base Consideration Transferred</link:label>
    <link:label id="lab_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Base Consideration Transferred</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationBaseConsiderationTransferred" xlink:label="loc_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:to="lab_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration - net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales since acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income since acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory costs stepped up to acquisition date fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement period adjustment to intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Measurement period adjustment to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value of assets acquired and liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:type="arc" />
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:to="lab_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:type="arc" />
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:type="arc" />
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:type="arc" />
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life of intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill expected to be tax deductible</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_3FBA229F784D31183BE085ED3C518CB1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_59668CF3DF0556309620FB6A4E5B9D44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_3FBA229F784D31183BE085ED3C518CB1_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_59668CF3DF0556309620FB6A4E5B9D44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_59668CF3DF0556309620FB6A4E5B9D44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_59668CF3DF0556309620FB6A4E5B9D44" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_59668CF3DF0556309620FB6A4E5B9D44" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_80E87A8946CCE49C367B85F146C1901B_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_80E87A8946CCE49C367B85F146C1901B_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2F67D1573AB3FA2A83FF85F146C1762C_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_D6EE4F30926D5168A3C773CFBDBC7FBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2F67D1573AB3FA2A83FF85F146C1762C_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_D6EE4F30926D5168A3C773CFBDBC7FBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_D6EE4F30926D5168A3C773CFBDBC7FBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_D6EE4F30926D5168A3C773CFBDBC7FBA" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_D6EE4F30926D5168A3C773CFBDBC7FBA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8A1152725DD42440B22686085B472A01_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_124AD704A3335F63AC767B2CF5CE938B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8A1152725DD42440B22686085B472A01_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_124AD704A3335F63AC767B2CF5CE938B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_124AD704A3335F63AC767B2CF5CE938B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_124AD704A3335F63AC767B2CF5CE938B" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_124AD704A3335F63AC767B2CF5CE938B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0DE659F6EA427574AC0F85F146C121D0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21BF6DB9692C5AE3AF0C6EEE01D4E0AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0DE659F6EA427574AC0F85F146C121D0_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21BF6DB9692C5AE3AF0C6EEE01D4E0AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21BF6DB9692C5AE3AF0C6EEE01D4E0AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21BF6DB9692C5AE3AF0C6EEE01D4E0AF" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21BF6DB9692C5AE3AF0C6EEE01D4E0AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1B33C170804D8DDBB57F85F146C1F348_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_079232BE4D0C5BEF9421FD368D088C3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1B33C170804D8DDBB57F85F146C1F348_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_079232BE4D0C5BEF9421FD368D088C3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_079232BE4D0C5BEF9421FD368D088C3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_079232BE4D0C5BEF9421FD368D088C3F" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_079232BE4D0C5BEF9421FD368D088C3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_048FD86DF3A8349A80F085F146C2C05E_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41EB19022C8C5F84950E23DA0E41B4F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_048FD86DF3A8349A80F085F146C2C05E_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41EB19022C8C5F84950E23DA0E41B4F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41EB19022C8C5F84950E23DA0E41B4F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41EB19022C8C5F84950E23DA0E41B4F5" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41EB19022C8C5F84950E23DA0E41B4F5" xlink:type="arc" />
    <link:label id="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_8DDDFB0170A9E90EDB69860C2265662F_terseLabel_en-US" xlink:label="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After 2024</link:label>
    <link:label id="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_8DDDFB0170A9E90EDB69860C2265662F_label_en-US" xlink:label="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_8DDDFB0170A9E90EDB69860C2265662F_documentation_en-US" xlink:label="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:label="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:to="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9A1DB508346E4B5C097485F146C2BF6C_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13915146C68256768FBFB4EE2280FED3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9A1DB508346E4B5C097485F146C2BF6C_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13915146C68256768FBFB4EE2280FED3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13915146C68256768FBFB4EE2280FED3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13915146C68256768FBFB4EE2280FED3" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13915146C68256768FBFB4EE2280FED3" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_73078EFD0FECA1A7097685F146C2C4E3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_BBA60CA31F655D86875F52C926D5F622" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_73078EFD0FECA1A7097685F146C2C4E3_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_BBA60CA31F655D86875F52C926D5F622" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_BBA60CA31F655D86875F52C926D5F622" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_BBA60CA31F655D86875F52C926D5F622" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_BBA60CA31F655D86875F52C926D5F622" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_96812C0D615FB572878D85F146C24EA7_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_11AD1FDBCE215E2E8CC3896928B4B5B4" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_96812C0D615FB572878D85F146C24EA7_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_11AD1FDBCE215E2E8CC3896928B4B5B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_11AD1FDBCE215E2E8CC3896928B4B5B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_11AD1FDBCE215E2E8CC3896928B4B5B4" xlink:to="lab_us-gaap_OperatingLeaseLiability_11AD1FDBCE215E2E8CC3896928B4B5B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_BCC1C1F818472AED4AD285F146C3F9E9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_BCC1C1F818472AED4AD285F146C3F9E9_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_A1731724DC758DAFADF885F146C3DEEF_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_EE7F4FBDFEB653228301262C3DBB346D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_A1731724DC758DAFADF885F146C3DEEF_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_EE7F4FBDFEB653228301262C3DBB346D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_EE7F4FBDFEB653228301262C3DBB346D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_EE7F4FBDFEB653228301262C3DBB346D" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_EE7F4FBDFEB653228301262C3DBB346D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_F703AA0E3558C610628A860F66A9F8DF_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_D5078C9373725796991CA81CD68CD90E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_F703AA0E3558C610628A860F66A9F8DF_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_D5078C9373725796991CA81CD68CD90E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_D5078C9373725796991CA81CD68CD90E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_D5078C9373725796991CA81CD68CD90E" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_D5078C9373725796991CA81CD68CD90E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5305515CA0AACBB643DF85F146C31D42_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6899D7C5C66653CBA4081AEE3FB640D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5305515CA0AACBB643DF85F146C31D42_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6899D7C5C66653CBA4081AEE3FB640D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6899D7C5C66653CBA4081AEE3FB640D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6899D7C5C66653CBA4081AEE3FB640D8" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6899D7C5C66653CBA4081AEE3FB640D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_507D38D440C44E0150FF860EEABF98D7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_60203F3BD237537DAECEC50658456482" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_507D38D440C44E0150FF860EEABF98D7_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_60203F3BD237537DAECEC50658456482" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_60203F3BD237537DAECEC50658456482" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_60203F3BD237537DAECEC50658456482" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_60203F3BD237537DAECEC50658456482" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_83ADE9FEA032E231F6B6860EEAE5F76E_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67CA90407234503587E20C05C9B07E69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_83ADE9FEA032E231F6B6860EEAE5F76E_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67CA90407234503587E20C05C9B07E69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67CA90407234503587E20C05C9B07E69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67CA90407234503587E20C05C9B07E69" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67CA90407234503587E20C05C9B07E69" xlink:type="arc" />
    <link:label id="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_AB5A580B907F8793D6F7861155A4A143_terseLabel_en-US" xlink:label="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After 2024</link:label>
    <link:label id="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_AB5A580B907F8793D6F7861155A4A143_label_en-US" xlink:label="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_AB5A580B907F8793D6F7861155A4A143_documentation_en-US" xlink:label="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:label="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:to="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_0D55506A018DBBE19F6785F146C4BE86_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_FE89C8E332BD54EE92E7784CAB781E41" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_0D55506A018DBBE19F6785F146C4BE86_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_FE89C8E332BD54EE92E7784CAB781E41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_FE89C8E332BD54EE92E7784CAB781E41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_FE89C8E332BD54EE92E7784CAB781E41" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_FE89C8E332BD54EE92E7784CAB781E41" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_37C34774FCE60E4D7C0085F146C4615C_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1F5BFF4B68075102A6AB07556145CA53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_37C34774FCE60E4D7C0085F146C4615C_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1F5BFF4B68075102A6AB07556145CA53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1F5BFF4B68075102A6AB07556145CA53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1F5BFF4B68075102A6AB07556145CA53" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1F5BFF4B68075102A6AB07556145CA53" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6CF30E434C37E134559E85F146C496DD_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_247017400D0751C9A97E87E5AF8FCD33" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6CF30E434C37E134559E85F146C496DD_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_247017400D0751C9A97E87E5AF8FCD33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_247017400D0751C9A97E87E5AF8FCD33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_247017400D0751C9A97E87E5AF8FCD33" xlink:to="lab_us-gaap_FinanceLeaseLiability_247017400D0751C9A97E87E5AF8FCD33" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_E8047F159F92D02D379085F146C5A68D_terseLabel_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_E8047F159F92D02D379085F146C5A68D_label_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_E8047F159F92D02D379085F146C5A68D_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_A6ED426D91CC984D102385F146C55131_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_A6ED426D91CC984D102385F146C55131_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_A6ED426D91CC984D102385F146C55131_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:label="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:to="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearOne_677A66F71AA4C1A949EA85F146C5D1DB_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearOne_677A66F71AA4C1A949EA85F146C5D1DB_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year One</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearOne_677A66F71AA4C1A949EA85F146C5D1DB_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year One</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearOne" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_BB148C6A7180ED479ABE86155960C118_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_BB148C6A7180ED479ABE86155960C118_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_BB148C6A7180ED479ABE86155960C118_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_FE4E4679604DFCCEF7CC8612B7695775_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_FE4E4679604DFCCEF7CC8612B7695775_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_FE4E4679604DFCCEF7CC8612B7695775_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearThree" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_7C5C0FB85F9B9A446CCF8612B81B9313_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_7C5C0FB85F9B9A446CCF8612B81B9313_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_7C5C0FB85F9B9A446CCF8612B81B9313_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearFour" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_C55124C7D1966D0562F085F146C6DAF2_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">After 2024</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_C55124C7D1966D0562F085F146C6DAF2_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due after Year Four</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_C55124C7D1966D0562F085F146C6DAF2_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due after Year Four</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_9FD82CDDACC4F1E401FF85F146C6CB16_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_9FD82CDDACC4F1E401FF85F146C6CB16_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_9FD82CDDACC4F1E401FF85F146C6CB16_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDue" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:to="lab_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_F5D92F2F9A82C9547E3F85F146C6991D_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_F5D92F2F9A82C9547E3F85F146C6991D_label_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_F5D92F2F9A82C9547E3F85F146C6991D_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:to="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:type="arc" />
    <link:label id="lab_prgo_LeaseLiabilities_4310933BCCA66BC34A7685F146C6780C_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_prgo_LeaseLiabilities_4310933BCCA66BC34A7685F146C6780C_label_en-US" xlink:label="lab_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liabilities</link:label>
    <link:label id="lab_prgo_LeaseLiabilities_4310933BCCA66BC34A7685F146C6780C_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Liabilities</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilities" xlink:label="loc_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:to="lab_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893_label_en-US" xlink:label="lab_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:to="lab_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:type="arc" />
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:type="arc" />
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:type="arc" />
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption of new accounting standards</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:to="lab_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary Shares Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:to="lab_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:to="lab_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:to="lab_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:to="lab_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:to="lab_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock plan (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation for stock options</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation for restricted stock</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:to="lab_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares withheld for payment of employees' withholding tax liability (shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares withheld for payment of employees' withholding tax liability</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Minority share purchase (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Minority share purchase</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_CD2E8417FC087D28C9376A868C2498C5_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_CD2E8417FC087D28C9376A868C2498C5" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_CD2E8417FC087D28C9376A868C2498C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_CD2E8417FC087D28C9376A868C2498C5" xlink:to="lab_us-gaap_SharesOutstanding_CD2E8417FC087D28C9376A868C2498C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_15DA0CEBA6971D1798E66A868C24112C_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_15DA0CEBA6971D1798E66A868C24112C" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, ending</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_15DA0CEBA6971D1798E66A868C24112C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_15DA0CEBA6971D1798E66A868C24112C" xlink:to="lab_us-gaap_StockholdersEquity_15DA0CEBA6971D1798E66A868C24112C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="lab_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $6.3 and $6.7, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_6F1403A6613825CA1CC346E0686743D0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_6F1403A6613825CA1CC346E0686743D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_6F1403A6613825CA1CC346E0686743D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_6F1403A6613825CA1CC346E0686743D0" xlink:to="lab_us-gaap_InventoryNet_6F1403A6613825CA1CC346E0686743D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F" xlink:to="lab_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3" xlink:type="arc" />
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1_terseLabel_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and indefinite-lived intangible assets</link:label>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1_label_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill And Indefinite Lived Intangibles</link:label>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1_documentation_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets.  Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.  Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:to="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_58C4FB4C5FA55D67C2F846E068677A1F_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_58C4FB4C5FA55D67C2F846E068677A1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible assets, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_58C4FB4C5FA55D67C2F846E068677A1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_58C4FB4C5FA55D67C2F846E068677A1F" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_58C4FB4C5FA55D67C2F846E068677A1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E" xlink:to="lab_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_D52B940CDE1270C2741946E06868DC99_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_D52B940CDE1270C2741946E06868DC99" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D52B940CDE1270C2741946E06868DC99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_D52B940CDE1270C2741946E06868DC99" xlink:to="lab_us-gaap_Assets_D52B940CDE1270C2741946E06868DC99" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790" xlink:to="lab_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E" xlink:type="arc" />
    <link:label id="lab_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4_terseLabel_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4_label_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4_documentation_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccruedCustomerPrograms" xlink:label="loc_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:to="lab_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current indebtedness</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507" xlink:to="lab_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F" xlink:to="lab_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F_label_en-US" xlink:label="lab_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F" xlink:to="lab_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies - Refer to Note 14</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C" xlink:to="lab_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:to="lab_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:type="arc" />
    <link:label id="lab_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896_terseLabel_en-US" xlink:label="lab_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Controlling interests:</link:label>
    <link:label id="lab_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896_label_en-US" xlink:label="lab_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Controlling Interest [Abstract]</link:label>
    <link:label id="lab_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896_documentation_en-US" xlink:label="lab_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Controlling Interest [Abstract]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ControllingInterestAbstract" xlink:label="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:to="lab_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, $0.0001 par value per share, 10 shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61" xlink:to="lab_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, &#8364;0.001 par value per share, 10,000 shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583" xlink:to="lab_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_E3EECC2B80BF2FD3BEC346E0686C47F1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_E3EECC2B80BF2FD3BEC346E0686C47F1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total controlling interests</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_E3EECC2B80BF2FD3BEC346E0686C47F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_E3EECC2B80BF2FD3BEC346E0686C47F1" xlink:to="lab_us-gaap_StockholdersEquity_E3EECC2B80BF2FD3BEC346E0686C47F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242" xlink:to="lab_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Disclosures of Balance Sheet Information</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, issued and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B" xlink:to="lab_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, issued and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B" xlink:to="lab_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_87A2910F427535FC14E685ED3DFA6CD5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_17F46D200A8851CEA83BFDDEFACA2259" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_87A2910F427535FC14E685ED3DFA6CD5_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_17F46D200A8851CEA83BFDDEFACA2259" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_17F46D200A8851CEA83BFDDEFACA2259" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_17F46D200A8851CEA83BFDDEFACA2259" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_17F46D200A8851CEA83BFDDEFACA2259" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29_label_en-US" xlink:label="lab_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29" xlink:to="lab_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="lab_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution</link:label>
    <link:label id="lab_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E_label_en-US" xlink:label="lab_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Production and Distribution Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductionAndDistributionCosts" xlink:label="loc_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E" xlink:to="lab_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895" xlink:to="lab_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Administration</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD" xlink:to="lab_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD" xlink:to="lab_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD" xlink:type="arc" />
    <link:label id="lab_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906_negatedTerseLabel_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other operating expense (income)</link:label>
    <link:label id="lab_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906_label_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Income (Loss)</link:label>
    <link:label id="lab_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906_documentation_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Operating Income (Loss)</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherOperatingIncomeLoss" xlink:label="loc_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:to="lab_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8" xlink:to="lab_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0D57EDAB242E44D6339947885CB421EB_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_0D57EDAB242E44D6339947885CB421EB" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income (loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0D57EDAB242E44D6339947885CB421EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_0D57EDAB242E44D6339947885CB421EB" xlink:to="lab_us-gaap_OperatingIncomeLoss_0D57EDAB242E44D6339947885CB421EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in financial assets</link:label>
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A_label_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A" xlink:to="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_90D1561F360DBB23A90047885CB753D7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_90D1561F360DBB23A90047885CB753D7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_90D1561F360DBB23A90047885CB753D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_90D1561F360DBB23A90047885CB753D7" xlink:to="lab_us-gaap_NetIncomeLoss_90D1561F360DBB23A90047885CB753D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (loss) per share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:to="lab_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A" xlink:to="lab_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662" xlink:to="lab_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_702E9A9B5E747852757E47885CB91CF8_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_702E9A9B5E747852757E47885CB91CF8" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_702E9A9B5E747852757E47885CB91CF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_702E9A9B5E747852757E47885CB91CF8" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_702E9A9B5E747852757E47885CB91CF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A06326A38660549C33AD47885CBAAC59_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A06326A38660549C33AD47885CBAAC59" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A06326A38660549C33AD47885CBAAC59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A06326A38660549C33AD47885CBAAC59" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A06326A38660549C33AD47885CBAAC59" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows From (For) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to derive cash flows:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss (Gain) on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8" xlink:to="lab_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_C99C89ABC45C3192F28E46E06806898C_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_C99C89ABC45C3192F28E46E06806898C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in financial assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_C99C89ABC45C3192F28E46E06806898C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_C99C89ABC45C3192F28E46E06806898C" xlink:to="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_C99C89ABC45C3192F28E46E06806898C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_4803E72DC24EF5A226DF46E0680BAF74_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_4803E72DC24EF5A226DF46E0680BAF74" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_4803E72DC24EF5A226DF46E0680BAF74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_4803E72DC24EF5A226DF46E0680BAF74" xlink:to="lab_us-gaap_RestructuringCharges_4803E72DC24EF5A226DF46E0680BAF74" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt premium</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-cash adjustments, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash due to:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF" xlink:type="arc" />
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB_terseLabel_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB_label_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB_documentation_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:to="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash from (for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows From (For) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:type="arc" />
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B_terseLabel_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B_label_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Royalties Received, Investing Activities</link:label>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B_documentation_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from Royalties Received, Investing Activities</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:to="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_B6D25B67E3FAE5702ED146E0680F1376_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_B6D25B67E3FAE5702ED146E0680F1376" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of equity method investment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_B6D25B67E3FAE5702ED146E0680F1376" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_B6D25B67E3FAE5702ED146E0680F1376" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_B6D25B67E3FAE5702ED146E0680F1376" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BD2A0C5F04133D0ABFC946E0680FF07D_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BD2A0C5F04133D0ABFC946E0680FF07D" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of businesses, net of cash acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BD2A0C5F04133D0ABFC946E0680FF07D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BD2A0C5F04133D0ABFC946E0680FF07D" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BD2A0C5F04133D0ABFC946E0680FF07D" xlink:type="arc" />
    <link:label id="lab_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33_terseLabel_en-US" xlink:label="lab_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the Royalty Pharma contingent milestone</link:label>
    <link:label id="lab_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33_label_en-US" xlink:label="lab_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Contingent Milestone Payment</link:label>
    <link:label id="lab_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33_documentation_en-US" xlink:label="lab_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from Contingent Milestone Payment</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ProceedsfromContingentMilestonePayment" xlink:label="loc_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:to="lab_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Asset acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other investing, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash from (for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows From (For) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings (repayments) of revolving credit agreements and other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred financing fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Premiums on early debt retirement</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of ordinary shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83" xlink:to="lab_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash from (for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_DC32606281582AAA2EB646E068139402_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_DC32606281582AAA2EB646E068139402" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_DC32606281582AAA2EB646E068139402" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_DC32606281582AAA2EB646E068139402" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_DC32606281582AAA2EB646E068139402" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:to="lab_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="lab_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">December 31, 2019</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:to="lab_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase accounting adjustments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Business divestitures</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_E97E4FA653563D045286472B7811B711_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill_E97E4FA653563D045286472B7811B711" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">September 26, 2020</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_E97E4FA653563D045286472B7811B711" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_E97E4FA653563D045286472B7811B711" xlink:to="lab_us-gaap_Goodwill_E97E4FA653563D045286472B7811B711" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasePayments_908088713E957E47AC0385ED3B9B51A3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_A51A3A30FF5254CF9B7267F5A296E4B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_908088713E957E47AC0385ED3B9B51A3_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_A51A3A30FF5254CF9B7267F5A296E4B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_A51A3A30FF5254CF9B7267F5A296E4B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_A51A3A30FF5254CF9B7267F5A296E4B4" xlink:to="lab_us-gaap_OperatingLeasePayments_A51A3A30FF5254CF9B7267F5A296E4B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_FFCE6E90E1F052E5B8FA85ED3B9B0FD3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_3D3DCBD34BD15C9EA34C8AACA49A1634" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_FFCE6E90E1F052E5B8FA85ED3B9B0FD3_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_3D3DCBD34BD15C9EA34C8AACA49A1634" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_3D3DCBD34BD15C9EA34C8AACA49A1634" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_3D3DCBD34BD15C9EA34C8AACA49A1634" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_3D3DCBD34BD15C9EA34C8AACA49A1634" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_AE490CD278EA653FCA6B85ED3B9C1AFA_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_561705CAB6B05522B61E893EE1775B79" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_AE490CD278EA653FCA6B85ED3B9C1AFA_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_561705CAB6B05522B61E893EE1775B79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_561705CAB6B05522B61E893EE1775B79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments_561705CAB6B05522B61E893EE1775B79" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments_561705CAB6B05522B61E893EE1775B79" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_C3B05020583B0AC3C55085ED3B9C30EF_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_13C630A034D855FAA1FE119C6C6E3366" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leased assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_C3B05020583B0AC3C55085ED3B9C30EF_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_13C630A034D855FAA1FE119C6C6E3366" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_13C630A034D855FAA1FE119C6C6E3366" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_13C630A034D855FAA1FE119C6C6E3366" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_13C630A034D855FAA1FE119C6C6E3366" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_F362B7A507E654F75AB885ED3B9C8C2C_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1CB7FDD1E1B2584DAB1E6A015FF0CDC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_F362B7A507E654F75AB885ED3B9C8C2C_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1CB7FDD1E1B2584DAB1E6A015FF0CDC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1CB7FDD1E1B2584DAB1E6A015FF0CDC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1CB7FDD1E1B2584DAB1E6A015FF0CDC2" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1CB7FDD1E1B2584DAB1E6A015FF0CDC2" xlink:type="arc" />
    <link:label id="lab_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313_terseLabel_en-US" xlink:label="lab_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upper respiratory</link:label>
    <link:label id="lab_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313_label_en-US" xlink:label="lab_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upper Respiratory [Member]</link:label>
    <link:label id="lab_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313_documentation_en-US" xlink:label="lab_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Upper Respiratory [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_UpperRespiratoryMember" xlink:label="loc_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:to="lab_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:type="arc" />
    <link:label id="lab_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599_terseLabel_en-US" xlink:label="lab_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digestive health</link:label>
    <link:label id="lab_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599_label_en-US" xlink:label="lab_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Digestive Health [Member]</link:label>
    <link:label id="lab_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599_documentation_en-US" xlink:label="lab_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Digestive Health [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DigestiveHealthMember" xlink:label="loc_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:to="lab_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:type="arc" />
    <link:label id="lab_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592_terseLabel_en-US" xlink:label="lab_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pain and sleep-aids</link:label>
    <link:label id="lab_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592_label_en-US" xlink:label="lab_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pain and Sleep-aids [Member]</link:label>
    <link:label id="lab_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592_documentation_en-US" xlink:label="lab_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pain and Sleep-aids [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PainandSleepaidsMember" xlink:label="loc_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:to="lab_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:type="arc" />
    <link:label id="lab_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA_terseLabel_en-US" xlink:label="lab_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nutrition</link:label>
    <link:label id="lab_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA_label_en-US" xlink:label="lab_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nutrition [Member]</link:label>
    <link:label id="lab_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA_documentation_en-US" xlink:label="lab_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nutrition [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NutritionMember" xlink:label="loc_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:to="lab_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:type="arc" />
    <link:label id="lab_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166_terseLabel_en-US" xlink:label="lab_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Healthy lifestyle</link:label>
    <link:label id="lab_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166_label_en-US" xlink:label="lab_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Healthy Lifestyle [Member]</link:label>
    <link:label id="lab_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166_documentation_en-US" xlink:label="lab_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Healthy Lifestyle [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HealthyLifestyleMember" xlink:label="loc_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:to="lab_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:type="arc" />
    <link:label id="lab_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702_terseLabel_en-US" xlink:label="lab_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Oral self-care</link:label>
    <link:label id="lab_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702_label_en-US" xlink:label="lab_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oral Self-care [Member]</link:label>
    <link:label id="lab_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702_documentation_en-US" xlink:label="lab_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Oral Self-care [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralSelfcareMember" xlink:label="loc_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:to="lab_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:type="arc" />
    <link:label id="lab_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3_terseLabel_en-US" xlink:label="lab_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Skincare and personal hygiene</link:label>
    <link:label id="lab_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3_label_en-US" xlink:label="lab_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Skincare and Personal Hygiene [Member]</link:label>
    <link:label id="lab_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3_documentation_en-US" xlink:label="lab_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Skincare and Personal Hygiene [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SkincareandPersonalHygieneMember" xlink:label="loc_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:to="lab_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:type="arc" />
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB_terseLabel_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vitamins, minerals, and supplements</link:label>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB_label_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB_documentation_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_VitaminsMineralsandSupplementsMember" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:to="lab_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:type="arc" />
    <link:label id="lab_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D_terseLabel_en-US" xlink:label="lab_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Animal health</link:label>
    <link:label id="lab_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D_label_en-US" xlink:label="lab_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Animal Health [Member]</link:label>
    <link:label id="lab_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D_documentation_en-US" xlink:label="lab_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Animal Health [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AnimalHealthMember" xlink:label="loc_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:to="lab_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:type="arc" />
    <link:label id="lab_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D_terseLabel_en-US" xlink:label="lab_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other CSCA</link:label>
    <link:label id="lab_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D_label_en-US" xlink:label="lab_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other CSCA [Member]</link:label>
    <link:label id="lab_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D_documentation_en-US" xlink:label="lab_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other CSC [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCSCAMember" xlink:label="loc_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:to="lab_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:type="arc" />
    <link:label id="lab_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918_terseLabel_en-US" xlink:label="lab_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other CSCI</link:label>
    <link:label id="lab_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918_label_en-US" xlink:label="lab_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other CSCI [Member]</link:label>
    <link:label id="lab_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918_documentation_en-US" xlink:label="lab_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other CSCI [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCSCIMember" xlink:label="loc_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:to="lab_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_29C98D6795714E0413D885ED3CFB862A_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract_8452BDB10253561EAA72C5265CF29DD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_8452BDB10253561EAA72C5265CF29DD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract_8452BDB10253561EAA72C5265CF29DD5" xlink:to="lab_us-gaap_RestructuringChargesAbstract_8452BDB10253561EAA72C5265CF29DD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_F2B92EB73A3BF3D2539D85ED3CFBD271_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4CA4D56E95EE57BB93B6A46ECCF58EC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_F2B92EB73A3BF3D2539D85ED3CFBD271_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4CA4D56E95EE57BB93B6A46ECCF58EC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4CA4D56E95EE57BB93B6A46ECCF58EC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4CA4D56E95EE57BB93B6A46ECCF58EC5" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4CA4D56E95EE57BB93B6A46ECCF58EC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_52AFC601452F818B5C2885ED3DF70D1A_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_E4DC46591DED5E828B5E84B3ABAAF2D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_52AFC601452F818B5C2885ED3DF70D1A_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_E4DC46591DED5E828B5E84B3ABAAF2D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_E4DC46591DED5E828B5E84B3ABAAF2D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_E4DC46591DED5E828B5E84B3ABAAF2D5" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_E4DC46591DED5E828B5E84B3ABAAF2D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_64A5838E2AFDCABAEFF785ED3DF81184_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock_CDDAD86BEB075539BC747053E1F28D43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Security Expense (Income)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_64A5838E2AFDCABAEFF785ED3DF81184_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock_CDDAD86BEB075539BC747053E1F28D43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_CDDAD86BEB075539BC747053E1F28D43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock_CDDAD86BEB075539BC747053E1F28D43" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock_CDDAD86BEB075539BC747053E1F28D43" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_7B8A8A9F94C1F89D449558320F383435_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_7B8A8A9F94C1F89D449558320F383435_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_7AC2A2D0B725145EEFA658320F3C3125_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_7AC2A2D0B725145EEFA658320F3C3125_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_90A10E879F431520232C58320F3CD711_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_90A10E879F431520232C58320F3CD711_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:type="arc" />
    <link:label id="lab_prgo_RightofUseAsset_B59E1F0A88199AD9D1EE58320F3CB483_totalLabel_en-US" xlink:label="lab_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:label id="lab_prgo_RightofUseAsset_B59E1F0A88199AD9D1EE58320F3CB483_label_en-US" xlink:label="lab_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:label id="lab_prgo_RightofUseAsset_B59E1F0A88199AD9D1EE58320F3CB483_documentation_en-US" xlink:label="lab_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RightofUseAsset" xlink:label="loc_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:to="lab_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_789FE2F89A187248B37E58320F3C4BC9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_789FE2F89A187248B37E58320F3C4BC9_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_D76812BE07DCDE82966258320F3D268D_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liability, current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_D76812BE07DCDE82966258320F3D268D_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_A6FC4945860C64D5E52458320F3DE4AA_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_A6FC4945860C64D5E52458320F3DE4AA_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_B7AE3CFAEEE465CF57A758320F3D75ED_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_B7AE3CFAEEE465CF57A758320F3D75ED_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_1E825D6470892BD2AE7558320F3D194B_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:to="lab_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_82A35F445681EC031C8C58320F3DD5EC_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:to="lab_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2DBDD0786C43CE6796C05838559A81D2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2DBDD0786C43CE6796C05838559A81D2_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8C95F3610B5A7755958F58401545A846_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8C95F3610B5A7755958F58401545A846_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_E57BC29460C7E5F8D89D58439A2EA49D_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_E57BC29460C7E5F8D89D58439A2EA49D_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E6D479044D2D10B740F35847CB183BE2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E6D479044D2D10B740F35847CB183BE2_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_37180D405D9388F12CCE58498DA5858D_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_37180D405D9388F12CCE58498DA5858D_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_64EBA092CB40AB7AC61C85ED3BECB2EC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1132033510665AC0A2BD3B0456C3E105" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of effective income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_64EBA092CB40AB7AC61C85ED3BECB2EC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1132033510665AC0A2BD3B0456C3E105" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1132033510665AC0A2BD3B0456C3E105" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1132033510665AC0A2BD3B0456C3E105" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1132033510665AC0A2BD3B0456C3E105" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_E3888BCA87846E57FACA85ED3CFF135B_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D8732545D86564580C1973B8C56B279" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D8732545D86564580C1973B8C56B279" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D8732545D86564580C1973B8C56B279" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D8732545D86564580C1973B8C56B279" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_52479DC001EE55F267FB85ED3CFF92A1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_A99F491605145E06A80FFF8535BCB9DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_52479DC001EE55F267FB85ED3CFF92A1_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_A99F491605145E06A80FFF8535BCB9DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_A99F491605145E06A80FFF8535BCB9DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_A99F491605145E06A80FFF8535BCB9DF" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_A99F491605145E06A80FFF8535BCB9DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_883DA6CD2DACFFAB0A9B85ED3CDE7740_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_C5C9B59C2BCC53159BD7E06D8BE033D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_C5C9B59C2BCC53159BD7E06D8BE033D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_C5C9B59C2BCC53159BD7E06D8BE033D4" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_C5C9B59C2BCC53159BD7E06D8BE033D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1A2DC83B950E629E3FFA85ED3CDE0482_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36AC35CC8331508B89E4464633EF3783" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1A2DC83B950E629E3FFA85ED3CDE0482_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36AC35CC8331508B89E4464633EF3783" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36AC35CC8331508B89E4464633EF3783" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36AC35CC8331508B89E4464633EF3783" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36AC35CC8331508B89E4464633EF3783" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:to="lab_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:type="arc" />
    <link:label id="lab_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22_terseLabel_en-US" xlink:label="lab_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Pharma Contingent Milestone Payments</link:label>
    <link:label id="lab_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22_label_en-US" xlink:label="lab_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Pharma Contingent Milestone Payments [Member]</link:label>
    <link:label id="lab_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22_documentation_en-US" xlink:label="lab_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Pharma Contingent Milestone Payments [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:to="lab_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measured on a recurring basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Pharma Contingent Milestone Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments received</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_A800AE21CDE10CCD2B674D57918B5DCC_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_A800AE21CDE10CCD2B674D57918B5DCC" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_A800AE21CDE10CCD2B674D57918B5DCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_A800AE21CDE10CCD2B674D57918B5DCC" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_A800AE21CDE10CCD2B674D57918B5DCC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Settlements and other adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_E83E9C974C5911DDC4354D57918B87B9_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_E83E9C974C5911DDC4354D57918B87B9" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_E83E9C974C5911DDC4354D57918B87B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_E83E9C974C5911DDC4354D57918B87B9" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_E83E9C974C5911DDC4354D57918B87B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_F7CCE013FF40401A11AB85ED3CB80AA5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_95A7FACA9F0150F8BAEDF4C094D678D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_F7CCE013FF40401A11AB85ED3CB80AA5_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_95A7FACA9F0150F8BAEDF4C094D678D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_95A7FACA9F0150F8BAEDF4C094D678D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock_95A7FACA9F0150F8BAEDF4C094D678D6" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock_95A7FACA9F0150F8BAEDF4C094D678D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_153A905ECF651F1793DF4F80C8A39112_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_49E1A475170755B68186B2097BCBED80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term - Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_153A905ECF651F1793DF4F80C8A39112_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_49E1A475170755B68186B2097BCBED80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_49E1A475170755B68186B2097BCBED80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_49E1A475170755B68186B2097BCBED80" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_49E1A475170755B68186B2097BCBED80" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_108173BF14169581B9084F80C8A43480_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_986DF83B5FD9536280A588B547430304" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average lease term - Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_108173BF14169581B9084F80C8A43480_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_986DF83B5FD9536280A588B547430304" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_986DF83B5FD9536280A588B547430304" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_986DF83B5FD9536280A588B547430304" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_986DF83B5FD9536280A588B547430304" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6F931AA5F911B6AC96004F80C8A4712A_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_CFED391033135084B5BC812BF8EF5CE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate - Operating lease (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6F931AA5F911B6AC96004F80C8A4712A_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_CFED391033135084B5BC812BF8EF5CE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_CFED391033135084B5BC812BF8EF5CE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_CFED391033135084B5BC812BF8EF5CE5" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_CFED391033135084B5BC812BF8EF5CE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_1130198F2FDB1E2993B24F80C8A4D27E_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_55A0554A2C6754D2AA668ACC8EDB7D4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate - Finance lease (percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_1130198F2FDB1E2993B24F80C8A4D27E_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_55A0554A2C6754D2AA668ACC8EDB7D4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_55A0554A2C6754D2AA668ACC8EDB7D4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_55A0554A2C6754D2AA668ACC8EDB7D4C" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_55A0554A2C6754D2AA668ACC8EDB7D4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_353230BB4872D609A34685ED3BA46A17_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_F003A6FEAE6E5170943A58E1E8E3A32F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_353230BB4872D609A34685ED3BA46A17_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_F003A6FEAE6E5170943A58E1E8E3A32F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_F003A6FEAE6E5170943A58E1E8E3A32F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_F003A6FEAE6E5170943A58E1E8E3A32F" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_F003A6FEAE6E5170943A58E1E8E3A32F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Derivative Financial Instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Adjustments(1)</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-Retirement and Pension Liability Adjustments, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:type="arc" />
    <link:label id="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15_terseLabel_en-US" xlink:label="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15_label_en-US" xlink:label="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15_documentation_en-US" xlink:label="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:label="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:type="arc" />
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OCI before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_6791B98756BC6D97B62485ED3CEC0CEE_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_54CD6E81934D57AC8CF549F748EDD4AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_6791B98756BC6D97B62485ED3CEC0CEE_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_54CD6E81934D57AC8CF549F748EDD4AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_54CD6E81934D57AC8CF549F748EDD4AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock_54CD6E81934D57AC8CF549F748EDD4AF" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock_54CD6E81934D57AC8CF549F748EDD4AF" xlink:type="arc" />
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38_label_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38_documentation_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:type="arc" />
    <link:label id="lab_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72_terseLabel_en-US" xlink:label="lab_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Evamist Branded Product</link:label>
    <link:label id="lab_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72_label_en-US" xlink:label="lab_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Evamist Branded Product [Member]</link:label>
    <link:label id="lab_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72_documentation_en-US" xlink:label="lab_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Evamist Branded Product [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_EvamistBrandedProductMember" xlink:label="loc_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:to="lab_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:type="arc" />
    <link:label id="lab_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87_verboseLabel_en-US" xlink:label="lab_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Generic Product</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GenericProductAcquisitionMember" xlink:label="loc_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:to="lab_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:type="arc" />
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07_verboseLabel_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trademarks, trade names, and brands</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TrademarksTradeNamesandBrandsMember" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:to="lab_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:type="arc" />
    <link:label id="lab_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8_verboseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Distribution and license agreements and supply agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:to="lab_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed product technology, formulations, and product rights</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships and distribution networks</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:to="lab_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks, trade names, and brands</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:to="lab_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:type="arc" />
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4_terseLabel_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite And Indefinite Lived Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4_label_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite And Indefinite Lived Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4_documentation_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite and Indefinite-Lived Assets By Major Class [Line Items]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived intangibles:</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets amortization expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of indefinite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_F81A8172C323EB511BF085ED3BE9F7AE_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_D4C54930424A5B0A9A65D804785CF913" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_F81A8172C323EB511BF085ED3BE9F7AE_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_D4C54930424A5B0A9A65D804785CF913" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_D4C54930424A5B0A9A65D804785CF913" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_D4C54930424A5B0A9A65D804785CF913" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_D4C54930424A5B0A9A65D804785CF913" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_02469F515A43DC509E3485ED3BEA629A_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_E8728FD865A754669F2E7DC24416359F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_02469F515A43DC509E3485ED3BEA629A_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_E8728FD865A754669F2E7DC24416359F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_E8728FD865A754669F2E7DC24416359F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_E8728FD865A754669F2E7DC24416359F" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_E8728FD865A754669F2E7DC24416359F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FDEE466748A9FAB0A88385ED3D0D4E96_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_FDEE466748A9FAB0A88385ED3D0D4E96_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_335E8DC2C935F858BB6B85ED3D0D7064_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_335E8DC2C935F858BB6B85ED3D0D7064_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:to="lab_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_726791F7C5DCFDFCF84985ED3D0E945F_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_726791F7C5DCFDFCF84985ED3D0E945F_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:type="arc" />
    <link:label id="lab_prgo_ContingentConsiderationMember_5A04979F15B31CFAE11F85ED3D0E2585_terseLabel_en-US" xlink:label="lab_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_prgo_ContingentConsiderationMember_5A04979F15B31CFAE11F85ED3D0E2585_label_en-US" xlink:label="lab_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_prgo_ContingentConsiderationMember_5A04979F15B31CFAE11F85ED3D0E2585_documentation_en-US" xlink:label="lab_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationMember" xlink:label="loc_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:to="lab_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_06CFB702914760A487EB85ED3D0EEF86_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_06CFB702914760A487EB85ED3D0EEF86_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:to="lab_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_1561CBCFE56BD47F89F685ED3D0FB035_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_1561CBCFE56BD47F89F685ED3D0FB035_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:to="lab_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_5EBA084651D4818368EA85ED3D0FC957_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_5EBA084651D4818368EA85ED3D0FC957_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_C9D25FD1C1EB8D4D131385ED3D0FC82E_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_C9D25FD1C1EB8D4D131385ED3D0FC82E_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:to="lab_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_D2448E10F7D9F015EEA985ED3D10768E_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_D2448E10F7D9F015EEA985ED3D10768E_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:to="lab_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:type="arc" />
    <link:label id="lab_prgo_MeasurementInputProjectedRoyaltiesMember_346DA1BD0D4325B4471E85ED3D10DE6D_terseLabel_en-US" xlink:label="lab_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Projected Royalties</link:label>
    <link:label id="lab_prgo_MeasurementInputProjectedRoyaltiesMember_346DA1BD0D4325B4471E85ED3D10DE6D_label_en-US" xlink:label="lab_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Projected Royalties [Member]</link:label>
    <link:label id="lab_prgo_MeasurementInputProjectedRoyaltiesMember_346DA1BD0D4325B4471E85ED3D10DE6D_documentation_en-US" xlink:label="lab_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Projected Royalties [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_MeasurementInputProjectedRoyaltiesMember" xlink:label="loc_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:to="lab_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_BDEC57932B492BAB6B4985ED3D1026FF_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_BDEC57932B492BAB6B4985ED3D1026FF_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9CEE43734EBAF8FFAB3285ED3D10EA5A_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9CEE43734EBAF8FFAB3285ED3D10EA5A_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:type="arc" />
    <link:label id="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_3DC24002B339A3D892F785ED3D101A10_terseLabel_en-US" xlink:label="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration payments: sales-based milestones</link:label>
    <link:label id="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_3DC24002B339A3D892F785ED3D101A10_label_en-US" xlink:label="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Payments, Sales-based Milestones</link:label>
    <link:label id="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_3DC24002B339A3D892F785ED3D101A10_documentation_en-US" xlink:label="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Payments, Sales-based Milestones</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestones" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:to="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:type="arc" />
    <link:label id="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_3DF8CDA792079A15684E85ED3D12FA90_terseLabel_en-US" xlink:label="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration payments: sales-based milestones (percent)</link:label>
    <link:label id="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_3DF8CDA792079A15684E85ED3D12FA90_label_en-US" xlink:label="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Payments, Sales-based Milestones, Percent</link:label>
    <link:label id="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_3DF8CDA792079A15684E85ED3D12FA90_documentation_en-US" xlink:label="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Payments, Sales-based Milestones, Percent</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:to="lab_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_084FC76917DB0D7427D685ED3C38DD34_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_DC2EF6C9BFD65AD3B0F08F028A01BEAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_084FC76917DB0D7427D685ED3C38DD34_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_DC2EF6C9BFD65AD3B0F08F028A01BEAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_DC2EF6C9BFD65AD3B0F08F028A01BEAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_DC2EF6C9BFD65AD3B0F08F028A01BEAE" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_DC2EF6C9BFD65AD3B0F08F028A01BEAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:to="lab_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:to="lab_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:type="arc" />
    <link:label id="lab_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C_terseLabel_en-US" xlink:label="lab_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BCS</link:label>
    <link:label id="lab_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C_label_en-US" xlink:label="lab_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BCS [Member]</link:label>
    <link:label id="lab_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C_documentation_en-US" xlink:label="lab_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BCS [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BCSMember" xlink:label="loc_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:to="lab_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of reporting unit in excess of net book value (percent)</link:label>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366_label_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:to="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_10FE850342DA7D0582FB85ED3CCEF15C_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_772F2C8B7ABC5004B8587FA5CB6B579C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_10FE850342DA7D0582FB85ED3CCEF15C_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_772F2C8B7ABC5004B8587FA5CB6B579C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_772F2C8B7ABC5004B8587FA5CB6B579C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_772F2C8B7ABC5004B8587FA5CB6B579C" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_772F2C8B7ABC5004B8587FA5CB6B579C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_7B7F499B469BA96F375585ED3CCFEF12_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8D60BD59134B5E09846811E59EFD3E35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_7B7F499B469BA96F375585ED3CCFEF12_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8D60BD59134B5E09846811E59EFD3E35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8D60BD59134B5E09846811E59EFD3E35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8D60BD59134B5E09846811E59EFD3E35" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8D60BD59134B5E09846811E59EFD3E35" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_70938CDADFDF548B292BAFE96D5E930A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_70938CDADFDF548B292BAFE96D5E930A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:type="arc" />
    <link:label id="lab_prgo_CSCIMember_219163484331F321C9F1AFE96D602B80_terseLabel_en-US" xlink:label="lab_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CSCI</link:label>
    <link:label id="lab_prgo_CSCIMember_219163484331F321C9F1AFE96D602B80_label_en-US" xlink:label="lab_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CSCI [Member]</link:label>
    <link:label id="lab_prgo_CSCIMember_219163484331F321C9F1AFE96D602B80_documentation_en-US" xlink:label="lab_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CSCI [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CSCIMember" xlink:label="loc_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:to="lab_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_97B172C0BC3DB1E848F7AFE96D61016E_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_97B172C0BC3DB1E848F7AFE96D61016E_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_18A69BC31E1608A40806AFE96D61D1F5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_18A69BC31E1608A40806AFE96D61D1F5_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="lab_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_8567A2450E20AE29D856AFE96D62A94C_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_8567A2450E20AE29D856AFE96D62A94C_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:to="lab_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:type="arc" />
    <link:label id="lab_prgo_RestructuringAdditionalCharges_EB2EDC40DADB901CE96EAFE96D64D752_terseLabel_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional charges</link:label>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_EB2EDC40DADB901CE96EAFE96D64D752_label_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring, Additional Charges</link:label>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_EB2EDC40DADB901CE96EAFE96D64D752_documentation_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring, Additional Charges</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RestructuringAdditionalCharges" xlink:label="loc_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:to="lab_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRestructuring_04A9AE537F064FD14DC8AFE96D64257F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_04A9AE537F064FD14DC8AFE96D64257F_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:to="lab_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_7DA6F1DBFE47C79982B3AFE96D64C2A7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-cash adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_7DA6F1DBFE47C79982B3AFE96D64C2A7_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_118EE02DA11E0E4AEF36AFE96D65D309_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_E2FA5E075C3B5DF6A6B1BB70CF61B745" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_E2FA5E075C3B5DF6A6B1BB70CF61B745" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_E2FA5E075C3B5DF6A6B1BB70CF61B745" xlink:to="lab_us-gaap_RestructuringReserve_E2FA5E075C3B5DF6A6B1BB70CF61B745" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_E57A3533EF6CD7FBE96C85ED3DB669FC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_5A5DB7DA50B654D0A311F35239A4837F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_E57A3533EF6CD7FBE96C85ED3DB669FC_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_5A5DB7DA50B654D0A311F35239A4837F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5A5DB7DA50B654D0A311F35239A4837F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_5A5DB7DA50B654D0A311F35239A4837F" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_5A5DB7DA50B654D0A311F35239A4837F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="lab_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis" xlink:label="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:to="lab_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:to="lab_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:type="arc" />
    <link:label id="lab_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember" xlink:label="loc_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:to="lab_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456_label_en-US" xlink:label="lab_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:to="lab_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="lab_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:type="arc" />
    <link:label id="lab_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32_terseLabel_en-US" xlink:label="lab_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">States' May 2019 Case Alleging Conspiracy (which does not Name Perrigo a Defendant)</link:label>
    <link:label id="lab_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32_label_en-US" xlink:label="lab_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">States' May 2019 Case Alleging Conspiracy (which does not Name Perrigo a Defendant) [Member]</link:label>
    <link:label id="lab_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32_documentation_en-US" xlink:label="lab_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">States' May 2019 Case Alleging Conspiracy (which does not Name Perrigo a Defendant) [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember" xlink:label="loc_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:to="lab_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:type="arc" />
    <link:label id="lab_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6_terseLabel_en-US" xlink:label="lab_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Overarching Conspiracy Class Actions</link:label>
    <link:label id="lab_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6_label_en-US" xlink:label="lab_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Overarching Conspiracy Class Actions [Member]</link:label>
    <link:label id="lab_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6_documentation_en-US" xlink:label="lab_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Overarching Conspiracy Class Actions [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OverarchingConspiracyClassActionsMember" xlink:label="loc_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:to="lab_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:type="arc" />
    <link:label id="lab_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC_terseLabel_en-US" xlink:label="lab_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Drugstore Chain</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC_label_en-US" xlink:label="lab_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Drugstore Chain [Member]</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC_documentation_en-US" xlink:label="lab_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Drugstore Chain [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitDrugstoreChainMember" xlink:label="loc_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:to="lab_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:type="arc" />
    <link:label id="lab_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1_terseLabel_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Suffolk County of New York</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1_label_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Suffolk County of New York [Member]</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1_documentation_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Suffolk County of New York [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember" xlink:label="loc_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:to="lab_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:type="arc" />
    <link:label id="lab_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A_terseLabel_en-US" xlink:label="lab_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Drug Wholesaler and Distributor</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A_label_en-US" xlink:label="lab_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Drug Wholesaler and Distributor [Member]</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A_documentation_en-US" xlink:label="lab_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Drug Wholesaler and Distributor [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember" xlink:label="loc_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:to="lab_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:type="arc" />
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9_terseLabel_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State Attorney General Complaint</link:label>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9_label_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State Attorney General Complaint [Member]</link:label>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9_documentation_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">State Attorney General Complaint [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_StateAttorneyGeneralComplaintMember" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:to="lab_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:type="arc" />
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26_terseLabel_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canadian Class Action Complaint</link:label>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26_label_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Canadian Class Action Complaint [Member]</link:label>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26_documentation_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Canadian Class Action Complaint [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CanadianClassActionComplaintMember" xlink:label="loc_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:to="lab_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:type="arc" />
    <link:label id="lab_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C_terseLabel_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Supermarket Chains</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C_label_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Supermarket Chains [Member]</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C_documentation_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Supermarket Chains [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSupermarketChainsMember" xlink:label="loc_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:to="lab_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:type="arc" />
    <link:label id="lab_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56_terseLabel_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Supermarket Chains, Amended Complaint</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56_label_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Supermarket Chains, Amended Complaint [Member]</link:label>
    <link:label id="lab_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56_documentation_en-US" xlink:label="lab_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-Fixing Lawsuit, Supermarket Chains, Amended Complaint [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember" xlink:label="loc_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:to="lab_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Managed Care Organization</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Managed Care Organization [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Managed Care Organization [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitManagedCareOrganizationMember" xlink:label="loc_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:to="lab_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Health Insurance Carrier</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Health Insurance Carrier [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Health Insurance Carrier [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthInsuranceCarrierMember" xlink:label="loc_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:to="lab_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Healthcare Service Company</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Healthcare Service Company [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Healthcare Service Company [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthcareServiceCompanyMember" xlink:label="loc_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:to="lab_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Medicare Advantage Claims Recovery Company</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Medicare Advantage Claims Recovery Company [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Medicare Advantage Claims Recovery Company [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember" xlink:label="loc_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:to="lab_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Several Counties in New York</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Several Counties in New York [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Several Counties in New York [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember" xlink:label="loc_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:to="lab_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Healthcare Management Organization</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Healthcare Management Organization [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Healthcare Management Organization [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthcareManagementOrganizationMember" xlink:label="loc_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:to="lab_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Harris County of Texas</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Harris County of Texas [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Harris County of Texas [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHarrisCountyofTexasMember" xlink:label="loc_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:to="lab_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:type="arc" />
    <link:label id="lab_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB_terseLabel_en-US" xlink:label="lab_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Highfields Capital I LP, et al. v. Perrigo Company plc, et al.</link:label>
    <link:label id="lab_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB_label_en-US" xlink:label="lab_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Highfields Capital I LP, et al. v. Perrigo Company plc, et al. [Member]</link:label>
    <link:label id="lab_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB_documentation_en-US" xlink:label="lab_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Highfields Capital I LP, et al. v. Perrigo Company plc, et al. [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member" xlink:label="loc_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:to="lab_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:type="arc" />
    <link:label id="lab_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E_terseLabel_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Health Plans</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E_label_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Health Plans [Member]</link:label>
    <link:label id="lab_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E_documentation_en-US" xlink:label="lab_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Price-fixing Lawsuit, Health Plans [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthPlansMember" xlink:label="loc_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:to="lab_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:type="arc" />
    <link:label id="lab_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19_terseLabel_en-US" xlink:label="lab_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BlackRock Global Allocation Fund, et al. v. Perrigo Co. plc, et al.</link:label>
    <link:label id="lab_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19_label_en-US" xlink:label="lab_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BlackRock Global Allocation Fund, et al. v. Perrigo Co. plc, et al. [Member]</link:label>
    <link:label id="lab_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19_documentation_en-US" xlink:label="lab_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BlackRock Global Allocation Fund, et al. v. Perrigo Co. plc, et al. [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member" xlink:label="loc_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:to="lab_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:type="arc" />
    <link:label id="lab_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F_terseLabel_en-US" xlink:label="lab_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cases Filed in Israel</link:label>
    <link:label id="lab_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F_label_en-US" xlink:label="lab_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cases Filed in Israel [Member]</link:label>
    <link:label id="lab_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F_documentation_en-US" xlink:label="lab_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cases Filed in Israel [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CasesFiledinIsraelMember" xlink:label="loc_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:to="lab_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:type="arc" />
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC_terseLabel_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al.</link:label>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC_label_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]</link:label>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC_documentation_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:to="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:type="arc" />
    <link:label id="lab_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2_terseLabel_en-US" xlink:label="lab_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In re Perrigo Company plc Sec. Litig.</link:label>
    <link:label id="lab_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2_label_en-US" xlink:label="lab_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In re Perrigo Company plc Sec. Litig. [Member]</link:label>
    <link:label id="lab_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2_documentation_en-US" xlink:label="lab_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">In re Perrigo Company plc Sec. Litig. [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InrePerrigoCompanyplcSec.Litig.Member" xlink:label="loc_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:to="lab_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:type="arc" />
    <link:label id="lab_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16_terseLabel_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Talcum Powder Litigation</link:label>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16_label_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Talcum Powder Litigation [Member]</link:label>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16_documentation_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Talcum Powder Litigation [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TalcumPowderLitigationMember" xlink:label="loc_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:to="lab_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:type="arc" />
    <link:label id="lab_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA_terseLabel_en-US" xlink:label="lab_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ranitidine Litigation</link:label>
    <link:label id="lab_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA_label_en-US" xlink:label="lab_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ranitidine Litigation [Member]</link:label>
    <link:label id="lab_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA_documentation_en-US" xlink:label="lab_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ranitidine Litigation [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanitidineLitigationMember" xlink:label="loc_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:to="lab_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:type="arc" />
    <link:label id="lab_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70_terseLabel_en-US" xlink:label="lab_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carmignac, First Manhattan and Similar Cases</link:label>
    <link:label id="lab_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70_label_en-US" xlink:label="lab_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carmignac, First Manhattan and Similar Cases [Member]</link:label>
    <link:label id="lab_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70_documentation_en-US" xlink:label="lab_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carmignac, First Manhattan and Similar Cases [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CarmignacFirstManhattanandSimilarCasesMember" xlink:label="loc_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:to="lab_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:type="arc" />
    <link:label id="lab_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF_terseLabel_en-US" xlink:label="lab_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Manhattan and Similar Cases</link:label>
    <link:label id="lab_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF_label_en-US" xlink:label="lab_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Manhattan and Similar Cases [Member]</link:label>
    <link:label id="lab_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF_documentation_en-US" xlink:label="lab_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First Manhattan and Similar Cases [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FirstManhattanandSimilarCasesMember" xlink:label="loc_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:to="lab_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:type="arc" />
    <link:label id="lab_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712_terseLabel_en-US" xlink:label="lab_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mason Capital, Pentwater and Similar Cases</link:label>
    <link:label id="lab_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712_label_en-US" xlink:label="lab_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mason Capital, Pentwater and Similar Cases [Member]</link:label>
    <link:label id="lab_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712_documentation_en-US" xlink:label="lab_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mason Capital, Pentwater and Similar Cases [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_MasonCapitalPentwaterandSimilarCasesMember" xlink:label="loc_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:to="lab_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:type="arc" />
    <link:label id="lab_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B_terseLabel_en-US" xlink:label="lab_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Harel Insurance and TIAA-CREFF Cases</link:label>
    <link:label id="lab_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B_label_en-US" xlink:label="lab_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Harel Insurance and TIAA-CREFF Cases [Member]</link:label>
    <link:label id="lab_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B_documentation_en-US" xlink:label="lab_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Harel Insurance and TIAA-CREFF Cases [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HarelInsuranceandTIAACREFFCasesMember" xlink:label="loc_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:to="lab_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:type="arc" />
    <link:label id="lab_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346_terseLabel_en-US" xlink:label="lab_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Roofers' Pension Fund</link:label>
    <link:label id="lab_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346_label_en-US" xlink:label="lab_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Roofers' Pension Fund [Member]</link:label>
    <link:label id="lab_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346_documentation_en-US" xlink:label="lab_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Roofers' Pension Fund [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoofersPensionFundMember" xlink:label="loc_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:to="lab_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:type="arc" />
    <link:label id="lab_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3_terseLabel_en-US" xlink:label="lab_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Cases Related to Events in 2015-2017</link:label>
    <link:label id="lab_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3_label_en-US" xlink:label="lab_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Cases Related to Events in 2015-2017 [Member]</link:label>
    <link:label id="lab_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3_documentation_en-US" xlink:label="lab_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Cases Related to Events in 2015-2017 [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCasesRelatedtoEventsin20152017Member" xlink:label="loc_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:to="lab_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:type="arc" />
    <link:label id="lab_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683_terseLabel_en-US" xlink:label="lab_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In Israel (Cases Related to Irish Tax Events)</link:label>
    <link:label id="lab_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683_label_en-US" xlink:label="lab_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Israel (Cases Related to Irish Tax Events) [Member]</link:label>
    <link:label id="lab_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683_documentation_en-US" xlink:label="lab_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">In Israel (Cases Related to Irish Tax Events) [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InIsraelCasesRelatedtoIrishTaxEventsMember" xlink:label="loc_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:to="lab_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:type="arc" />
    <link:label id="lab_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A_terseLabel_en-US" xlink:label="lab_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acetaminophen Litigation</link:label>
    <link:label id="lab_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A_label_en-US" xlink:label="lab_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acetaminophen Litigation [Member]</link:label>
    <link:label id="lab_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A_documentation_en-US" xlink:label="lab_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acetaminophen Litigation [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AcetaminophenLitigationMember" xlink:label="loc_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:to="lab_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="lab_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F_terseLabel_en-US" xlink:label="lab_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of products included in expedited cases</link:label>
    <link:label id="lab_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F_label_en-US" xlink:label="lab_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Products included in Expedited Cases</link:label>
    <link:label id="lab_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F_documentation_en-US" xlink:label="lab_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Products included in Expedited Cases</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofProductsincludedinExpeditedCases" xlink:label="loc_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:to="lab_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2_terseLabel_en-US" xlink:label="lab_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of putative classes</link:label>
    <link:label id="lab_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2_label_en-US" xlink:label="lab_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Putative Classes</link:label>
    <link:label id="lab_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2_documentation_en-US" xlink:label="lab_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Putative Classes</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofPutativeClasses" xlink:label="loc_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:to="lab_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06_terseLabel_en-US" xlink:label="lab_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of sets of class action complaints</link:label>
    <link:label id="lab_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06_label_en-US" xlink:label="lab_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Sets of Class Action Complaints</link:label>
    <link:label id="lab_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06_documentation_en-US" xlink:label="lab_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Sets of Class Action Complaints</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofSetsofClassActionComplaints" xlink:label="loc_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:to="lab_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB_terseLabel_en-US" xlink:label="lab_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases alleging only state law claims</link:label>
    <link:label id="lab_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB_label_en-US" xlink:label="lab_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Cases Alleging Only State Law Claims</link:label>
    <link:label id="lab_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB_documentation_en-US" xlink:label="lab_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Cases Alleging Only State Law Claims</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCasesAllegingOnlyStateLawClaims" xlink:label="loc_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:to="lab_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Manufacturers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Manufacturers</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfManufacturers" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:to="lab_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96_terseLabel_en-US" xlink:label="lab_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Other Pharmaceutical Companies</link:label>
    <link:label id="lab_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96_label_en-US" xlink:label="lab_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Other Pharmaceutical Companies</link:label>
    <link:label id="lab_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96_documentation_en-US" xlink:label="lab_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Other Pharmaceutical Companies</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofOtherPharmaceuticalCompanies" xlink:label="loc_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:to="lab_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of former employees</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Former Employees</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Former Employees</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofFormerEmployees" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:to="lab_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:type="arc" />
    <link:label id="lab_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302_terseLabel_en-US" xlink:label="lab_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of current employees</link:label>
    <link:label id="lab_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302_label_en-US" xlink:label="lab_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityNumberOfEmployees" xlink:label="loc_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:to="lab_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of additional states and territories</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Additional States and Territories</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Additional States and Territories</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofAdditionalStatesandTerritories" xlink:label="loc_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:to="lab_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of generic prescription pharmaceuticals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Generic Prescription Pharmaceuticals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Generic Prescription Pharmaceuticals</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:to="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of formulations of products manufactured by the company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Formulations of Products Manufactured by the Company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Formulations of Products Manufactured by the Company</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany" xlink:label="loc_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:to="lab_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of products manufactured by the Company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Prescription Pharmaceuticals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Prescription Pharmaceuticals</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfPrescriptionPharmaceuticals" xlink:label="loc_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:to="lab_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5_terseLabel_en-US" xlink:label="lab_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases included in expedited schedule</link:label>
    <link:label id="lab_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5_label_en-US" xlink:label="lab_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Cases Included in Expedited Schedule</link:label>
    <link:label id="lab_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5_documentation_en-US" xlink:label="lab_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Cases Included in Expedited Schedule</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCasesIncludedinExpeditedSchedule" xlink:label="loc_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:to="lab_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of supermarket chains</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Supermarket Chains</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Supermarket Chains</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfSupermarketChains" xlink:label="loc_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:to="lab_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A_terseLabel_en-US" xlink:label="lab_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases with similar factual allegations</link:label>
    <link:label id="lab_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A_label_en-US" xlink:label="lab_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Cases with Similar Factual Allegations</link:label>
    <link:label id="lab_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A_documentation_en-US" xlink:label="lab_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Cases with Similar Factual Allegations</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCaseswithSimilarFactualAllegations" xlink:label="loc_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:to="lab_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of defendants</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Defendants</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:to="lab_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57_terseLabel_en-US" xlink:label="lab_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of health plans</link:label>
    <link:label id="lab_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57_label_en-US" xlink:label="lab_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies, Number of Health Plans</link:label>
    <link:label id="lab_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57_documentation_en-US" xlink:label="lab_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingencies, Number of Health Plans</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingenciesNumberofHealthPlans" xlink:label="loc_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:to="lab_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE_terseLabel_en-US" xlink:label="lab_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of dozens of manufacturers</link:label>
    <link:label id="lab_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE_label_en-US" xlink:label="lab_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Dozens of Manufacturers</link:label>
    <link:label id="lab_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE_documentation_en-US" xlink:label="lab_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Dozens of Manufacturers</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofDozensofManufacturers" xlink:label="loc_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:to="lab_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of individuals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Individuals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Individuals</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfIndividuals" xlink:label="loc_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:to="lab_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of co-defendants</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Co-defendants</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Co-defendants</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofCodefendants" xlink:label="loc_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:to="lab_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfCases" xlink:label="loc_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:to="lab_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases voluntarily dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases stayed</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Cases Stayed</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Cases Stayed</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfCasesStayed" xlink:label="loc_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:to="lab_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of current or former directors and officers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Current Or Former Directors And Officers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Current Or Former Directors And Officers</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:to="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Damages sought by plaintiff</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency exchange rate, remeasurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Exchange Rate, Remeasurement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:to="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of defendants added</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Defendants Added</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Defendants Added</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofDefendantsAdded" xlink:label="loc_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:to="lab_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of defendants dismissed without prejudice</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Defendants Dismissed without Prejudice</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Defendants Dismissed without Prejudice</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice" xlink:label="loc_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:to="lab_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of lawsuits</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Lawsuits</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Lawsuits</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofLawsuits" xlink:label="loc_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:to="lab_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:type="arc" />
    <link:label id="lab_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F_terseLabel_en-US" xlink:label="lab_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of tenders accepted for a portion of the defense costs and liability from a retailer</link:label>
    <link:label id="lab_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F_label_en-US" xlink:label="lab_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Tenders Accepted</link:label>
    <link:label id="lab_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F_documentation_en-US" xlink:label="lab_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Tenders Accepted</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofTendersAccepted" xlink:label="loc_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:to="lab_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of master complaints</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Master Complaints</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Master Complaints</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofMasterComplaints" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:to="lab_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of master complaints naming the company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Master Complaints Naming Company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Master Complaints Naming Company</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:to="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of claims for indemnification or defense</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Claims for Indemnification or Defense</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Claims for Indemnification or Defense</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofClaimsforIndemnificationorDefense" xlink:label="loc_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:to="lab_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:type="arc" />
    <link:label id="lab_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Retailers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Retailers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Retailers</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofRetailers" xlink:label="loc_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:to="lab_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_AB0EA999BDAC7EA96E5A503C7F0FD999_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_43C4663BFE6B5E688411DB9318C4E1C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_AB0EA999BDAC7EA96E5A503C7F0FD999_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_43C4663BFE6B5E688411DB9318C4E1C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_43C4663BFE6B5E688411DB9318C4E1C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_43C4663BFE6B5E688411DB9318C4E1C2" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_43C4663BFE6B5E688411DB9318C4E1C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0BB00B21EBE12492BF5F503C7F108F7E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5DFCEC47FB365B9AB824AE8EEB19C2C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0BB00B21EBE12492BF5F503C7F108F7E_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5DFCEC47FB365B9AB824AE8EEB19C2C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5DFCEC47FB365B9AB824AE8EEB19C2C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5DFCEC47FB365B9AB824AE8EEB19C2C5" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5DFCEC47FB365B9AB824AE8EEB19C2C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_93CC7689BBF04CC6901985ED3B9846B1_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_295CB21A9ACC586EAF61AA9A3BB0C1FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_93CC7689BBF04CC6901985ED3B9846B1_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_295CB21A9ACC586EAF61AA9A3BB0C1FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_295CB21A9ACC586EAF61AA9A3BB0C1FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_295CB21A9ACC586EAF61AA9A3BB0C1FB" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_295CB21A9ACC586EAF61AA9A3BB0C1FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_AB262ABFF3733FFA655585ED3C7E6D9F_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_FE44A1468A9D5122A85620A964A05667" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_AB262ABFF3733FFA655585ED3C7E6D9F_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_FE44A1468A9D5122A85620A964A05667" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_FE44A1468A9D5122A85620A964A05667" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_FE44A1468A9D5122A85620A964A05667" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_FE44A1468A9D5122A85620A964A05667" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_681D6A5C981A99C35D9F85ED3C7EAD60_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock_EA8E4BBC7E815A6B809025B292429FC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_681D6A5C981A99C35D9F85ED3C7EAD60_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock_EA8E4BBC7E815A6B809025B292429FC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_EA8E4BBC7E815A6B809025B292429FC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock_EA8E4BBC7E815A6B809025B292429FC5" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock_EA8E4BBC7E815A6B809025B292429FC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_E1CD0E7995C02852B3DA85ED3BED8FA0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_A957C42B709056BEB9F7FE92C6489339" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_E1CD0E7995C02852B3DA85ED3BED8FA0_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_A957C42B709056BEB9F7FE92C6489339" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_A957C42B709056BEB9F7FE92C6489339" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_A957C42B709056BEB9F7FE92C6489339" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_A957C42B709056BEB9F7FE92C6489339" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_A88211D7C0F7BF43F77A85ED3CD1E9D1_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F455B7F2315A55D9837BA55A4136C9F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_A88211D7C0F7BF43F77A85ED3CD1E9D1_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F455B7F2315A55D9837BA55A4136C9F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F455B7F2315A55D9837BA55A4136C9F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F455B7F2315A55D9837BA55A4136C9F0" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F455B7F2315A55D9837BA55A4136C9F0" xlink:type="arc" />
    <link:label id="lab_srt_StatementGeographicalAxis_6645A940BDC4FFEC6BF14EBBAC2DF8DC_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_6645A940BDC4FFEC6BF14EBBAC2DF8DC_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:to="lab_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:type="arc" />
    <link:label id="lab_srt_SegmentGeographicalDomain_30714E95422656FBCE624EBBAC2EB245_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_30714E95422656FBCE624EBBAC2EB245_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="lab_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:type="arc" />
    <link:label id="lab_country_US_BA26E8278E584C4A8C564EBBAC2E9C53_terseLabel_en-US" xlink:label="lab_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_BA26E8278E584C4A8C564EBBAC2E9C53_label_en-US" xlink:label="lab_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:to="lab_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:type="arc" />
    <link:label id="lab_srt_EuropeMember_BFB2F1E3B552D43197F04EBBAC2E73BE_terseLabel_en-US" xlink:label="lab_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_BFB2F1E3B552D43197F04EBBAC2E73BE_label_en-US" xlink:label="lab_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:to="lab_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:type="arc" />
    <link:label id="lab_prgo_OtherGeographicalAreasMember_8FCF26C95E699B2BA3D34EBBAC2EBCAC_terseLabel_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other countries</link:label>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_8FCF26C95E699B2BA3D34EBBAC2EBCAC_label_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_8FCF26C95E699B2BA3D34EBBAC2EBCAC_documentation_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherGeographicalAreasMember" xlink:label="loc_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:to="lab_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:type="arc" />
    <link:label id="lab_country_IE_C5A0233A5B1BC49A15334EBBAC2F4B59_terseLabel_en-US" xlink:label="lab_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_C5A0233A5B1BC49A15334EBBAC2F4B59_label_en-US" xlink:label="lab_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE" xlink:label="loc_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:to="lab_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:type="arc" />
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated derivatives:</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:to="lab_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:to="lab_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Fair Value, Amount Not Offset Against Collateral</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Fair Value, Amount Not Offset Against Collateral</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:type="arc" />
    <link:label id="lab_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6_label_en-US" xlink:label="lab_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:to="lab_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:type="arc" />
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:to="lab_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:type="arc" />
    <link:label id="lab_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD_label_en-US" xlink:label="lab_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:to="lab_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Long-term Growth Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09_label_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Long-term Revenue Growth Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:to="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:type="arc" />
    <link:label id="lab_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:to="lab_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:type="arc" />
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:type="arc" />
    <link:label id="lab_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963_terseLabel_en-US" xlink:label="lab_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Pharma</link:label>
    <link:label id="lab_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963_label_en-US" xlink:label="lab_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Pharma [Member]</link:label>
    <link:label id="lab_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963_documentation_en-US" xlink:label="lab_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Pharma [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaMember" xlink:label="loc_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:to="lab_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:type="arc" />
    <link:label id="lab_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1_terseLabel_en-US" xlink:label="lab_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Pharma 2020 Contingent Milestone Payments</link:label>
    <link:label id="lab_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1_label_en-US" xlink:label="lab_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Pharma 2020 Contingent Milestone Payments [Member]</link:label>
    <link:label id="lab_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1_documentation_en-US" xlink:label="lab_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Pharma 2020 Contingent Milestone Payments [Member]</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:to="lab_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:type="arc" />
    <link:label id="lab_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840_terseLabel_en-US" xlink:label="lab_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfers among level 1, 2, and 3</link:label>
    <link:label id="lab_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840_label_en-US" xlink:label="lab_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount</link:label>
    <link:label id="lab_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840_documentation_en-US" xlink:label="lab_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssetsLevel1Level2Level3TransfersAmount" xlink:label="loc_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:to="lab_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:type="arc" />
    <link:label id="lab_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F_terseLabel_en-US" xlink:label="lab_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F_label_en-US" xlink:label="lab_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Assumption, Volatility</link:label>
    <link:label id="lab_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F_documentation_en-US" xlink:label="lab_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Assumption, Volatility</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssumptionVolatility" xlink:label="loc_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:to="lab_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:type="arc" />
    <link:label id="lab_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE_terseLabel_en-US" xlink:label="lab_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate of return</link:label>
    <link:label id="lab_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE_label_en-US" xlink:label="lab_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Assumptions, Rate of Return</link:label>
    <link:label id="lab_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE_documentation_en-US" xlink:label="lab_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Assumptions, Rate of Return</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssumptionsRateofReturn" xlink:label="loc_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:to="lab_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in fair value of milestone payment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair valued contingent milestone payment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:type="arc" />
    <link:label id="lab_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6_terseLabel_en-US" xlink:label="lab_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales included in calculation for milestone payment</link:label>
    <link:label id="lab_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6_label_en-US" xlink:label="lab_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Sales Included in Calculation For Milestone Payment</link:label>
    <link:label id="lab_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6_documentation_en-US" xlink:label="lab_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Sales Included in Calculation For Milestone Payment</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NetSalesIncludedinCalculationForMilestonePayment" xlink:label="loc_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:to="lab_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments received</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:type="arc" />
    <link:label id="lab_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359_terseLabel_en-US" xlink:label="lab_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Pharma contingent payment sales threshold</link:label>
    <link:label id="lab_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359_label_en-US" xlink:label="lab_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset, Adjusted Fair Value if Sales Threshold Met</link:label>
    <link:label id="lab_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359_documentation_en-US" xlink:label="lab_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset, Adjusted Fair Value if Sales Threshold Met</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AssetAdjustedFairValueifSalesThresholdMet" xlink:label="loc_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:to="lab_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:type="arc" />
    <link:label id="lab_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC_terseLabel_en-US" xlink:label="lab_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales threshold to trigger milestone payment</link:label>
    <link:label id="lab_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC_label_en-US" xlink:label="lab_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Sales Threshold For Milestone Payment</link:label>
    <link:label id="lab_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC_documentation_en-US" xlink:label="lab_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Sales Threshold For Milestone Payment</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NetSalesThresholdForMilestonePayment" xlink:label="loc_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:to="lab_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income recognized from change is asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:to="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:type="arc" />
    <link:label id="lab_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45_terseLabel_en-US" xlink:label="lab_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting unit, fair value (percent)</link:label>
    <link:label id="lab_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45_label_en-US" xlink:label="lab_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit, Fair Value, Percent</link:label>
    <link:label id="lab_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45_documentation_en-US" xlink:label="lab_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reporting Unit, Fair Value, Percent</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ReportingUnitFairValuePercent" xlink:label="loc_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:to="lab_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:type="arc" />
    <link:label id="lab_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B_terseLabel_en-US" xlink:label="lab_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Blended jurisdictional tax rates (percent)</link:label>
    <link:label id="lab_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B_label_en-US" xlink:label="lab_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Blended Jurisdictional Tax Rates, Percent</link:label>
    <link:label id="lab_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B_documentation_en-US" xlink:label="lab_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Blended Jurisdictional Tax Rates, Percent</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BlendedJurisdictionalTaxRatesPercent" xlink:label="loc_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:to="lab_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2557960DBE1B9660E0CB85ED3B7BDEB1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2318D1C2FE20599BA8830A9A060CB960" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2557960DBE1B9660E0CB85ED3B7BDEB1_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2318D1C2FE20599BA8830A9A060CB960" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2318D1C2FE20599BA8830A9A060CB960" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2318D1C2FE20599BA8830A9A060CB960" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2318D1C2FE20599BA8830A9A060CB960" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings - Foreign currency forward contracts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:type="arc" />
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5_totalLabel_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</link:label>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5_label_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5_documentation_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:to="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726_totalLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:type="arc" />
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814_terseLabel_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814_label_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</link:label>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814_documentation_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:to="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net gain expected to be reclassified out of AOCI into earnings in the next 12 months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:type="arc" />
    <link:label id="lab_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F_terseLabel_en-US" xlink:label="lab_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rosemont Pharmaceuticals</link:label>
    <link:label id="lab_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F_label_en-US" xlink:label="lab_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rosemont Pharmaceuticals [Member]</link:label>
    <link:label id="lab_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F_documentation_en-US" xlink:label="lab_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rosemont Pharmaceuticals</link:label>
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RosemontPharmaceuticalsMember" xlink:label="loc_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:to="lab_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of business</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>prgo-20200926_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:href="prgo-20200926.xsd#AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestitures" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestitures" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresDivestitureDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails" xlink:href="prgo-20200926.xsd#AcquisitionsAndDivestituresProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsTables" xlink:href="prgo-20200926.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:href="prgo-20200926.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:href="prgo-20200926.xsd#CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Contingencies" xlink:href="prgo-20200926.xsd#Contingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesDetails" xlink:href="prgo-20200926.xsd#ContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/CoverPage" xlink:href="prgo-20200926.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:href="prgo-20200926.xsd#DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:href="prgo-20200926.xsd#EarningsPerShareAndShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurements" xlink:href="prgo-20200926.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:href="prgo-20200926.xsd#FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:href="prgo-20200926.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssets" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsGoodwillDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="prgo-20200926.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxes" xlink:href="prgo-20200926.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:href="prgo-20200926.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesTables" xlink:href="prgo-20200926.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Indebtedness" xlink:href="prgo-20200926.xsd#Indebtedness" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#IndebtednessAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:href="prgo-20200926.xsd#IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessTables" xlink:href="prgo-20200926.xsd#IndebtednessTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Inventories" xlink:href="prgo-20200926.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesDetails" xlink:href="prgo-20200926.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesTables" xlink:href="prgo-20200926.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Investments" xlink:href="prgo-20200926.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsDetails" xlink:href="prgo-20200926.xsd#InvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsTables" xlink:href="prgo-20200926.xsd#InvestmentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/Leases" xlink:href="prgo-20200926.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:href="prgo-20200926.xsd#LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:href="prgo-20200926.xsd#LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:href="prgo-20200926.xsd#LeasesLeaseCashFlowClassificationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:href="prgo-20200926.xsd#LeasesLeaseExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesTables" xlink:href="prgo-20200926.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:href="prgo-20200926.xsd#LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringCharges" xlink:href="prgo-20200926.xsd#RestructuringCharges" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:href="prgo-20200926.xsd#RestructuringChargesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesTables" xlink:href="prgo-20200926.xsd#RestructuringChargesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognition" xlink:href="prgo-20200926.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfContractBalancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:href="prgo-20200926.xsd#RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:href="prgo-20200926.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformation" xlink:href="prgo-20200926.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationDetails" xlink:href="prgo-20200926.xsd#SegmentInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationTables" xlink:href="prgo-20200926.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="prgo-20200926.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_6BCFA1115E7E53F48816223E26B9CEAA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_295CB21A9ACC586EAF61AA9A3BB0C1FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_6BCFA1115E7E53F48816223E26B9CEAA" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_295CB21A9ACC586EAF61AA9A3BB0C1FB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_E3CCB15A38362232721146E06625D306" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_E3CCB15A38362232721146E06625D306" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_21F22B71A609213AD43246E066252370" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_21F22B71A609213AD43246E066252370" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21F22B71A609213AD43246E066252370" xlink:to="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_724841368EE696B00C1546E06626F613" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5A6CB9C516391EE4E9A346E066269401" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_C4F7DA74964B740AF7C446E066268BCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EF9BA2F80BD1632EEA8A46E066277F42" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_10DE967F46FB9CD7C16C46E0662634AD" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EF9BA2F80BD1632EEA8A46E066277F42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_429B0187E7CCFABE286846E066255CF5" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:label="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_FCD71BB73D219F5FBACB46E06627DD96" xlink:to="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_5A0BD2C08FAB926FB9CF46E06627D6DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_StockholdersEquity_5A0BD2C08FAB926FB9CF46E06627D6DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_F30F88AFF52F81AF2AC246E0662732CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_76BAC1EF10CF75FA4A9546E0662827DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0627074126FDDD9C230846E06628302B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0627074126FDDD9C230846E06628302B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_B1E80FDA7DCE2E7E509446E066282DAD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_4D4F0CF79FD5D9F7B90D46E066270F15" xlink:to="loc_us-gaap_StockholdersEquity_B1E80FDA7DCE2E7E509446E066282DAD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_C5C9B59C2BCC53159BD7E06D8BE033D4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36AC35CC8331508B89E4464633EF3783" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_C5C9B59C2BCC53159BD7E06D8BE033D4" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_36AC35CC8331508B89E4464633EF3783" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestitures" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_527569E54D4E5C43859AE8B9F9C2861F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1ECBB623BAFD5F1FA05BC04E39831030" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_527569E54D4E5C43859AE8B9F9C2861F" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1ECBB623BAFD5F1FA05BC04E39831030" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6F984441C6E0B38AB1A38A65D7A6254B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6F984441C6E0B38AB1A38A65D7A6254B" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_13FB3E43ED5494A80DD08A6699DCEB0B" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_27ADB0863E2E6415A2AD8A6699F2FFBD" xlink:to="loc_us-gaap_SubsequentEventMember_AC2CA81FAC77890B8F8C8A66CB7B1D5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05E31CE53340394BEC2E8A65D7A7D4C8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_8D47F010E32EFE6CE3D88A65D7A7A595" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BrandMember" xlink:label="loc_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_C4B223B66225CB7C0C188A65D7A718B2" xlink:to="loc_prgo_BrandMember_7D48CBA02A074926DCD68A65D7A8B3D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_27FD4AFE4248B1EF25208A65D7A8B057" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SanofiBrandsMember" xlink:label="loc_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_SanofiBrandsMember_5122DBBDD9C2B83E53058A65D7A8FDAB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DexsilMember" xlink:label="loc_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_DexsilMember_FAEFE86615EF3A06CE718A65D7A99EB1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SteripodMember" xlink:label="loc_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_SteripodMember_30CF6A11C6505488F67A8A65D7A9EA99" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GenericProductAcquisitionMember" xlink:label="loc_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_GenericProductAcquisitionMember_29661BA614380B037BD18A65D7A965E7" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember" xlink:label="loc_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1B2313DF5375DFC202C98A65D7A855FC" xlink:to="loc_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_AEA734EE5C25D792466A8A65D7A9A13D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A795E69D500B6535AE698A65D7A626B7" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofBrandsAcquired" xlink:label="loc_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_prgo_NumberofBrandsAcquired_ABD62AFB0442458C880C8A65D7AA43EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_24735767C22207C0434B8A65D7AAE620" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6A1EA5EDAE84B321FD0B8A65D7AA8B2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_A71DF49205DEA4A7F6738A65D7ABD17D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3C72945D3EE49449E8188A65D7ABE21C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomefromSalesOwnedbytheCompanyPercent" xlink:label="loc_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5686C708AE0798A383CC8A65D7A9B43B" xlink:to="loc_prgo_IncomefromSalesOwnedbytheCompanyPercent_E7C7B77129DF2E29828F8A65D7AB7F09" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_4D8C8E5BF070A99C5DB4C698D21D97B5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_4D8C8E5BF070A99C5DB4C698D21D97B5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5DD79CC03C12CD8C4503C698D21F8906" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5DD79CC03C12CD8C4503C698D21F8906" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5DD79CC03C12CD8C4503C698D21F8906" xlink:to="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CSCIMember" xlink:label="loc_prgo_CSCIMember_86F2AFFF4EFC99E17A78C698D21FB690" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:to="loc_prgo_CSCIMember_86F2AFFF4EFC99E17A78C698D21FB690" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_D76E04E97251A7CBE2A3C6AD14ED76EB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_D15AD79120B7479FB5CAC698D21F8A23" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_D76E04E97251A7CBE2A3C6AD14ED76EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_91EA8A22131EC995E8F0C698D220E6AD" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RosemontPharmaceuticalsMember" xlink:label="loc_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:to="loc_prgo_RosemontPharmaceuticalsMember_7170F07DEF6B88138BD2C698D220308F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AnimalHealthMember" xlink:label="loc_prgo_AnimalHealthMember_AFB125643F323A36501FC6ADAF666AAC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_20874DDEDDC192AC2C6FC698D220AFD3" xlink:to="loc_prgo_AnimalHealthMember_AFB125643F323A36501FC6ADAF666AAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_C8EF3EC5037C392DC805C698D21E3F13" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_AC4AF8CB32F53F36BE95C698D221A120" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_AC4AF8CB32F53F36BE95C698D221A120" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_2E6A74C61753578E38C2C698D22148DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8DEB0429C01169B6030DC698D22049DB" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14AD5F53C4D80DAE49B5C698D221541C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6EC8848572E86F7405946A87FC3FB335" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6EC8848572E86F7405946A87FC3FB335" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_C83E0F03A1101BBEAAEE6A87FC3FE468" xlink:to="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:to="loc_srt_MinimumMember_FAC0081C974498DDF7EC6A87FC40D224" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9618167123B5E4D93B916A87FC3FA509" xlink:to="loc_srt_MaximumMember_8A80939D2D233668ACDF6A87FC40CD0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_BF1C6DB82055014CE9C86A87FC4023B9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_BF1C6DB82055014CE9C86A87FC4023B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BF1C6DB82055014CE9C86A87FC4023B9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_5D8D6B5A4701580DE83F6A87FC407E69" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanirGlobalHoldingsLLCMember" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227C82DBABFCA308FB6E6A87FC40545F" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_0E8873DDEBDF9F41D8836A87FC411004" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_30CAEA79423B7425FC736A87FC41F28B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_30CAEA79423B7425FC736A87FC41F28B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_30CAEA79423B7425FC736A87FC41F28B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember" xlink:label="loc_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember_20084986F64EDE3A8E826A87FC41C37A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_E19A8B54F9305BE020496A87FC426BDE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_E19A8B54F9305BE020496A87FC426BDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_6D9A19E309F6CA5915C86A87FC426021" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TrademarksTradeNamesandBrandsMember" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_EDBC1A92185A27DD95EF6A87FC41A79C" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_D68D33623EEA37F45D666A87FC42457C" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_8E2737D430F12873F30A6A87FC42B3D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_C5673EBFD8771C734A436A87FC421A8A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6F02F038A50E6A61EB7A6A87FC43019A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_D1D745840770847AD5636A87FC435AFC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_D1D745840770847AD5636A87FC435AFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_D1D745840770847AD5636A87FC435AFC" xlink:to="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_F05B7A43D72FFC7337526A87FC4432B1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_F05B7A43D72FFC7337526A87FC4432B1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_600E8F8D52F3323B85A26A87FC44CF6F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6322EEBDBFFA9C8FBDBD6A87FC43193F" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_600E8F8D52F3323B85A26A87FC44CF6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8846987493D22685C0616A87FC3F35F7" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1C1AB8D00993D45784266A87FC44813D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_A699DA50E1DF5CF6F6B46A87FC442283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_751EFDC098E9164092716A87FC45E1B9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationBaseConsiderationTransferred" xlink:label="loc_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_prgo_BusinessCombinationBaseConsiderationTransferred_440A3A705F6E93A8A0576A87FC45753C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8960E13114C9513DE6506A87FC456E85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_81D7F0098216E1E94E3A6A87FC455229" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_9749BCE00C7A5D4C31206A87FC455330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_9CDC698C7A7CC62019766A87FC4530C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1590ED3B3DA57D41E1066A87FC465B92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_58A26B651813E260CAB86A87FC46FB30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_27AAE63C749962635E076A87FC46AAA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5C618536705F35ACD5356A87FC468CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_267EF7C5D51F9EB362306A87FC478617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9E8839738D9803A611386A87FC47B767" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_573AF15232CD75B4D9FD6A87FC474B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_B4FB5850B3F505865CDF6A87FC47B04D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets_F9D8CEBD85D00AE1D5AB6A87FC4701D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_Goodwill_B49655F768DE67507E836A87FC486325" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_11BE332FF6F78929796F6A87FC48EFC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_E25E336E8EAB44E4BDB36A87FC483909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1CD296F4C0354CBE43CE6A87FC48D7B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_C2B9364A966A6BAE0A3B6A87FC48CBCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2E505195671D27773F2F6A87FC4832B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_E6AD9EB56C6F2C67D8AF6A87FC49D59C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities_95BE94707B7703AB54306A87FC49D572" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes_9511FCBCA1EC8CFB503C6A87FC4A87FC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms_09D2A247E2C6B2E475B46A87FC4AA257" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_65AA49F14E3E32BD5D086A87FC4A44AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_93BDA36897055CFC30B46A87FC4AE94A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5AB73AEFD1BD064CCF6F6A87FC4A1EE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_C59FD24CCAF39BA927636A87FC4644DF" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_A01D77546A411FEDA7BE6A87FC4B618A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_C30EF840B180C0D1A57C6A87FC4B3BCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9531348058BD8DDF56FE6A87FC44CD7F" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3CED88EBE4B76F1786F36A87FC4B3B28" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_4DDEC4D9CFDF5E0C8B300E729C8E7FBE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_43C4663BFE6B5E688411DB9318C4E1C2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_4DDEC4D9CFDF5E0C8B300E729C8E7FBE" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_43C4663BFE6B5E688411DB9318C4E1C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5DFCEC47FB365B9AB824AE8EEB19C2C5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_4DDEC4D9CFDF5E0C8B300E729C8E7FBE" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_5DFCEC47FB365B9AB824AE8EEB19C2C5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_98354C300DC205ACB1886A87FC54B77C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A22D1B3CF7224AB7F25D6A87FC5446F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_98354C300DC205ACB1886A87FC54B77C" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A22D1B3CF7224AB7F25D6A87FC5446F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_024BD5CF0EC7285588B56A87FC541451" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A22D1B3CF7224AB7F25D6A87FC5446F2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_024BD5CF0EC7285588B56A87FC541451" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_024BD5CF0EC7285588B56A87FC541451" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralCareAssetsofHighRidgeBrandsMember" xlink:label="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_E308078DF2536CD4CAC66A87FC552F8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:to="loc_prgo_OralCareAssetsofHighRidgeBrandsMember_E308078DF2536CD4CAC66A87FC552F8A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanirGlobalHoldingsLLCMember" xlink:label="loc_prgo_RanirGlobalHoldingsLLCMember_FE57AFBC7851DCA0F89A6A87FC55E959" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ECE8EFEBC63FBC89DEA16A87FC5402E2" xlink:to="loc_prgo_RanirGlobalHoldingsLLCMember_FE57AFBC7851DCA0F89A6A87FC55E959" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A22D1B3CF7224AB7F25D6A87FC5446F2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C7652E04887D47385F7E6A87FC556270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_A05DE0E5ACDF2A2715046A87FC553AA2" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9EB19A71DF8FB3F1F3046A87FC56F036" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1E4E64B6042F95DB89CF46E0686015C2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1E4E64B6042F95DB89CF46E0686015C2" xlink:to="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_D7E8ECA4D7AF3B3A329F46E0686623AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_27E1E3818125B5B5C7EF46E06866FB7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_6F1403A6613825CA1CC346E0686743D0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_InventoryNet_6F1403A6613825CA1CC346E0686743D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_D88BED85AC2CAAA78BAE46E0686760B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_AssetsCurrent_FD38D24C685BCB31172546E06867DC3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_A0836163E0231CC71FB246E068671A8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7B7DCC59F4FA4335D1FE46E0686766E3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_BC64B3AAC441DDF9A09346E06867F2C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_58C4FB4C5FA55D67C2F846E068677A1F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_58C4FB4C5FA55D67C2F846E068677A1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_53AB09A96E8B2FE5D36746E06868CD24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_E11F6DD2BB805C5A2FC346E06868556B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_AssetsNoncurrent_DAB373A0A46AE736DEC646E06868235E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D52B940CDE1270C2741946E06868DC99" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9D26C6A296223903ADEF46E068604048" xlink:to="loc_us-gaap_Assets_D52B940CDE1270C2741946E06868DC99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1E4E64B6042F95DB89CF46E0686015C2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_AccountsPayableCurrent_301FF45260DF011DA59946E068682790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B6A69DE3A5D9EAD1037146E068690C9E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccruedCustomerPrograms" xlink:label="loc_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_prgo_AccruedCustomerPrograms_7C71E429B38E6C594F9646E06869E8E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_77E8DAD4B2BA5165DA1546E068699C19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_E7FD288131D761D645BC46E068694E44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_LongTermDebtCurrent_C24675BE432AD8B96FB946E068691507" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_LiabilitiesCurrent_0E836D2B24F66A6527A246E0686A878F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_A61D2B15318142E26F8846E0686A903E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_A61D2B15318142E26F8846E0686A903E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_425CC7F7F9F46C986C9246E0686A8748" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_AE8A4DD5D125225607A846E0686AE66A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_53C8829290422E64E1B046E0686A7B08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_Liabilities_1DBB2AC1ED97E6136D1946E0686AA15F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_CommitmentsAndContingencies_949CF733883BC9CD00D146E0686BCE9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ControllingInterestAbstract" xlink:label="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:to="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:to="loc_us-gaap_PreferredStockValue_6A7E2525A30919963B1E46E0686BDD61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:to="loc_us-gaap_CommonStockValue_D94477DD8C5B2622DDB546E0686B2583" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_642AEB0CC6979C4DFB4546E0686C9C09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_EBA0C8F700C392DD019446E0686C3BF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_E3EECC2B80BF2FD3BEC346E0686C47F1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_74BD954EE10F894FBEA546E0686B3896" xlink:to="loc_us-gaap_StockholdersEquity_E3EECC2B80BF2FD3BEC346E0686C47F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:to="loc_us-gaap_MinorityInterest_BF36D26906FF4B6A382E46E0686C6242" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9BED1CC3D8CBDFF7E41046E0686BD5F1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_401265E853635073586E46E0686C1759" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4A585F2C63292483AF5846E068688C30" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_C031597A859BDB63456046E0686C8925" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1E4E64B6042F95DB89CF46E0686015C2" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_30B6BDAA9DE8CAE0910946E0686D8F5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EC4B795D8E0E433096FB46E0686D9EA9" xlink:to="loc_us-gaap_CommonStockSharesIssued_DC307AECDDEF781B9B2B46E0686DC46B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_E9A011041E9F5F7089B64A5DDDD2FBB8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_47086C0D4ED7587D985EEBC1018499DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_E9A011041E9F5F7089B64A5DDDD2FBB8" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_47086C0D4ED7587D985EEBC1018499DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_E9A011041E9F5F7089B64A5DDDD2FBB8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ABD93A3EC3A85CD69CA97EDCFE548F32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ABD93A3EC3A85CD69CA97EDCFE548F32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_C54BAEADFC995E0EA807A44A8A19CFC0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_C54BAEADFC995E0EA807A44A8A19CFC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EA432CE9AFDD57C5A28B4131DC06D828" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_EA432CE9AFDD57C5A28B4131DC06D828" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1323AC73D3EA5D67A37159ECB6D0A49E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2EB18A0F760D539F86720DD3E0815A9C" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1323AC73D3EA5D67A37159ECB6D0A49E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1BBA10845393D8C157A346E068050883" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:to="loc_us-gaap_NetIncomeLoss_1BBA10845393D8C157A346E068050883" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_90F6CBAE58458B4123D546E068055F37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_7C3FFD8D1F5ECEF3CB7746E068065B32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_ShareBasedCompensation_9544B83E846231C89C2446E0680615F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_E46F31488521DE3FDB0146E0680638FF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_AssetImpairmentCharges_E46F31488521DE3FDB0146E0680638FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_C99C89ABC45C3192F28E46E06806898C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_C99C89ABC45C3192F28E46E06806898C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_69669BC33C91CFEC79B646ED18B288A5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_69669BC33C91CFEC79B646ED18B288A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_4803E72DC24EF5A226DF46E0680BAF74" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_RestructuringCharges_4803E72DC24EF5A226DF46E0680BAF74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E3ECA11D3414D8D1471346E0680CCD8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_5A07CC6F58013CE49AFF46E0680CE659" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_E5068BF26DF83CBC074B46E0680553ED" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4FD289D505EA62716ABE46E0680CCBF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_500C952C358EA7934F3046E0680C2A59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_75B3CEA5810FFF85697D46E0680D0A52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_547FF23710A55898C8DA46E0680DAFAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_80D9AD2EE0727D7C381446E0680D52F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_BB23816A76D7689B26ED46E0680D6D0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49859DEC7DA8F90AB7E446E0680DEBEF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_23969796C85F62CB7F9046E0680E0ADB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_E0E8A879493954BE770546E0680E5BB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_274278E587C4C7D5B9FD46E0680E2ADC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3D7E898D642D219924E746E0680EA953" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_085AC2EF3B533AD4FE3746E0680CC6AC" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_B87CB92E469A44071CA346E0680E0C34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C54AA1DC5A2B1F14180346E06805D0BF" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_CAD83ACF60DAC9B9FB6E46E0680E3A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_335A6FD74E7383C9C48346E0680F672B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_B6D25B67E3FAE5702ED146E0680F1376" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_B6D25B67E3FAE5702ED146E0680F1376" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BD2A0C5F04133D0ABFC946E0680FF07D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BD2A0C5F04133D0ABFC946E0680FF07D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ProceedsfromContingentMilestonePayment" xlink:label="loc_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_prgo_ProceedsfromContingentMilestonePayment_14569FBFADE7D1D9195846E0680FEB33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_8736E9F0C128A3A4189346E0680F0112" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_BCCB18D1111C4FBB634246E068109F8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_243881DAF4ACD9E1A4F246E068105AF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_CB985073D2EA373B228C46E068108D90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_F60F82CAE77CC5E241FF46E0680FB1D1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_EDBFECC809307F17115246E06810D74F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_675D31D7E5A3357BF05A46E068103EFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_A16F017E99F8C7C34F0646E068110890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_DDB2267A8818939005A746E06811EE99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_BF09D5F72638EB617ACA46E0681173E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_96816B14DF36BA384B3F46F00F81F1C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_CE8788876246B483961946E068116ACB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_PaymentsOfDividends_20193F75D59280A1F37E46E06811BB83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ACBEB6C1D69E2F404E4B46E0681248DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9ECE77354CBF9FBFB22B46E0681063FC" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_471412B1CC68D51D39BF46E06812559A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28F0EE154AD23BF0CC8346E068121311" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1FB49C95DBE9BA8BE23546E068128A85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D3292B2BD32861892FC446E068124479" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_DC32606281582AAA2EB646E068139402" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A232C8C7C1B0395156A746E06804EB05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_DC32606281582AAA2EB646E068139402" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_98FF2E209E27D707D45646E0687AC646" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:to="loc_us-gaap_NetIncomeLoss_98FF2E209E27D707D45646E0687AC646" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5B3BC7E35E1661C10FC846E0688014C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96EC487962849C5377D646E06880A686" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9EE28E9BEC340A59B13846E0687BA425" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7BEE2D8B02C40A20D76046E068801196" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3567149F0D3BB9AB8D8F46E06880FEDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_743AD6E7A1A6097E1DD546E0687A3517" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8CA8CE42066D63C375EB46E06881EF39" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_FA6FB980A361D89FECE747885CB1BEC8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_FA6FB980A361D89FECE747885CB1BEC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_791661148E671C23AAE447885CB16F7C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_791661148E671C23AAE447885CB16F7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_GrossProfit_1BDAD973A65472FC98D947885CB14D29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductionAndDistributionCosts" xlink:label="loc_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_us-gaap_ProductionAndDistributionCosts_70878B1577DEAE1DA05147885CB2151E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_E79367F2F68D5D18FD0147885CB2FB3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_us-gaap_SellingAndMarketingExpense_77814CB59278A1F163C847885CB35895" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_BFD6B689FAFE3E61DFA247885CB3010D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_us-gaap_AssetImpairmentCharges_67FD1EE628A97B8A9C7547885CB344FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_us-gaap_RestructuringCharges_E2F488A2D9DEDE350BD447885CB3F8AD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherOperatingIncomeLoss" xlink:label="loc_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_prgo_OtherOperatingIncomeLoss_0108892A5A29C388A81547885CB4E906" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2E92494F71001576F18847885CB25110" xlink:to="loc_us-gaap_OperatingExpenses_034C398758E6A8EB7C7C47885CB4A8C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0D57EDAB242E44D6339947885CB421EB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_OperatingIncomeLoss_0D57EDAB242E44D6339947885CB421EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_7AF9D35397E73D7C13C947885CB4917A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_70F2165CA4B2A306BA9E47885CB5E448" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_70F2165CA4B2A306BA9E47885CB5E448" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8393B014B920EC0F970047885CB5F3B4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8393B014B920EC0F970047885CB5F3B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_FB3496C346DB5D35166447885CB56A7F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_FB3496C346DB5D35166447885CB56A7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_442B7D1CFB81C65269E747885CB65FB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8C9F21A740136A7AA68047885CB78728" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_90D1561F360DBB23A90047885CB753D7" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_NetIncomeLoss_90D1561F360DBB23A90047885CB753D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:to="loc_us-gaap_EarningsPerShareBasic_106CF9DC6592E1F99FB347885CB77C9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2C7FAB92E95ACA3DD51647885CB7811C" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4A3E0B2541C93CB8C0CA47885CB81662" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_78CF9BD03B3DA451B57647885CB1B5E6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_702E9A9B5E747852757E47885CB91CF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_702E9A9B5E747852757E47885CB91CF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A06326A38660549C33AD47885CBAAC59" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_223BDFBF6C25BAA27C6E47885CB999EC" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A06326A38660549C33AD47885CBAAC59" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_B730A1D72A3B5C1F999BB5B5FAAF688E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRevenueExtensibleList" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList_C9AEDF69DB9F5259BEE805028000FA96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_B730A1D72A3B5C1F999BB5B5FAAF688E" xlink:to="loc_us-gaap_TypeOfRevenueExtensibleList_C9AEDF69DB9F5259BEE805028000FA96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_8DE17555A4505A18950FEFA9FB251BE8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_B730A1D72A3B5C1F999BB5B5FAAF688E" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_8DE17555A4505A18950FEFA9FB251BE8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2E69621D79C882E2255FC23AD87105AD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2E69621D79C882E2255FC23AD87105AD" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_B9881FB83FEF3CD53DA4C23AD872D682" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_C6F15A750540D9EF11836A868C1597F4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_C6F15A750540D9EF11836A868C1597F4" xlink:to="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_F0AD73A1252F799BC73B6A868C1947EE" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_66C1DD2125574C0308DA6A868C19AA78" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_927DBA555E8611F383EB6A868C190BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36D311890CAC3CBBE0CA6A868C1B8FDA" xlink:to="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:to="loc_us-gaap_CommonStockMember_FAC193E7A50914E345EC6A868C1CAEB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A8DC46C2B208F16FEA586A868C1C03D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_03E60D157FA040B9BAC86A868C1C8CC6" xlink:to="loc_us-gaap_RetainedEarningsMember_08D13FA23246298377116A868C1CE1A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_71DF074C7D97C80FB7916A868C187893" xlink:to="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_18BB6A2E9A480E9D3D636A868C1D88AB" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_SharesOutstanding_382AB23F5E750B6631026A868C1DE585" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockholdersEquity_3E5AFEACBFFC15465B696A868C2277DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_4C02528C19E44E7CD8B66A868C23867D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_NetIncomeLoss_4C02528C19E44E7CD8B66A868C23867D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76184B6FE1DC263B24726A868C2320D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_20EB2106903A7731F4876A868C2373D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_40B05F19163791690C7B6A868C23C28B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_317AA8E0EFDDF8932E066A868C23BFE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_503C3BF99A38BC8D06B46A868C24BCD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_DividendsCommonStockCash_73B98929E9D275B9099C6A868C24D460" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_EC38320C62752DA641826A868C249226" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3C6C410D3EB98C8BDB906A868C24E610" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_D79886999F309230FCEA6A879D598538" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_86A8B8164FE08D14C6786A879DCBFB03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_CD2E8417FC087D28C9376A868C2498C5" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_SharesOutstanding_CD2E8417FC087D28C9376A868C2498C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_15DA0CEBA6971D1798E66A868C24112C" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_21A85A63EB27CC4993806A868C1DA143" xlink:to="loc_us-gaap_StockholdersEquity_15DA0CEBA6971D1798E66A868C24112C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D8732545D86564580C1973B8C56B279" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_A99F491605145E06A80FFF8535BCB9DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8D8732545D86564580C1973B8C56B279" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_A99F491605145E06A80FFF8535BCB9DF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7F87785BFD2D1AA911AE9368F9F22BD6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7F87785BFD2D1AA911AE9368F9F22BD6" xlink:to="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6D571DE1B368B50920699368F9F261F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6D571DE1B368B50920699368F9F261F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6D571DE1B368B50920699368F9F261F5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_74ED86063D30B6E4EA869368F9F38E19" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_78C1A2696EE9C3772E269368F9F309DE" xlink:to="loc_us-gaap_SubsequentEventMember_74ED86063D30B6E4EA869368F9F38E19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis" xlink:label="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_637DAE92A195DA8589059368F9F358C9" xlink:to="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember" xlink:label="loc_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_CC4FA57DC3B958D2ADEE9368F9F4D368" xlink:to="loc_us-gaap_PendingLitigationMember_4F07998DEE96A46ADE3F9368F9F4D402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_F449ED38676D176EBB939368F9F40456" xlink:to="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember" xlink:label="loc_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember_B95EEDE13217D10795C29368F9F5FE32" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OverarchingConspiracyClassActionsMember" xlink:label="loc_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_OverarchingConspiracyClassActionsMember_5ED17F65DC8617667D959368F9F5DAD6" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitDrugstoreChainMember" xlink:label="loc_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitDrugstoreChainMember_1A7136B601B8BD4C2A229368F9F5F9AC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember" xlink:label="loc_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember_DCB8E70B74E769359AAF9368F9F555E1" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember" xlink:label="loc_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember_2D39F5E69BA7FDA95F809368F9F5600A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_StateAttorneyGeneralComplaintMember" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_StateAttorneyGeneralComplaintMember_B82F85D1DBC3311CBDFA9368F9F66ED9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CanadianClassActionComplaintMember" xlink:label="loc_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_CanadianClassActionComplaintMember_2FDE3527F604519FE0109368F9F6EC26" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSupermarketChainsMember" xlink:label="loc_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitSupermarketChainsMember_45760D9E541A3DF8998E9368F9F6020C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember" xlink:label="loc_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember_B7C36D4CC1DDBA0A8E4A9368F9F6BC56" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitManagedCareOrganizationMember" xlink:label="loc_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitManagedCareOrganizationMember_EF11874950F4A44C5CFC9368F9F60DA2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthInsuranceCarrierMember" xlink:label="loc_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthInsuranceCarrierMember_2D4D47B2A2BA4A3206869368F9F65609" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthcareServiceCompanyMember" xlink:label="loc_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthcareServiceCompanyMember_978058439E7169259CA49368F9F7D0F9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember" xlink:label="loc_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember_62581EE4DA1ED775C09D9368F9F7AA6E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember" xlink:label="loc_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember_AB8B66E8D57D3DD258889368F9FC4791" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthcareManagementOrganizationMember" xlink:label="loc_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember_95DEA79C1CB72C8E9C919368F9FC1A02" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHarrisCountyofTexasMember" xlink:label="loc_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHarrisCountyofTexasMember_E05BFE383015011D531D9368F9FD947B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member" xlink:label="loc_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member_A2B605F2796CD82757B39368F9FD43BB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PricefixingLawsuitHealthPlansMember" xlink:label="loc_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_PricefixingLawsuitHealthPlansMember_A17D1180181F41E987129368F9FDEB3E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member" xlink:label="loc_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member_79A50B70F6B2E5D329499368F9FD1A19" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CasesFiledinIsraelMember" xlink:label="loc_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_CasesFiledinIsraelMember_CE856154D812CF287AEF9368F9FD961F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_4B2241E9B40866F2DC099368F9FD9EEC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InrePerrigoCompanyplcSec.Litig.Member" xlink:label="loc_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_InrePerrigoCompanyplcSec.Litig.Member_498CBFEB70800AB1F61B9368F9FDC0C2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TalcumPowderLitigationMember" xlink:label="loc_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_TalcumPowderLitigationMember_9B07C075B14927A6BAC69368F9FE7A16" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RanitidineLitigationMember" xlink:label="loc_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_RanitidineLitigationMember_D8FB5922E0E1475840C99368F9FEE2BA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CarmignacFirstManhattanandSimilarCasesMember" xlink:label="loc_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_CarmignacFirstManhattanandSimilarCasesMember_2978C18A9E3D4B67A1C29368F9FE0E70" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FirstManhattanandSimilarCasesMember" xlink:label="loc_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_FirstManhattanandSimilarCasesMember_3CDCB30EBD27C7F3F2819368F9FE52DF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_MasonCapitalPentwaterandSimilarCasesMember" xlink:label="loc_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_MasonCapitalPentwaterandSimilarCasesMember_8D7DBEEA2D8FEC5471CE9368F9FE8712" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HarelInsuranceandTIAACREFFCasesMember" xlink:label="loc_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_HarelInsuranceandTIAACREFFCasesMember_A801F467EEBAF3BEA5319368F9FFE37B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoofersPensionFundMember" xlink:label="loc_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_RoofersPensionFundMember_6BB48A7246197CC1E80F9368F9FF3346" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCasesRelatedtoEventsin20152017Member" xlink:label="loc_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_OtherCasesRelatedtoEventsin20152017Member_EE185C2328213F23B6439368F9FF83C3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InIsraelCasesRelatedtoIrishTaxEventsMember" xlink:label="loc_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember_BA085D22E688054C429E9368F9FF7683" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AcetaminophenLitigationMember" xlink:label="loc_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_AC756F2B47B5AD20FF1F9368F9F40C56" xlink:to="loc_prgo_AcetaminophenLitigationMember_096731C6D752EBD318AF9374FA2AEF9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_288FC5DB442FBBDDD9CB9368F9F2E0EE" xlink:to="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofProductsincludedinExpeditedCases" xlink:label="loc_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofProductsincludedinExpeditedCases_890A2FABDD43B09570FC9368F9FF537F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofPutativeClasses" xlink:label="loc_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofPutativeClasses_D91D5F02951D78DE7C859368FA000DE2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofSetsofClassActionComplaints" xlink:label="loc_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofSetsofClassActionComplaints_A63829266645C90F3B979368FA002E06" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCasesAllegingOnlyStateLawClaims" xlink:label="loc_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofCasesAllegingOnlyStateLawClaims_D21E29AF53374E7588D09368FA00E3BB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfManufacturers" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfManufacturers_ABC0ACB753695F8793879368FA00B144" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofOtherPharmaceuticalCompanies" xlink:label="loc_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofOtherPharmaceuticalCompanies_80EAC8451FA1366289689368FA00DA96" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofFormerEmployees" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofFormerEmployees_4F8CF4FBD0B071270DD19368FA006CC9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityNumberOfEmployees" xlink:label="loc_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_dei_EntityNumberOfEmployees_05903AF3873C09F58C559368FA018302" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofAdditionalStatesandTerritories" xlink:label="loc_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofAdditionalStatesandTerritories_5EE33FEAB7E7E748C22B9368FA019111" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_644AF13C4C632EF0057B9368FA010B2B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany" xlink:label="loc_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany_62C04B174713310FD0E49368FA013641" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfPrescriptionPharmaceuticals" xlink:label="loc_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals_EB31AD9FE83A2FC9F1289368FA01DBA0" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCasesIncludedinExpeditedSchedule" xlink:label="loc_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofCasesIncludedinExpeditedSchedule_51E4C6CD060B149CE7A59368FA0176E5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfSupermarketChains" xlink:label="loc_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfSupermarketChains_8856B0938CD993A84A649368FA026C47" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofCaseswithSimilarFactualAllegations" xlink:label="loc_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofCaseswithSimilarFactualAllegations_CBAD1B7A9C5F106562F39368FA02774A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_AB6CE33D83D016E4D3689368FA07FC49" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingenciesNumberofHealthPlans" xlink:label="loc_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingenciesNumberofHealthPlans_FD32E1E40273B31366FC9368FA072C57" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofDozensofManufacturers" xlink:label="loc_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofDozensofManufacturers_5D61CB1EB824AFC42EF59368FA070ABE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfIndividuals" xlink:label="loc_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfIndividuals_51ADA19476ADF7BDC7799368FA08354F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofCodefendants" xlink:label="loc_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofCodefendants_D84570D7A5B608BEC3709368FA087863" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfCases" xlink:label="loc_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfCases_9BD451E58CE559A804439368FA08AA45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_348C06C5483409490A2E9368FA08B9E8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberOfCasesStayed" xlink:label="loc_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberOfCasesStayed_A709EBD2243698ECEC1B9368FA080C62" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_5A85FA17DF6D473502369368FA089159" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_022CFB3AB4CEAC538C789368FA095E94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_72D4CCB9B050D343E4AF9368FA097DE5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofDefendantsAdded" xlink:label="loc_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofDefendantsAdded_86B3904F50DF53F5314F9368FA093F6F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice" xlink:label="loc_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice_9D32D7E709D868D4CD0B9368FA09EEDC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofLawsuits" xlink:label="loc_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofLawsuits_8AEB83C8F0B3F547E4429368FA09F1DF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofTendersAccepted" xlink:label="loc_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_NumberofTendersAccepted_A892428D392A4F67C6379368FA09D88F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofMasterComplaints" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaints_6840775FC5E49E263F469368FA0ABF61" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_84CB6BFC285F90906E1D9368FA0AD6D5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofClaimsforIndemnificationorDefense" xlink:label="loc_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense_2103E902046DDEF142609377246A268A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LossContingencyNumberofRetailers" xlink:label="loc_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:type="locator" />
    <link:presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_207F0E29C2BF680883139368F9FF463B" xlink:to="loc_prgo_LossContingencyNumberofRetailers_A250AC8AE8165575E09F9380DF21B4C1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_DocumentType_B8035B6BAD6A1A0838FDC22CA05D565F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_DocumentQuarterlyReport_3EB957839E068B56382DC22CA060ED3D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_DocumentPeriodEndDate_2D19D08413D9AB8A8284C22CA060700E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_DocumentTransitionReport_8A7639754CBA40DA6F24C22CA060602E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityFileNumber_549C9982DDE16D15DB23C22CA06002F3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityRegistrantName_408F5818B56BFEEA691CC22CA0615C12" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityIncorporationStateCountryCode_376383A0D4F872B8BE0CC22CA061FDAB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityAddressAddressLine1_28BEF2D8971969C14224C22CA06169A7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityAddressAddressLine2_FC2A8521DE2AC293B84CC22CA0618A2A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityAddressCityOrTown_0C2196F320561A2A360EC22CA0617D6B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityAddressCountry_7D733EE55E7C16A75ABFC22CA062C049" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityAddressPostalZipCode_4CBEBBC5E675267937FEC22CA062A8DA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_CountryRegion_0F3ED0A4A6068759DC53C22CA062932C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_CityAreaCode_05E5CCE569AAB0986499C22CA062804F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_LocalPhoneNumber_260C60036EE5B0881D80C22CA062419F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_Security12bTitle_C4BE8BEC38066410EE41C22CA0636637" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_TradingSymbol_11D6C4CF906AC9C1BCA3C22CA063269F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_SecurityExchangeName_9D777A95DFCCE590E849C22CA063DD66" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityCurrentReportingStatus_4AC762FD848B1F713CF8C22CA06346C7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityCentralIndexKey_11EB63C6F570AC9B2693C22CA063A20B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityInteractiveDataCurrent_3437F75A38F044B2B281C22CA0637AA5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_CurrentFiscalYearEndDate_8AB541129736ED9579B7C22CA0647264" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityFilerCategory_1D3CB0F7979AAD639152C22CA06970A6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntitySmallBusiness_3BF1FF4416A05C1BD2EEC22CA069621C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityEmergingGrowthCompany_CD502EB28B07758947CDC22CA069DCFB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityShellCompany_A34186A21677BAC23B59C22CA06A7882" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6BE73CD40CE496B270BCC22CA06A3017" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_DocumentFiscalYearFocus_56B8BF6ACC99E3A36090C22CA06A6F63" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_DocumentFiscalPeriodFocus_18568E909189617C8EF5C22CA06A5030" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_E46F6FB6D937E88FB220C22CA05A0703" xlink:to="loc_dei_AmendmentFlag_260607BB3D77EF9B4C50C22CA06A426B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5ED1C61994985ADD84F3345C543C32FA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_59668CF3DF0556309620FB6A4E5B9D44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5ED1C61994985ADD84F3345C543C32FA" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_59668CF3DF0556309620FB6A4E5B9D44" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_077B00E7EB9A6A13D88D46E066E73302" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_077B00E7EB9A6A13D88D46E066E73302" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_2BA546D24F3E0B372FD646E066E7A757" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="loc_us-gaap_HedgingDesignationAxis_2BA546D24F3E0B372FD646E066E7A757" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2BA546D24F3E0B372FD646E066E7A757" xlink:to="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5AE6E45504146A038A8B46E066E885C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_B3BC0217D039B3B3093946E066E892D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_547227A603672B21709346E066E705F2" xlink:to="loc_us-gaap_NondesignatedMember_B3BC0217D039B3B3093946E066E892D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_31174D15E8BA1D62BE8746E066E8F6C5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_31174D15E8BA1D62BE8746E066E8F6C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_31174D15E8BA1D62BE8746E066E8F6C5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85CA3C662AC957E0B5B946E066E90554" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_99AB23957103788F391446E066E976BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_99AB23957103788F391446E066E976BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3A1FC05C97BA3573B0BC46E066E89147" xlink:to="loc_us-gaap_OtherLiabilitiesMember_574B2176B85F3C14F6C646E066E90240" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_DB0A65BEED804620F3DD46E066E92DF8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_DB0A65BEED804620F3DD46E066E92DF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_DB0A65BEED804620F3DD46E066E92DF8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_5487246EEA0F6F4DD20F46E066EAC6F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_5487246EEA0F6F4DD20F46E066EAC6F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_AAC856EC9637A628922846E066EA64B5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_AD27A0ABB04FD901120846E066E96631" xlink:to="loc_us-gaap_CurrencySwapMember_AAC856EC9637A628922846E066EA64B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_FC0427C9CF70493926E846E066E74721" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_F42D28F17D28824C959446E066EBB34C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_FC2F1D385714D67DEF7546E066EA6503" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_86F85315C3207F7CA34046E066EBD157" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D0EE26A7BEEB5F4E98F211475186FB61" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D0EE26A7BEEB5F4E98F211475186FB61" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2D154082A38F57C592C3920D91D5197E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2D154082A38F57C592C3920D91D5197E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72E03FEBF664524A8FAB5D7FDF3A1833" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2D154082A38F57C592C3920D91D5197E" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72E03FEBF664524A8FAB5D7FDF3A1833" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72E03FEBF664524A8FAB5D7FDF3A1833" xlink:to="loc_us-gaap_InterestRateSwapMember_227D03F4B16A53E08D3529F4500334BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_314F6FA323C654CAA78AA7520BDD16F2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_us-gaap_SalesRevenueNetMember_1B138E5803A85EF38090A0B74CA874EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_us-gaap_CostOfSalesMember_ECF9997FEDF658CB8ED8E4C1CCC312C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_us-gaap_InterestExpenseMember_C975140D2D4E59899062F43EEA644410" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherExpenseIncomeNetMember" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5704A52C4FD756FB9444C678109DB346" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_910412239DC95AE0A3F302A4BFFA79BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0E7FE7EB3E37556C85F05A27D5BE2E90" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D4EE94D3E68755A5B172AF52B49B54BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_470B727D028D5E74B2C690ABA257B201" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_F09C64AF7EC65A28964A89AFF811FCC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_64D8B92B835A5DDA92C5D847967A06B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_98BA88A07C0A597A93E6F1A30A3ACEB8" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_2D85410FFE4058D3AF01A98A68DC0A0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_DF90CDD94AFB534BBC666E13FF40BFE7" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_BA8C0933CEA55437BE528135D4B63F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgesAbstract" xlink:label="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_28484661ACF45E4A90B16A43CA214228" xlink:to="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateCashFlowHedgesAbstract_C45FB91C6CFE59E083A72E9E4BC09CFA" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_016846BC6DBF51E4AA595E222B80554C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2CAAFB680D57D0B59F586A87FA5B0590" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2CAAFB680D57D0B59F586A87FA5B0590" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_12135F3A229BEF0FFDF76A87FA5CE8AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_12135F3A229BEF0FFDF76A87FA5CE8AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_12135F3A229BEF0FFDF76A87FA5CE8AE" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember" xlink:label="loc_us-gaap_TreasuryLockMember_521E608D2911A596FD426A87FA5DD52D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_TreasuryLockMember_521E608D2911A596FD426A87FA5DD52D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_D29C7EEEB588AADD19E66A87FA5DA121" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_InterestRateSwapMember_D29C7EEEB588AADD19E66A87FA5DA121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9614C3A101C811AE06C36A87FA5D24F4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9614C3A101C811AE06C36A87FA5D24F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_1158D5D6CABFD31705986A87FA5D81FE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_EF05EF9E360D5CE7517F6A87FA5C1AC8" xlink:to="loc_us-gaap_CurrencySwapMember_1158D5D6CABFD31705986A87FA5D81FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8563723B1D5A0517FC6F6A87FA5E9090" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8563723B1D5A0517FC6F6A87FA5E9090" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8563723B1D5A0517FC6F6A87FA5E9090" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_00B984A37FB28DCC0B3C6A87FA5F9338" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:to="loc_us-gaap_InterestExpenseMember_00B984A37FB28DCC0B3C6A87FA5F9338" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_BAFAEFD5360A6BF036C06A87FA5F337D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:to="loc_us-gaap_SalesRevenueNetMember_BAFAEFD5360A6BF036C06A87FA5F337D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_4A313799AECED3BA90C86A87FA5F7939" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D71702C50F4BB8DF7FC96A87FA5EC015" xlink:to="loc_us-gaap_CostOfSalesMember_4A313799AECED3BA90C86A87FA5F7939" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_408054369A61FEE0EC216A87FA5C37D9" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_DB8BDD6EA2A176A93D7D6A87FA5F03A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_F002D900E2BE0A8371BC6A87FA60165A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_B197CBC08A0D845679626A87FA60F90E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8B3D8D90DF697C6E58FC6A87FA60726B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_E6E1CC633E3E6EC1F04C6A87FA60D4C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_90361C47086022D264606A87FA61FA9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_0F83CAC39544B63ABE2A6A87FA6189C7" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_0F83CAC39544B63ABE2A6A87FA6189C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_E3C1D86E4ECEDCC4BCF36A87FA61D726" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_D3C4A15EE7FDE1A43C256A87FA61E814" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_DE4F3F9CF705D742F02B6A87FA5FB9E0" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_DC95D638371A46F5E6266A87FA616C8B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C58DFB1F4706DB4C79D946E066F15C31" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C58DFB1F4706DB4C79D946E066F15C31" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:to="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_60A2FCB85CFB422502F346E066F1444C" xlink:to="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_ILS" xlink:label="loc_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_ILS_363A1E416A66AE052BB546E066F2B101" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_EUR_EECD3F4E4F267DE4386146E066F24EA7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD" xlink:label="loc_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_USD_7392EF81AC73535C020346E066F26CFC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_DKK" xlink:label="loc_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_DKK_BBB6F0F950E374DD495346E066F358BC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP" xlink:label="loc_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_GBP_A49561C470BAFE114EED46E066F3F7C3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_SEK" xlink:label="loc_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_SEK_830B4F1825742FF35E9C46E066F3301F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CNY" xlink:label="loc_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_CNY_DDC43703595D0C133D3C46E066F37A18" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CAD" xlink:label="loc_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_CAD_FD9BE59BC9C8A34F314546E066F3F8E7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_PLN" xlink:label="loc_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_PLN_1AFAA45B7425C4E7A0CB46E066F3BCC9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_MXN" xlink:label="loc_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_MXN_20A0C8D53F31F121D6B546E066F4EEBB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_NOK" xlink:label="loc_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_NOK_C454CB41F84FEB4B3C5246E066F4CD1F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_CHF" xlink:label="loc_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_CHF_8D8F68A692A0262F66F646E066F497FA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_RON" xlink:label="loc_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_RON_541EA2AE5ECC85C2CEEA46E066F43149" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_XXX" xlink:label="loc_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1F1055FF00853DE23CBC46E066F2C06B" xlink:to="loc_currency_XXX_656CFE97D1D01375EC3246E066F4CB9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8F774D8039D3918FC24446E066F56CED" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:to="loc_us-gaap_CurrencySwapMember_DAAF2C5549C50BD0411946E066F51D65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ED7BA4932E57304F133346E066F58A67" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_78E6C2B1854DCD32C5CB46E066F57A57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_695BDFFD64549F05C37046E066F14166" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:to="loc_us-gaap_DerivativeNotionalAmount_EE4F019727F7EA7F2AE146E066F69478" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_F112EEA8155C1B4D2A1746E066F5F668" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_E37E90674673DFBEB2F146E066F69302" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1E4FF517FE88580AA3803B5D5012A88F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1E4FF517FE88580AA3803B5D5012A88F" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8DAF42A529A15041B8B013B87748D128" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8DAF42A529A15041B8B013B87748D128" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8DAF42A529A15041B8B013B87748D128" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryLockMember" xlink:label="loc_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:to="loc_us-gaap_TreasuryLockMember_EE665FED0F9F5E5492FBC2159FC05E77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_7CC878CD40FF5B53BECB240563D80DD1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_7CC878CD40FF5B53BECB240563D80DD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_334E67124F3B50EF8608F6F01B3593B2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6E38A92A77DE539AA4AF79A0CE2DA4CB" xlink:to="loc_us-gaap_InterestRateSwapMember_334E67124F3B50EF8608F6F01B3593B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_D66C760699A85B9CBD87E257B6359D50" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_D66C760699A85B9CBD87E257B6359D50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D66C760699A85B9CBD87E257B6359D50" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_E4383BBBC8DA5986BDE3879BF655AC03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_SalesRevenueNetMember_E4383BBBC8DA5986BDE3879BF655AC03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_17950FFFBCCD5A9A8A32DBCAB25CBD22" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_CostOfSalesMember_17950FFFBCCD5A9A8A32DBCAB25CBD22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6143C0670320555888D59368856A76FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_2303328B8D145D88AF651D6985C2D81B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_us-gaap_InterestExpenseMember_2303328B8D145D88AF651D6985C2D81B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherExpenseIncomeNetMember" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_8CAAB3CE14C8564189090E48CF418A14" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F3E409D562D752D5BFE542925396F8E9" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_8CAAB3CE14C8564189090E48CF418A14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:to="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_68F05FCA9DD25B4F821BD4F4BDFE82B2" xlink:to="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4CE2706BACAB5C75866C1A0C73D629B9" xlink:to="loc_us-gaap_NondesignatedMember_630B12CB28C35AA4ABE024444A417815" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_50B165308E515023987E3219628E5DAC" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FB189446B32B57B7AF29F75D760E0948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41E48D59E5505D11B4844322ED4A6C33" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41E48D59E5505D11B4844322ED4A6C33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_D6ED5B71487B5A628D1466CE7D7883B8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_D6ED5B71487B5A628D1466CE7D7883B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4255D0E60A3A5547B7D26229DB1815B8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4255D0E60A3A5547B7D26229DB1815B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3846FA7DDBA055ECAD42D9DEE004FA51" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3846FA7DDBA055ECAD42D9DEE004FA51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_A63B18840AAE5A27AABDBF4C949BE6AE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_A63B18840AAE5A27AABDBF4C949BE6AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_D57A08146A1C5BA99D7B1A541E462695" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_D57A08146A1C5BA99D7B1A541E462695" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_189B03E17ECB5C7892217FCD60156C22" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4F31A9D33E57513DB55CFB6E1E78AF7D" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_189B03E17ECB5C7892217FCD60156C22" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:label="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:to="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_AE189DD9B5D85EF2A688ED774ABDCC41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2DBD69CDC7525F53B7EC3455CFE610E4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2DBD69CDC7525F53B7EC3455CFE610E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EC43E1AB15EC55EBB615710D98CFB70F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_EC43E1AB15EC55EBB615710D98CFB70F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_50086BF860EB586A955A91755A718EE9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_50086BF860EB586A955A91755A718EE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_37B2B58FD3485FCB9FB23DDA1E659CA1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_EC2D43212AED5A5489DFD624320BADE0" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_37B2B58FD3485FCB9FB23DDA1E659CA1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_51A4077F082F51A3AE59191E01A772E4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_403437CE3829522F925A900130F44064" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51A4077F082F51A3AE59191E01A772E4" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_403437CE3829522F925A900130F44064" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_33B0C6408F8F66C97DFC47475E349667" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumeratorAbstract" xlink:label="loc_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33B0C6408F8F66C97DFC47475E349667" xlink:to="loc_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_NumeratorAbstract_401A520FF066EC41FFA047475E341A7C" xlink:to="loc_us-gaap_NetIncomeLoss_D0D2A4C50489570D820D47475E349128" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DenominatorAbstract" xlink:label="loc_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33B0C6408F8F66C97DFC47475E349667" xlink:to="loc_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C07EF79BDB696D79F40847475E3539F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_DFF0155143A3417D1E5747475E35F3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_82C4066D735B1A5A2D7047475E35AFFE" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19E66A72B6BF3FDB4BD547475E35250E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33B0C6408F8F66C97DFC47475E349667" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_67FED7798EFC3427B51947475E3525FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33B0C6408F8F66C97DFC47475E349667" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_D2DD2BF756BE10BF1E6347475E369BC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33B0C6408F8F66C97DFC47475E349667" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_180D7E1EEE935DBD293347475E36C013" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_28ECA272EDA45D569C3FEE413286DD60" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7C861CE8B3CE55A1B7F294482EC8C0CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_28ECA272EDA45D569C3FEE413286DD60" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7C861CE8B3CE55A1B7F294482EC8C0CD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_07EF422B9C8A5447A1AD374BF3D60B5E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5A5DB7DA50B654D0A311F35239A4837F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07EF422B9C8A5447A1AD374BF3D60B5E" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5A5DB7DA50B654D0A311F35239A4837F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5EA45DA95273280E1D354746C8E01046" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5EA45DA95273280E1D354746C8E01046" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_254A3A181A7699D944C4474D6CF58ADE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_srt_RangeAxis_254A3A181A7699D944C4474D6CF58ADE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_254A3A181A7699D944C4474D6CF58ADE" xlink:to="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_63CB12F13E112951D556474D9EF7778A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:to="loc_srt_MinimumMember_63CB12F13E112951D556474D9EF7778A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_471DF9C1633420CC1737474E00F97843" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6BE7BC8DCF6AD05F9EA3474D6CFC6BCB" xlink:to="loc_srt_MaximumMember_471DF9C1633420CC1737474E00F97843" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_BFFE1FA35823F36BD1924746EEB0CEB6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_BFFE1FA35823F36BD1924746EEB0CEB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_BFFE1FA35823F36BD1924746EEB0CEB6" xlink:to="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_513658F22DA97C9202F44747174327A2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_415E91EA4704C79521CD4746F0F54BC8" xlink:to="loc_prgo_RXPharmaceuticalsMember_513658F22DA97C9202F44747174327A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_9B9D885BE693A4D447A34746C8E0F14A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_ValuationTechniqueAxis_9B9D885BE693A4D447A34746C8E0F14A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_9B9D885BE693A4D447A34746C8E0F14A" xlink:to="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1958676D0DD9623DF7E54746C8E04310" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_979F2BD46086211788F74746C8E03A03" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1958676D0DD9623DF7E54746C8E04310" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6E4E7E0A8000289008BB4746C8E04D5D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6E4E7E0A8000289008BB4746C8E04D5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6E4E7E0A8000289008BB4746C8E04D5D" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationMember" xlink:label="loc_prgo_ContingentConsiderationMember_7D9B63BE20C201CAD5904746C8F022EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_71DD3A8602A5F40E4DD94746C8F024DA" xlink:to="loc_prgo_ContingentConsiderationMember_7D9B63BE20C201CAD5904746C8F022EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_8AD360A039E4135380924746C8F094B6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_D0FA5620112C8CD23B704746C8F0B2F7" xlink:to="loc_srt_ScenarioForecastMember_E71395E41B304C02A8484746C8F073BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7B17004100333C56F4534746C8F0BEBD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7B17004100333C56F4534746C8F0BEBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7B17004100333C56F4534746C8F0BEBD" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_8E6FEE5D67D958B636E74746C8F014BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_8E6FEE5D67D958B636E74746C8F014BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6BE5BDD0B3EC6EA24BEA4746C8F0D17E" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_CE15D21164710E8B49294746C8F03F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_359DB82E78542037FE634746C8F0AAAD" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaMember" xlink:label="loc_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8B70AC9771868253C59E4746C8F0B313" xlink:to="loc_prgo_RoyaltyPharmaMember_E26A28A76DD35F34744E4746C8F0A963" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_258ECF707924E3F9620E4746C8F07908" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_258ECF707924E3F9620E4746C8F07908" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_258ECF707924E3F9620E4746C8F07908" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_8D043D2469EEAEC4E5DA4746C8F0A3BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:to="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_8D043D2469EEAEC4E5DA4746C8F0A3BE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_E0074B07AEDB9197671D4746C8F09BF5" xlink:to="loc_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_E438E7B80D4AF7B2F8644746C8F02BC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_E72E8839CA22762872944746C8F0A51A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_E72E8839CA22762872944746C8F0A51A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_E72E8839CA22762872944746C8F0A51A" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_40C9FE06F3B19BEBB8114746C8F013DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_C880CF57F7415FF3359D4746C8F06F0F" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_40C9FE06F3B19BEBB8114746C8F013DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_64B8BC2548F47A4FF33E4746C8F0CF65" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_64B8BC2548F47A4FF33E4746C8F0CF65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_64B8BC2548F47A4FF33E4746C8F0CF65" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1031CDC45FD7B60BD8A24746C8F02D8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70F0FC4DA5AE39F26E354746C8F06490" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1031CDC45FD7B60BD8A24746C8F02D8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4088D7DB0C3FDA6019074746C8E0F1D1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_46B7EDF8FB905D34D34B4746C8F0C952" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_46B7EDF8FB905D34D34B4746C8F0C952" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssetsLevel1Level2Level3TransfersAmount" xlink:label="loc_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount_DD552FC13CCD673184664746C8F05840" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssumptionVolatility" xlink:label="loc_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_FairValueAssumptionVolatility_F690660525A7B796D2C44746C8F0B01F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssumptionsRateofReturn" xlink:label="loc_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_FairValueAssumptionsRateofReturn_7F74AE623D9F8E070F914746C8F072BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4B5F873C37EE8F6D4E1D4746C8F0620D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4B52499257379BD326544746C8F05A6B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NetSalesIncludedinCalculationForMilestonePayment" xlink:label="loc_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_NetSalesIncludedinCalculationForMilestonePayment_F4E6EA015872ABC445994746C8F03FD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_DF3C7FA32740EBA97FAB4746C8F08970" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AssetAdjustedFairValueifSalesThresholdMet" xlink:label="loc_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_AssetAdjustedFairValueifSalesThresholdMet_009B4837C2A4AFCDF6A34746C8F0B359" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NetSalesThresholdForMilestonePayment" xlink:label="loc_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_NetSalesThresholdForMilestonePayment_4543722EFF4D98AA92F64746C8F0FFDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_CFAE6B8211BCF62DC4064746C8F04932" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ReportingUnitFairValuePercent" xlink:label="loc_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_ReportingUnitFairValuePercent_A450560283CBF75BBBBB4746C8F08B45" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BlendedJurisdictionalTaxRatesPercent" xlink:label="loc_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2B2BDDF3BF5F4F3397474746C8F09D2F" xlink:to="loc_prgo_BlendedJurisdictionalTaxRatesPercent_7BEE2D62C85A10498811474BB72C977B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3C4EE31C62F3564ABCE8F4FD3FEDDC16" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3C4EE31C62F3564ABCE8F4FD3FEDDC16" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4C18E8DF35025B4DBC40092FF0AD5BF6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationMember" xlink:label="loc_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_20C9863A157C5C3DAD08182EA085E356" xlink:to="loc_prgo_ContingentConsiderationMember_1CF54EC2E212522F93662377FC745FA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_155C2B1C1B3457DDBEB7350ED563FDFD" xlink:to="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_3A1E56E3A95A52A792D5548AEC6E25B0" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_DEF56D08B193543D8239C2812B3961FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_65674AD837A1552184DEE47ECDDC95C3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_MeasurementInputProjectedRoyaltiesMember" xlink:label="loc_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:to="loc_prgo_MeasurementInputProjectedRoyaltiesMember_C37A0C1D4A1853D59B5E42D15DF677FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D8C40D82E021558E82D46B31D66E8E26" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_C1C77331015A57559231A1514E23A44C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_A0778C6886A95200AC19068B3E976F19" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestones" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:to="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestones_CF17D95D45265134A8396739072297FD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent" xlink:label="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_372E429368775A44BF190CD6D0F67DE5" xlink:to="loc_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent_857946EED3365AF6AA1C78EBB890DA49" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_CBB303B5AF072A22921F4732E66508A6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_CBB303B5AF072A22921F4732E66508A6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_FA5958D86BEBE281A4964732E6651C23" xlink:to="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1E8A177263D566610DC64732E666B97B" xlink:to="loc_prgo_RXPharmaceuticalsMember_F3911C7E63D06DA796974732E666E974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4DF8F0768187DB4B3BA14732E666199A" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_394BD1A31FB7EA0E1E734732E66737E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_C3B18772C296E24A25534732E66604BC" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32CBDDF218537CC1BDFD4732E667497D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B32898E077707EF7263C4732E66781F5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B32898E077707EF7263C4732E66781F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_B32898E077707EF7263C4732E66781F5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_CB87ED18CFAE685B80D84732E6676642" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_CB87ED18CFAE685B80D84732E6676642" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D7C2202BD76F6B28B57D4732E668ED36" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D7C2202BD76F6B28B57D4732E668ED36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35BE69E4C419359A4D754732E6675D25" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0A1FB9FFEC7C70C886AE4732E6682741" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_887C239A07F37A8351EE4732E6657971" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_CAEA6B03460009A560C04732E669021E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_1D3AD792F426105A94034732E6695087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_405101928A9095F2E6884732E669FEA8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure" xlink:label="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure_D63115EF70483B2720704732E66A1C87" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PotentialContingentMilestonePayments" xlink:label="loc_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_prgo_PotentialContingentMilestonePayments_279BE57728E2861C1C3C4732E66AE699" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1454F301298CBB8035EB4732E669CCB7" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_50792A44652B13700FE54732E66A9845" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_F859F5699B8142371A384732E6686EF2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_0BBC65EF2DA75B179BD54732E66A188F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6A5A3F002D435E55BAB04732E66B5BB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_C3867A98D79765A1EE4C4732E66A960A" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_A904EE01A3968ED753014732E66B0E29" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_49CDD57208C0ECB8469F4732E66893DF" xlink:to="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillFairValueDisclosure" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_39F6DB4D7054BBD89E194732E67067EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_D55F6C5D5815A75F817C4732E67083DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_Goodwill_B34FD9DA9FA8A5C8AEAE4732E671D68F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract_8F5EDD9EE111E32BE5AA4732E66BE3FC" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_01E72D978FB20C3E34BE4732E671A7E5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_69FA5B28B8DCCA65C23C4D5791860FB3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_69FA5B28B8DCCA65C23C4D5791860FB3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6267443C9932ACB59A9C4D5791898325" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RoyaltyPharmaContingentMilestonePaymentsMember" xlink:label="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_FBD0EA321771BF97E6004D57918A1DDD" xlink:to="loc_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_BA046A0818F6284BE2344D57918A6B22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6292CB4CE50CD232193B4D57918BEC81" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6292CB4CE50CD232193B4D57918BEC81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6292CB4CE50CD232193B4D57918BEC81" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_88DB52DE35858B3E6C864D57918B980C" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_35D9867C2C974A3A13C34D57918BB41D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11C4F73A0E59C03355C84D57918B5EEE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11C4F73A0E59C03355C84D57918B5EEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11C4F73A0E59C03355C84D57918B5EEE" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_D5EF270A68C9BC1748004D57918BED68" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_813441C73DEBFB7400D34D57918BF46E" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_D5EF270A68C9BC1748004D57918BED68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2ABBF8E923CD569B5EEC4D579188B2EF" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_BBA358488B2C3BBAED234D57918B37C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_7C353655051B70885B564D57918B2E2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2009334E52F8C8BA73474D57918BAC4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_A800AE21CDE10CCD2B674D57918B5DCC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8489077522EAE7128B0A4D57918B4D43" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_A800AE21CDE10CCD2B674D57918B5DCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_07BB9E8775EAB7BDAAE74D57918B797C" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2E41A6F00F7B2F4595E54D57918BD79F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_B75DE870A0C5F37F99DF4D57918B1329" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_EC64AC028971F65087874D57918BA5ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_E83E9C974C5911DDC4354D57918B87B9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6BA177353602945352014D57918B8DE5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_E83E9C974C5911DDC4354D57918B87B9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_F93EAE69571D5E949D4645F239521D18" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_F93EAE69571D5E949D4645F239521D18" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_225F050888BC596DB959B69F8BDFD42C" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_F668FCECB870500E96D555FB0A71A8D1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8DC38A63CF2A5BFEA7191F48E3AB4423" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_395CFC0166AF55038E8302297EF76F4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_8F9EF2E43EB25DB0879CED883BC5ABB4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="loc_us-gaap_DebtInstrumentAxis_8F9EF2E43EB25DB0879CED883BC5ABB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8F9EF2E43EB25DB0879CED883BC5ABB4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PublicBondsandPrivatePlacementMember" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:to="loc_prgo_PublicBondsandPrivatePlacementMember_E07C6DDDCE875B96A97A5351E2730F24" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PrivatePlacementNoteMember" xlink:label="loc_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3D6508F528FA59E69D538197BDF08E3A" xlink:to="loc_prgo_PrivatePlacementNoteMember_F9644EAA27BB5E4EA8068C2387DF3A0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9EDD64826C035589A1DDE63579217658" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_F0B2D40F102F55E3B077C3B751D766BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1A4D3EF82E9F56F1B03CC33D3B03AB63" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9FC54917311652F7BDF39636CB09F5D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91833DB414FB58B594CB86650B5ED773" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:to="loc_us-gaap_SeniorNotes_CF783763D9695D459BD94A25EFFAF8E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_074D1E1DBF34532D87A6F72F093AE822" xlink:to="loc_us-gaap_LongTermDebt_5F8135D8A57159AFA8A365ED4CEB8440" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7FCFAE52EDB65E4D87E0C0236C626B91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7FCFAE52EDB65E4D87E0C0236C626B91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90303C696297512EAE0A1EA4C56B45CD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_90303C696297512EAE0A1EA4C56B45CD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleofFairValueAssumptionsTableTextBlock" xlink:label="loc_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:to="loc_prgo_ScheduleofFairValueAssumptionsTableTextBlock_5103070434EA5E368ADDB2059B0108F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1C61EC3198A755599B4BA05EE76DB166" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1C61EC3198A755599B4BA05EE76DB166" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_594546008700513581ACE37C06E4FA72" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_594546008700513581ACE37C06E4FA72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_17731D1D36D85B949F7C5E8A0686E645" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18DF405ED4815FAB83C60D023DE7E165" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_17731D1D36D85B949F7C5E8A0686E645" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_055D9E1E0F8A554883D26C92146EFDCE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2318D1C2FE20599BA8830A9A060CB960" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_055D9E1E0F8A554883D26C92146EFDCE" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2318D1C2FE20599BA8830A9A060CB960" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B5730AB4D93006D87888472B78059496" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B5730AB4D93006D87888472B78059496" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9688C31E7D7DF147275547308588F54E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9688C31E7D7DF147275547308588F54E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9688C31E7D7DF147275547308588F54E" xlink:to="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_354EFE58E63542849328473086BE837B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BF5A50D3F84434E0B86F4730859E547E" xlink:to="loc_prgo_RXPharmaceuticalsMember_354EFE58E63542849328473086BE837B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:to="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_F629981BFF5DF5C838B2472B78062383" xlink:to="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_BCSMember" xlink:label="loc_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_C468BB0C8FB446B234DB472B7808E6BE" xlink:to="loc_prgo_BCSMember_F9DCC684738CD45FF635472B7809464C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_B558987B2505DB2E415E472B7806E301" xlink:to="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B3461CA8B90EC0EC51EE472B780A7C2B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:to="loc_us-gaap_Goodwill_B3461CA8B90EC0EC51EE472B780A7C2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_8926B5B6264807532C6D472B780A3366" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_EFC25BBD4843A41AA02F472B78094AD9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_EA25A309ADF27CEE069C472B780A8C1A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_320EB2F298D41701E0C1472B780EF8E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_320EB2F298D41701E0C1472B780EF8E9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8ED417BFD21CA6A33ECA472B780F82AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8ED417BFD21CA6A33ECA472B780F82AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8ED417BFD21CA6A33ECA472B780F82AA" xlink:to="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_7FA663DAB2A598DF7FD4472B780F8BAA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_7FA663DAB2A598DF7FD4472B780F8BAA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_70A8EE251866DE082F6F472B780FA7D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_70A8EE251866DE082F6F472B780FA7D4" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_F98435D4D0429BA2E9BE472B7810D56C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8EC3556B19059349FC1B472B780F281E" xlink:to="loc_prgo_RXPharmaceuticalsMember_F98435D4D0429BA2E9BE472B7810D56C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_883D7C548EA7A6CBDAAA472B780E9BA0" xlink:to="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9FC2A8AB96E7C83EA703472B78108848" xlink:to="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_Goodwill_5A4667C9FCBEE6AE19DA472B78100323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_199907DD5B9573C110F6472B78116BBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_459D217C2CFF0489E117472B78118DEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_14732FDC2D8AB229DDF0472B78117247" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1CBC2C1F708C174A95D6472D07D1C4AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73C922D0630B27D534A3472B78116038" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_E97E4FA653563D045286472B7811B711" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_Goodwill_E97E4FA653563D045286472B7811B711" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1AB9A615DFE5A23285CA472B78100E05" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1E125FDCA3F6B5B234EC472B78114389" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C7EF5228B31B66BB8451C686DDF58998" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C7EF5228B31B66BB8451C686DDF58998" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7BF3AE04ED13399789E9C686DDF7F70C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7BF3AE04ED13399789E9C686DDF7F70C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7BF3AE04ED13399789E9C686DDF7F70C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_EvamistBrandedProductMember" xlink:label="loc_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:to="loc_prgo_EvamistBrandedProductMember_7998DEEA9A61F879C3DFC686DDF79E72" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_GenericProductAcquisitionMember" xlink:label="loc_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_149C2776838EC5878A0FC686DDF71852" xlink:to="loc_prgo_GenericProductAcquisitionMember_462805C01A80347CC44CC686DDF88D87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_A54F85B2EAB783F7C81EC686DDF884F0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_A54F85B2EAB783F7C81EC686DDF884F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_A54F85B2EAB783F7C81EC686DDF884F0" xlink:to="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_9D046294FEB83328642AC686DDF96A29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_962C51B2E43178419F4DC686DDF81A89" xlink:to="loc_prgo_RXPharmaceuticalsMember_9D046294FEB83328642AC686DDF96A29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4895525DC7EA6C5EB53FC686DDF93CB1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4895525DC7EA6C5EB53FC686DDF93CB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4895525DC7EA6C5EB53FC686DDF93CB1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_TrademarksTradeNamesandBrandsMember" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_588E7228F7F64AE4CD17C686DDF90A07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_B292B09A1EDD588408D9C686DDFAA2B2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA8225B5255A0BDADFD8C686DDF9256D" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_B292B09A1EDD588408D9C686DDFAA2B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B8E2ACF8FB4133C368B8C686DDFC03D4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B8E2ACF8FB4133C368B8C686DDFC03D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B8E2ACF8FB4133C368B8C686DDFC03D4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_LicensingAgreementsMember_E571E3DD163C4A792585C686DDFC69F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9B3B623D7EEF65CE4AD4C686DDFDF90B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_CustomerRelationshipsMember_31784941A7648E48FA68C686DDFDA7B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_0BA069E7FE3DEE38ADF5C686DDFD8D23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D47F724F5A09FFD3D1ABC686DDFC9560" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_B58ECA4AFE46EE543056C686DDFE8EAD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_85B208A6BDA5D1F154FCC686DDF74C38" xlink:to="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_629D10400D2A9D2AEBFFC686DDFEC410" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_431351EA8078B9401A51C686DDFEB220" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_D25864965F8BD4D62D32C686DDFFB306" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5DA116E009D57DFE1C1CC686DDFFAF47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_DE876C49B7F5E2CA66ECC686DDFFB6D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_47FE0503C90B7495A971C686DDFF6BB1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_AssetImpairmentCharges_47FE0503C90B7495A971C686DDFF6BB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_998FF3FF30B21D675853C686DDFE48F4" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1AF93C50E1027D25B550C686DDFF0B1A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D91E5DCAE4F75AEFABBB408773FEDCC8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_B496013DE38753D9824ADB9801D3DE96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D91E5DCAE4F75AEFABBB408773FEDCC8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_B496013DE38753D9824ADB9801D3DE96" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D91E5DCAE4F75AEFABBB408773FEDCC8" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_E28DB3B6190A5C2D8FF9C597B0C66EE1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_E062A38D307D50419D94D9605055FC74" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6E5D5C6D96D552048FCC86134ADEB248" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_E062A38D307D50419D94D9605055FC74" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6E5D5C6D96D552048FCC86134ADEB248" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_E1A243C689738EFF95D293669262C008" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_E1A243C689738EFF95D293669262C008" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_91529276D9D1784F426B936A7519347C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_91529276D9D1784F426B936A7519347C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_91529276D9D1784F426B936A7519347C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_E32B2C5940F2012D0CE1936AA1A65D3A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_F00893C857C3926B528C936A751E998A" xlink:to="loc_us-gaap_SubsequentEventMember_E32B2C5940F2012D0CE1936AA1A65D3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_BCBA9D9ED4CC33257677936692661628" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueCommissionersIrelandMember" xlink:label="loc_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_E5AD84D9D6640837BD0493669266465F" xlink:to="loc_us-gaap_RevenueCommissionersIrelandMember_3E15EC4E7E4349BA47759366926787A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_265C8A72B7EC117A94F49366926574AA" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8C999B5A0DEB5183A0B1936692688C6D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_DE565D8C2E41EBCE0D26936692695A87" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_312DB1EDEE81EBCD4043936692690E32" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_6E8DF5542F67A748B6ED93669269C958" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_817DFB8897AC80CD9C7093669269412C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties" xlink:label="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties_ABC8872DE8234BE1EDA79366926984FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_F546CF1260EC675D4E2C93669269FC54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_C6F58777D4C2159D44D99366926A2838" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CumulativeDeferredChargeTaxLitigation" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_CumulativeDeferredChargeTaxLitigation_26594C6F9E2DE5EF68339366926A2ED8" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears" xlink:label="loc_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears_00DE1CEF18F46A1248249366926AB34A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_84750BDC4C738B4C46099366926AE432" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_21C99D0A652D25C525F19366926A0062" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_42DCEA4E0EF28B60848A9366926B338D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability" xlink:label="loc_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability_C8BEA22068038A3F493E9366926B314E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PeriodAvailabletoFileAppeal" xlink:label="loc_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_PeriodAvailabletoFileAppeal_3D15C18A83D38C04FC359367F3A270CF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal" xlink:label="loc_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_A16DFB9DDA9CECCD4A5893669267230A" xlink:to="loc_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal_15618E3E2DAEF57F8BF0936E02424A48" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_58D26878E21D54EE9247B742EFD6360D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1132033510665AC0A2BD3B0456C3E105" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_58D26878E21D54EE9247B742EFD6360D" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1132033510665AC0A2BD3B0456C3E105" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Indebtedness" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_18EE4AFBB07E5AE788ADE20B44218EA9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9521E3D9A1D657BCB6D4408BB9708143" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_18EE4AFBB07E5AE788ADE20B44218EA9" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_9521E3D9A1D657BCB6D4408BB9708143" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_D9122D59ED72832A5869478858B4E26C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_D9122D59ED72832A5869478858B4E26C" xlink:to="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_9506E4D2036824911DC0478858B58010" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_KazmiraLLCMember" xlink:label="loc_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_39EE608A18F50432803F478858B592FC" xlink:to="loc_prgo_KazmiraLLCMember_68B64ACFCF181987199D478858B6D858" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_6F52D2A7596BD4E1500B478858BB8ADD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:to="loc_us-gaap_DebtInstrumentAxis_6F52D2A7596BD4E1500B478858BB8ADD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6F52D2A7596BD4E1500B478858BB8ADD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2018RevolverMember" xlink:label="loc_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2018RevolverMember_72DD5B46F8BE7854183C478858BB28C3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2014EuroDenominatedTermLoandueDecember52019Member" xlink:label="loc_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2014EuroDenominatedTermLoandueDecember52019Member_9D71A1BB431CDED54FC1478858BC8211" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2018EuroDenominatedTermLoandueMarch82020Member" xlink:label="loc_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2018EuroDenominatedTermLoandueMarch82020Member_33D438FE75F465C78D9B478858BCFC3E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_A99476D7842BDF6B3891478858BCD6EF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_A99476D7842BDF6B3891478858BCD6EF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.150SeniorNotesdueJune152030Member" xlink:label="loc_prgo_A3.150SeniorNotesdueJune152030Member_B2A050DF4B0C5E8B5202478858BC7E3B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A3.150SeniorNotesdueJune152030Member_B2A050DF4B0C5E8B5202478858BC7E3B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_282AFDA27F5D8342C3F1478858BCC9AC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_282AFDA27F5D8342C3F1478858BCC9AC" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.5SeniornotedueDecember152021Member" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member_6BF09CF35D26CF4B41FD478858BD600B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_A3.5SeniornotedueDecember152021Member_6BF09CF35D26CF4B41FD478858BD600B" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueNovember2020Member" xlink:label="loc_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_NotedueNovember2020Member_90790ABFCEB0F154F4FD478858BD2F22" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueMay2021Member" xlink:label="loc_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_NotedueMay2021Member_079BAF7D31E147D13083478858BD78FA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NotedueNovember2021Member" xlink:label="loc_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_NotedueNovember2021Member_785CB8EEF4BC5853C6E8478858BD37DF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SeniorNotesdue2021Member" xlink:label="loc_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_435054810A0C9CAD1DCA478858BB8E8D" xlink:to="loc_prgo_SeniorNotesdue2021Member_0552E0BE0B02478A382A478858BD65C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7603A67E493D56F40939478858B5E0BD" xlink:to="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_BA04168D63302E12473A478858BE07AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_LineOfCredit_8E6ED4BD49EB56FB331D478858BE4114" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_RepaymentsOfDebt_0C291B8BC235D5303E7F478858BEADC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ACC820E10C9F12D0FE5F478858BE7062" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BE79696B239C3A180515478858BEADC2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BE79696B239C3A180515478858BEADC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_32AB1D2CA7EDF7A61BB3478858BF9674" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_SeniorNotes_B22E50F7D8526341BB98478858BFB089" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_80F0C132406C3C75858C478858BF1178" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_us-gaap_NotesPayable_498BC294FC01663234F0478858BF01E2" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NumberofPromissoryNotes" xlink:label="loc_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80F4A137FC145CD8E16E478858BE4BB0" xlink:to="loc_prgo_NumberofPromissoryNotes_B292D0EFADFD2AFD83A6478858BFB8AE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0E7E9A8AC18D4A56BC3747475E9636FB" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ScheduleOfDebtInstrumentsTable" xlink:label="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0E7E9A8AC18D4A56BC3747475E9636FB" xlink:to="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:to="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_766E75F80F27ABD8181D47475E96963A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A2019EuroDenominatedTermLoandueAugust152022Member" xlink:label="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A2019EuroDenominatedTermLoandueAugust152022Member_E7BCD582BA2E22F3B43F47475E978A1A" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.500UnsecuredSeniornotesdueMarch152021Member" xlink:label="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member_3ED4CE8EC3D6951463B347475E97C73D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.5SeniornotedueDecember152021Member" xlink:label="loc_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.5SeniornotedueDecember152021Member_8FBF4B0E3190C0E063B647475E98EAAF" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A5.105SeniornotedueJuly282023Member" xlink:label="loc_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A5.105SeniornotedueJuly282023Member_3D2A7075299C6B1AA2C447475E98CA7C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member" xlink:label="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member_C2EE740155E57508CC9A47475E985C98" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.9seniornotedue2024Member" xlink:label="loc_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.9seniornotedue2024Member_EFF34A5630F75C1049C047475E989196" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.375seniornotedueMarch152026Member" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_7F546903E2F5E509873747475E984303" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A3.150SeniorNotesdueJune152030Member" xlink:label="loc_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A3.150SeniorNotesdueJune152030Member_D7A8B48D2E31DD7A272647475E98A429" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member" xlink:label="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member_C31FBA55826CEE6EB79B47475E9978B5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_A4.9SeniorLoandue2044Member" xlink:label="loc_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60D89A1C0CA53C316EC047475E9796EA" xlink:to="loc_prgo_A4.9SeniorLoandue2044Member_507D8C13D7EFCC6E37F747475E99DC2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_EB58F3E927A2D303761B47475E96EDA9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_LoansPayable_2364A4E910BBA16A195147475E99A7DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentDescription_347294D94E12E4C4F01547475E99F581" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_391D5039EE9834CA188E47475E9A9F42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_SeniorNotes_83E5D74DA2589706283347475E9A63B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_OtherLongTermDebt_7AC59F0A760E51EF50F547475E9A90CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_05887E0816E1349B1A5747475E9A02CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_A107B656DD6EB2815AD247475E9A9418" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_75772D7EB02D1221D5D847475E9BE1F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_DebtCurrent_96353227942D5C9A8B0447475EA0B128" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_B8A3163911452C087E1047475E993CC7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_DCC3404126D68A364EE547475EA092CB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6EE8E128BE725AE095031FF254E0E286" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_54CD6E81934D57AC8CF549F748EDD4AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6EE8E128BE725AE095031FF254E0E286" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_54CD6E81934D57AC8CF549F748EDD4AF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_45D3252E30AC5866AFDB5515C2670150" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_95A7FACA9F0150F8BAEDF4C094D678D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_45D3252E30AC5866AFDB5515C2670150" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_95A7FACA9F0150F8BAEDF4C094D678D6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_0A02571BED8A5CC78F3AA10FC392F6E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:to="loc_us-gaap_InventoryFinishedGoods_0A02571BED8A5CC78F3AA10FC392F6E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaap_InventoryWorkInProcess_3A50A946793C5CBD9C5BFA38129C1466" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:to="loc_us-gaap_InventoryWorkInProcess_3A50A946793C5CBD9C5BFA38129C1466" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_4D3AE61520E85709BBD3173ABC5FC98B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:to="loc_us-gaap_InventoryRawMaterials_4D3AE61520E85709BBD3173ABC5FC98B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_EB64BEBEDE945EBCAE1F7BAB7EA3960D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_517859F575405233BA875E5C850FA5D8" xlink:to="loc_us-gaap_InventoryNet_EB64BEBEDE945EBCAE1F7BAB7EA3960D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_FBEF4B44250E5085A67A1D40AEEA0119" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_BF12312B702658F1AE5CADA7BAC5DCCE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_FBEF4B44250E5085A67A1D40AEEA0119" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_BF12312B702658F1AE5CADA7BAC5DCCE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Investments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_45E49534381250A78A43D9B0E5BE5B0E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_DC2EF6C9BFD65AD3B0F08F028A01BEAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_45E49534381250A78A43D9B0E5BE5B0E" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_DC2EF6C9BFD65AD3B0F08F028A01BEAE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_61383A9D4B7C5DBD9A785C36EDA97493" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_61383A9D4B7C5DBD9A785C36EDA97493" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_F39D1771C2DB5D248402C15CC3978907" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_F39D1771C2DB5D248402C15CC3978907" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_EFCD39B0AC4D5C0CB67EDD24A90A2060" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_F39D1771C2DB5D248402C15CC3978907" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_EFCD39B0AC4D5C0CB67EDD24A90A2060" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_KazmiraLLCMember" xlink:label="loc_prgo_KazmiraLLCMember_C28B94AEF16A5BB8B2155656ACE0DAB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_EFCD39B0AC4D5C0CB67EDD24A90A2060" xlink:to="loc_prgo_KazmiraLLCMember_C28B94AEF16A5BB8B2155656ACE0DAB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_C9B8981D42C35AB59BA81E79AA4B24A7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5A4A4F0B8D315FF9A6EB785D7FCEA2BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6C20D5AAB3B85038AFC0C895A2243521" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_880670AE3812544589AECF3899D14F36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_C8BF2638B3945D468963E9D957640184" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_C8BF2638B3945D468963E9D957640184" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F256B4A5EAC95CFBB9B5CE3BF8C3D4BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_C8BF2638B3945D468963E9D957640184" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F256B4A5EAC95CFBB9B5CE3BF8C3D4BB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherExpenseIncomeNetMember" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_06E3AC26AFAF50B586FD7891FF4C59D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F256B4A5EAC95CFBB9B5CE3BF8C3D4BB" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_06E3AC26AFAF50B586FD7891FF4C59D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_79B8E63DF0485570AD24805295EE3E82" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3401971F09EC5E74ACF97F12AA18AACE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquityMethodInvestments_FDBC5CA1D8BF5275908BEE53FD15DD32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8F91B5ABC2CD5D23A6AC22F136278FF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0469BCD01347591D9CAEBA8DD0637CAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3196AE92D72358D1B6C2A811E33077C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_437E2743E96D586EA9A53D4E2A3063F5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_EquityMethodInvestmentPeriodforPayment" xlink:label="loc_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0277C7B264505BD9895FDEB4E4B6A1C2" xlink:to="loc_prgo_EquityMethodInvestmentPeriodforPayment_DF4D457AB51B5E31B0BC8017A12718E9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_5BA52EFC1EF45636B0BA5CB7CE613594" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_E4DC46591DED5E828B5E84B3ABAAF2D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5BA52EFC1EF45636B0BA5CB7CE613594" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_E4DC46591DED5E828B5E84B3ABAAF2D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_CDDAD86BEB075539BC747053E1F28D43" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5BA52EFC1EF45636B0BA5CB7CE613594" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_CDDAD86BEB075539BC747053E1F28D43" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Leases" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_6121A3452D0650FA885D29703B1D6DEE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_FE44A1468A9D5122A85620A964A05667" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6121A3452D0650FA885D29703B1D6DEE" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_FE44A1468A9D5122A85620A964A05667" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_EA8E4BBC7E815A6B809025B292429FC5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6121A3452D0650FA885D29703B1D6DEE" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_EA8E4BBC7E815A6B809025B292429FC5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C364674F3BEC5795BDDE4318C0CE5121" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C364674F3BEC5795BDDE4318C0CE5121" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_D6EE4F30926D5168A3C773CFBDBC7FBA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_D6EE4F30926D5168A3C773CFBDBC7FBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_124AD704A3335F63AC767B2CF5CE938B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_124AD704A3335F63AC767B2CF5CE938B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21BF6DB9692C5AE3AF0C6EEE01D4E0AF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21BF6DB9692C5AE3AF0C6EEE01D4E0AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_079232BE4D0C5BEF9421FD368D088C3F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_079232BE4D0C5BEF9421FD368D088C3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41EB19022C8C5F84950E23DA0E41B4F5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41EB19022C8C5F84950E23DA0E41B4F5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:label="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_C2F6C5C577CA5D5AA6C1AE44689B05DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13915146C68256768FBFB4EE2280FED3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13915146C68256768FBFB4EE2280FED3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_BBA60CA31F655D86875F52C926D5F622" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_BBA60CA31F655D86875F52C926D5F622" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_11AD1FDBCE215E2E8CC3896928B4B5B4" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_096B7EF40EC2583297273E55FB80E19E" xlink:to="loc_us-gaap_OperatingLeaseLiability_11AD1FDBCE215E2E8CC3896928B4B5B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C364674F3BEC5795BDDE4318C0CE5121" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_EE7F4FBDFEB653228301262C3DBB346D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_EE7F4FBDFEB653228301262C3DBB346D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_D5078C9373725796991CA81CD68CD90E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_D5078C9373725796991CA81CD68CD90E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6899D7C5C66653CBA4081AEE3FB640D8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6899D7C5C66653CBA4081AEE3FB640D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_60203F3BD237537DAECEC50658456482" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_60203F3BD237537DAECEC50658456482" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67CA90407234503587E20C05C9B07E69" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_67CA90407234503587E20C05C9B07E69" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:label="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_F40F2FEF702E5A8CA179727D883E3D33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_FE89C8E332BD54EE92E7784CAB781E41" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_FE89C8E332BD54EE92E7784CAB781E41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1F5BFF4B68075102A6AB07556145CA53" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1F5BFF4B68075102A6AB07556145CA53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_247017400D0751C9A97E87E5AF8FCD33" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3B5EEAB33AEB53C0B8BDDEBCFBB00701" xlink:to="loc_us-gaap_FinanceLeaseLiability_247017400D0751C9A97E87E5AF8FCD33" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C364674F3BEC5795BDDE4318C0CE5121" xlink:to="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:label="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1751CB7B52B45B10BDD6323490E6A717" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearOne" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearOne_948DFF071DEF5054B2366580FA0247A5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_1286278C1C9052B5AAB055B137082C86" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearThree" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearThree_7C9DE63AEDAE51DC9358B866195B927E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueYearFour" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFour_931A40C8A7B156599BA284B476703BC7" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_CCB58ACC075254DF89D38315764315C5" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityPaymentsDue" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityPaymentsDue_4C19F8ED51CB551CA3CEB6D533A69039" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_2A3969BAD368581AA8F058775B4B219C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilities" xlink:label="loc_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_E65C51DE424055A49CD3361F59919F76" xlink:to="loc_prgo_LeaseLiabilities_920C90652648565681FA24E27148EC23" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0E1C7623D5DF521087C7F0F0AD28B66F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0E1C7623D5DF521087C7F0F0AD28B66F" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5D6764E43B105172815B6AD908EF513D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5D6764E43B105172815B6AD908EF513D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5D6764E43B105172815B6AD908EF513D" xlink:to="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_DE261E4C6F015D9284D9F5721F7018F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_DE261E4C6F015D9284D9F5721F7018F9" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_9501A7214B415F4CB6DE7FE378BB0418" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_9501A7214B415F4CB6DE7FE378BB0418" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_4B20AE90B47351CD9E88F6E5D883DE1F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_prgo_RXPharmaceuticalsMember_4B20AE90B47351CD9E88F6E5D883DE1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_CC7C987C7C935BE997810AEB5B770F89" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_05A57983389A5A1DB2DA8297F1C4454F" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_CC7C987C7C935BE997810AEB5B770F89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1B31B968032D512185C15FFE00733FE6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7A84B25BA4CE5C289023D58D393D523A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7A84B25BA4CE5C289023D58D393D523A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_E3F23DF3926C50E0AC7D12582123CD7C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RightofUseAsset" xlink:label="loc_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_prgo_RightofUseAsset_4C0B0CEBA54951219D66116C44691CD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_EED8EB4206315C22B491C382302AC24A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_150BC4EB5FD05501B18CBF81682929AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_C71F7737BE6350208BE3C39D8E10A98A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6604C9F1240D51D78D75C992C4857861" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LeaseLiabilities" xlink:label="loc_prgo_LeaseLiabilities_5C52231D014055C2862DE4A4A6F488B2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_prgo_LeaseLiabilities_5C52231D014055C2862DE4A4A6F488B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiability_167D5B5919CD5A6BAE8D124A15EC7DC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiability_174F01491318584DB4F9FA2097665B46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_93308DF1C3CD5D1A86A5312CDFBD4148" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0B690D24BFAF5CFD891B26A37DFB0594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3C6FB25C6BA9562885CD085FE6ADE2E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_E97AB760FB6E5EB1A58E248E9A9F351C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_B6A43080D250502C8291101BD0E82205" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_15508BE23FBE5CA8A8ED7AFE3C444A1A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1DCA49A8773554B990B103F38DA499A8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_A51A3A30FF5254CF9B7267F5A296E4B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1DCA49A8773554B990B103F38DA499A8" xlink:to="loc_us-gaap_OperatingLeasePayments_A51A3A30FF5254CF9B7267F5A296E4B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_3D3DCBD34BD15C9EA34C8AACA49A1634" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1DCA49A8773554B990B103F38DA499A8" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_3D3DCBD34BD15C9EA34C8AACA49A1634" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_561705CAB6B05522B61E893EE1775B79" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1DCA49A8773554B990B103F38DA499A8" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_561705CAB6B05522B61E893EE1775B79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_13C630A034D855FAA1FE119C6C6E3366" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1DCA49A8773554B990B103F38DA499A8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_13C630A034D855FAA1FE119C6C6E3366" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1CB7FDD1E1B2584DAB1E6A015FF0CDC2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1DCA49A8773554B990B103F38DA499A8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1CB7FDD1E1B2584DAB1E6A015FF0CDC2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_52815F92E6DF573E8A7E1E11CD3B32F6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_A93853146A5D50D5BB4C4BA987BFD0D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_52815F92E6DF573E8A7E1E11CD3B32F6" xlink:to="loc_us-gaap_OperatingLeaseCost_A93853146A5D50D5BB4C4BA987BFD0D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_52815F92E6DF573E8A7E1E11CD3B32F6" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_18AD06D45F7552B4B7F6F8B953FC63F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_18AD06D45F7552B4B7F6F8B953FC63F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_1B9D96F365D759BE9CA63043731521BD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_1B9D96F365D759BE9CA63043731521BD" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_FinanceLeaseCost" xlink:label="loc_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2FD7555A2499565B89EE1F22F590D8F7" xlink:to="loc_prgo_FinanceLeaseCost_1D211DB0CA3059BBB66E61FEAB673458" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_F096B4C7D57C576C9F363CB358DA944E" xlink:type="locator" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:label="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F096B4C7D57C576C9F363CB358DA944E" xlink:to="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0B2E99B28E3F550EA42829B57911C1FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_F2328572073658EAB5D2115FBDB97753" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F096B4C7D57C576C9F363CB358DA944E" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_F2328572073658EAB5D2115FBDB97753" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_B4987C4237D45CEA8C5759671F1C606D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F096B4C7D57C576C9F363CB358DA944E" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_B4987C4237D45CEA8C5759671F1C606D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C08EB032E9855A59B9038D36625C7D8C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F096B4C7D57C576C9F363CB358DA944E" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_C08EB032E9855A59B9038D36625C7D8C" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:label="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F096B4C7D57C576C9F363CB358DA944E" xlink:to="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_A1E2184B16895AEF9C8B3B70FD90C97F" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:label="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F096B4C7D57C576C9F363CB358DA944E" xlink:to="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_683B4F3BCD385A7581DFF05D89CE429E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_7AAB633772955E6788549E60D94BE9B0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_49E1A475170755B68186B2097BCBED80" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7AAB633772955E6788549E60D94BE9B0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_49E1A475170755B68186B2097BCBED80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_986DF83B5FD9536280A588B547430304" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7AAB633772955E6788549E60D94BE9B0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_986DF83B5FD9536280A588B547430304" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_CFED391033135084B5BC812BF8EF5CE5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7AAB633772955E6788549E60D94BE9B0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_CFED391033135084B5BC812BF8EF5CE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_55A0554A2C6754D2AA668ACC8EDB7D4C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7AAB633772955E6788549E60D94BE9B0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_55A0554A2C6754D2AA668ACC8EDB7D4C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_102F952BE9595101B96623AA80477C58" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_A957C42B709056BEB9F7FE92C6489339" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_102F952BE9595101B96623AA80477C58" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_A957C42B709056BEB9F7FE92C6489339" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_1B1D674E30F5599FAB684D8643B0738B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_1B1D674E30F5599FAB684D8643B0738B" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1D93448E69AD592C9ACD18CCC81BC90A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1D93448E69AD592C9ACD18CCC81BC90A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_DD0E2FCB79225001BF58E592BB3AB81D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1D93448E69AD592C9ACD18CCC81BC90A" xlink:to="loc_us-gaap_SegmentDomain_DD0E2FCB79225001BF58E592BB3AB81D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_CSCIMember" xlink:label="loc_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_DD0E2FCB79225001BF58E592BB3AB81D" xlink:to="loc_prgo_CSCIMember_CEBDFE580AFF5BDD8BCF9D6568E4214D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FD743F1594C252509A2117CD4274F51D" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_A79DE6BF53385B3180B467518ED75CA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:to="loc_us-gaap_RestructuringCharges_A79DE6BF53385B3180B467518ED75CA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4D06C98B6EE35B98BA8BC67D5F8E21D1" xlink:to="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_us-gaap_RestructuringReserve_293F7BB61B1D5017AB822B7BB69E8256" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RestructuringAdditionalCharges" xlink:label="loc_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_prgo_RestructuringAdditionalCharges_561774074FB45F0FAE66EAD6822BDB27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_us-gaap_PaymentsForRestructuring_6CCB2275C4235E6AAF050FD3CAAD6AE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9F424469836A5756B41092275AE38F24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_E2FA5E075C3B5DF6A6B1BB70CF61B745" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_FA6CAAA99467534E967BBFC9198011EA" xlink:to="loc_us-gaap_RestructuringReserve_E2FA5E075C3B5DF6A6B1BB70CF61B745" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_8452BDB10253561EAA72C5265CF29DD5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4CA4D56E95EE57BB93B6A46ECCF58EC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_8452BDB10253561EAA72C5265CF29DD5" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4CA4D56E95EE57BB93B6A46ECCF58EC5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77D42B70764D5D6DA30944BF93E66931" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_F003A6FEAE6E5170943A58E1E8E3A32F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77D42B70764D5D6DA30944BF93E66931" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_F003A6FEAE6E5170943A58E1E8E3A32F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_F66FD031B1875A3A93BD70958AABCE8D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_F66FD031B1875A3A93BD70958AABCE8D" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:to="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_FB934E158812537CA322D49B50DF6A19" xlink:to="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ContractManufacturingMember" xlink:label="loc_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_C2C38089A81754B8A7B040B32310D133" xlink:to="loc_prgo_ContractManufacturingMember_34D5BA7FFD3D54A486FDCFD96CD8221F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_CD73A9A6E73456AA9B55A12DACAF9627" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D14F278EA81A56A7803D9E8BD9816374" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_00FE0EF57FF15FADA10EC331B7A75BF2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_D14F278EA81A56A7803D9E8BD9816374" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77CDD74AE5125E9DB4623A3856340056" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_039171E9C8F65AB4B47D246F7900A019" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77CDD74AE5125E9DB4623A3856340056" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_039171E9C8F65AB4B47D246F7900A019" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_F1D5468075AF52F9AA05DE71E816D85D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6CDEAA3047BD537B9A9591EAA25A8F7A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_F1D5468075AF52F9AA05DE71E816D85D" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6CDEAA3047BD537B9A9591EAA25A8F7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6CDEAA3047BD537B9A9591EAA25A8F7A" xlink:to="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3ADCA8534DB456E08D0A3BDCB9B263D7" xlink:to="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_country_US_7692E6BF512D56A8AB86429E22E30468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_srt_EuropeMember_9F3A8358E2C1569D9B38AC751B1F9ED6" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherGeographicalAreasMember" xlink:label="loc_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_prgo_OtherGeographicalAreasMember_71C134FE08D152A1B0B324A926427AA5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE" xlink:label="loc_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_E5B5E6E45E8A5AE7A6917209C1052E76" xlink:to="loc_country_IE_728BDCD5DCF45B40AB3D6C5A40153957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4C3AA1AD59C357E9BA633E7B16BEA493" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6CDEAA3047BD537B9A9591EAA25A8F7A" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_4C3AA1AD59C357E9BA633E7B16BEA493" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62A69772209B59E694B414AB98A0A5A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4C3AA1AD59C357E9BA633E7B16BEA493" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62A69772209B59E694B414AB98A0A5A4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4D09329937C0443551DB46E067B8A8C3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4D09329937C0443551DB46E067B8A8C3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ED616FAFB0F580AC626D46E067B800D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ED616FAFB0F580AC626D46E067B800D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ED616FAFB0F580AC626D46E067B800D7" xlink:to="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_7DD6A242FFFD51F5661B46E067B9AC75" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_7DD6A242FFFD51F5661B46E067B9AC75" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_EECF75F314C2922C62C846E067B9649D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_EECF75F314C2922C62C846E067B9649D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_DCBFEF4E90057240620446E067B9E935" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6A899798C2B882CEBA6646E067B8CB2E" xlink:to="loc_prgo_RXPharmaceuticalsMember_DCBFEF4E90057240620446E067B9E935" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_A5BCD428539613D9C2F146E067B9BC5F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:to="loc_srt_ProductOrServiceAxis_A5BCD428539613D9C2F146E067B9BC5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_A5BCD428539613D9C2F146E067B9BC5F" xlink:to="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_UpperRespiratoryMember" xlink:label="loc_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_UpperRespiratoryMember_5BF3A12B10B9495B029946E067BAF313" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_DigestiveHealthMember" xlink:label="loc_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_DigestiveHealthMember_74F928B46419E629781846E067BA8599" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_PainandSleepaidsMember" xlink:label="loc_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_PainandSleepaidsMember_A391ADB57EC10B313C9746E067BA1592" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_NutritionMember" xlink:label="loc_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_NutritionMember_CE5C2DC63D25A3E4122646E067BA1EEA" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_HealthyLifestyleMember" xlink:label="loc_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_HealthyLifestyleMember_0B44D7C4C2F593F133B746E067BA6166" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OralSelfcareMember" xlink:label="loc_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_OralSelfcareMember_7317BBA0B1B91A421AA446E067BB2702" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_SkincareandPersonalHygieneMember" xlink:label="loc_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_SkincareandPersonalHygieneMember_4FEE91F97C81C22C89B946E067BBCAC3" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_VitaminsMineralsandSupplementsMember" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_VitaminsMineralsandSupplementsMember_3800FA90364FE6D2B49046E067BB07CB" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AnimalHealthMember" xlink:label="loc_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_AnimalHealthMember_D9DACC1BAF0948A3C6FA46E067BB8C7D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCSCAMember" xlink:label="loc_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_OtherCSCAMember_F9B456B7F543277EE1F546E067BB248D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_OtherCSCIMember" xlink:label="loc_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7835217CD5D39682D51346E067B9A513" xlink:to="loc_prgo_OtherCSCIMember_5D06299D382F313C32B146E067BC4918" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5653F419B67419F10E0F46E067BC6388" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2E99F1AAE36058806A9E46E067B87319" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5653F419B67419F10E0F46E067BC6388" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_05E64D35BFB9E9C173E746E067BC1D28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5653F419B67419F10E0F46E067BC6388" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_05E64D35BFB9E9C173E746E067BC1D28" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_D0A8807301965E22B56F178CAFD5CCDE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_772F2C8B7ABC5004B8587FA5CB6B579C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_D0A8807301965E22B56F178CAFD5CCDE" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_772F2C8B7ABC5004B8587FA5CB6B579C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8D60BD59134B5E09846811E59EFD3E35" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_D0A8807301965E22B56F178CAFD5CCDE" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8D60BD59134B5E09846811E59EFD3E35" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_39B2FF85BC2F514DB2465B8D3FF88F07" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_5C0150773F045588B87E539BE41EB9F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_39B2FF85BC2F514DB2465B8D3FF88F07" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_5C0150773F045588B87E539BE41EB9F8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_55C04C54C1BA2E2C6D2B9879AA70550B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_55C04C54C1BA2E2C6D2B9879AA70550B" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_06AC7A8B15A070E3E8A89879AA724ACE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_06AC7A8B15A070E3E8A89879AA724ACE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_06AC7A8B15A070E3E8A89879AA724ACE" xlink:to="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareAmericasMember" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_EC96DE24DEF416012F259879AA74B2BE" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_ConsumerSelfCareInternationalMember" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_698BF6308DD59C5CE69A9879AA74F3F4" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_RXPharmaceuticalsMember" xlink:label="loc_prgo_RXPharmaceuticalsMember_8E9FF91ADCBB893243619879AA7A1BFC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_prgo_RXPharmaceuticalsMember_8E9FF91ADCBB893243619879AA7A1BFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_19D0E0D6174DF3D35B8F9879AA73AC5D" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_788906DAD6B62C641E749879AA7ABCCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_80BC1EC9D4AF9FE212919879AA7157D3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_Assets_DF342671107E7EE5137D9879AA7A6A44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86D7E3DB764F621DDBE49879AA7C98D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86D7E3DB764F621DDBE49879AA7C98D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_OperatingIncomeLoss_330A59A6926F0DDA69819879AA7CBDE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DBB31596EE57CA1C9A349879AA7A2FFB" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8998E574537FEA3402DB9879AA7C1D27" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_1B41D7FBAD905B94B15B0202E089A2B0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_17F46D200A8851CEA83BFDDEFACA2259" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1B41D7FBAD905B94B15B0202E089A2B0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_17F46D200A8851CEA83BFDDEFACA2259" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_75E9E066E7E451579C63D3F5F28A9719" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F455B7F2315A55D9837BA55A4136C9F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75E9E066E7E451579C63D3F5F28A9719" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F455B7F2315A55D9837BA55A4136C9F0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1A117DF85D9F568780AD7B0C244EF17F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1A117DF85D9F568780AD7B0C244EF17F" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_422308B4BDB55C338C8A1CB03ED79D6A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_422308B4BDB55C338C8A1CB03ED79D6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_D6723707C9FA5DA6AC16DF9DC27F0EAB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_D6723707C9FA5DA6AC16DF9DC27F0EAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CBC76B7780585672B29B4A805FBB68C9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs_CBC76B7780585672B29B4A805FBB68C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_FD5C2DA28B745442B7F8FCFCC8847830" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_FD5C2DA28B745442B7F8FCFCC8847830" xlink:type="arc" />
    <link:loc xlink:href="prgo-20200926.xsd#prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation" xlink:label="loc_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:to="loc_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation_4B041524E4535BB2A6615C1980535E67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0CEB8EB1BD54551EAEF83EF0DDAF749B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_B0267B12C443567D933C5A948A7C40D0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0CEB8EB1BD54551EAEF83EF0DDAF749B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_735D139CAC4E5237A79FE85045843189" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97F0D4319B8A5606A89510AA8655EB2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_735D139CAC4E5237A79FE85045843189" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_97F0D4319B8A5606A89510AA8655EB2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2CE2487C52AF5A259CEDD954E5FE686E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_735D139CAC4E5237A79FE85045843189" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_2CE2487C52AF5A259CEDD954E5FE686E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9FA20E1615FE58B5A4CC62C1DB4E8B49" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_735D139CAC4E5237A79FE85045843189" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9FA20E1615FE58B5A4CC62C1DB4E8B49" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8477296395E95D6B81157B1A0F8580A0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_D4C54930424A5B0A9A65D804785CF913" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8477296395E95D6B81157B1A0F8580A0" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_D4C54930424A5B0A9A65D804785CF913" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_E8728FD865A754669F2E7DC24416359F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8477296395E95D6B81157B1A0F8580A0" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_E8728FD865A754669F2E7DC24416359F" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>chart-9c392cf67c4954c4ab1.jpg
<TEXT>
begin 644 chart-9c392cf67c4954c4ab1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $1 5H# 2(  A$! Q$!_\0
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M1+/1_#E_?WC@'Z6:;_P5 ^"'C;X\_LB_#[X0:OX)^*?P2_:M^"'[5WQIT_\
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M\)5X^O=3\9W&L0BVL]#D_;;Q#^RO>>(O^">^O?L3G7])T"]U_P#8WU+]EO\
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M/:?"VUUOX?Z9I4G@JU_X0#7?^$L^._P3\,VTQU#QBDC>/[*]^SDVYM)?H#X
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M #)O!-QXOM_'GP]^(FC^(M+\(:K)_P )'HNAWVDMI0\1P6.K7]K?3Z9IOV4
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MW3B6\JUU>\^(VNWJ R.4\R_M/$'AZ!RL1C1]NFQAY$>4;%D6&+/C_P"#C_\
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MIK_(NK2J4*M2C6ISI5J-2=*K2J1<*E.I3DX5*=2$DI0G"2<91DDXR332:/\
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M5JE2M5G*I5JSE4J3G)RG.<Y.4I2E)N4I2DVVVVVVVVV%%%%40%%%% !1110
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MMO\ B"G'/L;\WU7*.:UOX7^L63^VO?I[#VE[:VO;4_DPHHHK_6D_R "BBB@
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M/O$3Q,Q7O5LL\+>!</AZ$HW=+^U:N/P/M(R2O^]A7S;,E-M+3*M7:$6O])/
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M=\*_!W@J:TO/%5_X2TW3;34;W0?#&DZWKVM:I>_85%% !1110 4444 %%%%
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M22  ,D@4 .K\Z_\ @I]\4?'GPG_9N\,ZY\/O%GQ*\&:GXB_:?_9"^&^N:O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>chart-85469c30e3cc5f78a30.jpg
<TEXT>
begin 644 chart-85469c30e3cc5f78a30.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $1 5H# 2(  A$! Q$!_\0
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M_@J7^W%^T'_P3Y^ GBC]IKX<?LS?#K]H#X1?"[PK>>)_B]-XE_:*U'X,^,M
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MKX8ZUH^H7'A^TU[2_!_@3XT?#32O%D$7CGP7>77Q+^$FMZOHQ\&6<S:)#K2
M'Z*S_P#!5CX >-?%7[%UG^S;K?A']HKP'^UI^T]X^_9AU7Q]X2\87&F)\)?%
MWP^^"7C7XR:Q#KWAV_\ #,FK7'B**U\+Z9IUSX1UD>%;^UT_Q-IOB(7,]H]I
M;WV%^TO_ ,%7/A]^RO\ \%%/V3OV%/B7X U"V\/_ +5?@*_UO2_CM#KSG0_
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M*UZVG?"[5=4\4Z1;:AX2\,Z9\2[Q&@^'M_XIUW1;3QJX)\-2ZFGS5^)/CO\
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MP6^,MQX$^*.AZ7K^B2OX?N+B_>WM;G[67_!:WXG?"[X4?&B'X8_L6_&/PO\
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M\1? EM\0O!VD6'AWX@0^(]/2=+@ ]8_8_P#V]!^V-\3?VC?!_@W]G?XP>"O
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M>^(_ OA_6)K;P/=_$#[3:Z%9:7<_$:X/@W2]'N==U"YLM4U:#1]-N?A_2_\
M@C+X3^$'PW^(MA^SM^TW^U/H7QGU+X'_  Q_9?\ @+\8/'?Q?MKOQ%^RM^S=
M\./BKX?^(^F?!GX-ZEX0\ :'J2>!8GT>+3]6@\7GQ/XY\:^'=*T?P1JWQ&TC
M28H=7TWZ_P#^"@W[ /@+_@HO\'_#/P2^)_Q<^.?PK\'>'?B;X6^*L[? WQ%X
M+\/W_BG7O [W=[X1TOQC%XY\!?$+1/$7A;0]?GLO%D'AR_T633;GQ/H>@:E?
MQ7:Z3;P4 ?S[3_\ !5+_ (*0>-?@1X5U+0/&WP_^%OQ!^"__  3/_;!_X*>^
M-?%_B_\ 9R^R)^U9\-?@E^T-K?PX_9E\.W?PS\5^+=/N_@;X=_:%^#WA>\^*
M/CF[\-ZK=^+?#UWXF\*MX>&@Z9<KIUU]N_M3_MF_MN^%O'W[('Q7^$GQI^">
ME^'?VL_%O['^A_LP_L&6?PFO_'/Q?_:"\+_$Y?"GB3]K+QE\7/'FIS:3X@^$
M^A_ ?X>^)=6\6Z-XX\#P2>!O#.F^&;'_ (6=)-J_BFRT>+Z6^)?_  1D^$'Q
ME\(^#-"^*G[4O[;'CGQ?HGPP^+?P!^(GQDU;XK?#VV^+?[07[-?QL\7:3XS\
M>?LY_&OQ#I'P@T_2-6^%UWJ>B:?::4_@SP_X(\<:%I*75CIGC&$:EJ$EQJ^.
M_P#@D'X!\5?M@2?MG>$/VN_VU_@CX_7P/\-OA1IW@KX.?$#X1Z'\,M#^#?PR
M?1+K2_@]H&D^)O@CXN\3:+\.=?UC1F\0^+]#TSQ9:S:_KNJZE?SWL;?V<FG@
M'P9\*O\ @I!^W!XT_:A\ :M9>*OA;XD^"/[7'[4/_!3/]D'X#?!>7X4P6>K?
M"?7_ -B'PO\ $G4?@M\2]4\6CQSX<\4>/-2^+NN?!KQ+;?%+PIXEUCP9X<T:
MU\6Z#'X=UKP?'I%UJ]]^U/[#C_M@-^S[X=3]N2T\"67Q^M]5UVUUN'X=W,&I
M: ^B6UX(M!O'URUOY;37=0U*V634;B^M-!\&16L-S;:*_A>*XTJ?6]<\*^%G
M_!*?]G'X2?M72?M8>'_%'QIU35]+\?\ Q\^+GPX^#?B3QWIVI? OX.?%_P#:
MDA@M?V@?B=\-/"T'ABQ\3Z?XE^)ELNIPWUGXA\:^)/#'AU?%'BS_ (0S0/#O
M]OW>/TRH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "OYA?^#E?598?!/[).A+YODZAXO\
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ML6X?0]X,5V^#L=4I1U:GFG&3JMN.R3SFA-2:2]U*E%:>[%:?L[X!_P""9O[
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M:+S-MQ3G-K\*_P#@LW;7-G_P4@_:2L;G4+K4K;^U? .I6D%Y)+-;V":K\*?
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ME6/]H6R.$\[P3\,X(_%>KHR*,^6WBFX\#V^,A&0R(0P!0?C-_P $!]0NK/\
MX*#:3;0.JQ:M\&/BO8WH:-7:2WA7POJ:*C-S$PO-/MG,B88HKQ'Y)&%?P[P'
ME&)S#P#\:>/,S@I9GQ[5X@S2I4E>U7"Y9*M5C.,]'[N:XC-U&*7+^[IIZ72_
MO+CO.,-@/I!>"/ &63MEG 5+(,MA2BHWI8O,Z="CRR@O=C?*\/E4I/XO?FTM
MG+*_X+T6T$'_  41\:2PPQQ27OPM^$5U=NBX:YN%T+4+)9Y3_'(+6SM;<-_S
MRMXD_AS7XS5^Z'_!PE;S0_MXZ-+)!)%'=?L^?#>2"5XF1+A8O$WQ&@DDB<J%
MF6.5#"[(6".GEL0RX'X7U_4O@Q4]KX4^'\^W"V4T_BYOX&%A0W_[A_#]GX=;
M7/Y-\;J7L?%OQ"AWXHS.I\/+K6J^V>GK4U?VOBTO8****_33\M"BBB@ K^NG
M_@W*_9X?0/AK\9OVFM:TY([WX@Z[9_"WP+=S1NER/"O@ESJGC"\M'/[N33]:
M\7ZAIVF.1\QO/!4JD[4 K^6#X._"GQG\<_BEX"^$'P\TXZIXT^(OB?2_"OAZ
MU/$"7NI3;9-0OY.EOI6C627>LZQ=OB.TTK3[VYD(6(U_I*_LZ_ _PC^S;\$/
MAG\#O T.SPW\./"NG>'[:Y:-8KC5[Z-6N=<\17Z*S+_:?B77+G4M?U-E.#?:
MC/MP@51_)?TMN.J.2\%X7@S"UTLTXKQ-*KBZ<)>_1R/+:\,34J3L^:G]<S"G
MA</1NN2O2HX^%W[.<3^P/H@<!ULZXTQG&V*H/^S.%,-5H8.I./[NOG>9494(
M0@I+EJ?5,!4Q5>JTW+#UJN!G9.I!KVFBBBO\VS_3 **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSX_X*%?\
M$]OAA^WM\+HO#^ORQ^$?BEX22]O?AA\3[.PANK_0+ZYA<3Z#KL.U;C6? ^MS
M"!]:T6*XM[B*YM[75])N+;4[13<?H/17KY#GV;\,YO@<]R+'5LNS7+JRKX3%
MT&E.G-)QE&49*5.K1JTY2I5Z%6,Z->C.=*K"=.<HOR,^R'*.)\HQV19[@:.8
MY5F5%T,7A*Z?)4@VI1E&47&=*K3G&-6C6I2A5HU80JTIPJ0C)?YD7[0'[//Q
M;_9A^)FO?";XS^$;_P )^+M"GF"":.:31O$.EK*T=IXE\):PT,5KXB\,ZDH$
MMEJMED(6:RU"&PU2"[L+?Q2O]+;]I[]DKX$_M?\ P^G^'/QR\%6GB334^T3Z
M!KMLRZ=XP\&:K/%Y0UOP=XDBB>]T744(C:6("XTK4UB2UUK3-3L2]J_\?/[:
MG_!$']IS]G&]UKQ;\'--U']HGX/PS75W:WOA/3S/\4/#.EJ7ECA\6>!+*/[5
MK36L *SZ[X&@U.SF6&2\O-%T".1+=?\ 2CPH^DKPKQO0PV5<3UL+PMQ3RPI2
MABJT:.39K5LH^TR[&UY*&'JUIZK+L9.-52G"EAJ^-?,X_P"9/BY]&+BO@>OB
M<VX5HXOBKA7FG53PM%ULZRJE?F]GF&"HQ<\31I0=GF&$A*FXPE4Q-#!IQ4OQ
M/K^C/_@W.^"(\3_'_P",?QXU&S$NG_"CX?6/@S0KB51MB\5_$W4'FO+FV<@G
MS['PGX6U"UF"8*0>(5#'$NUOYU[NQO+"]NM.OK6YL=0L;B2TOK&]MYK2]L;J
M)S'+;7UG<QQ75G<1."DD%S#%,C JR @BO[EO^"(GPITWX$?\$\M$^(WB00Z1
M/\6M9\:?&WQ%?W:-&]GX4M5_L'PY+<.R@_85\'>$H==@(R@CU>616(DS7K?2
M9XE>1>%&:87#3OC.*<7@>'<(J;YI3IXR;Q>-Y8QNYTZN78/%8:32:OB::WE%
M2\GZ+O"[SSQ:RS&8JFXX/A3!XWB'&.K%PC3JX:$<+@7.4THTY4L?B\-B$I-2
M<</.RLI./X5_\' 'QL'Q'_;8M/AI870ET?X"_#G0O"\T,<GFPKXO\:[?'/B6
M92/E69-*OO!^FW" L8Y=-DC?:ZNJ^8_\$++B6#_@H_\ "6..=X4O/!?QBMKA
M%D*+=0CX?:E=K;RJ"!-&+BU@N1$V1YMM%+C=$I'YO?M ?%?4?CK\</BY\9=4
M:0W?Q/\ B)XM\;".4DFUL=>UFZN]'T],LQ6+3=%;3M.@CW$1PVD<:_*HK[M_
MX(M7=K:?\%*OV;GNIX[=9KCXG6<+2D@275W\'_'L5M;I@'][/(?+C' 9CC(K
MU,TX6CPM]'K.N%U%1JY5X89S0Q*C%24LQ60XO$YA4C%=:V83Q%5:MISO=M:^
M7E7%DN*?I&Y+Q2Y2G2S7Q/R6>%YI.+IY<\^PF$P%-MJ]J& A0IM-)24&K13L
MOKG_ (.,[&ZA_;)^%-](@%K??LW>'HK:0.C%Y-/^)/Q'6[4Q@ET$9O+?#, )
M/,.PML?'\_=?T8_\'(6G/'^TG^S[JYEC,5_\"=6TZ.$*WF1OI'Q$U.YEE=S\
MACF76H5B5?F5H)2_#1Y_G.KT? 2K[;P?X#G=/ER>=+1-*]#'8R@TT[NZ=.TG
MLY)M))I'E_2#H^P\9./(M-.IFU.OJTW_ +1@<)635MHM37*GJHV3N[L****_
M7C\:"C\@ "220  !DEB2 J@ DL2  "20!FCL22 %!9F8A551RS.S$*BJ.69B
M%49)( S7]*/_  2*_P""/VL_$'4_ W[5G[47A^UM/A?;E?$OPS^#_B+3I9-3
M^(=P@BE\/>,O&FF72I#8^ HY6_M;0O#]]%+>>,I;>PU#4K6V\*O%#XA^+X\X
M]X>\.N'\3Q!Q#BXT:-.,Z>"P<)1>-S7&^SE.C@,#2;O4K57'WINU'#T^:OB*
ME.C"<U]SX?>'O$?B3Q#AN'^'<)*K.<H3Q^.G%K!95@74A"MCL;52M"E24KQI
MQO6KU.6C0A4JSC%_5W_!!K_@G]9_#[P</VS/B=I\4GQ"\<V%]HWPBT6Y"M/X
M&\"7B"+5O$]Y 9"UGXI\>QE(+2">WAO=%\%Q(4E/_"7W\$'])->6>(/ U]8:
ME-XO^'L]MH_B5DC.J:1/NB\-^,(;= D=MK%O  MEJ21*(['7K6,7-O\ +%=)
M<V@V(R'XJP+"HU/P3\1=.U!%*WMC'X,UG58[:X3(EBAU'38)[&_AW F"ZM9&
MBN(FCD4(6*+_ )&\?<;YOXA\4YEQ1G,K5\;44,+A(3E/#Y;E]%RC@\NPW,H_
MN</3;YI\D)8C$3KXJI'VU>HW_L'X?\#9/X=<*Y9PMDL+X? T^?$XN4(PKYEF
M%51>+S#$V<KUL147NQ<YJA0A1PU.7L:%.*]59E499@HZ98@#/IDTBNCYVLK8
MZ[6!Q]<$U^7O_!3[XD?$/PA\.OV6K;X<ZQ\;-&/Q1_;%^#/P[\6Z1\!]3\/^
M&/B_XK\$>)/"/Q/U?5?"'AO5/%][H^DZ->7U[H>CW6HR7>N:!-%9Z9=01ZK;
MRMY4Q\+OBWJ7P#_X4CHFM>!_VP[BY_::_:CL/V?X;;]L#XI>"?$7BKP9%:?
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MT>XTNWL)_%GQ#\(^)/#G[0GB3PQ+J]WXU\*^"OC'\/8O$&BZ9I,6E7E[]\T
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MGB.$N(J4)X3&X:O"?M<GQD%R5*=2<'=R23NU=ZG^5_ V5YOE'B%P5/,,LS#
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M5MX?MM>M?$^N?"[X5^#O!4UI>>*K_P ):;IMIJ-[H/AC2=;U[6M4O?L*BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD)"C)( ]20!^9H
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M\<^'-2;2[W4M)NKKP]XV\)^(=%?4='U'4-&U06*ZEI%]>:;=VUQ)[%7*>!O
MO@WX9>$?#W@'X?>&-$\&^"_"FEVVC>'/#'AS3K;2M%T;3+12(;.PL;5(X88P
MS/+(0IDGGEFN)WEN)I97ZN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>chart-714199db9f68549eabb.jpg
<TEXT>
begin 644 chart-714199db9f68549eabb.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $1 5H# 2(  A$! Q$!_\0
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M1_AE\0-;O]6F^'$VA^'?%7QM\0Q>(OB9I]Q=>+/'?@OP]X?\*OX?\-F:^U
M'UM\,_\ @MW_ ,$[?&/[,WP"_:>\=_'_ ,&_!#PM^T-I&LZGX0\,?$S49;;Q
M?IL_A:2QA\:V&OZ?HMCJD=K#X!N=5TK3O&OBFWDN/ FB:I?06@\5W<<MO<S_
M $9^SW^VEIWQ_P#VKOVUOV;-'\(6-IHW[)$7[+EWI/Q-TSQA!XBT[XJZ=^TM
M\(+KXLV6I6&DVVCVMOH5EX?M88=/M+B#7?$,/B.WN8]5BDTZ/;:O^*&O_P#!
M'C_@HSK_ .Q]\#/V0[O]I3]GV#X?_#W]A_XP_L4^*?#'A[6OVC? GAB\N=:%
MCHWPL_:#NKOP!-X:\9?%?7+;P1:3^'?%G[/WQ.U]?@+8:Q>OXJ@T3QFT T67
M])O^";__  3]^*/[&_Q4_:0^(7Q#\;> O%-I\;/@Y_P3T^'NCZ?X.'B1[S1M
M;_9#_9:T_P"!7CR]U:YUW2],AN=-\3^);236/"4EG&+O^PV3^V[6PU M;* ?
M&;_\'#7P^7X7_P#!2O79?@)>V'QA_P"">7[0/_"L(OA'JWQ&;3H/CK\*+K]J
M'1?V6[+XX^#?%\_@0?8M.T[QK=:Y;>,O#MCH'B>#PCK>GZ%H%]XEEF\4VES9
M_KUJO[?7[&VB?M!:A^RKJG[1GPMM/VAM+TZ\U*_^$[>(HY/%5M]A\,S^-KK2
M)(889+(^*HO!-M/XS/@I+Y_&+^$XG\11:#)I(%V?PH_:;_X-]OB'\>_V=/'W
MA71OC9X+\$?M"7G[?/[4?[1?@[QM8'Q@G@SQ'^S3^U!^T/HOQF\6_L[?%6WM
MM)&K:G;BZ\,^#O&L"6FFZGI6D_$OP1I,VCW<%CJNK:Q7O>@?\$;/B5H7[?GB
M3XXW?C;X8>-/V<?$?[=<W_!0JVM?&/CC]K#_ (6GX-^+DO@^RTN+PCX8^#WA
M7XM>&?V5+J32O$U@EUX?^.'B;PEK7Q!T[P%>7WPTU3P_K^A?9&M0#]#OV*?^
M"EW[/7[>/[+WC;]J[X')XOU/P/X"\3?%WPWK_A:;0Y9_B#;7'PJU+6S!$- L
MC-:W>J^.O"6G:/XW\*:-I>IZE<-I/BW0-,U2>Q\1?VII6G?*?_!/;_@KIXM_
M;FU7PAXC/[/7PS\/_ /XA?#?Q#\1K#XN_"']K[X=?'[4?@>=%T^TURT\$?MD
M?#VU\'_#[5?V>/&^MZ'/="VLK74_B!I>G>)M)U?PUJVHVJV:ZO)[Y_P3K_8V
M^.W[('[(/CK]D[QK\3O!'_$G^)W[2FH_ GXL_"NQUFY\5:5X'^./Q)\<_%K0
MO$OC/P_\1-+N_"]O\3/"'B_XC:V%T;2K77? US8Z)H;7<FJ3WFKB7\[OA3_P
M2#_:Z3]IKP)^TQ\2O'/["OPD^,OPA^"O[0WP^3]HS]DW]GO7O!_Q3_:U^(7Q
MD^$^I?"WPY\3_P!K/X>:K'HGPGNK7P?J]Y9_&;4? FC0^+M*U[XDZ?;6>GWW
MA[PM"FGD ^POCG_P6O\ V/O#'[*_[0?[1W[,/Q'^&W[6FK?L\:C\$[;Q7\.?
M!WCV;PS=3:3\:OC=X,^#6B^)X-;OO#&IO<^%Q<>)]0U?2/$^B:-KGAOQ%+H4
MFE66L1&\2]A^W(_VZ/V0Y/VE'_8^7]H;X6G]I>-&#_!X>)K<^+!?)H1\5G0-
M@3^S#XN'A(?\):_@L:D?%J>%<^(WT0:,#>U_.KXC_P""$?[<OQ2\(?&EOBO^
MT%\#-7^)OQ<_8[_96_9JU/Q1=^-OVEOB-'JOC+]G+]L?X;_M%ZW\2]8O/B:F
MK2Z#IGQ'\/>&?$T-A\-_AGH_@GX<_##6[[1?#7A7PA<:*FL^*K_Z_P#"O_!&
MWXE^&?V^?$WQOO/&WPP\:?LY^(/VYM?_ ."@^G1>+O''[6!^*G@WXO:WX,.D
MQ>$?#?P;\,?%OPU^RC/_ &+XFWSZ-\;/$7A/6?B"OP\NKWX7ZOH&LZ'+;S6@
M!^KWP'_;X_8Z_:<\>^(_AA\!/VAOAO\ %#QWX8T2\\4WOASPQJ\\UYJ/A+3_
M ! WA6_\9>%I;RRL[+QOX+LO$H30KOQCX+NO$'AFVU6>TLIM52>\M$F^7(_^
M"NW[,_A']MC]IS]C+X^^,?AW\ ]?^"GC_P#9P^'GPR\1>-_B+;Q3_&[6/V@?
MA!H?Q,CDMM!ET*R@\$6?AS6-?T[P-%J6LZ[>:+KNLW=E$FJZ?J=Y!HS>$?\
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MKT5GX>M-3F_>+]J?]F3X;_M??!/Q5\"?BE<^,M+\->);KPWK%GXE^'/B[5/
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M=/\ B[\!/V@O@I\.?#EKX?\ #GA'X%?L[7GP8O?C1\=?VUOVQ/%GC=[3P_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]>O/;^%L\^@QDX_BQ]WG=C!I=P R>!G'((YSMP,CG)X7'WLC;G(H 6BDR"2
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MZ:KKL6IPPWFBZ*=,NA?:M;6=A)#,MR4/UK00#P?\_P"!'8]0: /R>\"?#O\
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MKNR?]WJC QZ$@?0$X_3%+2 8  Z  ?E2U_BD?[@+1+T04444#"BBB@ HHHH
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M^$VAR77CKX=Z+%I_QKTC3XYIKKQ/\-=*C(TWQI;VD0?SM7^'2/,FMND1FO/
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M.Y :)9&$J^>5]+_"KX:/9-;^*/$-N\=ZI,FDZ9,NUK0$$+?7<9Y%TRDFV@<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC#^R;\*!\/O%_P )_@SJ_P"T-XJ^$MOXA^..A7\_B"]^+'QXT"T_9\^)%O\
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>chart-808658f7fe4a50dc91f.jpg
<TEXT>
begin 644 chart-808658f7fe4a50dc91f.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #T =(# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^*/V[?VP;C]BKX5>"_BA;?"/Q3\:
MSXF^-GPL^%=WX)\#7HB\:?V-X[U:\B\2>)/">D'3=1;QAX@\)^&]+U;Q!I?@
M6%M-O/&=U8Q^'M/U:QU"^M7;AM=_X*!>$&^*&F^"_ 5M\/?$_@?Q/\%?V/?C
M?X&^,&M?%&3PWX(\:>'_ -KK]I^3]GKPGINAW.G^"_%#S:K?61T[Q#\.DR;;
MXA^*_$/ASP'>7/@VVU"?Q?8^N_M8_L_^)?C]!^SS#X;UK0=&/P?_ &KO@7\?
M-=.O+J+#5/#?PLUG5-2U?1M(_LZWN"NO:A'?1)I;WOD:>LL;F[N85VL?SL/_
M  2=\:>$OCI\7/%'PR^)/@W3O@5XK\6_L-^+_A+\+M7TW5K2[^"]O\!_^"A>
ME?MO?'OX>:!=:7IT]M=_#WQ9J<7BK4_@YI,EPD?@3Q!XXU#P.MGI'P[T#0'M
MP#]%/AS^W1^R1\6?%;>"OA]\>_A]XD\0_P!B>-O$-O;6VIW-I9:CI7PTU@:#
M\29M(UO5;+3]!UJX^'6KLECX_P!.TC5+[4O!4SH?$UII<3K(>R^#'[4WP"_:
M&F\16OP:^)OA_P <WOA>RTG5M5L-/75+"^'A_P 1?;QX9\6Z?9:YINE7>M>"
M/%3:5JB>%O'6AP:EX/\ $KZ9J*Z'KFH-8W0B_,.3_@E5X]\1? S]FKX'>)_B
M;X0TC3OAEX(_X*'^ _B/XA\+66O3:A/9_MJ^$_BEX5T+7O =I?6FGPOK7A&/
MXAIJ.MG6[C2Q>75K=K974_VD2O[_ /L7_L9?$GX*_$O4_B?\6=/^%\7B&P^"
M'ASX)>']5\*_&;]K/X[^)=8L[;7XO$7BC56UO]I3QWJFG_"_P/J>H:/X?N?#
MOP=\(^'?$4WAV_34[V_^*WB**>WL(P#5^"O_  4<\*?$7XD?MZ>!O'W@.X^%
MFE?L1^*?$07Q5<>)X/$4/Q7^%WA'2M3_ .$L^(NC:4FCZ1<Z)/X9\6>'M>\*
MZSX8,^LR6TA\.7ZZHZ>([6WAP?V?_P#@JC\#_''[,_P6^.7[2EQX;_91\;_%
MFT^*U]J?P;\2^,)_'6K_  \T_P"#_P 6?%/PG\:ZWXL\0:#X8L8M(\'^&-8\
M/6R>+O'_ (ATCP[X&\+:GJD>DZEX@#11W5SY!J?_  3(^)^H_%"?QNOQ)\ V
MVA>,_P!L_P"./Q(^+GA]]+U^[;QO^R%\9M;^"OQ0U+X0+)]FM1;>/+CXM?LY
M?#6#4;RXDF\-)\/?$?Q-TRTN'OO$"QRY7@7_ ()^?M7?!'2O&UU\,/%O[.'B
M_P 4?&?X5_'CX-_$9/B7;_$33]#\'Z;XY_:V_:F_:+^&OC[P@_AW0-4O_&DN
MG:+^U-XCT'XG?"K6X?!.F^+M7\,^&[C1?B3H=G:73WH!^ANH?MP_LG:9\6(_
M@?>_'3P)#\4#XQ\+?#VX\+B]O9I--\<>._#7A_Q=X!\)ZUJUOI\WA_0M>^(7
MA_Q5X>OOA[IVLZO87'CQM6L[+PBNLZA(UHOQ/X%_X+0_LO\ C35OA3>W1U7P
M5\-OB;H/[9%VGC'QE8>*K+7K#Q'^R-\8_A;\,+[0-,\!:;X.U+6_%-OXRT#X
MBWGQ,?6-&DDB\$>&/#=Y:^*;:#4X=>A\.KX)_P"":OC7X;_"?QW\)O#7Q!\,
MZKIU_P#M<?\ !-GXU^$=:\0+K::O>?#7]A7P?^P+X0US3/&K66GR1R^.O&47
M[(?B?4=$&G_;- LKKQ/X=2\O;9;?46MM[]FC]A'XQ?![XL_#CQ=XM\5?#?4?
M#?PA\/\ _!2/P9X7O- O_%MUXJ\1Z-^VA^U-\)_VC? 6OZM::IX<TVP\+:UX
M4MO"GBGPGXUTG3-:\0V=U<0^'=:T36;J'4]1TO0P#Z^/[;G[*#>._ WPXM_C
MO\/=0\4?$FQ\!W_@N/2M6FU?0];C^*FFMK'PNMD\7Z7:7G@VQU3XF:4(]2^'
M>BZIX@L=8\<6-U8W7A>PU2'4+![GSK]JG]K'QK\$?C%^SY\%/ 'A#X/:OKGQ
MT\+_ !S\7-XK^./QLU/X+>"/#.G_  3_ .%4)/IL>HZ1\,OB9?:YKOB>;XJ6
MQT^R2QTZ*SM="U&YEGN ZQQ_"WPF_P"":W[3'P@_X9<T[P7X^^$_@;5/A1\*
M?V(/A[\2OC'\,_'7QV\'>(_%NG?LR^%O"_A3XE^"_'?P(:+5?@)^TSH/Q T#
MP[J?A7X8_$#XF:9\/_B+\%_#7BF"+39=8N? WAQKCZY_;+_94^(7QK^.G[,?
MQD\'_#K]FSXR:1\$O"'[1?A3Q'\,/VEKW6].\.ZG<?&<?!E]!\3:!>Z9\*/B
M_;1ZKX9/PPU2TN4O?#EI//9>(62SU2$&\@G .\O?VW?A?\'_  GX0N_VJ_B/
M\"_ASXW\<Z9X]\3^%/#_ ,)_B!XR^-&B^*O!GP[U3P_I?BOQ#X4U&'X8>%/$
MOB&+PE+XGT9_' L/!SVGA.&\6\OKU]-@O;ZUXK]K[_@IC^SE^RO\'-<^(UKX
MX\$?$OQ7)\(-+^-'P[\!:'XN9(/B!X-\47<%AX#UI/&6B:)XIT+PQX>^(U]+
M-IWP]\1:]]GT_P <ZK:7>E^$3K=]:W<%N_P+^RY\24^-/P+^+VL^#OV?_@OI
MGPF_9T_:T^"#?"WX(:IX@U?PMIVI?'GXD_LW^.?"_B'PE?77PR^%T%G:JGP@
M\5S>-;3_ (1C3;@:QK6DS:?-K*S:G<VOPA<?\$NOVI?"G[,FO_LZ?#OQQ^SK
MJL?QF_88_9&_99^+WB3XAP_$6>/P1XV_9;^'<OPXF\4_#/1],\/7D?C+P9X[
MT*XW:5H'BBZ\$7GPY\56]WXYC/C%O$%]X6M0#]>;3]K+]G:^^,DGP!MOBQX5
ME^+":K?>'5\++/?;;CQ7IFB-XGU+P19^(#8CPI??$#3?"Z2>)M2^']GKUQXU
MT[P[#<:W>Z#!IEM<747BOPY_X*#_  .^-'[4WA;]FSX+^(_#?Q/AUCX+_'#X
MMZYX\\-Z[>/8:*/@_P#$CX+?#FSL=*LKG0(;#QIX:\9ZA\5-<;3/B#X7\07_
M (7CO_ &K:19W&JW%S-)IOR?H?\ P30\>:=\=;Z_U74_!'B+X.S_ +6/Q>_:
MJLO%VL?&G]K6;Q_H>H?%?6_'OQ 7PSX4_9ZM/B!I_P"S7X5\=^#/'WQ"U*Q\
M-_'6V?4#_P (+IT%K>_"2Y\8:IJ7B@^G?LG_ +'_ .TC\(_B?^S)J/Q5U_X!
M7_PZ_9'_ &./B)^Q]X$O/AO9^.8/'GQ$TW6O$G[.#^$_B%XHM/$.EVFA>!8_
M^$1_9_M+;7OAMH&J^+-/L?%&J2ZOIGB_4M-DM=+T< _56BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1G]^H*CC(_$Y_4G-&1ZC\Q7\!7_#ZS_@I9_T<=_YBGX-?_,#1_P^L_X*6?\
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M_P!2#U_K;_4=_P"$]\$?]#AX6_\ "BT7_P"3J/\ A/?!'_0X>%O_  HM%_\
MDZO\N+9'_P \H?\ OS%_\11LC_YY0_\ ?F+_ .(H_P")*\)_T<7$=/\ FE:?
ME?\ YJ'U^_[C_B=[$?\ 1N:7_B42\O\ J0>O];?ZCO\ PGO@C_H</"W_ (4>
MB_\ R=75HZR*KHRNCJK*RL&5E8!E964D,K @@@D$$$$@U_E:21Q&*<&&'_CW
MN/\ EC%_SPD_V*_U%/AC_P DX\ ]O^**\)\#@?\ (O:;V[5^%>-O@C1\(:'#
ME:EQ)4S]Y]4S2G*,\ICEGU7^S89<TTXYEC_;>V>.=TU2Y/9K6?/:/[WX&^.5
M3QCJ\1TZG#<,@604\KFI1S5YD\4\QECHM-/+\#['V7U---.IS^T>D.57[FFO
M]QO]UOY&G4U_N-_NM_(U^ 1W7JOS/Z#/\Y+_ (*1?\G[_M??]E_^(7_IR2OB
M:OMG_@I%_P G[_M??]E_^(7_ *<DKXFK_;'@K_DC>$O^R9R'_P!56$/\.N._
M^2VXN_[*7.__ %98D****^F/E HHHH **** "BBB@ HHHH _07_@E1_RD1_9
M+_[*F/\ U$O%-?Z(*?<7_=7^0K_.^_X)4?\ *1']DO\ [*F/_42\4U_H@I]Q
M?]U?Y"O\Y?ID_P#)><,?]DC3_P#5SFI_I7]"[_DW_$G_ &5M?_U4Y4.HHHK^
M03^Q0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#\"_^"ASV=K^TS<^&_C#^T[\!_#/P/\ &?@KX;>.M<^"WQ%_;!\0
M? 7QAXLT/X0:1\;KC0O@U9^!=$TRZ'A[P-\=?C_K?PQ\4>._VAH-0BO5\*_"
MC7?AIJGA[Q7IUII6FU^O/[*]AKFE_LS_ +/FG>)OB-I_Q@\0V/P4^%UKK?Q6
MTC5KW7]*^).JP>"=$BO_ !SIFO:D!J>NZ=XHN5DUBRUO4@-1U>VNXM2OP+RZ
MG _,[]I3Q5\:?A?^V/\ %WQ/^REK/C3Q/XEUSX'_  BOOV@? W@']C?0OV@/
M^$2M/"VH_$*+X:^)-7\;>)?VM_V=+V]\2Z_H=]XJBT;X1?#S3?&_B:31]'37
MY/#4-YXBTN[\0?K#\&?&=E\1OA%\+_'^G>+]*^(-AXU^'O@WQ7:>.M"\.ZAX
M/T;QE;^(/#VGZK%XHTKPEJVHZQJOA;3]<2[&I6OAO5-5U+4M"BN!I5_?75Y:
M33, >ET444 ?QH?\''W_ "=K\$_^S<K3_P!6AX\K^>:OZ&?^#C[_ ).U^"?_
M &;E:?\ JT/'E?SS5_KUX"?\F?X#_P"Q/+_U.Q9_CI](/_D\G'G_ &-X_P#J
M'A0HHHK]>/QH**** "BBB@ HHHH **** &R?ZJ?_ *][C_T1)7^HC\,?^2<>
M ?\ L2O"?_J/:;7^7=)_JI_^O>X_]$25_J(_#'_DG'@'_L2O"?\ ZCVFU_#O
MTT_]S\//^PCB?_TWD!_>/T(O]Y\1?^O'#/\ Z<SL[FFO]QO]UOY&G4U_N-_N
MM_(U_!4=UZK\S^_S_.2_X*1?\G[_ +7W_9?_ (A?^G)*^)J^V?\ @I%_R?O^
MU]_V7_XA?^G)*^)J_P!L>"O^2-X2_P"R9R'_ -56$/\ #KCO_DMN+O\ LI<[
M_P#5EB0HHHKZ8^4"BBB@ HHHH **** "BBB@#]!?^"5'_*1']DO_ +*F/_42
M\4U_H@I]Q?\ =7^0K_.^_P""5'_*1']DO_LJ8_\ 42\4U_H@I]Q?]U?Y"O\
M.7Z9/_)><,?]DC3_ /5SFI_I7]"[_DW_ !)_V5M?_P!5.5#J***_D$_L4***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI#
M^7([X[C^?3'?I0!_-[^T9^TQ\+O&WQ*;XA_#7]J#]F'X/>-_%OPYT#P1\<Y_
MA7_P57M/A"WBJX\+ZMXG73O"FJ66K_L2?%@7$_@VSUB_MM ^+W@IOA;\3%@U
MZ_T(W5K9>&_#]Q'^\7[/5AX2TOX#?!;3O .D^$="\#V/PH^'MKX/T7P#XMO/
M'O@;2?#%OX3TF+0M.\'^.=1TW1M1\9^&+33$MH=#\6:AI.F7_B/3D@UF]L+6
MZO984_G.U_\ :9T'5H],UWX:_P#!0JV\9Z+J%C,WB#4[7_@J%J^G^'-%\9PZ
MOJ]GKWA3PSJWAO\ X)E^/-+\2Z1H)M;6V36WU+1[]M0;4=*N?#MF=(6[U'^D
M#X':C+J_P7^$FK3:TOB2;4_AIX&U"7Q"OBF;QRNNR7GAG3;A]87QI<>%/ =Q
MXN74VD-X/$T_@CP?+KHF_M.3POH+W+:7:@'J5%%% '\:'_!Q]_R=K\$_^S<K
M3_U:'CROYYJ_H9_X./O^3M?@G_V;E:?^K0\>5_/-7^O7@)_R9_@/_L3R_P#4
M[%G^.GT@_P#D\G'G_8WC_P"H>%"BBBOUX_&@HHHH **** "BBB@ HHHH ;)_
MJI_^O>X_]$25_J(_#'_DG'@'_L2O"?\ ZCVFU_EW2?ZJ?_KWN/\ T1)7^HC\
M,?\ DG'@'_L2O"?_ *CVFU_#OTT_]S\//^PCB?\ ]-Y ?WC]"+_>?$7_ *\<
M,_\ IS.SN::_W&_W6_D:=37^XW^ZW\C7\%1W7JOS/[_/\Y+_ (*1?\G[_M??
M]E_^(7_IR2OB:OMG_@I%_P G[_M??]E_^(7_ *<DKXFK_;'@K_DC>$O^R9R'
M_P!56$/\.N._^2VXN_[*7.__ %98D****^F/E HHHH **** "BBB@ HHHH _
M07_@E1_RD1_9+_[*F/\ U$O%-?Z(*?<7_=7^0K_.^_X)4?\ *1']DO\ [*F/
M_42\4U_H@I]Q?]U?Y"O\Y?ID_P#)><,?]DC3_P#5SFI_I7]"[_DW_$G_ &5M
M?_U4Y4.HHHK^03^Q0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "D/3IGIQ^/\AU-+10!_.'XS^,GBWXQ>(]?U_X5_LA_M<?
M\$^=2O-2UB.7XP6?[+O[8^N_&GQ)/:ZC<P0>)-1^!_[-/A*U_9V\627-Q VJ
M:3-\</BA\3+*YL;NSGUCP+),9;!?WZ^$LVJW'PL^&T^N^(?%7BW6YO 7A"76
M/%/CKP;!\._&OB35)- T]K_7_%_@"VT;PY;>"/$^L79FU'7O"-OX?T*#PWJE
MQ=:/#H^F1V:V</H.U?[H_(4M %6]NTL+2YO)(KJ=+:%YFALK6>]NY509*6UI
M;))<7$S=$BAC>1SPJDUQ_P#PG^G_ /0O^.O_  AO$_\ \K:[JDP/0?D* /Y6
MO^"VG[(W[4'[5_[1?PM\;? /X#_$;Q]X7\/?!.V\*:OJMOIEAHB6>OIX\\7Z
MR^GFV\3:IHM[*RZ=J-C<&>"VEMB+A4$YE26./\:/^'47_!1/_HT[XF_]_?!O
M_P UE?Z'>U3U53^ _P *-B?W5_[Y'^%?TIP?]*#C7@OAG)^%LNR3A;$X')L,
M\+AZ^-PV;3Q56FZU2MS5I4,WP]%SO5G']W1IQLHZ7NS^9N,OHM<#<;\3YOQ5
MF>=<4X?'9SB5BL31P6*RN&%IS5*G2Y:,*V4UZJARTT[3K3E>_O6>G^>)_P .
MHO\ @HG_ -&G?$W_ +^^#?\ YK*/^'47_!1/_HT[XF_]_?!O_P UE?Z'>Q/[
MJ_\ ?(_PHV)_=7_OD?X5]+_Q./XA_P#1.\&=/^83._*__,]]?O\ N^8_XDP\
M-_\ HH.,_P#PLR;_ .<GK_3T_P \3_AU%_P43_Z-.^)O_?WP;_\ -91_PZB_
MX*)_]&G?$W_O[X-_^:RO]#O8G]U?^^1_A1L3^ZO_ 'R/\*/^)Q_$/_HG>#.G
M_,)G?E?_ )GOK]_W'_$F'AO_ -%!QG_X69-_\Y/7^GI_GB?\.HO^"B?_ $:=
M\3?^_O@W_P":RC_AU%_P43_Z-.^)O_?WP;_\UE?Z'>Q/[J_]\C_"C8G]U?\
MOD?X4?\ $X_B'_T3O!G3_F$SORO_ ,SWU^_[C_B3#PW_ .B@XS_\+,F_^<GK
M_3T_SQ/^'47_  43_P"C3OB;_P!_?!O_ ,UE'_#J+_@HG_T:=\3?^_O@W_YK
M*_T.]B?W5_[Y'^%&Q/[J_P#?(_PH_P")Q_$/_HG>#.G_ #"9WY7_ .9[Z_?]
MQ_Q)AX;_ /10<9_^%F3?_.3U_IZ?YXG_  ZB_P""B?\ T:=\3?\ O[X-_P#F
MLH_X=1?\%$_^C3OB;_W]\&__ #65_H=[$_NK_P!\C_"C8G]U?^^1_A1_Q./X
MA_\ 1.\&=/\ F$SORO\ \SWU^_[C_B3#PW_Z*#C/_P +,F_^<GK_ $]/\\)_
M^"4/_!10QR@?LF_$TEH9D4>=X-&6>)U49_X2SU(K^]KP)XNBT?P3X0TK4/#/
MCRWO],\+^'M/OK=O!'B-V@O++1K*UN82\-A+$YBFB="\4CQL5)1W7#'V/8G]
MU?\ OD?X4NU?0?D*_)O%+QHXC\6:62TL^RW)<!'(YX^IAGE%''4G5>81P4:R
MK_7,?C5)0^I4W3]FJ;7-/F<DTH_KOA3X*<->$53.ZG#^8YUCGGL,!#%+-ZV"
MK*DLO>*E2=#ZI@<&XN;Q=15/:.HFHPY5'WK\-_PG^G_]"_XZ_P#"&\3_ /RM
MI&\?:>58?\(_XZY!''@7Q.3T_P"P:/YUW6!Z#\A1@>@_(5^/['[&?PS_ +;G
M_!.3]N7XL_M>?M(_$OP#^S)\2]?\$^.?C#XR\3^%M;CC\-V2:KHFJ7RRV-\E
MGJ?B*RU"V6>,;A#>VEM<H,"6&-LJ/EO_ (=1?\%$_P#HT[XF_P#?WP;_ /-9
M7^AWL3^ZO_?(_P *-B?W5_[Y'^%?U5E7TM^/LIRS+<JH9!PA4H99@,'E]&=;
M"YRZLZ."P]+#4YU7#.X0=24*5YN$(1<FW&,59+^4,W^B#X?9QFN99MB<^XNA
MB,SQV+Q]>%'%Y1&E"KC*\\14C2C/)IR5.,JDE!2G*2BES2;NS_/$_P"'47_!
M1/\ Z-.^)O\ W]\&_P#S64?\.HO^"B?_ $:=\3?^_O@W_P":RO\ 0[V)_=7_
M +Y'^%&Q/[J_]\C_  KO_P")Q_$/_HG>#.G_ #"9WY7_ .9[Z_?]WG?\28>&
M_P#T4'&?_A9DW_SD]?Z>G^>)_P .HO\ @HG_ -&G?$W_ +^^#?\ YK*/^'47
M_!1/_HT[XF_]_?!O_P UE?Z'>Q/[J_\ ?(_PHV)_=7_OD?X4?\3C^(?_ $3O
M!G3_ )A,[\K_ /,]]?O^X_XDP\-_^B@XS_\ "S)O_G)Z_P!/3_/$_P"'47_!
M1/\ Z-.^)O\ W]\&_P#S64?\.HO^"B?_ $:=\3?^_O@W_P":RO\ 0[V)_=7_
M +Y'^%&Q/[J_]\C_  H_XG'\0_\ HG>#.G_,)G?E?_F>^OW_ ''_ !)AX;_]
M%!QG_P"%F3?_ #D]?Z>G^>)_PZB_X*)_]&G?$W_O[X-_^:RC_AU%_P %$_\
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MG]W_ *G/D_O\V?M%_P -9_ '_H?!_P"$YXK_ /E'1_PUG\ ?^A\'_A.>*_\
MY1U^+N3ZG\S1D^I_,T?\2^\&?]#+B;_PLRO_ .<_K_2U/^)B.-/^A9PUT_Y@
M\T_N_P#4Y\G]_FS]HO\ AK/X _\ 0^#_ ,)SQ7_\HZ/^&L_@#_T/@_\ "<\5
M_P#RCK\7<GU/YFC)]3^9H_XE]X,_Z&7$W_A9E?\ \Y_7^EJ?\3$<:?\ 0LX:
MZ?\ ,'FG]W_J<^3^_P V?M%_PUG\ ?\ H?!_X3GBO_Y1T?\ #6?P!_Z'P?\
MA.>*_P#Y1U^+N3ZG\S1D^I_,T?\ $OO!G_0RXF_\+,K_ /G/Z_TM3_B8CC3_
M *%G#73_ )@\T_N_]3GR?W^;/VB_X:S^ /\ T/@_\)SQ7_\ *.C_ (:S^ /_
M $/@_P#"<\5__*.OQ=R?4_F:,GU/YFC_ (E]X,_Z&7$W_A9E?_SG]?Z6I_Q,
M1QI_T+.&NG_,'FG]W_J<^3^_S9^XOAO]H+X8>,[BYL_!^J:SXHNK.%+F\M]%
M\)^*;J6UMY':*.>=3I$>R*256C1LG+@C'>NP_P"$_P!/_P"A?\=?^$-XG_\
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M<J_[#,W_ /5EB0HHHK\C/UX**** "BBB@ HHHH **** "BBB@ HHHH ****
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MX>,Z\O\ J8>3^_R/&?\ A@?6O^BF:5_X2E]_\OJ/^&!]:_Z*9I7_ (2E]_\
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M(XZHYCD20(V&,;HX&QE8R4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMQ:6MM;36TD,$2( ?SA7O@WX9ZA\,O$OQV^ 'A>V^ /[ 'BZW_8B_9MOKO\
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M&/$'C'1_%?BC2?%6M;?[2\0Z9XDU^PU>ZO+76-1BN<CPG\"/@CX#TCQ9X?\
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MZP1,/$WB"T\&>&/A]!J&I1%!%<3+X/\ !WAW0W>5'DGL]-@CG>4*H4 _FO\
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M6%YXDU3[3J>HW']H:S/>W?GW][-YOFW5P\GH5 !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>chart-a7f9749e3d245919a3a.jpg
<TEXT>
begin 644 chart-a7f9749e3d245919a3a.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #T =(# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^$1_9_M+;7OAMH&J^+-/L?%&J2ZOIGB_4M-DM=+T< _56BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/0@@BC_AJ3X!_P#12-(_\ M=_P#E37T7^IW%W_1+<1_^&/,__F4^;_USX/\
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MAK_P^Y7_ /-7FOO/?Z*\ _X:D^ ?_12-(_\  +7?_E31_P -2? /_HI&D?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Y7QU_R)7B__L5_$/\ Z9[VNJKE?'7_ ")7B_\
M[%?Q#_Z9[VNS+O\ D88'_L,PO_I^!Q9E_P B_'?]@F(_]-3/Y]HO]3!_UP@_
M]%)3Z9%_J8/^N$'_ **2GU_I;+=^K_,_S#CLO1?D%%%%(84444 %%%% !111
M0 4444 ?=O[!O_(\>._^Q2TK_P!/DM?J'7Y>?L&_\CQX[_[%+2O_ $^2U^H=
M?Q'XW_\ )PLS_P"P/*?_ %684_NKP,_Y-SE7_89F_P#ZLL2%%%%?D9^O!111
M0 4444 %%%% !1110!^!?_!0Y[.U_:9N?#?QA_:=^ _AGX'^,_!7PV\=:Y\%
MOB+^V#X@^ OC#Q9H?P@TCXW7&A?!JS\"Z)IET/#W@;XZ_'_6_ACXH\=_M#0:
MA%>KX5^%&N_#35/#WBO3K32M-K]>?V5[#7-+_9G_ &?-.\3?$;3_ (P>(;'X
M*?"ZUUOXK:1JU[K^E?$G58/!.B17_CG3->U(#4]=T[Q1<K)K%EK>I :CJ]M=
MQ:E?@7EU.!^9W[2GBKXT_"_]L?XN^)_V4M9\:>)_$NN? _X17W[0/@;P#^QO
MH7[0'_")6GA;4?B%%\-?$FK^-O$O[6_[.E[>^)=?T.^\51:-\(OAYIOC?Q-)
MH^CIK\GAJ&\\1:7=^(/UA^#/C.R^(WPB^%_C_3O%^E?$&P\:_#WP;XKM/'6A
M>'=0\'Z-XRM_$'A[3]5B\4:5X2U;4=8U7PMI^N)=C4K7PWJFJZEJ6A17 TJ_
MOKJ\M)IF /2Z*JWM[::;:7-_?W$5I96D+SW5S.XCA@AC&YY9'/"HH&23T%<?
M_P +.^'W_0X:#_X'P_XT =U17@7C#]JO]F;X>W]MI7C[]H'X->!M3O+,:A9Z
M;XR^)/A+POJ%W8&>6V%];66N:K8W-Q9FY@GMQ=11O 9X9H0_F1.J\E_PW1^Q
M9_T=M^S7_P"'N^''_P T5>QA^'L_Q=&GB,+D><8G#U8\U*OA\LQM:C5C=QYJ
M=6G0E"<>9-7C)JZ:W/'Q'$7#^$K5,-B\]R?"XBE+EJT,1F>"HUJ<K)\M2E4K
MQG"5FG:44[-/JCZJHKY5_P"&Z/V+/^CMOV:__#W?#C_YHJ/^&Z/V+/\ H[;]
MFO\ \/=\./\ YHJV_P!5N)_^B<S[_P -&8?_ #/YK[S#_6KA?_HI,@_\/&7?
M_-'FOO/JJBOE7_ANC]BS_H[;]FO_ ,/=\./_ )HJ/^&Z/V+/^CMOV:__  ]W
MPX_^:*C_ %6XG_Z)S/O_  T9A_\ ,_FOO#_6KA?_ **3(/\ P\9=_P#-'FOO
M/JJBOE7_ (;H_8L_Z.V_9K_\/=\./_FBH_X;H_8L_P"CMOV:_P#P]WPX_P#F
MBH_U6XG_ .B<S[_PT9A_\S^:^\/]:N%_^BDR#_P\9=_\T>:^\^JJ*^5?^&Z/
MV+/^CMOV:_\ P]WPX_\ FBH_X;H_8L_Z.V_9K_\ #W?#C_YHJ/\ 5;B?_HG,
M^_\ #1F'_P S^:^\/]:N%_\ HI,@_P##QEW_ ,T>:^\^JJ*^5?\ ANC]BS_H
M[;]FO_P]WPX_^:*C_ANC]BS_ *.V_9K_ /#W?#C_ .:*C_5;B?\ Z)S/O_#1
MF'_S/YK[P_UJX7_Z*3(/_#QEW_S1YK[SZJHKY5_X;I_8LY/_  UM^S7@ D_\
M7N^''  R2?\ BHN@')/85[7#\5/AQ<PQ7%OXU\.3P3Q1S03P:G;S0S0S(LD4
ML,L;,DL4L;K)'(C%'1E=258$\&-RK-,M5-YCEN/R]5G-47C<'B,*JK@HN:IN
MO3I\[@IP<^6_*IQO;F5^_ YME69NHLMS/+\P=%0=98'&8;%NDJG-[-U%0J5/
M9J?)+DYK<W++EORNW?T5PO\ PL[X??\ 0X:#_P"!\/\ C1_PL[X?#KXPT'_P
M/A_QK@/0.ZHKYGUC]L_]D3P[JNH:%X@_:@_9^T+6])NYK#5=&UKXO^ ]*U;3
M+ZW;;/9:CIM]KD%Y97<#?+-;7,,4T3<.BFLW_ANC]BS_ *.V_9K_ /#W?#C_
M .:*O;APSQ)5A"I3X?SNI3J1C.G4AE6/G"<)I2A.$HX=QE&49*491;4DTTVF
MCPZG$_#=*I.E5XAR.G5ISE3J4ZF;8"%2G.#Y9PG"6(4HSC+W91DDXO1I,^JJ
M*^5?^&Z/V+/^CMOV:_\ P]WPX_\ FBH_X;H_8L_Z.V_9K_\ #W?#C_YHJO\
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M+K&L:E<E'D%OI^F:=K=S>WLYCCDD$-M!))LC=]NU&(]:_P"%G?#X]/&&@_\
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M3!_UP@_]%)3ZU(_#WB 11 ^'_$ *PQ*0=!UD$,L:@@C[#P00013_ /A']?\
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M_P $^=2O-2UB.7XP6?[+O[8^N_&GQ)/:ZC<P0>)-1^!_[-/A*U_9V\627-Q
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MN/+\Y;-I8HY6M0XMVD1',99%( /YMEDT+1/V=O\ @MEJ7@OQ3\*/%J^!M/\
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M<[_]66)"BBBOICY0**** "BBB@ HHHH **** /T%_P""5'_*1']DO_LJ8_\
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MCU'][\,]1ZTN![_]]'_&C_B=3$_]&ZH?^)5/_P"A[^KORL?\20X+_HXV)_\
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M3$D23=L=7V.T;;65MKJ<,C;2=K*>&4X8'J!0 ^BB@G SS^ )/Y#)H **A%Q
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MA33-7UU;'2KSZXSSCGIGH<?GTS[9S^1KAOB5\,_ 'QB\#>)/AI\4?"&@>._
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M+X)\.VL-A^TW\;_BYX,\0?!'Q+IUGXL\3>$]5\*Z>OPT\'?%;P<=1G?6=?\
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M#_LOXM?%CX:?%3XL?$SXB:AI/@2_^'=W>?K'^P58Z+X6^,7_  4 ^&OPLLM
MTG]GCX>_M(^!=.^%GAWP;+:OX#\&^)?$7[-7P<\7?&CPCX+L]/N9M(\.Z9:?
M$+6I=>UCPGH4-EI&A^+_ !+XDD2QM-3U'5;>+ZR\'?LI?LO?#O\ X2+_ (5_
M^S?\!? I\7^&[[P=XL/@[X._#KPP?$_A'4S"=2\+>(O[$\-V(UOPYJ!MX#?:
M'J8NM+NS#%]HM9/+3;Z=X%^'_@/X7^&;#P7\-?!7A+X>^#]*:[?2_"G@?PWH
MOA+PUIK7]W-?WS:?H7A^RT[2K,WE]<7%Y=-;VD9N+N>:YF+S2N[ '7U\=?\
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M]^T)\,]#^%?[7NF7W[.WQ>^-GASPE=^)_$*>---M]'_:'@?XM:O%X6^,&I?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
3 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>chart-a264a626c33153a5abb.jpg
<TEXT>
begin 644 chart-a264a626c33153a5abb.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $1 5H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRCXW>(/C
M#X7^&?B+6_@+\.O!?Q7^*EFVCKX8\!_$+XF7WP?\):V+K6].M-8;5?B%IO@'
MXG7N@_V;H<^I:K9+#X)UDZI?V5MI#?8$OFU&T]7IKJ6  _O(W/HKJQ_,# ]Z
M /QE_8X_X*D_$+XP?!'XJ?M5?M?_  ;_ &?_ -C']EOX8:]\5_ FH?%6\_:V
MN/B5=K\1/@[\9=3^"OB?1M8\/ZG\"OACI^E:'JGB?0M83P?K%EXGUO6O$UP^
M@:;:>%([W7H(X.X\1?\ !:G]@.P\<_L;^#/!_P 9M$^)UO\ MI_%GQO\'_ '
MB_P'+)J_AKPCXJ\!:&UUJFF_$15MAX@\-:]?>+-1\&> -+\*W6A)X@&O^-]#
MU+6+31_"BW>OQ?/C?\$G/C%!^PGX8^ &D_%;X8V?QS^#W_!0_P 5?\%!OA%K
MNKZ%XK\1_!?7O%-M^U?XY_:'\"?#KXM>'8F\/^*-2\*ZCH?B[_A&_%DVAR?;
M-"\0Q6GB7PZVJR:)9+=\3X5_X)8?MB67[2WPF_;G\3?%#]FNY_:/_P"&[M7_
M &F/C1\-_#6E_%K1/@)IGPL\1_LAV?[%E]X9^%^H3?:_'&N_%#2OAU9R^.;C
MQ5XNT[P[H7CKQU?I8ZW8:-H.FG^TP#[/^*O_  5\_8RT'X9_MCZ[\#?C-\+?
MVAOC!^QY^S]\=OCQXE^"GA/QPVGZIXDT_P" VBZG=>*M.TOQ,-#U72[S3;'Q
M%8V_A3Q'XE\+0^+;/PIJE_ FIVS3E+62O^W'_P %,Y?V,O\ @GMX/_;NB^!.
MM?%N;Q2/V<&3X->&_%C:?XBG?X_:KX4TT:9H&M)X6UEM;UO0SXF\O2=/70;4
M^)[^WM[(2:3]M\Z#\KKO_@BA^WMX^N/&>H?'#]ICX+?$KQ;J7[%7_!2']D2T
M^(=UKWQ^&H>+[G]L;P\^G?#;X@ZC\-M3&H?"#X)Z#X0ECTS2?$7PD^ _A#0?
M#]A9:?=>(XM;\>ZUJ=K8Z'^L_P"TO^PW\1OC5^QE^S-^S=X<\:>#M$\8? _X
MH?L+>/-;\2:HFN_V#J=I^RK\1OAKXT\5P:(MEI]UJ:7NOVO@F]@\,_;[6& 7
M5S:#59;*'SIH@#*\ _\ !63X ^/OC/XA\/V^I^$M!_9KTC_@GO\ !_\ X*$6
MG[4?B;QY9:%X6D^'OQ8^(OQ"\"G1M<T+4M+MK?PVWA>+P')=ZOJ-[XFFOXM;
MNKSPG=:!9:II3M<X?QI_X+;_ /!/[X1?"WX$?&2P^,>E?%#X>_'O]I/0_P!F
M71_$/P\,NHVW@GQ?<1PZEXNU;XCV5];V6N^%--\!>';G3M;US1[G1I/&%];^
M(/#+:)X>O['6DU*W_.3XH_\ !O!J^O>//^"E5M\,/CKHG@7X'?MB_";X9Z;\
M!_ 5[IWB>^E_9Z^(G@K]J.']L#Q%X.L;#19]%M;+X#>+/C6?$VN1:-X.UK2M
M=\-V/Q&\1:=H5G92:-I=]?=__P .?/VGQ\*?#OC'3/%G[-WA_P#:QT#_ (*.
M?L[?MVW$-YX]_;(^+GPQ\7V/[/?@+4?AAHW@OX@_%_X]?$3XF?''Q5XHU'PU
MK6HW4?C6UT7P];:=:6/AGP5_8=YIN@0:_( ?H=_P4>_X*.6_[!]W^S;X3T_P
M/\/?$GC3]I_X@>+O OA#Q+\=OCKI'[,/[.W@N7P1X+F\:ZE)\3?CKK7@[Q_:
M^&]<\2PBT\/_  V\*6_A2_U'QOXCN)[.WN+&#3KJ<Z>E?\%-O@U\-?V;_AW\
M=OVZ&\.?L0:WX]\2^*O!^G^ _'7Q$T+XDVOB75?"=S?R7'B'X0^+OA[97I^+
MGPTUGPW:6WC;0?'FB>&].M_^$3U*RU+7].T$R+&^K_P4)_9I_:'_ &B_#7PW
MT_X*ZI^S)XR\+^'M4\36_P 7_P!E_P#;)^$=E\3/V=/V@_#7B31;>PTB;Q'J
MUAX:\1^/O /C#X8ZO:MX@\%ZSX1MI;#5'U35M(\5:=?6<EG+:?EKX,_X(Y?M
ME?![]G[X(?!WX/?M"?!CPMX:@^-7[8GQ3^/'P'\-7/Q_^$WP)T72?VH[?3D\
M#_#[X#>*/A?XETWX\:?\*OV<KVVU?4M.^$M_XX\%^&?C=>>)M3/CS4M$M+73
M[2$ _3#3O^"G?P0N/VB?B7\.-2USX?:1^SU\/OV%/@Y^W;%^U?=?$[2E^'&N
M?#GXO>/?B)X0L&A$NF0:3!X>M-,\#6WB*P\6Q>*+U=<&O0:7;:/;W$$4M[Z+
M!_P4T_8.O/@EI?[1-A^T[\,M3^$NM>/[GX4:5XBTJ^U;5-1O_B?9V$NLWOPZ
MMO!FGZ1<^/)?'%EH$$OB6]\*CPO_ &W9^%D/BBYLHO#^-2/XH+_P0)^-GB#]
MFK6/@/XH^.OPRT;4)?\ @F5^QM^QSH_B3PY9>/M2MU^,'['_ .UGXR_:=T;Q
M+J4'D^$M83X7>,FO/"_AC58]'U>P\::9#+KMQI:6]SIVC7MUZY%_P2 ^/=Q\
M"]>.MV?[,&J_M#^+_P!K?0?VC?$$J?'7_@HW#=:;8>%_@_\ \*;\/7_@;]L[
M5/COKO[4WA#XX6&B/.;KXH6NA3^&M:\%RVOPFUWX=ZEHVF6WB1P#]8OC;^W)
M\,/ W[ GQA_;_P#@OJ'A?]H?X8_#W]GSXC?'WP;-X.\86]MX;^)6F^ ?#FL:
MVVCV'C"UTW7$TEKR^T:ZT*_NI-&O[S0=2AO+6^T@W]C<6*\+\'_^"J_["?Q>
M^'MWXZTC]I7X/JWA:\^"OA[XG:;IWC :U%\./&7QYO=*\/\ P[T/7-3M].@@
MDTKQ-XSU,>#O#_C2*(>$-7UR":SCUB&ZCGMH?)+?]A#]I+7?^"0OQ8_8(^+/
M[0>E_%O]H/XG?L\_'WX2-\9?%I\2WF@:??\ Q:7QG%X-TO5-:O;:^\>>+-$^
M'&B>(M'\)2^-=>M+CQMXRM= ;Q-K-BNKZE+8Q_G9\8_^";7CCPM\%OVK_BQ^
MWWXM\(>-?#MI_P $S_A[_P $W/A)X<_8F^ OQH\9>+)O"_A#QO-XQ\"?&S6?
MACIMIXH\2W/Q9TOXPW?@G4?!_A;P1:WO@7X;6.B76LS^(-.TFZU>]T\ _HT\
M'?&GX7?$'QQ\5OAOX*\::+XE\;? _7O#7A?XK^']+EN)KKP/XB\7>%=.\;^'
M]%UN9K=+*/4[_P )ZOIFNBSM;JZGMK&_M#>I;2W$43?D)^Q'_P %A/&W[;?Q
M7T#2_ O[+OA%_@EXD\?_ !,\ :GK_A+]JOP#XW_:;^ -QX U+Q3H^DZ_^UQ^
MR(_@[PSXJ^".@>-]0\+FWL9=,\;>/=0\.3>(O"*:_9(FO)-#[_\ \$?_ ( _
M&+X,?L5^'/%/[2\5_:_M:_M2^+?%W[6/[5$E_8Q:1JEG\9/C5)97K>'+O155
MX= N_AU\/M*\!?#DZ%'YEMHTWA*2QC79"R5\,>$_^"1O[4GB/]L']F[X\_'O
MQG^Q=JFK_LS_ !MUWXK7?[9OP9^!VL?"/]O+]J3PW_PCWC[PUX>^%WQ[D\':
M?X6^$&F:%J6F^.+:+XB:OHC>)9/$:^$=-?1=*\/3ZSJ\K 'ZU_#?_@H7^Q#\
M7?$WQB\'_#G]J3X*^*M?^ .B>(O%'Q>M-/\ '&EI;^"?"G@^^NM*\8^+M1U6
M\>UT:\\(>#]6LKK2?%OBS1M1U/PYX9U:)M,UO4[&^9('\L\-_P#!77_@FMXN
M\(^*_'OA[]LKX(ZEX/\  GA?PCXU\;>((_$=U!IWA#PGX]^)UC\'?!OB#Q/+
M=Z9;OH6F>)/B)JNE:#I-SJ<=LMU'JNEZVN/#NI66L3_B+X$_X(1_$SX$?LU?
MM$_##XI>.-.^)7P[\ _L(_M7_LR? 7Q5\#KO]JCXG_M.^(_#_P 8+M/$'VNQ
M^"/Q2^/%I^SIX(U%M(\.:)IVN?!+X,Z#9:-\9_&B6NJKXJ\&WA2VO?FSP)^Q
M[^US_P %3O$G[8#^(H?"?A*V\7?L5?\ !.[X K\1O$O[)?[3/[)WPCNO&/[/
M/[:=E^T!XO\ A]9>!/CUX>M_B3X[UJU^&7@<)XIU[2=$D\$^'];\=^&_AOI5
M_J/A?PY'XGU4 _I8\(?\%:?^";7CWQ;X%\!^$/VS_@)K_C+XD_$B]^$7@SPU
M8>-(6UC5_B3:3V=M;^$7LI;:*72]5UVYU"SM_" UH:;;>-I[B*'P=<Z[(2H]
M)T__ (*$?L3ZK\8_B7^S]IO[37PBOOC)\']&\7Z[\1/A]:^*K>;7O#ME\/=.
MBU;X@Q21I&;34M5\ Z=/'=^.=!T2[U/7O!\39\1:;IK*RK^;_P 3_P#@D]\7
M/&OQ;_:/^)ND>/\ X4V<GQI_X*C?L"?MS:2=0M?%/]JVOPR_9 T;X46.N^ ?
M$%U;:))Y_B;5+WP-KMQX0AMIKOP[:)K(:^U'39;N]\GP[X8?\$2/C3\/OV@O
M'WB6\^)'PA\4_"32_&_[>'Q9^!?B/Q'XS_:ZUCXNZ'XU_;2\+_$C0ET?4_AO
M>_%[_AE_P,O@_P#X6OXHTOQG\3/!_P .=?\ %/Q?\-6VGP:UX<T/7I9M=@ /
MT,\3?\%G_P#@G%IOPD^/GQ;\%?M-?#WXPVO[._P"_P"&C_&7@WX6:Q%K_C?5
M/AQ=VVF+H%WX7TJ\73+35;C7_$.O>&_!2RM?V^F^&O&/B+2M#\<W_A:X>Y^S
M9_[0'_!6SX#_  5_X)@O_P %.])T^X\=?#W6?AOH'BSP!X*BU2?0;_QAXT\3
M7*Z-I7PY?Q!)H.IPZ/?0^*(M3T+5==?1KO3;<Z+J-[8IJ$+6"WGQ;IG_  1;
M^*H^%GPG^%][\4_A?I-IX2_X(5_'7_@E+XLU;0],\3W$DOQ6^,MA\/;63XKZ
M)83:5IL>H^"+2[\+:OJFHVNIW&F>)=1O+^-VL3-=WD\'U9\?/V#_ -H?]HG_
M ((V^(/^"?WBWQ?\&?#W[0'B/]G3PC\$KSQGX=D\?7/P>AO_  3J?ABSTW5[
M=M4TF3QV++4?"_A2RDOXYM*FGM]=O;N*"*;38H9& /3_  !_P5:_8_?3/V=O
M#?QU_:%_9P^$_P =?VA/ G@3QKH/PQT3XO7WC'0E@^)4CQ>!#I_CGQ'X$^&\
M\>F>-Y/)M_ ]]X\\*?#W4/%U_(]AHNC75Q&@F^C/ W[;?[*GQ,^/'C+]F+P!
M\;_!7B[X^?#RY\4VGCKX7:'<ZA>^*/"-QX,_X1[_ (2&/Q' NG+9Z/\ 8V\4
MZ)'"]]>PQZG+=31:4]])I^IK9?DM^UY_P27_ &E?CIX^_;J\%?#GXO\ P$T7
M]F?_ (*=:I\!-9_:;UCX@^!_&NM?M"?".Z^#7@[P+\/=2M?@9=Z9>/X)\9V?
MB/PW\/-&OO!Z_$:[T6/X3>*=1U?5]%M==@D@LA^B?[%/[(OBS]F?XA_M[^-_
M%OB#PIK[?M:_MG>*_P!HSPJ?#<6K1WV@^!M7^%?PL\!Z+X7\5/JEG:)+KNFZ
MEX(UR_D&ER7VDK!JT4MO=_:)[N"$ ^(_BW_P7K_9C\#>-/C/X'\(:6/$M_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&*>)A*%/&X+"Q4*;Q5>A/$U<74J4_K=1X>M3AT.0,9(&>GO]**_E2_X*@?\
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M*:Y:6,I3ER4:.)PT'TE%%%?@)_084444 %%%% !1110 4444 %%%% !1110
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M-&CXWJ&VD,N>=K#HZYZ..SC#CG!%/H _ KXC?$K]E?XP_MM7O[-/P_\ $?P
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M&M494(4R6D*W\9SG!5K%[C*\?>Q@9 ."0*P)-'UB(A9=(U:-B-P#Z9?*2#D
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M5F[RJ5)65Y2;LDHQM&,8HHHHKB.X**** "BBB@ HHHH **** "BBB@ HHHH
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M@R7VOZ=J>A64EQJVF:A9VWNH(/3GDC\0<'\B,4 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>chart-b33f6037e4655baeb60.jpg
<TEXT>
begin 644 chart-b33f6037e4655baeb60.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #T =(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^*/V[?VP;C]BKX5>"_BA;?"/Q3\:
MSXF^-GPL^%=WX)\#7HB\:?V-X[U:\B\2>)/">D'3=1;QAX@\)^&]+U;Q!I?@
M6%M-O/&=U8Q^'M/U:QU"^M7;AM=_X*!>$&^*&F^"_ 5M\/?$_@?Q/\%?V/?C
M?X&^,&M?%&3PWX(\:>'_ -KK]I^3]GKPGINAW.G^"_%#S:K?61T[Q#\.DR;;
MXA^*_$/ASP'>7/@VVU"?Q?8^N_M8_L_^)?C]!^SS#X;UK0=&/P?_ &KO@7\?
M-=.O+J+#5/#?PLUG5-2U?1M(_LZWN"NO:A'?1)I;WOD:>LL;F[N85VL?SL/_
M  2=\:>$OCI\7/%'PR^)/@W3O@5XK\6_L-^+_A+\+M7TW5K2[^"]O\!_^"A>
ME?MO?'OX>:!=:7IT]M=_#WQ9J<7BK4_@YI,EPD?@3Q!XXU#P.MGI'P[T#0'M
MP#]%/AS^W1^R1\6?%;>"OA]\>_A]XD\0_P!B>-O$-O;6VIW-I9:CI7PTU@:#
M\29M(UO5;+3]!UJX^'6KLECX_P!.TC5+[4O!4SH?$UII<3K(>R^#'[4WP"_:
M&F\16OP:^)OA_P <WOA>RTG5M5L-/75+"^'A_P 1?;QX9\6Z?9:YINE7>M>"
M/%3:5JB>%O'6AP:EX/\ $KZ9J*Z'KFH-8W0B_,.3_@E5X]\1? S]FKX'>)_B
M;X0TC3OAEX(_X*'^ _B/XA\+66O3:A/9_MJ^$_BEX5T+7O =I?6FGPOK7A&/
MXAIJ.MG6[C2Q>75K=K974_VD2O[_ /L7_L9?$GX*_$O4_B?\6=/^%\7B&P^"
M'ASX)>']5\*_&;]K/X[^)=8L[;7XO$7BC56UO]I3QWJFG_"_P/J>H:/X?N?#
MOP=\(^'?$4WAV_34[V_^*WB**>WL(P#5^"O_  4<\*?$7XD?MZ>!O'W@.X^%
MFE?L1^*?$07Q5<>)X/$4/Q7^%WA'2M3_ .$L^(NC:4FCZ1<Z)/X9\6>'M>\*
MZSX8,^LR6TA\.7ZZHZ>([6WAP?V?_P#@JC\#_''[,_P6^.7[2EQX;_91\;_%
MFT^*U]J?P;\2^,)_'6K_  \T_P"#_P 6?%/PG\:ZWXL\0:#X8L8M(\'^&-8\
M/6R>+O'_ (ATCP[X&\+:GJD>DZEX@#11W5SY!J?_  3(^)^H_%"?QNOQ)\ V
MVA>,_P!L_P"./Q(^+GA]]+U^[;QO^R%\9M;^"OQ0U+X0+)]FM1;>/+CXM?LY
M?#6#4;RXDF\-)\/?$?Q-TRTN'OO$"QRY7@7_ ()^?M7?!'2O&UU\,/%O[.'B
M_P 4?&?X5_'CX-_$9/B7;_$33]#\'Z;XY_:V_:F_:+^&OC[P@_AW0-4O_&DN
MG:+^U-XCT'XG?"K6X?!.F^+M7\,^&[C1?B3H=G:73WH!^ANH?MP_LG:9\6(_
M@?>_'3P)#\4#XQ\+?#VX\+B]O9I--\<>._#7A_Q=X!\)ZUJUOI\WA_0M>^(7
MA_Q5X>OOA[IVLZO87'CQM6L[+PBNLZA(UHOQ/X%_X+0_LO\ C35OA3>W1U7P
M5\-OB;H/[9%VGC'QE8>*K+7K#Q'^R-\8_A;\,+[0-,\!:;X.U+6_%-OXRT#X
MBWGQ,?6-&DDB\$>&/#=Y:^*;:#4X=>A\.KX)_P"":OC7X;_"?QW\)O#7Q!\,
MZKIU_P#M<?\ !-GXU^$=:\0+K::O>?#7]A7P?^P+X0US3/&K66GR1R^.O&47
M[(?B?4=$&G_;- LKKQ/X=2\O;9;?46MM[]FC]A'XQ?![XL_#CQ=XM\5?#?4?
M#?PA\/\ _!2/P9X7O- O_%MUXJ\1Z-^VA^U-\)_VC? 6OZM::IX<TVP\+:UX
M4MO"GBGPGXUTG3-:\0V=U<0^'=:T36;J'4]1TO0P#Z^/[;G[*#>._ WPXM_C
MO\/=0\4?$FQ\!W_@N/2M6FU?0];C^*FFMK'PNMD\7Z7:7G@VQU3XF:4(]2^'
M>BZIX@L=8\<6-U8W7A>PU2'4+![GSK]JG]K'QK\$?C%^SY\%/ 'A#X/:OKGQ
MT\+_ !S\7-XK^./QLU/X+>"/#.G_  3_ .%4)/IL>HZ1\,OB9?:YKOB>;XJ6
MQT^R2QTZ*SM="U&YEGN ZQQ_"WPF_P"":W[3'P@_X9<T[P7X^^$_@;5/A1\*
M?V(/A[\2OC'\,_'7QV\'>(_%NG?LR^%O"_A3XE^"_'?P(:+5?@)^TSH/Q T#
MP[J?A7X8_$#XF:9\/_B+\%_#7BF"+39=8N? WAQKCZY_;+_94^(7QK^.G[,?
MQD\'_#K]FSXR:1\$O"'[1?A3Q'\,/VEKW6].\.ZG<?&<?!E]!\3:!>Z9\*/B
M_;1ZKX9/PPU2TN4O?#EI//9>(62SU2$&\@G .\O?VW?A?\'_  GX0N_VJ_B/
M\"_ASXW\<Z9X]\3^%/#_ ,)_B!XR^-&B^*O!GP[U3P_I?BOQ#X4U&'X8>%/$
MOB&+PE+XGT9_' L/!SVGA.&\6\OKU]-@O;ZUXK]K[_@IC^SE^RO\'-<^(UKX
MX\$?$OQ7)\(-+^-'P[\!:'XN9(/B!X-\47<%AX#UI/&6B:)XIT+PQX>^(U]+
M-IWP]\1:]]GT_P <ZK:7>E^$3K=]:W<%N_P+^RY\24^-/P+^+VL^#OV?_@OI
MGPF_9T_:T^"#?"WX(:IX@U?PMIVI?'GXD_LW^.?"_B'PE?77PR^%T%G:JGP@
M\5S>-;3_ (1C3;@:QK6DS:?-K*S:G<VOPA<?\$NOVI?"G[,FO_LZ?#OQQ^SK
MJL?QF_88_9&_99^+WB3XAP_$6>/P1XV_9;^'<OPXF\4_#/1],\/7D?C+P9X[
MT*XW:5H'BBZ\$7GPY\56]WXYC/C%O$%]X6M0#]>;3]K+]G:^^,DGP!MOBQX5
ME^+":K?>'5\++/?;;CQ7IFB-XGU+P19^(#8CPI??$#3?"Z2>)M2^']GKUQXU
MT[P[#<:W>Z#!IEM<747BOPY_X*#_  .^-'[4WA;]FSX+^(_#?Q/AUCX+_'#X
MMZYX\\-Z[>/8:*/@_P#$CX+?#FSL=*LKG0(;#QIX:\9ZA\5-<;3/B#X7\07_
M (7CO_ &K:19W&JW%S-)IOR?H?\ P30\>:=\=;Z_U74_!'B+X.S_ +6/Q>_:
MJLO%VL?&G]K6;Q_H>H?%?6_'OQ 7PSX4_9ZM/B!I_P"S7X5\=^#/'WQ"U*Q\
M-_'6V?4#_P (+IT%K>_"2Y\8:IJ7B@^G?LG_ +'_ .TC\(_B?^S)J/Q5U_X!
M7_PZ_9'_ &./B)^Q]X$O/AO9^.8/'GQ$TW6O$G[.#^$_B%XHM/$.EVFA>!8_
M^$1_9_M+;7OAMH&J^+-/L?%&J2ZOIGB_4M-DM=+T< _56BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BD) ZD#/3_/L.3Z $G@4A= 0"Z@GD L 2#T(R><^U #J*3<N[;N&[&=N1NQ
MZXZX]Z0.C$JKJ6&<@,"1@X.0#D8/!]Z '44A900I8!CT!(R?H.II: "BBB@
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ME^)+G6[=-/\ [-O?#6JS^9:'1F9[C[4$F%PH6*/RR7_:JOX=O^#@7_D_L?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?P[?\' O_)_8_[(5\+?_3EXYK^XFOX=O^#@7_D_L?\ 9"OA;_Z<O'-?T[]$
MG_DZ\O\ LF,W_P#4G+3^7/I>_P#)HI?]E+DO_I.,/Q HHHK_ $[/\L@HHHH
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M_P!17E_5E;]>O^'Y_P#P4B_Z+%X1_P##-_#;_P"4U'_#\_\ X*1?]%B\(_\
MAF_AM_\ *:OR%HH_XA)X7?\ 1O."_P#Q&LH_^9/ZN_*Q_P 1B\5O^CB\9_\
MB1YKY?\ 45Y?U96_7K_A^?\ \%(O^BQ>$?\ PS?PV_\ E-1_P_/_ ."D7_18
MO"/_ (9OX;?_ "FK\A:*/^(2>%W_ $;S@O\ \1K*/_F3^KORL?\ $8O%;_HX
MO&?_ (D>:^7_ %%>7]65OUZ_X?G_ /!2+_HL7A'_ ,,W\-O_ )35]!?LG?\
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M_9!_Y-,_9>_[-V^"?_JM?#-?1-?.W[(/_)IG[+W_ &;M\$__ %6OAFOHFO\
M#[B'_D?YY_V.,S_]3:Y_NKPY_P D]D/_ &)LK_\ 4&@%%%%>.>R-;H/]Y/\
MT-:_S._VM/\ DZG]IC_LX3XV?^K.\4U_IB-T'^\G_H:U_F=_M:?\G4_M,?\
M9PGQL_\ 5G>*:_M?Z%__ "/..?\ L591_P"I>+/XA^FS_P D]P+_ -CC-_\
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MGX8_\)6#_P"3Z^O_ .(!<;_]!&0?^%V*_P#G?Z_T]/CO^)@N!?\ H'S_ /\
M"#">7_4P\_P];?I#:_L[_ BRUCXF:_;_  >^&B:S\9IK&X^+.I/X)\.3W7Q'
MFTR&&"P;QH]QITJ^(UM5MXI(X]46YC-TK7TB/>R27#Y=K^RU^S19:3JN@6?[
M/7P-M-#URZTZ]UK1K;X1?#NWTK5[S1X]2BTJZU33H?#:66H7.F1:QJT>GSWD
M$TME'J>HI:O$M]="7\\O^&S/CC_T$_#'_A*P?_)]'_#9GQQ_Z"?AC_PE8/\
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M@\-"BJDU=.I...J2C'1W:A)_W=[?>]%%%?DI^NA1110 4444 %%%% !1110
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MY_##_P"8:C_B&^_9?_Z+M^T%^?PP_P#F&K^BK/..>F>AQ^?3/MG/Y&BOM?\
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MP2/3J.N,X^N 3CT&3Q1_Q%7Q!_Z*;&_^"L'Y?]0WE^+[A_Q";P[_ .B7P/\
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M'Q%.-=N_]+UD2ZD_]J7/[Z^\^3YJ /YU;7_@IU^V[_PS=XU_:+?_ (0#2_\
MA//V$OVFOVGO"/AGQK/^S0+3X8?$#X3>%]$\2>#],^'?A3X9_M">.?C3\2?
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M?PY^%5YXP_;@^'?[/TWQ:^)5A^S-XN^*FF^!_B'^QU^T5\=;SPAXS^'?P/\
MC/XX^$7@SXMGQM\+?!Y^$>KZGJNGQ^+O"7C70AJOPRUJ>RN9_%O[9^!_V>O@
M)\,M%\3^&_AO\$OA%\/O#OC:V-GXRT'P1\-/!7A/1?%MLUG=Z>T'B;2M T/3
M['7X&L+Z]L6AU:"[A-G=W5ML\FXF1_%_'O["'[-7C?3_ ((>%[?X6_#WPA\-
M?@G\9->^-%M\)/"OPT^'.G_"[QQK_B/X-_%+X,:IIWC;P0_A>30-2TVXT?XI
M7VN236]C;ZI)X@T#P_/)?-:VLMO* ?B7>_MG?M-:5\5O^&B[GXF_\+#'[/'[
M!O\ P5BFMOAOX3\-Z'H_PH_:BUW]CS]JSP1\+_"/Q<MM.CU_4KC2O^$XTVV\
M/>(/$DWA/6YX_#<GA'Q;I?@O6+#PGXOU2WE],/[;/[<>FZ]X.^%S>/\ P%;W
M?Q,^,O[$OA[1_B%XST;]E[Q+XYT7PW^TCXG^+/AWQQ):?#']F_\ :(^*_AQO
M &N:%X&LO$O[/GCKQ7J^G:C<^(-+\7Z#X@D^(6DZ;'>M^]-O\'?A):2_#RXM
MOA?\.K>X^$>GZCI/PIG@\$>%X9OAGI>KZ.GA[5=.^'TD6E(_@NPU+0(X]#U"
MS\-'3+:]T=$TRZBELD6 8/A+]G3]G[P#9C3O WP,^#O@S3E\5Z;X\6P\)_#'
MP1X<LAXYT>*2#2?&8M=&T*R@'BS3()98=/\ $0C_ +8L8I)([2\A1W5@#\%?
M''[3W[66I?"CQ3IOQ.^,'@KQWX0\;?&3_@J#^P/K_AG1_A%HO@R_U32OV:_V
M</VS/'WA#XS+XET_Q+?WNG?%+5KG]GW3M&\6:#I-A!\.[G2_$>H7&B^%O#^H
MZ9%=W6!X$_;K_:)_9H_9@^'>D:'\1_A7^T7:ZM_P3O\ V2?C9X5\1Z#X7\)>
M']'^ FJ_$3XM_ K]G&(^(-0E^)6C>&?$?PTG\,_$C7?B9X1U+XI^./!5Q(WP
M-^)#^*?B.GA:ZOKKP-_1?/\ "CX77-N+2Y^&_@*XM1XA\5>+A;3^#O#DMN/%
M?CO3-?T7QOXF$,FFM&/$'C'1_%?BC2?%6M;?[2\0Z9XDU^PU>ZO+76-1BN<C
MPG\"/@CX#TCQ9X?\#_!WX6>#="\>1-!XXT7PI\//!_AW2?&43Z=+H[Q^*]-T
M?1K*R\1(^D3S:4R:Q!>H=.EDL2OV622)@#\6=*_:G_;D\0>-/AU^SO\ \+&\
M(> /$/B_]M'0O@;+\3_%OAW]F_XB_%_2?AWK_P"Q#^T1^TEK&A^.?AA\!_C!
MX_\ A1X/^)^D>*_A1X8OO FL7VIZ=;>(OAEXMT[4=:^'<\VFW6I^(OK[_@H5
M>?L\V!^"%A\8/AI)^U1\:]<A^)/AC]FO]DK4-:TRT\&_%_X@:EX<T(>*_B-X
MY\,:_(_@'0O"OPC\-6TMWXD^-WCJTU'1_@EX8\::^/"UAJ_Q#\:^#_#NO?=?
M@[X&?!3X>:7X?T/P!\'_ (7>!]$\)>(M0\7^%='\'_#[PCX9TKPSXLU;1]0\
M/:KXG\/Z?HFCV-IHOB'4]!U;5-$U#6]-AMM3O=(U*_TRYNI;&\N()*GQ._9]
M^ OQLN-%N_C+\$OA%\6KKPW!J%MX>N?B;\-?!?CVXT&VU:6QGU6WT:;Q7HFK
M2Z7!J4^EZ9-J$5BUO'>RZ=8R7*RO:6YC /Y>OVLO@[XW\#>!]=\!>*?BS\.?
MB)XO_8A_X)7?"W6?B'XS^*_BOQ+;^)],N;_XA?$KQ!/\5?\ @G1KMWK3ZQH7
MQ[T>#X6ZIX"T7XL?$MO$#ZCXD\._LS>%M?O+B8?$@:S_ %<>&?%&B>*=)DN=
M+O\ =+9I80:Q83S6JZ]X;U+4-$TOQ!#I'B;3DEFET+Q##I.LZ7J%WI6I1P7,
M,5];7+0&TN;>67@+K]FW]GB]@^'MK>? ?X,75K\(RK?"FVN?A;X$GM_ADR7E
MKJ"-\/89M >/P6RW]C97JGPVNF[;NTM;D8GMX9$[#P[\-?!/A75OB+K>AZ!8
M6>I?%CQ-;>+_ (@SK!$P\3>(+3P9X8^'T&H:E$4$5Q,O@_P=X=T-WE1Y)[/3
M8(YWE"J% /YK_%>A>&)/A/\ M-_M&?\ !/VRU/P5\'/@?^Q#^UG\/A^TM;>.
M]4N/C!^W?\5/%+Z==>*/C=9:U:W%_P"+OB;X4^ L_@[Q_P"*_"/[0WBZ.;7_
M (@_%GQ%=?\ "EEM/A-I%WK/CW[Y^!7PN^&=E^T]^U-\ /V3?%4/PH_9TUS]
MD/\ 9 \47VI_LX>*M!EMO"OQ;\7>-_VA-"N_$_A;4IQXNT#P]\0?B+\"/"?P
MXN/$/B>UTR;Q)X@T.W\(?$&YO6\0W6B>)KO]%?A]^RG^R_\ "77(_%'PK_9P
M^ OPT\2Q:=<Z/'XB^'_P>^'?@S78])O8HX+S2TU;PWX<TV_33KJ"&&&YLEN!
M;3Q111RQ.B*H[WX=_"CX7?"'1[OP]\*/AOX"^&6@:AJL^N7^A_#WP=X<\%:/
M>ZW=0VUO=:Q=Z9X9TW2[*YU6Y@L[2&XU":![N:*UMXI)FC@B5 #^;7X!^%O#
MFM?LG?\ !*Z[^(GASX??M"?#/0_A7^U[IE]^SM\7OC9X<\)7?B?Q"GC33;?1
M_P!H>!_BUJ\7A;XP:E\#O"6G>,M$\7-XKURZ\9>%](^+^I_%3PO'K7B70;V*
M3]HO^":&M_$7Q)^P;^RUKGQ5U*?6?&>I_"/P_<W>M7-[JFJ2:UHS2WJ>#M8&
ML:['!K^N1:KX*3PYJ%MK^OP6^O:[;7,.L:U;P:I>W<2?1OB'X!? OQ;X,T7X
M<^*O@Q\)_$OP]\.:BFK^'O GB#X<^#=:\&Z%JT;7[QZIHWA?4M%NM#TO48WU
M34G2]L;"WN5?4+YA+F[N/,]7CCCAC2*)$CBC18XXXU5$1$4*B(B@*B(H"JJ@
M*J@    4 /HHHH *^=/VN)/@W#^S5\:9_P!H;X@W_P +?@;;> =;N?BQXYTS
MQEJO@"\T7P#;1QS^)DB\6:"\>OZ4NKZ9'/H,X\/.GB'4+?59M)T%AJ^H6>?H
MNN6\:^!O!7Q)\,:KX)^(GA#POX]\&Z]%!#KGA+QIX?TCQ3X9UF&UO+?4+6+5
M= UVSO\ 2=1CMK^SM+Z".\M)DAO+6WN8PLT$3J ?SJI\,[..+P3XTUSX9:)^
MS)^QE^U=^WA^RGX6U#]D:2>T\.:1HWPF\'_"CXR'PAXS^/GP_P!%O[KP5\-O
M%_[5'QZM_@3H/C;X*!;.RN/"WA/X9>$?BO'??$WQ%\0O"L/,VK? *[T+Q]\*
MKKX3:)^U)XNL?VG/VZO@O_P3M_9;UOQ4O_"A[3X8)JOPX/Q.^*_B)[VYN/"W
M@#X1?L[_ !1N_%_P\;XR(+G6_@YH5W>?!#X!:->>,_%'ASP?JW] 7A[]EK]F
M7PCX9\8^"O"?[.WP*\+^#?B)#96WQ \)^'?A%\/M%\,^.;;36N'T^W\8Z#IO
MAVVTKQ/!8M=W;6<6MVE]':M=7#6ZQM-(6H^(OV1_V4_&&G>%M(\6_LS?L^>*
M=*\#:'_PC'@K3/$?P7^&VMZ?X/\ #7VH7H\/>%K+4O#-S;>'M#%X!=#2=(BL
M]/\ M(%P;<S?/0!_/I\;O!$_P\^&W[:6G?%[XB6GQ._:K_8[_8Q_8,T']CGX
MMZYKM]'XZOOB!I7@B]A\,?%7X1OJ.IS:U:>+OCI^UIHVM^&?$<^B:IJNK?$Y
MM)\._#OQIJ/B&P6/2I_VC_;6_::UG]D!/A'\<_$FHZ;;_LUZ=XB\:^#?V@4F
MT<W&KZ.WB?P+J^I?!CQ3I.M^?&-/:X^+GA;0O@XFCO!+!KNK_&CP](SPRZ/
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M\K76?!G[0?[&OA/P/X8^&UM+J_[)O[0EW^TW\9OAE\:]#^,MO^V-K7A_Q/\
M!B/PE^U'K][I-Q)X@EM_%7Q)U3QIJNB:_P#&:VT;XHZ1K7Q \9?#31=&F\->
M&O$-]'_1M7GO@SX2?"OX<ZMXNU_X??#3X?\ @77?'^J?VYX[UGP=X,\->&-6
M\:ZU]HOKK^V/%NHZ'IEA>>)-4^TZGJ-Q_:&LSWMWY]_>S>;YMU</)Z%0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>chart-d9320a08f029506eb1b.jpg
<TEXT>
begin 644 chart-d9320a08f029506eb1b.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #V 9(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD+*O4@=^3VZ9]AD@9
MZ<BER/7KT]Z "BD+*N-S!<G R0,GT&>]!900"P!;H"0"?H.I_"@!:*3<N2N1
MN R5R,@>I'7'O2D@=3CH.?4G 'XG@>] !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !117E7QU^+>A? /X*?%WXY>*-/UG5O#7P<^&7COXH^(-,\/6L=YK
MNH:+X!\,:IXIU.RT>VGFM[:34;JSTN6"T^V75I8QS2)+?7EI:)/<1 'JM%?E
M9X0_X*)_$.V_9_\ B5\<OC'^S-_PB]IX?^(/@+X>_"N7X7?&WP-\5?A]\7]<
M^*7QEG^!GA;3[+XG:EIWP^TSP@_AGQTVE_\ "R/%/B/2(_AQI?A/6M(\9^$/
M&'C"SN[C2=.])M_^"AO@#2OV7OC;^T7X_P# _BWPIJ?P"\:?$KX4>+_A;I5Q
MI?C?Q#XN^+_P[ECM+;P#\'M;\/L-&^)=QX_U"]TBQ\$ZA9)I;)=:C=6/C+3O
M"&J>&?%VGZ$ ?H517YB:U_P4FL8_#OASQ9X.^ WCSQYX=TG]DGX9?MJ_'O5=
M(\6> M,M_@S\&/BII'B'6O#EE9_V[JFGR?$WXB3:5X'^(VOIX3\/)I5C+X;\
M":I>GQ'!K.M>$?#OB#[N\7_&+X=>!_A7J/QHU_Q+9V_PYT_PS:>+!X@@66[7
M4M)U."TFT--$LK='O]:U7Q)+J&F:=X8T/3;>XU?Q!K.JZ7HVEV=SJ>H6MM(
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M,?\ @H?>?L_ZO\'==^'E_IG[+>E_L=>/7\=:7\#_ !UX%\81^"HO"&K^()]
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MP[\)>"=/\'7G[0GQET'P7;SV^I0>(KK]-?\ AL+]DC_HZ3]G/_P]WPS[]?\
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MO[.?_A[OAG_\T]'_  V%^R1_T=+^SG_X>[X9_P#S3T?ZN\0?]"+.?_#9C?\
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M]_V2'#__ *K,,?XN>-'_ "=CQ#_[*W.O_4RH%%%%?HY^9!1110 5],?L7?\
M)X7[*7_9R7P._P#5F>&J^9Z^F/V+O^3POV4O^SDO@=_ZLSPU7B\2?\D[G_\
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MO)/C[_R0SXS?]DH^(_\ ZAFMUZ&4_P#(URS_ +&&"_\ 4FD>=F__ "*<S_[
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M_G/Z_P!/0_XE;\;O^B0H]/\ FHN&/+_J<>;^YGY5U_4/_P &T?\ R,G[8/\
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M[/1O&WP@O+O6M0U77_$%SJOAWXI6UKI=M9>&OA?+?7TVF\/^S;^V=^T+\$/
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MIO\ M331_$'QMX4_9[^%_ASP7\*+S_@GCIWBWX??%7QAXYT?XL3>(/V]]/\
MAII<O@^XOM!\/7^@>$]5^!_B_P"*.B3>(-1O=!\01>,],L-6T6RT?PQJ$-MK
M=R ?NQ17\^FM_M1?MI_$7]LC]G_X,^&[SX3>'/BK\,?CA^W#\ _B,T'B'XIV
M'[/OCZR\,?LO?LR_'GP%\1-0^'MO?MXKUG4]%TOXS:'H%MX-U+Q3*-$\22>*
M/$FD>,SI\<.G7W1ZA_P5G^,WC#PUX6NOA%^S[+J'C;1?V;E^/?Q)\(P_#O\
M:0^,^E^(O$\7Q7^-WP;7X.>!/&?P0^&FKZ=X#MM?\5_L[?$>XT+XR?%FP@T4
M:7J7@RXF\ W$,WBN[\- '[T4FX9QD9Y&,]QU'U'<=N]? W[(?[2?QJ_:3^)7
M[25QXB\%>"/ 'P;^#?Q7U;X,>%=+N'\42?&?6?$VG^ O@_\ $2?5?&UG//\
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MCX'^&U_=VG@O0;7XW>$_'WACXL7/QKNK?0-6OY=;_?!"61&/!*J2/0D G]:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPSF\+_$G5/&%Y\0_!T/P]TVYU'2_ ]AX3\4:+IWA/2]8UW3=#L[*QUW6;>_
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MOQ$\0^"M%\.^(/&<[7%QXAU/4)[R]DN #X6\;?MP?M10_'KX2_ ZP^'/PO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>chart-d5285169e2e55593a5f.jpg
<TEXT>
begin 644 chart-d5285169e2e55593a5f.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #P 3X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XL_X*'_M>
MG]@W]CKXR_M8#P ?B@?A+:>"[K_A!1XF'@\Z]_PEWQ(\&_#[8/$;:)XC&F_8
M/^$M_M7<=&O?M/V#[%B#[3]I@][^-WQU^#W[-WPU\1?&'X\?$CPA\*/AEX4C
MM'U_QKXWUFUT/0["34+R#3M,L_M-RV^[U/5]2N;73-&TFPBNM4U?4[JVT_3+
M.ZO)XH7^5O\ @J5^R7X\_;F_8-_: _98^&'B7PAX0\>?%72O!%MX;\1>/5UM
MO"&G7OA/XH^!O'TAUT>&[/4-;^R75IX4N;%#IUG/,MS<P,P6(22+\??'?]D[
M_@I=^UUX$\"R?&_5/V%OA[\4?V8OVF/@'^UO^S,GPRU/]H'Q]\-?&OQ&^#]W
MXQM]5\$?M :7XW\*^%=9L?!.LZ%XH#Z!KO@-M3\1>&?%EM8>)H;&>;1;."X
M/ME_^"FG[ D7PC\$?'B;]K/X)P_"+XB^*_$?@+PAX\F\86\6AZIX\\(^']8\
M4>(_ LCR0K=Z5XVTG1-!U*ZNO".MVFF^(O-CM[&+39=0U#3;2\-1_P""FG[
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M9R^+'[%GPP/@3_A+O^&O?VC+WX!?VU_PD@T/_A 3:?![XD?%8>*/L!T35?\
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MT_Z!?[/O_AL_$?\ \\:C_B(0_;T_Z!?[/O\ X;/Q'_\ /&K7_B4KQ8[<-?\
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M%QDM'&2::?9IV:^9O&49Q4H24HR5U*+337=-:,****104444 %%%% !1110
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M>G_\>-G_ ->MM_Z(CJY7^%<_CE_BE^;/]ZX?!'_#'\D%%%%24%%%% '\@/\
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M>G_\>-G_ ->MM_Z(CJY7^%<_CE_BE^;/]ZX?!'_#'\D%%%%24%%%% '\@/\
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M_P *Y_'+_%+\V?[UP^"/^&/Y(****DH**** /Y ?^#DO_DNG[-/_ &2/QO\
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M_B+6-/O-;@\+^&(KU=#LOL3:/5O^^W_^*IP&!CG\22?S.30 4444 %-;H/\
M>3_T-:=36Z#_ 'D_]#6G'=>J_,#_ #"OCA_R6KXQ?]E9^)O_ *G?B&O+J]1^
M.'_):OC%_P!E9^)O_J=^(:\NK_<C*O\ D5Y;_P!@&#_]1Z9_A%G7_(XS7_L8
MXW_U)J!1117>>8%%%% !5NP_X_;/_K[M?_2F*JE6[#_C]L_^ONU_]*8JF?P2
M_P ,OR9=/^)3_P <?_2D?ZF.G_\ 'C9_]>MM_P"B(ZN53T__ (\;/_KUMO\
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M[-/_ &2/QO\ ^IQIU?S:U_KC]'G_ ),UP-_V 8__ -769'^/WTCO^3T<;_\
M87EW_JFRX****_9S\0"BBB@ HHHH _M,_P"#=#_DRSXF?]G+>,/_ %7'PMK]
M_*_ /_@W0_Y,L^)G_9RWC#_U7'PMK]_*_P @/'7_ ).[Q[_V/:O_ *8H'^RG
M@-_R9[P^_P"R?H?^GJX4445^3'ZX%%%% !1110 4444 %%%% !1110 45P/Q
M3^*/P_\ @G\.?&OQ;^*OBK2O _PX^'7AO5?%_C;Q?KDDL.C^&_#6B6S7FJZQ
MJ4L$-Q-'9V-LC33M%#*X13MC8\5^7/\ P_Z_X(X_])!?V??_  =>(?\ YFJ
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MRG 4Y.CB</A*E&HHU(RA)PG)*491;O%V]ZHKP7_AJ3]G7_HL7@W_ +^ZO_\
M*FC_ (:D_9U_Z+%X-_[^ZO\ _*FOU[_7W@7_ *+7A#_Q)LE_^;O/\^S/QK_B
M'W'W_1#<9?\ B+YY_P#,/G^?9GO5%>"_\-2?LZ_]%B\&_P#?W5__ )4T?\-2
M?LZ_]%B\&_\ ?W5__E31_K[P+_T6O"'_ (DV2_\ S=Y_GV8?\0^X^_Z(;C+_
M ,1?//\ YA\_S[,]ZHKP7_AJ3]G7_HL7@W_O[J__ ,J:/^&I/V=?^BQ>#?\
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M2^(?B'XC_$/7O =WJ_[0=I'J.L:]XLUGQCXKU73=?\0:AHFCIJ=AHEC^Z5%
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>chart-dbb01a79444f5cd1986.jpg
<TEXT>
begin 644 chart-dbb01a79444f5cd1986.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #P 6@# 2(  A$! Q$!_\0
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M>-=&CU#X??'KQSX6U+XE^&? -U+X U;PQXCTR&S6V /KW7?^"S_[(UW^UM\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC_'W2]?@\)^!_'>N:Y\1M%\-?#;PC=>!]=\)ZJNBS:5XL\9Z1XN^*7P_L-&
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M]_\ !UXA_P#F:H_X?]_\$<?^D@O[/O\ X.O$/_S-4 ?L)17Y5?#_ /X+??\
M!*'XJ>//!7PQ^'O[<_P,\5>/?B+XL\/>!O!/A?2]8UQ]4\2>+?%FKVFA>'-!
MTV.?P_!#)J&KZO?V>GV4<DT227-Q$C2(&W#]5?\ /Y4 %%%% !1110 4444
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M/!&MW\OAUI_P54U3Q9\+[KXP?#/]G"^\4^#?A9^S?9?M1?M-/JWQ;\,:'?\
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MPCXP\'CQ!X:\6ZX8M%\-ZIJFJ7%O:3 'TQ_PB/A;_H7-!_\ !+I?_P B4?\
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M%?+A^&$WQBN4^$UGX@F^(0\:W6K;?%Z_#Y/ ,L6OO^D .X C(R <'KR,\^]
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MT?L#_!'PM;Z+I7Q$T[PAX=UC]E;Q[\2/&_Q!F&E>)-7\?^*K'P1XBG\?S1>
M=&U#QEXVUO3E%U#XAU:3<+B7]R:* /R$^)'[#O[1<7[6U]^U5\)_$'P3U>ZL
M_P!K;3OV@]$\$?$?4O'NB0ZAX5'_  3P'[&.K^&;WQ'X;\+>)YO#GB>X\43W
M7BC3]?L-&\0:?:>&5%K=Z=>WUW/90^*:E_P2T^.&@KX4\;>&?&/P[\=?$C6_
MAI^T)X7^+'AG4OC#^U=^SE\,M.\9?M ?M+?$W]JJ[UKP9??L\^*[7Q?XU^'O
MA7QK\8?%_@B^^%_Q#6TF\=>#=(\'ZE#XT\!ZY9:Q#JW[S44 ?#'[$O[(]_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>cy20q310q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:prgo="http://www.perrigo.com/20200926"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="prgo-20200926.xsd" xlink:type="simple"/>
    <context id="FD2020Q3YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="I2020Q4Oct30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FI2020Q3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="FI2020Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="FI2019Q3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="FD2019Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="FI2019Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="FI2018Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_StatementGeographicalAxis_country_IE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_StatementGeographicalAxis_country_IE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_StatementGeographicalAxis_country_IE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_StatementGeographicalAxis_country_IE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkincareandPersonalHygieneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:DistributionandLicenseAgreementsandSupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-07</startDate>
            <endDate>2020-08-07</endDate>
        </period>
    </context>
    <context id="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="D2019Q3Jul2_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:GenericProductAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-02</startDate>
            <endDate>2019-07-02</endDate>
        </period>
    </context>
    <context id="D2020Q4Oct30_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SanofiBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-30</startDate>
            <endDate>2020-10-30</endDate>
        </period>
    </context>
    <context id="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-03</startDate>
            <endDate>2020-01-03</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="D2019Q3Jul1_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="D2019Q2May17_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:GenericProductAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-17</startDate>
            <endDate>2019-05-17</endDate>
        </period>
    </context>
    <context id="D2019Q3Jul1_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RosemontPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:CSCIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-19</startDate>
            <endDate>2020-06-19</endDate>
        </period>
    </context>
    <context id="D2019Q3Jul8_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AnimalHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-08</startDate>
            <endDate>2019-07-08</endDate>
        </period>
    </context>
    <context id="D2020Q4April1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:BudesonideNasalSprayandTriamcinoloneNasalSprayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="D2020Q1Feb13_us-gaap_BusinessAcquisitionAxis_prgo_DexsilMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:DexsilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">prgo:BrandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-13</startDate>
            <endDate>2020-02-13</endDate>
        </period>
    </context>
    <context id="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:RanirGlobalHoldingsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:SteripodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-03</startDate>
            <endDate>2020-01-03</endDate>
        </period>
    </context>
    <context id="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:OralCareAssetsofHighRidgeBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_ReportingUnitAxis_prgo_BCSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">prgo:BCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_EvamistBrandedProductMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:EvamistBrandedProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:GenericProductAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_ReportingUnitAxis_prgo_BCSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">prgo:BCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_prgo_MeasurementInputProjectedRoyaltiesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prgo:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">prgo:MeasurementInputProjectedRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prgo:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharma2020ContingentMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">prgo:RoyaltyPharmaContingentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PrivatePlacementNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RoyaltyPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">prgo:RoyaltyPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="D2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-17</startDate>
            <endDate>2020-06-17</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:RON</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:RON</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="I2020Q2Jun19_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-19</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.9SeniorLoandue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.9seniornotedue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5.105SeniornotedueJuly282023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_DebtInstrumentAxis_prgo_SeniorNotesdue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:SeniorNotesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.500UnsecuredSeniornotesdueMarch152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-06</instant>
        </period>
    </context>
    <context id="I2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-19</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2019EuroDenominatedTermLoandueAugust152022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-15</instant>
        </period>
    </context>
    <context id="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2014EuroDenominatedTermLoandueDecember52019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2014EuroDenominatedTermLoandueDecember52019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-08</instant>
        </period>
    </context>
    <context id="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-08</instant>
        </period>
    </context>
    <context id="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueMay2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NotedueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2020Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NotedueNovember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="D2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.150SeniorNotesdueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-19</startDate>
            <endDate>2020-06-19</endDate>
        </period>
    </context>
    <context id="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3.5SeniornotedueDecember152021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-06</instant>
        </period>
    </context>
    <context id="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018EuroDenominatedTermLoandueMarch82020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-15</instant>
        </period>
    </context>
    <context id="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NotedueNovember2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">prgo:KazmiraLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-08</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2018RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="I2018Q4Oct31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="D2020Q2May">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="I2018Q4Nov29_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-29</instant>
        </period>
    </context>
    <context id="I2019Q3Aug22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-08-22</instant>
        </period>
    </context>
    <context id="D2011Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2011-01-01</startDate>
            <endDate>2011-12-31</endDate>
        </period>
    </context>
    <context id="D2010Q1SD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2009-01-01</startDate>
            <endDate>2009-12-31</endDate>
        </period>
    </context>
    <context id="D2017Q1Aug15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2017-08-15</startDate>
            <endDate>2017-08-15</endDate>
        </period>
    </context>
    <context id="D2010Q4CollaborationPayment">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-12-31</endDate>
        </period>
    </context>
    <context id="D2014Q4CalendarYear">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="D2020Q3_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:RevenueCommissionersIrelandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-04</startDate>
            <endDate>2020-11-04</endDate>
        </period>
    </context>
    <context id="I2019Q2Apr26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitSupermarketChainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-22</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:MasonCapitalPentwaterandSimilarCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="I2019Q4Dec23_srt_LitigationCaseAxis_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitSeveralCountiesinNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-23</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_LitigationCaseAxis_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="I2019Q4Dec27_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthcareManagementOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-27</instant>
        </period>
    </context>
    <context id="FI2012Q2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2011-12-31</instant>
        </period>
    </context>
    <context id="I2020Q3Aug27_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitSuffolkCountyofNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-27</instant>
        </period>
    </context>
    <context id="I2019Q4Nov14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-11-14</instant>
        </period>
    </context>
    <context id="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-28</startDate>
            <endDate>2017-06-28</endDate>
        </period>
    </context>
    <context id="FI2020Q2_srt_LitigationCaseAxis_prgo_CanadianClassActionComplaintMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CanadianClassActionComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="I2018Q3Jul27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2018-07-27</instant>
        </period>
    </context>
    <context id="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OverarchingConspiracyClassActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CasesFiledinIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="I2017Q2Jun21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2017-06-21</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CasesFiledinIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StateAttorneyGeneralComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-10</instant>
        </period>
    </context>
    <context id="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_LitigationCaseAxis_prgo_OtherCasesRelatedtoEventsin20152017Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OtherCasesRelatedtoEventsin20152017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="I2018Q4Dec21_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitSupermarketChainsAmendedComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-21</instant>
        </period>
    </context>
    <context id="I2018Q3Aug03_srt_LitigationCaseAxis_prgo_PricefixingLawsuitManagedCareOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitManagedCareOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-03</instant>
        </period>
    </context>
    <context id="D2020Q1Feb_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:AcetaminophenLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_TalcumPowderLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="I2019Q4Dec11_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareServiceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthcareServiceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <context id="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-28</instant>
        </period>
    </context>
    <context id="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OverarchingConspiracyClassActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-14</instant>
        </period>
    </context>
    <context id="D2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthInsuranceCarrierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-16</startDate>
            <endDate>2019-01-16</endDate>
        </period>
    </context>
    <context id="I2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:InrePerrigoCompanyplcSec.Litig.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="I2019Q4Dec16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-16</instant>
        </period>
    </context>
    <context id="I2020Q2Jun9_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:OverarchingConspiracyClassActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-09</instant>
        </period>
    </context>
    <context id="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-14</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_LitigationCaseAxis_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:InIsraelCasesRelatedtoIrishTaxEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-18</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="I2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHealthInsuranceCarrierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-16</instant>
        </period>
    </context>
    <context id="I2017Q2May31_srt_LitigationCaseAxis_prgo_FirstManhattanandSimilarCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:FirstManhattanandSimilarCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="I2020Q3Sep4_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitDrugWholesalerandDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-04</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="I2020Q3Jul9_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugstoreChainMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PriceFixingLawsuitDrugstoreChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="D2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:InrePerrigoCompanyplcSec.Litig.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-31</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="I2017Q2May31_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:MasonCapitalPentwaterandSimilarCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="I2017Q2May31_srt_LitigationCaseAxis_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CasesFiledinIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="D2020Q4Oct6_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-06</startDate>
            <endDate>2020-10-06</endDate>
        </period>
    </context>
    <context id="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_RoofersPensionFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RoofersPensionFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="I2017Q2Apr30_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:HarelInsuranceandTIAACREFFCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-30</instant>
        </period>
    </context>
    <context id="I2020Q1Mar1_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHarrisCountyofTexasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:PricefixingLawsuitHarrisCountyofTexasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-01</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_LitigationCaseAxis_prgo_CarmignacFirstManhattanandSimilarCasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CarmignacFirstManhattanandSimilarCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:CSCIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="brand">
        <measure>prgo:brand</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="ratio">
        <measure>pure</measure>
    </unit>
    <unit id="EUR_PER_shares">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="lawsuit">
        <measure>prgo:lawsuit</measure>
    </unit>
    <unit id="product">
        <measure>prgo:product</measure>
    </unit>
    <unit id="pharmaceutical_company">
        <measure>prgo:pharmaceutical_company</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="promissory_note">
        <measure>prgo:promissory_note</measure>
    </unit>
    <unit id="manufacturer">
        <measure>prgo:manufacturer</measure>
    </unit>
    <unit id="case">
        <measure>prgo:case</measure>
    </unit>
    <unit id="retailer">
        <measure>prgo:retailer</measure>
    </unit>
    <unit id="supermarket">
        <measure>prgo:supermarket</measure>
    </unit>
    <unit id="tender">
        <measure>prgo:tender</measure>
    </unit>
    <unit id="claim">
        <measure>prgo:claim</measure>
    </unit>
    <unit id="complaint">
        <measure>prgo:complaint</measure>
    </unit>
    <unit id="plaintiff">
        <measure>prgo:plaintiff</measure>
    </unit>
    <unit id="individual">
        <measure>prgo:individual</measure>
    </unit>
    <unit id="USD_PER_ILS">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:ILS</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="health_plan">
        <measure>prgo:health_plan</measure>
    </unit>
    <unit id="class">
        <measure>prgo:class</measure>
    </unit>
    <unit id="defendant">
        <measure>prgo:defendant</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="FD2020Q3YTD"
      id="Fact-080589869AA4523694C24D6A1EB18D76-wk-Fact-080589869AA4523694C24D6A1EB18D76">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="FD2020Q3YTD"
      id="Fact-F52CC22CAFC6541AA5C1BC499C360BE5-wk-Fact-F52CC22CAFC6541AA5C1BC499C360BE5">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="FD2020Q3YTD"
      id="Fact-B7C367A42A2A5681BDE85D8E403B1477-wk-Fact-B7C367A42A2A5681BDE85D8E403B1477">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="FD2020Q3YTD"
      id="Fact-00A6A27193FD569BBECC43F49FA92970-wk-Fact-00A6A27193FD569BBECC43F49FA92970">2020</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey
      contextRef="FD2020Q3YTD"
      id="Fact-3A8649AF84BD555DBCD52F9D8D4B0802-wk-Fact-3A8649AF84BD555DBCD52F9D8D4B0802">0001585364</dei:EntityCentralIndexKey>
    <prgo:FairValueAssetsLevel1Level2Level3TransfersAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="Fact-69F1A902B6EB506097CEC8105F4743DF-wk-Fact-69F1A902B6EB506097CEC8105F4743DF"
      unitRef="usd">0</prgo:FairValueAssetsLevel1Level2Level3TransfersAmount>
    <prgo:FairValueAssetsLevel1Level2Level3TransfersAmount
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="Fact-70398BB5BF9D54E1B51D7CE2C36D44B5-wk-Fact-70398BB5BF9D54E1B51D7CE2C36D44B5"
      unitRef="usd">0</prgo:FairValueAssetsLevel1Level2Level3TransfersAmount>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2019Q1QTD"
      decimals="INF"
      id="Fact-1BC5D98B000A53BAB30A669FF3779455-wk-Fact-1BC5D98B000A53BAB30A669FF3779455"
      unitRef="usdPerShare">0.19</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2019Q2QTD"
      decimals="INF"
      id="Fact-AE29932A8FD55F6F97EC72EBA6B87E67-wk-Fact-AE29932A8FD55F6F97EC72EBA6B87E67"
      unitRef="usdPerShare">0.21</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2019Q3QTD"
      decimals="INF"
      id="Fact-BB7BFAC6451229877EBEC23AD3C4292A-wk-Fact-BB7BFAC6451229877EBEC23AD3C4292A"
      unitRef="usdPerShare">0.21</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2020Q1QTD"
      decimals="INF"
      id="Fact-BEFBB065E2235886BF32D3FC32A6D007-wk-Fact-BEFBB065E2235886BF32D3FC32A6D007"
      unitRef="usdPerShare">0.23</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2020Q2QTD"
      decimals="INF"
      id="Fact-87AB193135CC5AA8BF7E1F46FB5F2D6F-wk-Fact-87AB193135CC5AA8BF7E1F46FB5F2D6F"
      unitRef="usdPerShare">0.23</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2020Q3QTD"
      decimals="INF"
      id="Fact-4AD8C02FC9D31266C63CC23AD304215A-wk-Fact-4AD8C02FC9D31266C63CC23AD304215A"
      unitRef="usdPerShare">0.23</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-36FF158B285751FDBBA35BFED8EDF509-wk-Fact-36FF158B285751FDBBA35BFED8EDF509"
      unitRef="EUR_PER_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="FI2020Q3"
      decimals="INF"
      id="Fact-5561F050463B50EB8963E7AC68F57744-wk-Fact-5561F050463B50EB8963E7AC68F57744"
      unitRef="EUR_PER_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-C5D6331F141C590C9481D4188B0F3AF8-wk-Fact-C5D6331F141C590C9481D4188B0F3AF8"
      unitRef="shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2020Q3"
      decimals="INF"
      id="Fact-41C5F3DB27985BB09E029C7C7D98D774-wk-Fact-41C5F3DB27985BB09E029C7C7D98D774"
      unitRef="shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="FI2020Q3"
      id="Fact-7F6ACDB680D5575C828B63660769F7D4-wk-Fact-7F6ACDB680D5575C828B63660769F7D4">us-gaap:DebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="FI2020Q3"
      id="Fact-D12C984E2926521EB58CC5F84FF5302F-wk-Fact-D12C984E2926521EB58CC5F84FF5302F">us-gaap:LongtermDebtNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="FI2020Q3"
      id="Fact-E85449064D685A11A629FCBF8473E3CA-wk-Fact-E85449064D685A11A629FCBF8473E3CA">us-gaap:OtherNoncurrentAssets</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="Fact-C38866AB76F55F639DB0CB5920AA88AA-wk-Fact-C38866AB76F55F639DB0CB5920AA88AA"
      unitRef="usd">868400000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:LineOfCredit
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember"
      decimals="INF"
      id="Fact-95BE3103A6095233A6D5CFB41CD8AF32-wk-Fact-95BE3103A6095233A6D5CFB41CD8AF32"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="FD2018Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember"
      decimals="INF"
      id="Fact-10A4623254485662BBCF1F72D511E284-wk-Fact-10A4623254485662BBCF1F72D511E284"
      unitRef="case">1</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="FI2020Q3"
      id="Fact-E21D998F4F345CA1B04090D1D5405947-wk-Fact-E21D998F4F345CA1B04090D1D5405947">us-gaap:OtherCurrentLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="FI2020Q3"
      id="Fact-EF1A4F985B4355C8ADD8D2BE74CA2789-wk-Fact-EF1A4F985B4355C8ADD8D2BE74CA2789">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-E50ED4A92D1C518FBC448851806CD181-wk-Fact-E50ED4A92D1C518FBC448851806CD181"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="FI2020Q3"
      decimals="INF"
      id="Fact-E5E7F435D0A6551A8D86B8D48872B0BE-wk-Fact-E5E7F435D0A6551A8D86B8D48872B0BE"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-D3818411758F5BF7B0B7403E2ED87EDF-wk-Fact-D3818411758F5BF7B0B7403E2ED87EDF"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2020Q3"
      decimals="INF"
      id="Fact-7183F9DE039652CF96B33D3EC27D6A04-wk-Fact-7183F9DE039652CF96B33D3EC27D6A04"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="Fact-297D872A7AF7549EBE87C23B32F1EE6F-wk-Fact-297D872A7AF7549EBE87C23B32F1EE6F"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="Fact-180A933B76D3555598DC0D1DC25BBFF1-wk-Fact-180A933B76D3555598DC0D1DC25BBFF1"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="Fact-50CD09433BF05683836AC666AA95ED8B-wk-Fact-50CD09433BF05683836AC666AA95ED8B"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="Fact-75EB8D316FF858B7A25C9B228BAEB451-wk-Fact-75EB8D316FF858B7A25C9B228BAEB451"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="FD2020Q3YTD"
      id="Fact-7D52EBE017A655778785E719D7A559F4-wk-Fact-7D52EBE017A655778785E719D7A559F4">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList
      contextRef="FD2020Q3YTD"
      id="Fact-B86F185E22895AFA8B10AD27E84E64D5-wk-Fact-B86F185E22895AFA8B10AD27E84E64D5">us-gaap:ProductMember</us-gaap:TypeOfRevenueExtensibleList>
    <dei:DocumentType
      contextRef="FD2020Q3YTD"
      id="d6876e980-wk-Fact-5AA0D2C5246452E6B4E3246A0F193E25">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="FD2020Q3YTD"
      id="d6876e1001-wk-Fact-2CE5869673FC52E1A46A97E59314C942">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="FD2020Q3YTD"
      id="d6876e1010-wk-Fact-A56602DC41B21DAEB4A4C22C80CF8576">2020-09-26</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="FD2020Q3YTD"
      id="d6876e1032-wk-Fact-FC5BBF704F78587682A4D6E1C8F65F58">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="FD2020Q3YTD"
      id="d6876e1051-wk-Fact-C3D891927A6957EF9EA75A7BF637FA86">001-36353</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="FD2020Q3YTD"
      id="d6876e1060-wk-Fact-88AB4A4410E45D49B0E3B61BDF7CB822">Perrigo Company plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="FD2020Q3YTD"
      id="d6876e1085-wk-Fact-8A6233AF77755D239FEF5A89D89A6B11">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="FD2020Q3YTD"
      id="d6876e1122-wk-Fact-FD52F00C12A05676993C23782D4DF9E1">The Sharp Building,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="FD2020Q3YTD"
      id="d6876e1127-wk-Fact-784E7DD5B57856BD8CC1A42A3E8B2C3F">Hogan Place,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="FD2020Q3YTD"
      id="d6876e1132-wk-Fact-E22E7A90AFD85501BC5673EEEF93529B">Dublin 2,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="FD2020Q3YTD"
      id="d6876e1137-wk-Fact-574E860FE4A852C8A38DD8C574F4199E">IE</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="FD2020Q3YTD"
      id="d6876e1142-wk-Fact-819B865E1A475DE08F2BA8029FEFA056">D02 TY74</dei:EntityAddressPostalZipCode>
    <dei:CountryRegion
      contextRef="FD2020Q3YTD"
      id="d6876e1150-wk-Fact-A6A7A79C690358E9B108907CBC18D822">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="FD2020Q3YTD"
      id="d6876e1155-wk-Fact-674BEE2162B659E487821874B4C2FFA1">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="FD2020Q3YTD"
      id="d6876e1160-wk-Fact-6E85550F271D54DD93C4DD4822C7AAC6">7094000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="FD2020Q3YTD"
      id="d6876e1213-wk-Fact-E5C535CF577E58DEA93DD22375D80DAC">Ordinary shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="FD2020Q3YTD"
      id="d6876e1218-wk-Fact-9FBF779EDB3A54799BB56AF0B74CF091">PRGO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="FD2020Q3YTD"
      id="d6876e1223-wk-Fact-91E382F457A2593DAE24BCC89F5D2CFA">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="FD2020Q3YTD"
      id="d6876e1228-wk-Fact-91C82F7BF2B25BB49BD7816604829AE5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="FD2020Q3YTD"
      id="d6876e1242-wk-Fact-B48E57BAD9215D47983A81D5FA4DB713">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="FD2020Q3YTD"
      id="d6876e1278-wk-Fact-8309E7D80AF25FB28A79D4ED68A75663">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="FD2020Q3YTD"
      id="d6876e1328-wk-Fact-11A1699E695D5D72A13FC1619EDDD4FD">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="FD2020Q3YTD"
      id="d6876e1339-wk-Fact-564C3A8DE0AA500D93E04F56C83CC4C5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="FD2020Q3YTD"
      id="d6876e1504-wk-Fact-28C7C6ADE97E59D9A0B44DF8F9765673">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I2020Q4Oct30"
      decimals="INF"
      id="d6876e1526-wk-Fact-46487EDAD3B558C686FE3C82EBA771C2"
      unitRef="shares">136491307</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1177-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
      unitRef="usd">1213700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1196-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
      unitRef="usd">1191100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1215-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
      unitRef="usd">3773800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1235-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
      unitRef="usd">3514600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1250-wk-Fact-D6166CD88DD15F24801DF34453CB9491"
      unitRef="usd">785600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1269-wk-Fact-F244B3D2D80955E6B5620B5DF32AB4DB"
      unitRef="usd">778300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1288-wk-Fact-F6825A5E3B995584B76CA6D36B71F7AE"
      unitRef="usd">2427800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1308-wk-Fact-2C56732F6E4250198917B3F0D82295C2"
      unitRef="usd">2222100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1328-wk-Fact-81F2C0765D1F55CEBAE0B0B84CC8BAD1"
      unitRef="usd">428100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1347-wk-Fact-AD2ACF45FA9A594896046BDA40B217E8"
      unitRef="usd">412800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1366-wk-Fact-94F8C04EAA7A5E6A8ED126684364C4A7"
      unitRef="usd">1346000000.0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1386-wk-Fact-E0BE943D0E5D5FFDB6C129BEC94092EC"
      unitRef="usd">1292500000</us-gaap:GrossProfit>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1570-wk-Fact-99C564A157E95227BA2A1C248D3BAFD6"
      unitRef="usd">26100000</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1589-wk-Fact-07BF4A38132353559A3A90D57ED725BF"
      unitRef="usd">23400000</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1608-wk-Fact-CF83589A6DBE5EBD875948E1289631EF"
      unitRef="usd">73800000</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1628-wk-Fact-2B5974317800565A819F347B006A1CC9"
      unitRef="usd">70500000</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1648-wk-Fact-B76A2215A9FB5E669F6857D6D232EC96"
      unitRef="usd">42600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1667-wk-Fact-C96559780CA455C395496D78394DADC6"
      unitRef="usd">44000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1686-wk-Fact-A101BE0CE48450198FF03B004B337CF5"
      unitRef="usd">131600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1706-wk-Fact-6995F2F37A915DC7B3451C0F78757BC3"
      unitRef="usd">128000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1726-wk-Fact-8E1297B39280587C887EC2AEE44BDA00"
      unitRef="usd">138500000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1745-wk-Fact-FE9E6D0CB4915980B3F8753DAEB332A2"
      unitRef="usd">134100000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1764-wk-Fact-475D33601BDA5AA2B28FFC511898AB75"
      unitRef="usd">413900000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1784-wk-Fact-5CC9BFA62E165CB280B1F6231EDB396B"
      unitRef="usd">422800000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1804-wk-Fact-F213C6019F6758539A9F782BC2DE32E9"
      unitRef="usd">116400000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1823-wk-Fact-FB3A32D0E72C5E61B89842E6BC8586D0"
      unitRef="usd">131900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1842-wk-Fact-0D17087452555E1E91EE906BFD05727E"
      unitRef="usd">357800000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1862-wk-Fact-D5DFC8CE8BDE5D7588DDE4046D7C0722"
      unitRef="usd">384200000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1883-wk-Fact-4D169481AB5B5439BA8EBDCF9C20A388"
      unitRef="usd">202400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1902-wk-Fact-C0F88143E9155820ABA93477D1402976"
      unitRef="usd">10900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1921-wk-Fact-0066578628895F70805AFE67D1011EBB"
      unitRef="usd">202400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e1941-wk-Fact-940FE1DE4ED55FADA37E655425AB20A1"
      unitRef="usd">42900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e1961-wk-Fact-5BF31FADFAC15078AB8889D459B13191"
      unitRef="usd">800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e1980-wk-Fact-75C4561F82FE56D48E65977895A9597F"
      unitRef="usd">5200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e1999-wk-Fact-18F9BED0F94059D18D6FF41F640DA407"
      unitRef="usd">1900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2019-wk-Fact-CA124A1C3230592D914E7CD3C91A98A9"
      unitRef="usd">26700000</us-gaap:RestructuringCharges>
    <prgo:OtherOperatingIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2039-wk-Fact-67B631F017F15D3290CE486121FD8F8A"
      unitRef="usd">3200000</prgo:OtherOperatingIncomeLoss>
    <prgo:OtherOperatingIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2059-wk-Fact-67ACD959FE545FF6A7CC8890AB397236"
      unitRef="usd">-8900000</prgo:OtherOperatingIncomeLoss>
    <prgo:OtherOperatingIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2078-wk-Fact-65887CFEF969526A82AD691B482EBB58"
      unitRef="usd">3000000.0</prgo:OtherOperatingIncomeLoss>
    <prgo:OtherOperatingIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2099-wk-Fact-D2E3C15D6299558FAD65B4212506C6E5"
      unitRef="usd">-5700000</prgo:OtherOperatingIncomeLoss>
    <us-gaap:OperatingExpenses
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2119-wk-Fact-C8BC34D36EF350019379EC378D12FFF4"
      unitRef="usd">523600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2138-wk-Fact-E2E4D47006425A84B21A8A4FECE43DBF"
      unitRef="usd">358400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2157-wk-Fact-1CEDAF324F975565ADA1730C3B8A6584"
      unitRef="usd">1178400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2177-wk-Fact-8FFB3A412D4D5CE6853853A2555A9148"
      unitRef="usd">1080800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2279-wk-Fact-13D0525FEB2D521BAD5C1613BADE0743"
      unitRef="usd">-95500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2299-wk-Fact-6BF69FF58FFC512D8BE1DC951310FDC7"
      unitRef="usd">54400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2318-wk-Fact-CB2087D04AEC530794406BF111E1F908"
      unitRef="usd">167600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2338-wk-Fact-55D56F3E881C56179BCAACFE76CCD34E"
      unitRef="usd">211700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2440-wk-Fact-9A435B691FD4522F831473B58764B232"
      unitRef="usd">22200000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2460-wk-Fact-F1A3342D60F05ED0A88E726F9A316B8B"
      unitRef="usd">2600000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2480-wk-Fact-AA69DA9C163E5A8AB11F17B108E0C11E"
      unitRef="usd">25900000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2501-wk-Fact-8FC648BE938852AEAA299EA381B9DB24"
      unitRef="usd">18500000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2522-wk-Fact-5563699BAF3D5510876A69B2F5003B29"
      unitRef="usd">-34000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2541-wk-Fact-39CFAD777BBD500CA31E9B3E378D9D52"
      unitRef="usd">-30500000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2560-wk-Fact-2003F8F9485B5D92A9E51B11C3D690BB"
      unitRef="usd">-97600000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2580-wk-Fact-3BAD30E281D250B1806640BA4ED547C2"
      unitRef="usd">-90400000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2600-wk-Fact-7B895DB86A395FD8B2B3DCF0CCA06EA8"
      unitRef="usd">-400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2619-wk-Fact-D7BE36645A5C5C96AF8894AA8DB436F6"
      unitRef="usd">71000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2639-wk-Fact-097957692A2D57108C52A7A00CE0061D"
      unitRef="usd">-17100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2659-wk-Fact-A9690FAD7D5A5627A4159FEEA0CFF4AA"
      unitRef="usd">65600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2680-wk-Fact-2DE3346961E05C41A57A9022876AB1F7"
      unitRef="usd">-20000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2699-wk-Fact-936FEA0BC82A50A380BF335F54EC8FCF"
      unitRef="usd">-200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2718-wk-Fact-58778DCFB5C15CE5933FBA3C0454796C"
      unitRef="usd">-20000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2738-wk-Fact-43E7CF76DF365C59AED53F502E3D6F2B"
      unitRef="usd">-200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2759-wk-Fact-974556F193AF51178BEB5B79F11339B6"
      unitRef="usd">-127700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2779-wk-Fact-E7E85D617DAD56499190A63949698B6F"
      unitRef="usd">97300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2798-wk-Fact-7B964245CECA5999862A7250839E5546"
      unitRef="usd">58800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2818-wk-Fact-397684C7C0AF531288C3A768F51B87D8"
      unitRef="usd">205200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2838-wk-Fact-13F42C9E0AB7572EA0D58C2C70CC35B7"
      unitRef="usd">26900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2857-wk-Fact-A0900931255F52D09A510DBECD67D1F5"
      unitRef="usd">5100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2876-wk-Fact-963850785D655FAFBD85C4312DBB4FA5"
      unitRef="usd">46400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2896-wk-Fact-7B53CCA407665087A69A9D1AAB70AB08"
      unitRef="usd">40100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e2921-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD"
      unitRef="usd">-154600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e2941-wk-Fact-E71A91499A5557858B57177F0D58A3CB"
      unitRef="usd">92200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e2960-wk-Fact-08FB4EC393345107970F7A706AE01243"
      unitRef="usd">12400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e2980-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227"
      unitRef="usd">165100000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2020Q3QTD"
      decimals="2"
      id="d13015e3164-wk-Fact-3F016BC883125AE787BA41DAE927C058"
      unitRef="usdPerShare">-1.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d13015e3184-wk-Fact-B5FD5441F8D65F1BA1BFC4EFBF4713AA"
      unitRef="usdPerShare">0.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d13015e3203-wk-Fact-20DF8348799F54F08B2599045EB5C45B"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q3YTD"
      decimals="2"
      id="d13015e3223-wk-Fact-B992C4FB57B45FA58F50C2B3E56A779C"
      unitRef="usdPerShare">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2020Q3QTD"
      decimals="2"
      id="d13015e3243-wk-Fact-CA3135BEE17C548A8E59897B4A85B089"
      unitRef="usdPerShare">-1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d13015e3263-wk-Fact-6FC11F00A888585293AF5C83EC8D3BD6"
      unitRef="usdPerShare">0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d13015e3282-wk-Fact-7C4675C037705523A6385C1DB288F8AC"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q3YTD"
      decimals="2"
      id="d13015e3302-wk-Fact-B7A62C2E6A605695B4A26C863DA81F10"
      unitRef="usdPerShare">1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e3481-wk-Fact-78E62AC728A75531BF9A6E884F5303D3"
      unitRef="shares">136500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e3500-wk-Fact-1C2EF28688725C7D80F2C8088A76769A"
      unitRef="shares">136000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e3519-wk-Fact-C1E53D38F6B7552B9D0690947347E060"
      unitRef="shares">136300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e3539-wk-Fact-53FE4EB273C15CA4BE767C70DBCA9CA1"
      unitRef="shares">136000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d13015e3559-wk-Fact-5C5C30AFBA8C5A51A10D8E788B640859"
      unitRef="shares">136500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d13015e3578-wk-Fact-C8E3779330DE5F4FA67C150EA14283BA"
      unitRef="shares">136800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13015e3597-wk-Fact-F22C375A219F547E8118FB44221651D2"
      unitRef="shares">137500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13015e3617-wk-Fact-3543D9576257501785C04A94408B4FD0"
      unitRef="shares">136400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6879e1175-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD"
      unitRef="usd">-154600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d6879e1195-wk-Fact-E71A91499A5557858B57177F0D58A3CB"
      unitRef="usd">92200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6879e1214-wk-Fact-08FB4EC393345107970F7A706AE01243"
      unitRef="usd">12400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d6879e1234-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227"
      unitRef="usd">165100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6879e1331-wk-Fact-F683094658AD5E2C8D1FA45A6A9969B9"
      unitRef="usd">86500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d6879e1350-wk-Fact-EA8AB16F21255C328B59141405DC4BC1"
      unitRef="usd">-74000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6879e1370-wk-Fact-3B1B0553C98D57C89A2F4700B0C70E88"
      unitRef="usd">81000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d6879e1390-wk-Fact-BBA0FC2AB8B1531E945F753A3A024235"
      unitRef="usd">-63000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6879e1411-wk-Fact-DAF7525265345F5793CB7943623F36F0"
      unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d6879e1431-wk-Fact-617AD2395C3A5D5E9FE7767F467FCCEE"
      unitRef="usd">31600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6879e1450-wk-Fact-76F71DADF2EE503D85301BFEE96C5E4E"
      unitRef="usd">-12400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d6879e1471-wk-Fact-90F8C475DAB852CBA16B7D81E7545222"
      unitRef="usd">36000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6879e1491-wk-Fact-478BFF7CCE4353E685E6A39DAD607B5B"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d6879e1511-wk-Fact-8EB003F7711459F8AD7E555A65114AD1"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6879e1531-wk-Fact-A0331B96494C550E8A4CE6FDC2C0F84B"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d6879e1552-wk-Fact-FEA0B95E0F8551AA86210C3D0DF73E57"
      unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6879e1573-wk-Fact-41F0EC93E96E566ABA687EEFF4EA8600"
      unitRef="usd">83000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d6879e1592-wk-Fact-B55D38643BC659D6BE67B97A4EF336FC"
      unitRef="usd">-42900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6879e1612-wk-Fact-90E2EFBA909E53649BADCFE90EC3C82B"
      unitRef="usd">64300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d6879e1632-wk-Fact-C6BCC5C7D3735A9D9F2D6F32C48BA865"
      unitRef="usd">-28000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6879e1658-wk-Fact-A786637DA62856288BFEE40B02A94C11"
      unitRef="usd">-71600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d6879e1678-wk-Fact-7E2EFE2849E456AF96AFD44F2086A5F8"
      unitRef="usd">49300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6879e1697-wk-Fact-5FA57E2320045FDB95D3C798F257D892"
      unitRef="usd">76700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d6879e1717-wk-Fact-D21BD5A85B1359B1B6B160B843A21FA7"
      unitRef="usd">137100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1084-wk-Fact-B08D4E5650455C41A96B10AB95755662"
      unitRef="usd">849400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1103-wk-Fact-D151DAE0165F515AA946E2641B39957C"
      unitRef="usd">354300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1118-wk-Fact-5F34D6CB74115D559052A99CE98C66D1"
      unitRef="usd">1097700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1137-wk-Fact-7CAB09AD34E952A4BA0FD3BEB0AA603A"
      unitRef="usd">1243200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1157-wk-Fact-D5426A6C267D5922AD6216A00522426B"
      unitRef="usd">1100700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1176-wk-Fact-CE06DA9DF0A8583C86A12692EB25FCB9"
      unitRef="usd">967300000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1196-wk-Fact-A98CA9491C4A5F689031A6A85DBD7BEC"
      unitRef="usd">350500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1215-wk-Fact-C861EFF2BF4D503BB9201F2A42EDF17A"
      unitRef="usd">165800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1235-wk-Fact-E5ADCC0F3F7C50DF8823F83A70ECD24E"
      unitRef="usd">3398300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1254-wk-Fact-0C578EAB1BCA54999E98700EA58D4303"
      unitRef="usd">2730600000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1274-wk-Fact-A552481193E8551794060A0CDD695D03"
      unitRef="usd">918800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1293-wk-Fact-6B8804A158695C78AC4BEE502F7DA950"
      unitRef="usd">902800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1313-wk-Fact-E6F78C2EB5D957A0995950F29DB10E47"
      unitRef="usd">132200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1332-wk-Fact-E70D989FFA1C5AD380968DF9112E78C9"
      unitRef="usd">129900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <prgo:GoodwillAndIndefiniteLivedIntangibles
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1352-wk-Fact-E3EFA56D1F5259CFB31AF29E652531BE"
      unitRef="usd">3854100000</prgo:GoodwillAndIndefiniteLivedIntangibles>
    <prgo:GoodwillAndIndefiniteLivedIntangibles
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1371-wk-Fact-B98CD79C84835C2BBD3BB25BFCDF8122"
      unitRef="usd">4185500000</prgo:GoodwillAndIndefiniteLivedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1391-wk-Fact-9536CD6C7F7D5A3596D2A15D17CC7DA8"
      unitRef="usd">2895400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1410-wk-Fact-655BE46BAB8E5BD6AE9CAEEFADCBC8E4"
      unitRef="usd">2921200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1431-wk-Fact-95AB029F4A5054C3909C27A0726478BF"
      unitRef="usd">7300000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1450-wk-Fact-61902C9BDAB85E76811AD77E8ED57BBD"
      unitRef="usd">5400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1470-wk-Fact-DC2E5588F3A55F56AFFD7D98D434D642"
      unitRef="usd">369900000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1489-wk-Fact-AE36FC0EAA59592C9DF2A437B6CF2354"
      unitRef="usd">426000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1509-wk-Fact-7AFADFFB51955286BD8FE26FA0BD2172"
      unitRef="usd">8177700000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1528-wk-Fact-408650279E7E53A691D470FAC94022ED"
      unitRef="usd">8570800000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1553-wk-Fact-787E99A35A81503989617F4B938A50C2"
      unitRef="usd">11576000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1572-wk-Fact-BCC4DA49384256F793F37AC4E26ADB03"
      unitRef="usd">11301400000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1633-wk-Fact-2908C1A7F7435910B7170DD41A359689"
      unitRef="usd">536400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1652-wk-Fact-E1731DCD99FF5085B1CCB55F93CFE478"
      unitRef="usd">520200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1667-wk-Fact-EE9066D6FF6056D89507FB7A496DA3E6"
      unitRef="usd">155400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1686-wk-Fact-CB2A4B5BBA9753F6A6F3B1573368E59E"
      unitRef="usd">156400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <prgo:AccruedCustomerPrograms
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1706-wk-Fact-6C7D58AD71E45961A0FF7EC194B665F0"
      unitRef="usd">370100000</prgo:AccruedCustomerPrograms>
    <prgo:AccruedCustomerPrograms
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1725-wk-Fact-35AB05C2FEA1576C846CD69E954EFDC8"
      unitRef="usd">394400000</prgo:AccruedCustomerPrograms>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1745-wk-Fact-B133E738D00D55D7B2BA8209126EC1DD"
      unitRef="usd">237000000.0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1764-wk-Fact-3B702F5058385EA3B90581548AE01221"
      unitRef="usd">229200000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1784-wk-Fact-B085B78B882E5546B9BAF6F628653544"
      unitRef="usd">20900000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1803-wk-Fact-633E87256F8E5CA0B7A80FD1F0A965A0"
      unitRef="usd">32200000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1823-wk-Fact-1A290D85FA3C5B7F9821989DFADE8849"
      unitRef="usd">16500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1842-wk-Fact-D36C8F9CB1795F2FAD96068388C7EC47"
      unitRef="usd">3400000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1863-wk-Fact-BCA652715A7E57A6A707EDBB4CB8E558"
      unitRef="usd">1336300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1882-wk-Fact-68E4E10650DF5668B209C32F53CDF363"
      unitRef="usd">1335800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1902-wk-Fact-F430BF656C9D59D4B7C0DED9C182B3BC"
      unitRef="usd">3543600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1921-wk-Fact-3D3715BC11DE5A3DB437F324C420D917"
      unitRef="usd">3365800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1941-wk-Fact-DBD85E21F36550558404550CDA6EF93A"
      unitRef="usd">313500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1960-wk-Fact-95FD16A6604453A7855CCF5E8C283EB8"
      unitRef="usd">280600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e1980-wk-Fact-614067DF65F95D03B7E0545F687953F2"
      unitRef="usd">562200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e1999-wk-Fact-2961551383765F2683446732EB57DBAB"
      unitRef="usd">515100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2019-wk-Fact-BEF425A55D6E53768D309EFA034ADBA4"
      unitRef="usd">4419300000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2038-wk-Fact-07F72667C83F5EFFB564C38668FE0048"
      unitRef="usd">4161500000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2058-wk-Fact-BA6429A7F5A758F79B984087488DD3AC"
      unitRef="usd">5755600000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2077-wk-Fact-5F645EABEEF95366842A4F98F3610E1C"
      unitRef="usd">5497300000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="FI2020Q3"
      id="d73195e2097-wk-Fact-B0AE97948A365647988ED3C298466661"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="FI2019Q4"
      id="d73195e2116-wk-Fact-1548CD04FAF95D2FB8E3F13DCA074CFD"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2218-wk-Fact-E7C3674617595562A2DFD9FD40037E93"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2237-wk-Fact-9E7543ED2E6C5455890A0CB6AB55FD87"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2257-wk-Fact-0C98A059094859BC971510ADB80FFE29"
      unitRef="usd">7299700000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2276-wk-Fact-24AE47D344FA51D9AD3EBD89682ECE3D"
      unitRef="usd">7359900000</us-gaap:CommonStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2297-wk-Fact-34131CDA17AB5B55929586B106286EBA"
      unitRef="usd">203700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2316-wk-Fact-8D77E76C12D35A9AB036A03D933E13B4"
      unitRef="usd">139400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2336-wk-Fact-B1484A6A38415FB2B217BC927C6E1DD4"
      unitRef="usd">-1683100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2356-wk-Fact-0AC7FAF7146E559CB0A056BE9793B4A6"
      unitRef="usd">-1695500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2377-wk-Fact-846869810E8450D8BE8B8396EBFB23D6"
      unitRef="usd">5820300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2396-wk-Fact-D06E57F29B8B5F4A8D9A0640CB3E74C9"
      unitRef="usd">5803800000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2416-wk-Fact-DD18E88E31485C509A2C16EA786ED3EA"
      unitRef="usd">100000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2435-wk-Fact-813D32CDFA31544C97125290B6DAA56E"
      unitRef="usd">300000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2455-wk-Fact-31AC25C6418C5EF1B128E90C0ACF41AC"
      unitRef="usd">5820400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2474-wk-Fact-0B2C8A56E41B50B9A53F5BC365D5ADBB"
      unitRef="usd">5804100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2499-wk-Fact-55A9CC725DB7548C9E80765FF1C65801"
      unitRef="usd">11576000000.0</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2518-wk-Fact-5FF813B284E15ACC80A4BDE2078F8B0E"
      unitRef="usd">11301400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2615-wk-Fact-ED5C6E2B36D85F3C9F06E7627B85CF44"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2634-wk-Fact-D5715894AA7C55F88D22CB7CAD4F6EBC"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q3"
      decimals="-5"
      id="d73195e2654-wk-Fact-32F98CB82DCA5BDBA176F6B7D87B3808"
      unitRef="shares">136500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-5"
      id="d73195e2673-wk-Fact-979A52AFE87552A3A6D7CBF8E3134BF4"
      unitRef="shares">136100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1202-wk-Fact-919029BBB7BC51A196399921CAC3EAEC"
      unitRef="shares">135900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1221-wk-Fact-0BAAA231E16652EBA4BFF1D7844F22AC"
      unitRef="usd">7421700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e1240-wk-Fact-09E288712835517CB242674E00D62E5C"
      unitRef="usd">84600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e1260-wk-Fact-CA8D6337EF8858208913920FF026E877"
      unitRef="usd">-1838300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4"
      decimals="-5"
      id="d93954e1280-wk-Fact-8262C131AC5C5959962BF53EEBB9FE9F"
      unitRef="usd">5668000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e1348-wk-Fact-81A2E9EA594256FBB47E3FCF64A4F37B"
      unitRef="usd">-3400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"
      decimals="-5"
      id="d93954e1368-wk-Fact-1916987E127D505D80728AEB4FEB23E9"
      unitRef="usd">-3400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e1442-wk-Fact-E931C1D49E64575797D12B51F38AAA47"
      unitRef="usd">63900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d93954e1461-wk-Fact-C476197AFBDE55889E03CB06AAAB118C"
      unitRef="usd">63900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e1514-wk-Fact-9468C459B1BA520CBE9637AA7408EDE6"
      unitRef="usd">-15600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d93954e1554-wk-Fact-2915EEE6E8A55E56843B94167DBC5386"
      unitRef="usd">-15600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1575-wk-Fact-C1CF07C10DBB519A860643D50EAD94C2"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1681-wk-Fact-78FCFDFD363D536FA4AC69AAB161847A"
      unitRef="usd">1800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d93954e1739-wk-Fact-4709BDF0324D533FB868AFD4060A1809"
      unitRef="usd">1800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1773-wk-Fact-8CE442FD5C4B52E08AEF09D4E0309258"
      unitRef="usd">14200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d93954e1831-wk-Fact-A0A801FFCBBC527EBCB7936D312685BA"
      unitRef="usd">14200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1865-wk-Fact-63F757725D865244862C205B2724E4A3"
      unitRef="usd">25900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d93954e1924-wk-Fact-DC7BC9C15E75541AB6F89BB02D0A492E"
      unitRef="usd">25900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1945-wk-Fact-46F5B40FE3CC5D5EB5F3AA087845D7D1"
      unitRef="shares">100000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e1960-wk-Fact-A6736529B9D45F30A047D8EBAB8CCEA8"
      unitRef="usd">2400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d93954e2019-wk-Fact-29FEE159C13F5C00B36031ADE13E6DC2"
      unitRef="usd">2400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2041-wk-Fact-7D477C283C865F91BB95AEF78771A9AD"
      unitRef="shares">136000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2060-wk-Fact-64A78F5CB7F5520C9EF7B387AF62FFE8"
      unitRef="usd">7409400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e2079-wk-Fact-52D65AD178C557D68921EEE5F222793A"
      unitRef="usd">69000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e2099-wk-Fact-9ECCECE03CF45DEE8E5C9C4CA8650AA8"
      unitRef="usd">-1777800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q1"
      decimals="-5"
      id="d93954e2119-wk-Fact-BA5CF86B4B9F517A8135A942E8597EA7"
      unitRef="usd">5700600000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e2284-wk-Fact-950C2E193B105B5D85BCE025A13695DB"
      unitRef="usd">9000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d93954e2303-wk-Fact-2994FB3EB9F45485AC6AEDF70085CEA7"
      unitRef="usd">9000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e2356-wk-Fact-C5F74F6188435CB6ACD0EE8DCC48E439"
      unitRef="usd">30500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d93954e2395-wk-Fact-187DE2A4F2D4504584C31118D13F2F19"
      unitRef="usd">30500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2429-wk-Fact-E89CD54CBCEF530285FE3FC0F227D59C"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d93954e2487-wk-Fact-863DB1D0B01C5F4DA73891FCCA7A691B"
      unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2521-wk-Fact-F54F4DA3EBEF5ACABB306DC3B6AE465F"
      unitRef="usd">1300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d93954e2579-wk-Fact-11B6540D668255FF93E21E31A81E266D"
      unitRef="usd">1300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2613-wk-Fact-B8DCA67146195B438047C6521C7D3134"
      unitRef="usd">14200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d93954e2671-wk-Fact-F5113C2D5FCD5B8B905B16CB02F54686"
      unitRef="usd">14200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2705-wk-Fact-199818663C165C72B2F24C78ECF2A7E9"
      unitRef="usd">28900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d93954e2764-wk-Fact-3198362BEE0C56B28FF310B6BDE087D7"
      unitRef="usd">28900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2799-wk-Fact-BC7902EAE1DE5045B00816F79AAE5FE5"
      unitRef="usd">800000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d93954e2858-wk-Fact-51E0329C3BD957B692D203F9262DB8CB"
      unitRef="usd">800000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2879-wk-Fact-212CB96294545CEFB7D6F90C45CEA9CB"
      unitRef="shares">136000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e2898-wk-Fact-74C0A61F98BD52B4872C21399AE42374"
      unitRef="usd">7395500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e2917-wk-Fact-F562D6631F205CA9A74148758FAC34C5"
      unitRef="usd">99500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e2937-wk-Fact-86B334C9E383555D9177B5E4A091E01D"
      unitRef="usd">-1768800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q2"
      decimals="-5"
      id="d93954e2957-wk-Fact-3DA0E683129350C8AC6C516CF184A954"
      unitRef="usd">5726200000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e3123-wk-Fact-7E08041E3BC754679799E159D406B21F"
      unitRef="usd">92200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d93954e3142-wk-Fact-E71A91499A5557858B57177F0D58A3CB"
      unitRef="usd">92200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e3195-wk-Fact-09B0D8908379593DBB84F98C4B6C3A8E"
      unitRef="usd">-42900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d93954e3235-wk-Fact-B55D38643BC659D6BE67B97A4EF336FC"
      unitRef="usd">-42900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3270-wk-Fact-6A3FE5A4172B59959D7BA97CCE085663"
      unitRef="usd">400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d93954e3328-wk-Fact-D0E931DBF4D85009B6E0F1DA0C090D72"
      unitRef="usd">400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3348-wk-Fact-6A1FF210695B54B586FFAC8F0310C07E"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3454-wk-Fact-AC8479F1C2E855078A4981F6928A9366"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d93954e3512-wk-Fact-2A61D90847D35003A818AB8CA94E127C"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3546-wk-Fact-0D4FE56646D857FCACA46C9381BC4BC2"
      unitRef="usd">11900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d93954e3604-wk-Fact-679443BC21EE52F29E088721D5B21E0C"
      unitRef="usd">11900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3638-wk-Fact-919AB70CC29A5D69BB0BA9583432B19F"
      unitRef="usd">28800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d93954e3697-wk-Fact-C80667C4A6E951D498F67285A77E8519"
      unitRef="usd">28800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3732-wk-Fact-23275A4D5EF055188874C49208903E47"
      unitRef="usd">1100000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d93954e3791-wk-Fact-F451111BD0BE5E61AE4492DE6EEB71D0"
      unitRef="usd">1100000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3812-wk-Fact-BBCA5923A5225459864D35C83E57C2CC"
      unitRef="shares">136100000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e3831-wk-Fact-CA15807E74495141930F07036BE6E096"
      unitRef="usd">7378800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e3850-wk-Fact-151FD4BBAE745621AA3C874C258B59D2"
      unitRef="usd">56600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e3870-wk-Fact-C02B77CBCFBF54C9B36214973056E96D"
      unitRef="usd">-1676600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q3"
      decimals="-5"
      id="d93954e3890-wk-Fact-F9026000C3035C2593B1B2196B1BD8C3"
      unitRef="usd">5758800000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4138-wk-Fact-D507145B780057A29523743891388CF7"
      unitRef="shares">136100000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4157-wk-Fact-6A2E12D2A4705F1CAD4BAC51C4819680"
      unitRef="usd">7359900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e4176-wk-Fact-E2902A17BE1D5AB38330DA9EA8BD38AA"
      unitRef="usd">139400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e4196-wk-Fact-68733B1EC6A65C808BC698C3ABFA4E24"
      unitRef="usd">-1695500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d93954e4216-wk-Fact-D06E57F29B8B5F4A8D9A0640CB3E74C9"
      unitRef="usd">5803800000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e4284-wk-Fact-FAC3B202B6F15C9DB25C0420E219D498"
      unitRef="usd">106400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q1QTD"
      decimals="-5"
      id="d93954e4303-wk-Fact-59B9364B2F12503686C5D2B3F09AED37"
      unitRef="usd">106400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e4356-wk-Fact-0B0976D9C4A452B5ACE288E099408AF6"
      unitRef="usd">-103500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q1QTD"
      decimals="-5"
      id="d93954e4396-wk-Fact-DDFBA54E478D59FEAD34600C8AB93A0C"
      unitRef="usd">-103500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4417-wk-Fact-9CDE1314AEC8580F892FE575452FA159"
      unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4523-wk-Fact-B9255D57CBA55D2BA391BBF9660CFEF0"
      unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2020Q1QTD"
      decimals="-5"
      id="d93954e4581-wk-Fact-1F2B4A113C5C51F1863B4D4164625BC8"
      unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4615-wk-Fact-D79753EAC3E0596CBC5580855C00D6F6"
      unitRef="usd">15400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2020Q1QTD"
      decimals="-5"
      id="d93954e4673-wk-Fact-45FB7436848957F6AA51106CB5136FDB"
      unitRef="usd">15400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4707-wk-Fact-9A4BDDC843C35403BCDD46FC8407EA6F"
      unitRef="usd">30900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2020Q1QTD"
      decimals="-5"
      id="d93954e4766-wk-Fact-0FB2A9B13E9E5FE1B6F1AE2DCBDE4081"
      unitRef="usd">30900000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4787-wk-Fact-B25C967A781A593CB63EC7D41362EC4F"
      unitRef="shares">100000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4802-wk-Fact-ED0C78F363DB5EA288AA79233B1CCFDF"
      unitRef="usd">5600000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q1QTD"
      decimals="-5"
      id="d93954e4861-wk-Fact-F9A13477EEB557648843EA554A9116CF"
      unitRef="usd">5600000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4882-wk-Fact-731519E00E455588B3275DFC59D2DE04"
      unitRef="shares">136300000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e4901-wk-Fact-CE44ED2C63595C62AA2D71901D5B2C46"
      unitRef="usd">7339600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e4920-wk-Fact-07256A7AABE353CDA4D1DD1D92C4318E"
      unitRef="usd">35900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e4940-wk-Fact-5E34A4DFEAEF52D4AA6309DE69485E9D"
      unitRef="usd">-1589100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q1"
      decimals="-5"
      id="d93954e4960-wk-Fact-1A401CE6D02753EA973F1C551DDF1395"
      unitRef="usd">5786400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e5126-wk-Fact-92343C9C02BA581DA615F53B62104870"
      unitRef="usd">60600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q2QTD"
      decimals="-5"
      id="d93954e5145-wk-Fact-C341ED6A2E5D5867B1F7740A9C5E8CC3"
      unitRef="usd">60600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e5198-wk-Fact-F1BA7E81821D57B3B04D569C482F4A7F"
      unitRef="usd">84800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q2QTD"
      decimals="-5"
      id="d93954e5237-wk-Fact-31E8408E11B75A818843134129F7922B"
      unitRef="usd">84800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5257-wk-Fact-2B3CC67BA6B0541BAEDF2E147317A08C"
      unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5363-wk-Fact-E6AF07E6FE1C5952B2C2E0649C2452A6"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2020Q2QTD"
      decimals="-5"
      id="d93954e5421-wk-Fact-9BF7C70A25CC589DA6A3753F395CAD15"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5455-wk-Fact-1CD85BB0CFB752B49E220A96E6DD12BB"
      unitRef="usd">13100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2020Q2QTD"
      decimals="-5"
      id="d93954e5513-wk-Fact-F2F736B69A11553ABEBDB5C34420BF84"
      unitRef="usd">13100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5547-wk-Fact-07C5B950E1C9530D9448C25CD4696F56"
      unitRef="usd">31000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2020Q2QTD"
      decimals="-5"
      id="d93954e5606-wk-Fact-5C8E69A5B1EB53A1B2A599061F208A5C"
      unitRef="usd">31000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5627-wk-Fact-78AED5C819F356F0AF7FBD747BFE13E7"
      unitRef="shares">100000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q2QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5642-wk-Fact-5F82F53D4C335F219799BD41E88240E2"
      unitRef="usd">3900000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q2QTD"
      decimals="-5"
      id="d93954e5701-wk-Fact-D7ED7939C5B050E092F5DC926D15E0C8"
      unitRef="usd">3900000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5722-wk-Fact-93E6F763AC765C9EA1458E9B38DE81EF"
      unitRef="shares">136500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e5741-wk-Fact-60D762E5825150829B8F9EFB583EA4D1"
      unitRef="usd">7318200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e5760-wk-Fact-2A1C5E6A5B2B54FEAD2EEBBCC4261619"
      unitRef="usd">120700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e5780-wk-Fact-810ED380803957DE8D023266A73C47FF"
      unitRef="usd">-1528500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q2"
      decimals="-5"
      id="d93954e5800-wk-Fact-1318198479BF57A8810BAB00AE766131"
      unitRef="usd">5910400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e5965-wk-Fact-D5AF79DF33E0553DBCAD8C47E5EEE4D4"
      unitRef="usd">-154600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d93954e5985-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD"
      unitRef="usd">-154600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e6040-wk-Fact-927703C172E25D7797B907787A799936"
      unitRef="usd">83000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d93954e6079-wk-Fact-41F0EC93E96E566ABA687EEFF4EA8600"
      unitRef="usd">83000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6113-wk-Fact-01067141B0285BA19EA9A1F4ADA3DDA2"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d93954e6171-wk-Fact-8B6AC875DAE95993971D7D216F015CAE"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6205-wk-Fact-742D581D96CB56708D21103AA94EF9CF"
      unitRef="usd">13800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d93954e6263-wk-Fact-58F8626D7E215405B2FA2ED5071439C9"
      unitRef="usd">13800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6297-wk-Fact-74F8F9D79B465408AB6520B3B66178C7"
      unitRef="usd">31100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d93954e6356-wk-Fact-7F1E77FC635752808333DA75D33A2D1B"
      unitRef="usd">31100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6391-wk-Fact-2F4C180A219E5A06A9E41EC1B7582A35"
      unitRef="usd">500000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d93954e6450-wk-Fact-1301F3D90EBC5E2FAFD78799033B7D01"
      unitRef="usd">500000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6471-wk-Fact-043EECBD788D53ACB754B78C197305D3"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6485-wk-Fact-3D1620220EE451F4A9502D188524CEEF"
      unitRef="usd">1100000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d93954e6544-wk-Fact-8F4FBF61050458B4B3C358388326F8BB"
      unitRef="usd">1100000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:SharesOutstanding
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6565-wk-Fact-89FC093427065AB395F88B7182D71D4E"
      unitRef="shares">136500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d93954e6584-wk-Fact-F99B7AF9F64E581687294D6B33C2AA46"
      unitRef="usd">7299700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d93954e6603-wk-Fact-6E44D95C44115A8395CECBD5423A2DA3"
      unitRef="usd">203700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d93954e6623-wk-Fact-C269320FF2955943AB7A441DCB0952BC"
      unitRef="usd">-1683100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3"
      decimals="-5"
      id="d93954e6643-wk-Fact-846869810E8450D8BE8B8396EBFB23D6"
      unitRef="usd">5820300000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1125-wk-Fact-08FB4EC393345107970F7A706AE01243"
      unitRef="usd">12400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1144-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227"
      unitRef="usd">165100000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1200-wk-Fact-F53C91BDE1545CB7A7B87535C8EBE85F"
      unitRef="usd">284700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1219-wk-Fact-1EBD0EE6FC245540AA0CF754F341EF39"
      unitRef="usd">293500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1239-wk-Fact-45394A79770C5D8897868EE5B0D2D8AE"
      unitRef="usd">-18600000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1258-wk-Fact-F7C32398D30C5C45996AAF182AE08A6B"
      unitRef="usd">72400000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1279-wk-Fact-B8F7E44E3117500FBA940FB5C245BDC5"
      unitRef="usd">43900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1298-wk-Fact-37BB27C8399B52AA8DFF412DCB67A4F2"
      unitRef="usd">40900000</us-gaap:ShareBasedCompensation>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1318-wk-Fact-0066578628895F70805AFE67D1011EBB"
      unitRef="usd">202400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1337-wk-Fact-940FE1DE4ED55FADA37E655425AB20A1"
      unitRef="usd">42900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1357-wk-Fact-AA69DA9C163E5A8AB11F17B108E0C11E"
      unitRef="usd">25900000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1377-wk-Fact-8FC648BE938852AEAA299EA381B9DB24"
      unitRef="usd">18500000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1398-wk-Fact-58778DCFB5C15CE5933FBA3C0454796C"
      unitRef="usd">-20000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1417-wk-Fact-43E7CF76DF365C59AED53F502E3D6F2B"
      unitRef="usd">-200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1438-wk-Fact-18F9BED0F94059D18D6FF41F640DA407"
      unitRef="usd">1900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1457-wk-Fact-CA124A1C3230592D914E7CD3C91A98A9"
      unitRef="usd">26700000</us-gaap:RestructuringCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1477-wk-Fact-132A8191D6E85839813F643013F48C0D"
      unitRef="usd">25700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1496-wk-Fact-EFE1E702640F52489DE1AD255309E893"
      unitRef="usd">10100000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1516-wk-Fact-8F5740CE831C55538D0276ED799D083A"
      unitRef="usd">-1700000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1536-wk-Fact-647FA7FC6EB756D6988A8A56EA3642A1"
      unitRef="usd">-3800000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1557-wk-Fact-8358E596BDA4557C80C64844E121E06C"
      unitRef="usd">-12000000.0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1577-wk-Fact-18C532D0EF8653F6B10BD42099A23BC3"
      unitRef="usd">38300000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1597-wk-Fact-43F19EFD8A4451D2A9C05CEC800A6E8E"
      unitRef="usd">570000000.0</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1616-wk-Fact-929B96EEC4605CF3A757CFAC8F9F0884"
      unitRef="usd">523000000.0</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1677-wk-Fact-3A0C045B101459BAB6A01306BC42DC0E"
      unitRef="usd">-106400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1696-wk-Fact-EADE9CA2BDF45BA4AA255B64651FF2A0"
      unitRef="usd">12100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1717-wk-Fact-19A041549D865206A6A65FCB9DACF76A"
      unitRef="usd">93200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1737-wk-Fact-2B666BA3C8B45F30B768C2F5C262ECB0"
      unitRef="usd">78300000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1758-wk-Fact-80BEE97128A95061AA020B03F5829560"
      unitRef="usd">23800000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1778-wk-Fact-55AFE617029E577AAD3C4F3196E05370"
      unitRef="usd">4700000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1799-wk-Fact-910D30438BAF5942BBFADD9D77411048"
      unitRef="usd">15200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1818-wk-Fact-C0F826805E3C5DCE8399761ED23C3643"
      unitRef="usd">33700000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1838-wk-Fact-2819F56CAA1E53CD9CBE2563895954F6"
      unitRef="usd">-2200000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1858-wk-Fact-2488C50035825EB498108DA401C8C955"
      unitRef="usd">-10600000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <prgo:IncreaseDecreaseInAccruedCustomerPrograms
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1880-wk-Fact-E4C7C8A67C675697B868D6E5C68CE4C1"
      unitRef="usd">-35500000</prgo:IncreaseDecreaseInAccruedCustomerPrograms>
    <prgo:IncreaseDecreaseInAccruedCustomerPrograms
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1900-wk-Fact-D2ED3C5A50D05C95A50087BF1C07F11D"
      unitRef="usd">-82700000</prgo:IncreaseDecreaseInAccruedCustomerPrograms>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1921-wk-Fact-E85C4D94547D5939B4AD7BFF10A5B87D"
      unitRef="usd">-16000000.0</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1941-wk-Fact-8DF369619E0C5AE09B1E3C235A2D10C6"
      unitRef="usd">-24800000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e1962-wk-Fact-2371B8F5DC7350299C865823EFC2BAC9"
      unitRef="usd">-9000000.0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e1982-wk-Fact-44AB84F02F5E5D6599F952BC72D1C231"
      unitRef="usd">-65800000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2003-wk-Fact-B8C39DC0731157B0A7722241EDBB1564"
      unitRef="usd">-13900000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2022-wk-Fact-57BDBD2CBB0A5565B2D2BF7DFE00AE48"
      unitRef="usd">-20600000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2042-wk-Fact-376C912B89FA53BF8E41C9C039ED7B1C"
      unitRef="usd">44200000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2062-wk-Fact-B40D5D89C92E59639D35D6BCA6F0691A"
      unitRef="usd">224700000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2083-wk-Fact-16B85FB1A4205BC692DC5BDC4776C7C7"
      unitRef="usd">525800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2102-wk-Fact-8C65F63B772054D5B7DB1F1EC2D3736D"
      unitRef="usd">298300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <prgo:ProceedsfromRoyaltiesReceivedInvestingActivities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2163-wk-Fact-2DCA5A977293548E9EC79C42BB5B6DAD"
      unitRef="usd">3200000</prgo:ProceedsfromRoyaltiesReceivedInvestingActivities>
    <prgo:ProceedsfromRoyaltiesReceivedInvestingActivities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2182-wk-Fact-BE307687BEB85E06A2190299CB8EB98A"
      unitRef="usd">2200000</prgo:ProceedsfromRoyaltiesReceivedInvestingActivities>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2202-wk-Fact-A89EB36389905E01820EF04565506A05"
      unitRef="usd">15000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2222-wk-Fact-7D53F4105D1C50678CD0FE00D6A49171"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2242-wk-Fact-F81A03979969542981CFF0C72F1196B8"
      unitRef="usd">106000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2262-wk-Fact-C27C12EF117E53F79E869FB509FCEC04"
      unitRef="usd">749500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <prgo:ProceedsfromContingentMilestonePayment
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2283-wk-Fact-55C585F130B55907A21C9C23C7959A13"
      unitRef="usd">0</prgo:ProceedsfromContingentMilestonePayment>
    <prgo:ProceedsfromContingentMilestonePayment
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2302-wk-Fact-BE4A49FC30CC5C3DB0C3C38249A5BBA4"
      unitRef="usd">250000000.0</prgo:ProceedsfromContingentMilestonePayment>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2323-wk-Fact-5E98CE8BB7C151FC9DDA0203929EA2ED"
      unitRef="usd">34100000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2343-wk-Fact-9C1C73F90D9A5E029A02B3E03D7EC3AF"
      unitRef="usd">86200000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2364-wk-Fact-9CBE35742ADE5F3D8B7DC5292EB868EE"
      unitRef="usd">104300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2384-wk-Fact-40AF8462E0565D2E811A7D28A11C4AB8"
      unitRef="usd">90300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2405-wk-Fact-99738CEFD3EF5DA7BEBC2F1C2337F115"
      unitRef="usd">187800000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2424-wk-Fact-AEC794A4388A59A1845E8B33133F255D"
      unitRef="usd">183400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2444-wk-Fact-B3B45CCE25F25E849F40975DC17F4EBE"
      unitRef="usd">-8100000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2463-wk-Fact-EA34EC96385A5F7E85E536825C79DD8D"
      unitRef="usd">-600000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2483-wk-Fact-698B15B623535C10B4AFA068387EE671"
      unitRef="usd">-60300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2503-wk-Fact-BB5D52B604C351C494BF3728A6C8B8D2"
      unitRef="usd">-489800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2565-wk-Fact-95D980E8E959500BA87B9D5D432E67EE"
      unitRef="usd">743800000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2584-wk-Fact-87E245D04E6052CA95AC6AC8C5E355EA"
      unitRef="usd">600000000.0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2604-wk-Fact-8C2368EE2DD25DA4B4AD71A1BC305312"
      unitRef="usd">590000000.0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2624-wk-Fact-AEF78218F56852A3A5FB72FE99D34E74"
      unitRef="usd">476000000.0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2645-wk-Fact-520CBCA2C1F35128B48E2567D697E8F2"
      unitRef="usd">100000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2664-wk-Fact-600104C4EB20567BA2D4E58A58EA6D72"
      unitRef="usd">800000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2684-wk-Fact-D66E88AEF5A05C7D868CBD0E52EA4BC1"
      unitRef="usd">6700000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2704-wk-Fact-6A7EFC278FED58C992AF0D8182EAC639"
      unitRef="usd">1000000.0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2725-wk-Fact-B26EA1203062EFF0263846F00FA1FCF4"
      unitRef="usd">19000000.0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2745-wk-Fact-9491F5349BBB5E6CA1256218AAB22856"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2766-wk-Fact-A52BF06CDC225A11B05172EAFCB1CB86"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2785-wk-Fact-EC7630C811305379897F7C0D1DDBF35F"
      unitRef="usd">700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2805-wk-Fact-AE637BF800EA5FE08A302FD57CA35A6C"
      unitRef="usd">93000000.0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2825-wk-Fact-7A3348648872590EA2F12582E3F33F04"
      unitRef="usd">83600000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2846-wk-Fact-2D9421D511BD594785D2B54303FD3F11"
      unitRef="usd">-14900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2866-wk-Fact-54E055EDB9EF515CA1E074D94C1D1AF2"
      unitRef="usd">-7600000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2887-wk-Fact-184AAD8157AF534AB79D013A2D18FE83"
      unitRef="usd">20300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2906-wk-Fact-5213AD317A695D40B3E721D484F38FE1"
      unitRef="usd">33300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2926-wk-Fact-163AEE4D2536556C8791E7B5C6C841A9"
      unitRef="usd">9300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2945-wk-Fact-340BC6158CF958A6ACBC36025665A1E2"
      unitRef="usd">5600000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d13017e2965-wk-Fact-03BD4D7D560B5195A48D8ECC6EB9D90A"
      unitRef="usd">495100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d13017e2984-wk-Fact-6CCF08BBE7E25A19B1ACF22FFFF9B5AC"
      unitRef="usd">-152600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2019Q4"
      decimals="-5"
      id="d13017e3005-wk-Fact-ACD4FA4832435311AF626F2A11B39C26"
      unitRef="usd">354300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2018Q4"
      decimals="-5"
      id="d13017e3024-wk-Fact-46F1A11719E3509D8B11D5949905AEB3"
      unitRef="usd">551100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2020Q3"
      decimals="-5"
      id="d13017e3049-wk-Fact-58BB8483DAC05DE7AAF556A0DEE62432"
      unitRef="usd">849400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2019Q3"
      decimals="-5"
      id="d13017e3068-wk-Fact-FDB9871650AB5338976C30B8DEE11436"
      unitRef="usd">398500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-936C8E4E15C95481820A20F081C56695-0-wk-Fact-FCB7FFD329EF5B09B4409EDD660DE356">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES &lt;/span&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;General Information&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;The Company&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We are dedicated to making lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold.&#160;We are a leading provider of over-the-counter ("OTC") health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. We are also a leading producer of generic prescription pharmaceutical topical products such as creams, lotions, and gels as well as nasal sprays and inhalers. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Segment Reporting &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our reporting and operating segments are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-weight:bold;"&gt;Consumer Self-Care Americas&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; ("&lt;/span&gt;&lt;span style="font-family:Arial;font-weight:bold;"&gt;CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;") &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;comprises our consumer self-care business (OTC, contract manufacturing, infant formula, and oral self-care categories and our divested animal health category) in the U.S., Mexico and Canada. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-weight:bold;"&gt;Consumer Self-Care International&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; ("&lt;/span&gt;&lt;span style="font-family:Arial;font-weight:bold;"&gt;CSCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;") &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;comprises our branded consumer self-care business primarily in Europe, our consumer self-care businesses in the United Kingdom and Australia, and our divested liquid licensed products business in the United Kingdom.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-weight:bold;"&gt;Prescription Pharmaceuticals&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; ("&lt;/span&gt;&lt;span style="font-family:Arial;font-weight:bold;"&gt;RX&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;") &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;comprises our prescription pharmaceuticals business in the U.S., predominantly generics, and our pharmaceuticals and diagnostic businesses in Israel.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Certain prior period amounts have been reclassified from other current assets to other non-current assets on our balance sheet to conform to the current period presentation. Such reclassification had no impact on net income or earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Recent Accounting Standard Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:41%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Effective Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Effect on the Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;ASU 2018-14: Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;This guidance amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other post-retirement plans. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Upon adoption, we will no longer be required to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. We will be required to disclose an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, if applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;This guidance enhances and simplifies various aspects of the income tax accounting guidance in ASC 740.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Upon adoption, we do not expect a material impact on the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Recently Adopted Accounting Standard Update&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On January 1, 2020, we adopted ASU 2016-13 &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASC 326")&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which replaces the incurred loss methodology with an expected loss methodology that is referred to as the Current Expected Credit Loss ("CECL") methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We adopted ASC 326 using the modified retrospective method for all financial assets measured at amortized cost, which includes trade receivables and contract assets. The cumulative effect of adopting ASC 326 was not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and for reasonable and supportable forecasts. Historical credit loss experience provides the primary basis for estimation of expected credit losses. Adjustments to historical loss information may be made for significant changes in a geographic location&#x2019;s economic conditions. Receivables that do not share risk characteristics are evaluated on an individual basis. These receivables are not included in the collective evaluation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The allowance for credit losses is a valuation account that is deducted from the instruments&#x2019; cost basis to present the net amount expected to be collected. Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table presents the allowance for credit losses activity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:76.31027253668763%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Provision for credit losses, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Receivables written-off&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Recoveries collected&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Currency translation adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-DA42D19738E857629AFFB22794863D30-0-wk-Fact-5A518B35AE3F59DB898F38A665F26F20">&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-E5A54F1B17BE587F967FBD58E1FE1E73-0-wk-Fact-3EA6AE7C84AF547284EA4F35297682C4">In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-378B663A7FE55BED9FF5137D0F6159DD-0-wk-Fact-DC3A7A24EEF85A66A0D9657553463030">&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Recent Accounting Standard Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:41%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Effective Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Effect on the Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;ASU 2018-14: Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;This guidance amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other post-retirement plans. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Upon adoption, we will no longer be required to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. We will be required to disclose an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, if applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;This guidance enhances and simplifies various aspects of the income tax accounting guidance in ASC 740.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Upon adoption, we do not expect a material impact on the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Recently Adopted Accounting Standard Update&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On January 1, 2020, we adopted ASU 2016-13 &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASC 326")&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which replaces the incurred loss methodology with an expected loss methodology that is referred to as the Current Expected Credit Loss ("CECL") methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We adopted ASC 326 using the modified retrospective method for all financial assets measured at amortized cost, which includes trade receivables and contract assets. The cumulative effect of adopting ASC 326 was not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and for reasonable and supportable forecasts. Historical credit loss experience provides the primary basis for estimation of expected credit losses. Adjustments to historical loss information may be made for significant changes in a geographic location&#x2019;s economic conditions. Receivables that do not share risk characteristics are evaluated on an individual basis. These receivables are not included in the collective evaluation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The allowance for credit losses is a valuation account that is deducted from the instruments&#x2019; cost basis to present the net amount expected to be collected. Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible. &lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-DAD6D04F9120500CB67116019A77492C-0-wk-Fact-4FA43792D28258389AAB9F24102E520C">As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:41%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Effective Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;font-weight:bold;"&gt;Effect on the Financial Statements or Other Significant Matters&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;ASU 2018-14: Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;This guidance amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other post-retirement plans. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Upon adoption, we will no longer be required to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. We will be required to disclose an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, if applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;This guidance enhances and simplifies various aspects of the income tax accounting guidance in ASC 740.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Upon adoption, we do not expect a material impact on the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-C9AD8225A0DC550694B80F95BDFBB8CB-0-wk-Fact-E4DC6DFEC5555D89A910B803CC08DF90">&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table presents the allowance for credit losses activity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:76.31027253668763%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Provision for credit losses, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Receivables written-off&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Recoveries collected&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Currency translation adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="FI2020Q2"
      decimals="-5"
      id="d6883e1525-wk-Fact-735196DD20B957B2B4120AF2E1F8FCC4"
      unitRef="usd">6200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="FI2019Q4"
      decimals="-5"
      id="d6883e1544-wk-Fact-D8CCAD9B9909561382639359A4072805"
      unitRef="usd">6700000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6883e1559-wk-Fact-2D3950B91EEE50C5B016195A43D7013C"
      unitRef="usd">600000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6883e1578-wk-Fact-8DA8E7845E455D179A16B9DABBD41403"
      unitRef="usd">1500000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6883e1598-wk-Fact-30F36CAE4BFF566AB85A0A2B722C9823"
      unitRef="usd">700000</us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs>
    <us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6883e1618-wk-Fact-DC57F56A5B995A5D88CE6C68A5BE63A4"
      unitRef="usd">1700000</us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6883e1639-wk-Fact-46E908BBFEFA5A05B302AEB1AB1A2DA5"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6883e1658-wk-Fact-46D3EAF1F94352FB93E5F5837EF471E9"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <prgo:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d6883e1678-wk-Fact-4631D656036557AA89B5DC95B7760EBE"
      unitRef="usd">200000</prgo:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation>
    <prgo:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d6883e1697-wk-Fact-A58FD694406551FFBD1A08A9D2DD954D"
      unitRef="usd">-200000</prgo:AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="FI2020Q3"
      decimals="-5"
      id="d6883e1723-wk-Fact-5A1CD941C7525446B4A569E7E33C711B"
      unitRef="usd">6300000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="FI2020Q3"
      decimals="-5"
      id="d6883e1742-wk-Fact-5A1CD941C7525446B4A569E7E33C711B"
      unitRef="usd">6300000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-B4B3C4CF674951868DB5B341E0157BC4-0-wk-Fact-8B06042F419950608C3ABA2436E54B80">&lt;span style="font-family:Arial;font-weight:bold;"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We generated net sales in the following geographic locations&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;(in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:526px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:134px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;820.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;785.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,571.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,323.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Europe&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;326.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;334.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,011.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;991.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;All other countries&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;66.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;191.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;200.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"/&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  Derived from the location of the entity that sells to a third party.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:72px;text-indent:72px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)  Includes Ireland net sales of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$10.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$22.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;, respectively, and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$5.2&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$17.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(3)  Includes net sales generated primarily in Israel, Mexico, Australia and Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Product Category&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We re-aligned our product categories in our &lt;/span&gt;&lt;span style="font-family:Arial;"&gt;CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;"&gt;CSCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following is a summary of our net sales by category (in millions); the comparative periods reflect the product category re-alignment: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:304px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Upper respiratory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;114.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;123.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;385.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;377.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Digestive health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;107.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;85.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;326.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;293.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Pain and sleep-aids&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;100.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;89.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;318.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;272.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Nutrition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;100.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;97.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;290.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;282.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Healthy lifestyle&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;86.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;87.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;253.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;250.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Oral self-care&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;199.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Skincare and personal hygiene&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;49.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Vitamins, minerals, and supplements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Animal health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;43.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;60.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;48.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;664.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;613.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,992.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,777.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Skincare and personal hygiene&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;83.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;88.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;275.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;296.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Upper respiratory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;62.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;72.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;191.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;193.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Vitamins, minerals, and supplements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;52.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;46.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;139.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;133.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Pain and sleep-aids&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;49.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;120.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Healthy lifestyle&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;38.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;124.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;134.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Oral self-care&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Digestive health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other CSCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;88.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;100.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;339.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;347.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,042.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,025.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;210.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;230.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;738.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;711.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)&#160;&#160;&#160;&#160;Includes net sales from our OTC contract manufacturing business.&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$76.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$190.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, respectively, and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$73.9&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$207.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table provides information about contract assets from contracts with customers (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Short-term contract assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-A01B50A38DD65B02A6CDE424EABA9C45-0-wk-Fact-61AD78FA54AD553FA6F12F1D2C9F9FA9">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We generated net sales in the following geographic locations&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1) &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;(in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:526px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:134px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;820.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;785.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,571.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,323.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Europe&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;326.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;334.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,011.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;991.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;All other countries&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;66.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;191.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;200.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"/&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  Derived from the location of the entity that sells to a third party.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:72px;text-indent:72px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)  Includes Ireland net sales of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$10.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$22.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;, respectively, and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$5.2&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$17.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(3)  Includes net sales generated primarily in Israel, Mexico, Australia and Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Product Category&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We re-aligned our product categories in our &lt;/span&gt;&lt;span style="font-family:Arial;"&gt;CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;"&gt;CSCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following is a summary of our net sales by category (in millions); the comparative periods reflect the product category re-alignment: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:304px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:79px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Upper respiratory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;114.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;123.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;385.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;377.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Digestive health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;107.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;85.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;326.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;293.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Pain and sleep-aids&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;100.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;89.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;318.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;272.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Nutrition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;100.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;97.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;290.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;282.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Healthy lifestyle&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;86.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;87.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;253.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;250.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Oral self-care&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;199.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Skincare and personal hygiene&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;49.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Vitamins, minerals, and supplements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Animal health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;43.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;60.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;48.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;664.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;613.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,992.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,777.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Skincare and personal hygiene&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;83.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;88.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;275.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;296.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Upper respiratory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;62.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;72.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;191.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;193.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Vitamins, minerals, and supplements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;52.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;46.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;139.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;133.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Pain and sleep-aids&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;49.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;120.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Healthy lifestyle&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;38.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;124.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;134.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Oral self-care&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Digestive health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other CSCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;88.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;100.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;339.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;347.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,042.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,025.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;210.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;230.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;738.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;711.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)&#160;&#160;&#160;&#160;Includes net sales from our OTC contract manufacturing business.&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d78798e1206-wk-Fact-DE9A4C836BA8550DB1E1A87EB6EAE22E"
      unitRef="usd">820800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d78798e1225-wk-Fact-392CC0D02686521681FB64A94FFD57EC"
      unitRef="usd">785900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d78798e1244-wk-Fact-DD3F6F8837535D62BCEAA41CB8BB7E87"
      unitRef="usd">2571100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d78798e1264-wk-Fact-18CC7AAB145A5D47B3481557211BBDCA"
      unitRef="usd">2323200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember"
      decimals="-5"
      id="d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1"
      unitRef="usd">326600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_srt_EuropeMember"
      decimals="-5"
      id="d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA"
      unitRef="usd">334600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember"
      decimals="-5"
      id="d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0"
      unitRef="usd">1011000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_srt_EuropeMember"
      decimals="-5"
      id="d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681"
      unitRef="usd">991300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember"
      decimals="-5"
      id="d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E"
      unitRef="usd">66300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember"
      decimals="-5"
      id="d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E"
      unitRef="usd">70600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember"
      decimals="-5"
      id="d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152"
      unitRef="usd">191700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_prgo_OtherGeographicalAreasMember"
      decimals="-5"
      id="d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560"
      unitRef="usd">200100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d78798e1444-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
      unitRef="usd">1213700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d78798e1463-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
      unitRef="usd">1191100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d78798e1482-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
      unitRef="usd">3773800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d78798e1502-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
      unitRef="usd">3514600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_country_IE"
      decimals="-5"
      id="d78798e1535-wk-Fact-777739C88F5458FD97072B94A884ACB5"
      unitRef="usd">10800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_country_IE"
      decimals="-5"
      id="d78798e1539-wk-Fact-D490B719F9405AAEA6CD9E886BC21C81"
      unitRef="usd">22300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_country_IE"
      decimals="-5"
      id="d78798e1551-wk-Fact-785C42BE34D450829F0F567A78E16CBC"
      unitRef="usd">5200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_country_IE"
      decimals="-5"
      id="d78798e1556-wk-Fact-09CB522366FF5AE2A4653792E4240826"
      unitRef="usd">17300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e1908-wk-Fact-0BA2FB3E6CEFDE829E52C23D08C7F02A"
      unitRef="usd">114200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e1927-wk-Fact-07165EDB3C0005A6D9D2C23D4017AF82"
      unitRef="usd">123400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e1946-wk-Fact-058668D8C7005426B4C3D67A9EF7BA2C"
      unitRef="usd">385500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e1966-wk-Fact-EEDAC2A820335BAE87547B31EBD9B783"
      unitRef="usd">377400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e1981-wk-Fact-98212D0D96F6C3C466A6C23D091CC246"
      unitRef="usd">107100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2000-wk-Fact-C74F19076DA00A5A112EC23D401D8661"
      unitRef="usd">85000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2019-wk-Fact-D8FA5406EF085766869DD5593BBE73C1"
      unitRef="usd">326100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2039-wk-Fact-2D3B683CCB6757D19D2C95D94D3569F4"
      unitRef="usd">293600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2059-wk-Fact-034B81C2CBF9BD393C6BC23D090C4C72"
      unitRef="usd">100600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2078-wk-Fact-A071C9820456842D5C8DC23D400BDA15"
      unitRef="usd">89400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2097-wk-Fact-9563BEF0C0E95D478DFD17FFD936C48D"
      unitRef="usd">318700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2117-wk-Fact-8DA178F61A0B599B8927F372D1AD84EA"
      unitRef="usd">272000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2137-wk-Fact-284B913344E890E80267C23D08DE1D31"
      unitRef="usd">100100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2156-wk-Fact-62E52EE1F31D31AECA10C23D4005FDC0"
      unitRef="usd">97100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2175-wk-Fact-6C2AFC76F3FB504D9DEA13D586331121"
      unitRef="usd">290900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_NutritionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2195-wk-Fact-43B0F047528459B790AAD8A9134D6AA2"
      unitRef="usd">282600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2215-wk-Fact-B655005C6314FA6A5234C23D08EAFD02"
      unitRef="usd">86100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2234-wk-Fact-5B5B45D14A2090C385D7C23D40001AF2"
      unitRef="usd">87900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2253-wk-Fact-02352B46854A58049795BE464FC233D9"
      unitRef="usd">253400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2273-wk-Fact-4D78AA98677C5D8A90ACFBB38F4EAF9B"
      unitRef="usd">250000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2293-wk-Fact-B8F573B70839E2A8BBFFC23D091C44CD"
      unitRef="usd">81100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2312-wk-Fact-AF98BE21034CD26C4FE6C23D3FBF0A4B"
      unitRef="usd">54200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2331-wk-Fact-1EDEA42D38F954E886C6569B8C981F6C"
      unitRef="usd">199600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2351-wk-Fact-8BD2C497D6995B9FBEC20505802E4864"
      unitRef="usd">54200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2371-wk-Fact-C9CD9CB7062A2550FB5AC23D08E347EF"
      unitRef="usd">49200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2390-wk-Fact-56C2DDD0574A5F4F2A28C23D3FE2DE4F"
      unitRef="usd">45400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2409-wk-Fact-8433D7C2B404533EAFB42C71B825CE9F"
      unitRef="usd">138800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2429-wk-Fact-E1FC9D6A150754FCB60DFBF799663B3D"
      unitRef="usd">136700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2449-wk-Fact-560EE9F6818EE9154A68C23D08C74EBA"
      unitRef="usd">6300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2468-wk-Fact-B0487950B5F34DB9F3D2C23D3FF990C4"
      unitRef="usd">6200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2487-wk-Fact-98DD498FAEFC5940AEE42CD74D33C288"
      unitRef="usd">19100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2507-wk-Fact-1C660C6F8C885777917A013B8B8DFE59"
      unitRef="usd">18700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2528-wk-Fact-29AAAE7CC23E70F54FDDC23D08B8004C"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2547-wk-Fact-6E4DC9AC015A4D32CCEDC23D3FDC3B64"
      unitRef="usd">1800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2566-wk-Fact-152380BDE3875A368ADC1645FA22C174"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2586-wk-Fact-E721BAA9C2B050908B37049D4B6BBD68"
      unitRef="usd">43700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2608-wk-Fact-2B31A4553CCB3532E5BFC23D08D85530"
      unitRef="usd">19300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2627-wk-Fact-FC07D92174658F508F43C23D40114902"
      unitRef="usd">22900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599"
      unitRef="usd">60100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCAMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4"
      unitRef="usd">48300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2686-wk-Fact-C31A12065CA4018CCDDCC23D08FB9B33"
      unitRef="usd">664000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2705-wk-Fact-6F06EEC2D6D104D37336C23D40236485"
      unitRef="usd">613300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2724-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
      unitRef="usd">1992200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d78798e2744-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
      unitRef="usd">1777200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2846-wk-Fact-1CEE4F89C13D0FD65017C23D090738E5"
      unitRef="usd">83100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2865-wk-Fact-49F7A7C0DF94949D258AC23D3FEE6494"
      unitRef="usd">88900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2884-wk-Fact-96A1FE303DEB527D9AE1AA9ABB759C95"
      unitRef="usd">275400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_SkincareandPersonalHygieneMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2904-wk-Fact-A43072A5AB705B8C9F96F1F79BA64C42"
      unitRef="usd">296500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2924-wk-Fact-511A300C66A83A6A98A6C23D08C7DB95"
      unitRef="usd">62300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2943-wk-Fact-CD334F190A4079CC036CC23D4030E2C7"
      unitRef="usd">72100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2962-wk-Fact-51F74971F2425151B7F21CDE4D75CA25"
      unitRef="usd">191900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e2982-wk-Fact-203E920C49D0599D8A5AEB6E8CADC555"
      unitRef="usd">193900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3002-wk-Fact-EABE5FE0AFF8E6951059C23D08F21821"
      unitRef="usd">52900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3021-wk-Fact-5209399D4C0D67ADF0D7C23D3FCB5161"
      unitRef="usd">46200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3040-wk-Fact-1BC7BA0E70C2579693D29CA3419C0AD3"
      unitRef="usd">139900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_VitaminsMineralsandSupplementsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3060-wk-Fact-1B3ED369658C5A089B57614E70D0B4C2"
      unitRef="usd">133100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3080-wk-Fact-6585952DEDEDBD690281C23D091CD8F4"
      unitRef="usd">49000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3099-wk-Fact-0D30585BDB8F6CB1E0DCC23D402A8636"
      unitRef="usd">40500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3118-wk-Fact-92B66DC3F3165509AACC0627F70E5ED9"
      unitRef="usd">136000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_PainandSleepaidsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3138-wk-Fact-7549CA5CE3735D7A960AB846BCAAD4B2"
      unitRef="usd">120300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3158-wk-Fact-367FB9D370F1C284D64CC23D09017471"
      unitRef="usd">40600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3177-wk-Fact-4C7D6B25F1C676F25CDBC23D3FC53AEB"
      unitRef="usd">38200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3196-wk-Fact-EDC8D1B7C46D575D9E0373FAA1D31DE6"
      unitRef="usd">124700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_HealthyLifestyleMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3216-wk-Fact-83D0FE368A125A93BD1316D73741EF9D"
      unitRef="usd">134200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3236-wk-Fact-8B51BAB28B593BE0AFB0C23D092CA27D"
      unitRef="usd">25200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3255-wk-Fact-2BDA96D43C5AFB711DA8C23D4036B5FD"
      unitRef="usd">24300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3274-wk-Fact-4A580B34A6A65C3582B04D244E112F75"
      unitRef="usd">68800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OralSelfcareMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3294-wk-Fact-E4219D2880045D41BD97B0E73287F360"
      unitRef="usd">27700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3314-wk-Fact-D44FDABBBFA4C08856D2C23D090CEE66"
      unitRef="usd">6800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3333-wk-Fact-589D1B628216950C54C2C23D3FD69344"
      unitRef="usd">5300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3352-wk-Fact-2120E84AB0985415B71B435911C6E4F9"
      unitRef="usd">17900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_DigestiveHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3372-wk-Fact-DC1E744471D659E3998040BADDACF6CF"
      unitRef="usd">19300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3395-wk-Fact-AC489B599FC5ECFC2807C23D08B8F63A"
      unitRef="usd">19100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3414-wk-Fact-AF406491037E2EFA5369C23D3FE7F0FE"
      unitRef="usd">32000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3433-wk-Fact-5D0DBD67D2B657C3B59581DD44F1C634"
      unitRef="usd">88200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_OtherCSCIMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3453-wk-Fact-B9EA1E3D2DD758478C3781F4783BED45"
      unitRef="usd">100800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3473-wk-Fact-F13FA3A1ED61A1698A2CC23D090CBAD3"
      unitRef="usd">339000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3492-wk-Fact-83F126B674510C0DDA76C23D403C42D9"
      unitRef="usd">347500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3511-wk-Fact-A8E55B983BFE55EAA0C2CD7EB512EAAB"
      unitRef="usd">1042800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d78798e3531-wk-Fact-6A9C3E189E13591A95A5A88A23378280"
      unitRef="usd">1025800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d78798e3551-wk-Fact-9FCC6F1E4EF2B5BD9BB0C23D092C86FD"
      unitRef="usd">210700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d78798e3570-wk-Fact-447E72E2DB5FAC45B5C1C23D3FF3CCC7"
      unitRef="usd">230300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d78798e3589-wk-Fact-F4F655B41C045B60A17D25F0408DC766"
      unitRef="usd">738800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d78798e3609-wk-Fact-F09B459D0AD95E23A8B13DB22EF55A16"
      unitRef="usd">711600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d78798e3634-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
      unitRef="usd">1213700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d78798e3653-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
      unitRef="usd">1191100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d78798e3672-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
      unitRef="usd">3773800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d78798e3692-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
      unitRef="usd">3514600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember"
      decimals="-5"
      id="d78798e3755-wk-Fact-E70B3C3C55A9528BA86FD04C9A959E2B"
      unitRef="usd">76700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember"
      decimals="-5"
      id="d78798e3759-wk-Fact-6B512596A05852E7BEF8BA3349BB7D7B"
      unitRef="usd">190700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember"
      decimals="-5"
      id="d78798e3771-wk-Fact-36F823D4B9555AFC812CCA6BB27FD04F"
      unitRef="usd">73900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember"
      decimals="-5"
      id="d78798e3776-wk-Fact-DF965D55DD065D4BAC8E430BCBB4F56F"
      unitRef="usd">207000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-2330D0F775F8505E9693D047096B3182-0-wk-Fact-F626EE55B6FD5AC9B03F2FD841D58078">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table provides information about contract assets from contracts with customers (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Short-term contract assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d78798e3909-wk-Fact-520F91612E125B18A6A44E728BB41C70"
      unitRef="usd">21200000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d78798e3928-wk-Fact-F8E15D2E4CBE528F8016731B697B7111"
      unitRef="usd">26300000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-61E0E639A20E565B805CB864BF579610-0-wk-Fact-640E7239819158E69F0618C9014DA863">&lt;span style="font-family:Arial;font-weight:bold;"&gt;ACQUISITIONS AND DIVESTITURES&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Acquisitions During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Nine Months Ended September 26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Sanofi Brands&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;August&#160;7, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we entered into a definitive agreement to acquire &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; Eastern European OTC dermatological skincare and hair loss treatment brands, Emolium&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, Iwostin&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, and Loxon&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; from Sanofi for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#x20ac;52.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and additional consideration for the transfer of related inventory on hand. On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;October&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, the transaction closed for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#x20ac;53.3&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; (approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$62.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;), subject to post-closing conditions. The acquisition will be accounted for as a business combination and operating results attributable to the products will be included in our CSCI segment. This transaction builds on our self-care transformation and strengthens our skincare and personal hygiene portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Oral Care Assets of High Ridge Brands&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;April&#160;1, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we acquired the oral care assets of High Ridge Brands ("Dr. Fresh") for total purchase consideration of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$113.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, subject to customary post-closing adjustments, including a working capital settlement. After post-closing adjustments as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, total cash consideration paid was &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$106.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, net of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$2.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; that we allocated as prepayment of contract consideration for transitional services to be received related to the transaction. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; This acquisition includes the children&#x2019;s oral care value brand, Firefly&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, in addition to the REACH&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and Dr. Fresh&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; brands, and a licensing portfolio. The U.S. operations, which represent a significant portion of the business, will be reported in our CSCA segment and the remaining non-U.S. operations will be reported in our CSCI segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we incurred &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$0.1&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$4.2&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of general transaction costs (legal, banking and other professional fees), respectively. The amounts were recorded in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Administration&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; expenses within the CSCA segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The acquisition of Dr. Fresh was accounted for as a business combination and has been reported in our Condensed Consolidated Statements of Operations as of the acquisition date. From &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;April&#160;1, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; through &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, the acquisition generated &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Net sales&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$44.4&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and Net income of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$0.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which included &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$2.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; related to inventory costs stepped up to acquisition date fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We are in the process of gathering significant relevant information needed to complete the valuation for the assets acquired and liabilities assumed. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired and liabilities assumed will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset and liability fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we recorded measurement period adjustments relating to valuation updates that reduced the acquisition basis of definite lived intangibles by &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$0.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and reduced goodwill by &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$0.4&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; with an offsetting increase to working capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the consideration paid for Dr. Fresh and the provisional amounts of the assets acquired and liabilities assumed (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:534px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:368px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:154px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Oral Care Assets of High Ridge Brands (Dr. Fresh)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Purchase price paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;106.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Assets acquired:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;20.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;43.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;66.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;122.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payroll and related taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accrued customer programs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;106.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The goodwill of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$15.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Dr. Fresh into Perrigo. Preliminarily, goodwill of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$14.1&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$1.8&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; was allocated to our CSCA and CSCI segments, respectively. We are currently evaluating the tax deductibility of the provisional goodwill. We expect some portion to be deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, license agreements, and customer relationships which are being amortized over a weighted average useful life of approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;17.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; years&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names and developed technology were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Dexsil&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;February&#160;13, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we acquired Dexsil&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;,&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt; &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;a silicon supplement brand, from RXW Group Nv, for total cash consideration paid of approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$8.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. The transaction was accounted for as an asset acquisition, in which we capitalized the consideration paid as a brand-named intangible asset. We began amortizing the brand intangible over a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;-year useful life. Operating results attributable to the product are included within our CSCI segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Steripod&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae; &lt;/sup&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;January&#160;3, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we acquired Steripod&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. Total consideration paid was &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$26.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. The transaction was accounted for as an asset acquisition, in which we capitalized &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$25.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; as a brand-named intangible asset. The remainder of the purchase price was allocated to working capital. We began amortizing the brand intangible over a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;-year useful life. Operating results attributable to the product are included within our CSCA segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Acquisition Accounted for as a Business Combination During the Year Ended December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Ranir Global Holdings, LLC &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;July&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we acquired &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the outstanding equity interest in Ranir Global Holdings, LLC ("Ranir"), a privately-held company, for total base consideration of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$750.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in a debt-free, cash-free transaction. After post-closing adjustments, total cash consideration paid was &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$747.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, net of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$11.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cash acquired. We funded the transaction with cash on hand and borrowings under the 2018 Revolver (as defined in &lt;/span&gt;&lt;a href="#sF883DFF8F7F254E1ACF1AFCBB94077B2" style="font-family:Arial;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Note 10&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Ranir is headquartered in Grand Rapids, Michigan and is a leading global supplier of private label and branded oral self-care products. Ranir's U.S. operations are reported in our CSCA segment and its non-U.S. operations are reported in our CSCI segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The acquisition of Ranir was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From July&#160;1, 2019 through December 31, 2019, Ranir generated &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Net sales&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$151.4&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and had &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$7.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of Net income, which is inclusive of a non-recurring charge of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$5.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; related to inventory costs stepped up to acquisition date fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the consideration paid for Ranir and the amounts of the assets acquired and liabilities assumed (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:522px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:378px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:131px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Ranir&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Purchase price paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;759.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Assets acquired:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;59.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;292.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Definite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;48.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;260.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;41.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;In-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;39.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;389.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;844.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payroll and related taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accrued customer programs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;85.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;759.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The goodwill of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$292.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Perrigo and Ranir. Goodwill of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$212.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$80.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; was &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;background-color:#ffffff;"&gt;allocated to our CSCA and CSCI segments, respectively.&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We expect &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$252.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; to be deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, developed product technologies, and customer relationships. Trademarks and trade names were assigned useful lives that ranged from &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; years. Developed product technologies were assigned &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;-year useful lives and customer relationships were assigned &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;-year useful lives. Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names, developed technology, and in-process research and development ("IPR&amp;amp;D") were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates. The opening balance sheet is final. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Acquisitions During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Nine Months Ended September 28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Generic Product Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;July&#160;2, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we purchased the Abbreviated New Drug Application ("ANDA") for a generic gel product for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$49.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in cash, which we capitalized as a developed product technology intangible asset. We launched the product during the third quarter of 2019 and began amortizing it over a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;-year useful life. Operating results attributable to the product are included within our RX segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;May&#160;17, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we purchased the ANDA for a generic product used to relieve pain, for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$15.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in cash, which we capitalized as a developed product technology intangible asset. We launched the product during the third quarter of 2019 and began amortizing it over a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;-year useful life. Operating results attributable to the product are included within our RX segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Budesonide Nasal Spray and Triamcinolone Nasal Spray&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;April&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we purchased product ANDAs and other records and registrations of Budesonide Nasal Spray, a generic equivalent of Rhinocort Allergy&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, and Triamcinolone Nasal Spray, a generic equivalent of Nasacort Allergy&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, from Barr Laboratories, Inc. ("Barr"), a subsidiary of Teva Pharmaceuticals, for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$14.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in cash. We previously developed and marketed the products in collaboration with Barr under a development, marketing and commercialization agreement that originated in August 2003. Under this prior agreement, we paid Barr a percentage of net income from products sold by Perrigo in the U.S. By purchasing the assets from Barr and terminating the original development, marketing and commercialization agreement, we are now entitled to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the income from sales of the product. Operating results attributable to these products are included within our &lt;/span&gt;&lt;span style="font-family:Arial;"&gt;CSCA&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; segment. The intangible assets acquired are classified as developed product technology with a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;-year useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Pro Forma Impact of Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table presents unaudited pro forma information as if the Ranir acquisition had occurred on &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;January&#160;1, 2018&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and as if the acquisition of Dr. Fresh had occurred on &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;January&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and had been combined with the results reported in our Condensed Consolidated Statements of Operations for all periods presented (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:539px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:134px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;(Unaudited)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,217.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,803.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,732.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(154.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;108.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;180.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"&gt;&lt;span style="font-family:Arial;font-size:11pt;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, depreciation of property, plant and equipment that have been revalued, certain acquisition-related charges, and related tax effects.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Divestitures During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Nine Months Ended September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Rosemont Pharmaceuticals Business &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;June&#160;19, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we completed the sale of our U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for cash consideration of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#xa3;155.6&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; (approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$195.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;). The sale resulted in a pre-tax loss of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$18.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; recorded in our CSCI segment in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on the Condensed Consolidated Statements of Operations. The charge included professional fees and a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$46.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; write-off of foreign currency translation adjustment from Accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Divestitures During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Nine Months Ended September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Animal Health Business&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;July&#160;8, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we completed the sale of our animal health business to PetIQ for cash consideration of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$182.5&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which resulted in a pre-tax gain of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$71.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; recorded in our CSCA segment in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <prgo:NumberofBrandsAcquired
      contextRef="D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember"
      decimals="INF"
      id="d14264e999-wk-Fact-88E00E5FB0987BE3D98D470D0E1EC6BC"
      unitRef="brand">3</prgo:NumberofBrandsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember"
      decimals="-5"
      id="d14264e1016-wk-Fact-57A1CF50FE8AE51523574710A9CBF2D9"
      unitRef="eur">52000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2020Q4Oct30_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="d14264e1024-wk-Fact-6556DD63010CA8B0D6D28A6513B98ECB"
      unitRef="eur">53300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2020Q4Oct30_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="d14264e1028-wk-Fact-31EC76D625B41FDDDF548A674B8AF80C"
      unitRef="usd">62000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2020Q4April1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1047-wk-Fact-B1C83BFC9C705FFB9C714F470F8EA4AC"
      unitRef="usd">113000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1055-wk-Fact-189E5FFA2E49A18CEC9F471B70881D8E"
      unitRef="usd">106000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1059-wk-Fact-F7F0231568F056F48812D7D1F043E4C8"
      unitRef="usd">2000000.0</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e1095-wk-Fact-90FFF9958A33B9E3F475C69EC83EE486"
      unitRef="usd">100000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e1099-wk-Fact-8911545EDCDA51C4B2A17FA09743936E"
      unitRef="usd">4200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1127-wk-Fact-E86C012F30D953D2A53D8257C5719FAC"
      unitRef="usd">44400000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1131-wk-Fact-85085DACB2ED5C61987781647D7CEEF9"
      unitRef="usd">700000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e1136-wk-Fact-DC8166D791FB54C8A568343A1524DE3C"
      unitRef="usd">2000000.0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e1160-wk-Fact-6E1090EA1E0370D5572647177AB5DEA8"
      unitRef="usd">-700000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2020Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e1164-wk-Fact-B956351F13673B8D6F41471973E724F4"
      unitRef="usd">-400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      id="TextSelection-BA2240AF43B555D795BE5241A92AD87D-0-wk-Fact-5C0D743C8DE35C6C9216214BF8513718">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the consideration paid for Dr. Fresh and the provisional amounts of the assets acquired and liabilities assumed (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:534px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:368px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:154px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Oral Care Assets of High Ridge Brands (Dr. Fresh)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Purchase price paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;106.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Assets acquired:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;20.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;43.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;66.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;122.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payroll and related taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accrued customer programs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;106.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2020Q3Apr1-Sep26_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1224-wk-Fact-189E5FFA2E49A18CEC9F471B70881D8E"
      unitRef="usd">106000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1281-wk-Fact-5690939657A9719E3271471E030F2DE4"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1301-wk-Fact-0D5FCEF0F1C36847F6E4471E943CB563"
      unitRef="usd">23400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1321-wk-Fact-B4A42733994A1300BC90471EA37A5A37"
      unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1341-wk-Fact-E98E23146FF1AFE038F6471EB2D887B0"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1361-wk-Fact-BBF67EF052E1B7E76561471EC391AC16"
      unitRef="usd">2600000</prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1381-wk-Fact-C592AD988D1C2800517B471ED1C35BA1"
      unitRef="usd">15900000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember"
      decimals="-5"
      id="d14264e1406-wk-Fact-DB2BF6E09265BE1D8F25471F873EB184"
      unitRef="usd">2200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="-5"
      id="d14264e1422-wk-Fact-46275AF75AB88C3247A8471F85AE58F3"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember"
      decimals="-5"
      id="d14264e1442-wk-Fact-974AADFFF5FD7B70B1AE471F84D57B52"
      unitRef="usd">20600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember"
      decimals="-5"
      id="d14264e1462-wk-Fact-5D4C83F5D4AA15AFD453471F84D5AAC9"
      unitRef="usd">43200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1487-wk-Fact-A8B1D2B58E1913411949471F84E5C5EC"
      unitRef="usd">66100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1507-wk-Fact-4EE19551C6ACF42D3086471F9B412D93"
      unitRef="usd">122200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1548-wk-Fact-1150F92DC389CF482F44471FAFEADFE4"
      unitRef="usd">6000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1563-wk-Fact-F88E05DD92862DEC47AB471FC0492408"
      unitRef="usd">4000000.0</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1583-wk-Fact-71401E0EE68240DC89D6471FCC25168D"
      unitRef="usd">700000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1603-wk-Fact-6AE3565AE9918860569D471FDCB0195B"
      unitRef="usd">3000000.0</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1623-wk-Fact-75BD4D5EAAA0D3553C6A471FE9D753A4"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1649-wk-Fact-1D129D9A23EC8686C1C2471FFC335D35"
      unitRef="usd">16200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1669-wk-Fact-526C4CFA59CCF72913514720118C7B66"
      unitRef="usd">106000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      decimals="-5"
      id="d14264e1682-wk-Fact-C592AD988D1C2800517B471ED1C35BA1"
      unitRef="usd">15900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e1686-wk-Fact-15CFF4B2B7A056828D55E0301E503B37"
      unitRef="usd">14100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="I2020Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d14264e1690-wk-Fact-1E0DA6DDB3E85F6B81CB860709185940"
      unitRef="usd">1800000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="D2020Q4April1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember"
      id="d14264e1694-wk-Fact-DD0EB3D65ECE54929B61CC02525CD6AF">P17Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="D2020Q1Feb13_us-gaap_BusinessAcquisitionAxis_prgo_DexsilMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember"
      decimals="-5"
      id="d14264e1729-wk-Fact-84AAF4D957035954A7128FC2B3DFA6E5"
      unitRef="usd">8000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="D2020Q1Feb13_us-gaap_BusinessAcquisitionAxis_prgo_DexsilMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember"
      id="d14264e1733-wk-Fact-2AFA8AD6FC355DE3A9E457D3A30F49B8">P25Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember"
      decimals="-5"
      id="d14264e1760-wk-Fact-9BC8C203D2065486A33C4759043579FE"
      unitRef="usd">26000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember"
      decimals="-5"
      id="d14264e1764-wk-Fact-5FB95FEBAF7350E68D86F36A4F52CCA3"
      unitRef="usd">25100000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="D2020Q1Jan3_us-gaap_BusinessAcquisitionAxis_prgo_SteripodMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_BrandMember"
      id="d14264e1768-wk-Fact-F4004F05AFF55CB28796ABF8C389D466">P25Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="2"
      id="d14264e1793-wk-Fact-E68D84BCEFB65C30BB2D613E7DAB11EF"
      unitRef="ratio">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <prgo:BusinessCombinationBaseConsiderationTransferred
      contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1797-wk-Fact-825F9EA7AC1350F3902F571540C382D5"
      unitRef="usd">750000000.0</prgo:BusinessCombinationBaseConsiderationTransferred>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1801-wk-Fact-381CF6D750525AF0AD36B58DD6AB8C81"
      unitRef="usd">747700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1805-wk-Fact-1F1547DE73B95D6197B769223F2019E0"
      unitRef="usd">11500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1831-wk-Fact-DE340A29F8BF5367A492D669179CE54C"
      unitRef="usd">151400000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1835-wk-Fact-B074B1B8132153629E56DF133670C7AA"
      unitRef="usd">7600000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="D2019Q4Jul1-Dec31_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1839-wk-Fact-40F89CE067E651F1B0CA7B0EFA90545F"
      unitRef="usd">5700000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="FD2020Q3YTD_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      id="TextSelection-C0159BCD3983554D8214468EA7C30D6C-0-wk-Fact-BE345AA164585017ABE0DBD97586C462">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the consideration paid for Ranir and the amounts of the assets acquired and liabilities assumed (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:522px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:378px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:131px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Ranir&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Purchase price paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;759.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Assets acquired:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;59.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;292.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Definite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;48.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;260.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;41.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;In-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;39.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;389.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;844.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payroll and related taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Accrued customer programs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;85.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;759.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1897-wk-Fact-48661FFB66ED5B178383C29BB4E5CBC9"
      unitRef="usd">759200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1959-wk-Fact-1F1547DE73B95D6197B769223F2019E0"
      unitRef="usd">11500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1974-wk-Fact-64CCF72213A8517197D7445508C913D4"
      unitRef="usd">40600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e1994-wk-Fact-31B1D8817D645459BA2518228D3210DF"
      unitRef="usd">59000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2014-wk-Fact-D091DE1A78B250F3858D490EBF1BA49E"
      unitRef="usd">4000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2034-wk-Fact-89A8BEA6111E5B4D933C6340D623D3AB"
      unitRef="usd">40800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2054-wk-Fact-34716EC0D4C25AE78A3354D660F6BC10"
      unitRef="usd">3700000</prgo:BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets>
    <us-gaap:Goodwill
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2074-wk-Fact-8AFACF6C6A325041A51767010F4B962F"
      unitRef="usd">292700000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="-5"
      id="d14264e2123-wk-Fact-6B19ED27C7CB58AD81286AFAE04C29C3"
      unitRef="usd">48600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember"
      decimals="-5"
      id="d14264e2138-wk-Fact-AD66AE8E6C6B5760BC03C880B7D98347"
      unitRef="usd">260000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember"
      decimals="-5"
      id="d14264e2158-wk-Fact-B6764A8130455276A774262FB5B9FE4D"
      unitRef="usd">41000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d14264e2201-wk-Fact-8703B1F68EAC55D5B7BBDC310F798CC2"
      unitRef="usd">39700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2226-wk-Fact-31CA45B41D885D20B0C668FD85D1BDD4"
      unitRef="usd">389300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2241-wk-Fact-D8D39702D8875A81B30E367B7EE73DF9"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2266-wk-Fact-3A0015BA90C75E07903497AD9A58CE23"
      unitRef="usd">844400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2307-wk-Fact-E7080E51F0B65C31BFC11E17F51679C1"
      unitRef="usd">17600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2323-wk-Fact-8401C278D603555BB86FCC38CEA99B3E"
      unitRef="usd">7700000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2343-wk-Fact-4A95F4FBE39E5656998B5528FB72F9DE"
      unitRef="usd">5500000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2363-wk-Fact-631E20BF90A8556593C1B1EDBAD2DFFB"
      unitRef="usd">5700000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2383-wk-Fact-6A9E945C3FE25C53B2BD955A0D840F75"
      unitRef="usd">45900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2403-wk-Fact-054D4139F8BA5794A735378DD4D4AF58"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2428-wk-Fact-6B8DA38F28EF5FC483927801660F6DFF"
      unitRef="usd">85200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2448-wk-Fact-3622042B715455BC913D4DFF07B32FEB"
      unitRef="usd">759200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="I2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember"
      decimals="-5"
      id="d14264e2463-wk-Fact-8AFACF6C6A325041A51767010F4B962F"
      unitRef="usd">292700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e2467-wk-Fact-2814265B3CC650459363EC8B07055D30"
      unitRef="usd">212600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d14264e2471-wk-Fact-FFE7310EBCCB579B8E1CBAA92D2C16EF"
      unitRef="usd">80100000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="FI2020Q3_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e2481-wk-Fact-1F54E8462E435591AA143EFDE818C729"
      unitRef="usd">252300000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="D2019Q3Jul1_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember"
      id="d14264e2486-wk-Fact-0C3E19BFD1675C5389DFA086833E3D29">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="D2019Q3Jul1_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember"
      id="d14264e2490-wk-Fact-B704A82C0510542081E738310F645C99">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      id="d14264e2494-wk-Fact-B155DC6F44625522AFA33E8D86EA6621">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="D2019Q3Jul1_us-gaap_BusinessAcquisitionAxis_prgo_RanirGlobalHoldingsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember"
      id="d14264e2498-wk-Fact-C3A89F6EF2DF5D7D91364A5803DDC8F8">P24Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="D2019Q3Jul2_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="-5"
      id="d14264e2535-wk-Fact-D8FCFC11917FC440B41FC6A60DE5B094"
      unitRef="usd">49000000.0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="D2019Q3Jul2_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      id="d14264e2539-wk-Fact-D1365010AB336CC361A2C6A817B7F95D">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="D2019Q2May17_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="-5"
      id="d14264e2553-wk-Fact-2DBE4FBAD0945E85927CF318157E75C8"
      unitRef="usd">15700000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="D2019Q2May17_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      id="d14264e2557-wk-Fact-02EB613E4FCE5344BB36055DD1237828">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="-5"
      id="d14264e2584-wk-Fact-1A2A2FFC6D305A39B25C771D682AB622"
      unitRef="usd">14000000.0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <prgo:IncomefromSalesOwnedbytheCompanyPercent
      contextRef="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="INF"
      id="d14264e2588-wk-Fact-35D40805E8515210A1BC3234B4B176F8"
      unitRef="ratio">1</prgo:IncomefromSalesOwnedbytheCompanyPercent>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="D2019Q2Apr1_us-gaap_BusinessAcquisitionAxis_prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TechnologyBasedIntangibleAssetsMember"
      id="d14264e2598-wk-Fact-12759B5D447F5797B8DC1F1D2AA41F6C">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-8847CFA703D9597AAC7FBEA5428C41FE-0-wk-Fact-E5D1DB4D66A958758D180634260EF358">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table presents unaudited pro forma information as if the Ranir acquisition had occurred on &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;January&#160;1, 2018&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and as if the acquisition of Dr. Fresh had occurred on &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;January&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and had been combined with the results reported in our Condensed Consolidated Statements of Operations for all periods presented (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:539px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:134px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;(Unaudited)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,217.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,803.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,732.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(154.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;108.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;180.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d14264e2823-wk-Fact-527738FC112B5E34BD355D924001142C"
      unitRef="usd">1213700000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d14264e2842-wk-Fact-D1823D5D276057EC84978C0DB57FA482"
      unitRef="usd">1217100000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d14264e2861-wk-Fact-07ABD67D641E5564A5FEB4FEFB8E3DC4"
      unitRef="usd">3803400000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d14264e2881-wk-Fact-CFA4DE3A158A5736AECB749DF70B37BE"
      unitRef="usd">3732600000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d14264e2901-wk-Fact-591A3699447351B68A12FDB49D29146A"
      unitRef="usd">-154500000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d14264e2921-wk-Fact-C112C408D34357708ABBD23EB379C334"
      unitRef="usd">108100000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d14264e2940-wk-Fact-E826BD760242599EBA36E14F60473A3E"
      unitRef="usd">18600000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d14264e2960-wk-Fact-D6009E6C4B4A58B49A39FFEC40A19629"
      unitRef="usd">180700000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember"
      decimals="-5"
      id="d14264e2998-wk-Fact-17E3945D01A95182A37455FF51C8BC5D"
      unitRef="gbp">155600000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember"
      decimals="-5"
      id="d14264e3002-wk-Fact-937B0E65A0715D3DA1F9C3896396656F"
      unitRef="usd">195000000.0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember"
      decimals="-5"
      id="d14264e3006-wk-Fact-D8966BB1B0B953A6B7B824D44C6A0CB6"
      unitRef="usd">-18700000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember"
      decimals="-5"
      id="d14264e3016-wk-Fact-D2D8D330B26653D5AABD633FEA959B44"
      unitRef="usd">-46400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="D2019Q3Jul8_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e3043-wk-Fact-66AE698EC7B024AF9068C6AE7E526651"
      unitRef="usd">182500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="D2019Q3Jul8_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_AnimalHealthMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d14264e3047-wk-Fact-79DC13E7F160F4F0C7EAC6AFD865C86D"
      unitRef="usd">71700000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-8AC01F771CBF52CDB532DEDBEE3296FB-0-wk-Fact-05D99BF4C8D45E7380A01E2678CAF2AF">&lt;span style="font-family:Arial;font-weight:bold;"&gt;GOODWILL AND INTANGIBLE ASSETS&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="29"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Purchase accounting adjustments &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Business acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Business divestitures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Impairments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Currency translation adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,899.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,898.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,203.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(115.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,129.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,013.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(202.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;811.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,116.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(115.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(202.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,839.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  We had accumulated goodwill impairments of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$868.4&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; as of each of December 31, 2019 and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)  We had accumulated goodwill impairments of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$109.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$311.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; as of December 31, 2019 and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;RX U.S. Reporting Unit Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, our RX U.S. reporting unit had an indication of potential impairment driven primarily by the stoppage of production and distribution of albuterol sulfate inhalation aerosol and voluntary U.S. nationwide recall to the retail level, after we learned that some units may not dispense due to clogging, combined with a decline in market multiples. We prepared an impairment test as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and determined the carrying value of the RX U.S. reporting unit exceeded its estimated fair value. We recognized a goodwill impairment of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$202.4&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, leaving &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$811.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of goodwill in this reporting unit after the impairment. The change in fair value from previous estimates was driven by the financial impact of the recall in the current period and related changes in estimates of future cash flows (refer to &lt;/span&gt;&lt;a href="#sBFE17B0A00B45FB196C8960332ACE955" style="font-family:Arial;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Note 6&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Other Reporting Unit Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;June&#160;27, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, our Branded Consumer Self-care ("BCS") reporting unit included in the CSCI segment had an indication of potential impairment which was driven by a decrease in forecasted cash flows in the second half of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; related to impacts from the COVID-19 pandemic. We prepared an impairment test as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;June&#160;27, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and determined that the fair value of the BCS reporting unit exceeded net book value by less than &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, consistent with our last annual impairment test as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;October&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.&#160;While &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; impairment was recorded as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;June&#160;27, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, future developments such as deterioration in business performance or market multiples could reduce the fair value of this reporting unit and lead to impairment in a future period. There was no indication of impairment during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. Goodwill remaining in this reporting unit was &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$995.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Intangible assets and related accumulated amortization consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.85534591194968%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;In-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;50.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total indefinite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Definite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;134.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;83.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;126.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,335.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;731.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,392.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;755.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,866.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;776.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,805.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;671.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,462.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;313.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,353.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;250.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-compete agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total definite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,805.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,909.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,685.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,763.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,819.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,909.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,753.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,763.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We recorded amortization expense of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$73.9&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$219.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, respectively, and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$78.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$227.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Evamist Branded Product&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;During the three months ended September 28, 2019, we identified impairment indicators related to our Evamist branded product, which is a definite-lived intangible asset in our &lt;/span&gt;&lt;span style="font-family:Arial;"&gt;RX&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; segment. The indicators related to a decline in sales volume and a corresponding reduction in our long-range revenue forecast. We recorded an asset impairment of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$10.8&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Generic Product&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;During the three months ended June 29, 2019, we identified impairment indicators for a certain definite-lived intangible asset related to changes in pricing and competition in the market, which lowered the projected cash flows we expect to generate from the asset. We recorded an asset impairment of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$27.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in our RX segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;In-process R&amp;amp;D &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We recorded impairment charges of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$4.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on certain IPR&amp;amp;D assets in the CSCA and RX segments during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, due to changes in projected development and regulatory timelines.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-AB2FC31CEBB55474BAB527118C4880B9-0-wk-Fact-38E0C72831E55AADBDD0D47C276284EC">&lt;div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="29"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Purchase accounting adjustments &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Business acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Business divestitures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Impairments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Currency translation adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,899.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,898.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,203.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(115.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,129.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,013.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(202.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;811.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,116.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(115.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(202.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,839.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  We had accumulated goodwill impairments of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$868.4&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; as of each of December 31, 2019 and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)  We had accumulated goodwill impairments of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$109.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$311.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; as of December 31, 2019 and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d18029e1233-wk-Fact-9B07A567BB515B1B9308B55A729EDEFD"
      unitRef="usd">1899100000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d18029e1252-wk-Fact-2CDC47E3D27A5213B5F0A8BD5A2B51F2"
      unitRef="usd">-10400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d18029e1273-wk-Fact-EFB27D1937B65FFFB14197E2FC548E1E"
      unitRef="usd">14100000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d18029e1292-wk-Fact-6342767680C65B9DA0F853DF56342238"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d18029e1311-wk-Fact-E19F2A17F6CA5120A1D828C9C16DFF64"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d18029e1331-wk-Fact-10F7FBF60F1E503CAE7C2C1FC971C6AC"
      unitRef="usd">-4000000.0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d18029e1351-wk-Fact-51C26CB2A9D9598AA3710CF35F1E5D05"
      unitRef="usd">1898800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1373-wk-Fact-D9AC2B84885C5079A384B35225979290"
      unitRef="usd">1203700000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1392-wk-Fact-F517600BDA77548BB75F8EDE3B58EAEA"
      unitRef="usd">12000000.0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1411-wk-Fact-06EE885C336D559890E9C0003A71C4FD"
      unitRef="usd">1800000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1431-wk-Fact-529F834E8BC45200AAA6A530453B7278"
      unitRef="usd">115600000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1451-wk-Fact-DEC07CC035AE59A39FBD6E863364E0AF"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1471-wk-Fact-8AFFEC2E9E6C53B4A4EBDD28B0FBE7F5"
      unitRef="usd">27500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1490-wk-Fact-71631B201A095930921056960D3E9895"
      unitRef="usd">1129400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1517-wk-Fact-397C83A0249153ACAFF833332FBC93C2"
      unitRef="usd">1013900000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1536-wk-Fact-15F3950C89195B8AB60F572451958777"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1555-wk-Fact-D48BD2E94F145A76A5EF2CAD1ECCB884"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1575-wk-Fact-E2A067A72A7050A1B47B74D981EB006A"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1594-wk-Fact-212539EC2EE557549BA0175770657AA3"
      unitRef="usd">202400000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1615-wk-Fact-52DE8508E9D450FE88B0F7906CEBEA51"
      unitRef="usd">-400000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1635-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
      unitRef="usd">811100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4"
      decimals="-5"
      id="d18029e1665-wk-Fact-F640560DE1B05837A43A92F60C44E0D3"
      unitRef="usd">4116700000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d18029e1684-wk-Fact-C42E97F8297F5D7399C86906FA63F086"
      unitRef="usd">1600000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d18029e1704-wk-Fact-69716D2F92625A6EB0094BC31E92AA92"
      unitRef="usd">15900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d18029e1723-wk-Fact-2E8E9C6404FF5CCD81C2600939B468D8"
      unitRef="usd">115600000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d18029e1743-wk-Fact-62B61D2745B25324A56137F4EF2474EF"
      unitRef="usd">202400000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d18029e1764-wk-Fact-BE3763BEE40E5AF8B25DF881E89468FA"
      unitRef="usd">23100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q3"
      decimals="-5"
      id="d18029e1783-wk-Fact-248FCA9AED205126B0C1390A37E150E0"
      unitRef="usd">3839300000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d18029e1804-wk-Fact-7BD3F3E2CE5356958C1964237A2D2E54"
      unitRef="usd">868400000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1821-wk-Fact-43F6794FAEAA222D6AB1472E08CE955C"
      unitRef="usd">109200000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1825-wk-Fact-2DFC56C3FB0C5FEBB7C8E043421D92BD"
      unitRef="usd">311600000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1861-wk-Fact-42B3AB8BE2AD78DD55A147301E355CC4"
      unitRef="usd">202400000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e1865-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
      unitRef="usd">811100000</us-gaap:Goodwill>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="FI2020Q3_us-gaap_ReportingUnitAxis_prgo_BCSMember"
      decimals="2"
      id="d18029e1903-wk-Fact-012EE67D328A5813992D524B716A1A8C"
      unitRef="ratio">0.10</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2020Q3QTD_us-gaap_ReportingUnitAxis_prgo_BCSMember"
      decimals="INF"
      id="d18029e1912-wk-Fact-7FA33B6745775C0DA5352400119FD02C"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_ReportingUnitAxis_prgo_BCSMember"
      decimals="-5"
      id="d18029e1928-wk-Fact-D16310DA500C51AE9ACCD4FC2AC47C6E"
      unitRef="usd">995500000</us-gaap:Goodwill>
    <prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-731C8A51282257ACB45EC0E3FEBB6C69-0-wk-Fact-EF9946F0D4E55BD587C698574C7D72FA">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Intangible assets and related accumulated amortization consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.85534591194968%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;In-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;50.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total indefinite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;Definite-lived intangibles&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:none;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;134.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;83.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;126.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,335.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;731.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,392.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;755.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,866.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;776.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,805.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;671.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,462.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;313.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,353.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;250.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-compete agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total definite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,805.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,909.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,685.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,763.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,819.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,909.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,753.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,763.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember"
      decimals="-5"
      id="d18029e2249-wk-Fact-641550394E9C5ED9B4FCFADBF9F0D276"
      unitRef="usd">4000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_prgo_TrademarksTradeNamesandBrandsMember"
      decimals="-5"
      id="d18029e2287-wk-Fact-CFB8EDD39F095A069429BD2B3EC48DF3"
      unitRef="usd">18800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d18029e2322-wk-Fact-B2F668A867AA51058C70C5FD6EA5DACB"
      unitRef="usd">10800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d18029e2360-wk-Fact-791C8B2140625B8B8BDE770C5DD5497E"
      unitRef="usd">50000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q3"
      decimals="-5"
      id="d18029e2405-wk-Fact-239B4AB169425F7FB769C5BEDA6E4225"
      unitRef="usd">14800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-5"
      id="d18029e2443-wk-Fact-2C94F03BB2B25D0D941702094D8F714C"
      unitRef="usd">68800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember"
      decimals="-5"
      id="d18029e2567-wk-Fact-1ED514F49402506C9F309505D7886B06"
      unitRef="usd">134700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember"
      decimals="-5"
      id="d18029e2586-wk-Fact-635D5EF1B774576D83297C516BF68B10"
      unitRef="usd">83800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember"
      decimals="-5"
      id="d18029e2605-wk-Fact-0D4CD2B9E854570F912C2135307398C9"
      unitRef="usd">126700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember"
      decimals="-5"
      id="d18029e2625-wk-Fact-A40A6B4881B75393AB27E019457D9F7F"
      unitRef="usd">81100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-5"
      id="d18029e2640-wk-Fact-4C8BA4B2E34D577FA2DB8D918D8BE1D6"
      unitRef="usd">1335700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-5"
      id="d18029e2659-wk-Fact-7309965C33235FDBB63E1FF8918DA9AB"
      unitRef="usd">731800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-5"
      id="d18029e2678-wk-Fact-02EC7B5AC11B57039D2F8EF4DE83E3B9"
      unitRef="usd">1392800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-5"
      id="d18029e2698-wk-Fact-5A52889D13565796A0301B30F0A9A03E"
      unitRef="usd">755300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d18029e2718-wk-Fact-08E39CD9514A574291B708DC32FCE638"
      unitRef="usd">1866800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d18029e2737-wk-Fact-5F16BAD18A105384A880265F27B86CC8"
      unitRef="usd">776000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d18029e2756-wk-Fact-A9F9B16E7F6753F0B2F01BA3A2C8DFDF"
      unitRef="usd">1805600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d18029e2776-wk-Fact-8A65BEF6A27452938D033F848754DC4C"
      unitRef="usd">671400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d18029e2796-wk-Fact-5F30AF751D5F51759248271A457DAEE6"
      unitRef="usd">1462700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d18029e2815-wk-Fact-FEA1E5117F9F5A2CB637700CBD1E1701"
      unitRef="usd">313100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d18029e2834-wk-Fact-926D689A0ED9524D87FC899D5B20AB2E"
      unitRef="usd">1353500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d18029e2854-wk-Fact-97054A07F55E5D3685F4AD63DB035807"
      unitRef="usd">250100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember"
      decimals="-5"
      id="d18029e2875-wk-Fact-C2C1AED96AC65E47BBA64156190D4774"
      unitRef="usd">5200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember"
      decimals="-5"
      id="d18029e2894-wk-Fact-57FC564B12205054B169D8792642146E"
      unitRef="usd">5000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember"
      decimals="-5"
      id="d18029e2913-wk-Fact-93E5BC89A31E5A0C8354D2F278F1B06B"
      unitRef="usd">6500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember"
      decimals="-5"
      id="d18029e2933-wk-Fact-76DEFA84BF5B53A9B14575366C3209E0"
      unitRef="usd">6000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3"
      decimals="-5"
      id="d18029e2958-wk-Fact-A5DDBE2F5BC85D0C8B48C23D4ECF658F"
      unitRef="usd">4805100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3"
      decimals="-5"
      id="d18029e2977-wk-Fact-F7E49D4866FB55C1951A664B4985F6A3"
      unitRef="usd">1909700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d18029e2996-wk-Fact-8517B956B5E7519BA5BE7A95D0A82F83"
      unitRef="usd">4685100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-5"
      id="d18029e3016-wk-Fact-B96B9E5C830450C7BBB4FD9C10389FEF"
      unitRef="usd">1763900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2020Q3"
      decimals="-5"
      id="d18029e3036-wk-Fact-02B117AEA9925D1CB807B640458CA089"
      unitRef="usd">4819900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3"
      decimals="-5"
      id="d18029e3055-wk-Fact-F7E49D4866FB55C1951A664B4985F6A3"
      unitRef="usd">1909700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-5"
      id="d18029e3074-wk-Fact-65E09C1B01BB547ABFD482910050B042"
      unitRef="usd">4753900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-5"
      id="d18029e3094-wk-Fact-B96B9E5C830450C7BBB4FD9C10389FEF"
      unitRef="usd">1763900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d18029e3117-wk-Fact-9EC6EFD4DD3D5D5AB75DE9600F9BE5CD"
      unitRef="usd">73900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d18029e3121-wk-Fact-B5DA864A4FA15076A7E87E8E669E0A74"
      unitRef="usd">219300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d18029e3133-wk-Fact-C505C4899C9C5A9293E87934EEE6ED3E"
      unitRef="usd">78700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d18029e3138-wk-Fact-66166F7248AF5BEDB989DACED3CFEE17"
      unitRef="usd">227700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_EvamistBrandedProductMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e3166-wk-Fact-00CA28DDDFE0EAE3C85FC67F7C3F6E8D"
      unitRef="usd">10800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="FD2019Q3QTD_us-gaap_BusinessAcquisitionAxis_prgo_GenericProductAcquisitionMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d18029e3181-wk-Fact-DD63AB03777E5F359E6EEA8EF7EDAC20"
      unitRef="usd">27800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="FD2019Q3YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d18029e3198-wk-Fact-2C11426402B0567B9D1302BC48D83069"
      unitRef="usd">4300000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-6D2CD836F40B54D9A5626724D7C2C5C0-0-wk-Fact-C52B8ADCA548578E9A542C854737DA46">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;INVENTORIES&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Major components of inventory were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finished goods&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;618.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;530.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Work in process&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;201.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;186.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Raw materials&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;280.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;250.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,100.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;967.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-A0E361EBEE395B398B287272648AE6BB-0-wk-Fact-218EADB08F0D5097A46E15D5669F3805">&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Major components of inventory were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finished goods&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;618.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;530.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Work in process&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;201.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;186.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Raw materials&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;280.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;250.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,100.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;967.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="FI2020Q3"
      decimals="-5"
      id="d15087e1062-wk-Fact-8B19980750E35AC98CB21D832B04F623"
      unitRef="usd">618900000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="FI2019Q4"
      decimals="-5"
      id="d15087e1081-wk-Fact-DE7C2F955B7454D2B4D68A47BADF8E28"
      unitRef="usd">530300000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="FI2020Q3"
      decimals="-5"
      id="d15087e1096-wk-Fact-8191C19286A4508A862070650CC9EA04"
      unitRef="usd">201300000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="FI2019Q4"
      decimals="-5"
      id="d15087e1115-wk-Fact-3DEDF1ADA57053B9B54C97105981E7D8"
      unitRef="usd">186900000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials
      contextRef="FI2020Q3"
      decimals="-5"
      id="d15087e1135-wk-Fact-4484925822985B248571616685E1B0E8"
      unitRef="usd">280500000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="FI2019Q4"
      decimals="-5"
      id="d15087e1154-wk-Fact-7535C309593C5FADBC2F891060401DBF"
      unitRef="usd">250100000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="FI2020Q3"
      decimals="-5"
      id="d15087e1179-wk-Fact-D5426A6C267D5922AD6216A00522426B"
      unitRef="usd">1100700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d15087e1198-wk-Fact-CE06DA9DF0A8583C86A12692EB25FCB9"
      unitRef="usd">967300000</us-gaap:InventoryNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-B819797A9B905466AA0C3E79EF3354D3-0-wk-Fact-C4BB90B5A48956B397DC72E7AEAAD2D8">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On January 1, 2020, we adopted ASU 2018-13: Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement ("Topic 820"). The amendments in this ASU remove disclosure requirements in Topic 820 related to the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. Additionally, Topic 820 adds disclosure requirements for the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. We have amended certain of our quantitative Level 3 fair value measurement disclosures to add the range and weighted average of significant unobservable inputs used.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="25"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Investment securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Funds associated with Israeli severance liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Royalty Pharma contingent milestone&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Contingent consideration payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Measured at fair value on a non-recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Goodwill&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;811.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,013.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;811.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,036.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;, goodwill with a carrying amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$1,013.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; was written down to a fair value of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$811.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;. During the year ended December 31, 2019, goodwill with a carrying amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$1,122.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; was written down to a fair value of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$1,013.1&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$55.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; were written down to a fair value of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$23.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;There were &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; transfers within Level 3 fair value measurements during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; or the year ended &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Royalty Pharma Contingent Milestone Receipts &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The table below summarizes the change in fair value of the Royalty Pharma contingent milestone (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:555px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:85px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:85px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;99.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;89.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;323.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payments received&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(250.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Change in fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;91.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;91.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We value our contingent milestone payment from Royalty Pharma using a modified Black-Scholes Option Pricing Model ("BSOPM"). Key inputs in the BSOPM are the estimated volatility and rate of return of royalties on global net sales of Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; that are received by Royalty Pharma until the contingent milestones are resolved. As of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, volatility and the estimated fair value of the milestones had a positive relationship such that higher volatility translates to a higher estimated fair value of the contingent milestone payments. Rate of return and the estimated fair value of the milestones had an inverse relationship, such that a lower rate of return correlates with a higher estimated fair value of the contingent milestone payments. We assess volatility and rate of return inputs quarterly by analyzing certain market volatility benchmarks and the risk associated with Royalty Pharma achieving the underlying projected royalties. The table below represents the volatility and rate of return:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:306px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:113px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Rate of return&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, the fair value of the Royalty Pharma contingent milestone payment related to 2020 increased by &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$22.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$25.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, respectively, to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$121.2&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which is recorded on the Condensed Consolidated Balance Sheets within &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. The adjustments were driven by higher projected global net sales of Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; compared to the estimates in the prior period, and the estimated probability of achieving the earn-out. During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, the fair value of the Royalty Pharma contingent milestone payments increased by &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$2.6&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$18.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, respectively. These adjustments were driven by higher projected global net sales of Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;  &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;and the estimated probability of achieving the earn-out. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The Royalty Pharma payments from Biogen for Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae; &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;were &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$337.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in 2018, which triggered the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$250.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; milestone payment received during the first quarter of 2019. There is &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; contingent milestone based on 2019 sales of Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. In order for us to receive the remaining contingent milestone payment of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$400.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, Royalty Pharma payments from Biogen for Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; sales, as defined in the agreement, in 2020 must exceed &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$351.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. If Royalty Pharma payments from Biogen for Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; sales do not meet the prescribed threshold in 2020, we will write off the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$121.2&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; asset and record a loss. If the prescribed threshold is exceeded, we will increase the asset to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$400.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and recognize income of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$278.8&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Change in financial assets&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contingent Consideration Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The table below summarizes the change in fair value of contingent consideration payments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:202px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Changes in value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Settlements and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product. The fair value adjustments are recorded in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Other operating expense (income)&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;  on the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, the contingent consideration payments liability was primarily comprised of sales-based milestones related to an IPR&amp;amp;D asset acquired in a prior transaction in our RX segment. The contingent consideration payments liability also included certain event-based milestones, which were immaterial. The fair value of our contingent consideration sales-based milestones as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, was calculated using the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:29%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Valuation Technique&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Unobservable Input&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Range (Weighted Average)&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Contingent consideration payments: sales-based milestones &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Discounted cash flow&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Projected royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;36.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Projected year of payment of sales-based milestones&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2021 - 2036 (2027)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Unobservable inputs were weighted based on the relative estimated milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The discount rate of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;26.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; was based on our assessment of the rate of return and development and commercialization risk of the related IPR&amp;amp;D project. We reevaluate the significant unobservable inputs of the sales-based milestones quarterly based on project developments and changes in contingent elements of the liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Non-recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;RX U.S. Reporting Unit Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;When determining the fair value of our RX U.S. reporting unit for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we utilized a combination of comparable company and discounted cash flow techniques. In our comparable company market approach, we considered observable market information and transactions for companies that we deemed to be of a comparable nature, scope, and size of our RX U.S. reporting unit (Level 2 inputs). Our cash flow projections included revenue assumptions related to new and existing products, plus gross margin and operating expenses based on the reporting unit&#x2019;s growth plans (Level 3 inputs). In our discounted cash flow analysis, we used a long-term growth rate of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;0.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which assumes new product launches will, over time, offset decreases in cash &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;flows of existing portfolio products with definite lives. We used a discount rate of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;10.3%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in this analysis. The discount rate correlates with the required investment return and risk that we believe market participants would apply to the projected growth rate. In addition, we burdened projected free cash flows with the capital spending deemed necessary to support the cash flows and applied blended jurisdictional tax rates ranging from &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;19.1%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;21.7%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. We weighted indications of fair value resulting from the market approach and present value techniques, considering the reasonableness of the range of measurements and the point within the range that we determined was most representative of fair market conditions (refer to &lt;/span&gt;&lt;a href="#s4FA8299FAFB154038583DC7BC119296B" style="font-family:Arial;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Note 4&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Fixed Rate Long-term Debt&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our fixed rate long-term debt consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:520px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:233px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Public Bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Carrying Value (excluding discount)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,760.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,600.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,969.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,618.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Private placement note&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Carrying value (excluding premium)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;151.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;168.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;168.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, promissory notes related to our equity method investment in Kazmira, and variable rate long-term debt, approximate their fair value.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-8B64CE1B91EE5DE39C592F6D321B5C39-0-wk-Fact-E2A3B1D2ECBF5A87BF8C1A37C312ED46">&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="25"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:7%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Investment securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Funds associated with Israeli severance liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Royalty Pharma contingent milestone&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Contingent consideration payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Measured at fair value on a non-recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Goodwill&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;811.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,013.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;811.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,036.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;, goodwill with a carrying amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$1,013.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; was written down to a fair value of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$811.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;. During the year ended December 31, 2019, goodwill with a carrying amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$1,122.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; was written down to a fair value of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$1,013.1&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$55.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; were written down to a fair value of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$23.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;. &lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1582-wk-Fact-36CC7507C53E5EFBBE8E4413DD4BEEFC"
      unitRef="usd">3300000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1601-wk-Fact-1838DBF169C1538B88EB59775EC327BA"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1621-wk-Fact-F22ECE751D645C979608C36AF04C07B4"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1640-wk-Fact-178AA8E8AB9C5C7889057FBD7D15AC3A"
      unitRef="usd">6600000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1659-wk-Fact-FA31AD55D51B5459A8752EB80F3033DD"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1679-wk-Fact-385A898358845DBFA1EA5AB5DED0153B"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1699-wk-Fact-1DB59FBBCAA35893A9BEEEDAC114B0E5"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1718-wk-Fact-DB0A2D589FBF52669F9F5F11CC7C520F"
      unitRef="usd">8700000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1737-wk-Fact-AE99261ED3A85F759090F061621842DB"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1757-wk-Fact-63EFA36EDCDF5EB19BBB6AFCA5199774"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1776-wk-Fact-99A47401F6015E34803D431E962E6D94"
      unitRef="usd">4300000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1796-wk-Fact-0AEC62F90D695732B894CA5FBF811A06"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1821-wk-Fact-833BDAB7B08056F8B1C0DE558D3EE7AA"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1840-wk-Fact-93347F2201625BECBA2B1760F3A4B483"
      unitRef="usd">7700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1859-wk-Fact-F54310EB528E54C28FEBF15CD78D5FD9"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1879-wk-Fact-DBF399AA6756580D998F9FC7976D4155"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1898-wk-Fact-E5EC0E8325835F2EAE4B892431038874"
      unitRef="usd">26300000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1918-wk-Fact-EF47A67E240755CBA16B112A0898053A"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1943-wk-Fact-B53E4E09B3715F4FB2D150FE92BBBB83"
      unitRef="usd">0</prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure>
    <prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1962-wk-Fact-CFD1B6B384FA5765BD6D28A4E54C3179"
      unitRef="usd">14200000</prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure>
    <prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e1981-wk-Fact-677519CF07355F7082AECC553D252A8E"
      unitRef="usd">0</prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure>
    <prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2001-wk-Fact-CB9D298C57E1535695A0DC77F11D55BE"
      unitRef="usd">0</prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure>
    <prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2020-wk-Fact-412BD16712405A6A93E52C5E8C0997D8"
      unitRef="usd">14600000</prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure>
    <prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2040-wk-Fact-9DA31FF39F755DB688F7BE630441060C"
      unitRef="usd">0</prgo:FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure>
    <prgo:PotentialContingentMilestonePayments
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2065-wk-Fact-FA343B8446865774B105DBF6BCF394A1"
      unitRef="usd">0</prgo:PotentialContingentMilestonePayments>
    <prgo:PotentialContingentMilestonePayments
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2084-wk-Fact-9984B460F91B5157B54F137E02ED3154"
      unitRef="usd">0</prgo:PotentialContingentMilestonePayments>
    <prgo:PotentialContingentMilestonePayments
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2103-wk-Fact-26102473A78C561EB83D3D9ADFE3AA6B"
      unitRef="usd">121200000</prgo:PotentialContingentMilestonePayments>
    <prgo:PotentialContingentMilestonePayments
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2123-wk-Fact-9E7CFD90316A5CA88125B27AD8DD245C"
      unitRef="usd">0</prgo:PotentialContingentMilestonePayments>
    <prgo:PotentialContingentMilestonePayments
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2142-wk-Fact-7405618011BE525CAB5898AB369E4CB9"
      unitRef="usd">0</prgo:PotentialContingentMilestonePayments>
    <prgo:PotentialContingentMilestonePayments
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2162-wk-Fact-765023F3B9C05E499162491E34C54261"
      unitRef="usd">95300000</prgo:PotentialContingentMilestonePayments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2192-wk-Fact-37FD76B65D8B5C0F9A6E97BD4F5F93FE"
      unitRef="usd">3300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2211-wk-Fact-EBBF8FFF73FC5F539410DBAFBE7948EC"
      unitRef="usd">30600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2231-wk-Fact-83D9E0FCB9F256A09F7143A6F73C7325"
      unitRef="usd">121200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2250-wk-Fact-5D83EE77A4AA58CCA6C9EDB160DE0933"
      unitRef="usd">6600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2269-wk-Fact-03A818074D5659FF8749F34A29041FD4"
      unitRef="usd">45200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2289-wk-Fact-63D6BFA7FA3F54F99CD9564A2CD89CCC"
      unitRef="usd">95300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2571-wk-Fact-332609C5F06C5B1C835BD9FD52E5C751"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2590-wk-Fact-AA255E2C13CC5C07B17E50FECE1AEC2C"
      unitRef="usd">8800000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2610-wk-Fact-3CF3C04A179B5BC0AFB81A99FB32E49B"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2629-wk-Fact-92F3E12F01035F4785325F22869DDADA"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2648-wk-Fact-B8C82417C95352FA81BA7C209D2E870D"
      unitRef="usd">8400000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2668-wk-Fact-5299C0D20DE553C89AF99FE594FB2B34"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2688-wk-Fact-73C3064026B6533C9707501785AF3D2F"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2707-wk-Fact-D9BA1E889AA35B048737D21CE7D53415"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2726-wk-Fact-9EA999B5AD8F51B09514EDABAE08D19E"
      unitRef="usd">12800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2746-wk-Fact-4706F93EA3C15D8FA3DE760F24C0AAFF"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2765-wk-Fact-ED05330B56BB501F82053A5033746A97"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2785-wk-Fact-D842AED3E5685AF8A8F7278C7199717C"
      unitRef="usd">11900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2815-wk-Fact-265FE7951A835E5EB4F33EAC739F7456"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2834-wk-Fact-8048B5BB99615B858B6AFD0515E8DB15"
      unitRef="usd">8800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2854-wk-Fact-061CE9757D7253D9B3BA3AA25857FEF8"
      unitRef="usd">12800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2873-wk-Fact-B25B1FB54F0D5C04AC307C9B20345D75"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2892-wk-Fact-E6A743672E5D548B9A4DD6D82D8C5788"
      unitRef="usd">8400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e2912-wk-Fact-64459C5EFEB05D16A2627BFD5D2087AF"
      unitRef="usd">11900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3323-wk-Fact-54659D50AABB58A8AD490252A3CAEC7D"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3342-wk-Fact-8A111B173C555B0CB5779ABD1C5D2650"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3362-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
      unitRef="usd">811100000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3381-wk-Fact-E1A5E9B08C5A58CBB315756126068B88"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3400-wk-Fact-7C700D4A75525FDDAC3C3171E75DFFE5"
      unitRef="usd">0</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3420-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
      unitRef="usd">1013100000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3442-wk-Fact-36210C25EE665D12BAF6DC136D86364C"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3461-wk-Fact-4B312B45A7B45F5AA356D35F99AED5E3"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3480-wk-Fact-6BF6FF194208528A9F268E547BB40BDD"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3500-wk-Fact-98E41D9BAFA85AA09C857F17FB3EF40F"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3519-wk-Fact-E609865B9D3A57D7B8FF4D93924A4F7E"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3539-wk-Fact-4834881B4668519E87F6E7AF053C9407"
      unitRef="usd">23300000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3569-wk-Fact-8B6B4BFA0AE15F5BB80F5E9237EA3770"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3588-wk-Fact-6A742F0FC83A56B48D66F8A555F1015D"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3608-wk-Fact-E9470754EDD750E69E007E10862FCA31"
      unitRef="usd">811100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3627-wk-Fact-F7CF883001755C41B7EE516136604022"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3646-wk-Fact-3E93E11C81BC59A39D05BE5C9126C275"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3666-wk-Fact-24BE0F9CCA515A0CB0B233F26F70F768"
      unitRef="usd">1036400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d57757e3724-wk-Fact-1DBACFC7E2FAD86095884735D7A95AFC"
      unitRef="usd">1013500000</us-gaap:Goodwill>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3728-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
      unitRef="usd">811100000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d57757e3734-wk-Fact-FB61E320C0B958E7A1A8AF9CC4D9A307"
      unitRef="usd">1122300000</us-gaap:Goodwill>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3739-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
      unitRef="usd">1013100000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3754-wk-Fact-4E97D7D4712B5F31AB299EA02A429AF8"
      unitRef="usd">55300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember"
      decimals="-5"
      id="d57757e3758-wk-Fact-4834881B4668519E87F6E7AF053C9407"
      unitRef="usd">23300000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <prgo:FairValueAssetsLevel1Level2Level3TransfersAmount
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d57757e3773-wk-Fact-2253F06DCC95551785B866D13CCAB527"
      unitRef="usd">0</prgo:FairValueAssetsLevel1Level2Level3TransfersAmount>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-69817A63A21653B9B54CE971E0DC09B0-0-wk-Fact-66216B36DB5D5C94ADB99832D1B392D7">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The table below summarizes the change in fair value of the Royalty Pharma contingent milestone (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:555px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:85px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:85px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;99.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;89.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;323.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payments received&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(250.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Change in fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;91.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;121.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;91.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2020Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4006-wk-Fact-518FF95A1F715EA9B33D3218344051E2"
      unitRef="usd">99000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2019Q2_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4025-wk-Fact-4B26F13DB8065CB492AE8373631552A8"
      unitRef="usd">89100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2019Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4044-wk-Fact-C664B0C12A56573C8DC0426C0ABDDCAA"
      unitRef="usd">95300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2018Q4_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4064-wk-Fact-FB7F0371B61D5F82855EFE3FA5AC72BE"
      unitRef="usd">323200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4079-wk-Fact-2E89A2325EF45A799E383073E7C632F0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4098-wk-Fact-04E6CF7A80795345BC6E2ABC957ED8F0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4117-wk-Fact-4197538218665FA8B056AA04C344B1D2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4137-wk-Fact-8D90D929A87850118518728341537D08"
      unitRef="usd">250000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4158-wk-Fact-33D18A5B3DF6516C85BDA7251C707652"
      unitRef="usd">22200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4177-wk-Fact-65AC4873392B5E35B04618367BBBA5C8"
      unitRef="usd">2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4196-wk-Fact-2FB983C2B2055588A90FC662E28905E5"
      unitRef="usd">25900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4216-wk-Fact-147B3B0A6C3A5392B2939A5090D14FFB"
      unitRef="usd">18500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4241-wk-Fact-E2E568A1657D57B9B3C65222EE5D73C0"
      unitRef="usd">121200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2019Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4260-wk-Fact-7AF8594DC19A5A1E89CAD97EF55E5829"
      unitRef="usd">91700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4279-wk-Fact-E2E568A1657D57B9B3C65222EE5D73C0"
      unitRef="usd">121200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2019Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4299-wk-Fact-7AF8594DC19A5A1E89CAD97EF55E5829"
      unitRef="usd">91700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <prgo:ScheduleofFairValueAssumptionsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-F5F9A21F3D1E5B789C1A6A6D7B72CD37-0-wk-Fact-D8FD89044C2356179621D661B7E62A8E">The table below represents the volatility and rate of return:&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:306px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:113px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Rate of return&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:ScheduleofFairValueAssumptionsTableTextBlock>
    <prgo:FairValueAssumptionVolatility
      contextRef="FD2020Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember"
      decimals="3"
      id="d57757e4411-wk-Fact-CAF9A001C1265BD9AF3AEA94735066AD"
      unitRef="ratio">0.300</prgo:FairValueAssumptionVolatility>
    <prgo:FairValueAssumptionVolatility
      contextRef="FD2019Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember"
      decimals="3"
      id="d57757e4426-wk-Fact-9AE24A1D56425A24AA7367FE703A8212"
      unitRef="ratio">0.300</prgo:FairValueAssumptionVolatility>
    <prgo:FairValueAssumptionsRateofReturn
      contextRef="FD2020Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember"
      decimals="4"
      id="d57757e4442-wk-Fact-5569E3B2762C5F52820711B433CCF8AF"
      unitRef="ratio">0.0684</prgo:FairValueAssumptionsRateofReturn>
    <prgo:FairValueAssumptionsRateofReturn
      contextRef="FD2019Q3QTD_srt_CounterpartyNameAxis_prgo_RoyaltyPharmaMember"
      decimals="4"
      id="d57757e4457-wk-Fact-A4E0EEE110B35CDFB52AF74A5F10EE3F"
      unitRef="ratio">0.0799</prgo:FairValueAssumptionsRateofReturn>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2020Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4482-wk-Fact-33D18A5B3DF6516C85BDA7251C707652"
      unitRef="usd">22200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2020Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4486-wk-Fact-2FB983C2B2055588A90FC662E28905E5"
      unitRef="usd">25900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4490-wk-Fact-BB2F6E822DA159DC92FDFCBF0642E6AB"
      unitRef="usd">121200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2019Q3QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4512-wk-Fact-65AC4873392B5E35B04618367BBBA5C8"
      unitRef="usd">2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="FD2019Q3YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4516-wk-Fact-147B3B0A6C3A5392B2939A5090D14FFB"
      unitRef="usd">18500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <prgo:NetSalesIncludedinCalculationForMilestonePayment
      contextRef="FD2018Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember"
      decimals="-5"
      id="d57757e4536-wk-Fact-F3C0158D2E2D5F3AB41DFF5F43A0CDC1"
      unitRef="usd">337500000</prgo:NetSalesIncludedinCalculationForMilestonePayment>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="FD2019Q1QTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember"
      decimals="-5"
      id="d57757e4540-wk-Fact-EA22D2657A735EC6AE55D3AF071E41C6"
      unitRef="usd">250000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <prgo:NetSalesIncludedinCalculationForMilestonePayment
      contextRef="FD2019Q4YTD_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember"
      decimals="-5"
      id="d57757e4544-wk-Fact-676F99D1727459929CF44CCF5DD05A6E"
      unitRef="usd">0</prgo:NetSalesIncludedinCalculationForMilestonePayment>
    <prgo:AssetAdjustedFairValueifSalesThresholdMet
      contextRef="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember"
      decimals="-5"
      id="d57757e4553-wk-Fact-1C55D070B86C5CD9AB56239ABF64ACB3"
      unitRef="usd">400000000.0</prgo:AssetAdjustedFairValueifSalesThresholdMet>
    <prgo:NetSalesThresholdForMilestonePayment
      contextRef="FD2020Q4YTD_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember"
      decimals="-5"
      id="d57757e4561-wk-Fact-55AE1DFB862C5D14970EB9755F7524D4"
      unitRef="usd">351000000.0</prgo:NetSalesThresholdForMilestonePayment>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="FI2020Q3_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4569-wk-Fact-BB2F6E822DA159DC92FDFCBF0642E6AB"
      unitRef="usd">121200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <prgo:AssetAdjustedFairValueifSalesThresholdMet
      contextRef="FI2020Q4_srt_StatementScenarioAxis_srt_ScenarioForecastMember"
      decimals="-5"
      id="d57757e4573-wk-Fact-18C2B646E31D597EB425F17529709E77"
      unitRef="usd">400000000.0</prgo:AssetAdjustedFairValueifSalesThresholdMet>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="FD2020Q4YTD_srt_StatementScenarioAxis_srt_ScenarioForecastMember_us-gaap_FairValueByAssetClassAxis_prgo_RoyaltyPharmaContingentMilestonePaymentsMember"
      decimals="-5"
      id="d57757e4578-wk-Fact-A84D2832B76153EDBFBE9FB62084B091"
      unitRef="usd">278800000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-6F2DFA1C6D5D5CEEBDFDC0155E0E7EEE-0-wk-Fact-BB2D066CA98F51A69CC4A92819F4F859">&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The table below summarizes the change in fair value of contingent consideration payments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:202px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Changes in value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Settlements and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2020Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4818-wk-Fact-FDE8D81E2B8C51338CB1F673959FC1BC"
      unitRef="usd">12100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2019Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4837-wk-Fact-27065BEF097357698B574D47843D64A7"
      unitRef="usd">12100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4856-wk-Fact-30B36C59B80950ADAFB632B2929D5A2E"
      unitRef="usd">11900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4876-wk-Fact-99EB50F5421A52C2A38EBD54CC0A92E8"
      unitRef="usd">15300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="FD2020Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4891-wk-Fact-A981082373AE5731B772D5FEDB570885"
      unitRef="usd">700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="FD2019Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4910-wk-Fact-8E0C508AFDDE549DBCCBE884C8B12D9C"
      unitRef="usd">1100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="FD2020Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4929-wk-Fact-1602300E8B42538BB234BFD06BD6A609"
      unitRef="usd">900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="FD2019Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4949-wk-Fact-DC47CC2B317C54DAA95F6535B0A9F909"
      unitRef="usd">-900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="FD2020Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4970-wk-Fact-DD854960707B5D899A1586238FFF35AF"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="FD2019Q3QTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e4989-wk-Fact-E1035CD67C3E5386BC3CB3D4E65AAAAF"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="FD2020Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e5008-wk-Fact-93924379FB7E5F2C866FD402EB6FFDFA"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="FD2019Q3YTD_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e5028-wk-Fact-519DEA7ABB0D5371B3A97892C0AD524B"
      unitRef="usd">1200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e5054-wk-Fact-DD51C41395C35D49ACE49FCED409D1EC"
      unitRef="usd">12800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2019Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e5073-wk-Fact-EE5D61B7D8AA5602B14AC4C33924D237"
      unitRef="usd">13200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e5092-wk-Fact-DD51C41395C35D49ACE49FCED409D1EC"
      unitRef="usd">12800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2019Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-5"
      id="d57757e5112-wk-Fact-EE5D61B7D8AA5602B14AC4C33924D237"
      unitRef="usd">13200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-7A49C6773C7058F085111A186D163D1E-0-wk-Fact-416277D257565845BF8EFE33D02DC630">The fair value of our contingent consideration sales-based milestones as of &lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, was calculated using the following significant unobservable inputs:&lt;/span&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:29%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Valuation Technique&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Unobservable Input&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Range (Weighted Average)&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Contingent consideration payments: sales-based milestones &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Discounted cash flow&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Projected royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;36.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Projected year of payment of sales-based milestones&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2021 - 2036 (2027)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Unobservable inputs were weighted based on the relative estimated milestone payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <prgo:ContingentConsiderationPaymentsSalesbasedMilestones
      contextRef="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_prgo_MeasurementInputProjectedRoyaltiesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember"
      decimals="-5"
      id="d57757e5347-wk-Fact-18CDA24ABA5350E1A3F97CD23B3121FA"
      unitRef="usd">36800000</prgo:ContingentConsiderationPaymentsSalesbasedMilestones>
    <prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent
      contextRef="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember"
      decimals="3"
      id="d57757e5422-wk-Fact-D10AEA480BAA578F9C80C861911D054B"
      unitRef="ratio">0.260</prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent>
    <prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent
      contextRef="FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember"
      decimals="3"
      id="d57757e5451-wk-Fact-D10AEA480BAA578F9C80C861911D054B"
      unitRef="ratio">0.260</prgo:ContingentConsiderationPaymentsSalesbasedMilestonesPercent>
    <prgo:ReportingUnitFairValuePercent
      contextRef="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember"
      decimals="3"
      id="d57757e5491-wk-Fact-158429DCEC7C5AD1ED67473E4B7A4416"
      unitRef="ratio">0.000</prgo:ReportingUnitFairValuePercent>
    <prgo:ReportingUnitFairValuePercent
      contextRef="FD2020Q3QTD_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember"
      decimals="3"
      id="d57757e5498-wk-Fact-6774F4B6B5662C7436854741D51BD622"
      unitRef="ratio">0.103</prgo:ReportingUnitFairValuePercent>
    <prgo:BlendedJurisdictionalTaxRatesPercent
      contextRef="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember"
      decimals="3"
      id="d57757e5502-wk-Fact-9FED2571DEF4336DFE49474BB74B8C62"
      unitRef="ratio">0.191</prgo:BlendedJurisdictionalTaxRatesPercent>
    <prgo:BlendedJurisdictionalTaxRatesPercent
      contextRef="FD2020Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember"
      decimals="3"
      id="d57757e5506-wk-Fact-7970A23F06CAFF1E7E9A474DBB190CB9"
      unitRef="ratio">0.217</prgo:BlendedJurisdictionalTaxRatesPercent>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-5E7CD08147D65E45A4BAF77FE52CE498-0-wk-Fact-564E65AAF4D853BF87A6096BC28029C9">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our fixed rate long-term debt consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:520px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:233px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:56px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Public Bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Carrying Value (excluding discount)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,760.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,600.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,969.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,618.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:14px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Private placement note&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Carrying value (excluding premium)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;151.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;168.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;168.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember"
      decimals="-5"
      id="d57757e5815-wk-Fact-68F0395B64E15DEEAD44DC02FA262544"
      unitRef="usd">2760000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember"
      decimals="-5"
      id="d57757e5853-wk-Fact-C5FB5FCB320A58F291D514066509E654"
      unitRef="usd">2600000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d57757e5893-wk-Fact-FFE5F38C1B0D5D86B230990470AAD965"
      unitRef="usd">2969900000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d57757e5931-wk-Fact-1C520AC6E91D5F1FB5D03A6CB8376713"
      unitRef="usd">2618400000</us-gaap:SeniorNotes>
    <us-gaap:LongTermDebt
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember"
      decimals="-5"
      id="d57757e6154-wk-Fact-3D6A1C6BB42F57AA98740C6E6155A54E"
      unitRef="usd">157100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember"
      decimals="-5"
      id="d57757e6193-wk-Fact-F3B9ABAB784B5538B44753DB0BA191D1"
      unitRef="usd">151400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d57757e6232-wk-Fact-7C44EEC5C9C45FEB9BA63B95668FD79A"
      unitRef="usd">168000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_PrivatePlacementNoteMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-5"
      id="d57757e6271-wk-Fact-738D0D61D0295AD59A21FEE8582FA011"
      unitRef="usd">168400000</us-gaap:LongTermDebt>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-493DD824957053D499BFA3CB8987FE8B-0-wk-Fact-53693C5C0A995CDB95CC12D684DACED7">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;INVESTMENTS&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.79643231899266%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:28%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:39%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Measurement Category&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value method&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Equity method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;69.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Measured at fair value using the Net Asset Value practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="18"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Measurement Category&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Income Statement Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Equity method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 17, 2020, we announced our entrance into the cannabidiol&#160;(&#x201c;CBD&#x201d;) market through a strategic investment in and long-term supply agreement with Kazmira LLC ("Kazmira"), a leading supplier of hemp-based CBD products free of tetrahydrocannabinol (&#x201c;THC-free&#x201d;) based in Watkins, Colorado. In addition to the supply agreement, we acquired an approximate &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;20%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; equity stake in Kazmira for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$50.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; with &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$15.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; paid at close of the transaction and the balance due within &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; months thereafter. Our minority equity investment initiates the first phase of the partnership in which we will collaborate to scale-up Kazmira&#x2019;s facilities and laboratories, in accordance with current Good Manufacturing Practices, to produce THC-free CBD from industrial hemp that meets our standards for reliability and consistency. In the second phase of the partnership, we will work to launch THC-free hemp-based CBD products in a number of global markets, while leveraging our supply agreement with Kazmira, which is exclusive for the U.S. store brand market. We will report our equity method earnings from Kazmira in our Condensed Consolidated Financial Statements on a quarterly lag.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-DE19D03B396E55629125301FCD68052B-0-wk-Fact-853A12CEDBC45B45A17EEAA8D9292C04">&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.79643231899266%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:28%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:39%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Measurement Category&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value method&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Equity method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;69.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Measured at fair value using the Net Asset Value practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d19403e1088-wk-Fact-E4FF286F423256099229C90435975EBC"
      unitRef="usd">3300000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d19403e1107-wk-Fact-1E0CDA974D835AF888E93386A1CD81AD"
      unitRef="usd">6600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember"
      decimals="-5"
      id="d19403e1144-wk-Fact-5B9A12A4436158F6ACA797BEE8428DE3"
      unitRef="usd">1800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember"
      decimals="-5"
      id="d19403e1163-wk-Fact-657D3A9C033253C599DE3B568A3ADD2A"
      unitRef="usd">2300000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquityMethodInvestments
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember"
      decimals="-5"
      id="d19403e1198-wk-Fact-82B53E17CE0D58D29BEE362B2AB09405"
      unitRef="usd">69500000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember"
      decimals="-5"
      id="d19403e1217-wk-Fact-8EEC5AC762325F3790845453033E6004"
      unitRef="usd">17800000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-9B2D8853973D55CD947A5158CFBD5526-0-wk-Fact-3A6606E6C18C517A81849A0458BE40F7">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="18"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Measurement Category&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Income Statement Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Fair value method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Equity method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1504-wk-Fact-9F6291E1145D52F288BD2EF9BED0B445"
      unitRef="usd">400000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1524-wk-Fact-A2D180A28B035243A6FED6498DBC5CE5"
      unitRef="usd">-900000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1539-wk-Fact-F80D4EB782525CDD8598A7F5EEB94E48"
      unitRef="usd">-2200000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1558-wk-Fact-1E077FA3175E531BB80A2294FE0A20D9"
      unitRef="usd">-8800000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1593-wk-Fact-59D6D236DA0350A686D6463CBD543B31"
      unitRef="usd">1100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1613-wk-Fact-657351420B8C5868A1080B22600FC9B1"
      unitRef="usd">300000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1629-wk-Fact-C95FEA61C7C155DBA34E8664AE877537"
      unitRef="usd">2600000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d19403e1649-wk-Fact-5C9784C2C3765D27AD658F430F0D73B6"
      unitRef="usd">2100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="2"
      id="d19403e1672-wk-Fact-0681BED7FD8054539575AD8B9DE20DE8"
      unitRef="ratio">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="-5"
      id="d19403e1676-wk-Fact-7553203D6C915DDA8B019E969B431527"
      unitRef="usd">50000000.0</us-gaap:EquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="D2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="-5"
      id="d19403e1680-wk-Fact-81E39720DC06545EB6E8B07ABD9E53BE"
      unitRef="usd">15000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <prgo:EquityMethodInvestmentPeriodforPayment
      contextRef="D2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      id="d19403e1684-wk-Fact-DAA9B3FADFA3575D81B6B9539B35920B">P18M</prgo:EquityMethodInvestmentPeriodforPayment>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-873C0C9658C65743A34C68B91D294820-0-wk-Fact-2AE4FE836E2452C1A3D3925E58F3A083">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Cross Currency Swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On August 15, 2019, we entered into a cross-currency swap designated as a net investment hedge to hedge the EUR currency exposure of our net investment in European operations. This agreement is a contract to exchange floating-rate Euro payments for floating-rate U.S. dollar payments. The payments are based on a notional basis of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#x20ac;450.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$498.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;) and settle quarterly. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Interest Rate Swaps &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;There were no active designated or non-designated interest rate swaps as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Foreign Currency Forwards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Net Investment Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 19, 2020, we entered into a foreign currency forward contract designated as a net investment hedge of the GBP currency exposure of our net investment in certain of our U.K. operations. The hedge had a notional basis of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#xa3;155.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$194.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;) and was settled during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Foreign currency forward contracts were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:55.55555555555556%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Israeli Shekel (ILS)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;398.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;712.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;European Euro (EUR)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;193.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;United States Dollar (USD)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;83.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;92.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Danish Krone (DKK)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;59.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;51.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;British Pound (GBP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;56.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;86.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Swedish Krona (SEK)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;42.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Chinese Yuan (CNY)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;20.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Canadian Dollar (CAD)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;41.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Polish Zloty (PLZ)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Mexican Peso (MPX)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Norwegian Krone (NOK)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Switzerland Franc (CHF)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Romanian New Leu (RON)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;961.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,257.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The maximum term of our forward currency exchange contracts is &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; months.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Effects of Derivatives on the Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:742px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:237px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Asset Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total designated derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:654px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:218px;"/&gt;&lt;td style="width:237px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liability Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:743px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:206px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:58px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contract&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(11.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(12.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:240px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Treasury locks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contract&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(29.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1) Net &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;loss&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$9.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; is expected to be reclassified out of AOCI into earnings during the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:240px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:68px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:240px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:68px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:768px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="19"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:200px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:166px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Non-Designated Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Income Statement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(14.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(27.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(15.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(26.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;785.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;34.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,427.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;97.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Treasury locks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;778.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(71.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,222.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;90.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(65.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-5"
      id="d46894e989-wk-Fact-6FE8FC7C70A353D09CA85E95F01DCDBC"
      unitRef="eur">450000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-5"
      id="d46894e993-wk-Fact-8DC8EEC9295F528F89F4CC91C97E0A14"
      unitRef="usd">498000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="I2020Q2Jun19_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1033-wk-Fact-FA1A3706AA0F50A1ABB1E596DDBB9B55"
      unitRef="gbp">155000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="I2020Q2Jun19_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1037-wk-Fact-9582C69F0CA55225A0094282A347E78B"
      unitRef="usd">194500000</us-gaap:DerivativeNotionalAmount>
    <prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-C620C3E9F6675D28A61BE45C2DC3AD54-0-wk-Fact-BB0ECD8758B75218800CF7FD6903C2E2">&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Foreign currency forward contracts were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:55.55555555555556%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Israeli Shekel (ILS)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;398.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;712.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;European Euro (EUR)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;193.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;United States Dollar (USD)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;83.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;92.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Danish Krone (DKK)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;59.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;51.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;British Pound (GBP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;56.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;86.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Swedish Krona (SEK)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;42.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Chinese Yuan (CNY)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;20.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Canadian Dollar (CAD)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;41.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Polish Zloty (PLZ)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Mexican Peso (MPX)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Norwegian Krone (NOK)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Switzerland Franc (CHF)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Romanian New Leu (RON)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;961.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,257.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1185-wk-Fact-9D14F6FD826057508A770B4CB3464B22"
      unitRef="usd">398000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_ILS_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1204-wk-Fact-EA28353A03185E62A977737D8ECF4CF8"
      unitRef="usd">712700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1224-wk-Fact-204707CB183D57488728317C1EF38913"
      unitRef="usd">193500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_EUR_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1243-wk-Fact-F75B0855E2B559D2B5913AFDA5F80D0D"
      unitRef="usd">157600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1268-wk-Fact-A18F2427381052658DEC467EBF33B4AC"
      unitRef="usd">83100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_USD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1287-wk-Fact-9B149008209F57DD8B5AF4785E78922F"
      unitRef="usd">92400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1312-wk-Fact-F8E2849B1D2C58298BFEFCBF2DAE3491"
      unitRef="usd">59100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_DKK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1331-wk-Fact-831F6E7435725FAC882EB87FFE8B42B3"
      unitRef="usd">51700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1356-wk-Fact-B43AF619DEC554D0A52A7C057A4FCD87"
      unitRef="usd">56900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_GBP_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1375-wk-Fact-689DC5B775995233B4C1A3609E02747D"
      unitRef="usd">86900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1400-wk-Fact-C5E070F418D95C3CB54E05BAF8577662"
      unitRef="usd">45900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_SEK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1419-wk-Fact-8D5B44DE6D7852CFAACCC2ECFED84CDA"
      unitRef="usd">42000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1444-wk-Fact-543061E4FBEC59EDAFF620751FA07BE5"
      unitRef="usd">40300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_CNY_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1463-wk-Fact-3152B595DA135DC99AF507E9694D2727"
      unitRef="usd">20900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1488-wk-Fact-A79A42D39AFE5B8C9807959D1ED1B7E4"
      unitRef="usd">27500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_CAD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1507-wk-Fact-1A0FA050930C5CA1A18CF02A0DC3FBBA"
      unitRef="usd">41300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1532-wk-Fact-A0C26FE0F4E55D27BDF54A3755F2D5D5"
      unitRef="usd">16600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_PLN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1551-wk-Fact-6FB1CE0CD4E9589A93C3CA42E58E6529"
      unitRef="usd">21500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1577-wk-Fact-5DC35844A0EE5016B546B492AC7D1985"
      unitRef="usd">13700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_MXN_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1596-wk-Fact-79055ED6A8EC560393B422E6DBB69001"
      unitRef="usd">9700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1621-wk-Fact-98C2B758F4BD54DF92D001C6098B84E2"
      unitRef="usd">7700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_NOK_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1640-wk-Fact-C8E6AA596D1255E184BDBFC13FED68C4"
      unitRef="usd">6600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1665-wk-Fact-5BD8422386525FA1BDF0ED0E2F477517"
      unitRef="usd">4900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_CHF_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1684-wk-Fact-EA93CCE4A79E57D39EAF35C8F35F5D34"
      unitRef="usd">4100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1709-wk-Fact-8BB0F91B222E50EAAC770276B9F46EE9"
      unitRef="usd">4100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_RON_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1728-wk-Fact-72490E8C6F78568FBBEDFC736264AC5F"
      unitRef="usd">2300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1753-wk-Fact-5826FBC76E615164AF01FB71FA6EB4F2"
      unitRef="usd">10000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_srt_CurrencyAxis_currency_XXX_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1772-wk-Fact-A84E1758A9DB5199AD6653536C0DEE99"
      unitRef="usd">7500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1802-wk-Fact-BFF31DA155645AC29116EE0F01BBC56E"
      unitRef="usd">961300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e1821-wk-Fact-C3D40E92DBEF5D819B4ACA8AB6616595"
      unitRef="usd">1257200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      id="d46894e1837-wk-Fact-347CF64549A85DC5814B5F47B64B30EF">P18M</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-AF4978E033FE555ABEBFABB3F4B2553F-0-wk-Fact-81652683FFE35765B3070EF2A9BB230F">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:742px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:237px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Asset Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total designated derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:654px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:218px;"/&gt;&lt;td style="width:237px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liability Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-designated derivatives:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2106-wk-Fact-A8166D7055835AD28723D079531BF15A"
      unitRef="usd">4500000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2125-wk-Fact-2745E9955AC45B1EB75682E036BD9C7D"
      unitRef="usd">1000000.0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2150-wk-Fact-1EEA78ED871E5D7E89902FD8AB95D4C1"
      unitRef="usd">7700000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2169-wk-Fact-52224F8FE8865E78A12CBDC265BE0FF5"
      unitRef="usd">26300000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2020Q3_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2204-wk-Fact-AF1DF41DD88953DD98D986EBD75FAB4E"
      unitRef="usd">12200000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2019Q4_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2223-wk-Fact-21DB91D2B4EB5E4E95B61DCDDE62E970"
      unitRef="usd">27300000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e2304-wk-Fact-5D04E54EF83356778A03B3DA468CD9A4"
      unitRef="usd">4200000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e2323-wk-Fact-03D018CA9DC658B2BF03769317FE4992"
      unitRef="usd">3300000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2572-wk-Fact-7AD6C422083F5669BCF37F131A6D7D95"
      unitRef="usd">6700000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d46894e2591-wk-Fact-5B529DB2AC2D547C9FA2DF0E4781FC7D"
      unitRef="usd">4700000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="FI2020Q3_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e2672-wk-Fact-7B8336FF16A8563FA7310124425E8E2B"
      unitRef="usd">2100000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e2691-wk-Fact-CFCBF37D5E5557DB92F53C6B00381D4E"
      unitRef="usd">3700000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-AB4882FADC4756FDA95E26A432F836D6-0-wk-Fact-C3F2DD3E16D45904955BB85D36491B6B">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:743px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:206px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:58px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contract&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(11.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(12.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:240px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Treasury locks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contract&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(29.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1) Net &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;loss&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;span&gt;$9.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; is expected to be reclassified out of AOCI into earnings during the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:240px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:68px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:240px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:68px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:126px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:95px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Instrument&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recorded in OCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e3102-wk-Fact-F9BB330908A958B389DE6D9A65D75614"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e3131-wk-Fact-CF1F8CB77897545D89804CC70A99C8C0"
      unitRef="usd">-400000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e3162-wk-Fact-4FE1B746FAE85DB1B49F9CFB005E5F07"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e3182-wk-Fact-0A925A88A82D5544BF55E75FFACAF962"
      unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e3212-wk-Fact-B82207B6F36A57BB8993A663C46192D2"
      unitRef="usd">-100000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e3243-wk-Fact-35818FEE1DD35FA2B83D7A9C065ACC80"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e3298-wk-Fact-337CC590139B5BB78093EF8A0A2F45B9"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e3328-wk-Fact-C741D96B2BB45DDA91D807EE06EC8EA3"
      unitRef="usd">300000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e3358-wk-Fact-1747913D54B05B5BB27B3AAAE6C58495"
      unitRef="usd">-2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e3388-wk-Fact-FE25B67C3DAC54E486BC0B3C3E0B22CE"
      unitRef="usd">600000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e3418-wk-Fact-6681933326045EAEBA00C707B9A1085F"
      unitRef="usd">300000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-5"
      id="d46894e3530-wk-Fact-F424503B07F4577F985CCE39F88E8ADF"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e3591-wk-Fact-220D175BD38153BDBB6D82D5FB07CD45"
      unitRef="usd">900000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e3611-wk-Fact-9C85F8E333ED5CC6B3213EB433D2214B"
      unitRef="usd">-11700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e3672-wk-Fact-62533127690553D6A9EF5B45B9E0A7AC"
      unitRef="usd">-100000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e3704-wk-Fact-D052A3B050575AC195770FB75B127428"
      unitRef="usd">-12000000.0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e3765-wk-Fact-03CAD9D624F252368697F44B4CD08714"
      unitRef="usd">800000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4166-wk-Fact-599FFCCBEE295646BFAB4B90802D2614"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4195-wk-Fact-4E4E6875C0055BD9A818AFF6C683AD6D"
      unitRef="usd">-100000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4226-wk-Fact-13A500EE2DAF5B3BA398046A1BA652E0"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4246-wk-Fact-21E5ECF72BF157788F6A7ECF9B4C5A3A"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4275-wk-Fact-D535B0A4FF2F5C598E2CAA02D4E152CC"
      unitRef="usd">-1300000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4306-wk-Fact-28BD628AD3725EDD9C96928BBED8C160"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e4331-wk-Fact-0D4BBC7E5651503EA28DC2F31CF06DD6"
      unitRef="usd">7400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e4360-wk-Fact-E8B4F9BB720D52049DCE56F8C025444B"
      unitRef="usd">-100000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e4391-wk-Fact-91F60300B0E55D5A861F966B5614DE6D"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e4446-wk-Fact-28833CA101C751CD9BD27C34A22E99C5"
      unitRef="usd">300000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e4476-wk-Fact-6F916AB2EF7457A097AE031F0FD942C0"
      unitRef="usd">900000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e4506-wk-Fact-AB00C328FFCF5CB3851B97436FC40313"
      unitRef="usd">7400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e4535-wk-Fact-B8105E0702895BF28D6B5C3F324DF880"
      unitRef="usd">-1200000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e4566-wk-Fact-7BAF1B1517AB5DD2884CE85CD45200FE"
      unitRef="usd">1000000.0</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-5"
      id="d46894e4678-wk-Fact-29E7FACF98905FD6A4F2915EDDDBFD85"
      unitRef="usd">-18600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4739-wk-Fact-1943B7319D9750658295047FA3F01742"
      unitRef="usd">5600000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e4760-wk-Fact-B13EFE4368D2570FA220BB1C13CE1E61"
      unitRef="usd">-11200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e4821-wk-Fact-A3B4F3D7480A5B1FA65E2A47FFB4C677"
      unitRef="usd">-100000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e4852-wk-Fact-1304196B6B745288B99541373B5E5AF1"
      unitRef="usd">-29800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e4913-wk-Fact-888679DD295157B09E5D018A488001B2"
      unitRef="usd">5500000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="FI2020Q3"
      decimals="-5"
      id="d46894e4932-wk-Fact-F83673EC6FC750CE8C9EB4EC0077DD8B"
      unitRef="usd">-9400000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e5331-wk-Fact-C4F61373C5CB589D9021A8D9C6F79A57"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e5360-wk-Fact-E7E78F71BBF1561EBF0A75498EC2113A"
      unitRef="usd">-400000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e5391-wk-Fact-420D7C1D01425699B540FD8CDF433697"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e5411-wk-Fact-E835612657E951B2A0627D709061FB0D"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e5440-wk-Fact-98D4CB4B715E5A6D9BE71C1C7D730A00"
      unitRef="usd">500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e5470-wk-Fact-D7A7D7BFFEDF5D30B4BC5F2DCA3D10B5"
      unitRef="usd">-200000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e5526-wk-Fact-76211C3FE6E95B39B847EFEB8BA3C189"
      unitRef="usd">500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e5556-wk-Fact-494EBF65ADEB5969825276951CD89017"
      unitRef="usd">300000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d46894e5586-wk-Fact-B2D20690AE255B47BED53F915BE05075"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d46894e5615-wk-Fact-392782BD04A85150A41A871708CE7B63"
      unitRef="usd">600000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d46894e5645-wk-Fact-379ED6809C9B5064933BE135C5BC6513"
      unitRef="usd">100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-5"
      id="d46894e5757-wk-Fact-DD8EB5992B68D4FBDE30C6CFB50C4534"
      unitRef="usd">30100000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e5817-wk-Fact-787D02DE69487AA678E0C6CFF6C9D52D"
      unitRef="usd">1700000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e6217-wk-Fact-EC680F6AF58D5F639FCBAA2015365B4D"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e6246-wk-Fact-337BCF5FA9D45C6AB94351EB1FBA8B9C"
      unitRef="usd">-1300000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e6277-wk-Fact-0FD55D6AD71B571C9F29A154B933E220"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember"
      decimals="-5"
      id="d46894e6297-wk-Fact-A514A87AAF0E5DE7B4CC734B1F95401B"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e6326-wk-Fact-8895ACBD0AA65D59B7AB31D086EF861A"
      unitRef="usd">800000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e6356-wk-Fact-5EEB269411165131849D4C5C5F76D200"
      unitRef="usd">-200000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e6412-wk-Fact-7D27581043FA53499880273DBD5D000E"
      unitRef="usd">-900000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e6443-wk-Fact-F50059C19B485D778BC2E64CF3F6DE19"
      unitRef="usd">-1900000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d46894e6474-wk-Fact-A311F3C562F75FC99BED5731D6DC6C60"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d46894e6503-wk-Fact-DBBA0B64F13F5020B77FA09536226083"
      unitRef="usd">-1400000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d46894e6534-wk-Fact-22F3646BA2A053808BAB41BF94150A9C"
      unitRef="usd">-2100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-5"
      id="d46894e6647-wk-Fact-DD8EB5992B68D4FBDE30C6CFB50C4534"
      unitRef="usd">30100000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e6707-wk-Fact-787D02DE69487AA678E0C6CFF6C9D52D"
      unitRef="usd">1700000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-67ABA3FAB1965BAF8192A13BD9296519-0-wk-Fact-0AE07E05C1715C6D81FD1D1CB9F636BB">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:768px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="19"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:200px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:166px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Non-Designated Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Income Statement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other (income) expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(14.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(27.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-left:12px;text-indent:-12px;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(15.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(26.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-5"
      id="d46894e6978-wk-Fact-DAAADB183FF6513C8699DBA964587595"
      unitRef="usd">8500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-5"
      id="d46894e6997-wk-Fact-0CABFBF24B7F530AA2D6411A0E1BAE11"
      unitRef="usd">-14700000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-5"
      id="d46894e7018-wk-Fact-037C67AB1EEB5AEFBE5898B7FEBA78B4"
      unitRef="usd">1400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-5"
      id="d46894e7037-wk-Fact-1823CCB5C5465F5290BFE8C5330F8B26"
      unitRef="usd">-27800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e7068-wk-Fact-ABD9D14BC2F25529839BC3958EE8A31E"
      unitRef="usd">1700000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e7087-wk-Fact-A3017ACA4EC75C46860D1D339A75D6FE"
      unitRef="usd">-500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e7108-wk-Fact-7AC3A230869A51D493933B05B64AF679"
      unitRef="usd">5900000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e7127-wk-Fact-E8F318C9DE365593A1BA752E49BA320A"
      unitRef="usd">1300000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e7167-wk-Fact-F9B49A6D45F7557CB7FDD1AFB31780E1"
      unitRef="usd">10200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e7186-wk-Fact-A4BB7E752EB25B69A9021542E484675D"
      unitRef="usd">-15200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e7207-wk-Fact-8BCD871B33765EBF83CAA425DF318139"
      unitRef="usd">7300000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q3YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-5"
      id="d46894e7226-wk-Fact-8B65B3D3A1695F7FA5FD2C490BF38C95"
      unitRef="usd">-26500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-ED862E47D4FF5BFF8AA9D241CC1A8B64-0-wk-Fact-CF8BC13C43FE5BA68C06943843BB0903">&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;785.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;34.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,427.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;97.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Treasury locks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;778.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(71.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:353px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:69px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Interest Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,222.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;90.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(65.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;The effects of cash flow hedging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e7597-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
      unitRef="usd">1213700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e7616-wk-Fact-D6166CD88DD15F24801DF34453CB9491"
      unitRef="usd">785600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e7636-wk-Fact-5563699BAF3D5510876A69B2F5003B29"
      unitRef="usd">-34000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d46894e7655-wk-Fact-7B895DB86A395FD8B2B3DCF0CCA06EA8"
      unitRef="usd">-400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e8028-wk-Fact-B82207B6F36A57BB8993A663C46192D2"
      unitRef="usd">-100000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e8048-wk-Fact-337CC590139B5BB78093EF8A0A2F45B9"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e8068-wk-Fact-239E956BB72F51A9A15E0470AD5E0832"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e8087-wk-Fact-99E83F3538E0533E8BF4FDBFE4ADACB7"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e8112-wk-Fact-35818FEE1DD35FA2B83D7A9C065ACC80"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e8131-wk-Fact-C741D96B2BB45DDA91D807EE06EC8EA3"
      unitRef="usd">300000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e8151-wk-Fact-C0074B9CCAA558B8AF98847BBBD685FF"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e8170-wk-Fact-C35EA94B92E6554F8601B1E60A1F1E31"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e8283-wk-Fact-FADB15BCB8655C61AD81A9CB13897F9B"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e8302-wk-Fact-826A8490D3965850B01F0E35C58DBFAF"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e8322-wk-Fact-CF1F8CB77897545D89804CC70A99C8C0"
      unitRef="usd">-400000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e8342-wk-Fact-23280D6B0B3D57E28663DC8E0492ACE8"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e8692-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
      unitRef="usd">3773800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e8711-wk-Fact-F6825A5E3B995584B76CA6D36B71F7AE"
      unitRef="usd">2427800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e8731-wk-Fact-2003F8F9485B5D92A9E51B11C3D690BB"
      unitRef="usd">-97600000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d46894e8750-wk-Fact-097957692A2D57108C52A7A00CE0061D"
      unitRef="usd">-17100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e9123-wk-Fact-E8B4F9BB720D52049DCE56F8C025444B"
      unitRef="usd">-100000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e9143-wk-Fact-28833CA101C751CD9BD27C34A22E99C5"
      unitRef="usd">300000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e9163-wk-Fact-97D1655FB6435CA2849860725E4A5115"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e9182-wk-Fact-29EFA7F241755307A488B6B6B4A79B18"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e9207-wk-Fact-91F60300B0E55D5A861F966B5614DE6D"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e9226-wk-Fact-6F916AB2EF7457A097AE031F0FD942C0"
      unitRef="usd">900000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e9246-wk-Fact-158CF7CCA37B553583A56B9D9C0C5E9B"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2020Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e9265-wk-Fact-64A883DF228957AAA143159FE21A4E8D"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e9378-wk-Fact-793F4C5A03705FA6B4A38A93A017CB36"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e9397-wk-Fact-FEB07EA63AF0523DBBAC5CAA2CFA0B48"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e9417-wk-Fact-4E4E6875C0055BD9A818AFF6C683AD6D"
      unitRef="usd">-100000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_TreasuryLockMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e9437-wk-Fact-0BCF786186E059579ED3AAD98C522FF3"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e9549-wk-Fact-66AD461E202D597A92E804CC4DC2C0A8"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e9568-wk-Fact-77B7508D8DC6566C8AA433FAA4D3920D"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e9588-wk-Fact-D535B0A4FF2F5C598E2CAA02D4E152CC"
      unitRef="usd">-1300000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e9608-wk-Fact-EA597E258A7959E49CB2B97546EBDC86"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d46894e9921-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
      unitRef="usd">1191100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d46894e9940-wk-Fact-F244B3D2D80955E6B5620B5DF32AB4DB"
      unitRef="usd">778300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d46894e9960-wk-Fact-39CFAD777BBD500CA31E9B3E378D9D52"
      unitRef="usd">-30500000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d46894e9979-wk-Fact-D7BE36645A5C5C96AF8894AA8DB436F6"
      unitRef="usd">71000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e10353-wk-Fact-98D4CB4B715E5A6D9BE71C1C7D730A00"
      unitRef="usd">500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e10372-wk-Fact-76211C3FE6E95B39B847EFEB8BA3C189"
      unitRef="usd">500000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e10392-wk-Fact-023DA22505D95809ABC7F7B518F19B7A"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e10411-wk-Fact-F8D2FB23A4465F278F2CDAB4DDE422D8"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e10436-wk-Fact-D7A7D7BFFEDF5D30B4BC5F2DCA3D10B5"
      unitRef="usd">-200000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e10456-wk-Fact-494EBF65ADEB5969825276951CD89017"
      unitRef="usd">300000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e10476-wk-Fact-872395A1712D54BF9DE8E068033B2A95"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e10495-wk-Fact-D466F0ED96C25004B6782E0F981F2752"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e10608-wk-Fact-DA9FA53ABF68508F97D819D3DFD7A988"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e10627-wk-Fact-9835F8C6807C51F7B5B2248143C949C2"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e10647-wk-Fact-E7E78F71BBF1561EBF0A75498EC2113A"
      unitRef="usd">-400000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e10667-wk-Fact-F4EC940011CF56539060EAB48A0FE12E"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d46894e10978-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
      unitRef="usd">3514600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d46894e10997-wk-Fact-2C56732F6E4250198917B3F0D82295C2"
      unitRef="usd">2222100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d46894e11017-wk-Fact-3BAD30E281D250B1806640BA4ED547C2"
      unitRef="usd">-90400000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d46894e11036-wk-Fact-A9690FAD7D5A5627A4159FEEA0CFF4AA"
      unitRef="usd">65600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e11410-wk-Fact-8895ACBD0AA65D59B7AB31D086EF861A"
      unitRef="usd">800000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e11429-wk-Fact-7D27581043FA53499880273DBD5D000E"
      unitRef="usd">-900000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e11450-wk-Fact-E3BD00A3BB2D531F8FBB4C2383E49A37"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e11469-wk-Fact-04BB1C8DDF89528BBA6071943104D868"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e11494-wk-Fact-5EEB269411165131849D4C5C5F76D200"
      unitRef="usd">-200000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e11514-wk-Fact-F50059C19B485D778BC2E64CF3F6DE19"
      unitRef="usd">-1900000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e11535-wk-Fact-A6A3B82C499F5F44A52AAF974CEDD17E"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e11554-wk-Fact-36E4891153C85874A42784B6BB1468DC"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesRevenueNetMember"
      decimals="-5"
      id="d46894e11667-wk-Fact-7D5EAFC93BBB5A3696599DC92B7CBDC1"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d46894e11686-wk-Fact-7271AB4BD14F501F9D0020235C9C7B91"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d46894e11706-wk-Fact-337BCF5FA9D45C6AB94351EB1FBA8B9C"
      unitRef="usd">-1300000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember"
      decimals="-5"
      id="d46894e11726-wk-Fact-60CBEF83BE8F5570912E79BF51E98A6E"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-19B4F9B8492757099F9E331B541BD6C0-0-wk-Fact-9C5803FFA7295E38B5A7B9B707158A6D">&lt;span style="font-family:Arial;font-weight:bold;"&gt;LEASES&lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;129.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;161.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current indebtedness&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;106.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;101.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;164.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;158.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The below table shows our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:796px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="33"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;41.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;42.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;35.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;36.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unallocated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;46.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;50.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;129.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;133.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:177px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:87px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating leases&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"/&gt;&lt;span style="font-family:Arial;font-size:8pt;"/&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  Includes short-term leases and variable lease costs, which are immaterial&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:24px;text-indent:48px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The annual future maturities of our leases as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:192px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;After 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Total lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;188.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Less: Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;164.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:473px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:473px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-A3279B220BBB5DC489A0807C71BAD32F-0-wk-Fact-6239D2B9EA45519CB10C4B13E02823E5">&lt;span style="font-family:Arial;font-weight:bold;"&gt;LEASES&lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;129.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;161.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current indebtedness&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;106.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;101.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;164.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;158.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The below table shows our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:796px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="33"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;41.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;42.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;35.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;36.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unallocated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;46.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;50.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;129.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;133.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:177px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:87px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating leases&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"/&gt;&lt;span style="font-family:Arial;font-size:8pt;"/&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  Includes short-term leases and variable lease costs, which are immaterial&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:24px;text-indent:48px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The annual future maturities of our leases as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:192px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;After 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Total lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;188.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Less: Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;164.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:473px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:473px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <prgo:AssetsandLiabilitiesLesseeTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-D9F3A961531D53EDB050ACF704134DAE-0-wk-Fact-10C8A2EA4CD95EE0889E18810ED7C527">&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;129.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;161.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:160px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:306px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current indebtedness&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;106.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;101.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;164.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;158.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The below table shows our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:796px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="33"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:73px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8.5pt;"&gt;&lt;span style="font-family:Arial;font-size:8.5pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;15.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;41.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;42.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;35.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;36.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unallocated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;46.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;50.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;129.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;27.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;133.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</prgo:AssetsandLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1090-wk-Fact-E6F78C2EB5D957A0995950F29DB10E47"
      unitRef="usd">132200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1109-wk-Fact-E70D989FFA1C5AD380968DF9112E78C9"
      unitRef="usd">129900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1139-wk-Fact-77848684BD345B8E855AE2F8637F8D71"
      unitRef="usd">29200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1158-wk-Fact-2BA975E647E95BB5B5E1DD5F9F64E60C"
      unitRef="usd">27600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <prgo:RightofUseAsset
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1198-wk-Fact-D29717650C8151568B9C06B28A21AE73"
      unitRef="usd">161400000</prgo:RightofUseAsset>
    <prgo:RightofUseAsset
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1217-wk-Fact-2551717F29E05A94903E0ED76D21A7B8"
      unitRef="usd">157500000</prgo:RightofUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1382-wk-Fact-2E038EB8989F507486229B44351F5D0C"
      unitRef="usd">31600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1401-wk-Fact-006E56C6678E5F358A2BD95B10942A1F"
      unitRef="usd">32000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1431-wk-Fact-6EC9622FE4F4522DA664A376025886AA"
      unitRef="usd">6500000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1450-wk-Fact-347D4591F71A53FDA11AE77ACE07CF8F"
      unitRef="usd">3400000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1541-wk-Fact-A42F5C49CA0C5D40AE9633D00CF40658"
      unitRef="usd">106900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1560-wk-Fact-5D9C10947FFD542BBB375BC20899A221"
      unitRef="usd">101700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1595-wk-Fact-7AFD9A407FB25005B06FA9AC060142CA"
      unitRef="usd">19800000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1614-wk-Fact-2ED2BBE193CA5462A356F995C37140C0"
      unitRef="usd">21100000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <prgo:LeaseLiabilities
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e1654-wk-Fact-DA0868E164755B6AB278E653758C7BE5"
      unitRef="usd">164800000</prgo:LeaseLiabilities>
    <prgo:LeaseLiabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e1673-wk-Fact-1550D1905399561E8B51F131EE7C6477"
      unitRef="usd">158200000</prgo:LeaseLiabilities>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2245-wk-Fact-0A24B5EDF75B5E0F8BAB8CF2F95CE38C"
      unitRef="usd">22500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2264-wk-Fact-2687F5CA861D56F0A52A216FEAE0DBA3"
      unitRef="usd">22400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2284-wk-Fact-F56524CCAA5E5D5182C8B976E0754F7F"
      unitRef="usd">15800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2303-wk-Fact-A6654748BDDC51F98CF26C21C8038F29"
      unitRef="usd">16800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2322-wk-Fact-AAE9145F96205B1BAAF972E1D55FF5D5"
      unitRef="usd">22800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2342-wk-Fact-B0F2DE8D8E2C52738C942A7418CD02CD"
      unitRef="usd">22800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2361-wk-Fact-DAB52B839AD25E77B780B7D3AA81BA7C"
      unitRef="usd">16000000.0</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d24840e2380-wk-Fact-5E2AD08F1EC256CE9397A2E7DE10CF4A"
      unitRef="usd">16600000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2400-wk-Fact-38FD8E1AB2645639A55C4F604E5C840A"
      unitRef="usd">32800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2419-wk-Fact-130FAA6C93195E2FBBF1C38CC0CE9AF1"
      unitRef="usd">41600000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2438-wk-Fact-E3B2EA48C9765C1F9A69A0AB562183D2"
      unitRef="usd">5700000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2458-wk-Fact-164D93A34AB05B568CB4897E91940D2A"
      unitRef="usd">5800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2477-wk-Fact-9E9E9068F4C05A7997A12FAB6739FCB4"
      unitRef="usd">33500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2497-wk-Fact-C8ED786505CF59D4BEAB6F63BB69908D"
      unitRef="usd">42400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2516-wk-Fact-B6E4AAA7D9AC530CB089B55430AAE567"
      unitRef="usd">2500000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d24840e2535-wk-Fact-65CD5DF3004A516AB695DDEBC8269663"
      unitRef="usd">2900000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2560-wk-Fact-BC8F390BE28C56E6A18174C7B8D0FD71"
      unitRef="usd">30700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2579-wk-Fact-D8453BDC413F5317B0617E0992C3266C"
      unitRef="usd">35100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2598-wk-Fact-29873327758C5DF6891A1C0E55355218"
      unitRef="usd">700000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2618-wk-Fact-AAD391CA35DA553694DF31B4E6CF3F03"
      unitRef="usd">800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2637-wk-Fact-8FDC609CDD615D58A04299A0DF4285EB"
      unitRef="usd">31900000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2657-wk-Fact-631F80864EDA50CEA1D4A540A3DBFFB6"
      unitRef="usd">36300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2676-wk-Fact-4E7890D862B5544BAB85CE463F2DBD59"
      unitRef="usd">700000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d24840e2695-wk-Fact-E813185A69A25BCD80F80C0A2D939B23"
      unitRef="usd">800000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2720-wk-Fact-15FD8798A5AF511CB00B88A879FBBEDC"
      unitRef="usd">46200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2739-wk-Fact-762622E785545FC98A65EE04564F7DD0"
      unitRef="usd">30800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2758-wk-Fact-547E3AC54ED5557385F4BC36601B7FAF"
      unitRef="usd">7000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2778-wk-Fact-046BF7343B605BC4B054DC6392BAF50A"
      unitRef="usd">4200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2797-wk-Fact-AE281FE50AA557E5926C8B64A9416D7E"
      unitRef="usd">50300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2817-wk-Fact-0E33F8D09E44534DAE23F636A3B825D1"
      unitRef="usd">32200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2836-wk-Fact-0F6908E177D65C619938711DE1F83FC2"
      unitRef="usd">7100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d24840e2855-wk-Fact-50A967927E24586881E15E0D154E70D6"
      unitRef="usd">4200000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e2885-wk-Fact-E6F78C2EB5D957A0995950F29DB10E47"
      unitRef="usd">132200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e2904-wk-Fact-E70D989FFA1C5AD380968DF9112E78C9"
      unitRef="usd">129900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e2924-wk-Fact-77848684BD345B8E855AE2F8637F8D71"
      unitRef="usd">29200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e2943-wk-Fact-2BA975E647E95BB5B5E1DD5F9F64E60C"
      unitRef="usd">27600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e2962-wk-Fact-C4FAB7EFBE345C5CACFA184428C74B1F"
      unitRef="usd">138500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e2982-wk-Fact-9CB668778CAC5AE6818D7220F616AFD3"
      unitRef="usd">133700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e3001-wk-Fact-808BFB1A78645289A7794C45B8425FE8"
      unitRef="usd">26300000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d24840e3020-wk-Fact-BF7B87762556547281235ADA652485A8"
      unitRef="usd">24500000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-47F5B4075EBD5FA28A76167AFED8BEB6-0-wk-Fact-6FC033A8900651C4BFDB518AEB57944C">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:177px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:87px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating leases&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;32.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"/&gt;&lt;span style="font-family:Arial;font-size:8pt;"/&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  Includes short-term leases and variable lease costs, which are immaterial&lt;/span&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d24840e3257-wk-Fact-C9C00F121CB951659C3760707A8C41F4"
      unitRef="usd">10600000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d24840e3276-wk-Fact-17F7D38C41C65D89B57E9524630DF06F"
      unitRef="usd">11000000.0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e3296-wk-Fact-1D68F3544CDE5E28B26B49940823EEB2"
      unitRef="usd">32100000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e3315-wk-Fact-5BE07753BFF65ECD8A5D8EE3A14DA068"
      unitRef="usd">33900000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d24840e3514-wk-Fact-E5DC962A24105EC8A2999E54FB498E22"
      unitRef="usd">1200000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d24840e3533-wk-Fact-CEDA58BA85D65F54B9F9960A967EA702"
      unitRef="usd">900000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e3553-wk-Fact-DA5DE931E7295537B63FEC05393A604C"
      unitRef="usd">3400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e3572-wk-Fact-D9EEFC2D36F95D8FAB9E4A66AD4B1FE0"
      unitRef="usd">2300000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d24840e3592-wk-Fact-5E6FF5C959AF5FB294F15DF423E48773"
      unitRef="usd">200000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d24840e3611-wk-Fact-A6D129F6970B59F288377CC8902A6BD1"
      unitRef="usd">200000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e3630-wk-Fact-96591D55C01D52D092712DB88F177FB1"
      unitRef="usd">600000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e3650-wk-Fact-DBA961647DF6553B8567A0E93F1E1CFD"
      unitRef="usd">400000</us-gaap:FinanceLeaseInterestExpense>
    <prgo:FinanceLeaseCost
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d24840e3680-wk-Fact-C8E9D2B32EDA5030A6C8F5FC64F52374"
      unitRef="usd">1400000</prgo:FinanceLeaseCost>
    <prgo:FinanceLeaseCost
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d24840e3699-wk-Fact-F43840A85B5256ECB9C06ABF39291DBA"
      unitRef="usd">1100000</prgo:FinanceLeaseCost>
    <prgo:FinanceLeaseCost
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e3719-wk-Fact-C31F2682A35B5D98B5F10F1BF9D17EBC"
      unitRef="usd">4000000.0</prgo:FinanceLeaseCost>
    <prgo:FinanceLeaseCost
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e3738-wk-Fact-2DFE43349F495AAE922054A93C80EED6"
      unitRef="usd">2700000</prgo:FinanceLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-93C3972108115223BCABD3172586A4A3-0-wk-Fact-F93B55CEB729515EB3CA025161ED9FEC">&lt;div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The annual future maturities of our leases as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:192px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;After 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Total lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;188.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Less: Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;164.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-F3C5BF7F88545CE2B4905A9457EB3E09-0-wk-Fact-94E8D687252B5C3ABFF3B6480B36A343">&lt;div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The annual future maturities of our leases as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:192px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:75px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;25.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;29.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;After 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;14.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Total lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;30.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;188.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Less: Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;138.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;164.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e3892-wk-Fact-8DCA306B42275B0187BD985740EEF0BD"
      unitRef="usd">9600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e3911-wk-Fact-74CC2A473DF1579FBFE40FF7E09E5E8F"
      unitRef="usd">1400000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <prgo:LeaseLiabilityPaymentsRemainderofFiscalYear
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e3931-wk-Fact-84D1E386E63A5A809037B8EAFBF1902A"
      unitRef="usd">11000000.0</prgo:LeaseLiabilityPaymentsRemainderofFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e3951-wk-Fact-B1C23D85B22456C29F96BE94DD729332"
      unitRef="usd">33200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e3970-wk-Fact-974AC05037785A01B295C02B01D730C1"
      unitRef="usd">6900000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <prgo:LeaseLiabilityPaymentsDueYearOne
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e3989-wk-Fact-BF7A818FE9A15245820CD546AD399D63"
      unitRef="usd">40100000</prgo:LeaseLiabilityPaymentsDueYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4015-wk-Fact-EE5E306001CC518C8C46400AE969B36A"
      unitRef="usd">25300000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4034-wk-Fact-FD4CB199498D5D748E6B2DF9049C13DE"
      unitRef="usd">4200000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <prgo:LeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4053-wk-Fact-58DC6C4AF59E5E72A569A3AFF802BB2C"
      unitRef="usd">29500000</prgo:LeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4079-wk-Fact-FDC61D2B4E875A1A9E5445D7DD6E7CCA"
      unitRef="usd">18700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4098-wk-Fact-F76D10AAC0555442B8A6237819A015F3"
      unitRef="usd">2500000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <prgo:LeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4117-wk-Fact-8E07D0D54380579CAA7A482982077FF6"
      unitRef="usd">21200000</prgo:LeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4143-wk-Fact-DDE3B1C05FCF5CC5A9B008D908C17B50"
      unitRef="usd">16000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4162-wk-Fact-92B3FC0AB6695BD184BF8894DBC880B8"
      unitRef="usd">1400000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <prgo:LeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4181-wk-Fact-882824021FC4572A978695EAF643177E"
      unitRef="usd">17400000</prgo:LeaseLiabilityPaymentsDueYearFour>
    <prgo:LesseeOperatingLeaseLiabilitytobePaidafterYearFour
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4207-wk-Fact-9850409A4AF9537F829BBFE51920B932"
      unitRef="usd">54600000</prgo:LesseeOperatingLeaseLiabilitytobePaidafterYearFour>
    <prgo:FinanceLeaseLiabilitytobePaidafterYearFour
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4226-wk-Fact-564D8D5D3F555F248C814ADA6725B0D0"
      unitRef="usd">14300000</prgo:FinanceLeaseLiabilitytobePaidafterYearFour>
    <prgo:LeaseLiabilityPaymentsDueafterYearFour
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4245-wk-Fact-BCDB5EBAE14B561AB52B09DA5F582229"
      unitRef="usd">68900000</prgo:LeaseLiabilityPaymentsDueafterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4271-wk-Fact-620F94638DFD567F94E5EE8EABAC4637"
      unitRef="usd">157400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4290-wk-Fact-EF142D5D38BA53AA9D87277CF362E38A"
      unitRef="usd">30700000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <prgo:LeaseLiabilityPaymentsDue
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4309-wk-Fact-351C117D423C545989845F04B1DDEB71"
      unitRef="usd">188100000</prgo:LeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4335-wk-Fact-51FBE160895D5786B57A7873F234607A"
      unitRef="usd">18900000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4354-wk-Fact-BD12D618893E5E88A95DE8F29400CD03"
      unitRef="usd">4400000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <prgo:LeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4373-wk-Fact-31099CD0B72D585C8C18A377CB34942D"
      unitRef="usd">23300000</prgo:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4404-wk-Fact-C4FAB7EFBE345C5CACFA184428C74B1F"
      unitRef="usd">138500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4423-wk-Fact-808BFB1A78645289A7794C45B8425FE8"
      unitRef="usd">26300000</us-gaap:FinanceLeaseLiability>
    <prgo:LeaseLiabilities
      contextRef="FI2020Q3"
      decimals="-5"
      id="d24840e4443-wk-Fact-DA0868E164755B6AB278E653758C7BE5"
      unitRef="usd">164800000</prgo:LeaseLiabilities>
    <prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-F81B8B353BFF5E258B64339A49F59119-0-wk-Fact-A53BE1B1774551DE830FA450606E8825">&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:473px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;6.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;background-color:#cceeff;"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2020Q3"
      id="d24840e4568-wk-Fact-CAA4CC9CE899590CA825DE726554F8E3">P6Y6M14D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2019Q3"
      id="d24840e4582-wk-Fact-98DF8366DB435FBEB0B8B09C11A5E7E2">P6Y6M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2020Q3"
      id="d24840e4602-wk-Fact-416A5C049BE057CFA82402018CB3B365">P9Y10D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2019Q3"
      id="d24840e4616-wk-Fact-91FDFB7F937959E5B5B7839437DA3223">P10Y10M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2020Q3"
      decimals="4"
      id="d24840e4672-wk-Fact-B2ABD19EF5125F4D8E3C2C758F2A7A0A"
      unitRef="ratio">0.0380</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2019Q3"
      decimals="4"
      id="d24840e4687-wk-Fact-CAB38A800B635D569AAF2B2B98DEB9CF"
      unitRef="ratio">0.0417</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2020Q3"
      decimals="4"
      id="d24840e4708-wk-Fact-7D3E4689BCE1538E943B00D3D53983D8"
      unitRef="ratio">0.0320</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2019Q3"
      decimals="4"
      id="d24840e4723-wk-Fact-4A30C8E167AC5470A35502638FE5372D"
      unitRef="ratio">0.0350</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <prgo:LesseeCashFlowClassificationsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-BDBA49A8318B56E68D2AE85B5E2F98BE-0-wk-Fact-54FEDE533FAB54D7A9607F7DBCBFE3E3">&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:473px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:89px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;33.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:9px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Leased assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;26.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</prgo:LesseeCashFlowClassificationsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e4916-wk-Fact-DC12FD08CCC85B95A3740E6E684C52F8"
      unitRef="usd">31200000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e4935-wk-Fact-810C887854EC562DB96DB9EBB8F9E095"
      unitRef="usd">33600000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e4960-wk-Fact-2CB2E7C861BA5F09A3C27DDBDA6DCCFA"
      unitRef="usd">600000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e4979-wk-Fact-CCF2C0E8303F53E7B14F5487866693D0"
      unitRef="usd">400000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e5004-wk-Fact-2CC7226A9D7754D1AB5BC505FDA47901"
      unitRef="usd">3100000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e5023-wk-Fact-63AA5071E5FB5668B91AB208EF68E817"
      unitRef="usd">2200000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e5094-wk-Fact-433A3E0531835095A8E27239D1D51B75"
      unitRef="usd">4700000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e5113-wk-Fact-4FAABEEC8A055EF893D6F89410B2B58C"
      unitRef="usd">19000000.0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d24840e5138-wk-Fact-DC40CDB996225DBA9847ACC8454BC50E"
      unitRef="usd">26200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d24840e5157-wk-Fact-9B1977136DA759E9AEA5C70CDCB9D453"
      unitRef="usd">5300000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-26DCA37977AD578FB3E19C8656FC95C8-0-wk-Fact-DA110A30ADB95094950386357C70EF1B">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;INDEBTEDNESS&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Total borrowings outstanding are summarized as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.48427672955975%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:5%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Term loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2019 Term loan due August 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;600.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;600.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Notes and Bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:underline;"&gt;Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:underline;"&gt;Due&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.500%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;March 15, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;280.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.500%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;December 15, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;309.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.105%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;July 28, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;151.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.000%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;November 15, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;215.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;215.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.900%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;December 15, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.375%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;March 15, 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.150%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;June 15, 2030&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;750.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.300%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;November 15, 2043&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;90.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;90.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.900%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;December 15, 2044&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;303.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;303.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total notes and bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,917.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,751.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Other financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;61.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unamortized premium (discount), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Deferred financing fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(17.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(14.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total borrowings outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,560.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,369.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current indebtedness&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(16.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total long-term debt less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,543.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,365.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:72px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We are in compliance with all covenants under our debt agreements as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Revolving Credit Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On March 8, 2018, we entered into a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$1.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; borrowings outstanding under the 2018 Revolver as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Term Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On March 8, 2018, we refinanced the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#x20ac;350.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; outstanding under the previous term loan with the proceeds of a new &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#x20ac;350.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$431.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;) term loan, maturing on March 8, 2020 (the "2018 Term Loan"). During the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we made &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$24.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in scheduled principal repayments on the 2018 Term Loan. On August 15, 2019, we refinanced the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#x20ac;284.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$317.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;) outstanding under the 2018 Term Loan with the proceeds of a new &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$600.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; term loan, maturing on August 15, 2022. As a result of the refinancing, during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we recorded a loss of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$0.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, consisting of the write-off of deferred financing fees in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Notes and Bonds&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;2020 Notes and 2021 Notes Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 19, 2020, Perrigo Finance Unlimited Company, a public unlimited company incorporated under the laws of Ireland ("Perrigo Finance") and an indirect wholly-owned finance subsidiary of Perrigo whose primary &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;purpose is to finance the business and operations of Perrigo and its affiliates, issued $&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;750.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in aggregate principal amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;3.150%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; Senior Notes due 2030 (the &#x201c;2020 Notes") and received net proceeds of $&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;737.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; after fees and market discount. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2020 Notes will mature on June 15, 2030. The 2020 Notes are governed by a base indenture and a third supplemental indenture (collectively, the "2020 Indenture"). The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo and no other subsidiary of Perrigo guarantees the 2020 Notes. There are no restrictions under the 2020 Notes on Perrigo's ability to obtain funds from its subsidiaries. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. On July 6, 2020, the proceeds of the 2020 Notes were used to fund the redemption of Perrigo Finance's &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$280.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;3.500%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; Senior Notes due March 15, 2021 and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$309.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;3.500%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; Senior Notes due December 15, 2021 (collectively, the "2021 Notes"). The balance will be used for general corporate purposes which may include the repayment or redemption of additional indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;As a result of the early redemption of the 2021 Notes, during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we recorded a loss of $&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;20.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on the Condensed Consolidated Statements of Operations, consisting of the premium on debt repayments, the write-off of deferred financing fees, and the write-off of the remaining bond discounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Other Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". The balance outstanding under the facilities was &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$0.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. There were &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; borrowings outstanding under the facilities as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 17, 2020, we incurred debt of $&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;34.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; related to our equity method investment in Kazmira pursuant to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; Promissory Notes, with &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$3.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$5.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$24.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; to be settled in November 2020, May 2021 and November 2021, respectively (refer to &lt;/span&gt;&lt;a href="#sF4B58DD1964A5338A17E7D9B8F660A6D" style="font-family:Arial;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We have financing leases that are reported in the above table under "Other financing" (refer to &lt;/span&gt;&lt;a href="#s5C415D6F8F16571ABE301BD0CB1A1A36" style="font-family:Arial;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Note 9&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;).&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-3CC330EE8B6B507C91C5920EB7051A64-0-wk-Fact-F4C0E4B87BE654EAB59764BEA2BE9109">&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Total borrowings outstanding are summarized as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.48427672955975%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:5%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Term loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;2019 Term loan due August 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;600.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;600.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Notes and Bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:underline;"&gt;Coupon&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;text-decoration:underline;"&gt;Due&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.500%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;March 15, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;280.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.500%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;December 15, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;309.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.105%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;July 28, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;157.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;151.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.000%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;November 15, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;215.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;215.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.900%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;December 15, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.375%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;March 15, 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;700.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3.150%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;June 15, 2030&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;750.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.300%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;November 15, 2043&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;90.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;90.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4.900%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&lt;span style="white-space:nowrap"&gt;December 15, 2044&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;303.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;303.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total notes and bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,917.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,751.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:normal;"&gt;Other financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;61.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unamortized premium (discount), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Deferred financing fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(17.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(14.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total borrowings outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,560.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,369.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Current indebtedness&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(16.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total long-term debt less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,543.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,365.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:24px;text-indent:72px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1)  Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LoansPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member"
      decimals="-5"
      id="d27108e1206-wk-Fact-5DBD723F8CA05E91A4DE5E7408145B0B"
      unitRef="usd">600000000.0</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member"
      decimals="-5"
      id="d27108e1225-wk-Fact-33822536587A5AEEAA3C879BE36327E1"
      unitRef="usd">600000000.0</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"
      decimals="INF"
      id="d27108e1427-wk-Fact-7B8E6A30547951F8B99BE6BD717917F3"
      unitRef="ratio">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"
      id="d27108e1432-wk-Fact-76C54A7D72495AD9BBE6CA09A4C949B1">2021-03-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"
      decimals="-5"
      id="d27108e1447-wk-Fact-23A1CEB354B65121905F0D8A99CF3C8C"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"
      decimals="-5"
      id="d27108e1466-wk-Fact-0F07F502238856719195123582CEE69F"
      unitRef="usd">280400000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member"
      decimals="INF"
      id="d27108e1487-wk-Fact-8ADD1509DCF05121AD93145957B69581"
      unitRef="ratio">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member"
      id="d27108e1492-wk-Fact-A6480BDBD64A53118A050C806E8E2AB1">2021-12-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member"
      decimals="-5"
      id="d27108e1507-wk-Fact-B0228E40039F5C75A539BA4157FE1E40"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member"
      decimals="-5"
      id="d27108e1526-wk-Fact-BD72C25AE70D5DC2B25EFBEB165F3E67"
      unitRef="usd">309600000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member"
      decimals="INF"
      id="d27108e1547-wk-Fact-86F912DFCED45D7FB2E1514F9EE589E4"
      unitRef="ratio">0.05105</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member"
      id="d27108e1552-wk-Fact-08EF9BC9348C54B681F5C4E593B63CBA">July 28, 2023</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member"
      decimals="-5"
      id="d27108e1569-wk-Fact-6E1AF8334F855FAC88056E8F024E4292"
      unitRef="usd">157100000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.105SeniornotedueJuly282023Member"
      decimals="-5"
      id="d27108e1588-wk-Fact-FFEF8242A15558DEA4FAC150709AF729"
      unitRef="usd">151400000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"
      decimals="INF"
      id="d27108e1609-wk-Fact-C51A5E106AC156D2838EEB6CAB8974A8"
      unitRef="ratio">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"
      id="d27108e1614-wk-Fact-11CD92C9D0A95D96A8324FC5E1013A46">2023-11-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"
      decimals="-5"
      id="d27108e1629-wk-Fact-8553C53280E35E32867AC83B54575328"
      unitRef="usd">215600000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member"
      decimals="-5"
      id="d27108e1648-wk-Fact-EBF37C34A9E254D384507AECD1F4B433"
      unitRef="usd">215600000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member"
      decimals="INF"
      id="d27108e1669-wk-Fact-606FE2D771E6585A9CEAD9A926CE50FF"
      unitRef="ratio">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member"
      id="d27108e1674-wk-Fact-E16CA418CD925843ADCB588C6B2B08D2">2024-12-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member"
      decimals="-5"
      id="d27108e1689-wk-Fact-62304D75160A571993DE4E1CD5822D0B"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.9seniornotedue2024Member"
      decimals="-5"
      id="d27108e1708-wk-Fact-0B0780ED5E775049B542666D79B3147B"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member"
      decimals="INF"
      id="d27108e1730-wk-Fact-50782DAE575D51EE8D6954767F9741C2"
      unitRef="ratio">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member"
      id="d27108e1735-wk-Fact-11AEDD2CEA2C5BF88FAE7C107E324367">2026-03-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member"
      decimals="-5"
      id="d27108e1750-wk-Fact-1CC5F57FCADF58C684215049A0F241C7"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.375seniornotedueMarch152026Member"
      decimals="-5"
      id="d27108e1769-wk-Fact-F507A4C4427755EC91163DABBCC12188"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member"
      decimals="INF"
      id="d27108e1790-wk-Fact-A85A0640E48A5079A4BA4DB2C4B7DC6F"
      unitRef="ratio">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member"
      id="d27108e1795-wk-Fact-298A6395E8FF5E54B0DDF87EEE0752ED">2030-06-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member"
      decimals="-5"
      id="d27108e1810-wk-Fact-7DF57422509E585982327D708B14DEBF"
      unitRef="usd">750000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member"
      decimals="-5"
      id="d27108e1829-wk-Fact-31A781BA333C5D9FB1AEB5B196812DBA"
      unitRef="usd">0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"
      decimals="INF"
      id="d27108e1850-wk-Fact-868CAE4A932F58B497DD293686A9D859"
      unitRef="ratio">0.05300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"
      id="d27108e1855-wk-Fact-4C3959F7C4F650A1A46198C5B8EC0DCE">2043-11-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"
      decimals="-5"
      id="d27108e1870-wk-Fact-878B6D963FB2530EA6BD743872C8973B"
      unitRef="usd">90500000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member"
      decimals="-5"
      id="d27108e1889-wk-Fact-6543969CEBB95CDBA9C4BFFB53FDA3DA"
      unitRef="usd">90500000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member"
      decimals="INF"
      id="d27108e1910-wk-Fact-7C5C00B66D1952B58EC734328114F56B"
      unitRef="ratio">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member"
      id="d27108e1915-wk-Fact-DB19A32ABA4457AAAF2E8FCF16993FBE">2044-12-15</us-gaap:DebtInstrumentDescription>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member"
      decimals="-5"
      id="d27108e1930-wk-Fact-ED39FBFD8D9E5C91B0C41E65B649E312"
      unitRef="usd">303900000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A4.9SeniorLoandue2044Member"
      decimals="-5"
      id="d27108e1949-wk-Fact-E3F18C7A02135CC69249D5928A0F6117"
      unitRef="usd">303900000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e1990-wk-Fact-9287490D823B54F082FA392FBF2C5CCB"
      unitRef="usd">2917100000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2009-wk-Fact-0E26F4BB1DB55033810AD395060886C5"
      unitRef="usd">2751400000</us-gaap:SeniorNotes>
    <us-gaap:OtherLongTermDebt
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e2050-wk-Fact-E1606F88A73B53699223D55D86E69F20"
      unitRef="usd">61100000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2069-wk-Fact-54C51A8585625AC9AB67CB9BC8A3374E"
      unitRef="usd">24600000</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e2110-wk-Fact-29FD9101EDBB53578915241ABA78EEC3"
      unitRef="usd">200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2130-wk-Fact-EA2CAFB37A95549DA517A71C654F0520"
      unitRef="usd">-7300000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e2171-wk-Fact-F26D5AF10B645E769088134C9E400D65"
      unitRef="usd">17900000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2191-wk-Fact-783A800C9508564DBBB5D1765C72E822"
      unitRef="usd">14100000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e2233-wk-Fact-F9DBBE31BCD8596CBE4EEE8DB2DD76B8"
      unitRef="usd">3560100000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2252-wk-Fact-351A0889B8BF598DB9BF4859F7B30948"
      unitRef="usd">3369200000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e2293-wk-Fact-3DC6FA6B46FE5173B7B7759E90882478"
      unitRef="usd">16500000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2313-wk-Fact-F97CC33280EC5755AA584B26ECDD59A0"
      unitRef="usd">3400000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e2360-wk-Fact-F430BF656C9D59D4B7C0DED9C182B3BC"
      unitRef="usd">3543600000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2379-wk-Fact-3D3715BC11DE5A3DB437F324C420D917"
      unitRef="usd">3365800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember"
      decimals="INF"
      id="d27108e2466-wk-Fact-6B432C6B3CF353168878C00C722488D5"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCredit
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_A2018RevolverMember"
      decimals="INF"
      id="d27108e2470-wk-Fact-6D997290DE2C5304B374D8345AFBB958"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2014EuroDenominatedTermLoandueDecember52019Member"
      decimals="INF"
      id="d27108e2493-wk-Fact-88898D4DE08558EC91EF920714CF24DF"
      unitRef="eur">350000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member"
      decimals="INF"
      id="d27108e2497-wk-Fact-422DF42600FA5C348994915785CD8DD0"
      unitRef="eur">350000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2018Q2Mar08_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member"
      decimals="INF"
      id="d27108e2501-wk-Fact-8EADDE1CD06E58758A049F437FFE21B8"
      unitRef="usd">431000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="FD2019Q3YTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member"
      decimals="-5"
      id="d27108e2514-wk-Fact-7A20F829733B53878A6EDFBA4EF3C35D"
      unitRef="usd">24700000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member"
      decimals="INF"
      id="d27108e2518-wk-Fact-659453EFD17A58A0962F503CFC8053E6"
      unitRef="eur">284400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member"
      decimals="INF"
      id="d27108e2522-wk-Fact-BA3EB8507FA85CBF9F1E1C418B06D5C4"
      unitRef="usd">317100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2019Q3Aug15_us-gaap_DebtInstrumentAxis_prgo_A2019EuroDenominatedTermLoandueAugust152022Member"
      decimals="INF"
      id="d27108e2526-wk-Fact-572D4C796BC95348ACEA306D3660380B"
      unitRef="usd">600000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q3QTD_us-gaap_DebtInstrumentAxis_prgo_A2018EuroDenominatedTermLoandueMarch82020Member"
      decimals="-5"
      id="d27108e2539-wk-Fact-0902512623DA08C58560C6E098F62B56"
      unitRef="usd">-200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member"
      decimals="INF"
      id="d27108e2568-wk-Fact-A65552EF47D75CCDBA0598D4BFC2C274"
      unitRef="usd">750000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="I2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member"
      decimals="INF"
      id="d27108e2572-wk-Fact-9A1B04E42A3154BCAB58972A60B885CB"
      unitRef="ratio">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="D2020Q2Jun19_us-gaap_DebtInstrumentAxis_prgo_A3.150SeniorNotesdueJune152030Member"
      decimals="-5"
      id="d27108e2576-wk-Fact-4D074E9D378E5B92A82ECB723A48EEDC"
      unitRef="usd">737100000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"
      decimals="-5"
      id="d27108e2580-wk-Fact-0F07F502238856719195123582CEE69F"
      unitRef="usd">280400000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.500UnsecuredSeniornotesdueMarch152021Member"
      decimals="INF"
      id="d27108e2584-wk-Fact-07C24C03C80158F3A2252BD158D30E76"
      unitRef="ratio">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member"
      decimals="-5"
      id="d27108e2589-wk-Fact-BD72C25AE70D5DC2B25EFBEB165F3E67"
      unitRef="usd">309600000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="I2020Q3Jul6_us-gaap_DebtInstrumentAxis_prgo_A3.5SeniornotedueDecember152021Member"
      decimals="INF"
      id="d27108e2593-wk-Fact-DB453EC39671531FA828D10925165378"
      unitRef="ratio">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3QTD_us-gaap_DebtInstrumentAxis_prgo_SeniorNotesdue2021Member"
      decimals="-5"
      id="d27108e2611-wk-Fact-6537BFE5729390A2695E4757BF3733B9"
      unitRef="usd">-20000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="FI2020Q3"
      decimals="-5"
      id="d27108e2632-wk-Fact-79BCEF2D5DBB5748894EEFDF225D68B7"
      unitRef="usd">300000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="FI2019Q4"
      decimals="-5"
      id="d27108e2640-wk-Fact-CD24F5BAA60E5E6DAB76867F2DE185D4"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:NotesPayable
      contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="-5"
      id="d27108e2655-wk-Fact-A60DF794312B7106AE8D475B2900A31C"
      unitRef="usd">34300000</us-gaap:NotesPayable>
    <prgo:NumberofPromissoryNotes
      contextRef="I2020Q2Jun17_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="INF"
      id="d27108e2659-wk-Fact-5989D17103B95CF7B39A84EA8751A934"
      unitRef="promissory_note">2</prgo:NumberofPromissoryNotes>
    <us-gaap:NotesPayable
      contextRef="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2020Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="-5"
      id="d27108e2663-wk-Fact-4E08E8264768FF35E04E475BD2152F3B"
      unitRef="usd">3700000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueMay2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="-5"
      id="d27108e2667-wk-Fact-C6F80EF26B04617D9D06475C1899D4FE"
      unitRef="usd">5800000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="I2020Q2Jun17_us-gaap_DebtInstrumentAxis_prgo_NotedueNovember2021Member_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_prgo_KazmiraLLCMember"
      decimals="-5"
      id="d27108e2671-wk-Fact-66B33A4611CF13CF31A1475C54D309F1"
      unitRef="usd">24800000</us-gaap:NotesPayable>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-A282DCC5F31F5308BD0D78DF0FA1EB81-0-wk-Fact-9BBBE923DD395D55A8C0BBBDBC6F1CC7">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY&lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(154.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;92.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;165.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Weighted average shares outstanding for basic EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Dilutive effect of share-based awards*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Weighted average shares outstanding for diluted EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;137.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Anti-dilutive share-based awards excluded from computation of diluted EPS*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;*  In the period of a net loss, diluted shares equal basic shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Shareholders' Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;In October 2018, our Board of Directors authorized up to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$1.0&#160;billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of share repurchases with no expiration date, subject to the Board of Directors&#x2019; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program. We did not repurchase any shares during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-B77A81E8428E5776A32397D1C9913924-0-wk-Fact-A7C3FE4B89FE589A9401DB06F36C501A">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(154.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;92.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;165.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Weighted average shares outstanding for basic EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Dilutive effect of share-based awards*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Weighted average shares outstanding for diluted EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;137.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;136.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Anti-dilutive share-based awards excluded from computation of diluted EPS*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;*  In the period of a net loss, diluted shares equal basic shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d29539e1261-wk-Fact-43B1EF7FDF8150C38F5979ACBBE122DD"
      unitRef="usd">-154600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d29539e1281-wk-Fact-E71A91499A5557858B57177F0D58A3CB"
      unitRef="usd">92200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29539e1295-wk-Fact-08FB4EC393345107970F7A706AE01243"
      unitRef="usd">12400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d29539e1315-wk-Fact-9F5322C8C8525C9CA6B100916F0EB227"
      unitRef="usd">165100000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d29539e1484-wk-Fact-78E62AC728A75531BF9A6E884F5303D3"
      unitRef="shares">136500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d29539e1503-wk-Fact-1C2EF28688725C7D80F2C8088A76769A"
      unitRef="shares">136000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29539e1517-wk-Fact-C1E53D38F6B7552B9D0690947347E060"
      unitRef="shares">136300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d29539e1537-wk-Fact-53FE4EB273C15CA4BE767C70DBCA9CA1"
      unitRef="shares">136000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d29539e1557-wk-Fact-8E7B51E0001651F59334F63E30A68520"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d29539e1576-wk-Fact-A829969C34F8533CBEBD61A503F3030A"
      unitRef="shares">800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29539e1590-wk-Fact-AD7CC1BE401157C8B74B161CB4B58DB3"
      unitRef="shares">1200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d29539e1610-wk-Fact-D577BC6DA12759CFAC580716E5395C92"
      unitRef="shares">400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d29539e1630-wk-Fact-5C5C30AFBA8C5A51A10D8E788B640859"
      unitRef="shares">136500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d29539e1649-wk-Fact-C8E3779330DE5F4FA67C150EA14283BA"
      unitRef="shares">136800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29539e1663-wk-Fact-F22C375A219F547E8118FB44221651D2"
      unitRef="shares">137500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d29539e1683-wk-Fact-3543D9576257501785C04A94408B4FD0"
      unitRef="shares">136400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d29539e1780-wk-Fact-6EEFC2D6DBC153698EBF0227D6A28251"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d29539e1799-wk-Fact-6DF28A47AB0B5975A658DB56F5C2CA31"
      unitRef="shares">1500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29539e1813-wk-Fact-6B00D7D90C21501FB740932FEEDF4550"
      unitRef="shares">1500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d29539e1833-wk-Fact-8A4E1F61401D575EBEACA2D6DA95348C"
      unitRef="shares">1800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="I2018Q4Oct31"
      decimals="INF"
      id="d29539e1900-wk-Fact-C716557A9C245E7585E05BF21B218794"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-A3A00063D01F5E0CBBEFCD4A9131B8C0-0-wk-Fact-AAD21562617650B699130BEF0EE14C8D">&lt;span style="font-family:Arial;font-weight:bold;"&gt;ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/span&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Changes in our AOCI balances, net of tax were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Fair Value of Derivative Financial Instruments, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;span style="font-family:Arial;font-size:7pt;font-weight:bold;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Post-Retirement and Pension Liability Adjustments, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total AOCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;139.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;OCI before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;34.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;46.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;64.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Balance at September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;213.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;203.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1) Refer to &lt;/span&gt;&lt;a href="#sA0BB308013C05849BCFF1B0C8BBA3C08" style="font-family:Arial;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Note 3&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; Rosemont Pharmaceuticals business divestiture for information regarding amounts reclassified from AOCI.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-E7BDB5B72A4B593F9CB0B8EF21536F9A-0-wk-Fact-58842F08D572509B85844DB3049A3CAA">&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Changes in our AOCI balances, net of tax were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Fair Value of Derivative Financial Instruments, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;span style="font-family:Arial;font-size:7pt;font-weight:bold;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Post-Retirement and Pension Liability Adjustments, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total AOCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;132.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(6.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;139.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;OCI before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;34.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;46.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;64.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Balance at September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;213.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;203.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;(1) Refer to &lt;/span&gt;&lt;a href="#sA0BB308013C05849BCFF1B0C8BBA3C08" style="font-family:Arial;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;Note 3&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt; Rosemont Pharmaceuticals business divestiture for information regarding amounts reclassified from AOCI.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d29815e1117-wk-Fact-18AEB8A226835859BC4F2C9F05D03ADC"
      unitRef="usd">12700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d29815e1136-wk-Fact-20C3F5BB631951E59307A7F3386B3E62"
      unitRef="usd">132900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"
      decimals="-5"
      id="d29815e1155-wk-Fact-CA3BF53D4128507687F2D2ACF02ECEB5"
      unitRef="usd">-6200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d29815e1176-wk-Fact-E2902A17BE1D5AB38330DA9EA8BD38AA"
      unitRef="usd">139400000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d29815e1191-wk-Fact-B704476621A95EA3B6E3CF878EE12E32"
      unitRef="usd">-11200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d29815e1211-wk-Fact-550DC8BC68425D2B98C7D150862FFCDB"
      unitRef="usd">34600000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"
      decimals="-5"
      id="d29815e1230-wk-Fact-2C73FE3A1E5F566287F2C0343F92DFBB"
      unitRef="usd">-4300000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29815e1251-wk-Fact-DB11CD00771E584986E590D4B7BAB658"
      unitRef="usd">19100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d29815e1271-wk-Fact-0097DAC1E6C4571C9BC996F74323E894"
      unitRef="usd">1200000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d29815e1291-wk-Fact-FDEAF037013B58459AEF9E1FD7C07376"
      unitRef="usd">-46400000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"
      decimals="-5"
      id="d29815e1310-wk-Fact-20A33940652B5DCEB9B329A4C88DFB3D"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29815e1330-wk-Fact-60A1D1F26E955A0F9D5841335FED0076"
      unitRef="usd">-45200000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d29815e1355-wk-Fact-B20327F26C6F5C67B17997AFA514E0A0"
      unitRef="usd">-12400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d29815e1375-wk-Fact-3625B4BE859F52CA908CA7E007B560A4"
      unitRef="usd">81000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"
      decimals="-5"
      id="d29815e1394-wk-Fact-50C63609DB25589EB10E3138E31074EA"
      unitRef="usd">-4300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d29815e1415-wk-Fact-90E2EFBA909E53649BADCFE90EC3C82B"
      unitRef="usd">64300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d29815e1435-wk-Fact-5496BF5985345B02B5E84A7C61AD3683"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d29815e1454-wk-Fact-D9CA19BBFB455C538C5BA1FBD32A2C97"
      unitRef="usd">213900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"
      decimals="-5"
      id="d29815e1473-wk-Fact-4B48C4082C165BFB9A36FE77D43C9D8F"
      unitRef="usd">-10500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d29815e1494-wk-Fact-6E44D95C44115A8395CECBD5423A2DA3"
      unitRef="usd">203700000</us-gaap:StockholdersEquity>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-96C3B68073D75B6297223B0BDB2DF01E-0-wk-Fact-D6017A71618352BD9F97F604BFBAD07D">&lt;span style="font-family:Arial;font-weight:bold;"&gt;INCOME TAXES&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The effective tax rates were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:391px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:78px;"/&gt;&lt;td style="width:14px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(21.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;78.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The effective tax rate for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; increased compared to the prior period primarily due to non-deductible goodwill impairments and Base Erosion and Anti-Abuse Tax ("BEAT"), offset by additional interest deductions provided for in the U.S. Coronavirus Aid, Relief, and Economic Security ("CARES") Act and the early adoption of the final and proposed business interest expense deduction limitation regulations in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The Tax Cuts and Jobs Act of 2017 introduced a new tax on U.S. corporations that derive benefits from certain deductible payments to non-U.S. affiliates called the Base Erosion and Anti-Abuse Tax ("BEAT"). BEAT applies when base eroding payments exceed three percent of total deductions and where BEAT exceeds adjusted regular income tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We recorded a valuation allowance against all U.S. deferred tax assets as of December 31, 2016. We have continued to maintain a full valuation allowance against all U.S. deferred tax assets since and intend to continue maintaining this valuation allowance until there is sufficient evidence to support the reversal of all or some portion of these allowances. Given our current earnings and anticipated future earnings, we believe there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available that all or a portion of the valuation allowance against the U.S. deferred tax assets will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense in the period of the release. The exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we actually achieve.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;IRS Audit of Fiscal Years Ended June 29, 2013, June 28, 2014, and June 27, 2015&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;In connection with its audits of Perrigo Company, a Michigan corporation and wholly-owned indirect subsidiary of Perrigo Company plc, for the fiscal years ended June 29, 2013, June 28, 2014, and June 27, 2015 the IRS issued a draft Notice of Proposed Adjustment ("NOPA") on August 22, 2019, reducing Perrigo Company&#x2019;s deductible interest expense for fiscal tax years 2014-2015 on &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$7.5 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; in debts owed by it to Perrigo Company plc. A final NOPA was issued in early May 2020 without change.&#160;The debts were incurred in connection with the Elan merger transaction in 2013. The final NOPA caps the interest rate on the debts for U.S. federal tax purposes at &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;130.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the Applicable Federal Rate (a blended rate reduction of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;4.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; per annum), on the stated ground that the loans were not negotiated on an arms&#x2019;-length basis. The final NOPA proposes a reduction in gross interest expense of approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$480.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for fiscal years 2014 and 2015. If the IRS were to prevail in its proposed adjustment, the Company estimates an increase in tax expense of approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$170.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, excluding interest and penalties, for fiscal years ended June 28, 2014 through June 27, 2015. In addition, we expect the IRS to seek similar adjustments for the period from June 28, 2015 through December 31, 2018 with potential section 163(j) carryover impacts beyond December 2018. If those further adjustments were sustained, based on preliminary calculations and subject to further analysis, the Company's current best estimate is that the additional tax expense will not exceed &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$200.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, excluding interest and penalties. No further adjustments beyond this period are expected. The Company strongly disagrees with the IRS position, as reflected in its detailed written response to the draft NOPA on September 20, 2019. At this stage, we are unable to estimate the liability, if any, associated with this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;IRS Audit of Fiscal Years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$163.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of Federal income tax, penalties, and interest assessed and collected by the IRS, plus statutory interest thereon from the dates of payment, for the fiscal tax years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012 (the &#x201c;2009 tax year,&#x201d; &#x201c;2010 tax year,&#x201d; &#x201c;2011 tax year,&#x201d; and &#x201c;2012 tax year,&#x201d; respectively). In response to our complaint, the United States District Court for Western District of Michigan scheduled a new trial date for January 26, 2021. The IRS audits of those years culminated in the issuances of two statutory notices of deficiency: (1) on August 27, 2014 for the 2009 and 2010 tax years and (2) on April 20, 2017 for the 2011 and 2012 tax years. The statutory notices of deficiency both included un-agreed income adjustments related principally to transfer pricing adjustments regarding the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States. In addition, the statutory notice of deficiency for the 2011 and 2012 tax years included the capitalization of certain expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits. We fully paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and filed timely claims for refund on June 11, 2015 and June 7, 2017 for the 2009-2010 tax years and 2011-2012 tax years, respectively. Upon the disallowance of such refund claims, we timely filed the above complaint, which seeks refunds of tax, interest, and penalties of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$37.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the 2009 tax year, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$61.5&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the 2010 tax year, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$40.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the 2011 tax year, and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$24.7&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; for the 2012 tax year, for a total of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$163.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Other non-current assets&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Other non-current assets&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; on our balance sheet during the three months ended July 1, 2017. The total cumulative deferred charge that the Company is seeking to receive in this litigation is approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$101.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which reflects (i) a deduction of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$29.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; from the total reflected above due to overpayments credited to succeeding years and (ii) the impact of a previously conceded royalty due to Perrigo U.S. on all omeprazole sales that equates to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;24.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the above refund claims. That &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;24.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; concession would also apply to any omeprazole adjustments that may be asserted by the IRS for future years. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;IRS Audit of Fiscal Years Ended December 31, 2011, December 31, 2012, and December 31, 2013&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, Inc. ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The NOPA carries forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#x2019;s intellectual property, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The NOPA proposes a &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;payment of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$843.0&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, which represents additional tax and a &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;40.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; penalty. This amount excludes consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagree with the IRS position and will pursue all available administrative and judicial remedies, including those available under the U.S. - Ireland Income Tax Treaty to alleviate double taxation. Accordingly, on April 14, 2020, we filed a request for Competent Authority Assistance with the IRS. The request was accepted and is under review. No payment of the additional amounts is required until the matter is resolved administratively, judicially, or through treaty negotiation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On December 22, 2016, we received a NOPA from the IRS regarding the deductibility of litigation costs related to the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012, and December 31, 2013.&#160;We strongly disagree with the IRS&#x2019;s position asserted in the NOPA and are contesting it.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Irish Revenue Audit of Fiscal Years Ended December 31, 2012 and December 31, 2013&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On October 30, 2018, we received an audit finding letter from the Irish Office of the Revenue Commissioners (&#x201c;Irish Revenue&#x201d;) for the years ended December 31, 2012 and December 31, 2013. The audit finding letter relates to the tax treatment of the 2013 sale of the Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; intellectual property and other assets related to Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; to Biogen Idec from Elan Pharma. The consideration paid by Biogen to Elan Pharma took the form of an upfront payment and future contingent royalty payments. Irish Revenue issued a Notice of Amended Assessment (&#x201c;NoA&#x201d;) on November 29, 2018 which assesses an Irish corporation tax liability against Elan Pharma in the amount of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;&#x20ac;1,636&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, not including interest or any applicable penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We strongly disagree with this assessment and believe that the NoA is without merit and incorrect as a matter of law. We will pursue all available administrative and judicial avenues as may be necessary or appropriate. In connection with that, we filed an appeal of the NoA on December 27, 2018 in the Tax Appeals Commission which is the statutory body charged with considering whether the NoA is properly founded as a matter of tax law. Separately, we were also granted leave by the Irish High Court on February 25, 2019 to seek judicial review of the issuance of the NoA by Irish Revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The judicial review case is based on our belief that, by issuing the NoA, Irish Revenue breached Elan Pharma's rights and legitimate expectations as a taxpayer. The Irish High Court heard the judicial review case in June 2020 and, on November 4, 2020, the High Court ruled that the issuance of the NoA did not violate the Company&#x2019;s rights and legitimate expectations. Because the Irish High Court did not quash the NoA, absent an appeal by Elan Pharma, the amended assessment can be examined on its merits by the Irish Tax Appeals Commission. Our case before the Irish Tax Appeals Commission has been stayed since February 2019 by Order of the Irish High Court pending determination of the judicial review case. We will now assess the Irish High Court's decision before deciding whether to pursue an appeal of the judicial review case to the Irish Court of Appeal or reactivate our appeal before the Tax Appeals Commission. Any appeal against the judgment of the High Court in the judicial review case would have to be filed within &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;28 days&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the Order made by the High Court consequent upon the judgment delivered on November 4, 2020. That Court Order is expected to be made within a period of weeks once the question of liability for the litigation costs of the judicial review case has been decided by the High Court. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"/&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;No&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; payment will be required unless both the judicial review case and the appeal pending before the Tax Appeals Commission are finally determined against Elan Pharma.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Israel Tax Authority Audit of Fiscal Year Ended June 27, 2015 and Calendar Years Ended December 31, 2015 through December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The Israel Tax Authority is auditing our fiscal year ended June 27, 2015, and calendar years ended December 31, 2015, December 31, 2016 and December 31, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Although we believe that our tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments, which could be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. However, we are not able to estimate a reasonably possible range of how these events may impact our unrecognized tax benefits in the next twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-9E4DEBE991DB5F069BB67BA24AF85175-0-wk-Fact-267F0B4893975E3E8A3294B1F26DAB98">&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The effective tax rates were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:391px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:78px;"/&gt;&lt;td style="width:14px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:82px;"/&gt;&lt;td style="width:10px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(21.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;78.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2020Q3QTD"
      decimals="3"
      id="d30888e1122-wk-Fact-72FF522241F751AC91A8CDC58E3C3D1A"
      unitRef="ratio">-0.211</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q3QTD"
      decimals="3"
      id="d30888e1137-wk-Fact-FEF77BDDC2F55F999C146F29AF630924"
      unitRef="ratio">0.052</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2020Q3YTD"
      decimals="3"
      id="d30888e1152-wk-Fact-D7A79F155FAB5D298669F1205CF46F8F"
      unitRef="ratio">0.789</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q3YTD"
      decimals="3"
      id="d30888e1167-wk-Fact-27B55B8AF0085FDE8E8FEBFA8BB7C1C5"
      unitRef="ratio">0.196</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense
      contextRef="I2019Q3Aug22"
      decimals="-8"
      id="d30888e1230-wk-Fact-C15D35249C2359AD879B3DF291570412"
      unitRef="usd">7500000000</prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense>
    <prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate
      contextRef="D2020Q2May"
      decimals="INF"
      id="d30888e1234-wk-Fact-7EA7F21841D0503E8470D5B0E669495D"
      unitRef="ratio">1.300</prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate>
    <prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes
      contextRef="D2020Q2May"
      decimals="INF"
      id="d30888e1238-wk-Fact-E48AF6F8B2175DF0A5854F427ABE0862"
      unitRef="ratio">0.040</prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes>
    <prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense
      contextRef="D2020Q2May"
      decimals="-5"
      id="d30888e1242-wk-Fact-E8DE17E0AA865769A0069B8E148779A0"
      unitRef="usd">480000000.0</prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense>
    <prgo:IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties
      contextRef="D2020Q2May"
      decimals="-5"
      id="d30888e1246-wk-Fact-931D00279F8A512682217AE2320F7867"
      unitRef="usd">170000000.0</prgo:IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss
      contextRef="D2020Q2May"
      decimals="-5"
      id="d30888e1251-wk-Fact-3CEE011507385562B8B3C3B5B1ABD0B8"
      unitRef="usd">200000000.0</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="D2017Q1Aug15"
      decimals="-5"
      id="d30888e1266-wk-Fact-6D6B772E0FD653CEB6994AB5DC1F0837"
      unitRef="usd">163600000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="D2010Q1SD"
      decimals="-5"
      id="d30888e1270-wk-Fact-254902D2F5535AE4ADAB37C1E7EB788B"
      unitRef="usd">37200000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="D2010Q4CollaborationPayment"
      decimals="-5"
      id="d30888e1274-wk-Fact-2C066AAC4D795C57ABEF7AABA022BD3E"
      unitRef="usd">61500000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="D2011Q4"
      decimals="-5"
      id="d30888e1278-wk-Fact-A5B7F3DEC4E451E483E43E28533E3BE7"
      unitRef="usd">40200000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="D2014Q4CalendarYear"
      decimals="-5"
      id="d30888e1282-wk-Fact-AAFADD0718665901B1DF5E45C39B6A91"
      unitRef="usd">24700000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="D2017Q1Aug15"
      decimals="-5"
      id="d30888e1287-wk-Fact-6D6B772E0FD653CEB6994AB5DC1F0837"
      unitRef="usd">163600000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <prgo:CumulativeDeferredChargeTaxLitigation
      contextRef="FI2020Q3"
      decimals="-5"
      id="d30888e1299-wk-Fact-4EF4ECD3A0495D56B6B6655E957AAFA5"
      unitRef="usd">101800000</prgo:CumulativeDeferredChargeTaxLitigation>
    <prgo:IncomeTaxOverpaymentsAppliedtoSucceedingYears
      contextRef="FI2020Q3"
      decimals="-5"
      id="d30888e1303-wk-Fact-40E91CABFC1E52A4A5DD92190DE0F574"
      unitRef="usd">29700000</prgo:IncomeTaxOverpaymentsAppliedtoSucceedingYears>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="FD2020Q3YTD"
      decimals="3"
      id="d30888e1307-wk-Fact-CFAD64D8F16B5E57A37BD03B262F7E82"
      unitRef="ratio">0.240</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="FD2020Q3YTD"
      decimals="3"
      id="d30888e1312-wk-Fact-CFAD64D8F16B5E57A37BD03B262F7E82"
      unitRef="ratio">0.240</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty
      contextRef="I2019Q2Apr26"
      decimals="-5"
      id="d30888e1333-wk-Fact-4E171A3FA42A559099D4E1DFF67FB6C3"
      unitRef="usd">843000000.0</prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty>
    <prgo:IRSNoticeofProposedAdjustmentPenaltyPercent
      contextRef="I2019Q2Apr26"
      decimals="3"
      id="d30888e1337-wk-Fact-DC365657B2F75423BB6AA1203AA231F3"
      unitRef="ratio">0.400</prgo:IRSNoticeofProposedAdjustmentPenaltyPercent>
    <prgo:IncomeTaxExaminationUnsettledAssessedAuditLiability
      contextRef="I2018Q4Nov29_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember"
      decimals="-6"
      id="d30888e1367-wk-Fact-AE424E11E4375AC2A4A9607697F16AC7"
      unitRef="eur">1636000000</prgo:IncomeTaxExaminationUnsettledAssessedAuditLiability>
    <prgo:PeriodAvailabletoFileAppeal
      contextRef="D2020Q3_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      id="d30888e1383-wk-Fact-B1829FAF2B517253BE6C9367F415E064">P28D</prgo:PeriodAvailabletoFileAppeal>
    <prgo:PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal
      contextRef="D2020Q3_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_RevenueCommissionersIrelandMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d30888e1394-wk-Fact-C03892B4264911A98D09936E030C3B0A"
      unitRef="usd">0</prgo:PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-F39B2842DE065CA6B6970EED5C36E563-0-wk-Fact-4AC64A7CC87D56D5B80C846188DB4EC2">&lt;span style="font-family:Arial;font-weight:bold;"&gt;CONTINGENCIES&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Price-Fixing Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Perrigo is a defendant in several cases in the generic pricing multidistrict litigation &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;MDL No. 2724 (United States District Court for Eastern District of Pennsylvania)&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. This multidistrict litigation, which has many cases that do not include Perrigo, includes class action and opt-out cases for federal and state antitrust claims, as well as complaints filed by various of the States alleging violations of state antitrust laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On July 14, 2020, the court issued an order designating the following cases to proceed on a more expedited basis than the other cases in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;MDL No. 2724:&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; (a) the States&#x2019; May 2019 case alleging an overarching conspiracy involving more than &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;120&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; products (which does not name Perrigo a defendant) and (b) class actions alleging &#x201c;single drug&#x201d; conspiracies involving Clomipramine, Pravastatin, and Clobetasol. Perrigo is a defendant in the Clobetasol cases but not the others. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Class Action Complaints&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;(a) Single Drug Conspiracy Class Actions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We have been named as a co-defendant with certain other generic pharmaceutical manufacturers in a number of class actions alleging single-product conspiracies to fix or raise the prices of certain drugs and/or allocate customers for those products starting, in some instances, as early as June 2013. The class actions were filed on behalf of putative classes of (a) direct purchasers, (b) end payors, and (c) indirect resellers. The products in question are Clobetasol gel, Desonide, and Econazole. The court denied motions to dismiss each of the complaints alleging &#x201c;single drug&#x201d; conspiracies involving Perrigo, and the cases are proceeding in discovery. As noted above, the Clobetasol cases have been designated to proceed on a more expedited schedule than the other cases. That schedule has not yet been set.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;(b) &#x201c;Overarching Conspiracy&#x201d; Class Actions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The same &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; putative classes, including (a) direct purchasers, (b) end payors, and (c) indirect resellers, have filed &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; sets of class action complaints alleging that Perrigo and other manufacturers (and some individuals) entered into an &#x201c;overarching conspiracy&#x201d; that involved allocating customers, rigging bids and raising, maintaining, and fixing prices for various products. Each class brings claims for violations of Sections 1 and 3 of the Sherman Antitrust Act as well as several state antitrust and consumer protection statutes. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Filed in June 2018, and later amended in December 2018 (with respect to direct purchasers) and April 2019 (with respect to end payors and indirect resellers), the first set of &#x201c;overarching conspiracy&#x201d; class actions include allegations against Perrigo and approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other manufacturers involving &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;135&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; drugs with allegations dating back to March 2011. The allegations against Perrigo concern only &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; formulations (cream and ointment) of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the products at issue, Nystatin. The court denied motions to dismiss the first set of &#x201c;overarching conspiracy&#x201d; class actions, and they are proceeding in discovery. &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;None&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of these cases are included in the group of cases on a more expedited schedule pursuant to the court&#x2019;s July 14, 2020 order.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;In December 2019, both the end payor and indirect reseller class plaintiffs filed a second set of "overarching conspiracy&#x201d; class actions against Perrigo, dozens of other manufacturers of generic prescription pharmaceuticals, and certain individuals dating back to July 2009 (end payors) or January 2010 (indirect resellers). The direct purchaser plaintiffs filed their second round overarching conspiracy complaint in February 2020 with claims dating back to July 2009. On March 11, 2020, the indirect reseller plaintiffs filed a motion to amend their second round December 2019 complaint, and that motion was granted. On September 4, 2020, the end payor plaintiffs amended their second round complaint. On October 21, 2020, the direct purchaser plaintiffs amended their second round complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;This second set of overarching complaints allege conspiracies relating to the sale of various products that are not at issue in the earlier-filed overarching conspiracy class actions, the majority of which Perrigo neither makes nor sells. The amended indirect reseller complaint alleges that Perrigo conspired in connection with its sales of Betamethasone Dipropionate lotion, Imiquimod cream, Desonide cream and ointment, and Hydrocortisone Valerate cream. The amended end payor complaint alleges that Perrigo conspired in connection with its sale of the following drugs: Adapalene, Ammonium Lactate, Betamethasone Dipropionate, Bromocriptine Mesylate, Calcipotriene Betamethasone Dipropionate, Ciclopirox, Clindamycin Phosphate, Erythromycin, Fenofibrate, Fluocinonide, Fluticasone Propionate, Halobetasol Proprionate, Hydrocortisone Acetate, Hydrocortisone Valerate, Imiquimod, Methazolamide, Mometasone Furoate, Permethrin, Prochlorperazine Maleate, Pormethazine HCL, Tacrolimus, and Triamcinolone Acetonide. The amended direct purchaser complaint alleges that Perrigo conspired in connection with its sale of the following drugs: Adapalene, Ammonium Lactate, Betamethasone Dipropionate, Bromocriptine Mesylate, Ciclopirox, Clindamycin Phosphate, Fenofibrate, Fluocinonide, Halobetasol Proprionate, Hydrocortisone Valerate, Methazolamide, Permethrin, Prochlorperazine Maleate, Promethazine HCL, Tacrolimus, and Triamcinolone Acetonide.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Perrigo has not yet responded to the second set of overarching conspiracy complaints, and responses are currently or will be stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Opt-Out Complaints&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On January 22, 2018, Perrigo was named a co-defendant along with &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other manufacturers in a complaint filed by &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; supermarket chains alleging that defendants conspired to fix prices of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic prescription pharmaceutical products starting in 2013. On December 21, 2018, an amended complaint was filed that adds additional products and allegations against a total of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; manufacturers for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;33&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; products. The only allegations specific to Perrigo relate to Clobetasol, Desonide, Econazole, Nystatin cream, and Nystatin ointment. Perrigo moved to dismiss this complaint on February 21, 2019. The motion was denied on August 15, 2019. The case is proceeding in  discovery. On February 3, 2020, the plaintiffs requested leave to file a second amended complaint. The proposed amended complaint adds dozens of additional products and allegations to the original complaint. Perrigo is discussed in connection with allegations concerning an additional drug, Fenofibrate. Defendants opposed the motion for leave to file a second amended complaint and the court has yet to rule on the issue.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On August 3, 2018, a large managed care organization filed a complaint against Perrigo alleging price-fixing and customer allocation concerning &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; different products among &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; manufacturers including Perrigo. The only allegations specific to Perrigo concern Clobetasol. Perrigo moved to dismiss this complaint on February 21, 2019. Plaintiff filed a second amended complaint in April 2019 that adds additional products and allegations. The amended allegations that concern Perrigo include: Clobetasol, Desonide, Econazole, and Nystatin. The motion to dismiss was denied on August 15, 2019. The case is proceeding in discovery.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On January 16, 2019, a similar suit was brought by a health insurance carrier in the U.S. District Court for the District of Minnesota alleging a conspiracy to fix prices of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; products among &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; defendants. The only &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;allegations specific to Perrigo concern Clobetasol gel, Desonide, Econazole, Nystatin cream, and Nystatin ointment. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On July 18, 2019, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;87&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; health plans filed a Praecipe to Issue Writ of Summons in Pennsylvania state court to commence an action against &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic pharmaceutical manufacturers and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; individuals, alleging antitrust violations concerning generic pharmaceutical drugs. While Perrigo was named as a defendant, no complaint has been filed and the precise allegations and products at issue have not been identified&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Proceedings in the case, including the filing of a complaint, have been stayed at the request of the plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On December 11, 2019, a health care service company filed a complaint against Perrigo and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;38&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other multi-district litigation ("MDL") complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin cream/ointment. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On December 16, 2019, a Medicare Advantage claims recovery company filed a complaint against Perrigo and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, and Econazole. The complaint was originally filed in the District of Connecticut but will be consolidated into the MDL. Perrigo has not yet had the opportunity to respond to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On December 23, 2019, several counties in New York filed an amended complaint against Perrigo and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was originally filed in New York State court but was removed to federal court and will likely be consolidated into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On December 27, 2019, a healthcare management organization filed a complaint against Perrigo and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was filed originally in the Northern District of California but will be consolidated into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On March 1, 2020, Harris County of Texas filed a complaint against Perrigo New York, Inc. and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The products at issue that plaintiffs claim Perrigo manufacturers or sells include: Adapalene, Betamethasone Dipropionate, Ciclopirox, Clindamycin, Clobetasol, Desonide, Econazole, Ethinyl Estradiol/Levonorgestrel, Fenofibrate, Fluocinolone, Fluocinonide, Gentamicin, Glimepiride, Griseofulvin, Halobetasol Propionate, Hydrocortisone Valerate, Ketoconazole, Mupirocin, Nystatin, Olopatadine, Permethrin, Prednisone, Promethazine, Scopolamine, and Triamcinolone Acetonide&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The complaint was originally filed in the Southern District of Texas but has been transferred to the MDL. Harris County amended its complaint in May 2020. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;In May 2020, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;seven&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; health plans filed a writ of summons in the Pennsylvania Court of Common Pleas in Philadelphia concerning an as-yet unfiled complaint against Perrigo, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; dozen other manufacturers, and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;seventeen&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; individuals, concerning alleged antitrust violations in connection with the pricing and sale of generic prescription pharmaceutical products. No complaint has yet been filed, so the precise allegations and products at issue are not yet clear. In addition, Defendants are in the process of being served, and proceedings in the case will likely be stayed.  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 9, 2020, a health insurance carrier filed a complaint against Perrigo New York, Inc. and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was filed in the Eastern District of Pennsylvania and has been transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On July 9, 2020, a drugstore chain filed a complaint against Perrigo New York, Inc. and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;color:#000000;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. Perrigo is also listed in connection with Fenofibrate. The complaint was filed in the Eastern District of Pennsylvania and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On August 27, 2020, Suffolk County of New York filed a complaint against Perrigo New York, Inc. and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin cream and ointment. The other products at issue that plaintiffs claim Perrigo manufacturers or sells include: Adapalene gel; Albuterol; Benazepril HCTZ; Clotrimazole; Diclofenac Sodium; Fenofibrate; Fluocinonide; Glimepiride; Ketoconazole; Meprobamate; Imiquimod; Triamcinolone Acetonide; Erythromycin/Ethyl Solution; Betamethasone Valerate; Ciclopirox Olamine; Terconazole; Hydrocortisone Valerate; Fluticasone Propionate; Desoximetasone; Clindamycin Phosphate; Halobetasol Propionate; Hydrocortisone Acetate; Promethazine HCL, Mometasone Furoate; and Amiloride HCTZ. The complaint was filed in the Eastern District of New York and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On September 4, 2020, a drug wholesaler and distributor filed a complaint against Perrigo New York, Inc. and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on Adapalene Cream, Ammonium Lactate cream and lotion, Betamethasone Dipropionate lotion, Bromocriptine tablets, Calcipotriene Betamethasone Dipropionate (Cal Beta Dip) Ointment, Ciclopirox shampoo cream and solution, Clindamycin solution, Clobetasol, Desonide cream and ointment, Econazole cream, Erythromycin base alcohol solution, Fenofibrate, Fluticasone lotion, Halobetasol cream and ointment, Hydrocortisone Acetate suppositories, Hydrocortisone valerate cream, Imiquimod cream, Methazolamide tablets, Mometasone furoate cream, ointment and solution, Nystatin, Prochlorperazine suppositories, Promethazine HCL suppositories, Tacrolimus ointment, and Triamcinolone cream and ointment. The complaint was filed in the Eastern District of Pennsylvania and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;State Attorney General Complaint &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 10, 2020, the Connecticut Attorney General&#x2019;s office filed a lawsuit on behalf of Connecticut and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other states and territories against Perrigo, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other generic pharmaceutical manufacturers, and certain individuals (including &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; former and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; current Perrigo employee), alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of eighty products. The allegations against Perrigo focus on the following drugs: Adapalene Cream, Ammonium Lactate cream and lotion, Betamethasone dipropionate lotion, Bromocriptine tablets, Calcipotriene Betamethasone Dipropionate (Cal Beta Dip) Ointment, Ciclopirox cream and solution, Clindamycin solution, Desonide cream and ointment, Econazole cream, Erythromycin base alcohol solution, Fluticasone cream and lotion, Halobetasol cream and ointment, Hydrocortisone Acetate suppositories, Hydrocortisone Valerate cream, Imiquimod cream, Methazolamide tablets, Nystatin ointment, Prochlorperazine suppositories, Promethazine HCL suppositories, Tacrolimus ointment, and Triamcinolone cream and ointment. The Complaint was filed in the District of Connecticut&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; but has been transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Canadian Class Action Complaint&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. Perrigo has not yet responded to the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Securities Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;In the United States (cases related to events in 2015-2017)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On May 18, 2016, a shareholder filed a securities case against us and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund v. Papa, et al.&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;).&#160;The plaintiff purported to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations of Securities Exchange Act sections 10(b) (and Rule 10b&#x2011;5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa.&#160;In general, the allegations concerned the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015.&#160;The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016.&#160;On July 19, 2016, a different shareholder filed a securities class action against us and our former CEO, Joseph Papa, also in the District of New Jersey (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Wilson v. Papa, et al.&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;). The plaintiff purported to represent a class of persons who sold put options on our shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims were the same as those made in the original complaint filed in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case described above. On December 8, 2016, the court consolidated the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case and the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Wilson&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case under the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case number. In February 2017, the court selected the lead plaintiffs for the consolidated case and the lead counsel to the putative class. In March 2017, the court entered a scheduling order.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 21, 2017, the court-appointed lead plaintiffs filed an amended complaint that superseded the original complaints in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case and the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Wilson&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case. In the amended complaint, the lead plaintiffs seek to represent &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; classes of shareholders: (i) shareholders who purchased shares during the period from April 21, 2015 through May 3, 2017 on the U.S. exchanges; (ii) shareholders who purchased shares during the same period on the Tel Aviv exchange; and (iii) shareholders who owned shares on November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (the final day of the Mylan tender offer) regardless of whether the shareholders tendered their shares. The amended complaint names as defendants us and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#x2019;Connor). The amended complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&#x2011;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;5) and 14(e) against all defendants and 20(a) control person liability against the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; individuals. In general, the allegations concern the actions taken by us and the former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; royalty stream. The amended complaint does not include an estimate of damages. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#x2019; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#x2019;Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the Tysabri&#xae; accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are Perrigo Company plc, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issues regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;generic prescription pharmaceuticals. The defendants who remain in the case (the Company, Mr. Papa, and Ms. Brown) have filed answers denying liability, and the discovery stage of litigation has begun. Discovery in the class action is currently scheduled to end in January 2021. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On November 14, 2019, the court granted the lead plaintiffs&#x2019; motion and certified &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Defendants filed a petition for leave to appeal in the Third Circuit challenging the certification of the tender offer class. On April 30, 2020, the Third Circuit denied leave to appeal. The District Court has approved the issuance of a notice of the pendency of the class action, and the notice has been sent to shareholders who are eligible to participate in the classes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Unless otherwise noted, each of the lawsuits discussed in the following sections is pending in the U.S. District Court for the District of New Jersey and has been assigned to the same judges hearing the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case. The allegations in the complaints relate to events during certain portions of the 2015 through 2017 calendar years, including the period of the Mylan tender offer. All but one of these lawsuits allege violations of federal securities laws, but none are class actions. &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;One&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; lawsuit (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Highfields&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;) alleges only state law claims. Discovery in all these cases, except &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Highfields&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, is underway and currently scheduled to end in early September 2021. We intend to defend all these lawsuits vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt;Carmignac, First Manhattan&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt;and Similar Cases&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. The following &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;seven&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases were filed by the same law firm and generally make the same factual assertions but, at times, differ as to which securities laws violations they allege:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Case&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Date Filed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac Gestion, S.A. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;11/1/2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;First Manhattan Co. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;2/16/2018; amended 4/20/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;10/29/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Schwab Capital Trust, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;1/31/2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;2/22/2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Principal Funds, Inc., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;3/5/2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;3/31/2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The original complaints in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case and the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;First Manhattan&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case named Perrigo, Mr. Papa, Ms. Brown, and Mr. Coucke as defendants. Mr. Coucke was dismissed as a defendant after the plaintiffs agreed to apply the July 2018 ruling in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case to these two cases. The complaints in each of the other cases name only Perrigo, Mr. Papa, and Ms. Brown as defendants. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Each complaint asserts claims under Sections 10(b) (and Rule 10b-5 thereunder) and all cases except &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Aberdeen&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; assert claims under Section 14(e) of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The control person claims against the individual defendants are limited to the period from April 2015 through April 2016 in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case. The complaints in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;First Manhattan&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases also assert claims under Section 18 of the Exchange Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Each complaint alleges inadequate disclosures concerning the valuation and integration of Omega, the financial guidance we provided, our reporting about the generic prescription pharmaceutical business and its prospects, and the activities surrounding the efforts to defeat the Mylan tender offer during 2015, and, in each of the cases other than &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, alleged price fixing activities with respect to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic prescription pharmaceuticals. The &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;First Manhattan&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; complaint also alleges improper accounting for the Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; asset. With the exception of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, each of these cases relates to events during the period from April 2015 through May 2017. Many of the allegations in these cases overlap with the allegations of the June 2017 amended complaint in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case, though the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Nationwide Mutual, Schwab Capital, Aberdeen, Principal Funds &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;and&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt; Kuwait &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;complaints do &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;not include the factual allegations that the court dismissed in the July 2018 ruling in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;After the court issued its July 2018 opinion in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case, the parties in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;First Manhattan &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;conferred and agreed that the ruling in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case would apply equally to the common allegations in their cases. The later filed cases adopted a similar posture. The defendants in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and other cases listed above filed motions to dismiss addressing the additional allegations in such cases. On July 31, 2019, the court granted such motions to dismiss in part and denied them in part. That ruling applies to each of the above cases. The defendants have filed answers in each case denying liability. Each case is currently in the discovery phase.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt;Mason Capital&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt;,&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt;Pentwater&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt;and Similar Cases&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;. &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The following &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;eight&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases were filed by the same law firm and generally make the same factual allegations:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Case&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Date Filed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Mason Capital L.P., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;1/26/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Pentwater Equity Opportunities Master Fund Ltd., et al. &#160;v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;1/26/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;11/15/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;11/15/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;12/18/2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;12/20/2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Burlington Loan Management DAC v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;2/12/2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;3/2/2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The complaints in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Mason Capital&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case and the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Pentwater &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;case originally named Perrigo and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; current or former directors and officers of Perrigo as defendants. In the July 2018 &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; ruling, the court dismissed without prejudice each of the defendants other than Perrigo, Mr. Papa and Ms.&#160;Brown from that case; these plaintiffs later agreed that this ruling would apply to their cases as well. The complaints in each of the other cases in the above table name only Perrigo, Mr. Papa, and Ms. Brown as defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Each complaint asserts claims under Section 14(e) of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The complaints in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;WCM &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;case and the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Universities Superannuation Scheme &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;case also assert claims under Section 10(b) of the Exchange Act and Rule 10b-5 thereunder.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Each complaint alleges inadequate disclosure during the tender offer period in 2015 and at various times concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; asset. The &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;WCM &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;complaint also makes these allegations for the period through May 2017 and the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Universities Superannuation Scheme&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; complaint also concerns certain times during 2016. Many of the factual allegations in these cases overlap with the allegations of the June 2017 amended complaint in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case, and the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Mason Capital &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Pentwater&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases include factual allegations similar to those in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;After the court issued its July 2018 opinion in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case, the parties in each of the above cases&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;conferred and agreed that the ruling in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case would apply equally to the common allegations in their cases. The defendants in each of these cases have filed answers denying liability, and each of the cases is currently in the discovery phase.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt;Harel Insurance&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt;and&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt;TIAA-CREF&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt;Cases&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. The following &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases were filed by the same law firm and generally make the same factual allegations relating to the period from February 2014 through May 2017 (in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Harel&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case) and from August 2014 through May 2017 (in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;TIAA-CREF&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Case&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Date Filed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;2/13/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;4/20/2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The complaints in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Harel&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;TIAA-CREF&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases originally named Perrigo and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; current or former directors and officers of Perrigo as defendants (adding &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; more individual defendants not sued in the other cases described in this section). In the July 2018 &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; ruling, the court dismissed without prejudice &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; defendants other than Perrigo, Mr. Papa and Ms.&#160;Brown from that case. These plaintiffs later agreed that that ruling would apply to these cases as well and also dismissed their claims against the two additional individuals that only these plaintiffs had named as defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Each complaint asserts claims under Sections 10(b) and 14(e) of the Securities Exchange Act and Rule 10b-5 thereunder against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The complaint in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Harel&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case also asserts claims based on Israeli securities laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Each of the complaints alleges inadequate disclosure around the tender offer events in 2015 and at various times during the relevant periods concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; asset from February 2014 until the withdrawal of past financial statements in April 2017. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;After the court issued its July 2018 opinion in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case, the parties in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Harel&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;TIAA-CREF&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases conferred and agreed that such ruling would apply equally to the common allegations in their cases. The defendants in each of these cases have filed answers denying liability, and each of the cases is currently in the discovery phase.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;text-decoration:underline;"&gt;Other Cases Related to Events in 2015-2017&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. Certain allegations in the following &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases also overlap with the allegations of the June 2017 amended complaint in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case and with allegations in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;one&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; or more of the other individual cases described in the sections above:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Case&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;Date Filed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;2/6/2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Highfields Capital I LP, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;6/4/2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;4/21/2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Each of the above complaints names Perrigo, Mr. Papa, and Ms. Brown as defendants. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Sculptor Master Fund (formerly OZ)&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; complaint asserts claims under Sections 10(b) and 14(e) of the Securities Exchange Act and Rule 10b-5 thereunder against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The parties have agreed that the court's rulings in July 2018 in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case and in July 2019 in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Carmignac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and related cases will apply to this case as well. The defendants have filed answers denying liability. The plaintiffs are participating in the discovery proceedings in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case and the various individual cases described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;BlackRock Global&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; complaint also asserts claims under Securities Exchange Act section 10(b) (and SEC Rule 10b-5) and section 14(e) against all defendants and section 20(a) control person claims against the individual defendants largely based on the same events during the period from April 2015 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer period in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic prescription pharmaceuticals, alleged lower performance in the generic prescription drug business during 2015 and alleged improper accounting for the Tysabri&#xae; asset. The parties have begun discussions about the schedule for how this case should proceed.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt; Highfields &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;federal case complaint asserted claims under Sections 14(e) and 18 of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. As originally filed in the U.S. District Court for the District of Massachusetts, the&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt; Highfields&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; complaint also alleged claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. The factual allegations generally were similar to the factual allegations in the Amended Complaint in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case described above, except that the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Highfields&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs. In March 2020, the District of Massachusetts court granted defendants&#x2019; motion and transferred the case to the U.S. District Court for the District of New Jersey so that the activities in the case could proceed in tandem with the other cases in the District of New Jersey described above. After the transfer, in June 2020, the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Highfields&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; plaintiffs voluntarily dismissed their federal lawsuit. The same &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Highfields&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; plaintiffs the same day then filed a new lawsuit in Massachusetts State Court asserting the same factual allegations as in their federal lawsuit and alleging only Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In September 2020, the defendants submitted a motion to dismiss' plaintiffs filed an opposition in late October; defendants&#x2019; reply is due in mid-November 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;In Israel (cases related to events in 2015-2017)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Because our shares are traded on the Tel Aviv exchange under a dual trading arrangement, we are potentially subject to securities litigation in Israel. &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;Three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases were filed; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; was voluntarily dismissed in each of 2017 and 2018 and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; was stayed in 2018. We are consulting Israeli counsel about our response to these allegations and we intend to defend this case vigorously. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Israel Elec. Corp. Employees&#x2019; Educ. Fund v. Perrigo Company plc, et al.&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp;amp; Young LLP (the Company&#x2019;s auditor), and &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#x2019;Connor). The complaint alleges violations under U.S. securities laws of Securities Exchange Act sections 10(b) (and Rule 10b&#x2011;5) and 14(e) against all defendants and 20(a) control person liability against the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; individuals or, in the alternative, under Israeli securities laws. In general, the allegations concern the actions taken by us and our former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure concerning purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company, alleges price fixing activities with respect to &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri&#xae; royalty stream. The plaintiff indicates an initial, preliminary class damages estimate of &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;2.7 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; NIS (approximately &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$760.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;million at &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;1&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; NIS = &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;0.28&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cents). After the other &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;In the United States (cases related to Irish Tax events)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On January 3, 2019, a shareholder filed a complaint against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in the U.S. District Court for the Southern District of New York (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Masih v. Perrigo Company, et al.&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;). Plaintiff purported to represent a class of shareholders for the period November 8, 2018 through December 20, 2018, inclusive. The complaint alleged violations of Securities Exchange Act section 10(b) (and Rule 10b&#x2011;5) against all defendants and section 20(a) control person liability against the individual defendants. In general the allegations contended that the Company, in its Form 10&#x2011;Q filed November 8, 2018, disclosed information about an October 31, 2018 audit finding letter received from Irish tax authorities but failed to disclose enough material information about that letter until December 20, 2018, when we filed a current report on Form 8&#x2011;K about Irish tax matters. The plaintiff did not provide an estimate of class damages. The court selected lead plaintiffs and changed the name of the case to In re &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Perrigo Company plc Sec. Litig&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;. The lead plaintiffs filed an amended complaint on April &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;12, 2019, which named the same defendants, asserted the same class period, and invoked the same Exchange Act sections. The amended complaint generally repeated the allegations of the original complaint with a few additional details and adds that the defendants also failed to timely disclose the Irish tax authorities&#x2019; Notice of Amended Assessment received on November 29, 2018. Defendants filed a motion to dismiss on May 3, 2019. On May 31, 2019, the plaintiffs filed a second amended complaint, which asserted a longer class period (March 1, 2018 through December 20, 2018) and added &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; additional individual defendant, former CEO Uwe Roehrhoff. In general, the second amended complaint contends that Perrigo&#x2019;s disclosures about the Irish tax audit were inadequate beginning with Perrigo&#x2019;s 10-K filed on March 1, 2018 through December 20, 2018 and repeats many of the allegations of the April 2019 amended complaint. The &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;second&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; amended complaint alleges violations of Securities Exchange Act section 10(b) (and SEC Rule 10b-5) against all defendants and section 20(a) control person liability against the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; individual defendants. All defendants filed a joint motion to dismiss, and the motion was fully briefed. On January 23, 2020, the court granted the motion to dismiss in part and denied it in part, dismissing Mr. Roehrhoff as a defendant and dismissing allegations of inadequate disclosures related to the audit by Irish Revenue during the period March 2018 through October 30, 2018. The court permitted the plaintiffs to pursue their claims against us, Mr. Kessler, and Mr. Winowiecki related to disclosures after Perrigo received the October 30, 2018 audit findings letter and later events through December 20, 2018. The defendants filed answers on February 13, 2020 denying liability, and the court held a scheduling conference on February 28, 2020, and issued a scheduling order on March 3, 2020. Discovery on the remaining issues is underway. Plaintiffs filed a motion for class certification, which was granted in September 2020. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;In Israel (case related to Irish Tax events)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Baton v. Perrigo Company plc, et. al&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;In re Perrigo Company plc Sec. Litig &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;case in New York federal court. This case alleges that persons who invested through the Tel Aviv stock exchange can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. In 2019, the court granted &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; requests by Perrigo to stay the proceedings pending the resolution of proceedings in the United States.&#160;Perrigo filed a further request for a stay in February 2020, and the court granted the stay indefinitely. The plaintiff has filed a motion to lift the stay; Perrigo has filed an opposition; the court has requested further briefing from the plaintiff. We intend to defend the lawsuit vigorously. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Claim Arising from the Omega Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On December 16, 2016, we and Perrigo Ireland 2 brought an arbitral claim ("Claim") against Alychlo NV ("Alychlo") and Holdco I BE NV (together the "Sellers") in accordance with clause 26.2 of the Share Purchase Agreement dated November 6, 2014 ("SPA") and the rules of the Belgian Centre for Arbitration and Mediation ("CEPANI"). Our Claim relates to the accuracy and completeness of information about Omega provided by the Sellers as part of the sale process, the withholding of information by the Sellers during that process and breaches of Sellers&#x2019; warranties. We are seeking monetary damages from the Sellers. The Sellers served their respective responses to the Claim on February 20, 2017. In its response, Alychlo has asserted a counterclaim for monetary damages contending that we breached a warranty in the SPA and breached the duty of good faith in performing the SPA. Alychlo subsequently filed papers seeking permission to introduce an additional counterclaim theory of recovery related to the Irish tax issues disclosed by the Company such that if the position of the Irish tax authorities prevails, Alychlo would have further basis for its counterclaim against Perrigo. In June 2019, the Tribunal denied permission for Alychlo to introduce the additional counterclaim and dismissed certain aspects of the original Alychlo counterclaim. There can be no assurance that our Claim will be successful, and the Sellers deny liability for the Claim. To the extent that aspects of Alychlo&#x2019;s counterclaim survived the Tribunal&#x2019;s ruling in June 2019, we deny that Alychlo is entitled to any relief (including monetary relief). The arbitration proceedings are confidential as required by the SPA and the rules of the CEPANI.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Other Matters &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our Board of Directors received a shareholder demand letter dated October 30, 2018 relating to the allegations in the securities cases and price fixing lawsuits described above. The letter demands that the Board of Directors initiate an action against certain current and former executives and Board members to recover damages &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;allegedly caused to the Company. In response, the Company reminded the shareholder that any derivative claim can only proceed in accordance with Irish law, the law that governs the Company&#x2019;s internal affairs. The shareholder responded that he would file a lawsuit asserting derivative claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;On October 2, 2019, the shareholder filed a derivative action in the U.S. District Court for the District of New Jersey styled &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford, et al.&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; The case was assigned to the same judges who are handling the Roofers' Pension Fund securities class action and related opt out cases described above. In addition to the Company, the lawsuit names as defendants current Board members Alford, Classon, Karaboutis, Kindler, O&#x2019;Connor, Parker, and Samuels, current CEO Kessler, former Board members Smith, Brlas, Cohen, Fouse, Hoffing, Jandernoa, Kunkle, and Morris, former CEO Hendrickson, former CEO Papa, former CFO Brown, former CFO Winowiecki, and former Executive Vice Presidents Boothe and Coucke. The lawsuit seeks to authorize the shareholder to pursue claims on behalf of the Company against all the individual defendants for breach of their fiduciary duties and for unjust enrichment, and against the current director defendants, former director Mr. Smith, and current CEO Mr. Kessler for violations of Securities Exchange Act &#xa7;&#xa7; 14(a) (proxy statement disclosures) and 29(b) (disgorgement as a result of alleged violations of &#xa7;&#160;14(a)). The complaint alleges that the following events indicate that the individuals in their respective capacities failed to exercise appropriate control over the management of the Company and made inadequate public disclosures concerning the integration of Omega after acquisition; the Company&#x2019;s past and prospective organic growth; the defense against the Mylan 2015 tender offer; the alleged collusive pricing activities regarding generic prescription products; the accounting by the Company for the Tysabri&#xae; royalty stream; the 2018 Irish tax audit including potential liabilities for Irish taxes; and the April 2019 assertion of tax liabilities by the U.S. Internal Revenue Service (many of these factual events also underlie the multiple securities cases discussed earlier in this Note 14). All defendants have filed motions to dismiss asserting various reasons to dismiss. Plaintiff filed his opposition in March 2020. Defendants&#x2019; filed replies in support of dismissal in June 2020. The court granted the motion to dismiss without prejudice on August 21, 2020. No appeal or other proceedings have been filed by the plaintiff. Therefore, we consider this case to have ended. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Talcum Powder&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The Company has been named, together with other manufacturers, in product liability lawsuits in state courts in California&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;,&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; Florida, Missouri, New Jersey and Illinois and in the Southern District of Mississippi alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos.&#160;All but one of these cases involve a legacy talcum powder product that has not been manufactured by the Company since 1999.&#160; One of the pending actions involves a current prescription product that contains talc as an excipient. The Company has been named in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;32&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; additional matter. The Company has several defenses and intends to aggressively defend these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Ranitidine&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;In February 2020, the resulting actions involving Zantac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re Zantac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. This MDL now includes &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; master complaints. The Company is named in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of those: the Master Personal Injury Complaint and the Consolidated Consumer Class Action Complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:11pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; As of October 6, 2020, the Company has been named in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;forty-two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; of the MDL&#x2019;s consolidated personal injury lawsuits in various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company is named in these lawsuits with manufacturers of the national brand Zantac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and other manufacturers of ranitidine products distributors, repackagers,&lt;/span&gt;&lt;span style="font-family:Arial;font-size:11pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;and/or retailers. Plaintiffs seek compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence.&#160;The Company is named in this lawsuit with manufacturers of the national brand Zantac&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:6pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; and other manufacturers of ranitidine products and/or retailers. This action has been noticed to the MDL, but the New Mexico Attorney General is opposing consolidation. Some of the Company&#x2019;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these and other consolidated cases. We intend to defend all of these lawsuits vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:174%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;font-style:italic;"&gt;Acetaminophen&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The Company has received requests for indemnification and defense of several consumer fraud claims involving its store brand infants&#x2019; and children&#x2019;s acetaminophen products.&#160;In September 2020, the Company was directly named as a defendant in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; suit filed in the Central District of California. The Company has also received &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; different claims for indemnification or defense from &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; different retailers for lawsuits filed in California, Illinois and Pennsylvania, with nationwide class action allegations.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;The Plaintiffs generally allege that the children&#x2019;s and infants&#x2019; acetaminophen products have identical drug concentration amounts, yet the infants&#x2019; product costs more than the children&#x2019;s product and consumers have been misled into purchasing the more expensive product. The Company will aggressively defend the suit in which it is named and is continuing to assess whether, or to what extent, the Company may contribute in the lawsuits filed against its retail customers.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <prgo:NumberofProductsincludedinExpeditedCases
      contextRef="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember"
      decimals="INF"
      id="d35415e1017-wk-Fact-0D463B1A1EA15B7AA2AF09FB67E5B9FA"
      unitRef="product">120</prgo:NumberofProductsincludedinExpeditedCases>
    <prgo:NumberofPutativeClasses
      contextRef="FI2012Q2"
      decimals="INF"
      id="d35415e1050-wk-Fact-3BEA7C6212B4571684B839F34B95CDEB"
      unitRef="class">3</prgo:NumberofPutativeClasses>
    <prgo:NumberofSetsofClassActionComplaints
      contextRef="FI2012Q2"
      decimals="INF"
      id="d35415e1054-wk-Fact-01ECC4ABB7F25EB39D63AAA1CC6A6A0B"
      unitRef="class">2</prgo:NumberofSetsofClassActionComplaints>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember"
      decimals="INF"
      id="d35415e1064-wk-Fact-6BB88D42245F5F0480216FDE214C4BD2"
      unitRef="manufacturer">27</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember"
      decimals="INF"
      id="d35415e1068-wk-Fact-9E5795780E385A808ECF45DFB5C66BCC"
      unitRef="product">135</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany
      contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember"
      decimals="INF"
      id="d35415e1072-wk-Fact-ECCE8AEFC4635838A1BE336ADEC4533C"
      unitRef="product">2</prgo:LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany>
    <prgo:LossContingencyNumberOfPrescriptionPharmaceuticals
      contextRef="I2019Q2Apr_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember"
      decimals="INF"
      id="d35415e1076-wk-Fact-E22E9FD4344E59848AE450D605F42835"
      unitRef="product">1</prgo:LossContingencyNumberOfPrescriptionPharmaceuticals>
    <prgo:NumberofCasesIncludedinExpeditedSchedule
      contextRef="I2020Q3Jul14_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember"
      decimals="INF"
      id="d35415e1080-wk-Fact-6E9FD07F3911E6B5111BC621E383C7B8"
      unitRef="case">0</prgo:NumberofCasesIncludedinExpeditedSchedule>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember"
      decimals="INF"
      id="d35415e1115-wk-Fact-45BC06B0C9445817893D12373A3AA60F"
      unitRef="manufacturer">35</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberOfSupermarketChains
      contextRef="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember"
      decimals="INF"
      id="d35415e1119-wk-Fact-284E3A35F648596598E751BF824C89D2"
      unitRef="supermarket">3</prgo:LossContingencyNumberOfSupermarketChains>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2018Q1Jan22_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsMember"
      decimals="INF"
      id="d35415e1123-wk-Fact-740A598B7E455966B78EE4423341C591"
      unitRef="product">31</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2018Q4Dec21_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember"
      decimals="INF"
      id="d35415e1127-wk-Fact-2655EFFD47F35AE19B3094A479AEFA78"
      unitRef="manufacturer">39</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2018Q4Dec21_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember"
      decimals="INF"
      id="d35415e1131-wk-Fact-B5F5BE2A1AF65BF4A29DC66B02F006DF"
      unitRef="product">33</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2018Q3Aug03_srt_LitigationCaseAxis_prgo_PricefixingLawsuitManagedCareOrganizationMember"
      decimals="INF"
      id="d35415e1141-wk-Fact-6B1BBB1138C85A8FA7310F8FAF96A4E2"
      unitRef="product">17</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2018Q3Aug03_srt_LitigationCaseAxis_prgo_PricefixingLawsuitManagedCareOrganizationMember"
      decimals="INF"
      id="d35415e1145-wk-Fact-D7525966FB055731BF650EE61055BB2E"
      unitRef="manufacturer">27</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember"
      decimals="INF"
      id="d35415e1156-wk-Fact-6EE49B86884D57DBB241764B3D7450DA"
      unitRef="product">30</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <us-gaap:LossContingencyNumberOfDefendants
      contextRef="D2019Q1Jan16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthInsuranceCarrierMember"
      decimals="INF"
      id="d35415e1160-wk-Fact-57B342874F685EEFAD38BD486F996037"
      unitRef="defendant">30</us-gaap:LossContingencyNumberOfDefendants>
    <prgo:LossContingenciesNumberofHealthPlans
      contextRef="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember"
      decimals="INF"
      id="d35415e1173-wk-Fact-3E821DFA608B5CF28740BD8F76557E68"
      unitRef="health_plan">87</prgo:LossContingenciesNumberofHealthPlans>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember"
      decimals="INF"
      id="d35415e1177-wk-Fact-D4885976F1835B5BA29F5504471B14F5"
      unitRef="manufacturer">53</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberOfIndividuals
      contextRef="I2019Q3Jul18_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthPlansMember"
      decimals="INF"
      id="d35415e1181-wk-Fact-6881A07F08C95A8CBBB33673A4C5E406"
      unitRef="individual">17</prgo:LossContingencyNumberOfIndividuals>
    <prgo:LossContingencyNumberofCodefendants
      contextRef="I2019Q4Dec11_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareServiceCompanyMember"
      decimals="INF"
      id="d35415e1195-wk-Fact-DC0FEF4C1D9450FAAAC4798699FFEAB3"
      unitRef="defendant">38</prgo:LossContingencyNumberofCodefendants>
    <prgo:LossContingencyNumberofCodefendants
      contextRef="I2019Q4Dec16_srt_LitigationCaseAxis_prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember"
      decimals="INF"
      id="d35415e1205-wk-Fact-EB57FADA75C15E2688B30E2EE3293532"
      unitRef="defendant">39</prgo:LossContingencyNumberofCodefendants>
    <prgo:LossContingencyNumberofCodefendants
      contextRef="I2019Q4Dec23_srt_LitigationCaseAxis_prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember"
      decimals="INF"
      id="d35415e1215-wk-Fact-9D3E460FA2525AEE8CDB74F27165B790"
      unitRef="defendant">28</prgo:LossContingencyNumberofCodefendants>
    <prgo:LossContingencyNumberofCodefendants
      contextRef="I2019Q4Dec27_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHealthcareManagementOrganizationMember"
      decimals="INF"
      id="d35415e1226-wk-Fact-731930D2CE4D55D7A17024AAE275A311"
      unitRef="defendant">25</prgo:LossContingencyNumberofCodefendants>
    <prgo:LossContingencyNumberofCodefendants
      contextRef="I2020Q1Mar1_srt_LitigationCaseAxis_prgo_PricefixingLawsuitHarrisCountyofTexasMember"
      decimals="INF"
      id="d35415e1236-wk-Fact-E12016DD556D5D44B0730E7964A10226"
      unitRef="defendant">29</prgo:LossContingencyNumberofCodefendants>
    <prgo:LossContingenciesNumberofHealthPlans
      contextRef="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember"
      decimals="INF"
      id="d35415e1250-wk-Fact-7C829317C0395EF4886493F6EF75F588"
      unitRef="health_plan">7</prgo:LossContingenciesNumberofHealthPlans>
    <prgo:NumberofDozensofManufacturers
      contextRef="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember"
      decimals="INF"
      id="d35415e1254-wk-Fact-2484FCAD39D9554CB799612DC73CB485"
      unitRef="manufacturer">3</prgo:NumberofDozensofManufacturers>
    <prgo:LossContingencyNumberOfIndividuals
      contextRef="I2020Q2May31_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember"
      decimals="INF"
      id="d35415e1258-wk-Fact-5DDC7BFDD033522BAC5CE0491D85A3D6"
      unitRef="defendant">17</prgo:LossContingencyNumberOfIndividuals>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2020Q2Jun9_srt_LitigationCaseAxis_prgo_OverarchingConspiracyClassActionsMember"
      decimals="INF"
      id="d35415e1268-wk-Fact-9A8B1A21D1F854C2AE4E44E0B9A6F03A"
      unitRef="manufacturer">25</prgo:LossContingencyNumberOfManufacturers>
    <prgo:NumberofOtherPharmaceuticalCompanies
      contextRef="I2020Q3Jul9_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugstoreChainMember"
      decimals="INF"
      id="d35415e1281-wk-Fact-3648945122F1ADD7D153476DA6CDF76D"
      unitRef="pharmaceutical_company">39</prgo:NumberofOtherPharmaceuticalCompanies>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2020Q3Aug27_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember"
      decimals="INF"
      id="d35415e1292-wk-Fact-3DC1FEE8852F165BE74647624B98BB66"
      unitRef="manufacturer">35</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2020Q3Sep4_srt_LitigationCaseAxis_prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember"
      decimals="INF"
      id="d35415e1302-wk-Fact-89B8669C2306F4F940DC4771CF6B7F9A"
      unitRef="manufacturer">39</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberofAdditionalStatesandTerritories
      contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember"
      decimals="INF"
      id="d35415e1317-wk-Fact-49418E65FBC158F99500D502BB32CDC1"
      unitRef="plaintiff">50</prgo:LossContingencyNumberofAdditionalStatesandTerritories>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember"
      decimals="INF"
      id="d35415e1321-wk-Fact-44A3DC0FE7675BC88DCD49E04B249996"
      unitRef="manufacturer">35</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberofFormerEmployees
      contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember"
      decimals="INF"
      id="d35415e1325-wk-Fact-CDA5965856765588A7A7587CAA12051A"
      unitRef="defendant">1</prgo:LossContingencyNumberofFormerEmployees>
    <dei:EntityNumberOfEmployees
      contextRef="I2020Q2Jun10_srt_LitigationCaseAxis_prgo_StateAttorneyGeneralComplaintMember"
      decimals="INF"
      id="d35415e1329-wk-Fact-2D2399A6D92C50B59ED3EC07C786EC8C"
      unitRef="defendant">1</dei:EntityNumberOfEmployees>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="FI2020Q2_srt_LitigationCaseAxis_prgo_CanadianClassActionComplaintMember"
      decimals="INF"
      id="d35415e1349-wk-Fact-BBE9FD49CEC35734BB5D2BAA54CDCFEA"
      unitRef="manufacturer">29</prgo:LossContingencyNumberOfManufacturers>
    <prgo:NumberofPutativeClasses
      contextRef="I2017Q2Jun21"
      decimals="INF"
      id="d35415e1413-wk-Fact-F5F5DA77944C54FBBBB7F3165D50EBF8"
      unitRef="class">3</prgo:NumberofPutativeClasses>
    <prgo:LossContingencyNumberOfIndividuals
      contextRef="I2017Q2Jun21"
      decimals="INF"
      id="d35415e1417-wk-Fact-FE8F4D05E7A05FAEA93D61528F674586"
      unitRef="individual">11</prgo:LossContingencyNumberOfIndividuals>
    <prgo:LossContingencyNumberOfIndividuals
      contextRef="I2017Q2Jun21"
      decimals="INF"
      id="d35415e1426-wk-Fact-FE8F4D05E7A05FAEA93D61528F674586"
      unitRef="individual">11</prgo:LossContingencyNumberOfIndividuals>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2017Q2Jun21"
      decimals="INF"
      id="d35415e1430-wk-Fact-916DF117B1B153ED948A4644D5D7E515"
      unitRef="product">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2018Q3Jul27"
      decimals="INF"
      id="d35415e1438-wk-Fact-C82576AAEECE5B129A332E34086FCBC8"
      unitRef="product">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:NumberofPutativeClasses
      contextRef="I2019Q4Nov14"
      decimals="INF"
      id="d35415e1451-wk-Fact-2A9D9DC0BB1A5E07AE98E944CFA27FDD"
      unitRef="class">3</prgo:NumberofPutativeClasses>
    <prgo:NumberofCasesAllegingOnlyStateLawClaims
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member"
      decimals="INF"
      id="d35415e1464-wk-Fact-F658D9F2940B55568BE37B0F760E24D4"
      unitRef="lawsuit">1</prgo:NumberofCasesAllegingOnlyStateLawClaims>
    <prgo:NumberofCaseswithSimilarFactualAllegations
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_CarmignacFirstManhattanandSimilarCasesMember"
      decimals="INF"
      id="d35415e1487-wk-Fact-194B08FCAC0758A98CBE45C16C15BAB1"
      unitRef="case">7</prgo:NumberofCaseswithSimilarFactualAllegations>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2017Q2May31_srt_LitigationCaseAxis_prgo_FirstManhattanandSimilarCasesMember"
      decimals="INF"
      id="d35415e1636-wk-Fact-B6A89A8C20BE5CCB82741E268A56A9BC"
      unitRef="product">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:NumberofCaseswithSimilarFactualAllegations
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember"
      decimals="INF"
      id="d35415e1716-wk-Fact-B339F893C09854C3B13291355A2B36FA"
      unitRef="case">8</prgo:NumberofCaseswithSimilarFactualAllegations>
    <prgo:LossContingencyNumberOfIndividuals
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember"
      decimals="INF"
      id="d35415e1841-wk-Fact-990BFB7E40C15139A27A0B271CA7E2A5"
      unitRef="individual">11</prgo:LossContingencyNumberOfIndividuals>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2017Q2May31_srt_LitigationCaseAxis_prgo_MasonCapitalPentwaterandSimilarCasesMember"
      decimals="INF"
      id="d35415e1868-wk-Fact-1BF3199A844E5867A0BDAF5AE90C9C0E"
      unitRef="product">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:NumberofCaseswithSimilarFactualAllegations
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember"
      decimals="INF"
      id="d35415e1937-wk-Fact-881FB5461B2B5F0C8D9E31414ACD2B52"
      unitRef="case">2</prgo:NumberofCaseswithSimilarFactualAllegations>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember"
      decimals="INF"
      id="d35415e2005-wk-Fact-B11025368B8958A89D3E2DBAD4C70112"
      unitRef="defendant">13</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberofDefendantsAdded
      contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember"
      decimals="INF"
      id="d35415e2009-wk-Fact-F2F3AD2578F057ED8B9A9589E20903BD"
      unitRef="defendant">2</prgo:LossContingencyNumberofDefendantsAdded>
    <prgo:LossContingencyNumberofDefendantsDismissedwithoutPrejudice
      contextRef="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember"
      decimals="INF"
      id="d35415e2018-wk-Fact-AF68AE6429BF5DF78CA58757455F3333"
      unitRef="defendant">8</prgo:LossContingencyNumberofDefendantsDismissedwithoutPrejudice>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="I2018Q3Jul31_srt_LitigationCaseAxis_prgo_RoofersPensionFundMember"
      decimals="INF"
      id="d35415e2022-wk-Fact-28C0F7CD747F59E6B890E6370F3FA46D"
      unitRef="defendant">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2017Q2Apr30_srt_LitigationCaseAxis_prgo_HarelInsuranceandTIAACREFFCasesMember"
      decimals="INF"
      id="d35415e2041-wk-Fact-043FCCC08E9C5C21A8B2D5C3C25042EA"
      unitRef="product">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:NumberofCaseswithSimilarFactualAllegations
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_OtherCasesRelatedtoEventsin20152017Member"
      decimals="INF"
      id="d35415e2073-wk-Fact-A9109D55DF955A4398375132ECC55386"
      unitRef="case">3</prgo:NumberofCaseswithSimilarFactualAllegations>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2017Q2May31_srt_LitigationCaseAxis_prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member"
      decimals="INF"
      id="d35415e2175-wk-Fact-95340D0CE81C58569777B8AF64EFB0C2"
      unitRef="product">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberOfCases
      contextRef="FI2018Q4_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember"
      decimals="INF"
      id="d35415e2220-wk-Fact-E30E7E1C165A5AD29B9C7642DF3D9077"
      unitRef="case">3</prgo:LossContingencyNumberOfCases>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="FD2017Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember"
      decimals="INF"
      id="d35415e2224-wk-Fact-AD688CFD93C85FCEB214CBA0270F203E"
      unitRef="case">1</us-gaap:LossContingencyClaimsDismissedNumber>
    <prgo:LossContingencyNumberOfCasesStayed
      contextRef="FD2018Q4YTD_srt_LitigationCaseAxis_prgo_CasesFiledinIsraelMember"
      decimals="INF"
      id="d35415e2228-wk-Fact-0618BF4735DA568D88A8FBA40C2D6531"
      unitRef="case">1</prgo:LossContingencyNumberOfCasesStayed>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"
      decimals="INF"
      id="d35415e2243-wk-Fact-657E4A8A4AAD5A44B57F2E5D3096214F"
      unitRef="defendant">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"
      decimals="INF"
      id="d35415e2247-wk-Fact-657E4A8A4AAD5A44B57F2E5D3096214F"
      unitRef="defendant">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="I2017Q2Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"
      decimals="INF"
      id="d35415e2251-wk-Fact-BEBC799C111C544FAF3AAD985652E1B8"
      unitRef="product">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"
      decimals="-8"
      id="d35415e2255-wk-Fact-EB281AA612295526872DB9259FA8EC5F"
      unitRef="ils">2700000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"
      decimals="-5"
      id="d35415e2260-wk-Fact-42DEACAC78E05FCEB855DEF06739F86C"
      unitRef="usd">760000000.0</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:ForeignCurrencyExchangeRateRemeasurement1
      contextRef="FI2020Q3_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"
      decimals="2"
      id="d35415e2268-wk-Fact-BB1BD07F7C395E71AC610CA6797902AE"
      unitRef="USD_PER_ILS">0.28</us-gaap:ForeignCurrencyExchangeRateRemeasurement1>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="D2017Q1Jun28_srt_LitigationCaseAxis_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"
      decimals="INF"
      id="d35415e2272-wk-Fact-E1CA703305D85218AE5D01555A3260E8"
      unitRef="case">2</us-gaap:LossContingencyClaimsDismissedNumber>
    <prgo:LossContingencyNumberofDefendantsAdded
      contextRef="D2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member"
      decimals="INF"
      id="d35415e2302-wk-Fact-C6A0CF03093254F8897150B15DAF1311"
      unitRef="defendant">1</prgo:LossContingencyNumberofDefendantsAdded>
    <prgo:LossContingencyNumberOfIndividuals
      contextRef="I2019Q2May31_srt_LitigationCaseAxis_prgo_InrePerrigoCompanyplcSec.Litig.Member"
      decimals="INF"
      id="d35415e2310-wk-Fact-AD276F19FECA525D969F4A65C0EAAA45"
      unitRef="defendant">3</prgo:LossContingencyNumberOfIndividuals>
    <prgo:LossContingencyNumberOfCasesStayed
      contextRef="FD2019Q4YTD_srt_LitigationCaseAxis_prgo_InIsraelCasesRelatedtoIrishTaxEventsMember"
      decimals="INF"
      id="d35415e2333-wk-Fact-B52D812C0C1E5D3593B9A532611FCB2E"
      unitRef="case">2</prgo:LossContingencyNumberOfCasesStayed>
    <prgo:LossContingencyNumberofLawsuits
      contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_TalcumPowderLitigationMember"
      decimals="INF"
      id="d35415e2389-wk-Fact-E93ADE9E20235EF88E2B459017B40C27"
      unitRef="lawsuit">32</prgo:LossContingencyNumberofLawsuits>
    <prgo:NumberofTendersAccepted
      contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_prgo_TalcumPowderLitigationMember"
      decimals="INF"
      id="d35415e2393-wk-Fact-C3DC59D97B8755F68CD56263A697C902"
      unitRef="tender">1</prgo:NumberofTendersAccepted>
    <prgo:LossContingencyNumberofMasterComplaints
      contextRef="D2020Q1Feb_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember"
      decimals="INF"
      id="d35415e2422-wk-Fact-C0E551755D6C54B29C3DCCF893468937"
      unitRef="complaint">3</prgo:LossContingencyNumberofMasterComplaints>
    <prgo:LossContingencyNumberofMasterComplaintsNamingCompany
      contextRef="D2020Q1Feb_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember"
      decimals="INF"
      id="d35415e2426-wk-Fact-9D77F2344D54543BA5AD38E0625B3810"
      unitRef="complaint">2</prgo:LossContingencyNumberofMasterComplaintsNamingCompany>
    <prgo:LossContingencyNumberofLawsuits
      contextRef="D2020Q4Oct6_srt_LitigationCaseAxis_prgo_RanitidineLitigationMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="d35415e2436-wk-Fact-C73D1F8C3D68D6692FF14777EDF2913E"
      unitRef="lawsuit">42</prgo:LossContingencyNumberofLawsuits>
    <prgo:LossContingencyNumberofLawsuits
      contextRef="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember"
      decimals="INF"
      id="d35415e2466-wk-Fact-7A12FEFF77C64129B3719373930766AE"
      unitRef="lawsuit">1</prgo:LossContingencyNumberofLawsuits>
    <prgo:LossContingencyNumberofClaimsforIndemnificationorDefense
      contextRef="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember"
      decimals="INF"
      id="d35415e2470-wk-Fact-0B9DAE5E3BD64AD2A2CC9377252B97D1"
      unitRef="claim">14</prgo:LossContingencyNumberofClaimsforIndemnificationorDefense>
    <prgo:LossContingencyNumberofRetailers
      contextRef="D2020Q3Sep_srt_LitigationCaseAxis_prgo_AcetaminophenLitigationMember"
      decimals="INF"
      id="d35415e2474-wk-Fact-A15BCD5F03265EBD77FF9380DFA23265"
      unitRef="retailer">9</prgo:LossContingencyNumberofRetailers>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-5F03528CA64658F3991231ABDF8C87E9-0-wk-Fact-09BF950CBA29536C95A0BD7658BD9CAD">&lt;span style="font-family:Arial;font-weight:bold;"&gt;RESTRUCTURING CHARGES&lt;/span&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. The following reflects our restructuring activity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:184px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:8px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Additional charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(13.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(25.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-cash adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The charges incurred during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; were primarily associated with actions taken to streamline the organization. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The charges incurred during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; were primarily associated with the reorganization of our executive management team and other actions taken to streamline the organization. Of the amount recorded during the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$10.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; related primarily to the sales force reorganization in France within the CSCI segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;There were no other material restructuring programs that significantly impacted any other reportable segments for the &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;three and nine months ended&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;26, 2020&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;September&#160;28, 2019&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;.  All charges are recorded in &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Restructuring&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; expense on the Condensed Consolidated Statements of Operations. The remaining &lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;span&gt;$7.9&#160;million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt; liability for employee severance benefits is expected to be paid within the next year.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-4238780E1BCB5489BEF8902BEDC89BA3-0-wk-Fact-3679E983AE585CE298C5F9FDC37CCBF2">The following reflects our restructuring activity (in millions):&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:184px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:5px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;td style="width:8px;"/&gt;&lt;td style="width:6px;"/&gt;&lt;td style="width:86px;"/&gt;&lt;td style="width:4px;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;28, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;9.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;24.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Additional charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;23.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(2.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(13.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(25.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Non-cash adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q2"
      decimals="-5"
      id="d40578e1187-wk-Fact-4F3964B14EE95490B87E3FFFDB7DDEEA"
      unitRef="usd">9800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q2"
      decimals="-5"
      id="d40578e1206-wk-Fact-7CC0F84D6A345497AAF4CA4E4FFF43A1"
      unitRef="usd">23800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4"
      decimals="-5"
      id="d40578e1225-wk-Fact-511D9364691053989384ED52AD2CDC34"
      unitRef="usd">19600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2018Q4"
      decimals="-5"
      id="d40578e1245-wk-Fact-B9F4AC0D70B65EAFBE81C240B2898B3C"
      unitRef="usd">24000000.0</us-gaap:RestructuringReserve>
    <prgo:RestructuringAdditionalCharges
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d40578e1260-wk-Fact-5027DCF09BFB558BB07011C9C82D585B"
      unitRef="usd">800000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d40578e1279-wk-Fact-FBFF309707355AD1AB6670F1280213A5"
      unitRef="usd">5200000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d40578e1298-wk-Fact-0E15AD82BEE25DC6AE3CA6734D412410"
      unitRef="usd">1900000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d40578e1318-wk-Fact-C547FD32F6535A0E974A4315579924FD"
      unitRef="usd">23300000</prgo:RestructuringAdditionalCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d40578e1338-wk-Fact-6E2355E2D0A55FCFA793110D38370D1B"
      unitRef="usd">2900000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d40578e1358-wk-Fact-62D4F9D32DA956278C6358123439915C"
      unitRef="usd">7000000.0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d40578e1378-wk-Fact-AA94A569A2CD516288E739DF6C330940"
      unitRef="usd">13800000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d40578e1399-wk-Fact-5AD16F6B45895769B8BC259C08574F67"
      unitRef="usd">25000000.0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d40578e1420-wk-Fact-45E5EFB7B7ED5C17A0906D343F9F8B57"
      unitRef="usd">-200000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d40578e1439-wk-Fact-AF622381152F57DEB3FC4930905BB9F2"
      unitRef="usd">500000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d40578e1459-wk-Fact-EDC3BE1E581356D29E3C32795A4E2E39"
      unitRef="usd">-200000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d40578e1479-wk-Fact-F52BF1BCB3E9593FB43B2E58D98B1AEA"
      unitRef="usd">800000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q3"
      decimals="-5"
      id="d40578e1505-wk-Fact-16B6FB6754E958CF9DECBF310B4A9FAB"
      unitRef="usd">7900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q3"
      decimals="-5"
      id="d40578e1524-wk-Fact-42F66091CD3254BBA7B22CFE879574EB"
      unitRef="usd">21500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q3"
      decimals="-5"
      id="d40578e1543-wk-Fact-16B6FB6754E958CF9DECBF310B4A9FAB"
      unitRef="usd">7900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q3"
      decimals="-5"
      id="d40578e1563-wk-Fact-42F66091CD3254BBA7B22CFE879574EB"
      unitRef="usd">21500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember"
      decimals="-5"
      id="d40578e1612-wk-Fact-6BCE28B04E8F5C28B56A631BB78D6501"
      unitRef="usd">10800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q3"
      decimals="-5"
      id="d40578e1639-wk-Fact-16B6FB6754E958CF9DECBF310B4A9FAB"
      unitRef="usd">7900000</us-gaap:RestructuringReserve>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-D4615D0F0CE753FAA708F2A6819774A3-0-wk-Fact-511B45A992595EA49367552C720E8FC9">&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt;SEGMENT INFORMATION&lt;/span&gt;&lt;span style="font-family:Arial;font-size:10pt;font-weight:bold;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;Our segments reflect the way in which our management makes operating decisions, allocates resources, and manages the growth and profitability of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The tables below show select financial measures by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,747.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,990.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,606.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,682.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,221.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,628.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11,576.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11,301.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;664.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;123.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;613.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;339.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;347.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;43.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;210.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(180.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;230.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unallocated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(48.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(59.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(95.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;73.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;78.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,992.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;354.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;38.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,777.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;283.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,042.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;116.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,025.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;130.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;738.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(81.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;63.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;711.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;65.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unallocated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(151.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(185.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;167.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;219.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;211.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;227.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-5B8274CA90E157E4A5DEEC1D423311B7-0-wk-Fact-A057D712AB7B5763AF2C82E109C9D2CF">&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;The tables below show select financial measures by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Total Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September&#160;26, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,747.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,990.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,606.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;4,682.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,221.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;2,628.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11,576.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;11,301.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;664.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;123.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;613.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;81.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;12.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;339.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;40.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;347.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;13.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;43.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;210.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(180.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;230.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;19.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;22.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unallocated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(48.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(59.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,213.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(95.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;73.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,191.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;54.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;78.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 26, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;September 28, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;font-weight:bold;"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,992.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;354.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;38.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,777.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;283.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;31.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;CSCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,042.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;45.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;116.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;1,025.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;18.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;130.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;RX&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;738.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(81.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;63.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;711.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;95.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;65.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Unallocated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(151.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;(185.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,773.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;167.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;219.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;3,514.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;211.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;span style="font-family:Arial;font-size:9pt;"&gt;&lt;span&gt;227.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Arial;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1128-wk-Fact-36FDF8D4279E5CAFAA12EF1BE812082A"
      unitRef="usd">4747200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1147-wk-Fact-B87D7D253CD955E1BF55873356FBEC64"
      unitRef="usd">3990200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1167-wk-Fact-6C070F8FE2A258BCAA04FE47D8CB343A"
      unitRef="usd">4606900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1186-wk-Fact-C79FBE4AA1B557B19287603E98A44953"
      unitRef="usd">4682700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e1211-wk-Fact-31E2A4C682EF5323A59FF85A4D167B53"
      unitRef="usd">2221900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e1230-wk-Fact-8713CFA4FB47519D85EC2F5EBED81C61"
      unitRef="usd">2628500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q3"
      decimals="-5"
      id="d50250e1260-wk-Fact-787E99A35A81503989617F4B938A50C2"
      unitRef="usd">11576000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d50250e1279-wk-Fact-BCC4DA49384256F793F37AC4E26ADB03"
      unitRef="usd">11301400000</us-gaap:Assets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1710-wk-Fact-C31A12065CA4018CCDDCC23D08FB9B33"
      unitRef="usd">664000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1729-wk-Fact-C89D22E6E9CA5E50834397537E7B2327"
      unitRef="usd">123600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1748-wk-Fact-0B33B5C5FF885D1BAE86AB582252604A"
      unitRef="usd">12400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1768-wk-Fact-6F06EEC2D6D104D37336C23D40236485"
      unitRef="usd">613300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1787-wk-Fact-239DA0A88AE75A0F9A803976AD4C7B89"
      unitRef="usd">81300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e1807-wk-Fact-6A2183DDFC69564E898F481F638AC97A"
      unitRef="usd">12600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1822-wk-Fact-F13FA3A1ED61A1698A2CC23D090CBAD3"
      unitRef="usd">339000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1841-wk-Fact-5260E9F4A2DF546D8CC452BDD999F598"
      unitRef="usd">10200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1860-wk-Fact-8041DE7321B053E3B385DB022D7ED73E"
      unitRef="usd">40200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1880-wk-Fact-83F126B674510C0DDA76C23D403C42D9"
      unitRef="usd">347500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1899-wk-Fact-959017DBBDB65EBAACCE34DB825B3009"
      unitRef="usd">13200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e1918-wk-Fact-4458EA2AE6A45785B5D0FA8119917AAE"
      unitRef="usd">43300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e1939-wk-Fact-9FCC6F1E4EF2B5BD9BB0C23D092C86FD"
      unitRef="usd">210700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e1958-wk-Fact-CDFB00C196EB55CEA23996FD31CFFF78"
      unitRef="usd">-180600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e1978-wk-Fact-D1C25D59C38D5C878C2248130458DD42"
      unitRef="usd">21300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e1998-wk-Fact-447E72E2DB5FAC45B5C1C23D3FF3CCC7"
      unitRef="usd">230300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e2017-wk-Fact-7FDAC38E20E559D7941F85B994D675AA"
      unitRef="usd">19700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e2036-wk-Fact-28131B4CD3545A8DB2A0C9ED7C4ABCDE"
      unitRef="usd">22800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e2057-wk-Fact-0886091FEEEC5A6D812E8857AB370693"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e2076-wk-Fact-65FA39AC6EA756CEB014077D3B8CF8F4"
      unitRef="usd">-48700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e2096-wk-Fact-AE27E980A1ED57EFB7E33C6204186E68"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e2116-wk-Fact-B4A94A8CD7FB565B861F00AB95595EFB"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e2135-wk-Fact-6F95439F3BFD592E9D554A2540BDF831"
      unitRef="usd">-59800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e2155-wk-Fact-A85FA3C33F435E15A1CFCA97967A740F"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d50250e2181-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
      unitRef="usd">1213700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d50250e2200-wk-Fact-13D0525FEB2D521BAD5C1613BADE0743"
      unitRef="usd">-95500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3QTD"
      decimals="-5"
      id="d50250e2220-wk-Fact-9EC6EFD4DD3D5D5AB75DE9600F9BE5CD"
      unitRef="usd">73900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d50250e2240-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
      unitRef="usd">1191100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d50250e2259-wk-Fact-6BF69FF58FFC512D8BE1DC951310FDC7"
      unitRef="usd">54400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d50250e2279-wk-Fact-C505C4899C9C5A9293E87934EEE6ED3E"
      unitRef="usd">78700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e2714-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
      unitRef="usd">1992200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e2733-wk-Fact-76AFF08E4B5B50CC8C0DB1080AEB8051"
      unitRef="usd">354500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e2752-wk-Fact-08726A0E89E457488B109B42527C52D8"
      unitRef="usd">38600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e2772-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
      unitRef="usd">1777200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e2791-wk-Fact-DEF0585FE46552D4874EF1ED8E36A4F6"
      unitRef="usd">283300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember"
      decimals="-5"
      id="d50250e2811-wk-Fact-A9426829A0605D579909324D52E7C8EE"
      unitRef="usd">31900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e2826-wk-Fact-A8E55B983BFE55EAA0C2CD7EB512EAAB"
      unitRef="usd">1042800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e2845-wk-Fact-A6D847CCF2CB5FF39546A9B99C6325E3"
      unitRef="usd">45700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e2864-wk-Fact-2829346B5F8A5D11BAF5F91EFF483403"
      unitRef="usd">116900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e2884-wk-Fact-6A9C3E189E13591A95A5A88A23378280"
      unitRef="usd">1025800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e2903-wk-Fact-3A7CE3BE43245464A74C978BFC46F418"
      unitRef="usd">18400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareInternationalMember"
      decimals="-5"
      id="d50250e2922-wk-Fact-75A9D3F0A04F5C16AC0F912F2BED1050"
      unitRef="usd">130400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e2943-wk-Fact-F4F655B41C045B60A17D25F0408DC766"
      unitRef="usd">738800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e2962-wk-Fact-71635A61367B5E91857261EBAEAC64EA"
      unitRef="usd">-81200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e2982-wk-Fact-8AB6BA57A1E75662AFCB0EC056124A9C"
      unitRef="usd">63800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e3002-wk-Fact-F09B459D0AD95E23A8B13DB22EF55A16"
      unitRef="usd">711600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e3021-wk-Fact-C265CE623C185F01897A6F90441C5ADD"
      unitRef="usd">95000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_prgo_RXPharmaceuticalsMember"
      decimals="-5"
      id="d50250e3040-wk-Fact-37B7C6473A2557F88A9B7147931EE2DC"
      unitRef="usd">65400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e3061-wk-Fact-352F2D30828B55B28B374FEC64A21776"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e3080-wk-Fact-DCD4E44E8E295C25B16C16973C41B4BE"
      unitRef="usd">-151400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e3100-wk-Fact-9C31299FD8415D5CB07E1CDB4E1CA8EF"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e3120-wk-Fact-C09992B79A7C519A939DA4519EB61D12"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e3139-wk-Fact-02FCF54DD3F95D4780FA81E532C680FC"
      unitRef="usd">-185000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3YTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_MaterialReconcilingItemsMember"
      decimals="-5"
      id="d50250e3159-wk-Fact-362133ADCF78592791A3004DAC2B8146"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d50250e3185-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
      unitRef="usd">3773800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d50250e3204-wk-Fact-CB2087D04AEC530794406BF111E1F908"
      unitRef="usd">167600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3YTD"
      decimals="-5"
      id="d50250e3223-wk-Fact-B5DA864A4FA15076A7E87E8E669E0A74"
      unitRef="usd">219300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d50250e3243-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
      unitRef="usd">3514600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d50250e3262-wk-Fact-55D56F3E881C56179BCAACFE76CCD34E"
      unitRef="usd">211700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d50250e3282-wk-Fact-66166F7248AF5BEDB989DACED3CFEE17"
      unitRef="usd">227700000</us-gaap:AmortizationOfIntangibleAssets>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#d78798e2253-wk-Fact-02352B46854A58049795BE464FC233D9"
          xlink:label="d78798e2253-wk-Fact-02352B46854A58049795BE464FC233D9"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl" xlink:label="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes net sales from our OTC contract manufacturing business.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2253-wk-Fact-02352B46854A58049795BE464FC233D9"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1946-wk-Fact-058668D8C7005426B4C3D67A9EF7BA2C"
          xlink:label="d78798e1946-wk-Fact-058668D8C7005426B4C3D67A9EF7BA2C"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1946-wk-Fact-058668D8C7005426B4C3D67A9EF7BA2C"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560"
          xlink:label="d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl" xlink:label="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Derived from the location of the entity that sells to a third party.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnote id="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl" xlink:label="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes net sales generated primarily in Israel, Mexico, Australia and Canada.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1419-wk-Fact-05D7B2A18D4052F19881E110E575E560"
          xlink:to="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1411-wk-Fact-06EE885C336D559890E9C0003A71C4FD"
          xlink:label="d18029e1411-wk-Fact-06EE885C336D559890E9C0003A71C4FD"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl" xlink:label="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">We had accumulated goodwill impairments of <xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$868.4&#160;million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> as of each of December 31, 2019 and </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1411-wk-Fact-06EE885C336D559890E9C0003A71C4FD"
          xlink:to="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d27108e1552-wk-Fact-08EF9BC9348C54B681F5C4E593B63CBA"
          xlink:label="d27108e1552-wk-Fact-08EF9BC9348C54B681F5C4E593B63CBA"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-7A8EDA421AAF55FDAD0D4EAB26DA18BC-0-wk-Footnote-7A8EDA421AAF55FDAD0D4EAB26DA18BC_lbl" xlink:label="TextSelection-7A8EDA421AAF55FDAD0D4EAB26DA18BC-0-wk-Footnote-7A8EDA421AAF55FDAD0D4EAB26DA18BC_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d27108e1552-wk-Fact-08EF9BC9348C54B681F5C4E593B63CBA"
          xlink:to="TextSelection-7A8EDA421AAF55FDAD0D4EAB26DA18BC-0-wk-Footnote-7A8EDA421AAF55FDAD0D4EAB26DA18BC_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e4331-wk-Fact-0D4BBC7E5651503EA28DC2F31CF06DD6"
          xlink:label="d46894e4331-wk-Fact-0D4BBC7E5651503EA28DC2F31CF06DD6"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl" xlink:label="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net <xhtml:span style="font-family:Arial;font-size:8pt;">loss</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> of </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$9.4 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> is expected to be reclassified out of AOCI into earnings during the next 12 months.</xhtml:span><xhtml:div style="line-height:120%;text-align:center;font-size:10pt;"><xhtml:span style="font-family:Arial;font-size:10pt;"><xhtml:br/></xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e4331-wk-Fact-0D4BBC7E5651503EA28DC2F31CF06DD6"
          xlink:to="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e4852-wk-Fact-1304196B6B745288B99541373B5E5AF1"
          xlink:label="d46894e4852-wk-Fact-1304196B6B745288B99541373B5E5AF1"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e4852-wk-Fact-1304196B6B745288B99541373B5E5AF1"
          xlink:to="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681"
          xlink:label="d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl" xlink:label="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes Ireland net sales of <xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$10.8 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> and </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$22.3 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> for the </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">three and nine months ended</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">, respectively, and </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$5.2&#160;million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> and </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$17.3 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> for the </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">three and nine months ended</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">September&#160;28, 2019</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">, respectively.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681"
          xlink:to="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1339-wk-Fact-138D0076896B5646AE65D9732FBCA681"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2566-wk-Fact-152380BDE3875A368ADC1645FA22C174"
          xlink:label="d78798e2566-wk-Fact-152380BDE3875A368ADC1645FA22C174"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2566-wk-Fact-152380BDE3875A368ADC1645FA22C174"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1536-wk-Fact-15F3950C89195B8AB60F572451958777"
          xlink:label="d18029e1536-wk-Fact-15F3950C89195B8AB60F572451958777"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl" xlink:label="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">We had accumulated goodwill impairments of <xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$109.2 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> and </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$311.6 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> as of December 31, 2019 and </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1536-wk-Fact-15F3950C89195B8AB60F572451958777"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d24840e3276-wk-Fact-17F7D38C41C65D89B57E9524630DF06F"
          xlink:label="d24840e3276-wk-Fact-17F7D38C41C65D89B57E9524630DF06F"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl" xlink:label="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"><xhtml:span style="font-family:Arial;font-size:10pt;"/><xhtml:span style="font-family:Arial;font-size:8pt;"/><xhtml:span style="font-family:Arial;font-size:8pt;">(1)  Includes short-term leases and variable lease costs, which are immaterial</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d24840e3276-wk-Fact-17F7D38C41C65D89B57E9524630DF06F"
          xlink:to="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1264-wk-Fact-18CC7AAB145A5D47B3481557211BBDCA"
          xlink:label="d78798e1264-wk-Fact-18CC7AAB145A5D47B3481557211BBDCA"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1264-wk-Fact-18CC7AAB145A5D47B3481557211BBDCA"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2507-wk-Fact-1C660C6F8C885777917A013B8B8DFE59"
          xlink:label="d78798e2507-wk-Fact-1C660C6F8C885777917A013B8B8DFE59"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2507-wk-Fact-1C660C6F8C885777917A013B8B8DFE59"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d24840e3296-wk-Fact-1D68F3544CDE5E28B26B49940823EEB2"
          xlink:label="d24840e3296-wk-Fact-1D68F3544CDE5E28B26B49940823EEB2"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d24840e3296-wk-Fact-1D68F3544CDE5E28B26B49940823EEB2"
          xlink:to="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2331-wk-Fact-1EDEA42D38F954E886C6569B8C981F6C"
          xlink:label="d78798e2331-wk-Fact-1EDEA42D38F954E886C6569B8C981F6C"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2331-wk-Fact-1EDEA42D38F954E886C6569B8C981F6C"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e4246-wk-Fact-21E5ECF72BF157788F6A7ECF9B4C5A3A"
          xlink:label="d46894e4246-wk-Fact-21E5ECF72BF157788F6A7ECF9B4C5A3A"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e4246-wk-Fact-21E5ECF72BF157788F6A7ECF9B4C5A3A"
          xlink:to="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e4678-wk-Fact-29E7FACF98905FD6A4F2915EDDDBFD85"
          xlink:label="d46894e4678-wk-Fact-29E7FACF98905FD6A4F2915EDDDBFD85"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e4678-wk-Fact-29E7FACF98905FD6A4F2915EDDDBFD85"
          xlink:to="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1"
          xlink:label="d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1"
          xlink:to="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1281-wk-Fact-2AFDD02CF9B955AAA2398CDB544F3AA1"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2039-wk-Fact-2D3B683CCB6757D19D2C95D94D3569F4"
          xlink:label="d78798e2039-wk-Fact-2D3B683CCB6757D19D2C95D94D3569F4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2039-wk-Fact-2D3B683CCB6757D19D2C95D94D3569F4"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3442-wk-Fact-36210C25EE665D12BAF6DC136D86364C"
          xlink:label="d57757e3442-wk-Fact-36210C25EE665D12BAF6DC136D86364C"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl" xlink:label="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family:Arial;font-size:8pt;">During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$55.3 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> were written down to a fair value of </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$23.3 million</xhtml:span></xhtml:span>.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3442-wk-Fact-36210C25EE665D12BAF6DC136D86364C"
          xlink:to="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1225-wk-Fact-392CC0D02686521681FB64A94FFD57EC"
          xlink:label="d78798e1225-wk-Fact-392CC0D02686521681FB64A94FFD57EC"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1225-wk-Fact-392CC0D02686521681FB64A94FFD57EC"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1517-wk-Fact-397C83A0249153ACAFF833332FBC93C2"
          xlink:label="d18029e1517-wk-Fact-397C83A0249153ACAFF833332FBC93C2"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1517-wk-Fact-397C83A0249153ACAFF833332FBC93C2"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA"
          xlink:label="d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA"
          xlink:to="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1300-wk-Fact-3B43B213044552B68363A71E1B7B75FA"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1861-wk-Fact-42B3AB8BE2AD78DD55A147301E355CC4"
          xlink:label="d18029e1861-wk-Fact-42B3AB8BE2AD78DD55A147301E355CC4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1861-wk-Fact-42B3AB8BE2AD78DD55A147301E355CC4"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2195-wk-Fact-43B0F047528459B790AAD8A9134D6AA2"
          xlink:label="d78798e2195-wk-Fact-43B0F047528459B790AAD8A9134D6AA2"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2195-wk-Fact-43B0F047528459B790AAD8A9134D6AA2"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3539-wk-Fact-4834881B4668519E87F6E7AF053C9407"
          xlink:label="d57757e3539-wk-Fact-4834881B4668519E87F6E7AF053C9407"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d57757e3758-wk-Fact-4834881B4668519E87F6E7AF053C9407"
          xlink:label="d57757e3758-wk-Fact-4834881B4668519E87F6E7AF053C9407"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3539-wk-Fact-4834881B4668519E87F6E7AF053C9407"
          xlink:to="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3758-wk-Fact-4834881B4668519E87F6E7AF053C9407"
          xlink:to="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3461-wk-Fact-4B312B45A7B45F5AA356D35F99AED5E3"
          xlink:label="d57757e3461-wk-Fact-4B312B45A7B45F5AA356D35F99AED5E3"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3461-wk-Fact-4B312B45A7B45F5AA356D35F99AED5E3"
          xlink:to="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2273-wk-Fact-4D78AA98677C5D8A90ACFBB38F4EAF9B"
          xlink:label="d78798e2273-wk-Fact-4D78AA98677C5D8A90ACFBB38F4EAF9B"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2273-wk-Fact-4D78AA98677C5D8A90ACFBB38F4EAF9B"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e3672-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:label="d78798e3672-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e1482-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:label="d78798e1482-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d13015e1215-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:label="d13015e1215-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d50250e3185-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:label="d50250e3185-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d46894e8692-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:label="d46894e8692-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e3672-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1482-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d13015e1215-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d50250e3185-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e8692-wk-Fact-4E25116FA7FC53F3A10D6A8025D523CC"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1431-wk-Fact-529F834E8BC45200AAA6A530453B7278"
          xlink:label="d18029e1431-wk-Fact-529F834E8BC45200AAA6A530453B7278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1431-wk-Fact-529F834E8BC45200AAA6A530453B7278"
          xlink:to="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1615-wk-Fact-52DE8508E9D450FE88B0F7906CEBEA51"
          xlink:label="d18029e1615-wk-Fact-52DE8508E9D450FE88B0F7906CEBEA51"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1615-wk-Fact-52DE8508E9D450FE88B0F7906CEBEA51"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3323-wk-Fact-54659D50AABB58A8AD490252A3CAEC7D"
          xlink:label="d57757e3323-wk-Fact-54659D50AABB58A8AD490252A3CAEC7D"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl" xlink:label="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:div style="line-height:120%;text-align:left;font-size:8pt;"><xhtml:span style="font-family:Arial;font-size:8pt;">During the </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">three months ended</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">, goodwill with a carrying amount of </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$1,013.5 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$811.1 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">. During the year ended December 31, 2019, goodwill with a carrying amount of </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$1,122.3 million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:span>$1,013.1&#160;million</xhtml:span></xhtml:span><xhtml:span style="font-family:Arial;font-size:8pt;">. </xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3323-wk-Fact-54659D50AABB58A8AD490252A3CAEC7D"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e4166-wk-Fact-599FFCCBEE295646BFAB4B90802D2614"
          xlink:label="d46894e4166-wk-Fact-599FFCCBEE295646BFAB4B90802D2614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e4166-wk-Fact-599FFCCBEE295646BFAB4B90802D2614"
          xlink:to="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d19403e1144-wk-Fact-5B9A12A4436158F6ACA797BEE8428DE3"
          xlink:label="d19403e1144-wk-Fact-5B9A12A4436158F6ACA797BEE8428DE3"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-0-wk-Footnote-2A32F48D88195E6AAF1DE8E30AB8BCED_lbl" xlink:label="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-0-wk-Footnote-2A32F48D88195E6AAF1DE8E30AB8BCED_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:div style="line-height:120%;font-size:8pt;padding-left:0px;"><xhtml:span style="font-family:Arial;font-size:8pt;">(1) </xhtml:span></xhtml:div><xhtml:div style="line-height:120%;text-align:left;font-size:8pt;"><xhtml:span style="font-family:Arial;font-size:8pt;">Measured at fair value using the Net Asset Value practical expedient.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d19403e1144-wk-Fact-5B9A12A4436158F6ACA797BEE8428DE3"
          xlink:to="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-0-wk-Footnote-2A32F48D88195E6AAF1DE8E30AB8BCED_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d24840e3315-wk-Fact-5BE07753BFF65ECD8A5D8EE3A14DA068"
          xlink:label="d24840e3315-wk-Fact-5BE07753BFF65ECD8A5D8EE3A14DA068"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d24840e3315-wk-Fact-5BE07753BFF65ECD8A5D8EE3A14DA068"
          xlink:to="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e3433-wk-Fact-5D0DBD67D2B657C3B59581DD44F1C634"
          xlink:label="d78798e3433-wk-Fact-5D0DBD67D2B657C3B59581DD44F1C634"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-5B20844D52F450CDAEB6F6645EF39AB1-0-wk-Footnote-5B20844D52F450CDAEB6F6645EF39AB1_lbl" xlink:label="TextSelection-5B20844D52F450CDAEB6F6645EF39AB1-0-wk-Footnote-5B20844D52F450CDAEB6F6645EF39AB1_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:div style="line-height:120%;text-align:left;font-size:8pt;"><xhtml:span style="font-family:Arial;font-size:8pt;">Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e3433-wk-Fact-5D0DBD67D2B657C3B59581DD44F1C634"
          xlink:to="TextSelection-5B20844D52F450CDAEB6F6645EF39AB1-0-wk-Footnote-5B20844D52F450CDAEB6F6645EF39AB1_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d19403e1163-wk-Fact-657D3A9C033253C599DE3B568A3ADD2A"
          xlink:label="d19403e1163-wk-Fact-657D3A9C033253C599DE3B568A3ADD2A"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d19403e1163-wk-Fact-657D3A9C033253C599DE3B568A3ADD2A"
          xlink:to="TextSelection-2A32F48D88195E6AAF1DE8E30AB8BCED-0-wk-Footnote-2A32F48D88195E6AAF1DE8E30AB8BCED_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4"
          xlink:label="d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-0688D3D2ED7051959163C0B2BE4AA6D3-0-wk-Footnote-0688D3D2ED7051959163C0B2BE4AA6D3_lbl" xlink:label="TextSelection-0688D3D2ED7051959163C0B2BE4AA6D3-0-wk-Footnote-0688D3D2ED7051959163C0B2BE4AA6D3_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4"
          xlink:to="TextSelection-0688D3D2ED7051959163C0B2BE4AA6D3-0-wk-Footnote-0688D3D2ED7051959163C0B2BE4AA6D3_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2666-wk-Fact-66AD9ECE3C3C53E28D56F0D34652F6D4"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1813-wk-Fact-6B00D7D90C21501FB740932FEEDF4550"
          xlink:label="d29539e1813-wk-Fact-6B00D7D90C21501FB740932FEEDF4550"
          xlink:type="locator"/>
        <link:footnote id="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl" xlink:label="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In the period of a net loss, diluted shares equal basic shares.<xhtml:div style="line-height:120%;text-align:left;font-size:8pt;"><xhtml:span style="font-family:Arial;font-size:8pt;"><xhtml:br/></xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1813-wk-Fact-6B00D7D90C21501FB740932FEEDF4550"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3480-wk-Fact-6BF6FF194208528A9F268E547BB40BDD"
          xlink:label="d57757e3480-wk-Fact-6BF6FF194208528A9F268E547BB40BDD"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3480-wk-Fact-6BF6FF194208528A9F268E547BB40BDD"
          xlink:to="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2175-wk-Fact-6C2AFC76F3FB504D9DEA13D586331121"
          xlink:label="d78798e2175-wk-Fact-6C2AFC76F3FB504D9DEA13D586331121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2175-wk-Fact-6C2AFC76F3FB504D9DEA13D586331121"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1799-wk-Fact-6DF28A47AB0B5975A658DB56F5C2CA31"
          xlink:label="d29539e1799-wk-Fact-6DF28A47AB0B5975A658DB56F5C2CA31"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1799-wk-Fact-6DF28A47AB0B5975A658DB56F5C2CA31"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1780-wk-Fact-6EEFC2D6DBC153698EBF0227D6A28251"
          xlink:label="d29539e1780-wk-Fact-6EEFC2D6DBC153698EBF0227D6A28251"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1780-wk-Fact-6EEFC2D6DBC153698EBF0227D6A28251"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1490-wk-Fact-71631B201A095930921056960D3E9895"
          xlink:label="d18029e1490-wk-Fact-71631B201A095930921056960D3E9895"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1490-wk-Fact-71631B201A095930921056960D3E9895"
          xlink:to="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599"
          xlink:label="d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599"
          xlink:to="TextSelection-0688D3D2ED7051959163C0B2BE4AA6D3-0-wk-Footnote-0688D3D2ED7051959163C0B2BE4AA6D3_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2646-wk-Fact-777144FBFE5E5103902E9DDC8B110599"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3400-wk-Fact-7C700D4A75525FDDAC3C3171E75DFFE5"
          xlink:label="d57757e3400-wk-Fact-7C700D4A75525FDDAC3C3171E75DFFE5"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3400-wk-Fact-7C700D4A75525FDDAC3C3171E75DFFE5"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2409-wk-Fact-8433D7C2B404533EAFB42C71B825CE9F"
          xlink:label="d78798e2409-wk-Fact-8433D7C2B404533EAFB42C71B825CE9F"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2409-wk-Fact-8433D7C2B404533EAFB42C71B825CE9F"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3739-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
          xlink:label="d57757e3739-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d57757e3420-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
          xlink:label="d57757e3420-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3739-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3420-wk-Fact-89F91D62F67958A3B9E9B1F07E1A8FBE"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3342-wk-Fact-8A111B173C555B0CB5779ABD1C5D2650"
          xlink:label="d57757e3342-wk-Fact-8A111B173C555B0CB5779ABD1C5D2650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3342-wk-Fact-8A111B173C555B0CB5779ABD1C5D2650"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1833-wk-Fact-8A4E1F61401D575EBEACA2D6DA95348C"
          xlink:label="d29539e1833-wk-Fact-8A4E1F61401D575EBEACA2D6DA95348C"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1833-wk-Fact-8A4E1F61401D575EBEACA2D6DA95348C"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d50250e2714-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
          xlink:label="d50250e2714-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e2724-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
          xlink:label="d78798e2724-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d50250e2714-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2724-wk-Fact-8A512266646C595482EF17DA8AAAAA8E"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1471-wk-Fact-8AFFEC2E9E6C53B4A4EBDD28B0FBE7F5"
          xlink:label="d18029e1471-wk-Fact-8AFFEC2E9E6C53B4A4EBDD28B0FBE7F5"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1471-wk-Fact-8AFFEC2E9E6C53B4A4EBDD28B0FBE7F5"
          xlink:to="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2351-wk-Fact-8BD2C497D6995B9FBEC20505802E4864"
          xlink:label="d78798e2351-wk-Fact-8BD2C497D6995B9FBEC20505802E4864"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2351-wk-Fact-8BD2C497D6995B9FBEC20505802E4864"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2117-wk-Fact-8DA178F61A0B599B8927F372D1AD84EA"
          xlink:label="d78798e2117-wk-Fact-8DA178F61A0B599B8927F372D1AD84EA"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2117-wk-Fact-8DA178F61A0B599B8927F372D1AD84EA"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1557-wk-Fact-8E7B51E0001651F59334F63E30A68520"
          xlink:label="d29539e1557-wk-Fact-8E7B51E0001651F59334F63E30A68520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1557-wk-Fact-8E7B51E0001651F59334F63E30A68520"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e7597-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:label="d46894e7597-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d13015e1177-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:label="d13015e1177-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d50250e2181-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:label="d50250e2181-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e3634-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:label="d78798e3634-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e1444-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:label="d78798e1444-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e7597-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d13015e1177-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d50250e2181-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e3634-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1444-wk-Fact-91F79D5851FA52E297E9A21CD478C108"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2097-wk-Fact-9563BEF0C0E95D478DFD17FFD936C48D"
          xlink:label="d78798e2097-wk-Fact-9563BEF0C0E95D478DFD17FFD936C48D"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2097-wk-Fact-9563BEF0C0E95D478DFD17FFD936C48D"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2487-wk-Fact-98DD498FAEFC5940AEE42CD74D33C288"
          xlink:label="d78798e2487-wk-Fact-98DD498FAEFC5940AEE42CD74D33C288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2487-wk-Fact-98DD498FAEFC5940AEE42CD74D33C288"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3500-wk-Fact-98E41D9BAFA85AA09C857F17FB3EF40F"
          xlink:label="d57757e3500-wk-Fact-98E41D9BAFA85AA09C857F17FB3EF40F"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3500-wk-Fact-98E41D9BAFA85AA09C857F17FB3EF40F"
          xlink:to="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1865-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
          xlink:label="d18029e1865-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d18029e1635-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
          xlink:label="d18029e1635-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1865-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1635-wk-Fact-9D985AB062A15CAAA5B25E7BBAD599D8"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1576-wk-Fact-A829969C34F8533CBEBD61A503F3030A"
          xlink:label="d29539e1576-wk-Fact-A829969C34F8533CBEBD61A503F3030A"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1576-wk-Fact-A829969C34F8533CBEBD61A503F3030A"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e4506-wk-Fact-AB00C328FFCF5CB3851B97436FC40313"
          xlink:label="d46894e4506-wk-Fact-AB00C328FFCF5CB3851B97436FC40313"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e4506-wk-Fact-AB00C328FFCF5CB3851B97436FC40313"
          xlink:to="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E"
          xlink:label="d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1380-wk-Fact-ABF377E39EE159B3802E06FF0A131D7E"
          xlink:to="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3728-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
          xlink:label="d57757e3728-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d57757e3362-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
          xlink:label="d57757e3362-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3728-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3362-wk-Fact-AD7AFCD46C655745AAECBB9C28AF1F0C"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1590-wk-Fact-AD7CC1BE401157C8B74B161CB4B58DB3"
          xlink:label="d29539e1590-wk-Fact-AD7CC1BE401157C8B74B161CB4B58DB3"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1590-wk-Fact-AD7CC1BE401157C8B74B161CB4B58DB3"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e9921-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:label="d46894e9921-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e1463-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:label="d78798e1463-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e3653-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:label="d78798e3653-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d13015e1196-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:label="d13015e1196-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d50250e2240-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:label="d50250e2240-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e9921-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1463-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e3653-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d13015e1196-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d50250e2240-wk-Fact-AD8DF8663E025098BD5438A9C8F58044"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d50250e2772-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
          xlink:label="d50250e2772-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e2744-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
          xlink:label="d78798e2744-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d50250e2772-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2744-wk-Fact-AE2A52E95701500B86A6BF9CAAA33050"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d46894e4760-wk-Fact-B13EFE4368D2570FA220BB1C13CE1E61"
          xlink:label="d46894e4760-wk-Fact-B13EFE4368D2570FA220BB1C13CE1E61"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e4760-wk-Fact-B13EFE4368D2570FA220BB1C13CE1E61"
          xlink:to="TextSelection-7ACFB08571BF59F18A819B39ECF73646-0-wk-Footnote-7ACFB08571BF59F18A819B39ECF73646_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e3453-wk-Fact-B9EA1E3D2DD758478C3781F4783BED45"
          xlink:label="d78798e3453-wk-Fact-B9EA1E3D2DD758478C3781F4783BED45"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e3453-wk-Fact-B9EA1E3D2DD758478C3781F4783BED45"
          xlink:to="TextSelection-5B20844D52F450CDAEB6F6645EF39AB1-0-wk-Footnote-5B20844D52F450CDAEB6F6645EF39AB1_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E"
          xlink:label="d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1361-wk-Fact-C27B36FC327D5A71A15FB8BA0596B59E"
          xlink:to="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d24840e3257-wk-Fact-C9C00F121CB951659C3760707A8C41F4"
          xlink:label="d24840e3257-wk-Fact-C9C00F121CB951659C3760707A8C41F4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d24840e3257-wk-Fact-C9C00F121CB951659C3760707A8C41F4"
          xlink:to="TextSelection-830F1F97A407573CA5716CF20061222C-0-wk-Footnote-830F1F97A407573CA5716CF20061222C_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1555-wk-Fact-D48BD2E94F145A76A5EF2CAD1ECCB884"
          xlink:label="d18029e1555-wk-Fact-D48BD2E94F145A76A5EF2CAD1ECCB884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1555-wk-Fact-D48BD2E94F145A76A5EF2CAD1ECCB884"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d29539e1610-wk-Fact-D577BC6DA12759CFAC580716E5395C92"
          xlink:label="d29539e1610-wk-Fact-D577BC6DA12759CFAC580716E5395C92"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d29539e1610-wk-Fact-D577BC6DA12759CFAC580716E5395C92"
          xlink:to="TextSelection-B6EDD2E44AD0C152CC06C717AC585C86-0-wk-Footnote-B6EDD2E44AD0C152CC06C717AC585C86_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0"
          xlink:label="d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0"
          xlink:to="TextSelection-4217738E32425A0CA150B80B85D9D810-0-wk-Footnote-4217738E32425A0CA150B80B85D9D810_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1319-wk-Fact-D58D7821538356EE819781C809128CF0"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2019-wk-Fact-D8FA5406EF085766869DD5593BBE73C1"
          xlink:label="d78798e2019-wk-Fact-D8FA5406EF085766869DD5593BBE73C1"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2019-wk-Fact-D8FA5406EF085766869DD5593BBE73C1"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1373-wk-Fact-D9AC2B84885C5079A384B35225979290"
          xlink:label="d18029e1373-wk-Fact-D9AC2B84885C5079A384B35225979290"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1373-wk-Fact-D9AC2B84885C5079A384B35225979290"
          xlink:to="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152"
          xlink:label="d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1399-wk-Fact-DACAA1F24EE25CAB82E98A79F16E3152"
          xlink:to="TextSelection-B07C29DEEA865040B5EFECAB0E134D95-0-wk-Footnote-B07C29DEEA865040B5EFECAB0E134D95_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1244-wk-Fact-DD3F6F8837535D62BCEAA41CB8BB7E87"
          xlink:label="d78798e1244-wk-Fact-DD3F6F8837535D62BCEAA41CB8BB7E87"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1244-wk-Fact-DD3F6F8837535D62BCEAA41CB8BB7E87"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1206-wk-Fact-DE9A4C836BA8550DB1E1A87EB6EAE22E"
          xlink:label="d78798e1206-wk-Fact-DE9A4C836BA8550DB1E1A87EB6EAE22E"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1206-wk-Fact-DE9A4C836BA8550DB1E1A87EB6EAE22E"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d50250e3243-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:label="d50250e3243-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e1502-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:label="d78798e1502-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d13015e1235-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:label="d13015e1235-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d78798e3692-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:label="d78798e3692-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#d46894e10978-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:label="d46894e10978-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d50250e3243-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1502-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d13015e1235-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e3692-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d46894e10978-wk-Fact-E0F764EE2C9C5D2993F09FF9E600FE60"
          xlink:to="TextSelection-7183E8AEE5A15A4A96FA1C391EA803B0-0-wk-Footnote-7183E8AEE5A15A4A96FA1C391EA803B0_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3381-wk-Fact-E1A5E9B08C5A58CBB315756126068B88"
          xlink:label="d57757e3381-wk-Fact-E1A5E9B08C5A58CBB315756126068B88"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3381-wk-Fact-E1A5E9B08C5A58CBB315756126068B88"
          xlink:to="TextSelection-C785D581BAF15E1CA19271F3E1581273-0-wk-Footnote-C785D581BAF15E1CA19271F3E1581273_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2429-wk-Fact-E1FC9D6A150754FCB60DFBF799663B3D"
          xlink:label="d78798e2429-wk-Fact-E1FC9D6A150754FCB60DFBF799663B3D"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2429-wk-Fact-E1FC9D6A150754FCB60DFBF799663B3D"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1575-wk-Fact-E2A067A72A7050A1B47B74D981EB006A"
          xlink:label="d18029e1575-wk-Fact-E2A067A72A7050A1B47B74D981EB006A"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1575-wk-Fact-E2A067A72A7050A1B47B74D981EB006A"
          xlink:to="TextSelection-AD9B5153C36A578AA6F24D2F139CDE19-0-wk-Footnote-AD9B5153C36A578AA6F24D2F139CDE19_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d57757e3519-wk-Fact-E609865B9D3A57D7B8FF4D93924A4F7E"
          xlink:label="d57757e3519-wk-Fact-E609865B9D3A57D7B8FF4D93924A4F7E"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d57757e3519-wk-Fact-E609865B9D3A57D7B8FF4D93924A4F7E"
          xlink:to="TextSelection-0E3A02B437EA58B7829EF2E995C33F82-0-wk-Footnote-0E3A02B437EA58B7829EF2E995C33F82_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e2586-wk-Fact-E721BAA9C2B050908B37049D4B6BBD68"
          xlink:label="d78798e2586-wk-Fact-E721BAA9C2B050908B37049D4B6BBD68"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e2586-wk-Fact-E721BAA9C2B050908B37049D4B6BBD68"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d78798e1966-wk-Fact-EEDAC2A820335BAE87547B31EBD9B783"
          xlink:label="d78798e1966-wk-Fact-EEDAC2A820335BAE87547B31EBD9B783"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d78798e1966-wk-Fact-EEDAC2A820335BAE87547B31EBD9B783"
          xlink:to="TextSelection-D704D04D0F345BF0B86B79128CCC9F42-0-wk-Footnote-D704D04D0F345BF0B86B79128CCC9F42_lbl"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#d18029e1392-wk-Fact-F517600BDA77548BB75F8EDE3B58EAEA"
          xlink:label="d18029e1392-wk-Fact-F517600BDA77548BB75F8EDE3B58EAEA"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="d18029e1392-wk-Fact-F517600BDA77548BB75F8EDE3B58EAEA"
          xlink:to="TextSelection-AAF2B058377252C08C16DBD93163BDBC-0-wk-Footnote-AAF2B058377252C08C16DBD93163BDBC_lbl"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615200733144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document period end date</a></td>
<td class="text">Sep. 26,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity registrant name</a></td>
<td class="text">Perrigo Company plc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">The Sharp Building,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Hogan Place,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 TY74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">7094000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity central index key</a></td>
<td class="text">0001585364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current calendar year end date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity filer category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity small business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity emerging growth company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,491,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document calendar year focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document calendar period focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615208264472">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,213.7<span></span>
</td>
<td class="nump">$ 1,191.1<span></span>
</td>
<td class="nump">$ 3,773.8<span></span>
</td>
<td class="nump">$ 3,514.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">785.6<span></span>
</td>
<td class="nump">778.3<span></span>
</td>
<td class="nump">2,427.8<span></span>
</td>
<td class="nump">2,222.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">428.1<span></span>
</td>
<td class="nump">412.8<span></span>
</td>
<td class="nump">1,346.0<span></span>
</td>
<td class="nump">1,292.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductionAndDistributionCosts', window );">Distribution</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26.1<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
<td class="nump">73.8<span></span>
</td>
<td class="nump">70.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42.6<span></span>
</td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">131.6<span></span>
</td>
<td class="nump">128.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">138.5<span></span>
</td>
<td class="nump">134.1<span></span>
</td>
<td class="nump">413.9<span></span>
</td>
<td class="nump">422.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">116.4<span></span>
</td>
<td class="nump">131.9<span></span>
</td>
<td class="nump">357.8<span></span>
</td>
<td class="nump">384.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">202.4<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">202.4<span></span>
</td>
<td class="nump">42.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_OtherOperatingIncomeLoss', window );">Other operating expense (income)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3.2)<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">523.6<span></span>
</td>
<td class="nump">358.4<span></span>
</td>
<td class="nump">1,178.4<span></span>
</td>
<td class="nump">1,080.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(95.5)<span></span>
</td>
<td class="nump">54.4<span></span>
</td>
<td class="nump">167.6<span></span>
</td>
<td class="nump">211.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22.2)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(25.9)<span></span>
</td>
<td class="num">(18.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34.0<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">97.6<span></span>
</td>
<td class="nump">90.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(71.0)<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
<td class="num">(65.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (loss) before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(127.7)<span></span>
</td>
<td class="nump">97.3<span></span>
</td>
<td class="nump">58.8<span></span>
</td>
<td class="nump">205.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26.9<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">46.4<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (154.6)<span></span>
</td>
<td class="nump">$ 92.2<span></span>
</td>
<td class="nump">$ 12.4<span></span>
</td>
<td class="nump">$ 165.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.13)<span></span>
</td>
<td class="nump">$ 0.68<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.13)<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136.5<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="nump">136.3<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136.5<span></span>
</td>
<td class="nump">136.8<span></span>
</td>
<td class="nump">137.5<span></span>
</td>
<td class="nump">136.4<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Derived from the location of the entity that sells to a third party.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_OtherOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_OtherOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionAndDistributionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to the production and distribution of goods or services to customers and clients.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionAndDistributionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115942104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (parenthetical)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfRevenueExtensibleList', window );">Revenue, Product and Service [Extensible List]</a></td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121551570&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfRevenueExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfRevenueExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122446456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (154.6)<span></span>
</td>
<td class="nump">$ 92.2<span></span>
</td>
<td class="nump">$ 12.4<span></span>
</td>
<td class="nump">$ 165.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">86.5<span></span>
</td>
<td class="num">(74.0)<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="num">(63.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Change in fair value of derivative financial instruments, net of tax</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="nump">31.6<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Change in post-retirement and pension liability, net of tax</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">83.0<span></span>
</td>
<td class="num">(42.9)<span></span>
</td>
<td class="nump">64.3<span></span>
</td>
<td class="num">(28.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (71.6)<span></span>
</td>
<td class="nump">$ 49.3<span></span>
</td>
<td class="nump">$ 76.7<span></span>
</td>
<td class="nump">$ 137.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615200742424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 849.4<span></span>
</td>
<td class="nump">$ 354.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $6.3 and $6.7, respectively</a></td>
<td class="nump">1,097.7<span></span>
</td>
<td class="nump">1,243.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,100.7<span></span>
</td>
<td class="nump">967.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">350.5<span></span>
</td>
<td class="nump">165.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,398.3<span></span>
</td>
<td class="nump">2,730.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">918.8<span></span>
</td>
<td class="nump">902.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">132.2<span></span>
</td>
<td class="nump">129.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_GoodwillAndIndefiniteLivedIntangibles', window );">Goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">3,854.1<span></span>
</td>
<td class="nump">4,185.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-lived intangible assets, net</a></td>
<td class="nump">2,895.4<span></span>
</td>
<td class="nump">2,921.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">369.9<span></span>
</td>
<td class="nump">426.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">8,177.7<span></span>
</td>
<td class="nump">8,570.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,576.0<span></span>
</td>
<td class="nump">11,301.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">536.4<span></span>
</td>
<td class="nump">520.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related taxes</a></td>
<td class="nump">155.4<span></span>
</td>
<td class="nump">156.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="nump">370.1<span></span>
</td>
<td class="nump">394.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">237.0<span></span>
</td>
<td class="nump">229.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income taxes</a></td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current indebtedness</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,336.3<span></span>
</td>
<td class="nump">1,335.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">3,543.6<span></span>
</td>
<td class="nump">3,365.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">313.5<span></span>
</td>
<td class="nump">280.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">562.2<span></span>
</td>
<td class="nump">515.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">4,419.3<span></span>
</td>
<td class="nump">4,161.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,755.6<span></span>
</td>
<td class="nump">5,497.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Refer to Note 14</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ControllingInterestAbstract', window );"><strong>Controlling interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, $0.0001 par value per share, 10 shares authorized</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, &#8364;0.001 par value per share, 10,000 shares authorized</a></td>
<td class="nump">7,299.7<span></span>
</td>
<td class="nump">7,359.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">203.7<span></span>
</td>
<td class="nump">139.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="num">(1,683.1)<span></span>
</td>
<td class="num">(1,695.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total controlling interests</a></td>
<td class="nump">5,820.3<span></span>
</td>
<td class="nump">5,803.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">5,820.4<span></span>
</td>
<td class="nump">5,804.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 11,576.0<span></span>
</td>
<td class="nump">$ 11,301.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Supplemental Disclosures of Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued and outstanding (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued and outstanding (in shares)</a></td>
<td class="nump">136.5<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Controlling Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_GoodwillAndIndefiniteLivedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets.  Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.  Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_GoodwillAndIndefiniteLivedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122568296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in EUR per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119688504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity Statement - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary Shares Issued</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Adoption of new accounting standards</div></th>
<th class="th">
<div>Adoption of new accounting standards </div>
<div>Retained Earnings (Accumulated Deficit)</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning at Dec. 31, 2018</a></td>
<td class="nump">$ 5,668.0<span></span>
</td>
<td class="nump">$ 7,421.7<span></span>
</td>
<td class="nump">$ 84.6<span></span>
</td>
<td class="num">$ (1,838.3)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">63.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(15.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(25.9)<span></span>
</td>
<td class="num">$ (25.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Mar. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Mar. 30, 2019</a></td>
<td class="nump">5,700.6<span></span>
</td>
<td class="nump">$ 7,409.4<span></span>
</td>
<td class="nump">69.0<span></span>
</td>
<td class="num">(1,777.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning at Dec. 31, 2018</a></td>
<td class="nump">5,668.0<span></span>
</td>
<td class="nump">$ 7,421.7<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
<td class="num">(1,838.3)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">165.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (28.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Minority share purchase (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Sep. 28, 2019</a></td>
<td class="nump">$ 5,758.8<span></span>
</td>
<td class="nump">$ 7,378.8<span></span>
</td>
<td class="nump">56.6<span></span>
</td>
<td class="num">(1,676.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning at Mar. 30, 2019</a></td>
<td class="nump">5,700.6<span></span>
</td>
<td class="nump">$ 7,409.4<span></span>
</td>
<td class="nump">69.0<span></span>
</td>
<td class="num">(1,777.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">30.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(28.9)<span></span>
</td>
<td class="num">(28.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 29, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Jun. 29, 2019</a></td>
<td class="nump">5,726.2<span></span>
</td>
<td class="nump">$ 7,395.5<span></span>
</td>
<td class="nump">99.5<span></span>
</td>
<td class="num">(1,768.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">92.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(42.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(28.8)<span></span>
</td>
<td class="num">(28.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">$ (1.1)<span></span>
</td>
<td class="num">$ (1.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Minority share purchase (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Sep. 28, 2019</a></td>
<td class="nump">$ 5,758.8<span></span>
</td>
<td class="nump">$ 7,378.8<span></span>
</td>
<td class="nump">56.6<span></span>
</td>
<td class="num">(1,676.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning at Dec. 31, 2019</a></td>
<td class="nump">5,803.8<span></span>
</td>
<td class="nump">$ 7,359.9<span></span>
</td>
<td class="nump">139.4<span></span>
</td>
<td class="num">(1,695.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">106.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(103.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(30.9)<span></span>
</td>
<td class="num">$ (30.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">(5.6)<span></span>
</td>
<td class="num">$ (5.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Mar. 28, 2020</a></td>
<td class="nump">5,786.4<span></span>
</td>
<td class="nump">$ 7,339.6<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
<td class="num">(1,589.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning at Dec. 31, 2019</a></td>
<td class="nump">5,803.8<span></span>
</td>
<td class="nump">$ 7,359.9<span></span>
</td>
<td class="nump">139.4<span></span>
</td>
<td class="num">(1,695.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">$ 64.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Minority share purchase (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Sep. 26, 2020</a></td>
<td class="nump">$ 5,820.3<span></span>
</td>
<td class="nump">$ 7,299.7<span></span>
</td>
<td class="nump">203.7<span></span>
</td>
<td class="num">(1,683.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning at Mar. 28, 2020</a></td>
<td class="nump">5,786.4<span></span>
</td>
<td class="nump">$ 7,339.6<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
<td class="num">(1,589.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">60.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">84.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(31.0)<span></span>
</td>
<td class="num">$ (31.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="num">$ (3.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Jun. 27, 2020</a></td>
<td class="nump">5,910.4<span></span>
</td>
<td class="nump">$ 7,318.2<span></span>
</td>
<td class="nump">120.7<span></span>
</td>
<td class="num">(1,528.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(154.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(154.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">83.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation for stock options</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(31.1)<span></span>
</td>
<td class="num">(31.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Minority share purchase (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Minority share purchase</a></td>
<td class="num">$ (1.1)<span></span>
</td>
<td class="num">$ (1.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Sep. 26, 2020</a></td>
<td class="nump">$ 5,820.3<span></span>
</td>
<td class="nump">$ 7,299.7<span></span>
</td>
<td class="nump">$ 203.7<span></span>
</td>
<td class="num">$ (1,683.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122573928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends paid (in dollars per share)</a></td>
<td class="nump">$ 0.23<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615214310360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From (For) Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 12.4<span></span>
</td>
<td class="nump">$ 165.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to derive cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">284.7<span></span>
</td>
<td class="nump">293.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss (Gain) on sale of business</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="num">(72.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">43.9<span></span>
</td>
<td class="nump">40.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">202.4<span></span>
</td>
<td class="nump">42.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in financial assets</a></td>
<td class="num">(25.9)<span></span>
</td>
<td class="num">(18.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">25.7<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt premium</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other non-cash adjustments, net</a></td>
<td class="num">(12.0)<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Subtotal</a></td>
<td class="nump">570.0<span></span>
</td>
<td class="nump">523.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in cash due to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">106.4<span></span>
</td>
<td class="num">(12.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(93.2)<span></span>
</td>
<td class="num">(78.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(23.8)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">15.2<span></span>
</td>
<td class="nump">33.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Payroll and related taxes</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(10.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IncreaseDecreaseInAccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="num">(35.5)<span></span>
</td>
<td class="num">(82.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(16.0)<span></span>
</td>
<td class="num">(24.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Accrued income taxes</a></td>
<td class="num">(9.0)<span></span>
</td>
<td class="num">(65.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Subtotal</a></td>
<td class="num">(44.2)<span></span>
</td>
<td class="num">(224.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash from (for) operating activities</a></td>
<td class="nump">525.8<span></span>
</td>
<td class="nump">298.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From (For) Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investment</a></td>
<td class="num">(15.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(106.0)<span></span>
</td>
<td class="num">(749.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ProceedsfromContingentMilestonePayment', window );">Proceeds from the Royalty Pharma contingent milestone</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Asset acquisitions</a></td>
<td class="num">(34.1)<span></span>
</td>
<td class="num">(86.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(104.3)<span></span>
</td>
<td class="num">(90.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of business</a></td>
<td class="nump">187.8<span></span>
</td>
<td class="nump">183.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing, net</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash from (for) investing activities</a></td>
<td class="num">(60.3)<span></span>
</td>
<td class="num">(489.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From (For) Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Issuances of long-term debt</a></td>
<td class="nump">743.8<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(590.0)<span></span>
</td>
<td class="num">(476.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Borrowings (repayments) of revolving credit agreements and other financing, net</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing fees</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Premiums on early debt retirement</a></td>
<td class="num">(19.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of ordinary shares</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends</a></td>
<td class="num">(93.0)<span></span>
</td>
<td class="num">(83.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing, net</a></td>
<td class="num">(14.9)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash from (for) financing activities</a></td>
<td class="nump">20.3<span></span>
</td>
<td class="nump">33.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">495.1<span></span>
</td>
<td class="num">(152.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">354.3<span></span>
</td>
<td class="nump">551.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 849.4<span></span>
</td>
<td class="nump">$ 398.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncreaseDecreaseInAccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncreaseDecreaseInAccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ProceedsfromContingentMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Contingent Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ProceedsfromContingentMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Royalties Received, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ProceedsfromRoyaltiesReceivedInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615120955736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">General Information</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">The Company</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are dedicated to making lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold.&#160;We are a leading provider of over-the-counter ("OTC") health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. We are also a leading producer of generic prescription pharmaceutical topical products such as creams, lotions, and gels as well as nasal sprays and inhalers. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Segment Reporting </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our reporting and operating segments are as follows: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Consumer Self-Care Americas</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">CSCA</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our consumer self-care business (OTC, contract manufacturing, infant formula, and oral self-care categories and our divested animal health category) in the U.S., Mexico and Canada. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Consumer Self-Care International</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">CSCI</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our branded consumer self-care business primarily in Europe, our consumer self-care businesses in the United Kingdom and Australia, and our divested liquid licensed products business in the United Kingdom.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-weight:bold;">Prescription Pharmaceuticals</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> ("</span><span style="font-family:Arial;font-weight:bold;">RX</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">") </span><span style="font-family:Arial;font-size:10pt;">comprises our prescription pharmaceuticals business in the U.S., predominantly generics, and our pharmaceuticals and diagnostic businesses in Israel.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Reclassifications</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Certain prior period amounts have been reclassified from other current assets to other non-current assets on our balance sheet to conform to the current period presentation. Such reclassification had no impact on net income or earnings per share.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standard Pronouncements</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:17%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:41%;"/></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted </span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Standard</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Description</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2018-14: Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans  </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other post-retirement plans. </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">December 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we will no longer be required to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. We will be required to disclose an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, if applicable. </span></div><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance enhances and simplifies various aspects of the income tax accounting guidance in ASC 740.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">January 1, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we do not expect a material impact on the Consolidated Financial Statements.</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Standard Update</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 1, 2020, we adopted ASU 2016-13 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASC 326")</span><span style="font-family:Arial;font-size:10pt;">, which replaces the incurred loss methodology with an expected loss methodology that is referred to as the Current Expected Credit Loss ("CECL") methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We adopted ASC 326 using the modified retrospective method for all financial assets measured at amortized cost, which includes trade receivables and contract assets. The cumulative effect of adopting ASC 326 was not material. </span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Allowance for Credit Losses</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and for reasonable and supportable forecasts. Historical credit loss experience provides the primary basis for estimation of expected credit losses. Adjustments to historical loss information may be made for significant changes in a geographic location&#8217;s economic conditions. Receivables that do not share risk characteristics are evaluated on an individual basis. These receivables are not included in the collective evaluation.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The allowance for credit losses is a valuation account that is deducted from the instruments&#8217; cost basis to present the net amount expected to be collected. Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible. </span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table presents the allowance for credit losses activity (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:76.31027253668763%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:57%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Provision for credit losses, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Receivables written-off</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Recoveries collected</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Currency translation adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615120204456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">REVENUE RECOGNITION</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Revenue is recognized when or as a customer obtains control of promised products. The amount of revenue recognized reflects the consideration we expect to be entitled to receive in exchange for these products.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Disaggregation of Revenue</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We generated net sales in the following geographic locations</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></span><span style="font-family:Arial;font-size:10pt;">(in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:526px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:134px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">U.S.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>820.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>785.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,571.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,323.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Europe</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>326.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>334.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,011.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>991.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">All other countries</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>66.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>191.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>200.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"/></span><span style="font-family:Arial;font-size:8pt;">(1)  Derived from the location of the entity that sells to a third party.</span></div><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:72px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(2)  Includes Ireland net sales of </span><span style="font-family:Arial;font-size:8pt;"><span>$10.8 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$22.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, respectively, and </span><span style="font-family:Arial;font-size:8pt;"><span>$5.2&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$17.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:8pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(3)  Includes net sales generated primarily in Israel, Mexico, Australia and Canada.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:Arial;font-size:10pt;font-style:italic;">Product Category</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We re-aligned our product categories in our </span><span style="font-family:Arial;">CSCA</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;">CSCI</span><span style="font-family:Arial;font-size:10pt;"> segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following is a summary of our net sales by category (in millions); the comparative periods reflect the product category re-alignment: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:304px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Upper respiratory</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>114.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>123.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>385.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>377.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Digestive health</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>107.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>85.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>326.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>293.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Pain and sleep-aids</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>100.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>89.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>318.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>272.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Nutrition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>100.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>97.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>290.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>282.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Healthy lifestyle</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>86.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>87.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>253.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>250.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Oral self-care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>199.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Skincare and personal hygiene</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>49.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Vitamins, minerals, and supplements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Animal health</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>43.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other CSCA</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>60.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>48.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total CSCA</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>664.0</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>613.3</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,992.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,777.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Skincare and personal hygiene</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>83.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>88.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>275.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>296.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Upper respiratory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>62.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>72.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>191.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>193.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Vitamins, minerals, and supplements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>52.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>46.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>139.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>133.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Pain and sleep-aids</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>49.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>120.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Healthy lifestyle</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>38.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>124.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>134.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Oral self-care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Digestive health</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other CSCI</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>88.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>100.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>339.0</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>347.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,042.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,025.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>210.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>230.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>738.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>711.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)&#160;&#160;&#160;&#160;Includes net sales from our OTC contract manufacturing business.</span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&#160;&#160;&#160;&#160;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized on an over time basis. Predominately, over time customer contracts exist in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was </span><span style="font-family:Arial;font-size:10pt;"><span>$76.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$190.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, respectively, and </span><span style="font-family:Arial;font-size:10pt;"><span>$73.9&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$207.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Contract Balances</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table provides information about contract assets from contracts with customers (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:26%;"/><td style="width:38%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Short-term contract assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615117536712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and Divestitures</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">ACQUISITIONS AND DIVESTITURES</span><span style="font-family:Arial;font-size:10pt;"> </span><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 26, 2020</span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Sanofi Brands</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"/><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">August&#160;7, 2020</span><span style="font-family:Arial;font-size:10pt;">, we entered into a definitive agreement to acquire </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> Eastern European OTC dermatological skincare and hair loss treatment brands, Emolium</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, Iwostin</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, and Loxon</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> from Sanofi for </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;52.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and additional consideration for the transfer of related inventory on hand. On </span><span style="font-family:Arial;font-size:10pt;">October&#160;30, 2020</span><span style="font-family:Arial;font-size:10pt;">, the transaction closed for </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;53.3&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> (approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$62.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">), subject to post-closing conditions. The acquisition will be accounted for as a business combination and operating results attributable to the products will be included in our CSCI segment. This transaction builds on our self-care transformation and strengthens our skincare and personal hygiene portfolio.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Oral Care Assets of High Ridge Brands</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">April&#160;1, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired the oral care assets of High Ridge Brands ("Dr. Fresh") for total purchase consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>$113.0 million</span></span><span style="font-family:Arial;font-size:10pt;">, subject to customary post-closing adjustments, including a working capital settlement. After post-closing adjustments as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, total cash consideration paid was </span><span style="font-family:Arial;font-size:10pt;"><span>$106.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, net of </span><span style="font-family:Arial;font-size:10pt;"><span>$2.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> that we allocated as prepayment of contract consideration for transitional services to be received related to the transaction. </span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"> This acquisition includes the children&#8217;s oral care value brand, Firefly</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, in addition to the REACH</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and Dr. Fresh</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> brands, and a licensing portfolio. The U.S. operations, which represent a significant portion of the business, will be reported in our CSCA segment and the remaining non-U.S. operations will be reported in our CSCI segment.</span></div><div style="line-height:120%;text-align:left;text-indent:42px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we incurred </span><span style="font-family:Arial;font-size:10pt;"><span>$0.1&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$4.2&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> of general transaction costs (legal, banking and other professional fees), respectively. The amounts were recorded in </span><span style="font-family:Arial;font-size:10pt;">Administration</span><span style="font-family:Arial;font-size:10pt;"> expenses within the CSCA segment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The acquisition of Dr. Fresh was accounted for as a business combination and has been reported in our Condensed Consolidated Statements of Operations as of the acquisition date. From </span><span style="font-family:Arial;font-size:10pt;">April&#160;1, 2020</span><span style="font-family:Arial;font-size:10pt;"> through </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, the acquisition generated </span><span style="font-family:Arial;font-size:10pt;">Net sales</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span>$44.4&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and Net income of </span><span style="font-family:Arial;font-size:10pt;"><span>$0.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which included </span><span style="font-family:Arial;font-size:10pt;"><span>$2.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> related to inventory costs stepped up to acquisition date fair value.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are in the process of gathering significant relevant information needed to complete the valuation for the assets acquired and liabilities assumed. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired and liabilities assumed will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset and liability fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we recorded measurement period adjustments relating to valuation updates that reduced the acquisition basis of definite lived intangibles by </span><span style="font-family:Arial;font-size:10pt;"><span>$0.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and reduced goodwill by </span><span style="font-family:Arial;font-size:10pt;"><span>$0.4&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> with an offsetting increase to working capital. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the consideration paid for Dr. Fresh and the provisional amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:534px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:368px;"/><td style="width:6px;"/><td style="width:154px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Oral Care Assets of High Ridge Brands (Dr. Fresh)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase price paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>106.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>20.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>43.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>66.1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>122.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>106.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$15.9 million</span></span><span style="font-family:Arial;font-size:10pt;"> arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Dr. Fresh into Perrigo. Preliminarily, goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$14.1&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$1.8&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> was allocated to our CSCA and CSCI segments, respectively. We are currently evaluating the tax deductibility of the provisional goodwill. We expect some portion to be deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, license agreements, and customer relationships which are being amortized over a weighted average useful life of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>17.8</span></span><span style="font-family:Arial;font-size:10pt;"> years</span><span style="font-family:Times New Roman;font-size:10pt;">.</span><span style="font-family:Arial;font-size:10pt;"> Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names and developed technology were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Dexsil</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup>&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"/><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">February&#160;13, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired Dexsil</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">,</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:Arial;font-size:10pt;">a silicon supplement brand, from RXW Group Nv, for total cash consideration paid of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$8.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">. The transaction was accounted for as an asset acquisition, in which we capitalized the consideration paid as a brand-named intangible asset. We began amortizing the brand intangible over a </span><span style="font-family:Arial;font-size:10pt;"><span>25</span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our CSCI segment. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Steripod</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup>&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">January&#160;3, 2020</span><span style="font-family:Arial;font-size:10pt;">, we acquired Steripod</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, a leading toothbrush accessory brand and innovator in the toothbrush protector market, from Bonfit America Inc. Total consideration paid was </span><span style="font-family:Arial;font-size:10pt;"><span>$26.0 million</span></span><span style="font-family:Arial;font-size:10pt;">. The transaction was accounted for as an asset acquisition, in which we capitalized </span><span style="font-family:Arial;font-size:10pt;"><span>$25.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> as a brand-named intangible asset. The remainder of the purchase price was allocated to working capital. We began amortizing the brand intangible over a </span><span style="font-family:Arial;font-size:10pt;"><span>25</span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our CSCA segment. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition Accounted for as a Business Combination During the Year Ended December 31, 2019</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Ranir Global Holdings, LLC </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">July&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;">, we acquired </span><span style="font-family:Arial;font-size:10pt;"><span>100%</span></span><span style="font-family:Arial;font-size:10pt;"> of the outstanding equity interest in Ranir Global Holdings, LLC ("Ranir"), a privately-held company, for total base consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>$750.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> in a debt-free, cash-free transaction. After post-closing adjustments, total cash consideration paid was </span><span style="font-family:Arial;font-size:10pt;"><span>$747.7 million</span></span><span style="font-family:Arial;font-size:10pt;">, net of </span><span style="font-family:Arial;font-size:10pt;"><span>$11.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> cash acquired. We funded the transaction with cash on hand and borrowings under the 2018 Revolver (as defined in </span><a href="#sF883DFF8F7F254E1ACF1AFCBB94077B2" style="font-family:Arial;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 10</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Ranir is headquartered in Grand Rapids, Michigan and is a leading global supplier of private label and branded oral self-care products. Ranir's U.S. operations are reported in our CSCA segment and its non-U.S. operations are reported in our CSCI segment. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The acquisition of Ranir was accounted for as a business combination and has been reported in our Consolidated Statements of Operations as of the acquisition date. From July&#160;1, 2019 through December 31, 2019, Ranir generated </span><span style="font-family:Arial;font-size:10pt;">Net sales</span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span>$151.4&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and had </span><span style="font-family:Arial;font-size:10pt;"><span>$7.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> of Net income, which is inclusive of a non-recurring charge of </span><span style="font-family:Arial;font-size:10pt;"><span>$5.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> related to inventory costs stepped up to acquisition date fair value. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the consideration paid for Ranir and the amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:522px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:378px;"/><td style="width:6px;"/><td style="width:131px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Ranir</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase price paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>759.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>59.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>292.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Definite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>48.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>260.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>41.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Indefinite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>39.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>389.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>844.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>85.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>759.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$292.7 million</span></span><span style="font-family:Arial;font-size:10pt;"> arising from the acquisition consists largely of the anticipated growth from new product sales, sales to new customers, the assembled workforce, and the synergies expected from combining the operations of Perrigo and Ranir. Goodwill of </span><span style="font-family:Arial;font-size:10pt;"><span>$212.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$80.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> was </span><span style="font-family:Arial;font-size:10pt;background-color:#ffffff;">allocated to our CSCA and CSCI segments, respectively.</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">We expect </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span>$252.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> to be deductible for income tax purposes. The definite-lived intangible assets acquired consisted of trademarks and trade names, developed product technologies, and customer relationships. Trademarks and trade names were assigned useful lives that ranged from </span><span style="font-family:Arial;font-size:10pt;"><span>20</span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span>25</span></span><span style="font-family:Arial;font-size:10pt;"> years. Developed product technologies were assigned </span><span style="font-family:Arial;font-size:10pt;"><span>10</span></span><span style="font-family:Arial;font-size:10pt;">-year useful lives and customer relationships were assigned </span><span style="font-family:Arial;font-size:10pt;"><span>24</span></span><span style="font-family:Arial;font-size:10pt;">-year useful lives. Customer relationships were valued using the multi-period excess earnings method. Trademarks and trade names, developed technology, and in-process research and development ("IPR&amp;D") were valued using the relief from royalty method. Significant judgment was applied in estimating the fair value of the intangible assets acquired, which involved the use of significant estimates and assumptions with respect to the timing and amounts of cash flow projections, including revenue growth rates, projected profit margins, and discount rates. The opening balance sheet is final. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 28, 2019</span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Generic Product Acquisitions</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">July&#160;2, 2019</span><span style="font-family:Arial;font-size:10pt;">, we purchased the Abbreviated New Drug Application ("ANDA") for a generic gel product for </span><span style="font-family:Arial;font-size:10pt;"><span>$49.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in cash, which we capitalized as a developed product technology intangible asset. We launched the product during the third quarter of 2019 and began amortizing it over a </span><span style="font-family:Arial;font-size:10pt;"><span>20</span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our RX segment.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">May&#160;17, 2019</span><span style="font-family:Arial;font-size:10pt;">, we purchased the ANDA for a generic product used to relieve pain, for </span><span style="font-family:Arial;font-size:10pt;"><span>$15.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in cash, which we capitalized as a developed product technology intangible asset. We launched the product during the third quarter of 2019 and began amortizing it over a </span><span style="font-family:Arial;font-size:10pt;"><span>20</span></span><span style="font-family:Arial;font-size:10pt;">-year useful life. Operating results attributable to the product are included within our RX segment.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Budesonide Nasal Spray and Triamcinolone Nasal Spray</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">April&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;">, we purchased product ANDAs and other records and registrations of Budesonide Nasal Spray, a generic equivalent of Rhinocort Allergy</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, and Triamcinolone Nasal Spray, a generic equivalent of Nasacort Allergy</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">, from Barr Laboratories, Inc. ("Barr"), a subsidiary of Teva Pharmaceuticals, for </span><span style="font-family:Arial;font-size:10pt;"><span>$14.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in cash. We previously developed and marketed the products in collaboration with Barr under a development, marketing and commercialization agreement that originated in August 2003. Under this prior agreement, we paid Barr a percentage of net income from products sold by Perrigo in the U.S. By purchasing the assets from Barr and terminating the original development, marketing and commercialization agreement, we are now entitled to </span><span style="font-family:Arial;font-size:10pt;"><span>100%</span></span><span style="font-family:Arial;font-size:10pt;"> of the income from sales of the product. Operating results attributable to these products are included within our </span><span style="font-family:Arial;">CSCA</span><span style="font-family:Arial;font-size:10pt;"> segment. The intangible assets acquired are classified as developed product technology with a </span><span style="font-family:Arial;font-size:10pt;"><span>10</span></span><span style="font-family:Arial;font-size:10pt;">-year useful life.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Pro Forma Impact of Business Combinations</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table presents unaudited pro forma information as if the Ranir acquisition had occurred on </span><span style="font-family:Arial;font-size:10pt;">January&#160;1, 2018</span><span style="font-family:Arial;font-size:10pt;"> and as if the acquisition of Dr. Fresh had occurred on </span><span style="font-family:Arial;font-size:10pt;">January&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;"> and had been combined with the results reported in our Condensed Consolidated Statements of Operations for all periods presented (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:539px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:134px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(Unaudited)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,217.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,803.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,732.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(154.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>108.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>180.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><span style="font-family:Arial;font-size:11pt;"/><span style="font-family:Arial;font-size:10pt;">The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, depreciation of property, plant and equipment that have been revalued, certain acquisition-related charges, and related tax effects.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Divestitures During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 26, 2020</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Rosemont Pharmaceuticals Business </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"/><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">June&#160;19, 2020</span><span style="font-family:Arial;font-size:10pt;">, we completed the sale of our U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for cash consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>&#163;155.6&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> (approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$195.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">). The sale resulted in a pre-tax loss of </span><span style="font-family:Arial;font-size:10pt;"><span>$18.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> recorded in our CSCI segment in </span><span style="font-family:Arial;font-size:10pt;">Other (income) expense, net</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations. The charge included professional fees and a </span><span style="font-family:Arial;font-size:10pt;"><span>$46.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> write-off of foreign currency translation adjustment from Accumulated other comprehensive income.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Divestitures During the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Nine Months Ended September 28, 2019</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Animal Health Business</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On </span><span style="font-family:Arial;font-size:10pt;">July&#160;8, 2019</span><span style="font-family:Arial;font-size:10pt;">, we completed the sale of our animal health business to PetIQ for cash consideration of </span><span style="font-family:Arial;font-size:10pt;"><span>$182.5&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which resulted in a pre-tax gain of </span><span style="font-family:Arial;font-size:10pt;"><span>$71.7 million</span></span><span style="font-family:Arial;font-size:10pt;"> recorded in our CSCA segment in </span><span style="font-family:Arial;font-size:10pt;">Other (income) expense, net</span><span style="font-family:Arial;font-size:10pt;"> on the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615116084840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">GOODWILL AND INTANGIBLE ASSETS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="29"/></tr><tr><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Purchase accounting adjustments </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Business acquisitions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Business divestitures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Impairments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency translation adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,899.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,898.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,203.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(115.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,129.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,013.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(202.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>811.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total goodwill</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,116.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(115.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(202.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,839.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)  We had accumulated goodwill impairments of </span><span style="font-family:Arial;font-size:8pt;"><span>$868.4&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> as of each of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(2)  We had accumulated goodwill impairments of </span><span style="font-family:Arial;font-size:8pt;"><span>$109.2 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$311.6 million</span></span><span style="font-family:Arial;font-size:8pt;"> as of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">RX U.S. Reporting Unit Goodwill </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, our RX U.S. reporting unit had an indication of potential impairment driven primarily by the stoppage of production and distribution of albuterol sulfate inhalation aerosol and voluntary U.S. nationwide recall to the retail level, after we learned that some units may not dispense due to clogging, combined with a decline in market multiples. We prepared an impairment test as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and determined the carrying value of the RX U.S. reporting unit exceeded its estimated fair value. We recognized a goodwill impairment of </span><span style="font-family:Arial;font-size:10pt;"><span>$202.4&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, leaving </span><span style="font-family:Arial;font-size:10pt;"><span>$811.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> of goodwill in this reporting unit after the impairment. The change in fair value from previous estimates was driven by the financial impact of the recall in the current period and related changes in estimates of future cash flows (refer to </span><a href="#sBFE17B0A00B45FB196C8960332ACE955" style="font-family:Arial;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 6</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Other Reporting Unit Goodwill</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;">, our Branded Consumer Self-care ("BCS") reporting unit included in the CSCI segment had an indication of potential impairment which was driven by a decrease in forecasted cash flows in the second half of </span><span style="font-family:Arial;font-size:10pt;">2020</span><span style="font-family:Arial;font-size:10pt;"> related to impacts from the COVID-19 pandemic. We prepared an impairment test as of </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;"> and determined that the fair value of the BCS reporting unit exceeded net book value by less than </span><span style="font-family:Arial;font-size:10pt;"><span>10%</span></span><span style="font-family:Arial;font-size:10pt;">, consistent with our last annual impairment test as of </span><span style="font-family:Arial;font-size:10pt;">October&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;">.&#160;While </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;"> impairment was recorded as of </span><span style="font-family:Arial;font-size:10pt;">June&#160;27, 2020</span><span style="font-family:Arial;font-size:10pt;">, future developments such as deterioration in business performance or market multiples could reduce the fair value of this reporting unit and lead to impairment in a future period. There was no indication of impairment during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. Goodwill remaining in this reporting unit was </span><span style="font-family:Arial;font-size:10pt;"><span>$995.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Intangible Assets</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Intangible assets and related accumulated amortization consisted of the following (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.85534591194968%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Indefinite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>50.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Definite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>134.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>83.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>126.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,335.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>731.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,392.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>755.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,866.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>776.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,805.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>671.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,462.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>313.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,353.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>250.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-compete agreements</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,805.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,909.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,685.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,763.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,819.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,909.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,753.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,763.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We recorded amortization expense of </span><span style="font-family:Arial;font-size:10pt;"><span>$73.9&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$219.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, respectively, and </span><span style="font-family:Arial;font-size:10pt;"><span>$78.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$227.7 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Evamist Branded Product</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the three months ended September 28, 2019, we identified impairment indicators related to our Evamist branded product, which is a definite-lived intangible asset in our </span><span style="font-family:Arial;">RX</span><span style="font-family:Arial;font-size:10pt;"> segment. The indicators related to a decline in sales volume and a corresponding reduction in our long-range revenue forecast. We recorded an asset impairment of </span><span style="font-family:Arial;font-size:10pt;"><span>$10.8&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Generic Product</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the three months ended June 29, 2019, we identified impairment indicators for a certain definite-lived intangible asset related to changes in pricing and competition in the market, which lowered the projected cash flows we expect to generate from the asset. We recorded an asset impairment of </span><span style="font-family:Arial;font-size:10pt;"><span>$27.8 million</span></span><span style="font-family:Arial;font-size:10pt;"> in our RX segment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In-process R&amp;D </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"> </span><span style="font-family:Arial;font-size:10pt;">We recorded impairment charges of </span><span style="font-family:Arial;font-size:10pt;"><span>$4.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> on certain IPR&amp;D assets in the CSCA and RX segments during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, due to changes in projected development and regulatory timelines.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615117289752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">INVENTORIES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Major components of inventory were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finished goods</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>618.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>530.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>201.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>186.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Raw materials</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>280.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>250.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,100.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>967.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115966136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 1, 2020, we adopted ASU 2018-13: Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement ("Topic 820"). The amendments in this ASU remove disclosure requirements in Topic 820 related to the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. Additionally, Topic 820 adds disclosure requirements for the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. We have amended certain of our quantitative Level 3 fair value measurement disclosures to add the range and weighted average of significant unobservable inputs used.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Measured at fair value on a recurring basis:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Investment securities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Funds associated with Israeli severance liability</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Royalty Pharma contingent milestone</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.6</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Contingent consideration payments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Measured at fair value on a non-recurring basis:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>811.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,013.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>811.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,036.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">During the </span><span style="font-family:Arial;font-size:8pt;">three months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,013.5 million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$811.1 million</span></span><span style="font-family:Arial;font-size:8pt;">. During the year ended December 31, 2019, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,122.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,013.1&#160;million</span></span><span style="font-family:Arial;font-size:8pt;">. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$55.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> were written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$23.3 million</span></span><span style="font-family:Arial;font-size:8pt;">. </span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">There were </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;"> transfers within Level 3 fair value measurements during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> or the year ended </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Royalty Pharma Contingent Milestone Receipts </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the change in fair value of the Royalty Pharma contingent milestone (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:555px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:160px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:85px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:85px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>99.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>89.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>323.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payments received</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(250.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in fair value</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>91.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>91.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We value our contingent milestone payment from Royalty Pharma using a modified Black-Scholes Option Pricing Model ("BSOPM"). Key inputs in the BSOPM are the estimated volatility and rate of return of royalties on global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> that are received by Royalty Pharma until the contingent milestones are resolved. As of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, volatility and the estimated fair value of the milestones had a positive relationship such that higher volatility translates to a higher estimated fair value of the contingent milestone payments. Rate of return and the estimated fair value of the milestones had an inverse relationship, such that a lower rate of return correlates with a higher estimated fair value of the contingent milestone payments. We assess volatility and rate of return inputs quarterly by analyzing certain market volatility benchmarks and the risk associated with Royalty Pharma achieving the underlying projected royalties. The table below represents the volatility and rate of return:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:306px;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:113px;"/><td style="width:82px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Volatility</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Rate of return</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.84</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.99</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, the fair value of the Royalty Pharma contingent milestone payment related to 2020 increased by </span><span style="font-family:Arial;font-size:10pt;"><span>$22.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$25.9 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively, to </span><span style="font-family:Arial;font-size:10pt;"><span>$121.2&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which is recorded on the Condensed Consolidated Balance Sheets within </span><span style="font-family:Arial;font-size:10pt;">Prepaid expenses and other current assets</span><span style="font-family:Arial;font-size:10pt;">. The adjustments were driven by higher projected global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> compared to the estimates in the prior period, and the estimated probability of achieving the earn-out. During the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, the fair value of the Royalty Pharma contingent milestone payments increased by </span><span style="font-family:Arial;font-size:10pt;"><span>$2.6&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$18.5 million</span></span><span style="font-family:Arial;font-size:10pt;">, respectively. These adjustments were driven by higher projected global net sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;  </sup></span><span style="font-family:Arial;font-size:10pt;">and the estimated probability of achieving the earn-out. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></span><span style="font-family:Arial;font-size:10pt;">were </span><span style="font-family:Arial;font-size:10pt;"><span>$337.5 million</span></span><span style="font-family:Arial;font-size:10pt;"> in 2018, which triggered the </span><span style="font-family:Arial;font-size:10pt;"><span>$250.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> milestone payment received during the first quarter of 2019. There is </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;"> contingent milestone based on 2019 sales of Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">. In order for us to receive the remaining contingent milestone payment of </span><span style="font-family:Arial;font-size:10pt;"><span>$400.0 million</span></span><span style="font-family:Arial;font-size:10pt;">, Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales, as defined in the agreement, in 2020 must exceed </span><span style="font-family:Arial;font-size:10pt;"><span>$351.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">. If Royalty Pharma payments from Biogen for Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> sales do not meet the prescribed threshold in 2020, we will write off the </span><span style="font-family:Arial;font-size:10pt;"><span>$121.2&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> asset and record a loss. If the prescribed threshold is exceeded, we will increase the asset to </span><span style="font-family:Arial;font-size:10pt;"><span>$400.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> and recognize income of </span><span style="font-family:Arial;font-size:10pt;"><span>$278.8&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Change in financial assets</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Contingent Consideration Payments</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the change in fair value of contingent consideration payments (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:202px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Changes in value</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Settlements and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product. The fair value adjustments are recorded in </span><span style="font-family:Arial;font-size:10pt;">Other operating expense (income)</span><span style="font-family:Arial;font-size:10pt;">  on the Condensed Consolidated Statements of Operations.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, the contingent consideration payments liability was primarily comprised of sales-based milestones related to an IPR&amp;D asset acquired in a prior transaction in our RX segment. The contingent consideration payments liability also included certain event-based milestones, which were immaterial. The fair value of our contingent consideration sales-based milestones as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, was calculated using the following significant unobservable inputs:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:29%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Valuation Technique</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Unobservable Input</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Range (Weighted Average)</span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Contingent consideration payments: sales-based milestones </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Discounted cash flow</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Projected royalties</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Projected year of payment of sales-based milestones</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021 - 2036 (2027)</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Unobservable inputs were weighted based on the relative estimated milestone payments.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The discount rate of </span><span style="font-family:Arial;font-size:10pt;"><span>26.0%</span></span><span style="font-family:Arial;font-size:10pt;"> was based on our assessment of the rate of return and development and commercialization risk of the related IPR&amp;D project. We reevaluate the significant unobservable inputs of the sales-based milestones quarterly based on project developments and changes in contingent elements of the liability.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Non-recurring Fair Value Measurements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"> The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">RX U.S. Reporting Unit Goodwill </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">When determining the fair value of our RX U.S. reporting unit for the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we utilized a combination of comparable company and discounted cash flow techniques. In our comparable company market approach, we considered observable market information and transactions for companies that we deemed to be of a comparable nature, scope, and size of our RX U.S. reporting unit (Level 2 inputs). Our cash flow projections included revenue assumptions related to new and existing products, plus gross margin and operating expenses based on the reporting unit&#8217;s growth plans (Level 3 inputs). In our discounted cash flow analysis, we used a long-term growth rate of </span><span style="font-family:Arial;font-size:10pt;"><span>0.0%</span></span><span style="font-family:Arial;font-size:10pt;">, which assumes new product launches will, over time, offset decreases in cash </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">flows of existing portfolio products with definite lives. We used a discount rate of </span><span style="font-family:Arial;font-size:10pt;"><span>10.3%</span></span><span style="font-family:Arial;font-size:10pt;"> in this analysis. The discount rate correlates with the required investment return and risk that we believe market participants would apply to the projected growth rate. In addition, we burdened projected free cash flows with the capital spending deemed necessary to support the cash flows and applied blended jurisdictional tax rates ranging from </span><span style="font-family:Arial;font-size:10pt;"><span>19.1%</span></span><span style="font-family:Arial;font-size:10pt;"> to </span><span style="font-family:Arial;font-size:10pt;"><span>21.7%</span></span><span style="font-family:Arial;font-size:10pt;">. We weighted indications of fair value resulting from the market approach and present value techniques, considering the reasonableness of the range of measurements and the point within the range that we determined was most representative of fair market conditions (refer to </span><a href="#s4FA8299FAFB154038583DC7BC119296B" style="font-family:Arial;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 4</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Fixed Rate Long-term Debt</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:520px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:233px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Public Bonds</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Carrying Value (excluding discount)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,760.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,600.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,969.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,618.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Private placement note</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Carrying value (excluding premium)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>151.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>168.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>168.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div>The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, promissory notes related to our equity method investment in Kazmira, and variable rate long-term debt, approximate their fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115985064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">INVESTMENTS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.79643231899266%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:28%;"/><td style="width:1%;"/><td style="width:39%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Equity method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Measured at fair value using the Net Asset Value practical expedient.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions):</span></div><div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:24%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Equity method</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 17, 2020, we announced our entrance into the cannabidiol&#160;(&#8220;CBD&#8221;) market through a strategic investment in and long-term supply agreement with Kazmira LLC ("Kazmira"), a leading supplier of hemp-based CBD products free of tetrahydrocannabinol (&#8220;THC-free&#8221;) based in Watkins, Colorado. In addition to the supply agreement, we acquired an approximate </span><span style="font-family:Arial;font-size:10pt;"><span>20%</span></span><span style="font-family:Arial;font-size:10pt;"> equity stake in Kazmira for </span><span style="font-family:Arial;font-size:10pt;"><span>$50.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> with </span><span style="font-family:Arial;font-size:10pt;"><span>$15.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> paid at close of the transaction and the balance due within </span><span style="font-family:Arial;font-size:10pt;"><span>18</span></span><span style="font-family:Arial;font-size:10pt;"> months thereafter. Our minority equity investment initiates the first phase of the partnership in which we will collaborate to scale-up Kazmira&#8217;s facilities and laboratories, in accordance with current Good Manufacturing Practices, to produce THC-free CBD from industrial hemp that meets our standards for reliability and consistency. In the second phase of the partnership, we will work to launch THC-free hemp-based CBD products in a number of global markets, while leveraging our supply agreement with Kazmira, which is exclusive for the U.S. store brand market. We will report our equity method earnings from Kazmira in our Condensed Consolidated Financial Statements on a quarterly lag.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115998744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Cross Currency Swaps</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 15, 2019, we entered into a cross-currency swap designated as a net investment hedge to hedge the EUR currency exposure of our net investment in European operations. This agreement is a contract to exchange floating-rate Euro payments for floating-rate U.S. dollar payments. The payments are based on a notional basis of </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;450.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$498.0 million</span></span><span style="font-family:Arial;font-size:10pt;">) and settle quarterly. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Swaps </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"/><span style="font-family:Arial;font-size:10pt;">There were no active designated or non-designated interest rate swaps as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Forwards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Net Investment Hedge</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 19, 2020, we entered into a foreign currency forward contract designated as a net investment hedge of the GBP currency exposure of our net investment in certain of our U.K. operations. The hedge had a notional basis of </span><span style="font-family:Arial;font-size:10pt;"><span>&#163;155.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$194.5 million</span></span><span style="font-family:Arial;font-size:10pt;">) and was settled during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"/><span style="font-family:Arial;font-size:10pt;">Foreign currency forward contracts were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:55.55555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:44%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Notional Amount</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Israeli Shekel (ILS)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>398.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>712.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">European Euro (EUR)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>193.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">United States Dollar (USD)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>83.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>92.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Danish Krone (DKK)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>59.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>51.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">British Pound (GBP)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>56.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>86.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Swedish Krona (SEK)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Chinese Yuan (CNY)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>20.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Canadian Dollar (CAD)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>41.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Polish Zloty (PLZ)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Mexican Peso (MPX)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Norwegian Krone (NOK)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Switzerland Franc (CHF)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Romanian New Leu (RON)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>961.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,257.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The maximum term of our forward currency exchange contracts is </span><span style="font-family:Arial;font-size:10pt;"><span>18</span></span><span style="font-family:Arial;font-size:10pt;"> months.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Effects of Derivatives on the Financial Statements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:742px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:306px;"/><td style="width:237px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total designated derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:654px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:218px;"/><td style="width:237px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:743px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:206px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:58px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contract</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(12.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:240px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Treasury locks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(18.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contract</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(29.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1) Net </span><span style="font-family:Arial;font-size:8pt;">loss</span><span style="font-family:Arial;font-size:8pt;"> of </span><span style="font-family:Arial;font-size:8pt;"><span>$9.4 million</span></span><span style="font-family:Arial;font-size:8pt;"> is expected to be reclassified out of AOCI into earnings during the next 12 months.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:240px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:68px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:240px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:68px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:768px;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:200px;"/><td style="width:5px;"/><td style="width:166px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(14.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(27.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(15.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(26.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>785.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>34.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,427.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>97.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Treasury locks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>778.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(71.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,222.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>90.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(65.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121150584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">LEASES</span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:160px;"/><td style="width:5px;"/><td style="width:306px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>129.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>161.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:160px;"/><td style="width:5px;"/><td style="width:306px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-Current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>106.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>101.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Long-term debt, less current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>164.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>158.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The below table shows our lease assets and liabilities by reporting segment (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:796px;border-collapse:collapse;text-align:left;"><tr><td colspan="33"/></tr><tr><td style="width:72px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>41.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>42.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>35.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>36.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>46.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>50.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>129.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>133.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Lease expense was as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:177px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:Arial;font-size:8pt;"/><span style="font-family:Arial;font-size:8pt;">(1)  Includes short-term leases and variable lease costs, which are immaterial</span><span style="font-family:Arial;font-size:8pt;">.</span></div><div style="line-height:120%;padding-left:24px;text-indent:48px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The annual future maturities of our leases as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:192px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">After 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Total lease payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>188.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Less: Interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Present value of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>164.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our weighted average lease terms and discount rates are as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:473px;"/><td style="width:5px;"/><td style="width:89px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:89px;"/><td style="width:10px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Weighted-average remaining lease term (in years)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.58</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.03</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted-average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Operating leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.80</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.50</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our lease cash flow classifications are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:473px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Financing cash flows for finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new finance lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new operating lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">LEASES</span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:160px;"/><td style="width:5px;"/><td style="width:306px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>129.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>161.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:160px;"/><td style="width:5px;"/><td style="width:306px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-Current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>106.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>101.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Long-term debt, less current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>164.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>158.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The below table shows our lease assets and liabilities by reporting segment (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:796px;border-collapse:collapse;text-align:left;"><tr><td colspan="33"/></tr><tr><td style="width:72px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>41.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>42.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>35.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>36.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>46.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>50.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>129.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>133.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Lease expense was as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:177px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:Arial;font-size:8pt;"/><span style="font-family:Arial;font-size:8pt;">(1)  Includes short-term leases and variable lease costs, which are immaterial</span><span style="font-family:Arial;font-size:8pt;">.</span></div><div style="line-height:120%;padding-left:24px;text-indent:48px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The annual future maturities of our leases as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:192px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">After 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Total lease payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>188.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Less: Interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Present value of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>164.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our weighted average lease terms and discount rates are as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:473px;"/><td style="width:5px;"/><td style="width:89px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:89px;"/><td style="width:10px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Weighted-average remaining lease term (in years)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.58</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.03</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted-average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Operating leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.80</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.50</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our lease cash flow classifications are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:473px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Financing cash flows for finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new finance lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new operating lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615116102584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Indebtedness</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">INDEBTEDNESS</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total borrowings outstanding are summarized as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.48427672955975%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:2%;"/><td style="width:13%;"/><td style="width:27%;"/><td style="width:5%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Term loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2019 Term loan due August 15, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>600.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>600.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Notes and Bonds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:underline;">Coupon</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:underline;">Due</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.500%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">March 15, 2021</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>280.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.500%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">December 15, 2021</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>309.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.105%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>July 28, 2023</span></span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>151.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.000%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">November 15, 2023</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>215.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>215.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.900%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">December 15, 2024</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.375%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">March 15, 2026</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.150%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">June 15, 2030</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>750.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.300%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">November 15, 2043</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>90.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>90.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.900%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">December 15, 2044</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>303.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>303.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total notes and bonds</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,917.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,751.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Other financing</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>61.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unamortized premium (discount), net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred financing fees</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(17.9</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(14.1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total borrowings outstanding</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,560.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,369.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(16.5</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(3.4</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total long-term debt less current portion</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,543.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,365.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:72px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)  Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We are in compliance with all covenants under our debt agreements as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Revolving Credit Agreements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 8, 2018, we entered into a </span><span style="font-family:Arial;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:Arial;font-size:10pt;"> revolving credit agreement maturing on March 8, 2023 (the "2018 Revolver"). There were </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;"> borrowings outstanding under the 2018 Revolver as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> or </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Term Loans</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 8, 2018, we refinanced the </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;350.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> outstanding under the previous term loan with the proceeds of a new </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;350.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$431.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">) term loan, maturing on March 8, 2020 (the "2018 Term Loan"). During the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, we made </span><span style="font-family:Arial;font-size:10pt;"><span>$24.7 million</span></span><span style="font-family:Arial;font-size:10pt;"> in scheduled principal repayments on the 2018 Term Loan. On August 15, 2019, we refinanced the </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;284.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> (</span><span style="font-family:Arial;font-size:10pt;"><span>$317.1 million</span></span><span style="font-family:Arial;font-size:10pt;">) outstanding under the 2018 Term Loan with the proceeds of a new </span><span style="font-family:Arial;font-size:10pt;"><span>$600.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> term loan, maturing on August 15, 2022. As a result of the refinancing, during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of </span><span style="font-family:Arial;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:Arial;font-size:10pt;">, consisting of the write-off of deferred financing fees in </span><span style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Notes and Bonds</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">2020 Notes and 2021 Notes Redemption</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 19, 2020, Perrigo Finance Unlimited Company, a public unlimited company incorporated under the laws of Ireland ("Perrigo Finance") and an indirect wholly-owned finance subsidiary of Perrigo whose primary </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">purpose is to finance the business and operations of Perrigo and its affiliates, issued $</span><span style="font-family:Arial;font-size:10pt;"><span>750.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </span><span style="font-family:Arial;font-size:10pt;"><span>3.150%</span></span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due 2030 (the &#8220;2020 Notes") and received net proceeds of $</span><span style="font-family:Arial;font-size:10pt;"><span>737.1 million</span></span><span style="font-family:Arial;font-size:10pt;"> after fees and market discount. Interest on the 2020 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2020 Notes will mature on June 15, 2030. The 2020 Notes are governed by a base indenture and a third supplemental indenture (collectively, the "2020 Indenture"). The 2020 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo and no other subsidiary of Perrigo guarantees the 2020 Notes. There are no restrictions under the 2020 Notes on Perrigo's ability to obtain funds from its subsidiaries. Perrigo Finance may redeem the 2020 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2020 Indenture. On July 6, 2020, the proceeds of the 2020 Notes were used to fund the redemption of Perrigo Finance's </span><span style="font-family:Arial;font-size:10pt;"><span>$280.4 million</span></span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span>3.500%</span></span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due March 15, 2021 and </span><span style="font-family:Arial;font-size:10pt;"><span>$309.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> of </span><span style="font-family:Arial;font-size:10pt;"><span>3.500%</span></span><span style="font-family:Arial;font-size:10pt;"> Senior Notes due December 15, 2021 (collectively, the "2021 Notes"). The balance will be used for general corporate purposes which may include the repayment or redemption of additional indebtedness.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">As a result of the early redemption of the 2021 Notes, during the </span><span style="font-family:Arial;font-size:10pt;">three months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we recorded a loss of $</span><span style="font-family:Arial;font-size:10pt;"><span>20.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> in </span><span style="font-family:Arial;font-size:10pt;">Loss on extinguishment of debt</span><span style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations, consisting of the premium on debt repayments, the write-off of deferred financing fees, and the write-off of the remaining bond discounts.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Financing</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". The balance outstanding under the facilities was </span><span style="font-family:Arial;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. There were </span><span style="font-family:Arial;font-size:10pt;"><span>no</span></span><span style="font-family:Arial;font-size:10pt;"> borrowings outstanding under the facilities as of </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span><span style="font-family:Arial;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 17, 2020, we incurred debt of $</span><span style="font-family:Arial;font-size:10pt;"><span>34.3 million</span></span><span style="font-family:Arial;font-size:10pt;"> related to our equity method investment in Kazmira pursuant to </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> Promissory Notes, with </span><span style="font-family:Arial;font-size:10pt;"><span>$3.7 million</span></span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;"><span>$5.8 million</span></span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;"><span>$24.8 million</span></span><span style="font-family:Arial;font-size:10pt;"> to be settled in November 2020, May 2021 and November 2021, respectively (refer to </span><a href="#sF4B58DD1964A5338A17E7D9B8F660A6D" style="font-family:Arial;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 7</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have financing leases that are reported in the above table under "Other financing" (refer to </span><a href="#s5C415D6F8F16571ABE301BD0CB1A1A36" style="font-family:Arial;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Note 9</span></a><span style="font-family:Arial;font-size:10pt;">).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122326216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share and Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share and Shareholders' Equity</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY</span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Earnings per Share</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(154.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>92.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>165.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards*</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>137.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS*</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">*  In the period of a net loss, diluted shares equal basic shares.</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Shareholders' Equity</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Share Repurchases</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span style="font-family:Arial;font-size:10pt;">In October 2018, our Board of Directors authorized up to </span><span style="font-family:Arial;font-size:10pt;"><span>$1.0&#160;billion</span></span><span style="font-family:Arial;font-size:10pt;"> of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program. We did not repurchase any shares during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115944072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Changes in our AOCI balances, net of tax were as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value of Derivative Financial Instruments, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign Currency Translation Adjustments</span><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Post-Retirement and Pension Liability Adjustments, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total AOCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>139.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">OCI before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(11.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>34.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amounts reclassified from AOCI</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>46.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(12.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>64.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at September 26, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>213.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>203.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1) Refer to </span><a href="#sA0BB308013C05849BCFF1B0C8BBA3C08" style="font-family:Arial;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Note 3</span></a><span style="font-family:Arial;font-size:8pt;"> Rosemont Pharmaceuticals business divestiture for information regarding amounts reclassified from AOCI.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615117485384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">INCOME TAXES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The effective tax rates were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:391px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:78px;"/><td style="width:14px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(21.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>78.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;"/><span style="font-family:Arial;font-size:10pt;">The effective tax rate for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> increased compared to the prior period primarily due to non-deductible goodwill impairments and Base Erosion and Anti-Abuse Tax ("BEAT"), offset by additional interest deductions provided for in the U.S. Coronavirus Aid, Relief, and Economic Security ("CARES") Act and the early adoption of the final and proposed business interest expense deduction limitation regulations in the current period.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Tax Cuts and Jobs Act of 2017 introduced a new tax on U.S. corporations that derive benefits from certain deductible payments to non-U.S. affiliates called the Base Erosion and Anti-Abuse Tax ("BEAT"). BEAT applies when base eroding payments exceed three percent of total deductions and where BEAT exceeds adjusted regular income tax.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We recorded a valuation allowance against all U.S. deferred tax assets as of December 31, 2016. We have continued to maintain a full valuation allowance against all U.S. deferred tax assets since and intend to continue maintaining this valuation allowance until there is sufficient evidence to support the reversal of all or some portion of these allowances. Given our current earnings and anticipated future earnings, we believe there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available that all or a portion of the valuation allowance against the U.S. deferred tax assets will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense in the period of the release. The exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we actually achieve.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">IRS Audit of Fiscal Years Ended June 29, 2013, June 28, 2014, and June 27, 2015</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In connection with its audits of Perrigo Company, a Michigan corporation and wholly-owned indirect subsidiary of Perrigo Company plc, for the fiscal years ended June 29, 2013, June 28, 2014, and June 27, 2015 the IRS issued a draft Notice of Proposed Adjustment ("NOPA") on August 22, 2019, reducing Perrigo Company&#8217;s deductible interest expense for fiscal tax years 2014-2015 on </span><span style="font-family:Arial;font-size:10pt;"><span>$7.5 billion</span></span><span style="font-family:Arial;font-size:10pt;"> in debts owed by it to Perrigo Company plc. A final NOPA was issued in early May 2020 without change.&#160;The debts were incurred in connection with the Elan merger transaction in 2013. The final NOPA caps the interest rate on the debts for U.S. federal tax purposes at </span><span style="font-family:Arial;font-size:10pt;"><span>130.0%</span></span><span style="font-family:Arial;font-size:10pt;"> of the Applicable Federal Rate (a blended rate reduction of </span><span style="font-family:Arial;font-size:10pt;"><span>4.0%</span></span><span style="font-family:Arial;font-size:10pt;"> per annum), on the stated ground that the loans were not negotiated on an arms&#8217;-length basis. The final NOPA proposes a reduction in gross interest expense of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$480.0 million</span></span><span style="font-family:Arial;font-size:10pt;"> for fiscal years 2014 and 2015. If the IRS were to prevail in its proposed adjustment, the Company estimates an increase in tax expense of approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$170.0 million</span></span><span style="font-family:Arial;font-size:10pt;">, excluding interest and penalties, for fiscal years ended June 28, 2014 through June 27, 2015. In addition, we expect the IRS to seek similar adjustments for the period from June 28, 2015 through December 31, 2018 with potential section 163(j) carryover impacts beyond December 2018. If those further adjustments were sustained, based on preliminary calculations and subject to further analysis, the Company's current best estimate is that the additional tax expense will not exceed </span><span style="font-family:Arial;font-size:10pt;"><span>$200.0 million</span></span><span style="font-family:Arial;font-size:10pt;">, excluding interest and penalties. No further adjustments beyond this period are expected. The Company strongly disagrees with the IRS position, as reflected in its detailed written response to the draft NOPA on September 20, 2019. At this stage, we are unable to estimate the liability, if any, associated with this matter. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">IRS Audit of Fiscal Years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 15, 2017, we filed a complaint in the United States District Court for the Western District of Michigan to recover </span><span style="font-family:Arial;font-size:10pt;"><span>$163.6 million</span></span><span style="font-family:Arial;font-size:10pt;"> of Federal income tax, penalties, and interest assessed and collected by the IRS, plus statutory interest thereon from the dates of payment, for the fiscal tax years ended June 27, 2009, June 26, 2010, June 25, 2011, and June 30, 2012 (the &#8220;2009 tax year,&#8221; &#8220;2010 tax year,&#8221; &#8220;2011 tax year,&#8221; and &#8220;2012 tax year,&#8221; respectively). In response to our complaint, the United States District Court for Western District of Michigan scheduled a new trial date for January 26, 2021. The IRS audits of those years culminated in the issuances of two statutory notices of deficiency: (1) on August 27, 2014 for the 2009 and 2010 tax years and (2) on April 20, 2017 for the 2011 and 2012 tax years. The statutory notices of deficiency both included un-agreed income adjustments related principally to transfer pricing adjustments regarding the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States. In addition, the statutory notice of deficiency for the 2011 and 2012 tax years included the capitalization of certain expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits. We fully paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and filed timely claims for refund on June 11, 2015 and June 7, 2017 for the 2009-2010 tax years and 2011-2012 tax years, respectively. Upon the disallowance of such refund claims, we timely filed the above complaint, which seeks refunds of tax, interest, and penalties of </span><span style="font-family:Arial;font-size:10pt;"><span>$37.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2009 tax year, </span><span style="font-family:Arial;font-size:10pt;"><span>$61.5&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2010 tax year, </span><span style="font-family:Arial;font-size:10pt;"><span>$40.2 million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2011 tax year, and </span><span style="font-family:Arial;font-size:10pt;"><span>$24.7&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> for the 2012 tax year, for a total of </span><span style="font-family:Arial;font-size:10pt;"><span>$163.6 million</span></span><span style="font-family:Arial;font-size:10pt;">. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in </span><span style="font-family:Arial;font-size:10pt;">Other non-current assets</span><span style="font-family:Arial;font-size:10pt;"> on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in </span><span style="font-family:Arial;font-size:10pt;">Other non-current assets</span><span style="font-family:Arial;font-size:10pt;"> on our balance sheet during the three months ended July 1, 2017. The total cumulative deferred charge that the Company is seeking to receive in this litigation is approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$101.8 million</span></span><span style="font-family:Arial;font-size:10pt;">, which reflects (i) a deduction of </span><span style="font-family:Arial;font-size:10pt;"><span>$29.7 million</span></span><span style="font-family:Arial;font-size:10pt;"> from the total reflected above due to overpayments credited to succeeding years and (ii) the impact of a previously conceded royalty due to Perrigo U.S. on all omeprazole sales that equates to </span><span style="font-family:Arial;font-size:10pt;"><span>24.0%</span></span><span style="font-family:Arial;font-size:10pt;"> of the above refund claims. That </span><span style="font-family:Arial;font-size:10pt;"><span>24.0%</span></span><span style="font-family:Arial;font-size:10pt;"> concession would also apply to any omeprazole adjustments that may be asserted by the IRS for future years. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">IRS Audit of Fiscal Years Ended December 31, 2011, December 31, 2012, and December 31, 2013</span><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, Inc. ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The NOPA carries forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#8217;s intellectual property, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The NOPA proposes a </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">payment of </span><span style="font-family:Arial;font-size:10pt;"><span>$843.0&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, which represents additional tax and a </span><span style="font-family:Arial;font-size:10pt;"><span>40.0%</span></span><span style="font-family:Arial;font-size:10pt;"> penalty. This amount excludes consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagree with the IRS position and will pursue all available administrative and judicial remedies, including those available under the U.S. - Ireland Income Tax Treaty to alleviate double taxation. Accordingly, on April 14, 2020, we filed a request for Competent Authority Assistance with the IRS. The request was accepted and is under review. No payment of the additional amounts is required until the matter is resolved administratively, judicially, or through treaty negotiation.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 22, 2016, we received a NOPA from the IRS regarding the deductibility of litigation costs related to the IRS audit of Athena for the years ended December 31, 2011, December 31, 2012, and December 31, 2013.&#160;We strongly disagree with the IRS&#8217;s position asserted in the NOPA and are contesting it.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Irish Revenue Audit of Fiscal Years Ended December 31, 2012 and December 31, 2013</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On October 30, 2018, we received an audit finding letter from the Irish Office of the Revenue Commissioners (&#8220;Irish Revenue&#8221;) for the years ended December 31, 2012 and December 31, 2013. The audit finding letter relates to the tax treatment of the 2013 sale of the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> intellectual property and other assets related to Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> to Biogen Idec from Elan Pharma. The consideration paid by Biogen to Elan Pharma took the form of an upfront payment and future contingent royalty payments. Irish Revenue issued a Notice of Amended Assessment (&#8220;NoA&#8221;) on November 29, 2018 which assesses an Irish corporation tax liability against Elan Pharma in the amount of </span><span style="font-family:Arial;font-size:10pt;"><span>&#8364;1,636&#160;million</span></span><span style="font-family:Arial;font-size:10pt;">, not including interest or any applicable penalties.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We strongly disagree with this assessment and believe that the NoA is without merit and incorrect as a matter of law. We will pursue all available administrative and judicial avenues as may be necessary or appropriate. In connection with that, we filed an appeal of the NoA on December 27, 2018 in the Tax Appeals Commission which is the statutory body charged with considering whether the NoA is properly founded as a matter of tax law. Separately, we were also granted leave by the Irish High Court on February 25, 2019 to seek judicial review of the issuance of the NoA by Irish Revenue.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The judicial review case is based on our belief that, by issuing the NoA, Irish Revenue breached Elan Pharma's rights and legitimate expectations as a taxpayer. The Irish High Court heard the judicial review case in June 2020 and, on November 4, 2020, the High Court ruled that the issuance of the NoA did not violate the Company&#8217;s rights and legitimate expectations. Because the Irish High Court did not quash the NoA, absent an appeal by Elan Pharma, the amended assessment can be examined on its merits by the Irish Tax Appeals Commission. Our case before the Irish Tax Appeals Commission has been stayed since February 2019 by Order of the Irish High Court pending determination of the judicial review case. We will now assess the Irish High Court's decision before deciding whether to pursue an appeal of the judicial review case to the Irish Court of Appeal or reactivate our appeal before the Tax Appeals Commission. Any appeal against the judgment of the High Court in the judicial review case would have to be filed within </span><span style="font-family:Arial;font-size:10pt;"><span>28 days</span></span><span style="font-family:Arial;font-size:10pt;"> of the Order made by the High Court consequent upon the judgment delivered on November 4, 2020. That Court Order is expected to be made within a period of weeks once the question of liability for the litigation costs of the judicial review case has been decided by the High Court. </span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:Arial;font-size:10pt;"><span>No</span></span><span style="font-family:Arial;font-size:10pt;"> payment will be required unless both the judicial review case and the appeal pending before the Tax Appeals Commission are finally determined against Elan Pharma.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Tax Authority Audit of Fiscal Year Ended June 27, 2015 and Calendar Years Ended December 31, 2015 through December 31, 2017</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Israel Tax Authority is auditing our fiscal year ended June 27, 2015, and calendar years ended December 31, 2015, December 31, 2016 and December 31, 2017.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Although we believe that our tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments, which could be material.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">. However, we are not able to estimate a reasonably possible range of how these events may impact our unrecognized tax benefits in the next twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121024184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">CONTINGENCIES</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Price-Fixing Lawsuits</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Perrigo is a defendant in several cases in the generic pricing multidistrict litigation </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">MDL No. 2724 (United States District Court for Eastern District of Pennsylvania)</span><span style="font-family:Arial;font-size:10pt;">. This multidistrict litigation, which has many cases that do not include Perrigo, includes class action and opt-out cases for federal and state antitrust claims, as well as complaints filed by various of the States alleging violations of state antitrust laws.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On July 14, 2020, the court issued an order designating the following cases to proceed on a more expedited basis than the other cases in </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">MDL No. 2724:</span><span style="font-family:Arial;font-size:10pt;"> (a) the States&#8217; May 2019 case alleging an overarching conspiracy involving more than </span><span style="font-family:Arial;font-size:10pt;"><span>120</span></span><span style="font-family:Arial;font-size:10pt;"> products (which does not name Perrigo a defendant) and (b) class actions alleging &#8220;single drug&#8221; conspiracies involving Clomipramine, Pravastatin, and Clobetasol. Perrigo is a defendant in the Clobetasol cases but not the others. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Class Action Complaints</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">(a) Single Drug Conspiracy Class Actions</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We have been named as a co-defendant with certain other generic pharmaceutical manufacturers in a number of class actions alleging single-product conspiracies to fix or raise the prices of certain drugs and/or allocate customers for those products starting, in some instances, as early as June 2013. The class actions were filed on behalf of putative classes of (a) direct purchasers, (b) end payors, and (c) indirect resellers. The products in question are Clobetasol gel, Desonide, and Econazole. The court denied motions to dismiss each of the complaints alleging &#8220;single drug&#8221; conspiracies involving Perrigo, and the cases are proceeding in discovery. As noted above, the Clobetasol cases have been designated to proceed on a more expedited schedule than the other cases. That schedule has not yet been set.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">(b) &#8220;Overarching Conspiracy&#8221; Class Actions</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The same </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> putative classes, including (a) direct purchasers, (b) end payors, and (c) indirect resellers, have filed </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> sets of class action complaints alleging that Perrigo and other manufacturers (and some individuals) entered into an &#8220;overarching conspiracy&#8221; that involved allocating customers, rigging bids and raising, maintaining, and fixing prices for various products. Each class brings claims for violations of Sections 1 and 3 of the Sherman Antitrust Act as well as several state antitrust and consumer protection statutes. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Filed in June 2018, and later amended in December 2018 (with respect to direct purchasers) and April 2019 (with respect to end payors and indirect resellers), the first set of &#8220;overarching conspiracy&#8221; class actions include allegations against Perrigo and approximately </span><span style="font-family:Arial;font-size:10pt;"><span>27</span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers involving </span><span style="font-family:Arial;font-size:10pt;"><span>135</span></span><span style="font-family:Arial;font-size:10pt;"> drugs with allegations dating back to March 2011. The allegations against Perrigo concern only </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> formulations (cream and ointment) of </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> of the products at issue, Nystatin. The court denied motions to dismiss the first set of &#8220;overarching conspiracy&#8221; class actions, and they are proceeding in discovery. </span><span style="font-family:Arial;font-size:10pt;"><span>None</span></span><span style="font-family:Arial;font-size:10pt;"> of these cases are included in the group of cases on a more expedited schedule pursuant to the court&#8217;s July 14, 2020 order.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In December 2019, both the end payor and indirect reseller class plaintiffs filed a second set of "overarching conspiracy&#8221; class actions against Perrigo, dozens of other manufacturers of generic prescription pharmaceuticals, and certain individuals dating back to July 2009 (end payors) or January 2010 (indirect resellers). The direct purchaser plaintiffs filed their second round overarching conspiracy complaint in February 2020 with claims dating back to July 2009. On March 11, 2020, the indirect reseller plaintiffs filed a motion to amend their second round December 2019 complaint, and that motion was granted. On September 4, 2020, the end payor plaintiffs amended their second round complaint. On October 21, 2020, the direct purchaser plaintiffs amended their second round complaint.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">This second set of overarching complaints allege conspiracies relating to the sale of various products that are not at issue in the earlier-filed overarching conspiracy class actions, the majority of which Perrigo neither makes nor sells. The amended indirect reseller complaint alleges that Perrigo conspired in connection with its sales of Betamethasone Dipropionate lotion, Imiquimod cream, Desonide cream and ointment, and Hydrocortisone Valerate cream. The amended end payor complaint alleges that Perrigo conspired in connection with its sale of the following drugs: Adapalene, Ammonium Lactate, Betamethasone Dipropionate, Bromocriptine Mesylate, Calcipotriene Betamethasone Dipropionate, Ciclopirox, Clindamycin Phosphate, Erythromycin, Fenofibrate, Fluocinonide, Fluticasone Propionate, Halobetasol Proprionate, Hydrocortisone Acetate, Hydrocortisone Valerate, Imiquimod, Methazolamide, Mometasone Furoate, Permethrin, Prochlorperazine Maleate, Pormethazine HCL, Tacrolimus, and Triamcinolone Acetonide. The amended direct purchaser complaint alleges that Perrigo conspired in connection with its sale of the following drugs: Adapalene, Ammonium Lactate, Betamethasone Dipropionate, Bromocriptine Mesylate, Ciclopirox, Clindamycin Phosphate, Fenofibrate, Fluocinonide, Halobetasol Proprionate, Hydrocortisone Valerate, Methazolamide, Permethrin, Prochlorperazine Maleate, Promethazine HCL, Tacrolimus, and Triamcinolone Acetonide.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Perrigo has not yet responded to the second set of overarching conspiracy complaints, and responses are currently or will be stayed.</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Opt-Out Complaints</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 22, 2018, Perrigo was named a co-defendant along with </span><span style="font-family:Arial;font-size:10pt;"><span>35</span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers in a complaint filed by </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> supermarket chains alleging that defendants conspired to fix prices of </span><span style="font-family:Arial;font-size:10pt;"><span>31</span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceutical products starting in 2013. On December 21, 2018, an amended complaint was filed that adds additional products and allegations against a total of </span><span style="font-family:Arial;font-size:10pt;"><span>39</span></span><span style="font-family:Arial;font-size:10pt;"> manufacturers for </span><span style="font-family:Arial;font-size:10pt;"><span>33</span></span><span style="font-family:Arial;font-size:10pt;"> products. The only allegations specific to Perrigo relate to Clobetasol, Desonide, Econazole, Nystatin cream, and Nystatin ointment. Perrigo moved to dismiss this complaint on February 21, 2019. The motion was denied on August 15, 2019. The case is proceeding in  discovery. On February 3, 2020, the plaintiffs requested leave to file a second amended complaint. The proposed amended complaint adds dozens of additional products and allegations to the original complaint. Perrigo is discussed in connection with allegations concerning an additional drug, Fenofibrate. Defendants opposed the motion for leave to file a second amended complaint and the court has yet to rule on the issue.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 3, 2018, a large managed care organization filed a complaint against Perrigo alleging price-fixing and customer allocation concerning </span><span style="font-family:Arial;font-size:10pt;"><span>17</span></span><span style="font-family:Arial;font-size:10pt;"> different products among </span><span style="font-family:Arial;font-size:10pt;"><span>27</span></span><span style="font-family:Arial;font-size:10pt;"> manufacturers including Perrigo. The only allegations specific to Perrigo concern Clobetasol. Perrigo moved to dismiss this complaint on February 21, 2019. Plaintiff filed a second amended complaint in April 2019 that adds additional products and allegations. The amended allegations that concern Perrigo include: Clobetasol, Desonide, Econazole, and Nystatin. The motion to dismiss was denied on August 15, 2019. The case is proceeding in discovery.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 16, 2019, a similar suit was brought by a health insurance carrier in the U.S. District Court for the District of Minnesota alleging a conspiracy to fix prices of </span><span style="font-family:Arial;font-size:10pt;"><span>30</span></span><span style="font-family:Arial;font-size:10pt;"> products among </span><span style="font-family:Arial;font-size:10pt;"><span>30</span></span><span style="font-family:Arial;font-size:10pt;"> defendants. The only </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">allegations specific to Perrigo concern Clobetasol gel, Desonide, Econazole, Nystatin cream, and Nystatin ointment. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On July 18, 2019, </span><span style="font-family:Arial;font-size:10pt;"><span>87</span></span><span style="font-family:Arial;font-size:10pt;"> health plans filed a Praecipe to Issue Writ of Summons in Pennsylvania state court to commence an action against </span><span style="font-family:Arial;font-size:10pt;"><span>53</span></span><span style="font-family:Arial;font-size:10pt;"> generic pharmaceutical manufacturers and </span><span style="font-family:Arial;font-size:10pt;"><span>17</span></span><span style="font-family:Arial;font-size:10pt;"> individuals, alleging antitrust violations concerning generic pharmaceutical drugs. While Perrigo was named as a defendant, no complaint has been filed and the precise allegations and products at issue have not been identified</span><span style="font-family:Times New Roman;font-size:10pt;">. </span><span style="font-family:Arial;font-size:10pt;">Proceedings in the case, including the filing of a complaint, have been stayed at the request of the plaintiffs.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 11, 2019, a health care service company filed a complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span>38</span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other multi-district litigation ("MDL") complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin cream/ointment. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 16, 2019, a Medicare Advantage claims recovery company filed a complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span>39</span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, and Econazole. The complaint was originally filed in the District of Connecticut but will be consolidated into the MDL. Perrigo has not yet had the opportunity to respond to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 23, 2019, several counties in New York filed an amended complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span>28</span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was originally filed in New York State court but was removed to federal court and will likely be consolidated into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 27, 2019, a healthcare management organization filed a complaint against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span>25</span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was filed originally in the Northern District of California but will be consolidated into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On March 1, 2020, Harris County of Texas filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span>29</span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The products at issue that plaintiffs claim Perrigo manufacturers or sells include: Adapalene, Betamethasone Dipropionate, Ciclopirox, Clindamycin, Clobetasol, Desonide, Econazole, Ethinyl Estradiol/Levonorgestrel, Fenofibrate, Fluocinolone, Fluocinonide, Gentamicin, Glimepiride, Griseofulvin, Halobetasol Propionate, Hydrocortisone Valerate, Ketoconazole, Mupirocin, Nystatin, Olopatadine, Permethrin, Prednisone, Promethazine, Scopolamine, and Triamcinolone Acetonide</span><span style="font-family:Times New Roman;font-size:10pt;">. </span><span style="font-family:Arial;font-size:10pt;">The complaint was originally filed in the Southern District of Texas but has been transferred to the MDL. Harris County amended its complaint in May 2020. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In May 2020, </span><span style="font-family:Arial;font-size:10pt;"><span>seven</span></span><span style="font-family:Arial;font-size:10pt;"> health plans filed a writ of summons in the Pennsylvania Court of Common Pleas in Philadelphia concerning an as-yet unfiled complaint against Perrigo, </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> dozen other manufacturers, and </span><span style="font-family:Arial;font-size:10pt;"><span>seventeen</span></span><span style="font-family:Arial;font-size:10pt;"> individuals, concerning alleged antitrust violations in connection with the pricing and sale of generic prescription pharmaceutical products. No complaint has yet been filed, so the precise allegations and products at issue are not yet clear. In addition, Defendants are in the process of being served, and proceedings in the case will likely be stayed.  </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 9, 2020, a health insurance carrier filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span>25</span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. The complaint was filed in the Eastern District of Pennsylvania and has been transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On July 9, 2020, a drugstore chain filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;color:#000000;"><span>39</span></span><span style="font-family:Arial;font-size:10pt;"> other pharmaceutical companies alleging an overarching conspiracy to fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. Perrigo is also listed in connection with Fenofibrate. The complaint was filed in the Eastern District of Pennsylvania and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On August 27, 2020, Suffolk County of New York filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span>35</span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin cream and ointment. The other products at issue that plaintiffs claim Perrigo manufacturers or sells include: Adapalene gel; Albuterol; Benazepril HCTZ; Clotrimazole; Diclofenac Sodium; Fenofibrate; Fluocinonide; Glimepiride; Ketoconazole; Meprobamate; Imiquimod; Triamcinolone Acetonide; Erythromycin/Ethyl Solution; Betamethasone Valerate; Ciclopirox Olamine; Terconazole; Hydrocortisone Valerate; Fluticasone Propionate; Desoximetasone; Clindamycin Phosphate; Halobetasol Propionate; Hydrocortisone Acetate; Promethazine HCL, Mometasone Furoate; and Amiloride HCTZ. The complaint was filed in the Eastern District of New York and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On September 4, 2020, a drug wholesaler and distributor filed a complaint against Perrigo New York, Inc. and </span><span style="font-family:Arial;font-size:10pt;"><span>39</span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on Adapalene Cream, Ammonium Lactate cream and lotion, Betamethasone Dipropionate lotion, Bromocriptine tablets, Calcipotriene Betamethasone Dipropionate (Cal Beta Dip) Ointment, Ciclopirox shampoo cream and solution, Clindamycin solution, Clobetasol, Desonide cream and ointment, Econazole cream, Erythromycin base alcohol solution, Fenofibrate, Fluticasone lotion, Halobetasol cream and ointment, Hydrocortisone Acetate suppositories, Hydrocortisone valerate cream, Imiquimod cream, Methazolamide tablets, Mometasone furoate cream, ointment and solution, Nystatin, Prochlorperazine suppositories, Promethazine HCL suppositories, Tacrolimus ointment, and Triamcinolone cream and ointment. The complaint was filed in the Eastern District of Pennsylvania and will be transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">State Attorney General Complaint </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 10, 2020, the Connecticut Attorney General&#8217;s office filed a lawsuit on behalf of Connecticut and </span><span style="font-family:Arial;font-size:10pt;"><span>50</span></span><span style="font-family:Arial;font-size:10pt;"> other states and territories against Perrigo, </span><span style="font-family:Arial;font-size:10pt;"><span>35</span></span><span style="font-family:Arial;font-size:10pt;"> other generic pharmaceutical manufacturers, and certain individuals (including </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> former and </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> current Perrigo employee), alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of eighty products. The allegations against Perrigo focus on the following drugs: Adapalene Cream, Ammonium Lactate cream and lotion, Betamethasone dipropionate lotion, Bromocriptine tablets, Calcipotriene Betamethasone Dipropionate (Cal Beta Dip) Ointment, Ciclopirox cream and solution, Clindamycin solution, Desonide cream and ointment, Econazole cream, Erythromycin base alcohol solution, Fluticasone cream and lotion, Halobetasol cream and ointment, Hydrocortisone Acetate suppositories, Hydrocortisone Valerate cream, Imiquimod cream, Methazolamide tablets, Nystatin ointment, Prochlorperazine suppositories, Promethazine HCL suppositories, Tacrolimus ointment, and Triamcinolone cream and ointment. The Complaint was filed in the District of Connecticut</span><span style="font-family:Times New Roman;font-size:10pt;">,</span><span style="font-family:Arial;font-size:10pt;"> but has been transferred into the MDL. Perrigo has not yet responded to the complaint, and responses are currently stayed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Canadian Class Action Complaint</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span>29</span></span><span style="font-family:Arial;font-size:10pt;"> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. Perrigo has not yet responded to the complaint.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Securities Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In the United States (cases related to events in 2015-2017)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On May 18, 2016, a shareholder filed a securities case against us and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund v. Papa, et al.</span><span style="font-family:Arial;font-size:10pt;">).&#160;The plaintiff purported to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa.&#160;In general, the allegations concerned the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015.&#160;The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016.&#160;On July 19, 2016, a different shareholder filed a securities class action against us and our former CEO, Joseph Papa, also in the District of New Jersey (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson v. Papa, et al.</span><span style="font-family:Arial;font-size:10pt;">). The plaintiff purported to represent a class of persons who sold put options on our shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims were the same as those made in the original complaint filed in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case described above. On December 8, 2016, the court consolidated the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</span><span style="font-family:Arial;font-size:10pt;"> case under the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case number. In February 2017, the court selected the lead plaintiffs for the consolidated case and the lead counsel to the putative class. In March 2017, the court entered a scheduling order.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 21, 2017, the court-appointed lead plaintiffs filed an amended complaint that superseded the original complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</span><span style="font-family:Arial;font-size:10pt;"> case. In the amended complaint, the lead plaintiffs seek to represent </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> classes of shareholders: (i) shareholders who purchased shares during the period from April 21, 2015 through May 3, 2017 on the U.S. exchanges; (ii) shareholders who purchased shares during the same period on the Tel Aviv exchange; and (iii) shareholders who owned shares on November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (the final day of the Mylan tender offer) regardless of whether the shareholders tendered their shares. The amended complaint names as defendants us and </span><span style="font-family:Arial;font-size:10pt;"><span>11</span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The amended complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b</span><span style="font-family:Times New Roman;font-size:10pt;">&#8209;</span><span style="font-family:Arial;font-size:10pt;">5) and 14(e) against all defendants and 20(a) control person liability against the </span><span style="font-family:Arial;font-size:10pt;"><span>11</span></span><span style="font-family:Arial;font-size:10pt;"> individuals. In general, the allegations concern the actions taken by us and the former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span>six</span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> royalty stream. The amended complaint does not include an estimate of damages. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#8217; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#8217;Connor, and Marc Coucke. The court also dismissed without prejudice claims arising from the Tysabri&#174; accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are Perrigo Company plc, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issues regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span>six</span></span><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">generic prescription pharmaceuticals. The defendants who remain in the case (the Company, Mr. Papa, and Ms. Brown) have filed answers denying liability, and the discovery stage of litigation has begun. Discovery in the class action is currently scheduled to end in January 2021. We intend to defend the lawsuit vigorously.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On November 14, 2019, the court granted the lead plaintiffs&#8217; motion and certified </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Defendants filed a petition for leave to appeal in the Third Circuit challenging the certification of the tender offer class. On April 30, 2020, the Third Circuit denied leave to appeal. The District Court has approved the issuance of a notice of the pendency of the class action, and the notice has been sent to shareholders who are eligible to participate in the classes.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Unless otherwise noted, each of the lawsuits discussed in the following sections is pending in the U.S. District Court for the District of New Jersey and has been assigned to the same judges hearing the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case. The allegations in the complaints relate to events during certain portions of the 2015 through 2017 calendar years, including the period of the Mylan tender offer. All but one of these lawsuits allege violations of federal securities laws, but none are class actions. </span><span style="font-family:Arial;font-size:10pt;"><span>One</span></span><span style="font-family:Arial;font-size:10pt;"> lawsuit (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;">) alleges only state law claims. Discovery in all these cases, except </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;">, is underway and currently scheduled to end in early September 2021. We intend to defend all these lawsuits vigorously.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Carmignac, First Manhattan</span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">and Similar Cases</span><span style="font-family:Arial;font-size:10pt;">. The following </span><span style="font-family:Arial;font-size:10pt;"><span>seven</span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed by the same law firm and generally make the same factual assertions but, at times, differ as to which securities laws violations they allege:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:76%;"/><td style="width:24%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac Gestion, S.A. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">11/1/2017</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan Co. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/16/2018; amended 4/20/2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">10/29/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Schwab Capital Trust, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">1/31/2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/22/2019</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Principal Funds, Inc., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3/5/2020</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3/31/2020</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The original complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan</span><span style="font-family:Arial;font-size:10pt;"> case named Perrigo, Mr. Papa, Ms. Brown, and Mr. Coucke as defendants. Mr. Coucke was dismissed as a defendant after the plaintiffs agreed to apply the July 2018 ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case to these two cases. The complaints in each of the other cases name only Perrigo, Mr. Papa, and Ms. Brown as defendants. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint asserts claims under Sections 10(b) (and Rule 10b-5 thereunder) and all cases except </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Aberdeen</span><span style="font-family:Arial;font-size:10pt;"> assert claims under Section 14(e) of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The control person claims against the individual defendants are limited to the period from April 2015 through April 2016 in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> case. The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan</span><span style="font-family:Arial;font-size:10pt;"> cases also assert claims under Section 18 of the Exchange Act.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint alleges inadequate disclosures concerning the valuation and integration of Omega, the financial guidance we provided, our reporting about the generic prescription pharmaceutical business and its prospects, and the activities surrounding the efforts to defeat the Mylan tender offer during 2015, and, in each of the cases other than </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;">, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span>six</span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals. The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan</span><span style="font-family:Arial;font-size:10pt;"> complaint also alleges improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> asset. With the exception of </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;">, each of these cases relates to events during the period from April 2015 through May 2017. Many of the allegations in these cases overlap with the allegations of the June 2017 amended complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, though the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Nationwide Mutual, Schwab Capital, Aberdeen, Principal Funds </span><span style="font-family:Arial;font-size:10pt;">and</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> Kuwait </span><span style="font-family:Arial;font-size:10pt;">complaints do </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">not include the factual allegations that the court dismissed in the July 2018 ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After the court issued its July 2018 opinion in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, the parties in </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">First Manhattan </span><span style="font-family:Arial;font-size:10pt;">conferred and agreed that the ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case would apply equally to the common allegations in their cases. The later filed cases adopted a similar posture. The defendants in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and other cases listed above filed motions to dismiss addressing the additional allegations in such cases. On July 31, 2019, the court granted such motions to dismiss in part and denied them in part. That ruling applies to each of the above cases. The defendants have filed answers in each case denying liability. Each case is currently in the discovery phase.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Mason Capital</span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">,</span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Pentwater</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">and Similar Cases</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">. </span><span style="font-family:Arial;font-size:10pt;">The following </span><span style="font-family:Arial;font-size:10pt;"><span>eight</span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed by the same law firm and generally make the same factual allegations:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:76%;"/><td style="width:24%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital L.P., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">1/26/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater Equity Opportunities Master Fund Ltd., et al. &#160;v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">1/26/2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">11/15/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">11/15/2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">12/18/2019</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">12/20/2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Burlington Loan Management DAC v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/12/2020</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">3/2/2020</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital</span><span style="font-family:Arial;font-size:10pt;"> case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater </span><span style="font-family:Arial;font-size:10pt;">case originally named Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span>11</span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo as defendants. In the July 2018 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> ruling, the court dismissed without prejudice each of the defendants other than Perrigo, Mr. Papa and Ms.&#160;Brown from that case; these plaintiffs later agreed that this ruling would apply to their cases as well. The complaints in each of the other cases in the above table name only Perrigo, Mr. Papa, and Ms. Brown as defendants.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint asserts claims under Section 14(e) of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">WCM </span><span style="font-family:Arial;font-size:10pt;">case and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Universities Superannuation Scheme </span><span style="font-family:Arial;font-size:10pt;">case also assert claims under Section 10(b) of the Exchange Act and Rule 10b-5 thereunder.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint alleges inadequate disclosure during the tender offer period in 2015 and at various times concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span>six</span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> asset. The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">WCM </span><span style="font-family:Arial;font-size:10pt;">complaint also makes these allegations for the period through May 2017 and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Universities Superannuation Scheme</span><span style="font-family:Arial;font-size:10pt;"> complaint also concerns certain times during 2016. Many of the factual allegations in these cases overlap with the allegations of the June 2017 amended complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, and the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Mason Capital </span><span style="font-family:Arial;font-size:10pt;">and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Pentwater</span><span style="font-family:Arial;font-size:10pt;"> cases include factual allegations similar to those in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> case described above.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After the court issued its July 2018 opinion in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, the parties in each of the above cases</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> </span><span style="font-family:Arial;font-size:10pt;">conferred and agreed that the ruling in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case would apply equally to the common allegations in their cases. The defendants in each of these cases have filed answers denying liability, and each of the cases is currently in the discovery phase.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">Harel Insurance</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">and</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">Cases</span><span style="font-family:Arial;font-size:10pt;">. The following </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed by the same law firm and generally make the same factual allegations relating to the period from February 2014 through May 2017 (in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> case) and from August 2014 through May 2017 (in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;"> case):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:76%;"/><td style="width:24%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/13/2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">4/20/2018</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The complaints in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;"> cases originally named Perrigo and </span><span style="font-family:Arial;font-size:10pt;"><span>13</span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo as defendants (adding </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> more individual defendants not sued in the other cases described in this section). In the July 2018 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> ruling, the court dismissed without prejudice </span><span style="font-family:Arial;font-size:10pt;"><span>8</span></span><span style="font-family:Arial;font-size:10pt;"> of the </span><span style="font-family:Arial;font-size:10pt;"><span>11</span></span><span style="font-family:Arial;font-size:10pt;"> defendants other than Perrigo, Mr. Papa and Ms.&#160;Brown from that case. These plaintiffs later agreed that that ruling would apply to these cases as well and also dismissed their claims against the two additional individuals that only these plaintiffs had named as defendants.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each complaint asserts claims under Sections 10(b) and 14(e) of the Securities Exchange Act and Rule 10b-5 thereunder against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> case also asserts claims based on Israeli securities laws.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each of the complaints alleges inadequate disclosure around the tender offer events in 2015 and at various times during the relevant periods concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span>six</span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleged improper accounting for the Tysabri</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> asset from February 2014 until the withdrawal of past financial statements in April 2017. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After the court issued its July 2018 opinion in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case, the parties in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Harel</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">TIAA-CREF</span><span style="font-family:Arial;font-size:10pt;"> cases conferred and agreed that such ruling would apply equally to the common allegations in their cases. The defendants in each of these cases have filed answers denying liability, and each of the cases is currently in the discovery phase.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;text-decoration:underline;">Other Cases Related to Events in 2015-2017</span><span style="font-family:Arial;font-size:10pt;">. Certain allegations in the following </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> cases also overlap with the allegations of the June 2017 amended complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and with allegations in </span><span style="font-family:Arial;font-size:10pt;">one</span><span style="font-family:Arial;font-size:10pt;"> or more of the other individual cases described in the sections above:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:76%;"/><td style="width:24%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Case</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">Date Filed</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">2/6/2019</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields Capital I LP, et al. v. Perrigo Company plc, et al.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">6/4/2020</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">4/21/2020</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Each of the above complaints names Perrigo, Mr. Papa, and Ms. Brown as defendants. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Sculptor Master Fund (formerly OZ)</span><span style="font-family:Arial;font-size:10pt;"> complaint asserts claims under Sections 10(b) and 14(e) of the Securities Exchange Act and Rule 10b-5 thereunder against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. The parties have agreed that the court's rulings in July 2018 in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and in July 2019 in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Carmignac</span><span style="font-family:Arial;font-size:10pt;"> and related cases will apply to this case as well. The defendants have filed answers denying liability. The plaintiffs are participating in the discovery proceedings in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case and the various individual cases described above.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">BlackRock Global</span><span style="font-family:Arial;font-size:10pt;"> complaint also asserts claims under Securities Exchange Act section 10(b) (and SEC Rule 10b-5) and section 14(e) against all defendants and section 20(a) control person claims against the individual defendants largely based on the same events during the period from April 2015 through May 2017. Plaintiffs contend that the defendants provided inadequate disclosure during the tender offer period in 2015 and point to disclosures at various times during the period concerning valuation and integration of Omega, the financial guidance provided by us during that period, alleged price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span>six</span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, alleged lower performance in the generic prescription drug business during 2015 and alleged improper accounting for the Tysabri&#174; asset. The parties have begun discussions about the schedule for how this case should proceed.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> Highfields </span><span style="font-family:Arial;font-size:10pt;">federal case complaint asserted claims under Sections 14(e) and 18 of the Securities Exchange Act against all defendants, as well as control person liability under Section 20(a) of the Securities Exchange Act against the individual defendants. As originally filed in the U.S. District Court for the District of Massachusetts, the</span><span style="font-family:Arial;font-size:10pt;font-style:italic;"> Highfields</span><span style="font-family:Arial;font-size:10pt;"> complaint also alleged claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. The factual allegations generally were similar to the factual allegations in the Amended Complaint in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case described above, except that the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;"> plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs. In March 2020, the District of Massachusetts court granted defendants&#8217; motion and transferred the case to the U.S. District Court for the District of New Jersey so that the activities in the case could proceed in tandem with the other cases in the District of New Jersey described above. After the transfer, in June 2020, the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;"> plaintiffs voluntarily dismissed their federal lawsuit. The same </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Highfields</span><span style="font-family:Arial;font-size:10pt;"> plaintiffs the same day then filed a new lawsuit in Massachusetts State Court asserting the same factual allegations as in their federal lawsuit and alleging only Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In September 2020, the defendants submitted a motion to dismiss' plaintiffs filed an opposition in late October; defendants&#8217; reply is due in mid-November 2020.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In Israel (cases related to events in 2015-2017)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Because our shares are traded on the Tel Aviv exchange under a dual trading arrangement, we are potentially subject to securities litigation in Israel. </span><span style="font-family:Arial;font-size:10pt;"><span>Three</span></span><span style="font-family:Arial;font-size:10pt;"> cases were filed; </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> was voluntarily dismissed in each of 2017 and 2018 and </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> was stayed in 2018. We are consulting Israeli counsel about our response to these allegations and we intend to defend this case vigorously. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al.</span><span style="font-family:Arial;font-size:10pt;"> The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp; Young LLP (the Company&#8217;s auditor), and </span><span style="font-family:Arial;font-size:10pt;"><span>11</span></span><span style="font-family:Arial;font-size:10pt;"> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The complaint alleges violations under U.S. securities laws of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the </span><span style="font-family:Arial;font-size:10pt;"><span>11</span></span><span style="font-family:Arial;font-size:10pt;"> individuals or, in the alternative, under Israeli securities laws. In general, the allegations concern the actions taken by us and our former executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure concerning purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company, alleges price fixing activities with respect to </span><span style="font-family:Arial;font-size:10pt;"><span>six</span></span><span style="font-family:Arial;font-size:10pt;"> generic prescription pharmaceuticals, and alleges improper accounting for the Tysabri&#174; royalty stream. The plaintiff indicates an initial, preliminary class damages estimate of </span><span style="font-family:Arial;font-size:10pt;"><span>2.7 billion</span></span><span style="font-family:Arial;font-size:10pt;"> NIS (approximately </span><span style="font-family:Arial;font-size:10pt;"><span>$760.0</span></span><span style="font-family:Arial;font-size:10pt;">&#160;million at </span><span style="font-family:Arial;font-size:10pt;">1</span><span style="font-family:Arial;font-size:10pt;"> NIS = </span><span style="font-family:Arial;font-size:10pt;"><span>0.28</span></span><span style="font-family:Arial;font-size:10pt;"> cents). After the other </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund</span><span style="font-family:Arial;font-size:10pt;"> case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In the United States (cases related to Irish Tax events)</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 3, 2019, a shareholder filed a complaint against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in the U.S. District Court for the Southern District of New York (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Masih v. Perrigo Company, et al.</span><span style="font-family:Arial;font-size:10pt;">). Plaintiff purported to represent a class of shareholders for the period November 8, 2018 through December 20, 2018, inclusive. The complaint alleged violations of Securities Exchange Act section 10(b) (and Rule 10b&#8209;5) against all defendants and section 20(a) control person liability against the individual defendants. In general the allegations contended that the Company, in its Form 10&#8209;Q filed November 8, 2018, disclosed information about an October 31, 2018 audit finding letter received from Irish tax authorities but failed to disclose enough material information about that letter until December 20, 2018, when we filed a current report on Form 8&#8209;K about Irish tax matters. The plaintiff did not provide an estimate of class damages. The court selected lead plaintiffs and changed the name of the case to In re </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Perrigo Company plc Sec. Litig</span><span style="font-family:Arial;font-size:10pt;">. The lead plaintiffs filed an amended complaint on April </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">12, 2019, which named the same defendants, asserted the same class period, and invoked the same Exchange Act sections. The amended complaint generally repeated the allegations of the original complaint with a few additional details and adds that the defendants also failed to timely disclose the Irish tax authorities&#8217; Notice of Amended Assessment received on November 29, 2018. Defendants filed a motion to dismiss on May 3, 2019. On May 31, 2019, the plaintiffs filed a second amended complaint, which asserted a longer class period (March 1, 2018 through December 20, 2018) and added </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> additional individual defendant, former CEO Uwe Roehrhoff. In general, the second amended complaint contends that Perrigo&#8217;s disclosures about the Irish tax audit were inadequate beginning with Perrigo&#8217;s 10-K filed on March 1, 2018 through December 20, 2018 and repeats many of the allegations of the April 2019 amended complaint. The </span><span style="font-family:Arial;font-size:10pt;">second</span><span style="font-family:Arial;font-size:10pt;"> amended complaint alleges violations of Securities Exchange Act section 10(b) (and SEC Rule 10b-5) against all defendants and section 20(a) control person liability against the </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> individual defendants. All defendants filed a joint motion to dismiss, and the motion was fully briefed. On January 23, 2020, the court granted the motion to dismiss in part and denied it in part, dismissing Mr. Roehrhoff as a defendant and dismissing allegations of inadequate disclosures related to the audit by Irish Revenue during the period March 2018 through October 30, 2018. The court permitted the plaintiffs to pursue their claims against us, Mr. Kessler, and Mr. Winowiecki related to disclosures after Perrigo received the October 30, 2018 audit findings letter and later events through December 20, 2018. The defendants filed answers on February 13, 2020 denying liability, and the court held a scheduling conference on February 28, 2020, and issued a scheduling order on March 3, 2020. Discovery on the remaining issues is underway. Plaintiffs filed a motion for class certification, which was granted in September 2020. We intend to defend the lawsuit vigorously.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">In Israel (case related to Irish Tax events)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (</span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Baton v. Perrigo Company plc, et. al</span><span style="font-family:Arial;font-size:10pt;">.). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in the </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">In re Perrigo Company plc Sec. Litig </span><span style="font-family:Arial;font-size:10pt;">case in New York federal court. This case alleges that persons who invested through the Tel Aviv stock exchange can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. In 2019, the court granted </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> requests by Perrigo to stay the proceedings pending the resolution of proceedings in the United States.&#160;Perrigo filed a further request for a stay in February 2020, and the court granted the stay indefinitely. The plaintiff has filed a motion to lift the stay; Perrigo has filed an opposition; the court has requested further briefing from the plaintiff. We intend to defend the lawsuit vigorously. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Claim Arising from the Omega Acquisition</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On December 16, 2016, we and Perrigo Ireland 2 brought an arbitral claim ("Claim") against Alychlo NV ("Alychlo") and Holdco I BE NV (together the "Sellers") in accordance with clause 26.2 of the Share Purchase Agreement dated November 6, 2014 ("SPA") and the rules of the Belgian Centre for Arbitration and Mediation ("CEPANI"). Our Claim relates to the accuracy and completeness of information about Omega provided by the Sellers as part of the sale process, the withholding of information by the Sellers during that process and breaches of Sellers&#8217; warranties. We are seeking monetary damages from the Sellers. The Sellers served their respective responses to the Claim on February 20, 2017. In its response, Alychlo has asserted a counterclaim for monetary damages contending that we breached a warranty in the SPA and breached the duty of good faith in performing the SPA. Alychlo subsequently filed papers seeking permission to introduce an additional counterclaim theory of recovery related to the Irish tax issues disclosed by the Company such that if the position of the Irish tax authorities prevails, Alychlo would have further basis for its counterclaim against Perrigo. In June 2019, the Tribunal denied permission for Alychlo to introduce the additional counterclaim and dismissed certain aspects of the original Alychlo counterclaim. There can be no assurance that our Claim will be successful, and the Sellers deny liability for the Claim. To the extent that aspects of Alychlo&#8217;s counterclaim survived the Tribunal&#8217;s ruling in June 2019, we deny that Alychlo is entitled to any relief (including monetary relief). The arbitration proceedings are confidential as required by the SPA and the rules of the CEPANI.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Matters </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our Board of Directors received a shareholder demand letter dated October 30, 2018 relating to the allegations in the securities cases and price fixing lawsuits described above. The letter demands that the Board of Directors initiate an action against certain current and former executives and Board members to recover damages </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">allegedly caused to the Company. In response, the Company reminded the shareholder that any derivative claim can only proceed in accordance with Irish law, the law that governs the Company&#8217;s internal affairs. The shareholder responded that he would file a lawsuit asserting derivative claims.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On October 2, 2019, the shareholder filed a derivative action in the U.S. District Court for the District of New Jersey styled </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford, et al.</span><span style="font-family:Arial;font-size:10pt;"> The case was assigned to the same judges who are handling the Roofers' Pension Fund securities class action and related opt out cases described above. In addition to the Company, the lawsuit names as defendants current Board members Alford, Classon, Karaboutis, Kindler, O&#8217;Connor, Parker, and Samuels, current CEO Kessler, former Board members Smith, Brlas, Cohen, Fouse, Hoffing, Jandernoa, Kunkle, and Morris, former CEO Hendrickson, former CEO Papa, former CFO Brown, former CFO Winowiecki, and former Executive Vice Presidents Boothe and Coucke. The lawsuit seeks to authorize the shareholder to pursue claims on behalf of the Company against all the individual defendants for breach of their fiduciary duties and for unjust enrichment, and against the current director defendants, former director Mr. Smith, and current CEO Mr. Kessler for violations of Securities Exchange Act &#167;&#167; 14(a) (proxy statement disclosures) and 29(b) (disgorgement as a result of alleged violations of &#167;&#160;14(a)). The complaint alleges that the following events indicate that the individuals in their respective capacities failed to exercise appropriate control over the management of the Company and made inadequate public disclosures concerning the integration of Omega after acquisition; the Company&#8217;s past and prospective organic growth; the defense against the Mylan 2015 tender offer; the alleged collusive pricing activities regarding generic prescription products; the accounting by the Company for the Tysabri&#174; royalty stream; the 2018 Irish tax audit including potential liabilities for Irish taxes; and the April 2019 assertion of tax liabilities by the U.S. Internal Revenue Service (many of these factual events also underlie the multiple securities cases discussed earlier in this Note 14). All defendants have filed motions to dismiss asserting various reasons to dismiss. Plaintiff filed his opposition in March 2020. Defendants&#8217; filed replies in support of dismissal in June 2020. The court granted the motion to dismiss without prejudice on August 21, 2020. No appeal or other proceedings have been filed by the plaintiff. Therefore, we consider this case to have ended. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Talcum Powder</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has been named, together with other manufacturers, in product liability lawsuits in state courts in California</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;">,</span><span style="font-family:Arial;font-size:10pt;"> Florida, Missouri, New Jersey and Illinois and in the Southern District of Mississippi alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos.&#160;All but one of these cases involve a legacy talcum powder product that has not been manufactured by the Company since 1999.&#160; One of the pending actions involves a current prescription product that contains talc as an excipient. The Company has been named in </span><span style="font-family:Arial;font-size:10pt;"><span>32</span></span><span style="font-family:Arial;font-size:10pt;"> individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> additional matter. The Company has several defenses and intends to aggressively defend these lawsuits.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Ranitidine</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">In February 2020, the resulting actions involving Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;">/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. This MDL now includes </span><span style="font-family:Arial;font-size:10pt;"><span>three</span></span><span style="font-family:Arial;font-size:10pt;"> master complaints. The Company is named in </span><span style="font-family:Arial;font-size:10pt;"><span>two</span></span><span style="font-family:Arial;font-size:10pt;"> of those: the Master Personal Injury Complaint and the Consolidated Consumer Class Action Complaint.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:11pt;"><span style="font-family:Arial;font-size:10pt;"> As of October 6, 2020, the Company has been named in </span><span style="font-family:Arial;font-size:10pt;"><span>forty-two</span></span><span style="font-family:Arial;font-size:10pt;"> of the MDL&#8217;s consolidated personal injury lawsuits in various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company is named in these lawsuits with manufacturers of the national brand Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and other manufacturers of ranitidine products distributors, repackagers,</span><span style="font-family:Arial;font-size:11pt;font-weight:bold;"> </span><span style="font-family:Arial;font-size:10pt;">and/or retailers. Plaintiffs seek compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence.&#160;The Company is named in this lawsuit with manufacturers of the national brand Zantac</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></span><span style="font-family:Arial;font-size:10pt;"> and other manufacturers of ranitidine products and/or retailers. This action has been noticed to the MDL, but the New Mexico Attorney General is opposing consolidation. Some of the Company&#8217;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these and other consolidated cases. We intend to defend all of these lawsuits vigorously.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:174%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Acetaminophen</span><span style="font-family:Arial;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The Company has received requests for indemnification and defense of several consumer fraud claims involving its store brand infants&#8217; and children&#8217;s acetaminophen products.&#160;In September 2020, the Company was directly named as a defendant in </span><span style="font-family:Arial;font-size:10pt;"><span>one</span></span><span style="font-family:Arial;font-size:10pt;"> suit filed in the Central District of California. The Company has also received </span><span style="font-family:Arial;font-size:10pt;"><span>14</span></span><span style="font-family:Arial;font-size:10pt;"> different claims for indemnification or defense from </span><span style="font-family:Arial;font-size:10pt;"><span>9</span></span><span style="font-family:Arial;font-size:10pt;"> different retailers for lawsuits filed in California, Illinois and Pennsylvania, with nationwide class action allegations.&#160; </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div>The Plaintiffs generally allege that the children&#8217;s and infants&#8217; acetaminophen products have identical drug concentration amounts, yet the infants&#8217; product costs more than the children&#8217;s product and consumers have been misled into purchasing the more expensive product. The Company will aggressively defend the suit in which it is named and is continuing to assess whether, or to what extent, the Company may contribute in the lawsuits filed against its retail customers.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615208443768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text"><span style="font-family:Arial;font-weight:bold;">RESTRUCTURING CHARGES</span><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. The following reflects our restructuring activity (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:184px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/><td style="width:8px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Additional charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(13.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(25.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-cash adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The charges incurred during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> were primarily associated with actions taken to streamline the organization. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The charges incurred during the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;"> were primarily associated with the reorganization of our executive management team and other actions taken to streamline the organization. Of the amount recorded during the </span><span style="font-family:Arial;font-size:10pt;">nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">, </span><span style="font-family:Arial;font-size:10pt;"><span>$10.8 million</span></span><span style="font-family:Arial;font-size:10pt;"> related primarily to the sales force reorganization in France within the CSCI segment. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">There were no other material restructuring programs that significantly impacted any other reportable segments for the </span><span style="font-family:Arial;font-size:10pt;">three and nine months ended</span><span style="font-family:Arial;font-size:10pt;"> </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> or </span><span style="font-family:Arial;font-size:10pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:10pt;">.  All charges are recorded in </span><span style="font-family:Arial;font-size:10pt;">Restructuring</span><span style="font-family:Arial;font-size:10pt;"> expense on the Condensed Consolidated Statements of Operations. The remaining </span><span style="font-family:Arial;font-size:10pt;"><span>$7.9&#160;million</span></span><span style="font-family:Arial;font-size:10pt;"> liability for employee severance benefits is expected to be paid within the next year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615117405480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><span style="font-family:Arial;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</span><span style="font-family:Arial;font-size:10pt;font-weight:bold;"> </span><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our segments reflect the way in which our management makes operating decisions, allocates resources, and manages the growth and profitability of the Company.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The tables below show select financial measures by reporting segment (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:38%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,747.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,990.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,606.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,682.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,221.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,628.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11,576.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11,301.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:17%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>664.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>123.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>613.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>339.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>347.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>43.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>210.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(180.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>230.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(48.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(59.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(95.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>78.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:17%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,992.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>354.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>38.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,777.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>283.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,042.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>116.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,025.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>130.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>738.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(81.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>63.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>711.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>65.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(151.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(185.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>167.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>219.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>211.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>227.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122462088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended </span><span style="font-family:Arial;font-size:10pt;">December&#160;31, 2019</span>.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text">In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standard Pronouncements</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Below are recent Accounting Standard Updates ("ASU") that we are still assessing to determine the effect on our Condensed Consolidated Financial Statements. We do not believe that any other recently issued accounting standards could have a material effect on our Condensed Consolidated Financial Statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:17%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:41%;"/></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted </span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Standard</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Description</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2018-14: Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans  </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other post-retirement plans. </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">December 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we will no longer be required to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. We will be required to disclose an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, if applicable. </span></div><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance enhances and simplifies various aspects of the income tax accounting guidance in ASC 740.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">January 1, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we do not expect a material impact on the Consolidated Financial Statements.</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Standard Update</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">On January 1, 2020, we adopted ASU 2016-13 </span><span style="font-family:Arial;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASC 326")</span><span style="font-family:Arial;font-size:10pt;">, which replaces the incurred loss methodology with an expected loss methodology that is referred to as the Current Expected Credit Loss ("CECL") methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We adopted ASC 326 using the modified retrospective method for all financial assets measured at amortized cost, which includes trade receivables and contract assets. The cumulative effect of adopting ASC 326 was not material. </span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;">Allowance for Credit Losses</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and for reasonable and supportable forecasts. Historical credit loss experience provides the primary basis for estimation of expected credit losses. Adjustments to historical loss information may be made for significant changes in a geographic location&#8217;s economic conditions. Receivables that do not share risk characteristics are evaluated on an individual basis. These receivables are not included in the collective evaluation.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The allowance for credit losses is a valuation account that is deducted from the instruments&#8217; cost basis to present the net amount expected to be collected. Trade receivables and contract assets are charged off against the allowance when the balance is no longer deemed collectible. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115892552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of New Accounting Pronouncements</a></td>
<td class="text">As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:17%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:41%;"/></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted </span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Standard</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Description</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effective Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2018-14: Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans  </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other post-retirement plans. </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">December 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we will no longer be required to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. We will be required to disclose an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period, if applicable. </span></div><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">This guidance enhances and simplifies various aspects of the income tax accounting guidance in ASC 740.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">January 1, 2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Upon adoption, we do not expect a material impact on the Consolidated Financial Statements.</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Allowance for Credit Losses</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table presents the allowance for credit losses activity (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:76.31027253668763%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:57%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Provision for credit losses, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Receivables written-off</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Recoveries collected</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Currency translation adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615116110536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We generated net sales in the following geographic locations</span><span style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></span><span style="font-family:Arial;font-size:10pt;">(in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:526px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:134px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">U.S.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>820.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>785.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,571.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,323.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Europe</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>326.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>334.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,011.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>991.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">All other countries</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>66.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>191.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>200.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"/></span><span style="font-family:Arial;font-size:8pt;">(1)  Derived from the location of the entity that sells to a third party.</span></div><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:72px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(2)  Includes Ireland net sales of </span><span style="font-family:Arial;font-size:8pt;"><span>$10.8 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$22.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, respectively, and </span><span style="font-family:Arial;font-size:8pt;"><span>$5.2&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$17.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:8pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(3)  Includes net sales generated primarily in Israel, Mexico, Australia and Canada.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:Arial;font-size:10pt;font-style:italic;">Product Category</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">We re-aligned our product categories in our </span><span style="font-family:Arial;">CSCA</span><span style="font-family:Arial;font-size:10pt;"> and </span><span style="font-family:Arial;">CSCI</span><span style="font-family:Arial;font-size:10pt;"> segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following is a summary of our net sales by category (in millions); the comparative periods reflect the product category re-alignment: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:304px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:79px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Upper respiratory</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>114.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>123.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>385.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>377.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Digestive health</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>107.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>85.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>326.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>293.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Pain and sleep-aids</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>100.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>89.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>318.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>272.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Nutrition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>100.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>97.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>290.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>282.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Healthy lifestyle</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>86.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>87.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>253.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>250.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Oral self-care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>199.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Skincare and personal hygiene</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>49.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Vitamins, minerals, and supplements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Animal health</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>43.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other CSCA</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>60.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>48.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total CSCA</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>664.0</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>613.3</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,992.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,777.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Skincare and personal hygiene</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>83.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>88.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>275.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>296.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Upper respiratory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>62.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>72.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>191.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>193.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Vitamins, minerals, and supplements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>52.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>46.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>139.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>133.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Pain and sleep-aids</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>49.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>120.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Healthy lifestyle</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>38.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>124.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>134.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Oral self-care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Digestive health</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other CSCI</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>88.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>100.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>339.0</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>347.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,042.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,025.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>210.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>230.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>738.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>711.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total net sales</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)&#160;&#160;&#160;&#160;Includes net sales from our OTC contract manufacturing business.</span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&#160;&#160;&#160;&#160;</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(3)</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer Balances</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table provides information about contract assets from contracts with customers (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:26%;"/><td style="width:38%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Short-term contract assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615117372872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table presents unaudited pro forma information as if the Ranir acquisition had occurred on </span><span style="font-family:Arial;font-size:10pt;">January&#160;1, 2018</span><span style="font-family:Arial;font-size:10pt;"> and as if the acquisition of Dr. Fresh had occurred on </span><span style="font-family:Arial;font-size:10pt;">January&#160;1, 2019</span><span style="font-family:Arial;font-size:10pt;"> and had been combined with the results reported in our Condensed Consolidated Statements of Operations for all periods presented (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:539px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:134px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">(Unaudited)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,217.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,803.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,732.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(154.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>108.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>180.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the consideration paid for Dr. Fresh and the provisional amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:534px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:368px;"/><td style="width:6px;"/><td style="width:154px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Oral Care Assets of High Ridge Brands (Dr. Fresh)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase price paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>106.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>20.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>43.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>66.1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>122.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>106.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the consideration paid for Ranir and the amounts of the assets acquired and liabilities assumed (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:522px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:378px;"/><td style="width:6px;"/><td style="width:131px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Ranir</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase price paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>759.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>59.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>292.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Definite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>48.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>260.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>41.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Indefinite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>39.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>389.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>844.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payroll and related taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Accrued customer programs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>85.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>759.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119153048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="29"/></tr><tr><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Purchase accounting adjustments </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Business acquisitions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Business divestitures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Impairments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency translation adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,899.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,898.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,203.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(115.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,129.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,013.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(202.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>811.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total goodwill</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,116.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(115.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(202.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,839.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)  We had accumulated goodwill impairments of </span><span style="font-family:Arial;font-size:8pt;"><span>$868.4&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> as of each of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">.</span></div><span style="font-family:Arial;font-size:8pt;">(2)  We had accumulated goodwill impairments of </span><span style="font-family:Arial;font-size:8pt;"><span>$109.2 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$311.6 million</span></span><span style="font-family:Arial;font-size:8pt;"> as of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite and Indefinite-lived Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Intangible assets and related accumulated amortization consisted of the following (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.85534591194968%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Indefinite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>50.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:none;">Definite-lived intangibles</span><span style="font-family:Arial;font-size:9pt;text-decoration:none;">:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Distribution and license agreements and supply agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>134.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>83.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>126.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,335.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>731.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,392.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>755.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,866.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>776.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,805.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>671.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,462.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>313.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,353.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>250.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-compete agreements</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,805.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,909.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,685.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,763.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,819.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,909.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,753.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,763.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615120938312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Major Components of Inventory</a></td>
<td class="text"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Major components of inventory were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:9pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finished goods</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>618.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>530.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Work in process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>201.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>186.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Raw materials</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>280.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>250.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,100.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>967.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615325521608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value, Assets Measured on Recurring and Nonrecurring Basis</a></td>
<td class="text"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Measured at fair value on a recurring basis:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Investment securities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Funds associated with Israeli severance liability</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Royalty Pharma contingent milestone</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.6</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Contingent consideration payments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Measured at fair value on a non-recurring basis:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Goodwill</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>811.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,013.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>811.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,036.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">During the </span><span style="font-family:Arial;font-size:8pt;">three months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,013.5 million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$811.1 million</span></span><span style="font-family:Arial;font-size:8pt;">. During the year ended December 31, 2019, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,122.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,013.1&#160;million</span></span><span style="font-family:Arial;font-size:8pt;">. </span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(2)</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$55.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> were written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$23.3 million</span></span><span style="font-family:Arial;font-size:8pt;">. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the change in fair value of the Royalty Pharma contingent milestone (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:555px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:160px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:85px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:85px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>99.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>89.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>323.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payments received</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(250.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Change in fair value</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>91.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>121.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>91.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ScheduleofFairValueAssumptionsTableTextBlock', window );">Schedule of Fair Value Assumptions</a></td>
<td class="text">The table below represents the volatility and rate of return:<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:306px;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:113px;"/><td style="width:82px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Volatility</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Rate of return</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.84</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.99</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Level 3 Liabilities</a></td>
<td class="text"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The table below summarizes the change in fair value of contingent consideration payments (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:202px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Changes in value</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Settlements and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value of Contingent Consideration</a></td>
<td class="text">The fair value of our contingent consideration sales-based milestones as of <span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;">, was calculated using the following significant unobservable inputs:</span><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:29%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Valuation Technique</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Unobservable Input</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Range (Weighted Average)</span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Contingent consideration payments: sales-based milestones </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Discounted cash flow</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Projected royalties</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>36.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Projected year of payment of sales-based milestones</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021 - 2036 (2027)</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Unobservable inputs were weighted based on the relative estimated milestone payments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:520px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:233px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:56px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Public Bonds</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Carrying Value (excluding discount)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,760.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,600.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,969.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,618.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Private placement note</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Carrying value (excluding premium)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>151.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>168.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>168.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleofFairValueAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Fair Value Assumptions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleofFairValueAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122797448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Equity Securities</a></td>
<td class="text"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.79643231899266%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:28%;"/><td style="width:1%;"/><td style="width:39%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Equity method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Measured at fair value using the Net Asset Value practical expedient.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Security Expense (Income)</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions):</span></div><div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:24%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Measurement Category</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Fair value method</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Equity method</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122899848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock', window );">Schedule of Foreign Currency Forward Contracts</a></td>
<td class="text"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;font-style:italic;"/><span style="font-family:Arial;font-size:10pt;">Foreign currency forward contracts were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:55.55555555555556%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:44%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Notional Amount</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Israeli Shekel (ILS)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>398.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>712.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">European Euro (EUR)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>193.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">United States Dollar (USD)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>83.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>92.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Danish Krone (DKK)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>59.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>51.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">British Pound (GBP)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>56.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>86.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Swedish Krona (SEK)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>42.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Chinese Yuan (CNY)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>20.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Canadian Dollar (CAD)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>41.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Polish Zloty (PLZ)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Mexican Peso (MPX)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Norwegian Krone (NOK)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Switzerland Franc (CHF)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Romanian New Leu (RON)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>961.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,257.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:742px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:306px;"/><td style="width:237px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total designated derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:654px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:218px;"/><td style="width:237px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The following tables summarize the effect of derivative instruments designated as hedging instruments in Accumulated Other Comprehensive Income ("AOCI") (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:743px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:206px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:58px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contract</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(11.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(12.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:240px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span><span style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Treasury locks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(18.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contract</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(29.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1) Net </span><span style="font-family:Arial;font-size:8pt;">loss</span><span style="font-family:Arial;font-size:8pt;"> of </span><span style="font-family:Arial;font-size:8pt;"><span>$9.4 million</span></span><span style="font-family:Arial;font-size:8pt;"> is expected to be reclassified out of AOCI into earnings during the next 12 months.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:240px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:68px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:786px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:240px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:68px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:126px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:95px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Classification of Gain/(Loss) Recognized into Earnings Related to Amounts Excluded from Effectiveness Testing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings on Derivatives Related to Amounts Excluded from Effectiveness Testing</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash flow hedges:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net sales</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net investment hedges:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cross-currency swap</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Amount of Gain/(Loss) Recognized against Earnings</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:768px;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:200px;"/><td style="width:5px;"/><td style="width:166px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other (income) expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(14.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(27.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(15.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(26.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Classification of Gain (Loss) Recognized in Earnings on Fair Value and Cash Flow Hedging Relationships</a></td>
<td class="text"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>785.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>34.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,427.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>97.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Treasury locks</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>778.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(71.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:707px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:353px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Cost of Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Other (Income) Expense, net</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,222.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>90.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(65.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The effects of cash flow hedging:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Gain (loss) on cash flow hedging relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amount of gain or (loss) reclassified from AOCI into earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Foreign Currency Forward Contracts [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118089096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AssetsandLiabilitiesLesseeTableTextBlock', window );">Balance Sheet Location of Lease Assets and Liabilities</a></td>
<td class="text"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:160px;"/><td style="width:5px;"/><td style="width:306px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating lease assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>129.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>161.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:676px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:160px;"/><td style="width:5px;"/><td style="width:306px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-Current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other non-current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>106.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>101.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Long-term debt, less current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>164.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>158.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The below table shows our lease assets and liabilities by reporting segment (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:796px;border-collapse:collapse;text-align:left;"><tr><td colspan="33"/></tr><tr><td style="width:72px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:73px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Financing</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8.5pt;"><span style="font-family:Arial;font-size:8.5pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>41.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>42.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>35.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>36.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>46.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>50.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>129.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>27.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>133.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Expense</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Lease expense was as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:177px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>32.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Interest</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:Arial;font-size:8pt;"/><span style="font-family:Arial;font-size:8pt;">(1)  Includes short-term leases and variable lease costs, which are immaterial</span><span style="font-family:Arial;font-size:8pt;">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease Maturity</a></td>
<td class="text"><div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The annual future maturities of our leases as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:192px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">After 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Total lease payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>188.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Less: Interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Present value of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>164.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Liability Maturity</a></td>
<td class="text"><div style="line-height:120%;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The annual future maturities of our leases as of </span><span style="font-family:Arial;font-size:10pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:10pt;"> are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:468px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:192px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:75px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2022</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>25.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>29.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2024</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>16.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">After 2024</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>14.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Total lease payments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>188.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Less: Interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Present value of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>138.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>164.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock', window );">Weighted Average Lease Terms and Discount Rates</a></td>
<td class="text"><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our weighted average lease terms and discount rates are as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:473px;"/><td style="width:5px;"/><td style="width:89px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:89px;"/><td style="width:10px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Weighted-average remaining lease term (in years)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>6.58</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.03</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.90</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted-average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;background-color:#cceeff;">Operating leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.80</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.50</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LesseeCashFlowClassificationsTableTextBlock', window );">Lease Cash Flow Classifications</a></td>
<td class="text"><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:96px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Our lease cash flow classifications are as follows (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:473px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:89px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>33.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Operating cash flows for finance leases</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Financing cash flows for finance leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new finance lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Leased assets obtained in exchange for new operating lease liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>26.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AssetsandLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AssetsandLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeCashFlowClassificationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Cash Flow Classifications [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeCashFlowClassificationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122899848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Total borrowings outstanding are summarized as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.48427672955975%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:2%;"/><td style="width:13%;"/><td style="width:27%;"/><td style="width:5%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Term loan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">2019 Term loan due August 15, 2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>600.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>600.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Notes and Bonds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:underline;">Coupon</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;text-decoration:underline;">Due</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.500%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">March 15, 2021</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>280.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.500%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">December 15, 2021</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>309.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.105%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>July 28, 2023</span></span><span style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>157.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>151.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.000%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">November 15, 2023</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>215.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>215.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.900%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">December 15, 2024</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.375%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">March 15, 2026</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>700.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3.150%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">June 15, 2030</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>750.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.300%</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">November 15, 2043</span></span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>90.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>90.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4.900%</span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span><span style="white-space:nowrap">December 15, 2044</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>303.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>303.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total notes and bonds</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,917.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,751.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:normal;">Other financing</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>61.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unamortized premium (discount), net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Deferred financing fees</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(17.9</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(14.1</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total borrowings outstanding</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,560.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,369.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Current indebtedness</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(16.5</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(3.4</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total long-term debt less current portion</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,543.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,365.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:72px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1)  Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115905304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share and Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings per Share, Basic and Diluted</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Net income (loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(154.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>92.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>165.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards*</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>137.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>136.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS*</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">*  In the period of a net loss, diluted shares equal basic shares.</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118277032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">Changes in our AOCI balances, net of tax were as follows (in millions): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value of Derivative Financial Instruments, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign Currency Translation Adjustments</span><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Post-Retirement and Pension Liability Adjustments, net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total AOCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>132.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>139.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">OCI before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(11.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>34.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Amounts reclassified from AOCI</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>46.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Other comprehensive income (loss)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(12.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>64.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Balance at September 26, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>213.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>203.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">(1) Refer to </span><a href="#sA0BB308013C05849BCFF1B0C8BBA3C08" style="font-family:Arial;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Note 3</span></a><span style="font-family:Arial;font-size:8pt;"> Rosemont Pharmaceuticals business divestiture for information regarding amounts reclassified from AOCI.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121031656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective income tax rate reconciliation</a></td>
<td class="text"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The effective tax rates were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:391px;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:78px;"/><td style="width:14px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/><td style="width:5px;"/><td style="width:82px;"/><td style="width:10px;"/></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(21.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>78.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">%</span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118640936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text">The following reflects our restructuring activity (in millions):<div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:594px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:184px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/><td style="width:8px;"/><td style="width:6px;"/><td style="width:86px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;28, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>9.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>24.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Additional charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>23.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(2.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(13.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(25.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Non-cash adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Ending balance</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615115919464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;">The tables below show select financial measures by reporting segment (in millions):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:38%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br/>2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,747.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,990.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,606.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>4,682.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,221.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>2,628.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11,576.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>11,301.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:17%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>664.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>123.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>613.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>81.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>12.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>339.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>40.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>347.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>43.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>210.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(180.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>230.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(48.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(59.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,213.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(95.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>73.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,191.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>54.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>78.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:17%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">September 28, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Net </span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCA</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,992.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>354.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>38.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,777.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>283.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>31.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">CSCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,042.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>45.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>116.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>1,025.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>130.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">RX</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>738.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(81.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>63.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>711.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>95.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>65.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Unallocated</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(151.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>(185.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,773.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>167.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>219.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>3,514.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>211.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;"><span>227.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122879912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 6.2<span></span>
</td>
<td class="nump">$ 6.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses, net</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs', window );">Receivables written-off</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Recoveries collected</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation', window );">Currency translation adjustment</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loans and leases that have been written off from both loan receivables and allowance reserve for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615123211672">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Revenue by Geographic Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,213.7<span></span>
</td>
<td class="nump">$ 1,191.1<span></span>
</td>
<td class="nump">$ 3,773.8<span></span>
</td>
<td class="nump">$ 3,514.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">820.8<span></span>
</td>
<td class="nump">785.9<span></span>
</td>
<td class="nump">2,571.1<span></span>
</td>
<td class="nump">2,323.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">326.6<span></span>
</td>
<td class="nump">334.6<span></span>
</td>
<td class="nump">1,011.0<span></span>
</td>
<td class="nump">991.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember', window );">All other countries</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">66.3<span></span>
</td>
<td class="nump">70.6<span></span>
</td>
<td class="nump">191.7<span></span>
</td>
<td class="nump">200.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 22.3<span></span>
</td>
<td class="nump">$ 17.3<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Derived from the location of the entity that sells to a third party.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes Ireland net sales of <span style="font-family:Arial;font-size:8pt;"><span>$10.8 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$22.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, respectively, and </span><span style="font-family:Arial;font-size:8pt;"><span>$5.2&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$17.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> for the </span><span style="font-family:Arial;font-size:8pt;">three and nine months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;28, 2019</span><span style="font-family:Arial;font-size:8pt;">, respectively.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes net sales generated primarily in Israel, Mexico, Australia and Canada.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121852328">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th" colspan="2"><div>Sep. 26, 2020</div></th>
<th class="th" colspan="2"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,213.7<span></span>
</td>
<td class="nump">$ 1,191.1<span></span>
</td>
<td class="nump">$ 3,773.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,514.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">664.0<span></span>
</td>
<td class="nump">613.3<span></span>
</td>
<td class="nump">1,992.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,777.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Upper respiratory</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">114.2<span></span>
</td>
<td class="nump">123.4<span></span>
</td>
<td class="nump">385.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">377.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Digestive health</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">107.1<span></span>
</td>
<td class="nump">85.0<span></span>
</td>
<td class="nump">326.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">293.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Pain and sleep-aids</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.6<span></span>
</td>
<td class="nump">89.4<span></span>
</td>
<td class="nump">318.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">272.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Nutrition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.1<span></span>
</td>
<td class="nump">97.1<span></span>
</td>
<td class="nump">290.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">282.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Healthy lifestyle</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">86.1<span></span>
</td>
<td class="nump">87.9<span></span>
</td>
<td class="nump">253.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">250.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Oral self-care</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">81.1<span></span>
</td>
<td class="nump">54.2<span></span>
</td>
<td class="nump">199.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">54.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Skincare and personal hygiene</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49.2<span></span>
</td>
<td class="nump">45.4<span></span>
</td>
<td class="nump">138.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">136.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Vitamins, minerals, and supplements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">19.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">18.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Animal health</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">43.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Other CSCA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19.3<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="nump">48.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">339.0<span></span>
</td>
<td class="nump">347.5<span></span>
</td>
<td class="nump">1,042.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,025.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Upper respiratory</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62.3<span></span>
</td>
<td class="nump">72.1<span></span>
</td>
<td class="nump">191.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">193.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Digestive health</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Pain and sleep-aids</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49.0<span></span>
</td>
<td class="nump">40.5<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">120.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Healthy lifestyle</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">124.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">134.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Oral self-care</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">24.3<span></span>
</td>
<td class="nump">68.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Skincare and personal hygiene</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83.1<span></span>
</td>
<td class="nump">88.9<span></span>
</td>
<td class="nump">275.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">296.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Vitamins, minerals, and supplements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52.9<span></span>
</td>
<td class="nump">46.2<span></span>
</td>
<td class="nump">139.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">133.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Other CSCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19.1<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">100.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 210.7<span></span>
</td>
<td class="nump">$ 230.3<span></span>
</td>
<td class="nump">$ 738.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 711.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Derived from the location of the entity that sells to a third party.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes net sales from our OTC contract manufacturing business.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_UpperRespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_UpperRespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_DigestiveHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_DigestiveHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_PainandSleepaidsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_PainandSleepaidsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_NutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_NutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_HealthyLifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_HealthyLifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OralSelfcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OralSelfcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_SkincareandPersonalHygieneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_SkincareandPersonalHygieneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_VitaminsMineralsandSupplementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_VitaminsMineralsandSupplementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_AnimalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_AnimalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OtherCSCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OtherCSCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OtherCSCIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OtherCSCIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615117356136">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,213.7<span></span>
</td>
<td class="nump">$ 1,191.1<span></span>
</td>
<td class="nump">$ 3,773.8<span></span>
</td>
<td class="nump">$ 3,514.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prgo_ContractManufacturingMember', window );">Contract manufacturing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 76.7<span></span>
</td>
<td class="nump">$ 73.9<span></span>
</td>
<td class="nump">$ 190.7<span></span>
</td>
<td class="nump">$ 207.0<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Derived from the location of the entity that sells to a third party.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615116092264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Short-term contract assets</a></td>
<td class="nump">$ 21.2<span></span>
</td>
<td class="nump">$ 26.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615129259096">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Oral Care Assets of High Ridge Brands and Ranir Global Holdings,LLC Acquisitions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration - net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106.0<span></span>
</td>
<td class="nump">$ 749.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustment to goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,839.3<span></span>
</td>
<td class="nump">$ 3,839.3<span></span>
</td>
<td class="nump">$ 4,116.7<span></span>
</td>
<td class="nump">3,839.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustment to goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,898.8<span></span>
</td>
<td class="nump">1,898.8<span></span>
</td>
<td class="nump">1,899.1<span></span>
</td>
<td class="nump">1,898.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustment to goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,129.4<span></span>
</td>
<td class="nump">1,129.4<span></span>
</td>
<td class="nump">1,203.7<span></span>
</td>
<td class="nump">1,129.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 113.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Prepayment of contract consideration for transitional services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net sales since acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income since acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets', window );">Operating lease assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.1<span></span>
</td>
<td class="nump">66.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.2<span></span>
</td>
<td class="nump">122.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes', window );">Payroll and related taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.0<span></span>
</td>
<td class="nump">106.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">17 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | CSCA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Inventory costs stepped up to acquisition date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">General transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Measurement period adjustment to intangibles</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustment to goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | CSCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Distribution and License Agreements and Supply Agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Developed product technology, formulations, and product rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Customer relationships and distribution networks</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember', window );">Oral Care Assets of High Ridge Brands (Dr. Fresh) | Trademarks, trade names, and brands</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 759.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Outstanding equity interest acquired (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationBaseConsiderationTransferred', window );">Total base consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration - net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net sales since acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income since acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Inventory costs stepped up to acquisition date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets', window );">Operating lease assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">844.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes', window );">Payroll and related taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">759.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC | CSCA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212.6<span></span>
</td>
<td class="nump">212.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be tax deductible</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252.3<span></span>
</td>
<td class="nump">252.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC | CSCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80.1<span></span>
</td>
<td class="nump">$ 80.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC | In-process research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Indefinite-lived intangibles</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC | Developed product technology, formulations, and product rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC | Customer relationships and distribution networks</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember', window );">Ranir Global Holdings, LLC | Trademarks, trade names, and brands</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Ranir Global Holdings, LLC | Trademarks, trade names, and brands</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Ranir Global Holdings, LLC | Trademarks, trade names, and brands</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Estimated fair value of assets acquired and liabilities assumed:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">We had accumulated goodwill impairments of <span style="font-family:Arial;font-size:8pt;"><span>$868.4&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> as of each of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationBaseConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Base Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationBaseConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118566728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Divestitures (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 07, 2020 </div>
<div>EUR (&#8364;) </div>
<div>brand</div>
</th>
<th class="th">
<div>Feb. 13, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 17, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember', window );">Sanofi Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofBrandsAcquired', window );">Number of brands acquired | brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price paid | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 52.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember', window );">Steripod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Developed product technology, formulations, and product rights | Generic Product Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payments to acquire the ANDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.0<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Developed product technology, formulations, and product rights | Budesonide Nasal Spray and Triamcinolone Nasal Spray</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payments to acquire the ANDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IncomefromSalesOwnedbytheCompanyPercent', window );">Income from sales owned by the company (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandMember', window );">Brand | Dexsil</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandMember', window );">Brand | Steripod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Sanofi Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price paid</a></td>
<td class="nump">$ 62.0<span></span>
</td>
<td class="nump">&#8364; 53.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomefromSalesOwnedbytheCompanyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income from Sales Owned by the Company, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomefromSalesOwnedbytheCompanyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofBrandsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Brands Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofBrandsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_GenericProductAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_GenericProductAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_DexsilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_DexsilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119678584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Pro Forma Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Net sales</a></td>
<td class="nump">$ 1,213.7<span></span>
</td>
<td class="nump">$ 1,217.1<span></span>
</td>
<td class="nump">$ 3,803.4<span></span>
</td>
<td class="nump">$ 3,732.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="num">$ (154.5)<span></span>
</td>
<td class="nump">$ 108.1<span></span>
</td>
<td class="nump">$ 18.6<span></span>
</td>
<td class="nump">$ 180.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615214242184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Divestiture (Details)<br> &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 08, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187.8<span></span>
</td>
<td class="nump">$ 183.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18.6)<span></span>
</td>
<td class="nump">$ 72.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_CSCIMember', window );">CSCI | Rosemont Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of business</a></td>
<td class="nump">&#163; 155.6<span></span>
</td>
<td class="nump">$ 195.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Animal health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_CSCIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_CSCIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RosemontPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RosemontPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_AnimalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_AnimalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119695064">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th" colspan="2"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">December 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4,116.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Business divestitures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(115.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(202.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">September 26, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,839.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,839.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">December 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,899.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Business divestitures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">September 26, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,898.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,898.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">December 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,203.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Business divestitures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(115.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">September 26, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,129.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,129.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">868.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">868.4<span></span>
</td>
<td class="nump">$ 868.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">December 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,013.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Business divestitures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(202.4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(202.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">September 26, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">811.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">811.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 311.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 311.6<span></span>
</td>
<td class="nump">$ 109.2<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">We had accumulated goodwill impairments of <span style="font-family:Arial;font-size:8pt;"><span>$868.4&#160;million</span></span><span style="font-family:Arial;font-size:8pt;"> as of each of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">We had accumulated goodwill impairments of <span style="font-family:Arial;font-size:8pt;"><span>$109.2 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$311.6 million</span></span><span style="font-family:Arial;font-size:8pt;"> as of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615215049688">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th" colspan="2"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,839,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,839,300,000<span></span>
</td>
<td class="nump">$ 4,116,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">202,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=prgo_BCSMember', window );">BCS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 995,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 995,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Fair value of reporting unit in excess of net book value (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">811,100,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 811,100,000<span></span>
</td>
<td class="nump">$ 1,013,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 202,400,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 202,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">We had accumulated goodwill impairments of <span style="font-family:Arial;font-size:8pt;"><span>$109.2 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$311.6 million</span></span><span style="font-family:Arial;font-size:8pt;"> as of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=prgo_BCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=prgo_BCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615200694488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible categories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles:</a></td>
<td class="nump">$ 14.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">4,805.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,805.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,685.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,909.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,909.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,763.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total other intangible assets</a></td>
<td class="nump">4,819.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,819.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,753.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible assets amortization expense</a></td>
<td class="nump">73.9<span></span>
</td>
<td class="nump">$ 78.7<span></span>
</td>
<td class="nump">219.3<span></span>
</td>
<td class="nump">$ 227.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">202.4<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">202.4<span></span>
</td>
<td class="nump">42.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Distribution and license agreements and supply agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">134.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">83.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed product technology, formulations, and product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">1,335.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,335.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,392.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">731.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships and distribution networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">1,866.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,866.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,805.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">776.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">776.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">671.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks, trade names, and brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">1,462.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,462.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,353.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">313.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember', window );">Trademarks, trade names, and brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles:</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles:</a></td>
<td class="nump">10.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible assets amortization expense</a></td>
<td class="nump">$ 21.3<span></span>
</td>
<td class="nump">22.8<span></span>
</td>
<td class="nump">$ 63.8<span></span>
</td>
<td class="nump">$ 65.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_EvamistBrandedProductMember', window );">Evamist Branded Product | RX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_GenericProductAcquisitionMember', window );">Generic Product | RX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite and Indefinite-Lived Assets By Major Class [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_EvamistBrandedProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_EvamistBrandedProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_GenericProductAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_GenericProductAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118149800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 618.9<span></span>
</td>
<td class="nump">$ 530.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">201.3<span></span>
</td>
<td class="nump">186.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">280.5<span></span>
</td>
<td class="nump">250.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 1,100.7<span></span>
</td>
<td class="nump">$ 967.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615200727624">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Instruments at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Measured at fair value on a non-recurring basis:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,839.3<span></span>
</td>
<td class="nump">$ 4,116.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-lived intangible assets carrying value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,895.4<span></span>
</td>
<td class="nump">2,921.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Measured at fair value on a recurring basis | Level 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Cross-currency swap</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure', window );">Funds associated with Israeli severance liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_PotentialContingentMilestonePayments', window );">Royalty Pharma contingent milestone</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Measured at fair value on a recurring basis | Level 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Cross-currency swap</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure', window );">Funds associated with Israeli severance liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_PotentialContingentMilestonePayments', window );">Royalty Pharma contingent milestone</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30.6<span></span>
</td>
<td class="nump">45.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Measured at fair value on a recurring basis | Level 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Cross-currency swap</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure', window );">Funds associated with Israeli severance liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_PotentialContingentMilestonePayments', window );">Royalty Pharma contingent milestone</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">121.2<span></span>
</td>
<td class="nump">95.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">121.2<span></span>
</td>
<td class="nump">95.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Measured at fair value on a non-recurring basis</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Measured at fair value on a non-recurring basis:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-lived intangible assets carrying value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Measured at fair value on a non-recurring basis | Level 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Measured at fair value on a non-recurring basis:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Measured at fair value on a non-recurring basis | Level 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Measured at fair value on a non-recurring basis:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Measured at fair value on a non-recurring basis | Level 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">811.1<span></span>
</td>
<td class="nump">1,036.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Measured at fair value on a non-recurring basis:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">811.1<span></span>
</td>
<td class="nump">1,013.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Definite-lived intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">23.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Measured at fair value on a non-recurring basis:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">811.1<span></span>
</td>
<td class="nump">1,013.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX | Measured at fair value on a non-recurring basis</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Measured at fair value on a non-recurring basis:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,013.5<span></span>
</td>
<td class="nump">$ 1,122.3<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">During the </span><span style="font-family:Arial;font-size:8pt;">three months ended</span><span style="font-family:Arial;font-size:8pt;"> </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span><span style="font-family:Arial;font-size:8pt;">, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,013.5 million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$811.1 million</span></span><span style="font-family:Arial;font-size:8pt;">. During the year ended December 31, 2019, goodwill with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,122.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> was written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$1,013.1&#160;million</span></span><span style="font-family:Arial;font-size:8pt;">. </span></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family:Arial;font-size:8pt;">During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of </span><span style="font-family:Arial;font-size:8pt;"><span>$55.3 million</span></span><span style="font-family:Arial;font-size:8pt;"> were written down to a fair value of </span><span style="font-family:Arial;font-size:8pt;"><span>$23.3 million</span></span>.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">We had accumulated goodwill impairments of <span style="font-family:Arial;font-size:8pt;"><span>$109.2 million</span></span><span style="font-family:Arial;font-size:8pt;"> and </span><span style="font-family:Arial;font-size:8pt;"><span>$311.6 million</span></span><span style="font-family:Arial;font-size:8pt;"> as of December 31, 2019 and </span><span style="font-family:Arial;font-size:8pt;">September&#160;26, 2020</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Unobservable Input Reconciliation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PotentialContingentMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Contingent Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PotentialContingentMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119125736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Measured on a recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Contingent Consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="nump">$ 11.9<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in value</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements and other adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember', window );">Royalty Pharma Contingent Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Royalty Pharma Contingent Milestone Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember', window );">Royalty Pharma Contingent Milestone Payments | Measured on a recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Royalty Pharma Contingent Milestone Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">99.0<span></span>
</td>
<td class="nump">89.1<span></span>
</td>
<td class="nump">$ 323.2<span></span>
</td>
<td class="nump">95.3<span></span>
</td>
<td class="nump">323.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(250.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Change in fair value</a></td>
<td class="nump">22.2<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">$ 121.2<span></span>
</td>
<td class="nump">$ 91.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121.2<span></span>
</td>
<td class="nump">$ 91.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615123861704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount', window );">Transfers among level 1, 2, and 3</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Income recognized from change is asset</a></td>
<td class="nump">22.2<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">$ 18.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember', window );">Royalty Pharma Contingent Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NetSalesIncludedinCalculationForMilestonePayment', window );">Net sales included in calculation for milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 337.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember', window );">Royalty Pharma Contingent Milestone Payments | Measured on a recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Increase (decrease) in fair value of milestone payment</a></td>
<td class="nump">22.2<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Estimated fair valued contingent milestone payment</a></td>
<td class="nump">121.2<span></span>
</td>
<td class="nump">91.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121.2<span></span>
</td>
<td class="nump">91.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.3<span></span>
</td>
<td class="nump">$ 323.2<span></span>
</td>
<td class="nump">$ 99.0<span></span>
</td>
<td class="nump">$ 89.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember', window );">Royalty Pharma 2020 Contingent Milestone Payments | Measured on a recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Estimated fair valued contingent milestone payment</a></td>
<td class="nump">$ 121.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=prgo_RoyaltyPharmaMember', window );">Royalty Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssumptionVolatility', window );">Volatility</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FairValueAssumptionsRateofReturn', window );">Rate of return</a></td>
<td class="nump">6.84%<span></span>
</td>
<td class="nump">7.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AssetAdjustedFairValueifSalesThresholdMet', window );">Royalty Pharma contingent payment sales threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Scenario, Forecast | Royalty Pharma Contingent Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AssetAdjustedFairValueifSalesThresholdMet', window );">Royalty Pharma contingent payment sales threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NetSalesThresholdForMilestonePayment', window );">Net sales threshold to trigger milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Income recognized from change is asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 278.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Discounted Cash Flow | Contingent Consideration | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent', window );">Contingent consideration payments: sales-based milestones (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX | Discounted Cash Flow | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ReportingUnitFairValuePercent', window );">Reporting unit, fair value (percent)</a></td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX | Discounted Cash Flow | Measurement Input, Long-term Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ReportingUnitFairValuePercent', window );">Reporting unit, fair value (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | RX | Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BlendedJurisdictionalTaxRatesPercent', window );">Blended jurisdictional tax rates (percent)</a></td>
<td class="nump">19.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | RX | Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_BlendedJurisdictionalTaxRatesPercent', window );">Blended jurisdictional tax rates (percent)</a></td>
<td class="nump">21.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AssetAdjustedFairValueifSalesThresholdMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset, Adjusted Fair Value if Sales Threshold Met</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AssetAdjustedFairValueifSalesThresholdMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BlendedJurisdictionalTaxRatesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Blended Jurisdictional Tax Rates, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BlendedJurisdictionalTaxRatesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration Payments, Sales-based Milestones, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FairValueAssetsLevel1Level2Level3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FairValueAssetsLevel1Level2Level3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FairValueAssumptionVolatility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Assumption, Volatility</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FairValueAssumptionVolatility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FairValueAssumptionsRateofReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Assumptions, Rate of Return</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FairValueAssumptionsRateofReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NetSalesIncludedinCalculationForMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Sales Included in Calculation For Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NetSalesIncludedinCalculationForMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NetSalesThresholdForMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Sales Threshold For Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NetSalesThresholdForMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ReportingUnitFairValuePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reporting Unit, Fair Value, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ReportingUnitFairValuePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharmaContingentMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=prgo_RoyaltyPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=prgo_RoyaltyPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prgo_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prgo_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119720296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Contingent Consideration (Details) - Contingent Consideration - Discounted Cash Flow<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prgo_ContingentConsiderationMember', window );">Measurement Input, Projected Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ContingentConsiderationPaymentsSalesbasedMilestones', window );">Contingent consideration payments: sales-based milestones</a></td>
<td class="nump">$ 36.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prgo_ContingentConsiderationMember', window );">Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent', window );">Contingent consideration payments: sales-based milestones (percent)</a></td>
<td class="nump">26.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ContingentConsiderationPaymentsSalesbasedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration Payments, Sales-based Milestones</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ContingentConsiderationPaymentsSalesbasedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration Payments, Sales-based Milestones, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prgo_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prgo_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=prgo_MeasurementInputProjectedRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=prgo_MeasurementInputProjectedRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615120240488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public bonds</a></td>
<td class="nump">$ 2,917.1<span></span>
</td>
<td class="nump">$ 2,751.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember', window );">Public Bonds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public bonds</a></td>
<td class="nump">2,969.9<span></span>
</td>
<td class="nump">2,618.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_PrivatePlacementNoteMember', window );">Private placement note | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Private placement note</a></td>
<td class="nump">168.0<span></span>
</td>
<td class="nump">168.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Public Bonds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public bonds</a></td>
<td class="nump">2,760.0<span></span>
</td>
<td class="nump">2,600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Private placement note | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Private placement note</a></td>
<td class="nump">$ 157.1<span></span>
</td>
<td class="nump">$ 151.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_PrivatePlacementNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_PrivatePlacementNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121037896">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 17, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Amount paid for investment upon close of the transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember', window );">Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity securities, fair value method, other expense (income)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity securities, equity method, other expense (income)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">$ (2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, fair value method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, fair value method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity securities, equity method, other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember', window );">Kazmira, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity securities, equity method, other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership Interest (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Amount paid for investment upon close of the transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_EquityMethodInvestmentPeriodforPayment', window );">Period for payment of balance of equity method investment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial;font-size:8pt;">(1) </span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;">Measured at fair value using the Net Asset Value practical expedient.</span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_EquityMethodInvestmentPeriodforPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Period for Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_EquityMethodInvestmentPeriodforPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615123792968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 498.0<span></span>
</td>
<td class="nump">&#8364; 450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 961.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 155.0<span></span>
</td>
<td class="nump">$ 194.5<span></span>
</td>
<td class="nump">$ 1,257.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum remaining maturity of foreign currency derivatives</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_ILS', window );">Israeli Shekel (ILS) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 398.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">European Euro (EUR) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">193.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States Dollar (USD) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">83.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_DKK', window );">Danish Krone (DKK) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">59.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_GBP', window );">British Pound (GBP) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">56.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SEK', window );">Swedish Krona (SEK) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">45.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CNY', window );">Chinese Yuan (CNY) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">40.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canadian Dollar (CAD) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_PLN', window );">Polish Zloty (PLZ) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">16.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexican Peso (MPX) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_NOK', window );">Norwegian Krone (NOK) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CHF', window );">Switzerland Franc (CHF) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_RON', window );">Romanian New Leu (RON) | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_XXX', window );">Other | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_DKK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_DKK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SEK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SEK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_PLN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_PLN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_NOK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_NOK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_RON">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_RON</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118130440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated derivatives:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">$ 12.2<span></span>
</td>
<td class="nump">$ 27.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated derivatives: | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated derivatives: | Other non-current assets | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated derivatives: | Other accrued liabilities | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liability Derivatives</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Non-designated derivatives: | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Non-designated derivatives: | Other accrued liabilities | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liability Derivatives</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121926024">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th" colspan="2"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2.6)<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet', window );">Amount of Gain/(Loss) Reclassified from AOCI into Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet', window );">Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Net gain expected to be reclassified out of AOCI into earnings in the next 12 months</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness', window );">Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember', window );">Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury Lock | Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness', window );">Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury Lock | Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury Lock | Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2.6)<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">30.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap | Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Net <span style="font-family:Arial;font-size:8pt;">loss</span><span style="font-family:Arial;font-size:8pt;"> of </span><span style="font-family:Arial;font-size:8pt;"><span>$9.4 million</span></span><span style="font-family:Arial;font-size:8pt;"> is expected to be reclassified out of AOCI into earnings during the next 12 months.</span><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"><br/></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on the cash flow hedging instrument excluded from the assessment of cash flow hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615200709240">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,213.7<span></span>
</td>
<td class="nump">$ 1,191.1<span></span>
</td>
<td class="nump">$ 3,773.8<span></span>
</td>
<td class="nump">$ 3,514.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">785.6<span></span>
</td>
<td class="nump">778.3<span></span>
</td>
<td class="nump">2,427.8<span></span>
</td>
<td class="nump">2,222.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34.0<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">97.6<span></span>
</td>
<td class="nump">90.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(71.0)<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
<td class="num">(65.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Non-designated derivatives:</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of Gain/(Loss) Recognized against Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.2<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="num">(26.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember', window );">Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember', window );">Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury Lock | Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury Lock | Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury Lock | Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Treasury Lock | Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Other (income) expense, net | Non-designated derivatives:</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of Gain/(Loss) Recognized against Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.5<span></span>
</td>
<td class="num">(14.7)<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(27.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Interest expense, net | Non-designated derivatives:</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of Gain/(Loss) Recognized against Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Derived from the location of the entity that sells to a third party.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122620040">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,213.7<span></span>
</td>
<td class="nump">$ 1,191.1<span></span>
</td>
<td class="nump">$ 3,773.8<span></span>
</td>
<td class="nump">$ 3,514.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">785.6<span></span>
</td>
<td class="nump">778.3<span></span>
</td>
<td class="nump">2,427.8<span></span>
</td>
<td class="nump">2,222.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34.0<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">97.6<span></span>
</td>
<td class="nump">90.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(71.0)<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
<td class="num">(65.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember', window );">Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember', window );">Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Net Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Derived from the location of the entity that sells to a third party.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615122006072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Balance Sheet Location of Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 132.2<span></span>
</td>
<td class="nump">$ 129.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">29.2<span></span>
</td>
<td class="nump">27.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_RightofUseAsset', window );">Right-of-Use Asset</a></td>
<td class="nump">161.4<span></span>
</td>
<td class="nump">157.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">31.6<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liability, current</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">106.9<span></span>
</td>
<td class="nump">101.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liability, noncurrent</a></td>
<td class="nump">19.8<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="nump">164.8<span></span>
</td>
<td class="nump">158.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">138.5<span></span>
</td>
<td class="nump">133.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 26.3<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherNoncurrentAssets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherCurrentLiabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:DebtCurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilitiesNoncurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:LongtermDebtNoncurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 22.5<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">22.8<span></span>
</td>
<td class="nump">22.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">32.8<span></span>
</td>
<td class="nump">41.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">42.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">30.7<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">31.9<span></span>
</td>
<td class="nump">36.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">46.2<span></span>
</td>
<td class="nump">30.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118607608">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
<td class="nump">$ 32.1<span></span>
</td>
<td class="nump">$ 33.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FinanceLeaseCost', window );">Total finance leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:144px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:Arial;font-size:8pt;"/><span style="font-family:Arial;font-size:8pt;">(1)  Includes short-term leases and variable lease costs, which are immaterial</span><span style="font-family:Arial;font-size:8pt;">.</span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121954600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Annual Future Maturities of Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2020</a></td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">33.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">25.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">18.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour', window );">After 2024</a></td>
<td class="nump">54.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">157.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">138.5<span></span>
</td>
<td class="nump">$ 133.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2020</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_FinanceLeaseLiabilitytobePaidafterYearFour', window );">After 2024</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">30.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">26.3<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lease Liabilities, Payments, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear', window );">2020</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearOne', window );">2021</a></td>
<td class="nump">40.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">29.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">21.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueafterYearFour', window );">After 2024</a></td>
<td class="nump">68.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">188.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">23.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 164.8<span></span>
</td>
<td class="nump">$ 158.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FinanceLeaseLiabilitytobePaidafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FinanceLeaseLiabilitytobePaidafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Payments, Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Remainder of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsRemainderofFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615116103416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Weighted Average Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term - Operating leases</a></td>
<td class="text">6 years 6 months 14 days<span></span>
</td>
<td class="text">6 years 6 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average lease term - Finance leases</a></td>
<td class="text">9 years 10 days<span></span>
</td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - Operating lease (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">4.17%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - Finance lease (percent)</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615118105656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cash Flow Classifications (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 31.2<span></span>
</td>
<td class="nump">$ 33.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows for finance leases</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows for finance leases</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Leased assets obtained in exchange for new finance lease liabilities</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 26.2<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615200756600">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Indebtedness - Schedule of Borrowings Outstanding (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jul. 06, 2020</div></th>
<th class="th"><div>Jun. 19, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,917.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,751.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">61.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized premium (discount), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Deferred financing fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(17.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total borrowings outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,560.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,369.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current indebtedness</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,543.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,365.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member', window );">2019 Term loan due August 15, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member', window );">3.500% Unsecured Senior notes due March 15, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mar. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member', window );">3.500% Senior note due December 15, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dec. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">309.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member', window );">5.105% Senior note due July 28, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">July 28, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.105%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 157.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member', window );">4.00% unsecured senior notes due November 15, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nov. 15,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 215.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member', window );">3.9% senior note due December 15, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dec. 15,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member', window );">4.375% senior note due March 15, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mar. 15,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.150SeniorNotesdueJune152030Member', window );">3.150% Senior Notes due June 15, 2030</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Jun. 15,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member', window );">5.30% unsecured senior notes due November 15, 2043</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nov. 15,  2043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 90.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member', window );">4.9% senior notes due December 15, 2044</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Series</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dec. 15,  2044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Notes and Bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 303.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 303.9<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5.105SeniornotedueJuly282023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.150SeniorNotesdueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.150SeniorNotesdueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615120618728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jul. 06, 2020</div></th>
<th class="th">
<div>Jun. 17, 2020 </div>
<div>USD ($) </div>
<div>promissory_note</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 15, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 15, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 08, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 08, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,917,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,917,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,751,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2018RevolverMember', window );">2018 Revolver due March 8, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2014EuroDenominatedTermLoandueDecember52019Member', window );">2014 Term loan due December 5, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 350,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2018EuroDenominatedTermLoandueMarch82020Member', window );">2018 Term loan due March 8, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 317,100,000<span></span>
</td>
<td class="nump">&#8364; 284,400,000<span></span>
</td>
<td class="nump">$ 431,000,000.0<span></span>
</td>
<td class="nump">&#8364; 350,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member', window );">2019 Term loan due August 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.150SeniorNotesdueJune152030Member', window );">3.150% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">3.15%<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Net proceeds from issuance of senior notes</a></td>
<td class="nump">$ 737,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member', window );">3.500% Unsecured Senior notes due March 15, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member', window );">3.500% Senior note due December 15, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 309,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_SeniorNotesdue2021Member', window );">Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember', window );">Kazmira, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofPromissoryNotes', window );">Number of promissory notes | promissory_note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember', window );">Kazmira, LLC | Note due November 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember', window );">Kazmira, LLC | Note due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember', window );">Kazmira, LLC | Note due November 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Promissory Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2018RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2018RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2014EuroDenominatedTermLoandueDecember52019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2014EuroDenominatedTermLoandueDecember52019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2018EuroDenominatedTermLoandueMarch82020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2018EuroDenominatedTermLoandueMarch82020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2019EuroDenominatedTermLoandueAugust152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.150SeniorNotesdueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.150SeniorNotesdueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.500UnsecuredSeniornotesdueMarch152021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3.5SeniornotedueDecember152021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_SeniorNotesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_SeniorNotesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=prgo_KazmiraLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NotedueNovember2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NotedueNovember2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NotedueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NotedueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NotedueNovember2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NotedueNovember2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615121994024">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share and Shareholders' Equity (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (154,600,000)<span></span>
</td>
<td class="nump">$ 60,600,000<span></span>
</td>
<td class="nump">$ 106,400,000<span></span>
</td>
<td class="nump">$ 92,200,000<span></span>
</td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="nump">$ 63,900,000<span></span>
</td>
<td class="nump">$ 12,400,000<span></span>
</td>
<td class="nump">$ 165,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding for basic EPS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.3<span></span>
</td>
<td class="nump">136.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based awards (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding for diluted EPS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137.5<span></span>
</td>
<td class="nump">136.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive share-based awards excluded from computation of diluted EPS (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of ordinary shares (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In the period of a net loss, diluted shares equal basic shares.<div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;"><br/></span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119735528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="nump">$ 5,910.4<span></span>
</td>
<td class="nump">$ 5,786.4<span></span>
</td>
<td class="nump">$ 5,803.8<span></span>
</td>
<td class="nump">$ 5,726.2<span></span>
</td>
<td class="nump">$ 5,700.6<span></span>
</td>
<td class="nump">$ 5,668.0<span></span>
</td>
<td class="nump">$ 5,803.8<span></span>
</td>
<td class="nump">$ 5,668.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">83.0<span></span>
</td>
<td class="nump">84.8<span></span>
</td>
<td class="num">(103.5)<span></span>
</td>
<td class="num">(42.9)<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
<td class="nump">64.3<span></span>
</td>
<td class="num">(28.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">5,820.3<span></span>
</td>
<td class="nump">5,910.4<span></span>
</td>
<td class="nump">5,786.4<span></span>
</td>
<td class="nump">5,758.8<span></span>
</td>
<td class="nump">5,726.2<span></span>
</td>
<td class="nump">5,700.6<span></span>
</td>
<td class="nump">5,820.3<span></span>
</td>
<td class="nump">5,758.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Fair Value of Derivative Financial Instruments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">213.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Post-Retirement and Pension Liability Adjustments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="num">(10.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning</a></td>
<td class="nump">120.7<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
<td class="nump">139.4<span></span>
</td>
<td class="nump">99.5<span></span>
</td>
<td class="nump">69.0<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
<td class="nump">139.4<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">83.0<span></span>
</td>
<td class="nump">84.8<span></span>
</td>
<td class="num">(103.5)<span></span>
</td>
<td class="num">(42.9)<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending</a></td>
<td class="nump">$ 203.7<span></span>
</td>
<td class="nump">$ 120.7<span></span>
</td>
<td class="nump">$ 35.9<span></span>
</td>
<td class="nump">$ 56.6<span></span>
</td>
<td class="nump">$ 99.5<span></span>
</td>
<td class="nump">$ 69.0<span></span>
</td>
<td class="nump">$ 203.7<span></span>
</td>
<td class="nump">$ 56.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccumulatedOtherComprehensiveIncomeRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615123245096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 04, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 15, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2011 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2009 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 22, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 26, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 29, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate reconciliation, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.10%)<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">78.90%<span></span>
</td>
<td class="nump">19.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense', window );">Income tax examination, debts subject to limit of deductibility of interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate', window );">Interest rate cap on debts for U.S. Federal tax purposes, as percent of Applicable Federal Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes', window );">Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense', window );">IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties', window );">Income tax examination, estimated increase to tax expense from audit adjustment to fiscal years 2014 and 2015, excluding interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Income tax examination, estimate of additional tax expense for the period from June 28, 2015 through December 31, 2019, excluding interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax examination, penalties and interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,700,000<span></span>
</td>
<td class="nump">$ 40,200,000<span></span>
</td>
<td class="nump">$ 61,500,000<span></span>
</td>
<td class="nump">$ 37,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_CumulativeDeferredChargeTaxLitigation', window );">Cumulative deferred charge related to tax litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears', window );">Income tax overpayments applied to succeeding years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent', window );">Royalty conceded on all omeprazole sales as a percent of refund claims (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty', window );">IRS notice of proposed adjustment amount from 2011,2012 and 2013 audit of Athena, including penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 843,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent', window );">IRS notice of proposed adjustment, penalty (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_RevenueCommissionersIrelandMember', window );">Revenue Commissioners, Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability', window );">Unsettled audit assessment from income tax examination | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,636<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Revenue Commissioners, Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_PeriodAvailabletoFileAppeal', window );">Period available to file appeal against the judgment of the High Court</a></td>
<td class="text">28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal', window );">Payment required before final determination of the judicial review case and appeal pending before the Tax Appeals Commission</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CumulativeDeferredChargeTaxLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Deferred Charge, Tax Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CumulativeDeferredChargeTaxLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Adjustment, Penalty, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAdjustmentPenaltyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Unsettled Assessed Audit Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Overpayments Applied to Succeeding Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of Assessment due before Final Determination of Tax Case and Appeal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PeriodAvailabletoFileAppeal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period Available to File Appeal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PeriodAvailabletoFileAppeal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated amount of loss resulting from an adverse tax position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_RevenueCommissionersIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_RevenueCommissionersIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615033638536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Details)<br> $ in Millions, &#8362; in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 06, 2020 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>defendant</div>
</th>
<th class="th">
<div>Jan. 16, 2019 </div>
<div>product </div>
<div>defendant</div>
</th>
<th class="th">
<div>Jun. 28, 2017 </div>
<div>USD ($) </div>
<div>product </div>
<div>case </div>
<div>defendant</div>
</th>
<th class="th">
<div>Jun. 28, 2017 </div>
<div>ILS (&#8362;) </div>
<div>product </div>
<div>case </div>
<div>defendant</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>lawsuit </div>
<div>case </div>
<div>retailer </div>
<div>claim </div>
<div>individual </div>
<div>defendant </div>
<div>$ / &#8362;</div>
</th>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>complaint</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>lawsuit </div>
<div>case </div>
<div>tender </div>
<div>individual </div>
<div>defendant </div>
<div>$ / &#8362;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>case</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>case</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>case</div>
</th>
<th class="th">
<div>Sep. 04, 2020 </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Aug. 27, 2020 </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Jul. 14, 2020 </div>
<div>product </div>
<div>case</div>
</th>
<th class="th">
<div>Jul. 09, 2020 </div>
<div>pharmaceutical_company</div>
</th>
<th class="th">
<div>Jun. 27, 2020 </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Jun. 10, 2020 </div>
<div>defendant </div>
<div>manufacturer </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Jun. 09, 2020 </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>manufacturer </div>
<div>health_plan </div>
<div>defendant</div>
</th>
<th class="th">
<div>Mar. 01, 2020 </div>
<div>defendant</div>
</th>
<th class="th">
<div>Dec. 27, 2019 </div>
<div>defendant</div>
</th>
<th class="th">
<div>Dec. 23, 2019 </div>
<div>defendant</div>
</th>
<th class="th">
<div>Dec. 16, 2019 </div>
<div>defendant</div>
</th>
<th class="th">
<div>Dec. 11, 2019 </div>
<div>defendant</div>
</th>
<th class="th">
<div>Nov. 14, 2019 </div>
<div>class</div>
</th>
<th class="th">
<div>Jul. 18, 2019 </div>
<div>manufacturer </div>
<div>individual </div>
<div>health_plan</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>product </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Dec. 21, 2018 </div>
<div>product </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Aug. 03, 2018 </div>
<div>product </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>defendant</div>
</th>
<th class="th">
<div>Jul. 27, 2018 </div>
<div>product</div>
</th>
<th class="th">
<div>Jan. 22, 2018 </div>
<div>product </div>
<div>manufacturer </div>
<div>supermarket</div>
</th>
<th class="th">
<div>Jun. 21, 2017 </div>
<div>product </div>
<div>individual </div>
<div>class</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>product</div>
</th>
<th class="th">
<div>Apr. 30, 2017 </div>
<div>product</div>
</th>
<th class="th">
<div>Dec. 31, 2011 </div>
<div>class</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofPutativeClasses', window );">Number of putative classes | class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofSetsofClassActionComplaints', window );">Number of sets of class action complaints | class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfIndividuals', window );">Number of individuals | individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember', window );">States' May 2019 Case Alleging Conspiracy (which does not Name Perrigo a Defendant)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofProductsincludedinExpeditedCases', window );">Number of products included in expedited cases | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_OverarchingConspiracyClassActionsMember', window );">Overarching Conspiracy Class Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany', window );">Number of formulations of products manufactured by the company | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals', window );">Number of products manufactured by the Company | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofCasesIncludedinExpeditedSchedule', window );">Number of cases included in expedited schedule | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitDrugstoreChainMember', window );">Price-Fixing Lawsuit, Drugstore Chain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofOtherPharmaceuticalCompanies', window );">Number of Other Pharmaceutical Companies | pharmaceutical_company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember', window );">Price-Fixing Lawsuit, Suffolk County of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember', window );">Price-Fixing Lawsuit, Drug Wholesaler and Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember', window );">State Attorney General Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofFormerEmployees', window );">Number of former employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of current employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofAdditionalStatesandTerritories', window );">Number of additional states and territories | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember', window );">Canadian Class Action Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSupermarketChainsMember', window );">Price-Fixing Lawsuit, Supermarket Chains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfSupermarketChains', window );">Number of supermarket chains | supermarket</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember', window );">Price-Fixing Lawsuit, Supermarket Chains, Amended Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitManagedCareOrganizationMember', window );">Price-fixing Lawsuit, Managed Care Organization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthInsuranceCarrierMember', window );">Price-fixing Lawsuit, Health Insurance Carrier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfDefendants', window );">Number of defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthcareServiceCompanyMember', window );">Price-fixing Lawsuit, Healthcare Service Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCodefendants', window );">Number of co-defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember', window );">Price-fixing Lawsuit, Medicare Advantage Claims Recovery Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCodefendants', window );">Number of co-defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember', window );">Price-fixing Lawsuit, Several Counties in New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCodefendants', window );">Number of co-defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthcareManagementOrganizationMember', window );">Price-fixing Lawsuit, Healthcare Management Organization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCodefendants', window );">Number of co-defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHarrisCountyofTexasMember', window );">Price-fixing Lawsuit, Harris County of Texas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCodefendants', window );">Number of co-defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member', window );">Highfields Capital I LP, et al. v. Perrigo Company plc, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofCasesAllegingOnlyStateLawClaims', window );">Number of cases alleging only state law claims | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthPlansMember', window );">Price-fixing Lawsuit, Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingenciesNumberofHealthPlans', window );">Number of health plans | health_plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfIndividuals', window );">Number of individuals | individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member', window );">BlackRock Global Allocation Fund, et al. v. Perrigo Co. plc, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_CasesFiledinIsraelMember', window );">Cases Filed in Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfCases', window );">Number of cases | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of cases voluntarily dismissed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfCasesStayed', window );">Number of cases stayed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member', window );">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of cases voluntarily dismissed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers', window );">Number of current or former directors and officers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought by plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 760.0<span></span>
</td>
<td class="nump">&#8362; 2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1', window );">Foreign currency exchange rate, remeasurement | $ / &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_InrePerrigoCompanyplcSec.Litig.Member', window );">In re Perrigo Company plc Sec. Litig.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfIndividuals', window );">Number of individuals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofDefendantsAdded', window );">Number of defendants added</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember', window );">Talcum Powder Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofLawsuits', window );">Number of lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofTendersAccepted', window );">Number of tenders accepted for a portion of the defense costs and liability from a retailer | tender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_RanitidineLitigationMember', window );">Ranitidine Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofMasterComplaints', window );">Number of master complaints | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofMasterComplaintsNamingCompany', window );">Number of master complaints naming the company | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_CarmignacFirstManhattanandSimilarCasesMember', window );">Carmignac, First Manhattan and Similar Cases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofCaseswithSimilarFactualAllegations', window );">Number of cases with similar factual allegations | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_FirstManhattanandSimilarCasesMember', window );">First Manhattan and Similar Cases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_MasonCapitalPentwaterandSimilarCasesMember', window );">Mason Capital, Pentwater and Similar Cases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofCaseswithSimilarFactualAllegations', window );">Number of cases with similar factual allegations | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfIndividuals', window );">Number of individuals | individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_HarelInsuranceandTIAACREFFCasesMember', window );">Harel Insurance and TIAA-CREFF Cases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofCaseswithSimilarFactualAllegations', window );">Number of cases with similar factual allegations | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers', window );">Number of current or former directors and officers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofDefendantsAdded', window );">Number of defendants added</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice', window );">Number of defendants dismissed without prejudice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_RoofersPensionFundMember', window );">Roofers' Pension Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers', window );">Number of current or former directors and officers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_OtherCasesRelatedtoEventsin20152017Member', window );">Other Cases Related to Events in 2015-2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofCaseswithSimilarFactualAllegations', window );">Number of cases with similar factual allegations | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_InIsraelCasesRelatedtoIrishTaxEventsMember', window );">In Israel (Cases Related to Irish Tax Events)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfCasesStayed', window );">Number of cases stayed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_AcetaminophenLitigationMember', window );">Acetaminophen Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofLawsuits', window );">Number of lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense', window );">Number of claims for indemnification or defense | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofRetailers', window );">Loss Contingency, Number of Retailers | retailer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingenciesNumberofHealthPlans', window );">Number of health plans | health_plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_NumberofDozensofManufacturers', window );">Number of dozens of manufacturers | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberOfIndividuals', window );">Number of individuals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Ranitidine Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_LossContingencyNumberofLawsuits', window );">Number of lawsuits | lawsuit</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingenciesNumberofHealthPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingencies, Number of Health Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingenciesNumberofHealthPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfCasesStayed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases Stayed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfCasesStayed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Generic Prescription Pharmaceuticals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfIndividuals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Individuals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfIndividuals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfPrescriptionPharmaceuticals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Prescription Pharmaceuticals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfPrescriptionPharmaceuticals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfSupermarketChains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Supermarket Chains</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfSupermarketChains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofAdditionalStatesandTerritories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional States and Territories</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofAdditionalStatesandTerritories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofClaimsforIndemnificationorDefense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Claims for Indemnification or Defense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofClaimsforIndemnificationorDefense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofCodefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Co-defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofCodefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Current Or Former Directors And Officers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofDefendantsAdded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Defendants Added</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofDefendantsAdded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Defendants Dismissed without Prejudice</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofFormerEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Former Employees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofFormerEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Formulations of Products Manufactured by the Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofMasterComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Master Complaints</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofMasterComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofMasterComplaintsNamingCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Master Complaints Naming Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofMasterComplaintsNamingCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofRetailers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Retailers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofRetailers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofCasesAllegingOnlyStateLawClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Cases Alleging Only State Law Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofCasesAllegingOnlyStateLawClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofCasesIncludedinExpeditedSchedule">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Cases Included in Expedited Schedule</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofCasesIncludedinExpeditedSchedule</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofCaseswithSimilarFactualAllegations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Cases with Similar Factual Allegations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofCaseswithSimilarFactualAllegations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofDozensofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Dozens of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofDozensofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofOtherPharmaceuticalCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Other Pharmaceutical Companies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofOtherPharmaceuticalCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofProductsincludedinExpeditedCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Products included in Expedited Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofProductsincludedinExpeditedCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofPutativeClasses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Putative Classes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofPutativeClasses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofSetsofClassActionComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Sets of Class Action Complaints</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofSetsofClassActionComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofTendersAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Tenders Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofTendersAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateRemeasurement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of defendants named in a legal action.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_OverarchingConspiracyClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_OverarchingConspiracyClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitDrugstoreChainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PriceFixingLawsuitDrugstoreChainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSupermarketChainsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSupermarketChainsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitManagedCareOrganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitManagedCareOrganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthInsuranceCarrierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthInsuranceCarrierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthcareServiceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthcareServiceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthcareManagementOrganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthcareManagementOrganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHarrisCountyofTexasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitHarrisCountyofTexasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_PricefixingLawsuitHealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_CasesFiledinIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_CasesFiledinIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_InrePerrigoCompanyplcSec.Litig.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_InrePerrigoCompanyplcSec.Litig.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_RanitidineLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_RanitidineLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_CarmignacFirstManhattanandSimilarCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_CarmignacFirstManhattanandSimilarCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_FirstManhattanandSimilarCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_FirstManhattanandSimilarCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_MasonCapitalPentwaterandSimilarCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_MasonCapitalPentwaterandSimilarCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_HarelInsuranceandTIAACREFFCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_HarelInsuranceandTIAACREFFCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_RoofersPensionFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_RoofersPensionFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_OtherCasesRelatedtoEventsin20152017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_OtherCasesRelatedtoEventsin20152017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_InIsraelCasesRelatedtoIrishTaxEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_InIsraelCasesRelatedtoIrishTaxEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_AcetaminophenLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_AcetaminophenLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615117721096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 26.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">9.8<span></span>
</td>
<td class="nump">23.8<span></span>
</td>
<td class="nump">19.6<span></span>
</td>
<td class="nump">24.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">23.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
<td class="num">(25.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash adjustments</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 21.5<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_CSCIMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RestructuringAdditionalCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Additional Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RestructuringAdditionalCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_CSCIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_CSCIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140615119104936">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th" colspan="2"><div>Sep. 26, 2020</div></th>
<th class="th" colspan="2"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,576.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,576.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 11,301.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,213.7<span></span>
</td>
<td class="nump">$ 1,191.1<span></span>
</td>
<td class="nump">3,773.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,514.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(95.5)<span></span>
</td>
<td class="nump">54.4<span></span>
</td>
<td class="nump">167.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">211.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">73.9<span></span>
</td>
<td class="nump">78.7<span></span>
</td>
<td class="nump">219.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">227.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,747.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,747.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,990.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">664.0<span></span>
</td>
<td class="nump">613.3<span></span>
</td>
<td class="nump">1,992.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,777.2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">123.6<span></span>
</td>
<td class="nump">81.3<span></span>
</td>
<td class="nump">354.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">283.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">38.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,606.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,606.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,682.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">339.0<span></span>
</td>
<td class="nump">347.5<span></span>
</td>
<td class="nump">1,042.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,025.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
<td class="nump">45.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40.2<span></span>
</td>
<td class="nump">43.3<span></span>
</td>
<td class="nump">116.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">130.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember', window );">RX</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,221.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,221.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,628.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">210.7<span></span>
</td>
<td class="nump">230.3<span></span>
</td>
<td class="nump">738.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">711.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(180.6)<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
<td class="num">(81.2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">95.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">22.8<span></span>
</td>
<td class="nump">63.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">65.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Unallocated</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(48.7)<span></span>
</td>
<td class="num">(59.8)<span></span>
</td>
<td class="num">(151.4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(185.0)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Derived from the location of the entity that sells to a third party.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes net sales from our OTC contract manufacturing business.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>99
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M@[U.'?"+2\>UQQ/KU835N+Z+FW6]AGP_+#=PV=BW6N3:-C@:[W=QI_Z1JUJ
MGR;#!9^P*LL]VGG![7H&4'X!MHF8J;6N6P1.]BCK:--,#ZAB+S&##@/U9;E_
M5E^M]RMGQ2Z=U3Q>;G9^87H\9B3B&PBUS\?0=62Y?UB>*)$66W!KH92(B\.
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M:M]]MC=&ULWKPQMIC"R;RRUGL&JM 7Q_*Z&.ZF[L&\G]&^CS?P%02P,$%
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M;@WDW^_+LOG^IOU>AN-WB=S\'U!+ P04    "  =0F51GJR:+*,"  "<!P
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M$2"^SW68&C"*DVJ)/Q5YOD^91XT#I1^R-V"?I;9F1XDJVLJ2^<);\$NIJ#'
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M;&4DVIQ4&TK8*VNX4%WV7CS*7'?964U8HR3W"DQYR0O>8[>A*/#LQ$*;#56
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M2)++9KIV^_SFUJ+* \SN3?*G^Z8^[-.SX%8HN_=?OGYISCR':7<P-=^3$]X
M-%;?2$9Y5FB1_BP,A&NC%^K*D.E;2AP#8S^L8?)*G_O.T&]]RH'>"__!RH93
M8/BJLWN[^R9V%CX%[<G#![7WW"SH^*_$'%M1@,,.,^$C57APNO(?AE#T<)*_
M1>/%X9X(L#[7VC4/)&#WI?#T=U!+ P04    "  =0F51)&KBEH02  "8.P
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MGJ'J/^[=N,U753:LL^">Y<@#U=2Z<)ZM90)[^U4> ACZ2QG;CHT]#TE8VR[
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M##]MGKGJ/'W.=.8E"C]4+RX*,FP$";9::].F@B,W<<IW1/GD@)PS$HZ U",
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MUS#0U=H6WR<#'#=H<YCLT!8&P^1%)##%[P2,/$;CDTY&R2@Z@;=Q,T@AHG;
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M/B5+KO@R3 6ZTT=\\X%!DI3%=;3MM_MU>O(4")CSFP4.ZAW,H+W]D'V^1>R
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MM<#3Y@@7M:4-/%1BO)*C8+Y<!\>0,I'6HM'#"=A K@0U! -'!%=R(6C''%_
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MQN'9:0"ZN7N;B565O^\VRM+MZ8<%_:Z@=@=H/U?*[B=.0?<#-/D74$L#!!0
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M[!3+FAD<*_$'+VS9#ZX"*'##:F$7:G^'AW@N'5^NA/&_L&]\.]T \MI851W
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M&EX^.1)^G#XT;LV_QT+2;-R*_PMN#T9 +^#[N7--^D +Y!_HO?@_4$L#!!0
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MEJF)2#XCHI<(*1)A:++-+8  ,@E&G;H &%"7L-366!G93R"[RUE30!2QDG%
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M5^>1<I>>N41&,^!]M8HKNK.FH&J0>=#"U*J95F%AULQ?2^UD/Q7,_C@>#6E
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M^ZG6M?T#-UA"K$_@/?\G4$L#!!0    ( !U"95%=@Z<B500  #X*   9
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;*U637/;-A#]*QA-#LZ,2TF4OT?6
MC*PZB0]Q/)+='#H]0.121 T"*@!:5G]]WX*4+$T=IVE[D/#!W;=O%[L+#%?6
M/?J2*(CG2AM_V2E#6%YTNSXKJ9(^L4LR^%)85\F I5MT_=*1S*-2I;MIKW?2
MK:0RG=$P[MVYT=#602M#=T[XNJJD6U^1MJO+3K^SV9BJ11EXHSL:+N6"9A0>
MEG<.J^X6)5<5&:^L$8Z*R\ZX?W%UQ/)1X!=%*[\S%^S)W-I'7MSDEYT>$R)-
M66 $B>&))J0U X'&'RUF9VN2%7?G&_0/T7?X,I>>)E9_57DH+SMG'9%3(6L=
MIG;UB5I_CADOL]K'?[%J9 >#CLAJ'VS5*H-!I4PSRN<V#CL*9[UO**2M0AIY
M-X8BRY]ED*.ALROA6!IH/(FN1FV04X8/918<OBKHA=&4?'!U%FJGS$),2ND6
MY(?= &@6Z&8MS%4#DWX#YEQ\MB:47ER;G/)]_2XH;7FE&UY7Z9N ,UHF(CTY
M%&DO[;V!-]CZ.8AX@Q_Q4_PZGF,;F?';&R:.MB:.HHFC_QK*[\!<S^ZG#Y/[
MA^G-[4<Q^32>?KR>B:\DEN24S54FM5Z+(!\IIC0R.UB41UYG% >32Q,$/:-L
M/5R4)A>J6CK[1 *E[&1@=E04*E-D\/.)V&<>"T6%M5 FTW4.#$]/4#09'0I-
M* &@JR RZX,_C 8<:1DHQY;Q* =&*8B1[TL2A=4H?=Y#P7$U>F%KA\6K1@^4
M09YK#<?\^PL .**]Y!*W"-C^#I(E4#4G%S-F9W5V^.:W*UHH8]C\7&KV3[P3
MY\D9_M-!'/KGR0FOCI*>&.>YXG!++;(V?7H0.DY2T4_.66,@[N0:#0L.'J38
M>B\.3J&(H<]P&-/CN+ZUYJ=,^E+(_'>4>*/2 ]!!+SG&]W;**G!PG]\I@,&H
M#\&]!4=ZPPL'5SOD@LB;X 9\"S&0?%B&XU<U\:-7XL<5)U;DD'%.H5,KI)OT
MWF8JGO%*A;+-/!_3,"8@SI)DQ;D<K>&6D$;]*5DJ^;^XG3&W_OGWN#&BHUT&
MPA8QY>B9LIIO 710@RN' R\">$?;%HKN!SW[4L1-6=D:4(XRZ_)]W_Z11X?B
M79_/NTW\;3V]. DBC.:E1@QQ%V=_\Q%U\R$6:8P"5BP_F4UN4+X+]C2> R(7
MPV=LZR\N-O05)/5^/:)A+)RL$(=2!N'5PBAT#'06<$$[091 3YIUB^)H:5V0
M<TT;:Y'EO\D\:+T2H42,]4OA24<OP8:K^PVL[7W"MC&P,(5USC-OM<IC;&<!
M0\,4Z?&E:8T0:-+5$;]H&.T=%]GF8+22<Z6Y3[%W5"VU71.]-$@Q)T.% J;R
MD4>,$PYOCHR5*M\]&T//0:Q)NN2URZ>[<Z=7!*_YY>+189%HS?6^W=T^CL;-
MF^!%O'E9?4;0%%):4P'57G)ZW!&N>:TTBV"7\84PMP'OC3@M\< CQP+X7E@;
M-@LVL'TRCOX"4$L#!!0    ( !U"95'4 /+@_0,  #$)   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;-566V_;-A3^*P=:,3B ((G4U9ECP$G;S<!R
M09QN X8]T#)M$9%(CZ3G9K]^AY2LIEN:/O1I+^*Y?CPWBIP=E7XT#><6/G:M
M-!=!8^W^/(Y-W?".F4CMN43-5NF.663U+C9[S=G&.W5M3).DB#LF9#"?>=F=
MGL_4P;9"\CL-YM!U3#]=\E8=+P(2G 3W8M=8)XCGLSW;\16W'_9W&KEX1-F(
MCDLCE 3-MQ?!@IQ?9L[>&_PB^-$\H\%ELE;JT3'+S460N(!XRVOK$!@N?_$K
MWK8.",/X<\ ,QBV=XW/ZA/[>YXZYK)GA5ZK]56QL<Q%4 6SXEAU:>Z^./_$A
MG]SAU:HU_@O'WI9. Z@/QJIN<,8(.B'[E7T<ZO#,H4J^X$ '!^KC[C?R4;YE
MELUG6AU!.VM$<X1/U7MC<$*ZIJRL1JU /SM?\1V6V,)2]@W&2LUBB\!.'=<#
MR&4/0K\ ,H5K)6UCX)W<\,WG_C$&-$9%3U%=TE<!5WP? 2U"H E-7L%+QRQ3
MCY=^)<M[OE?:"KF#WQ=K8S7.Q!^OP&<C?.;ALV\KXE= WOUX_>[F 98W[V_O
MKQ</R]L;N#W@^>G!C3L";I;!-AR.[ F$A&,CZ@846G5,XAGR473LD1O 8ZN9
M3W7#:^'.D F!M:VJF>4.S*!;S9U0;@9WX[%WF+UMO'BOU598MA:ML$^@MEY_
MI;H]DT\1/""#RA;]UNYT@VG<QY\XV K)9"U8"QUGYJ"=T1-N>VK D!9,,(U.
MM*T+\.P<'I1%EX4Q'#/&,;"\6W/M9^$MKWLF)2%<K:X6\ :RL,S*B"*5AM-I
M@A0JEB@NDB*:NK6B40GWOP$-*24HHF%!JR@?-GH#A(1Y641)3Z8)B3),3'/^
MV4S_*Q0WEL]%E1.1*=S@7W3%7$%NQ_(O9:TZ#I.?E3%GR%DF=P*+UB<)B\X5
MY&\_--_L/U2E*+(^(9I&A5\Q*123-$IQK8A?4%KTY4K3*=H35[[,?5*L:0YH
MC;QS<>5#;0D34B7H=(8LBFF:X)=,44%I5,$'>9JO#7S_744)_0$F687JLY$?
MY?D4/3[)QW:$%/<MD9I,<PSB#*DRQ;XY%9F2B""59SZ?TD'?X#'Z'[>*X-C2
M?H QJ]RM5=^SL"S[R:95W[;4C:_O%PF3S!4\R[$ A+A)1Q'-440J+ W!QF2N
M:R6"53#!AE.L9)$B4Q*"^%C;!(H<K5YL&LG=,7BA:Z1RCO]M6XK1.G2,NRA]
M_!3GPD<=YB0;),0WEM(R*E_ZZ\;/KK&.ZYV_K W4ZB!M?Z.-TO$]L.BOP4_F
M_6/BFNF=D 9:OD57'-T\ -U?T#UCU=Y?BFME\8KU9(-O&JZ= >JW2MD3XS88
M7TGS?P!02P,$%     @ '4)E46CH$#.Z"   LQ8  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&ULI5AK<^.V%?TK&'6FLSMC/?W87=?VC/S8Q&DV\5B[
M33N=?H#(*PF[),  H&3WU^=< *0H1W:=YHLMDL!]G'ON SC;&/O-K8B\>"@+
M[<Y[*^^KT^'092LJI1N8BC2^+(PMI<>C70Y=94GF85-9#">CT<FPE$KW+L["
MNSM[<69J7RA-=U:XNBRE?;RDPFS.>^->\^)>+5>>7PPOSBJYI!GY+]6=Q=.P
ME9*KDK131@M+B_/>='QZ><+KPX)_*-JXSF_!GLR-^<8/M_EY;\0&44&99PD2
M_]9T147!@F#&KTEFKU7)&[N_&^D?@^_P92X=79GB%Y7[U7GO?4_DM)!UX>_-
MYGM*_ARSO,P4+OP5F[CV^*@GLMIY4Z;-L*!4.OZ7#PF'SH;WHV<V3-*&2; [
M*@I67DLO+\ZLV0C+JR&-?P17PVX8IS0'9>8MOBKL\Q>S& QA%F*FEEHM5":U
M%],L,[7V2B_%G2E4ILB)-\VOMV=##]4L8)@E-9=1S>09-1_$)Z/]RHD;G5.^
MNW\(DUN[)XW=EY,7!<ZH&HC)R8&8C":C%^0=MC@<!GF'S\C;Y_"_IW/G+7CS
MGQ<4'+4*CH*"HV<47$JG',.,W'&DO612[@/RE6+N.F+$YQ6!WYDI*ZD?V8=:
MRSI7GG)Q98"X=O&7@VNYY-<?E98Z4[(0,\@@I)EW8B77).9$FHVLI,4ZI8-@
MFV,U@9M^);X,9@.Q)$U6%L4C?Z:*1<HMA)55$%X5S)K>=]/I7>^M0 &!-$]6
ME6+1:E<Z%I:0H3J/&CS<41K8UR%UG?!&3*U764%B/&+O[VE9%W'7K/_/0>"K
MS:&Z>#S@[8\B-T(;#S%94>= IRAX7Y2\JW)AC,=2V&KIUUJQU_-'P58'FQG5
M@CQUC'8M9(, _?^'MEN9NH N$EQ-&>G,Z*^UCN6J!>)_"]IU(GD<!)K:BJG6
M-=;?4V6L%Y#,U0PP]O\>W&,5CR2M(,Y,<4T9E7.RXG#,N37^\ +UCUOJ'[_(
MV;LM&Q""K/7GF01X6=BM#B:;2FF&"0)+J=$^&(J#$&:9?T7=C-"\86W*!5)B
MJ>; %\ [JZWE=^"L!3H10P/!MKO];3!6Y<2<T$#&.:Z5#)L4"ZGL3C(W_/JS
MN=<&D&UJ^,N13 D6C?4IY<,+:&;/2_G56.4?^V:CL=_5<QBOI$4Q0XH41<R_
M5"8$2IMV,F48BYS+@K.\:PL5"DTG6!WYN0W=X 5FG+3,.'DQF/? 5'L4D5OG
M:NCH5&% HW-I<[>/(B]*Y3GFU%4RH_->B(]=4R^IVJ<!I=1HO,Q2),*D(E#]
MF"?/[?E2<2RYO$UG7U#=_$IZL:&P#71C&CH'OO F5*\<!<0"20IQH\4"0PGG
M(H?U#[!D('ZAIK+-$1M:4]3,\8STM0VD*D+:J<JN@12!Y,H3PBS!&B[*T/,G
MS)HZY,=FMP7L@,JX1(L.&*9-0"@WE8?]QC5>8)&L*K1?.2\XD9!Y ;!,V:PN
MV?Z,J?P:VHB?@-&_,-5.60L6M:&[)I=95864O0DN8RX4F)XH/3("K'5OGB+W
M?PY =\>E3](#0R? !2Z:[_OCHU/ 5F)T=B%9^O?DT5E8!/BE::&\ZU_C'^=I
M>B'ND'ZN_UWLK.+-K)Y[E+E,O!L?]R>CMZ?B6KFL,*X&3!^M+(D'WO[52NHE
MA1[)1G?6W,=V%NWFHK57(3H8)HIEK6*+AUB=LR=7K)>ERAPQ@QBSIH-0)[("
M)66!%KM59;NJ+!6!*H'W4>,\::S2.+\MMY5QOF^WZ%1LT^!I'YJ,D'&\CX,)
M 5L2:2,* P!L;*2I@;/J:%W,.%G&0AG'F;JLHX71!"Z(EE9LVIK' SPC1Q\J
M4"&*"I(S@WC_ES/*A1U&4RJ]FM@QJTR.8#6>9O!+ +)(8$T/'@.$RQ!8[K8A
MD8/]SUDM-9L ,'9Z"R8%Q^6:H^DZ!%SB^!6+.#8[VHE!E@BB(JL; \V\4,LH
MO)D#HA,'0BTZ:3AH6/VA/YZ<BML(SV?YP-7O<R3H$;-SIC H@1>AY$%:)RM9
MP<[&7<Z17L7&PPZX*(8'\#5X9FJ\=AP+MQW@@B0O'[H%IY4&/P-[CT8#\8/$
M\(.6'4DTWD.B5$UCN+O5$&;(;2UX10ULJU)3<9[O&^)G_<2T43!&-CLCXB?]
M\6%'V6T8B6..]<45&(,P_ACCG2)Q.#E!)#Z!)77*)V"VNY(GP+TBN95=L02T
M,UBS4MD*- (%.3()=XQ-%#DF2D+ESDUAEH]Q6(V,C4GSNQ6AOBOFY8)LXKJ,
M8J]8*"R]:39W[(515S=7/\*BCK X=)>[3K:JL[@[Y<&VA["<'9-@3:?9P)[M
M@,^]V[M&!5+><P7!"83SGS,[Y.\V6@$V4;N&^B5* 1B<PUUO36 OEY:H/<Z/
M2/T_H*^)1QH''0]O>1Q0U)KMC[F# 2T<6)/ "%0J=VQ T^$7*0=@;F/\!M'@
M1&CX'P9&LPD9Q0;ODNAF/]J<+*\Q+'3ZUMO,%$5$",F#H]>2S-+*"@Y#;A:'
MS> )8;)B^UZ(=S.P8XC%V(]IF"MN9\G.Z:\A91SY*48F2W2$)&QJAV/^%*MO
MH$NH5'7%9ZKPC,^42<>8?[]?,1N,29SQQ&RT5GG**IR5PPW,/)SL64UR,Y7]
M_8XB/)UC#LC;<?=W?I;RD?M,R9%YVCDZW4'N0_ZO?WD_&;_[&^P'(*;$ERTP
ML>8U<0YHIG+J5F%^5NX;*^#(PW>XE<70TUH6=>S / M >:Z ")]3 PPAW.X)
MC;"O<Z+/FWZV94\CMN6+W&'P+E$X[*)=WS22EA)04 ?4%]:4G0N)@'?")/;X
M&#=$()T%4[_W:>9X.D@D<RF'B:].%<9PR6@MD+FAUT<U6P<W&%]B>X^'./9A
M.QKEA#JY3;30U?<=WX:=B\22H)*O2\-Q0?MXI]B^;6]DI_$B<KL\7N=^@L4\
MDQ2TP-;1X!V.]39>D<8'S+;A6G)NO#=E^+DB &)Y ;[SC4;SP K:>^J+WP!0
M2P,$%     @ '4)E452N]/H;!0  >PL  !D   !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL?5;;;N,V$/V5@5L4#A#?E#B;39T CK/9IFC2(,YV411]H*61
MQ2Y%:DDJMOOUG2'E6^'X11)%SIG;F>&,%L9^<P6BAV6IM+MN%=Y75[V>2PLL
MA>N:"C7MY,:6PM/2SGNNLBBR(%2J7M+O7_1*(77K9A3^/=N;D:F]DAJ?+;BZ
M+(5=W:(RB^O6H+7^\2+GA><?O9M1)>8X1?^E>K:TZFU0,EFB=M)HL)A?M\:#
MJ]LAGP\'_I"X<#O?P)[,C/G&BX?LNM5G@U!AZAE!T.L-)Z@4 Y$9WQO,UD8E
M"^Y^K]'O@^_DRTPXG!CU56:^N&Y=MB##7-3*OYC%+]CX$PQ,C7+A"8MX=IBT
M(*V=-V4C3!:44L>W6#9QV!&X[+\CD#0"2; [*@I6W@DO;D;6+,#R:4+CC^!J
MD";CI.:D3+VE74ER_F8:DP$FAZF<:YG+5&@/XS0UM?92S^'9*)E*=-!^%3.%
M[F34\Z28Q7MIH^0V*DG>4?(1'HWVA8-/.L-L7[Y'!F^L3M96WR9' :=8=2&Y
M.(6DG_2/X)UMHG 6\,[>P3OD[E_CF?.66//W$07G&P7G0<'Y>P93,66U0H[S
M$U%U5Z$UFKY3)*I[=RBXQZ''#C0ABBUBM8<(PB)(YVK,3F&!Q"^E0&2F\N +
MXY">PH=#HJK(=TXRU)0H2SL(J;1I73HO",]UX053 E4K> B(NXY,Z4PF;.;@
MR7CXDQK*F+70H?4.W*%+K:Q"/7[*<PPE"41<;)9 &ZSU7FI2*(5B6=\X8BS\
M3IMVCZF/PGNT#L;3+\2&P65G<'X%$U-2UW*"%75>T$L;(. 6->;2N\X=O319
MUOR 9R6TZWRFE26=[6D]\Z:2*7P8##M)_^0*[J1+E7$UA>G>BA*YUW0FA=!S
MHHHWP>B=,R_XO6Z4.J#6"0<5PFLA'<QKF7%T@6!UQIY,6"^CBHQR1C#F#4^!
M8@BI$E;F*\BVJNRN*HM*<,1)-FLTSAJ-5=-)&<:$,%;&^8[=1J=BF[ID*C%G
M1OMG@UA@\*5B.4XF 6Q)I TH0P&@OK@Q(ZJ.UF&(BBB9( XDMV"B4ATMC":D
ME"B+!9M&1)":U@BXK(@*$2H@IX;R_2_]$"Y(&!WYD!/SV3$K34;)6GN:DE]
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M#7_DOUP?COM_ 'QD:B70P6=\"5&\&&A7E?^F]A,C2_<=NY &X7##-4<&*7L
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MU_9>X33MK12BYHT6LB&*;ZY&2WIQD]C[[L)O@N_TX)W82-92?K"'N^)J%%I
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MMKFR%_!](Z4Y'*R#?GV__@=02P,$%     @ '4)E42"A=5)N @  (04  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S$N>&ULC51-3QLQ$/TKHQ6'(J']3$)
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M[9K?,#3>@>^71&YG>(+^59R] E!+ P04    "  =0F51&,YCA!P'   (%@
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M_@1+3K6&LI77NN &.TLM&EF+KC*+2IAT+C18RXD(*WOT$=N#SC=*S'D4,O&
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MVUQLENL6T8R)35\+.?_ZT-7CU0CN"$/08QL71LY'B6W0N=6@TW=-0L+71/V
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MJ)UJ63.+=UK\X(6KYM$D@@)+U@CWK-LON*MG[/ER+6SX0MO%CH<1Y(UU6N[
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M"2Z- ^[OA=!GQ1PP_9ZL_@%02P,$%     @ '4)E48G3:3 # P  K0@  !D
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M7#,:,:D%8'XIA#ITM('RB\WP?U!+ P04    "  =0F51'K)B[SP)  #<-
M&0   'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6S-6VUOH[@6_BM6M%?:E682
ML(V!JJTT39HFTLYNU=[9>Z5J/]#$2=#PDL7.='MU?_PUA,9@.Z9IA'3GPY3
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M3AIK@Y_6]O% Y1+L?B6E.0;N?$[/4?8;4$L#!!0    ( !U"95%G4 97> P
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M\2B[75$24&$FZ/<+SM5N8 XSBB.^\?]02P,$%     @ '4)E4;,:\9ZN @
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MU"*K/K)5-SS=E1^%GE/.T[B\W%(2T*SH()Z_I"E_NRD<-)\ZE[\!4$L#!!0
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MA3LMJ0Z#_TK0\<&]@1OU/WQN<B/<TX1O6K1XW_QP]+ME.SD#_8*_UH8Q.FD
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M-)&E"J+^/- IS;)2D[+CGT;I8+MF*=C^_*(]KIQ7SMP10:<L^SU=R-798#P
M"WI/-IG\S!Y_H8U#E8$)RT3U&SPV6&\ DHV0+&^$E05Y6M1_R5,3B): TF,7
M0(T VA?P.P1P(X#[KN W G[?%8)&(.@K$#8"817[.EA5I&=$DO-3SAX!+]%*
M6_FA2E<EK0*<%F5EW4JNODV5G#S_R-CB,<TR0(H%N"HD*9;I74;!A1!4"G#<
MOI<029>,IU2 ]S,J29J)#PKQ]78&WK_[ -Z!M #72I>J&'$ZDLJZ<HU1TEAR
M65N".BS!X)H5<B7 O%C0A45^YI:?..1'*BK;T*"7T%PBI\);NAX"%!X!Y"'/
M8L^TC_BX%(<3FSL_MOK\QU:/W>(SF@P!AC;QG5CB;9GA2A_NT!>G12I5555%
MIA[\^O*3(I7%2ZE=/H-K\C?C8)H1(<"?GY0*<"5I+OYR&.!O#? K _P. _2J
MQUFU:KJM:W%B*]9:75BI*^GYX1SZP_'IZ*&=PCZ@V 2%XQ9HQYU@ZT[@=.<C
M9\+ZC-5B46LQ?^P%0[AG>#]8;(&%XS9LQ_AP:WSH-/XB23;Y)E-LHI*?,R[3
M?TG99FS^A(8%<.)-AM&>/_U@L046A7@XL?L3;?V)G/Y\89)D@,D5Y:VR J2J
M:YM3D27Z<-(RHW:J'RRVP**@TZGQUJGQ*P_,GB. M%(%Z)/:VPAJ\VYLV!,I
M:[S6SUZ93<?&$Q*-C12;:I$*!MY%S4U5"$4M73NQF&QC,7''(E^3E*O]E 3)
MBO EM69U8AKHH:&_YZN)@IZ1^5ZJYB;*1UUIAY[>$'A.9V>ID#R]V]0;/T78
M69J4J09DR2DM@R"JVV*S7F?/K;L.EH:M[0@\3*. 2)N OH];&[F=W&'?*-1^
ML-@&0V%7J4+=:2'^:>S:J&K;,,9&E^N%BFTH./0F[9\.WW03A^XN/J,/:A9:
M*\_6G"TVB022)JN"96SY? 3*.:MTO-Q_'E4U^H+BY7SA+%#=>&%PH +5[1.Z
M^V=W@5KZ&\:!6:']<+$5-T%=FQ>H&R9T=\PWU:C9WR(,S2+M!8MML"!HM9%=
MCW2WA.YV.:U&-;4!X+2IP%6ZKHERT2;4@LKJU,!5"+HMP<EA:A'I;H'<W:*S
M%ANYG=H9AZ&1MYZXV(I36];0GCFD.PZ"/ZT6&U5!NWJB<-^C'J"X ;7="2/8
M:O&[WNCFA=S-ZPLG"YH356%'0):?04%RVM#A'5>_7:6'=)=!!QKHD&X&R-T,
MNDO/-TO%#Y%!@SUQL0V'U0X[Z$B6[B7(/<6]J?3,60Q#; QV_6"Q!88"KVNP
M0[HU(7=K^I45QPG+UU32?CM#I'L&B@Y4<9KDD9ODNRO.'$Z"(=I/30]0; &%
MG86F&P5R#S!O*K2)05_!OB>O0F(+I(.IL>XUV-UK?HS;L.X(^$ S"-8TCMTT
M_N;CJD9?.]Y[X^+L=4B,+3-)YUD5;AW^N4>2J^)8[<03JB+%J:"$)ZMZ9U1O
MYTN.<$5-=P3L'RAQFM*QF]+?GCB3B:%G[))ZH>(&-6D_EUY'\C2E8S>EMPX_
MV+UR9QO7??^Z#[SFV!PD_*X]-]8= ;NGB,]_N%*F61V/#U0UFI_Q*P=,WWW8
MUBC>.?""^Z=B4VPY4$)FD9FZ0F/.G]M0P="WG^_MGM5KIO?=3#]_(+F:FL!E
M2>HJ#3?-'/\?<.;<UQ3O'XCB?4WQ_BL4W^=0<>I;&-GK8F1?,[+O9N2/M* \
M37H'MO6:Y4 4[&L*]E^AX'Z!#<P')S(".VJ]6573_;)Z!RY PC:%K-]^;>]N
MW[-?5&^7]^Y?PI,IM-R?P9-Y_19=JZ]?ZE\KT]-"@(S>JZ6\8:0,YO5[\OI"
MLG7U7O>.2<GRZN.*JET1+P'J^WO&Y,M%N<#VOQ7._P=02P,$%     @ '4)E
M42K_#8MK @  - 8  !D   !X;"]W;W)K<VAE971S+W-H965T-30N>&ULC55-
M3^,P$/TK5L0!I-U\-J&@-A*T0LL!"=%E.:SVX";3UL*)L[;;P+]G[(0HI6EW
M+XD_YKUY;QQ/)K60KVH#H,E;P4LU=39:5]>>I[(-%%2YHH(2=U9"%E3C5*X]
M54F@N045W M]/_$*RDHGG=BU1YE.Q%9S5L*C)&I;%%2^WP(7]=0)G,^%)[;>
M:+/@I9.*KF$!^KEZE#CS.I:<%5 J)DHB835U;H+K66+B;< O!K7JC8EQLA3B
MU4SN\ZGC&T' (=.&@>)K!S/@W!"AC+\MI].E-,#^^)/]SGI'+TNJ8";X"\OU
M9NJ,'9+#BFZY?A+U#VC]Q(8O$US9)ZF;V%'BD&RKM"A:,"HH6-F\Z5M;AQX@
M&!T!A"T@_%] U (B:[119FW-J:;I1(J:2!.-;&9@:V/1Z(:5YA076N(N0YQ.
M[\L=E%I(!HJ<ST%3QM4%^4Z>%W-R?G9!S@@KR0/C'&NN)I[&E ;H92W];4,?
M'J%?0.62,/E&0C_T!^"ST_ Y9"Z) @,/KO;A'AKMW(:=V]#R1?]P^T[F3&5<
MJ*T$\OMFJ;3$[^G/B0Q1ER&R&49',MRQDN%IY&0M1#Y8L :?6+RY8[LT"<8N
MNMOUZW(8%4>^&W51>^)&G;C127$O>*/,>5929* &U34$E[V\6/I>WD;=850P
M3GH>]M3%G;KXI+HG6N.7K4$RR@>UQ8?:QKX;?]$V$!7[;C"L+>FT)2>U_12:
M<BQ==UF&]"4'9Q8$ON]>?A%X&':57!X<K=>[TZ:?/E"Y9J4B'%:(0U;T*9L>
MU4RTJ.PU7PJ-3<,.-]C609H W%\)H3\GIG-T/XKT U!+ P04    "  =0F51
M@$ZKZQ((  ";+@  &0   'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6R]6MMN
MVS@0_17"Z$,+M+9(2K(=) &:&-TMT )%L[T Q3XP-A,+U<5+TG$#[,<O*2NB
M9%%#Q<DV0!M;FAD=#CGG4!.>[@KQ4ZXY5^A7EN;R;+16:G,RF<CEFF=,CHL-
MS_6=FT)D3.FOXG8B-X*S5>F4I1,2!/$D8TD^.C\MKWT2YZ?%5J5)SC\))+=9
MQL3]!4^+W=D(CQXN?$YNU\I<F)R?;M@MO^+JR^:3T-\F=915DO%<)D6.!+\Y
M&[W%)XMIZ5!:?$WX3C8^(S.4ZZ+X:;Z\7YV- H.(IWRI3 BF?]WQ2YZF)I+&
M\4\5=%0_TS@V/S]$?U<.7@_FFDE^6:3?DI5:GXUF([3B-VR;JL_%[D]>#2@R
M\99%*LO_T:ZR#49HN96JR"IGC2!+\OUO]JM*Q! '4CF0 P<<]CC0RH$.=0@K
MA[#,S'XH91X63+'S4U'LD##6.IKY4":S]-;#3W(S[U=*Z+N)]E/G[U@BT%>6
M;CGZR)G<"JXG54GT!KU+<I8O$Y:B][E48KN_SA1JN+Q<<,625+[2]E^N%NCE
MBU?H!4IR]#%)4SVM\G2B-$CSJ,FR G2Y!T1Z %WQS1B1^#4B 0D<[@O8?<&7
M8T2Q<<?SMOM$IZ;.#ZGS0\IXM"=>E925&?B-&?A=.7"S8E%>Y&\$7VZ%2/);
ML_H2>0(\DM:/I.4CPYY'_E$4JYW.'UHR(>Y-:)85VURY<KF/%)>13(G?G=,9
MG8_IZ>2NF;.N68AQ/)[69BV@80TT!($N^$V2)XJ_277IKO2T*Y;?)M<I1TQ*
MKA=+/8 R:2[\^P=,&\#(;!Z-PP/\#K,YP6/BQA_5^",0/S2W!_.*_D4?^!U/
M$08F.*Z?&X-KZFV9'6BI3.M(4W $[_,[+I6I3"0-X$0EW%ESTTX":6>1=&WB
M<>S.\*S&-P/Q:6K6Q)LCDTN>+^^1%JH=$RNT+'(E-.<[P>YC1@T@P0%4R*(%
M=%X#G8- +T4AY9L:IMRQC0O9W(L,LF@APX%EZ !.XC9?25-2A69CI9?K+E%K
M]%X*QM-$S_L=%YJH.4H3=IVDB;IWDF[@A0Z:M+$WU 6#V#\7]RQ5]^C3FFF1
M+J==UY19KUF2ZJ5;Y$Y:J**":"&3-EK+]9B :/\JE):[/7DY89$!9>0PZJTC
M;#4!4Y S/E23J^L;(@YLN1O#Y'U<:59!P8F!3-I@+5%CF*DO[;K1\&2RTDO>
M;!N=$",_1,BD#=%R.HX'K)W43I,36^S'!IFTL5F5P+!,'"-T!%IEEO_Q[(E2
MARU%8YBC!XL=]M,T:-+>*%J>)AZ>/JJBJJ!-NIB-XWGKYP"\PR5LT% ;OJ5J
M E/U0 FLHC0?/FUL)"N$72,2]T)L[,5A?GX6)21=?L9A8RM9C<!IU4/CQ-(X
M@??V1^IA%15:T:!)&ZW5" )KA$\/27=?3H-&DBID7:LPZMN[$ZL))'H.1226
MP0G,X$?6;^RHWUG0_,&'"7&YA#WYL"1/8))_C$96H<#U!)FT(5HU(/#KP""-
MK&(\*J$NE[Z$6KTAL-X<HYH4>O^W2D*#)ZHFM;1.85H?K)K4O^<&3=KX+*=3
M#Z<?57554! L9-(&V^C,P/0]4".IGZY!DS8Z2]?4LZ5_#GFD_AT^:-+&;MF<
MPCO\(X6QBMJ2Z59CJ$+<-9M'??L1:A6##MGS]^LC[1*]$UW7#$!G!8%.GT,@
MJ:5O^G]T<ZB_G0.:M,%:]J:>CLXCY+ *U9ZG\>P0I<,*C^=NH*$E^Q!^;1@D
MBF%WR^] Z++J1V@E)(0EY)$]<&"MA586PM_6=P\MO8<PO3^]H;VHGM"<@JBW
MEL-&IQVF]D>F8U"[.K3D',);;?]^)+2<&3Z-,T-_BP0T:<.R9!G"9/F<Z\T2
M:@@3ZL-?>AQYN/"X_L!_.[/G)UO0I#T02[8A3+:^PG$.$ [Y@[@'Z._M@";M
M/Q19DHY@DCZV_J N6F0).,)/K+_($FOTM!YWY-]9@R9M6)9Z([B__8SU%UE6
MC6!6A>K/X]I3?Y%_]PR:M ?2^$,FO'L^IOX\(7OJ+_)WUT&3]@"M:D2P:AQ;
M?]#[>&3%(8+%84#]6<Z/AO1 @/IS]#+T)NZPY>$PPP&-^[H>D:7R:/Z["C&V
M]!K#] H5HL>UIQ!C1UO=D4:'&0XP;=BU1V0I.X;WS,=4I"=D3T7&_KY-[&C'
MT[Y-:6RE)(:EY/-W:/(M]<>_C?IC2_WQ,.H?<,CFPA/J!W7/2[?M[5R!7;-R
M!?:\M<56$V)/1^6[9L'G>W6+&Z=;X.,MSSF?EJ)CN/O]F$-35:CX,.71X=0X
M[# AO85C-*!]Q;)N[-GM.EGL O8R9T)/Y(8M^=EH([CDXHZ/SA?;,K=JS?4_
MP3G*BERM)>+Y2L_)%=\HGEUS49^Q0Z_1[4/RRH8A.\PA*F[0"_RZ3)%IQYF3
M?6C')-J)1"F>HU6QRY$JM&=SOK53N>!KES%J8+OG3%28%GRYA_1P;F\HHG(R
M'H=H/XPF)N@8EA6PJ4>%G-Q\X?$:G(Z5KS$!I,FT'VR.N.#^)!EQ>'"!TF/5
M<.J1+B=%7GB\OG&T9II&ELMMMDW+CG:]+I)LHS'OSZ26\QK,QZ0>)LM7Z 75
MBR^VETJ[3FY+TVY1N$8]:9RRS;BX+4\K2[0TF=X?.JROUB>B+\J#PX?7X]G)
MI6:+[AU=\/K.W'5G&IQ<ZN7DNH/UG?TY:0MK?VS[(Q.W22Y1RF\TQ& \U9(A
M]B>A]U]4L2G/!E\72A59^7'-V8H+8Z#OWQ2%>OAB'E"?1S__#U!+ P04
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MZ#N)#Q0]4R(/@D+9*(D>T M=\W3-8D9,"? -^DJ/-$8!>I*2 H2D$?K*R!M
M%*,2?9Y315@LOX#QM]<Y^OSI"_J$6(J>61P#A1RY"B+6?MUU'MTTB\Z_$EV
MGGFJ=A(MTHA&%OM%NWW88N]"IHIT^>=T3?U6PE>Z=Y#?_PWYGN]9XIG=8S[4
MYCBTF,_;S9^)<%#@735??"SXY7\.OI++H"B]P/!UKZG)ZBU"NL% EUH?A&#I
M5C<*)M$_YW)K\=0M/'6-I^"*IQD4 3!#82.XE"RBPA1U"W6OH.ZUBIC2+4O3
M+.R8I&MJ*_*,HF\H=*L_3K#OX)%[+%?./:"Y!=1S@BIH80%A)ZR"EC>8*LGH
M%\GHMR9CMB.09:G?^:-N*;9<9 R#DE_/&=12T<3@>B86-IZZQB;FH0RJ:!P4
M&@>M&F'6JCAODKH#<K6C I'H+^C59M4F.J/LE8.M2;Z)6-Q$+ =-N=CQ[7*'
MA=QAJUQHG#>*>]A\6+XSK,FS@()2:)G">YB6-Y@J(L-"9-@J\H6_DUB]H]6.
MP&8%E=H%C"X*,SBE:$7>+8^WX@Y[EZ'KM3:D7^6P-.5QJ\(SF6ZS%+9RMEDZ
MSSG*)?;@]SQ[;K%_\>W_LNQ"V__X6,"7"82#_^4Y7 81[GY\7.0<Y><0UEK;
M+,>4WX-AZ'AA^:\V.W*3<LL/_.9;:&$.&S-F:4%5R:H)NHQ3W#Y/[RG4:<[1
MUD]O0Q:W(4L+I.6-N(Q)?,^<U&-RH[??5V<E;@XPWZ\_L)D-Y?3K8BV@7F-@
M6E!XZ/2NZ+V,3-P^,V\/D9R@NOO!3:E-6(CKVX?%?63+6V296+=TMDJHV)I3
ML$1K?DA5MM<M5HN3]I,Y7];6I_AQCBWK"WTR-V>Y"WUVK(?M/G0+B6*Z 5>P
M38(Z%-E).;M1?&].=F]<P3G17.XH@=VM!L#W&\[5^48[*'ZOF/P+4$L#!!0
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M!,?<*&QF@<DOFK@=;Q\#!S7!0S/!?Z6J!Y*JO%0%I &,;,NV?ZO<3'\_<-,
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MNG)N\_1>/WT1;)/<0W]A0K @>5Q3(B.@#.3W2\;$[D55D/^Z8O _4$L#!!0
M   ( !U"95&GOR@\80,  $8-   9    >&PO=V]R:W-H965T<R]S:&5E=#8R
M+GAM;,57P6[;.!#]%4+HH04:291L.0YL XF-H@'2W:!&VT.Q!T8:VT0I4DO2
M<0+LQ^]04B0EMM5%4V,O%BG./,[,XSQ3DYW2/\P&P)*'7$@S]3;6%A=!8-(-
MY,SXJ@")*RNE<V9QJM>!*32PK'3*11"%81+DC$MO-BG?W>K91&VMX!)N-3';
M/&?Z\0J$VDT]ZCV]^,S7&^M>!+-)P=:P!/NEN-4X"QJ4C.<@#5>2:%A-O4MZ
M,:=CYU!:?.6P,YTQ<:G<*?7#3:ZSJ1>ZB$! :AT$P\<]S$$(AX1Q_%V#>LV>
MSK$[?D+_4":/R=PQ W,EOO',;J;>N4<R6+&ML)_5[B/4"0T=7JJ$*7_)KK8-
M/9)NC55Y[8P1Y%Q63_90%Z+C0 =''*+:(?JO#G'M$)>)5I&5:2V89;.)5CNB
MG36BN4%9F](;L^'2T;BT&E<Y^MG9 C2_9ZZ4Y%H:J[=(D36$R8Q\A&S-Y9I<
MNDISR\&0,W+%!),ID&5YQFY4RDHVWB[ ,B[,.S3YLER0MV_>D3>$2_*)"X$&
M9A)8C-;M&:1U9%=59-&1R)90^"1*WI,HC,(#[O-^]P6D/HFI<Z?CY^X!UJ@I
M5-04*BKQ!D?Q#%]+9B'#4_)4,W/1@QPWR'&)'/^4 O.>?&!<DZ],;(%\OT%#
M<FTA-W_U;#-HMAGT)G!I##+6V>P0)15$4D(X!;B?T<B/)L%]M_#[1M'(CQNC
M9]$-F^B&OU)>\@^YU5 PGA%X0.DR4)U-93>@L3^TQN-*F$O-H"UV-O:MK!?2
M1X(ZMV,Z(ZF25J-DF)Y")DVHR2GY&C7;C%[/5P4QZE Q\(<OZ*ILAEU.#W-U
MWD1V_HM<_5G2(I4\VZ-FKI4Q9PTQ9L>*GB*-FU#&I^2"AJU,AJ]GH\;HTC'R
M1R_H.& 4)<?:AW9TG+Z*%):F>HN+@K,[+BHY?V7#T%8[:712FEHII7%O%6[J
M[!Y_2E6\QT*R3]6^T:!C]#S&5H=IOQ#_@>V1_?]R1UMIIL.3LM<**TU^0Y,E
M!TAY^1=UP"@^VF.M(M-^2>YG[G1]U@HS/3\I4ZWLTO%OZK/Q_F7!IR_9VC>*
M]_HLZ%QRW1?&)Z;Q>FJ(@!5ZA?X(#[&N+NW5Q*JBO/?>*8NWZ'*XP0\=T,X
MUU=*V:>)NTHWGTZS?P%02P,$%     @ '4)E4:C"$C^L!P  &3$  !D   !X
M;"]W;W)K<VAE971S+W-H965T-C,N>&ULS5O;;MLX$/T5PNA#"C2V14F^!$F
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M6\SF(*2I8#@4W!R>3#>>M4?IJ'SI]+8*<50*=;JN0EZP2UGX*(^>27W]/=.
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M)G/TGLV78;)$%[KXH0J91*=H$E$IPT4XH^G$X OT!TQ?=/*!2_E67TZH7*$
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M#THF=F>PNPO%U^F9X2U7BL?IUQ6C<R8T 'Y?<*X>+W2 _"1\_"]02P,$%
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M[DE,T@4%,UD\4[8@,LUL!>[RG/(<D'0)IA&91W'$(^'R_H%R$L7Y!^'\/'L
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M@D G.114^[($@3N95 4U.%7+0)<*:.J<"AZ$G4X<%)0);S)R:X]J,I(KPYF
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M1V2<OT"3;PB^S5[X6' A>)1]W%#/I[$RD+^ON.R,8D/MH'R-:?8_4$L#!!0
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M'@K)&F>)?&*[>U(.:*CT I:(_!OM2JS90T$F)$M+,D20QK3XQ>^E$0<$=]!
ML$N"72- QWJ"4Q*<.J&IAT%)&'0E#$O"L"O!+0EN5X)7$KRNA%%)&'5UR2\)
M?M<>+',_<V:=XC51JLDNDJ[(DCS%9ECBR9BS'>(*#WKJ(L_3G ^9%5.UI%:2
MP],8>'(RQYS&="/0(^%H%6%.$*9A<16Q)"1<_([FKUDL?Z"S&9$X3L0YND3?
M5C-T]MLY$@HH4$S10YPDL$C$V) 0EU(W@C*&:1&#W1"#@QX8E9% <QJ24,-?
MM//]%KX!?E2FV'M3IG:KX(IL^\AV+Y!MVJ8FGED[?9E1H'N-]'D[_0%SH(\:
MZ7==@L_IEJ^A?^D2O-](O^\0O&,VTA>_YOSRU\;^M9W^9R A>"NGCUKRR*D6
MEY/K.0UZ?V0IX5@R?M4B-JC$!KG8H$D,]M>8!BPEZ"QA0ISK%EHAX><2:C=]
MFUQ:PX%KJL_8>#O,X5.H:^J \U.@9;H##?+N%.G;M@;X10,T-;A[38R.KP$N
M-#':NA"7&J [M(Z11],SK*9GV#K7,T(9O*$_FVVWDG-;9_M[7@N0$.$W2*$-
MV;]HH2H2$M[0\,Y&4%"I<B(.T/QQI<N&H@OO<+".VQ_69JU #8]1-7_U2D[-
MW':E(Q^\R@>OU8=9G&2JZ$)DO88J#+%UX<2EJJ/ G1WFH4!GL/\4!NE6Q6U[
M%W];_^C,\TX&4T]W[\04LS^J&7>*L?IVS3:=SD!OVZBR;?2_I$^H[ 580P*-
M.B60'E5W0H?RZEI+O5:#&W[EAM_JQ@V5\66XSR1-_I#W(,F@=D!KSE($[]AM
M)G%>\D.^'7B$SEJRK#V&ABSS/\TR7Y-!-=<6'3!+'6:D]]4R/ZI'LW54*\F"
M%SA:;3,>1. HVG*VX3B]0#B3$>/Q3V5RRC(J==MQJ7Z\M^P_#;$=5+96:VQ/
M551"32/CD/5P:MPOA9:IG);*;=/R.63Q.639"CD>MRI>CUL^RA#+^0^Y=_L)
M:T&1C&!&"8]9J!S$B$(-HFJ/BVI1E&:2UPPGY694-/5UFZ!Q<%"!TFB3GZ4%
M+#C(CV*KK5JK\_IM?DJMM4^MJWM+T[ZPKI:Z]AO+A@<Z)7 !GN0'6^,CI.(/
M!2AF-S$5*"%K",_L>S!/O#BC%S>2;?.CU3.3<%3++R."X="D /!\S9C<WZ@.
MJG]*)O\"4$L#!!0    ( !U"95%[OXXC! 8  $H>   9    >&PO=V]R:W-H
M965T<R]S:&5E=#<T+GAM;+U9VV[;.!#]%<+H0P(TMDA=+ 6.@<2.+2\:-$BV
MW8?%/C V'6LKB5Z*CM._7^H2ZT**5NL@?6@D^<SPB#-SAJ1&>\I^)!M".'B-
MPCBYZFTXWUX.!LER0R*<].F6Q.*7-641YN*6/0^2+2-XE1E%X0 9AC.(<!#W
MQJ/LV3T;C^B.AT%,[AE(=E&$V<\;$M+]50_VWAX\!,\;GCX8C$=;_$P>"?^V
MO6?B;G#PL@HB$B<!C0$CZZO>-;Q<F%9JD"&^!V2?5*Y!^BI/E/Y(;Q:KJYZ1
M,B(A6?+4!19_7LB$A&'J2?#XKW#:.XR9&E:OW[S/LI<7+_.$$S*AX5_!BF^N
M>FX/K,@:[T+^0/<^*5[(3OTM:9AD_X-]@35Z8+E+.(T*8\$@"N+\+WXM)J)B
M(/RH#5!A@)H&5HN!61B870VLPL#J:F 7!G97 Z<P<+H:# N#8==9<@L#M^L(
M7F'@9>F0QR\+_A1S/!XQN@<L10MOZ46609FUB'D0I\G^R)GX-1!V?'R]7.ZB
M78@Y68&O?$,8F-!(E,TFS><7 A;QDD8$G'VA27(.SJ:$XR 45Q?@V^,4G'TZ
M!Y] $(.[( Q%[B:C 1>D4M>#94'@)B> 6@B8X([&?). VWA%5@I[7V_O:>P'
M8C(.,X+>9N0&:1T^DFT?(.<S0 8R%'PF>O,_=K$P'[::3_7F=Y@)<[?5_+8+
M^<P<>@KS61?R7JOYO -YTV@U]T^;^<5OOWLM$<Q#:9B9/_.TTOC[@88A$,J[
MQVSUCV9<ZS"NE8UKM8Q[@T,<+\EG\$2>@S@.XF=55>4^G,Q'VM%>QK8'C;XU
M&KQ4DU4!&[I.$S95P%S#[+MUV*W*&W+ZJ Z;J6"&T7?JL'D.\ZHPQVD,Z7=C
MMCCBJQ8(^Q (6QN(KY.%B(%84!#1UI<A3I)@'2PQ;Q$Z/_<VK'" 7A^J.3@'
M#HZ6PW5$=S%/*@1$-JX9C<"UH*=BX4@L++L2H1J+X8'%4#\36?HO:^D?%)TA
M3#O#9Q"+A1E= XY?5=F:N[<KI%RSD:E#B;=K-<,\E4$74&2#W<A3!<Q"?:^1
MIC+*-)JNYJH1[68J^S+*L?J--US(DW"!6E+4/03&[:85)%ZU"(4K4;-=9#3)
M310PA9Y,%3"%GMRJ8+;;#.=,!9/U9*Z"R7KB=WO3Q5%NM4AXATAXVDC,<,#
M=QSN2%H&4\*"%YRNX\$LB$6( AR*AI%PMA,[!9ZTUTMM<&B4RSCC0YL5K"P@
MX>GM:EHXJ8DCZ@\;$3R&JE-$)47TKD)>N*L7/6P345@N**#YSF)>.*PS:252
MKC"@?HEQJI[[A?\Z+U21@3JQLN-"?<OMH&=0;K-2C?M'0'5V92^&^F8LZD9L
MGF,PV3%&XN5/\"?#<1)FB02N5_^*[5I6W6?P7%=:9=>%PX\MZK*MP(Y]15_4
MLI1"4^JS_E%8G62IN% ON;]<UI[<\*U*%ZEO%TOI1<8[5W7AL+9&<]J*!Y5*
MC/1*?')5%_YKR[26]2LJQ1?IQ;=#22-9;Q$TI3PZ"JLS+&49Z67YGB;\XH'P
M@)&T? &.5^"^.,_[$N"G( SXSVI]=^S>J-1C9'UHH:-2<%%'P=46.I+E]$):
MIOG'4'6*I>HBO>K^:IDC>0=T8;6)/RK%&.GW0+]1YO*"WVAA40HST@OSZ34N
MB[%F=DHM1GHM[E+ELOR*S5MSP^4?A=4/<TJ9-H_(=*<:TYT;E4)LP@\M9[,4
M6[.CV&K/CDQ92*'8*#56XQ,%S+2;JCQ5.3,]:4>H@'E>,_BS E4M&:<QX%SA
MR;7ZME?]U\BI;AP7O^2Y'J'*H:*^V9Q\E%+XUYZEF/*V07&8HD I3U-4.,5Q
MB@*F.$]1#FJWK<+,LH6:'4]-VP7(E,\2D7A=*>UEF*(ZI@J87!VW"I3M-$\N
M9@J47!QS4S[D;!:'W^T=%\=HY4$85+XK180]9Q\E$Y&\HA'FY^B'IX</G]?9
MY[[&\QMX.8>*YSZ\7.2?-4OW^5?6.\R$@"4@)&LQE)A]D>\L_W"9WW"ZS;YJ
M/5'.:91=;@A>$98"Q.]K2OG;33K X?/Q^']02P,$%     @ '4)E40;*1?YW
M!@  11D  !D   !X;"]W;W)K<VAE971S+W-H965T-S4N>&ULM5EM;]LV$/XK
MA+<.*1#8(OW>)0%2)TW2-FV0+-N'81]HB;;92J)*4DX\],?O2-&2$\NTD*Y!
M$$L6[^6Y.]X]5(X>A/RJ%HQI])C$J3IN+;3.WG0Z*ERPA*JVR%@*3V9")E3#
MK9QW5"89C:Q0$G=($ PZ">5IZ^3(?G<C3XY$KF.>LAN)5)XD5*[>LE@\'+=P
M:_W%+9\OM/FB<W*4T3F[8_H^NY%PURFU1#QAJ>(B19+-CENG^,UG0HR 7?$G
M9P]JXQH9*%,AOIJ;J^BX%1B/6,Q";510^%BR"8MCHPG\^.:4MDJ;1G#S>JW]
MG04/8*94L8F(_^*17ARW1BT4L1G-8WTK'BZ9 ]0W^D(1*_L7/;BU00N%N=(B
M<<+@0<+3XI,^ND!L"!"\0X X =)4H.L$NL\%=KG4<P*]IA;Z3J#_3 #W=@@,
MG,"@J86A$Q@VM3!R J.F%L9.8-Q4  ?KS 6-1<ID-\XV7J<;-\XW7B<<;V5\
MI\@ZY;AQSO$ZZ47!=XJ*M]OEC&IZ<B3% Y)F/>@S%W;/67G8)3PU[>%.2WC*
M04Z?7*6A2!CZ@SXRA0[.F*8\5J_1;[^,NH/>[XBGZ)K',6QD==318,](=4*G
M^VVAF^S0_4DLVRCH'2(2D.#^[@P=_/JZ1LO$K^4TG[<1[ALM>+A;RYE?RS5=
MH2[>Y\JY7\D=R]J(#/9I>==$R\@"&M>(7_PO3ES^F!-7?O$S%K9=/#'9[<3[
MYEKP;BT?FFOQ!.1C8RW!>+>6ZP;%2D@1UMU:/NW1DLEUBGU:/C?8?F1LM8S.
M[V_1@=O5SW1UH&64?8.4?8-8Y=V]?0--1*IY.F=IN$)_?X1UZ$JS1/WCL=(M
MK72ME=X.*^>S&;/\ 1J1M:?!GJ2: 3,)11KRF%/#,@Y1QF3(4EVWI_TF#@AN
MX^!5[3[V2_;;)'A5MW_]8L-1>UPK=^F7P^/VX+G<DZ#VRJ#VO(JNJE"R1PI3
MQ84P8E.M@"=.OT#,D18HY@G72,S@291#&J80;KTR7_!4,\F4!@7 4Q6KVRB%
M$V/KA"&IRY-A/W _1YUE#8!^":"_!X"S;BLAI!D"GEEX#WP9W;?OVN@=BYBD
ML469Y3(3BJE#1-6Z4 R*TRR+>4BG,2N7WX+&NN'B=PAW@W;@S<V@A#9X46YD
MD0' "1,9'$XA)546;!RBG)FDF7!XHU 'S^]4;P^X80ENZ =W>X=2H7G(3/0S
M*8P_$:)Y!&5&HR_ =Q*3&D!A\;*R\&*V57(6Y(RK$."M&)7*M+D>HFED+OIU
M*(=;%=D;>0MR5 (;O2AKX"Z'$XQ-50B'-V4S5"QS(*1(:@.P&QFH?0QC$$GG
M55#,0]!(8\WK,UP Z&]@QT,O]G&)??Q#V$VJ:00 X5M7B9L9U MFMB0741&+
M]SG,#\=+^O!4BGR^0#"<63)E<CWFQR\+PGBK (B_(^&@HM'!B\)0^F.]:] W
M)\[0II=XT!T\]=)QM.VEI#>L6?F^9F4O(#4K/]2L'.!^S<J/-2N[0^*+YL:A
M!'NC.<F3/*9V\,-1GTEH!RA<4#DW@S^V.\IM))A(?&YC74OG\78L@0S5H+EH
MM/0IG(HK8=*T.,22R8RNS#:'DC #J,"B\C!DS-:SW?.U:,AVNL=UZ;YHLO(I
MEHJ183\-N14K*.@5,O2+F2EDWO'$,0* F:3_"FC5BL:FWN%W<]I*-LMA"X0Q
MY0D<-=V3.MYUL<<%LF\@X8H*X3U<:,=(JGHQ340.'[8YF6/*H3GQK)MQU_5N
M0R:@DZ7TT'1ZUY>*K;^JI?_;Y&C4ZWH[446.\!YVM _2NBFMO$GXM,=,;Q_E
MP17GP7Y^<<N6+ 7V,A%)PI5Y\<@DD+4KL]73R&>B8AYX^!./*[@B MC/!.ZA
MJ6L=5ZQ& >-2MI!L!?':,8&^KU^XU)[R"I.8/)L(.PJE&MS8/[GO\JEBWW+C
MV_G2_/V.7IP)4@U*$OS$3)!JA!#_"+DI2 5=4AY;BF])%7Q"TV5 1.B<\A0F
ML2$@7_)HGK@V9>XO.7".B<AEW7GR[1[#9(0BNE(^$!N';/_@N"DF!?3.;SDW
M0W#*@#0!<^*&2T4,V$190\YWP,)##D\E6YJW\Z%AG:9=.=RP]VUW<IJ,B,G%
MJ7VJ-C)?"WU[KCSO5YV-=Y'F'PS7,+4AT"AF,Y )VD-H*[)X9U_<:)'9UY-3
MH;5([.6"43BWF 7P?":$7M^8-Y[E?TY._@-02P,$%     @ '4)E42YPKOFB
M#P  &ET  !D   !X;"]W;W)K<VAE971S+W-H965T-S8N>&ULO5Q[<]LV$O\J
M&%_GFLXX-L&GU$LRH_@5)4[BVD[3]N;F!B8ABV>*5$'2CCOY\ ?P(4 D $)Q
MF7\2RP86B]W%#[N+7;UXR,A=OL2X %]629J_W%L6Q?KGP\,\7.(5R@^R-4[I
M7Q896:&"?B2WA_F:8!15DU;)H6U9_N$*Q>G>JQ?5[R[(JQ=9621QBB\(R,O5
M"I''USC)'E[NP;WV%Y?Q[;)@OSA\]6*-;O$5+CZM+PC]=+BA$L4KG.9QE@*"
M%R_W9O#GV3OH5E.J,;_&^"$7?@9L,S=9=L<^S*.7>Q;C"2<X+!@11/^[QT<X
M21@MRLF?#=F]S:ILHOAS2_VTVC[=S@W*\5&6?(ZC8OER;[('(KQ 95)<9@]O
M<+,EC]$+LR2O_@4/S5AK#X1E7F2K9C+E8!6G]?_H2R,*88(-%1/L9H+=G6 K
M)CC-!*<SP5&QY#83W,X$5\62UTSP3"?XS02_,\%7[2%H)@3=33N*"9-FPJ0S
MP?,4$Z;-A&EG IRH%&>UFK.,IVR4W=6V>DJK;MC3MZ^:TBH<=C6NGM*J''9U
M;JOD!5NEPZ[6'>4JK=IA5^]JQEK%PZ[F75<UI54][.I>O4JK?-C5OJO:OMUJ
MW^YJ7VF2=JM]NW?6E5,VA[VG?>645OMV3_O**:WV[9[VE5-:[=M=[3-9RJ>T
MVK>[VG<#U916^W97^XZ2L5;[=E?[ZBFM]NVN]I53G%;[CK'VG5;[CC'2.ZWV
MG:[VE<;O;,"^A_8JXW=:[3L][:LN"*?5OM/5OGHOK?:=KO:5!N.TVG<J[1_6
M=VIU(1^C KUZ0;('0-AX2H_]4-WJU7QZ#\<I<T&N"D+_&M-YQ:NC+"WB]!:G
M88QS\.P8%RA.\I_ #R!.P?LX2:B7D.^#?_YCXOCVO]@O7S>_?'%8T/49E<.P
M6>MUO9:M6.MC6!P R]\'MF5;"7K(R[B04#G24WF/'H$#&1$XI9X&3B.4RL@<
MZ\F\1>D!@'Y-9TVRJ P+';F3 7(E)6=/*G+!IZMC\.R'GQJJ(?6/=)1/=Z \
M/[\"SQIEF-(_T]._PFM*?ULKC"2I3 &3,$$Q-;THOH^C$B6;E7X AZU92!9]
MHU_T%-_01:?UHF&V6M-%I,S/OXWY@O*(R<Y<O]6O=HS#@XWML64D)-Z9DY@H
M2)R;DP@4)-X;B,UR:[&M4%HN:"!0$DPDI#[H2<W*6ZJ!P(C4QR%+3^B1;+@2
MC%M"Z<* DM68UWJ):*02XK*(0Y3\EUD;2A\E1'\Q.8AF.[TT( 6MFM3&-D6:
M]8&(%PL)\2L#XNWF!_B\-L7:;4I+C))B^5_*9*I#GD]#U EE%':D(*'SJ\&!
MJ!6COQ(^F]!QANG\9D"GO5IT='XWH6-PU?VAI_,ANV_/%86M!.6RNWLV,SF<
M]34T%6V!@ZQ@%;(%!KR#V9I:@V-M7<@#UCL;<!5JA39@:TARP&VHX,YR=B(Y
MZ#HD_$K0J7DVZ"DDFW/0\B8C,^ 05)Z1;2NWF)=K3 &5W&$I]8&;OT;1YO9J
MJ',34EKG@!\@.(6!9N<#][MH@CHR.]SQ4+*C0^JC;QQU>^.HVQ511T'T/,MS
ML.VM__N<C@'S J_R_VA6<#8K.-4*K@HFRM4-)B!;@'59()87!!7S=*6O0*68
M/VJ:7D63Y3OO7SDO#N^W#&)XR#O=D*W-N)O-N(:;H<Y@SOZO=E E/+,4;%Q.
MW=YF[]P>6[:<+6_#EF?(%E4BQ<X0K G.0Q*O*[:V717&F\8*3[T>=WY7]+HA
M6QOP-QOP#3? #RWCDW^28H+?XP-".2/!AI% R\@5-5&<_PC8R6<W!CBBGB*8
M)0F^I2>$G91\'1,4/H)G#\LX7((HHX:<9@7X@%887&!"XML,('#<(NY/FC,T
MV7 U&>F43C<K3$U/:6T:.95]F)01CEATCK^L<107] /SG/46]'':UXIMR=4"
M+9Y0L+0,?KS'!)%PV='"477\9M7QT^$A%#(7<"190PZZT#:4]M8-2,4Z<.E?
M-82WL,/K',_7LD&!0@$<QJ$ICC\=8U[#/C)#QU.PR,$9FJ(S>T0K$U19Q991
M"_*-P,TC*)88-*';$,O&J TY;$-3W-8R>&3&8!^5%6 (.2Q#4URNS[T<$]@+
M9E0FF%UZ\L#Z(^Q#M0H2.%1#/59?4"/$ST_C+PP3SNLLS3XX)N5M7F2$BFU)
MKV+=>>7P"\?"7\@!&)HB\$>J<P(NM@Y48P-QC;VFJ8<+V,=B9RJ7N\VAV-9#
ML5SN5^5BD25WE-$R+1[9/C[@!_![1NYT;BJ'97LL6+8%7W@D6/Y@]Q%7!6<V
M1UQ;C[AJ^P:?EUF"<Y10;E$:@>,X+TA\4U*SUPF" ZGMCB5LCGVV*?;M*.SW
M=A_HE$;-D<[6(UWE^(%90468XD=PQNZXYMA)DLC;BW#$LH.QY,JQRIZ,(]?+
MAK"1$7-8LTUAC=W)]"=,!9H]8BP+C2YMB>\HY\#A<.7HX4JXPTI"<%KH66BH
MF;# P<N!ABR@B%Z9U"NAII57H49U?@L6-E#+:^!=DZ2];%82V?,4-ZG#@<_1
M ]\12E$4HW3+G3:R?4=( SAC91HX;CFF#N".MO^+(_'N%)CB<(AS]!"GNB@W
MB:[:1='%+0X',,<?2[X<OQR]Q_7-\IV=-91-P,7A6.>88MW38Y(S1P)_JI//
MX<\QA3\AOPG"2NV4GX&DYYDC\=\4&2R.A^ZWN6]=J]P'LQ5[[XR,@,#E8.B.
MY<FY'-#<D3RYV9$K<>442.!R\'._7_!\Y$K2FBJK$!*;>NBLK6+1L8KW]&*X
M91: :#SUD=S2".2O*JK6:8GCH^N-90D<%EW3"'972SAV^S&K*HWB<@AU32'T
MZ99P[/9!%:HXY*#JZD%5;@EOJE<X,$_SDJ TQ,PDJ+^BBS=<CI+N="1#\#CL
M>:9NX),%?^SU?41'X81Y'!<]4R=Q\UHG<U"/O;X'J%R< Z:G!TR=TD-V^*\P
MN8_#32Y*IQ*.BMY8+J''<<TS=0G#[+E6L+][?1_0F2@$*[S,F/B /5S%45R)
M=1;=4W8HQC+7.U[EX!*'V3TFCR:"YB#HC>4;>AS8/%-@&Q+T;Y[$%U1<L1Z'
M+>];8.L*WS=Q?$EW7V4P3?)2'H<N;RSH\CET^<81[(!H/_M]9+(5-NQS9/+U
MR#0(#K6;L&*QM:&3X'-D\L=ZH?8Y$/FF[MF0@'_U^\Z7K8AC? Y2_K<X7V_8
M#9L+"=5K_ 7I@D6?HY(_EN?E"T^ZQF\' T+]Y$L\+04@^!R0?#T@O8EOEXL8
M)Q'=*5K'!46!.3B_V <TPD') ;@_V#S7M@\LZR1L_ZP3 <<D?ZQW Y\#D&\:
M8=9/-*A]J\[2Y+%.,H$$/8"POE^^ G6)])FO2[]50^;:(=M/[AS? I.(5.%Q
M7B1(FR$).(P%8P6> 4>K8*S LZ6\E=E3A'4!1[; %-GJ,CJ67*PR#P-5=2U=
MD9N)(K0(.,X%IL[8+F4>+563,"?@$!CH';/7"0KO+K/P#IPEV0T%AUF29&%U
M;X'3,HWD.'%@B!$!A\E@+-\L$(I:OE_0.0_ZWINB^B?@0!GHG;>C"KI.XZ1^
M6I[G!.%$MW4.C\%8_MF$X]?$V#]KJF-45?P32> HE]V$P]K$-&ZL5[_/$NHP
M(!)3^(_B?!7G.96JAJ=^/-D!_7/MD&VV.5).3)&R9IO>5(]Z/OOXJ&*"P^-$
M#X^UH8&3A-56'F5D?0!.VL>A'\$)/0,'%1A\N[,PX> X&>O1=<)!;_+="@5/
M)H.%@J?:(=M;X'@YV:TD94=S/YE(?,TNV[HAVVQS")X8A\?-*V1&VB?1*"8X
M+#)2/P9FBP5UAXC,43Z92!)^L,N]=LPV^T(!HAZ@C]&*1GCTE&;E[;)@A4FZ
M5\J3AMI4X"'PK2ZC]2!6&L3E?*"XV"<<\2=ZA_@T(SB^31LYAX\ ?PF7B)XI
M0*@OO \(#5117I(Z7OT*]+U;9\UJK!:)ERX="$%U[1</#MLNR^1WRU1_M\S9
M5S+(L =<,<PZCXOX5H<_4WZ/3,=RCZ<<]*>FH"\X@+)FS:GD%48A2@[V4U-?
MF$>C[$$>1U(.)"6*"@XXQ$_U_N\U2L)R!2ZRAX@R4NEN*%$RY=@^'2NFGW+P
MG9J";Q-%Z@/*^;2/I(X"2J<<2J>F4%KW8[+R^Q"O624B!52 P#HCU77&1BQQ
MK>V<U7GF10VQ28QNXB0N'L&"9"LZH^U*I;NI:4HW(P%6Q5XXKD[UN'J)4FH%
M$5.3F3D(!=UC.;[0$JNR35W?%<H+^M-V"X2F!?=-2]K@C$-+*-^V3-WA/D<I
M6K$4PW;1[P"3?==75?9K"?7?UE#!#5G1.PI1#_(T)GG!,JA+5!0HK>SS*E[%
M"2)5\X&VJMT2RK>ML1Y;H"548%O&SRV5=_80%TN0-]NITA\TTJY25$UQMM)1
M.VN7$D4?=&Y=_9C.+H2R;$OO)C]-)T)UM356[ \MH4S:^H[1?[N8@4\/+:'
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MBNW;>K3KZ.-Q'W"F+YOT%Q->FPJ3\]9/BBKJ=*#0M0,'VG;H!1=5I1]F-BA
MH3-62A0*C3?0,74I=ZJQN&[IFB0OA!X=:-RD$V5_X;K_?<=BE&LH:]=1L29
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M0<\-[-92=$B2$]VK@79R7=!^/;V'%;LU#_;C'^]_[Q:H\,ML6<%1H->J5>
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ '4)E49E<G",0!@
MG"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  =0F5126T&+2H%  #1%0  &               @($."   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ '4)E4>/S')[H!@
M(1X  !@              ("!;@T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( !U"95$29"79.0(  %,%   8              " @8P4
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  =0F51:M*C
MWZ\#  !(#   &               @('[%@  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ '4)E43"YP:-7!P  C1X  !@
M ("!X!H  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( !U"
M95&<A5]P_P(  !<)   8              " @6TB  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    "  =0F51S&5YI)(*  !71   &
M        @(&B)0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ '4)E49ZLFBRC @  G <  !@              ("!:C   'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !U"95&@%;1<D@@  -HD   8
M              " @4,S  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    "  =0F51W*=#<8$,   R'P  &0              @($+/   >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !U"95$25Q513P@
M #44   9              " @<-(  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ '4)E421JXI:$$@  F#L  !D              ("!
M25$  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  =0F51
MU;N%O/D(  "!%P  &0              @($$9   >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( !U"95&N;U((:P(  !(%   9
M      " @31M  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ '4)E48Z: 49G#P  M"X  !D              ("!UF\  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  =0F51E$TP?($%  !2#
M&0              @(%T?P  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( !U"95%XZ%:6-PH  )XL   9              " @2R%  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ '4)E49N9L)+)
M!0  61D  !D              ("!FH\  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    "  =0F51+1U27S0)   L%P  &0
M@(&:E0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( !U"
M95%\\[AJ"P0   P)   9              " @06?  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ '4)E40E,S@2( P  ;0<  !D
M         ("!1Z,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    "  =0F51'MST*!\4  "L-P  &0              @($&IP  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !U"95%=$B6^ZB   "&%
M   9              " @5R[  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ '4)E45V#IR)5!   /@H  !D              ("!?=P
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  =0F51U #R
MX/T#   Q"0  &0              @($)X0  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( !U"95%HZ! SN@@  +,6   9
M  " @3WE  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
M'4)E452N]/H;!0  >PL  !D              ("!+NX  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    "  =0F51F"Y@?.H&  !M$   &0
M            @(& \P  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( !U"95$%.J*.V04  .40   9              " @:'Z  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ '4)E49_H@@?F!
MR@L  !D              ("!L0 ! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    "  =0F51(*%U4FX"   A!0  &0              @('.
M!0$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( !U"95$8
MSF.$' <   @6   9              " @7,( 0!X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ '4)E41_[G:=' P  - @  !D
M     ("!Q@\! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M"  =0F51L*,;,AL)  #&*@  &0              @(%$$P$ >&PO=V]R:W-H
M965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !U"95%)U7L\*P8   H3   9
M              " @98< 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L!
M A0#%     @ '4)E42T%R9"S P  Q0<  !D              ("!^"(! 'AL
M+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  =0F51E"]_KCP#
M   R!P  &0              @('B)@$ >&PO=V]R:W-H965T<R]S:&5E=#,W
M+GAM;%!+ 0(4 Q0    ( !U"95%<^%3!<@,  %0'   9              "
M@54J 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ '4)E
M41AGA4U' @  # 4  !D              ("!_BT! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    "  =0F51DYZ<SI@"  #'!0  &0
M        @(%\, $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( !U"95&JSW.EL0,  *H(   9              " @4LS 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ '4)E48G3:3 # P  K0@
M !D              ("!,S<! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    "  =0F511E-[K:<$  "]$0  &0              @(%M.@$
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( !U"95$>LF+O
M/ D  -PT   9              " @4L_ 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ '4)E41N^WKDA P  N@D  !D
M ("!OD@! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  =
M0F517/;IYB$"  ":!   &0              @($63 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( !U"95%G4 97> P  /-,   9
M          " @6Y. 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#
M%     @ '4)E44<,Y%ZM!   [A,  !D              ("!'5L! 'AL+W=O
M<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  =0F51LQKQGJX"  "0
M!P  &0              @($!8 $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM
M;%!+ 0(4 Q0    ( !U"95$:>0]>?P,  # ,   9              " @>9B
M 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ '4)E4>8O
MI1Z,!0  ]AP  !D              ("!G&8! 'AL+W=O<FMS:&5E=',O<VAE
M970U,2YX;6Q02P$"% ,4    "  =0F51#D=@1*\#  !M#0  &0
M    @(%?; $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M !U"95%^7:.7: 8  +D@   9              " @45P 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ '4)E42K_#8MK @  - 8  !D
M             ("!Y'8! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    "  =0F51@$ZKZQ((  ";+@  &0              @(&&>0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( !U"95&:#K!B, 0
M +L0   9              " @<^! 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ '4)E4?C2 **_!@  UB,  !D              ("!
M-H8! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  =0F51
MG27*(J8"   1!P  &0              @($LC0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( !U"95',R>!4&0,  (<+   9
M      " @0F0 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ '4)E4>^B]JZ&!   LA(  !D              ("!69,! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  =0F51]_I1XRL&  !I(0
M&0              @($6F $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+
M 0(4 Q0    ( !U"95&GOR@\80,  $8-   9              " @7B> 0!X
M;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ '4)E4:C"$C^L
M!P  &3$  !D              ("!$*(! 'AL+W=O<FMS:&5E=',O<VAE970V
M,RYX;6Q02P$"% ,4    "  =0F51#WW.MRP'  "0*P  &0
M@('SJ0$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( !U"
M95%$^ OE#08  !4?   9              " @5:Q 0!X;"]W;W)K<VAE971S
M+W-H965T-C4N>&UL4$L! A0#%     @ '4)E4?I!!N.2!0  IQP  !D
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M=#<P+GAM;%!+ 0(4 Q0    ( !U"95&A4:<6XP8  -(D   9
M  " @=_* 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @
M'4)E49Z"5Q=>!@  @R(  !D              ("!^=$! 'AL+W=O<FMS:&5E
M=',O<VAE970W,BYX;6Q02P$"% ,4    "  =0F51\]K8*8 $   U$0  &0
M            @(&.V $ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4
M Q0    ( !U"95%[OXXC! 8  $H>   9              " @47= 0!X;"]W
M;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ '4)E40;*1?YW!@
M11D  !D              ("!@.,! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX
M;6Q02P$"% ,4    "  =0F51+G"N^:(/   :70  &0              @($N
MZ@$ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( !U"95%*
MIC/R>P,  , ,   9              " @0?Z 0!X;"]W;W)K<VAE971S+W-H
M965T-S<N>&UL4$L! A0#%     @ '4)E40/=6T8E!@  D!T  !D
M     ("!N?T! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
M"  =0F51V"LLZJP"  !C$@  #0              @ $5! ( >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( !U"95&7BKL<P    !,"   +              "
M >P& @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( !U"95$O -GFF 4  #HS   /
M              "  =4' @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  =
M0F51>@0#75P"   A+@  &@              @ &:#0( >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  =0F51+B@*V!4"  #\+   $P
M            @ $N$ ( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     5@!6
+ )$7  !T$@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>517</ContextCount>
  <ElementCount>506</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>151</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>26</UnitCount>
  <MyReports>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001001 - Statement - Condensed Consolidated Statements of Operations (parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Operations (parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004000 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005000 - Statement - Condensed Consolidated Statements of Shareholders' Equity Statement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity Statement</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1005001 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1006000 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsAndDivestitures</Role>
      <ShortName>Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillAndIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Derivative Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities</Role>
      <ShortName>Derivative Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Indebtedness</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Indebtedness</Role>
      <ShortName>Indebtedness</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Earnings Per Share and Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity</Role>
      <ShortName>Earnings Per Share and Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2118100 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2119100 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2120100 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2301302 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2302301 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RevenueRecognition</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AcquisitionsAndDivestitures</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/GoodwillAndIntangibleAssets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Inventories</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/FairValueMeasurements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Investments</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Indebtedness (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessTables</Role>
      <ShortName>Indebtedness (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Indebtedness</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables</Role>
      <ShortName>Earnings Per Share and Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2319301 - Disclosure - Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringChargesTables</Role>
      <ShortName>Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RestructuringCharges</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2320301 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SegmentInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2401403 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2402402 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2402403 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Revenue by Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2402404 - Disclosure - Revenue Recognition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails</Role>
      <ShortName>Revenue Recognition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2402405 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Acquisitions and Divestitures - Oral Care Assets of High Ridge Brands and Ranir Global Holdings,LLC Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails</Role>
      <ShortName>Acquisitions and Divestitures - Oral Care Assets of High Ridge Brands and Ranir Global Holdings,LLC Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Acquisitions and Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails</Role>
      <ShortName>Acquisitions and Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AcquisitionsAndDivestitures</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Acquisitions and Divestitures - Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails</Role>
      <ShortName>Acquisitions and Divestitures - Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2403405 - Disclosure - Acquisitions and Divestitures - Divestiture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails</Role>
      <ShortName>Acquisitions and Divestitures - Divestiture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Goodwill and Intangible Assets - Intangible categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/InventoriesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Instruments at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Fair Value Measurements - Fair Value of Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2408406 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InvestmentsDetails</Role>
      <ShortName>Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/InvestmentsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2411406 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails</Role>
      <ShortName>Leases - Balance Sheet Location of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Leases - Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesLeaseExpenseDetails</Role>
      <ShortName>Leases - Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2412404 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails</Role>
      <ShortName>Leases - Annual Future Maturities of Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails</Role>
      <ShortName>Leases - Weighted Average Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Leases - Lease Cash Flow Classifications (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails</Role>
      <ShortName>Leases - Lease Cash Flow Classifications (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails</Role>
      <ShortName>Indebtedness - Schedule of Borrowings Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - Indebtedness - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails</Role>
      <ShortName>Indebtedness - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Earnings Per Share and Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails</Role>
      <ShortName>Earnings Per Share and Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/IncomeTaxesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2418401 - Disclosure - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ContingenciesDetails</Role>
      <ShortName>Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Contingencies</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2419402 - Disclosure - Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringChargesDetails</Role>
      <ShortName>Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RestructuringChargesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="cy20q310q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2420402 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SegmentInformationTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cy20q310q.htm">cy20q310q.htm</File>
    <File>cy20q310qex311.htm</File>
    <File>cy20q310qex312.htm</File>
    <File>cy20q310qex32.htm</File>
    <File>prgo-20200926.xsd</File>
    <File>prgo-20200926_cal.xml</File>
    <File>prgo-20200926_def.xml</File>
    <File>prgo-20200926_lab.xml</File>
    <File>prgo-20200926_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>chart-714199db9f68549eabb.jpg</File>
    <File>chart-808658f7fe4a50dc91f.jpg</File>
    <File>chart-85469c30e3cc5f78a30.jpg</File>
    <File>chart-9c392cf67c4954c4ab1.jpg</File>
    <File>chart-a264a626c33153a5abb.jpg</File>
    <File>chart-a7f9749e3d245919a3a.jpg</File>
    <File>chart-b33f6037e4655baeb60.jpg</File>
    <File>chart-d5285169e2e55593a5f.jpg</File>
    <File>chart-d9320a08f029506eb1b.jpg</File>
    <File>chart-dbb01a79444f5cd1986.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>105
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cy20q310q.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "contextCount": 517,
   "dts": {
    "calculationLink": {
     "local": [
      "prgo-20200926_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "prgo-20200926_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "cy20q310q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prgo-20200926_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prgo-20200926_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "prgo-20200926.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 751,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 28,
    "http://www.perrigo.com/20200926": 2,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 35
   },
   "keyCustom": 92,
   "keyStandard": 414,
   "memberCustom": 88,
   "memberStandard": 61,
   "nsprefix": "prgo",
   "nsuri": "http://www.perrigo.com/20200926",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.perrigo.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101100 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102100 - Disclosure - Revenue Recognition",
     "role": "http://www.perrigo.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103100 - Disclosure - Acquisitions and Divestitures",
     "role": "http://www.perrigo.com/role/AcquisitionsAndDivestitures",
     "shortName": "Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105100 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.perrigo.com/role/GoodwillAndIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107100 - Disclosure - Inventories",
     "role": "http://www.perrigo.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108100 - Disclosure - Fair Value Measurements",
     "role": "http://www.perrigo.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109100 - Disclosure - Investments",
     "role": "http://www.perrigo.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111100 - Disclosure - Derivative Instruments and Hedging Activities",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities",
     "shortName": "Derivative Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112100 - Disclosure - Leases",
     "role": "http://www.perrigo.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113100 - Disclosure - Indebtedness",
     "role": "http://www.perrigo.com/role/Indebtedness",
     "shortName": "Indebtedness",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001000 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114100 - Disclosure - Earnings Per Share and Shareholders' Equity",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity",
     "shortName": "Earnings Per Share and Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115100 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117100 - Disclosure - Income Taxes",
     "role": "http://www.perrigo.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118100 - Disclosure - Contingencies",
     "role": "http://www.perrigo.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119100 - Disclosure - Restructuring Charges",
     "role": "http://www.perrigo.com/role/RestructuringCharges",
     "shortName": "Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120100 - Disclosure - Segment Information",
     "role": "http://www.perrigo.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2201201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2301302 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2302301 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://www.perrigo.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.perrigo.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001001 - Statement - Condensed Consolidated Statements of Operations (parenthetical)",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical",
     "shortName": "Condensed Consolidated Statements of Operations (parenthetical)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Inventories (Tables)",
     "role": "http://www.perrigo.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308301 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309301 - Disclosure - Investments (Tables)",
     "role": "http://www.perrigo.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311301 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312301 - Disclosure - Leases (Tables)",
     "role": "http://www.perrigo.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313301 - Disclosure - Indebtedness (Tables)",
     "role": "http://www.perrigo.com/role/IndebtednessTables",
     "shortName": "Indebtedness (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314301 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables)",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables",
     "shortName": "Earnings Per Share and Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317301 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.perrigo.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319301 - Disclosure - Restructuring Charges (Tables)",
     "role": "http://www.perrigo.com/role/RestructuringChargesTables",
     "shortName": "Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320301 - Disclosure - Segment Information (Tables)",
     "role": "http://www.perrigo.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q2",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401403 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)",
     "role": "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails",
     "shortName": "Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q2",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402402 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails",
     "shortName": "Revenue Recognition - Schedule of Revenue by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD_srt_StatementGeographicalAxis_country_US",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402403 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails",
     "shortName": "Revenue Recognition - Schedule of Revenue by Product (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_UpperRespiratoryMember_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402404 - Disclosure - Revenue Recognition - Additional Information (Details)",
     "role": "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
     "shortName": "Revenue Recognition - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD_srt_ProductOrServiceAxis_prgo_ContractManufacturingMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402405 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails",
     "shortName": "Revenue Recognition - Schedule of Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Acquisitions and Divestitures - Oral Care Assets of High Ridge Brands and Ranir Global Holdings,LLC Acquisitions (Details)",
     "role": "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
     "shortName": "Acquisitions and Divestitures - Oral Care Assets of High Ridge Brands and Ranir Global Holdings,LLC Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "D2020Q4April1_us-gaap_BusinessAcquisitionAxis_prgo_OralCareAssetsofHighRidgeBrandsMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "prgo:NumberofBrandsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "brand",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403403 - Disclosure - Acquisitions and Divestitures (Details)",
     "role": "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
     "shortName": "Acquisitions and Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "D2020Q3Aug7_us-gaap_BusinessAcquisitionAxis_prgo_SanofiBrandsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "prgo:NumberofBrandsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "brand",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403404 - Disclosure - Acquisitions and Divestitures - Pro Forma Information (Details)",
     "role": "http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails",
     "shortName": "Acquisitions and Divestitures - Pro Forma Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004000 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403405 - Disclosure - Acquisitions and Divestitures - Divestiture (Details)",
     "role": "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
     "shortName": "Acquisitions and Divestitures - Divestiture (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "D2020Q2Jun19_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_prgo_RosemontPharmaceuticalsMember_us-gaap_StatementBusinessSegmentsAxis_prgo_CSCIMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)",
     "role": "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405403 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)",
     "role": "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
     "shortName": "Goodwill and Intangible Assets - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD_us-gaap_ReportingUnitAxis_prgo_BCSMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405404 - Disclosure - Goodwill and Intangible Assets - Intangible categories (Details)",
     "role": "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Inventories (Details)",
     "role": "http://www.perrigo.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Instruments at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details)",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q2_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "prgo:FairValueAssetsLevel1Level2Level3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "prgo:FairValueAssetsLevel1Level2Level3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_prgo_MeasurementInputProjectedRoyaltiesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "prgo:ContingentConsiderationPaymentsSalesbasedMilestones",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Fair Value Measurements - Fair Value of Contingent Consideration (Details)",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails",
     "shortName": "Fair Value Measurements - Fair Value of Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD_us-gaap_FinancialInstrumentAxis_prgo_ContingentConsiderationMember_us-gaap_MeasurementInputTypeAxis_prgo_MeasurementInputProjectedRoyaltiesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "prgo:ContingentConsiderationPaymentsSalesbasedMilestones",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408406 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails",
     "shortName": "Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3_us-gaap_DebtInstrumentAxis_prgo_PublicBondsandPrivatePlacementMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409402 - Disclosure - Investments (Details)",
     "role": "http://www.perrigo.com/role/InvestmentsDetails",
     "shortName": "Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD_us-gaap_IncomeStatementLocationAxis_prgo_OtherExpenseIncomeNetMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411402 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411403 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411406 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412402 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)",
     "role": "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails",
     "shortName": "Leases - Balance Sheet Location of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412403 - Disclosure - Leases - Lease Expense (Details)",
     "role": "http://www.perrigo.com/role/LeasesLeaseExpenseDetails",
     "shortName": "Leases - Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412404 - Disclosure - Leases - Annual Future Maturities of Leases (Details)",
     "role": "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails",
     "shortName": "Leases - Annual Future Maturities of Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)",
     "role": "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails",
     "shortName": "Leases - Weighted Average Lease Terms and Discount Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005000 - Statement - Condensed Consolidated Statements of Shareholders' Equity Statement",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity Statement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:LesseeCashFlowClassificationsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Leases - Lease Cash Flow Classifications (Details)",
     "role": "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails",
     "shortName": "Leases - Lease Cash Flow Classifications (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "prgo:LesseeCashFlowClassificationsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413402 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details)",
     "role": "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails",
     "shortName": "Indebtedness - Schedule of Borrowings Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413403 - Disclosure - Indebtedness - Additional Information (Details)",
     "role": "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
     "shortName": "Indebtedness - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414402 - Disclosure - Earnings Per Share and Shareholders' Equity (Details)",
     "role": "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails",
     "shortName": "Earnings Per Share and Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q2",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ratio",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417402 - Disclosure - Income Taxes (Details)",
     "role": "http://www.perrigo.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ratio",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "I2019Q4Nov14",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "prgo:NumberofPutativeClasses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "class",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418401 - Disclosure - Contingencies (Details)",
     "role": "http://www.perrigo.com/role/ContingenciesDetails",
     "shortName": "Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "I2019Q4Nov14",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "prgo:NumberofPutativeClasses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "class",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419402 - Disclosure - Restructuring Charges (Details)",
     "role": "http://www.perrigo.com/role/RestructuringChargesDetails",
     "shortName": "Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q2",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420402 - Disclosure - Segment Information (Details)",
     "role": "http://www.perrigo.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_prgo_ConsumerSelfCareAmericasMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005001 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006000 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cy20q310q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 151,
   "tag": {
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "Canadian Dollar (CAD)"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CHF": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Switzerland, Francs",
        "terseLabel": "Switzerland Franc (CHF)"
       }
      }
     },
     "localname": "CHF",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CNY": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "China, Yuan Renminbi",
        "terseLabel": "Chinese Yuan (CNY)"
       }
      }
     },
     "localname": "CNY",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_DKK": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Denmark, Kroner",
        "terseLabel": "Danish Krone (DKK)"
       }
      }
     },
     "localname": "DKK",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "European Euro (EUR)"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "British Pound (GBP)"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_ILS": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Israel, New Shekels",
        "terseLabel": "Israeli Shekel (ILS)"
       }
      }
     },
     "localname": "ILS",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MXN": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Mexico, Pesos",
        "terseLabel": "Mexican Peso (MPX)"
       }
      }
     },
     "localname": "MXN",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_NOK": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Norway, Krone",
        "terseLabel": "Norwegian Krone (NOK)"
       }
      }
     },
     "localname": "NOK",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_PLN": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Poland, Zlotych",
        "terseLabel": "Polish Zloty (PLZ)"
       }
      }
     },
     "localname": "PLN",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_RON": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Romania, New Lei",
        "terseLabel": "Romanian New Leu (RON)"
       }
      }
     },
     "localname": "RON",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SEK": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Sweden, Kronor",
        "terseLabel": "Swedish Krona (SEK)"
       }
      }
     },
     "localname": "SEK",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States Dollar (USD)"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_XXX": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "No currency",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "XXX",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current calendar year end date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document calendar period focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document calendar year focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document period end date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity central index key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity common stock, shares outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity emerging growth company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity filer category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees",
        "terseLabel": "Number of current employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity registrant name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity small business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "prgo_A2014EuroDenominatedTermLoandueDecember52019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2014 Euro-Denominated Term Loan due December 5, 2019 [Member]",
        "label": "2014 Euro-Denominated Term Loan due December 5, 2019 [Member]",
        "terseLabel": "2014 Term loan due December 5, 2019"
       }
      }
     },
     "localname": "A2014EuroDenominatedTermLoandueDecember52019Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2018EuroDenominatedTermLoandueMarch82020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2018 Euro-Denominated Term Loan due March 8, 2020 [Member]",
        "label": "2018 Euro-Denominated Term Loan due March 8, 2020 [Member]",
        "terseLabel": "2018 Term loan due March 8, 2020"
       }
      }
     },
     "localname": "A2018EuroDenominatedTermLoandueMarch82020Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2018RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2018 Revolver [Member]",
        "label": "2018 Revolver [Member]",
        "terseLabel": "2018 Revolver due March 8, 2023"
       }
      }
     },
     "localname": "A2018RevolverMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A2019EuroDenominatedTermLoandueAugust152022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2019 Euro-Denominated Term Loan due August 15, 2022 [Member]",
        "label": "2019 Euro-Denominated Term Loan due August 15, 2022 [Member]",
        "terseLabel": "2019 Term loan due August 15, 2022"
       }
      }
     },
     "localname": "A2019EuroDenominatedTermLoandueAugust152022Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3.150SeniorNotesdueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.150% Senior Notes due June 15, 2030 [Member]",
        "label": "3.150% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "3.150% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A3.150SeniorNotesdueJune152030Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3.500UnsecuredSeniornotesdueMarch152021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.500% Unsecured Senior notes due March 15, 2021 [Member]",
        "label": "3.500% Unsecured Senior notes due March 15, 2021 [Member]",
        "terseLabel": "3.500% Unsecured Senior notes due March 15, 2021"
       }
      }
     },
     "localname": "A3.500UnsecuredSeniornotesdueMarch152021Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3.5SeniornotedueDecember152021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.5% Senior note due 2021 [Member]",
        "label": "3.5% Senior note due December 15, 2021 [Member]",
        "terseLabel": "3.500% Senior note due December 15, 2021"
       }
      }
     },
     "localname": "A3.5SeniornotedueDecember152021Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3.9seniornotedue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.9% senior note due 2024 [Member]",
        "label": "3.9% senior note due 2024 [Member]",
        "terseLabel": "3.9% senior note due December 15, 2024"
       }
      }
     },
     "localname": "A3.9seniornotedue2024Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.00% Unsecured Senior Notes due November 15, 2023 [Member]",
        "label": "4.00% Unsecured Senior Notes due November 15, 2023 [Member]",
        "terseLabel": "4.00% unsecured senior notes due November 15, 2023"
       }
      }
     },
     "localname": "A4.00UnsecuredSeniorNotesdueNovember152023Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4.375seniornotedueMarch152026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.375% senior note due March 15, 2026 [Member]",
        "label": "4.375% senior note due March 15, 2026 [Member]",
        "terseLabel": "4.375% senior note due March 15, 2026"
       }
      }
     },
     "localname": "A4.375seniornotedueMarch152026Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4.9SeniorLoandue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.9% Senior Loan due 2044 [Member]",
        "label": "4.9% Senior Loan due 2044 [Member]",
        "terseLabel": "4.9% senior notes due December 15, 2044"
       }
      }
     },
     "localname": "A4.9SeniorLoandue2044Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A5.105SeniornotedueJuly282023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.105% Senior note due July 28, 2023 [Member]",
        "label": "5.105% Senior note due July 28, 2023 [Member]",
        "terseLabel": "5.105% Senior note due July 28, 2023"
       }
      }
     },
     "localname": "A5.105SeniornotedueJuly282023Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.30% Unsecured Senior Notes due November 15, 2043 [Member]",
        "label": "5.30% Unsecured Senior Notes due November 15, 2043 [Member]",
        "terseLabel": "5.30% unsecured senior notes due November 15, 2043"
       }
      }
     },
     "localname": "A5.30UnsecuredSeniorNotesdueNovember152043Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation",
        "label": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceforCreditLossForeignCurrencyTranslation",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.",
        "label": "Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "AccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AccumulatedOtherComprehensiveIncomeRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Roll Forward]",
        "label": "Accumulated Other Comprehensive Income [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeRollForward",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_AcetaminophenLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acetaminophen Litigation [Member]",
        "label": "Acetaminophen Litigation [Member]",
        "terseLabel": "Acetaminophen Litigation"
       }
      }
     },
     "localname": "AcetaminophenLitigationMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AnimalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Animal Health [Member]",
        "label": "Animal Health [Member]",
        "terseLabel": "Animal health"
       }
      }
     },
     "localname": "AnimalHealthMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AssetAdjustedFairValueifSalesThresholdMet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset, Adjusted Fair Value if Sales Threshold Met",
        "label": "Asset, Adjusted Fair Value if Sales Threshold Met",
        "terseLabel": "Royalty Pharma contingent payment sales threshold"
       }
      }
     },
     "localname": "AssetAdjustedFairValueifSalesThresholdMet",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AssetsandLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assets and Liabilities, Lessee [Table Text Block]",
        "label": "Assets and Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Balance Sheet Location of Lease Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_BCSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "BCS [Member]",
        "label": "BCS [Member]",
        "terseLabel": "BCS"
       }
      }
     },
     "localname": "BCSMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "BlackRock Global Allocation Fund, et al. v. Perrigo Co. plc, et al. [Member]",
        "label": "BlackRock Global Allocation Fund, et al. v. Perrigo Co. plc, et al. [Member]",
        "terseLabel": "BlackRock Global Allocation Fund, et al. v. Perrigo Co. plc, et al."
       }
      }
     },
     "localname": "BlackRockGlobalAllocationFundetal.v.PerrigoCo.plcetal.Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_BlendedJurisdictionalTaxRatesPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Blended Jurisdictional Tax Rates, Percent",
        "label": "Blended Jurisdictional Tax Rates, Percent",
        "terseLabel": "Blended jurisdictional tax rates (percent)"
       }
      }
     },
     "localname": "BlendedJurisdictionalTaxRatesPercent",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_BrandMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Brand [Member]",
        "label": "Brand [Member]",
        "terseLabel": "Brand"
       }
      }
     },
     "localname": "BrandMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Budesonide Nasal Spray and Triamcinolone Nasal Spray [Member]",
        "label": "Budesonide Nasal Spray and Triamcinolone Nasal Spray [Member]",
        "terseLabel": "Budesonide Nasal Spray and Triamcinolone Nasal Spray"
       }
      }
     },
     "localname": "BudesonideNasalSprayandTriamcinoloneNasalSprayMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_BusinessCombinationBaseConsiderationTransferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Base Consideration Transferred",
        "label": "Business Combination, Base Consideration Transferred",
        "verboseLabel": "Total base consideration"
       }
      }
     },
     "localname": "BusinessCombinationBaseConsiderationTransferred",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Right-of-use Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredandLiabilityAssumedOperatingLeaseRightofuseAssets",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesAccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesOtherAccruedLiabilities",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Payroll and Related Taxes",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesPayrollandRelatedTaxes",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_CSCIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CSCI [Member]",
        "label": "CSCI [Member]",
        "terseLabel": "CSCI"
       }
      }
     },
     "localname": "CSCIMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CanadianClassActionComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Canadian Class Action Complaint [Member]",
        "label": "Canadian Class Action Complaint [Member]",
        "terseLabel": "Canadian Class Action Complaint"
       }
      }
     },
     "localname": "CanadianClassActionComplaintMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CarmignacFirstManhattanandSimilarCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carmignac, First Manhattan and Similar Cases [Member]",
        "label": "Carmignac, First Manhattan and Similar Cases [Member]",
        "terseLabel": "Carmignac, First Manhattan and Similar Cases"
       }
      }
     },
     "localname": "CarmignacFirstManhattanandSimilarCasesMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CasesFiledinIsraelMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cases Filed in Israel [Member]",
        "label": "Cases Filed in Israel [Member]",
        "terseLabel": "Cases Filed in Israel"
       }
      }
     },
     "localname": "CasesFiledinIsraelMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "label": "Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "totalLabel": "Amount of Gain/(Loss) Reclassified from AOCI into Earnings"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossReclassifiedtoEarningsNet",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Concession of Royalty Due on Sales as Percent of Refund Claims, Percent",
        "label": "Concession of Royalty Due on Sales as Percent of Refund Claims, Percent",
        "terseLabel": "Royalty conceded on all omeprazole sales as a percent of refund claims (percent)"
       }
      }
     },
     "localname": "ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_ConsumerSelfCareAmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Consumer Self-Care Americas [Member]",
        "label": "Consumer Self-Care Americas [Member]",
        "terseLabel": "CSCA"
       }
      }
     },
     "localname": "ConsumerSelfCareAmericasMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ConsumerSelfCareInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Consumer Self-Care International [Member]",
        "label": "Consumer Self-Care International [Member]",
        "terseLabel": "CSCI"
       }
      }
     },
     "localname": "ConsumerSelfCareInternationalMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ContingentConsiderationPaymentsSalesbasedMilestones": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Consideration Payments, Sales-based Milestones",
        "label": "Contingent Consideration Payments, Sales-based Milestones",
        "terseLabel": "Contingent consideration payments: sales-based milestones"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentsSalesbasedMilestones",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ContingentConsiderationPaymentsSalesbasedMilestonesPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Consideration Payments, Sales-based Milestones, Percent",
        "label": "Contingent Consideration Payments, Sales-based Milestones, Percent",
        "terseLabel": "Contingent consideration payments: sales-based milestones (percent)"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentsSalesbasedMilestonesPercent",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_ContractManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract Manufacturing [Member]",
        "label": "Contract Manufacturing [Member]",
        "terseLabel": "Contract manufacturing"
       }
      }
     },
     "localname": "ContractManufacturingMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ControllingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Controlling Interest [Abstract]",
        "label": "Controlling Interest [Abstract]",
        "terseLabel": "Controlling interests:"
       }
      }
     },
     "localname": "ControllingInterestAbstract",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_CumulativeDeferredChargeTaxLitigation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cumulative Deferred Charge, Tax Litigation",
        "label": "Cumulative Deferred Charge, Tax Litigation",
        "terseLabel": "Cumulative deferred charge related to tax litigation"
       }
      }
     },
     "localname": "CumulativeDeferredChargeTaxLitigation",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DexsilMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Dexsil [Member]",
        "label": "Dexsil [Member]",
        "terseLabel": "Dexsil"
       }
      }
     },
     "localname": "DexsilMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DigestiveHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Digestive Health [Member]",
        "label": "Digestive Health [Member]",
        "terseLabel": "Digestive health"
       }
      }
     },
     "localname": "DigestiveHealthMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DistributionandLicenseAgreementsandSupplyAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Distribution and License Agreements and Supply Agreements [Member]",
        "label": "Distribution and License Agreements and Supply Agreements [Member]",
        "terseLabel": "Distribution and License Agreements and Supply Agreements"
       }
      }
     },
     "localname": "DistributionandLicenseAgreementsandSupplyAgreementsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_EquityMethodInvestmentPeriodforPayment": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Period for Payment",
        "label": "Equity Method Investment, Period for Payment",
        "terseLabel": "Period for payment of balance of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentPeriodforPayment",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_EvamistBrandedProductMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Evamist Branded Product [Member]",
        "label": "Evamist Branded Product [Member]",
        "terseLabel": "Evamist Branded Product"
       }
      }
     },
     "localname": "EvamistBrandedProductMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_FairValueAssetsLevel1Level2Level3TransfersAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount",
        "label": "Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount",
        "terseLabel": "Transfers among level 1, 2, and 3"
       }
      }
     },
     "localname": "FairValueAssetsLevel1Level2Level3TransfersAmount",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Unobservable Input Reconciliation [Abstract]",
        "label": "Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Measured at fair value on a non-recurring basis:"
       }
      }
     },
     "localname": "FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_FairValueAssumptionVolatility": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value Assumption, Volatility",
        "label": "Fair Value Assumption, Volatility",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "FairValueAssumptionVolatility",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_FairValueAssumptionsRateofReturn": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value Assumptions, Rate of Return",
        "label": "Fair Value Assumptions, Rate of Return",
        "terseLabel": "Rate of return"
       }
      }
     },
     "localname": "FairValueAssumptionsRateofReturn",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance leases"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_FinanceLeaseLiabilitytobePaidafterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, after Year Four",
        "label": "Finance Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "After 2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitytobePaidafterYearFour",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite and Indefinite-Lived Assets By Major Class [Line Items]",
        "label": "Finite And Indefinite Lived Assets By Major Class [Line Items]",
        "terseLabel": "Finite And Indefinite Lived Assets By Major Class [Line Items]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedAssetsByMajorClassLineItems",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_FirstManhattanandSimilarCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First Manhattan and Similar Cases [Member]",
        "label": "First Manhattan and Similar Cases [Member]",
        "terseLabel": "First Manhattan and Similar Cases"
       }
      }
     },
     "localname": "FirstManhattanandSimilarCasesMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure",
        "label": "Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure",
        "terseLabel": "Funds associated with Israeli severance liability"
       }
      }
     },
     "localname": "FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness",
        "label": "Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_GenericProductAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generic Product Acquisition [Member]",
        "label": "Generic Product Acquisition [Member]",
        "terseLabel": "Generic Product Acquisition",
        "verboseLabel": "Generic Product"
       }
      }
     },
     "localname": "GenericProductAcquisitionMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_GoodwillAndIndefiniteLivedIntangibles": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets.  Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.  Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.",
        "label": "Goodwill And Indefinite Lived Intangibles",
        "terseLabel": "Goodwill and indefinite-lived intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIndefiniteLivedIntangibles",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_HarelInsuranceandTIAACREFFCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Harel Insurance and TIAA-CREFF Cases [Member]",
        "label": "Harel Insurance and TIAA-CREFF Cases [Member]",
        "terseLabel": "Harel Insurance and TIAA-CREFF Cases"
       }
      }
     },
     "localname": "HarelInsuranceandTIAACREFFCasesMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_HealthyLifestyleMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Healthy Lifestyle [Member]",
        "label": "Healthy Lifestyle [Member]",
        "terseLabel": "Healthy lifestyle"
       }
      }
     },
     "localname": "HealthyLifestyleMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Highfields Capital I LP, et al. v. Perrigo Company plc, et al. [Member]",
        "label": "Highfields Capital I LP, et al. v. Perrigo Company plc, et al. [Member]",
        "terseLabel": "Highfields Capital I LP, et al. v. Perrigo Company plc, et al."
       }
      }
     },
     "localname": "HighfieldsCapitalILPetal.v.PerrigoCompanyplcetal.Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_IRSNoticeofProposedAdjustmentPenaltyPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "IRS Notice of Proposed Adjustment, Penalty, Percent",
        "label": "IRS Notice of Proposed Adjustment, Penalty, Percent",
        "terseLabel": "IRS notice of proposed adjustment, penalty (percent)"
       }
      }
     },
     "localname": "IRSNoticeofProposedAdjustmentPenaltyPercent",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment Amount, Including Penalty",
        "label": "IRS Notice of Proposed Audit Adjustment Amount, Including Penalty",
        "terseLabel": "IRS notice of proposed adjustment amount from 2011,2012 and 2013 audit of Athena, including penalty"
       }
      }
     },
     "localname": "IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense",
        "label": "IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense",
        "terseLabel": "IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015"
       }
      }
     },
     "localname": "IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_InIsraelCasesRelatedtoIrishTaxEventsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In Israel (Cases Related to Irish Tax Events) [Member]",
        "label": "In Israel (Cases Related to Irish Tax Events) [Member]",
        "terseLabel": "In Israel (Cases Related to Irish Tax Events)"
       }
      }
     },
     "localname": "InIsraelCasesRelatedtoIrishTaxEventsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense",
        "label": "Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense",
        "terseLabel": "Income tax examination, debts subject to limit of deductibility of interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties",
        "label": "Income Tax Examination, Estimated Increase to Tax Expense from Audit Adjustment, Excluding Interest and Penalties",
        "terseLabel": "Income tax examination, estimated increase to tax expense from audit adjustment to fiscal years 2014 and 2015, excluding interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationEstimatedIncreasetoTaxExpensefromAuditAdjustmentExcludingInterestandPenalties",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes",
        "label": "Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes",
        "terseLabel": "Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes"
       }
      }
     },
     "localname": "IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IncomeTaxExaminationUnsettledAssessedAuditLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Examination, Unsettled Assessed Audit Liability",
        "label": "Income Tax Examination, Unsettled Assessed Audit Liability",
        "terseLabel": "Unsettled audit assessment from income tax examination"
       }
      }
     },
     "localname": "IncomeTaxExaminationUnsettledAssessedAuditLiability",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxOverpaymentsAppliedtoSucceedingYears": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Overpayments Applied to Succeeding Years",
        "label": "Income Tax Overpayments Applied to Succeeding Years",
        "terseLabel": "Income tax overpayments applied to succeeding years"
       }
      }
     },
     "localname": "IncomeTaxOverpaymentsAppliedtoSucceedingYears",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomefromSalesOwnedbytheCompanyPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income from Sales Owned by the Company, Percent",
        "label": "Income from Sales Owned by the Company, Percent",
        "terseLabel": "Income from sales owned by the company (percent)"
       }
      }
     },
     "localname": "IncomefromSalesOwnedbytheCompanyPercent",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IncreaseDecreaseInAccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.",
        "label": "Increase Decrease In Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_InrePerrigoCompanyplcSec.Litig.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In re Perrigo Company plc Sec. Litig. [Member]",
        "label": "In re Perrigo Company plc Sec. Litig. [Member]",
        "terseLabel": "In re Perrigo Company plc Sec. Litig."
       }
      }
     },
     "localname": "InrePerrigoCompanyplcSec.Litig.Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate",
        "label": "Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate",
        "terseLabel": "Interest rate cap on debts for U.S. Federal tax purposes, as percent of Applicable Federal Rate"
       }
      }
     },
     "localname": "InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]",
        "label": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]",
        "terseLabel": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al."
       }
      }
     },
     "localname": "IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_KazmiraLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Kazmira, LLC [Member]",
        "label": "Kazmira, LLC [Member]",
        "terseLabel": "Kazmira, LLC"
       }
      }
     },
     "localname": "KazmiraLLCMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_LeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Liabilities",
        "label": "Lease Liabilities",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Liabilities, Payments, Due [Abstract]",
        "label": "Lease Liabilities, Payments, Due [Abstract]",
        "terseLabel": "Lease Liabilities, Payments, Due [Abstract]"
       }
      }
     },
     "localname": "LeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_LeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due",
        "label": "Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDue",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 5.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Four",
        "label": "Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year One",
        "label": "Lease, Liability, Payments, Due Year One",
        "totalLabel": "2021"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 4.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Three",
        "label": "Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 3.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Two",
        "label": "Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2022"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueafterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 6.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due after Year Four",
        "label": "Lease, Liability, Payments, Due after Year Four",
        "totalLabel": "After 2024"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueafterYearFour",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsRemainderofFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Payments, Remainder of Fiscal Year",
        "label": "Lease, Liability, Payments, Remainder of Fiscal Year",
        "totalLabel": "2020"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsRemainderofFiscalYear",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "totalLabel": "Less: Interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LesseeCashFlowClassificationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Cash Flow Classifications [Table Text Block]",
        "label": "Lessee, Cash Flow Classifications [Table Text Block]",
        "terseLabel": "Lease Cash Flow Classifications"
       }
      }
     },
     "localname": "LesseeCashFlowClassificationsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "After 2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilitytobePaidafterYearFour",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "label": "Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "terseLabel": "Weighted Average Lease Terms and Discount Rates"
       }
      }
     },
     "localname": "LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_LossContingenciesNumberofHealthPlans": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingencies, Number of Health Plans",
        "label": "Loss Contingencies, Number of Health Plans",
        "terseLabel": "Number of health plans"
       }
      }
     },
     "localname": "LossContingenciesNumberofHealthPlans",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfCases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases",
        "label": "Loss Contingency, Number Of Cases",
        "terseLabel": "Number of cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfCases",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfCasesStayed": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases Stayed",
        "label": "Loss Contingency, Number Of Cases Stayed",
        "terseLabel": "Number of cases stayed"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesStayed",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Generic Prescription Pharmaceuticals",
        "label": "Loss Contingency, Number Of Generic Prescription Pharmaceuticals",
        "terseLabel": "Number of generic prescription pharmaceuticals"
       }
      }
     },
     "localname": "LossContingencyNumberOfGenericPrescriptionPharmaceuticals",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfIndividuals": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Individuals",
        "label": "Loss Contingency, Number Of Individuals",
        "terseLabel": "Number of individuals"
       }
      }
     },
     "localname": "LossContingencyNumberOfIndividuals",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Manufacturers",
        "label": "Loss Contingency, Number Of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberOfManufacturers",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfPrescriptionPharmaceuticals": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Prescription Pharmaceuticals",
        "label": "Loss Contingency, Number Of Prescription Pharmaceuticals",
        "terseLabel": "Number of products manufactured by the Company"
       }
      }
     },
     "localname": "LossContingencyNumberOfPrescriptionPharmaceuticals",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfSupermarketChains": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Supermarket Chains",
        "label": "Loss Contingency, Number Of Supermarket Chains",
        "terseLabel": "Number of supermarket chains"
       }
      }
     },
     "localname": "LossContingencyNumberOfSupermarketChains",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofAdditionalStatesandTerritories": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional States and Territories",
        "label": "Loss Contingency, Number of Additional States and Territories",
        "terseLabel": "Number of additional states and territories"
       }
      }
     },
     "localname": "LossContingencyNumberofAdditionalStatesandTerritories",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofClaimsforIndemnificationorDefense": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Claims for Indemnification or Defense",
        "label": "Loss Contingency, Number of Claims for Indemnification or Defense",
        "terseLabel": "Number of claims for indemnification or defense"
       }
      }
     },
     "localname": "LossContingencyNumberofClaimsforIndemnificationorDefense",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofCodefendants": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Co-defendants",
        "label": "Loss Contingency, Number of Co-defendants",
        "terseLabel": "Number of co-defendants"
       }
      }
     },
     "localname": "LossContingencyNumberofCodefendants",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Current Or Former Directors And Officers",
        "label": "Loss Contingency, Number of Current Or Former Directors And Officers",
        "terseLabel": "Number of current or former directors and officers"
       }
      }
     },
     "localname": "LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofDefendantsAdded": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Defendants Added",
        "label": "Loss Contingency, Number of Defendants Added",
        "terseLabel": "Number of defendants added"
       }
      }
     },
     "localname": "LossContingencyNumberofDefendantsAdded",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofDefendantsDismissedwithoutPrejudice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Defendants Dismissed without Prejudice",
        "label": "Loss Contingency, Number of Defendants Dismissed without Prejudice",
        "terseLabel": "Number of defendants dismissed without prejudice"
       }
      }
     },
     "localname": "LossContingencyNumberofDefendantsDismissedwithoutPrejudice",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofFormerEmployees": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Former Employees",
        "label": "Loss Contingency, Number of Former Employees",
        "terseLabel": "Number of former employees"
       }
      }
     },
     "localname": "LossContingencyNumberofFormerEmployees",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Formulations of Products Manufactured by the Company",
        "label": "Loss Contingency, Number of Formulations of Products Manufactured by the Company",
        "terseLabel": "Number of formulations of products manufactured by the company"
       }
      }
     },
     "localname": "LossContingencyNumberofFormulationsofProductsManufacturedbytheCompany",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Lawsuits",
        "label": "Loss Contingency, Number of Lawsuits",
        "terseLabel": "Number of lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberofLawsuits",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofMasterComplaints": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Master Complaints",
        "label": "Loss Contingency, Number of Master Complaints",
        "terseLabel": "Number of master complaints"
       }
      }
     },
     "localname": "LossContingencyNumberofMasterComplaints",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofMasterComplaintsNamingCompany": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Master Complaints Naming Company",
        "label": "Loss Contingency, Number of Master Complaints Naming Company",
        "terseLabel": "Number of master complaints naming the company"
       }
      }
     },
     "localname": "LossContingencyNumberofMasterComplaintsNamingCompany",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofRetailers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Retailers",
        "label": "Loss Contingency, Number of Retailers",
        "terseLabel": "Loss Contingency, Number of Retailers"
       }
      }
     },
     "localname": "LossContingencyNumberofRetailers",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_MasonCapitalPentwaterandSimilarCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mason Capital, Pentwater and Similar Cases [Member]",
        "label": "Mason Capital, Pentwater and Similar Cases [Member]",
        "terseLabel": "Mason Capital, Pentwater and Similar Cases"
       }
      }
     },
     "localname": "MasonCapitalPentwaterandSimilarCasesMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_MeasurementInputProjectedRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Projected Royalties [Member]",
        "label": "Measurement Input, Projected Royalties [Member]",
        "terseLabel": "Measurement Input, Projected Royalties"
       }
      }
     },
     "localname": "MeasurementInputProjectedRoyaltiesMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NetSalesIncludedinCalculationForMilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Sales Included in Calculation For Milestone Payment",
        "label": "Net Sales Included in Calculation For Milestone Payment",
        "terseLabel": "Net sales included in calculation for milestone payment"
       }
      }
     },
     "localname": "NetSalesIncludedinCalculationForMilestonePayment",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_NetSalesThresholdForMilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Sales Threshold For Milestone Payment",
        "label": "Net Sales Threshold For Milestone Payment",
        "terseLabel": "Net sales threshold to trigger milestone payment"
       }
      }
     },
     "localname": "NetSalesThresholdForMilestonePayment",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_NotedueMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Note due May 2021 [Member]",
        "label": "Note due May 2021 [Member]",
        "terseLabel": "Note due May 2021"
       }
      }
     },
     "localname": "NotedueMay2021Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NotedueNovember2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Note due November 2020 [Member]",
        "label": "Note due November 2020 [Member]",
        "terseLabel": "Note due November 2020"
       }
      }
     },
     "localname": "NotedueNovember2020Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NotedueNovember2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Note due November 2021 [Member]",
        "label": "Note due November 2021 [Member]",
        "terseLabel": "Note due November 2021"
       }
      }
     },
     "localname": "NotedueNovember2021Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NumberofBrandsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Brands Acquired",
        "label": "Number of Brands Acquired",
        "terseLabel": "Number of brands acquired"
       }
      }
     },
     "localname": "NumberofBrandsAcquired",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofCasesAllegingOnlyStateLawClaims": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Cases Alleging Only State Law Claims",
        "label": "Number of Cases Alleging Only State Law Claims",
        "terseLabel": "Number of cases alleging only state law claims"
       }
      }
     },
     "localname": "NumberofCasesAllegingOnlyStateLawClaims",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofCasesIncludedinExpeditedSchedule": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Cases Included in Expedited Schedule",
        "label": "Number of Cases Included in Expedited Schedule",
        "terseLabel": "Number of cases included in expedited schedule"
       }
      }
     },
     "localname": "NumberofCasesIncludedinExpeditedSchedule",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofCaseswithSimilarFactualAllegations": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Cases with Similar Factual Allegations",
        "label": "Number of Cases with Similar Factual Allegations",
        "terseLabel": "Number of cases with similar factual allegations"
       }
      }
     },
     "localname": "NumberofCaseswithSimilarFactualAllegations",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofDozensofManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Dozens of Manufacturers",
        "label": "Number of Dozens of Manufacturers",
        "terseLabel": "Number of dozens of manufacturers"
       }
      }
     },
     "localname": "NumberofDozensofManufacturers",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofOtherPharmaceuticalCompanies": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Other Pharmaceutical Companies",
        "label": "Number of Other Pharmaceutical Companies",
        "terseLabel": "Number of Other Pharmaceutical Companies"
       }
      }
     },
     "localname": "NumberofOtherPharmaceuticalCompanies",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofProductsincludedinExpeditedCases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Products included in Expedited Cases",
        "label": "Number of Products included in Expedited Cases",
        "terseLabel": "Number of products included in expedited cases"
       }
      }
     },
     "localname": "NumberofProductsincludedinExpeditedCases",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofPromissoryNotes": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Promissory Notes",
        "label": "Number of Promissory Notes",
        "terseLabel": "Number of promissory notes"
       }
      }
     },
     "localname": "NumberofPromissoryNotes",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofPutativeClasses": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Putative Classes",
        "label": "Number of Putative Classes",
        "terseLabel": "Number of putative classes"
       }
      }
     },
     "localname": "NumberofPutativeClasses",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofSetsofClassActionComplaints": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Sets of Class Action Complaints",
        "label": "Number of Sets of Class Action Complaints",
        "terseLabel": "Number of sets of class action complaints"
       }
      }
     },
     "localname": "NumberofSetsofClassActionComplaints",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofTendersAccepted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Tenders Accepted",
        "label": "Number of Tenders Accepted",
        "terseLabel": "Number of tenders accepted for a portion of the defense costs and liability from a retailer"
       }
      }
     },
     "localname": "NumberofTendersAccepted",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Numerator: [Abstract]",
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_NutritionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nutrition [Member]",
        "label": "Nutrition [Member]",
        "terseLabel": "Nutrition"
       }
      }
     },
     "localname": "NutritionMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OralCareAssetsofHighRidgeBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oral Care Assets of High Ridge Brands [Member]",
        "label": "Oral Care Assets of High Ridge Brands [Member]",
        "terseLabel": "Oral Care Assets of High Ridge Brands (Dr. Fresh)"
       }
      }
     },
     "localname": "OralCareAssetsofHighRidgeBrandsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/AcquisitionsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OralSelfcareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oral Self-care [Member]",
        "label": "Oral Self-care [Member]",
        "terseLabel": "Oral self-care"
       }
      }
     },
     "localname": "OralSelfcareMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherCSCAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other CSC [Member]",
        "label": "Other CSCA [Member]",
        "terseLabel": "Other CSCA"
       }
      }
     },
     "localname": "OtherCSCAMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherCSCIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other CSCI [Member]",
        "label": "Other CSCI [Member]",
        "terseLabel": "Other CSCI"
       }
      }
     },
     "localname": "OtherCSCIMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherCasesRelatedtoEventsin20152017Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Cases Related to Events in 2015-2017 [Member]",
        "label": "Other Cases Related to Events in 2015-2017 [Member]",
        "terseLabel": "Other Cases Related to Events in 2015-2017"
       }
      }
     },
     "localname": "OtherCasesRelatedtoEventsin20152017Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherExpenseIncomeNetMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Expense (Income), Net [Member]",
        "label": "Other Expense (Income), Net [Member]",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherExpenseIncomeNetMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherGeographicalAreasMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Geographical Areas [Member]",
        "label": "Other Geographical Areas [Member]",
        "terseLabel": "All other countries"
       }
      }
     },
     "localname": "OtherGeographicalAreasMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherOperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Operating Income (Loss)",
        "label": "Other Operating Income (Loss)",
        "negatedTerseLabel": "Other operating expense (income)"
       }
      }
     },
     "localname": "OtherOperatingIncomeLoss",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_OverarchingConspiracyClassActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Overarching Conspiracy Class Actions [Member]",
        "label": "Overarching Conspiracy Class Actions [Member]",
        "terseLabel": "Overarching Conspiracy Class Actions"
       }
      }
     },
     "localname": "OverarchingConspiracyClassActionsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PainandSleepaidsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pain and Sleep-aids [Member]",
        "label": "Pain and Sleep-aids [Member]",
        "terseLabel": "Pain and sleep-aids"
       }
      }
     },
     "localname": "PainandSleepaidsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payment of Assessment due before Final Determination of Tax Case and Appeal",
        "label": "Payment of Assessment due before Final Determination of Tax Case and Appeal",
        "terseLabel": "Payment required before final determination of the judicial review case and appeal pending before the Tax Appeals Commission"
       }
      }
     },
     "localname": "PaymentofAssessmentduebeforeFinalDeterminationofTaxCaseandAppeal",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PeriodAvailabletoFileAppeal": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period Available to File Appeal",
        "label": "Period Available to File Appeal",
        "terseLabel": "Period available to file appeal against the judgment of the High Court"
       }
      }
     },
     "localname": "PeriodAvailabletoFileAppeal",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_PotentialContingentMilestonePayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Potential Contingent Milestone Payments",
        "label": "Potential Contingent Milestone Payments",
        "terseLabel": "Royalty Pharma contingent milestone"
       }
      }
     },
     "localname": "PotentialContingentMilestonePayments",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PriceFixingLawsuitDrugWholesalerandDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-Fixing Lawsuit, Drug Wholesaler and Distributor [Member]",
        "label": "Price-Fixing Lawsuit, Drug Wholesaler and Distributor [Member]",
        "terseLabel": "Price-Fixing Lawsuit, Drug Wholesaler and Distributor"
       }
      }
     },
     "localname": "PriceFixingLawsuitDrugWholesalerandDistributorMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PriceFixingLawsuitDrugstoreChainMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-Fixing Lawsuit, Drugstore Chain [Member]",
        "label": "Price-Fixing Lawsuit, Drugstore Chain [Member]",
        "terseLabel": "Price-Fixing Lawsuit, Drugstore Chain"
       }
      }
     },
     "localname": "PriceFixingLawsuitDrugstoreChainMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PriceFixingLawsuitSuffolkCountyofNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-Fixing Lawsuit, Suffolk County of New York [Member]",
        "label": "Price-Fixing Lawsuit, Suffolk County of New York [Member]",
        "terseLabel": "Price-Fixing Lawsuit, Suffolk County of New York"
       }
      }
     },
     "localname": "PriceFixingLawsuitSuffolkCountyofNewYorkMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PriceFixingLawsuitSupermarketChainsAmendedComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-Fixing Lawsuit, Supermarket Chains, Amended Complaint [Member]",
        "label": "Price-Fixing Lawsuit, Supermarket Chains, Amended Complaint [Member]",
        "terseLabel": "Price-Fixing Lawsuit, Supermarket Chains, Amended Complaint"
       }
      }
     },
     "localname": "PriceFixingLawsuitSupermarketChainsAmendedComplaintMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PriceFixingLawsuitSupermarketChainsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-Fixing Lawsuit, Supermarket Chains [Member]",
        "label": "Price-Fixing Lawsuit, Supermarket Chains [Member]",
        "terseLabel": "Price-Fixing Lawsuit, Supermarket Chains"
       }
      }
     },
     "localname": "PriceFixingLawsuitSupermarketChainsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitHarrisCountyofTexasMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Harris County of Texas [Member]",
        "label": "Price-fixing Lawsuit, Harris County of Texas [Member]",
        "terseLabel": "Price-fixing Lawsuit, Harris County of Texas"
       }
      }
     },
     "localname": "PricefixingLawsuitHarrisCountyofTexasMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitHealthInsuranceCarrierMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Health Insurance Carrier [Member]",
        "label": "Price-fixing Lawsuit, Health Insurance Carrier [Member]",
        "terseLabel": "Price-fixing Lawsuit, Health Insurance Carrier"
       }
      }
     },
     "localname": "PricefixingLawsuitHealthInsuranceCarrierMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitHealthPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Health Plans [Member]",
        "label": "Price-fixing Lawsuit, Health Plans [Member]",
        "terseLabel": "Price-fixing Lawsuit, Health Plans"
       }
      }
     },
     "localname": "PricefixingLawsuitHealthPlansMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitHealthcareManagementOrganizationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Healthcare Management Organization [Member]",
        "label": "Price-fixing Lawsuit, Healthcare Management Organization [Member]",
        "terseLabel": "Price-fixing Lawsuit, Healthcare Management Organization"
       }
      }
     },
     "localname": "PricefixingLawsuitHealthcareManagementOrganizationMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitHealthcareServiceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Healthcare Service Company [Member]",
        "label": "Price-fixing Lawsuit, Healthcare Service Company [Member]",
        "terseLabel": "Price-fixing Lawsuit, Healthcare Service Company"
       }
      }
     },
     "localname": "PricefixingLawsuitHealthcareServiceCompanyMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitManagedCareOrganizationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Managed Care Organization [Member]",
        "label": "Price-fixing Lawsuit, Managed Care Organization [Member]",
        "terseLabel": "Price-fixing Lawsuit, Managed Care Organization"
       }
      }
     },
     "localname": "PricefixingLawsuitManagedCareOrganizationMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Medicare Advantage Claims Recovery Company [Member]",
        "label": "Price-fixing Lawsuit, Medicare Advantage Claims Recovery Company [Member]",
        "terseLabel": "Price-fixing Lawsuit, Medicare Advantage Claims Recovery Company"
       }
      }
     },
     "localname": "PricefixingLawsuitMedicareAdvantageClaimsRecoveryCompanyMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PricefixingLawsuitSeveralCountiesinNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price-fixing Lawsuit, Several Counties in New York [Member]",
        "label": "Price-fixing Lawsuit, Several Counties in New York [Member]",
        "terseLabel": "Price-fixing Lawsuit, Several Counties in New York"
       }
      }
     },
     "localname": "PricefixingLawsuitSeveralCountiesinNewYorkMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PrivatePlacementNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Private Placement Note [Member]",
        "label": "Private Placement Note [Member]",
        "terseLabel": "Private placement note"
       }
      }
     },
     "localname": "PrivatePlacementNoteMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ProceedsfromContingentMilestonePayment": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from Contingent Milestone Payment",
        "label": "Proceeds from Contingent Milestone Payment",
        "terseLabel": "Proceeds from the Royalty Pharma contingent milestone"
       }
      }
     },
     "localname": "ProceedsfromContingentMilestonePayment",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ProceedsfromRoyaltiesReceivedInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from Royalties Received, Investing Activities",
        "label": "Proceeds from Royalties Received, Investing Activities",
        "terseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "ProceedsfromRoyaltiesReceivedInvestingActivities",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PublicBondsandPrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Public Bonds and Private Placement",
        "label": "Public Bonds and Private Placement [Member]",
        "verboseLabel": "Public Bonds"
       }
      }
     },
     "localname": "PublicBondsandPrivatePlacementMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RXPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "RX Pharmaceuticals [Member]",
        "label": "RX Pharmaceuticals [Member]",
        "terseLabel": "RX"
       }
      }
     },
     "localname": "RXPharmaceuticalsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RanirGlobalHoldingsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ranir Global Holdings, LLC [Member]",
        "label": "Ranir Global Holdings, LLC [Member]",
        "terseLabel": "Ranir Global Holdings, LLC"
       }
      }
     },
     "localname": "RanirGlobalHoldingsLLCMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/AcquisitionsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RanitidineLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ranitidine Litigation [Member]",
        "label": "Ranitidine Litigation [Member]",
        "terseLabel": "Ranitidine Litigation"
       }
      }
     },
     "localname": "RanitidineLitigationMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ReportingUnitFairValuePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reporting Unit, Fair Value, Percent",
        "label": "Reporting Unit, Fair Value, Percent",
        "terseLabel": "Reporting unit, fair value (percent)"
       }
      }
     },
     "localname": "ReportingUnitFairValuePercent",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_RestructuringAdditionalCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring, Additional Charges",
        "label": "Restructuring, Additional Charges",
        "terseLabel": "Additional charges"
       }
      }
     },
     "localname": "RestructuringAdditionalCharges",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right-of-Use Asset",
        "label": "Right-of-Use Asset",
        "totalLabel": "Right-of-Use Asset"
       }
      }
     },
     "localname": "RightofUseAsset",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RoofersPensionFundMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Roofers' Pension Fund [Member]",
        "label": "Roofers' Pension Fund [Member]",
        "terseLabel": "Roofers' Pension Fund"
       }
      }
     },
     "localname": "RoofersPensionFundMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RosemontPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rosemont Pharmaceuticals",
        "label": "Rosemont Pharmaceuticals [Member]",
        "terseLabel": "Rosemont Pharmaceuticals"
       }
      }
     },
     "localname": "RosemontPharmaceuticalsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RoyaltyPharma2020ContingentMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Royalty Pharma 2020 Contingent Milestone Payments [Member]",
        "label": "Royalty Pharma 2020 Contingent Milestone Payments [Member]",
        "terseLabel": "Royalty Pharma 2020 Contingent Milestone Payments"
       }
      }
     },
     "localname": "RoyaltyPharma2020ContingentMilestonePaymentsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RoyaltyPharmaContingentMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Royalty Pharma Contingent Milestone Payments [Member]",
        "label": "Royalty Pharma Contingent Milestone Payments [Member]",
        "terseLabel": "Royalty Pharma Contingent Milestone Payments"
       }
      }
     },
     "localname": "RoyaltyPharmaContingentMilestonePaymentsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RoyaltyPharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Royalty Pharma [Member]",
        "label": "Royalty Pharma [Member]",
        "terseLabel": "Royalty Pharma"
       }
      }
     },
     "localname": "RoyaltyPharmaMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_SanofiBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sanofi Brands [Member]",
        "label": "Sanofi Brands [Member]",
        "terseLabel": "Sanofi Brands"
       }
      }
     },
     "localname": "SanofiBrandsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ScheduleOfDebtInstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Debt Instruments [Table]",
        "label": "Schedule of Debt Instruments [Table]",
        "terseLabel": "Schedule of Debt Instruments [Table]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTable",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]",
        "label": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]",
        "terseLabel": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]",
        "label": "Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite and Indefinite-lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_ScheduleofFairValueAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Fair Value Assumptions [Table Text Block]",
        "label": "Schedule of Fair Value Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Assumptions"
       }
      }
     },
     "localname": "ScheduleofFairValueAssumptionsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Foreign Currency Forward Contracts [Table Text Block]",
        "label": "Schedule of Foreign Currency Forward Contracts [Table Text Block]",
        "terseLabel": "Schedule of Foreign Currency Forward Contracts"
       }
      }
     },
     "localname": "ScheduleofForeignCurrencyForwardContractsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_SeniorNotesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes due 2021 [Member]",
        "label": "Senior Notes due 2021 [Member]",
        "terseLabel": "Senior Notes due 2021"
       }
      }
     },
     "localname": "SeniorNotesdue2021Member",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_SkincareandPersonalHygieneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Skincare and Personal Hygiene [Member]",
        "label": "Skincare and Personal Hygiene [Member]",
        "terseLabel": "Skincare and personal hygiene"
       }
      }
     },
     "localname": "SkincareandPersonalHygieneMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_StateAttorneyGeneralComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "State Attorney General Complaint [Member]",
        "label": "State Attorney General Complaint [Member]",
        "terseLabel": "State Attorney General Complaint"
       }
      }
     },
     "localname": "StateAttorneyGeneralComplaintMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "States' May 2019 Case Alleging Conspiracy (which does not Name Perrigo a Defendant) [Member]",
        "label": "States' May 2019 Case Alleging Conspiracy (which does not Name Perrigo a Defendant) [Member]",
        "terseLabel": "States' May 2019 Case Alleging Conspiracy (which does not Name Perrigo a Defendant)"
       }
      }
     },
     "localname": "StatesMay2019CaseAllegingConspiracywhichdoesnotNamePerrigoaDefendantMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_SteripodMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Steripod [Member]",
        "label": "Steripod [Member]",
        "terseLabel": "Steripod"
       }
      }
     },
     "localname": "SteripodMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_TalcumPowderLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Talcum Powder Litigation [Member]",
        "label": "Talcum Powder Litigation [Member]",
        "terseLabel": "Talcum Powder Litigation"
       }
      }
     },
     "localname": "TalcumPowderLitigationMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_TrademarksTradeNamesandBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trademarks, Trade Names, and Brands [Member]",
        "label": "Trademarks, Trade Names, and Brands [Member]",
        "terseLabel": "Trademarks, trade names, and brands",
        "verboseLabel": "Trademarks, trade names, and brands"
       }
      }
     },
     "localname": "TrademarksTradeNamesandBrandsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_UpperRespiratoryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upper Respiratory [Member]",
        "label": "Upper Respiratory [Member]",
        "terseLabel": "Upper respiratory"
       }
      }
     },
     "localname": "UpperRespiratoryMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_VitaminsMineralsandSupplementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vitamins, Minerals and Supplements [Member]",
        "label": "Vitamins, Minerals and Supplements [Member]",
        "terseLabel": "Vitamins, minerals, and supplements"
       }
      }
     },
     "localname": "VitaminsMineralsandSupplementsMember",
     "nsuri": "http://www.perrigo.com/20200926",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r70",
      "r125"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r133",
      "r139",
      "r216",
      "r339",
      "r340",
      "r341",
      "r359",
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adoption of new accounting standards"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r133",
      "r139",
      "r216",
      "r339",
      "r340",
      "r341",
      "r359",
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r133",
      "r139",
      "r216",
      "r339",
      "r340",
      "r341",
      "r359",
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r335",
      "r338",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r525",
      "r567",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r335",
      "r338",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r525",
      "r567",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r196",
      "r315",
      "r317",
      "r526",
      "r566",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r196",
      "r315",
      "r317",
      "r526",
      "r566",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r325",
      "r335",
      "r338",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r525",
      "r567",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r325",
      "r335",
      "r338",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r525",
      "r567",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r197",
      "r198",
      "r315",
      "r318",
      "r569",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r315",
      "r318",
      "r569",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r283",
      "r336",
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r16",
      "r37",
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $6.3 and $6.7, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r32",
      "r533",
      "r551"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r75",
      "r80",
      "r81",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Post-Retirement and Pension Liability Adjustments, net of tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r80",
      "r88",
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Fair Value of Derivative Financial Instruments, net of tax"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r39",
      "r78",
      "r79",
      "r80",
      "r553",
      "r575",
      "r576"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r77",
      "r80",
      "r81",
      "r130",
      "r131",
      "r132",
      "r405",
      "r571",
      "r572"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r73",
      "r80",
      "r81",
      "r405",
      "r462",
      "r463",
      "r464",
      "r465",
      "r467"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments(1)"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Useful life of intangible assets"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities.",
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Subtotal"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to derive cash flows:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld for payment of employees' withholding tax liability"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "terseLabel": "Compensation for restricted stock"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Compensation for stock options"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r205",
      "r217",
      "r219",
      "r222"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "terseLabel": "Recoveries collected"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForLoanAndLeaseLossesWriteOffs": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loans and leases that have been written off from both loan receivables and allowance reserve for credit loss.",
        "label": "Allowance for Loan and Lease Losses, Write-offs",
        "negatedTerseLabel": "Receivables written-off"
       }
      }
     },
     "localname": "AllowanceForLoanAndLeaseLossesWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r98",
      "r117",
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt premium"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r117",
      "r247",
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible assets amortization expense",
        "verboseLabel": "Intangible Asset Amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive share-based awards excluded from computation of diluted EPS (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r117",
      "r261"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "verboseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r123",
      "r178",
      "r185",
      "r192",
      "r214",
      "r401",
      "r407",
      "r458",
      "r531",
      "r550"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r67",
      "r123",
      "r214",
      "r401",
      "r407",
      "r458"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r123",
      "r214",
      "r401",
      "r407",
      "r458"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r414",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Supplemental Disclosures of Balance Sheet Information"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r334",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/AcquisitionsTables",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r334",
      "r337",
      "r378",
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/AcquisitionsTables",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/AcquisitionsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Outstanding equity interest acquired (percent)"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r376",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill expected to be tax deductible"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r376",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r376",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "General transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "auth_ref": [
      "r391",
      "r392",
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Asset",
        "terseLabel": "Prepayment of contract consideration for transitional services"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r390",
      "r392",
      "r394"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Net income since acquisition"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Net sales since acquisition"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Measurement period adjustment to intangibles"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory",
        "terseLabel": "Inventory costs stepped up to acquisition date fair value"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Estimated fair value of assets acquired and liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Indefinite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Total intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r380",
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Definite-lived intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r380",
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r380",
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r14",
      "r48",
      "r119"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r114",
      "r119",
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r114",
      "r460"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r60",
      "r282",
      "r538",
      "r558"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies - Refer to Note 14"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r291"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares Issued"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in EUR per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, issued and outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary shares, \u20ac0.001 par value per share, 10,000 shares authorized"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r87",
      "r92",
      "r542",
      "r563"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r91",
      "r100",
      "r541",
      "r562"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r122",
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "auth_ref": [
      "r304",
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "terseLabel": "Short-term contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r96",
      "r526"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer relationships and distribution networks"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships and distribution networks"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "negatedLabel": "Current indebtedness"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Indebtedness"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/Indebtedness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r532",
      "r534",
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentDescription": {
     "auth_ref": [
      "r31",
      "r33",
      "r299",
      "r532",
      "r534",
      "r546",
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.",
        "label": "Debt Instrument, Description",
        "terseLabel": "Series"
       }
      }
     },
     "localname": "DebtInstrumentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r471",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "negatedTerseLabel": "Deferred financing fees"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r58",
      "r126",
      "r299",
      "r300",
      "r301",
      "r302",
      "r470",
      "r471",
      "r474",
      "r547"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r470",
      "r471",
      "r472",
      "r473",
      "r474"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Unamortized premium (discount), net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "totalLabel": "Total borrowings outstanding"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r344",
      "r345"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r124",
      "r357",
      "r363",
      "r364",
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r344",
      "r345"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r117",
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r68",
      "r69",
      "r71",
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Amount Not Offset Against Collateral",
        "terseLabel": "Asset Derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r68",
      "r69",
      "r71",
      "r433"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral",
        "terseLabel": "Liability Derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of Gain/(Loss) Recognized against Earnings"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r415",
      "r419",
      "r426",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r413",
      "r415",
      "r426",
      "r431",
      "r432",
      "r434",
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r411",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of derivatives"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated derivatives:"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "verboseLabel": "Developed product technology, formulations, and product rights"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r334",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r93",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r145",
      "r147",
      "r152",
      "r153",
      "r154",
      "r158",
      "r159",
      "r543",
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r93",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r147",
      "r152",
      "r153",
      "r154",
      "r158",
      "r159",
      "r543",
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r160"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share and Shareholders' Equity"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]",
        "terseLabel": "The effects of cash flow hedging:"
       }
      }
     },
     "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate reconciliation, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135",
      "r142",
      "r144",
      "r163",
      "r216",
      "r298",
      "r303",
      "r339",
      "r340",
      "r341",
      "r359",
      "r360",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r467",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r11",
      "r123",
      "r214",
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r11",
      "r123",
      "r214",
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership Interest (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r49",
      "r179",
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity securities, equity method, other non-current assets"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Security Expense (Income)"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities, fair value method"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedTerseLabel": "Equity securities, fair value method, other expense (income)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Royalty Pharma Contingent Milestone Payments",
        "verboseLabel": "Measured at fair value on a recurring basis:"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.",
        "label": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r445",
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r439",
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r440",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r439",
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r439",
      "r440",
      "r443",
      "r444",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "verboseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r326",
      "r327",
      "r332",
      "r333",
      "r440",
      "r498"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r326",
      "r327",
      "r332",
      "r333",
      "r440",
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r440",
      "r500"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r445",
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r445",
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Level 3 Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value",
        "verboseLabel": "Increase (decrease) in fair value of milestone payment"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedTerseLabel": "Payments received",
        "terseLabel": "Payments received"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "verboseLabel": "Estimated fair valued contingent milestone payment"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Changes in value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Settlements and other adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r439",
      "r440",
      "r443",
      "r444",
      "r448",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Measured at fair value on a non-recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r449",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Measured on a recurring basis",
        "verboseLabel": "Measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsReconciliationOfLevel3AssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "negatedLabel": "Change in financial assets",
        "negatedTerseLabel": "Change in financial assets",
        "terseLabel": "Income recognized from change is asset"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r414",
      "r421",
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r478",
      "r483",
      "r491"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "prgo_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r480",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r476",
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total finance lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liability, current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liability, noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsRemainderofFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r479",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "prgo_RightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r478",
      "r483",
      "r491"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "prgo_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r488",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - Finance lease (percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r487",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average lease term - Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r207",
      "r208",
      "r218",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful life of intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r248",
      "r252",
      "r255",
      "r258",
      "r527",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets, Fair Value Disclosure",
        "terseLabel": "Definite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r255",
      "r528"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r248",
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r255",
      "r527"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Definite-lived intangible assets, net",
        "verboseLabel": "Definite-lived intangible assets carrying value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r423"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails": {
       "order": 2.0,
       "parentTag": "prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings",
        "verboseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings - Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Net gain expected to be reclassified out of AOCI into earnings in the next 12 months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Liability at Fair Value",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Foreign Currency Cash Flow Hedges [Abstract]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.",
        "label": "Foreign Currency Exchange Rate, Remeasurement",
        "terseLabel": "Foreign currency exchange rate, remeasurement"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateRemeasurement1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Line Items]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Line Items]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about derivative instruments designated as foreign currency fair value hedging instruments.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Table]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Table]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net gain (loss) relating to components of the gain (loss) on the cash flow hedging instrument excluded from the assessment of cash flow hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net",
        "totalLabel": "Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net"
       }
      }
     },
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r424"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness",
        "terseLabel": "Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r117",
      "r406"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Loss (Gain) on sale of business",
        "terseLabel": "Gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r117",
      "r295",
      "r296"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "Administration"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r232",
      "r234",
      "r530"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "September 26, 2020",
        "periodStartLabel": "December 31, 2019",
        "terseLabel": "Goodwill carrying amount",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Business acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillFairValueDisclosure": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Fair Value Disclosure",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r235",
      "r241"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated impairments"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r117",
      "r233",
      "r238",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairments",
        "terseLabel": "Goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r240",
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase accounting adjustments",
        "verboseLabel": "Measurement period adjustment to goodwill"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Business divestitures"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r95",
      "r123",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r214",
      "r458"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r413",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r117",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of indefinite lived intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r127",
      "r366"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r89",
      "r117",
      "r175",
      "r211",
      "r539",
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity securities, equity method, other expense (income)"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r334",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r265",
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r352",
      "r353",
      "r355",
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r348",
      "r354",
      "r356",
      "r361",
      "r367",
      "r369",
      "r370",
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Estimated amount of loss resulting from an adverse tax position.",
        "label": "Income Tax Examination, Estimate of Possible Loss",
        "terseLabel": "Income tax examination, estimate of additional tax expense for the period from June 28, 2015 through December 31, 2019, excluding interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Income tax examination, penalties and interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r124",
      "r143",
      "r144",
      "r176",
      "r346",
      "r362",
      "r368",
      "r565"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.",
        "label": "Increase (Decrease) in Operating Capital",
        "negatedTotalLabel": "Subtotal"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in cash due to:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r154"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r251",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r257"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangibles:"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r251",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r246",
      "r253"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r423"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails": {
       "order": 1.0,
       "parentTag": "prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings",
        "verboseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings - Interest rate swap agreements"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Interest Rate Cash Flow Hedges [Abstract]",
        "terseLabel": "Interest rate swap agreements"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r15",
      "r66"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r209",
      "r529",
      "r545",
      "r577"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease Liability Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc3": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsRemainderofFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r53",
      "r123",
      "r186",
      "r214",
      "r402",
      "r407",
      "r408",
      "r458"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r42",
      "r123",
      "r214",
      "r458",
      "r536",
      "r556"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r55",
      "r123",
      "r214",
      "r402",
      "r407",
      "r408",
      "r458"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r33",
      "r34",
      "r123",
      "r214",
      "r402",
      "r407",
      "r408",
      "r458"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "verboseLabel": "Distribution and license agreements and supply agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r33",
      "r534",
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "verboseLabel": "Borrowings outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Outstanding balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayable": {
     "auth_ref": [
      "r33",
      "r534",
      "r548"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Loans Payable",
        "terseLabel": "Term loans"
       }
      }
     },
     "localname": "LoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r33",
      "r294",
      "r534",
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "verboseLabel": "Private placement note"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current indebtedness"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r290",
      "r292",
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Number of cases voluntarily dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r282",
      "r285",
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought by plaintiff"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNumberOfDefendants": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of defendants named in a legal action.",
        "label": "Loss Contingency, Number of Defendants",
        "terseLabel": "Number of defendants"
       }
      }
     },
     "localname": "LossContingencyNumberOfDefendants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Unallocated"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum remaining maturity of foreign currency derivatives"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue.",
        "label": "Measurement Input, Long-term Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Long-term Growth Rate"
       }
      }
     },
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r12",
      "r396"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r62",
      "r123",
      "r214",
      "r458",
      "r535",
      "r555"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash from (for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash Flows From (For) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash from (for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From (For) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r114",
      "r115",
      "r118"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash from (for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows From (For) Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r11",
      "r82",
      "r85",
      "r90",
      "r118",
      "r123",
      "r134",
      "r137",
      "r138",
      "r139",
      "r140",
      "r143",
      "r144",
      "r151",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r214",
      "r458",
      "r540",
      "r561"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Non-designated derivatives:"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r33",
      "r534",
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Promissory notes"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r80",
      "r88"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "OCI before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r178",
      "r184",
      "r188",
      "r191",
      "r194"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)",
        "verboseLabel": "Operating Income (Loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r484",
      "r491"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "netLabel": "Present value of lease liabilities",
        "verboseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesOfLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r481",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "prgo_RightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r488",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - Operating lease (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r487",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r13",
      "r129",
      "r165",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r76",
      "r78",
      "r399",
      "r404"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Change in post-retirement and pension liability, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r399",
      "r400",
      "r404"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r74",
      "r78"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Change in fair value of derivative financial instruments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r417",
      "r422",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r72",
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of Gain/(Loss) Recorded in OCI, Net investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r83",
      "r86",
      "r399",
      "r400",
      "r404"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r414",
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r33",
      "r534",
      "r552"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "terseLabel": "Other financing"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "verboseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other non-cash adjustments, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r102",
      "r105",
      "r128"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r113",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Premiums on early debt retirement"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Deferred financing fees"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r103",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Purchase price paid",
        "verboseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions of businesses, net of cash acquired",
        "terseLabel": "Cash consideration - net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity method investment",
        "terseLabel": "Amount paid for investment upon close of the transaction"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "terseLabel": "Payments to acquire the ANDA"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments to Acquire Other Productive Assets",
        "negatedLabel": "Asset acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, issued and outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred shares, $0.0001 par value per share, 10 shares authorized"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r17",
      "r46",
      "r47"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Net proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Issuance of ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Net proceeds from issuance of senior notes"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r108",
      "r112",
      "r128"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r107",
      "r110",
      "r120"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less",
        "terseLabel": "Borrowings (repayments) of revolving credit agreements and other financing, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionAndDistributionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense related to the production and distribution of goods or services to customers and clients.",
        "label": "Production and Distribution Costs",
        "terseLabel": "Distribution"
       }
      }
     },
     "localname": "ProductionAndDistributionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r26",
      "r27",
      "r262",
      "r557"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r94",
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses, net"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r80",
      "r88"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r243",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Fair value of reporting unit in excess of net book value (percent)"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r343",
      "r588"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r117",
      "r267",
      "r272",
      "r276"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges",
        "verboseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r268",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r267",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash adjustments"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r38",
      "r303",
      "r342",
      "r554",
      "r574",
      "r576"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135",
      "r142",
      "r144",
      "r216",
      "r339",
      "r340",
      "r341",
      "r359",
      "r360",
      "r571",
      "r573"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueCommissionersIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government of Ireland.",
        "label": "Revenue Commissioners, Ireland [Member]",
        "terseLabel": "Revenue Commissioners, Ireland"
       }
      }
     },
     "localname": "RevenueCommissionersIrelandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r183",
      "r189",
      "r190",
      "r196",
      "r197",
      "r200",
      "r314",
      "r315",
      "r526"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r316",
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r486",
      "r491"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r486",
      "r491"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r164",
      "r200"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Net Sales"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesClassificationOfGainLossOfCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r80",
      "r466",
      "r467"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r378",
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/AcquisitionsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Classification of Gain (Loss) Recognized in Earnings on Fair Value and Cash Flow Hedging Relationships"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of effective income tax rate reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r11",
      "r123",
      "r213",
      "r214",
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r242",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r242",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r19",
      "r43",
      "r44",
      "r45"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Major Components of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r136",
      "r139",
      "r161",
      "r162"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of New Accounting Pronouncements"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r425",
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Amount of Gain/(Loss) Recognized against Earnings"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r270",
      "r271",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r270",
      "r271",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r166",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r200",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r178",
      "r182",
      "r188",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r199",
      "r200",
      "r201"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r537",
      "r559"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "netLabel": "Notes and Bonds",
        "terseLabel": "Senior Notes",
        "verboseLabel": "Public bonds"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleOfFixedRateLongTermDebtDetails",
      "http://www.perrigo.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleOfBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld for payment of employees' withholding tax liability (shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r166",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r200",
      "r242",
      "r264",
      "r269",
      "r277",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDivestitureDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsAtFairValueDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationOfAssetsAndLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleOfRevenueByProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r61",
      "r130",
      "r131",
      "r132",
      "r135",
      "r142",
      "r144",
      "r163",
      "r216",
      "r298",
      "r303",
      "r339",
      "r340",
      "r341",
      "r359",
      "r360",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r467",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r163",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r35",
      "r36",
      "r298",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted stock plan (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r61",
      "r298",
      "r303"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r35",
      "r36",
      "r298",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Minority share purchase (shares)",
        "verboseLabel": "Repurchases of ordinary shares (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r35",
      "r36",
      "r298",
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Minority share purchase"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r36",
      "r40",
      "r41",
      "r123",
      "r206",
      "r214",
      "r458"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "totalLabel": "Total controlling interests"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfShareholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r123",
      "r130",
      "r131",
      "r132",
      "r135",
      "r142",
      "r214",
      "r216",
      "r303",
      "r339",
      "r340",
      "r341",
      "r359",
      "r360",
      "r397",
      "r398",
      "r409",
      "r458",
      "r461",
      "r462",
      "r467",
      "r572",
      "r573"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r468",
      "r493"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/ContingenciesDetails",
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r468",
      "r493"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/ContingenciesDetails",
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r468",
      "r493"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/ContingenciesDetails",
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Developed product technology, formulations, and product rights"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresDetails",
      "http://www.perrigo.com/role/AcquisitionsAndDivestituresOralCareAssetsOfHighRidgeBrandsAndRanirGlobalHoldingsllcAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks, trade names, and brands"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillAndIntangibleAssetsIntangibleCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r207",
      "r208",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Treasury Lock"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectOfCashFlowHedgesIncludedInAociDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible List]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_TypeOfRevenueExtensibleList": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.",
        "label": "Revenue, Product and Service [Extensible List]",
        "terseLabel": "Revenue, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfRevenueExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Discounted Cash Flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFairValueOfContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r146",
      "r154"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average shares outstanding for diluted EPS",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r145",
      "r154"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding for basic EPS"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.perrigo.com/role/EarningsPerShareAndShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 26
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3098-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14172-108612"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28567-108399"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16)(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r589": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r591": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r592": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r593": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r594": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>106
<FILENAME>0001585364-20-000096-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001585364-20-000096-xbrl.zip
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MHI212EA"=@<9XJN45H8&]3(W$U<_R&.L^8I=!243%6=)- %5CZ7:3BKT@D)
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M 9UN3)"U!Q(.#:*W$GLF\?5J,#\258_/6"H.0<DM^K!SK3)#Y4HVQ6M,<?3
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M UC0I%04141XX34C -#N#8,J!]*6C])Q>8SRGX?*(O(>8$Y*Y*-N^N??5-G
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MJ)D&VP:#Z,-=&*_2R7R*)13U!$D+L@>^L"2CD;R!@=[VIWNYVZC-YW!AU)$
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MNBWYJS?M4,%<"]KXG6G;$9SP=*.ZO*.2X[ZE-=_?[_!O_(7]E#>0F_01<X9
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M9@H5?HOB^ 5UPY^$Y_==$J7"5ZVZ7=4&H(W3)9O=9"@S2N_P51<$*"5K$8Y
MJ?L"FQD'CZ.&T;R0 "(Z&=VTG1X&GTL@M?1FG(;_.U33^"/MH4BG,2FLI+<0
MPPI#=O0Q)&-(X;UI4.(1J'_#ZMQ&"&#^0?=FR^TU\'C%4Z@W.AK*AG/$ +^)
M%=V<L7!.%()464^D0E-1G)2%[F(>JE4B$3\E.8TAS6H<LAA.[KE:*FS!Y/9<
M/O[Z59Z^;6.(;S55GKIUD>*]N7AP%:5#K7]/E3T^ZP,FINLTD$ ";ZEA@.WN
M(Q [CH^($=PPAN%<;\!T,4D/7;F'G;H87Z;.J^PAFMR@M*)UZ>D_\\I\GB!P
M_G+C0#3^[A@G7?58B$70(U/ZN7V7Q?45UTLX;;M+A.B7ZS?"2\30OIB4+ET@
MM-H/S(.3I>(=/F_MX7E1M\;WY//[]64!#!&>J(J/BQ):C^+-<.X0/UGXH>#6
MOK'] 1,T%JL"2/75H,R E[5T58HH@^^PEF< RO]P6;3E*1:?P#AGE78$$B53
MP6F*41)?/^X@K_SNV>=V77=84N0>T(J'#6KH.=>MOH\W.0(9H[0.]% G*.&]
M2AZDY=@H5I0$!=\'YVJNW#\"]>+/T34I@4GDK8"]X=B.F05[:GSAVP7DLT-L
M8>6;MNGY'[<SL>:)%PL.ZSW3!!%?Z1<!J\>4W[: 83B%0/P^VY/F;S6]6^1-
M3!MXAM/2(BRZF%$YOB^58M8*2IY]FW0AA.]'M57"E^'^Q\3E0?-\^>+6XNBN
M[6BH6BO+[SBRU<DY5Y0D=3N9P8+2;3TL@-[?GO]!%MCDH/#0O  =LOD6NMN-
M$VA[LC*6W#Z6#C&@;M#>4,)F*A 8NC1@?^  W/0M.;5-O^0V2T[H.P(Q^S"X
MX(GM+L RR>CI2AJWDB3-D8KI+YG+)N$3 AD2Q[Z*)6R^/+C%6'+CI#(*JS>6
M5*;_S3+9?L99RFPR1(O:0C/L&G]XZ-%[P^XPH\D"S>"&QNN?IRKA$\HH^7U%
MH61P]);&$2C!GSC*O+:,AW%N1A[((!VO4S/BZ)</+D>-+8E39GOU1)34!ACB
MXU'G4)#)AU!1W_: #3_8HQ+2ELPDX;T3,GV(<#L<W]@\H[1]$=OI$1Z8^15\
MI:,#_@S.>JQ1XVE'():'^'BW4^-1O##%R_-TK<\XE=*?^BPMSSA"5+C9G%"7
M2V%??*ASH_4W-?2&#9OXY^,F/_VANK(59JJR_)C=S#ZP XSM@45R28*;+@6?
MT:22AA?6OXC$.,QHI/F-W4"S^;A=HB".$S\.RM.$F>L!-_JKD%SU^L"GCT#>
MG$GPL\HHY\A@8B&8V1_/H\Q0&GRS$:[;&YXW"ZV>)K>';QY0;$V!@3K&9UT$
M085E#N5-%4_L$IMA2+JL<54D[8FI;,YKI(Y_=?M6,8]0W^9 >IM-A<D1,^RF
M=C/8D?XF4XC IC'.G[0\M[YKIWBM_]>&Y@93@EJ2?F$Q"Q6$>:EJF]D>, C"
M5 &+^2<)#*-J96@<5.7[L&MI3*EFRMQY<45D6*[FL&66<BP*3AU(,L19*G]/
MKF!Z7AV@&(H;\,F2F]5!)2FB.\DYE91/P3;9Z'LA=?GC(6Z!N;#GN]G0?/U\
MK"PGZW=!TSY[TIV"HIM%;2NEJ55#!_410;D=?>"D)FM#=$7"7\__T?8@)W3!
MD],&"0J7HH%"K.Z>P?R",UCA!S*<<T<@FFD34$6RN**'2,0WY>RC>]G:I&/+
M&864I:49$WTA'YO&U.I%WUE81MK]FSL?"_O>+WRJDW[&Q[AVC O/9&GIA]7Z
M3'2^O!GS3I6!$FX4U)WDX\'1BE2Y]9)^@YS$)BDI41'[\(FG@*.#S08VAF]L
MW]J7I@GS2BLNJH"Y?/&E\3?3'O%K/A] ^'M[^7,;^/H&(+AK;[LLN R(<A&$
M:X.-A=_*V9_$I^B_@(0Z,N5XHIB>51(AO^ +SF.*=?)>7X098\H$,ZA?GNSE
MN#NW"K'57CE9 6:FZ* G'-K<>7J:8ZAK_9.VZ1;@S5OY!5K6(Y=S/!PO]QG!
MY*8(=R]9$PQ=EX32'*;NW%U>+:'S-=(:H0V(S5!RI[_!E$<#\)(*,:64$%^8
M9\C0)F%4B[AO$3^2E6Z&2/>TQ. 4^#'U+E_[(:UA+W:=9,(.[K@?4P;\TV@U
M[/7J;]^V;O.%6$FML&</ZLAFPQ?RZ?S>C#,#5#QM? )UGBJY,I#Z>D8#'RLN
M/EO[H(O%'^XUL8DR/6R+Y& TU@'FO5E7#!!D\R\/#V5OZ3HF+G$(6+^?#"AM
MFMYU&6M2KJ([(AM[W.0HLDD:&!;D+*%].1;G3.R\'J#0*RY,%7\97NK?+E-^
M&K(@9FN.3V8;5LAEUC9]:RUU*_OZQ VI$*VI)]QK0<4BT<%<0Z&WQ-62WG_9
M;_TETV,P5*P'JOKD]*"10U?#[M)4]V1/N5N>S"O9N#P5D=0*RZ;R,T90I=VN
MFKXO]5""E<;0^U9E_@]WY>^V>@M)5=\-_EW#2E*#W/*?R#6SH^9>5ODRQF$3
MU#O %MMC5V5TUG>X^&VRPGXMP^28&4:?W>P20Q;\Z89S0<Z0E32)6QK@,\C9
M'GW9?]K3@Q_09HO!QW[4+'S*5ZQ7&K%QKOG;)W8/]'%HJ-Q*Q"I=2%G*Y&):
M>8&WR;VDTVZF]\.2Y:;"?:7"#,7FHFMK)BK<TF!\-KF7IGZ8E7EBA&RK!(3Z
M37^2Y9K+BM>:$/%UMIQ)A-FW7_T^8\RP\L:F1N6ZF:]$87-5AAJKZ&IF;F-U
MZU'>)$5;B5'1S'8<0O2U27IZ64VIY,GCKSR[MD1Y+>*<@49+PJY>9&*QT,KX
M;NO]> ,L*4]!!/DM;;;1:/TCH?&DGL,H.FXR.?4'[]\<+[F*19F)"-]J1^B2
M7\!0D8[&T'?6%O'1/LTNJVMODR^9_]> _.\:0P.]0LXX<>??F4S9;D1B3>#@
M.R1Y)1(9K&RJ=\S-P,""2\$^A'6:R;@<6+AY%S(HY75?\3R_*KJAFLYU!(J)
MTV=90AD</C^&>X1I0V3GC16MWD(Q*Z=<7C5G0(3$44EYU*%M_5)8&W=KB:6U
M]:SF (*]A=O]PGUPVQ/1T'T4E/2'S1)'9M</L!5X/IU3/KR]V@K+";*V6'N\
M:GZ*[>K? M@7NNR:-&%:^UCA7JJXSEV5-.3K'CI_.?5.YT@-GUF7IH62347>
MX:/P<5G>!>M;#/G*T@J8PN%]Z,?;_VU8XS8;%XO--;!-D!S3OLCQ+X=UL98(
M,":.0+Q1VO"YEP_'8M#G)"F,M)"AZ]UDE>3PAKFR?]ILV)N7."D_DB[DVL<H
MPD8\GS6PH^$,'2ISL2"EJZIFH>GZCB YOO=6!]E_^*4-:[AQ&^I#W$AM87Z(
M$4&R+NH:NOL4@S4C;OF?=VGDPH7+I]NHY/XE&2!3O>&B.08PVI2Q8@;TEZY;
M6C05>,?_TNBX=NU4V(]< ^Y?B ETAF[7< #;];2_Q;Y[YCG@WY\6.>KJM[VS
M(N-!U';1U%PRO99:J'TGE)P7:F&^X/774C?/P$AEZ5D/Y5#'6#6.]G!C577$
MF[_)KQV[T'$$<L8)#):< 'BR1OL^CZC=.75KORGK>V$?E9FH>,H<9?8P9/\E
M2JH$UQE;:-VB&*G"C+*9@-A)_M-U?@U&!KV=,#X"&7;=4[4L47_Q=3/$XE7%
M%MLX1P^3-*KD(!C=K87V+CG&J53(XS)TCS35V*(A:Z$'+812\/8'IZH_N'B@
M65+7ORJ"$$:ZZ3S#%8O.>DHP^RY<GWJH,+A$:VACYC*Y$,_,S>IUH>:DZ@UY
MT#/6"]$&S(YM2#"9;S7_VUJQO)J?<%!OT'JRL.OUT0BY-C?8_JF?GF,+DO"_
M?WM>_QUZ*1[>,U<D+K7R8$ H;U50I[V)&%<G=T]>Z<=9GNS@OMM5O&07IB3[
MBS#1J;*:GJC!)]**!U*DVH86CN EUYB1ALT'5]-@+]HO%PO7#W'W&L*<_':_
M;T_T$XMTQJN&'91CWVQ9K1S0CI/E6534Y^5_?J0895-M":5V%*.:R*OX9PQ%
MX+Y(S=A)9(/Z?=6%PI8;6O$X$W?7/_J\U!/-4SFU#;XA&[ 0Y7)9PC3CS9(R
M!4U83BUFF:9?)%MQ @@29S0$7G$UOO'U1C-_Q%),[1>S&X*!M;^RG)R)N0Y.
MG@MBBVE?K<<0TIU?STB@9:&4V\O 1<Z4+E&Q4-+R)CR@%GG,ZX-?AG%XK,1-
M[:SCN>@*/&K#>LB3^[=EJ:LQ?H6Q;N#.3%R UTECL:*Q%-?D[D,T$3R!EB>9
MN@/AO> :RI_S2]I^.HW'#&@PU&RP4H[TI-1<=L N+RO.^<GU.D,MRV9^V_(8
M:#K$?5_Q_E<M46-N9-A>N@1Q5NB>_[>U0P^=83GLI^^Q-%\<F8DO7,@&[E;.
MPJ>K_:+GG1PCX&=5?4"]XB]E)>65@OGUF<=U@77U$EEL*?XUOL(**?XO9.P*
MEE:7['WJE59-5I_9^WQ/$W.^J7'XH,!7?=)"IB#<XJJMA<^DBQI L\YQ2<U.
M?3N?XUG@6R?LNUX0H;YGX-9"8>GF1ID#&Q0X<>I:/O5''R9^B?-C?&1T)I#0
M'R'S4@^GV7O'5/31'QY3B1X'N))@Z461V4$%F@*#U9<BC$A%MV3$0.S#'^P
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M7Z3#L1R!J-4B9WL9HA1$0MW2[UYQY=DF!)N/0^:SB3L;;I)36P]=+S$S94W
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M36M"25T/\FE=P-;*=C*>L^LLW?7P)5V26)((%H6(4",= #&!Z".0SR*4))M
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ML=:I6X19T23!74P.88@(RH>".@(U>[$^MB92(#RB[ <9%$P7,I5'_=09(MU
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ME &,6GXS104]A3R3V%-H4=(""\XI&1!?JYHBPD^6B%H54??GR$K:D0)<T&'
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MQ4P%I*.>,A_UAO4<D2*QO:UH&2>>]8"] 3T$:R<1;44$_:]])-1\RS!Q>6$
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MKFGD^- ZYN?G)<5RK,Q7DS!?%=9Y/[>1>:WF*2AR8]8-D@GJ5RVF["AI.--
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MC4>,-4!JOC0\%[_"HE_7CQ2(G&R[%K2!:AN>&X0 ^D3V\#OQVFSIJLB!<WB
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M H?8-5LH-L:OA[[)R%TN\\ L;#$M9+4*\S@OT0*>/36%2MT,:BO7+:!R4U\
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M#%=&JNMI^G 80"BDF8BI^@ ;-L^2,&9\Y6+=M7? S?Y@6'$]C (3!%@;"E'
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MNI3,BW^CJRQ25\.IP#?E@4%<./A->16RE ;K]DQL\_G0ES=+3R 6:K9 QY]
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M\N)Z- #U38^F?'2_5EEH_=.J.@%O WD*-/!Y.\ N)ARW=Y(S^$;:<N4C7#K
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M=Q/SPJQ'Z,8:<W5[5"^M?W4M8I=8!0];RK8%^ '^634!B][4C%H,SP4?\7L
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MI:Y&>5L*9Y:GB&7J.KGEC'D,&9W8NT'DHOD3>,Y9V$3D1D3;*-F3$VDWC W
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M^;.T:CM!WN7#SSL//AH$/1PJS*C-@AZF&9?D5=H><[6+@Y,P\M@.!)*1C)7
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MO1YBPK9>D:[Q6MR"2&(TN1? 9N(+U2X/DU22G1B]Q;=3&4M3,,&A=<.>H\W
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MXS[T(GKP>]K6'_W?,="*LJ[V) 4AK\WTD;X/P_UT%PSNF$4U>1":?IQGI"2
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M4$,,+ 98^OD? ;2"742W2N&MAF3:_?2W)#0_:7H!+0@@3$T#6"1?NAEH2*+
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M7Q*QGQ9K3$J)LCE#2T=$/P= %S*.&ND:82=MG%Z*O-)&YQE!:4#5+H#8*</
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M^"SJG4IS$PR>RM8&TC8BU,1J^A"L"(M]"1ZY0#G^&]$:0D<9)Z@P)L0AUZR
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M)PTSVO\(F5G)7$@K8V<$-[<"!:.W+SPC>(\=H)I0!8VK" "WD(37H"B3S[^
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M:GC7/+S9H:AL@L2+3RT"8M^W;-EYR JGH,XD2M<*LQN;1JV3Y$N]R%M9T&N
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M>WET%6& /8]5G76*2Z$@X34 OYMI0FGG-UCVS2U(3U$[,"P[4E,@T-13"L4
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M3UZMAUTNEVI6TZ^V9"$GEN!6:L=KJ@$SVL51:@]KU1;..)O%!8)-7)QV9_4
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M!"3_IL700]1A<S)I=  C9*BXD&G'%KS$(H1I1V+C]7 )%\D6.'9,RFF7)(P
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M64/(@N03^*)(Y$&X*V5A9(2MMM"Q#SIK%,$]KXY=YK]#9P\[ 0 -Q8-A_#%
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MNKS>5>@UGR;9 =GW#A,U)M45QFO)+J3%V$?B8]=&]H*JBUPB?FN,V&N^'#A
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M5TK^@A0<Q-LE9MVWK']]$"K\V]GF7QZC0+?^]B1S\5_'W_ 7'YIA.MZ;@GZ
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M3KO+@<=%Y"DMV .\-3>F40Y$@9<YW[.&K^+N&9P']AKC1,I_XUTL4Z;&^R2
M3669%7)@RB=3XU:*V4\EK/'_RF:I"%FW',#QP=CS5D*!UT/B(&Z \B*(E6H)
M'I,#?>*1COH!T^H*MF2P077?TTIHX-D)JJ/'78O>?4_BO#(6W3KQRDV[YMB<
MU0WS(\03R&8T3 YL 5-!*!/6DP-F9C+7A_^N%$=(W5?,[!>?I+-7O?)G3IY0
M,VLYONCD R3O=&[4Q?HV_NH'[&EEK\,C]_9^-6JGWWCK^.WQ%=0]+T;]^/7N
MJ)Q0+5A1DWDMXOK!4XMV[+7QO'4+_O.ZV'"Y]^#EJ 7D(\(BD8H)I\6@C_R9
MCR,3.8T\Y 53,2WN,ES^A1"A.*0#BY<#NG) 9":VQ/S\9UC_P@>6*%S-<WK/
MKE7,B $^37.\,%.?7_QWA(DM]Y$#0^=GGGVKRI(#6LX7<2:?EHSG8'!6ELQ+
M!I;R6IC8?% ??,<6"]#E=#S47KTBBU3@8IDJ9BX'ZOT;*.A]SI2A1 G]$$6T
M/2<IWNG4M'E$8^/MVK<;IT8$$CDP.FBH3H3M_V3/V.TBPZO9<L!9T"7(9"$9
MB_5DBX]Z8<LF:W@CX*@L$MM+_@<;O/_14/#.1,NE3Y*1#Y/#K4L^[;L4E[=R
MH9.JA+-FCF3#DAMQ%S4(!WY1]\X&7'A5Y^/_[<+)E1'V +T/-EP6\H8D!T!8
M[S:NMW#;*:/4;WC^QQ.;V).F2)4<4*5H@M\>L_Z9GT_6?/MP"MW+\I9-\)U<
M2RU4>+]>E;.0W-^]9 ;WB$@F'MWY$R,3KYI1-PTU+-W6%"]1YW"!1Y["<))K
M0?R'3E?^X\B\SO/_CH']ISMWPE.0'5_CNQ^/[3FR/XY-T->) QVVD5:6M$9%
MBSZ>[.Y6PL?R:53E1N2DD58N]7A=0'^\[%/LC<N$F?FF_Y+(>_^5WH$.M%_?
M[= M^U#F</<*?]G98SZ+[^[/_[/FI9]WTX%'C(]=M,6$LDAQ+OGPW3?G;WS
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MI*\A@Y9<'=2RR]PF0MU=U'RA0DT=K L ^9%G7DGK,,-GY=U<PV'U>Z1,H5-
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MUFHN&>KGET)VK^Q1"^5CIZVF.W!Z>:SM+L<S_4*EFDS:'!V^]V11\V%5(>!
M\&!M'WUM+4OU5LX0;4G!<%H(O4"M=8)1B'>K5^H8WTR39V@>5Y(Y63,!O\^>
MZOWY#[E7Z;$4[]<IK73PYH]E']U"$:NIU]CNT"N!P1>0^+69=S S->_U]M!P
M*!)KH,QS51W=LJ72FJW0+56Q\5A-X!A]&5!XVR&"%IDFHP3#[5^R3U7N&\7'
M*_VF H1)FAP?T,R'8Z2PCK)K).-<Q<H-LWUMJS$,]EWT,OC3>&[9G[SC;5D
M/C(2,QFM\<J%JGM5DR5R)3]/D'N?]D#2KOMWFLB!Y)+FKC"+UXD>MTW'#]RG
MG8;2N-T7?4=%VY%U$$XF<AIE;T5:U$-28),UW%=U5>)"H;U5:1*<)X5>M6FC
M L-0<XK28[R3W(J.'$_,B?DVZ_&#W[I[8\=QMR.K'Y7OG]"6'4K\JN[+LCVC
MB66')J(W;CQ6MV./0]%UF^8FAV84RJI$"1_Z(419IK:=2!!Z<0)N!!1>H+,U
M=:K<+N6:R=?LO<S9K^'*%K7C<X_^@Z-#Q.*;./<4G+>X(:"],9R0=PAZRR_*
M=LPY3?<]^D/+@OOEU8#># SB):%N8GW>C/B"OOEXG%:U7C=ZU*57@\,P@:]@
M$B?[-CW#_YUCG"!A;4*'6)[MJ6]?U./NEKV1G^>\F52^^JSCJ&N3W=MFGM.B
M]H:$$#A%V)+"Z_!=3#+$LI78A[P" ?HE)D*/_^)>BLI>B(7JM=NAPA(S@44<
MS7@M=(.FK40J"!]J 7*#T:4BAW4=#WN@[GSS%F8X*&2H7%EAL*/TM[<'6R&'
MI6/P>VE+>[["5Q\!ZK"*S)4%!&=!V>I-E>_$;CCCGJLDCGVS\1#15>2'%"^E
MI^/]U>A\:ZF0>8D]C/B,DJ* ;'%>E=O,K 1][>R!V1)CM&;8;D$UXE$H3FI_
MR?UPC5#^L]#7<)CE (GSV#M"D^CP6BE[VP?%%@8-E]$[)WMR"*HGP2[5FFFZ
MWR 4)YB9/B-K55##TZ9BG=,?=,K=ZT'<2^Q*#,RYHZ'[R,0=08O_@'?\^A58
MHX^WPQ@^'*)JNKKY"'& FN91/Z!T?S@NW)])U^B=*&NR N_L\ LAZC^.]\H,
M&CZ"'>8_6;(E06\UW?H&/HN"%*?"AU=:3&465"+VQ?ZCIC*VOZY*O\P.%B&Y
M#<P=*U@GUBGD^&H9_Z @%5PJXPD:2UN1Y,',N:K&EA;62;KO@-C%F-J$<"2)
M<KZIWB00I[8FKQPAY0-;C1%-\UT65 ?E#HC#($$KN1&=F1=;YO0@8+.PRI64
M;YX/5O$\QQ1:<+:@$Y=77"_<)&FSFE\,/L0'OV\.VL*^"5PCVMP3(A>;/G3
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M:4YHEHE0#-.0=2K@M3?3-CIPFH3XF22))[<&8A3-2B?]G!A5.C"32=*(>LP
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M4JF\\K[_WOO..7W??]>[ZZWU[GHWK%HDE9KVWM_^OF]3M3"\-BB!&9LW;-H
M3)H$ )/('\#0#020G_YKKR\'^:\>8Y+A"6!E"B"3Z$:3Y@.3K28964TR- )4
M\CJG_I\; /_K-6FRT92IQB:F9N86Y ;5,X#)DXR,)D\QFCIURA3RVR3R>V"*
MU51KYQ7?&-ML/V R_^C,E6?/7S=U67NOWG9'*[)@U7<_GC,SM[.?-=MAX2+7
MQ4N6>GAZ>:]>XQ.P;OV&P(V;-N_<M7M/R-Y]H9'?1QV,CHD]=.QXPHE$]LE3
MR2FI:=STC,P+%W^^E)?_M\L%-XJ*;Y:4WKI]YWYE5?6#FH>/:ALDC=*FYM^>
M_OZJK;VC4_:Z2ZY2:_Y\][ZWKW\ _?AI=$P[CGV>^!+7),#HWT+_R[BLR+@F
M3YEB-,7D2UR3)B=^V<!JRE3G%<;6WVPW.7#49O[*LZ8SUYZ_?J_>S&75#L3V
MNQ];S>T6>*@6HE]"^Y?(_G.!G?M_%-F_!?;O<<F!:4:3R.(960$@0!"+;V0"
M_V\L6"5A3M5%\%][:WVP9[J]%(":::)R+SWW0:R:ZK3(B>(SCB]46/LY(KIO
M4<>80A<'UFM0Y4YTO#D>IZC2)P_M31X&8Y-["&\H ?/7>4.>J'T3E4>U]G-&
MBE3YJ2Y527"3R+LS_KC_](;@M1\M?;=4ZH*?L1ZWCR5M?B_;TEIUQ?1N=3!S
M9^V#MM%GOF5/U:G$'@-P[B;G*<=/_TC\K4)NI-V+'5 S3=D!S7S;XX(I86Q6
M8X1_>+S0N30"8ZAY9X5)SK+ M*$Q2]90_I["F8_N!93N:UGYYLV3/^R<%V2A
MX\UPER]A'JX+9]L\N0^Q.L #+*YX)GR0)H]44H=9NE6N$G>&]BPZ+F$ZX!LP
M,%'CF!123ZTRSM? YEC(OGO(ULKK[&OTLW<QRVK0BATMS>MT6I36=+(J;/5R
M@-X%8TM*A\SL&\ I$/N*MA)SI330TD5N*/6,T%GS5'B 9<>]P_[40*=V^FU7
M@Y-_^[BVYE1(3M55FV_:[]X5NE3(8T7S/T76W,L*SM_6[M$=)-E.)J" \R24
MT4!)X5,]J?)N91*_@9K;LU"$<!N8<QF:((]6_*C:?[YV9"LZ/;^H-"]ADG>*
M8-D1)5I>T^EUHL?LJXW$,OZ&;!/P*F<*>;3MQ,L0I@UG.I2$25$3Y4(#(#6#
ME:43?'RFKZ8EA>[4Y^3=)K+K._& ?[_IILZ337L"FXA5+M4BF=\F]=550_29
M:$T&?1[[E:QA)W:QL717AZJMZO;H\%)YK]H 9,/W%4T,S-4[7?P]G-V*%<CV
MH[P4,(:/+3U8YIWNP>RRT)[75W!,^V!S\(@BTX$B=8[6^-LHG?C'T&/U3/OC
M<>XNZ]MPZL+\<Q]$<_&UM0]0^"RT6R,VCVDI&?2^1FUEXE[10ZJ3.C=VEK8=
M:6FL<VP&*UEIN)FF)?T3'H1L?"@;#6<T*"S?RRK\=I^\+MS6*+_8-4!WZ/1X
MN,=SXP?:\.9 [Z[7^V6_,RW%ROL& &'P9Q$O#$"E]["]ABFGJGKKF=.)=L+)
MH>6,GR\:U'BBEII>3AO]/*KW;BIP3;^P.NI>6XBJ.</3EV6&#4KO[Z=PY8'I
M5]V_0^/?5G>DOE/T-N,V(&&V'BXW /5KQ <NB]:P\[5\C(JVJ01#;U&W^DW(
M?9E:S!,YX;YMPZ*E6*^&D>5A1E])O*B-N!FGHLY@ES):Z4M#-PFPTXU>SQ)+
M'8.H9HJ5$I6.[8S"UG"]A0$X3)D!>>CSJP8-0 :U<FN-AI7&1QAN+&P1*#4
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MG?5S)H.O_9Z);*><XP,B2]SFL0AVW$0[4R4X!]Y3<,&#CQ<3"\/W=PV&5A7
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MR[KEN_Y;X#VX_AOP>T4.E3K&Z K44(=4:GYJ =@,OM9IQEJ:^%.P.$UU?I:
M8XE-/&OD6^!'D2QIX1QT5X^QO=,BY'UE[#6V&I[!=FTZM>?2W?T8W.BSZ^B#
M2^ZB4O_G LW=:K)R'OJ[U]N$]BAE/?94!PY2Y_BYZ1AP_0;.\D,1CO?1D.$H
M'0C-1TW.BI77)OAGA(SRT/Y"5ST?/ZI29-,M.HBY6/Z3O#RR=U/6E[,OUHM
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M:6Q)75M@H5^UO9W8A5)P*]=F8@WR@D>&QR1=*<T,8Q!S0%4+MG"ZX-87$[1
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MKS6LNG02;H_FJP99PY]F#XYJ>^4_ 3ZG_M3]$LF/^&K-J-,Y<3H#2P_0CAJ
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M;-VZ<=:T'\G7L?VEN*O(U !<ES0HL.TQ8OQJX#^M^/NZT1^17NG:+R QO=0
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MR&M])\:2]UL*\"?DM#V6<!F^ /Y&*3Y<+(S6?']S@:@FO^]*T'[^<M8ZW>"
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M_GS7SYR&[4P>3$Y!8LR%IU]@_^7&5;TL'?Y<4$10Q[\@U0 4G_MRU\8'I1B
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MXJ;X:%6'O >S4<FRA,[*"K<(?O.I.1%K$/SH:9-L W $GLV.W(V,YR[C3#(
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MQQT;=,'$8%!M:"T/$;$G#0:6BIK=4RY$',L/RNEB9U<IYT0664(G.==QK)0
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M6'&JZS1 .T\#=Y._VK L@#?E<KK&<SCNG6TS-(2X$$3TZ36T!62PK),/OR>
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MJTS) #-<RWUEDG.LU0RQ #6% R!Q,"1*GA3KP9R6O(]6)_]XS:C<W"Z]JJ3
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MU,YJ(>CQ9<>YK0Y<(R:U<R*<Y#A"J)J5UAQ"DYNI[H ^/\#C=R,Z]H<R]SX
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M$/CZ6!4P+]*H/RI^,:'>E/IEN!SMI-5PA+1^.Q4 .\OJQ><&%V%@*%*DC0M
MO-S96T[(/$FH5++O-:Q5$UE_\FV9LR"377 BG37HT!WG9>$/O[C^T7S0L+-A
MS\K7GGY8/OK=9/PY# E*:;$):8@91^&6[>DJB^*>HU6.U:7E5-%Z'[.\$#\P
MFXPY\@A\]C0MO8%BT0KD2&;W?'NS?QCH([O%+67,[Z=!M+%QR%:Q&7X*'6TQ
M-(U(R$]V6@$:"IT9%4K!)D*CZ=74$^>+MCJ_C2,$O#VII.FRG@!5G#9N'T5.
M'5]^0DZ<Q;!K(LQ&#1%J%V\>@^K_"##U@S@'H/4<*1&S,,;V7<SH,$],OZ;#
MNVV6]LMWEDD'J(*"J-'X=CA9(.GKGG[!*SRATOT"9-A#XA9B?YGJ*'3\"K1'
M@<]BS6,FPHV0N)ELQ%H9J<5978>&6@H!49 D&5UUD.FDR?/T4GM]S%<(: 9C
M)/,18/XGXH0DAT4 )VP75W<W&-QEZ,E)=^0$(V0GM)Y?>IK5"NRL.G>F4W%_
MBI3<J:9^L!CS*4<B:7WYZ%P'*9#-L8SC9ILPG.7L)@.N@6>!)\L4!,Y6T1>Q
MQ*$V$!.=#\=+$W?X4+,$K(4=2OISYQ$K<3IS!S<R^E0%(U^84#[99T!)U-1\
MXA'"^?HN2@LF#7X/Z4KS6PBSX)[O>]#%(I!_ /)-8]*AD^W!7E1OL+0YQ(0*
MGUK*/%"@%MF2NY'5??1S++P+L("W/"HA]!*H^#[J*L$TLN_H-1V5^?M)&W7N
M ."$%@[_NF%JF':6/ =Q4V]B[H5\FSB] E4&I,6-.X/Q@GR@DCN>I]X.)_JG
M*4XVRMBY0?/SX]2^#.L60J5O"KJ6N1^D9F#V9SG$S>6'$<[RW#OHG@=*1H,P
M8<OT.J7@+AA>SS?FDNQ&; V3:=WQGFLA0%4$Y\LD\))\K,J1L![/C3(MCMW'
M%=AX*-Q:"'@X;"<XSA<JK1EBE:6F!%TYRG/"YI,A/4^<Q,_;<H_AWS+-/T>R
M^FCEF^KI7(IQX#'(EG]"WH$_MX:Y4D==_"C,TO+=82]1P*2-Z/A$-6PM$Z=+
M"#P;M .8:P]M9G4D<%N)&0"X2YE-T"?91[I/95;G4%4^W?PC?"-&HN)#-1B\
M'=YXK5GN(4Y]$$G2!]EG4&O:0!^#Z%T-#\C(!,9A>:NXK;XL23>0GQ^L 3<?
M,&;/O'O!2Q_'Z3YM\[<GG_^('4>H@;Z[GC65.>#V73P[9S'V]9OW3*-MB\]N
M<<_$?27(N&.KU [,I5!@VC=QAR&MHXN_1)]C0ICQ,0;FBOJF3I.L,+EY*.QV
M1-$R+2YE#U@O+%K33;)$5J'=KR>C:9OK"/,;[&1G,*.*<LL^&J7'ANQ&6Q0?
MM+@<">BGQ?5>%0$S>"N9!#A$.J G*Q\2BN<C7C"POK;\J8*2/DU-_49R"OMD
MEF,D;8XG7L8U8SS[_%S6TS*> !@\QSPJGK2(?(YI1H\GY=_F)?_B8K-N$-^9
MN5+WW7/\FWC5X8Y8!\?9_;(_%6JR@I2BWAS,N S8,G^HA],E"YEK,;#\D1$O
MLN";5B!A;L)RRIYVICWF%AS+:TKDSQN7L&RK^/BK.^BS=CB=1=Y*P)W\-R\_
M#(F<0YCXU\?'>4L847)V\F3Y_%$AR_,Q>"M/)LZIQ>:DF'T%Q&Q@)?R0HH^L
MI&1,G:E@)IX *[> 1X8R;UV@=CLY97?HDWING/8T:>54ZC4!BP:1'9U,*CCD
MUTUGK16#EX?D!Z<L"MY&RY^BLT9/8*+*,_]YU-VFRT/-!9UK)<.*G<'+'U_:
M''D67?"3)_4T_Y"D][ L7^B@S"3-@WUO#O.^XW?S5L%7QRWJAK(]?6Y$#*Z"
M914CMDOA9KD$#WL(>7;=GA8RM@7R0V=UR&:R-<P5%-FV-_C(=RR5PO%[.DO!
MS[XEI=VFN_2$@P1,,,>B;2S+CNI&NQ_@)<4U5RK"!_&@Z$TUS82AIM6"0\D-
MN@J-@SP_&=$%-9[>\H$]J!E;D*,GGYU\';[U7"86),MHNAAX?ZSSI\B^7NLX
M=BVYC^6)OB3K\2/8!G!\L\2RP3%>GF/0$DH"^:V$>;ZEC/HV=$[G!"&=-+?H
MD[(EU*$=\9;B%S"HPO4)M6ET[M'.V(SK7?O65']?U2G+B#,PL+Y*_^7&:9)_
M)_DG?*^ "CIE@%/[06YV7#FA!5W/A[-D7O%!< _4L1_.EVIQ"R/KE@U:=;D"
MLYF'.WG+!Y@'P3.=#1YQ2==&K(!4Y$3),+5N?6G9</[Z!;V1TQ?=0O@"=F^E
MC-9"-OG8IQ1$ZWM:W&1$224IZ&PXI@FUO1#BT>Q./.MI)_>B"_L\ T-M<P/O
M[]AJ,'!2M:)KIL.=$&\7Q>Z&3MN]#"\55EUX ?\^=ZQ'AL\87 SS910#AD(0
MNAX*:XWV5\1GTKSA44B]#>1F\%9%&1[2E,DE1HC[??BZGJ P4KDKV:_]GM-8
M'''NP6&38?? *\6\/V++22]?+BKCPO:<L5.)85#BCD?PVELUEZ#GW^C&&MG\
MNJ.59K3X=0FHUUH>AP1 >YIY\U]+H=B$L!:)(?,'R %HV0+I^<('(J3U!*NH
M.^9<^88X!_A0$;DJ_!K^-Q<M[HV_*OP^2,M$;?UE9*M1U!#*X2<?ZJPB6R&_
MPE,*=9(3/2VAP6KJ=#5EEA@3K>B21CA&CI\U&IC NB,#%B!>=2 _/=9AW&'K
MHXXXCPB7Z#5]B=P6^CG"?-YL>/5SV52+TM!;!A@<B+3Z\##:7!W8[6I#"85(
M#Q+E!!-&GC!T*33_>AF<UTI:"3DUWI:,AMI!Y(RXI&!:3USP\T*??9W'/Y5$
MX$O^RWM-3TE:N><PF."Y,UTA;@L^D[>H%HH7<-.+"'RP-IOI&G?J;L2K47?S
M6V>(:PJTN.]Y':Z)=HOWA7^:>+'UV73?]W[E%8<NF8EN!&PBK$.\-+E:7!@M
MM8"3.?G"0"8?K<.0#%F2"$ZUDI;#A7*^#3,"VEJ)5?^>QXD#U"8JR1X6R=FV
M44^E23]-MGZHE!F$;)8(ZEK?!DZYW[H:[UI>*1!\I($4XANU@&<*<9+7L Q[
M0\*+/%XS9\G*(R:5"YE;H<#Z0S)^2E O1&X1&\+.K;R5F*W"Y)SM(I@FC\'\
M'%D0HB<;?"P+<6BR7;X?\98Y[+#;G^G1J=Z>B8/K]V/UFX ^*1A*<2'H#2(K
MPN]AA C93DL.MO,6,_>\8BT>F2(L//*0(Y<@*\AF+L1%PWR3!D"O=55LHPUJ
M=P >;47M*J'Z\ 0=:(W5;Z]B3QP>M!]+5#LWWV24;GH(>\F\G+VA2UI<4[FO
MT,H\MR WZ\9;L=IYAVP5;Z;OD9O#[BF7.3?>(,[T&8RMY/G#"3:\J[>6\U*.
M1"2%)4:N2*65?,LOWF*T68M[6"K$K.0 HZ-5,K>=8A7"F&JEF5JTL0@05\B>
M"?,I\!D%D%HT!_:0B\W#62M!<G;#Q@HXGMK#6LATQ\0-<>@5?:(+P __VGLS
M0E->[G>[!^*/Z:H7,[U?>9K):$:($?C6UAK$"\Z#\9M>-3C>@2N;W/>)FK\X
M%@KY<QKV')82C1E'\;;(JL>/'F3*IV2UN1V8C^$]OO!9_N7[HFC?@$3^ VS"
M'C  7I5)6FJ@,H0$UG!D +R?M;Z3M!1NC1UJ6!L5NJYS@HZ'$Z:"+UA?+4L_
M]B[O>Y";-O%F[-M7?U2(4Z_CL>NDPW[O2=::7."H<@Y">XQY&F6JU?%":"FP
M !:U=4^?C2(Y/ (_9"GXZ9<=;S&]X609/:VV0",2<.8POX<FS]5>+MJ :9(4
MYO)BAJCU561!.R,YJ)-<ZYJ<--%EJO.E%LO7(\IS/+?7/(\(K()K0Q=U >&P
M)]&BE6X*QU"[8R7&4;6V!M\<+$P-.*NR\;/8WAEKH^O;,:$A)3EY;,CL]W6<
ML'AYU&0 5JK7,3$AY.BI&P&E"8)JT\DR*N,#.0/ TZO(ML@6./$>[".Z_]%J
M*J6\@7HC2F+8$"PS/-YQX%M!9$QJUKT<BYS7_4MD3WGDD@*:2^)[4YUO>@HC
M84P))+<5Z8%<@<2"82$,M7_%-"/GT 3QT]_^^S(G@9]S+Q;K:<[IU>*,F&O=
MA/7*] [FMD[$4)'C^F-[0PAV@T#HR-09Q/=F[_!T(%<VVDC>T3%>WMA#A3U
MT4'L$>TD(A8W3I%U/7=$8&KFW.63W_G=C!B< <U*.XWL ]M:OFSJ<,DX%JMF
M'&/.4M!,X)_$.R[W):WN^:'KYVUK#A<,/HNB^V/T\@LH&F.K/6 W.7H'ZA$
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M+#G:^+(ZBK6[=Z8X4SV)5BCY/B'U:D;N/% IV:^/<!4J%D,?;]J.;U\F:+W
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MP*WR#/X@)!S8K,W39+JW14/@#E:M\7\L7,CY;54SLV)$;$U+5K%.NRT#RDJ
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MR# #;(T_O^$^S4[3%+G0&_GZIVN4RZF>G8HKK<IZI'6#NM!;[7&*!&/T*:5
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M<#S(RZR YP%?+9ER9]QL>XZ)[/$-77#J;1 2^:@)*^2WAJ;B-M< $F8<__#
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M^\P_?6Q._V5!YZ+DD']? O]G&V(:^"]02P,$%     @ '4)E47\7[2GT:P,
MDH\P  T   !C>3(P<3,Q,'$N:'1M[+WK=MLXMB[Z>^VGX/$:>^WJ<<H) 1(D
MF*K.'N"MRMV)D[)=:W6?/S5H";;8D4@5225Q/_V9H"2+EDE=;$KB!3VJD]@$
M+W/BF_<)X.?_^WTR5K[R) WCZ*]GZ(UZIO!H$ _#Z/ZO9[_?^.?T[/^^_U\_
M_S_GY_^PKSXH;CR837B4*4["@XP/E6]A-E+^9\C3+\I=$D^4_XF3+^'7X/Q\
M?M/TW0#=W1(TQ(-;;.D(F]0:WJHDT$P^M+ >#'[\_@[K^&Z J!&H!.O:(+ T
M@JA&@T& +$3)W?)AJ[</%F^?I?"=B]<KC\.<>/J0A/>C3,$J5I>?-+\^RH!>
MH#E*_WHVRK+IN[=OOWW[]N:;]B9.[M\BR[+>?A=CSN:#WJ4C/@@?A]X%Z6T^
M,,TF;_-+;\4KSE5TKJ''6\+!.7SD>3 >/][X_389OTGYX,U]_/5M84#)[8-X
M%F7)P^9'K TJ>4R<C<9A</O\TX=A^G9QL>SC!W?G830,DZ""Z,?K%3>GP^H;
MTV')3?S/69@]E'_G_%K)3;/T/(G'/'U^V_)*R4WAL.P&\1YQI>2&N_3\-BN_
M([]4-GO)8%K!]/Q2&=?NIN<S0'1<P;CEY0U82;/A9IS @#+6ER [9WL9K./!
M]*Z"??FE,LJR:5+];<NKR__# Q!=HX\/QA7,A"LE;[Q-X[N[\COR2V4?F3R5
MLQ7SDRK9RK^\6KP75Y?_+Z$+Y(\G_/NT4CKSJQ42-KRM0LK\8LEM@)[DOOQE
M^:626X:#P30N40+BGOFULL_CY3>DO$)/;M21Y<P?#4K(%R^!"V5OB:O4=URJ
MO/G@?!(G%5*_O%HZ,R,^C,/S, PJN%8<4?* * @':3DS\DL"1N;:'/$J]22N
ME'WD=%#!C.F@9'A6(>]9F;#G'YD;I$J)?S*DA)ZDQ';D&"U37FE2P>:D2F(W
M&^7"B V2^SALLUI;C-B@VOBP"L?B2@D)][.@@F)QI6SV*H0Q*Q-&L&=A5#'=
M\VLE-WU/5[)5\**PJJ*W__CXX1H /PG$O5D0#?@*M>'FJ2@,$(RSUJQX&NL8
MF4]>G-^^>+7V=C%B];YIP@?"7ZR\QWH;) /A-KQ=#7Z*Z\J/?;Q<@N>HPKY&
M99IG6#&[PU(\+W1)G*6CS=I&C"@S_=\'H\VS4!Q1*>Y;1+U<S,%%6["[W'];
M7BS7YIO=T\?K91Q^G%NT 0D5,  AJ+8+BXOE1J[2P%725\*6%7&EGFUP7Z%,
MQ)4*G[/:CYA?+/4WHPIW+(Y*AH]Y4*%2Q)72YT_*/PDN5+AN%3!ZO%3&K>AK
M!;.BKV7#OU>A!8&NB<9AQ$5L_$239N# I=5@60ZH$LS-0EGAE"ZBRFK#M!I0
MYMY7Z*I2+PE(N!N-*^*<Q<6RZ<UNJ]QYN%)VPRQ)>#1X*"=H>75#8+0U@"[G
MI;! &\U3N6D:1.?3H$Q'+"Z40[@4O!MT_AT?1G&5<5\;5"$T18P\$9ER;$#D
M>L^K)#^_5AIS5 4<93)68?S",N,71H,L^%XEPN):J6:M<GWC4D4,GOX@&MY5
M?=CJ>GEVXCX(IN5A9>%BA11OE."*2%[HA<K[EE?+S/AL4J[=AEGR-GN8\K<P
M@B?AH,B8=%:BII=<@8MEKB*HR2_5*3=Q]4D6:5.,FU;$N/=Q14"=7]H@4>D(
MC/<H'E>$'\^&E4U 4N7-)V4?NP1!J2 6+I;KIDJ]5*:3%DIRLVU8'U7RWFE2
M\#'$!$YYDH3W\9NE;58M;*QS=CM3*_@IYKE,@RPQ4*I%GF'L:5P@+M\&*2\*
M3;7 E#L.54%;?JE"CWS]LUI:OOY9Z066&89'+[#,0"SCILI9+@PH00J?_*O"
M+Q)7RB1N6A6O3TNG%-S*P7ACGC._7,&0]+8ZD2,NEMP65 EE4"J4<^TU+<N1
MK)3;M#13DHRCJG?EE\KD*:A(>L.%"A94"D1^K4SKPNR'&R1B/32/XF@'@Q!'
MYVM&(>%W7.@/7OFN15SU.+!(%K^O\/H7%RNF*N&5&8O'RY6,##=(E[BZR5K,
M)CO8BOF@,DLQK?AHN%#F:H=W7RO>E5^JQO%&[LROESD$/-LVB3"D8,<$)LKC
M^/Q*A0=:<=?CI8T)QBW)F$+N:#W!R.\JB3,$. L>;U)=QDG*@ANA7#=JWG*M
M>UNA;6[+U,RCF=YNR,N-.,3=E0%Y&4UA&E?!=7ZMPG27AMBK^F&9-5EZ/5S$
M99_C,*HHRY2/*X]:TML*CW!^K0QD%4%[J<&=)T8K.+JXN"EY%P^^;4G>P8@R
MR@85L15<V,S9S0YGM?,GRFV#8#S0-I3CYM<K#7]54FM^L<QZPT,KS#=<J7A/
MN"FI%98&#N)*=;PQOU@)\V%9@/BD4%Z:40(^%X@3JF@IP*N$TMLL":+T+DXF
M01;F^35$SE5:,BMX\Z3@\D\HUX3;WH_/5UY^L0MA:PFZ&EQYW7(3'\NY* HM
MU268DI++H ).@U*/KFIT4CK\,5N^.0BO9D(RJWC=;),=J,YO%4:4::YX4)6=
MA"N5#M<F;ZO"_1RN1:N/UG9^<0U*&R&TB1&;NV761I6K\MLJ-TM<*C6.HZKZ
M.%PIS8%L<,7_\:&0 EDHY$I-7:8M*RQ=Z>#IM&(JX4*I3WB_I7RV\ OOBQ43
M/JMJ+YF5!6MA4)6"%E>JT)65HHO,T96=O?]?__'SB =#^/L_?I[P+%#$Z'/1
M5P0.BA-'F8#$#7B<9\I@_M-?SS+^/7L[;P)[F]^8A=F8OU]VG_W\=OXS//KM
MXMD_W\;#A_<_#\.O2IH]C(&Y=_"P\[M@$HX?WMV$$YXJE_R;<A5/@NBG_%H:
M_IN_0^HT^PD^LG@G4#P=!P\B%N-G[W\.O[\3+^')_)_A<,BC_)]P_7(>A<V_
M_'MV);Q;WQ6<^DW[YXU[ID3!1#R1A^\8?/E0?+T_#N[/E! FTP\&&=@3E5"+
M&A9C.L&:8>D.UEV#(<]&U#6-\V]?SG<:>*;,+<5?S\"TO+N- 1!!=!>,4R B
M_^OGMT\^^@4T.+D89WZ8@E7[)P\2+QJZ@+@".3[!CH.QPWS'(#IBC#C(=G3+
M<C1#M3WR2,ZV@6?OS\\1!K2]_K.7N)E_]V>X+1[Z\+NT\-VV">\UF8X99L2@
MR'8]2ESJZ:IF(]TT'[][V\"S][]I=7^R8/7Z!ZLJ,Q@VD:7Y+C$LV_8<1]=\
MW?*9A2U37>%FR\"S]^(+7O_)7@12^>"(J" 87T1#_OWO_*'PP1JCAFXQG^JV
M2PAQ;<<EV+=<ZNHV8!L_?O"V@6?O514\(4HT0Z_X;#^!!X'+I SY()P$PO4]
M)V?*+ KG),S2X=DSFI#UFUZ@2:1;W_E!F/QW,)YQEJ8\2S_PKWR,\C]Q_J=V
MD[MH/$G91-C( KV&Y2-FJ=@V/)NHAFJ9CN=0I!)?-W7-]1_IW380Z%V2N:3K
M572*N?NM/CI-5;.H;1,;IHCH'K()<H$"#&+BZKJ]DOAM _>C\^+2?THHR/7U
M*$AXZ<2B L$+$_[.B2>3.+K.XL$7-_P:@EH?ILN'N."YPU_# IV@G8@+! #X
M&-%L9FL@6#!WOF::EDY6=&X;"'2^0=;!2,6O)Y5YV+(TS"AH#.(;OF5ZCHD]
MFQDV-3UCI0RW#12D8G0P4K77DVK;INTSQ] )PMBBINF!?L0:<S5'QQ9F*[V_
M9> A206)K0' MN?;MFH0#V.-4&K8OH9=S7=@_@Q750LF;LO G%3M8*36 &!J
M,AL,'M*(XQ#&J.V;'O)UP[>)CUUCI7NW#3PPJ34 6&<N=53L.Y:K(6P8CJ$Y
M<URJ.D9D!>!M U])JO?[U1^?O:L_4O&=Z1JU%W/KNH'4ST'R*;G.1/B2VZ$5
MVU8.A.'[8/9M3(E)D._:-M/ F'C@?+D^4:V5 [%EH* 4/(B#D2HF]G6D$F(@
M7R6J;FC@$G@VM0S-,T'[4)^8IJX_DKIMX&M)?>%LYO2D;):-X@3"K")>P38:
MFH9\I".'6*ICZ12Y.J)@+WT-G+Y'TK8-/'N/U,?_U4[@ECG<0*#X7%]S;6Q:
ME( >M3P56X[IF. 3N# G*X'<,G G DL=](KO]\-(U!H_\"#E'\+@-AP+AWT>
MT^5X%!''I[OYL! BI3@-Q;N\[Q"6I^'M&.Y*G[A^OL$<US:H"N;?) [%U#8T
MPU!-<'=,=T7JMH%G[Y??Z/+;;/%)^X0D^U!\&4>#5Q#M(NQ85 ?/!QL$0_1-
M*-@.B%9\GVB@7Q^)WC9P1?2'.+K/>#(1Q*^^KF;ZK\2"O$]WOZ=S'_]%M$.H
MJ^N6:NBN00E#B!G8\AT;:#(U3W-6QF;;P!7MG\1:FQ71\_BCMK!NH:K^6+SM
MCT>J;;%RD:?I-;\7/Z;L>YC^(4*A/YPX2L5KK_GXS@$IOQ"MHE&>@0_&'_GD
MEB?K;/XECH??PO'X8C*%.(H/V0"B]]E8:/CYK\0K/L1I,7YW-/"L#&:;AB]<
M9\UR;=6QB855<$,H6[%RV\"S]]2@^NNTX';&"6A>1&F6Y&F)%;>8R/)?\:_Q
M^"M/RKGS 1C]Z<X!OH1%+%G$]C2D:@PB7H(U^-LECF^#5G0I X_SD0';!KXF
M;ASDW4C/0@N:9P+^2)/LCP\@$??Y[#LPM@ 3^"GUPS%0%5VD2< KL"&F7:0Y
MP^A>9,"=<1!.4C=,)R$@?0@ S^]919DJTPVL81 ?2@P#V[;C(]_$+D'(PW2E
M4K<-!.M1A\WX-.5)(#Z^/JOA8>1:%O5U7].)PY"MZJJENL@ENDHL?16';!NX
MID06W[3\QI!7J9$:Z'^E#?%\Q'1?F'U=(V .F>M2%]N>J3M,K-!>L6#+P#46
M%&C?:D=>$;Q4.("?\^8BD/-=W5P/7%979Q9VP15"U+<= #.%?ZF&XR**5FS8
M,G#NYK["S]U(:QDN7D"K9_HPB:[*#$(0HRX$UM0%,DQLJ[97H'7SP%?3NH]/
M_Y3,#5ZOJU%$=81, I$'1-'PI::N:AZ&J,OT"MG.;0-77N]1?/J="301U7S+
M]53- F_.\2W#UC17\QQLN@93"[[NEH$O(O")FU-*7W5&+*?LBD]GR6 $.FSH
MSA+09_,RR/7B48]D8LN$><#,9+Y)=,NS/6HZ6+,U["//*V1.M@U\1=9Z$WW_
M?"5]H#*8I6G@3;F@4 F!4,L1)L7!$(+Y_DKE;!MX /HJ$D)[T4=4QU4M'3[<
M5XE!-:I!Y&6 _\@L A)FKS('6P8>B+[7SI])/%"&&C)\GQ)JFPP3Q[(QQ)/,
MLW6RFK]M S?0MV/1:_G]HG@-_FV<9B(. #O DZ_A@%='S2[!("XJ,H6"-TUJ
M4E#YR')-!C#S"YIDR\"5\?^<Q,/9()M[H*\KY3VE"CQ['LVJ:;&IX2,J,L74
M(LQGU :_U,6F!W$O!'^KHLBV@;O2\O9I#?ZQG3E]_[-879"W]DT"($[)E[2\
M&^4=I\)C/U\ND7CS740[\\NBU14 &TZF8U'K?_OT&?/7%=^1_YC& %7Q4][=
M_6[!T#E3"@S-.Q?F0WA>&Q6_6/Y&Y'6S\"[DB9*_CI?VHCD7?W]:[5R_.7_'
MV_67+-XQS46H^-8T"Y),5.S?+[LYA!^Q?JUP Y\7^!?#K7-LK-XV7 Y>_NKQ
M?<M?+#BSA5&/,>8R)F>#/V?AW(->Q5M7010FOXSCVV#\:SP6VR.E'SXXBYCK
M6*Q^Y.,\:Y#_:OZ[(;SY^W0<#L(%<I5A.!$R(Q;L+J%=0>#9^[P&NXG"G]^6
MOF3^36^??50_(/$I"<8B0S//&<5WOX;WHZMP>,_M)(B&:9>PL1.I?0#)W(W7
M/PTR36VBAITOZ,GFA"/U7%,?'[FX\DKI^*T=EL4XQ_1T:F09"36<46(IBE&
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M (>B2U1/WJSAV]ZLRT ]+KYLG&N 9GPZR5J]>ZDM3TIK(+B;IP*DU]A"K_$
MBG'_ $(JQA:&!K*GKQGSW#A#(+?7:$CFLWYG2+9BM<G,-RAI\#*_0&J&UG@#
MLGNWF=[ R3NJY(Y,#4#%P3-A3<R0',X9>IF?*SVAAB0\ZH>"W >T"8[-052;
M7*'64BD_0-]/PZW<8?K8&D[T03K$Y7+W-LE]@S*@A329:/U[Y.$O/+Y/@NDH
M' 3C'#:#>!9ER<,?%U[3\2#Z[RKI.'N_(.3=A=>+1%9A2:J8X,4YE(_G>1:.
M?H>[Q)&A'X-H=@=_Y^>5MD,#B!DO(VQQS-P&RHX#@=.?!%&4<0F!$T"@65I
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MY0=X'LR=DL[ 5*2C6#0A+5M>LU&0K5/Q+7CZJ7EC8W[S@I"_S,/4'W"!VEN
M 0RZ_1?0(F[*Q\.=XE,6#Q.]V&G^)?F7B@# 4I5A\)"^V:7%=:, %'0.<@#_
MINUC&Q/;UBW;-2DR#%6GV&(>>9[^=&9) I\V;PX7*B@+LEE:5\[C[/T_>5IC
M>F-9I=VM97=CX_WCXK.7?\7S/R_C/;J3MW^>OD?#;U$=T :H R$7(!*3,,M
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M[@2W>[P%\':&*[K<1[Y?JK5'I.YW[A/0=Q#B#RC?FF4A9CBVZJ@^09I!'<_
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M!8'8$A"1.'")>%#1LXMLF+? /D+W"T<5NG(_I0R8DD@ *K@1@CN#E'.$:*M
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M+IVO161[(4(.VRU3NM_>R0C;0X3MLZBM5=P'DDO*63 9D:4< F$H4EP!8!P
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MVAG+N(6>K@V;%FNMMYI_%U'3 =2\U/YM+U'%6>7W95A0P',G3\"5\MH*:DA
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MD\5,TH(73 G&"C/ @NJCBCKGV"#%F49(6PLLR+^3_K $S\WK&2:V5MOW!>@
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M!#V FN5)!M/I/+S-73'C^6PZ"R_">+J4,?36.CV#543%66J80QHS*ZC'1GK
M'&>(:T&-)XT<_!]+(12EW:8?BA5_T>%0;E LBK!G:EAG8B '!4%<Q3@LY9 *
M293BAE(OA$7(:&Z4)9ZY9N?DUT#P@4$=(7CX"7B-NB1;$8A["3I:@0XC+X71
M EFCJ+9:0<X\T]P*KK$ C1X@M1H*6Q-ZC1.A+/9Q/30IMI>XX;@JG<6EHDAY
M)S@-_V+%+#?:YYFKF&C?T!=7QLT&DNH1W+098G];F?3'(E/A_GKQMS:<X6"4
MO5\ZAA#X_2^U\?6R/)_A%2-\2"!/CV_=$:SGQLFR).WEQ4G2T?<\J3ROY#_-
M2_K/;K+$C$<!X-,@X<*KPNU>',+V00B.>N'GDHM9N%!4 #]M3&(YMX>3:L[A
MW?.3WG"*R<.V!,7?F\GR%^[2S]G[JTF6_OM]>AV&\W,Z_)I^GX;G_/%FLIA)
M6H!VRB0-:B/7T")'L5$"D2"5.")8*NRMSK^3_K $*V[F0VZS%C4MU#T 6'9U
M77[XM7S<U7C8SPWZH-H./H\34VYW<C?L+9?FE62;O$\^A(U/X&-+^\S>;YN@
M'YNT^_3IPU_.$W/^VT=U]J_DXZ_FS?#VR/#,^9EU9Q?.A@&>79S_^L&JR_#F
MXC+\\YL[N[Q(SGUR\5?UR?WU_%?K/ETLLUW=W_[^X?)?[4QE3>;UTV"4A,^'
M008$73C[ULON9E5-OB2]#5;(;/J'MQWC?)3.^X/ MEH>1^W[/R@>>3Y5\?U!
MSCO+]_4'C'+I.OQ!-X&@U$0*<93TLN%P\>F?WH%WQ?LP\-[R_2-SOQS<!J9]
MEGU-/HUOTX9&=IM./@]&Y?#2^6R\O% J>,65KX/^[";<'2:_B+8&;C),[Z;9
MS\L7OSP4S^_NK;I[%0W*=T\;?>4S"/O]+^\:ZD'Y&7_Z(]CV1\\,H_5GP?9_
ML2,/6VT55PZ5[T'@:R53A77I'-"6)->],Z0T/@J)7UH@CR_.9/QU>W9<5VU6
M_&[U>6^#*%X!CBV12:T@24$B126PXM4/Y<!*\GFF+&(DGZ,DGV5]FX(^ED5N
MBC<_U8MLVF?K@D7:.4K:*0X1;)*Y=RCJR'%N_T(O.6ZG^8M9=P>Y]:IP/1QE
M2\!E\ETZ"T*QE]U>99,$PY,$ 2C>.C^BF^GX$DM*,H@ JD(Q4 (DM=9<&PH5
ME Q+*1$TRF"G7/,P=,%JSJL0\"-!&/$W\E^+^__KWF]>9NOGFO!X5#32_#:8
MWM]5"_#\5FQD6T$<VFHA^3VK!W3,&4&MB[WM[OWNSAJ]M.=[R]00K!WX5DHA
M#!UDC"*G%='>0\L%(1ZA52H\;)VKK=\=@R"XF]K[D:E%IA:9VMLR-0(JIB8=
M$H)#)#"ED!N-"&*<.  L0X[NBJFMT.J@-68GR"F+G"YRNLCI#H+3/5X:?LGJ
M6,7JC!*68<R=%X(*!(2$6"+@/4#,"=YHK;DE5O>PXOSK^-IJ]>0%%KNI--T$
M^-9(YJW:0T2&&!GB7C'$9_FAJ/BA0 P9F-<MI(9**B5#VE/LG-;2.^G7Y8>M
M%"-C3+1;QV>_M+3#.?.C^N.[@@S'U\DH^UID2\]'LSQ7NG#VII/^KF),VP7?
M_5&T_<GB/Z9 WOZ=?HD$%0DJ$E0DJ.X2U H&.":B5MU>(2>=HI(@RKS6A#OL
MC6=$$8_Y"A5SGS# IY/9?YG2?SCXDKGKZZPW^QAV8MP_OU[J'X4-OM*-_?^>
M3V>Y&5]:YITS[W&KU>/6LN [9Z1'/M!U/L J/@ E9%)P!Q&W%% K $=".4V\
MTPB[];H];9T/1 AO!N$CJ/ATELV2P3,Y^+OS,W95D>Q>=95C=O\>8H&C2)N1
M-B-M1MJ,M-EV[(B0*L';20P-M$0Z1BBG7'(+D:;08Z&4(HU8>M",RBR>7\?3
MZ0/MW185=N#?+NU.3>UGU'.&=Y/@'<$;P;LK\+(JD=D0SJ#DRFOK*!5".H"-
M!BP@5T,H&CE_JX$WXJ[38=T-*:S(RDQZ];3,9!C((89NN\G!CXE11X**!'7@
M!+6"AYW"JH2L)$P80J6&6E$$C':28:X4)T XZ]A#"?]4SGTN\(/T/[^^3+\]
MVJ3R8SH):GE;"GWKIP!6RI:EK1X'V ]G?$1[E]$>Q4<DJ)V+CUH%<B0A=<XQ
M)Q2ECC)!L)8$,FZUH5CL3'Q$-G\$,=?F0^KE/]\75S9<FD_9-%!=+R]T-<US
M"9*[8?I$,ZWC\0A17K7:,=!XP T$5FL*I1(,,((M!4Y920QZ-".C+%9HYY,P
ML3)YHBSC4:UV<9OZFD[Z!1?PX\EU-IC-B\(;[6B,6RKQ 4[10?NAHO_WL/R_
M,; 8:3/29J3-2)N1-B-M1MKL&FT>SG'6W [)1M.B'7-N02P,RC)E/$9#.\K[
MCHG%=8^@7O9%,%%EIW#AC;?>8H8MQ<PKH@R3>6H*@X)P]= 749W3F%Z.59A:
M_NOI\&,ZZ'\8F?1N,$N'A6-"I].L7\=OX38X+Y'[*?N?^6 ZF&47V>3+H)>5
M#HU/66_\>53\XBX\%NOFS<!3<0A-Y2**NXSB*!8B046"B@3578)Z6<_@6-[K
M&80#J:T'&)&@9V"O!1/*6P(84%" QBG4M]8SHIZP3U'-MLW,R8,0YEL[@+HJ
M&KKG^XA^N</RRZT@96I-R85QA"!OJ2&:(@>$<AY(2QS 0"(JVI,R#\+N?P_"
M8L^M6A*C\)$S[!%GB%(KTF:DS4B;D3;;UJ@$KN(#"B@!H/=&:T,1=]IH+C&S
M&"(FJ&XQ/M"N1A4UHJ.*$Z?3FR3\_"#PA/[T)/D=.(4RN<LF29&6&@/%W10=
MQR0AND=0*QQ3$:S*6F?8<\HYHC9<180(A@P"5"..B",*/Y0$=@G'FK6:X[3+
M1C!JM]?D?AQ;B2CM,DHCVX\$%0DJ$E1W"6H%/4*BZKBK-5P;:2!UG%("E69>
M2*T!LD 1B=S&>D34 ];3 XX@T%L>F4R^#F8W-]FP7\1Z[]+ON:Z9=\S);N^&
MX^]9-OW/\I;Q,!]<,DN_)<-!>C48!FWTK3UD;X]E4MD$A'FJ"? .&T,M=9IZ
MK!007!!JN86/=Y[/G4%^/+E,O_VS6N5PX7&_4.</K\+.MO[KG"D1?<6'QPYJ
M/3\5XYA1)+6T)' "H #A5CBMM##&J>?"[Y^RHA#1Y;A#7&%M[:'5?@.1)426
MT"&6$$.;D38C;4;:C+39MBJ5JS"UHF#>.4BE@=A3 X#&#&"HK(/8,=NL$;0-
M52JJ0F_A8-D&?C><C$Z'Z:B7)>DL^2V=]&X2#$Z2G$QVY*OM<I-O!$CM-*TE
MG!LDL!&,>@FUEE0YSP7G4$EE'_>'G,]G17/F,.M'6JT%+';#TP$Q:[=)>"=[
M@1]!K*$C^&R#S?YN@QGN+<.I>5P845P$!4%S3_/2TS(P&XT%5YXA[UW#X[)2
M<\=V.<ZZJ@,_(4"VJSY$AA,93F0XKV<XO+)+*+*,*@NY,)1RRX1$T#E'/4*(
M2]S(!]X2PVF]=OUS?7)D5'LB%XI<Z,W=([)B0](9XTS>2<L3:IT3CAIIB%'!
M[@*J&6G:$AO:?OMY>,(Y;[60P%J^DK<C]2/-6(W,JO/,ZCE>!6NN7*VH\8)I
MHJ6GD"L!,562(">HY$XUNG>NRJM:4&WH"0>@U4X-W=1N7O:\=B&J<I,5-\J[
M;]OF+F\38.GN>L0UJ-$$CC01:2+21*2)2!.1)B)-O'H]#N=8_5DV2P:%,S6>
MH(]NV;>V12)!18**!!4)*A)4FYY*)&J-S"DPR$&)-0144RNH-@X@JB!FDEK]
MT%,9](.J]>RC::3H]2=R-HNI/./L;#>,&P$7 ;<6X## M2QO2;S&3DM/*!%4
M&::<]1P 0<TCH8'5 !>QTN4C[1L26)'N$G:^EN^ROHVV1^<GXMF>>+8GTF:D
MS4B;K2LDE%6MZ:GGQ#,H!,'4:*:,!<X):PP1CN!&FY:GDB]S_:3H0G^9?OLX
MGN3/5+/99' UGZ57P^QR_#&=!,V_+9MAE^F@&)S2@RX+&SG 87& *)TB;7:5
M-E>03K(J-P4%MPXIXI$E%! JB,$00F$A]LC#G4FG*$7:,KUW$@5M/J2X8S *
MH)W]_+ZXLB$=7]3[4B?9MVS2&TRS?@R;=E-,'),TZ!Y!O<ST":K2IYV0QE)B
MM'&>8H $]0Y[ SQ"W%)I'DV?_C"=SK.^G4_"Q,JF$?](A_.LWAO2+4':EA&R
MC4.PX!0?@A\VXK'+>(P,/A)4)*A(4-TEJ!4T!L&K+J ,6PTMT  :ZHE5' L)
MO3&**R9A(XVA/8TA2OPN1UZWW35Z6C<"W]IYU54.WSU/1?0I'IM/D:*J9)NG
M)!<1V.E@7BJCM,: 68,U4XXPZMMK<%@7)>LU-NR(40I;%5&1(42&$(55I,U(
MFY$V(VUVB3974*1JE>$@U(P28!D3B%+O)78(.@R5@ XQUJA]^]:*5%2$]BF&
MV[:M/KGO-EZ:[3%2VTV9<4RBH7L$];($8+ ZS:*%-8IQ2!B45!,L .&&!6/;
M<(LA)NU)@$_WZ"UDP=\#(]]SDYJ<HD-P^T8X=QG.43Y$@HH$%0FJNP2U@L+!
MZ[Y["+%!EGICJ19: JHA,QH@3PD3K*L*1U08CBI.G$YODOZRB_E)\CMPBF!R
METV2HAG/6SO2NBHANN<.B?[-0_1O/EMSGH/:Z1,I!12,80,9-1QIY!$Q7#CC
MD>*N<?K$+B%?,QAS7M!E.Q2)4QD;]D7 'R;@HS"*M!EI,])FI,WV%256E9'#
M4 K,D'8.&,HT$MYC"#33U@'!;:.JU:L5I:CHM*SH'$Z@M^RHFWS-^UYGPWX1
MZ[U+O^?*=#*^3K+;N^'X>Y9-_[.\I6R-G<S2;\EPD%X-AD'=CJ'@;DJ-8Q(.
MW2.H561 K4&;-EP"Y)2#UN6E&C0  C+/I5*.>D>WW;^^(_8T>/O6;9VSFB..
MHV"(@B$25"2H2%!K:AJ"BJHC-70 (VFPMI)RS20*&@#V$C%DM3"-T[[;T#2B
MIK!%LW.GWJ(-9ZG383KJ94DZ2_Z_^2A+D#Q)<BIY:R=9IYNEBMHI@B!*C)8,
M24()-<YK;IF7P.1OE&RBN;3WS^>SZ2P=Y;-^M%<J:M$4*(+VT_62-C!KMY7\
M4R32S2ZLQ^P6;ET&;W?O=];H^<4]WUNF)BL5A1,#%(->"FTITD1P9!#$4BI'
M$.:-Q/@5.T"WR=7655OX29CN;DI91J86F5ID:F_*U"3DM>3;8& QAJ%'@!HE
M%2<P<#8JO#*8F(:'=TM,;9>EWZ6,G"YRNLCI#H33/>MBDKA>4$[CP-*DPP)3
M2FU@@UQ31Q20T '8.-J^)5:W66>\:5B]<.UY _6$,]&J(ZK=Q(BW T=,#XT,
M\> 9XK/\D%;\$%L%'!,8!BY)@1'*,$,A,QX*HL+=Z_+#%E0T>L(1:_5HU)YI
M:2_[U'<8Y+K)BAOEW;=M\Z.MQKNZ.^TCFNK]#N.XPX<YU;C#AS[5N,.'/M5C
MW.$C.,-^ELUBE^GU)AG]M5U.?XNT&6DSTF:DS4B;!TN;+_HV,415$4ON@  $
M.JP-IX1QR:5TD$I+ -,(-OI!!,VH:BK[:((P?OU1I,TB/<]%L-%N?*,1O!&\
MNP(O056O4 Z5A$1*12GE@@I-.>3< TN%PLWLX=7 &W'71MAA:R?(-Z2P(FLH
M;'TM;2@9!G*(Q\"[R<&/B5%'@HH$=> $]7(J%H:R*L('I 962" PEU1BJ[4@
M7@I#-#-8"?=0PC^5$YH+_"#]SZ\OTV\?QY/\F6HVFPRNYK/T:IA=CC^FDZ"6
MMZ70MYZENDHV%T&MUKA9*V.K<TE9$>U1?$3Q<3 $M8+X0+@2'YI2BP4C6!M&
MI67:,:XE5\1YC)DWNQ(?D<UWZ.CXMF*NS8<4=PQ& =*SG]\75S9<FHMZR^DD
M6S8H?VO'6%>%2/?\)M%?>6S^2L3!O3AB"GM'%8$<:2J#06.Y5I(;XX"@C.%'
M$ZD_3*?SK&_GDS"QLN?$/]+A/*MW171+1M"6_;*=VFCDH%VB$=J'!>TH=B)M
M1MJ,M!EILVV5"*.J5HH%3F)HM2=64 "D9@YX:!4P0 ++T?94HJC2=#G*^P;&
M]:<'/:*3NV$Z.HBP\ J0)*)FI4#O$01,4DV)IH)YKXSP ,. 2MZ(N3P!R;)4
MVX-.>NIK.ND7GC0_GEQG@]F\**ZV?:ME@S)NX!0>0NN]Z-CN,D1CI"025"2H
M2%"1H")!18+J*D'M0QARPUVI%T OVBE-ZS''M_;?=)4BNV>[1[?:L;G5"*UZ
M\@5[G7#IH4%.4 JX4$0*Z)E$0DG,V#-=$B['*DPM__5T^#$=]#^,3'HWF*7#
MQYLDU)UNG[)@GD\'L^PBFWP9]++2$? IZXT_CP9/=E3H3'QR)QT"(T.(#"$*
MJTB;D38C;4;:[*0B16%UQ!0I!JT$09NRF * E8!":6&4) XBWL@@?FM%*BI"
M^Q35;-M6GSP(81Y$]'(/_431\=AE@EI! A!6'4&TQ#O*&&%64.Z-,HHP([&
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M":$4ERCV,C'&VQ4,MZ+A'XJJ>-&G<8^@O'9/@!.6<)QPW",<IUW2)%!)H))
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M,_%FXLW$FR_G30::H[S,$6(E-81 2)4('S!QLX@2%!.OU?V[0]WSYC8;!B"
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M@(9$Y B3#([+8SWFJIL/ YBA)O2$.=3"4VLXI@!):02C F'G#=+*K%2\_2&
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MI QB@1B6F$I% $<"T*XX"LK_(IUP%#]>CEK/68,;/XFWEI2^C]N=TV7.^*T
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MLYF37-UU'L2O.<?=GA5-O)5X*_%6'WF+@H:W'/"<Q1BWD89:)"7V0'HO'0/
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M_)/W^6!4%6V8#HMB\B8?G/^@6\\A=\Y&@+8Z;6&B!33(:"^UQ1*;6)XOQA2
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M#XMC^Q#[OL^[8I+OD</Q6Z_7VW/XN^-P4?<%"4G(K&%.H \L>S.@(#>(AH
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M]%.A&.4UR&>+=#"*LOB>YF2?L4=90_A2UFCHNX:9OO0YH&&H[7\A":T9'8I
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M\EOSAY+LOA14=PAR[86RW0])<'4D&R;/I7"%D=-%?*=VVCL\8J$,U]T]A0@
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M%[<UI;F?;TS'N1^LJ2_?*P==9/^Z?,(D=L>IO6:P@@6T81@0#EG@ T-\1%7
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M]>>K=K'ARBBJJZG!8'&]*/P#1>7709-.RJ"6CKD+.MZ C=T;[;!OP%81:M^
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MT^3:H=KW<;*H.3WS;BR:E1*@Q/W+\32:#BHA,9A7"%(B=#X<^Y+\5&[NS?)
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M9(:]A!.FB'Z.AU7;;6\>#T93.]>KV^.<#A9%:^VR3$IU53Z%!SPQFP? 'DZ
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M5N]TAYA6^\/L PYV=L^\6/F+G7L^=1D4:1TFKZ@Q.D"A4W:HL7J.)L)'V)#
M#QD5+83YM=2!AN3A>*WZ"@^NH]5[/D#HL>I]8A6O4P="'A!IB& LU)3Z4%*H
M&".:2$%#IO"^'"^M'&]*(-L-7.K1JT>O'KTZCEZ-\$U!(=>2,DT#3J'4BNJ
M*VF5+B50*)Z#7H]XE%K1M)CH-:T>JWJL>D]8A0&LL4I+IF5 ?8$!H<#G6FL2
M&NE#@(4,@[U54VQ%T^(,G\IWC5YOK_-Q15->E!/5SKN([2X.DX5[XE[<V]T
MJ$=FV64@PJQ1PDE#R%6@I$340%\+P#4C%I6$KX!8*>%T'WT^Q?.7:Y),C@64
M>X2>-=O9607I?>E!/9QT&$XH[3U(/;CTX-*#RQ[ A==Q@8P&P)I(&D"M*>%*
MAQ9ID(0 4* !0>WH*JTY>3C=IYG4PTD/)SV</!M.&F'&O0_F(, E][7\/(_L
M8*KO-Z6*1YY<+-RGQ;4=S.#.U";C:7PRBG/8@0C\Y9?MY[KY>)[S_F;A2R)F
M/W8?T-]C+W5MR8?QT(L:].O%/V9Y(]+DTJO&^]RYYG?]ZV,\"6%] BT#GP56
MK!N##354:4Y-(!D H=265<U]GFQRV^?+^VQYC_],82O\[=RT4MM]#?\5$L2N
MQ\1^NL>,SURXO%[+'A<=P1H(J5&"D?^?O3=M;AO)TH7_"L+W]@U7A*W*?7&]
MMR-R0[=GJEP>V]7=<[]T0"0D<8HBV0!IE?K7OYD 25"D5BXB2&;%C%LDL>1R
MSG.6/(LBJ8(4<*:X$_[_'&/2 ;6:0K7.HO_W5A8=07E/R=UD.PONWYN,K_)U
M%WU\5>1YM6L#S\')M?_]JDQRSZ?==4>TYGU?\]&XBF"MR1&Q=TG8A#6?]LYC
M0SG*_5)_S_NW[W9-EPOQQ(8":HB0TDA#E402>[J4F#CGF+.K=:=?2I=>&&\+
M#,0]CH,# @/<Q"LR!AE+.2)"I50[JZ605AF_WB9U#JYD4:^SZ%L" \3O6?4(
M!H^#@0A@ .56P.!L?25FCTK4_TS*<>_B=M,AU!_#Q1]Z8__DCG^"^^YO*,>)
M#G76O#+UN6X2ML]AME#=M)/"FX45>]5\LL@>R9Q@DQFMODMN<H]7?@"]BUX(
MN[\>9;TB9&HD?ES>EAD/B[*NVNY_'0^3X:1(9EMQ/MV*:;\V_ZRK7N<JZ95)
M]G X?WT*ZK^H'O4\7GGSYR__6)>WR_PR3.<L^>;7Y/XYA=%VPF:%494>'LOD
M^[#O[9<*93*/LT5@S>$@F-S^QC#9"N?K.?2'P9?BIQ=4_>_Y8)('B,L[6>G?
M>D?_'\PFWZSR;M5_MG :"8Q"PEJ;.N"4PT;0U#"><H-3YL2J^A]&^G$^4'.5
M%9?YPY)^GO2C)Z5?R=+;[?^:],I>&%.5%#0J+H?_G%+.E(>G+%RG!,T?\'7L
M]R6\<O:DK_4.ELUCOOSCLQ_.==;))Y6]O<52/N">JO-;U#;6@_46X-4.D?TO
M^2!X"C9"]'T+OKW ^7],/&0A^1(D#[J7![2\&&<>O9X"Z06,[%P%@"L#YHW\
M9H51!7"L\_MZ,S@, PT5=_*Y,.@/;_(B/,+_XN7$_WC]QG_RV'B5!!=S&48=
M7"&A*>@PN0RDX%^97!3#Z^J>:B#[AE'1&/36,JPTP)QS1U-,I;>7G!(NY<ZK
M\F@E$7,G,#KEF"G#+%S2)BCU)L0JE&[)A)A*WB__F(OWPT6-'2#JQ\%[SVL=
MO^')E_^378]^LLGAKL^V4?6^!5L7/!9A:0&-.C67[QB5%MJ((0,A"=V!D0:4
M<1T:BOF_#1%68,!60\WF8UWU*WP<S,1")16>.M9M_ YSV&F>\+)\\8^#SS75
M?LG+/"LZ5VK0G?8:"T/=&C*1W3DZ_1[-A.O'SS/>J^,^9_+1?#6JDIT->I5)
MMQ'T:[[ZV)PA76]&+>L=,_6AVQ!%M9)%?AE."(?%;3+N7><!4LHEB1#V.]!M
M;S#)ZO.\_6IV]X/B[.MED%P83\>/(2^6S@Q7)K#A:6\"Q=+R5?]>%;-'C+++
M_/UYD6>_O\\N_'@^9/V;[+;T+_KQJIA.):O@J@0*24!"'R5*J4<GK1$VV FG
M%+9<T7!/=F<-GKDSR^?::^W$-.H= ):?7]0_WM2O.Q_VN_YQG_/"OVB8&*_I
M9H/;9-3OK,M9[Y./GD42N)8LW,IL0R%$KUW3YX]@%X3^)+GO1B>YNZ^??OWF
M$IK\G_\E$(0_S5'OSN'UP\=MR]%0WSU7>OBQO;+3'Y:3(O_F;]/]8>?W-Q47
MA(]?\WY>"9OWS"+C!3-+"="46*DH0XPC8KE!AAKP'BP<U" ME#6*$D&Y</Y:
M@HR@Q/.35835TMBC6MY5XQ>_![Y)<B\R1P%BBDF^EBIU=UD_?OJ;^_3MUR\?
MW=>UV.2>1S:ZZU)D04TW:^W8U\Y5WIWT\Z#^3/?.3(K"__4M1$,\NGL*.,R@
MT\YA23660B/!$??JEU#.P]O"[B'H8<YJ(%)@*9#<;YB#U%+&9(H%H"O+OR2E
MUJ$=^(1H.';]_LV?*_6R<DT,!Y5VY?7PWFR;D^"/\"J95Q#[E0/BK5<MILI?
M^<.'M>8QE<GK#US>$R2W\.X[,6Y@=+=!:_B\.+A!4'S[=R+&(*CCPZI('Z^@
M]OO37__O&_"F^NQ?V9E]OF>\W[Q652:?\IODR_ Z6XD(O/;F3F]0#R^;C(>S
M+^H P^J;FUYW?/6!RC.*!1<$, X$E93]:18>Y05Q/QN5^8?9'RN$\F:>%S8O
M"R;>/)PU5K^1\#_]-+MH^3?X\$^(K'7;>C\]\V5/9\8=3TSH?(?Q'@J_O2!/
M<(7SUU"W[Q%Y]X295"B[&&MR6D'")TX0-N\LT .&<WIH+.P=%8UK9SWW$#!<
M>A4NN1P.'^JZMG66>'#!IC17B=JU2P>^7K#Y!HG^Z\UTYQ'H% B>0\!04[%$
M0RD%X-0KZU09*8Q&T.O-2 .2,K22+3<W V:4%=R=NZL(QZ#8;HSY3DDSEBAY
MK727"$M'"$N+Q\?.F^FII%1S$HIR:V*94(1K95/AT$H'^>?"TI:27R@&]YR-
MG PLK5%[I)WJT=^'Q>_3(Y-PGK9A<>W#*IX]9;K%ZF500@,E$DP1_ZL2# $.
M& 7&2*? 2A+&G.G",LX/)7>F"WCNW2K3M5:J'X'P/FJ>@0N]7+%U-H7**LH!
MQ5IJ2HSD$% IH./V84'U!,]L*TM3L*WJSRT7.8=LJG_);A*_C7GX<=<=UXZD
M >.4'7'#CH0((A$5"$E!-0IG@3!D$PGJH ;N87;TJ__+;/%W)\$$>-66*^VK
M6G?*!FWDWGNY=Z%]*J>8&@PDE=C05%GM;4 A(6"  &CU2CF$9W+OEF3IUON8
M'ASW'D^?TUG-R9I^>EMHGK*EDBL'YHO:0CV65OND()>-3XH2Q!0SB'%+)4+*
M,@29 H BY']9:1<W1Z=/^7B')>,@ *];,JZ=/JD3,*HC&ITZ&BVD,A@'F%72
MID )*K 13$'$)'(:T=3H>ZKF/H9&6U*1)./;]8L?)A;MK%[4W<C\-2M(;1R%
M]T1H_C2>7:<.<@V\?-2$IAI*9H1D &.DC)-T)9[]U8.:V7:"FM.L5_PMZT_R
M)JBY?#0N5@LHN>1*:@DH84PI8+#CTJ4X-*#%BU'-1/N+-%5$A*XB6')K.'*A
M6+:R*'@7'XEJ?O(]VX]J3M7'+\G?U,^_N>07I[[^]L7]XCY]>\4(YR>"@I^S
M))NL*#J$F.*MQA#_.DC^(_,+7MPFL*[Q5"589]WA*&0@>1H(Z4WB/<0?DL I
M2<4JR2]Y%ABERDQZ^VTX\NPF$/CA0](P4>+EQW5^,RQ^?V^FR4WC897YM7#-
ME_Q?DU[]G#II^Z%WO)F_Y,T/=8T+__!!M[ZQRCCKE=5H_0U>K4NZS3N*Q7?X
M2^=/6LS[KG*PK[VQ'G*LWTVSK;)R.*B&]2X9%]F@O,B+,CG/QS=Y/DA^#LE9
M":PNK?]&(0 [/.@B3.)[-8FK7EZ$%+_;=W5JN!=PG=NZ-%#O.J3"A5M6GMT/
MSROK883;PK-JGIB>=.;U:M7OQ8LOO&Y6K3Q+E%>0PGU9/]3=:F;N%:?RP36:
M%2Y:R$F;#/QJ]#W==)/+K.<7)8S,WSL;2#4WS\O#D%T?$BFK-/MDZ+^O(]2+
M_"H?E+WOH?:(_UR5#@DYI9.B2@A\8B+)5=[O)MFX>H_?]ME"%_DHE([R#ZA?
MWJQ87:<D?*HA*.33>QTENZPJ$9:>@WL77E_QVST9#,_+O/A>Q8SW!J.)?]VD
MK*EBFH#W]#K_W>^T?WY-E"'Q?YH<Z=\5$KC_-?%OZHVS4//HB8<M[$K%,'ZG
MMC2AEN6.;R:LZQ3;*41T?QU\F9&2&G0_#0=SRM)9V2N?SG41FA'CH);0.6H=
MEH9*E#*+$=348+D@TQU26$.+G-$I58+K5!BH,#<8(F>?R%1Z\CVK,OV%A4NV
M+R("V-89%>>>&6Z2<G)]G17^@G()FZ;$?M$;9(-.K_+/E7X2-0=W,K\?><7$
M"X1_?ELC[VCD<;%ZQZSJ1L<C\V7EVEO*7%DOQ?]!I?D8TT\@ )OEFR#Z=,()
MV'9ZR'H9+/%=\5VGF#ET[/.;8Q&$>\B$V5LB5+)<:C?N^O'N^BS;*<'P;A61
M%YW9'L_N'_O\3CRY;^HQB7M_LGN/XMZ?[-[CN/<GN_<1\T]W[R/FG^[>WX?Y
MSS9H7C66?&OSG_J%W_QY=C:QY/$>#I)LX>#K/)Q/?%@GM.84(NV?Y)TC7H23
MG7C<_;C[<?=/<^)Q]^/NQ]T_S8G'W=_K6<_V+: Z1FL=X^;0-_(EU'P$<SWV
M^<6]/)[YQ;T\GOG%O3R>^<6]/)[YG<Q>;ODL8U?%-E9?LAC9_K[Z9B/U/[3B
M^YZ7XRJ!I0R'&[WQFD4YCM6V>]6*N(^3PX9;_=I%;Q^<S*ZS]BGGE.>0BJ;<
M-F;&< JXH=A1EVKMA",$8FN)=BXU]V7MUVQ1WI-G?']5D7F?P/D=^G;^YU]G
M^835 >N=MH+S:SY6.5_5!7"I4^K"(Q?2*].0_I</.K?W/V_ARG*>9[6U+H7X
M=2KQ/I<E8LFTB'BGCG@,-)6\H<#"ZA0R:2#%0@OA-)7^.F<PXEJU#?%0"Q'O
MWWDQ[&;E56 6@2#Z*0)>!+P(>"T"/-0 7HJ0,XY3:!FA1G+)@#"8J100 [B^
MMXKZ/@$/1\"+@!<!+P+>BP"/- 4M(!=*"2>4EH8:+H0$E*?:<@NI,GAC#2_4
MICLQFY:=L8AX$?$BXK4(\6A3"3A5&"I+J:504T*E$IPBIP5(,<#8WMOW?)^(
M%VW:"'@1\"+@O0SP%DJ?8T&5D )3(0BU.E70*:HTM<X"2/&]I<_W"7C1IMTW
MX*T7BGK !]CIL,C]^Y) )X&FPM[?9$6WHO6PPZ_5?;EEZ'^<G>!F&"D;C(16
M4YEJ;93R."FQDMHY9Y6!D&C@Z$HIRII@S)1>C(>&U&_+7_/N95V=4HWG4'2:
M![V[1,S6:H*1Y=O-\APV/1BL!@I9S^RI3BEB3*8RI2F$QG!#$5CI5]4NEF^C
M5;CD!Q-;[6P3>3[R_'H\C_F<YY63$C'H+%:"IIQ*($$*6#@"% 39%5.H73Q_
M:H919/G(\NNQ/&U8GF&7*LR<-3:E3D.IM68J-8I"*3E?.='?C.5/X;@KLGQD
M^?:Q/&=SEI=2$4X 3!F U&$B +8$0R<9<LS*EK/\ 6CV9*M1VY'G(\^OQ_.R
MX7F@G&$HE< R23E&6DCB9;RW[06$"K!V\WS4[-MVLG'D.7N/G#F98EB6[^<G
M(>5--HIGXNN!ZE878=]H*Q;"I 7&VBK--1" LE1H:(!UE J+G>-J)6IP&6VG
MIVH5T,;4N),\8XX <G( LA!V+#$F/$5>DV*(:F>T0AIR!E*LB"8"MQY #L!*
MXUL]?XD($A%D[PBR&,9+"8; :8J$H\0@D3J=0FHL%Y:F5K8>04[-YHL $@%D
M[P"R$!9K=8JE5(IQRJ@ 5DJ1RM1PR9DED#X9\O5B (EG0Q% (H <.(#()H#,
M46> $QA1@6F*G')$"XF"6H*%>/ID>>\ <@ V#&*Q0%"$D*."$+D0@^I2PKT"
MXA !G%*C%60:0J2 QQE 5[.O6P<AT8C9-X"<7JZ.7_PRR<IRV.EEX[R;W/3&
M5\G'LLCR?B\I/546V:"3)_U>=M[K]\:W\>3_Z$[^)<%S#-44.^* U)A#FI)4
M(PLI2)U$VO_7N))'Q>7P0T4\:DX[?_>D,Z6<S\-R[*Y'_>%MP"&=#_*+7JS;
M>-S1 !$&#AP&6%.<U:06:J:Q(*FBG%%MF45"D> <QI#+PX.! S#/(#E#$0@B
M$.P="$03F\+\5U":%'!,:<J!0,H90RFVB"(EW.$!P:D961$&(@RL P,(+)0N
M-EI:)(6AW$&**9-4 6LX3R&TE.I7@(%XWA-A(,+ /F  -8%F!")M(>,0$4 5
M4Q([B@QUP@ IN16'!P.'819LLP1F!(((!.L!P6+$J548IBF6*:?4:B9$RK5C
M&! " 0/F\( @F@5M.V+9;]+0ANST97B;]<>WR>>KS.]G1;W^[:&GE[\I+\?#
M01[/K]<\OQX6W;R8S02._DC*8;_73?X7J/X[JO-M!!A=K+5+L!:$,,'\ST1#
M$"I0,FT\$!,%[X#NY^'84YM_J9F3WB\SRON<57A;QL.7K9]HKTN;K=7*(N0<
M6<@, H(L%'<01!,&4@DUA91K2E*(N0/(60PI:2&DM-%B.ZT@F0@944NY"RD0
M-!$DB$& ",>*"T,9=%I@BZU4-G58*:9;""EMM/V6G4 (;O5P."HJ$74.'G50
M@SK2<9-:"3!DBAHE!$14(ZZLL!81:K: .O$$*D).A)P3AQS2Q,AQ KQ^(P"$
MVE'D04=3(872F$E'C)8MA)R3LYTBY$3(.73(60C+Y8P"A%.LI0'4$2G]CT1"
MAXFAQ!M>+82< ["M)-UN6N3!@<YZ64\(M/+D[=MPG/5#1E-^JGV&MCZ_*46'
M*U;)>:>;N4ZGN9U-Z+4 7S: CWEJ.=.,6J&I :E4S$FN+4EI*G'JEE-:J]S5
MF&?U -#C7>#\9EP1HZPBOIT8OB'8Q)4[K5.1IBG'J:$IQ9) 8+5*M>.2"&=:
MA&]MM)V7\0ULMUEZ!+@(<!'@7@YP>+&VLY4.I$;+%%&F@$PY)%@QCWB&8[12
M%VV/ '< EOJ.3D$CPAT\PATBB.T=IV@3T.\-S%!LGBNB%!7&*&:DL]KOH'5
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MO%CL?36YKN"L_!;DT:/MK%*:2H5@BBUT5'.O>D'%%+-<<V0LY@OMK*Q(K9"
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M3R^=IB"E!$%%D4$*"Z<M)<8 )9';6H&9ER*E.#VDI&?XJ)%RO;-2V,X:^=-
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MQ'K?W80[NSP-RW[9)M8'2X]NX>,\%TZOMK-R3TW]8=9;BWQ_6\T%J#-BYKF
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MV0\+S\Y%F&O]HK/D[]/A%_EH6(P7Z__41]U-=:!J?6<BW(\^7&J&0=^NYK;
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MI+N]S7)6#ER_Q U)V)*F03!\?Y@.>^&WR^ZI^8I/3D9/0\#B>Q:TQZ1 X8
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MM7ICC:>T6W$0(P)>!+RC !ZJ*DPA3JB3DE)E"-70:4Z90 Y@IJTT?"UWXS"
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MU3TCE1.IX\(1#Y:M\4;IZ<QMF/].^\.//^6VZ\_)MZR7#_(FMT^"U=%-MFD
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MBVO.&HOE<<\5/2+A72.\*1&,N/K=)OQ0W7EB>>RH*JZJB@)5Q;84UL1CRXD
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MW"4Y5^]Q>J#-(;L8G>_RZD?"NT9XE/<NKWXDO&N$1WG?+334T.,1BRRT<3
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MK%[;AS1B1SL/JRCB720\$AZMP$Y;@9OW1ER9@0AYS C3"BE L0!"*TV@]I)
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M1?2*Z+4G>M$E] * $RV-48I2H87R4@C"M=:6">K]&:'76;CT(H!% (L MB^
M\:7N?9@Z)0.$(<<H)5XP #5T#"CHH<-KA1T;"&#GYDYL'H;MEM#6T%3^1:.
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M2CH*-80&6R:!?O6H16E$SDS(5]-*WH$QVV2\2?Z!M3JQ(X))!)-S Q-:E?<
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MW[OQ_"<>TA_9Y?=QEOYVF=Z&\7Q*!T_IGY/PHH]WXQDI6\[X<U#;:<IG_ \
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MJ#]0M:PN-R=OUTINKH(9$:@]]"WXEI^@P-]N%N&!>/[T-8#>,1V12T[$)64
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MQH6B $8!W$D !:P$$#B,O;! .D(H)C8()/8,,X6U0-2^<=2@'G_P\2Q!%'?
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M+J!>5QY7M<#G /2/0=C>!?..8QW/_I;(C?? L5;WNIN5M"=<_YI-IF5%7'5
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M?'N7\X8/.\;(L';"F:^]\ZP_&V:?SB+VW-VC"QN#,7!.:*8IX$9"0R4"3G-
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MH,L#XH-/@R?-'UV>#Z;9NUC?E(6#N,S3R4IYWC4\PJC&(V8H4=QR1"155NJ
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MCMH-3YFL!]TZJ+S F'A!J5=&"$"9$QX@X@B2: \FU[VDP,[SC"COIE]WQ'8
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MIG4MKF^+(FT/1Q7WPU!Q &__/TD2B>-L/)Z.XH3H-7-(F;,6.4*4!<%B0L8
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MHX/  $RPE\AZ?;BT^LA^!-+JW-%.)G>$_@@RF=8RV6H(C06 \T#I@DC!')7
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MS("T&E$JI-,0. RQ"'\ )VXE+?[P>.*SSN7I=,R.H78,]1DPU$W\E,!:QY3
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M21!CPZS"A&U1]R2)_YNDDTG MB*Y/,]&R6G\;>Q<'//]EN_,?@0)&!\>F4F
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MR33(IIB,')]9)B1O6OC\]TE0$ (D3O^1Q0<$M#U/PRE$MAQ_&)C>H%@\91A
M7Z);$)B!(Z?70!T>U)O.PN.#I.V=1RQY8OZUFF5=7JYNO+FBU8#;'<F3#[1
M$HQOK+;\>Y[7F83?LW>G 2G^^2X]"^MYGPXOTZLBZM#G^7PK6UH3-^WEG8YX
M;N\!P++3LW6Z_>> VH/OXR36OZ2CJV0R[.VJP+Y+/@1].($[I6FVLMMY90'$
M3XS"=3I^ VU;2)U&#TN=QH^;65Q]C#>_#UQG..C%E/4O7Q,U"T9%Y$=^$-TA
MR=^"K)KGBR5_G@6;#LE2_..W\X^B_$@JZZ&ZQ,M+=/=:FR=1O?9:C_1A%)%C
M5"%#*<.3J'ZG\;1+67"#U,-Q)K\. L__GHZ::OQ<Y1T'D?!N?#G*HG+4'^11
MS@1Y4PSZ@S2_6O.\R#K>+JW[LPJV5R5LLUU@6SXFXLN@*&:E>MG/ T]- HD/
M>J5L_[PP .OBYV *?/ST605+,FQ$S;Z'RPE"Y0/#B_.HUT=1>V/I924*_[EH
MFB<KMF3<V7Q74<A7.XMK?U>N-KQO1\99^33_<Y-3LSD0UT!J,45$&H2I5%9P
MJ;'U2$+* 8'+,?63_/NX+H]Q/\(:1B6 ;78Z+;Y6JL-T_$LTC,=G=K[S4C<8
MGWV8[]Y5F[_N[OQ0>3O#\2*TH3Q2+-V=<G-\8TUU>1(6,@S_N.'TO+]/)2SH
M-*+_9?037 6*B,K2&LP]2=3<M1#Q)[D,%LD<[\(S*D_$KT&UC0Z>DK;&L^E<
MYSJIW#]1G:O>598M!'5P5BJ-@U6RC(CMAF$G%UD>-==I;(VR@/JH)(]*/6PL
MJ)=.BO*'2[PLG6ES?:]Z<<304EL^"VIP/L?3R2R/1%+$OFL/0M#-^%D7^'*G
MN$=0$&@!!=@)PH&E&CC&))'4WL#/:C>EGSV=S)$S;"3N([8EG*\^+3Y71OKX
M3$7KOA?M"E]M,_[V.H)6 3@4 +;)'?_AH]_:(8_!FK;5?W@@=L[U\WI#R7Q'
M2=Q2\CI-PK62=9:PSI?.K/##/8)2+$'IB%">>:$#=Z1!AU!44.()XDH[(-C=
MK.;+8LF#D:ZVT@1X?Y9-QP'J<W#/-]^ ^IZA2O8 TV#L!5$67A3]J!5Q%M/2
M,*\B,)7959IEXT#U%;,8C:?!=OT>!%MY9RF#@X%W4<P%T[MP=M\#XRC-NA76
M,/>#5E;] D4"'PDO7.<3C7Z'2?C-CW (TRSPM3V*+5)'WYVP#G('E!*,<B85
MB"5SPD$B.)?UJ)$*E[Y\K<3\^&PAY$NML1;T=BFI-XJJM3BS:QT_$>NX0'+1
MBJAJJ!>U:E%J15&].$D^G"T5HA)G@AB;Y%ETL4181Q5OZ0]/EZ?TMOS-0LS%
M@NB+TK>:CI;AAM)+T7!:/"IZL+JG+0[B B NO5 4(B900'SE$$; <\'XG:S&
MS3<7.$RUL>FXO*'<5?1!WT @]Z,WG$6G\ )_PE%_S@)130=;,9Z=I_[R_2'1
MV^B?KG95TWT9*EEL[.TJGC65\[DV'OWBX]GW\^L*><#!T3(B5/H5(\[TIDN\
MC)[.+/MG4@25,OK$:SPLEG;!W!E6!@6:[Z3+=][T HM*:9H$RSZ8OF'9Q5R7
M@@R__L>;H!GE^57,M2@C7KWPKM/L:APVO7Q0?,B<@,91D9_EY>2LYO)*DBK"
MQS0V5GI;1@U*1AQH+(:.1M'F"6?66T:.XK$V_&_+AX:#O@I<^AKE_;%8^FU/
M2U8\Q]7HBEW*@T:LK4F/<R_G=!&RV",YTGJ@+C;. 0@IX%A0RI 6&ANLJ89*
M6Z#%K67X:RCRT]GGTL,\+!M.[Y&T$'A*TCH)ENE:W)JC8QE#F*-_=-Y6Q!/=
MU=\:/+J8YN/1]QC='13I]SR+8:R%S1!IK/*X1_I+8]N*LV'YC(4(Z&<!@6/4
M[#(?3 .]1 =W4*HK#W5I*%0F=%0; O0;?9A!92,',VA:K320PO>LI/*XV%D5
M*@A/6>)NJ<,,YM[DM\D@R(W2J5 4XUZEQ\P7'AX6?A".["39R5\23W)P=O7D
M+IM'=8<UN7+)?X%<N$S*/ ,(%A]I^1$V/"BX B;JO&/U_9^6[B!8'1@O<?NL
MI):T3+D8QH#?,HTA,*/P3=E,JDCL(-#E('!Z,PX$OA1F?PW$D.6C^NL Q:5+
M+=!*#"A%P;1'GLUJ%8I9ICE'#GC+:&#@FDE)8JJK@1X(O-+S=1W/7FI :M2_
M2[&&_"\PG"FD;6A%#*])>6M)M8ZT-3>LZRC=VZ92M @!5UR]",94J4>/RGJS
M.8L]O5HPX?#3X:SDD-/9=!P4@^5/RP!K %&IWI3\MD2?&'NK,@]6'*2U*[$-
MBD]>QT='JQ&!G^,3EL]_6UZ$/]=?0K#I2[CZ97Q;?0-:O2$*FRK;:WCUIM06
MF^*GC%XOR.SM=D2VD<"*>4.795I*!']YXN5O_YR.9E%KF^=EP4K.1HY;N\0K
MA; Z_Z#:E5102=/2U584LS( 7]YZ.6Y ?%1:I^47_:R*AO>NWB>QXU;#\<SG
MZO0"YB5$YB8=:( ^7GJ-JI].\F#1S<4Q;_PR0&3^R_KDY[Z .Y:5G(YC+& 4
MU9>PN=GH7:E8]!?$T-15@K9;GD!8Q2AF%,2X<%0=HH<R-A(+UTL'^O7?+-II
ME0K^+.^=!^WY;=1@JF$BE;H2]>7 ">+:BK#8&":-USY],\GD6A>O:,A&X[Y8
MRXMO6"'3-?N_L?T[SK ^F3(3+)V4TOG?Z<TT@+E"7BP"Y_DBO2SK5YE&DW30
M3\I$N-KU&W,'1E6KL7E*P^)Q,5NC%#=GX:B_EPT+DV%Z6<P":I9Y+S&UY:IZ
M:&D>++G2O&=9Q,G(QA;,Y^UU=32)*7QAZR7HUQY3A7>5! PZ7;3U>X$X+RIC
M+>B6T5T5SJ#D,!#.S;0ES^$K* KDNS6('8_]W?4C?WN-59PDOTT6?NR@]"XS
M'2*BS'KGBY54:RNE]GRU\Z7'PSD=ETE"2^YR>1ZX1&F-%O/?WWU@#_6J;A;4
MO-$.BA()D(UU9Y@J1Y15&G,#'7>:"[$RO^?!@AK\!7YM8UH/YFMJSUKT?RUY
MY%*T[!4B=<P"&<"84H98+JFAT;_MN5): 82TQ6X/$"$F=F4ZG0==/U?J01L3
ME>":<%H5HFH;4$T-8J^ JB,2BFKNL76&.$*A(P([@AT2%&.'M6M?QX5_(6UX
MCL%C$$Y3:2MYVQYA(FK/OE)>60LX%(Q1":"&UM, 'H.E9DK"UF%" O&D,9R4
MYM%8;L-S1-8TZ-T3T304Y_)R.D\ZWJ_X$;RS$^\XQDJ97JA7171&+]T!M7_@
M+EV^5 SKG.BB3A\-:G'^/2NUVAU76':J+I/E%^[D*AUU9\.XRBD^G4]F*\ZS
MH#/V9_E"EZ_2XYLE-LFO:5#OET[[M\MBC>V/;;T2?N3']N=9T%<K%9I7>%81
M_;P)>4RAOK'A.C"P< U'IVQ0:,NWE+ZE+/ZL/.GPU3 81-_GF87%XX7PI*SG
M9#A/G+%8@9CF09D._\<H=3+H4T%$T&LA/+/<N)WOVY3;#FSFE^5.UG=Z;X.-
M '@B]A8IJ(R/N7.^2%X/WI2YXFUE;VP$" :-P27 26B4]L&TH$@11:V5"$I@
M ^^GG*R/J7[Z/<L7=3)E:DK6GXZ_SF+):#1D2_?TW@"#Y!I!W):BM'#*5:17
M!T\JZW%>3C=N;#_I!;PL?0]E$<?B")I>FT$ ;NDK*F./9?2\C,L/QK,B&M3C
MP"'*#)[Q51"8RZ*]109:F:Y5Y?<GX?@G>?KO\3 K'25S1T/VKUGI'6NT<&\]
MYP>#6CLP09ECQ H/F:8ND"[FV@*L$4.>.W$]Y\?$[16Q+&M\]J7:H9UEX]'7
MN/Y&SM:7T@0WI04_O[C?G@EH'[D]\WRM"EVN>24B2]]G?AV&J /0W0#J+7<[
MK^\):QJ7Y8"E%S,*T0:1-7V8):E5M4NE<I!?]_A761-59=7<\?I\@VM/D-9_
M,Z<C_+UY"56ZY,W+>$=<:'\ZQU.#;3\QT2K<P!89\I?90K'LE^F$OP^BR[G,
M%UB*SPCLAL__9FA@D:%0!Q/FN0?+T$M$$A6NC-+D8S;+QT7IJ(]QN*"$G"2O
M7U5?OGJSM!J:$;('X%*E><_SJ8, SDI7]V78R6*!?RR3K*./O-QN#!.53NY&
MWD3E_H\._S*'>SH>_[-4&JJH7L4C(C.-9['<Z!^C_?(NZ.21/T7O=U;:47&5
M_5B>-YZ4 8"R9BQ)>_^:#4IK8GY*0<>'4@8@E6\LSDO>5M;%EN&!M"S,F*9E
M>E1@=><!B<)C%BK'M:X+99U5F<?Q8S(<!UA4KUA60$3G>!GQG%6!F$E@A5=O
MXS/.RRV&]U?-^9<94BL(T!\'JR;LIC)&@C)4-3,(W#0N_X^Q^#H&]>;!S[0?
M<&R\"&7=3&A]5K6!I*L-[&H#GZHV$#^L-I \]M21N8VU9VL8-ZQA!SE4V"N"
M%*422&G#)>L]XUZ'X[EG KHJ'5X?1O.DP,HA>K6N4 H%(8M8"\:Q('B-TMRB
MF[IV74RBB"H[QUS/2JWJWO=GYS3Z<UJ#&664ZV#6Q.F 6C.E BYBI1"&_FYX
M+4$UA\U:N^86$.UNV)!]5 I50>JK*".C<Z]J$E EI,9.*4'9&O3GK<DB054-
M?*:E>A:!-JWR,+)%MXBK1C9U(W>I-H$&%^41EGD(*QFIZQ-2J[+1F*P\F>7%
MK.Q?T6@!D?8O!J.8$%(Y.^/-_PB$TQN4GIB+K%_F80T6Y#3/S*E_'Q2JN8I5
MNDR"/(G:97A*Y;<JV\!\"[)U6EEZ087Y/2:A+B8CAF,H3^<D4;WH8Q[$';VM
M$VYB!6HT<*\E!>;9OV;Q9*+N%&5@5F9LJ%E86]FV2 53,ZI=O>M'4FDRBQ_'
M2L*TUXN9ME5&60!@M9FH76>79=IP@QG>2 5?^-4'1?G$05YF\,R;CLSS:JLO
MB_&PU-JO'73<Y.*<RPWGRSS[:75:B[JC>#B=<73-.*H+"*H*8G;3/MIH%YTO
MVT_-&VX$X#:<]+UQ,=W*1&K;!JKDQ9V$O;0(:@)?^$7FP9UR]R5#R:L&/3$U
M/*;'3Q^ 2,]A3N<^'"CYH#A/O@13,+8>NH\K!6UVFW2D7)+RI]YT7!Y/E5@I
M;E#R:$YU9X/*;A]F)5^M2;L$SZ?8]VC956@!K" 9+@:ETS$+0'H]SY"]!M!Y
M@NQV_HQ; #J/3J];9L5$B@43B2*_9.Y-D1(?L<R_C!>^717I:3[8696;31:W
MWV@Z.AU/?MY@2K')M*1)3B(%SB8/J.U?XZDHSVY<E>!4G9H:'/;9;_G_9^_+
MG]M&DG3_%83?[EL[@I9Q'ZVW&X&S6S.VY;8\VSO[2P=$0A+&),$!2,F:O_YE
M9E4!!1*D*!X297%BIJ=%@D"ACCR__!+>(<B+ZVRLG(&]R;8GA818&URV1=K6
M( 6(+N_%[^ .T@]8\(KB5F#04O)JK,PF<%_D]N(V"8%$65B+.9C7^*D(+HE4
MV8G2%F$U:4=#U^&/V(;W"<G*V#KX:?E<^/49@4%_+FZYXO5$"2#Y)1P#2_6K
M['$R;PGN^[H@J<;;RJ_+%5=#LK65(P,C-FQ8TE7^C$1&[,>F#@ZG%IN&8_DA
MYF,]6W5LSTDTVP\?KG#]VQB->C!-?0X%)C7Q4;SQHE_C_F["3.I>W?2\OFMM
MPWZ&1[;ZHO/U:PDU;FHO]$//9F7+C[77S;[W;&,1Q+-3/Q8+)AMGHO9Q$&X%
MWD_:,"XTY7M'C=FB=5QJ':(#VIQ@E X-O2!'K,!Q1I]$\*0@B_*4U]C @24J
M(?2*A/N"AG%Z1\[F9@YD2GN6:"2Y SO.,-!.1$4E \. FP=Z@*H'%OE8TJGL
M^(WQ%QF#Y(G7*61WP.%2B<L3]#U]^D4E60-<9N75'/C^LAC<<XP/+Y$4$ANW
MZMU-QB/M]30RW89X=R208.@H>>Y([N'\76"DG1 _]#:L?2YF0*_+=(PZ<)AA
MSD"D-4F _@;;BA?<P)"3[+)D13.LQLBK:[HE9QV]5C$UHD1&GBJX?TL7'$_6
M'-WN_%SVB89!2JD0NHP8D_G>1.8BF&GA5\(L]^;T+>85L!Y*UG?_4;%T#PO[
M#+/KG)?NLM)C4<B.NPGV$&AR+-']UK4U;C*1(^L>.R\2(78D>%:OI<3KT K^
M7KII.6/E&UQH=&VE 1@O*,IO\V(H:H[G.;L>?L43)<CZ*9(%=^Y[\9!_SM+J
MIIG?]+)B DY( Y[ XI/;XZ9$QH]D+1'[<,DE47N.D$L IP+3B"0$J_;AZQ8<
M)\HYELKAQ%YFH$:S!W^AW*189I[A1H15''!BV^8TXTF&)Y\C<[^8WX5YF/!*
MI4$&@D48'>+JKG5O)/:XN.-3T'GK_ZC(3*"A\E?"OP<M@5?4<G]>_G;N.1$Q
MH4=Q 7;%YT:A^B6T*VZ))&M6UFO83.BRR?>9@8!7RS2T,(AKV:&2)HZK@<YA
MWC6Y6ACQI= QG&)W%X%TWJ6@;7>Z3=XCT%S=2_Q$#RS-T2TCB.W0 \,T,34K
M5NTV"O +\1/X0NM.BP2&RV:IB[C!V*EI65]Y,8.S]\\9LK3 3Z;?[B?M.\U]
M+PQ3R>1\7V7]7P:S<I#>O_DOW9WOZ*# Y]66,7F^#]B9&J6#6K%*.P,U.QLH
MN%7%N+V1!B#AP9%D(F)>6G)$&;L->T9>U9P1?"_14_E62B6>X3NJ>RN(?1J>
M2(%H?I8;!TG$(A9BDJM.72UHZ/PV&*GFG;<D>3CP^-_^AKF_G)K7U+F%JN%Z
M>F#JMNEIFN^YD>J!+(A50PV-0/7;LH"Y]L55X[ /9AF3H G2CT6RHBBNX/"'
ML$?@.+\4@;$L(ZO6CJRZ*%7 F;TKR@$8!P@I>*A-SZ,S?3SJ0FKU,I.3/D-4
MKU3+O?1XUM483'\)C?Z@UJ,0/E'*H</'EQ7-FL4@RJ&W-]ASG+XJTVS(9K')
M W:$ZUM\QHY4.RTJUU8&]9>S83F[F([-6F\=HBO5N1XY9STF!-ZL17>VR+(A
MBICZ8EU6Q>:MQ3R;W1FN=XY.KW2]/\1 $.SF5B\*,&]P=8CLK&$FI#*PNC=%
M*A@S[S*!)*Q_A)UBL ,&&C^4U&\R\10Z:H)\/$+"2=D8=6;;RZ%?<5(" 14G
MZ 0=;8&:$+F$ELF$]CW98G _AK\<Y%=7&=69480>Q]N\8%$VG][DR(1!G!=2
M^PCJJE35)'/P;N#%#2L!*\".%16/U?-<<;DX(O(XTGI4O!$7!1=8$SLX&^)>
M\)0/!7F<-PHV+*R)-YA%R?@@6#2+=_B1IX[HO0;9'"\'SQAPF[3N5B(@]@-L
M@H*E::QNAAF2\Y9H3V$!;THPS//U?""FC19E#[^.C71A85Y@4OK \:YS]/M'
MO.L1[_IT>-?' E9W?X:#&@%?*Q5"8<WJN!G1>-;YNZJ!8E%6HIW0H-H *B^$
MZQBS/,GA*Z(T11&?WB$)Y207W=:(2 FS"AES[$6#._H9:K+\*N_#(\N\@J?R
MWY0\.]Z,%&]$P+#FH3VFA^I"CO?PEAE>,D(W @,,)&)1F!?]/BBRE1VCX.>@
MI BCQO7Z/>\Y)5I#S<:\]=*_>)>EIGD<CHLS)K7'-$V_8TNLL5QMR0F!L--D
M!NIGS/0-;XTD*6B.ZT"$H5QROGE">+>M($^4WXH[;!-6TV]B>'J!@#/MG-"2
M]8&Z4FZ*.UP0['YW2U!>G M1I@IKMGS2EZ[DR1KJZ>"5*OTC)9%369[E^IH9
M^9H?6X:MNU9LZJ'N>UI@)I$7HJY*G\R&;VNCS^??8D4SB7)/TT[KK=F.^BZM
MT6QS>)"KSVH=_?$@%#B./EA3$7A'PZ(":PTE<# L^M_?= CDQ/ "W37U*%9M
M*_3MP/8<-8XC*S3LV+*-]PV_E>F'MND[8>@ZD65'5N"JH6O:FNM&@1F'J[L8
M/?@<[0T<@7XZ09.GG&6;3&UX_OG;V>=?X\_A67RQT2'MN&D3]YSK'KRNREOG
MS;>9.'UM>_!G\3O!(VDEJ[&M.D7><T3RS6K:MPF6^?>G(KU:S*;DC,$WMVF)
MND69WD_8I</LFL'-&F5]AZR!8Q31=>2,;H/W'['&'2VKH,9M8U:LZI?Y9488
MBN*NP>8B'_WE$%-;6(A1WK)*1=E#0M>0=[)%5(&X(Q4FPG$FE-0"%7,F&/YX
MBT9XCTO)SVYH7'@24U(P0NT,I'XWK'5@DS9@('2&3,1I$H/B7E]GE2*^%6@[
M7ELHCX&_^8!G*E!;\QOR(21HD33O70I.ZN_9,+\I"B)CQ%K#,>=E&%(_C(JT
M:?WFY/C2ZBUYWT.R#&BSD6N/ Y8ZK]*K\0DCJGMA--7M1,5$I91\78CPSEAP
MA$!^W'&6H@?<7Y>C"!17&Z=C,F=!+ G'7PI0\$@#6;ZM^$*SSSDAS_"^C@N)
M%[Q-L:\\\6=6#;:5;U]FH<" !&/F7!-71KLY?\TM.'<ELQ093I\BZF3.LAQT
M4=*\BB',32L;]'E3"'N'MBOLIP'3H.(4TR(-"D[:7W=(D*3*7-I-+ T,G!G6
MW.IK)J=I--"C;FRW^8#U[&SZ;J?7U_A2TZRW$/O9]>J]W-#FSC,"75$$4/K9
M^R3_@7+P(]][+W?*=J^519B%^A"SDYHRXO4*G1[<D&F5U6X(F*EDZ8KR\A'J
MU8$@A):.T>:&W%R2YU/T4?E<G"BZHYO*VP=)JN-TD:3Z2S8>5_?#VW2<I^^V
MX*/#X.J2]Q6!SAM"/8[O^:RQ"&TA(6 SP38DZNNP9' (QH'"L\6$F9],WU-/
M.[H)T9UPRG0B;IZ2PPFJ&TQN)#'F7+PI$K=AK+UJJ-XJ[H9?WM?6$Q=Y? JQ
M..\:5Y*ANN18AOP,%-LO3=3LNFR%T<:U '1]!CGB\'H0Y80-@36%-T]K$_:J
M0!IE_(OOBD+8K,0VQ0(YJ)P8O17K%UU;8"Q$5)_"O1RL7S8-K;Y-WTF[B<,
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M'ZQ9%455N5F#MHH(,0E=?Z+$J(_93%R6!#J4NEJU0TX7&3=.6$L"HPY4P:3
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MB7]"Y6!=J>EV==AC]M0S3=QN-A/BZSYH']"!W7CKO- =,F<JPG;8P^YX(9M
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M$YMJJ%F:X?FZXZN![FBA[\2ZOU8;NJ6M'?>7LSF\[I";M&J=*P ]FT>='3(
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MF[[KF[X?6;YI!I:3Z+$5&:IG@WI.]D;;X_RNPSG4W952G9T(.A!T'NKC0,<
M3X&4LJ6Y7)JV/3AZGTV(Z-Y^HJK8O\P&]PRRV0/_&TY/!G_!>>PI?TG[6&-[
M/U82D.W@*L>@%,;*;W@SI/XBWQS<]Q+O4F0<!8I1-91I_>_PBU^Q@CXL;C*X
M^2=PEE$D_07#4^6X@&M_Q?#"0/GK;/Q]"%?_EF$66?E4P  Y[4!$+#_G?%?#
M?AG#EIZG9!&\'+=Y,>0ZB[DB%'";8S[!*7@ !%/)*!B!@,$AJ-ZI)0,;5^!?
M.G$O35)#SE#L\6PZQ[/Y[&=3IJ@J6/R4E:).X12D&)?J\>VZC*L'HTL\7=%;
M*&/E(*$Z0HR?3=/O<% 9WH>._ZR6"]D/N#D^M)(L.7DW@FU8@ F14V@$[H/8
M1N4R)_@0TV[\!3K4JS:G7A<T7XTZY'%[*I/O0E=)T"<P 28%Y2%EV-.D+"Z'
MV:@5QL$;$Q9*0<F5L]!9KQ8/^;@/D@5C#6![%"P6"L*@**_3<=Y7KD$&8B'M
MM*URQ:^?'1NE6PTK3A 'H>-YH:9IH66:B9\8<*X]U[(M/=8"=X_8J"<]S"\5
M'U7CF:I'X)G*XAZ$PCT,I\S2T1P"F<1('W8ZGFCX(\?P60_',<Q'<(9 SS(K
M>I".4GQN5DUAQJ94D+W'/=G@]>) =S7?MS5=]RQ+MUU'CP)/M[S$=^/02AZ(
MR$1LW!<H.*;_G0YG<T2;+!JC/>GVR_$,-%L/NXSPG>>M5"+ZB;.P\4"&#H?P
M+UMNP,]G%V"73&!/_:#E!0FZU>K^V\KEM9NP*")J_- /'3=6*>#F6E84)ZKM
M&%[BVN$+7-Y9-6@MKU4OK[UR>1U;/5%W+%D8X^:([1%40AO>1]MF8_WG'B6%
MU)P]"+0@4IW$"0W/BAW-#VU-#7W;\1Q/U?V%V"V8FUE^/6;F9_]>F.Q?8?M_
MS499BA8#YA>T#1A/=KB=_G81_?DE_OKGV<<+>5OI:UJ>ZHF^<])>A(-6[^0\
M/@,#[&^9G8;%-]9"WU$-0[4BU](UUP=W VQ R_(-$"RQNWV(_CF$QB$V :SA
M:SSJ1]F8SA _IR63K JY8(K7LA443):^F("3(*)JQ6P*GG?-\W+H/&PM4-_;
M.8 +CR1(@7$$2J!RO>7P'9P(T0]=S$:.%.]W/.!.@?:.T'A6HR:DX/A++Z':
M>X:>5FI,OB=A5ZJ.9/U9F5<WRK?T!T_;;Y&I/XQ9W7E*(AT3<R7SN3U,2DAQ
M]8ZTA.S^UWXOQ@S"^%SY!%H7A,%?LZH:(OQK+IX0)N?*5PS2#90_<C@6>=;_
MGJ^#I 5+$%71> &+]O>B_*Z\W9E<^916^4U'?F/+W,8[J8Y,"E&LE=@04\ C
M*'64A&61W#I\$F5]@=YAW_08$A)QCMTQT($< WTXT/E G'/#ZK[N*.<2''83
MVNJ*;$U9AJ2&0-9K!QL,Z4$Q$ F#YF/^G>_M^0GMB<@2*4FFH<G*9A#2L4!5
M*8;&5X"2)YC=(;4WS*9H/I6P'#DJ!@IY,3$T!3&4PD8N^"Q?P@VO4AI%4^^7
M*=F8%A0=-MQ.':.@5^0/8FRS':M_A\B_NZPYPCSLS^)9F)2B"7'Y?/R5W[L9
M*CP2'E#-QQ8$SI:7"N*4R.&#5F!!;#Q*6E+5!1:"M9)\;(^P[<9T(1IZ,E4F
MR?$QC'MW]D-'^A*W_XE"-N'&+)&+*4P)H+>8P2L$[>^+*N>:JQ0ZEG,=R[F>
MKIQ+4[>LY]+6/AX;SH:F"TOJ[B;OW_!.(@TFNU70Q&NFZF^9\*PKK:EZ^[;X
M+E_2F8-<AA%HZE9 ZF>I>%8'LZFH;Y)^S*A"E2LPLZ0F*EBPG ^9U(:/J\YR
M>()&-*H-:]:98\DT'%[=J1*%0P>;&!,H,#910./#7%75B"DPKEIA"S689:_'
ML4Q-5Z9:]2U J/&G#9S#.U'.^=^:6+R6Y]O<J4)4^&!QIL5JUTN:*L,"5JEL
M+:GREI61: _9;N_$]&Z*\EDG_&*H3?@EM'TU3%1#]0S=,A/7]1S-4@/-BOQ$
M,[0UH'0/='O#Z(NW3K'\V;C,%J(KJ)OI!UNG<)\"8=?9<J@Y'KW:'0*/Z6]@
MH7TMLIORIKBZ6DS>+MMOPM[EQX]/6(WG:7%'U/7L\I%#DY4B/U)*]1*+-2B-
M2D=__J::^OZO_" 4HB#JP9W,*7A0^%1@48YK\%.'#*J).+S%%V82;L,58;.X
M\7(N3'X'AN1Q_M,"6\I.O:?]20Q-E3#5NF,GFI?$H6_I5N397F+ZH'75V/=]
MTUHGJWS6H!T6T\<'*2WV0D*^K.JXO1F$"OH'$<0LJ+1>#9?@7R'.]VJ&NO^R
MS.$V ])R(MZCD^H3I4?MFD7I)I+*!"\:F3/H,8-LG%/3#?%I3UR&T@-9_FJ9
MA@C%M'D/]O/FVCDQT GP6,!M,/%U><\EVE>,[<VZX)RB:E.24+7[K@J#H7%1
MX5>\[&I._4\)7%K-,E[L-L=)-*L8M6$K[H4?2%$NZ15:TIF2+<('J4T;0J?,
MC;0=:*A$  "?Q;KJ\<JDI;)X@=RLS6N&$0'1R$;CVV-9.XMFT]QD0S*,&%<*
M7LK:<U!1G7Q+AGO&L9!=R]JVM'Y(=-B-;N%#H* @9TWC2-HR&\'$$Z\:WH9Z
M:1 J"CS-%F73G &(L31FC_6QO/$J[_-"/6:\X8D19R"?K]%[HMC]SQFJEXOI
M]A2>_RFB\?61%<'%)?'X,4?O[2<:OZSL8'=Q]B"=PN"7UQ&<*!L3VYT(Q"_/
MOJ4R0I(=?CYWER0FIU(J=)1^1Z$BZ!VZ2IY%.)Y\<:YETHI#_VOO;]<D#RS\
MN3IJN:G9)Q*?=3JE9GC!1<?)K%.^W.P5=' 53@@67N3CVZQB:I.IGE:Y!2O"
MJ(LN^KA[::+:E=_=@%;V,&+M9(UVF,BM[5YP&<;]?#+,A D^SRK;XH"A'-,2
M.WTASEUDU2,"W6=C*7+0MJ?V9X\;33U%8.F1J^FA&FJ(U+8\(_!\R]!M34O"
M0(^W+X;S'BZ&.^,E<.VN0"3E0<BS[D '#I(HP?R$9:[0O!0'K@$Y9"WB5AGJ
M ,9<,9P)EL4.>M=6JIHW318/$';*%6R;&\H>T2!(VJ3LV;EL2M5F5+?QSG\
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MS;/\'9[TFD*7L50TE\CT-S6SM!0FZ\.^[+-W;]#%8-R7_1SSDUB,"6X'WE(
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M)9KV?#(B?T^H<JZ:V?UF$]+6#7<FBXUPMEPICFQT/8,B"TPV]W,!:<%R1'Q
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MVUY]"+OQ(1Q?TY,X21PGM$U-]P+#T3S#,3Q#=6S;W]J',& :5KH0K8.S*]C
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M^E53L-&;SA<";/2J*Y*]IFHY;J9IKE.'XLS$\&PST,PX]BS34P/7B8TD2:+
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MZDV:S[1B*TX")W"0J4=S?-53[0@,XL1+W,!:.+%=*?2+;#H=9H,_6%O3$!9
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M+ Y7BRS'@=HS!J.>J@W /A_+BF6;3F]LRSIXYH8SW.IR=JI0]NDXV#:Z<LO
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MDANH^71VCMMMV?P:V/RWLDNS@83:!!8OFE(UA<$/.($[>(J4*,87PR5>JB3
M\\*;C M>W1P%/Y]Y[ET0QO#)A@CX$$<N\Y]DS[>VY]_>(<H=GXC-,:V##N3!
M):'+[Y1P[Y?Y[2/&5?",<\\)LWABX;,+<%@<+(:?3;/P,?\Y#WG?1>&#"'.
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M\0L8V+\XO;OC2?E"L1<R>FND@#W \]$=O_/,K:FI2P&R7P5M\(5MF'QT8_O
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M(55Z)SGKI:_"-W0GDXAGY\TH(WJ&C[IH>HE^AN]NG(]#2I$,>0A@YH%.GK/
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M9;U>"[MYM%P-]^%4%G<+^G#15LD[JYIN:![;M)@/+8^<AD=LX[R0"AMHN+>
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MPF2>E@+TPD$I*J<,&EV[EI1!7F,BL!3^7WM?VMTV<K3[^=Y?@:/,9.Q[*)H
M"2[C9,[A.J,WMN5(FDS>CR#1)#$& 0:+9.;7WZKJ!0TN6DC(HFA,DHE(8NFE
MNO9Z*HE"AW,W'?M)G%I"DT#ZHL1.&+Y_0,9CXV#H/WWD"BVC@AF'F*["SZD7
MN1(_(]:2:FK9- K*2AQU[,:@VQJ,;,MN-H;M3MNRANU!MV,W1V:C>V@RRR%I
MB<3'%B%"A@13#.9SAA5H'(/%3\EX>>X,EX$YZ+0&S4&M76O8O4:OW6F9O9YE
MV:/AL%:SFT>4X3*Z^-3]U+_H?C#ZEY\&%S<7EY\JQH>+?_Y^ 1_^MV)T/PV
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M&N3E&)3Q0S%"'0P2@P>8X1K@.V84X!2U,HA0(UZ'U9/P$\\M4R6^6>IK@ E
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MS"GMQ\^1*@3.B1A? 5L3^2&-0C>-$"5V$>N4NJ=/A5R[H1H9*GP]T22)0J$
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M=E3 VP8PG;Q5189_LI,E!\0?2NAT%!6&8+J2/>V8-=7687]$IQ$QVH<3_:?
MY M,.4W"[3(WI"#@"07"1T>_@"IR+9B2MZ"J([\-^>8WK^E4271*YQ$7I\"A
MKSN/\%^H+.G7O/?5%#I6*7#OMLGI'Y L;E5(2],X5DE.&[O,SWP'3IFFTCF
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MY>L#](;\??W]W89:ANA>S$'K:\BT)TI&H7,W$!GHQCB;$?<S):X_+6#1O3'
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MBL"'D>3/P '#M 9;)\%4PX:M,5GG:<!:IC895W0MCJ=VH^%6#B\3_^16M%O
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MBL4HG1"#3Y>,/!L%K4I&J[3*)14/$INU',F=SQ=(:(HLBQ%D\ )$4R@ IY8
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M;Y%&"#8HU<QSI7PNB>J$G+EUU;2L'B*R5KG'Y;&.G*GPA'B2W$6*>-3?@@G
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MBC,E@UL5D+;IE4L^/OKY/#E "_>KKO[I']!CCW"\/*@(5AA(' 4B6LTH_UB
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M_WWM_N\+?9WNQ_T?GVZCL8F6[RM_/;NYWM\^XHA9#A,+<H\99 +$3QDP3A,
MA3>18L1*H23RHD&]1J;[D?L@J&?FRGE$>.I]+8=EQXC#1'#,2Z\)!1HFG]-1
M#P@7#,3E#>-'D1ZLP8T2]%]5-#OE0+Z 4*=VFM]32FQO&'C_V&%TN0\F*$&
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M4T.4A&2(X704_;0)5PV.V76;W\ZN=$Z@UFO1.<>A=NXBMGYJG$8T[-M>RHN
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MEVT:ZGG"Z^.5]ZMWB<MQFHNPN;A^L' /K&^WO=U_Z#["AZ_PWC^PP (2PH5
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MUSGNI;0TY&O>)UYGD)]/\W163)^IB*>(S8$.$JJ8"?!2R+"$SA$G%2ZIEP3
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M!T(YP*506&!CA&+4<B4UP96F<T>*_T/\ZDL""GW_Z*]C'@*G=I4H+JECTE(
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M9QS-)HE+^'80@QB*H'R\"0.Y"1I.-B]B*J?%_7!'MOWV;,;O[0BJF+Q?/IQ
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M".P_#]O?9RM/_(<Q']WL][1(B =<2A&I8HJP0![V6_H(Z#7U<[7MOBFC\BZ
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MS.)U=+,YV"[18;H@(,,AAUKBD55<T;#Q8BL#GNIB-9A6V%M-9+H!\K*EBG)
M%$6&>,LI\UH20@SC @)I-2;URRQWJ</T+S.GP=272'Q,IUGQ(?N2S9;9V^QX
M7-/.YQ.H(1:."H"5H,YC 2100/, GN#$-:BJV94&TQ*O\O;1Z>V"-B\6[ZY6
M(SY^/_O\V<09+Z4,V['UC JCA;/"$0.-,1@BTZ>V<E:.-T6F[[/*QLVY\E'E
MR?.)D9Q" BRRQ%$II 0,>8)=O'@F! [0,[0;KK>!3NW,0RO/U,V;U^0=6KB/
M-4DD! 0BA*4UDBH'%/88($6T]XI+75_GZRS=4+L\;1F@OB;T9I?Q 9WR#/ZO
MR>+&+(M%&'V@)5;7C->,19'%M*B?TF\'IGN-WI(@Y4X2BQT3X32FJ(8<*4^1
M)E)3H@>XZ7=\&=0]B/WJ!K_F^3A>6'_,YE\FHYBP?;HKV^GQ1@GA0=V)=APD
M+'71A=ZPH -IA2C7" PPU+EC46D-J[[UA_7BN%DIPQI9085XWB3Q0!I&E.<N
MG*\4$C+\(:3RX7 ,O6F@.W:F170L#2TAU7? 67Z7S=/%*F7#HW$?D(C##1-&
MK- 2:8'#0FBMDLA0*PB7C"O ='U_J,XTD8[EHE6\^I(.=W65C18/ODO1 )P5
M[V8?LF(9FK^[>K>F)I\5ZG.QVB4/B$R-WA(DB"",064\H8XH">+= <%&(4@0
MJA^YU%G-E8[EJ'L0>XXQ*+VBGQ)409PJM4^LE\!8*\/*JRD.6IAAC#F(O2=
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M4,$31$5R$6'LX1@_ *G0J)7+SDHWZ,44W\?\#8S::#&CYZSC9-AYQMLJJD,
MZ\]@%3EBE("Z'UM<-(ENVMD* _)!'X[KA>V_>*_%YS(\=R(3XKI9KI!Y]W]G
M_WR8KV9OW[KC?9V^?ZX2R@IF7'01*ZR5Q%K[P_R$5SU"] 9S]P]*A:8<5F.)
MC6^/\1/:S8\/5R(FS[.17 OK6< <(7M8E57&Y^O$ V=+EE1?>L-R&6)WRGU[
M;4C%*$><*8P,<MH9#V+0/*XPJ(DWE.Q#LJ/4[XW0S\@+DSSYI\ "A<YO0Q!6
M'^HOS>)+O3I^A+_P:"6)]]PR$94-4G&&%77M+(ER^17Z!SO%^P/>%,6D%^58
MV*X:7R^;G8,V=119/;QM9LO;;>WKF]UT.#RF3Q/VO#=5VDMLL+6,8N>#3[W@
M\&&-3A&<7Q9RL*OW\G0?%+)^&_KUF?T"+_ZDTK .F[W[:RI*/:,J!LDC$]Q)
MY74K_T!OI?GWJX-=NP\@" ;#JQ<WZ->G9;;WV_4& YL2<IH?SGI1931HP,)+
MQ8CU45BJ]"._>Q'R;V 'NW OSQ%#(I;/$_0OH)Y\K)?S9O5KLZG7,)M_WR[K
M-!=Z2BQT&%M98A!'/C*+' ]@ <$<VG7(0/-;?PUV]5Z8\N5!ZD-L4$53C,?-
M=E7?[B>U/$QJ)Y5V+(A/DOV,MU1$$1.](3)RKR@CCL9'1G;:3#!9J3@## =7
M+U9XFLHS+:4K!YP<7(ET^>\BY9X(!ZS-<&P=55Z@'DW_!DL<*D_XTBAET_O7
M_11^;;[L/GM:YWMU0*61U,C8Z()%N\[/[&G&))+\4-O!LGG*TK44,GUI^<OL
MZ^FM^M*S%4S3FB@]Q0%DB\<4@:0YS%.JF)^(,5@VSB 4[ -*P8W8C8(_#JBD
MX@X6&4!JN'TM^:#:&5/I>X0U#I9/,_1.S(,FFYC?JG6G:?G:\Q7BG 1DX;^=
MXF<H: &/IP#OXSJ[$M]9(60NX_6.LYMZGUC1V>O]-*2R!C$LE!>4(A(PK)*V
M*PQ(CEIJ/HOT;PL'AF5#,Q;QTX+?W3E0YN?'"/[\L4H%$3RSGNE@N8B64NP?
MH<$X/XM^)!]I?R+W@&,LPGZHVWS,=W=I^4>(^_VC%7)$8PM&&@%5GE-$@VPO
M]X/Q+C^$822?9W\"]X1D+"+_%;!9IS(-]?K=,OR10N>W\_6G?7N=$U0_.;8R
MSBF2FNTX'5-IZQCXXYIEGSS$D1R=_=F@-$:7.=*?5\+ZN$GNVD.*W.R^>[CW
ML9=4L%8MM+"$:D<-5HB#Q?BT._(Y923':.ECOR!88[',^U63DO77$:!ZLUYO
M9\L;..+VJNS;9GF?//PG)$K75U24&(L]<48&'Z41V-K6/(U:R'P%8B0W:G]V
M&0BJL9CEF85SA!^>/5590@)'47K%B: ,EJ%;(S9:I'0VR4=RH/8G>3X:E[ %
MP'#99<G&V7SU'[/%%GZQMV/>;3>[TF)P%':T%[J\*J&*'*:$(>&H2^T$51M;
M$C&6$RRK-*1-,0!D8S'1CL'?S[Z>R"5[_EC%=%*L-8L.82$HH2RVX>,1X9"O
M/HSDP^U/_!YPY'MOMVF-NT(*J0Q]L_KZFD _]CC(,@UZ;XC&1Y^N^Q0UXE&6
M*=.C ,%(GMM\ZA7$9?C\X:=TVX\WG^K;[0*$BFU6J^8?($S6SP3+SY-X"S!3
M+*C&0$[BD))@IS')) ]:4^<ZE7_OZCU_Q/3;R:Q?2ZKM,*H*EJM(@R;2$$\1
ME:#^'>8O@C?Y2M-(R;6=\6^&PF322;9]\TRD$"G,#J06@&&]PBHY'O=0:#%J
M5[9.>29%R7LZW^0\>*XQQT @K[3!#CG#J8.M%ER[OR3 -?$NG7U(UC79( ^A
MGY$7+L,#Y^>;C,X"I8+0+A>0'*1UGBMB#0F$1&I9RL7<KU 9//E+UQQB]0M(
M/@^QZXI1I:E-75#!42\TQTS0Y#'<K\U).F;VZ66X84BXIARCJJ)-0=>!8HT<
M"@A6(@XK4<&8_!"J\3-5L@E?&J5\>O._8/3M=/Y]N_A*4JH,/4'MTT,KFE(R
MD>1$:R<L-H8XUJ["F>][T$_O:K8WK8MCE$]I]I<?Q$T;^]5&\^TX\!39SWQ/
MY4@(DB',>>"2(Y5"ZMOU<:?S7>;C9Z/D\<"P@/41]7K]G#-3 LQ) ?_:D"K$
M2)GA@J(HN<.(Z4=LE,8ZOV?J^#DGN6*]$#9]MCB5_)M)/"D2XN2V/CFVDJG+
MBD8TD B\B;225+;K8!3EA\R.GUZ2NY5+@S3=+$(OC;),>0(ZB(>_$$D>-1##
M2+Y7=_R<D]P-71JD/FH:[7*&L-,ZVUGOJ0"L: T'&U2X$$2P4K=^3C!!+<]F
M@O'35G(5N"$!ZR/J=1N&L_,>P!1.'=ZO#ZDXDEXY3+T,T3D1J(RMS-+>]6BP
M>(&TEES)7@B<T:)@8)X= AB>/U81*IAA06-DK<'"X.1).*S$R!X5OT9/>SCW
MRJX ')?QMOMZ?;.:?WZE'=C),15EDFCF-0N8!.981"F*<[_&R-7D"\7T)WDI
M;'[6H&A U'.4"B5J19DS6*EP0,'HR/*CFD;/HBC#(07!FFZ<JZ*!>\F\(5SI
ME "@:.M.-H+:*\J9R"5Z/AIC4?7=YE/=-:;]AV<K:1S7$1DI4. X1(XB?^14
MY/+CW4;/=<BE<%],+B/P_[:</32KS?R?]:V?KV]2-.W[5?TPWS[\6G?/=3WZ
ME@IQ!2@B!;HQIDQ;;'BKT1I$>O#&Z(D-941^2;0NE Y=GYT-W8ZH#$;2"BZ\
M!W.5*,R-)X^[@N%\!_WH.0]EN"$7F3$IG\1:Z@MDEK<?/P'KII]=\_ [0'';
MB1%.OZ"27$H"1J]%Q&-"0/'QZK!Z&W"<O .P#%\4!VI,-G';U:H^R0N'IRHM
M**>$2,V(YTX;9='A)M(@B\D$.T8/0? \-,9S^SSI,ZGT_4D"OSR@\LY1AA@F
MP@L 2[ 0>+LZ35Q^I;#QTR'R?4$%D!DS(6+XCFI? (!F-1_I(\<S.,I^:PSL
M]@TIQOG(I;-?GN+C7V[+L7[;(2&F^TLJ1*1TTA+!..+6:Z5Y],&RP*PPN%OJ
M_H60.-6OKML+*JFM"H+ZB)CB7**DBRK$B>8AT*#R73:%LVR&(.KWOILA$)MT
M#LYE&]U%JCV6$BCB+4\@,K![,8>#4DNE4:<$M4LTNBO-)[U[WYT'Y%@ZY>7[
MCVEAE;"<<.6TDMI(S0V+"CF-G:1"5T82JAB/B&+$(\@'$P ^S*/"6BA^H38E
MY9OB=6:0 AW*"H/^Y^'6$)VGVB+C&%B&R%DA@P=DC$:&(#%FW\\AN^6-R8OG
M09H=-I/=+<\1934S(6)AN+7*$LRYX,*X@+RQ8YZ  W;+ZTR%H]WRSL-J++%A
M9XM4O>CCI[K>O$WT270XKBB]-J1RH##HE/!''.7&<FV-P@%$J&$6T,KGAO.#
M*J:D#Q7"ZY(<<?*\>'U0Y2TE42D/(B?)1R,L#NUY:C"F5ZK$]*=J!S89!L)K
MY23A"/+<&$NMXH@J$T$8@W%L"&&4D_R@K2$5C#'YY#R QF*#]ZOZ\VQ^&_[X
M#)#5:[.\W84@'"X4S'I=;]:OZAWGOZ0"=1T4=F25I[ #HC8IW!@V@8PN&&)[
M%*,?2BDI0=(?2A0.A->H83Y/]P\=V>3(J$HI).#4#E1APAGC2IO@(E4:]'D6
M:7XJUF QGP/P13F QF*$-Z":/^Q##G<77-V4U".C*J=L)((J2S7CG@FE!0W:
M:RX%0UCE%S ]/[1S2GIJ.<@NS!HG=8RCXRILB;.1.4QT$ +6S3DZ:%M>!4ZN
M5&$M0MYN+#,,D-?-5;!Z89GAP3C-7;166^X"M5$YZIGM$5DPH/(Z/L^<!U.V
MQVMW#!Z4H_V$?JTWQYU?1X942 1J'!$FFLB1Y4I$#Y8:CL#]7/O\?,#!5,Y"
M5&@& 6A<G_G'E,4(P-?K^.77^4FG^+>/5Q2874L<D0Z.!\F,BUI&3(S!RI@>
M0<.#D7Z$F^@"2%WVWN3\B^)U%;UUW!DXVVSD1'*-E V!T^@Q]Y[F1R(,9E^,
MQ@E]P;JD0$A=1%(3D3,%0SNL4E%CRXUUQ'GN"34"!"&)F HB58SY7JO!$LDN
M)" R$1M7+4P33&T?SA<;G<97B EMG4>8,M@4V&MG@C7*>R2H=#U:L V6@38"
MMPP!W67/EW?_6-:K]:?YYTYIJYW?45$PG$S0Q(-EQ97'5CAB%,:!4@38YRNB
M@Z6W7>P,Z@_?: [T0S.SWQIS TM9U><+GZZOJ!B5@4@&EISPH*4'HPT'E3\0
M0V$;Q7P&&BP';@0&&@B];.OUY<\#'\^;V[MF=9CN:X9LM]&5C\PS+HWE<!@'
MBBVR3B$L#282JS#!GC\#<L)PP V?*?&M>WC ./RW]6P]_/O-<KF=+>)VLUW5
MO\PV!P7RW=W^MX,G3^P_\]+-S+N[_6V*6=Z^G<]^3RV 3F9SC) 95<.DZMVL
MGQ7Y>-LA#>'$R IV"J-((4]@#R'B%-$8(VP]"HH0U.FH&'/-IQ(.CHRJL(5]
MK(5"E'B."5;<I;O2@)"D-(;\N\/"60;%:/9]4E@Q;":=3_#H#[7;]7S7;&?_
M\?6)V\:CXRKNA11PM%"+$<<R94P#';Q&*D2.>]3T'CA/H C1O\]1*8C4>'5D
M=E,\>0'TS7-5<'#84\4#D\(3:UF$_:4H09%JIJXV[JT0 7\H.S,@=-/F$\0-
MEUI1JL!8,-A;X@V(91FQ8XRS4<.5.E\,CL$%YP&3;4RY9KG>/M2KC_7BSLU6
MM8&?YS>SUV.-.HRJ?" "!^9$*I[F-5',Z\@EP5$BK'H4B1CN5B@/^V8H3(K1
M<U>X;+G3T&>+\XCZPM!*<X1!_&!FD[QAS@H?9 Q4*FM1G[(PP]WRE*=L?V"R
MR?OAO]Y_FJT>9C?U=@/,M3BQ3U]YO&*6(!,TLDQ2CIW70:DH O=*41_P!-MM
M%"!C&3#&.D[!N ?Y,5M\J,$D2!UUE_<[(^9D$.CQ@95S,F7VI3\IM[L"Q!B6
M;[F5$L4>S:R'NV+I1?I!8!DM#!CL%9 SR_N=&?)A?O]I\^[N;^MZYVHY%@A\
M;%PEC0*>Y]8P%[@C2B-"/5>>:O@_,FKOQ8XL,)1A7Q*GL7@BSI?)^78F1QP9
M504:86%@71#A. K(..DQX8I@0IWOT9!GL$-]*'XHAU+^"9\^VQPCZ4N/5<PA
MBURPAC.=/!+:"X&Q )DH=#K3IG>BEZ9A 5@N(]9;=_G7TX79C@^L0O J6$:0
MH!@$%K$,%DD5H8@81]@$PR?&$>P]@;J$9#^#*8X-JS!'UC'08Z)''&P4BY6S
M46$!2!+=H['>8"$18\CVGC!=6$YT*O%W<FSE)(Y24FF#H !D"D&DCFK8&:#Y
M:I4O+08+=AA96F1C=5&!T8D[3HRLA$#,Z8@)0YYC+Y67W&E-'%-<*I$?MCE8
M^,.H8B,;J6RU\)OOSU\LZ?_B<Q5WG!"*/<(,)!M8,8+XP PS(C*E>A3U'ZQ@
M[R"*84]<+BSQSY?S%1;2<\LUULYS(ZP)"LP59C /8+BX"=;M'5FZGXG0167Z
MN9*\PC(UK@&MEF+%%?.611T-05H*P2WK$;$Q6"7?407XF0!-P+?S>.?X[F[_
MU'RV>-^L=_0)*:!J/?]] 0M<9WJ!NK^_TA3HX"-83"E# 1LE#*>8.!^M9YCE
MBQ9\=0[$2P Z#2]%$7XL]8D*6:&!>,RF#$L7O=+8$F&H! @1U_E%#?#5^3 O
MA.D4G"3%960/]*@3T1+N0*_07!"EN/-(\1B$\8&$'DG15^.1O2BBD_'1#"DH
M<[Y2!2V-E0)%*P(/J7.1"H2I7;.Z= &>SYD_BYMX!%@GXB(:3F)F88@Y3ZXU
M0J,-W!EE5/#2Q$ =8V"8];B9_CG<U2. .G1&SCZ#9/>GFZT_Q47S#[>8K=?S
MN_D^D62L));=GX>"'2-]<IP4I/^LDR%2WYHO(-SN]QR46MJDU)RVDUWJ8SH\
MT!_JU)CG)F4I+>_=I]GJ?LC5O_2U2^<??3NG9KT!&L"_U:LO]=L.24A=AE?,
M(^&T@F,G4&[A!Z.L2[ZM" <0]IU\]0.%A#^F)'ZSD-TB%JG4=%K2&:U03KZE
MBEXR&C%8)XYPD+C:$(RE\XQ(%CD>,ZO@:*926<*^V@FE-&!_PO0E[#5EH,8)
M;3S7Q&GC/%;..86MTVC,8+G,<HD%F>"L=*;SD)MVF@IH:E2QZ!"%_\,*:0M6
M9TR)[@))2=E/F<[4F8!'$UD*0S=M/O&@UI/HK-0$]A&H^1&L0,#.6FJL&O7\
M*97.5(8+S@,F/_WEHWMS(LOE\8G*!>MCX J9&+GU'D[7J+W@0@5&,!N56#FA
M\)TQ;4JL?ZR-=\QH.*DB[Q\'D:)]$( 'R!QN*4@=RX3D.%F^8 +WN X8BK*#
M*H0%,+H(]0\ ?&@6B]BL_C%;W79EA!]'5M$(9XS1.JV2,CB I+71::P5PCCD
M*W*#W1"-QQ.]X;HD>YS)$Q71-,):!+;8\U29QBI";/H7'13A8U:SR&&$/K3J
MP -GPI.?Y_"-57)[.]^G4[XN\#N,JKC 4C($5HM-"F4T08A@O$@K\):,V8/I
M0J0MC])86[LM,P8K_V;^1[;W:T,JX9PE!(XQ1B@'<\-$Q%'T%*#TPO2X?!WL
M[G6H+5X(HDO*]X_U9K.H;_]SOOG4;#?ITH"<*?)?>$.E(R,I"TA18;A,!;\Q
M""@ )'4 B21?11SL$G3,4Z _8D/?([VDTPY]O_*A_E(OMW5*(;[?#Q_S6T^"
M_,WRKED][$O67_B"P\_7L_O[57U_* )WF':7RXU30RN$8D A<ADCYM%X@U%P
ME&(KC>0V=@I='W75IVXRC@VKG)?4I/93DC(.\EA;S@TFWC@3M>BANQ2^NBA'
MMF8P=,:\IUBO-L\8!_[V/=/ /U7O5\TM"*MWJX\@7><WKW5C?^W1*EH-$AUS
ME9I3I7K.E!#/  3DHS!XS(HZ9]U"E*%I4Q2=3%WF'#JGJ_;#!->O>I"//E\I
MK%24SAGA39#(8F<9TS(PI4R(+%[9C4-_VOW(!,.C=AVLXHBC"BEM%):<666D
M10Q92F"-'E-Z&4YXY=)A)$8X#Y/\^P8X1U:SF\TOL^7V;G;01D^6V7IM2$69
MY]; P>FIY\RPU"C(1:^%\V"<]ZC+5-PU50C]9A!@QK-6=Z=9:LO03CY93&Z[
MWC0/J1O4S6)[FUPPZW6*$KS];?;'4<OU[+=5J34ED2H T :.4*D03?6K4DUO
M+*B<X$7'8.KC\/ -;])^;_(]!7&T2SJ4WAXC=N_UR1Q^9[_^M6[N5[//G^8W
M;]L6:C^Q/<H<-0:G6W!'N0S:&D%ID!8+&PS3G<[9Z[%'0;0&8RABTGHXCZTV
MFFL,_T2X 1UKS,"G?O9H9[*=8X^>A\[D[-''D(^G'3Q;'#%*7WV^HL8[HSA-
M*;1<!*0\,M1Z9[4E@OHQW1;E+-/.U&W*0S2DS7&('WD^PZ,VQZO/5Q1)S(+F
MC!#!1;0N",*"M<:18 GC5VB>%B!@<P'HKH-? K<\B,!X4(:#:6Z$QI(@[6")
M),A1+]T[V:AC<<-YP'0C]KI=_KJ^^<M]\^5_[W(^5E_W!#_\Y7MZ'_ZY^MO'
M%XC[],M*"DUV<4.8>-"9E;%*,*(#(0$$INB1_3^$C5H ^*8G!$-NT+!=-9_K
M5QT.WS]2Z4B-HBDST6$NM->6*N,DQQ9''7S^-BP>(%&6>#V!R/8/[;I"?R-!
M5O6IXOK'QE02.TQ93%('<V)2>RU*F(&/,B*-F5!D0UD"ED9F!$'Z)AP1I&]"
M)8F"4\-S[R+CEB%CJ1>.&X8PIYKG:\[%(Q"&$:1G0_#G<>L) B!*20!%RW40
M.K458,9J91!@?(UNO5PK?'CX+NG6>_2D'7SI/[/[C M.(\/:"@E_1HP"B@ST
M9R&M$U1U4AROQWU&@H8U&A.H0%PI)(P.A]4J24>]L>_G/NM,MG/<9^>A\R=,
M.P45%(MHHD4Q)>@X081O 4+H2MUJG:E^5I[I>5!-.W\0C$FMI5:.6*5(*EPO
M1+L69TFHOO-@3<-[5IA.1Q,)\Q"Z;JI/RCDV)6*7B^(HWP1/>B\,823&Z#F.
M7 AL#W/7R=,P/1T^$_LSFN"=ATDQ>A9N@A>"BY)'BIDCFA#@;:?:50BF\Z\V
M1FJ"5X2R_8')3QTKTP3/.QM#9$$CQ"5A2!#$VMD&32?D2BM(QC)@C! 7F1TJ
M;;A-E4L4IUI@ZK4C$;<KL8[GQ]"=OSLOISD70N<ZXE^EHIRD>C7<PZI4:LE-
M'T\5^'F:2G-_$G4*A,T#Y^<@_*3TYHG0N] 9_+?/(-H^U.O/\U4"]>OQ(_CE
MIRMN(S686(RL9II;1%+RXFZN!K2(4>G7)]RY,^9-:4RRZ>?G]_5Z,_]2_UL]
M6VP^'2??BP]7DD5-%.CO#.L@2.J8VFI[1G&=[^$<Y"ZY,/5*0))-O/>S5/+U
M]N.BKC_/YK<G]-^7GZX,U=AXRV5PP&O 64[+=JZ8Z_S&0(/<)!<F7Q%,LNGW
MZW:SVJ%VG'#?/5;MNM!Z)Z@GW-# ,"'B<7:A1P6;02Z,"U.L'QC9I-IO[Z]O
MYW>PW;\N7@^U.?)TA2QC7CJPBB/7-&)*[2-;"2SRHVZ*5[4>@'!%,,D/P%G-
M%LEE<3-;G:#=CT]68%E):PVRV()<8 0,L-8HMD2B?!%9O$/B '3KC4<VS3[^
M]WR9O@H"^GV]6B<'T[]]O9_7RQ,4/#6N8C$$C:.63F%'B%/:MKJ5=<;EZYO%
MNQH.0,_"Z&13]S_FF]G#?+G^9;ZL@<76Z1C>?OZ\O[H]H<IT&5M1A5 T&E$!
M*Q(^-?=%[3J0=#:;RL4['@Y Y0$0RJ:T6<X?@,DZ&!@_/EEY[8US&(P>I)DR
MJ?F+:>>HG,QWLA?O7S@ %7OCT2]@U7UTID.,ZM-C5=0I%M[*R!DE4H: X:?V
M9&"J1[9'\7Z#0QR5O=#H3:L3%6^_>ZSB'H%IJCU5)#D4'"6V]3<YIO&4VO<-
M2*L\-/X\(:B(!\$\Y3:F"R"')0VM?NZP)Q-*\Q@\DFUX^,8/01VZ5-KAJO)9
MI;(QOW7I,-K#C#[4GYM5:B_V;&IO.X32=AE>>6LIYEJ$P*4SV&E#F592&R,-
MB;&3FCO0ZA_#FX\LQ'X]_+)[^Y?.;ZL4@ET6G/;,1!T#P2150=QA@[GT8UXL
M' V^+4OH5]O # 7<GS N%PGCI%$6<X,D"C0HHPX $6;<F*%ZF>U@!F"&L\)U
MST-PVH&;6'M0(KS DOE(TW&OXF$MU#CNIQEY4)A.1R,X\Q"Z;JI/*NQ@2L0N
M9/<.$JX+<D[X0)@/8"((A$DD_#!W9HD=-08[)QJP,_9GA.N>A\E4PW6%5C8*
MBI1/R8?<I4Y&[2HB&(33B5,8D++]@;ETN*X*.L9T/>^L59H21D6KC1AL8W[;
MZI'"=;/(6 :,L8[37^"(6<UGB^1G6-[,%TF[3";,JP3O-K"22FDDO/'""N($
MPT$^6D#6N7S2#U:KOQ_I!X%E+"9(7K#-,0-K_T %2# B),9(!@FV+:;2M[,7
MADTPQWU0:ST+E3^/.UH)+P/U5@H6!<'>V]#"ZK3JUN3X(H?X,-PR/(1CL=:[
MS_5JML?G!J;^MED?DQTO/%U1B@S71H#2$9'W\(-JST)G?<AGC:$5@V%8HS]$
MHYT4#VGY_SQ<UX"&.EO>SW]?U*=/D*,#*Z6U M 8IS(&0 T1;]O58M^CD\;0
MZL) )TM)M(:^J?KQ+F?PFZKMP\-L]?7=W<?Y_7)^!UKV<F-N=D6*@!+OF\7\
M9G[Y[YO%HOE'JOP<FY5;U;?S3=K8(]2![C:]J<!TDED.7)O^^'VVKO_/__K_
M4$L#!!0    ( !U"95%))28! TL! #5D$  5    <')G;RTR,#(P,#DR-E]L
M86(N>&ULW+WIDAM)=B7\?YXBOAZ33;59LLOW129IS-=63;-(&EFM;DW99VE@
M(I()52:"#2"Y]-./1P"!1&Y(]XCP0+1DI2XN67'//>[W^+V^_LO__G9S77PI
M5^M%M?S7W\$_@-\5Y?*BFB^6G_[U=W_^\$I],#_]]+O__6__XU_^OU>O_JK?
MORYL=7%[4RXWA5F5LTTY+[XN-E?%7^;E^K?B<E7=%'^I5K\MOLQ>O=K^1T7S
MB^O%\K=_KO_GXVQ=%M_6BW]>7UR5-[/7U<5LT]B^VFP^__.//W[]^O4/WSZN
MKO]0K3[]B # /^[_JV=_HO[=J_;'7M5_] JB5QC^X=MZ_KLB>+A<-[8CC+0_
M_NW1SW_%S4]#*>6/S=_N?W2]>.H'PV?ACW_]^?6'QL]7B^5Z,UM>E+_[M_]1
M%%LZ5M5U^;Z\+.I___G]3\^BDS_6/_'CLOQ4\_VN7"VJ^8?-;+5Y/?M87@<8
MS=>N5N7ETY^X7JWN?:%F2-8,058S]#]?^/#F^^?R7W^W7MQ\O@[T_-@#?P?
MF\=@<Z%K2'C3!>0Q5A]^<&"\OX30+8=%_/B3 V/>=C2WG.?HOP\_.S#V82%G
M[1G59G8]<,]X],EG,5_7/_4Z_&KW@_77C\AO8WPGJ@<?+K]MRN6\G#>B>>_3
MQ6+^K[\+OSJ_7;_Z-)M]/G>SU3(,6NO0"SY<S5:E^KC>K&87FW.$'4$<: R<
M%MQ9(3D2U%ELM,*,J?/F>^?E\M6?/[36FS^*_#Z%B@#./1#(AU]CY:B$$CH
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M64=YC*ZRAFF-:<AA%L^.UEE#LM=-0GU9JIO:[KF"@&M&F;7,:20@51;M!9M
MT5LNXTV-(XVV?1I]GY 5EV6_J?$$-KM(W\ ,#B-S 52Q175*-=M3$ZU<Z61.
M4:4Z>'%4D;JRDJ(^=9Y89_=J.?]P%>2O_K6I;CXNEN5\9YQ3SI'E3@-D(4+0
M4BMVQK6#7IYOJLWL.EZ%!C"95!ONT<4OU]?_2?&Q6JVJKT&*UD5UNUEO9LMY
M<J$X%,7Q"C4RN^F"=7904M9S< W*YK=G10OT9"+V,GLO:-J ]$]'XH9TZ@G%
M&YRS% $TMR'O"!8DPQ0CQ"5!EAJIA :[2^D4T!#M4ZYXG8O]<H<,*TW.=D"*
MQ7(>8)7S9;GND%E%$Q6O58,RU$.0=CC&EYN=X1<T)96FZ0A',O(GU*&;]_';
M#^_FR=X$QW;&K#&8  (1LTPHS(ASM#4FD=%I&Q$[F<@\_WTW",^;&+@.HE#L
ML!6?ZT+XR-::0:F,TXL16$R3COL3XV>%^W9Q?5MGB*V<%#_/-K>KQ>;8%J],
M^QN?HNKH3L=>W$Y#;_HZ\6CWXP"<Q*J0NFCFFT+G>5==+RY"CU$?0Q4XNP@&
M@50:8V$$$=ICS+3CBGIN#8-,L9<N-HJP !6$W'I!K?24"2Z LEP#@PAQ'O*,
MKS#<@2I:5,6O+:Z13P\\3]"1P!F U6D$SQ".5(/WN,0@NKZNOLZ"N[Y:V>KV
MX^;R]GH'8OV^O"@77^J=S.^KZ^O+:O5UMIJ?$T<YM!YAJ8 RD#!;S^LVL86X
M(2!EE$^W'FH9QD/F8@C!E'$K,39422)4;=N"S E "ZZX0W=6[+TH LK"K,KY
M8A/J]9 :_%I#+_P6>^*AJ PM$ZEZ)VV43F(X<'ODT<I46H]):+8FFHBRYO/O
MH>!F9G)8'3Y'P ,KK*;0&(1ILZ;6AKAF0)Q_+E>+:OYA,UM%;C",-$P0PD!H
MHH-M:IK42D&C 7:62\N2GHE]B#$ZVG7Y:;%<UIG/Q]EUC7F*$=P[;*.Y_D>*
MU7BG.@5H(F>Q4?EN57U9K$-1_X3Q<RY""J:$KD6 2.2<9*"-Q2 -4?=R1!FR
MC"/, 3?2*VH5"V,[L[X^M,X]<"KWI,<>6S.<7FR'T^LPG);K#MMO^E$:E\&,
MQN8 R<IA>N*^?2Z7Z[+XX7WY);33[/KWXPK<,=Z.R-H@=$]#S(9QI<K0';NG
M$_615+6<ORYG(?*;L/W+:K$IWUY>KL^-4Q*0>G5(&6.:A2*Q"SB,O>VR9R;:
MM#:<:1[J6"I"O".-I"8J_,YKS82)6U#MO8?F+A37Q=> ;1/^O+J\[%ZJ]6([
MO4#+SG WI;M7@36WYM2KU@W*XO5NZ&B UF2//-,;25]D'C=$ TQ#^P;WZD@F
M-QQK T]TE1?5E^: ^3D66!I/J "< T90/9?<!BLA("F]2S;N+37(*B0T)Y00
MI+D7WGACA"!<X-S37'=(BHM0^I8705RSS%XET#WHY%4>IG/.79T5.]#?IUCT
MWA':?]8JO6VFIY_#NM=MSJHKCW$75CZRMT<5.NZVW];=-D L%Y^6V]7=B^^_
MK&;+]?7V3L"Z4H<.*4@U$)XKQ8QI(]X2D'!S?W\L1 ,"*2*.4$RU1HHQ2 V4
M8=3!U+'<5ZFUD(K-':9B-O^OV_7FYM@>F].TRW$EGF*3Y!7FG1/%OA4/W)A8
MTZ7<RCFM)NQV>><H31EYS6=O/I\86L=NJ2E<&CJBM]5IXB'+TA$!-AA1=7'%
M:AS6$-QJ@^>,[):.W#)RMVZD66"<%DY#;2FIQ4DY+[#SP%KE.9%)TZWW$4:+
M@&O.(/SW7C.*I?D?*56.=ZK;FE$:9]&;8^LYC;MM.PP#!CC%R'A,*8>:AO#W
M AAA@&;^I2=3G_DJK<\S>8D<LYYR[(3B#CH(C<4:(Y_QH=0MD)/M.+O/P['M
MF=T(FT9\= 7_<#MF'PZBKT )JCRK=ZPUUDRU#H8@$0 ;:+00G"EK&05MGU?:
M)UU^_<3GE<2"8DB8HI8"&T928HA64G#M+;"Y7US>(RJN&WX3;T'I0%><1&1F
M*DTF[DAJT-2GU-9C7X3RB(\C<M&#O&E(1A\''MZ%TI>+^*%RO2Y+WYQ>+QMC
M![=9WHV@@$/"O0'8&FO"H"T :<,#*Z^2CI5$643><DJI0D1*RJ@6TCGH$?)4
M AOJZLP"LX/725X&HC0V*1F;S=1<I<87JOH=H3LI.@!YPCPF@KJCZ<V0U$]#
MP@;VZ5$R-#QCL4)W:/7]XM/5YNWEG]>E"H V:GM_RG:" 'C-0R) A?;""@H4
M"[G!+BY#6A#UY'FJ32B4!<P2ZH/C2!/-/?-"2XI]/3- ,HO=(98TJ1N,U#BQ
M.P6?:7+W0.8:D*^JRU<!9M'@/"NBV,XB>)'T'9&\H1M@&J(WN%=5WF[;7?C:
M.WEWNQS/@1# &TTU4SSDE H8;7=Q"1T523=E'K,#M;22><QHD':IG32*84 P
MQY BJ',_8]+"Z2YNR<2E"UI.SGJ)V/Z6[QVRTXG6 XHBA:HKL=,3I\Z>'!&D
M?NQ$;50X-->4LHQ89*TW@ELE$"6:[FL?&/XA,3<S/?UE:!&$5@.C, CHM6;,
M,>B=THQC0I-NY.A\ =-EA^*Q(U$1^P"R<M1+6([.1PW!3L)2>U:6NBV<I[ 5
MM_[]T,GG5K,[DS&!M>GNV*LAND-:;O;'JII_75Q?J^4\Z'!H_$6]IETGANOZ
M+L_K:GV[*O>%L:^[.W7*<RD\59AB105U%EL*)..Q^S/3C%H9$AIKE",A*U7.
MJ^ [ 8)S[)TU)J-:M#B;?>MW2+=UU+JXPWJR&:0D)H]D*WE:9!KY2R;?JC'Z
M=.+K(Q=7Y?SVNGQ[V:+YI?RVT8&,W\X5T@I#8R$'@4-3/T:)VM"%0B?-*AVS
MHXED &+KL. 46RD0459+ 6 PY63N=;D66E%=%BVXQ&=*^I 8IW]C\9>F=D]1
M5_SZ2[U+HJCQ%0W D07N"%5'Y&P(@J<A7H-X\O!%E,'8B2J^[LR%G&:Q*1N%
MG)>7S6]>+[Z4CP2SZ7-WF"RDFEN+H4,(A(Q;(D)V40<!45$["89!XI"P&FL&
M)5#U;GKAO314UC?PA&S,97_U\B!"MQ[L,I/6AU?7M1./4Y6$&B=_:T54C)-J
MJ(XJ^G;?1NI>&Q6OGVZC%*D]1;,EE+*3:KYNI>_+H39 ,\;5S'W9?*[&'JV5
M)E"3C^=K=8HX2"L3ZHLEEK>E#Q29:MD4)']9;*[,[7I3W92K?9&BF%20&UOO
MD!4:A4I?^$82#&9 F]AL-]8<#Z8L)\I1B*B35A.&L,*",DP H!DSWQW"HNXT
M18NQ^!I %BW*DU7XD>P=28:'YG\:B?'@7E5Y>VU:B#YILE:(/ZZJ];J]V%DQ
M:RCAU !!"!<J!"9M ]18RE)J^CB+()2\'#IIA&=4::()MX@PSR4 "L"TYR4Z
M),#[%P^*BS9,9PD9[L#TQNG?^,RFJ=_3@G?6[A;Y6)]L*H^=ESO))?!1K!Y1
MQ6%;91J:.+!/5<Y^G*:'/RTO@KGF$><ZE[^[#Y?4%^(B9:@F1G*/E?0">$TH
M5 BAV.=?GON\YA@H:(,!K*F!7DJI-=74*^69$!G?X=LB*O:03I9_/$/-D<CJ
M2^8T8JFW%]6P72PM7GX)/_WV<I?#N&^;<KFNBXS7BWHA$2E@(,"4"@(8$\8S
MU<9,O82=DC4<LV.D<M:SD!))3U&]D\,)0 $2  "OLJ\$[$"=%>]6U?RV3A3J
M)Y/*U9=%&,-^O<-:U& 3KV7N16^<)(W%;*=*J2^I693J"&-'U&H(GJ>A6(-X
M4@W?"[LH5[WCH5Z<>+O:=:X'MCFRTCB@G",B9!J>:8';((,$)!T'BK,HK(/-
MH0!" 5502 J\"VYZC2C4+FU?5X?+80*\C%+6F^\441N3ZM12J#_+&;7M!>)>
M5+FAB)^2W@WFTY/*-RQC:=7.+[-O3VW!\I(H;&$]SX2HU]QKLYV4L-0"8I,J
MGJ=-.,!"-BHL!MQ20*"TDEC)@K93Z@W/>'AE5_4$6%/87'6$HQ?+GW[,3B/
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MD)7%V( ^-E?XI@S8?IE]"P*TJ.;ASU?;E]NW_]X#D\XAX:2NE\V HE)#+';
MM"(HZ6++$>!DSINW:PH7]R)_L5M3N*YSYW].RWG':* X$9Y8VZ3I\HM+/<T9
MC5JTZWMG3J71_2D^(MLCMM\TE'Q,AZN3Q<HP>O]@F]\OJ]ER'5"$O#(,2\WO
MME6[FO_7[7I3#UM[-^J'[,-?;#:KQ<?;39.%5N]FS:WD5&-MN,/40<:@J2\$
MV/D@ "0F:0EF6L@SCR+MEMR+=DONYLZ18K;W)''^9%H4]AQVIM_N@X]0CS9J
M'SC=S)X<N%W<^7TXM)T5.^^+0_>+355L"9C&>)>E;3L,C:?M8],>14_,3>2
M.X46'*(6N[?MHYZ)K_]078:AY7UY<6^JOO9K]NU<,F>(X)(A0:2AF'/+6HB*
MB:1'BD8%EGM=XRK\KB[)BLMZI>)+LU(1M'%^MQGZ<C\'O;B;FCLKEEL1W<R^
M#5?!#=^L_6NYD[;HX&/F@\V 9X?+6&?%K':K>.C7=BP]TLZC%W^I;=*Q#,S6
M]-,>RO*ZGE :9N:_[T!DZS<TR[DNE^$7FW<A%-=IXR;7H:BU0@-D0DV+@.4,
M[,=-*-GYLOQ4;VGXI?_8E!UKE*K)K:H]<JO#</6Y6F]>K<K-8K5=7Z@UZG/M
M<="KZ\7LX^)ZL?D^_"B5O\W[C5C3:.?!1J\?ME[]?O?&W\Z[8N=>4?O7CEKU
M1&7="1Z-7H>5WY2KO+Y-UV&0&ZVW3'O &X^&R,%OY'89='7L""I,&8=$>F"Q
MUE)I885O47EG=<J=7[FQ)-5=Z=>$O;@NEJ? &J25!EP?&ZF!,BZ._6/,($:2
MWG>Y;(#FG/9(,;BW71;*!F,Y_AWP1X!:,.?"*&$<08 QR[#!G#J]LPB=QS)%
MT_O8R:S7YGFE3GWTNP>7<<H[%HUIJAJMIU/0T2,4'M'((8B?AOX-XLFCE[N'
M8B?J[KCF4?!UJ A?[V8#%N7Z=1G^L'RX-908$7)ES"&G@E!7SQIQ(S1BA%AH
MHNX02+,(-')2:B0<]I0"IP@22&K*)80&^J0'O3O,^>O9=;/!_,-5&<)NOYT\
MQ-_K>LM%L?6C*:8//$FXBVPXZH\+WNE83Y.^IPD]*[8P^]W[-AS7"1>]G83S
M;C>[#<=]W$UNL=0\,8SDH78"=[4-[U.5LS.F)<>-9M8OM#ZP!C'PE'#L,")<
M&\$U<&V\:4.3-GL]9\,CC 3E"'#,J'!*4XL@I%Y;+3FG./- LATNW+=ZWCWQ
M9K/.K,6EP&,0EC8&-(C.BAK3R0]N/</.D<RV+Y_3R&I[>U$-V\O2A&9[U*EL
MC+92]_WGV>9V%?[]$(&D7#M"#80$2RB1\JP-(Z,\3A&?%+N:2,$-09C;8-R%
MI)YR*AF''AH&6-KC"YT>HVLRVZTPM1C3E&E0FN/4ZE0,IRG8/7+/]ME4\YK=
M^F)V7?QG.5OM23^YR"60>D3X<C3--,0PBV=5_HZ=FIW5B>#;S^4JE W+3U%(
M)$?&,L4(P\AZPY2B:A?55)NTMZZZV#= . UP2%8%I?51!PGJ]\@90]1P*TQF
M$=V#W<GH'FY'0<W2!+%IX&G93TT1:[1GQ8,&N">UDY'7#M0>S2_S-=0TY#:K
MAX_RTMQL1LW ;F'\I5Q\NJKOY?D2X'S:C@6_E*N;NF*O7Q&I+U%[/]N4C^[B
M@Q [)@$RCCE+"&)*MA* 2-RMY / 4- A*(B&3$BJG)<! J[O K02&,ESW][:
MPBYVN'>:W"!O)K5:[$4#/F'B,'/K1,S<3J=ANNET8MOTF^?-W%P)D[_3:;9N
M,\(C-%_<5'$O(I^;/QZG=28PJ3R2H]7H/3]YA&VWR=^_H^SQ0S_"(PV]%5(H
M39D@KIU9I= 1ESB>QAFM+^8F'FMCL0@9/!70>@]HP%"O]LK<*YW;B+X[\_(
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M.'+2$1W<-S[WL+1?>5_5-]BMZQOL9I]697-O1V)M,@2W:3L81J*UXUZ&YD[
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MY=$L2*E]MCTE&098J-QDKX72(M.9(!Q&?[[#<3'Z;=_:JB$=$&C]/P[W4?8
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M^<;D#IN;E='"EP^C*(P+(K'"#&).<<$@E1T(AI37<X>!FXXL5:J\KO'^NK:
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MI%XO=PUH9CPM.F S\=Z@Z[6>/81/3SV*2V5O0?)D,:XF_<"1BRCU)W9BJC3
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M_F.2UE,*G/D**0M/>'A%(?JR-AVQZ&W!,[HQC T?"6FN'NC-4LWWY2Q5,%>
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M:J2-W!IBLK,8KY)=C3*ICC"]]W4'L>N\R3L6L?UV?!M./S6<-@"3]PZ<!MP
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MB_ENM7M_S1<+6S5MM;GY4*U7BX?F?X^-XQ28":3*499)A5*89CEA6"LD\K2
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MO9@=(.FQ&0ZFZYY,]Q/W9]AP5?@A1$Y0Y@>9<T[KA_/D?*QK;EI:S=<?2TO
M:FTG"OORMHLRE+$<$,45$225)(.:9FVC7$CI5+0C4%.1Q?YOANFZ<Y5+ST-9
M QET6\P8D3S/=8O#6L4!6%(C\Y:?0.>HSA)U[KQ4&(:GL>00RIBGYY]"<N2\
MP/OR0L;;U::L <R4$ CBW#XL126',N?HT'1:N)4."=I@["7<<TN$R6\69S,,
M?==K@Y#MN$ [-L]]E:TWQ7&67QUH.[?>&I+U::A=6).>KJB&Y\M5^?AN5^[-
MAQ<H2PF%$%!-30L04=5]..%9-OM6;K]4KNKF^*$^X^JT?>?A];FRK[ W:/PT
MRI46-Q6*P(>?SKQ"010-:=H\HQ*>K$Q#!WQ!5X-Z@M]8?G]7;N>-?BRJV_)M
M9:NK(<!QSHF9;A= *?,%ZS9>I% :^@WL/BU$'^4'4$F#*OG%XOJ3WX#OQ9W;
MZ(]-FI\4^+(511N>H>2,4 PA<!JJ,<B"*EQW\LP-;FTZ\J\Z#WE__6:S-_UH
M]65=MB+&\IR97"3#B!;:)",@5:)K%*J4>N8,PQJ+KC)'1$U"D9P"]DPN!O+J
MF'2,1ZAG,G("S!Y%><KLV'G*69[.Y2]A")Z&0H4RYFF^$Y*CUW1KM]W//MKW
M__CWU6XF&=*@ (B;+ L*H3G7FG!&"XD*G1'FLESC]XFQUV/LYLUNO[(E,OY:
MSNT%P.: E@7GN ;C2=%YI8G'CN<J2C]B7-3$F'BB).9?3U7D$0?/B$4_CBZK
M"3TQ5T-ZA><(;U>#<P(9-/,H6[919RI'(H?=IW,,<J\Q[OB9EQKEJKJ=KS:^
MX]R5*,>1'H&C0&/]-7K"CO87MWKZ,C61$>^+^NF8[V6URZC_ZVJSNKV_;3^_
MX!( !F5.LRQG2A54R^;S,Z#2U.F(D/^G1A[Y+1CW >[)R>M#/!X=?H.\Q1%F
M>]=I4#^R_(5AW8^=RP_LGKBKH?W"8W#/OY]\/N,,Y"A7J4H1(H1QJ8KN\Z4"
MW'EP>WUJ[,'=@/$8W'Z<. SN:'1X#NX&QYB#^]3REP9W+W8F,+C[X:Z&]@N/
M,[_OM_-U?;JXGO-7U_^QNOGZ<;6\*<5VOEEV!SNP8HK8"WL40,R T@P=&J::
M.*7R 9N++ <69-*<DZ]AVG4P"S2ID28-U.07M?US4IB/^>JXFQ&2[_.*<B&J
M/?<ZG%CN<5HX$,4>YX7'I[K?B>% E+L=&W8BY1G!C\#H!(X.!S:HBM;[/&*'
MF52NMG]95U_FZ_^HUK;T_>[M6]FV!S1C%"FEA2KR(H.*,=2V!R$ [A=%!K42
M.5+4V)(&7-*ANTH,/@^]&D:C0R08C4&_ / R>7U4?QB+'F(_&IO]-'X(JV["
M?HZ E_0\"&D3D/$P=E2ANY.':*O5;K]=?;FO[Y9LEF]7BW*S*_G-MFQ*=YCO
M?;J_NUL_'+_5@C%DL2QGI""95AIQIEG:@9&(.DW](T.(+/>GP.LZLBWTY BT
M_G:#_N2['CH6T3\.H6(:KO&+([V]TB?,1'2/1PR:AIOZ!:B([G*+7[W)>RFX
MQ??&!"+?"$96H_9PSY*C][M]=5MN/Y9K>T7PZ6&9[HZFRCG,-0)Y023'.<22
MM6VG!*30J_9HD!8C1\0.9+*U*&T![*^KNV;\+D_'^:;<_UYM_^%YT#\0Z>?C
MWN7X]@MS';Y?6X _'LV[T(U+)^+.'-4+2_PT3NP%MNEI(=,(C#E-'CYOY\OR
M=FX&<OW5N_EM:97XT4(3TRE%5&4(%# ULY<" =XU*Y!;;;U@C466OR/$JV1O
MOTXV%N55+8!?:J >N640=AV2_+&)]=.Y4T[KKY-W1T[[[PH$(=<C11^;Y'[)
M>!"RW=)N!T)>2K!#<CF!5#JH.56D/N>7'K_9+,OKU6:U+]^NOOT8D<3#7^=_
MK[9R/=_MZI.GBC"%$$F1UAS1(L.*D Y%AJE779'0;4>.&4>XOZXMWN?R.(]#
MX]$\X)8U7Y)\O[@RG/<HV;,G@6?RZ%BNF$9&'<VZ:IP.'51/CQBLQC>GJV<2
M$XJT*!2C%$J*,IYUFP4IY,QI?3YF^Q?7U:NDQIW4P.M$Q_/@?E3O!-';Z(X)
MK;E]?'()'7Z.V/Y:/,A-/X4>#[/03Y,#L.FNRQ^VU:+<[3Z6N]+\T5?[_%_Y
MK5Q7=W;RU:V\%" M &(< TTX@5K0+L=& .:>2ARBQ>C:^^M=@S+9MC";-> C
M4%^%#<*SJZ:.3;&OBB8MP.3C*;LG&"^T].O$W%F9#,G\5(0QJ$T_2&%XQES%
M[\/\H=YH^US5#Z!N2W&_6VT,EG+WEZVM= $EY((I /(<*9/\LBSM<N&,0:3\
MBDX,;LYG1/8J.R'GNZ_URWNK95WVXTRMB2C#[S6&SHR\8.1.8]"%,Z>*U D]
MW_9M6Y'5[9=54PA85O5#2P:,/.UQ=0HTXR3/E1WM4!58%J0@(NM0I"GS>M H
M=-N1<X\/V_*N<5+[#N9^.U_L'P_+Y-I,,<SW-\TKS?-ULBNWWU8+WP?8@[O%
M+4&YI$?\4I4.:7("]2HY@DT>H;UJ)H$C/Q?L1^89#8WEEFE(:C3KGKXD')5%
M7\$]>=K]0[FU[U'.;\KWU_]9-46]C#Z5N_VNC07+&<50%TJ"G.D<D@SD*6WO
MTF=80^%T,2XRA,CR^_Y^O[./<]JB=:6!M'](5BW&9-YB3'ZY:PSQK/L7RRE^
MJGM!?_04WQ/$5\D1LXV/#>KD #OI<%]&A/VX==#B2,Z:EB3',O(%98[*J=.Y
MHV=BA)CORD?1X;--[Z[+K86098 C3@$NB,X19QQ@VD&@&$FWB6B4IJ-/2INZ
MRE\,1L>IZ0AT.QQ*NB3/(7)<"_9Q=IN<P+TD^1Z'EB[IA'X'F((ZP^T@DR=)
M+QUJBL7U! XX13.M&J&O!EL3?5?NWU_;)<)#9&0Y,=,6!&$F<PR1T@2##@+1
M#/O,%H(V''F.\.,Z:?*KO1)0+]C8G\U?2T)'X-YM4G QVOUB5 <SV5==AI\<
MD5XE[QKR:\=<9@;@0V2_=>S^_IA&MA_'-/?U[:'\#5CK_K"M"OO(RLE;*Q_+
M;^7FWDP[6C3EIY5A\61JHN9[\\_]_7P]8U#1PD1MED*BH<XSC;KM+XS3M->J
MS'CH(HNQ'?J[^;K<)3N+L='>!N3@Q?#8?NN]7#XAEX68;!ASDMJ>TR>IKI+6
M)*OLG5&MDT_,2JQ=5TECV<67WH<YQF]Q?J1.,(WH<4'[7U_@']438>.0GF\W
MMDC'^ZU]W,,);DZS7$@-@*0<JTPBF![")D8(A ]'$4".$)56S9LWHX2E&&X,
M&9TN[,&(0:JSS$A@8FW[R:.5OZ,&!ZV(?>-GBETQ:>@5PJ+[95@D^V::MV=?
M3A"_V1A \S5?+*K[S>'9JKMU:0 N_WZ_V]NYX9N-B<RF.SS,<JDDR9G!2J4D
M*8 Y[<XZ801D@'E5?(S13T*W0))%9;=7=_OR[JY<)O=W=BGF)*@E2],+DNOY
M:IM\FZ_ORQ!!;@0/#XEQTW)NH!#7&?4XR+5V)4?#DJ-E)IP=;+._VEHWA>@V
MV$7>P6V\3C'EV#8B"TZA;6RO#(AL)X&UK8<BK?+.(,Z!5D@@Q3%5&=00=  (
M%GDZ,%CU;39R_/E+N2EME>?ZL.M\44>:.A(-CB^]>>X=,L:@.$04.)VN=,69
MY%G.QU+T%QCT$^FA;IBL[@XV['4I#</=I?+^[IKE;H893XD@&#*(=$J Y**K
M)44*$6():PR4D;7W],FSNW*[JI;)_(#3IO^K(];+IOL>CKU,PA_'I]-)^5_O
M!S]%TG\P8\2TW[]K3#8 C<U#Y-2_KV=<P]M?JFKY^VJ]_F &[-?YKCSB.:+8
MS5+*N29(TBS/24H0UJ [YT4XY]#O$FJ8-J,?^GTU]-RT=OC%G4",N\60\:GV
MBP<=/A,#6H2G6G^"<5Q-=Z+MC#Z'I7T:6AO8IBIF1QV<XG\L%]7-9O6O<OEF
M:5I>7:_FA](HW=$M;DMHS[^LUD;(RYWYV?VM^6;S*U]V]8W9F<1YH=),2EZ@
M7/ \I:2KF$*R3!4#<_RQ8$9.\O5NO[JMI_C'M7N[A3EO2L@=KKS9 AWKHRWV
MY]:8?Q^<^(_F[MZ9_Q0]'2+U/]J5G!K650_DIZX_,2YIK;LZEAEL+1RY6DL\
M5_FE_V/WCVG$I"D0\?H$X#*^N43TJT\V;Y;:_(H1\3ID8TD@PXC82R((<ZDP
MPAUH)I57W:X+0QWC1H?5N?KZ1GD$=KGPUL>?XX>XR*Z<1)@[= [MT"\F'^E^
M]-A(T6Y 5_GC1;PA9$2,>H-]=)'(=[_=FC]H?M-\2FFPU\MV*:&ZH!(K#(M<
M"UO5N#N-1AF!]&+QKR_@R%&PG?C;HI<=I@O&O]Y>O4 4',.ATXB%C:6':L<G
MQO[$(?$%]XT5&(?VGC]@>!Q,2<P@&<9?EPB5)^?9-&,HIXBIG '$"82HV]*B
M@I*+Q49WA".=?%X%.-PPAK_&CWIQ7#6),#>=0\S#O3-2%//O#7^\L-6#@XAQ
MJJ]'+CZ'JTO@KI;Z^UW]2.YF^7[_M=PV/YMABG@!<8I2J2@6F<H+U=F2">CU
MU-8T+8@<V%IL2=F :UZWK2R^9-%F]\WFWT3F?L-ZPX4G@Z-UA$F$S:>SPZZK
MM>;7?U@3T/[&SQM=G9U\B3EDD$[WQXO.$3@::Y89T*.7B.X?MM5=N=T_?# B
MM&_7E^OW/68B*P1F& A48( 9P5(5A\P$9.I2T;P_XNC1NP%VE=Q9:+6DEAVX
M*UN%[G)A>X";QP_3XWAX$F'YV&=J8Z\.FYGG7[*:?!!^T84C!=WA7>B/%V0#
M<!(QJ(;R6-\JWV> =[CG1]P/+>KW=W69T<W-VW*^*S^N;K[NJ^O[76OPK,@5
MDUHHAA4 7$.%N>B@ _,OEQ@Z*<"10^@!7;*V\+QFNY/BJ6<=\LG[-'K0?#YF
M/APCYK&+U-8FM;F_5M>_WN_*U^:N$^XOPTJG3[[?A"RY?KG^T[MJ>PS_/)-)
M3;)[3+-*_&4I>:6Z_ 3\Y7M3TF1I.<&XH(0I32@&5+/N&#8C*,7]+D.^^K'1
M[SO^Y;7KC%&OVCG<IG.F:!HS&G_8+]R)\[3[,F<ZCA>5(10:H;0H2$%9GN8T
M)]TLANEB<$6[43!&SOY5^_3ZKVO[]OI)#8N+[WIY.?(2QSWB^' 22V1%TR?>
MUGUB2O4L0KAKM!,@_AUD&N'BXBQ$/072URN7"6;+5I_KH7@$W^:7.L7& J*9
MYB++=":4.(1CE(,+!KAAN*,?9ER^%/8N&O &.OL207 \/T\B,)[TG*?!\:<_
MQ/&*,T<+FV&ZU!\QE 9B)FIX#>F]R\X?FU^NCY9\_CK?'.; 4*K49 J9! AG
M4N@,2=W9H*CP>N=O6L@CA]WF[=I)3C%[^_J2$\\QW#R1J/LDR%ZUYR;WQNSD
M,JN%H[IT]"GKT*[U1XR^P;@997H;QH.7B, UYG?&PZ='/F<R%3DB&<\)X41P
M#3CJME*8%/)B]<OZH8U]IJ-6QTVU^74J=QAZ.G7\\!K?GY,(J4T/.=KYT\]>
MG_7;2'%S6)_YX\7*@7Q$C(\A/'6Y8IZS5&. 88X)A2JEE*(B/:Q8(V/$;&^G
M6.,'04=X7E'O8(GG_/+2D<[55>.'M@A>FD0L^]E#UZBQRK,3_/&"DR\!T:MJ
M>OKB@O?13W_0%L?Z,'^PGS$S<TB5:X&))$4J"56,=S;D"N>7OH<^ 'GDJ=JA
MRMA=@^?BU\R'.'G\F#:N?R<1[KIKY2<_O$H.W>C#*]UH\M'P58^.>X<\0,_Z
MX\70@-S$OS,>S(,1KKD=#)B[&=!<=%\LMO?EZ>_/<BQTGE% !:4 <8&S0ZTU
M8PAU>@YSPO!'62Z=-[A.WW6(=JMI-+^?C\@31O['",MM>9>V9[W](_6L:+?G
MIMC#1KM+-V)/BW&S+I#OPMRS&[LC_72W[D8GJ/\=O,OX<@(9GTE5C?>-K"S;
M)X8_S[_7=D!82"$YU)+)0F" 9&M'_;\32?AZHH^<[[6H:H7=MD]Z[RVPR43E
MOEZ_>+HW@L.GF^V=]JONJ?C/?XA^-9ED;X3^-?U<S[^?32'7>]YUETGU!G:C
M/WRF-Y2?\1*]()Z<0)[7YJKR?K>O;LOMAVUULYW?[F8@5RE/,ZI3242J,UO2
MLC.$I]CI98()PX^_NU;/AQ<MKN2N!3:9B-S;[Q=/]<9P^71SO:YG=>8G'_XP
M/6LRR=X8/6SZV9Y_3YM"MO>"[RZ3[@WM2'_X?&\P0>,E?&%\>8E35*J\+HTU
M-D,]79(DF/,L+V"FD4:I4%B![CD2GF5<7^KH5$^XD3.Z#E6RVBR,_WW6[29$
MT@5.2HW@SDED:X<.8@SMLP\VO1-1SWMNI&-0 [O-'^_LTU!"(AYX"N*K2T3&
MXXV<IUMXLQP)Q1%A.048RT(B< SK.L_XI:+C ,BC7_[T/M$T,<(N$"U'<N\D
M(N;)+= ?CY3\O&'S91>.%#H#]*$_7O@,04K$$!K,9Y<(HZ=!'W-!$=>%@D(!
MDDE9'(H;<JAU>JFKHCX81[DO.HG@Z.6Y\:-A+*=-(OS](>:(XT\,^_2)/UXX
MZ\5"Q/C5WRN1 U97@.CYJ%ON9QQ 12DV(36#L-"*4]$5)A($,CY"P!J,,7+
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M@[F0"M@<.49<Z;S0'*!4IW;76I!FO&I<4.)U2\FY44(EST$&:(HR#!!F5*=
M BQS :@F>7S]\[R=%([.</(7G,EHZC?^'217_@9JGY<+?A[I\S.KA_+UX,WI
MCM&S;3]_4)P+S#$#(@>T8#1'BA24$0@QYAF'F=.A1-\VBPP4::$+"E*-.9,<
M4EM%4#&&-%+([Z#V2'>*0E)Z7OLNR68,Z>M_<R@DYQXWAB[$?;^;0F%]X'8_
MR)V@9^)*+(HG<!\HAE55W(X9-IN> 86QR=DY@$P)H6%>$-JN]65",^)S[^?5
MQ@K-<LDT0JE0.-,Z3S6E+)-<4 9UYG?FZ1+W?8;3&2:+#LIDJ!!R>H1I6DGS
M@&39F>F?(TEV-\<S.?;D:9!^O7B"'5&),DJS0FHS<\T4E:"KK)$1B+T*2_NU
M# LLBB(S4V9 ,00I)]S,!3 F,,.2X]@)\I![.H$I'B!PH[ ;2NVF<AO'BTE?
M(1SLD0FKXG#;7"0R$(.#]')&9(',8$691%1#E&&<ZV[0YD2IV;=R^Z4:I(RS
M-*, T@P 9>V1.<^I9M2DL@4KI.?$ZA2.\U -?>.F)Y4#]"\HAV%T;@):YJM9
MSBQ.6)O<;7#1($]&'(LBO7Y$73.0T0+BO,A3!5*%:-[E"I@3ICRJ(#DT1K#$
M4.DLS8!=0\JM8<2H;)Z;61@ET3,P*S8G& _SH5V_FS3A6'98O!R;8#]QFC"W
M7F6-QN6X;QVCX5R[UBSJ<\LH.)436(4,:DX5J<OUC0T_'K>O'EUM(5IE*5$Y
ME#)GF3*9,.I&&(8(NJP_>C<*;1045.!49%A ()0B*$59#C3A%-+(ZY#N=X;"
MT^D;#$9DLD=0>&[]<=?C5E!DTOM&B1')'Q M0CFA1]@X3Y!3^ C$\=3"2"BS
M7@PG07D;$%;:@QGO-^6,4,H)*2CD/).0YUFN>3<.%51B8"PY:2G/F"H*0$W<
M+## F4@1(9B!@@,SU^)^1:I[!1#'"U*!B.L=-2)Q%BY4V)3VU4M/,2@='!,B
M41L^$#A1/$3\CTSX*7X/!B<K\WUL>5W;>S,T7-#M'0LA8,:DC1<,F!2+YMSN
MH4.,<P(DA"R,H-N68,I(2IF$,@<F9&'.A9D-"8@H8*ED?JM'O03=\2Y7(.*&
M"GIHSB((^KD;6S$H#27HH:F-*.@>E^+Z"/KSU]O",CAU0?>RQ5G0_1D*(.CU
MI9%"9SHCU R:3!52ZH)*TQ9,!24YIA0'DO2Z+2ISI0GB6G&-H9(YPDPP0F".
M19Y2OS(&O43=\;):,/(&RWIPWF((^]DK:7&(#2;NP0F.*>\^=_]Z"?P+M_A"
M\SAYD?>SQEWF>[ T7.CKX\SV9C0HA)GRYB+GF9GVRJ(>40R*'$$41N?KILS'
M\0Q(QJF F. \%SQEF<@HH0 ).<)JOM]3-X.I&ZKRP5F+(/+>3]8,9C64Q =G
M-Z+"!WEZQO^F8F 2IR[O?L8XJWL/CH:)^Y,':S"&:2:I@CDA"F"2'IXQ)(H7
MZ7"%?]*>%)AQ*0'%*39I&LL58@AB2C+SOS+VFGO/=\W"4#E$\>.Q&%;VA[Q7
M%H;E$!$@'MMQPD#H=\A<:/&."/U(G7)8Z&F14VP8PM:P #'+"\52J91I+RN@
MS@ LNLIA1 KH=)OPE28R"?.":66WE\V EAQ)+8C""'&2 ^17@6/,.X1#J1L2
M X*R%E3VQ^$NA+('Y3"*F,<2;V^]=J9JRA+M;H23*GMRTD.(7[QJ5&"5IT5:
MY-R,DAQG5*/#\,ASJ'JJ\HOMI1SEQ$Q$[,OUF$'.60$PHQ2+3*0PEY$ENL]E
MR*!T>BOU*$P.E>T>%Q[C4=Q;T$>A.I2Z#[]CZB3U'K=%8S ZN2 PW**7(T(@
MMGK=T9J9C!_D" DI.2%"HHP?'E<DE &G1WZ?_^0\!3('!*<D8YA@PF#!TTRG
M%&9,RS3V2[ZA[G[VI,U7\$,SUD/:3Z_X1.5FP VIH!P%N@X5^-*3D\3Z4#$U
M,?7"?N[NDB<#KA?F/YD.4=I^\7G^95W.*%0%H':1,*>2@4+0'!+.").0499[
MO?CK^=%>$NE_0?6 )OFMQN/YH)LO3^<E<02*_#31G9TH%]\?\_",* PD;!I7
MW?N"KX)T&C==V&WW,WE_>[\V<>);J:^OR\7^0[E=5<OWUWQ9W=GHP;^O=K,"
M<$41ARE."YKG0E(DVF9S,U]Q*C\<K+'(VG'$F#0@KY(&IDVU.J#);Q:JHZR$
MH_F\T%R$83_I"4*NBRH9+DX4R?SKJ1JYDO6,/@7G^;**%=Z<*E)_#*=JJK+W
M^&:$2*A4:AK&1E0! DSQKF'.*0NE:X[-34/9&K !M<V5[.'J%H'G*/KV&L6C
M*5P#I*?&>;(]?97S-<A#YWIQ%21_6_[]?K>W&>1?R]LOY=9,+:D2'&-L;_3
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M%M5MV;;/F9(9D:E( 2L@*33'!^$"2.4^@A*NU=B+34>@28TT>00U:;#Z"4]
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M)K\2$$P$PU[/=R4'5<J*EQIB:84ERFK&@8250-215A*.)]NW?O6$*/OL,EV
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MX0BH)CIW6.*JC/KP+!Z%Y]?1X?$[+XZ@[+7SXYSLS^ \.:M[S41?<5CZ_03
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M+7E;"B"TU99@)F';1\P:7FEB."J#CG%"[%I-L7.8<*P@@:3D @) E<:08DM
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M5$H(P3FN*$'8&:%26L4!9R4 )G<)X^/1N!^$+<*BASA&ZF+(C5"YS+R.$;A
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MCE_(9J,WW=KVHNA!=M=X',JBA7G^%>\+U 4N@L>0/P^Q2^Z5QU)Y/&NC=N4
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MZJ%:%]MVA:9O/\A22'R(,A;2""?<!,BP!8U#2CV%96J+K3I?NNZQO@$M6G"
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M)DFUFG?-+<OZIC52@IVZE85L2-C4F#F?ES^-&OD%8QJ??:GRX "O/N.;M\_
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ME_;V'J2BZDT(DAI P1TWH5-IAP03-5[4>/K7B',4JXKSZ>9Q..J6QYN#I*L
M_*KUQ7098/PMG^WAZ=YR"8(>(<VA8F$Y"K&R!*-:5H0YN"P>]L2+HCL-],6V
M%TVUQ5V:3_>P;.OS"0362<8]83Z8")8;R,Q:-H:)LI?%KI;T7+2/;%^L>=*5
MZA.H84Q_=L!R=?+_M^SN2U8VLT.:U)1P1 2!F GGF&0:!+N1UG@$:Q)?%M,B
M.5'TB?49N/>Y3*>SU=EF-?Z/Q2HHZQC*[:D@H8J9 "^%#$OH''%AG5)++PF
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M>]UR#,2%'4?O7+]%1\"?3!DUS>_2R3^R=#*_W<^3UT\FRFN(*"/88X059A1
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M=-<,1ET]B(X/LOBKYYQ+LWWUG-U7Y/YSEETO)N_SZWU;4$V*)V%Z=5X0H*$
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M?RTQIWU@>YN8&E+GN2S>8E&%F#-!M=$80HYH+8LU."9;V_&I!3J/U6]KZHF
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M&*,']VUTFP81/J;S[&-VEZ6S1;F\&P#NX5?C.A*.J@ODM-2  HL)=F1]XW+
M@-NHS=(A)5GJD&==8=WVK/GHZU;C\9'VU:O2B6 :2T!\D,13'/X'R486[%E4
M<J[OSLW<$LK=,6:S2JCVYHK%_*K,_F,Q#K/SR2S:66,B+4:6NV!A6L%$Z#$6
MU+:E=,Y&Y2S^#ES4O2'?-MO6EP8<:[K7Q1*AG!;8" ]TZ"F$.T)0W7H/X](%
M?J^>ZY/AC=[S^ES=>!N6 :-1=C_?/5OM>#Q10B*"A,42*>(9-PS7I]\"N44,
M&8:4J:GK?:XX6-L>(7Y+9P'*P^?;&Q9/F"" <^H-=40ZQ'  9"V-"F#%Q#0/
M*2]3SR-&),Q=D^;W*F70S6DQ\WOK2@0QFFEOD*!> @F86U^O%>2TS,8LI8:4
MR.G,=(K!O'5'Y-*%?EV4[\(P>3?-K_/5Y31%N32W9L>:QP?K2Q $V,G0/L*L
M=1X2Q,)*@%=)%A5B(BI9V/?JVFX?][9Y]C&;I_GD>+?VIERB$ 7*!!M.0$8I
MIRX8;1*+L*Q$4!,3-=5]O\[K4_%]Y,???GD%;6CJ'\NOMGZSKN<56O>KBT9^
M'A5W*Y!-=<_Q57J3/7]U]FU>V73C'UL_C[U\H?HRFY?I:+Z%J*^>21QAGGG-
MPHC-7; >-4+ (&04H%7$5*,8DE::;HO1HG+151D)=[3\Z2.)%@#3,.^$*4;!
M*FQ'>+MNN*6,7D@VM0B%%:T UU'B@+I%_]\B+0-ZDX>/V7U1[J+LCJ<3[+2D
M7&#I !.:5LF<UJ(PX"RV,>Z&2^5 '(8=T^$J*_-B[*9CF\X/C0+/GDV0A=("
M02"V4FFA! IFZ5H,#D!,4.V ;+)VJ1"#8,=$^%RFT]DR 4&C@>'EXXE0G&')
M:5B:* *L8AYMA&$ Q=!A0*96R[-#'(B=IIBI+I;<&<.V[;&$$FFD#(.9=9!9
M2*U&N&X\0#XF.'9 >_?M," 2O$XU_S&[R2O1IO/?T[M=<\*V1Q,"A*<"5I.:
M]LXI)J%9"P&IB;J*9D"[ZFTR( K 3EGP;CHJRC H+16QS$ACBL5T7CY4T=I[
M2;&W9(+#"">P I9XP9$6VH&-B-ZJF*PN ]I!;Y,C;>+9*674>!P4,UO_J)P/
MVZ)U]CZ?H"" 1U9(#B63!A*TF0$ADRKF(-^ ML';I$<\BCV3 AU)"I1X@Y2@
M"%J'5'6GGPYV<BV.4"C&_SN@/>YN27$LBGV0PH1?/Y2?BS^G32CQ^'024 C$
M]A@!RF!H.@XKYUH4;MFEI ;K@!$G@]@+'U;S6B,RK!Y-N.48.T>IXP8RQ:FJ
M]L660E1IHZ*2!%R<5[(%!/N@P54QFZ>3_Y??'S0UMQ5(PN+9:6VH8YPBQ@,^
MON9U& !M5%:2BW-2MH9C1\18L[1:)Q6[9HEGSR3 8V>!(HH!)CB5UM!Z)1TF
M/10323FD1%CMJ#\&NJXT7O&QS-(]G?_I(PF@CAKC:+!KE092,")EW6@!XL[N
M7YSG,0*YCM3]/BAD<G5;3/=[&U\^EB &# OPL3!U:2 $M +4C2=01JG]XMR-
MD>AUI/I/V6A1!D)"].5S/M^: W';8XDAVBTS PC &(' .0+7C<>,X:AD/Q?G
M9XQ$KR/5?R[3<3Z]^?1P]Z68[-#[LV<2""TSQ'@)F#+20&U4/3=AQ.+Z^\4Y
M#F.@Z[BSUR?%]NPM;'LTD99SKB2UOIJR)'""U),5MI;%W(@RI!Q.[7;Z" 0[
M7>BMSS^O=CTKH@:=+/9?8K&]2$*4X0QY*XC0T'.(C1>U4(29J+G@0GV#K2#9
M+3U"\\IT4L6E?OO?V7Y_T(MGPV#G-,.&><I!&.UT&. V@YU"(,8U.*043:T2
M(@K"CG<A X1!NOQK9M-YNJ;N@>W';4423##WG"HL/"!$(XW$QNSA2EU*?J9V
M-QY;0+(K+\&J,3Z?A97-_\W2<G\(VZ['$Z$T)1 BR<-:R$K*I>9K80A'+"KC
MQ,4Y"UM"L?.XI=*$1MT4!W82GCV90(N-!IY++I6R#$M(T5H$&8;!&/MR2.F3
MV@Y?.A7 3CGPZ2Z=3/1BED^SV7ZK\MF3"=8>>D\(9$'XL$ZRR-4>;\D0C#J$
M?W&NQ'@ .^6 N\O*ZC[97\OBS_GM[I./!THDQE* 7)CC='6<4TC"31VM+:WQ
M4?;DQ?D9VP.RV_'A-IM,FE#BZ8.)P@0*IA!DG&ME$-:T7C\K+D14@KV+<SM&
MX]?M K.XNZMBZ8K1'Y]N QK_/WO?VMTVCJ3]C^;%K7#YB&M/=M-)3I+>F?W$
MH[;I1-.VF-$ET]E?_P*2*#N.)5$"25%,[V9[$YL@@:H'A:I"719O5\O%<C)+
M3K/#UN:!@04W7E#K&+*>*6Z(0*8.L-$4X1Q?Q)"J [5J>K9'SX[S(QZ5WA!_
MLD^KV/-T =Q($[BV5BE/4ZB-JN];=*1=5N'HT7DOVR%B+WC8)/0T1\23YPLL
M@4NOD,)2<2RL] 'JY0"B.3W?AE2ZIPM,G$_&CE"AX]QNU_.[G^P[0;Y[)MW
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M(:?$C:7"3<<8V(>T;'I?R,E]UNGP>CHK7RW+AT9G<QO?*8@AQKG4F00"BV)
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M2IUAF 4#TH!BUD@>#PH3#X>X$4<:2Y(%J0XZ[9W#C,MFT6W\M^=DT.U&%H1
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M8 JT$K5>$;C)BMD\N63(J#2Z5NC=VSFYF^>/&^"15O>)5B>=GQFO+;!.(8>
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MHJ&FBR)9\8$#Q&"'N,E!Z%F\.-L#]M^3_WN8SB>O7]N]2<(O/E=P:3C3-MB
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MKP(?Q\&^YPL$0#PR\<]:2=8T:CV[DPOR7+*C]\FV1-7+7.&\;E#S=\^(0J+
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M/NW12OLSO7W)$0,$SR.9 R ,.&8Q)9 Y<HA1]M%+,W35)F-17Z!/J8C^06;
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M!SI>&0W?4[*L\Z%*^\E*2B:KC#$GU/5642L9%UH$&1&ETGWN=9CA8<H8=&G
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M     &-H87)T+3<Q-#$Y.61B.68V.#4T.65A8F(N:G!G4$L! A0#%     @
M'4)E460$];B!30  F%H  !T              ( !?68  &-H87)T+3@P.#8U
M.&8W9F4T834P9&,Y,68N:G!G4$L! A0#%     @ '4)E4;?"WOG8:   AV\
M !T              ( !.;0  &-H87)T+3@U-#8Y8S,P93-C8S5F-SAA,S N
M:G!G4$L! A0#%     @ '4)E460%FJ8I:   Y&X  !T              ( !
M3!T! &-H87)T+3EC,SDR8V8V-V,T.34T8S1A8C$N:G!G4$L! A0#%     @
M'4)E43M.+<-M:   M6X  !T              ( !L(4! &-H87)T+6$R-C1A
M-C(V8S,S,34S835A8F(N:G!G4$L! A0#%     @ '4)E43?7;</<2P  !5D
M !T              ( !6.X! &-H87)T+6$W9CDW-#EE,V0R-#4Y,3EA,V$N
M:G!G4$L! A0#%     @ '4)E42BK*9CL20  3U<  !T              ( !
M;SH" &-H87)T+6(S,V8V,#,W930V-35B865B-C N:G!G4$L! A0#%     @
M'4)E4;/!>*2C1@  Y50  !T              ( !EH0" &-H87)T+60U,C@U
M,38Y93)E-34U.3-A-68N:G!G4$L! A0#%     @ '4)E4>60'GK_5   BE\
M !T              ( !=,L" &-H87)T+60Y,S(P83 X9C R.34P-F5B,6(N
M:G!G4$L! A0#%     @ '4)E4>#$3A"[,   V#D  !T              ( !
MKB # &-H87)T+61B8C Q83<Y-#0T9C5C9#$Y.#8N:G!G4$L! A0#%     @
M'4)E47\7[2GT:P, DH\P  T              ( !I%$# &-Y,C!Q,S$P<2YH
M=&U02P$"% ,4    "  =0F51=H*REMT'   1+P  $@              @ '#
MO08 8WDR,'$S,3!Q97@S,3$N:'1M4$L! A0#%     @ '4)E46\2\:K-!P
MPRX  !(              ( !T,4& &-Y,C!Q,S$P<65X,S$R+FAT;5!+ 0(4
M Q0    ( !U"95&(Z9(-UP4  %L\   1              "  <W-!@!C>3(P
M<3,Q,'%E>#,R+FAT;5!+ 0(4 Q0    ( !U"95'\/%FYWAP  "50 0 1
M          "  =/3!@!P<F=O+3(P,C P.3(V+GAS9%!+ 0(4 Q0    ( !U"
M95$L9^>U]C   %,X @ 5              "  >#P!@!P<F=O+3(P,C P.3(V
M7V-A;"YX;6Q02P$"% ,4    "  =0F511[NN3VB,  !'K@8 %0
M    @ $)(@< <')G;RTR,#(P,#DR-E]D968N>&UL4$L! A0#%     @ '4)E
M44DE)@$#2P$ -600 !4              ( !I*X' '!R9V\M,C R,# Y,C9?
M;&%B+GAM;%!+ 0(4 Q0    ( !U"95&F+U5L[\8  "+2"0 5
M  "  =KY" !P<F=O+3(P,C P.3(V7W!R92YX;6Q02P4&     !, $P S!0
&_, )

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
